data_1cz5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cz5 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 7.6 p30 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.506 0.67 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -154.12 -169.98 19.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.475 ' CG2' HD12 ' A' ' 33' ' ' LEU . 48.1 pt -131.2 159.92 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.05 -1.265 . . . . 0.0 110.195 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.56 115.98 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.01 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.595 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.2 pt? -141.1 -175.13 4.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.672 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 3.7 ptt-85 -109.6 133.71 52.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.763 -1.211 . . . . 0.0 110.844 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.576 ' CG1' ' O ' ' A' ' 80' ' ' SER . 12.6 p -61.84 129.75 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 110.544 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -110.36 159.66 17.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.337 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.532 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.1 tt0 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.138 -0.976 . . . . 0.0 110.689 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 69.0 mtt85 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.015 0.436 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 84.4 t -110.39 119.9 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.972 -1.08 . . . . 0.0 109.948 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 3.0 ptt180 -93.09 118.12 30.85 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.491 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD22 ' CB ' ' A' ' 30' ' ' SER . 2.7 mt -136.58 -179.27 5.59 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.728 -0.607 . . . . 0.0 109.958 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 1.4 p-10 -103.06 176.24 5.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.697 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 79.6 mt-10 -59.78 -44.48 93.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.344 -0.847 . . . . 0.0 109.25 -174.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.545 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 72.1 m -68.41 -43.32 77.46 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.014 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.542 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.1 m -60.09 -40.02 88.17 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.122 -0.986 . . . . 0.0 109.713 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.507 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 26.1 ttp180 -86.66 -33.92 19.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.732 -0.605 . . . . 0.0 111.135 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 62.2 ttt180 -89.39 -12.6 39.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.909 -1.119 . . . . 0.0 110.814 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 1.4 pp -59.76 -32.45 70.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.935 -1.103 . . . . 0.0 109.702 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 12.2 mt -101.65 -74.51 0.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 36' ' ' ALA . 33.7 t0 -170.24 -23.81 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.687 -0.633 . . . . 0.0 109.604 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.613 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -34.71 121.27 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.436 0.636 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.07 -179.34 3.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 mm -60.07 126.15 17.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.65 23.87 63.8 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.07 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -88.54 171.29 10.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.655 -1.497 . . . . 0.0 109.91 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.449 HG23 ' CG2' ' A' ' 92' ' ' THR . 84.8 t -99.2 130.15 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.264 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 52' ' ' GLY . 2.2 m -117.96 139.95 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.813 . . . . 0.0 110.437 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.456 ' HB2' HG21 ' A' ' 90' ' ' VAL . 88.7 tt0 -108.59 142.83 38.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.574 ' O ' ' OG1' ' A' ' 50' ' ' THR . 3.7 mp -119.91 150.5 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.924 -1.11 . . . . 0.0 110.703 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -152.57 93.48 1.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 111.124 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' CG ' HG12 ' A' ' 85' ' ' VAL . 4.1 tmtm? -99.06 -66.95 0.87 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.933 -1.104 . . . . 0.0 109.748 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG23 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.52 -34.58 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 109.407 176.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 85.9 mtt180 -131.59 -174.12 3.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.583 -0.698 . . . . 0.0 109.246 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' O ' HD22 ' A' ' 130' ' ' LEU . 35.5 mttt -89.14 139.44 30.47 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.351 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.54 159.81 40.91 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.431 0.634 . . . . 0.0 110.154 -177.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.15 161.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.035 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -178.87 179.85 48.76 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.678 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 59.2 ttt180 -117.17 164.46 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.503 -0.998 . . . . 0.0 110.237 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -94.05 141.79 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.463 -176.037 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.533 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.4 m-85 -137.62 166.37 24.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.508 -0.745 . . . . 0.0 110.496 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -89.23 121.94 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 110.084 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.468 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . . . -62.96 140.01 58.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.002 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.662 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.1 mmt85 -56.15 -49.68 91.82 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.055 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.16 98.74 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.726 1.382 . . . . 0.0 108.923 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 37.18 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.3 p-10 -147.71 -29.2 0.33 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -85.04 -28.51 25.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 109.106 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.451 ' C ' ' HB3' ' A' ' 27' ' ' ASP . 4.8 m-80 -81.13 41.51 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.857 -0.527 . . . . 0.0 110.636 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -97.83 8.97 43.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.595 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.9 27.08 0.05 OUTLIER Glycine 0 N--CA 1.479 1.552 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.475 HG21 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -141.11 142.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.25 -1.147 . . . . 0.0 109.561 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 9' ' ' LEU . 2.8 p -119.97 127.47 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.044 -1.035 . . . . 0.0 109.973 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 33.9 ttm180 -92.86 118.46 31.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.461 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 2.5 pt -129.34 166.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.775 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.09 168.89 18.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.5 p -60.82 -29.65 69.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.65 -46.41 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.161 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.451 ' HB3' ' HB ' ' A' ' 69' ' ' ILE . 13.5 tpt -60.04 -44.38 94.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -60.03 -40.14 88.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.849 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -66.43 -31.24 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 73' ' ' MET . 99.7 m-20 -59.98 -39.85 87.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.762 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.5 p -99.36 -39.64 8.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.846 -1.159 . . . . 0.0 110.801 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.554 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 110.2 30.72 3.29 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -104.54 167.91 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.13 -1.217 . . . . 0.0 110.36 -177.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.576 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 165.53 11.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.173 176.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 1.1 mp -53.83 139.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.995 -1.065 . . . . 0.0 110.203 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.488 ' N ' HG12 ' A' ' 11' ' ' VAL . . . 76.54 2.08 73.55 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -58.23 -160.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 O-C-N 120.91 -1.347 . . . . 0.0 110.509 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.9 ptpt -130.88 108.93 10.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.532 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -118.87 155.2 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.128 -0.983 . . . . 0.0 110.052 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -106.6 119.96 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.199 -0.938 . . . . 0.0 109.908 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.504 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 95.0 t -105.1 121.78 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 87.7 mtm-85 -112.38 140.35 47.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.995 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.613 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 41.1 tttm -72.33 143.01 48.81 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.533 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.463 HG21 ' CG ' ' A' ' 161' ' ' PRO . 1.9 m -150.22 -169.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.511 -0.743 . . . . 0.0 109.909 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.24 169.05 17.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.449 ' CG2' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.98 156.2 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -150.26 174.47 12.8 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.28 102.96 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.867 -1.146 . . . . 0.0 110.031 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.453 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -52.84 132.46 36.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.306 -0.871 . . . . 0.0 110.163 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -96.06 -28.66 14.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.996 . . . . 0.0 110.995 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 46.2 tttp -150.05 119.9 7.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.831 -1.168 . . . . 0.0 110.281 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.462 HG13 HG12 ' A' ' 170' ' ' ILE . 9.3 p -132.45 137.63 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.87 -1.144 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.489 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 28.1 m -107.77 145.76 33.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 1.0 OUTLIER -147.66 169.76 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.144 -0.973 . . . . 0.0 110.864 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.469 ' HB1' ' HG2' ' A' ' 173' ' ' ARG . . . -141.4 86.05 11.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 110.924 -175.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 22.0 Cg_exo . . . . . 0 C--N 1.305 -1.763 0 O-C-N 123.881 1.464 . . . . 0.0 109.834 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.512 ' C ' ' CD1' ' A' ' 116' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.065 0.459 . . . . 0.0 109.903 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.486 ' N ' HG22 ' A' ' 116' ' ' ILE . 46.7 mt-10 -61.77 -40.26 94.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -70.0 -31.43 69.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.718 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -59.89 -39.76 86.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.551 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.482 HG12 HD13 ' A' ' 170' ' ' ILE . 69.6 t -60.2 -46.27 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.148 -0.97 . . . . 0.0 109.238 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.589 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.17 -40.03 92.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 110.267 175.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -60.0 -41.87 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.3 -39.83 28.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -0.793 . . . . 0.0 110.586 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.491 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 92.0 mt -91.04 -8.39 49.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.884 -174.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 3.7 tt -41.96 166.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 164' ' ' ILE . 30.9 ptt-85 34.2 54.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.449 -0.782 . . . . 0.0 111.607 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 124' ' ' LEU . 6.6 mtt-85 -135.17 150.2 72.16 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.89 -1.131 . . . . 0.0 111.163 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.9 Cg_endo -69.02 133.11 26.06 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 124.096 1.577 . . . . 0.0 109.618 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.532 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 90.4 mmm -128.54 145.67 51.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.485 -1.384 . . . . 0.0 111.607 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 13.6 tp -149.77 114.4 5.29 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.703 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.0 pm0 -49.11 139.67 10.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 0.0 110.573 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.703 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 94.5 mm-40 79.73 -1.33 2.13 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.066 0.46 . . . . 0.0 110.593 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.557 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 1.1 p30 -69.02 -171.05 0.28 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.126 -0.984 . . . . 0.0 110.41 175.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 22.2 m-80 -149.97 158.8 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.4 ' CG1' ' HB2' ' A' ' 150' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.092 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 45.7 m-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.276 0.56 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.39 109.78 16.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.993 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.557 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 5.9 t -76.54 139.98 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.241 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.3 t -120.47 -24.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.121 -0.987 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 87.6 tttt -143.11 151.08 40.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.872 -1.143 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.512 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 39.2 p -141.6 154.62 45.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.626 -0.672 . . . . 0.0 109.626 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.692 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.5 -33.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 111.235 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 26.5 Cg_exo -55.54 -165.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.314 1.165 . . . . 0.0 110.165 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 8.6 t -88.64 40.94 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.8 mttt 59.99 18.76 7.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 158' ' ' SER . 16.3 m -106.32 160.28 26.79 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.508 -0.745 . . . . 0.0 109.813 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.554 ' HA ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.71 122.24 9.37 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 124.024 1.539 . . . . 0.0 110.064 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 12.1 m -129.87 159.9 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.0 tt0 -108.15 128.55 54.8 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.219 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 126' ' ' ARG . 20.1 mm -72.22 153.74 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.68 -0.637 . . . . 0.0 110.425 -175.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.552 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.09 167.04 26.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -57.57 -20.07 29.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -1.088 . . . . 0.0 110.352 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -88.87 -14.0 37.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.246 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.539 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 64.1 m -60.41 141.7 56.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 86.5 mttt -96.05 145.92 25.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.04 . . . . 0.0 109.985 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.482 HD13 HG12 ' A' ' 120' ' ' VAL . 1.5 mt -125.21 157.85 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.192 -0.943 . . . . 0.0 110.853 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.489 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 21.6 mt-10 -131.76 133.56 44.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.651 -0.655 . . . . 0.0 110.114 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 172' ' ' ILE . 40.7 mm -115.07 131.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.598 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.469 ' HG2' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.137 -176.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.166 0.507 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -148.81 -161.75 9.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 39.1 pt -129.99 160.09 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -1.107 . . . . 0.0 109.43 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.9 mt -108.48 120.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.294 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 67' ' ' VAL . 2.6 pt? -144.48 -171.66 3.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.477 -0.765 . . . . 0.0 109.648 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 9.5 ptp85 -106.93 135.73 47.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.81 -1.181 . . . . 0.0 110.948 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.575 HG12 ' HB2' ' A' ' 83' ' ' ASP . 14.4 p -62.39 131.06 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.629 -0.669 . . . . 0.0 110.738 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -114.23 146.21 40.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.863 . . . . 0.0 110.561 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.2 tt0 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.0 110.321 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.471 ' HD3' ' HB2' ' A' ' 53' ' ' ARG . 25.1 mmt85 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.558 ' CG1' HG23 ' A' ' 67' ' ' VAL . 89.8 t -109.98 119.66 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.062 . . . . 0.0 110.347 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.506 ' HD3' ' HD2' ' A' ' 68' ' ' ARG . 1.1 ptm180 -100.56 121.25 41.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.92 -1.113 . . . . 0.0 110.135 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -134.06 176.8 8.25 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 25.9 p-10 -89.56 179.85 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.753 -1.217 . . . . 0.0 110.416 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -60.05 -40.21 88.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.362 -0.836 . . . . 0.0 109.169 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.506 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 22.9 t -70.0 -44.4 69.42 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.529 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.598 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.1 m -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.923 -1.111 . . . . 0.0 109.401 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 56.4 ttp85 -74.76 -43.04 56.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.694 -0.629 . . . . 0.0 111.623 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -88.77 -12.97 40.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 111.212 -170.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.598 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 1.2 pp -56.76 -32.63 65.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 109.505 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 12.7 mt -105.27 -75.01 0.64 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.189 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' A' ' 36' ' ' ALA . 13.0 t0 -170.12 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.637 . . . . 0.0 109.676 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.544 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -26.77 118.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.539 0.685 . . . . 0.0 111.264 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.56 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -104.96 177.32 4.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.81 123.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.93 -1.106 . . . . 0.0 109.86 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.03 29.06 59.41 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 32.8 m-20 -89.12 176.44 6.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.71 -1.465 . . . . 0.0 109.296 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.52 ' CG2' HG22 ' A' ' 92' ' ' THR . 89.8 t -99.32 129.25 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.074 -1.016 . . . . 0.0 110.373 -176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.465 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.3 m -119.58 147.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.791 . . . . 0.0 110.319 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.55 142.16 45.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.423 -0.798 . . . . 0.0 109.606 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.558 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 4.3 mp -114.23 148.04 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.036 -1.04 . . . . 0.0 110.22 -177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 89.1 tt0 -150.21 89.44 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.02 -1.05 . . . . 0.0 111.222 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.549 ' CG ' HG12 ' A' ' 85' ' ' VAL . 14.4 tmtt? -98.37 -66.39 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 173.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.588 HG23 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.05 -38.82 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.708 0.766 . . . . 0.0 109.162 177.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.582 ' CG ' ' HA ' ' A' ' 77' ' ' CYS . 19.7 ptp180 -142.38 -163.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.46 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -88.69 130.51 35.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 111.132 -174.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.543 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -130.69 162.59 29.1 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.246 0.546 . . . . 0.0 110.339 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.567 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -124.6 160.82 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.378 -0.826 . . . . 0.0 110.609 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.92 -179.73 48.71 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 62.0 mtp180 -111.03 175.2 5.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -1.205 . . . . 0.0 109.876 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.56 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -99.64 133.54 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.075 -1.016 . . . . 0.0 110.167 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -117.44 166.82 11.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 176.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 38.7 ptt180 -97.16 125.65 41.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.027 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -64.2 133.05 52.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.81 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.577 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.03 -46.85 99.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.986 174.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 23.7 Cg_endo -91.64 98.61 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.549 . . . . 0.0 109.028 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.04 33.81 0.09 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.595 -0.69 . . . . 0.0 110.91 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 59' ' ' PRO . 34.6 m-20 -147.53 -29.08 0.35 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.187 -0.945 . . . . 0.0 110.705 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.55 -28.43 26.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 37.8 m-80 -81.25 42.08 0.64 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.706 -0.621 . . . . 0.0 110.284 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 35.6 tttt -98.42 9.38 43.25 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.278 -0.889 . . . . 0.0 109.582 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.64 26.47 0.05 OUTLIER Glycine 0 N--CA 1.482 1.724 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 176.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.438 HG22 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -140.12 142.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.273 -1.133 . . . . 0.0 109.448 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.558 HG23 ' CG1' ' A' ' 24' ' ' VAL . 12.7 p -120.05 119.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.666 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.534 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 77.7 mtt180 -90.08 111.14 22.15 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.447 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 1.1 pt -127.69 161.3 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.608 -0.682 . . . . 0.0 110.355 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -80.01 169.59 17.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.522 -0.736 . . . . 0.0 109.795 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 80.0 p -62.39 -16.03 52.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.2 -49.2 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 110.363 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.422 ' HB3' ' HE3' ' A' ' 73' ' ' MET . 97.8 mmm -63.73 -40.13 95.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 0.0 109.361 176.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttp180 -60.32 -42.19 95.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 109.997 173.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -70.23 -33.56 71.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.235 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -60.11 -40.0 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.582 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 31.7 p -99.06 -39.38 8.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.021 -1.049 . . . . 0.0 110.694 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.588 ' CA ' HG23 ' A' ' 47' ' ' VAL . . . 114.75 47.85 0.56 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -122.87 168.54 12.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.071 -1.252 . . . . 0.0 110.75 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.526 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.93 170.93 8.11 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -58.09 140.11 16.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.925 -1.109 . . . . 0.0 110.644 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.523 ' N ' HG11 ' A' ' 11' ' ' VAL . . . 76.61 -0.29 65.48 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 172.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.575 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -58.55 -160.81 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.032 -1.275 . . . . 0.0 110.211 175.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.3 pttt -130.02 115.54 17.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 109.809 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.549 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.4 m -123.04 157.65 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.0 ttpt -110.04 120.44 42.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 110.005 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.492 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 69.1 t -99.63 123.81 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.893 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 38.3 mtp85 -109.98 157.75 18.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.791 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -102.26 138.42 39.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 110.153 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 m -150.12 -169.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.443 -0.786 . . . . 0.0 110.324 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -127.48 172.81 10.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.629 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.52 HG22 ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.04 163.23 12.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 111.086 -176.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -150.01 168.11 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 mm -89.64 99.81 9.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.556 -1.34 . . . . 0.0 110.466 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.531 ' CB ' HG22 ' A' ' 162' ' ' VAL . . . -57.2 136.62 56.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 110.226 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.552 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 6.2 pttt -106.05 -24.21 12.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.074 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.462 ' HE2' ' OE1' ' A' ' 171' ' ' GLU . 83.3 tttt -147.0 119.92 8.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.904 -1.123 . . . . 0.0 110.434 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.47 HG23 HG22 ' A' ' 155' ' ' THR . 8.2 p -138.09 140.28 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 110.492 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.515 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.4 m -117.97 135.81 53.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -0.885 . . . . 0.0 110.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -141.27 167.74 21.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -178.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 151' ' ' LYS . . . -132.94 103.12 13.1 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.384 -0.822 . . . . 0.0 110.562 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.4 Cg_exo . . . . . 0 C--N 1.305 -1.736 0 O-C-N 124.106 1.582 . . . . 0.0 110.132 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 8.5 tp . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.252 0.548 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.492 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 95.0 mt-10 -60.08 -43.92 95.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 109.831 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.68 -35.57 78.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -38.3 82.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.385 -0.822 . . . . 0.0 109.817 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.549 ' CG1' HD12 ' A' ' 170' ' ' ILE . 62.4 t -60.03 -49.02 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.673 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.637 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 5.3 mt-30 -60.06 -41.17 91.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.872 . . . . 0.0 110.045 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -60.05 -39.99 87.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 110.444 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.97 -41.2 19.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 127' ' ' ARG . 52.3 mt -95.27 -3.43 47.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.059 -1.025 . . . . 0.0 110.972 -173.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.637 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.7 tt -43.43 163.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -174.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 164' ' ' ILE . 34.0 ptt180 33.84 49.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.492 -0.755 . . . . 0.0 111.371 -177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 10.8 ttt85 -132.11 143.34 48.53 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.966 -1.084 . . . . 0.0 111.105 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.763 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 17.4 Cg_endo -63.76 127.24 19.17 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.062 1.559 . . . . 0.0 109.811 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.548 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 93.4 mmm -123.52 140.02 53.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.402 -1.436 . . . . 0.0 110.926 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.504 ' CD2' ' O ' ' A' ' 49' ' ' LYS . 19.1 tp -139.59 112.37 7.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.577 -0.702 . . . . 0.0 109.7 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.0 pt-20 -46.68 142.05 3.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.012 -1.055 . . . . 0.0 110.435 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 85.4 mm-40 82.43 -2.74 1.41 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.228 0.537 . . . . 0.0 110.42 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.52 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 3.6 p-10 -70.21 -178.96 1.8 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 110.115 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.547 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 14.8 m-80 -148.29 129.54 14.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.086 . . . . 0.0 110.718 -177.528 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 28.2 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.202 0.525 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.547 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 21.2 tptm -99.92 106.72 18.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.52 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 2.1 t -79.37 134.37 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -0.965 . . . . 0.0 109.898 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.98 -23.19 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.157 -0.964 . . . . 0.0 110.737 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 8.6 tptp -140.2 127.12 20.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.85 -1.156 . . . . 0.0 110.609 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.538 HG21 ' CB ' ' A' ' 131' ' ' GLU . 33.8 p -126.79 170.01 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.586 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -88.82 -41.56 0.45 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.531 -178.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 16.4 Cg_exo -61.75 -176.3 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.631 1.332 . . . . 0.0 110.179 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -90.25 -156.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.964 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -71.77 -2.58 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.271 -0.893 . . . . 0.0 110.38 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.87 138.7 32.96 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.374 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.567 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.99 142.38 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.224 1.644 . . . . 0.0 110.51 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.763 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 10.8 m -129.92 159.47 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 109.516 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.2 tt0 -106.17 127.2 53.04 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.138 -0.976 . . . . 0.0 110.063 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.548 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 12.2 mm -69.73 156.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.624 -0.673 . . . . 0.0 109.862 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.428 ' N ' HG22 ' A' ' 164' ' ' ILE . . . -144.01 166.65 27.02 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.61 -24.42 21.31 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.437 -1.037 . . . . 0.0 109.993 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -88.55 -16.92 31.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.588 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.572 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 80.3 m -56.82 153.13 11.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.0 109.989 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 68.4 mttm -100.7 152.94 19.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 110.032 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.598 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 19.7 mm -114.65 131.56 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 110.927 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.515 ' CB ' ' OG1' ' A' ' 99' ' ' THR . 23.6 mt-10 -114.24 129.55 56.63 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.162 -0.962 . . . . 0.0 110.109 170.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 171' ' ' GLU . 38.1 mm -130.92 140.0 49.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.042 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 178.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.414 0.626 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.13 -163.99 10.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.487 HG22 ' CD1' ' A' ' 34' ' ' LEU . 34.8 pt -137.56 158.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -1.186 . . . . 0.0 110.096 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.6 mt -102.21 115.55 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.15 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.6 pt? -140.0 -171.86 3.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.791 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.2 ptt180 -111.4 140.57 45.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.829 -1.169 . . . . 0.0 110.797 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 80' ' ' SER . 11.7 p -61.75 136.23 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 110.58 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -115.99 152.17 34.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.172 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.502 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 85.5 tt0 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 96.2 mtt180 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.236 0.541 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.501 HG13 ' CG2' ' A' ' 67' ' ' VAL . 67.0 t -113.21 120.61 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.283 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -95.09 120.54 35.48 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.467 175.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD21 ' CB ' ' A' ' 30' ' ' SER . 3.6 mt -134.93 171.32 14.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.554 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 5.3 p-10 -89.02 170.42 10.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.335 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.479 ' HA ' ' NH1' ' A' ' 31' ' ' ARG . 46.7 mt-10 -56.16 -40.03 73.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.95 . . . . 0.0 109.019 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.602 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 5.2 t -65.29 -58.81 5.01 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.213 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.557 ' CB ' HD21 ' A' ' 26' ' ' LEU . 61.7 m -49.6 -30.02 8.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.593 -1.317 . . . . 0.0 109.635 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.479 ' NH1' ' HA ' ' A' ' 28' ' ' GLU . 11.9 ttp-105 -81.0 -49.46 10.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 111.136 178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 32' ' ' ARG . 38.4 mtm105 -93.45 -14.36 26.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 0.0 111.43 -171.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.602 ' HB3' ' O ' ' A' ' 29' ' ' SER . 1.0 OUTLIER -60.84 -28.7 69.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.907 -1.121 . . . . 0.0 110.195 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 55.7 mt -103.66 -73.69 0.66 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.142 -0.974 . . . . 0.0 109.996 175.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 36' ' ' ALA . 30.4 t0 -168.65 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.451 0.643 . . . . 0.0 109.442 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -33.31 118.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.419 0.628 . . . . 0.0 110.961 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -104.42 175.92 5.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 38' ' ' ILE . 33.1 mm -60.0 123.95 13.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.908 -1.12 . . . . 0.0 109.785 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.417 ' H ' HG13 ' A' ' 54' ' ' VAL . . . 76.48 28.19 60.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 65.7 m-20 -89.29 171.07 10.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.703 -1.469 . . . . 0.0 109.503 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.458 HG12 HG22 ' A' ' 90' ' ' VAL . 73.7 t -99.15 129.95 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 0.0 110.06 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.436 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.7 m -118.21 144.71 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.388 -0.82 . . . . 0.0 110.358 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.0 tt0 -112.41 140.21 47.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.597 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.2 mp -122.74 143.97 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.041 -1.037 . . . . 0.0 110.395 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.8 tt0 -150.49 100.03 2.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.134 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 9.1 tmtm? -98.31 -66.99 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.017 . . . . 0.0 109.956 173.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.513 HG22 ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -101.63 -34.54 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.388 174.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 90.0 mtt-85 -134.59 -179.68 5.74 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.5 -0.75 . . . . 0.0 109.486 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HD3' ' OE2' ' A' ' 43' ' ' GLU . 24.3 mttp -89.19 141.87 28.14 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.181 -0.95 . . . . 0.0 110.843 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.597 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 9.3 p -143.41 169.98 16.65 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.471 0.653 . . . . 0.0 109.901 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.42 167.35 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.447 -0.783 . . . . 0.0 110.079 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.41 -172.36 41.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -122.78 164.56 18.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -1.137 . . . . 0.0 110.329 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.507 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -96.81 137.69 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 110.419 -173.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.49 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.6 m-85 -128.12 165.53 20.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.493 -0.754 . . . . 0.0 110.262 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -89.73 122.68 33.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.972 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -62.29 134.1 56.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.562 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -57.8 -48.75 96.61 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.031 174.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 36.3 Cg_endo -92.42 98.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.91 1.479 . . . . 0.0 109.013 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.53 36.32 0.09 Allowed 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.527 -0.733 . . . . 0.0 110.692 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 59' ' ' PRO . 70.7 m-20 -143.67 -30.62 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.157 -0.965 . . . . 0.0 110.446 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 66' ' ' ILE . 21.1 mt-10 -87.14 -28.28 22.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 0.0 109.27 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.487 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 23.6 m120 -81.13 40.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.758 -0.589 . . . . 0.0 110.492 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 4.82 47.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.22 30.18 0.07 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 62' ' ' GLU . 46.3 pt -140.62 146.96 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.518 -0.989 . . . . 0.0 109.257 174.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.507 ' N ' HD13 ' A' ' 9' ' ' LEU . 2.7 p -120.01 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.783 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.496 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 15.2 tpp180 -90.09 110.28 21.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.126 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.538 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.5 pt -130.82 166.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 110.516 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.02 171.1 15.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -63.91 -21.94 66.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.77 -49.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.512 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 1.3 mmt -60.72 -43.28 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 66.0 ttp85 -59.99 -40.53 89.49 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.925 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -70.38 -29.0 65.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.34 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 98.5 m-20 -59.97 -39.15 84.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 26.9 p -98.14 -37.76 9.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 110.51 -175.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.513 ' CA ' HG23 ' A' ' 47' ' ' VAL . . . 115.56 35.38 1.3 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.526 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -113.08 165.24 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.095 -1.238 . . . . 0.0 110.54 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.555 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.43 170.62 8.11 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.358 -0.839 . . . . 0.0 109.339 178.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.541 ' HA ' HG12 ' A' ' 11' ' ' VAL . 0.8 OUTLIER -53.41 141.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.929 -1.107 . . . . 0.0 110.382 178.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.515 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 75.42 1.55 65.44 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 172.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.55 ' HB2' HG11 ' A' ' 11' ' ' VAL . 1.8 m-20 -59.51 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.853 -1.381 . . . . 0.0 110.572 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.2 pttt -132.89 108.81 9.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 1.1 m -121.22 153.0 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.5 tttt -103.08 124.74 49.12 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.481 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 73.2 t -107.21 123.97 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.799 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.529 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.5 mtt180 -113.65 136.89 52.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.548 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.542 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 27.5 tttt -72.24 143.53 48.76 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.952 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 41' ' ' VAL . 1.9 m -148.07 -169.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 109.832 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 174.32 10.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.698 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.55 159.24 17.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.967 -1.083 . . . . 0.0 111.229 -174.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.46 ' CG ' HG11 ' A' ' 162' ' ' VAL . 16.9 pt-20 -150.34 176.38 10.95 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.2 mm -93.18 99.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.341 -1.474 . . . . 0.0 110.867 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -56.67 139.79 49.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 0.0 110.297 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.569 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.97 -27.18 10.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 111.147 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.569 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 79.0 tttt -150.0 124.77 9.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.838 -1.163 . . . . 0.0 110.283 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.52 ' CG2' HG21 ' A' ' 155' ' ' THR . 9.1 p -138.92 148.97 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.512 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 88.9 m -120.03 130.69 54.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.819 . . . . 0.0 109.762 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -136.43 169.22 18.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.767 -176.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.487 ' HB3' ' CD ' ' A' ' 173' ' ' ARG . . . -130.42 88.82 46.18 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.863 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.518 ' CD ' HG22 ' A' ' 172' ' ' ILE . 17.3 Cg_exo . . . . . 0 C--N 1.304 -1.799 0 O-C-N 124.125 1.592 . . . . 0.0 110.385 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 9.7 tp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.15 0.5 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.52 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 47.0 mt-10 -69.91 -40.11 75.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.07 -30.85 71.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -59.99 -40.88 90.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.538 ' HB ' HG23 ' A' ' 170' ' ' ILE . 44.7 t -61.17 -43.37 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.613 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 4.6 mt-30 -60.07 -44.52 94.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.116 -0.99 . . . . 0.0 110.114 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -60.01 -46.7 88.62 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.526 -0.734 . . . . 0.0 109.837 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 124' ' ' LEU . . . -73.66 -42.47 61.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.614 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.6 mm? -98.56 6.9 46.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 0.9 OUTLIER -48.67 166.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 120.77 -1.206 . . . . 0.0 109.735 -177.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 164' ' ' ILE . 32.9 ptt180 33.01 45.14 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.465 -0.772 . . . . 0.0 111.412 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.499 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -127.26 138.53 32.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.805 -1.185 . . . . 0.0 111.113 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.801 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 9.3 Cg_endo -57.51 129.06 31.92 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 124.031 1.543 . . . . 0.0 110.176 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.548 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.6 mmm -125.96 137.82 53.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.601 -1.312 . . . . 0.0 110.608 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.516 ' CD2' ' CA ' ' A' ' 50' ' ' THR . 12.7 tp -137.48 115.01 11.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pt-20 -48.78 143.63 5.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.981 -1.075 . . . . 0.0 110.655 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.04 -10.63 0.9 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.366 0.603 . . . . 0.0 110.374 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.536 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -70.38 178.3 2.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 176.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.553 ' OD1' ' CG ' ' A' ' 151' ' ' LYS . 1.1 m-80 -148.64 129.4 14.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.326 -0.859 . . . . 0.0 109.124 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.683 ' HB ' ' CE1' ' A' ' 150' ' ' PHE . 1.6 mt . . . . . 0 N--CA 1.491 1.617 0 C-N-CA 118.211 -1.396 . . . . 0.0 111.459 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.683 ' CE1' ' HB ' ' A' ' 135' ' ' ILE . 7.4 p90 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.759 0.79 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.553 ' CG ' ' OD1' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -100.32 113.88 26.93 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.829 -0.544 . . . . 0.0 109.737 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.536 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -76.1 135.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.684 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.9 t -123.58 -26.7 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 110.697 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -144.38 131.6 20.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 110.443 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.52 HG21 ' CG2' ' A' ' 98' ' ' VAL . 37.3 p -130.0 169.38 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 109.775 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.04 -39.88 0.44 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.822 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 16.0 Cg_exo -61.52 -175.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.583 1.307 . . . . 0.0 110.727 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.1 t -90.5 -163.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.81 . . . . 0.0 110.258 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -68.11 -6.43 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 160' ' ' VAL . 27.4 m -86.64 141.68 34.22 Favored Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.388 -0.82 . . . . 0.0 110.125 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.556 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.93 144.69 11.4 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.177 1.619 . . . . 0.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.801 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 10.9 m -129.91 159.27 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.089 -1.007 . . . . 0.0 109.545 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 67.4 tt0 -107.36 127.66 53.77 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.27 -0.894 . . . . 0.0 109.957 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.548 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 9.1 mm -69.36 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.917 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -140.9 167.66 25.56 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HA ' HD13 ' A' ' 125' ' ' ILE . 20.6 pt-20 -57.44 -21.19 35.27 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.416 -1.05 . . . . 0.0 110.32 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.55 -17.72 26.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 110.74 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.555 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 30.2 m -57.59 156.72 7.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.906 . . . . 0.0 110.364 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -103.97 154.53 19.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 110.277 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.613 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 2.1 mm -120.0 129.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.772 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.512 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 53.4 mt-10 -117.83 130.02 56.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.12 -0.988 . . . . 0.0 110.419 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.518 HG22 ' CD ' ' A' ' 102' ' ' PRO . 37.1 mt -135.62 135.22 51.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.309 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' HB3' ' A' ' 101' ' ' ALA . 13.1 ptp180 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.276 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.161 0.505 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 88' ' ' ARG . . . -147.41 -159.74 8.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.481 ' CD1' HD22 ' A' ' 33' ' ' LEU . 43.6 pt -139.58 152.05 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -1.141 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 96.7 mt -97.42 119.67 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.797 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.2 pt? -135.91 -168.34 2.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.291 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.558 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 26.4 ttm105 -106.03 130.66 53.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 111.059 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 82' ' ' GLY . 14.4 p -61.65 139.02 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.379 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.6 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -120.24 153.55 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.487 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.321 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.604 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 84.2 mtt85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.005 0.431 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' TYR . 77.4 t -109.98 115.43 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.011 -1.056 . . . . 0.0 109.987 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 0.7 OUTLIER -88.09 117.4 26.94 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.683 178.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.11 172.64 11.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 109.551 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 7.0 p-10 -92.76 176.64 6.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.863 -1.148 . . . . 0.0 110.022 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -40.06 87.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.449 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.575 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.5 t -69.51 -44.98 69.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 110.57 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.614 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.7 m -59.98 -39.99 87.6 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.102 -0.999 . . . . 0.0 109.608 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.444 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 36.9 ttp180 -74.7 -43.4 55.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.772 -0.58 . . . . 0.0 111.444 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -91.41 -11.53 37.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.821 -1.174 . . . . 0.0 111.201 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.614 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 1.3 pp -58.65 -32.88 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.855 -1.153 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 13.0 mt -105.21 -74.07 0.66 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.927 . . . . 0.0 110.316 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 45.6 t0 -170.16 -24.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.559 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -24.61 119.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.557 0.694 . . . . 0.0 111.407 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 1.1 pt-20 -105.69 175.14 5.59 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.2 mm -58.16 120.75 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.917 -1.114 . . . . 0.0 109.813 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.72 33.82 54.78 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.2 m-20 -89.11 177.1 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.458 . . . . 0.0 109.477 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 92' ' ' THR . 70.6 t -99.08 121.64 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.09 . . . . 0.0 110.166 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 54' ' ' VAL . 1.5 m -116.8 139.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.489 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.8 141.36 38.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 109.863 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.711 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 2.1 mp -120.48 146.63 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.013 -1.054 . . . . 0.0 110.296 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.0 tt0 -150.95 97.16 2.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.961 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.541 ' CG ' HG13 ' A' ' 85' ' ' VAL . 1.7 tmtt? -98.41 -67.36 0.85 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.825 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.536 HG23 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.01 -35.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.16 174.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 71.9 mtt85 -135.46 -178.74 5.25 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.776 -0.578 . . . . 0.0 109.571 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.504 ' O ' HD21 ' A' ' 130' ' ' LEU . 28.0 mttt -89.04 137.14 32.58 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.655 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.711 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 10.9 p -140.56 166.78 23.8 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.394 0.616 . . . . 0.0 109.834 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -122.98 166.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.448 -0.782 . . . . 0.0 110.196 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 42' ' ' VAL . . . -178.99 -169.54 39.73 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -129.94 162.8 27.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.186 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -89.03 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 0.0 110.426 -173.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.604 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 2.2 m-85 -134.68 166.31 23.23 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.504 -0.747 . . . . 0.0 110.251 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 51.9 ptt85 -90.69 128.36 36.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -65.9 139.98 58.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.577 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -54.74 -49.58 90.73 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.881 -1.137 . . . . 0.0 108.868 175.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.4 Cg_endo -92.71 98.79 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.904 1.476 . . . . 0.0 108.893 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.47 34.37 0.08 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.41 -0.806 . . . . 0.0 110.918 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 59' ' ' PRO . 54.6 t0 -146.26 -27.51 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 110.769 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -86.12 -28.2 24.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.258 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.492 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 33.6 m-80 -81.75 43.56 0.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.676 -0.64 . . . . 0.0 110.312 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 30.3 pttt -97.43 8.96 43.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.404 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.88 27.13 0.05 OUTLIER Glycine 0 N--CA 1.479 1.541 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.492 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 43.5 pt -140.24 142.87 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -1.083 . . . . 0.0 109.4 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 67' ' ' VAL . 3.1 p -119.94 121.12 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.005 -1.059 . . . . 0.0 110.058 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.6 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 97.3 mtt180 -89.87 116.02 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.5 pt -126.75 171.72 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.66 -0.65 . . . . 0.0 110.645 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -80.01 168.05 19.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.881 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 m -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.316 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.506 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.5 t -62.82 -43.62 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -60.0 -46.52 89.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.628 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.405 ' NH1' ' HB3' ' A' ' 74' ' ' ARG . 6.4 ttp-105 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.554 174.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -69.99 -23.84 63.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.483 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 4.2 m120 -60.07 -39.1 84.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.08 -1.013 . . . . 0.0 110.352 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 31.4 p -98.27 -35.03 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.047 -1.033 . . . . 0.0 110.532 -175.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.536 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 112.47 26.63 4.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -103.46 169.97 8.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -1.166 . . . . 0.0 110.309 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.47 178.73 4.2 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 178.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.489 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -64.74 141.25 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.388 177.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.558 ' HA2' ' CG ' ' A' ' 10' ' ' ARG . . . 78.69 -3.85 62.58 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 172.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.518 ' HB2' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -57.3 -167.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.98 -1.306 . . . . 0.0 110.098 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 50.7 pttt -127.01 114.65 18.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.12 -0.987 . . . . 0.0 109.748 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.541 HG13 ' CG ' ' A' ' 46' ' ' LYS . 1.1 m -119.33 155.57 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 83.6 tttt -105.61 125.44 50.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.459 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 76.0 t -106.85 121.4 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 41.3 mtm180 -110.63 135.61 51.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 19.4 tttt -83.81 138.64 33.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.3 m -150.04 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.088 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -126.48 168.99 13.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.907 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.536 ' CG2' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.73 163.47 12.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.093 -1.005 . . . . 0.0 111.05 -175.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' OE2' HG23 ' A' ' 160' ' ' VAL . 12.5 pt-20 -150.08 169.46 21.21 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.62 100.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.53 ' CB ' HG22 ' A' ' 162' ' ' VAL . . . -56.85 138.19 53.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.29 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 169' ' ' LYS . 16.9 ptpt -96.66 -29.34 13.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 110.981 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 169' ' ' LYS . 16.1 tttp -150.66 124.63 9.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.731 -1.231 . . . . 0.0 110.842 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.45 HG12 HG12 ' A' ' 170' ' ' ILE . 5.4 p -134.34 142.05 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 0.0 110.653 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 86.8 m -118.54 141.7 48.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.329 -0.857 . . . . 0.0 110.109 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -139.24 169.79 17.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.709 -178.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.562 ' CB ' ' HD2' ' A' ' 173' ' ' ARG . . . -141.12 99.7 6.53 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.615 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo . . . . . 0 C--N 1.304 -1.786 0 O-C-N 123.878 1.462 . . . . 0.0 110.17 179.786 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.139 0.495 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.98 -40.55 89.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.966 . . . . 0.0 109.693 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -68.69 -38.94 80.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 109.943 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -60.08 -39.99 88.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.251 -0.905 . . . . 0.0 109.341 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.549 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.8 t -67.02 -45.93 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 109.89 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.558 ' NE2' ' O ' ' A' ' 168' ' ' THR . 4.2 mt-30 -59.98 -44.41 94.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.97 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -60.07 -48.6 81.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.441 0.639 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.05 -40.1 75.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.46 -0.775 . . . . 0.0 110.535 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.607 ' CD2' ' N ' ' A' ' 124' ' ' LEU . 3.9 mm? -97.53 -0.06 46.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.883 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.5 tt -47.3 166.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 110.171 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 164' ' ' ILE . 34.1 ptt180 33.08 46.68 0.1 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.659 -0.651 . . . . 0.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 7.6 mmt180 -129.79 150.42 75.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.676 -1.265 . . . . 0.0 111.192 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 22.2 Cg_endo -67.22 130.72 23.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 124.192 1.627 . . . . 0.0 109.876 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.528 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 87.8 mmm -127.13 137.58 53.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.556 -1.34 . . . . 0.0 111.077 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.521 ' CD2' ' CA ' ' A' ' 50' ' ' THR . 10.9 tp -140.21 113.67 8.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.622 -0.674 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -45.22 146.68 0.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.172 . . . . 0.0 110.394 -176.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.85 -0.53 3.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.741 -0.599 . . . . 0.0 110.627 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 3.2 p30 -69.91 -176.19 1.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.054 174.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 17.1 m-80 -145.94 150.06 35.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.592 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.313 0.577 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -122.39 101.9 7.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.603 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.503 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 2.3 t -77.47 138.79 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.68 -21.94 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 111.09 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.526 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 10.5 tptm -139.84 129.83 24.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.678 -1.264 . . . . 0.0 110.965 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.451 HG22 ' CA ' ' A' ' 131' ' ' GLU . 66.7 p -130.49 164.59 24.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.244 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.666 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.29 -36.67 0.42 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 110.916 -176.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 31.4 Cg_exo -53.1 -174.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.363 1.191 . . . . 0.0 110.401 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 4.9 t -86.84 41.44 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.28 -0.887 . . . . 0.0 110.264 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 158' ' ' SER . 40.7 mmtm 61.41 19.56 10.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.747 . . . . 0.0 109.901 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 158' ' ' SER . 23.5 m -102.29 159.92 27.9 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.392 -0.818 . . . . 0.0 109.712 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.547 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 5.4 Cg_endo -53.81 119.66 6.61 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.059 1.557 . . . . 0.0 110.217 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 5.2 m -126.61 158.3 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -104.56 128.71 52.61 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.152 -0.967 . . . . 0.0 110.052 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 126' ' ' ARG . 12.8 mm -71.08 152.65 8.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.827 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.06 168.32 25.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.37 -20.87 21.34 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.975 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -90.99 -18.57 24.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 110.684 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.558 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 30.5 m -57.89 148.41 25.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 110.473 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 96' ' ' LYS . 49.6 mttp -96.35 147.19 24.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.004 . . . . 0.0 109.702 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.549 HD12 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mt -130.03 160.03 41.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.093 -1.004 . . . . 0.0 110.982 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.475 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 25.3 mt-10 -137.78 133.6 34.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.754 -0.591 . . . . 0.0 110.231 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.445 ' CD1' HD12 ' A' ' 100' ' ' LEU . 39.5 mm -120.02 120.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.341 -0.85 . . . . 0.0 109.39 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.562 ' HD2' ' CB ' ' A' ' 101' ' ' ALA . 4.7 ptp85 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 110.439 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 122.005 0.907 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.11 -166.84 13.41 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.545 ' CG2' HD13 ' A' ' 33' ' ' LEU . 41.3 pt -131.89 160.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -1.138 . . . . 0.0 109.535 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.18 117.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.5 pt? -139.58 -172.39 3.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 33.1 ptt180 -111.12 140.51 45.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.597 -1.314 . . . . 0.0 110.93 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 11' ' ' VAL . 9.6 p -62.29 138.09 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.497 -0.752 . . . . 0.0 110.675 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.585 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -119.06 144.71 46.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 86.1 tt0 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.524 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.585 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 80.8 mtt180 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.384 0.611 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 55' ' ' TYR . 53.0 t -120.09 121.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.885 . . . . 0.0 110.303 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 1.8 ptt180 -91.27 120.71 32.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.7 -1.25 . . . . 0.0 109.881 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 1.2 mp -135.49 169.15 17.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 109.821 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.0 p-10 -94.48 -170.05 2.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.941 -1.1 . . . . 0.0 111.069 -175.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -0.76 . . . . 0.0 109.904 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.61 -43.66 93.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.752 . . . . 0.0 110.105 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.656 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 54.6 m -58.64 -32.14 68.79 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.464 -0.773 . . . . 0.0 109.44 177.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.457 ' C ' HD21 ' A' ' 33' ' ' LEU . 70.6 ttt180 -84.57 -44.31 13.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.704 -0.622 . . . . 0.0 110.887 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 33' ' ' LEU . 75.9 mtp85 -77.44 -11.14 59.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.171 -0.956 . . . . 0.0 110.127 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.656 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -40.87 -29.36 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.888 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.559 ' H ' HD23 ' A' ' 33' ' ' LEU . 84.0 mt -141.15 -61.44 0.48 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 110.107 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.9 t0 -169.62 -36.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.529 -0.732 . . . . 0.0 109.498 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . 9.99 114.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.263 0.554 . . . . 0.0 112.101 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.84 173.03 6.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.647 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 38' ' ' ILE . 33.2 mm -60.08 120.23 5.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.949 -1.094 . . . . 0.0 109.825 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.27 34.36 46.22 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.466 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.9 m-20 -88.88 174.91 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.819 -1.4 . . . . 0.0 109.492 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 71.7 t -99.15 126.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.888 -1.132 . . . . 0.0 110.479 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.472 ' O ' HG21 ' A' ' 42' ' ' VAL . 3.5 m -119.61 146.08 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.819 . . . . 0.0 110.572 -177.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.12 140.7 46.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 109.677 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.593 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.3 mp -125.85 143.67 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.944 -1.097 . . . . 0.0 110.512 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.14 98.97 2.76 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.054 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.541 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.8 tmtm? -98.56 -66.46 0.9 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.226 -0.921 . . . . 0.0 109.695 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.528 HG23 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.77 -37.12 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 174.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.563 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -129.88 -178.97 4.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.757 -0.589 . . . . 0.0 109.826 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HB3' HD23 ' A' ' 130' ' ' LEU . 12.8 mttp -91.86 134.66 34.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.593 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.8 p -139.56 165.05 28.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.499 -0.751 . . . . 0.0 110.129 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.82 162.71 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.59 -0.694 . . . . 0.0 110.339 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.86 -171.38 42.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.21 177.14 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -1.134 . . . . 0.0 110.371 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -103.0 133.13 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 110.548 -175.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.585 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -125.54 165.93 17.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.432 -0.792 . . . . 0.0 110.658 176.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -91.52 125.03 36.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.738 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -65.67 137.78 57.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.881 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.549 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.24 -48.6 96.73 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.903 -1.123 . . . . 0.0 109.105 173.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 39.9 Cg_endo -91.86 97.99 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.838 1.441 . . . . 0.0 109.108 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.474 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 19.5 pt-20 -74.64 36.46 0.11 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.519 -0.738 . . . . 0.0 110.699 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 82.2 m-20 -144.3 -34.93 0.36 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.154 -0.966 . . . . 0.0 110.649 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -85.1 -28.6 25.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 109.241 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 3.2 m-80 -81.03 39.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.8 -0.563 . . . . 0.0 110.697 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 3.0 pttp -98.24 12.85 33.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.665 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.02 25.95 0.06 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.511 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.6 pt -140.66 142.62 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.492 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 9' ' ' LEU . 2.2 p -120.33 121.75 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.969 -1.082 . . . . 0.0 109.922 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.585 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 77.4 mtt180 -89.43 117.72 28.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.94 -1.1 . . . . 0.0 110.176 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.23 172.36 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.428 0.632 . . . . 0.0 110.361 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 34.0 p-10 -76.41 168.74 19.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 0.0 109.773 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -67.11 -27.85 67.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.0 -43.66 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.965 . . . . 0.0 110.486 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.404 ' CE ' HD11 ' A' ' 44' ' ' ILE . 3.1 tpt -60.02 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.072 -1.018 . . . . 0.0 109.683 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -59.99 -40.01 87.72 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 0.0 109.853 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -72.2 -25.99 61.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 88.6 m-20 -68.55 -29.13 67.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.022 . . . . 0.0 110.625 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 31.0 p -99.26 -37.01 9.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 110.496 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.528 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 112.98 23.84 5.11 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.22 167.43 9.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -1.183 . . . . 0.0 110.351 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.521 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -116.75 166.42 12.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 178.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.52 ' HA ' HG12 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -51.4 140.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.486 178.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 77.27 -0.67 67.42 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 172.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.1 m-20 -56.31 -160.99 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 12.7 pttm -135.51 112.19 10.07 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.489 -0.757 . . . . 0.0 109.861 175.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.541 HG11 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.49 158.94 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.749 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 55.5 tttp -110.75 123.57 50.3 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.188 -0.945 . . . . 0.0 109.955 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.521 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.8 t -105.59 123.64 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 109.873 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.463 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.7 mtt180 -112.42 139.32 48.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.733 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.526 ' HE3' ' CB ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -79.06 141.06 37.72 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 110.437 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.511 HG21 ' CG ' ' A' ' 161' ' ' PRO . 2.0 m -150.01 -168.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 109.999 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.498 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 47.1 ptt85 -139.59 171.04 14.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.566 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.403 ' OG1' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.41 158.7 16.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.995 -1.066 . . . . 0.0 111.309 -173.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -150.86 175.23 12.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.24 101.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.663 -1.273 . . . . 0.0 110.587 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.525 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -57.05 137.44 55.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HD2' ' CD1' ' A' ' 156' ' ' LEU . 19.5 ptpt -101.12 -26.4 13.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 110.814 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -150.8 119.95 6.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.897 -1.127 . . . . 0.0 110.584 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 170' ' ' ILE . 7.4 p -135.19 140.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.871 -1.143 . . . . 0.0 110.977 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.9 m -112.21 144.37 41.73 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.346 -0.846 . . . . 0.0 109.962 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.4 OUTLIER -141.87 165.74 26.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.179 -0.95 . . . . 0.0 110.941 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . . . -139.95 90.72 10.65 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 110.368 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 37.9 Cg_exo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.955 1.503 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.204 0.526 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -60.02 -43.12 95.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.675 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.43 -39.8 89.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.756 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.02 -40.03 87.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.815 . . . . 0.0 109.669 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.534 ' CG1' ' CD1' ' A' ' 170' ' ' ILE . 54.4 t -60.02 -47.25 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.571 ' NE2' ' O ' ' A' ' 168' ' ' THR . 4.1 mt-30 -59.95 -44.51 94.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.511 -0.743 . . . . 0.0 110.06 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -60.11 -44.04 95.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.57 -0.706 . . . . 0.0 110.19 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.6 -42.09 59.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.492 ' O ' ' CB ' ' A' ' 127' ' ' ARG . 4.5 mm? -95.92 0.68 52.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.172 -0.955 . . . . 0.0 111.205 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.6 tt -46.04 166.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.851 -1.155 . . . . 0.0 110.261 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.9 ptm180 32.63 49.31 0.15 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.603 -0.686 . . . . 0.0 111.237 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -129.1 134.68 26.58 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.029 -1.044 . . . . 0.0 110.955 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.759 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.7 Cg_exo -59.75 125.73 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.931 1.49 . . . . 0.0 109.785 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 127' ' ' ARG . 99.7 mmm -124.35 140.46 52.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.445 -1.409 . . . . 0.0 111.031 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.566 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 12.6 tp -140.99 111.6 6.94 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.58 -0.7 . . . . 0.0 109.503 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pm0 -47.07 137.42 7.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 110.612 -173.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.59 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 1.3 tp-100 80.41 -3.39 1.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.243 0.545 . . . . 0.0 110.358 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.566 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.4 p30 -69.12 -173.59 0.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 175.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.465 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 7.9 m-80 -146.32 140.3 26.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 O-C-N 120.969 -1.082 . . . . 0.0 110.447 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 67.7 m-85 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.188 0.518 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.441 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 23.7 tptm -97.14 103.68 15.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.303 -0.873 . . . . 0.0 109.882 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 132' ' ' GLN . 3.9 t -74.87 134.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.46 HG13 ' HG3' ' A' ' 154' ' ' LYS . 37.9 t -115.18 -30.17 2.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 110.751 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.46 ' HG3' HG13 ' A' ' 153' ' ' VAL . 68.5 mttt -143.4 160.0 41.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 0.0 111.163 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.461 HG22 HG23 ' A' ' 98' ' ' VAL . 81.5 p -150.0 162.55 40.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.652 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.83 -38.69 0.44 Allowed Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 21.4 Cg_exo -57.68 -166.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.535 1.282 . . . . 0.0 110.139 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.6 t -89.69 -169.23 2.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.913 . . . . 0.0 109.671 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -64.16 -7.9 10.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 110.605 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.1 m -83.38 152.13 63.73 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 121.416 -0.803 . . . . 0.0 110.578 -176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.581 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 4.6 Cg_endo -52.98 142.57 52.92 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.303 1.686 . . . . 0.0 110.952 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.759 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 7.2 m -132.46 158.11 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 110.033 171.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 83.2 tt0 -105.36 126.32 51.97 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 110.213 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 126' ' ' ARG . 13.1 mm -69.77 159.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 110.438 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.448 ' N ' HG22 ' A' ' 164' ' ' ILE . . . -143.65 167.84 26.52 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -58.58 -19.95 42.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.336 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.63 -22.03 20.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.571 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 94.2 m -54.99 147.32 15.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.635 -0.666 . . . . 0.0 110.283 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.7 mmtm -95.52 156.72 16.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.937 -1.102 . . . . 0.0 110.014 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.534 ' CD1' ' CG1' ' A' ' 120' ' ' VAL . 2.4 mt -135.68 164.25 33.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.992 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 37.0 mt-10 -139.26 137.01 35.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.621 -0.675 . . . . 0.0 110.276 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.404 HD11 ' CG2' ' A' ' 120' ' ' VAL . 47.1 mm -119.95 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.937 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.509 ' NE ' ' HB3' ' A' ' 101' ' ' ALA . 3.4 ptp180 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 0.0 110.29 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.563 0.697 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -144.32 -160.47 8.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 46.2 pt -132.98 147.76 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -1.145 . . . . 0.0 109.815 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.8 mt -96.24 119.08 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.7 pt? -136.61 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 110.287 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.514 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 24.0 ttp180 -106.08 130.38 53.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.419 -0.801 . . . . 0.0 110.998 -174.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.565 HG21 ' CD ' ' A' ' 74' ' ' ARG . 10.2 p -61.21 139.55 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.523 -0.735 . . . . 0.0 110.416 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -125.79 153.33 44.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.467 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 46.2 tt0 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.93 . . . . 0.0 110.062 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.566 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 98.1 mtt180 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.218 0.532 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 55' ' ' TYR . 92.8 t -116.14 120.01 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.206 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.528 ' HD3' ' HD2' ' A' ' 68' ' ' ARG . 1.1 ptm180 -93.54 119.97 33.25 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.852 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -138.43 178.6 7.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.547 -0.72 . . . . 0.0 109.737 -176.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 15.2 p-10 -94.2 177.01 6.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.815 -1.178 . . . . 0.0 110.635 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.0 -44.74 94.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.521 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.3 t -60.49 -43.13 97.33 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.264 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.607 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 47.0 t -59.97 -41.15 91.34 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.257 176.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 67.4 ttt180 -68.98 -44.17 73.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.662 . . . . 0.0 111.363 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 33' ' ' LEU . 25.4 tpt180 -90.32 -20.69 22.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.859 -1.15 . . . . 0.0 111.74 -170.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.607 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -47.84 -30.36 3.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.73 -1.231 . . . . 0.0 108.988 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.592 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 18.0 mt -115.67 -78.16 0.58 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.798 . . . . 0.0 110.393 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -172.23 11.65 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.473 -0.767 . . . . 0.0 110.515 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -50.03 127.75 17.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.094 -1.004 . . . . 0.0 110.337 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.527 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -112.61 176.31 5.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.5 mm -59.66 119.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.828 -1.17 . . . . 0.0 109.83 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.61 36.83 47.62 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.26 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 25.6 m-20 -87.97 169.19 12.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.752 -1.44 . . . . 0.0 109.228 170.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 54.3 t -98.78 120.36 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.858 -1.151 . . . . 0.0 110.15 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG1' ' HE2' ' A' ' 89' ' ' LYS . 2.8 m -116.85 139.79 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.554 -0.716 . . . . 0.0 110.101 -176.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 85.9 tt0 -106.55 138.34 42.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.872 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.607 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -116.97 140.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.147 -0.97 . . . . 0.0 109.859 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 84.4 tt0 -150.16 96.29 2.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.087 -1.008 . . . . 0.0 111.186 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.636 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 37.9 tttp -99.53 -71.07 0.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 172.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.478 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.16 -34.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.47 175.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 87.3 mtt-85 -139.77 179.71 6.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.051 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' CD ' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -89.04 134.14 34.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 110.781 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.525 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 1.7 p -138.48 172.06 13.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.679 . . . . 0.0 109.322 174.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.597 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 3.0 m -127.93 168.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.45 -175.9 45.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 40.8 ttm180 -121.71 165.75 15.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.439 -1.036 . . . . 0.0 109.975 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -94.57 135.85 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 110.553 -172.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.566 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -130.5 167.27 18.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 110.509 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -89.6 125.97 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.429 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB2' ' ND2' ' A' ' 63' ' ' ASN . . . -65.23 140.08 58.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.847 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.583 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -55.45 -49.96 89.54 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.947 174.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 33.9 Cg_endo -92.81 98.56 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.873 1.46 . . . . 0.0 108.974 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -73.64 35.13 0.08 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.561 -0.712 . . . . 0.0 110.91 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -145.91 -29.77 0.41 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.152 -0.968 . . . . 0.0 110.531 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.12 -27.25 26.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.167 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.489 ' ND2' ' HB2' ' A' ' 57' ' ' ALA . 31.5 m-80 -81.22 41.15 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.775 -0.578 . . . . 0.0 110.386 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.474 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -98.2 7.96 45.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.37 26.32 0.05 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 66' ' ' ILE . 45.6 pt -140.02 141.34 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.252 -1.146 . . . . 0.0 109.411 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.48 ' HB ' HD12 ' A' ' 9' ' ' LEU . 10.2 p -121.51 125.85 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.053 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 77.8 mtt180 -89.52 116.32 27.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.941 -1.099 . . . . 0.0 110.107 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.489 ' CD1' ' HD3' ' A' ' 74' ' ' ARG . 1.4 pp -129.97 170.07 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.209 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -79.83 164.24 23.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.945 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -68.01 -18.79 64.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.09 -50.02 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 110.313 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.486 ' CE ' ' CD1' ' A' ' 44' ' ' ILE . 19.3 ttt -59.98 -45.7 91.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.443 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.565 ' CD ' HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.991 174.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -62.03 -36.42 81.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 109.84 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -67.79 -26.37 66.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 110.755 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 24.3 p -99.36 -30.99 11.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.022 -1.049 . . . . 0.0 110.547 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.478 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 106.75 19.73 9.47 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.631 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.23 169.34 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.243 . . . . 0.0 110.838 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.528 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -120.31 178.53 4.61 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.475 -0.765 . . . . 0.0 109.458 177.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -66.4 142.26 16.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 110.35 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.519 ' N ' HG11 ' A' ' 11' ' ' VAL . . . 77.36 -4.78 54.23 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 172.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.555 ' HB2' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.89 -162.08 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.053 -1.263 . . . . 0.0 110.067 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 16.4 pttp -137.2 116.15 12.36 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.636 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -119.55 160.72 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 82.8 tttt -109.37 120.62 43.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.025 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 87.3 t -101.67 123.69 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 0.0 110.204 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.548 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 93.9 mtt180 -106.88 151.4 25.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 109.763 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.457 ' CD ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -99.07 132.44 44.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.049 -1.032 . . . . 0.0 110.215 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.3 m -149.91 -168.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.561 -0.712 . . . . 0.0 110.125 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.511 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 40.1 ptt180 -129.07 171.67 12.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.636 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.74 164.72 12.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 111.023 -175.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.465 ' CG ' HG13 ' A' ' 162' ' ' VAL . 18.8 pt-20 -150.04 169.51 21.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 109.421 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.515 HD13 ' HG3' ' A' ' 163' ' ' GLU . 40.0 mm -90.66 99.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.843 -1.161 . . . . 0.0 110.607 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -57.27 140.07 50.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 110.423 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 169' ' ' LYS . 1.5 ptpt -101.68 -29.03 12.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HD3' ' OE2' ' A' ' 171' ' ' GLU . 40.2 ttmt -150.79 129.35 12.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.367 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.472 HG23 ' CG2' ' A' ' 155' ' ' THR . 9.7 p -139.67 139.99 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.009 -1.057 . . . . 0.0 110.782 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 14.5 m -102.71 138.67 39.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.873 . . . . 0.0 110.042 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -132.03 159.96 37.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.696 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.18 81.82 43.39 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.432 -0.793 . . . . 0.0 110.396 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 19.7 Cg_exo . . . . . 0 C--N 1.304 -1.775 0 O-C-N 123.936 1.493 . . . . 0.0 110.33 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.124 0.488 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.48 -42.58 99.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -70.04 -30.12 67.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.93 -39.93 83.07 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.56 ' CG1' HD11 ' A' ' 170' ' ' ILE . 56.0 t -60.07 -43.79 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.316 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.608 ' NE2' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -59.63 -45.06 93.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.987 -1.07 . . . . 0.0 109.575 175.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -59.94 -40.09 87.77 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.22 -22.18 38.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.165 -0.959 . . . . 0.0 110.938 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -130.03 7.22 5.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.94 -1.1 . . . . 0.0 110.674 -174.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 0.1 OUTLIER -44.26 173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.311 -0.868 . . . . 0.0 110.883 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.7 ptm180 34.9 46.63 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.498 -0.751 . . . . 0.0 111.29 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 8.9 ttt180 -123.33 129.7 24.81 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.87 -1.144 . . . . 0.0 111.19 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.801 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.5 Cg_endo -66.26 125.9 14.8 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.954 1.502 . . . . 0.0 109.647 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.455 ' C ' HD11 ' A' ' 130' ' ' LEU . 97.6 mtp -140.01 151.62 45.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.27 -1.519 . . . . 0.0 112.092 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.602 ' N ' ' CD2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -126.03 146.16 50.01 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.443 0.639 . . . . 0.0 109.975 172.23 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.4 pm0 -57.18 140.02 50.83 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 172.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 75.2 -0.75 3.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.75 -0.594 . . . . 0.0 110.262 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.552 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 0.7 OUTLIER -67.81 -172.81 0.3 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 109.942 176.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 17.1 m-80 -141.18 149.72 41.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.016 -1.052 . . . . 0.0 110.493 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 66.5 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.416 0.627 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -118.05 102.21 8.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.922 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.552 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 2.5 t -74.93 135.73 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.791 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.42 -31.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 110.669 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 155' ' ' THR . 54.7 tttm -139.39 148.76 43.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.954 -1.091 . . . . 0.0 110.953 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 24.4 p -145.07 159.7 42.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.76 -0.588 . . . . 0.0 109.836 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.674 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -90.46 -38.05 0.4 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.344 -0.847 . . . . 0.0 111.015 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 12.6 Cg_exo -60.15 -173.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.434 1.228 . . . . 0.0 110.911 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 159' ' ' LYS . 5.4 t -90.17 -168.47 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 158' ' ' SER . 8.7 ptpt -66.3 -6.01 12.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.7 m -86.36 152.33 54.97 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.599 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.597 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.6 Cg_endo -51.52 132.42 40.38 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.289 1.678 . . . . 0.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.801 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 3.5 m -121.96 152.92 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.609 -1.237 . . . . 0.0 110.269 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.515 ' HG3' HD13 ' A' ' 94' ' ' ILE . 18.1 pt-20 -103.47 127.93 50.75 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.879 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.577 ' CG2' ' OE1' ' A' ' 121' ' ' GLN . 19.3 mm -71.04 153.4 8.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.136 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.608 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -143.69 167.29 26.7 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.494 ' HG2' HD12 ' A' ' 125' ' ' ILE . 99.0 mt-10 -56.61 -20.58 21.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -1.062 . . . . 0.0 110.397 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.94 -9.91 47.04 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.667 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.535 ' CG2' HD11 ' A' ' 164' ' ' ILE . 95.6 m -62.44 146.65 50.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.167 -0.958 . . . . 0.0 109.886 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.5 mttt -97.43 143.97 27.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 109.64 176.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.56 HD11 ' CG1' ' A' ' 120' ' ' VAL . 2.1 mm -106.84 129.45 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.481 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 64.7 mt-10 -116.31 135.2 54.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 110.156 172.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.44 HG12 ' HG ' ' A' ' 100' ' ' LEU . 41.3 mt -140.1 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.873 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 173' ' ' ARG . 3.5 ptm85 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.228 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.9 p30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.139 0.495 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.71 -159.13 8.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 20.6 pt -137.2 169.35 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -112.51 120.51 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.011 -1.056 . . . . 0.0 110.444 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.7 pt? -139.41 -167.66 2.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.776 . . . . 0.0 109.747 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 34.9 ptt180 -118.88 140.02 50.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.794 -1.191 . . . . 0.0 110.715 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 81' ' ' ILE . 4.6 p -62.35 147.7 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -122.3 147.66 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.903 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.483 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.1 tt0 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.497 ' HG3' ' CG ' ' A' ' 55' ' ' TYR . 59.8 ttt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.171 0.51 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 55.5 t -112.56 112.53 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 0.0 110.271 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.544 ' HD3' ' HD2' ' A' ' 68' ' ' ARG . 7.4 ptt180 -84.24 117.37 23.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.689 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 30' ' ' SER . 1.8 mp -134.83 170.62 15.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.993 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.468 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.0 p-10 -105.57 -175.18 2.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 110.507 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -59.91 -42.09 93.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.184 -0.947 . . . . 0.0 109.643 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -67.4 -49.56 63.29 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.3 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.629 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 72.4 m -57.9 -27.44 63.31 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.119 -0.988 . . . . 0.0 109.56 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 39.9 ttm180 -86.43 -46.08 10.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.822 -0.549 . . . . 0.0 110.957 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -79.71 -8.58 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.629 ' CD2' ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -43.85 -28.7 0.47 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -0.779 . . . . 0.0 110.136 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 33' ' ' LEU . 83.2 mt -141.76 -59.43 0.47 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 110.272 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.602 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.4 t0 -170.56 -30.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.424 -0.798 . . . . 0.0 110.066 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.602 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -15.35 120.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.437 0.637 . . . . 0.0 111.581 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -105.87 -177.51 3.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.0 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.5 mm -63.73 119.4 7.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.062 -1.024 . . . . 0.0 110.135 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.447 ' H ' HG13 ' A' ' 54' ' ' VAL . . . 73.25 35.95 56.3 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 1.4 m-20 -89.81 178.3 6.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.056 -1.261 . . . . 0.0 109.499 173.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.489 HG22 ' OG1' ' A' ' 92' ' ' THR . 97.0 t -99.65 127.76 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.015 -1.053 . . . . 0.0 110.301 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.447 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.1 m -120.95 149.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.514 -0.741 . . . . 0.0 110.683 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -111.93 140.8 46.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.594 -0.691 . . . . 0.0 109.982 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.625 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.5 mp -124.92 144.01 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.926 -1.109 . . . . 0.0 110.731 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -150.21 98.79 2.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 110.827 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.568 ' CG ' HG11 ' A' ' 85' ' ' VAL . 9.2 tmtm? -97.94 -64.36 1.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.559 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.527 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.17 -36.94 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.817 0.818 . . . . 0.0 109.098 175.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 70.5 mtt85 -128.95 -173.47 2.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' HD23 ' A' ' 130' ' ' LEU . 29.3 mttt -96.18 141.75 29.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.122 -0.986 . . . . 0.0 110.902 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.625 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.5 p -145.0 168.2 20.84 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.374 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.598 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.57 162.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.447 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -171.66 41.39 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.216 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -121.72 166.44 14.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.458 -1.025 . . . . 0.0 110.165 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -99.94 149.69 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.004 . . . . 0.0 110.412 -175.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.0 m-85 -139.16 167.84 21.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.511 -0.743 . . . . 0.0 110.339 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -88.62 122.77 32.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.844 . . . . 0.0 110.052 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.496 ' CB ' ' OD1' ' A' ' 63' ' ' ASN . . . -64.3 138.3 58.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.715 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 2.4 mtp180 -58.35 -47.21 99.21 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.309 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.715 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 56.2 Cg_endo -93.51 98.96 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.675 1.355 . . . . 0.0 108.69 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.423 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.5 pt-20 -73.28 35.65 0.08 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.587 -0.696 . . . . 0.0 110.784 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 59' ' ' PRO . 73.3 m-20 -146.07 -30.79 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.96 -28.78 25.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.433 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 5.3 m120 -80.53 39.64 0.48 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.723 -0.61 . . . . 0.0 110.64 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -98.96 13.34 33.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.072 -1.017 . . . . 0.0 109.663 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.72 26.42 0.05 OUTLIER Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.511 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.55 149.04 20.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.371 -1.076 . . . . 0.0 108.933 175.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 12' ' ' ALA . 7.6 p -126.55 131.81 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.928 -1.108 . . . . 0.0 110.348 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.544 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 3.5 ttt180 -89.59 116.24 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 110.325 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.526 HD12 ' CG2' ' A' ' 11' ' ' VAL . 1.7 pp -135.36 168.58 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.318 -0.864 . . . . 0.0 111.036 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.06 155.54 25.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.282 -0.886 . . . . 0.0 110.201 174.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' ' CG ' ' A' ' 75' ' ' ASN . 60.1 p -60.12 -23.37 63.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 110.147 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.6 t -68.09 -42.94 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 110.232 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -60.95 -50.91 71.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 109.974 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.609 ' HD2' ' CG2' ' A' ' 11' ' ' VAL . 13.2 mmp_? -60.14 -39.85 87.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 173.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 78.2 m-20 -60.12 -37.77 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' MET . 93.8 m-20 -59.94 -36.25 76.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 110.648 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 30.2 p -98.15 -39.33 8.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.105 -0.997 . . . . 0.0 110.531 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.527 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 119.18 36.17 0.89 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.51 ' HB2' ' HD3' ' A' ' 74' ' ' ARG . . . -116.48 170.2 8.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.327 . . . . 0.0 110.38 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.513 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.99 -176.83 3.43 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.649 ' HA ' HG12 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -66.57 143.42 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.487 178.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.511 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 76.13 0.95 67.16 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.3 m-20 -61.33 -165.4 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.071 -1.253 . . . . 0.0 110.581 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.0 pttt -130.64 112.94 13.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 0.0 109.945 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.568 HG11 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -122.68 161.15 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 109.995 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 26.4 ttmt -104.96 125.67 51.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.011 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.28 121.25 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.53 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.6 mtt180 -111.39 147.13 35.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.419 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -92.51 139.57 30.45 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.255 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.69 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.413 -0.804 . . . . 0.0 110.26 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -132.25 172.28 12.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.466 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.489 ' OG1' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.49 159.59 16.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.974 -1.079 . . . . 0.0 111.204 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -150.02 169.97 19.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 4.6 mp -89.56 99.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.731 -1.231 . . . . 0.0 110.241 -178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -55.0 138.04 44.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.772 . . . . 0.0 110.353 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.489 ' CG ' HD11 ' A' ' 156' ' ' LEU . 15.5 ptmt -98.39 -30.01 12.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.34 -0.85 . . . . 0.0 110.849 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HB3' HD11 ' A' ' 156' ' ' LEU . 14.7 tttp -151.06 125.61 9.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.85 -1.156 . . . . 0.0 110.803 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.499 HG11 ' O ' ' A' ' 98' ' ' VAL . 8.6 p -137.52 147.17 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.065 . . . . 0.0 111.044 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 171' ' ' GLU . 38.0 m -119.14 142.82 47.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.111 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -138.54 169.03 18.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.847 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.38 93.84 4.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.415 -0.803 . . . . 0.0 110.489 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.7 Cg_exo . . . . . 0 C--N 1.303 -1.864 0 O-C-N 124.201 1.632 . . . . 0.0 110.417 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 9.5 tp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.091 0.472 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 98.7 mt-10 -60.03 -42.12 93.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.27 -37.51 83.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 109.6 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -59.97 -42.42 94.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.517 ' CG1' HD13 ' A' ' 170' ' ' ILE . 53.1 t -60.26 -45.01 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 175.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.573 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.1 mt-30 -59.89 -43.97 94.5 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.568 -0.707 . . . . 0.0 109.951 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.31 -46.01 91.4 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.819 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.9 68.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 110.921 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 2.9 mm? -99.89 5.33 45.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.025 -1.047 . . . . 0.0 111.171 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.573 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.7 tt -48.71 170.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 36.6 ptt180 33.66 49.12 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.628 -0.67 . . . . 0.0 111.516 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -132.37 149.93 74.51 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.711 -1.243 . . . . 0.0 111.232 176.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.772 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.1 Cg_endo -68.73 128.19 16.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 124.174 1.618 . . . . 0.0 109.971 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.519 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.7 mmm -123.07 140.95 52.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.321 -1.487 . . . . 0.0 110.983 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 20.2 tp -139.24 104.19 4.94 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.695 -0.628 . . . . 0.0 109.386 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.642 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.5 pt-20 -45.24 137.09 4.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.046 -1.034 . . . . 0.0 110.7 -174.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 86.01 -6.06 0.8 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.27 0.557 . . . . 0.0 110.283 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.552 ' OD2' ' HB ' ' A' ' 152' ' ' VAL . 2.8 p30 -69.49 -178.31 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 110.359 177.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -147.1 153.09 39.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.941 -1.099 . . . . 0.0 110.65 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.7 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.188 0.518 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -112.4 111.95 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.552 ' HB ' ' OD2' ' A' ' 133' ' ' ASP . 2.7 t -78.15 137.57 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.89 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.48 -31.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.257 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.463 ' C ' HG23 ' A' ' 155' ' ' THR . 28.4 tttm -143.43 146.98 33.91 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.411 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.496 ' CG2' HG22 ' A' ' 98' ' ' VAL . 56.0 p -140.0 161.68 37.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.666 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.5 OUTLIER -89.26 -35.91 0.42 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.96 -1.087 . . . . 0.0 111.103 -177.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 15.3 Cg_exo -58.61 -167.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.327 1.172 . . . . 0.0 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.1 t -87.68 -173.88 4.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.792 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -67.9 -1.84 6.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.176 -0.953 . . . . 0.0 110.567 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.1 m -85.79 147.73 46.76 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.146 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.598 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.8 Cg_endo -47.45 139.07 17.74 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 O-C-N 124.358 1.715 . . . . 0.0 110.975 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.772 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 11.1 m -130.02 159.21 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 109.442 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.3 tt0 -106.61 127.23 53.17 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.048 -1.032 . . . . 0.0 110.229 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.519 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 16.6 mm -70.43 154.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.667 -0.646 . . . . 0.0 110.213 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.24 175.4 23.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.75 -26.05 63.61 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.341 -1.094 . . . . 0.0 109.992 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.36 -17.76 28.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 0.0 110.737 -176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.559 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 53.3 m -58.73 146.37 36.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 96' ' ' LYS . 98.6 mttt -100.01 153.14 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.955 -1.091 . . . . 0.0 109.467 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.517 HD13 ' CG1' ' A' ' 120' ' ' VAL . 2.1 mt -129.92 159.4 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.001 -1.062 . . . . 0.0 111.185 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.438 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 10.4 mt-10 -130.35 130.91 45.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.029 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.417 ' CD1' HD13 ' A' ' 100' ' ' LEU . 50.5 mm -119.91 127.18 75.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.32 -0.863 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 2.9 ptp180 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 67.3 t30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.122 0.487 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -147.09 -169.71 14.82 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.446 HG22 ' CD1' ' A' ' 34' ' ' LEU . 45.7 pt -134.82 159.99 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.228 -1.16 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.474 ' CD1' ' HB2' ' A' ' 86' ' ' LYS . 40.4 mm -98.37 116.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 110.331 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.3 pt? -139.37 -178.26 5.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.324 -0.86 . . . . 0.0 109.728 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 6.3 ptp180 -106.73 137.0 45.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 110.899 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.569 ' CG1' ' O ' ' A' ' 80' ' ' SER . 13.5 p -63.75 134.81 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.596 -0.69 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -119.79 153.47 35.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.421 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.509 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.904 . . . . 0.0 110.607 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.502 ' CD ' ' CZ ' ' A' ' 55' ' ' TYR . 18.1 mtt-85 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.364 0.602 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 55' ' ' TYR . 97.6 t -117.15 122.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.502 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 1.6 ptm180 -95.64 119.33 33.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.742 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.45 HD11 ' N ' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -140.69 174.85 10.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 0.0 109.513 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.1 p-10 -90.28 177.64 6.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.927 -1.108 . . . . 0.0 110.737 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.99 -41.1 91.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 108.801 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.612 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.0 t -62.77 -58.38 7.64 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.076 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.516 ' O ' HD21 ' A' ' 33' ' ' LEU . 58.4 m -49.91 -30.39 10.1 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.833 -1.167 . . . . 0.0 109.572 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.45 ' N ' HD11 ' A' ' 26' ' ' LEU . 40.3 ttm180 -81.62 -45.52 15.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 111.603 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -97.95 -10.6 24.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.267 . . . . 0.0 110.958 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.612 ' HB3' ' O ' ' A' ' 29' ' ' SER . 0.8 OUTLIER -59.94 -26.02 65.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.987 -1.07 . . . . 0.0 109.774 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 33' ' ' LEU . 54.4 mt -110.63 -75.87 0.61 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.145 -0.972 . . . . 0.0 110.277 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.534 ' HB3' ' CD ' ' A' ' 89' ' ' LYS . 9.4 t70 -168.27 -20.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.574 -0.704 . . . . 0.0 109.971 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -40.46 126.78 2.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.358 -0.839 . . . . 0.0 110.681 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.549 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.3 pt-20 -119.12 179.77 4.07 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 108.929 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' NH1' ' A' ' 31' ' ' ARG . 5.5 mm -55.81 127.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.06 . . . . 0.0 109.875 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.62 24.3 74.97 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.708 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 6.9 m-20 -89.01 169.94 11.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.754 -1.439 . . . . 0.0 109.855 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.427 HG23 ' CG2' ' A' ' 92' ' ' THR . 79.2 t -99.78 127.97 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 110.137 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 52' ' ' GLY . 2.6 m -116.02 143.71 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -113.28 143.2 44.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.735 . . . . 0.0 109.632 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -119.97 145.9 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.023 . . . . 0.0 110.198 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -151.8 88.53 1.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.062 -1.024 . . . . 0.0 111.612 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.593 ' HD3' ' CB ' ' A' ' 79' ' ' ALA . 31.0 tttm -99.23 -71.74 0.68 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 110.2 171.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.527 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.15 -34.71 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.507 -0.746 . . . . 0.0 109.409 178.06 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -141.3 -173.28 3.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.5 -0.75 . . . . 0.0 109.892 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.528 ' O ' HD22 ' A' ' 130' ' ' LEU . 2.1 mptm? -87.84 133.22 33.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 110.325 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.554 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -134.93 159.28 41.94 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.354 0.597 . . . . 0.0 110.318 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.39 162.17 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.825 . . . . 0.0 109.963 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.485 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -179.83 48.01 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.995 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.451 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 61.8 ttt180 -116.6 169.84 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 0.0 110.214 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.85 131.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 110.322 -175.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.502 ' CZ ' ' CD ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -121.3 163.67 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.551 -0.718 . . . . 0.0 110.009 175.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -90.68 124.19 34.88 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 110.134 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.459 ' HB2' ' OD1' ' A' ' 63' ' ' ASN . . . -63.22 139.25 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.565 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -58.74 -49.05 95.51 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.186 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 36.2 Cg_endo -91.06 98.78 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 108.922 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 15.7 pt-20 -73.07 35.93 0.08 Allowed 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.65 -0.657 . . . . 0.0 110.749 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.5 m-20 -148.91 -33.42 0.22 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.252 -0.905 . . . . 0.0 110.721 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.23 -26.49 28.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.987 . . . . 0.0 109.166 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.492 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 13.4 m120 -80.94 42.29 0.63 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.769 -0.582 . . . . 0.0 110.537 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 34.4 mtpt -97.79 10.0 41.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.563 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.48 28.84 0.05 OUTLIER Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.492 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.1 pt -140.59 143.88 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -1.154 . . . . 0.0 109.55 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.449 ' CB ' HD11 ' A' ' 9' ' ' LEU . 2.5 p -120.8 127.59 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.06 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.519 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 20.8 tpp180 -90.63 114.9 27.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.088 -1.008 . . . . 0.0 109.906 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 2.4 pt -130.05 161.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.99 169.94 17.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 110.047 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.442 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 21.5 t -60.2 -36.74 78.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 110.365 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.27 -45.9 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 109.888 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 13.7 tpt -60.13 -43.45 95.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.588 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -60.0 -40.03 87.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.761 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.41 -25.94 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 73' ' ' MET . 5.4 m120 -60.12 -40.02 88.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.655 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.447 ' HB2' HG23 ' A' ' 47' ' ' VAL . 28.0 p -99.91 -38.06 8.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.985 -1.072 . . . . 0.0 110.545 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.527 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 114.79 30.85 2.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.593 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.43 169.49 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -1.131 . . . . 0.0 110.74 -174.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.569 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.7 170.96 8.19 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.341 -0.849 . . . . 0.0 109.039 174.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -63.27 140.57 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.794 -1.192 . . . . 0.0 110.429 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 11' ' ' VAL . . . 77.82 -2.95 62.31 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 172.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.568 ' HB2' HG13 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -59.64 -159.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.101 -1.235 . . . . 0.0 110.394 174.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 54.6 pttt -138.79 119.76 14.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.78 . . . . 0.0 109.836 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.564 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -123.02 161.38 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 109.895 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.474 ' HB2' ' CD1' ' A' ' 8' ' ' ILE . 20.0 ttpt -105.31 120.02 40.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 62.6 t -103.71 121.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.7 mtt180 -111.3 131.84 54.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.358 -0.839 . . . . 0.0 110.146 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.534 ' CD ' ' HB3' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -74.91 137.87 41.99 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.45 -169.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.066 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -127.99 170.98 12.27 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.427 ' CG2' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.01 159.95 16.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 111.052 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.409 ' H ' ' HA ' ' A' ' 162' ' ' VAL . 16.9 pt-20 -146.29 173.68 12.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.94 99.03 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.681 -1.262 . . . . 0.0 110.178 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 162' ' ' VAL . . . -54.09 138.79 36.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -0.803 . . . . 0.0 110.301 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.535 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -103.96 -28.25 11.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.955 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.47 ' HE3' ' OE2' ' A' ' 171' ' ' GLU . 52.5 tttp -150.04 123.08 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.761 -1.212 . . . . 0.0 110.253 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.477 HG22 HG23 ' A' ' 155' ' ' THR . 9.7 p -137.07 140.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 110.484 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 21.7 m -110.98 134.52 52.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.968 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -130.79 159.83 36.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.392 -0.817 . . . . 0.0 110.162 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.494 ' CB ' ' HD2' ' A' ' 173' ' ' ARG . . . -128.74 100.04 22.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 110.438 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 124.007 1.53 . . . . 0.0 110.039 179.67 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 117' ' ' GLU . 8.2 tt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.067 0.46 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' N ' HG22 ' A' ' 116' ' ' ILE . 97.2 mt-10 -60.03 -44.81 94.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.62 -37.25 86.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 109.594 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -60.0 -39.99 87.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.812 . . . . 0.0 109.599 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.49 ' CG1' HD11 ' A' ' 170' ' ' ILE . 79.3 t -59.99 -46.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.992 . . . . 0.0 109.371 175.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.596 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.88 -39.82 86.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 175.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.05 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.81 65.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.353 -0.842 . . . . 0.0 110.577 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 125' ' ' ILE . 86.0 mt -91.04 -9.46 45.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.834 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 3.3 tt -42.39 167.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.591 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 164' ' ' ILE . 26.1 ptt180 33.26 46.2 0.1 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.692 -0.63 . . . . 0.0 111.429 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.501 ' CG ' ' HD2' ' A' ' 128' ' ' PRO . 18.8 ttm180 -132.07 142.5 45.33 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.653 -1.28 . . . . 0.0 111.225 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.796 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.7 Cg_endo -64.6 126.34 16.62 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 124.258 1.662 . . . . 0.0 109.427 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.542 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.4 mmm -124.6 145.58 49.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.395 -1.441 . . . . 0.0 111.076 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 12.8 tp -142.55 116.67 9.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.5 pm0 -47.9 148.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.911 -1.118 . . . . 0.0 110.517 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 74.98 -2.41 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.788 -0.57 . . . . 0.0 110.871 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.56 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 2.2 p30 -69.34 -171.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.463 ' C ' HG13 ' A' ' 135' ' ' ILE . 15.1 m-80 -149.44 132.15 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.538 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.463 HG13 ' C ' ' A' ' 134' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 110.486 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.326 0.584 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.452 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 15.3 tptm -97.77 106.35 18.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 109.725 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.56 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 2.8 t -76.64 134.47 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.995 . . . . 0.0 109.716 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.47 -20.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 110.457 -177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.5 tttm -139.58 140.42 37.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.68 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.477 HG23 HG22 ' A' ' 98' ' ' VAL . 47.0 p -139.75 161.53 37.33 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.7 -0.625 . . . . 0.0 109.602 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.69 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.55 -34.41 0.42 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 110.992 -177.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 29.4 Cg_exo -55.82 -168.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.343 1.181 . . . . 0.0 110.197 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 16.1 t -90.15 40.18 1.0 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.651 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 158' ' ' SER . 26.4 mmtp 59.97 42.31 16.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.07 160.06 68.64 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.533 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -49.53 120.11 5.42 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 124.09 1.574 . . . . 0.0 110.155 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 11.7 m -128.19 159.52 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.479 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -103.93 124.48 49.07 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.574 ' O ' ' N ' ' A' ' 126' ' ' ARG . 16.1 mm -72.06 153.67 7.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.817 -0.552 . . . . 0.0 110.301 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.53 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -140.8 166.67 25.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -58.14 -18.24 24.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.04 . . . . 0.0 110.29 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -89.21 -13.72 37.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.92 . . . . 0.0 110.375 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.501 ' HB ' ' OE1' ' A' ' 121' ' ' GLN . 7.2 m -62.52 150.82 39.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.014 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -98.6 153.62 18.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.27 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.59 HD12 ' HG2' ' A' ' 121' ' ' GLN . 3.6 mm -119.88 134.81 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 110.927 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.47 ' OE2' ' HE3' ' A' ' 97' ' ' LYS . 37.0 mt-10 -119.7 132.55 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.564 172.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.446 HG12 ' HG2' ' A' ' 117' ' ' GLU . 21.4 mm -127.33 122.78 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.457 -0.777 . . . . 0.0 109.748 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.494 ' HD2' ' CB ' ' A' ' 101' ' ' ALA . 13.3 ptp180 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.057 -1.027 . . . . 0.0 110.506 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.252 0.549 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.81 -166.49 11.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.594 ' CD1' HD12 ' A' ' 33' ' ' LEU . 20.5 pt -132.52 160.02 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.24 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.4 mt -100.12 117.81 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.7 pt? -136.87 -168.3 2.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.625 176.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 29.0 ptt180 -115.65 138.61 50.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.826 -1.172 . . . . 0.0 110.894 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 80' ' ' SER . 14.6 p -62.64 137.51 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.766 -0.584 . . . . 0.0 110.713 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -112.03 147.24 36.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 110.415 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.145 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.05 0.452 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 55' ' ' TYR . 75.2 t -117.15 113.56 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.02 . . . . 0.0 110.086 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.504 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 8.2 ptt180 -92.26 120.11 32.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.704 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 1.2 mp -135.38 165.75 24.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.071 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 23.1 p-10 -90.02 -176.48 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.115 -0.991 . . . . 0.0 110.584 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.1 -45.15 93.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.282 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 43.5 t -60.24 -49.25 78.36 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.165 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.628 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 74.7 m -56.68 -29.44 62.37 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.128 -0.983 . . . . 0.0 109.607 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 68.1 ttt-85 -82.5 -45.35 14.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.0 110.763 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -87.61 -0.26 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.628 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.5 pt? -52.56 -26.36 13.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.59 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 71.4 mt -142.27 -59.07 0.46 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.53 -0.731 . . . . 0.0 110.329 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.8 t0 -170.72 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 110.022 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.558 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -21.9 118.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.497 0.665 . . . . 0.0 111.373 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.502 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -107.78 176.75 5.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.8 mm -59.12 125.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.822 -1.174 . . . . 0.0 109.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.47 27.49 61.3 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.566 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 52.3 m-20 -89.49 173.29 8.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.428 . . . . 0.0 109.72 171.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.527 ' CG2' HG21 ' A' ' 92' ' ' THR . 64.7 t -99.48 131.45 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.017 -1.052 . . . . 0.0 110.269 -176.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG13 HG23 ' A' ' 54' ' ' VAL . 2.2 m -117.06 139.83 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.176 -0.953 . . . . 0.0 110.301 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -108.32 140.12 42.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.395 -0.816 . . . . 0.0 109.565 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.599 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.1 mp -122.78 145.45 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.903 -1.123 . . . . 0.0 110.592 -176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -150.13 95.19 2.25 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.834 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.536 ' CG ' HG12 ' A' ' 85' ' ' VAL . 12.6 tmtt? -97.92 -65.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.766 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.557 HG22 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.91 -36.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.457 -0.777 . . . . 0.0 109.225 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 68.2 mtp85 -127.99 -160.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.664 0.745 . . . . 0.0 110.111 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.467 ' HB3' HD21 ' A' ' 130' ' ' LEU . 3.1 mtmt -106.13 131.38 53.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 110.369 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.599 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.7 p -138.51 165.0 27.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.855 . . . . 0.0 110.112 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.559 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.39 166.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.603 -0.686 . . . . 0.0 109.913 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' C ' HG23 ' A' ' 42' ' ' VAL . . . -178.0 -174.28 44.17 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -122.07 164.96 16.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -1.083 . . . . 0.0 110.02 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -92.54 139.99 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 110.747 -172.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 24' ' ' VAL . 2.2 m-85 -125.81 162.5 24.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.52 -0.738 . . . . 0.0 110.125 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 8.7 ptp180 -89.91 124.6 34.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.34 -0.85 . . . . 0.0 109.905 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -64.5 136.4 57.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.809 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.578 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -57.85 -50.06 90.24 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 109.071 175.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 38.0 Cg_endo -92.98 98.01 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.867 1.456 . . . . 0.0 108.868 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.59 38.22 0.12 Allowed 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 59' ' ' PRO . 72.9 m-20 -143.75 -38.94 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.613 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 13.8 pt-20 -85.56 -22.39 28.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.007 . . . . 0.0 109.727 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.489 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 27.9 m-80 -81.68 37.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 110.715 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 54.4 pttt -98.43 12.25 35.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.997 -1.065 . . . . 0.0 109.547 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.82 26.53 0.05 OUTLIER Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.489 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -140.53 144.9 26.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.3 -1.117 . . . . 0.0 109.177 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 67' ' ' VAL . 6.5 p -125.83 129.91 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.029 -1.045 . . . . 0.0 110.265 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 58.8 ttt85 -89.7 119.93 30.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.539 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 3.8 pt -130.6 167.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.818 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -80.06 166.51 21.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.065 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.4 t -60.21 -39.98 88.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -43.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.038 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.511 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 13.3 tpt -60.06 -46.91 87.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.1 ttp85 -60.0 -39.99 87.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -70.06 -27.11 64.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.5 m-20 -60.01 -40.01 87.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.02 . . . . 0.0 110.767 -177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.479 ' HB2' HG23 ' A' ' 47' ' ' VAL . 29.5 p -99.53 -39.04 8.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.101 . . . . 0.0 110.723 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.557 ' CA ' HG22 ' A' ' 47' ' ' VAL . . . 116.13 40.73 0.8 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.61 160.73 17.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.025 -1.279 . . . . 0.0 110.659 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.554 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.9 168.88 9.14 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 176.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -53.04 139.01 11.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.034 -1.041 . . . . 0.0 110.609 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 75.65 2.58 70.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 171.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.62 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.885 -1.362 . . . . 0.0 110.228 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 22.8 pttt -131.94 109.83 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.536 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -119.97 150.24 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.955 . . . . 0.0 109.864 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 67.6 tttt -99.94 120.07 39.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.752 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.481 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.6 t -103.2 122.4 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.512 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.2 mtt180 -108.65 140.05 42.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.544 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -88.21 138.2 31.65 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.069 -1.02 . . . . 0.0 110.32 -178.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.4 m -150.17 -170.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.652 -0.655 . . . . 0.0 110.085 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.434 ' CA ' ' HB ' ' A' ' 41' ' ' VAL . 61.4 mtt180 -126.46 179.99 5.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.057 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.527 HG21 ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.76 162.73 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 111.209 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -150.03 169.13 21.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.23 97.87 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.33 -1.482 . . . . 0.0 110.3 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.54 ' CB ' HG21 ' A' ' 162' ' ' VAL . . . -56.22 138.82 49.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -0.837 . . . . 0.0 110.387 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HD2' ' CD1' ' A' ' 156' ' ' LEU . 18.6 ptpt -97.22 -27.17 14.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 111.153 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 31.5 tttt -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.82 -1.175 . . . . 0.0 110.558 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 155' ' ' THR . 5.7 p -136.13 142.53 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 171' ' ' GLU . 97.7 m -115.81 136.37 53.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.283 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -131.42 160.07 36.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.478 -0.763 . . . . 0.0 110.155 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -146.23 101.74 4.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.922 . . . . 0.0 110.883 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 15.4 Cg_exo . . . . . 0 C--N 1.305 -1.732 0 O-C-N 124.072 1.564 . . . . 0.0 110.299 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.418 HG21 ' N ' ' A' ' 117' ' ' GLU . 9.3 tp . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.177 0.513 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.468 ' HG2' HG12 ' A' ' 172' ' ' ILE . 98.9 mt-10 -60.01 -44.76 94.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.747 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -70.03 -40.0 75.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.839 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -59.87 -40.11 87.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.845 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 170' ' ' ILE . 49.0 t -60.05 -45.69 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.38 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.577 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 6.7 mt-30 -59.92 -47.7 84.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.609 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.51 -0.744 . . . . 0.0 110.41 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.47 ' HB1' HD22 ' A' ' 124' ' ' LEU . . . -69.35 -39.92 77.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.757 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.487 ' HB3' ' NE ' ' A' ' 127' ' ' ARG . 3.0 mm? -130.07 24.2 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 111.123 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.9 tt -48.31 176.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.094 . . . . 0.0 110.003 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 34.5 ptt180 33.96 49.14 0.27 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.527 -0.733 . . . . 0.0 111.204 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.49 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 36.9 ttp180 -128.35 142.59 45.19 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.925 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.2 Cg_endo -62.17 131.73 35.83 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.961 1.506 . . . . 0.0 110.079 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.511 ' CG ' HG12 ' A' ' 164' ' ' ILE . 96.7 mmm -123.48 140.03 53.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 110.952 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 19.7 tp -142.49 105.64 4.58 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.61 -0.681 . . . . 0.0 109.67 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.674 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.7 pt-20 -48.47 141.1 7.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.974 -1.079 . . . . 0.0 110.67 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 86.2 mm-40 79.93 -1.68 2.07 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.167 0.508 . . . . 0.0 110.498 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 1.9 p30 -69.98 -172.42 0.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.047 -1.033 . . . . 0.0 110.31 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -144.11 137.72 27.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.737 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.084 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 3.2 m-85 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.239 0.542 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -104.7 108.84 20.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.32 -0.862 . . . . 0.0 109.978 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.537 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 3.1 t -76.48 132.68 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.683 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 t -114.61 -30.1 2.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 111.108 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -144.75 150.2 36.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.782 -1.199 . . . . 0.0 111.272 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.493 HG22 HG23 ' A' ' 98' ' ' VAL . 72.3 p -140.33 161.32 37.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 109.427 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.654 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.64 -38.69 0.45 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.843 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 18.0 Cg_exo -58.39 -166.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.575 1.303 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.8 t -90.05 -171.09 3.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -65.33 -5.88 8.49 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.201 -0.937 . . . . 0.0 110.64 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.1 m -85.2 145.36 42.74 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.405 -0.81 . . . . 0.0 110.287 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.559 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -48.5 141.37 19.79 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.285 1.676 . . . . 0.0 110.796 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.782 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 11.2 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.493 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.4 tt0 -107.62 130.67 54.88 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.13 -0.982 . . . . 0.0 110.241 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 126' ' ' ARG . 19.0 mm -69.75 152.51 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 110.029 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.65 169.9 26.4 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -56.5 -17.97 10.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -1.117 . . . . 0.0 109.923 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.13 -25.76 18.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.567 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 91.3 m -56.57 142.3 39.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.791 . . . . 0.0 110.089 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 43.6 mmtm -91.96 154.86 18.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.856 -1.153 . . . . 0.0 110.186 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.577 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 1.4 mm -119.92 130.04 74.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.365 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 99' ' ' THR . 21.9 mt-10 -112.68 136.09 52.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 110.23 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.519 ' CD1' HG21 ' A' ' 170' ' ' ILE . 7.5 mm -124.59 134.86 65.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.608 -0.682 . . . . 0.0 109.57 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.556 ' O ' ' CD ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.344 -174.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 27.7 m120 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.316 0.579 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.493 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -149.36 -159.94 8.89 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.546 HG13 ' CD2' ' A' ' 9' ' ' LEU . 15.4 pt -138.97 163.96 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -1.188 . . . . 0.0 109.805 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.494 HD12 ' HG3' ' A' ' 86' ' ' LYS . 48.1 mm -101.0 120.49 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.299 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -140.87 -176.54 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.713 177.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 28.3 ptt180 -117.01 144.11 44.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.838 -1.164 . . . . 0.0 110.524 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.591 HG13 ' HA ' ' A' ' 81' ' ' ILE . 3.3 p -61.37 140.64 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.621 -0.674 . . . . 0.0 110.899 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -118.88 144.23 46.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 110.583 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.265 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.555 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 76.5 mtt85 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 84.8 t -119.73 116.17 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.979 -1.076 . . . . 0.0 110.269 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.548 ' NE ' ' HG3' ' A' ' 68' ' ' ARG . 3.8 ptt180 -88.17 119.46 28.58 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.68 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.523 HD12 ' CB ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -137.95 177.42 7.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.751 -0.593 . . . . 0.0 109.684 -175.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 22.2 p-10 -103.07 179.73 4.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -59.97 -44.87 94.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.406 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 68.0 m -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.03 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.648 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 28.6 t -65.3 -28.22 69.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 27.8 ttm180 -80.86 -46.72 14.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.556 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.98 -9.62 59.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.648 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.3 pt? -47.22 -24.25 0.68 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.693 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.596 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 66.5 mt -141.27 -62.78 0.47 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.548 -0.72 . . . . 0.0 110.266 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.3 t0 -172.89 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.534 -0.729 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -31.38 141.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.463 0.649 . . . . 0.0 111.509 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -131.23 171.2 13.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.411 HD13 ' CG ' ' A' ' 56' ' ' ARG . 38.4 mm -63.47 79.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.674 -1.266 . . . . 0.0 110.208 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 37' ' ' GLU . . . 169.32 -4.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.552 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.438 ' CG ' ' NZ ' ' A' ' 89' ' ' LYS . 95.9 m-20 -111.94 168.75 9.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.384 -1.657 . . . . 0.0 110.874 -170.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 90' ' ' VAL . 72.1 t -103.65 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.107 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.4 m -110.84 145.88 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.17 -0.956 . . . . 0.0 110.592 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 86.5 tt0 -109.38 140.78 42.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.82 . . . . 0.0 109.827 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.581 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.1 mp -121.21 143.16 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.991 -1.068 . . . . 0.0 110.622 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -149.42 97.71 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.845 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HD2' ' CB ' ' A' ' 79' ' ' ALA . 8.5 tmtm? -97.98 -62.52 1.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.518 HG23 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -109.3 -36.33 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.644 0.735 . . . . 0.0 109.237 175.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 78.9 mtt85 -125.7 -172.91 2.71 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.726 -0.609 . . . . 0.0 109.59 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.489 ' HG2' HD21 ' A' ' 130' ' ' LEU . 0.3 OUTLIER -100.13 133.2 44.87 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.108 178.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.581 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.4 p -140.45 167.48 22.05 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.445 0.641 . . . . 0.0 109.679 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.662 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 3.6 m -116.46 175.75 2.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.744 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.84 -179.17 48.54 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -121.02 167.81 12.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 0.0 110.075 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.93 135.02 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.152 -0.967 . . . . 0.0 110.73 -174.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.555 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 3.6 m-85 -130.6 166.61 20.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.756 . . . . 0.0 110.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.432 ' HG2' ' NH2' ' A' ' 31' ' ' ARG . 21.5 mtt180 -89.43 124.04 34.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.535 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . . . -65.13 137.88 57.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.712 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.68 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 8.6 mmm180 -57.44 -45.89 99.84 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 109.027 174.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.68 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.0 Cg_endo -92.01 98.54 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.748 1.393 . . . . 0.0 108.853 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -75.26 35.84 0.12 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 59' ' ' PRO . 55.2 t0 -146.59 -37.28 0.23 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 110.873 -177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 16.3 pt-20 -84.8 -20.58 30.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.503 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 2.9 m-80 -81.63 36.58 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 110.719 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 58.4 pttt -98.31 17.5 18.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.952 -1.093 . . . . 0.0 109.388 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 176.84 21.38 0.03 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.503 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.11 152.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.196 -1.179 . . . . 0.0 109.191 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 HG13 ' A' ' 24' ' ' VAL . 7.9 p -130.02 129.98 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.98 -1.075 . . . . 0.0 110.131 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.548 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 22.5 mmm180 -91.33 111.74 23.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.508 HD13 ' HG2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -136.06 171.78 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.383 -0.823 . . . . 0.0 110.553 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -81.24 166.9 20.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 0.0 110.263 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 79.5 p -69.94 -19.28 63.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.339 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.55 -47.29 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.112 -0.993 . . . . 0.0 110.483 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.491 ' CE ' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -61.33 -47.48 85.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 109.289 177.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.563 ' HD2' ' CG2' ' A' ' 11' ' ' VAL . 5.9 mmp_? -60.04 -39.94 87.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 110.245 173.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 71' ' ' SER . 47.8 t-20 -64.09 -31.82 73.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.959 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 10.7 m120 -60.01 -36.29 76.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.394 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.2 p -98.38 -38.79 9.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.059 -1.025 . . . . 0.0 110.581 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.518 ' CA ' HG23 ' A' ' 47' ' ' VAL . . . 119.79 40.05 0.63 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.553 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -120.85 166.17 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.062 -1.258 . . . . 0.0 110.611 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.532 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -118.7 176.17 5.39 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.591 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -55.84 142.58 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.074 -1.017 . . . . 0.0 110.418 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.52 ' N ' HG11 ' A' ' 11' ' ' VAL . . . 75.96 0.76 65.8 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 172.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.578 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.3 m-20 -59.82 -167.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.849 -1.383 . . . . 0.0 110.124 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.5 pttp -132.53 115.28 15.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.701 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.532 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -125.43 153.47 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 109.574 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HG3' HD12 ' A' ' 8' ' ' ILE . 60.7 tttt -99.94 121.48 41.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.095 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.485 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 65.6 t -98.99 119.99 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.956 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.493 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 87.2 mtm180 -116.2 142.53 46.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 109.807 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.438 ' NZ ' ' CG ' ' A' ' 40' ' ' ASP . 50.6 tttp -75.99 146.59 39.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.002 -1.061 . . . . 0.0 110.543 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 41' ' ' VAL . 1.9 m -149.98 -168.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.967 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -138.76 170.0 16.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.41 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.72 156.71 21.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 111.3 -175.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 1.2 pm0 -150.31 169.71 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.406 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 4.5 mp -89.13 98.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.595 -1.316 . . . . 0.0 110.402 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.526 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -55.51 163.45 1.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.422 -0.798 . . . . 0.0 110.819 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.514 ' CG ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -136.16 -17.86 1.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.456 -0.778 . . . . 0.0 110.913 -178.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.567 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 32.9 tttt -149.59 119.92 7.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.887 -1.133 . . . . 0.0 110.336 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' A' ' 155' ' ' THR . 5.5 p -137.2 140.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 110.718 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.4 m -109.29 135.08 50.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -130.11 160.97 32.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 110.418 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.15 87.42 39.23 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.58 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--N 1.307 -1.649 0 O-C-N 123.979 1.515 . . . . 0.0 110.218 179.786 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 11.9 tt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.218 0.533 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 170' ' ' ILE . 98.9 mt-10 -59.99 -44.76 94.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.046 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -67.92 -39.97 83.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.833 . . . . 0.0 110.025 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -40.0 88.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.905 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.539 ' HB ' HG22 ' A' ' 170' ' ' ILE . 54.6 t -62.15 -44.9 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.369 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.611 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 6.3 mt-30 -59.94 -45.44 92.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.086 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.38 -41.43 93.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.487 -0.758 . . . . 0.0 109.862 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.57 -48.05 61.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 110.68 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.4 mm? -105.14 12.97 31.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.1 -1.0 . . . . 0.0 111.513 -173.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.5 tt -49.34 169.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.615 -1.303 . . . . 0.0 110.391 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 29.0 ptt180 32.98 46.07 0.08 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.599 -0.688 . . . . 0.0 111.646 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.9 mmt85 -134.76 152.44 77.54 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 120.714 -1.241 . . . . 0.0 111.358 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.757 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.1 Cg_endo -62.04 123.25 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.225 1.645 . . . . 0.0 109.684 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.482 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 15.4 mmt -137.37 137.9 39.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.554 -1.341 . . . . 0.0 110.433 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.66 ' N ' ' CD1' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.81 145.2 24.78 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.478 0.656 . . . . 0.0 110.441 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 22.0 pt-20 -55.11 152.93 7.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -0.81 . . . . 0.0 111.112 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 81.95 -12.66 0.93 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.463 0.649 . . . . 0.0 110.298 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.571 ' HB3' HD11 ' A' ' 130' ' ' LEU . 0.7 OUTLIER -69.37 -174.27 0.65 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 110.388 177.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 8.3 m-80 -147.19 160.04 42.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.203 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.209 0.528 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -115.29 113.55 24.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 110.007 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.569 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 13.2 t -77.98 135.65 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.164 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 131' ' ' GLU . 9.9 t -111.99 -28.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 76.2 mttt -150.63 163.88 37.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.916 -1.115 . . . . 0.0 111.281 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.542 HG22 ' CG2' ' A' ' 98' ' ' VAL . 73.8 p -149.04 169.8 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.774 -0.579 . . . . 0.0 109.491 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.624 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 1.4 tt -88.49 -41.2 0.47 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.987 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 22.1 Cg_exo -56.44 -177.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.569 1.3 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.8 t -74.5 -172.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.565 174.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -69.98 -2.25 12.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.162 -0.961 . . . . 0.0 110.376 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 m -87.54 150.46 48.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 110.41 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.662 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.47 140.55 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.292 1.68 . . . . 0.0 110.985 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.757 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 5.5 m -130.02 160.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.603 171.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 21.9 pt-20 -102.52 124.63 48.43 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.948 -1.095 . . . . 0.0 110.082 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 126' ' ' ARG . 8.0 mm -71.15 154.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.666 -0.646 . . . . 0.0 110.272 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 163.66 26.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -53.23 -20.04 3.7 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.511 -0.993 . . . . 0.0 110.311 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.5 -23.12 22.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.715 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.588 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 90.2 m -54.94 145.91 19.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.963 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 85.9 mttt -95.6 149.43 21.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 110.366 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.611 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 1.3 mm -117.07 129.97 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 110.501 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 100' ' ' LEU . 57.6 mt-10 -115.45 136.26 53.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 110.166 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 120' ' ' VAL . 5.9 mt -135.27 133.61 52.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.104 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 110.315 -178.619 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.19 0.519 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -146.48 -165.1 11.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 23.0 pt -130.44 160.38 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -1.2 . . . . 0.0 110.17 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.5 mt -102.14 114.03 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.288 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.5 pt? -137.23 -174.32 3.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 109.786 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 30.7 ptt180 -111.55 139.59 46.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.727 -1.233 . . . . 0.0 111.025 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 80' ' ' SER . 13.5 p -62.7 135.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -116.53 145.74 43.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 86.2 tt0 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.359 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.503 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 99.0 mtt180 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.251 0.548 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 87.4 t -116.77 120.08 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.402 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 3.7 ptt180 -86.39 118.49 25.86 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.512 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.447 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 1.4 mp -131.4 173.08 11.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.847 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.489 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 11.6 p-10 -103.23 179.42 4.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.871 -1.143 . . . . 0.0 110.702 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 88.5 mt-10 -59.99 -41.05 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -0.871 . . . . 0.0 109.059 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.638 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -64.4 -59.67 4.08 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.123 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.499 ' O ' HD21 ' A' ' 33' ' ' LEU . 65.4 m -49.99 -31.22 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.835 -1.166 . . . . 0.0 109.08 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 40.0 ttm180 -72.29 -51.76 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.584 -0.698 . . . . 0.0 111.619 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -98.92 -3.49 35.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.742 -1.224 . . . . 0.0 111.178 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.638 ' HB3' ' O ' ' A' ' 29' ' ' SER . 0.6 OUTLIER -64.96 -24.06 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.074 . . . . 0.0 109.828 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 59.6 mt -120.62 -67.88 0.95 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.034 . . . . 0.0 110.469 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 36' ' ' ALA . 43.4 t0 -171.2 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.566 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.45 118.63 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.354 0.597 . . . . 0.0 110.72 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.8 pt-20 -106.59 -178.98 3.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.2 mm -62.3 126.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.882 -1.136 . . . . 0.0 109.803 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.35 22.94 66.55 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' CG ' ' HG2' ' A' ' 37' ' ' GLU . 77.7 m-20 -89.5 169.98 10.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.814 -1.404 . . . . 0.0 109.603 171.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.506 HG21 ' OG1' ' A' ' 92' ' ' THR . 71.8 t -99.23 136.18 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.989 -1.07 . . . . 0.0 110.087 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.4 HG22 ' C ' ' A' ' 52' ' ' GLY . 1.7 m -120.71 140.05 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.094 -1.004 . . . . 0.0 110.487 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -106.82 141.25 38.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.691 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.656 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.7 mp -124.21 143.03 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.995 -1.066 . . . . 0.0 110.582 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -149.89 97.24 2.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.534 ' HB2' HG12 ' A' ' 85' ' ' VAL . 5.5 tmtm? -97.88 -55.8 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.406 -0.809 . . . . 0.0 109.626 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.515 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.29 -34.6 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.795 0.807 . . . . 0.0 108.885 176.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.584 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -131.79 179.46 6.06 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.487 ' O ' HD23 ' A' ' 130' ' ' LEU . 12.0 mtmt -89.44 132.67 34.9 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.656 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.9 p -138.07 166.7 23.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.576 -0.702 . . . . 0.0 109.809 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.582 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.89 167.66 14.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.915 179.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.4 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.05 -175.08 44.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 68.9 ttt180 -122.45 166.16 15.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.428 -1.042 . . . . 0.0 110.334 -176.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -98.34 144.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.885 . . . . 0.0 110.513 -175.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 2.5 m-85 -138.06 168.19 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.371 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.41 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 68.1 mtm180 -88.73 121.76 31.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.74 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' ND2' ' A' ' 63' ' ' ASN . . . -62.66 140.05 58.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.711 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.596 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.84 -50.0 90.61 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.841 175.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 33.6 Cg_endo -93.06 98.41 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.841 1.443 . . . . 0.0 108.886 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.26 36.13 0.1 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.426 -0.796 . . . . 0.0 110.825 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 59' ' ' PRO . 59.2 m-20 -145.59 -34.32 0.33 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.096 -1.002 . . . . 0.0 111.058 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.559 ' OE2' ' CG ' ' A' ' 59' ' ' PRO . 14.9 pt-20 -87.19 -19.12 28.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 109.601 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.492 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 21.7 m-80 -81.21 39.64 0.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 110.622 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 pttt -97.79 13.43 30.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.492 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.6 pt -140.92 144.67 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.213 -1.169 . . . . 0.0 109.583 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.1 p -121.88 129.83 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.046 -1.034 . . . . 0.0 109.859 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -93.0 114.02 26.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 -178.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.441 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.9 pp -134.66 167.82 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -79.53 168.01 20.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 110.132 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 m -59.98 -39.73 86.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.279 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.1 t -61.25 -41.58 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.151 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -61.55 -48.22 81.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.256 -0.902 . . . . 0.0 109.699 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.418 ' HD2' ' CA ' ' A' ' 80' ' ' SER . 37.7 ttp180 -60.13 -40.13 88.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.027 -1.045 . . . . 0.0 109.457 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.484 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 92.6 m-20 -64.06 -33.06 74.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 73' ' ' MET . 64.4 m-20 -57.38 -34.93 69.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.584 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 30.5 p -99.38 -40.02 8.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.991 -1.068 . . . . 0.0 110.667 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.515 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.17 41.03 1.0 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.455 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -114.4 172.4 7.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.106 -1.232 . . . . 0.0 110.508 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.539 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.58 170.28 8.54 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 109.417 177.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.531 ' HA ' HG11 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -55.57 139.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.605 178.167 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 11' ' ' VAL . . . 77.08 3.83 82.18 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -59.86 -161.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.032 -1.275 . . . . 0.0 110.575 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 23.2 pttt -134.3 110.91 9.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.487 -0.758 . . . . 0.0 110.096 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 46' ' ' LYS . 1.2 m -120.01 153.99 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 109.886 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 54.2 tttt -101.07 118.62 37.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.634 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.494 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 74.8 t -102.11 120.91 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.932 . . . . 0.0 109.897 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.487 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 76.4 mtm180 -110.39 140.88 44.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 6.1 tttt -82.48 140.25 33.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 110.662 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.404 HG23 ' CD ' ' A' ' 161' ' ' PRO . 2.4 m -148.86 -165.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.492 0.663 . . . . 0.0 109.731 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.442 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.0 mtt85 -135.66 173.39 11.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.469 -0.77 . . . . 0.0 110.42 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.506 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -103.1 161.46 13.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 111.147 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -149.93 170.03 19.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 5.1 mp -89.46 97.14 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.569 -1.332 . . . . 0.0 110.351 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.514 ' HB1' HG22 ' A' ' 162' ' ' VAL . . . -55.11 140.06 39.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -0.778 . . . . 0.0 110.219 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.574 ' HD2' ' CD2' ' A' ' 156' ' ' LEU . 3.4 ptpt -106.09 -25.75 11.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 111.558 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HE2' ' OE1' ' A' ' 171' ' ' GLU . 72.2 tttt -150.3 131.92 14.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.441 -1.412 . . . . 0.0 110.709 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.432 HG21 HG23 ' A' ' 155' ' ' THR . 8.0 p -144.33 148.0 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.894 . . . . 0.0 110.652 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 59.5 m -120.68 136.8 54.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.43 -0.793 . . . . 0.0 110.195 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.56 161.66 29.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.472 ' CB ' ' HD2' ' A' ' 173' ' ' ARG . . . -139.09 89.58 12.47 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.456 -0.778 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo . . . . . 0 C--N 1.304 -1.766 0 O-C-N 123.988 1.52 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 20.9 tt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.062 0.458 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 41.7 mt-10 -68.96 -41.3 78.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.963 -1.086 . . . . 0.0 110.313 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.97 -32.81 71.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 122' ' ' ARG . 18.7 t80 -59.86 -39.51 85.45 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.521 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.529 ' CG1' HD11 ' A' ' 170' ' ' ILE . 78.8 t -60.0 -46.63 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.206 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.649 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -60.0 -39.74 86.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 174.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 27.4 tpt180 -60.0 -43.87 94.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.333 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 -40.55 46.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 79.1 mt -92.91 -7.58 45.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.071 -1.018 . . . . 0.0 110.58 -173.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.9 tt -42.71 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 164' ' ' ILE . 33.4 ptt180 30.4 52.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.659 -0.65 . . . . 0.0 111.262 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 30.9 ttm180 -132.71 142.96 46.7 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.047 -1.033 . . . . 0.0 110.895 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -65.59 123.94 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 124.007 1.53 . . . . 0.0 109.498 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.515 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 89.2 mmm -120.21 140.62 50.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.377 -1.452 . . . . 0.0 111.126 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 17.0 tp -141.15 107.29 5.21 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.713 -0.617 . . . . 0.0 109.649 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.601 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -45.0 140.78 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 110.905 -175.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.601 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 82.11 -2.95 1.49 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.409 0.624 . . . . 0.0 110.271 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 3.8 p-10 -68.63 -172.99 0.4 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.512 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -144.83 144.21 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.492 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.828 -1.17 . . . . 0.0 110.837 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 40.0 m-85 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.185 0.516 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -103.29 103.86 13.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.529 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 2.7 t -75.34 139.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.8 t -130.62 -24.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.022 -1.049 . . . . 0.0 111.443 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.485 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 5.8 tttp -139.36 125.31 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 110.926 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.441 HG21 ' CB ' ' A' ' 131' ' ' GLU . 69.2 p -128.09 163.95 23.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.456 -0.777 . . . . 0.0 109.433 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.653 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 1.1 tt -89.57 -38.2 0.42 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 110.97 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 15.4 Cg_exo -60.57 -176.06 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.485 1.255 . . . . 0.0 110.237 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.43 -162.7 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -69.59 -4.51 19.52 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.303 -0.873 . . . . 0.0 110.564 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.463 ' O ' HG21 ' A' ' 160' ' ' VAL . 35.9 m -86.37 140.5 34.18 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.059 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.582 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.7 Cg_endo -47.61 141.65 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.14 1.6 . . . . 0.0 110.48 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 5.6 m -128.3 158.18 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.785 173.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -105.9 124.15 49.12 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.885 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 126' ' ' ARG . 13.8 mm -70.14 152.37 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.743 -0.598 . . . . 0.0 109.53 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.602 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.06 166.89 26.2 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -58.0 -14.11 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.957 . . . . 0.0 110.287 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -90.13 -18.07 26.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.516 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 28.0 m -62.24 153.87 29.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 110.049 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 96' ' ' LYS . 44.8 mttt -103.6 155.6 18.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 0.0 110.014 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.529 HD11 ' CG1' ' A' ' 120' ' ' VAL . 6.5 mm -119.14 137.86 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 110.975 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.435 ' OE1' ' HE2' ' A' ' 97' ' ' LYS . 12.8 mt-10 -119.94 127.14 52.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 110.514 172.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 39.5 mm -123.34 123.83 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.175 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.472 ' HD2' ' CB ' ' A' ' 101' ' ' ALA . 4.3 ptp180 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 110.559 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.217 0.532 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -153.54 -167.81 16.4 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.494 ' CG2' HD11 ' A' ' 33' ' ' LEU . 22.8 pt -135.03 160.01 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -1.078 . . . . 0.0 109.651 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.5 mt -100.62 115.85 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.2 pt? -135.54 -170.86 2.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 109.562 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 49.8 ptt85 -114.79 139.99 49.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.739 -1.225 . . . . 0.0 110.855 -174.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.566 ' CG1' ' O ' ' A' ' 80' ' ' SER . 7.9 p -62.16 140.55 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.63 -0.669 . . . . 0.0 110.552 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -118.68 143.66 46.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 110.624 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 49.0 tp10 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.795 . . . . 0.0 110.091 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.579 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 62.6 mmt-85 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 53' ' ' ARG . 90.4 t -101.73 115.44 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.007 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.459 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 6.2 ptt180 -93.53 120.01 33.29 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.985 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' CD2' ' CB ' ' A' ' 30' ' ' SER . 2.1 mt -138.68 173.18 11.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.568 -0.708 . . . . 0.0 110.105 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.2 p-10 -95.06 -177.18 4.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -175.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.99 -49.27 78.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.506 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 23.2 t -60.36 -41.31 93.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.159 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.651 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 48.5 m -60.38 -31.11 70.04 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 175.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 66.8 ttt180 -83.43 -46.04 12.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 111.191 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -81.93 -6.04 58.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.903 -1.123 . . . . 0.0 110.235 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.651 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.7 pt? -44.33 -27.69 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.44 -0.787 . . . . 0.0 109.727 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.563 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 78.8 mt -143.67 -63.77 0.39 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 176.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -173.38 13.4 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.281 -0.887 . . . . 0.0 110.739 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.544 ' CB ' ' HE2' ' A' ' 89' ' ' LYS . . . -47.59 119.75 2.92 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.986 -1.071 . . . . 0.0 110.01 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.504 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.18 174.44 5.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.3 mm -62.47 122.22 12.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.885 -1.134 . . . . 0.0 109.672 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.424 ' CA ' ' NH2' ' A' ' 53' ' ' ARG . . . 77.46 32.06 48.53 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 19.6 m-20 -88.75 170.78 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.926 -1.338 . . . . 0.0 109.308 170.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.549 HG23 ' CG2' ' A' ' 92' ' ' THR . 69.9 t -99.14 129.61 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.02 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.7 m -115.33 136.37 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.057 -1.027 . . . . 0.0 110.471 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -109.52 143.93 38.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 109.781 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.595 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.5 mp -120.81 145.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.001 -1.062 . . . . 0.0 110.266 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.2 tt0 -152.4 87.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.906 -1.121 . . . . 0.0 111.321 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.597 ' HD3' ' CB ' ' A' ' 79' ' ' ALA . 33.8 tttp -98.99 -80.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 172.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.543 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -84.55 -36.18 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.778 . . . . 0.0 109.55 175.144 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.546 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 92.0 mtt-85 -139.54 -176.01 4.4 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.56 -0.713 . . . . 0.0 109.532 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.559 ' HG2' ' CD2' ' A' ' 130' ' ' LEU . 1.2 ttpm? -89.96 139.06 30.97 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -141.64 165.47 27.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.255 -174.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.571 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -128.44 163.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.365 -0.835 . . . . 0.0 110.283 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.476 ' C ' HG23 ' A' ' 42' ' ' VAL . . . -175.9 179.99 46.71 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 173.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.493 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 57.2 ttt85 -118.87 171.16 8.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -1.122 . . . . 0.0 110.07 -177.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.548 ' CG2' ' HE3' ' A' ' 89' ' ' LYS . 0.3 OUTLIER -101.3 132.44 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.829 -1.169 . . . . 0.0 111.416 -171.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.579 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -130.27 162.85 28.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.752 . . . . 0.0 110.392 171.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -91.43 128.6 37.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.548 -0.72 . . . . 0.0 110.305 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.42 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -65.06 140.77 58.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 110.047 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.572 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.12 -50.26 88.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.09 175.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.572 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 52.7 Cg_endo -92.21 97.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.892 1.469 . . . . 0.0 108.988 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.94 41.21 0.16 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.6 -0.687 . . . . 0.0 110.377 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 59' ' ' PRO . 27.3 m-20 -143.45 -38.58 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.294 -0.879 . . . . 0.0 110.807 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.11 -22.84 28.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.942 -1.099 . . . . 0.0 109.839 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.485 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 10.6 m-80 -81.71 38.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 110.758 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 61' ' ' ASP . 11.6 ptpt -98.46 13.05 33.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.72 25.48 0.05 OUTLIER Glycine 0 N--CA 1.481 1.647 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.485 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.8 pt -140.81 140.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.431 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.3 p -119.95 127.6 75.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 25.2 ttt85 -89.59 113.69 25.16 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.757 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.416 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 1.7 pp -129.11 170.54 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.422 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -79.19 164.47 24.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.991 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.4 m -59.91 -39.95 87.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 110.488 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.496 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.3 t -64.97 -44.43 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -175.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.487 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -60.8 -45.94 92.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.64 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -60.06 -40.04 88.1 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.58 -21.79 61.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.384 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 5.3 m120 -59.89 -39.77 86.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 110.711 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 27.8 p -98.49 -31.04 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.039 -1.038 . . . . 0.0 110.392 -176.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.543 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.09 29.08 3.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.597 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.29 156.14 17.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.205 -1.174 . . . . 0.0 110.505 -175.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.566 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -111.78 166.01 11.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 175.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.536 ' HA ' HG11 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -54.32 139.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.418 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.18 68.72 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 1.1 m-20 -60.15 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.84 -1.388 . . . . 0.0 110.451 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 11.6 pttt -134.5 112.35 10.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 110.122 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -118.76 148.98 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -0.893 . . . . 0.0 109.791 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -95.3 116.09 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.658 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.457 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 95.4 t -102.23 122.62 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.548 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.5 mtm180 -110.11 142.5 41.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HE3' ' CG2' ' A' ' 54' ' ' VAL . 1.4 tptm -95.94 129.57 43.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 110.239 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.55 -163.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.668 0.746 . . . . 0.0 110.095 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.467 ' CA ' ' HB ' ' A' ' 41' ' ' VAL . 35.5 mtp180 -127.04 179.59 5.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 110.349 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.549 ' CG2' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.18 169.13 8.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 111.258 -176.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -149.49 169.54 20.68 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.7 mm -89.61 99.81 9.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.486 -1.384 . . . . 0.0 110.337 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.53 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -55.28 139.29 43.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.279 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HD2' ' HG ' ' A' ' 156' ' ' LEU . 17.7 ptpt -101.8 -28.37 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 111.055 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -150.25 120.21 7.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.752 -1.217 . . . . 0.0 110.741 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.479 HG23 ' CG2' ' A' ' 155' ' ' THR . 8.7 p -131.75 140.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 110.764 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.409 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 98.6 m -113.09 143.8 43.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.393 -0.817 . . . . 0.0 110.098 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.4 OUTLIER -143.14 170.15 16.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -177.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.48 ' HB3' ' HD2' ' A' ' 173' ' ' ARG . . . -142.38 97.78 6.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 110.896 -175.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 109.912 179.492 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 117' ' ' GLU . 7.3 tp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.118 0.485 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.467 ' HG2' HG12 ' A' ' 172' ' ' ILE . 96.8 mt-10 -60.11 -42.84 95.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.082 -1.011 . . . . 0.0 109.432 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.54 -40.15 92.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.495 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.541 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 52.4 t80 -60.09 -40.92 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.193 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.529 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.4 t -63.84 -45.18 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.957 -1.089 . . . . 0.0 109.743 177.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 2.5 mt-30 -60.67 -44.7 96.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.663 -0.648 . . . . 0.0 110.472 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 1.9 ptm85 -69.6 -36.43 76.21 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.064 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -72.52 -42.95 64.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.681 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -102.27 1.09 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 110.998 -174.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.9 tt -43.19 171.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.042 . . . . 0.0 110.74 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.522 ' HG2' ' CG2' ' A' ' 125' ' ' ILE . 51.4 ptt85 32.57 53.8 0.34 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.634 -0.666 . . . . 0.0 111.504 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -139.71 151.28 65.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.917 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.812 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 21.1 Cg_endo -67.1 132.2 27.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.137 1.599 . . . . 0.0 109.81 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.569 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.7 mmm -128.43 146.71 50.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.34 -1.475 . . . . 0.0 111.195 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.559 ' CD2' ' HG2' ' A' ' 49' ' ' LYS . 12.7 tp -149.45 112.44 4.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.612 -0.68 . . . . 0.0 109.587 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 5.6 pt-20 -49.23 144.36 5.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.93 -1.106 . . . . 0.0 111.022 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 83.8 -8.45 1.04 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.429 0.633 . . . . 0.0 110.316 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.1 p30 -69.97 -170.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 110.617 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.406 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 13.9 m-80 -142.29 150.07 40.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.065 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.821 -1.175 . . . . 0.0 110.64 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.208 0.528 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.5 112.11 23.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 4.0 t -78.46 135.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.8 t -115.81 -30.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 110.953 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -145.6 149.48 34.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.863 -1.148 . . . . 0.0 110.935 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 131' ' ' GLU . 75.2 p -139.23 167.49 21.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.631 -0.668 . . . . 0.0 109.39 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.03 -39.1 0.44 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.123 -0.986 . . . . 0.0 110.872 -176.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 16.2 Cg_exo -59.01 -170.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.58 1.305 . . . . 0.0 110.162 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.8 t -90.25 -165.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -69.18 -2.98 11.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.715 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.64 143.78 34.33 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 110.415 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.571 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.1 Cg_endo -48.49 141.5 19.49 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.244 1.655 . . . . 0.0 110.964 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.812 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 9.1 m -130.07 159.95 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.035 . . . . 0.0 109.868 173.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -107.48 129.92 54.9 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.35 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.569 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 16.7 mm -72.03 154.11 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.624 -0.672 . . . . 0.0 110.381 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.95 171.46 26.12 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -55.04 -24.85 26.8 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.343 -1.092 . . . . 0.0 110.359 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.28 -17.17 27.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.17 -0.956 . . . . 0.0 110.851 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.54 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 85.3 m -58.45 140.56 53.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 0.0 110.16 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 70.9 mmtt -94.84 162.31 13.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.954 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.529 HD12 ' CG1' ' A' ' 120' ' ' VAL . 2.1 mt -139.37 160.23 28.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 111.12 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.413 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 26.2 mt-10 -137.99 132.78 32.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.467 HG12 ' HG2' ' A' ' 117' ' ' GLU . 43.6 mm -120.07 123.51 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.426 -0.796 . . . . 0.0 110.02 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 101' ' ' ALA . 11.1 ptp180 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.016 -1.053 . . . . 0.0 110.463 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 49.4 p30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.085 0.469 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -155.53 -166.48 15.71 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.098 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.568 ' CG2' HD12 ' A' ' 33' ' ' LEU . 40.0 pt -134.78 159.93 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.344 -1.092 . . . . 0.0 109.421 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 36.5 mt -98.57 124.33 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.005 . . . . 0.0 110.28 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -141.1 -172.68 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 110.478 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.555 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 25.5 ttp-105 -103.89 128.79 51.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 110.947 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 83' ' ' ASP . 7.1 p -63.02 137.87 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.558 -0.714 . . . . 0.0 110.5 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -127.48 160.15 32.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.288 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 85.1 tt0 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.306 -0.871 . . . . 0.0 110.555 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.411 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 11.0 ptp180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.33 0.586 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' TYR . 55.2 t -119.95 119.14 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.807 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 5.9 ptt180 -88.38 119.53 28.9 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.837 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.54 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 1.2 mp -138.81 164.77 28.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.672 -0.643 . . . . 0.0 109.843 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.6 p-10 -89.59 -179.79 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.036 -1.04 . . . . 0.0 110.702 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.265 -175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.0 t -67.12 -40.01 86.75 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.098 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.642 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 43.7 m -64.06 -27.94 69.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.224 -0.922 . . . . 0.0 109.496 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 61.1 ttt180 -85.12 -45.17 12.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.749 -0.594 . . . . 0.0 110.834 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 22.5 tpt180 -79.59 -9.96 59.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.812 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.642 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -41.12 -30.04 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.661 0.743 . . . . 0.0 109.859 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.584 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 80.5 mt -140.54 -60.57 0.51 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.706 -0.622 . . . . 0.0 110.56 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.7 t0 -171.06 -29.42 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.193 -0.942 . . . . 0.0 110.487 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.587 ' CB ' ' HG3' ' A' ' 89' ' ' LYS . . . -21.35 123.98 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.354 0.597 . . . . 0.0 111.469 -176.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.4 pt-20 -101.12 178.98 4.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.08 123.38 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.928 -1.107 . . . . 0.0 109.765 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' N ' HG11 ' A' ' 54' ' ' VAL . . . 73.9 30.59 61.22 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 175.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.411 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 6.3 m-20 -88.84 -179.87 6.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.326 . . . . 0.0 109.514 172.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.529 ' CG1' ' HG2' ' A' ' 161' ' ' PRO . 80.1 t -99.26 127.76 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.02 -1.05 . . . . 0.0 110.467 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.3 m -119.96 142.95 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 -177.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -110.54 142.91 41.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.489 -0.757 . . . . 0.0 109.812 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.575 ' O ' ' OG1' ' A' ' 50' ' ' THR . 3.7 mp -120.02 149.33 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.221 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.0 tt0 -151.88 94.45 1.97 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 110.845 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.542 ' CG ' HG13 ' A' ' 85' ' ' VAL . 12.7 tmtt? -98.6 -66.8 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.538 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.48 -35.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.645 0.736 . . . . 0.0 109.202 175.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 1.6 mmt85 -134.12 -167.83 2.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.61 -0.681 . . . . 0.0 109.625 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.489 ' O ' HD23 ' A' ' 130' ' ' LEU . 21.9 mttm -89.72 137.32 32.43 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.803 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.6 157.44 46.76 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.251 0.548 . . . . 0.0 110.2 178.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.568 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.3 160.82 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 109.967 177.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -178.72 -178.54 48.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.79 157.46 24.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.475 -1.014 . . . . 0.0 109.922 -176.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -85.03 135.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.962 -1.086 . . . . 0.0 110.216 -175.112 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -127.7 163.15 24.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.063 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -90.01 121.82 32.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 110.098 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.449 ' HB2' ' CG ' ' A' ' 63' ' ' ASN . . . -63.45 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.926 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.645 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 5.4 mtm180 -56.16 -45.77 99.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.045 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 40.8 Cg_endo -92.65 97.54 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.882 1.464 . . . . 0.0 109.004 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.1 pt-20 -75.29 36.06 0.12 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.562 -0.711 . . . . 0.0 110.681 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.9 m-20 -147.33 -37.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 110.558 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -84.73 -24.3 28.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.492 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -81.14 38.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.71 -0.619 . . . . 0.0 110.526 177.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.484 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.4 pttt -98.81 15.48 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -0.999 . . . . 0.0 109.406 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.09 24.34 0.03 OUTLIER Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.542 HG21 ' NH2' ' A' ' 10' ' ' ARG . 46.1 pt -140.77 156.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 109.046 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.465 HG23 HG13 ' A' ' 24' ' ' VAL . 3.4 p -135.38 131.48 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.908 -1.12 . . . . 0.0 110.144 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.521 ' NE ' ' HD3' ' A' ' 25' ' ' ARG . 42.9 ttp180 -92.76 118.66 31.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 110.123 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.488 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 2.6 pt -132.09 166.45 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.473 -0.767 . . . . 0.0 110.379 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.495 ' OD1' ' HB2' ' A' ' 73' ' ' MET . 21.4 p-10 -83.66 177.66 8.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 110.138 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t -63.48 -35.22 79.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.0 110.92 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 66.5 t -64.18 -46.16 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 110.123 -174.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.495 ' HB2' ' OD1' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -60.38 -43.72 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.554 177.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 6.8 ttm180 -59.95 -40.87 90.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.893 174.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -69.97 -25.91 63.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.291 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 5.4 m120 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 110.618 -175.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.476 ' HB2' HG23 ' A' ' 47' ' ' VAL . 29.1 p -99.1 -37.19 9.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.042 . . . . 0.0 110.425 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.538 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 116.4 21.92 4.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.462 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . . . -99.22 169.62 9.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.169 -1.194 . . . . 0.0 110.332 -175.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.26 171.14 7.73 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.351 -0.843 . . . . 0.0 109.366 178.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.481 ' HA ' HG11 ' A' ' 11' ' ' VAL . 0.8 OUTLIER -60.16 140.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 0.0 109.981 177.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.555 ' HA2' ' CG ' ' A' ' 10' ' ' ARG . . . 79.61 -4.79 63.11 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 171.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.542 ' HB2' HG13 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.04 -166.42 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.815 -1.403 . . . . 0.0 110.115 174.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 33.6 pttt -127.83 112.8 15.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.224 -0.922 . . . . 0.0 109.831 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.542 HG13 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.33 151.64 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 48.9 tttp -101.09 126.59 47.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.891 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.505 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.2 t -102.97 121.98 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.584 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 77.8 mtt85 -106.74 128.19 54.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.587 ' HG3' ' CB ' ' A' ' 36' ' ' ALA . 13.8 tmtt? -78.75 135.99 37.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.15 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -150.04 -169.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.49 -0.757 . . . . 0.0 110.234 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -126.6 173.3 9.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.494 -0.754 . . . . 0.0 109.671 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.466 ' OG1' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.0 162.5 12.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 110.953 -176.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' CG ' HG13 ' A' ' 162' ' ' VAL . 14.7 pt-20 -150.23 169.92 20.19 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.04 98.85 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.594 -1.316 . . . . 0.0 110.319 -176.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -57.48 139.7 52.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.538 ' CD ' HD22 ' A' ' 156' ' ' LEU . 13.0 ptpt -107.13 -24.62 11.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 111.292 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.454 ' HD3' HD13 ' A' ' 156' ' ' LEU . 63.6 tttp -149.97 119.62 7.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.706 -1.246 . . . . 0.0 110.619 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.526 ' CG2' HG23 ' A' ' 155' ' ' THR . 10.0 p -136.23 140.76 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 0.0 110.692 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 171' ' ' GLU . 99.7 m -111.97 142.1 44.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.081 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -134.04 165.86 24.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.614 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.07 89.5 11.11 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.795 . . . . 0.0 110.315 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo . . . . . 0 C--N 1.305 -1.754 0 O-C-N 124.061 1.559 . . . . 0.0 110.752 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.08 0.467 . . . . 0.0 109.948 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.575 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -62.43 -40.05 95.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.714 176.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -29.09 66.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.0 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.04 -40.01 87.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.542 ' CG1' ' CD1' ' A' ' 170' ' ' ILE . 54.5 t -65.01 -49.97 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.4 mt-30 -60.06 -44.58 94.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.813 . . . . 0.0 110.024 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -60.01 -44.09 94.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.647 -0.658 . . . . 0.0 110.211 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.05 -43.8 70.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -0.789 . . . . 0.0 110.544 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 3.5 mm? -99.05 2.81 46.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.4 tt -46.2 169.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.887 -1.133 . . . . 0.0 110.241 -175.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 28.8 ptt180 33.13 46.09 0.09 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.513 -0.742 . . . . 0.0 111.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -132.26 149.9 74.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.784 -1.198 . . . . 0.0 110.866 176.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.756 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.4 Cg_endo -63.83 133.41 38.91 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.182 1.622 . . . . 0.0 110.264 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.491 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 81.5 mmm -127.0 143.05 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.592 -1.317 . . . . 0.0 111.279 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.515 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 10.8 tp -148.27 110.7 4.68 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.729 -0.607 . . . . 0.0 109.442 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.2 pm0 -43.02 143.28 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.944 -1.097 . . . . 0.0 110.526 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.97 -2.48 2.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.873 -0.517 . . . . 0.0 110.429 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.534 ' OD1' ' CB ' ' A' ' 152' ' ' VAL . 3.6 p-10 -69.93 169.86 12.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.243 -0.911 . . . . 0.0 110.107 175.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 5.4 m120 -128.54 145.28 51.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.524 0 O-C-N 120.944 -1.097 . . . . 0.0 110.108 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 62.6 m-85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.397 0.618 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.423 ' HD2' ' ND2' ' A' ' 134' ' ' ASN . 32.0 tptt -103.26 104.77 14.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.845 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.534 ' CB ' ' OD1' ' A' ' 133' ' ' ASP . 2.2 t -76.65 139.26 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 109.851 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.26 -29.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 0.0 111.059 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 98' ' ' VAL . 38.4 ttpt -139.52 144.94 38.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.815 -1.178 . . . . 0.0 111.017 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.526 HG23 ' CG2' ' A' ' 98' ' ' VAL . 58.0 p -140.01 153.02 46.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.71 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.8 OUTLIER -89.82 -30.62 0.36 Allowed Pre-proline 0 C--N 1.297 -1.696 0 O-C-N 121.282 -0.886 . . . . 0.0 111.425 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 14.2 Cg_exo -58.63 -164.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.216 1.114 . . . . 0.0 109.921 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.3 t -89.98 -178.41 5.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 175.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -62.27 -8.47 5.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 110.469 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.7 m -84.76 146.25 45.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 110.238 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.568 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.45 141.3 14.66 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.255 1.661 . . . . 0.0 110.747 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 7.0 m -129.89 159.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 109.575 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.89 128.1 54.32 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.205 -0.934 . . . . 0.0 110.079 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 126' ' ' ARG . 11.9 mm -70.58 154.68 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 110.055 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.61 172.33 24.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.419 ' HG2' ' CD1' ' A' ' 125' ' ' ILE . 96.6 mt-10 -58.2 -26.26 62.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.898 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -87.38 -17.98 31.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.592 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.546 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 30.7 m -58.47 152.48 17.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 110.302 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' LYS . 23.0 mmtt -105.89 158.77 16.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.062 . . . . 0.0 109.875 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.542 ' CD1' ' CG1' ' A' ' 120' ' ' VAL . 1.8 mt -136.68 161.8 35.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 111.164 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.469 ' O ' HD22 ' A' ' 100' ' ' LEU . 12.0 mt-10 -139.06 131.66 28.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.756 -0.59 . . . . 0.0 110.219 175.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.9 mp -119.91 128.89 75.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 110.233 -178.25 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 t30 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.52 0.676 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -151.0 -153.7 6.25 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.564 ' CG2' HD21 ' A' ' 33' ' ' LEU . 11.9 pt -138.63 167.75 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -1.15 . . . . 0.0 109.412 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 85.4 mt -109.89 127.84 66.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.117 -0.989 . . . . 0.0 110.337 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.597 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -148.49 -179.04 6.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.511 -0.743 . . . . 0.0 109.962 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 2.8 ptt180 -104.74 138.89 40.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.939 -1.101 . . . . 0.0 110.601 -173.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.556 HG11 ' N ' ' A' ' 82' ' ' GLY . 11.2 p -63.07 130.43 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 110.356 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -110.93 153.5 25.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.909 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 86.4 tt0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.071 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.405 ' HG2' ' HD2' ' A' ' 53' ' ' ARG . 82.2 mtt180 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.95 0.405 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' TYR . 78.1 t -105.3 114.02 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.987 -1.071 . . . . 0.0 110.053 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 8.9 ptt180 -93.5 119.95 33.19 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.563 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.583 ' CD2' ' O ' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -139.84 171.94 13.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.682 -176.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.508 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 19.8 p-10 -95.43 -172.58 2.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.897 -1.127 . . . . 0.0 110.785 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.03 -46.97 87.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.578 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 18.2 m -65.24 -41.75 94.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.129 -175.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.584 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 64.3 m -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.155 -0.966 . . . . 0.0 109.558 175.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 41.1 ttm180 -73.27 -44.04 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 111.163 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -91.73 -7.82 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.919 -1.113 . . . . 0.0 111.201 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -52.23 -26.58 12.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.149 . . . . 0.0 109.329 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 41.9 mt -132.65 -66.01 0.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 110.785 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.456 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 28.8 t0 -171.82 -2.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.955 -1.091 . . . . 0.0 111.52 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -44.97 128.01 6.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.827 -1.17 . . . . 0.0 110.449 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.543 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 1.2 pt-20 -116.85 176.57 5.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.6 mm -57.96 122.41 7.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.812 -1.18 . . . . 0.0 109.855 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.406 ' H ' HG11 ' A' ' 54' ' ' VAL . . . 72.88 33.42 59.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.161 -1.018 . . . . 0.0 110.663 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 18.9 m-20 -89.2 176.23 7.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.667 -1.49 . . . . 0.0 109.596 172.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.477 HG23 HG21 ' A' ' 92' ' ' THR . 73.6 t -99.07 127.78 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.084 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 52' ' ' GLY . 4.6 m -120.0 151.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 110.229 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -122.99 142.9 50.33 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.716 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -119.9 147.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' OE1' ' CZ ' ' A' ' 88' ' ' ARG . 82.5 tt0 -151.29 93.14 1.87 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.931 -1.106 . . . . 0.0 110.846 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.538 ' HB2' HG13 ' A' ' 85' ' ' VAL . 8.9 tmtm? -97.94 -58.85 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.646 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.501 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.73 -31.51 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.676 0.75 . . . . 0.0 109.129 176.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 98.3 mtt180 -139.53 -172.57 3.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.642 -0.662 . . . . 0.0 109.747 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -88.41 130.32 35.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.177 -0.952 . . . . 0.0 110.825 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -131.03 154.31 48.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.805 -0.56 . . . . 0.0 110.26 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.637 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -117.91 164.36 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.517 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -176.77 179.0 47.96 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 18.2 ptp180 -111.53 -172.04 1.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -1.112 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.24 137.66 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.026 -1.046 . . . . 0.0 110.632 -175.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -127.89 164.13 22.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 110.194 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.27 123.67 33.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . . . -63.33 140.05 58.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.622 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 4.6 mmt180 -56.08 -49.55 92.48 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.903 -1.123 . . . . 0.0 108.877 174.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 18.7 Cg_endo -91.68 98.36 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.715 1.376 . . . . 0.0 108.831 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 11.1 pt-20 -74.97 35.29 0.1 Allowed 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 110.917 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 79.5 m-20 -145.43 -32.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.056 -1.027 . . . . 0.0 110.796 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.99 -25.55 24.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.513 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 4.1 m-80 -81.13 39.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 110.573 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.3 pttt -99.02 17.48 19.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 109.575 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.56 23.98 0.03 OUTLIER Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.513 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 44.5 pt -140.68 158.59 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.52 -0.988 . . . . 0.0 109.221 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 9' ' ' LEU . 3.4 p -129.98 137.13 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.087 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.504 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -97.31 118.02 32.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.05 -1.031 . . . . 0.0 110.1 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.554 HD12 ' CG2' ' A' ' 11' ' ' VAL . 1.1 pt -134.36 173.04 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.749 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 71' ' ' SER . 29.7 t0 -91.23 173.61 7.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.564 -0.71 . . . . 0.0 109.857 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 58.5 p -63.12 -25.29 68.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.438 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.7 t -68.49 -47.45 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.513 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -60.07 -42.81 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 109.768 176.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.02 -40.27 88.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 174.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -71.04 -26.86 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.395 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.4 m-20 -60.07 -39.9 87.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 110.808 -176.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.462 ' HB2' HG23 ' A' ' 47' ' ' VAL . 28.5 p -98.47 -36.53 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.965 -1.084 . . . . 0.0 110.657 -175.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 117.18 22.83 4.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -102.65 171.75 7.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -1.202 . . . . 0.0 110.311 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.515 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.91 179.05 4.08 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.509 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -65.22 140.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.053 -1.03 . . . . 0.0 110.423 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.556 ' N ' HG11 ' A' ' 11' ' ' VAL . . . 76.03 -3.21 52.72 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 173.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.547 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.52 -158.83 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.054 -1.262 . . . . 0.0 110.211 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 52.6 pttt -137.07 116.92 13.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 110.097 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 46' ' ' LYS . 1.3 m -125.81 160.07 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.433 -0.792 . . . . 0.0 109.823 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 33.0 ttmt -104.08 123.99 48.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.476 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 63.8 t -99.55 125.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.546 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtm180 -117.23 149.49 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 61.7 tttm -91.15 139.85 30.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.862 -1.149 . . . . 0.0 110.371 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 41' ' ' VAL . 2.3 m -138.84 -168.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 175.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.464 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 38.8 ptt180 -137.46 171.26 14.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.477 HG21 HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.26 159.55 16.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 0.0 111.193 -175.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.32 171.17 17.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.7 mm -88.62 98.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.287 -1.508 . . . . 0.0 110.096 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.563 ' HB3' ' CG2' ' A' ' 162' ' ' VAL . . . -58.62 139.96 55.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.392 -0.818 . . . . 0.0 110.365 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.579 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 1.4 pttt -97.46 -29.7 13.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.081 -1.012 . . . . 0.0 111.11 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -150.91 121.98 7.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 0.0 110.915 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 155' ' ' THR . 9.9 p -132.24 143.54 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.006 -1.059 . . . . 0.0 110.955 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.524 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 91.1 m -114.96 140.26 49.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 0.0 110.044 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -136.3 165.28 26.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.374 -177.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -136.33 82.11 35.56 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 111.033 -176.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.524 ' HD2' ' CD ' ' A' ' 173' ' ' ARG . 17.4 Cg_exo . . . . . 0 C--N 1.305 -1.754 0 O-C-N 123.869 1.458 . . . . 0.0 109.883 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.9 tp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.076 0.465 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' HG2' HG12 ' A' ' 172' ' ' ILE . 94.8 mt-10 -59.99 -46.81 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 109.516 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.39 -39.89 92.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -64.27 -39.99 95.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.475 -0.766 . . . . 0.0 109.942 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.503 ' CG1' ' CD1' ' A' ' 170' ' ' ILE . 58.4 t -60.59 -49.97 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.4 mt-30 -61.21 -41.82 97.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.645 -0.66 . . . . 0.0 110.238 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.1 -48.93 79.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.438 -0.789 . . . . 0.0 109.97 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.73 75.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.719 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.6 mm? -94.91 -1.74 51.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.138 -175.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.526 ' HA ' HG21 ' A' ' 164' ' ' ILE . 2.6 tt -46.95 166.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.931 -1.105 . . . . 0.0 110.109 -175.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.6 ptt180 33.76 49.56 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 0.0 111.458 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.43 ' O ' ' HG2' ' A' ' 129' ' ' MET . 6.8 tpt180 -135.07 140.95 36.36 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.899 -1.126 . . . . 0.0 111.373 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.683 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.1 Cg_exo -59.69 130.68 36.26 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 124.095 1.576 . . . . 0.0 109.734 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.533 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 15.4 mmt -134.9 141.78 46.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.409 -1.432 . . . . 0.0 110.972 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.502 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -146.42 130.0 16.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -51.32 145.63 8.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -175.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 76.51 -2.06 2.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.818 -0.551 . . . . 0.0 110.548 178.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.524 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 1.6 p30 -67.59 -171.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.196 -0.94 . . . . 0.0 109.874 173.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -150.37 159.02 44.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.34 -0.85 . . . . 0.0 109.532 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 110.122 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.5 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 20.4 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.188 0.518 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -119.95 109.98 16.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 3.9 t -74.97 139.38 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.06 -24.52 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 111.021 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -146.2 136.65 23.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.662 -1.274 . . . . 0.0 110.841 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.534 ' CG2' HG22 ' A' ' 98' ' ' VAL . 44.5 p -134.7 168.7 18.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.498 -0.752 . . . . 0.0 109.355 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.01 -35.98 0.42 Allowed Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.929 -178.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 22.9 Cg_exo -58.46 -174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.384 1.202 . . . . 0.0 110.531 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -156.36 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.59 -11.35 52.88 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 160' ' ' VAL . 33.1 m -87.11 139.45 32.43 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.637 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 9.3 Cg_endo -59.72 164.1 12.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.131 1.595 . . . . 0.0 111.002 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 14.8 m -140.37 166.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.561 -0.712 . . . . 0.0 110.101 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -103.02 126.48 50.22 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.833 -1.167 . . . . 0.0 109.954 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 126' ' ' ARG . 10.9 mm -70.11 153.73 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.588 -0.695 . . . . 0.0 109.661 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.49 168.25 25.9 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -56.62 -20.78 22.86 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -1.084 . . . . 0.0 110.033 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -91.35 -18.22 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.724 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.564 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 28.6 m -58.37 144.65 40.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 99.4 mttt -95.45 150.54 20.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 109.507 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.503 ' CD1' ' CG1' ' A' ' 120' ' ' VAL . 1.9 mt -129.95 160.05 41.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.83 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.524 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 65.2 mt-10 -135.62 145.32 46.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.566 -0.709 . . . . 0.0 110.295 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.496 HG12 ' HG2' ' A' ' 117' ' ' GLU . 30.9 mm -122.59 141.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.517 -0.739 . . . . 0.0 109.934 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.561 ' O ' ' CD ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -176.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.922 0.867 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 87' ' ' VAL . . . -151.8 -179.48 27.48 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 33.5 pt -134.8 159.18 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.879 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 85.5 mt -95.79 118.43 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.537 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.5 pt? -134.91 -169.28 2.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.344 -0.848 . . . . 0.0 110.382 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.514 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 38.1 ttp180 -103.91 130.15 51.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 110.965 -175.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 83' ' ' ASP . 10.5 p -61.1 137.95 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 110.277 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -122.72 149.82 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.502 ' OE1' ' HD3' ' A' ' 74' ' ' ARG . 86.5 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 33.7 ptt180 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 55' ' ' TYR . 53.6 t -99.96 110.1 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.065 . . . . 0.0 110.023 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -99.76 119.98 39.0 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.003 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -133.66 -169.43 2.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.525 -0.735 . . . . 0.0 110.375 -177.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 26.6 p-10 -106.85 -179.15 3.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 0.0 110.816 -175.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -60.04 -40.07 88.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.242 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 46.6 t -59.95 -49.69 76.7 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.083 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.662 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 75.4 m -59.97 -40.09 87.87 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.099 -1.001 . . . . 0.0 109.682 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 32.2 ttp180 -60.19 -46.29 90.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 172.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -67.31 -39.97 85.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 110.415 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.662 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 4.4 pp -74.84 -28.4 60.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 111.088 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD13 ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -99.48 -8.36 24.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.731 -1.231 . . . . 0.0 110.15 175.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 34' ' ' LEU . 12.4 t70 59.77 14.87 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.818 . . . . 0.0 109.82 -174.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -58.95 120.71 9.57 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.536 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -99.48 173.34 6.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -58.52 127.75 18.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.35 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.7 73.4 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.578 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.487 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 90.2 m-20 -88.33 166.46 14.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.478 -1.601 . . . . 0.0 108.756 169.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 92' ' ' THR . 93.7 t -98.75 129.33 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.737 -1.227 . . . . 0.0 110.1 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 52' ' ' GLY . 2.3 m -115.48 138.01 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.353 -177.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.488 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 83.0 tt0 -108.67 139.77 43.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.441 -0.787 . . . . 0.0 109.396 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -120.3 145.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 110.332 -176.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.9 tt0 -147.42 99.51 3.14 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 110.772 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.547 ' CG ' HG12 ' A' ' 85' ' ' VAL . 9.5 tmtt? -98.29 -65.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.67 173.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.576 HG22 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.26 -33.38 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.257 174.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 69.5 mtt85 -135.56 -178.31 5.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.761 -0.587 . . . . 0.0 109.479 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.488 ' HD3' ' OE2' ' A' ' 43' ' ' GLU . 24.3 mttt -89.3 136.95 32.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.547 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.545 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 1.8 p -141.42 168.71 19.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 110.1 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.565 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.6 164.14 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.54 -0.725 . . . . 0.0 110.379 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -177.61 -172.76 42.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.405 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.9 ptp85 -113.98 -174.87 2.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.536 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -113.59 139.46 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.609 -173.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.504 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 1.1 m-85 -132.65 164.6 26.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.894 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -98.91 126.92 44.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.436 -0.79 . . . . 0.0 110.079 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -66.31 140.58 58.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.215 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.557 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -56.5 -49.02 95.94 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 118.899 -1.121 . . . . 0.0 108.834 172.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 30.7 Cg_endo -91.72 97.24 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.864 1.455 . . . . 0.0 108.954 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.13 35.83 0.14 Allowed 'General case' 0 C--N 1.289 -2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 110.984 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 36.1 p-10 -143.08 -36.11 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 110.964 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 15.5 pt-20 -84.83 -20.43 30.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.936 -1.102 . . . . 0.0 109.585 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.492 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 4.7 m-80 -81.42 38.66 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.48 -0.762 . . . . 0.0 110.531 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.414 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 26.2 pttm -98.82 11.9 37.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.63 26.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.492 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.8 pt -140.15 143.03 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.311 -1.111 . . . . 0.0 109.358 175.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HB ' HD13 ' A' ' 9' ' ' LEU . 7.5 p -122.48 129.62 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.309 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.536 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 38.7 mmm-85 -90.01 116.62 28.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.243 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.441 HD13 ' CG2' ' A' ' 11' ' ' VAL . 2.9 pt -136.84 169.15 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 110.599 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.453 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 32.9 p-10 -78.5 169.29 18.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.57 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 79.6 p -70.04 -23.49 63.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' HB ' ' OD2' ' A' ' 70' ' ' ASP . 54.5 t -70.06 -43.98 78.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.979 -1.076 . . . . 0.0 110.186 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.507 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 9.7 tpt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.084 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 71' ' ' SER . 43.7 ptt85 -61.38 -35.56 77.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.806 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.462 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 64.1 t30 -71.88 -26.45 62.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.11 -0.994 . . . . 0.0 110.495 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.6 m-20 -60.01 -35.66 75.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.466 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.452 ' HB2' HG23 ' A' ' 47' ' ' VAL . 26.1 p -97.95 -36.61 10.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.281 -0.887 . . . . 0.0 110.202 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.576 ' CA ' HG22 ' A' ' 47' ' ' VAL . . . 122.34 28.22 1.51 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.435 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -110.81 161.05 16.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -1.113 . . . . 0.0 110.476 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.476 ' O ' HG12 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.77 179.02 4.09 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 178.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.453 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -60.44 139.73 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.926 -1.109 . . . . 0.0 110.646 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.533 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . 78.24 -3.51 62.01 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.534 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.95 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.024 -1.28 . . . . 0.0 110.088 174.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 54.7 pttt -133.07 113.56 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 110.073 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.547 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -119.94 166.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.312 -0.867 . . . . 0.0 110.028 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 84.6 tttt -114.21 127.57 55.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 109.973 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.543 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 92.8 t -107.55 122.81 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.099 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.483 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 12.3 mtt180 -109.67 140.5 43.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 34' ' ' LEU . 53.5 tttm -82.13 140.76 33.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.094 -1.004 . . . . 0.0 110.701 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.432 HG23 HG11 ' A' ' 41' ' ' VAL . 2.3 m -150.17 -170.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.78 -0.575 . . . . 0.0 109.688 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.42 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.5 mtp180 -132.48 163.41 28.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.713 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.548 ' CG2' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -94.67 161.31 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.977 0.894 . . . . 0.0 111.418 -174.277 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' CG ' HG11 ' A' ' 162' ' ' VAL . 13.6 pt-20 -150.09 170.33 19.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.437 HG21 ' OE2' ' A' ' 167' ' ' GLU . 37.6 mm -89.07 101.11 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.625 -1.297 . . . . 0.0 110.461 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -58.69 139.98 55.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 110.31 177.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.567 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -101.84 -26.5 13.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 111.04 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.567 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 23.3 tttt -150.33 128.64 12.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 110.221 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 155' ' ' THR . 7.2 p -140.8 144.98 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.996 -1.065 . . . . 0.0 110.616 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.541 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.3 m -116.51 133.42 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.827 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -131.94 160.81 34.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 110.371 -176.399 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.47 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -133.65 81.31 54.0 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 110.848 -176.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . 17.4 Cg_exo . . . . . 0 C--N 1.306 -1.704 0 O-C-N 123.933 1.491 . . . . 0.0 110.083 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 19.1 tt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 121.162 0.506 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.432 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 95.9 mt-10 -60.53 -40.06 90.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.957 . . . . 0.0 109.955 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -70.02 -35.94 74.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -60.04 -39.74 86.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.768 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' A' ' 170' ' ' ILE . 54.6 t -60.14 -45.32 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.611 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -60.04 -41.2 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.014 173.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -60.03 -39.9 87.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 124' ' ' LEU . . . -82.39 -42.69 18.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.845 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 4.6 mm? -94.83 0.84 55.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.019 -1.051 . . . . 0.0 111.156 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 0.5 OUTLIER -44.04 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.03 -1.044 . . . . 0.0 110.554 -176.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.99 52.63 0.48 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.577 -0.702 . . . . 0.0 111.589 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 124' ' ' LEU . 13.7 mmt180 -134.36 149.99 72.7 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.997 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.683 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.8 Cg_exo -66.11 132.32 29.57 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.975 1.513 . . . . 0.0 109.93 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.555 ' CG ' HG12 ' A' ' 164' ' ' ILE . 93.9 mmm -125.19 132.19 53.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.604 -1.31 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.589 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 19.7 tp -133.38 108.18 8.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.69 -0.631 . . . . 0.0 109.433 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.8 pt-20 -45.7 136.12 6.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.69 -1.256 . . . . 0.0 110.163 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.583 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 80.01 -2.6 2.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.947 -0.471 . . . . 0.0 110.326 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.4 p30 -69.37 -169.97 0.25 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.297 -0.877 . . . . 0.0 110.414 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 11.5 m-80 -144.96 159.17 43.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 110.516 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 58.8 m-85 . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.261 0.553 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 110.03 16.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.034 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 132' ' ' GLN . 3.1 t -76.23 136.72 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 36.6 t -116.72 -30.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 110.618 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.4 tptt -140.07 135.07 32.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 0.0 110.935 -177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.523 HG22 ' CG2' ' A' ' 98' ' ' VAL . 69.6 p -129.95 166.21 20.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.397 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.661 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.1 OUTLIER -88.8 -38.2 0.44 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.035 . . . . 0.0 110.81 -178.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 22.7 Cg_exo -57.8 -171.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.551 1.29 . . . . 0.0 110.497 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.95 -167.82 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 110.013 176.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.53 -9.45 8.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.181 -0.949 . . . . 0.0 110.695 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.21 144.51 41.12 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.478 -0.764 . . . . 0.0 110.628 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.565 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -47.9 141.63 16.4 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.885 1.723 . . . . 0.0 111.252 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 8.9 m -130.23 159.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 109.946 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 88.0 tt0 -109.32 130.56 55.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.237 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.574 ' CG2' ' OE1' ' A' ' 121' ' ' GLN . 12.8 mm -71.2 152.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.518 -176.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.59 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.85 169.8 25.48 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.565 ' HG2' ' CD1' ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.87 -23.61 45.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -1.142 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.437 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.5 pt-20 -87.06 -12.53 46.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.555 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 13.5 m -62.94 144.76 56.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.5 mttt -93.91 154.64 17.59 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 109.897 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.565 ' CG1' ' CG ' ' A' ' 121' ' ' GLN . 1.8 mm -116.87 136.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 111.038 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.541 ' CB ' ' OG1' ' A' ' 99' ' ' THR . 18.7 mt-10 -120.33 130.68 54.53 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 110.198 172.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 171' ' ' GLU . 34.9 mm -120.17 140.37 44.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.529 -0.732 . . . . 0.0 110.301 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.537 ' O ' ' CZ ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.301 -176.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.45 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 27.3 t30 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.081 0.943 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.516 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -155.47 -169.27 19.7 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.575 ' CG2' HD13 ' A' ' 33' ' ' LEU . 41.0 pt -133.29 162.86 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -1.14 . . . . 0.0 109.663 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.429 HG12 ' HD3' ' A' ' 86' ' ' LYS . 92.8 mt -107.62 126.55 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 85' ' ' VAL . 1.6 pt? -143.78 -165.49 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.657 -0.652 . . . . 0.0 109.447 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.553 ' NH2' HG23 ' A' ' 66' ' ' ILE . 19.9 ptt-85 -115.0 140.25 49.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 0.0 110.464 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 81' ' ' ILE . 13.6 p -60.75 137.75 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 110.635 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -115.3 139.97 49.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 110.56 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.474 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 109.918 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.586 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 39.8 mtm180 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.257 0.551 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.511 ' CG1' HG21 ' A' ' 67' ' ' VAL . 83.4 t -112.44 120.56 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.511 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 1.2 ptm180 -95.74 119.88 35.02 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.602 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.531 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 1.1 mp -136.36 173.72 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.7 -175.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.513 ' OD2' ' HA ' ' A' ' 64' ' ' LYS . 10.2 p-10 -95.71 -172.65 2.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 111.004 -176.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.491 ' OE2' ' NH1' ' A' ' 56' ' ' ARG . 49.7 mm-40 -59.73 -50.04 75.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 109.763 -175.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.533 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.5 t -64.1 -40.53 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.219 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.618 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 68.6 m -60.05 -29.34 68.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 70.9 ttt180 -87.35 -46.99 9.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.659 -0.651 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 33' ' ' LEU . 87.0 mtm180 -79.94 -6.94 58.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.801 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.618 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -42.03 -30.51 0.28 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.526 -0.734 . . . . 0.0 109.788 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.59 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 79.3 mt -141.53 -61.65 0.47 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 0.0 110.592 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' C ' ' A' ' 36' ' ' ALA . 26.8 t0 -172.46 -29.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.2 -0.937 . . . . 0.0 110.03 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.566 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -23.52 116.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.514 0.674 . . . . 0.0 111.357 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -109.5 168.38 9.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.279 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -46.08 125.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.063 -1.023 . . . . 0.0 109.806 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.48 21.32 67.11 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.609 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.498 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 81.3 m-20 -89.21 173.91 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.721 -1.458 . . . . 0.0 109.359 171.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.505 ' CG1' ' HG2' ' A' ' 161' ' ' PRO . 59.7 t -99.39 134.16 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.958 . . . . 0.0 110.144 -175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 42' ' ' VAL . 3.5 m -123.28 146.15 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.71 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -114.17 140.58 48.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.733 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.65 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.1 mp -124.81 138.94 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.687 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 87.6 tt0 -140.64 99.99 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 110.265 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HD2' ' CB ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -98.75 -66.47 0.9 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.618 -0.676 . . . . 0.0 109.401 177.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.531 HG23 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -111.3 -30.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.417 -0.802 . . . . 0.0 109.063 172.024 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.552 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 95.3 mtt180 -131.86 -179.82 5.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.619 173.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.446 ' C ' HG22 ' A' ' 50' ' ' THR . 35.0 mttt -89.17 138.34 31.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 111.011 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.65 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 5.5 p -142.57 167.7 21.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.55 0.69 . . . . 0.0 109.801 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -121.23 167.79 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -179.59 -168.46 38.49 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.467 ' N ' HG21 ' A' ' 42' ' ' VAL . 67.1 ttt180 -125.45 165.09 19.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.981 . . . . 0.0 110.592 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -94.23 136.08 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.269 -175.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.586 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 1.3 m-85 -133.61 163.69 28.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.472 175.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 43.0 ttt85 -92.3 125.96 37.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.936 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . . . -63.29 139.27 58.75 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.37 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.565 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 1.6 mtp180 -56.24 -48.57 96.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.763 174.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 34.2 Cg_endo -91.65 97.18 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.095 1.576 . . . . 0.0 108.965 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.12 35.93 0.11 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.547 -0.721 . . . . 0.0 110.737 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.2 p-10 -143.59 -31.85 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.45 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.62 -28.76 24.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.185 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.484 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 3.5 m-80 -80.98 39.81 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.474 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.513 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 14.2 pttm -98.79 9.41 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -0.923 . . . . 0.0 109.683 177.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -176.36 28.08 0.07 OUTLIER Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.553 HG23 ' NH2' ' A' ' 10' ' ' ARG . 44.6 pt -140.58 143.13 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.213 -1.169 . . . . 0.0 109.473 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.548 ' N ' HD13 ' A' ' 9' ' ' LEU . 3.9 p -119.34 124.48 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.045 -1.034 . . . . 0.0 109.898 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 1.7 mtp85 -91.39 117.22 29.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.285 -0.885 . . . . 0.0 110.074 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.53 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.4 pt -129.69 162.96 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.632 -0.668 . . . . 0.0 110.264 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.52 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 26.0 p-10 -76.78 177.55 7.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.851 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 10.4 m -68.87 -19.0 64.23 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.52 ' HB ' ' OD2' ' A' ' 70' ' ' ASP . 86.3 t -69.9 -48.37 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.989 -1.069 . . . . 0.0 110.331 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.493 ' HE1' ' OG1' ' A' ' 50' ' ' THR . 88.8 mmm -62.8 -40.27 96.83 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.548 174.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.07 -40.66 90.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 173.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 71' ' ' SER . 8.0 t30 -78.34 -32.58 49.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 110.577 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.377 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 20.9 p -99.91 -38.28 8.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.726 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.531 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 111.05 23.7 5.73 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.716 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -111.05 -178.07 3.37 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.008 -1.29 . . . . 0.0 111.295 -171.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -128.74 170.15 13.66 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 174.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.586 ' HA ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -56.37 154.54 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 110.156 178.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 74.84 -5.45 31.46 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 80' ' ' SER . 1.9 m-20 -56.27 -164.64 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.039 -1.271 . . . . 0.0 110.513 176.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 22.2 pttm -134.55 115.92 14.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 109.554 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.559 HG23 HD21 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -125.75 159.22 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.126 -177.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.6 ttpm? -111.72 121.04 44.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.77 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.5 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.3 t -99.65 120.06 48.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 4.6 mtt180 -112.11 139.38 47.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.826 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -86.14 138.59 31.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 89' ' ' LYS . 2.2 m -147.07 -169.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.501 -0.749 . . . . 0.0 110.221 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -127.51 166.48 17.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.822 . . . . 0.0 109.631 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.499 ' OG1' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -99.42 162.13 13.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 0.0 111.057 -176.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.424 ' CG ' HG11 ' A' ' 162' ' ' VAL . 13.7 pt-20 -150.33 169.3 21.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 94' ' ' ILE . 30.7 mm -89.93 98.28 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.603 -1.311 . . . . 0.0 110.469 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.551 ' CB ' HG21 ' A' ' 162' ' ' VAL . . . -56.82 141.03 46.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.308 -0.87 . . . . 0.0 110.361 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 169' ' ' LYS . 5.5 pttt -108.25 -22.01 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.193 -0.942 . . . . 0.0 111.14 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HB3' HD13 ' A' ' 156' ' ' LEU . 62.6 tttp -150.7 117.22 5.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.613 -1.305 . . . . 0.0 110.485 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.515 ' CG1' HG12 ' A' ' 170' ' ' ILE . 9.9 p -134.74 140.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.04 . . . . 0.0 110.588 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.7 m -108.02 140.31 41.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.078 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -134.71 165.09 26.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.105 -178.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.64 82.88 11.02 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.141 -0.974 . . . . 0.0 111.037 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 32.5 Cg_exo . . . . . 0 C--N 1.306 -1.662 0 O-C-N 123.921 1.485 . . . . 0.0 110.394 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.304 0.573 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.527 ' HG2' ' CD1' ' A' ' 172' ' ' ILE . 99.0 mt-10 -59.97 -45.32 93.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -70.02 -32.95 71.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 110.582 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -60.07 -39.98 87.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.139 -0.976 . . . . 0.0 109.062 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.593 ' CG1' ' CD1' ' A' ' 170' ' ' ILE . 53.9 t -60.52 -49.11 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.677 174.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.528 ' HG3' HG13 ' A' ' 170' ' ' ILE . 3.3 mt-30 -59.99 -42.65 94.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.0 -45.61 92.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 110.157 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 124' ' ' LEU . . . -69.95 -43.4 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.1 mm? -99.79 6.17 45.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.977 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 126' ' ' ARG . 1.6 tt -47.98 165.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.76 -1.212 . . . . 0.0 109.821 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 11.6 ptp180 35.3 47.7 0.33 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.445 -0.785 . . . . 0.0 111.387 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.538 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 7.4 mmt85 -129.37 150.88 76.78 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.791 -1.193 . . . . 0.0 110.965 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.3 Cg_endo -68.71 128.55 17.19 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 124.233 1.649 . . . . 0.0 109.716 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.482 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.9 mmm -124.76 139.84 53.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.446 -1.409 . . . . 0.0 110.885 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.488 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 16.7 tp -141.34 104.38 4.59 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.639 -0.663 . . . . 0.0 109.558 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.0 pt-20 -43.41 139.43 2.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.617 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.61 -7.01 0.98 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.184 0.516 . . . . 0.0 110.334 -177.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.49 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 3.3 p-10 -70.08 174.96 4.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 29.9 m-80 -141.38 149.72 41.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 110.108 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 28.6 m-85 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.339 0.59 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.52 108.48 15.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.92 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.49 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 3.3 t -77.16 140.02 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.816 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.4 t -120.51 -30.95 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.129 -0.982 . . . . 0.0 110.785 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -143.09 149.55 38.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.772 -1.205 . . . . 0.0 111.59 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.508 ' CG2' HG22 ' A' ' 98' ' ' VAL . 55.1 p -140.54 164.39 30.28 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.9 OUTLIER -88.42 -39.15 0.46 Allowed Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.893 . . . . 0.0 110.692 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 19.3 Cg_exo -58.56 -172.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.556 1.293 . . . . 0.0 110.38 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 -167.68 1.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.465 -0.772 . . . . 0.0 109.821 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -65.79 -4.88 7.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.219 -0.925 . . . . 0.0 110.983 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.7 145.26 41.26 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.424 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.569 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -49.35 141.31 25.09 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.221 1.643 . . . . 0.0 110.545 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 4.6 m -129.88 157.9 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 109.942 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 53.7 tt0 -106.91 128.01 53.94 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 110.2 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 126' ' ' ARG . 11.2 mm -70.85 156.48 7.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 110.275 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.74 169.73 25.96 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.458 ' HG2' ' CD1' ' A' ' 125' ' ' ILE . 98.9 mt-10 -57.85 -21.45 42.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 0.0 110.209 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -88.35 -21.6 24.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.884 . . . . 0.0 109.575 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 95' ' ' ALA . 26.6 m -56.89 162.07 2.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.514 -0.741 . . . . 0.0 110.231 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' LYS . 46.8 mtmt -121.02 149.82 42.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.464 176.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.593 ' CD1' ' CG1' ' A' ' 120' ' ' VAL . 1.2 mt -127.99 162.95 32.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 110.95 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.453 ' O ' HD22 ' A' ' 100' ' ' LEU . 35.8 mt-10 -138.35 137.29 37.2 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.521 0.676 . . . . 0.0 110.11 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 117' ' ' GLU . 4.3 mp -121.68 137.72 54.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.887 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.577 ' NE ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 0.0 110.096 -174.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.357 0.599 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.508 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -152.18 -161.88 10.48 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.447 HG23 HD12 ' A' ' 33' ' ' LEU . 42.5 pt -136.07 157.92 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -1.204 . . . . 0.0 110.0 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 mm -101.5 113.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.026 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -139.81 -173.8 3.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.885 -178.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 24.1 ptt-85 -115.77 139.81 49.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.943 -1.098 . . . . 0.0 110.619 -175.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 80' ' ' SER . 14.5 p -61.8 132.55 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.538 -0.726 . . . . 0.0 110.634 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -108.78 145.33 35.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.63 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.556 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 84.8 tt0 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.874 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 24.9 mmt85 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.089 0.471 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.473 HG12 HG21 ' A' ' 67' ' ' VAL . 85.6 t -110.45 119.98 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 0.0 110.195 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 5.1 ptt180 -90.25 116.66 28.4 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.753 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.523 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 1.1 mp -128.24 174.91 8.87 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 3.5 p-10 -91.67 177.54 6.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.84 -1.162 . . . . 0.0 110.404 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -60.04 -39.99 87.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 -176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -67.74 -58.33 4.82 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.107 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.533 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 68.3 m -49.99 -30.04 9.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 109.629 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -81.73 -47.95 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 111.261 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -93.91 -16.86 23.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.767 -1.208 . . . . 0.0 111.199 -171.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.586 ' HB3' ' O ' ' A' ' 29' ' ' SER . 1.1 pt? -60.0 -28.77 67.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.131 . . . . 0.0 110.24 -176.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 61.4 mt -101.91 -73.37 0.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 109.97 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' ALA . 12.6 t0 -170.02 -27.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -36.23 122.36 0.72 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.327 0.584 . . . . 0.0 110.933 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.575 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -115.65 179.32 4.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.2 mm -54.64 128.27 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.985 -1.072 . . . . 0.0 109.897 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.62 18.36 75.75 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.575 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 79.5 m-20 -89.17 161.86 16.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.649 -1.501 . . . . 0.0 109.635 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.442 HG22 ' OG1' ' A' ' 92' ' ' THR . 94.0 t -99.62 135.92 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.058 -1.026 . . . . 0.0 110.499 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 42' ' ' VAL . 3.5 m -119.98 153.12 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.861 . . . . 0.0 110.571 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -118.88 139.93 50.82 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.348 -0.845 . . . . 0.0 110.009 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.588 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 2.8 mp -119.98 145.11 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.049 . . . . 0.0 110.754 -177.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.49 95.28 2.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.353 -0.842 . . . . 0.0 111.023 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HG3' HG11 ' A' ' 85' ' ' VAL . 9.7 tmtm? -97.85 -59.19 1.82 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.995 . . . . 0.0 109.852 173.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG23 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -113.21 -33.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.58 -0.7 . . . . 0.0 109.22 175.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 78.9 mtm-85 -136.56 178.42 7.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 174.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.49 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.1 132.26 34.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.163 -0.96 . . . . 0.0 110.386 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.588 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.1 p -139.69 168.13 20.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.468 0.651 . . . . 0.0 109.695 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.676 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 2.8 m -115.24 175.16 2.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.55 -0.719 . . . . 0.0 110.66 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -177.78 179.75 48.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 174.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.49 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 51.1 mtp180 -125.82 176.13 7.16 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.274 -1.133 . . . . 0.0 110.027 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -99.15 127.07 52.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.351 -175.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.52 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -117.6 164.81 14.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 175.01 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -89.87 121.74 32.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.439 -0.788 . . . . 0.0 109.803 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -62.82 132.4 52.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.604 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.604 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.4 mtt-85 -57.11 -47.4 99.13 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.708 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.76 97.17 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.96 1.505 . . . . 0.0 108.975 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -75.56 33.51 0.11 Allowed 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.429 -0.794 . . . . 0.0 110.977 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 59' ' ' PRO . 72.6 m-20 -145.73 -28.54 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.055 -1.028 . . . . 0.0 110.631 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -87.03 -25.76 24.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 109.129 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 57' ' ' ALA . 18.3 m120 -81.1 42.33 0.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.639 -0.663 . . . . 0.0 110.269 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.528 ' CD ' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.73 9.52 43.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 0.0 109.788 176.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.89 27.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.577 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.456 ' CG2' ' NH2' ' A' ' 10' ' ' ARG . 45.8 pt -140.78 141.71 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.272 -1.134 . . . . 0.0 109.653 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.527 ' CB ' HD11 ' A' ' 9' ' ' LEU . 2.4 p -117.01 128.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.848 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.538 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 78.7 ttt180 -90.82 119.38 30.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.493 HD12 ' CG2' ' A' ' 11' ' ' VAL . 1.6 pp -133.31 165.03 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 110.473 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -80.01 169.2 18.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.734 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.2 m -60.04 -39.95 87.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.413 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.1 -46.6 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.927 . . . . 0.0 110.161 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 51' ' ' VAL . 16.8 tpt -60.06 -42.81 95.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.582 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -39.97 93.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.691 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -69.98 -23.41 63.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.443 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 73' ' ' MET . 75.3 m-20 -60.1 -39.99 88.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.033 -1.042 . . . . 0.0 110.641 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.509 ' O ' ' NH2' ' A' ' 48' ' ' ARG . 29.1 p -98.96 -37.09 9.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.901 -1.124 . . . . 0.0 110.577 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.509 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 114.92 33.18 1.72 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.451 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -109.99 162.79 14.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -1.212 . . . . 0.0 110.401 -177.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.529 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 169.96 8.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.349 -0.844 . . . . 0.0 109.26 177.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.556 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -52.79 144.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.194 177.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.454 ' N ' HG11 ' A' ' 11' ' ' VAL . . . 74.99 0.34 60.15 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 173.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.0 m-20 -58.89 -162.83 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.801 -1.411 . . . . 0.0 110.36 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.3 ptpt -135.13 113.64 11.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.477 -0.764 . . . . 0.0 109.77 176.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.549 HG11 ' HG3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -123.74 156.37 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.629 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -102.9 119.79 39.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.813 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.503 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 45.6 t -102.04 119.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.55 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 84.4 mtm-85 -116.76 140.48 49.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.998 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 24.0 tttm -72.34 145.33 47.85 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 110.879 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -147.4 -167.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.651 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -134.06 168.61 18.5 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 109.653 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -112.21 159.26 18.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.077 -1.015 . . . . 0.0 111.149 -174.295 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -150.08 170.54 18.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.3 96.49 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.467 -1.396 . . . . 0.0 110.219 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.52 ' HB3' ' CG2' ' A' ' 162' ' ' VAL . . . -56.58 147.81 21.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.508 -0.745 . . . . 0.0 110.643 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 169' ' ' LYS . 9.7 ptmt -115.69 -24.9 8.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.805 . . . . 0.0 111.01 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.429 ' HE3' ' OE1' ' A' ' 171' ' ' GLU . 42.7 tttp -149.99 125.84 10.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.759 -1.213 . . . . 0.0 110.691 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.546 ' CG1' HG12 ' A' ' 170' ' ' ILE . 7.3 p -139.46 146.96 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.176 -0.953 . . . . 0.0 110.293 176.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 95.4 m -119.56 138.37 53.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.601 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -140.01 174.17 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.47 ' CB ' ' HD2' ' A' ' 173' ' ' ARG . . . -143.95 102.38 4.88 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 110.752 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.0 110.048 179.524 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 9.7 tp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.235 0.541 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 41.3 tt0 -59.93 -42.75 94.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.857 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.67 -37.3 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.872 . . . . 0.0 109.817 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -59.99 -39.36 85.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.833 . . . . 0.0 109.684 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.548 ' CG1' HD13 ' A' ' 170' ' ' ILE . 67.3 t -60.03 -47.25 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.55 ' HA ' ' CD2' ' A' ' 124' ' ' LEU . 2.5 mt-30 -60.04 -41.37 92.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -60.11 -41.53 92.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 110.293 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.71 -48.58 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.919 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.55 ' CD2' ' HA ' ' A' ' 121' ' ' GLN . 0.3 OUTLIER -96.28 3.69 52.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.005 -1.06 . . . . 0.0 110.905 -172.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.544 ' HA ' ' CG2' ' A' ' 164' ' ' ILE . 3.4 tt -41.58 165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 110.492 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.95 47.43 0.18 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 111.319 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.7 OUTLIER -133.61 135.06 24.33 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.949 -1.094 . . . . 0.0 111.051 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 7.4 Cg_endo -54.33 119.76 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.815 1.429 . . . . 0.0 109.498 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG2' ' O ' ' A' ' 127' ' ' ARG . 93.5 mmm -133.26 141.94 48.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.586 -1.321 . . . . 0.0 110.738 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.688 ' N ' ' CD1' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.67 145.93 25.42 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.703 0.763 . . . . 0.0 110.752 175.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -53.47 158.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.594 -0.691 . . . . 0.0 111.085 -174.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.572 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.6 -6.17 1.84 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.83 -0.544 . . . . 0.0 110.798 177.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.571 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 1.3 p30 -70.22 169.15 14.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -136.01 138.95 42.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 120.986 -1.071 . . . . 0.0 110.338 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.262 0.553 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -108.6 108.39 19.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.571 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 2.2 t -79.72 136.22 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.036 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.89 -22.74 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 110.784 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -150.01 151.24 32.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.843 -1.161 . . . . 0.0 110.976 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 131' ' ' GLU . 34.5 p -141.66 169.39 17.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 109.389 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.649 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.44 -40.27 0.46 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.698 -178.197 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 17.1 Cg_exo -58.99 -164.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.718 1.378 . . . . 0.0 110.425 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.6 t -89.98 -171.36 3.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.804 175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -67.44 -6.09 17.78 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.165 -0.959 . . . . 0.0 110.498 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.8 m -87.59 148.3 43.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.405 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.676 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.23 143.34 7.86 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.267 1.667 . . . . 0.0 110.628 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.776 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 9.1 m -130.04 159.37 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.58 122.43 44.96 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.838 -1.163 . . . . 0.0 110.13 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 126' ' ' ARG . 8.0 mm -69.54 158.31 6.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.68 -0.638 . . . . 0.0 110.196 -176.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.462 ' N ' ' OG1' ' A' ' 168' ' ' THR . . . -142.64 167.08 26.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.53 -23.09 57.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -1.043 . . . . 0.0 110.248 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.99 -12.07 39.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.152 -0.967 . . . . 0.0 110.087 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 95' ' ' ALA . 5.6 m -57.75 179.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.129 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 96' ' ' LYS . 50.0 mtpt -140.54 159.66 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.548 HD13 ' CG1' ' A' ' 120' ' ' VAL . 4.3 mt -140.02 168.0 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 110.834 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.529 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 13.5 mt-10 -139.17 131.73 28.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.609 -0.682 . . . . 0.0 110.195 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.497 ' CD1' HD12 ' A' ' 100' ' ' LEU . 37.2 mm -119.97 119.94 61.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.87 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.47 ' HD2' ' CB ' ' A' ' 101' ' ' ALA . 6.1 ptp180 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.23 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.458 ' O ' HD13 ' A' ' 34' ' ' LEU . 32.2 m120 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.177 0.513 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.01 -166.2 13.85 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.592 ' CD1' HD13 ' A' ' 33' ' ' LEU . 37.3 pt -135.75 159.98 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -1.179 . . . . 0.0 109.811 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.7 mt -101.26 118.64 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.409 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.7 pt? -139.2 -170.78 2.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.7 ptp180 -107.9 135.45 49.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.818 -1.176 . . . . 0.0 110.802 -173.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.575 ' CG1' ' O ' ' A' ' 80' ' ' SER . 14.3 p -62.97 131.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.702 . . . . 0.0 110.774 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -113.91 152.97 30.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.522 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 110.246 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.492 ' NH2' ' CE2' ' A' ' 55' ' ' TYR . 69.4 mtp180 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.242 0.544 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 97.5 t -120.0 124.28 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.102 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HD3' ' CD ' ' A' ' 68' ' ' ARG . 7.2 ptt180 -92.27 120.05 32.45 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.786 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HB3' ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -134.05 164.81 26.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.574 -0.704 . . . . 0.0 109.825 -176.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -93.54 -177.34 4.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.004 -1.06 . . . . 0.0 110.555 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.02 -47.33 86.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.672 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 58.1 m -66.32 -43.74 85.33 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.45 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.613 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 55.8 p -60.81 -26.89 67.63 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 53.3 ttp180 -88.35 -45.93 9.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.584 -0.697 . . . . 0.0 110.89 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 99.5 mtt180 -76.59 -10.04 59.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 0.0 109.896 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.613 ' CD2' ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -41.25 -30.03 0.15 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.607 0.718 . . . . 0.0 109.948 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.586 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 73.8 mt -139.98 -61.18 0.53 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.574 -0.704 . . . . 0.0 110.63 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 16.2 t0 -169.98 -28.73 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.551 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.559 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -23.71 118.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.558 0.694 . . . . 0.0 111.457 -175.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.4 pt-20 -104.63 177.59 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.5 mm -58.1 122.59 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.963 -1.086 . . . . 0.0 109.933 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.51 30.14 60.67 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 33.8 m-20 -89.28 174.4 7.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.832 -1.393 . . . . 0.0 109.411 170.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 96.6 t -99.38 124.69 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.238 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.5 m -111.82 140.04 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.27 -0.893 . . . . 0.0 110.489 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -108.1 143.91 36.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.764 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.605 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -119.8 144.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.068 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -151.51 87.69 1.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.833 -1.167 . . . . 0.0 111.604 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.607 ' HD3' ' CB ' ' A' ' 79' ' ' ALA . 38.5 tttp -98.57 -75.95 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 110.287 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.497 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -91.78 -33.81 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.481 -0.762 . . . . 0.0 109.62 177.424 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 91.6 mtt180 -143.93 -172.31 3.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.49 ' O ' HD22 ' A' ' 130' ' ' LEU . 14.2 mptt -87.95 132.19 34.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.679 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -133.95 158.78 42.62 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.293 0.568 . . . . 0.0 110.226 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.12 161.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 110.174 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.46 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -176.92 179.39 47.89 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.82 -178.78 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.248 -1.148 . . . . 0.0 109.981 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -110.47 135.3 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 110.373 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -128.02 167.67 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.285 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 35.2 ptt180 -89.32 124.9 34.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.078 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' A' ' 63' ' ' ASN . . . -61.84 131.54 50.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.946 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.648 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 11.5 mtt180 -59.51 -42.09 90.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 C-N-CA 119.101 -1.039 . . . . 0.0 109.367 175.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 29.3 Cg_endo -94.33 99.83 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.886 1.467 . . . . 0.0 108.998 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 12.0 pt-20 -72.77 32.61 0.07 Allowed 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.392 -0.817 . . . . 0.0 110.859 -175.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.6 m-20 -148.58 -26.66 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 0.0 110.701 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 66' ' ' ILE . 52.9 mt-10 -86.26 -28.48 23.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 109.109 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.51 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 43.5 m-80 -81.12 42.22 0.64 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.361 0.6 . . . . 0.0 110.375 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HD3' ' OD2' ' A' ' 27' ' ' ASP . 37.2 mmtt -96.76 6.32 48.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.287 177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.4 29.55 0.05 OUTLIER Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.482 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -140.78 145.12 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.224 -1.162 . . . . 0.0 109.525 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.505 ' N ' HD13 ' A' ' 9' ' ' LEU . 2.6 p -123.17 130.0 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.827 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.535 ' CD ' ' HD3' ' A' ' 25' ' ' ARG . 71.3 ttt180 -91.6 114.62 27.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 110.131 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.57 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 1.6 pt -130.16 159.98 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.679 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -81.09 169.57 17.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 110.227 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -57.86 -22.55 48.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.07 -48.84 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.437 ' HE2' ' HB ' ' A' ' 50' ' ' THR . 97.0 mmm -60.03 -43.91 94.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.953 . . . . 0.0 109.6 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -59.98 -40.49 89.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.25 -0.906 . . . . 0.0 110.04 174.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -69.49 -35.87 75.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' HB3' HG22 ' A' ' 50' ' ' THR . 20.6 m120 -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.269 -0.894 . . . . 0.0 110.372 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.7 p -98.36 -35.79 10.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 110.607 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.497 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 109.92 28.05 4.34 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.607 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -100.39 177.63 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.242 . . . . 0.0 111.016 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.575 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -122.81 172.24 8.6 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -0.853 . . . . 0.0 109.196 175.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -62.19 142.23 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.717 -1.239 . . . . 0.0 110.561 179.239 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.539 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 74.55 -0.61 55.15 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 173.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.547 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -59.65 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.097 -1.237 . . . . 0.0 110.33 175.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 19.1 pttp -133.2 116.33 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.575 -0.703 . . . . 0.0 109.904 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.587 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -122.12 160.12 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 110.023 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 40.1 tttt -107.4 120.66 42.77 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.503 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 72.3 t -103.96 122.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 0.0 109.998 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.536 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 96.1 mtt180 -110.0 148.03 32.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.629 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.516 ' HG3' ' CA ' ' A' ' 36' ' ' ALA . 2.4 tmtt? -93.86 136.01 34.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.056 -1.027 . . . . 0.0 110.53 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.1 m -149.81 -170.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.927 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 52.7 mtt180 -132.85 164.41 26.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 110.41 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.487 ' CG2' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.45 159.39 17.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 111.224 -176.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.432 ' OE2' ' CG2' ' A' ' 160' ' ' VAL . 12.8 pt-20 -150.42 169.99 20.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.17 101.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.827 -1.17 . . . . 0.0 110.264 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.483 ' HB1' HG23 ' A' ' 162' ' ' VAL . . . -56.38 135.46 53.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.266 -0.896 . . . . 0.0 110.184 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.547 ' HD2' ' CD1' ' A' ' 156' ' ' LEU . 7.1 ptpp? -97.24 -29.75 13.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -0.973 . . . . 0.0 111.112 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 169' ' ' LYS . 47.3 tttm -151.27 126.66 10.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 110.789 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.488 HG21 ' CG2' ' A' ' 155' ' ' THR . 9.2 p -136.53 145.98 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.122 . . . . 0.0 110.881 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -119.74 139.45 52.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.051 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -134.55 166.09 23.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.505 -177.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.491 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . . . -139.51 89.65 11.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.33 -0.857 . . . . 0.0 110.466 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.0 Cg_exo . . . . . 0 C--N 1.305 -1.718 0 O-C-N 123.997 1.525 . . . . 0.0 110.434 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.478 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.2 tp . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.12 0.486 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -67.31 -39.98 85.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.905 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.04 -31.46 69.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.05 -41.69 92.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 110.076 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.545 ' CG1' HD13 ' A' ' 170' ' ' ILE . 55.0 t -60.08 -45.92 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.565 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.2 mt-30 -60.0 -42.74 94.93 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 110.273 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.13 -47.94 83.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.481 -0.762 . . . . 0.0 110.151 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.17 75.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.532 -0.73 . . . . 0.0 110.318 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 51.5 mt -93.76 -5.72 47.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.416 -176.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.597 ' HA ' ' CG2' ' A' ' 164' ' ' ILE . 2.5 tt -45.91 167.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.926 -1.109 . . . . 0.0 110.207 -172.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 164' ' ' ILE . 32.0 ptt180 33.82 48.24 0.21 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.672 -0.642 . . . . 0.0 111.768 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 9.3 mmt85 -136.57 148.98 65.93 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 120.533 -1.355 . . . . 0.0 111.83 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.784 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -66.19 130.6 24.52 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.24 1.652 . . . . 0.0 109.653 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.496 ' SD ' HG13 ' A' ' 164' ' ' ILE . 39.9 mtp -130.58 150.06 51.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.44 -1.412 . . . . 0.0 111.207 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.508 ' HB2' HG11 ' A' ' 51' ' ' VAL . 16.5 tp -144.44 107.93 4.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.663 -0.648 . . . . 0.0 109.637 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.2 pm0 -44.71 142.9 1.55 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.359 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.571 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 80.39 -0.85 1.96 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.125 0.488 . . . . 0.0 110.259 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.522 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 4.2 p-10 -70.0 179.4 2.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 109.85 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.504 ' OD1' ' HD2' ' A' ' 151' ' ' LYS . 13.4 m-80 -150.17 136.1 18.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.632 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.008 -1.057 . . . . 0.0 110.303 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 30.0 m-85 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.337 0.589 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.504 ' HD2' ' OD1' ' A' ' 134' ' ' ASN . 19.3 tptp -112.31 103.63 11.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.873 . . . . 0.0 109.75 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.522 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 2.1 t -77.44 140.01 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.14 -25.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 111.372 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.521 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 45.0 tptt -140.24 129.93 24.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.587 -1.321 . . . . 0.0 110.885 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.488 ' CG2' HG21 ' A' ' 98' ' ' VAL . 59.7 p -129.99 166.31 20.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.389 -0.82 . . . . 0.0 109.164 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.681 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.1 OUTLIER -89.05 -35.47 0.42 Allowed Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.084 -1.01 . . . . 0.0 110.98 -176.58 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 31.6 Cg_exo -53.1 -179.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.4 1.211 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -84.83 49.76 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.516 -179.238 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.6 mmtm 59.99 20.03 9.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 158' ' ' SER . 11.5 m -109.41 159.74 30.3 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.411 -0.806 . . . . 0.0 110.326 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.557 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 5.1 Cg_endo -53.87 123.29 13.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.198 1.631 . . . . 0.0 110.2 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 5.0 m -129.78 158.46 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.879 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -103.2 128.1 50.29 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.009 177.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.597 ' CG2' ' HA ' ' A' ' 125' ' ' ILE . 10.7 mm -70.26 154.22 8.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.636 -0.665 . . . . 0.0 110.036 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 164' ' ' ILE . . . -142.07 170.98 24.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.482 ' HG2' ' CD1' ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.88 -21.27 28.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -1.088 . . . . 0.0 110.074 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.45 -21.42 21.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 109.791 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.559 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 69.3 m -54.85 138.83 41.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.012 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.1 mttt -93.08 149.52 21.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.133 -0.979 . . . . 0.0 109.59 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.545 HD13 ' CG1' ' A' ' 120' ' ' VAL . 2.1 mt -130.0 160.52 40.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.935 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.513 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 30.8 mt-10 -135.19 136.12 41.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.637 -0.665 . . . . 0.0 110.173 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.423 ' CD1' HD11 ' A' ' 100' ' ' LEU . 40.6 mm -119.98 122.27 68.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.67 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.491 ' NE ' ' HB3' ' A' ' 101' ' ' ALA . 6.4 ptp180 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 110.148 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.486 0.66 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -150.72 -155.24 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 12.2 pt -131.08 159.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.13 . . . . 0.0 109.193 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 92.2 mt -100.64 122.5 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.011 -1.055 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.608 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -139.62 -175.81 4.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.596 177.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 33.5 ptt180 -110.68 139.72 45.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.869 -1.145 . . . . 0.0 110.964 -175.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 80' ' ' SER . 14.6 p -61.82 130.05 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.661 -0.649 . . . . 0.0 110.755 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.569 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -107.84 151.62 25.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 110.423 177.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.431 ' HB3' ' CG1' ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.145 0.498 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 78.7 t -119.46 118.46 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 3.2 ptt180 -88.6 117.36 27.5 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.431 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 55' ' ' TYR . 1.2 pt? -136.63 169.09 18.28 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.672 -0.642 . . . . 0.0 109.353 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 7.6 p-10 -97.12 -171.96 2.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.806 -1.184 . . . . 0.0 111.17 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -59.8 -49.22 78.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.49 -0.757 . . . . 0.0 109.476 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.8 t -62.03 -47.39 84.97 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.409 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.646 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 25.1 t -57.59 -29.64 64.64 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.173 -0.955 . . . . 0.0 109.545 178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 60.0 ttp85 -85.89 -45.47 11.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -80.09 -4.85 54.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.008 -1.058 . . . . 0.0 110.111 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.646 ' CD2' ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -47.49 -27.92 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.788 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 71.6 mt -139.9 -60.04 0.54 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.659 -0.65 . . . . 0.0 110.377 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' C ' ' A' ' 36' ' ' ALA . 44.1 t0 -170.75 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.905 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.583 ' HA ' ' HE2' ' A' ' 89' ' ' LYS . . . -19.94 124.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.563 0.697 . . . . 0.0 111.824 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.3 pt-20 -116.88 -179.76 3.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.7 mm -59.99 130.1 23.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.777 -1.202 . . . . 0.0 109.689 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.75 19.13 73.92 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.942 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 85.1 m-20 -90.24 171.9 9.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.595 -1.532 . . . . 0.0 109.779 172.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' A' ' 92' ' ' THR . 61.1 t -98.91 138.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 0.0 110.522 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.526 HG12 ' NZ ' ' A' ' 89' ' ' LYS . 1.9 m -126.46 139.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -107.41 145.3 33.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.595 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.578 ' O ' ' OG1' ' A' ' 50' ' ' THR . 3.6 mp -120.02 148.29 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 110.446 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -151.45 94.17 1.98 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.977 . . . . 0.0 110.779 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.538 ' CG ' HG13 ' A' ' 85' ' ' VAL . 8.8 tmtm? -98.84 -66.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.703 173.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.53 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -106.72 -32.78 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.481 175.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 74.6 mtt85 -136.87 -172.64 3.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.469 ' O ' HD23 ' A' ' 130' ' ' LEU . 36.7 mttt -88.83 139.28 30.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.984 -1.073 . . . . 0.0 111.05 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.69 160.18 39.94 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.299 0.571 . . . . 0.0 110.221 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.584 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.13 161.22 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.269 -0.894 . . . . 0.0 109.977 178.018 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' O ' HG21 ' A' ' 42' ' ' VAL . . . -177.62 -179.78 47.93 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 51.9 ttp180 -121.69 169.37 10.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -1.028 . . . . 0.0 110.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.44 ' N ' ' CG ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -91.48 138.86 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 111.014 -172.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -128.55 162.66 26.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.502 -0.749 . . . . 0.0 109.887 174.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -89.01 123.63 33.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.891 . . . . 0.0 110.128 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -64.19 139.13 58.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.576 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -59.99 -48.91 93.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.15 174.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.4 Cg_endo -91.67 99.1 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.866 1.456 . . . . 0.0 108.993 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -73.91 36.34 0.09 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.585 -0.697 . . . . 0.0 111.126 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 59' ' ' PRO . 61.6 t0 -145.39 -36.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.073 -1.017 . . . . 0.0 111.165 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.8 pt-20 -85.87 -24.43 26.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.905 -1.122 . . . . 0.0 110.172 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.591 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 31.6 m120 -82.3 37.82 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 110.695 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 49.1 pttt -98.49 18.17 17.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 109.641 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.79 20.85 0.03 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.519 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -141.61 157.01 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -1.068 . . . . 0.0 109.191 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.417 HG23 ' CG1' ' A' ' 24' ' ' VAL . 4.6 p -135.57 131.11 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.863 -1.148 . . . . 0.0 109.86 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.569 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 34.6 ttm180 -96.99 118.16 32.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.974 -1.079 . . . . 0.0 110.24 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 pt -131.69 172.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.639 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -78.61 170.08 17.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.371 -0.831 . . . . 0.0 109.978 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.2 p -65.34 -27.56 68.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 110.01 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.44 -46.12 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 12.7 tpt -60.33 -44.69 95.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.457 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 43.6 ttp180 -60.17 -40.03 88.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 0.0 109.721 174.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -71.48 -22.99 61.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.578 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 73' ' ' MET . 59.3 m-20 -60.01 -36.88 78.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 0.0 110.272 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.463 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.2 p -98.4 -38.82 9.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 0.0 110.319 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.53 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 117.21 36.36 1.03 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 177.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -110.45 167.93 9.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -1.204 . . . . 0.0 110.475 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.55 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.72 169.77 8.74 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.241 -0.912 . . . . 0.0 109.226 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.431 ' CG1' ' HB3' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -54.58 139.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.924 -1.11 . . . . 0.0 110.767 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.55 2.2 79.45 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 172.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -58.8 -162.88 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.023 -1.281 . . . . 0.0 110.445 175.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 21.9 pttm -133.61 113.48 12.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 109.981 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.538 HG13 ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -125.09 160.12 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.389 -0.82 . . . . 0.0 109.586 178.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.5 tttt -110.24 125.4 53.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 110.048 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.562 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 66.1 t -99.25 119.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 110.009 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.485 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 84.4 mtt85 -103.19 145.2 30.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.832 . . . . 0.0 109.234 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 36' ' ' ALA . 29.8 tptt -99.74 135.42 41.19 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.94 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.481 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 3.1 m -150.08 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.575 0.702 . . . . 0.0 110.132 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.426 ' CA ' ' HB ' ' A' ' 41' ' ' VAL . 33.1 mtp85 -127.87 172.41 10.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.598 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.542 ' CG2' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.46 163.42 12.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 111.172 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -150.22 169.94 20.14 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.3 mm -89.01 100.62 10.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.474 ' CB ' HG21 ' A' ' 162' ' ' VAL . . . -53.89 139.94 32.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.315 -0.866 . . . . 0.0 110.173 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.544 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 17.8 ptpt -95.56 -28.75 14.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.203 -0.936 . . . . 0.0 110.999 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 21.6 ttpt -150.6 120.0 6.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.707 -1.246 . . . . 0.0 110.616 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.424 HG21 HG23 ' A' ' 155' ' ' THR . 8.2 p -130.03 140.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.01 . . . . 0.0 111.022 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 171' ' ' GLU . 38.2 m -116.68 148.75 40.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.07 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.637 ' CD1' ' N ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -150.7 179.94 7.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 0.0 110.678 178.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HB1' ' CD ' ' A' ' 173' ' ' ARG . . . -144.45 101.14 4.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 111.117 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 150' ' ' PHE . 13.0 Cg_exo . . . . . 0 C--N 1.306 -1.696 0 O-C-N 124.038 1.547 . . . . 0.0 110.035 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 20.8 tt . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.186 0.517 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 98.0 mt-10 -60.22 -41.9 94.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.117 -0.99 . . . . 0.0 109.763 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -68.91 -36.05 77.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.16 -41.15 92.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.401 -0.812 . . . . 0.0 109.714 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 170' ' ' ILE . 58.5 t -60.27 -45.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.275 174.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.1 mt-30 -59.85 -41.8 92.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.576 -0.703 . . . . 0.0 110.319 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -60.18 -49.83 76.08 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.342 -0.849 . . . . 0.0 109.835 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.29 -40.29 70.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -0.753 . . . . 0.0 110.722 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.489 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.4 mm? -93.36 -0.87 56.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.956 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.548 ' HA ' HG21 ' A' ' 164' ' ' ILE . 2.2 tt -47.96 165.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.97 -1.081 . . . . 0.0 110.075 -177.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ILE . 9.7 ptm180 32.23 46.28 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.537 -0.727 . . . . 0.0 111.37 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.469 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -128.07 133.6 25.31 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.997 -1.064 . . . . 0.0 110.667 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.748 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.6 Cg_exo -58.49 139.35 90.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.995 1.524 . . . . 0.0 109.756 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.514 ' N ' ' O ' ' A' ' 162' ' ' VAL . 92.2 mmm -133.66 146.92 51.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.373 -1.455 . . . . 0.0 110.891 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.585 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 14.5 tp -147.8 112.12 5.24 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.564 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.3 pm0 -46.69 139.51 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.625 -1.297 . . . . 0.0 110.108 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 79.71 -3.14 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.254 0.549 . . . . 0.0 110.468 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.585 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.3 p30 -68.47 -169.96 0.18 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 175.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.408 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 23.5 m-80 -147.01 155.52 42.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.704 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 135' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.074 -1.016 . . . . 0.0 109.937 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 37.4 m-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.311 0.576 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 133' ' ' ASP . 18.6 tptm -115.13 108.79 17.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.666 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 132' ' ' GLN . 10.6 t -75.23 131.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.104 -0.998 . . . . 0.0 110.091 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.2 t -113.0 -25.44 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.216 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.31 151.16 34.9 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.707 -1.246 . . . . 0.0 111.12 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 82.4 p -142.54 162.27 35.92 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.673 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.9 -34.19 0.41 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.283 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.673 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 35.4 Cg_exo -54.39 -171.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.285 1.15 . . . . 0.0 110.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 15.7 t -88.19 43.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 0.0 110.35 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 158' ' ' SER . 33.1 mmtp 61.27 20.0 10.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.427 HG12 ' HB3' ' A' ' 158' ' ' SER . 18.2 m -105.58 154.75 38.95 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.584 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.61 119.89 4.67 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.08 1.568 . . . . 0.0 110.131 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.748 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 6.3 m -129.54 159.97 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.138 175.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.408 ' HG3' HG23 ' A' ' 92' ' ' THR . 75.7 mt-10 -110.01 136.72 48.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.104 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.548 HG21 ' HA ' ' A' ' 125' ' ' ILE . 14.7 mm -71.11 154.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.692 -0.63 . . . . 0.0 110.225 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.63 170.02 24.37 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 175.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -58.05 -23.11 53.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -1.119 . . . . 0.0 110.264 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -94.04 -15.61 24.63 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.135 -0.978 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 91.9 m -58.43 144.02 43.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 23.0 mttp -97.51 154.32 17.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.889 -1.132 . . . . 0.0 109.763 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 171' ' ' GLU . 2.7 mt -130.09 164.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 0.0 111.04 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.501 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 16.7 mt-10 -138.16 137.47 37.68 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.34 0.59 . . . . 0.0 110.147 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.513 HD12 HD22 ' A' ' 100' ' ' LEU . 31.8 mm -122.16 129.29 75.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.443 -0.785 . . . . 0.0 109.797 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.411 ' CD ' ' HB1' ' A' ' 101' ' ' ALA . 6.8 ptm180 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.081 -1.012 . . . . 0.0 110.275 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.255 0.55 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.538 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.89 -168.22 16.57 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.542 ' CD1' HD12 ' A' ' 33' ' ' LEU . 26.6 pt -134.16 166.77 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.386 -1.067 . . . . 0.0 109.861 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.434 HD12 ' HD3' ' A' ' 86' ' ' LYS . 35.2 mm -103.22 115.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 110.341 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.7 pt? -138.19 -172.75 3.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.088 -1.008 . . . . 0.0 109.7 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.6 ptt180 -112.19 138.0 49.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.838 -1.164 . . . . 0.0 110.765 -174.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.597 ' CG2' ' CD1' ' A' ' 69' ' ' ILE . 8.4 p -62.03 134.61 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.531 -0.73 . . . . 0.0 110.54 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -111.6 166.64 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 0.0 110.89 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.564 ' HB3' ' CG1' ' A' ' 81' ' ' ILE . 51.5 tp10 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.19 0.519 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.491 HG11 HG22 ' A' ' 67' ' ' VAL . 53.0 t -110.13 119.89 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.486 ' HD3' ' CD ' ' A' ' 68' ' ' ARG . 4.6 ptt180 -89.27 121.67 31.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.787 -1.196 . . . . 0.0 109.524 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -137.32 166.81 22.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.761 -174.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' N ' ' HB3' ' A' ' 63' ' ' ASN . 6.4 p-10 -101.49 -170.39 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.906 -1.121 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.1 -44.41 94.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.539 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 44.9 t -65.98 -49.9 66.2 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.346 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 58.1 m -56.38 -27.33 55.87 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 49.2 ttp180 -85.58 -48.29 9.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.87 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -83.08 -6.06 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.038 . . . . 0.0 110.011 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.592 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -44.12 -28.16 0.47 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.621 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.573 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 82.9 mt -143.8 -59.98 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.517 -0.74 . . . . 0.0 110.617 176.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.3 t0 -170.88 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.302 -0.873 . . . . 0.0 110.852 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -30.77 127.56 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 110.915 -175.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.518 ' O ' HG11 ' A' ' 54' ' ' VAL . 2.3 pt-20 -112.51 -178.08 3.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 38' ' ' ILE . 34.7 mm -59.98 120.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.945 -1.097 . . . . 0.0 109.976 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' N ' HG13 ' A' ' 54' ' ' VAL . . . 72.8 33.55 60.13 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 174.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 2.2 m-20 -89.52 178.86 6.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.806 -1.408 . . . . 0.0 109.556 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.484 HG22 ' OG1' ' A' ' 92' ' ' THR . 79.5 t -99.26 129.58 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.203 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 42' ' ' VAL . 7.5 m -123.57 147.2 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -0.792 . . . . 0.0 110.625 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 88' ' ' ARG . 86.0 tt0 -115.62 139.95 49.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.61 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.1 mp -122.78 147.61 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 0.0 110.566 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.4 tt0 -150.08 97.61 2.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 110.633 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.54 ' HD2' HG22 ' A' ' 47' ' ' VAL . 14.3 tmtt? -98.62 -67.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.566 HG23 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -102.32 -35.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.162 173.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 92.9 mtt-85 -127.63 -168.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.31 0.576 . . . . 0.0 109.736 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.536 ' HG2' ' CD2' ' A' ' 130' ' ' LEU . 1.3 ttpm? -103.73 137.2 42.1 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.36 -0.838 . . . . 0.0 110.212 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.61 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 8.7 p -142.8 170.53 15.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 110.254 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -122.84 167.76 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.521 -0.737 . . . . 0.0 109.902 177.185 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.472 ' O ' HG21 ' A' ' 42' ' ' VAL . . . -177.7 179.05 48.42 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -117.0 163.97 15.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.505 -0.997 . . . . 0.0 110.139 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -97.35 137.5 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.07 -1.018 . . . . 0.0 110.45 -172.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -122.12 166.48 14.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 110.116 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -89.65 124.44 34.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 110.328 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.427 ' HB2' ' CG ' ' A' ' 63' ' ' ASN . . . -64.33 132.58 50.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.097 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.74 -46.04 99.59 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.984 -1.072 . . . . 0.0 109.296 173.496 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 14.7 Cg_endo -89.89 99.18 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.022 1.538 . . . . 0.0 109.055 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.11 33.62 0.07 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.557 -0.715 . . . . 0.0 110.866 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 59' ' ' PRO . 52.8 t0 -148.78 -29.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 110.703 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.69 -29.22 22.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.438 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.462 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 4.7 m120 -80.94 39.35 0.49 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.699 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 11.3 ptpt -98.54 10.71 40.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.606 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.436 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.4 pt -141.05 142.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.304 -1.115 . . . . 0.0 109.436 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.491 HG22 HG11 ' A' ' 24' ' ' VAL . 1.8 p -119.47 125.89 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.117 -0.99 . . . . 0.0 109.995 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 70.4 ttt180 -90.05 113.04 24.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.597 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 3.0 pt -126.17 163.04 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.793 . . . . 0.0 110.77 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.92 158.67 35.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.81 . . . . 0.0 109.932 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.581 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 79.9 p -61.7 -24.64 66.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.59 -42.88 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 110.323 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -59.92 -49.98 75.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 109.929 178.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.581 ' NE ' ' HA ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -63.87 -33.44 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.682 176.238 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.484 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 60.4 t-20 -68.08 -32.57 72.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.962 . . . . 0.0 109.933 175.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 73' ' ' MET . 98.5 m-20 -60.03 -40.01 87.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.877 . . . . 0.0 110.535 -178.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.448 ' HB2' HG21 ' A' ' 47' ' ' VAL . 27.6 p -98.34 -38.52 9.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.602 -176.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.566 ' CA ' HG23 ' A' ' 47' ' ' VAL . . . 120.16 40.63 0.58 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.449 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -116.03 158.44 23.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.944 -1.327 . . . . 0.0 110.726 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.565 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -112.44 166.84 10.94 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 175.536 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.564 ' CG1' ' HB3' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -51.33 139.96 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.989 -1.069 . . . . 0.0 110.505 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 77.28 0.61 72.05 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 171.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.18 -160.12 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.876 -1.367 . . . . 0.0 110.225 174.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 40.1 pttt -132.62 113.32 12.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.549 -0.719 . . . . 0.0 109.813 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.535 HG13 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -124.35 159.67 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.201 -0.937 . . . . 0.0 109.898 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.6 ttpt -105.21 127.96 53.18 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.218 -0.927 . . . . 0.0 109.868 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.502 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 63.3 t -109.84 121.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 109.714 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.538 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 84.4 mtm180 -110.23 140.03 44.78 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.456 -0.777 . . . . 0.0 109.552 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.483 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -91.22 136.69 32.92 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.069 -1.02 . . . . 0.0 110.001 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 m -150.01 -171.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.539 -0.725 . . . . 0.0 110.212 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . 1.6 ptm85 -126.8 170.07 12.57 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.643 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.484 ' OG1' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.47 165.34 11.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.054 -1.029 . . . . 0.0 111.078 -175.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.412 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.4 pt-20 -149.96 167.72 25.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm -89.57 97.78 7.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.542 -1.349 . . . . 0.0 110.336 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -54.88 161.8 1.47 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 110.663 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.516 ' HG3' HD12 ' A' ' 156' ' ' LEU . 25.0 pttt -125.44 -24.71 3.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 110.493 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.554 ' CB ' HD12 ' A' ' 156' ' ' LEU . 15.7 tttp -150.92 127.81 11.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.843 -1.16 . . . . 0.0 110.394 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 155' ' ' THR . 7.4 p -139.94 144.65 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.351 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 171' ' ' GLU . 94.2 m -118.52 132.27 56.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 110.253 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.55 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.09 160.02 33.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.375 -178.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.474 ' CB ' ' HG2' ' A' ' 173' ' ' ARG . . . -138.83 93.69 10.55 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 34.7 Cg_exo . . . . . 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.264 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 117' ' ' GLU . 9.5 tp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.178 0.513 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 170' ' ' ILE . 96.7 mt-10 -59.92 -42.79 94.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.112 -0.992 . . . . 0.0 109.997 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.84 -37.49 76.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -59.96 -39.23 84.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.559 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.534 ' CG1' HD13 ' A' ' 170' ' ' ILE . 54.5 t -60.07 -47.8 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.674 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.587 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.39 -40.03 92.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 177.481 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.05 -46.43 89.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.61 -41.29 65.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.547 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.6 mm? -94.31 -4.3 48.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.168 -0.957 . . . . 0.0 111.227 -174.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.5 tt -44.49 167.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.774 -1.203 . . . . 0.0 110.267 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 164' ' ' ILE . 52.9 ptt85 33.3 51.21 0.3 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.666 -0.646 . . . . 0.0 111.788 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -137.79 150.22 67.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.833 -1.167 . . . . 0.0 111.074 175.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 18.2 Cg_endo -65.56 130.35 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.042 1.549 . . . . 0.0 110.026 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.551 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 88.1 mmm -125.0 139.17 54.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.515 -1.366 . . . . 0.0 111.052 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.567 ' CD2' ' CA ' ' A' ' 50' ' ' THR . 11.6 tp -144.15 113.59 7.02 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.636 -0.665 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 7.3 pm0 -47.47 143.87 3.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.116 . . . . 0.0 110.359 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.657 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 88.4 mm-40 81.33 -6.09 1.57 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.111 0.482 . . . . 0.0 110.334 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.536 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 2.1 p30 -69.88 173.78 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.149 -0.969 . . . . 0.0 109.903 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -137.72 146.9 44.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.802 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.085 -1.009 . . . . 0.0 110.144 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 29.4 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.242 0.544 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -104.87 110.63 23.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.072 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 3.5 t -76.37 138.86 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 t -117.38 -28.39 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.194 -0.941 . . . . 0.0 111.047 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.445 ' C ' HG23 ' A' ' 155' ' ' THR . 42.9 tttp -148.59 151.51 35.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.767 -1.208 . . . . 0.0 111.173 -177.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.482 HG21 HG22 ' A' ' 98' ' ' VAL . 63.8 p -139.75 158.29 44.34 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.704 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.4 OUTLIER -89.1 -34.01 0.4 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.867 -176.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 16.5 Cg_exo -56.99 -161.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.269 1.141 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.3 t -90.13 179.09 6.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 109.869 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.408 ' HE2' ' NZ ' ' A' ' 49' ' ' LYS . 13.9 tttt -61.31 -10.12 6.47 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.863 . . . . 0.0 110.425 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.6 m -84.66 153.13 61.04 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.467 -0.77 . . . . 0.0 110.159 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.539 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -48.87 142.76 18.68 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.248 1.657 . . . . 0.0 110.613 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 13.7 m -130.02 160.0 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -108.71 127.51 54.05 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.022 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.556 ' CG2' ' HA ' ' A' ' 125' ' ' ILE . 12.9 mm -71.08 153.05 8.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 121.434 0.635 . . . . 0.0 110.334 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.546 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.94 166.91 26.15 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -56.95 -19.81 20.12 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.369 -1.077 . . . . 0.0 110.197 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.16 -14.03 39.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.872 . . . . 0.0 110.326 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.525 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 21.0 m -62.04 147.8 46.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 109.856 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mttm -94.46 157.5 15.98 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.929 -1.107 . . . . 0.0 110.256 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.538 HD11 ' HG2' ' A' ' 121' ' ' GLN . 3.4 mm -118.93 129.91 74.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.363 -0.835 . . . . 0.0 110.691 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 99' ' ' THR . 20.1 mt-10 -110.96 130.08 55.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 110.225 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.465 HD13 HG21 ' A' ' 120' ' ' VAL . 33.5 mm -125.8 125.74 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.884 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.581 ' NE ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 0.0 110.713 -177.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.303 0.573 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.563 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -148.33 -161.04 9.35 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.53 ' CG2' HD23 ' A' ' 33' ' ' LEU . 47.6 pt -131.01 160.01 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.936 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.1 mt -99.55 114.46 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 110.239 -178.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.2 pt? -137.86 -172.39 3.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 109.96 178.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.8 ptp180 -115.55 139.05 50.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.785 -1.197 . . . . 0.0 110.714 -172.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 81' ' ' ILE . 4.6 p -61.17 137.91 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.505 -0.747 . . . . 0.0 110.115 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -120.97 155.6 33.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 110.478 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 86.5 tt0 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 175.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.563 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 95.6 mtt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.083 0.468 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 55' ' ' TYR . 92.8 t -116.6 120.03 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 110.237 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.485 ' NE ' ' HG3' ' A' ' 68' ' ' ARG . 0.9 OUTLIER -92.41 119.97 32.46 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.757 -1.177 . . . . 0.0 109.945 177.814 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.464 HD11 ' O ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -134.41 173.32 11.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.675 -177.06 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 30' ' ' SER . 17.5 p-10 -93.2 179.76 5.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.83 -1.169 . . . . 0.0 110.481 -178.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -59.97 -43.19 95.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.378 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.486 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 63.3 m -65.08 -44.56 88.52 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.545 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.589 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 59.4 m -60.0 -40.06 87.93 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.951 -1.093 . . . . 0.0 109.193 176.083 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 59.3 ttt180 -71.37 -44.4 65.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.876 -0.515 . . . . 0.0 111.734 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -93.34 -6.18 47.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.755 -1.216 . . . . 0.0 111.199 -169.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.591 HD11 ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -59.2 -31.37 68.96 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.584 -178.527 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.591 ' N ' HD11 ' A' ' 33' ' ' LEU . 31.6 mt -116.57 -66.4 1.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.111 -0.993 . . . . 0.0 110.674 175.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 36' ' ' ALA . 17.1 t0 -171.84 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.191 -0.943 . . . . 0.0 110.244 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.57 ' HA ' ' CE ' ' A' ' 89' ' ' LYS . . . -23.92 120.14 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.579 0.704 . . . . 0.0 111.408 -176.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.527 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -105.24 175.25 5.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.938 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.5 mm -56.69 127.15 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 120.966 -1.084 . . . . 0.0 109.663 178.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 54' ' ' VAL . . . 76.06 24.49 68.9 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.39 174.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 4.2 m-20 -88.81 174.0 8.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.724 -1.456 . . . . 0.0 109.247 171.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.525 ' CG1' ' HG2' ' A' ' 161' ' ' PRO . 92.6 t -102.59 130.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.995 -1.066 . . . . 0.0 110.432 -174.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG21 ' C ' ' A' ' 52' ' ' GLY . 2.2 m -115.02 137.31 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.34 141.67 38.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.435 -0.79 . . . . 0.0 109.847 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -120.99 148.2 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.024 -1.047 . . . . 0.0 110.182 -176.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -152.37 92.32 1.68 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 111.288 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.627 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 59.6 tttp -97.83 -77.05 0.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 0.0 110.123 172.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG22 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.0 -29.97 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.638 0.732 . . . . 0.0 109.688 176.76 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.6 mtt85 -141.34 -172.7 3.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.463 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' HD21 ' A' ' 130' ' ' LEU . 18.3 mttt -88.78 141.06 28.82 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.813 -177.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -140.37 156.47 46.4 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.388 0.614 . . . . 0.0 110.111 -179.103 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -126.07 160.15 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.142 -179.657 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.451 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -176.88 -177.45 45.84 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 96.0 mtt-85 -117.05 -179.01 3.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -1.071 . . . . 0.0 109.761 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -109.31 135.9 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.023 . . . . 0.0 110.681 -175.003 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.563 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -127.16 168.98 13.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.569 -0.707 . . . . 0.0 110.057 176.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -93.59 124.15 37.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 110.152 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -64.4 139.37 58.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.884 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.648 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.8 mtt-85 -57.31 -49.63 92.79 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.953 -1.092 . . . . 0.0 108.993 174.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 57.4 Cg_endo -93.08 98.51 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 109.034 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.54 37.07 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 121.593 -0.692 . . . . 0.0 110.482 -177.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 59' ' ' PRO . 68.3 m-20 -144.16 -33.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 110.461 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -85.62 -28.92 24.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.474 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 14.7 m120 -81.31 38.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.649 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.48 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 31.9 pttt -98.9 12.64 35.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.059 -1.026 . . . . 0.0 109.759 176.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.76 24.88 0.04 OUTLIER Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.474 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.07 142.87 29.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.336 -1.097 . . . . 0.0 109.28 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.461 HG22 HG11 ' A' ' 24' ' ' VAL . 2.9 p -119.97 126.05 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.024 -1.048 . . . . 0.0 109.894 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 31.9 mmt180 -89.95 102.33 15.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.009 . . . . 0.0 110.153 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.517 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 3.3 pt -125.26 169.93 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.408 -0.808 . . . . 0.0 110.68 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.09 161.68 26.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.41 -0.806 . . . . 0.0 109.992 177.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 43.8 m -63.16 -16.8 61.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -0.907 . . . . 0.0 110.324 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 63.8 t -71.16 -49.16 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.322 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.529 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -59.97 -49.5 77.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.907 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 71' ' ' SER . 3.7 ppt_? -64.08 -28.73 69.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.085 -1.009 . . . . 0.0 109.653 175.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.484 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 19.6 t-20 -73.08 -30.28 63.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.959 -1.088 . . . . 0.0 110.388 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 73' ' ' MET . 13.9 m120 -60.04 -40.02 87.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 110.87 -173.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 25.9 p -99.3 -37.23 9.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 0.0 110.605 -177.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.554 ' CA ' HG22 ' A' ' 47' ' ' VAL . . . 126.87 33.53 0.64 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.605 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.36 140.04 34.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -1.078 . . . . 0.0 110.179 -177.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.539 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -103.26 162.57 12.87 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.14 -0.975 . . . . 0.0 108.981 174.156 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.585 ' HA ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -52.84 135.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.013 -1.054 . . . . 0.0 110.649 -177.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.93 -0.25 66.98 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 172.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 80' ' ' SER . 0.2 OUTLIER -57.79 -160.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.982 -1.305 . . . . 0.0 110.427 176.683 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.5 OUTLIER -134.7 114.91 13.17 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.0 177.17 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.627 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 1.7 m -124.67 160.07 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.828 178.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.6 tttt -105.12 124.97 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.916 176.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.546 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 65.8 t -109.93 123.72 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.148 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.2 mtt85 -103.46 151.62 22.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 178.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.57 ' CE ' ' HA ' ' A' ' 36' ' ' ALA . 8.0 tmtt? -98.11 133.16 42.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.21 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.529 ' N ' ' HD3' ' A' ' 89' ' ' LYS . 2.3 m -150.3 -167.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.45 0.643 . . . . 0.0 109.975 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.516 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 27.5 mtp180 -129.29 178.11 6.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.807 . . . . 0.0 110.27 176.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.493 HG21 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.24 161.15 14.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 111.233 -175.888 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 157' ' ' PRO . 18.2 pt-20 -148.22 164.78 32.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.439 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 5.0 mp -88.86 97.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.47 -1.394 . . . . 0.0 110.22 -175.207 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.549 ' CB ' HG23 ' A' ' 162' ' ' VAL . . . -54.53 139.14 38.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 110.141 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.505 ' CD ' ' HG ' ' A' ' 156' ' ' LEU . 15.1 ptpt -100.09 -27.69 13.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.991 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.461 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 79.2 tttt -149.97 121.52 7.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.954 -1.091 . . . . 0.0 110.449 -176.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.443 HG23 ' CG2' ' A' ' 155' ' ' THR . 7.5 p -135.69 143.23 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 110.383 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 90.4 m -117.81 133.54 55.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 110.066 -177.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -132.35 164.9 25.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 110.223 -178.061 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.532 ' CB ' ' HG2' ' A' ' 173' ' ' ARG . . . -138.91 83.57 18.47 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.804 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.2 Cg_exo . . . . . 0 C--N 1.305 -1.727 0 O-C-N 123.94 1.495 . . . . 0.0 110.173 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 16.2 tt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.025 0.44 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.488 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 98.6 mt-10 -69.95 -39.95 75.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.093 -1.004 . . . . 0.0 110.049 175.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.03 -30.69 69.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 176.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.504 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 64.8 t80 -59.86 -37.78 80.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 109.53 176.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.544 ' CG1' HD13 ' A' ' 170' ' ' ILE . 54.4 t -59.88 -49.98 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 109.878 176.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.6 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 4.9 mt-30 -59.96 -44.11 94.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 110.312 177.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.567 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -63.58 -34.33 77.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 110.024 -175.825 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.567 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -84.22 -41.81 16.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.676 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.4 mm? -96.02 2.29 53.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 111.394 -174.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.4 tt -47.95 165.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.797 -1.189 . . . . 0.0 110.209 -175.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.537 ' HG2' ' CG2' ' A' ' 125' ' ' ILE . 9.7 ptp85 34.97 49.57 0.41 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.499 -0.75 . . . . 0.0 111.464 -178.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -132.5 136.47 27.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.782 -1.199 . . . . 0.0 110.907 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.762 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -60.07 129.78 31.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.041 1.548 . . . . 0.0 109.892 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.532 ' SD ' ' CG1' ' A' ' 164' ' ' ILE . 16.4 mtt -125.22 146.2 49.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.428 -1.42 . . . . 0.0 110.875 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.524 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 14.4 tp -144.18 105.59 4.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.616 -0.677 . . . . 0.0 109.6 -176.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.7 pm0 -43.11 143.86 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.345 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.534 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.15 -0.72 2.88 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.163 0.506 . . . . 0.0 110.392 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.533 ' OD1' ' CG2' ' A' ' 152' ' ' VAL . 3.9 p-10 -69.93 -179.46 1.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 174.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.404 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 18.4 m-80 -145.73 141.89 28.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.488 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 135' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 120.94 -1.1 . . . . 0.0 110.31 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 17.6 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.125 0.488 . . . . 0.0 109.94 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.404 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 33.4 tptt -121.12 102.22 8.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 109.874 178.14 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.533 ' CG2' ' OD1' ' A' ' 133' ' ' ASP . 2.2 t -77.06 140.73 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.6 t -131.23 -26.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 111.22 -176.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 6.4 tptm -140.04 134.54 31.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.843 -1.161 . . . . 0.0 110.591 -177.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 131' ' ' GLU . 48.8 p -134.02 165.54 24.79 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.54 -0.725 . . . . 0.0 109.396 176.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.66 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.45 -39.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.646 -176.927 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 17.2 Cg_exo -59.43 -170.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.639 1.336 . . . . 0.0 109.984 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.46 -158.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.27 -0.894 . . . . 0.0 109.998 177.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -70.19 -7.83 45.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 110.669 -177.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.1 149.5 45.4 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 110.931 -175.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.603 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.02 140.75 31.39 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.367 1.719 . . . . 0.0 110.811 179.761 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 4.6 m -130.08 157.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.022 -1.049 . . . . 0.0 109.96 172.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -103.61 130.0 50.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.314 -0.866 . . . . 0.0 110.37 177.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.532 ' CG1' ' SD ' ' A' ' 129' ' ' MET . 19.1 mm -71.34 150.23 9.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 178.135 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.92 170.13 24.65 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 175.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -53.77 -24.76 16.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.354 -1.086 . . . . 0.0 110.169 -176.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -89.67 -18.4 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.899 . . . . 0.0 111.025 -175.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.561 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 95.7 m -56.94 147.23 24.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.178 -0.951 . . . . 0.0 110.078 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' LYS . 74.1 mmtt -95.77 161.24 14.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.839 -1.163 . . . . 0.0 110.36 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.6 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 24.4 mm -119.97 130.63 74.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 110.696 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 99' ' ' THR . 21.7 mt-10 -113.97 126.2 54.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 110.368 171.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.537 HD11 ' CG2' ' A' ' 170' ' ' ILE . 32.1 mm -123.17 132.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.019 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.532 ' HG2' ' CB ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.995 . . . . 0.0 110.387 -176.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.233 0.54 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.6 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -146.33 -166.96 12.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.527 ' CD1' ' CD2' ' A' ' 33' ' ' LEU . 9.1 pt -136.28 159.96 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.439 -1.036 . . . . 0.0 109.418 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 96.7 mt -101.47 121.06 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.003 -1.061 . . . . 0.0 110.216 -179.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -136.96 -171.25 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 110.557 178.576 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HB3' HG21 ' A' ' 66' ' ' ILE . 53.0 ttp180 -107.51 132.85 52.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 111.099 -172.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 80' ' ' SER . 13.2 p -61.67 138.36 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.77 . . . . 0.0 110.314 176.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -123.05 145.01 48.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 110.597 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 174.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 97.3 mtt180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.159 0.504 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.468 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 87.9 t -119.44 120.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 -179.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 4.9 ptt180 -92.36 119.54 32.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.7 176.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -134.73 -172.31 3.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 0.0 110.179 179.836 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.9 p-10 -106.9 -179.93 4.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.046 . . . . 0.0 110.539 -178.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.01 -44.46 94.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.579 -177.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -59.9 -46.7 88.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.535 -0.728 . . . . 0.0 110.211 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.602 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 59.9 m -59.97 -36.5 77.26 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.062 -1.024 . . . . 0.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.545 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 35.0 ttp180 -70.06 -44.54 68.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.186 178.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -90.26 -10.36 44.52 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.838 -1.164 . . . . 0.0 111.687 -171.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -50.17 -27.06 5.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.711 -1.243 . . . . 0.0 109.135 -178.566 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 33' ' ' LEU . 59.0 mt -130.11 -69.24 0.67 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.511 -0.743 . . . . 0.0 110.583 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -172.63 11.19 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.948 -1.095 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.545 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -52.02 133.6 32.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.921 -1.112 . . . . 0.0 110.199 -176.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.533 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 1.1 pt-20 -118.32 174.32 6.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.408 HD11 HG23 ' A' ' 38' ' ' ILE . 28.2 mm -58.95 119.65 3.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 120.814 -1.179 . . . . 0.0 109.722 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.4 35.54 56.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.629 174.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 33.6 m-20 -89.1 178.93 6.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.633 -1.51 . . . . 0.0 109.718 172.348 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG21 ' OG1' ' A' ' 92' ' ' THR . 76.7 t -99.39 123.54 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 110.585 -176.086 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.412 HG21 ' C ' ' A' ' 52' ' ' GLY . 3.8 m -122.08 147.28 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.618 -0.676 . . . . 0.0 110.518 -177.029 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' OE2' ' HD2' ' A' ' 49' ' ' LYS . 85.3 tt0 -111.19 137.09 49.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.746 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -117.63 140.87 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.0 -1.063 . . . . 0.0 110.55 -176.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -151.59 96.67 2.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.611 -1.306 . . . . 0.0 112.106 -174.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.693 ' HD2' ' CB ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -98.43 -80.24 0.46 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.52 -1.362 . . . . 0.0 110.443 168.014 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.63 -36.67 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.717 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.679 ' CG ' ' HA ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -135.33 -155.5 0.65 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 109.388 172.067 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 48' ' ' ARG . 3.9 mtmm -114.85 133.81 55.65 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.072 0.939 . . . . 0.0 112.271 -177.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.626 ' OG1' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -119.5 179.88 4.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.311 177.5 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.589 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -136.09 160.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.871 170.646 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.412 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -179.66 -168.96 39.32 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.35 -168.25 1.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -1.048 . . . . 0.0 109.752 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.72 130.0 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 -178.534 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.466 ' O ' HD11 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -116.95 164.92 13.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 110.427 178.592 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.64 119.74 30.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.437 -0.79 . . . . 0.0 110.132 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -64.37 140.08 58.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.838 179.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.588 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.13 -50.64 86.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 118.876 -1.129 . . . . 0.0 108.919 175.294 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 50.9 Cg_endo -93.45 97.43 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.753 1.396 . . . . 0.0 108.946 178.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.21 38.73 0.14 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 110.711 -174.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 30.6 p-10 -142.32 -37.89 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.124 -0.985 . . . . 0.0 110.833 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.538 ' OE2' ' CG ' ' A' ' 59' ' ' PRO . 19.5 pt-20 -86.75 -18.9 30.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.003 -1.06 . . . . 0.0 109.676 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.497 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 9.8 m-80 -81.72 35.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.459 -0.775 . . . . 0.0 110.78 177.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.488 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.5 pttt -98.86 16.62 21.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 0.0 109.614 176.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.21 23.26 0.03 OUTLIER Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.497 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -140.39 156.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.149 174.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.445 HG21 HG13 ' A' ' 24' ' ' VAL . 2.8 p -136.36 131.05 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 54.1 ttp85 -91.05 118.55 30.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.0 -1.063 . . . . 0.0 110.009 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 pt -130.17 167.71 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 110.717 178.075 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.463 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 34.9 p-10 -80.02 170.71 16.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.1 178.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.441 ' OG ' ' OE2' ' A' ' 13' ' ' GLU . 58.3 m -59.98 -31.88 70.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 110.417 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.463 ' HB ' ' OD2' ' A' ' 70' ' ' ASP . 54.5 t -68.05 -46.5 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.703 -175.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.7 ttt -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.513 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -60.06 -42.89 95.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.12 172.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -71.75 -25.09 61.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.137 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.461 ' C ' ' NH1' ' A' ' 48' ' ' ARG . 94.3 m-20 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.569 -177.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.679 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 16.7 p -97.88 -37.93 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.791 -1.193 . . . . 0.0 110.92 -175.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 77' ' ' CYS . . . 112.58 31.48 2.55 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.693 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -115.07 178.11 4.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.289 . . . . 0.0 111.763 -170.197 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.538 ' O ' HG12 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -126.79 170.02 12.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.071 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -59.47 150.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.77 -1.206 . . . . 0.0 110.198 178.789 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 10' ' ' ARG . . . 75.56 -3.52 48.33 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 174.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.485 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.0 m-20 -58.58 -162.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.033 -1.275 . . . . 0.0 110.378 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 60.1 pttt -134.8 116.96 15.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.454 -0.779 . . . . 0.0 109.82 177.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.619 ' CG1' ' HE3' ' A' ' 46' ' ' LYS . 1.2 m -117.34 143.39 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 109.532 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 78.6 tttt -93.59 119.04 32.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 175.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.421 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 85.8 t -99.38 123.3 52.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.304 -0.873 . . . . 0.0 109.678 -178.144 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.6 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.6 mtt180 -110.0 146.16 35.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.659 179.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.543 ' CE ' ' HB3' ' A' ' 40' ' ' ASP . 27.1 tptt -96.65 134.8 39.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.056 -1.028 . . . . 0.0 110.152 -177.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.7 m -147.61 -170.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 110.125 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.446 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 14.2 ptm180 -127.24 171.21 11.66 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 177.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.496 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -97.86 162.92 13.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.966 -1.084 . . . . 0.0 111.019 -176.153 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.478 ' CG ' HG13 ' A' ' 162' ' ' VAL . 12.4 pt-20 -150.72 161.88 41.79 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.16 97.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.6 -1.312 . . . . 0.0 110.261 -176.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -54.92 165.0 0.7 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.372 178.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 169' ' ' LYS . 2.1 pttt -134.9 -19.25 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.364 -0.835 . . . . 0.0 110.632 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 77.4 tttt -150.74 119.99 6.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.895 -1.128 . . . . 0.0 110.558 176.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.484 HG23 ' CG2' ' A' ' 155' ' ' THR . 8.8 p -138.76 142.65 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.958 -1.089 . . . . 0.0 110.669 178.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 96.3 m -117.17 142.65 46.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.116 -179.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -139.8 172.64 12.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.337 -0.852 . . . . 0.0 110.334 -178.54 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 173' ' ' ARG . . . -143.99 94.04 5.95 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 0.0 111.021 -175.127 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 14.7 Cg_exo . . . . . 0 C--N 1.304 -1.768 0 O-C-N 124.001 1.527 . . . . 0.0 110.056 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 117' ' ' GLU . 12.8 tt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.29 0.567 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.501 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -59.96 -41.31 91.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 178.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.02 -33.33 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.741 175.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -60.0 -40.05 87.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.688 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.523 ' CG1' HD12 ' A' ' 170' ' ' ILE . 55.9 t -60.04 -45.65 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.963 175.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 168' ' ' THR . 2.7 mt-30 -60.03 -44.79 94.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.81 178.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -62.63 -42.48 99.62 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.492 -0.755 . . . . 0.0 110.144 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.28 -41.79 63.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 110.506 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.473 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.4 mm? -95.45 0.04 52.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.192 -0.943 . . . . 0.0 110.983 -176.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.5 ' HA ' HG23 ' A' ' 164' ' ' ILE . 2.9 tt -44.82 163.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.925 -1.109 . . . . 0.0 110.095 -177.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 32.6 ptt-85 33.78 48.33 0.21 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.54 -0.725 . . . . 0.0 111.281 -178.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.484 ' HG2' ' HD2' ' A' ' 128' ' ' PRO . 0.2 OUTLIER -134.04 137.76 29.05 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.854 -1.154 . . . . 0.0 111.195 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.794 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 32.5 Cg_exo -54.87 127.48 26.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.003 1.528 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.555 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.9 mmm -126.21 140.83 52.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.495 -1.378 . . . . 0.0 110.79 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.573 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 7.8 tp -139.69 112.02 7.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 -177.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.4 pt-20 -48.6 145.33 3.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.695 -1.253 . . . . 0.0 110.144 -177.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.557 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 74.58 -1.71 3.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.815 -178.744 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.573 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.9 p30 -68.81 -170.4 0.22 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.986 -1.071 . . . . 0.0 110.206 175.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -146.92 157.12 43.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.57 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.084 -1.01 . . . . 0.0 110.016 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 14.1 m-85 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.232 0.539 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.443 ' CE ' HG21 ' A' ' 153' ' ' VAL . 2.9 tmtm? -118.67 108.32 14.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 110.086 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.546 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -77.45 138.6 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 109.868 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.443 HG21 ' CE ' ' A' ' 151' ' ' LYS . 32.9 t -117.18 -32.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 110.915 -177.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 131' ' ' GLU . 60.9 tttm -148.38 149.29 31.5 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.363 -178.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.484 ' CG2' HG23 ' A' ' 98' ' ' VAL . 82.2 p -133.2 170.46 15.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.65 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.47 -37.64 0.45 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.031 . . . . 0.0 110.907 -177.746 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 23.8 Cg_exo -55.61 -171.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.415 1.218 . . . . 0.0 110.284 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 -158.35 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 110.077 176.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -85.4 42.58 0.96 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.221 -0.924 . . . . 0.0 110.269 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.3 m -140.03 158.73 66.6 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.957 . . . . 0.0 110.562 -177.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.589 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.48 136.58 40.54 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.267 1.667 . . . . 0.0 110.957 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 9.2 m -132.07 159.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 109.835 173.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -105.54 127.52 53.07 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.176 -0.953 . . . . 0.0 110.281 175.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.555 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 9.0 mm -71.21 157.39 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.653 -0.655 . . . . 0.0 110.376 -177.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.34 167.03 25.36 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -22.29 61.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.41 -1.053 . . . . 0.0 110.48 -177.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -88.72 -14.18 37.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.273 -178.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.542 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 10.0 m -58.16 155.39 11.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.489 -0.757 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.8 mttt -109.22 148.56 30.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 178.5 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.523 HD12 ' CG1' ' A' ' 120' ' ' VAL . 2.2 mt -130.23 160.0 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 111.254 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.414 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 10.2 mt-10 -133.5 132.16 40.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.671 -0.643 . . . . 0.0 110.02 175.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.459 HD13 ' HG ' ' A' ' 100' ' ' LEU . 48.5 mm -120.01 122.97 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.389 -0.819 . . . . 0.0 109.956 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.457 ' HD2' ' HB3' ' A' ' 101' ' ' ALA . 8.8 ptp180 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.006 -1.059 . . . . 0.0 110.469 -179.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.0 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.148 0.499 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.1 -160.04 8.91 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 14.7 pt -136.91 168.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.137 . . . . 0.0 109.51 178.403 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 93.2 mt -104.29 125.72 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.649 -177.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.609 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -147.44 178.61 8.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.645 -0.659 . . . . 0.0 109.694 178.279 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 11.7 ptp180 -104.22 137.83 41.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 110.768 -173.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 80' ' ' SER . 8.4 p -61.98 130.63 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 110.547 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -111.38 162.85 14.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 177.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 81.5 tt0 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 175.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.595 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 45.5 mtm180 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.046 0.45 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.575 ' CG2' HG22 ' A' ' 42' ' ' VAL . 85.2 t -117.95 122.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.942 -1.099 . . . . 0.0 110.494 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.514 ' HD2' ' HD2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -98.01 120.46 38.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.037 177.598 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -139.95 172.82 12.22 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.233 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -89.94 178.91 6.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.611 -1.306 . . . . 0.0 110.883 -175.156 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -59.91 -40.03 87.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.258 -178.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -50.07 55.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.311 -178.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.61 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 11.3 p -55.49 -34.63 64.75 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.145 -0.972 . . . . 0.0 109.566 177.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 40.0 ttm180 -81.18 -44.2 18.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.507 -0.746 . . . . 0.0 111.302 179.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -85.29 -10.02 56.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 110.81 -172.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.61 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 1.3 pp -57.01 -31.8 65.48 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.318 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 15.4 mt -105.68 -79.83 0.56 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 172.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.41 16.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.559 -0.713 . . . . 0.0 110.31 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB1' ' HG3' ' A' ' 31' ' ' ARG . . . -66.61 141.5 57.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.982 -1.074 . . . . 0.0 111.072 -171.032 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -133.63 -178.91 5.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.176 174.782 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.0 mm -74.5 74.72 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.854 -1.154 . . . . 0.0 110.279 178.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.419 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 172.23 -6.16 0.03 OUTLIER Glycine 0 N--CA 1.483 1.803 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.836 -169.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -107.96 159.95 16.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.292 -1.711 . . . . 0.0 110.773 -172.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 92' ' ' THR . 69.2 t -99.62 133.01 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.407 -0.808 . . . . 0.0 109.821 179.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.575 HG22 ' CG2' ' A' ' 24' ' ' VAL . 5.1 m -109.72 143.56 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 -175.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HB2' HG22 ' A' ' 90' ' ' VAL . 87.9 tt0 -111.75 141.44 45.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.676 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.576 ' O ' ' OG1' ' A' ' 50' ' ' THR . 4.1 mp -119.97 147.12 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 110.442 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.2 tt0 -151.16 94.51 2.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.022 -1.049 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG3' ' CG1' ' A' ' 85' ' ' VAL . 8.7 tmtt? -98.88 -66.21 0.91 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 173.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.53 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -107.09 -33.99 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 175.928 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 51.5 mtt85 -133.21 -168.23 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.591 -0.693 . . . . 0.0 109.445 175.091 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.522 ' O ' HD22 ' A' ' 130' ' ' LEU . 5.9 mtmt -91.52 138.43 31.58 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.597 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.98 158.11 45.2 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.26 0.552 . . . . 0.0 109.963 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.66 160.99 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.004 178.475 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -174.05 176.38 46.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 172.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 34.6 ttm180 -111.78 171.32 7.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -1.047 . . . . 0.0 110.139 -178.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 5.4 p -89.55 126.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.046 -1.034 . . . . 0.0 110.91 -172.051 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.595 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -123.32 167.22 14.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 175.523 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -99.25 126.38 45.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 110.088 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -64.16 137.45 57.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 178.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.664 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 6.2 mtt180 -59.05 -45.22 99.51 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 109.082 174.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 32.9 Cg_endo -92.97 98.39 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.794 1.418 . . . . 0.0 108.887 178.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 14.7 pt-20 -75.57 36.78 0.13 Allowed 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.485 -0.759 . . . . 0.0 110.855 -173.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 74.1 m-20 -144.65 -38.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.855 -177.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.2 pt-20 -84.21 -22.23 30.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.517 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 17.4 m-80 -81.65 39.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.542 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.525 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 61.2 mtpt -98.64 14.38 28.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.464 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.49 24.69 0.03 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.517 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 46.9 pt -141.82 157.16 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -1.048 . . . . 0.0 109.246 175.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 67' ' ' VAL . 2.8 p -131.55 129.98 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.037 -1.039 . . . . 0.0 109.935 178.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.575 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 81.6 mtt180 -96.78 120.11 36.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.054 -1.029 . . . . 0.0 110.681 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.43 168.28 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.613 -0.68 . . . . 0.0 110.533 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -78.95 174.97 10.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.425 -0.797 . . . . 0.0 110.193 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.441 ' CA ' ' OE2' ' A' ' 13' ' ' GLU . 83.3 p -62.69 -38.52 90.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.714 -177.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.9 -43.38 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.134 -0.979 . . . . 0.0 110.359 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.478 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 7.6 tpt -59.99 -47.86 84.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.64 178.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 63.5 ttp85 -60.17 -40.11 88.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 109.964 174.143 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.35 -24.62 62.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 93.9 m-20 -60.13 -39.57 86.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -177.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.441 ' HB2' HG23 ' A' ' 47' ' ' VAL . 29.1 p -98.27 -37.85 9.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -176.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.53 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 118.07 36.56 0.94 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -112.5 161.26 16.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -1.205 . . . . 0.0 110.367 -176.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.573 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -109.65 166.01 11.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.263 -0.898 . . . . 0.0 109.296 176.622 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.437 ' HA ' HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -51.09 138.16 8.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.04 -1.038 . . . . 0.0 110.553 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 78.46 0.21 78.02 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 171.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -56.05 -158.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.119 -1.224 . . . . 0.0 110.423 174.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 49.5 pttt -136.05 109.64 8.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.515 -0.741 . . . . 0.0 110.139 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.548 ' CG1' ' HG3' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -124.51 154.88 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.9 . . . . 0.0 109.883 179.68 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 34.3 ttmt -100.65 125.51 47.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 177.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.523 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 74.1 t -99.51 120.79 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.991 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.499 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 99.4 mtt180 -109.67 157.48 19.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 110.007 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -100.03 137.09 38.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 110.619 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.442 HG22 ' CG ' ' A' ' 161' ' ' PRO . 2.2 m -150.38 -169.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 110.369 177.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.41 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 34.7 mtp180 -133.75 179.98 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.826 . . . . 0.0 110.426 177.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.451 HG21 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.19 156.92 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.131 -177.259 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.435 ' H ' ' HA ' ' A' ' 162' ' ' VAL . 13.5 pt-20 -150.26 169.94 20.17 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.18 98.63 8.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 110.398 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 162' ' ' VAL . . . -56.02 135.41 52.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 110.262 178.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 169' ' ' LYS . 1.0 OUTLIER -98.09 -27.79 14.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 111.105 -178.809 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 14.4 ttpt -150.16 130.96 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.811 -1.181 . . . . 0.0 110.248 178.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.507 HG23 ' CG2' ' A' ' 155' ' ' THR . 9.4 p -138.31 140.06 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 110.95 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 90.3 m -106.1 133.94 50.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.53 -0.731 . . . . 0.0 110.02 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.545 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -128.34 160.0 33.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 110.502 -178.28 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.5 84.02 24.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 110.466 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 29.2 Cg_exo . . . . . 0 C--N 1.307 -1.654 0 O-C-N 123.884 1.465 . . . . 0.0 110.356 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.506 HD11 ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 170' ' ' ILE . 98.8 mt-10 -60.02 -43.76 95.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.97 . . . . 0.0 109.968 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -66.28 -34.26 77.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 109.69 175.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -37.26 78.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.626 177.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.551 ' CG1' HD13 ' A' ' 170' ' ' ILE . 54.5 t -60.16 -47.83 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 109.888 174.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.601 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 109.849 177.631 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -59.93 -41.25 91.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.119 179.035 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.83 -40.09 23.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.672 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 3.7 mm? -93.16 -0.88 56.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.109 -0.995 . . . . 0.0 111.091 -175.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.2 tt -47.92 168.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.861 -1.149 . . . . 0.0 110.242 -176.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.7 ptt-85 32.96 48.29 0.13 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 178.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.4 mmt180 -137.96 148.42 60.32 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.387 -1.446 . . . . 0.0 111.806 175.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.786 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.6 Cg_exo -62.9 132.69 38.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.321 1.695 . . . . 0.0 109.931 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.517 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.4 mmm -131.09 148.06 52.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.533 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 15.0 tp -145.7 115.06 7.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.581 -0.699 . . . . 0.0 109.772 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.9 pt-20 -49.32 136.38 15.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.114 . . . . 0.0 110.401 -176.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.615 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.14 -3.94 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.2 0.524 . . . . 0.0 110.273 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.538 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 1.4 p30 -68.04 -170.98 0.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.314 175.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.488 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 9.7 m-80 -150.94 134.46 16.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.476 -0.765 . . . . 0.0 109.445 178.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 0.0 110.713 -177.269 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.4 m-85 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.293 0.568 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 109.95 22.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 132' ' ' GLN . 3.4 t -75.96 135.64 26.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.705 179.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.8 -32.14 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.069 -1.02 . . . . 0.0 110.932 -176.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -148.35 139.22 23.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 110.673 -177.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.507 ' CG2' HG23 ' A' ' 98' ' ' VAL . 58.8 p -129.16 169.54 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.635 176.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.701 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.16 -32.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 111.18 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 24.6 Cg_exo -56.29 -165.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.372 1.196 . . . . 0.0 110.237 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 13.0 t -89.76 41.21 1.03 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.251 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 158' ' ' SER . 64.6 mttt 60.74 18.05 8.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.767 . . . . 0.0 109.657 -177.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.485 HG11 ' O ' ' A' ' 158' ' ' SER . 14.9 m -108.18 160.0 28.58 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 110.089 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.557 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.1 Cg_endo -50.18 121.15 7.14 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.167 1.614 . . . . 0.0 110.266 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 6.2 m -129.73 159.45 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.619 176.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -105.93 127.63 53.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.135 -0.978 . . . . 0.0 109.993 178.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.593 ' CG2' ' HA ' ' A' ' 125' ' ' ILE . 11.2 mm -71.85 153.09 8.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.678 -0.639 . . . . 0.0 110.285 -176.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.86 167.52 25.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -57.7 -19.62 28.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -1.047 . . . . 0.0 110.322 -176.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -90.0 -9.99 46.63 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 110.023 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.515 ' CG2' HD12 ' A' ' 164' ' ' ILE . 46.8 m -63.76 151.65 41.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 176.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 96' ' ' LYS . 38.6 mmtm -96.64 163.05 13.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 109.767 178.111 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.551 HD13 ' CG1' ' A' ' 120' ' ' VAL . 18.4 mm -122.66 132.59 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.297 -0.877 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.516 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 58.4 mt-10 -124.17 133.27 53.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.577 172.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 117' ' ' GLU . 6.1 mt -137.46 139.37 43.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.517 -0.739 . . . . 0.0 110.306 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 110.304 179.466 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.268 0.556 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -144.95 179.14 22.28 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 177.039 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 44.4 pt -135.34 159.04 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -1.177 . . . . 0.0 109.994 -179.402 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 96.8 mt -101.17 120.01 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.354 -178.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.51 HD22 HG23 ' A' ' 85' ' ' VAL . 2.0 pt? -138.36 -171.8 3.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.516 ' HG3' ' HA2' ' A' ' 82' ' ' GLY . 32.6 ttp180 -101.65 133.39 46.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.915 -174.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 82' ' ' GLY . 11.1 p -62.82 129.83 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 110.257 176.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -112.14 148.84 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 110.34 179.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 86.5 tt0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 176.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 33.1 ptt180 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.147 0.499 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 90.1 t -110.08 117.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.09 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.481 ' O ' ' OD1' ' A' ' 63' ' ' ASN . 1.3 ptm180 -96.81 120.56 37.37 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.981 -1.075 . . . . 0.0 109.909 178.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 55' ' ' TYR . 1.2 pt? -136.38 175.27 9.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.664 -0.648 . . . . 0.0 109.542 -175.39 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.558 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.4 p-10 -92.04 179.73 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.743 -175.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.08 -42.19 94.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 109.24 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 54.2 m -65.84 -55.89 14.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.074 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.558 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 23.3 t -49.91 -30.21 9.73 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.739 -1.225 . . . . 0.0 109.564 177.235 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.486 ' HA ' HD13 ' A' ' 26' ' ' LEU . 63.3 ttp85 -80.57 -48.86 12.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 111.327 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -94.42 -14.66 25.02 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.712 -1.242 . . . . 0.0 111.611 -173.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.601 ' HB3' ' O ' ' A' ' 29' ' ' SER . 1.1 pt? -60.05 -28.71 68.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 77.1 mt -103.36 -75.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.074 -1.016 . . . . 0.0 110.186 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.481 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 5.6 t70 -169.58 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.605 0.717 . . . . 0.0 109.176 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.531 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.52 119.38 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.4 0.619 . . . . 0.0 110.772 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -105.1 178.27 4.61 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.246 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.0 mm -60.22 127.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.872 -1.143 . . . . 0.0 110.074 177.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.55 23.36 67.78 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.717 172.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 81.8 m-20 -89.16 171.69 9.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.719 -1.459 . . . . 0.0 109.639 172.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.467 HG13 HG22 ' A' ' 92' ' ' THR . 76.4 t -98.92 129.3 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.09 -176.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 52' ' ' GLY . 1.7 m -117.06 141.12 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 -175.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -109.78 141.74 42.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 177.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.55 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 4.1 mp -120.46 151.29 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.816 -1.177 . . . . 0.0 110.559 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -150.71 93.11 1.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.353 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.74 ' HD2' ' CB ' ' A' ' 79' ' ' ALA . 9.1 ttpt -98.44 -65.13 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.703 174.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -111.82 -30.94 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.637 0.732 . . . . 0.0 109.264 176.112 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.4 mtt85 -136.64 -171.52 2.93 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.714 -0.616 . . . . 0.0 109.372 174.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' HD21 ' A' ' 130' ' ' LEU . 7.0 mttm -88.31 136.94 32.74 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.986 -1.072 . . . . 0.0 110.459 -177.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.549 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -135.85 156.88 48.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.349 0.595 . . . . 0.0 110.296 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.58 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.52 160.59 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.868 . . . . 0.0 109.793 176.999 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 42' ' ' VAL . . . 178.88 179.72 48.68 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.387 -1.387 . . . . 0.0 109.714 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -113.91 165.45 12.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -1.046 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -89.33 139.99 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.016 . . . . 0.0 110.693 -173.576 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -125.29 161.38 27.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.748 . . . . 0.0 110.443 175.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 56' ' ' ARG . 24.8 ttp-105 -93.62 127.02 39.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -0.835 . . . . 0.0 110.314 177.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.456 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -65.9 140.0 58.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.574 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 4.4 mmm180 -56.78 -46.76 99.82 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.969 -1.082 . . . . 0.0 109.127 173.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 32.0 Cg_endo -91.57 98.33 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.997 1.525 . . . . 0.0 109.127 178.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.56 35.68 0.1 Allowed 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.641 -0.662 . . . . 0.0 110.765 -175.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 59' ' ' PRO . 51.6 t0 -148.46 -34.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.37 -24.66 27.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.197 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.503 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -81.29 41.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.718 -0.614 . . . . 0.0 110.318 176.204 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 pttt -98.59 9.76 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 178.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.84 26.75 0.06 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 176.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 66' ' ' ILE . 46.0 pt -140.13 141.22 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -1.189 . . . . 0.0 109.645 175.036 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' HB ' HD13 ' A' ' 9' ' ' LEU . 2.6 p -120.02 121.93 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 73.5 ttt180 -91.95 118.16 30.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.24 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.01 160.04 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 110.41 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -75.78 159.99 30.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 177.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.4 t -53.45 -29.95 38.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.913 -175.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.55 -48.53 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 110.121 -175.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.444 ' CE ' HD12 ' A' ' 44' ' ' ILE . 3.5 tpt -60.0 -45.14 93.72 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.707 177.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 77' ' ' CYS . 66.9 ttp85 -60.01 -40.09 88.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.778 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -69.93 -27.43 64.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.152 -0.968 . . . . 0.0 110.384 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -21.79 63.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 110.825 -175.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 74' ' ' ARG . 18.6 p -101.78 -25.84 13.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.99 -1.069 . . . . 0.0 110.854 -178.009 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.474 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 98.0 23.47 13.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 176.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.74 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -109.02 -168.82 1.39 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.045 -1.268 . . . . 0.0 110.933 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.61 170.17 12.95 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.461 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -61.49 144.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 0.0 110.324 177.164 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.543 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . 77.74 -1.92 65.72 Favored Glycine 0 C--N 1.297 -1.638 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 172.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.532 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.3 m-20 -56.62 -167.2 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.035 -1.274 . . . . 0.0 110.189 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 44.1 pttt -127.16 113.33 16.24 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.392 -0.817 . . . . 0.0 109.753 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.57 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -121.15 158.13 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -177.122 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 85.2 tttt -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.729 175.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.527 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 62.8 t -104.22 122.03 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.945 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.529 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 89.4 mtt180 -110.34 140.22 44.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 109.429 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 11.0 tttt -84.77 138.95 32.3 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.077 -1.014 . . . . 0.0 110.237 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.0 m -150.05 -169.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 176.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -128.39 172.21 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.464 177.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.467 HG22 HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.06 163.15 12.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.004 -1.06 . . . . 0.0 111.018 -175.773 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' OE2' HG13 ' A' ' 162' ' ' VAL . 19.1 pt-20 -150.04 169.57 20.92 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.028 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.81 99.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.723 -1.236 . . . . 0.0 110.373 -176.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.566 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -57.25 140.77 48.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -0.837 . . . . 0.0 110.564 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.517 ' HG3' HD21 ' A' ' 156' ' ' LEU . 29.3 pttt -105.36 -26.08 12.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 111.316 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.55 ' CB ' HD21 ' A' ' 156' ' ' LEU . 22.0 tttp -148.16 128.56 13.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.687 -1.258 . . . . 0.0 110.623 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.56 HG23 ' CG2' ' A' ' 155' ' ' THR . 7.5 p -140.86 148.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.371 -0.83 . . . . 0.0 110.558 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -120.04 132.11 55.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.131 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -123.71 159.3 29.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.534 -178.53 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.402 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . . . -141.07 93.78 8.05 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.385 -0.822 . . . . 0.0 110.354 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.7 Cg_exo . . . . . 0 C--N 1.303 -1.83 0 O-C-N 124.057 1.556 . . . . 0.0 110.32 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 9.8 tp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.184 0.516 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 96.8 mt-10 -59.97 -41.74 92.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -35.21 74.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 175.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.392 -0.818 . . . . 0.0 110.2 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.544 ' CG1' HD13 ' A' ' 170' ' ' ILE . 54.6 t -60.52 -45.17 97.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 175.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.612 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 5.9 mt-30 -60.01 -42.8 95.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 110.335 175.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -59.98 -46.56 89.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.405 -0.81 . . . . 0.0 109.953 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.524 ' HB1' ' CD2' ' A' ' 124' ' ' LEU . . . -70.17 -46.71 64.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.516 -0.74 . . . . 0.0 110.741 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.524 ' CD2' ' HB1' ' A' ' 123' ' ' ALA . 4.6 mm? -100.76 8.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.075 -1.015 . . . . 0.0 111.827 -173.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.577 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.2 tt -49.12 165.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.56 -1.337 . . . . 0.0 109.852 -176.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 31.9 ptt180 33.31 45.98 0.09 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.428 -0.795 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -128.46 134.24 26.06 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.044 -1.035 . . . . 0.0 110.589 179.046 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.772 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 6.6 Cg_endo -54.2 129.42 34.38 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.881 1.464 . . . . 0.0 109.942 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.532 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.8 mmm -126.53 143.13 51.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.568 -1.333 . . . . 0.0 110.929 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.523 HD21 ' O ' ' A' ' 49' ' ' LYS . 13.6 tp -142.95 107.56 4.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 0.0 109.645 -177.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.606 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.2 pt-20 -46.24 140.34 4.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 0.0 110.822 -174.638 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.606 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.2 -3.37 1.24 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.256 0.55 . . . . 0.0 110.343 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.51 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 2.1 p30 -69.86 -171.02 0.37 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.302 -0.874 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.49 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 15.6 m-80 -142.48 156.53 45.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.067 176.435 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.328 -177.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.9 m-85 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.305 0.574 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.49 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 24.4 tptm -114.72 107.81 15.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.944 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 2.9 t -76.15 135.93 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 109.647 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.7 t -121.62 -27.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.934 -177.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 22.0 tttt -139.53 143.49 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.794 -1.191 . . . . 0.0 110.923 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.56 ' CG2' HG23 ' A' ' 98' ' ' VAL . 46.5 p -139.95 157.2 46.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.605 -0.685 . . . . 0.0 109.503 174.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.696 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 3.2 tp -88.97 -33.96 0.41 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 111.069 -177.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 15.3 Cg_exo -57.57 -165.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.38 1.2 . . . . 0.0 109.971 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 160' ' ' VAL . 6.4 t -90.09 179.71 5.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.222 -0.924 . . . . 0.0 109.901 175.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -60.28 -7.68 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 110.903 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 158' ' ' SER . 19.1 m -85.39 152.78 58.37 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.498 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.58 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.24 141.77 30.52 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.402 1.738 . . . . 0.0 110.933 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.772 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 6.2 m -129.98 158.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 172.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.9 tt0 -106.66 128.68 54.37 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.048 176.115 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.532 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 13.3 mm -70.23 156.25 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 110.125 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 171.2 24.49 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.532 ' HG2' ' CD1' ' A' ' 125' ' ' ILE . 98.9 mt-10 -59.01 -25.7 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.264 -1.139 . . . . 0.0 110.118 -178.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.68 -11.2 40.47 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.151 -0.968 . . . . 0.0 110.494 -176.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.543 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 92.1 m -59.0 145.71 40.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.093 -1.004 . . . . 0.0 110.343 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 79.0 mttt -93.59 147.29 23.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.956 -1.09 . . . . 0.0 109.945 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.612 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 1.0 OUTLIER -121.61 141.35 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -178.184 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.411 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 44.7 mt-10 -124.9 128.88 49.33 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 171.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 170' ' ' ILE . 2.7 mp -123.26 119.95 58.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.562 -0.711 . . . . 0.0 110.052 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.402 ' NE ' ' HB3' ' A' ' 101' ' ' ALA . 8.5 ptp180 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.42 ' O ' HD13 ' A' ' 34' ' ' LEU . 98.6 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.324 0.583 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.78 -169.99 14.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 177.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 21.4 pt -132.54 154.38 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -1.133 . . . . 0.0 109.952 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.0 mt -94.91 119.17 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.4 pt? -136.03 -168.85 2.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.221 -0.924 . . . . 0.0 110.314 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.508 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 20.2 ttp180 -106.55 130.01 54.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 110.957 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 82' ' ' GLY . 11.5 p -62.53 137.71 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 110.461 175.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -120.91 156.58 31.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.245 177.418 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 86.4 tt0 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.368 177.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.601 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 26.1 mmt180 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.293 0.568 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 55' ' ' TYR . 95.8 t -114.52 119.99 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 177.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -97.41 119.92 36.84 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.959 -1.088 . . . . 0.0 110.035 177.403 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.525 ' CD2' ' CB ' ' A' ' 30' ' ' SER . 1.8 mt -140.78 177.75 7.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.154 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 28.1 p-10 -93.65 179.35 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.833 -177.281 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.99 -40.97 90.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.349 -177.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.522 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -68.83 -42.68 76.84 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.308 -177.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.593 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 57.7 m -59.95 -40.84 90.36 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.031 -1.043 . . . . 0.0 109.573 177.008 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.568 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 52.3 ttp180 -74.19 -44.21 54.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 111.469 177.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -88.63 -11.61 44.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.88 -1.138 . . . . 0.0 111.07 -170.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 1.1 pp -57.73 -32.59 67.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.775 -1.203 . . . . 0.0 109.559 -177.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 17.1 mt -106.44 -72.65 0.71 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.122 -0.986 . . . . 0.0 110.475 175.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 36' ' ' ALA . 6.8 t0 -170.04 -27.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.717 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -28.68 124.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.383 0.611 . . . . 0.0 111.455 -178.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.469 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 2.6 pt-20 -113.48 -175.16 2.61 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.233 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 38' ' ' ILE . 19.3 mm -60.53 134.14 25.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.947 -1.096 . . . . 0.0 109.61 174.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.438 ' H ' ' CG1' ' A' ' 54' ' ' VAL . . . 79.77 14.62 80.74 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.237 172.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' CE ' ' A' ' 89' ' ' LYS . 87.0 m-20 -88.97 167.29 13.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.301 -1.705 . . . . 0.0 110.033 173.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.4 HG21 ' OG1' ' A' ' 92' ' ' THR . 50.1 t -99.71 129.08 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.046 -1.034 . . . . 0.0 110.454 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.491 HG13 ' CD ' ' A' ' 89' ' ' LYS . 1.4 m -114.59 146.09 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.903 . . . . 0.0 110.527 -178.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.5 tt0 -112.22 144.27 41.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.41 -0.806 . . . . 0.0 109.35 177.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 4.2 mp -117.18 148.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.948 -1.095 . . . . 0.0 110.586 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -151.06 90.6 1.62 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 111.178 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.552 ' CG ' ' CG1' ' A' ' 85' ' ' VAL . 13.4 tmtt? -98.21 -59.64 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.031 . . . . 0.0 109.86 172.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.541 HG21 ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -114.26 -35.52 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 109.069 177.532 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 83.9 mtm-85 -133.06 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.504 ' O ' HD23 ' A' ' 130' ' ' LEU . 9.3 mttp -88.34 130.71 35.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.075 -1.016 . . . . 0.0 110.175 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.522 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -129.96 168.11 17.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.643 -0.66 . . . . 0.0 110.391 -178.703 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -125.81 162.55 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.392 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.455 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.29 -176.97 47.41 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 176.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 54.9 mtp180 -123.38 -168.47 1.77 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -1.086 . . . . 0.0 109.977 -178.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -111.09 131.61 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.06 -1.025 . . . . 0.0 111.202 -174.03 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.601 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -125.65 162.76 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 0.0 110.467 175.146 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -90.0 125.87 35.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.496 -0.753 . . . . 0.0 110.061 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -64.62 139.75 58.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.075 -1.016 . . . . 0.0 110.035 178.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.63 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.2 mtp180 -58.51 -49.84 91.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 109.275 174.071 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 17.9 Cg_endo -91.53 99.46 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.812 1.427 . . . . 0.0 108.885 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.6 34.16 0.07 Allowed 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.527 -0.733 . . . . 0.0 110.857 -174.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -149.8 -30.77 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.674 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.47 -25.26 29.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.157 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 10.2 m-80 -81.25 40.07 0.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.774 -0.579 . . . . 0.0 110.554 179.082 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -97.81 11.71 36.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.041 . . . . 0.0 109.553 177.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.49 25.6 0.05 OUTLIER Glycine 0 N--CA 1.48 1.611 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 176.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.422 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 44.9 pt -140.11 141.21 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -1.217 . . . . 0.0 109.508 174.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.462 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 7.6 p -120.38 129.04 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.996 . . . . 0.0 110.16 -179.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.519 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 28.5 ttm180 -94.26 112.8 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.253 -177.043 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.4 pt -131.33 168.5 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.731 . . . . 0.0 110.632 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' OD1' ' HB2' ' A' ' 73' ' ' MET . 31.6 p-10 -81.8 176.15 9.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 177.626 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -70.01 -29.1 66.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.272 -0.893 . . . . 0.0 110.671 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.7 -47.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 0.0 110.42 -176.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.543 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -60.62 -43.45 97.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.515 178.965 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.428 ' NH1' HG13 ' A' ' 81' ' ' ILE . 45.3 ttp180 -60.02 -41.08 91.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.935 173.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.95 -24.29 63.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.543 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 95.6 m-20 -60.0 -37.46 79.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.011 . . . . 0.0 110.633 -177.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.47 ' HB2' HG23 ' A' ' 47' ' ' VAL . 30.0 p -98.26 -33.36 11.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 110.439 -177.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.528 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 113.94 26.75 3.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.423 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . . . -103.58 168.54 9.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -1.14 . . . . 0.0 110.275 -176.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.478 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -115.72 177.97 4.48 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.569 179.273 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.474 ' HA ' HG12 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -64.32 140.27 19.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.028 -1.045 . . . . 0.0 110.532 178.414 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.518 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 77.15 -3.35 58.3 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 173.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.513 ' HB2' HG11 ' A' ' 11' ' ' VAL . 1.1 m-20 -58.08 -167.44 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.913 -1.345 . . . . 0.0 110.303 175.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 19.1 pttp -128.36 111.58 13.5 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.885 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.552 ' CG1' ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -118.37 155.42 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.7 ttmt -100.24 123.6 44.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -0.968 . . . . 0.0 109.837 176.055 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.476 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 80.3 t -102.28 123.65 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.933 178.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.551 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtt180 -111.97 148.2 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.581 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.545 ' CD ' ' HB3' ' A' ' 36' ' ' ALA . 10.5 tptt -100.0 130.04 46.12 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.049 -179.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.06 -166.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.596 -0.69 . . . . 0.0 110.15 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -129.12 171.46 12.38 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.543 -0.723 . . . . 0.0 109.67 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -107.43 159.97 16.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 111.117 -174.618 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' OE2' ' HB3' ' A' ' 157' ' ' PRO . 19.6 pt-20 -147.8 173.46 12.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.5 mm -89.2 105.73 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.821 -1.175 . . . . 0.0 110.267 -175.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.485 ' CB ' HG21 ' A' ' 162' ' ' VAL . . . -57.2 139.24 53.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.537 ' HG3' ' CD2' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -101.34 -30.48 11.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.7 178.212 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 23.6 tttt -150.03 128.76 12.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.878 -1.139 . . . . 0.0 110.493 -179.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.459 HG21 ' CG2' ' A' ' 155' ' ' THR . 9.9 p -139.92 143.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 110.384 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 54.6 m -114.79 138.36 50.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.127 -178.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -133.42 165.43 24.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.484 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . . . -144.16 99.97 4.96 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 110.605 -177.112 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HD2' ' NH1' ' A' ' 173' ' ' ARG . 28.3 Cg_exo . . . . . 0 C--N 1.307 -1.622 0 O-C-N 123.887 1.467 . . . . 0.0 110.239 179.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 20.9 tt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.27 0.557 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 170' ' ' ILE . 95.6 mt-10 -60.01 -42.82 95.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -65.86 -40.02 91.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.843 . . . . 0.0 109.607 174.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -60.57 -39.97 89.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.471 -0.768 . . . . 0.0 109.916 178.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' A' ' 170' ' ' ILE . 54.6 t -60.09 -47.67 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.889 176.076 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.627 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 5.3 mt-30 -60.02 -43.78 95.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 176.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -59.99 -43.28 95.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.887 -176.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.59 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.56 -0.712 . . . . 0.0 110.597 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 47.9 mt -94.33 -4.7 48.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.021 . . . . 0.0 110.928 -171.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.4 tt -45.51 166.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.883 -1.136 . . . . 0.0 109.962 -172.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 164' ' ' ILE . 35.6 ptt180 33.45 46.72 0.12 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.7 -0.625 . . . . 0.0 111.578 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 9.0 tpp180 -134.13 135.3 24.02 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.73 -1.231 . . . . 0.0 111.547 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -59.51 124.19 14.96 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.989 1.521 . . . . 0.0 109.526 178.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.435 ' SD ' HG13 ' A' ' 164' ' ' ILE . 20.0 mtp -132.1 147.44 52.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.361 -1.462 . . . . 0.0 111.269 -177.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 49' ' ' LYS . 2.1 tp -148.36 115.95 6.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.649 -0.657 . . . . 0.0 109.23 -176.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -40.43 156.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.052 -1.03 . . . . 0.0 110.514 -174.412 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 70.58 -3.49 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.812 -0.555 . . . . 0.0 111.202 179.483 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD1' ' CB ' ' A' ' 152' ' ' VAL . 3.9 p-10 -70.18 178.64 2.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.925 -1.109 . . . . 0.0 109.882 173.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.455 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 20.0 m-80 -145.26 140.96 28.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 109.807 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 110.432 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.157 0.503 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.455 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 29.0 tptp -109.3 106.52 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.529 ' CB ' ' OD1' ' A' ' 133' ' ' ASP . 2.8 t -76.75 140.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 109.918 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.41 -23.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 111.242 -176.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.479 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 49.2 tptt -149.07 142.04 24.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.743 -1.223 . . . . 0.0 110.684 -176.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.512 HG23 ' CB ' ' A' ' 131' ' ' GLU . 72.5 p -140.02 160.01 40.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.497 -0.752 . . . . 0.0 109.372 176.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.72 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 10.8 tp -89.48 -29.17 0.35 Allowed Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.163 -0.96 . . . . 0.0 111.44 -175.422 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.72 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 35.5 Cg_exo -53.78 -170.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.086 1.045 . . . . 0.0 110.5 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -89.85 41.35 1.04 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 110.433 -178.254 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 158' ' ' SER . 37.1 mttt 62.31 19.95 11.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.452 -0.78 . . . . 0.0 109.851 -177.3 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 162' ' ' VAL . 20.0 m -110.37 160.04 29.89 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.495 -0.753 . . . . 0.0 110.057 178.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.505 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 5.3 Cg_endo -53.1 122.24 10.79 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.123 1.591 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 3.9 m -127.07 155.26 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 110.437 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -100.47 126.21 46.87 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.282 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.568 ' CG2' ' HA ' ' A' ' 125' ' ' ILE . 12.8 mm -70.39 153.21 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 110.005 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.412 ' N ' HG21 ' A' ' 164' ' ' ILE . . . -142.98 168.79 25.9 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 176.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -57.13 -21.77 34.94 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.231 -1.158 . . . . 0.0 110.229 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.53 -10.74 42.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.715 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.551 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 93.5 m -59.81 143.45 51.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.057 -1.027 . . . . 0.0 110.241 -179.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 86.4 mttt -90.02 149.22 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.032 -1.043 . . . . 0.0 109.892 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.593 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 4.5 mm -115.42 130.06 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.846 -177.271 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.462 ' O ' HD12 ' A' ' 172' ' ' ILE . 20.8 mt-10 -111.92 128.38 56.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.165 -0.96 . . . . 0.0 110.316 171.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 171' ' ' GLU . 39.2 mm -123.37 127.86 74.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.194 -177.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.487 ' NH1' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.344 0.592 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -59.98 -41.41 91.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 110.652 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.9 t -149.58 140.44 22.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 110.183 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -148.45 92.55 2.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 110.122 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 7.6 p30 -136.44 109.03 7.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 110.582 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -154.12 -169.98 19.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.475 ' CG2' HD12 ' A' ' 33' ' ' LEU . 48.1 pt -131.2 159.92 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.05 -1.265 . . . . 0.0 110.195 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.56 115.98 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.01 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.595 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.2 pt? -141.1 -175.13 4.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.672 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 3.7 ptt-85 -109.6 133.71 52.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.763 -1.211 . . . . 0.0 110.844 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.576 ' CG1' ' O ' ' A' ' 80' ' ' SER . 12.6 p -61.84 129.75 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 110.544 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -110.36 159.66 17.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.337 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.532 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.1 tt0 -175.74 142.18 0.53 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.138 -0.976 . . . . 0.0 110.689 176.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.68 171.38 17.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.386 -0.821 . . . . 0.0 110.038 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -59.93 133.1 55.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.113 -0.992 . . . . 0.0 110.128 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 p -175.4 -158.45 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.875 . . . . 0.0 110.084 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 43.2 p -71.54 159.26 34.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.682 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -69.89 -36.67 6.72 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.371 -0.831 . . . . 0.0 111.256 -177.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 16.9 Cg_exo -63.38 -175.01 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.515 1.271 . . . . 0.0 110.849 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.59 17.72 44.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.9 ptm -88.31 5.41 42.01 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.224 -1.162 . . . . 0.0 109.269 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -134.33 11.72 3.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 110.386 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 69.0 mtt85 -127.29 134.37 50.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 0.0 109.844 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 84.4 t -110.39 119.9 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.972 -1.08 . . . . 0.0 109.948 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 3.0 ptt180 -93.09 118.12 30.85 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.491 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD22 ' CB ' ' A' ' 30' ' ' SER . 2.7 mt -136.58 -179.27 5.59 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.728 -0.607 . . . . 0.0 109.958 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 1.4 p-10 -103.06 176.24 5.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.697 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 79.6 mt-10 -59.78 -44.48 93.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.344 -0.847 . . . . 0.0 109.25 -174.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.545 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 72.1 m -68.41 -43.32 77.46 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.014 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.542 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.1 m -60.09 -40.02 88.17 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.122 -0.986 . . . . 0.0 109.713 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.507 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 26.1 ttp180 -86.66 -33.92 19.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.732 -0.605 . . . . 0.0 111.135 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 62.2 ttt180 -89.39 -12.6 39.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.909 -1.119 . . . . 0.0 110.814 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 34' ' ' LEU . 1.4 pp -59.76 -32.45 70.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.935 -1.103 . . . . 0.0 109.702 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 12.2 mt -101.65 -74.51 0.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 36' ' ' ALA . 33.7 t0 -170.24 -23.81 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.687 -0.633 . . . . 0.0 109.604 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.613 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -34.71 121.27 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.436 0.636 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.07 -179.34 3.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 mm -60.07 126.15 17.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.65 23.87 63.8 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.07 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -88.54 171.29 10.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.655 -1.497 . . . . 0.0 109.91 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.449 HG23 ' CG2' ' A' ' 92' ' ' THR . 84.8 t -99.2 130.15 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.264 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 52' ' ' GLY . 2.2 m -117.96 139.95 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.813 . . . . 0.0 110.437 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' HB2' HG21 ' A' ' 90' ' ' VAL . 88.7 tt0 -108.59 142.83 38.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.574 ' O ' ' OG1' ' A' ' 50' ' ' THR . 3.7 mp -119.91 150.5 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.924 -1.11 . . . . 0.0 110.703 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -152.57 93.48 1.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 111.124 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' CG ' HG12 ' A' ' 85' ' ' VAL . 4.1 tmtm? -99.06 -66.95 0.87 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.933 -1.104 . . . . 0.0 109.748 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG23 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.52 -34.58 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 109.407 176.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 85.9 mtt180 -131.59 -174.12 3.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.583 -0.698 . . . . 0.0 109.246 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' O ' HD22 ' A' ' 130' ' ' LEU . 35.5 mttt -89.14 139.44 30.47 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.351 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.54 159.81 40.91 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.431 0.634 . . . . 0.0 110.154 -177.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.15 161.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.035 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -178.87 179.85 48.76 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.678 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 59.2 ttt180 -117.17 164.46 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.503 -0.998 . . . . 0.0 110.237 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -94.05 141.79 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.463 -176.037 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.533 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.4 m-85 -137.62 166.37 24.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.508 -0.745 . . . . 0.0 110.496 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -89.23 121.94 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 110.084 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.468 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . . . -62.96 140.01 58.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.002 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.662 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.1 mmt85 -56.15 -49.68 91.82 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.055 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.16 98.74 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.726 1.382 . . . . 0.0 108.923 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 37.18 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.3 p-10 -147.71 -29.2 0.33 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -85.04 -28.51 25.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 109.106 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.451 ' C ' ' HB3' ' A' ' 27' ' ' ASP . 4.8 m-80 -81.13 41.51 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.857 -0.527 . . . . 0.0 110.636 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -97.83 8.97 43.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.595 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.9 27.08 0.05 OUTLIER Glycine 0 N--CA 1.479 1.552 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.475 HG21 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -141.11 142.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.25 -1.147 . . . . 0.0 109.561 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 9' ' ' LEU . 2.8 p -119.97 127.47 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.044 -1.035 . . . . 0.0 109.973 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 33.9 ttm180 -92.86 118.46 31.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.461 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 2.5 pt -129.34 166.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.775 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.4 ' OD2' ' O ' ' A' ' 18' ' ' ASP . 3.8 t70 -80.09 168.89 18.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.5 p -60.82 -29.65 69.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.65 -46.41 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.161 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.451 ' HB3' ' HB ' ' A' ' 69' ' ' ILE . 13.5 tpt -60.04 -44.38 94.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -60.03 -40.14 88.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.849 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -66.43 -31.24 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 73' ' ' MET . 99.7 m-20 -59.98 -39.85 87.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.762 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.5 p -99.36 -39.64 8.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.846 -1.159 . . . . 0.0 110.801 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.554 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 110.2 30.72 3.29 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -104.54 167.91 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.13 -1.217 . . . . 0.0 110.36 -177.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.576 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 165.53 11.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.173 176.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 1.1 mp -53.83 139.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.995 -1.065 . . . . 0.0 110.203 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.488 ' N ' HG12 ' A' ' 11' ' ' VAL . . . 76.54 2.08 73.55 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -58.23 -160.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 O-C-N 120.91 -1.347 . . . . 0.0 110.509 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.9 ptpt -130.88 108.93 10.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.532 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -118.87 155.2 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.128 -0.983 . . . . 0.0 110.052 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -106.6 119.96 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.199 -0.938 . . . . 0.0 109.908 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.504 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 95.0 t -105.1 121.78 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 87.7 mtm-85 -112.38 140.35 47.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.995 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.613 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 41.1 tttm -72.33 143.01 48.81 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.533 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.463 HG21 ' CG ' ' A' ' 161' ' ' PRO . 1.9 m -150.22 -169.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.511 -0.743 . . . . 0.0 109.909 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.24 169.05 17.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.449 ' CG2' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.98 156.2 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -150.26 174.47 12.8 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.4 mm -89.28 102.96 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.867 -1.146 . . . . 0.0 110.031 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.453 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -52.84 132.46 36.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.306 -0.871 . . . . 0.0 110.163 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -96.06 -28.66 14.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.996 . . . . 0.0 110.995 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 46.2 tttp -150.05 119.9 7.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.831 -1.168 . . . . 0.0 110.281 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.462 HG13 HG12 ' A' ' 170' ' ' ILE . 9.3 p -132.45 137.63 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.87 -1.144 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.489 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 28.1 m -107.77 145.76 33.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 1.0 OUTLIER -147.66 169.76 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.144 -0.973 . . . . 0.0 110.864 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.469 ' HB1' ' HG2' ' A' ' 173' ' ' ARG . . . -141.4 86.05 11.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 110.924 -175.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 22.0 Cg_exo -60.01 126.09 19.37 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.881 1.464 . . . . 0.0 109.834 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.465 HG22 ' HB1' ' A' ' 177' ' ' ALA . 76.2 mt -89.44 95.14 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.004 . . . . 0.0 110.149 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.441 HD12 HD23 ' A' ' 110' ' ' LEU . 8.8 pt -150.79 -168.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.49 -0.756 . . . . 0.0 110.453 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.514 ' HB2' ' HG3' ' A' ' 108' ' ' GLN . 33.0 mmt180 -93.87 156.64 16.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.541 -0.725 . . . . 0.0 110.005 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -55.6 -22.52 22.73 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.118 -0.989 . . . . 0.0 110.14 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 36.2 p-10 -110.02 20.03 18.38 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 111.095 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.514 ' HG3' ' HB2' ' A' ' 105' ' ' ARG . 2.9 mt-30 -90.54 -80.07 0.34 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.837 -1.164 . . . . 0.0 110.795 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HB3' HD11 ' A' ' 104' ' ' ILE . 47.3 ttm-85 -119.83 -17.34 8.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.038 -1.039 . . . . 0.0 111.065 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -97.99 43.12 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.044 -1.035 . . . . 0.0 110.523 -177.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -110.41 47.88 0.94 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.589 -0.694 . . . . 0.0 110.578 176.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -111.49 -62.78 1.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 110.543 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 78.18 169.95 35.51 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 113' ' ' GLY . 96.1 mt-10 44.4 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.267 -1.137 . . . . 0.0 110.234 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.3 0.94 89.55 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.512 ' C ' ' CD1' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -60.91 -39.97 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -1.166 . . . . 0.0 109.903 177.018 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.486 ' N ' HG22 ' A' ' 116' ' ' ILE . 46.7 mt-10 -61.77 -40.26 94.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -70.0 -31.43 69.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.718 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -59.89 -39.76 86.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.551 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.482 HG12 HD13 ' A' ' 170' ' ' ILE . 69.6 t -60.2 -46.27 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.148 -0.97 . . . . 0.0 109.238 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.589 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.17 -40.03 92.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 110.267 175.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -60.0 -41.87 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.3 -39.83 28.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -0.793 . . . . 0.0 110.586 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.491 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 92.0 mt -91.04 -8.39 49.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.884 -174.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 3.7 tt -41.96 166.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 164' ' ' ILE . 30.9 ptt-85 34.2 54.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.449 -0.782 . . . . 0.0 111.607 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 124' ' ' LEU . 6.6 mtt-85 -135.17 150.2 72.16 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.89 -1.131 . . . . 0.0 111.163 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.9 Cg_endo -69.02 133.11 26.06 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 124.096 1.577 . . . . 0.0 109.618 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.532 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 90.4 mmm -128.54 145.67 51.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.485 -1.384 . . . . 0.0 111.607 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 13.6 tp -149.77 114.4 5.29 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.703 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.0 pm0 -49.11 139.67 10.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 0.0 110.573 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.703 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 94.5 mm-40 79.73 -1.33 2.13 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.066 0.46 . . . . 0.0 110.593 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.557 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 1.1 p30 -69.02 -171.05 0.28 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.126 -0.984 . . . . 0.0 110.41 175.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 22.2 m-80 -149.97 158.8 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -140.38 171.7 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.092 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.9 t -116.51 158.59 23.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.327 -0.858 . . . . 0.0 110.684 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.604 ' CG1' ' HD2' ' A' ' 138' ' ' PRO . 2.5 t -113.55 148.67 40.21 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.481 -0.762 . . . . 0.0 109.546 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.604 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 4.8 Cg_endo -51.78 76.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.845 1.445 . . . . 0.0 111.302 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 38.13 63.16 0.96 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.473 ' CD2' ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -123.59 153.99 39.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -1.19 . . . . 0.0 110.004 176.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -180.0 -167.14 0.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.2 -0.938 . . . . 0.0 110.38 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.573 ' N ' ' OG1' ' A' ' 141' ' ' THR . 83.7 mt -141.86 -131.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.656 -0.652 . . . . 0.0 109.923 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.52 -151.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 110.501 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.46 62.63 4.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -97.36 169.12 9.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.46 -1.024 . . . . 0.0 110.035 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -135.31 158.46 44.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.245 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.551 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 101.49 -91.5 0.93 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.06 44.33 2.05 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.457 -1.025 . . . . 0.0 111.021 177.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 2.9 pp -140.45 163.27 33.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.014 -1.054 . . . . 0.0 109.735 177.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 45.7 m-85 -90.71 131.92 36.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.02 . . . . 0.0 110.17 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.39 109.78 16.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.993 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.557 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 5.9 t -76.54 139.98 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.241 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.3 t -120.47 -24.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.121 -0.987 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 87.6 tttt -143.11 151.08 40.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.872 -1.143 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.512 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 39.2 p -141.6 154.62 45.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.626 -0.672 . . . . 0.0 109.626 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.692 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.5 -33.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 111.235 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 26.5 Cg_exo -55.54 -165.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.314 1.165 . . . . 0.0 110.165 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 8.6 t -88.64 40.94 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.8 mttt 59.99 18.76 7.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 158' ' ' SER . 16.3 m -106.32 160.28 26.79 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.508 -0.745 . . . . 0.0 109.813 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.554 ' HA ' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.71 122.24 9.37 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 124.024 1.539 . . . . 0.0 110.064 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 12.1 m -129.87 159.9 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.0 tt0 -108.15 128.55 54.8 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.219 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 126' ' ' ARG . 20.1 mm -72.22 153.74 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.68 -0.637 . . . . 0.0 110.425 -175.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.552 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.09 167.04 26.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -57.57 -20.07 29.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -1.088 . . . . 0.0 110.352 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -88.87 -14.0 37.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.246 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.539 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 64.1 m -60.41 141.7 56.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 86.5 mttt -96.05 145.92 25.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.04 . . . . 0.0 109.985 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.482 HD13 HG12 ' A' ' 120' ' ' VAL . 1.5 mt -125.21 157.85 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.192 -0.943 . . . . 0.0 110.853 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.489 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 21.6 mt-10 -131.76 133.56 44.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.651 -0.655 . . . . 0.0 110.114 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 172' ' ' ILE . 40.7 mm -115.07 131.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.598 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.469 ' HG2' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -86.91 149.6 24.69 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.137 -176.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 174' ' ' GLU . 85.5 tt0 -90.25 10.07 26.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.318 -0.864 . . . . 0.0 110.327 -174.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -122.08 74.57 38.79 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 174' ' ' GLU . 21.0 Cg_exo -64.64 -149.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.023 1.539 . . . . 0.0 110.418 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.465 ' HB1' HG22 ' A' ' 103' ' ' ILE . . . -73.73 53.11 0.43 Allowed 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.257 0.551 . . . . 0.0 110.237 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 25.5 t -107.36 113.86 27.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 178' ' ' SER . 81.0 tt0 60.0 19.74 8.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.6 t -101.74 112.44 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 110.105 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 182' ' ' GLU . 1.4 pt? -147.44 29.01 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 110.247 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 181' ' ' LEU . 99.1 mt-10 55.38 37.72 29.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -0.878 . . . . 0.0 110.118 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.07 -29.94 68.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.932 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.94 173.94 16.78 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.022 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.291 0.567 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -139.97 156.51 46.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.085 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 m -97.49 148.98 22.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -99.84 138.04 37.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 110.38 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -139.43 154.35 47.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 110.102 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -148.81 -161.75 9.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 39.1 pt -129.99 160.09 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -1.107 . . . . 0.0 109.43 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.9 mt -108.48 120.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.294 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 67' ' ' VAL . 2.6 pt? -144.48 -171.66 3.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.477 -0.765 . . . . 0.0 109.648 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 9.5 ptp85 -106.93 135.73 47.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.81 -1.181 . . . . 0.0 110.948 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.575 HG12 ' HB2' ' A' ' 83' ' ' ASP . 14.4 p -62.39 131.06 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.629 -0.669 . . . . 0.0 110.738 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -114.23 146.21 40.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.863 . . . . 0.0 110.561 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.2 tt0 -177.96 86.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.0 110.321 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.91 -26.93 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.902 . . . . 0.0 110.544 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -59.99 -49.06 79.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.094 -1.004 . . . . 0.0 110.51 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.408 ' OG ' ' HG2' ' A' ' 19' ' ' PRO . 87.5 p -154.95 151.28 28.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.347 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.2 p -118.44 -16.84 9.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 110.393 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.681 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -68.48 -35.75 7.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 111.302 -176.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 22.9 Cg_exo -60.3 -170.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.547 1.288 . . . . 0.0 110.666 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.511 ' N ' ' OD2' ' A' ' 70' ' ' ASP . . . 159.97 57.69 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.499 ' HG3' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -90.02 2.39 55.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -1.1 . . . . 0.0 110.032 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.46 39.89 27.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.368 -0.832 . . . . 0.0 110.346 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.499 ' CG ' ' HG3' ' A' ' 21' ' ' MET . 25.1 mmt85 -113.91 147.83 37.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.813 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.558 ' CG1' HG23 ' A' ' 67' ' ' VAL . 89.8 t -109.98 119.66 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.062 . . . . 0.0 110.347 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.506 ' HD3' ' HD2' ' A' ' 68' ' ' ARG . 1.1 ptm180 -100.56 121.25 41.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.92 -1.113 . . . . 0.0 110.135 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -134.06 176.8 8.25 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 25.9 p-10 -89.56 179.85 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.753 -1.217 . . . . 0.0 110.416 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -60.05 -40.21 88.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.362 -0.836 . . . . 0.0 109.169 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.506 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 22.9 t -70.0 -44.4 69.42 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.529 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.598 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.1 m -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.923 -1.111 . . . . 0.0 109.401 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 56.4 ttp85 -74.76 -43.04 56.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.694 -0.629 . . . . 0.0 111.623 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -88.77 -12.97 40.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 111.212 -170.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.598 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 1.2 pp -56.76 -32.63 65.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 109.505 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 12.7 mt -105.27 -75.01 0.64 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.189 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' A' ' 36' ' ' ALA . 13.0 t0 -170.12 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.637 . . . . 0.0 109.676 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.544 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -26.77 118.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.539 0.685 . . . . 0.0 111.264 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.56 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -104.96 177.32 4.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.81 123.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.93 -1.106 . . . . 0.0 109.86 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.03 29.06 59.41 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 32.8 m-20 -89.12 176.44 6.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.71 -1.465 . . . . 0.0 109.296 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.52 ' CG2' HG22 ' A' ' 92' ' ' THR . 89.8 t -99.32 129.25 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.074 -1.016 . . . . 0.0 110.373 -176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.465 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.3 m -119.58 147.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.791 . . . . 0.0 110.319 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.55 142.16 45.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.423 -0.798 . . . . 0.0 109.606 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.558 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 4.3 mp -114.23 148.04 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.036 -1.04 . . . . 0.0 110.22 -177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 89.1 tt0 -150.21 89.44 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.02 -1.05 . . . . 0.0 111.222 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.549 ' CG ' HG12 ' A' ' 85' ' ' VAL . 14.4 tmtt? -98.37 -66.39 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 173.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.588 HG23 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.05 -38.82 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.708 0.766 . . . . 0.0 109.162 177.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.582 ' CG ' ' HA ' ' A' ' 77' ' ' CYS . 19.7 ptp180 -142.38 -163.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.46 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -88.69 130.51 35.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 111.132 -174.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.543 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -130.69 162.59 29.1 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.246 0.546 . . . . 0.0 110.339 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.567 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -124.6 160.82 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.378 -0.826 . . . . 0.0 110.609 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.92 -179.73 48.71 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 62.0 mtp180 -111.03 175.2 5.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -1.205 . . . . 0.0 109.876 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.56 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -99.64 133.54 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.075 -1.016 . . . . 0.0 110.167 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -117.44 166.82 11.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 176.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 38.7 ptt180 -97.16 125.65 41.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.027 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -64.2 133.05 52.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.81 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.577 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.03 -46.85 99.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.986 174.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 23.7 Cg_endo -91.64 98.61 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.549 . . . . 0.0 109.028 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.04 33.81 0.09 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.595 -0.69 . . . . 0.0 110.91 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 59' ' ' PRO . 34.6 m-20 -147.53 -29.08 0.35 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.187 -0.945 . . . . 0.0 110.705 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.55 -28.43 26.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 37.8 m-80 -81.25 42.08 0.64 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.706 -0.621 . . . . 0.0 110.284 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 35.6 tttt -98.42 9.38 43.25 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.278 -0.889 . . . . 0.0 109.582 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.64 26.47 0.05 OUTLIER Glycine 0 N--CA 1.482 1.724 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 176.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.438 HG22 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -140.12 142.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.273 -1.133 . . . . 0.0 109.448 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.558 HG23 ' CG1' ' A' ' 24' ' ' VAL . 12.7 p -120.05 119.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.666 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 77.7 mtt180 -90.08 111.14 22.15 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.447 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 1.1 pt -127.69 161.3 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.608 -0.682 . . . . 0.0 110.355 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.511 ' OD2' ' N ' ' A' ' 20' ' ' GLY . 90.0 m-20 -80.01 169.59 17.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.522 -0.736 . . . . 0.0 109.795 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 80.0 p -62.39 -16.03 52.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.2 -49.2 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 110.363 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.422 ' HB3' ' HE3' ' A' ' 73' ' ' MET . 97.8 mmm -63.73 -40.13 95.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 0.0 109.361 176.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttp180 -60.32 -42.19 95.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 109.997 173.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -70.23 -33.56 71.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.235 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -60.11 -40.0 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.582 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 31.7 p -99.06 -39.38 8.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.021 -1.049 . . . . 0.0 110.694 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.588 ' CA ' HG23 ' A' ' 47' ' ' VAL . . . 114.75 47.85 0.56 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -122.87 168.54 12.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.071 -1.252 . . . . 0.0 110.75 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.526 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.93 170.93 8.11 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -58.09 140.11 16.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.925 -1.109 . . . . 0.0 110.644 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.523 ' N ' HG11 ' A' ' 11' ' ' VAL . . . 76.61 -0.29 65.48 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 172.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.575 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -58.55 -160.81 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.032 -1.275 . . . . 0.0 110.211 175.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.3 pttt -130.02 115.54 17.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 109.809 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.549 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.4 m -123.04 157.65 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.0 ttpt -110.04 120.44 42.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 110.005 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.492 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 69.1 t -99.63 123.81 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.893 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 38.3 mtp85 -109.98 157.75 18.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.791 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -102.26 138.42 39.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 110.153 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 m -150.12 -169.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.443 -0.786 . . . . 0.0 110.324 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -127.48 172.81 10.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.629 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.52 HG22 ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.04 163.23 12.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 111.086 -176.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -150.01 168.11 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 mm -89.64 99.81 9.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.556 -1.34 . . . . 0.0 110.466 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.531 ' CB ' HG22 ' A' ' 162' ' ' VAL . . . -57.2 136.62 56.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 110.226 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.552 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 6.2 pttt -106.05 -24.21 12.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.074 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.462 ' HE2' ' OE1' ' A' ' 171' ' ' GLU . 83.3 tttt -147.0 119.92 8.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.904 -1.123 . . . . 0.0 110.434 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.47 HG23 HG22 ' A' ' 155' ' ' THR . 8.2 p -138.09 140.28 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 110.492 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.515 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.4 m -117.97 135.81 53.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -0.885 . . . . 0.0 110.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -141.27 167.74 21.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -178.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 151' ' ' LYS . . . -132.94 103.12 13.1 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.384 -0.822 . . . . 0.0 110.562 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.4 Cg_exo -65.35 120.2 7.37 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.106 1.582 . . . . 0.0 110.132 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 81.3 mt -89.72 95.96 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.038 . . . . 0.0 110.249 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.515 HD13 ' CD1' ' A' ' 110' ' ' LEU . 15.0 pt -150.32 -164.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.29 -0.881 . . . . 0.0 110.744 178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.536 ' HB3' ' NH1' ' A' ' 105' ' ' ARG . 6.7 mmm180 -90.4 148.1 23.02 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.81 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -60.0 -14.51 16.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 0.0 110.241 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 36.1 p-10 -122.53 37.78 4.31 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.841 -0.537 . . . . 0.0 110.257 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.528 ' HG2' ' HB2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -86.77 -163.2 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.223 -0.923 . . . . 0.0 110.241 -178.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -88.95 -25.16 22.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.024 -1.048 . . . . 0.0 110.956 -173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.515 ' CD1' HD13 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -99.78 57.37 1.0 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.053 -1.029 . . . . 0.0 110.46 -177.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.505 ' HD2' ' O ' ' A' ' 108' ' ' GLN . 0.2 OUTLIER -139.91 129.95 24.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.154 -0.966 . . . . 0.0 109.64 173.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -143.75 -86.44 0.13 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.411 -0.806 . . . . 0.0 110.131 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 115' ' ' GLY . . . 170.92 -159.79 32.01 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.147 -175.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -43.87 82.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.102 -0.646 . . . . 0.0 110.949 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 113' ' ' GLY . . . 161.71 -32.36 0.34 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -170.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 8.5 tp -59.98 -39.02 79.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.757 -0.849 . . . . 0.0 109.565 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.492 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 95.0 mt-10 -60.08 -43.92 95.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 109.831 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.68 -35.57 78.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -38.3 82.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.385 -0.822 . . . . 0.0 109.817 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.549 ' CG1' HD12 ' A' ' 170' ' ' ILE . 62.4 t -60.03 -49.02 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.673 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.637 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 5.3 mt-30 -60.06 -41.17 91.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.872 . . . . 0.0 110.045 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -60.05 -39.99 87.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 110.444 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.97 -41.2 19.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 127' ' ' ARG . 52.3 mt -95.27 -3.43 47.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.059 -1.025 . . . . 0.0 110.972 -173.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.637 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.7 tt -43.43 163.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -174.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 164' ' ' ILE . 34.0 ptt180 33.84 49.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.492 -0.755 . . . . 0.0 111.371 -177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 10.8 ttt85 -132.11 143.34 48.53 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.966 -1.084 . . . . 0.0 111.105 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.763 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 17.4 Cg_endo -63.76 127.24 19.17 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.062 1.559 . . . . 0.0 109.811 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.548 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 93.4 mmm -123.52 140.02 53.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.402 -1.436 . . . . 0.0 110.926 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.504 ' CD2' ' O ' ' A' ' 49' ' ' LYS . 19.1 tp -139.59 112.37 7.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.577 -0.702 . . . . 0.0 109.7 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.0 pt-20 -46.68 142.05 3.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.012 -1.055 . . . . 0.0 110.435 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 85.4 mm-40 82.43 -2.74 1.41 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.228 0.537 . . . . 0.0 110.42 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.52 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 3.6 p-10 -70.21 -178.96 1.8 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 110.115 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.547 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 14.8 m-80 -148.29 129.54 14.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 1.3 mt -139.96 162.26 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.086 . . . . 0.0 110.718 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.0 t -140.97 147.4 38.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.459 -0.775 . . . . 0.0 110.251 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.575 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 11.4 t -106.61 -62.91 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.575 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 39.1 Cg_endo -71.82 153.37 58.8 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.286 1.15 . . . . 0.0 110.524 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -113.16 52.93 0.61 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.564 ' CD2' ' C ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -141.71 160.89 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -1.155 . . . . 0.0 110.457 -178.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -144.89 -165.46 2.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.444 -177.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.573 ' N ' ' OG1' ' A' ' 141' ' ' THR . 85.1 mt -130.54 -125.06 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.618 -0.676 . . . . 0.0 109.919 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.01 -157.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.31 55.79 4.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 142' ' ' LEU . 14.5 pt20 -97.43 161.68 13.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.475 -1.015 . . . . 0.0 110.216 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -137.48 151.48 48.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 110.112 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 118.19 -91.35 0.52 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 0.4 OUTLIER 41.49 44.28 2.47 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.322 -1.105 . . . . 0.0 111.016 177.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 3.6 pp -140.23 169.96 16.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.019 -1.05 . . . . 0.0 109.921 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 28.2 m-85 -91.57 125.89 36.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 110.067 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.547 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 21.2 tptm -99.92 106.72 18.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.52 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 2.1 t -79.37 134.37 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -0.965 . . . . 0.0 109.898 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.98 -23.19 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.157 -0.964 . . . . 0.0 110.737 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 8.6 tptp -140.2 127.12 20.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.85 -1.156 . . . . 0.0 110.609 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.538 HG21 ' CB ' ' A' ' 131' ' ' GLU . 33.8 p -126.79 170.01 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.586 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -88.82 -41.56 0.45 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.531 -178.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 16.4 Cg_exo -61.75 -176.3 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.631 1.332 . . . . 0.0 110.179 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -90.25 -156.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.964 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -71.77 -2.58 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.271 -0.893 . . . . 0.0 110.38 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.87 138.7 32.96 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.374 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.567 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.99 142.38 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.224 1.644 . . . . 0.0 110.51 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.763 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 10.8 m -129.92 159.47 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 109.516 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.2 tt0 -106.17 127.2 53.04 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.138 -0.976 . . . . 0.0 110.063 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.548 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 12.2 mm -69.73 156.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.624 -0.673 . . . . 0.0 109.862 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.428 ' N ' HG22 ' A' ' 164' ' ' ILE . . . -144.01 166.65 27.02 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.61 -24.42 21.31 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.437 -1.037 . . . . 0.0 109.993 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -88.55 -16.92 31.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.588 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.572 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 80.3 m -56.82 153.13 11.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.0 109.989 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 68.4 mttm -100.7 152.94 19.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 110.032 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.598 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 19.7 mm -114.65 131.56 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 110.927 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.515 ' CB ' ' OG1' ' A' ' 99' ' ' THR . 23.6 mt-10 -114.24 129.55 56.63 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.162 -0.962 . . . . 0.0 110.109 170.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 171' ' ' GLU . 38.1 mm -130.92 140.0 49.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.042 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.474 ' NE ' ' HB3' ' A' ' 175' ' ' GLU . 7.8 ptm180 -88.03 173.79 8.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' A' ' 174' ' ' GLU . 58.5 mp0 -111.31 -2.46 15.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -0.956 . . . . 0.0 110.779 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . 8.6 tt0 -99.41 107.93 47.7 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 110.336 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 11.9 Cg_exo -72.3 -154.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.089 1.573 . . . . 0.0 110.018 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.73 53.66 0.45 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.554 -0.716 . . . . 0.0 109.993 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.524 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 20.1 t -81.1 125.05 29.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.313 -0.867 . . . . 0.0 109.782 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 178' ' ' SER . 90.4 mt-10 60.05 19.9 9.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.435 -0.791 . . . . 0.0 109.982 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.59 ' O ' ' C ' ' A' ' 181' ' ' LEU . 62.3 t -109.96 120.02 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.59 ' C ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER 15.73 72.37 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.273 0.559 . . . . 0.0 111.747 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -140.71 160.25 40.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.864 . . . . 0.0 110.096 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -59.93 -30.08 68.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.144 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.28 -176.27 40.51 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.618 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.268 0.556 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.99 -39.97 87.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.204 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 m -98.05 144.76 27.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.223 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -129.6 163.45 25.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.027 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -127.16 160.37 31.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.965 . . . . 0.0 110.602 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.13 -163.99 10.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.487 HG22 ' CD1' ' A' ' 34' ' ' LEU . 34.8 pt -137.56 158.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -1.186 . . . . 0.0 110.096 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.6 mt -102.21 115.55 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.15 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.6 pt? -140.0 -171.86 3.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.791 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.2 ptt180 -111.4 140.57 45.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.829 -1.169 . . . . 0.0 110.797 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 80' ' ' SER . 11.7 p -61.75 136.23 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 110.58 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -115.99 152.17 34.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.172 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.502 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 85.5 tt0 -175.27 114.42 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 15' ' ' ASN . . . -100.02 3.43 44.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.146 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 28.3 m120 58.4 32.06 21.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.41 -0.806 . . . . 0.0 110.338 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 17' ' ' THR . 46.4 t -68.89 -47.98 64.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 65.2 p -140.03 151.83 45.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.152 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.69 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -76.05 -33.19 1.23 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.922 . . . . 0.0 111.52 -177.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 14.5 Cg_exo -65.52 159.02 49.93 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.347 1.183 . . . . 0.0 110.605 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.79 39.34 4.66 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.37 2.24 54.69 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.305 -1.115 . . . . 0.0 109.438 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.4 p -135.19 15.02 3.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.0 110.51 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 96.2 mtt180 -119.95 140.04 51.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.136 -0.978 . . . . 0.0 110.38 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.501 HG13 ' CG2' ' A' ' 67' ' ' VAL . 67.0 t -113.21 120.61 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.283 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -95.09 120.54 35.48 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.467 175.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD21 ' CB ' ' A' ' 30' ' ' SER . 3.6 mt -134.93 171.32 14.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.554 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 5.3 p-10 -89.02 170.42 10.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.335 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.479 ' HA ' ' NH1' ' A' ' 31' ' ' ARG . 46.7 mt-10 -56.16 -40.03 73.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.95 . . . . 0.0 109.019 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.602 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 5.2 t -65.29 -58.81 5.01 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.213 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.557 ' CB ' HD21 ' A' ' 26' ' ' LEU . 61.7 m -49.6 -30.02 8.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.593 -1.317 . . . . 0.0 109.635 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.479 ' NH1' ' HA ' ' A' ' 28' ' ' GLU . 11.9 ttp-105 -81.0 -49.46 10.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 111.136 178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 32' ' ' ARG . 38.4 mtm105 -93.45 -14.36 26.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 0.0 111.43 -171.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.602 ' HB3' ' O ' ' A' ' 29' ' ' SER . 1.0 OUTLIER -60.84 -28.7 69.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.907 -1.121 . . . . 0.0 110.195 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 55.7 mt -103.66 -73.69 0.66 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.142 -0.974 . . . . 0.0 109.996 175.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 36' ' ' ALA . 30.4 t0 -168.65 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.451 0.643 . . . . 0.0 109.442 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -33.31 118.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.419 0.628 . . . . 0.0 110.961 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -104.42 175.92 5.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 38' ' ' ILE . 33.1 mm -60.0 123.95 13.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.908 -1.12 . . . . 0.0 109.785 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' H ' HG13 ' A' ' 54' ' ' VAL . . . 76.48 28.19 60.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 65.7 m-20 -89.29 171.07 10.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.703 -1.469 . . . . 0.0 109.503 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.458 HG12 HG22 ' A' ' 90' ' ' VAL . 73.7 t -99.15 129.95 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 0.0 110.06 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.436 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.7 m -118.21 144.71 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.388 -0.82 . . . . 0.0 110.358 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.0 tt0 -112.41 140.21 47.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.597 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.2 mp -122.74 143.97 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.041 -1.037 . . . . 0.0 110.395 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.8 tt0 -150.49 100.03 2.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.134 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 9.1 tmtm? -98.31 -66.99 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.017 . . . . 0.0 109.956 173.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.513 HG22 ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -101.63 -34.54 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.388 174.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 90.0 mtt-85 -134.59 -179.68 5.74 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.5 -0.75 . . . . 0.0 109.486 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HD3' ' OE2' ' A' ' 43' ' ' GLU . 24.3 mttp -89.19 141.87 28.14 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.181 -0.95 . . . . 0.0 110.843 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.597 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 9.3 p -143.41 169.98 16.65 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.471 0.653 . . . . 0.0 109.901 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.42 167.35 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.447 -0.783 . . . . 0.0 110.079 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.436 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.41 -172.36 41.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -122.78 164.56 18.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -1.137 . . . . 0.0 110.329 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.507 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -96.81 137.69 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 110.419 -173.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.49 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.6 m-85 -128.12 165.53 20.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.493 -0.754 . . . . 0.0 110.262 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -89.73 122.68 33.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.972 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -62.29 134.1 56.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.562 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -57.8 -48.75 96.61 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.031 174.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 36.3 Cg_endo -92.42 98.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.91 1.479 . . . . 0.0 109.013 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.53 36.32 0.09 Allowed 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.527 -0.733 . . . . 0.0 110.692 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 59' ' ' PRO . 70.7 m-20 -143.67 -30.62 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.157 -0.965 . . . . 0.0 110.446 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 66' ' ' ILE . 21.1 mt-10 -87.14 -28.28 22.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 0.0 109.27 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.487 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 23.6 m120 -81.13 40.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.758 -0.589 . . . . 0.0 110.492 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 4.82 47.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.22 30.18 0.07 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 62' ' ' GLU . 46.3 pt -140.62 146.96 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.518 -0.989 . . . . 0.0 109.257 174.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.507 ' N ' HD13 ' A' ' 9' ' ' LEU . 2.7 p -120.01 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.783 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.496 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 15.2 tpp180 -90.09 110.28 21.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.126 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.538 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.5 pt -130.82 166.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 110.516 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 18' ' ' ASP . 11.5 t70 -80.02 171.1 15.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -63.91 -21.94 66.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.77 -49.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.512 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 1.3 mmt -60.72 -43.28 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 66.0 ttp85 -59.99 -40.53 89.49 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.925 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -70.38 -29.0 65.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.34 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 98.5 m-20 -59.97 -39.15 84.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 26.9 p -98.14 -37.76 9.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 110.51 -175.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.513 ' CA ' HG23 ' A' ' 47' ' ' VAL . . . 115.56 35.38 1.3 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.526 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -113.08 165.24 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.095 -1.238 . . . . 0.0 110.54 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.555 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.43 170.62 8.11 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.358 -0.839 . . . . 0.0 109.339 178.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.541 ' HA ' HG12 ' A' ' 11' ' ' VAL . 0.8 OUTLIER -53.41 141.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.929 -1.107 . . . . 0.0 110.382 178.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.515 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 75.42 1.55 65.44 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 172.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.55 ' HB2' HG11 ' A' ' 11' ' ' VAL . 1.8 m-20 -59.51 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.853 -1.381 . . . . 0.0 110.572 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.2 pttt -132.89 108.81 9.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 1.1 m -121.22 153.0 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.5 tttt -103.08 124.74 49.12 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.481 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 73.2 t -107.21 123.97 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.799 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.529 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.5 mtt180 -113.65 136.89 52.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.548 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.542 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 27.5 tttt -72.24 143.53 48.76 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.952 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 41' ' ' VAL . 1.9 m -148.07 -169.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 109.832 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 174.32 10.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.698 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.55 159.24 17.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.967 -1.083 . . . . 0.0 111.229 -174.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.46 ' CG ' HG11 ' A' ' 162' ' ' VAL . 16.9 pt-20 -150.34 176.38 10.95 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.2 mm -93.18 99.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.341 -1.474 . . . . 0.0 110.867 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -56.67 139.79 49.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 0.0 110.297 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.569 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.97 -27.18 10.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 111.147 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.569 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 79.0 tttt -150.0 124.77 9.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.838 -1.163 . . . . 0.0 110.283 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.52 ' CG2' HG21 ' A' ' 155' ' ' THR . 9.1 p -138.92 148.97 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.512 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 88.9 m -120.03 130.69 54.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.819 . . . . 0.0 109.762 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -136.43 169.22 18.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.767 -176.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.487 ' HB3' ' CD ' ' A' ' 173' ' ' ARG . . . -130.42 88.82 46.18 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.863 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.518 ' CD ' HG22 ' A' ' 172' ' ' ILE . 17.3 Cg_exo -61.66 124.34 14.41 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.125 1.592 . . . . 0.0 110.385 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.434 HG23 ' CB ' ' A' ' 177' ' ' ALA . 71.7 mt -97.61 106.35 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 110.314 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -150.99 -164.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 110.551 178.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 104' ' ' ILE . 27.1 mmm180 -88.52 158.87 18.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.475 -0.765 . . . . 0.0 109.984 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -57.71 -15.81 9.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.99 -1.069 . . . . 0.0 110.739 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -124.86 27.83 6.66 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.603 -0.686 . . . . 0.0 110.387 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.527 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 2.0 mm-40 -94.54 -80.09 0.41 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.062 -1.024 . . . . 0.0 110.542 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.401 ' NH2' ' HB3' ' A' ' 102' ' ' PRO . 36.5 ttp180 -113.39 -20.31 11.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 111.017 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -97.74 41.93 1.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.904 -1.122 . . . . 0.0 110.636 -174.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.93 62.81 1.59 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.252 -0.905 . . . . 0.0 110.495 174.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -146.52 -58.24 0.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.995 -1.066 . . . . 0.0 110.442 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.63 177.86 42.3 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 49.0 95.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.164 -1.198 . . . . 0.0 110.071 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.54 -9.92 73.86 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 9.7 tp -62.42 -43.04 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -1.185 . . . . 0.0 110.103 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.52 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 47.0 mt-10 -69.91 -40.11 75.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.07 -30.85 71.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -59.99 -40.88 90.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.538 ' HB ' HG23 ' A' ' 170' ' ' ILE . 44.7 t -61.17 -43.37 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.613 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 4.6 mt-30 -60.07 -44.52 94.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.116 -0.99 . . . . 0.0 110.114 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -60.01 -46.7 88.62 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.526 -0.734 . . . . 0.0 109.837 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 124' ' ' LEU . . . -73.66 -42.47 61.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.614 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.6 mm? -98.56 6.9 46.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 0.9 OUTLIER -48.67 166.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 120.77 -1.206 . . . . 0.0 109.735 -177.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 164' ' ' ILE . 32.9 ptt180 33.01 45.14 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.465 -0.772 . . . . 0.0 111.412 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.499 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -127.26 138.53 32.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.805 -1.185 . . . . 0.0 111.113 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.801 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 9.3 Cg_endo -57.51 129.06 31.92 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 124.031 1.543 . . . . 0.0 110.176 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.548 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.6 mmm -125.96 137.82 53.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.601 -1.312 . . . . 0.0 110.608 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.516 ' CD2' ' CA ' ' A' ' 50' ' ' THR . 12.7 tp -137.48 115.01 11.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pt-20 -48.78 143.63 5.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.981 -1.075 . . . . 0.0 110.655 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.04 -10.63 0.9 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.366 0.603 . . . . 0.0 110.374 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.536 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -70.38 178.3 2.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 176.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.553 ' OD1' ' CG ' ' A' ' 151' ' ' LYS . 1.1 m-80 -148.64 129.4 14.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.326 -0.859 . . . . 0.0 109.124 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.683 ' HB ' ' CE1' ' A' ' 150' ' ' PHE . 1.6 mt -140.05 164.85 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.211 -1.396 . . . . 0.0 111.459 -173.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 149' ' ' LEU . 10.2 t -138.13 149.97 46.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.721 -0.612 . . . . 0.0 109.822 175.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.614 ' CG1' ' CD ' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -99.98 -171.81 0.25 Allowed Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.614 ' CD ' ' CG1' ' A' ' 137' ' ' VAL . 1.9 Cg_endo -69.25 58.06 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.148 1.078 . . . . 0.0 109.907 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . -115.61 108.38 1.87 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pp -87.64 144.5 26.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -1.085 . . . . 0.0 109.843 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.6 OUTLIER -65.45 -166.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 111.054 -171.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.564 ' N ' ' OG1' ' A' ' 141' ' ' THR . 77.3 mt -140.1 -109.95 0.15 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.84 -0.538 . . . . 0.0 109.631 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.74 -155.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.156 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.34 55.89 4.97 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -98.89 162.56 13.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.361 -1.082 . . . . 0.0 110.259 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.9 t -139.9 155.89 46.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 110.232 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.486 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 112.17 -86.53 0.43 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 40.04 26.11 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.32 -1.106 . . . . 0.0 111.474 177.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 3.3 pp -140.43 166.11 25.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.894 -1.129 . . . . 0.0 108.866 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.683 ' CE1' ' HB ' ' A' ' 135' ' ' ILE . 7.4 p90 -113.17 140.39 47.96 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.244 -1.382 . . . . 0.0 111.169 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.553 ' CG ' ' OD1' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -100.32 113.88 26.93 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.829 -0.544 . . . . 0.0 109.737 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.536 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -76.1 135.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.684 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.9 t -123.58 -26.7 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 110.697 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -144.38 131.6 20.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 110.443 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.52 HG21 ' CG2' ' A' ' 98' ' ' VAL . 37.3 p -130.0 169.38 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 109.775 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.644 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.04 -39.88 0.44 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.822 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 16.0 Cg_exo -61.52 -175.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.583 1.307 . . . . 0.0 110.727 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.1 t -90.5 -163.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.81 . . . . 0.0 110.258 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -68.11 -6.43 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 160' ' ' VAL . 27.4 m -86.64 141.68 34.22 Favored Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.388 -0.82 . . . . 0.0 110.125 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.556 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.93 144.69 11.4 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.177 1.619 . . . . 0.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.801 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 10.9 m -129.91 159.27 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.089 -1.007 . . . . 0.0 109.545 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 67.4 tt0 -107.36 127.66 53.77 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.27 -0.894 . . . . 0.0 109.957 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.548 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 9.1 mm -69.36 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.917 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -140.9 167.66 25.56 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HA ' HD13 ' A' ' 125' ' ' ILE . 20.6 pt-20 -57.44 -21.19 35.27 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.416 -1.05 . . . . 0.0 110.32 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.55 -17.72 26.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 110.74 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.555 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 30.2 m -57.59 156.72 7.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.906 . . . . 0.0 110.364 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -103.97 154.53 19.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 110.277 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.613 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 2.1 mm -120.0 129.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.772 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.512 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 53.4 mt-10 -117.83 130.02 56.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.12 -0.988 . . . . 0.0 110.419 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.518 HG22 ' CD ' ' A' ' 102' ' ' PRO . 37.1 mt -135.62 135.22 51.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.309 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' HB3' ' A' ' 101' ' ' ALA . 13.1 ptp180 -88.82 164.98 14.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.276 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.479 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 98.3 mt-10 -98.83 11.5 38.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.71 109.72 45.23 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.955 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 14.7 Cg_exo -71.01 -154.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.159 1.61 . . . . 0.0 110.696 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.434 ' CB ' HG23 ' A' ' 103' ' ' ILE . . . -69.53 53.21 0.11 Allowed 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.727 -0.608 . . . . 0.0 110.17 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 82.0 p -83.03 120.45 25.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.301 -0.874 . . . . 0.0 110.18 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 178' ' ' SER . 83.8 tt0 60.06 18.72 7.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.364 -0.835 . . . . 0.0 110.422 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 92.1 t -92.75 4.29 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.362 -0.836 . . . . 0.0 110.03 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.07 66.81 1.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 0.0 110.186 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -148.44 160.57 42.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.275 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.0 139.98 57.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.291 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.428 ' O ' ' OXT' ' A' ' 185' ' ' GLY . . . 90.05 -2.19 81.31 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.428 ' OXT' ' O ' ' A' ' 184' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 118.025 -1.43 . . . . 0.0 109.551 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mtp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.257 0.551 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 4' ' ' ASN . 85.8 tt0 -59.94 -40.06 87.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.03 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m 51.86 49.9 19.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.285 -0.885 . . . . 0.0 110.301 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.402 ' HB2' ' HG2' ' A' ' 2' ' ' GLU . 11.4 t-20 -93.5 120.19 33.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -148.14 -170.74 3.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.961 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 88' ' ' ARG . . . -147.41 -159.74 8.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.481 ' CD1' HD22 ' A' ' 33' ' ' LEU . 43.6 pt -139.58 152.05 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -1.141 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 96.7 mt -97.42 119.67 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.797 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.2 pt? -135.91 -168.34 2.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.291 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.558 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 26.4 ttm105 -106.03 130.66 53.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 111.059 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 82' ' ' GLY . 14.4 p -61.65 139.02 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.379 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.6 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -120.24 153.55 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.487 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.5 tt0 -176.43 148.47 0.75 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.321 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.38 159.98 35.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.837 . . . . 0.0 110.341 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -52.08 -27.0 12.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 60.2 p -59.95 159.87 8.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.172 -0.955 . . . . 0.0 110.061 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 18' ' ' ASP . 82.0 p -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.935 . . . . 0.0 110.39 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 4.7 p-10 36.44 59.97 3.36 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.457 -0.777 . . . . 0.0 110.54 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 17.3 Cg_exo -62.0 167.4 10.66 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.915 1.482 . . . . 0.0 110.55 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.7 83.33 1.67 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.455 ' HE2' HG11 ' A' ' 72' ' ' VAL . 23.7 ptm -89.79 -10.01 47.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.303 -1.116 . . . . 0.0 110.107 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.1 p -99.39 1.89 44.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.604 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 84.2 mtt85 -110.84 129.47 55.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.461 -0.774 . . . . 0.0 109.909 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 55' ' ' TYR . 77.4 t -109.98 115.43 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.011 -1.056 . . . . 0.0 109.987 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.519 ' HD2' ' HD2' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -88.09 117.4 26.94 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.683 178.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.11 172.64 11.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 109.551 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 7.0 p-10 -92.76 176.64 6.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.863 -1.148 . . . . 0.0 110.022 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -40.06 87.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.449 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.575 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.5 t -69.51 -44.98 69.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 110.57 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.614 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.7 m -59.98 -39.99 87.6 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.102 -0.999 . . . . 0.0 109.608 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.444 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 36.9 ttp180 -74.7 -43.4 55.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.772 -0.58 . . . . 0.0 111.444 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -91.41 -11.53 37.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.821 -1.174 . . . . 0.0 111.201 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.614 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 1.3 pp -58.65 -32.88 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.855 -1.153 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 13.0 mt -105.21 -74.07 0.66 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.927 . . . . 0.0 110.316 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 45.6 t0 -170.16 -24.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.559 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -24.61 119.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.557 0.694 . . . . 0.0 111.407 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 1.1 pt-20 -105.69 175.14 5.59 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.2 mm -58.16 120.75 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.917 -1.114 . . . . 0.0 109.813 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.72 33.82 54.78 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.2 m-20 -89.11 177.1 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.458 . . . . 0.0 109.477 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 92' ' ' THR . 70.6 t -99.08 121.64 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.09 . . . . 0.0 110.166 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 54' ' ' VAL . 1.5 m -116.8 139.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.489 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.8 141.36 38.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 109.863 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.711 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 2.1 mp -120.48 146.63 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.013 -1.054 . . . . 0.0 110.296 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.0 tt0 -150.95 97.16 2.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.961 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.541 ' CG ' HG13 ' A' ' 85' ' ' VAL . 1.7 tmtt? -98.41 -67.36 0.85 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.825 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.536 HG23 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.01 -35.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.16 174.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 71.9 mtt85 -135.46 -178.74 5.25 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.776 -0.578 . . . . 0.0 109.571 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.504 ' O ' HD21 ' A' ' 130' ' ' LEU . 28.0 mttt -89.04 137.14 32.58 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.655 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.711 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 10.9 p -140.56 166.78 23.8 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.394 0.616 . . . . 0.0 109.834 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -122.98 166.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.448 -0.782 . . . . 0.0 110.196 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 42' ' ' VAL . . . -178.99 -169.54 39.73 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -129.94 162.8 27.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.186 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -89.03 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 0.0 110.426 -173.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.604 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 2.2 m-85 -134.68 166.31 23.23 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.504 -0.747 . . . . 0.0 110.251 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 51.9 ptt85 -90.69 128.36 36.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -65.9 139.98 58.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.577 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -54.74 -49.58 90.73 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.881 -1.137 . . . . 0.0 108.868 175.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.4 Cg_endo -92.71 98.79 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.904 1.476 . . . . 0.0 108.893 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.47 34.37 0.08 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.41 -0.806 . . . . 0.0 110.918 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 59' ' ' PRO . 54.6 t0 -146.26 -27.51 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 110.769 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -86.12 -28.2 24.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.258 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.492 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 33.6 m-80 -81.75 43.56 0.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.676 -0.64 . . . . 0.0 110.312 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 30.3 pttt -97.43 8.96 43.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.404 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.88 27.13 0.05 OUTLIER Glycine 0 N--CA 1.479 1.541 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.492 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 43.5 pt -140.24 142.87 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -1.083 . . . . 0.0 109.4 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 67' ' ' VAL . 3.1 p -119.94 121.12 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.005 -1.059 . . . . 0.0 110.058 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.6 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 97.3 mtt180 -89.87 116.02 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.5 pt -126.75 171.72 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.66 -0.65 . . . . 0.0 110.645 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -80.01 168.05 19.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.881 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 m -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.316 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.506 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.5 t -62.82 -43.62 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -60.0 -46.52 89.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.628 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HB3' ' NH1' ' A' ' 74' ' ' ARG . 6.4 ttp-105 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.554 174.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -69.99 -23.84 63.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.483 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 4.2 m120 -60.07 -39.1 84.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.08 -1.013 . . . . 0.0 110.352 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 31.4 p -98.27 -35.03 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.047 -1.033 . . . . 0.0 110.532 -175.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.536 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 112.47 26.63 4.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -103.46 169.97 8.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -1.166 . . . . 0.0 110.309 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.47 178.73 4.2 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 178.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.489 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -64.74 141.25 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.388 177.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.558 ' HA2' ' CG ' ' A' ' 10' ' ' ARG . . . 78.69 -3.85 62.58 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 172.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.518 ' HB2' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -57.3 -167.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.98 -1.306 . . . . 0.0 110.098 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 50.7 pttt -127.01 114.65 18.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.12 -0.987 . . . . 0.0 109.748 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.541 HG13 ' CG ' ' A' ' 46' ' ' LYS . 1.1 m -119.33 155.57 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 83.6 tttt -105.61 125.44 50.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.459 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 76.0 t -106.85 121.4 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.497 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 41.3 mtm180 -110.63 135.61 51.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 19.4 tttt -83.81 138.64 33.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.3 m -150.04 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.088 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -126.48 168.99 13.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.907 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.536 ' CG2' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.73 163.47 12.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.093 -1.005 . . . . 0.0 111.05 -175.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' OE2' HG23 ' A' ' 160' ' ' VAL . 12.5 pt-20 -150.08 169.46 21.21 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.62 100.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.53 ' CB ' HG22 ' A' ' 162' ' ' VAL . . . -56.85 138.19 53.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.29 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 169' ' ' LYS . 16.9 ptpt -96.66 -29.34 13.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 110.981 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 169' ' ' LYS . 16.1 tttp -150.66 124.63 9.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.731 -1.231 . . . . 0.0 110.842 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.45 HG12 HG12 ' A' ' 170' ' ' ILE . 5.4 p -134.34 142.05 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 0.0 110.653 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 86.8 m -118.54 141.7 48.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.329 -0.857 . . . . 0.0 110.109 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -139.24 169.79 17.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.709 -178.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.562 ' CB ' ' HD2' ' A' ' 173' ' ' ARG . . . -141.12 99.7 6.53 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.615 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.49 ' HB3' ' CD1' ' A' ' 110' ' ' LEU . 22.6 Cg_exo -60.33 125.98 18.86 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.878 1.462 . . . . 0.0 110.17 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.546 HD11 ' CD1' ' A' ' 149' ' ' LEU . 83.4 mt -91.95 106.38 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -0.957 . . . . 0.0 110.821 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 108' ' ' GLN . 1.9 pt -150.52 -173.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 82.4 mtp180 -140.66 -135.55 0.11 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.516 -0.74 . . . . 0.0 109.848 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -59.88 -13.56 11.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.89 -1.131 . . . . 0.0 109.48 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' OD2' ' HB2' ' A' ' 145' ' ' GLN . 54.2 p-10 -99.82 28.79 4.52 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.284 0.564 . . . . 0.0 109.833 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.597 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 12.8 pt20 -82.88 109.77 17.3 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.272 -0.893 . . . . 0.0 109.975 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.1 ttt85 -111.73 -13.46 13.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.619 -0.676 . . . . 0.0 110.123 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 102' ' ' PRO . 0.8 OUTLIER -99.22 52.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 110.023 -178.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.423 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -140.03 135.04 32.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.866 176.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' CD1' ' O ' ' A' ' 111' ' ' LYS . 10.0 m-85 -142.74 -40.04 0.33 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.961 . . . . 0.0 110.501 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 75.88 -176.23 51.3 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 113' ' ' GLY . 75.1 mm-40 41.46 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.169 -1.195 . . . . 0.0 109.994 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.15 -7.43 75.38 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.04 -35.9 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 110.127 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -59.98 -40.55 89.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.966 . . . . 0.0 109.693 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -68.69 -38.94 80.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 109.943 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -60.08 -39.99 88.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.251 -0.905 . . . . 0.0 109.341 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.549 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.8 t -67.02 -45.93 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 109.89 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.558 ' NE2' ' O ' ' A' ' 168' ' ' THR . 4.2 mt-30 -59.98 -44.41 94.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.97 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -60.07 -48.6 81.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.441 0.639 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.05 -40.1 75.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.46 -0.775 . . . . 0.0 110.535 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.607 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 3.9 mm? -97.53 -0.06 46.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.883 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.5 tt -47.3 166.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 110.171 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 164' ' ' ILE . 34.1 ptt180 33.08 46.68 0.1 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.659 -0.651 . . . . 0.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 7.6 mmt180 -129.79 150.42 75.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.676 -1.265 . . . . 0.0 111.192 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 22.2 Cg_endo -67.22 130.72 23.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 124.192 1.627 . . . . 0.0 109.876 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.528 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 87.8 mmm -127.13 137.58 53.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.556 -1.34 . . . . 0.0 111.077 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.521 ' CD2' ' CA ' ' A' ' 50' ' ' THR . 10.9 tp -140.21 113.67 8.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.622 -0.674 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -45.22 146.68 0.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.172 . . . . 0.0 110.394 -176.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.85 -0.53 3.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.741 -0.599 . . . . 0.0 110.627 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 3.2 p30 -69.91 -176.19 1.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.054 174.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 17.1 m-80 -145.94 150.06 35.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.592 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -134.34 170.35 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 t -136.44 165.82 24.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 0.0 110.57 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.583 ' CG1' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t -112.05 147.82 37.72 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.583 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 1.4 Cg_endo -46.55 177.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.856 1.45 . . . . 0.0 110.532 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.21 68.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.661 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -130.03 154.78 47.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -1.198 . . . . 0.0 111.03 179.271 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER 177.0 -167.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.039 . . . . 0.0 110.242 -178.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.542 ' N ' ' OG1' ' A' ' 141' ' ' THR . 0.5 OUTLIER -146.07 -122.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.522 -0.736 . . . . 0.0 109.847 178.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.514 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -52.88 -161.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 109.973 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.0 79.99 1.54 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.501 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 1.9 pt20 -94.89 165.17 12.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.384 -1.069 . . . . 0.0 110.096 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -140.03 153.76 46.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.418 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.54 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 80.18 -90.48 1.31 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.56 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 0.4 OUTLIER 42.47 48.54 4.56 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.541 -0.976 . . . . 0.0 110.832 176.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.546 ' CD1' HD11 ' A' ' 103' ' ' ILE . 2.6 pp -137.14 164.44 28.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.995 -1.066 . . . . 0.0 109.585 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -91.58 137.7 32.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.112 -0.993 . . . . 0.0 110.247 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -122.39 101.9 7.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.603 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.503 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 2.3 t -77.47 138.79 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.68 -21.94 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 111.09 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.526 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 10.5 tptm -139.84 129.83 24.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.678 -1.264 . . . . 0.0 110.965 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.451 HG22 ' CA ' ' A' ' 131' ' ' GLU . 66.7 p -130.49 164.59 24.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.244 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.666 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.29 -36.67 0.42 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 110.916 -176.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 31.4 Cg_exo -53.1 -174.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.363 1.191 . . . . 0.0 110.401 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 4.9 t -86.84 41.44 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.28 -0.887 . . . . 0.0 110.264 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 158' ' ' SER . 40.7 mmtm 61.41 19.56 10.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.747 . . . . 0.0 109.901 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 158' ' ' SER . 23.5 m -102.29 159.92 27.9 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.392 -0.818 . . . . 0.0 109.712 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.547 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 5.4 Cg_endo -53.81 119.66 6.61 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.059 1.557 . . . . 0.0 110.217 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 5.2 m -126.61 158.3 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -104.56 128.71 52.61 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.152 -0.967 . . . . 0.0 110.052 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 126' ' ' ARG . 12.8 mm -71.08 152.65 8.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.827 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.06 168.32 25.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.37 -20.87 21.34 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.975 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -90.99 -18.57 24.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 110.684 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.558 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 30.5 m -57.89 148.41 25.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 110.473 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 96' ' ' LYS . 49.6 mttp -96.35 147.19 24.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.004 . . . . 0.0 109.702 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.549 HD12 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mt -130.03 160.03 41.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.093 -1.004 . . . . 0.0 110.982 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.475 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 25.3 mt-10 -137.78 133.6 34.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.754 -0.591 . . . . 0.0 110.231 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.445 ' CD1' HD12 ' A' ' 100' ' ' LEU . 39.5 mm -120.02 120.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.341 -0.85 . . . . 0.0 109.39 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.562 ' HD2' ' CB ' ' A' ' 101' ' ' ALA . 4.7 ptp85 -93.5 163.8 13.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 110.439 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.9 mt-10 -101.83 13.08 35.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.852 . . . . 0.0 110.392 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.405 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . 1.3 tt0 -93.07 109.91 42.65 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.375 -0.828 . . . . 0.0 109.702 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.6 Cg_exo -71.9 -156.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.165 1.613 . . . . 0.0 110.68 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.438 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -80.46 52.96 1.73 Allowed 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.084 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 13.5 t -80.69 127.99 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.986 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 178' ' ' SER . 84.1 tt0 60.05 15.53 5.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.852 . . . . 0.0 110.404 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 63.1 t -117.96 123.78 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.206 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -141.63 79.85 1.7 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -0.95 . . . . 0.0 110.054 177.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -61.73 144.09 55.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.0 139.98 57.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.234 -0.916 . . . . 0.0 110.08 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 147.51 69.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.945 -1.475 . . . . 0.0 109.481 -179.465 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -120.23 140.29 51.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.902 . . . . 0.0 110.116 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -61.06 157.16 16.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.973 . . . . 0.0 110.25 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.402 ' OD1' ' CE ' ' A' ' 86' ' ' LYS . 65.0 t-20 -130.15 105.68 8.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 110.19 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -128.27 34.87 4.49 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.005 0.907 . . . . 0.0 109.836 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.11 -166.84 13.41 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.545 ' CG2' HD13 ' A' ' 33' ' ' LEU . 41.3 pt -131.89 160.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -1.138 . . . . 0.0 109.535 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.18 117.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.5 pt? -139.58 -172.39 3.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 33.1 ptt180 -111.12 140.51 45.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.597 -1.314 . . . . 0.0 110.93 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 11' ' ' VAL . 9.6 p -62.29 138.09 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.497 -0.752 . . . . 0.0 110.675 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.585 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -119.06 144.71 46.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 86.1 tt0 -179.0 100.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.524 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.4 -40.13 9.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 109.797 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -156.45 156.3 33.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.827 . . . . 0.0 109.711 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.55 165.77 25.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.601 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' ASP . 66.2 p -131.35 154.84 48.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.435 -0.79 . . . . 0.0 109.903 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' THR . 5.5 p-10 38.06 72.12 0.94 Allowed Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.516 -0.74 . . . . 0.0 109.92 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.83 151.31 33.3 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.325 1.697 . . . . 0.0 110.688 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.521 ' N ' ' OD2' ' A' ' 70' ' ' ASP . . . 95.44 40.04 4.3 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.494 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 25.0 ptp -89.47 -0.01 57.19 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.273 -1.133 . . . . 0.0 109.414 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 21' ' ' MET . 1.0 OUTLIER 42.74 45.86 4.26 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.392 -0.817 . . . . 0.0 110.438 176.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.585 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 80.8 mtt180 -136.41 141.77 43.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.115 -0.99 . . . . 0.0 110.56 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 55' ' ' TYR . 53.0 t -120.09 121.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.885 . . . . 0.0 110.303 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 1.8 ptt180 -91.27 120.71 32.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.7 -1.25 . . . . 0.0 109.881 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 1.2 mp -135.49 169.15 17.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 109.821 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.0 p-10 -94.48 -170.05 2.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.941 -1.1 . . . . 0.0 111.069 -175.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -0.76 . . . . 0.0 109.904 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.61 -43.66 93.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.752 . . . . 0.0 110.105 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.656 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 54.6 m -58.64 -32.14 68.79 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.464 -0.773 . . . . 0.0 109.44 177.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' C ' HD21 ' A' ' 33' ' ' LEU . 70.6 ttt180 -84.57 -44.31 13.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.704 -0.622 . . . . 0.0 110.887 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 33' ' ' LEU . 75.9 mtp85 -77.44 -11.14 59.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.171 -0.956 . . . . 0.0 110.127 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.656 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -40.87 -29.36 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.888 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.559 ' H ' HD23 ' A' ' 33' ' ' LEU . 84.0 mt -141.15 -61.44 0.48 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 110.107 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.9 t0 -169.62 -36.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.529 -0.732 . . . . 0.0 109.498 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . 9.99 114.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.263 0.554 . . . . 0.0 112.101 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.84 173.03 6.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.647 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 38' ' ' ILE . 33.2 mm -60.08 120.23 5.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.949 -1.094 . . . . 0.0 109.825 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.27 34.36 46.22 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.466 173.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.9 m-20 -88.88 174.91 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.819 -1.4 . . . . 0.0 109.492 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 71.7 t -99.15 126.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.888 -1.132 . . . . 0.0 110.479 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.472 ' O ' HG21 ' A' ' 42' ' ' VAL . 3.5 m -119.61 146.08 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.819 . . . . 0.0 110.572 -177.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.12 140.7 46.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 109.677 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.593 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.3 mp -125.85 143.67 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.944 -1.097 . . . . 0.0 110.512 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.14 98.97 2.76 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.054 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.541 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.8 tmtm? -98.56 -66.46 0.9 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.226 -0.921 . . . . 0.0 109.695 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.528 HG23 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.77 -37.12 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 174.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.563 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -129.88 -178.97 4.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.757 -0.589 . . . . 0.0 109.826 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HB3' HD23 ' A' ' 130' ' ' LEU . 12.8 mttp -91.86 134.66 34.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.593 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.8 p -139.56 165.05 28.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.499 -0.751 . . . . 0.0 110.129 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.82 162.71 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.59 -0.694 . . . . 0.0 110.339 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.86 -171.38 42.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.21 177.14 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -1.134 . . . . 0.0 110.371 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -103.0 133.13 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 110.548 -175.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.585 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -125.54 165.93 17.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.432 -0.792 . . . . 0.0 110.658 176.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -91.52 125.03 36.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.738 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -65.67 137.78 57.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.881 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.549 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.24 -48.6 96.73 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.903 -1.123 . . . . 0.0 109.105 173.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 39.9 Cg_endo -91.86 97.99 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.838 1.441 . . . . 0.0 109.108 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.474 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 19.5 pt-20 -74.64 36.46 0.11 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.519 -0.738 . . . . 0.0 110.699 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 82.2 m-20 -144.3 -34.93 0.36 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.154 -0.966 . . . . 0.0 110.649 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -85.1 -28.6 25.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 109.241 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 3.2 m-80 -81.03 39.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.8 -0.563 . . . . 0.0 110.697 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 3.0 pttp -98.24 12.85 33.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.665 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.02 25.95 0.06 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.511 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.6 pt -140.66 142.62 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.492 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 9' ' ' LEU . 2.2 p -120.33 121.75 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.969 -1.082 . . . . 0.0 109.922 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.585 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 77.4 mtt180 -89.43 117.72 28.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.94 -1.1 . . . . 0.0 110.176 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.23 172.36 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.428 0.632 . . . . 0.0 110.361 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 20' ' ' GLY . 34.0 p-10 -76.41 168.74 19.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 0.0 109.773 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -67.11 -27.85 67.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.0 -43.66 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.965 . . . . 0.0 110.486 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.404 ' CE ' HD11 ' A' ' 44' ' ' ILE . 3.1 tpt -60.02 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.072 -1.018 . . . . 0.0 109.683 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -59.99 -40.01 87.72 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 0.0 109.853 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -72.2 -25.99 61.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 88.6 m-20 -68.55 -29.13 67.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.022 . . . . 0.0 110.625 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 31.0 p -99.26 -37.01 9.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 110.496 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.528 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 112.98 23.84 5.11 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.22 167.43 9.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -1.183 . . . . 0.0 110.351 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.521 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -116.75 166.42 12.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 178.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.52 ' HA ' HG12 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -51.4 140.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.486 178.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 77.27 -0.67 67.42 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 172.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.1 m-20 -56.31 -160.99 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 12.7 pttm -135.51 112.19 10.07 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.489 -0.757 . . . . 0.0 109.861 175.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.541 HG11 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.49 158.94 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.749 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 55.5 tttp -110.75 123.57 50.3 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.188 -0.945 . . . . 0.0 109.955 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.521 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.8 t -105.59 123.64 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 109.873 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.463 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.7 mtt180 -112.42 139.32 48.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.733 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.526 ' HE3' ' CB ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -79.06 141.06 37.72 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 110.437 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.511 HG21 ' CG ' ' A' ' 161' ' ' PRO . 2.0 m -150.01 -168.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 109.999 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.498 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 47.1 ptt85 -139.59 171.04 14.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.566 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.403 ' OG1' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.41 158.7 16.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.995 -1.066 . . . . 0.0 111.309 -173.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -150.86 175.23 12.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.24 101.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.663 -1.273 . . . . 0.0 110.587 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -57.05 137.44 55.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HD2' ' CD1' ' A' ' 156' ' ' LEU . 19.5 ptpt -101.12 -26.4 13.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 110.814 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -150.8 119.95 6.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.897 -1.127 . . . . 0.0 110.584 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 170' ' ' ILE . 7.4 p -135.19 140.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.871 -1.143 . . . . 0.0 110.977 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.9 m -112.21 144.37 41.73 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.346 -0.846 . . . . 0.0 109.962 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.4 OUTLIER -141.87 165.74 26.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.179 -0.95 . . . . 0.0 110.941 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . . . -139.95 90.72 10.65 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 110.368 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 37.9 Cg_exo -55.15 129.84 37.46 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.955 1.503 . . . . 0.0 110.547 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.495 HG23 ' HB2' ' A' ' 177' ' ' ALA . 41.8 mm -89.98 88.68 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.174 -0.954 . . . . 0.0 110.244 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.582 ' HB ' ' CB ' ' A' ' 108' ' ' GLN . 1.0 OUTLIER -152.27 -167.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.885 176.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.504 ' O ' HD13 ' A' ' 104' ' ' ILE . 79.3 mmt-85 -92.39 165.26 13.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.477 -0.765 . . . . 0.0 110.091 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -59.89 -15.24 19.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.112 -0.993 . . . . 0.0 110.885 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 36.5 p-10 -122.98 25.44 8.57 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.59 -0.693 . . . . 0.0 110.623 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.582 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 1.2 mt-30 -93.51 -79.97 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 110.609 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.464 ' HG3' HG23 ' A' ' 104' ' ' ILE . 78.4 mtt180 -108.85 -27.28 9.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 109.824 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -97.64 41.35 1.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.537 -174.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 2.7 pttt -97.44 43.84 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.935 . . . . 0.0 110.347 174.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.462 ' HB2' HD12 ' A' ' 116' ' ' ILE . 21.5 m-85 -107.98 -40.73 5.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.523 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 77.81 -161.05 49.24 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' GLY . 19.2 pt-20 -32.14 144.83 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.878 -0.778 . . . . 0.0 110.723 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.4 -10.99 59.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 112' ' ' PHE . 6.7 tp -63.99 -37.14 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 110.066 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -60.02 -43.12 95.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.675 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.43 -39.8 89.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.756 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.02 -40.03 87.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.815 . . . . 0.0 109.669 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.534 ' CG1' ' CD1' ' A' ' 170' ' ' ILE . 54.4 t -60.02 -47.25 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.571 ' NE2' ' O ' ' A' ' 168' ' ' THR . 4.1 mt-30 -59.95 -44.51 94.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.511 -0.743 . . . . 0.0 110.06 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -60.11 -44.04 95.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.57 -0.706 . . . . 0.0 110.19 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.6 -42.09 59.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.492 ' O ' ' CB ' ' A' ' 127' ' ' ARG . 4.5 mm? -95.92 0.68 52.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.172 -0.955 . . . . 0.0 111.205 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.6 tt -46.04 166.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.851 -1.155 . . . . 0.0 110.261 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.9 ptm180 32.63 49.31 0.15 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.603 -0.686 . . . . 0.0 111.237 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -129.1 134.68 26.58 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.029 -1.044 . . . . 0.0 110.955 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.759 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.7 Cg_exo -59.75 125.73 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.931 1.49 . . . . 0.0 109.785 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 127' ' ' ARG . 99.7 mmm -124.35 140.46 52.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.445 -1.409 . . . . 0.0 111.031 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.566 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 12.6 tp -140.99 111.6 6.94 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.58 -0.7 . . . . 0.0 109.503 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pm0 -47.07 137.42 7.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 110.612 -173.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.59 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 1.3 tp-100 80.41 -3.39 1.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.243 0.545 . . . . 0.0 110.358 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.566 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.4 p30 -69.12 -173.59 0.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 175.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.465 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 7.9 m-80 -146.32 140.3 26.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -139.95 165.57 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.969 -1.082 . . . . 0.0 110.447 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 t -140.7 137.99 33.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 110.205 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.634 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 10.8 t -109.9 -68.08 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.66 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.634 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 34.2 Cg_endo -69.72 136.22 32.53 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.199 1.105 . . . . 0.0 110.162 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -98.62 46.77 1.48 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pp -123.97 143.44 50.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -1.094 . . . . 0.0 110.314 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -118.78 -168.63 1.58 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.187 -0.946 . . . . 0.0 110.5 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' A' ' 141' ' ' THR . 83.4 mt -142.3 -138.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.541 -0.724 . . . . 0.0 109.8 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.03 -154.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 110.1 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.18 68.04 2.68 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -94.3 168.89 10.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.484 -1.009 . . . . 0.0 110.153 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.3 t -140.0 159.04 43.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.229 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.527 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 80.66 -83.88 1.42 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 41.81 42.74 2.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.436 -1.038 . . . . 0.0 110.981 178.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 4.4 pp -140.04 173.37 11.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.023 -1.048 . . . . 0.0 109.686 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 67.7 m-85 -89.55 120.06 30.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.441 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 23.7 tptm -97.14 103.68 15.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.303 -0.873 . . . . 0.0 109.882 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 132' ' ' GLN . 3.9 t -74.87 134.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.46 HG13 ' HG3' ' A' ' 154' ' ' LYS . 37.9 t -115.18 -30.17 2.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 110.751 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.46 ' HG3' HG13 ' A' ' 153' ' ' VAL . 68.5 mttt -143.4 160.0 41.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 0.0 111.163 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.461 HG22 HG23 ' A' ' 98' ' ' VAL . 81.5 p -150.0 162.55 40.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.652 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.83 -38.69 0.44 Allowed Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 21.4 Cg_exo -57.68 -166.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.535 1.282 . . . . 0.0 110.139 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.6 t -89.69 -169.23 2.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.913 . . . . 0.0 109.671 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -64.16 -7.9 10.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 110.605 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.1 m -83.38 152.13 63.73 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 121.416 -0.803 . . . . 0.0 110.578 -176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.581 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 4.6 Cg_endo -52.98 142.57 52.92 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.303 1.686 . . . . 0.0 110.952 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.759 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 7.2 m -132.46 158.11 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 110.033 171.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 83.2 tt0 -105.36 126.32 51.97 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 110.213 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 126' ' ' ARG . 13.1 mm -69.77 159.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 110.438 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.448 ' N ' HG22 ' A' ' 164' ' ' ILE . . . -143.65 167.84 26.52 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -58.58 -19.95 42.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.336 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.63 -22.03 20.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.571 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 94.2 m -54.99 147.32 15.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.635 -0.666 . . . . 0.0 110.283 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.7 mmtm -95.52 156.72 16.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.937 -1.102 . . . . 0.0 110.014 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.534 ' CD1' ' CG1' ' A' ' 120' ' ' VAL . 2.4 mt -135.68 164.25 33.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.992 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 37.0 mt-10 -139.26 137.01 35.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.621 -0.675 . . . . 0.0 110.276 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.404 HD11 ' CG2' ' A' ' 120' ' ' VAL . 47.1 mm -119.95 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.937 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.509 ' NE ' ' HB3' ' A' ' 101' ' ' ALA . 3.4 ptp180 -88.64 152.02 22.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 0.0 110.29 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.452 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.4 mt-10 -89.79 -3.58 58.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 110.319 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -98.97 109.49 54.12 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.022 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.9 Cg_exo -70.59 -154.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.11 1.584 . . . . 0.0 110.568 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.495 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -76.92 53.3 0.92 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.345 0.593 . . . . 0.0 110.043 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 96.5 p -79.33 119.53 22.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.283 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 178' ' ' SER . 84.0 tt0 59.99 18.26 7.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.855 . . . . 0.0 110.655 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 181' ' ' LEU . 96.3 t -108.68 112.01 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.12 -0.988 . . . . 0.0 110.204 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 180' ' ' VAL . 0.5 OUTLIER 167.71 -42.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.438 -0.789 . . . . 0.0 110.108 177.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.457 ' HG3' HD13 ' A' ' 181' ' ' LEU . 98.9 mt-10 -60.5 -40.04 89.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.39 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -59.95 140.0 57.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.19 -31.14 29.11 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.428 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' HB2' ' HE3' ' A' ' 1' ' ' MET . 52.7 ttm . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.207 0.527 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.77 136.34 45.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.435 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 t -61.13 -39.99 92.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 110.359 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 5' ' ' ASN . 42.5 t30 -89.77 -80.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 110.242 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 1.4 t-20 65.92 -159.93 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.936 -1.102 . . . . 0.0 110.362 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -144.32 -160.47 8.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 46.2 pt -132.98 147.76 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -1.145 . . . . 0.0 109.815 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.8 mt -96.24 119.08 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.7 pt? -136.61 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 110.287 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.514 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 24.0 ttp180 -106.08 130.38 53.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.419 -0.801 . . . . 0.0 110.998 -174.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.565 HG21 ' CD ' ' A' ' 74' ' ' ARG . 10.2 p -61.21 139.55 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.523 -0.735 . . . . 0.0 110.416 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -125.79 153.33 44.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.467 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 46.2 tt0 -179.35 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.93 . . . . 0.0 110.062 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.59 -20.32 5.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.528 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -119.97 129.88 54.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.123 -0.986 . . . . 0.0 110.257 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.8 p -92.17 0.65 57.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.362 -0.836 . . . . 0.0 110.344 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 80.9 p -77.47 165.81 23.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.208 -0.933 . . . . 0.0 110.41 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 17' ' ' THR . 5.5 p-10 37.25 69.56 1.33 Allowed Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.65 -0.656 . . . . 0.0 110.205 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -56.74 165.77 4.45 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.101 1.58 . . . . 0.0 110.476 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 70' ' ' ASP . . . 161.93 88.65 0.07 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.7 ptp -89.8 -10.2 46.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -1.162 . . . . 0.0 110.165 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.5 p -93.07 2.5 56.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 110.042 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.566 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 98.1 mtt180 -119.85 135.78 54.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.007 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 55' ' ' TYR . 92.8 t -116.14 120.01 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.206 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.528 ' HD3' ' HD2' ' A' ' 68' ' ' ARG . 1.1 ptm180 -93.54 119.97 33.25 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.852 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -138.43 178.6 7.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.547 -0.72 . . . . 0.0 109.737 -176.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 15.2 p-10 -94.2 177.01 6.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.815 -1.178 . . . . 0.0 110.635 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.0 -44.74 94.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.521 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.3 t -60.49 -43.13 97.33 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.264 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.607 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 47.0 t -59.97 -41.15 91.34 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.257 176.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 67.4 ttt180 -68.98 -44.17 73.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.662 . . . . 0.0 111.363 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 33' ' ' LEU . 25.4 tpt180 -90.32 -20.69 22.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.859 -1.15 . . . . 0.0 111.74 -170.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.607 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -47.84 -30.36 3.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.73 -1.231 . . . . 0.0 108.988 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 18.0 mt -115.67 -78.16 0.58 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.798 . . . . 0.0 110.393 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -172.23 11.65 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.473 -0.767 . . . . 0.0 110.515 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -50.03 127.75 17.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.094 -1.004 . . . . 0.0 110.337 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.527 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -112.61 176.31 5.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.5 mm -59.66 119.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.828 -1.17 . . . . 0.0 109.83 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.61 36.83 47.62 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.26 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 25.6 m-20 -87.97 169.19 12.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.752 -1.44 . . . . 0.0 109.228 170.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 54.3 t -98.78 120.36 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.858 -1.151 . . . . 0.0 110.15 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.45 ' CG1' ' HE2' ' A' ' 89' ' ' LYS . 2.8 m -116.85 139.79 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.554 -0.716 . . . . 0.0 110.101 -176.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 85.9 tt0 -106.55 138.34 42.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.872 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.607 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -116.97 140.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.147 -0.97 . . . . 0.0 109.859 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 84.4 tt0 -150.16 96.29 2.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.087 -1.008 . . . . 0.0 111.186 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.636 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 37.9 tttp -99.53 -71.07 0.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 172.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.478 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.16 -34.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.47 175.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 87.3 mtt-85 -139.77 179.71 6.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.051 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' CD ' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -89.04 134.14 34.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 110.781 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.525 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 1.7 p -138.48 172.06 13.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.679 . . . . 0.0 109.322 174.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.597 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 3.0 m -127.93 168.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.45 -175.9 45.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 40.8 ttm180 -121.71 165.75 15.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.439 -1.036 . . . . 0.0 109.975 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -94.57 135.85 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 110.553 -172.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.566 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -130.5 167.27 18.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 110.509 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -89.6 125.97 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.429 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB2' ' ND2' ' A' ' 63' ' ' ASN . . . -65.23 140.08 58.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.847 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.583 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -55.45 -49.96 89.54 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.947 174.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 33.9 Cg_endo -92.81 98.56 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.873 1.46 . . . . 0.0 108.974 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -73.64 35.13 0.08 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.561 -0.712 . . . . 0.0 110.91 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -145.91 -29.77 0.41 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.152 -0.968 . . . . 0.0 110.531 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.12 -27.25 26.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.167 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.489 ' ND2' ' HB2' ' A' ' 57' ' ' ALA . 31.5 m-80 -81.22 41.15 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.775 -0.578 . . . . 0.0 110.386 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.474 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -98.2 7.96 45.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.37 26.32 0.05 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 66' ' ' ILE . 45.6 pt -140.02 141.34 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.252 -1.146 . . . . 0.0 109.411 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.48 ' HB ' HD12 ' A' ' 9' ' ' LEU . 10.2 p -121.51 125.85 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.053 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 77.8 mtt180 -89.52 116.32 27.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.941 -1.099 . . . . 0.0 110.107 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.489 ' CD1' ' HD3' ' A' ' 74' ' ' ARG . 1.4 pp -129.97 170.07 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.209 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 20' ' ' GLY . 95.7 m-20 -79.83 164.24 23.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.945 174.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -68.01 -18.79 64.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.09 -50.02 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 110.313 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.486 ' CE ' ' CD1' ' A' ' 44' ' ' ILE . 19.3 ttt -59.98 -45.7 91.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.443 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.565 ' CD ' HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.991 174.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -62.03 -36.42 81.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 109.84 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -67.79 -26.37 66.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 110.755 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 24.3 p -99.36 -30.99 11.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.022 -1.049 . . . . 0.0 110.547 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.478 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 106.75 19.73 9.47 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.631 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.23 169.34 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.243 . . . . 0.0 110.838 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.528 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -120.31 178.53 4.61 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.475 -0.765 . . . . 0.0 109.458 177.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -66.4 142.26 16.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 110.35 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.519 ' N ' HG11 ' A' ' 11' ' ' VAL . . . 77.36 -4.78 54.23 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 172.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.555 ' HB2' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.89 -162.08 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.053 -1.263 . . . . 0.0 110.067 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 16.4 pttp -137.2 116.15 12.36 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.636 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -119.55 160.72 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 82.8 tttt -109.37 120.62 43.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.025 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 87.3 t -101.67 123.69 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 0.0 110.204 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 93.9 mtt180 -106.88 151.4 25.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 109.763 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.457 ' CD ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -99.07 132.44 44.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.049 -1.032 . . . . 0.0 110.215 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.3 m -149.91 -168.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.561 -0.712 . . . . 0.0 110.125 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.511 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 40.1 ptt180 -129.07 171.67 12.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.636 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.74 164.72 12.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 111.023 -175.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.465 ' CG ' HG13 ' A' ' 162' ' ' VAL . 18.8 pt-20 -150.04 169.51 21.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 109.421 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.515 HD13 ' HG3' ' A' ' 163' ' ' GLU . 40.0 mm -90.66 99.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.843 -1.161 . . . . 0.0 110.607 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -57.27 140.07 50.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 110.423 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 169' ' ' LYS . 1.5 ptpt -101.68 -29.03 12.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HD3' ' OE2' ' A' ' 171' ' ' GLU . 40.2 ttmt -150.79 129.35 12.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.367 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.472 HG23 ' CG2' ' A' ' 155' ' ' THR . 9.7 p -139.67 139.99 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.009 -1.057 . . . . 0.0 110.782 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 14.5 m -102.71 138.67 39.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.873 . . . . 0.0 110.042 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -132.03 159.96 37.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.696 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.18 81.82 43.39 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.432 -0.793 . . . . 0.0 110.396 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 19.7 Cg_exo -60.54 132.96 45.95 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.936 1.493 . . . . 0.0 110.33 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.483 HG21 ' HB1' ' A' ' 177' ' ' ALA . 46.3 mm -91.88 95.39 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.206 -0.934 . . . . 0.0 110.054 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.559 HD11 ' O ' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -151.9 -166.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.38 -0.825 . . . . 0.0 110.726 178.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.564 ' HB2' ' HG2' ' A' ' 108' ' ' GLN . 28.8 mmm180 -88.99 156.91 18.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.467 -0.771 . . . . 0.0 109.587 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -57.52 -14.14 4.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 110.725 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 35.5 p-10 -127.9 32.13 4.99 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 121.619 -0.676 . . . . 0.0 110.437 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.564 ' HG2' ' HB2' ' A' ' 105' ' ' ARG . 4.8 mm-40 -89.95 -79.99 0.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.946 -1.096 . . . . 0.0 110.78 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -103.28 -32.35 9.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.01 -1.056 . . . . 0.0 110.876 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.467 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 1.4 pp -99.62 50.14 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 110.179 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -102.83 49.04 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.442 -0.787 . . . . 0.0 110.089 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.414 ' CE2' ' HE3' ' A' ' 111' ' ' LYS . 57.8 m-85 -124.55 -51.03 1.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.59 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 75.34 175.86 37.75 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 113' ' ' GLY . 96.0 mt-10 43.76 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.148 -1.207 . . . . 0.0 110.507 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.3 -2.91 87.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 110' ' ' LEU . 7.2 tp -59.98 -39.98 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -1.205 . . . . 0.0 110.18 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.48 -42.58 99.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -70.04 -30.12 67.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.93 -39.93 83.07 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.56 ' CG1' HD11 ' A' ' 170' ' ' ILE . 56.0 t -60.07 -43.79 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.316 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.608 ' NE2' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -59.63 -45.06 93.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.987 -1.07 . . . . 0.0 109.575 175.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -59.94 -40.09 87.77 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.22 -22.18 38.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.165 -0.959 . . . . 0.0 110.938 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -130.03 7.22 5.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.94 -1.1 . . . . 0.0 110.674 -174.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 0.1 OUTLIER -44.26 173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.311 -0.868 . . . . 0.0 110.883 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.7 ptm180 34.9 46.63 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.498 -0.751 . . . . 0.0 111.29 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 8.9 ttt180 -123.33 129.7 24.81 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.87 -1.144 . . . . 0.0 111.19 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.801 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.5 Cg_endo -66.26 125.9 14.8 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.954 1.502 . . . . 0.0 109.647 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.455 ' C ' HD11 ' A' ' 130' ' ' LEU . 97.6 mtp -140.01 151.62 45.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.27 -1.519 . . . . 0.0 112.092 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.602 ' N ' ' CD2' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -126.03 146.16 50.01 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.443 0.639 . . . . 0.0 109.975 172.23 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.4 pm0 -57.18 140.02 50.83 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 172.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 75.2 -0.75 3.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.75 -0.594 . . . . 0.0 110.262 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.552 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 0.7 OUTLIER -67.81 -172.81 0.3 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 109.942 176.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 17.1 m-80 -141.18 149.72 41.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.0 165.48 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.016 -1.052 . . . . 0.0 110.493 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.408 ' C ' HG21 ' A' ' 137' ' ' VAL . 22.9 t -140.66 149.36 42.16 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.363 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 139' ' ' GLY . 77.5 t -135.63 149.93 70.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.706 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 1.4 Cg_endo -46.76 83.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.931 1.49 . . . . 0.0 110.136 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . -139.84 101.58 0.31 Allowed Glycine 0 N--CA 1.482 1.734 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.4 pp -87.14 146.45 26.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.428 -1.043 . . . . 0.0 109.784 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.548 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -60.82 -170.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.083 -1.01 . . . . 0.0 110.89 -171.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.623 ' CD1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -143.61 -100.58 0.12 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.837 -0.539 . . . . 0.0 110.237 178.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.612 ' N ' HD22 ' A' ' 142' ' ' LEU . . . -78.54 50.18 0.94 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.325 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.64 68.01 1.86 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.546 ' CG ' HD23 ' A' ' 142' ' ' LEU . 17.2 pt20 -104.56 172.74 6.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.773 -1.427 . . . . 0.0 109.883 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -137.52 153.24 50.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.397 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 100.37 -90.72 0.93 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.5 OUTLIER 41.88 47.32 3.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.415 -1.05 . . . . 0.0 111.122 177.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.8 pp -140.1 167.86 21.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.961 -1.087 . . . . 0.0 110.073 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 66.5 m-85 -101.89 134.61 44.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.043 . . . . 0.0 110.665 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -118.05 102.21 8.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.922 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.552 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 2.5 t -74.93 135.73 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.791 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.42 -31.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 110.669 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 155' ' ' THR . 54.7 tttm -139.39 148.76 43.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.954 -1.091 . . . . 0.0 110.953 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 24.4 p -145.07 159.7 42.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.76 -0.588 . . . . 0.0 109.836 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.674 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -90.46 -38.05 0.4 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.344 -0.847 . . . . 0.0 111.015 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 12.6 Cg_exo -60.15 -173.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.434 1.228 . . . . 0.0 110.911 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 159' ' ' LYS . 5.4 t -90.17 -168.47 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 158' ' ' SER . 8.7 ptpt -66.3 -6.01 12.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.7 m -86.36 152.33 54.97 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.599 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.597 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.6 Cg_endo -51.52 132.42 40.38 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.289 1.678 . . . . 0.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.801 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 3.5 m -121.96 152.92 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.609 -1.237 . . . . 0.0 110.269 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.515 ' HG3' HD13 ' A' ' 94' ' ' ILE . 18.1 pt-20 -103.47 127.93 50.75 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.879 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.577 ' CG2' ' OE1' ' A' ' 121' ' ' GLN . 19.3 mm -71.04 153.4 8.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.136 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.608 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -143.69 167.29 26.7 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.494 ' HG2' HD12 ' A' ' 125' ' ' ILE . 99.0 mt-10 -56.61 -20.58 21.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -1.062 . . . . 0.0 110.397 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.94 -9.91 47.04 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.667 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.535 ' CG2' HD11 ' A' ' 164' ' ' ILE . 95.6 m -62.44 146.65 50.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.167 -0.958 . . . . 0.0 109.886 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.5 mttt -97.43 143.97 27.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 109.64 176.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.56 HD11 ' CG1' ' A' ' 120' ' ' VAL . 2.1 mm -106.84 129.45 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.481 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 64.7 mt-10 -116.31 135.2 54.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 110.156 172.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.44 HG12 ' HG ' ' A' ' 100' ' ' LEU . 41.3 mt -140.1 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.873 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 173' ' ' ARG . 3.5 ptm85 -87.9 -175.52 5.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.228 -175.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.479 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 24.5 pt-20 -120.32 -16.57 8.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.345 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.4 109.96 45.94 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.545 -0.722 . . . . 0.0 109.662 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 14.8 Cg_exo -69.97 -154.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.14 1.6 . . . . 0.0 110.599 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.483 ' HB1' HG21 ' A' ' 103' ' ' ILE . . . -76.88 51.48 0.79 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.694 -0.629 . . . . 0.0 110.207 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 36.6 t -110.72 111.49 22.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.995 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 178' ' ' SER . 79.7 tt0 59.89 19.98 8.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.439 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.571 ' O ' ' HG ' ' A' ' 181' ' ' LEU . 23.1 t -101.31 139.72 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.173 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER 39.83 42.83 1.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.562 -0.711 . . . . 0.0 110.561 -178.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -60.84 130.04 44.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.187 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.95 -30.07 68.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 110.221 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 62.95 -131.62 42.95 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 117.989 -1.451 . . . . 0.0 109.481 179.82 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 mmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.38 0.609 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -60.29 -39.7 87.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 110.225 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -60.13 -39.98 88.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.274 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.4 ' ND2' ' HD2' ' A' ' 159' ' ' LYS . 40.6 t-20 -101.01 113.47 26.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.225 -0.922 . . . . 0.0 110.309 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -160.46 154.93 23.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.078 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.71 -159.13 8.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 20.6 pt -137.2 169.35 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -112.51 120.51 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.011 -1.056 . . . . 0.0 110.444 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.7 pt? -139.41 -167.66 2.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.776 . . . . 0.0 109.747 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 34.9 ptt180 -118.88 140.02 50.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.794 -1.191 . . . . 0.0 110.715 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 81' ' ' ILE . 4.6 p -62.35 147.7 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -122.3 147.66 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.903 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.483 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.1 tt0 -177.2 129.13 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 173.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.08 -52.91 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.179 -0.951 . . . . 0.0 110.295 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -149.64 99.47 2.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.274 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.1 p -151.55 159.83 43.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.217 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.457 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 75.2 p -75.69 156.89 34.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.942 . . . . 0.0 109.885 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.643 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -59.91 -40.66 80.14 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 110.68 -177.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 13.4 Cg_exo -67.05 149.73 82.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.66 1.347 . . . . 0.0 110.228 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.471 ' C ' ' OD2' ' A' ' 70' ' ' ASP . . . 96.05 43.96 3.17 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -86.53 -0.42 56.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.428 -1.042 . . . . 0.0 109.485 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.8 p -100.53 5.74 44.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -0.86 . . . . 0.0 110.069 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' HG3' ' CG ' ' A' ' 55' ' ' TYR . 59.8 ttt180 -99.99 113.94 26.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.821 . . . . 0.0 110.091 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 55.5 t -112.56 112.53 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 0.0 110.271 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.544 ' HD3' ' HD2' ' A' ' 68' ' ' ARG . 7.4 ptt180 -84.24 117.37 23.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.689 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 30' ' ' SER . 1.8 mp -134.83 170.62 15.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.993 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.0 p-10 -105.57 -175.18 2.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 110.507 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -59.91 -42.09 93.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.184 -0.947 . . . . 0.0 109.643 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -67.4 -49.56 63.29 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.3 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.629 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 72.4 m -57.9 -27.44 63.31 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.119 -0.988 . . . . 0.0 109.56 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 39.9 ttm180 -86.43 -46.08 10.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.822 -0.549 . . . . 0.0 110.957 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -79.71 -8.58 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.629 ' CD2' ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -43.85 -28.7 0.47 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -0.779 . . . . 0.0 110.136 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 33' ' ' LEU . 83.2 mt -141.76 -59.43 0.47 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 110.272 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.602 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.4 t0 -170.56 -30.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.424 -0.798 . . . . 0.0 110.066 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.602 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -15.35 120.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.437 0.637 . . . . 0.0 111.581 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -105.87 -177.51 3.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.0 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.5 mm -63.73 119.4 7.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.062 -1.024 . . . . 0.0 110.135 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' H ' HG13 ' A' ' 54' ' ' VAL . . . 73.25 35.95 56.3 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 1.4 m-20 -89.81 178.3 6.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.056 -1.261 . . . . 0.0 109.499 173.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.489 HG22 ' OG1' ' A' ' 92' ' ' THR . 97.0 t -99.65 127.76 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.015 -1.053 . . . . 0.0 110.301 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.447 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.1 m -120.95 149.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.514 -0.741 . . . . 0.0 110.683 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -111.93 140.8 46.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.594 -0.691 . . . . 0.0 109.982 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.625 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.5 mp -124.92 144.01 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.926 -1.109 . . . . 0.0 110.731 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -150.21 98.79 2.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 110.827 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.568 ' CG ' HG11 ' A' ' 85' ' ' VAL . 9.2 tmtm? -97.94 -64.36 1.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.559 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.527 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.17 -36.94 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.817 0.818 . . . . 0.0 109.098 175.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 70.5 mtt85 -128.95 -173.47 2.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' HD23 ' A' ' 130' ' ' LEU . 29.3 mttt -96.18 141.75 29.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.122 -0.986 . . . . 0.0 110.902 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.625 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.5 p -145.0 168.2 20.84 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.374 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.598 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.57 162.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.447 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -171.66 41.39 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.216 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -121.72 166.44 14.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.458 -1.025 . . . . 0.0 110.165 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -99.94 149.69 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.004 . . . . 0.0 110.412 -175.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.0 m-85 -139.16 167.84 21.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.511 -0.743 . . . . 0.0 110.339 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -88.62 122.77 32.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.844 . . . . 0.0 110.052 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.496 ' CB ' ' OD1' ' A' ' 63' ' ' ASN . . . -64.3 138.3 58.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.715 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 2.4 mtp180 -58.35 -47.21 99.21 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.309 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.715 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 56.2 Cg_endo -93.51 98.96 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.675 1.355 . . . . 0.0 108.69 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.423 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.5 pt-20 -73.28 35.65 0.08 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.587 -0.696 . . . . 0.0 110.784 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 59' ' ' PRO . 73.3 m-20 -146.07 -30.79 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.96 -28.78 25.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.433 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.511 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 5.3 m120 -80.53 39.64 0.48 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.723 -0.61 . . . . 0.0 110.64 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -98.96 13.34 33.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.072 -1.017 . . . . 0.0 109.663 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.72 26.42 0.05 OUTLIER Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.511 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.55 149.04 20.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.371 -1.076 . . . . 0.0 108.933 175.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 12' ' ' ALA . 7.6 p -126.55 131.81 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.928 -1.108 . . . . 0.0 110.348 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.544 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 3.5 ttt180 -89.59 116.24 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 110.325 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.526 HD12 ' CG2' ' A' ' 11' ' ' VAL . 1.7 pp -135.36 168.58 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.318 -0.864 . . . . 0.0 111.036 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' OD2' ' C ' ' A' ' 20' ' ' GLY . 78.0 m-20 -82.06 155.54 25.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.282 -0.886 . . . . 0.0 110.201 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' ' CG ' ' A' ' 75' ' ' ASN . 60.1 p -60.12 -23.37 63.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 110.147 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.6 t -68.09 -42.94 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 110.232 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -60.95 -50.91 71.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 109.974 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.609 ' HD2' ' CG2' ' A' ' 11' ' ' VAL . 13.2 mmp_? -60.14 -39.85 87.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 173.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 78.2 m-20 -60.12 -37.77 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' MET . 93.8 m-20 -59.94 -36.25 76.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 110.648 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 30.2 p -98.15 -39.33 8.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.105 -0.997 . . . . 0.0 110.531 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.527 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 119.18 36.17 0.89 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.51 ' HB2' ' HD3' ' A' ' 74' ' ' ARG . . . -116.48 170.2 8.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.327 . . . . 0.0 110.38 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.513 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.99 -176.83 3.43 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.649 ' HA ' HG12 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -66.57 143.42 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.487 178.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.511 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 76.13 0.95 67.16 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.3 m-20 -61.33 -165.4 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.071 -1.253 . . . . 0.0 110.581 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.0 pttt -130.64 112.94 13.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 0.0 109.945 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.568 HG11 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -122.68 161.15 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 109.995 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 26.4 ttmt -104.96 125.67 51.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.011 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.28 121.25 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.53 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.6 mtt180 -111.39 147.13 35.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.419 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -92.51 139.57 30.45 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.255 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.69 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.413 -0.804 . . . . 0.0 110.26 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -132.25 172.28 12.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.466 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.489 ' OG1' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.49 159.59 16.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.974 -1.079 . . . . 0.0 111.204 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -150.02 169.97 19.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 4.6 mp -89.56 99.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.731 -1.231 . . . . 0.0 110.241 -178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -55.0 138.04 44.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.772 . . . . 0.0 110.353 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.489 ' CG ' HD11 ' A' ' 156' ' ' LEU . 15.5 ptmt -98.39 -30.01 12.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.34 -0.85 . . . . 0.0 110.849 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HB3' HD11 ' A' ' 156' ' ' LEU . 14.7 tttp -151.06 125.61 9.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.85 -1.156 . . . . 0.0 110.803 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.499 ' O ' HG11 ' A' ' 98' ' ' VAL . 8.6 p -137.52 147.17 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.065 . . . . 0.0 111.044 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 171' ' ' GLU . 38.0 m -119.14 142.82 47.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.111 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -138.54 169.03 18.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.847 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.38 93.84 4.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.415 -0.803 . . . . 0.0 110.489 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.7 Cg_exo -65.57 128.9 21.1 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.201 1.632 . . . . 0.0 110.417 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' A' ' 177' ' ' ALA . 91.3 mt -90.02 96.41 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 110.151 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.635 HG12 ' HB2' ' A' ' 108' ' ' GLN . 0.8 OUTLIER -150.01 -175.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.352 -0.842 . . . . 0.0 110.5 176.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.403 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 96.1 mtt180 -135.23 -134.18 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 109.575 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 106' ' ' LYS . 9.5 mtpp -60.68 -17.2 46.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.997 -1.064 . . . . 0.0 109.925 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -98.93 26.23 5.95 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.42 0.629 . . . . 0.0 110.015 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.635 ' HB2' HG12 ' A' ' 104' ' ' ILE . 28.5 pt20 -83.7 151.63 25.15 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.444 -0.785 . . . . 0.0 110.107 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -88.54 -14.9 36.58 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.385 -0.822 . . . . 0.0 110.174 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.436 HD22 ' HB2' ' A' ' 102' ' ' PRO . 0.6 OUTLIER -99.64 57.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 110.32 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -105.11 54.85 0.7 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.903 . . . . 0.0 110.405 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -131.27 -53.42 1.03 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 110.578 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 74.41 174.23 31.5 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -176.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.49 ' O ' ' O ' ' A' ' 113' ' ' GLY . 98.2 mt-10 47.79 102.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.083 -1.245 . . . . 0.0 110.089 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.55 57.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 9.5 tp -60.14 -36.44 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -1.203 . . . . 0.0 110.064 175.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 98.7 mt-10 -60.03 -42.12 93.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.27 -37.51 83.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 109.6 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -59.97 -42.42 94.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.517 ' CG1' HD13 ' A' ' 170' ' ' ILE . 53.1 t -60.26 -45.01 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 175.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.573 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.1 mt-30 -59.89 -43.97 94.5 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.568 -0.707 . . . . 0.0 109.951 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.31 -46.01 91.4 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.819 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.9 68.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 110.921 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 2.9 mm? -99.89 5.33 45.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.025 -1.047 . . . . 0.0 111.171 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.573 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.7 tt -48.71 170.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 36.6 ptt180 33.66 49.12 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.628 -0.67 . . . . 0.0 111.516 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -132.37 149.93 74.51 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.711 -1.243 . . . . 0.0 111.232 176.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.772 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.1 Cg_endo -68.73 128.19 16.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 124.174 1.618 . . . . 0.0 109.971 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.519 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.7 mmm -123.07 140.95 52.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.321 -1.487 . . . . 0.0 110.983 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 20.2 tp -139.24 104.19 4.94 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.695 -0.628 . . . . 0.0 109.386 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.642 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.5 pt-20 -45.24 137.09 4.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.046 -1.034 . . . . 0.0 110.7 -174.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 86.01 -6.06 0.8 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.27 0.557 . . . . 0.0 110.283 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.552 ' OD2' ' HB ' ' A' ' 152' ' ' VAL . 2.8 p30 -69.49 -178.31 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 110.359 177.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -147.1 153.09 39.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.03 160.64 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.941 -1.099 . . . . 0.0 110.65 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.0 t -140.51 157.18 45.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.671 -0.643 . . . . 0.0 110.355 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.581 ' CG1' ' HD2' ' A' ' 138' ' ' PRO . 91.2 t -99.55 148.39 34.65 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 109.942 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.581 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 1.9 Cg_endo -44.94 87.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.977 1.514 . . . . 0.0 110.995 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 46.0 60.31 4.55 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.506 ' CD2' ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -110.57 153.0 25.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.027 -1.278 . . . . 0.0 109.482 176.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -176.17 -171.83 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.067 -1.021 . . . . 0.0 110.749 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.55 ' N ' ' OG1' ' A' ' 141' ' ' THR . 82.7 mt -146.76 -127.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.891 -0.506 . . . . 0.0 109.796 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -58.4 -153.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.026 . . . . 0.0 110.176 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.29 75.63 2.18 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -96.33 170.07 9.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.476 -1.014 . . . . 0.0 110.385 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 t -135.99 154.16 51.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.968 . . . . 0.0 110.216 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.573 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 69.7 -84.31 0.28 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 43.68 49.7 6.65 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.584 -0.951 . . . . 0.0 110.946 178.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 pp -140.39 163.77 31.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.979 -1.075 . . . . 0.0 109.803 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.7 m-85 -91.02 126.49 36.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.078 -1.014 . . . . 0.0 110.049 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -112.4 111.95 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.552 ' HB ' ' OD2' ' A' ' 133' ' ' ASP . 2.7 t -78.15 137.57 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.89 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.48 -31.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.257 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.463 ' C ' HG23 ' A' ' 155' ' ' THR . 28.4 tttm -143.43 146.98 33.91 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.411 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.496 ' CG2' HG22 ' A' ' 98' ' ' VAL . 56.0 p -140.0 161.68 37.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.666 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.5 OUTLIER -89.26 -35.91 0.42 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.96 -1.087 . . . . 0.0 111.103 -177.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 15.3 Cg_exo -58.61 -167.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.327 1.172 . . . . 0.0 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.1 t -87.68 -173.88 4.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.792 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.4 ' HD2' ' ND2' ' A' ' 4' ' ' ASN . 12.3 ptpt -67.9 -1.84 6.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.176 -0.953 . . . . 0.0 110.567 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.1 m -85.79 147.73 46.76 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.146 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.598 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.8 Cg_endo -47.45 139.07 17.74 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 O-C-N 124.358 1.715 . . . . 0.0 110.975 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.772 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 11.1 m -130.02 159.21 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 109.442 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.3 tt0 -106.61 127.23 53.17 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.048 -1.032 . . . . 0.0 110.229 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.519 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 16.6 mm -70.43 154.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.667 -0.646 . . . . 0.0 110.213 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.24 175.4 23.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.75 -26.05 63.61 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.341 -1.094 . . . . 0.0 109.992 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.36 -17.76 28.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 0.0 110.737 -176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.559 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 53.3 m -58.73 146.37 36.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 96' ' ' LYS . 98.6 mttt -100.01 153.14 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.955 -1.091 . . . . 0.0 109.467 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.517 HD13 ' CG1' ' A' ' 120' ' ' VAL . 2.1 mt -129.92 159.4 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.001 -1.062 . . . . 0.0 111.185 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.438 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 10.4 mt-10 -130.35 130.91 45.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.029 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.417 ' CD1' HD13 ' A' ' 100' ' ' LEU . 50.5 mm -119.91 127.18 75.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.32 -0.863 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 2.9 ptp180 -88.6 144.51 26.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.553 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 85.6 tt0 -89.97 0.06 57.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 110.108 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -93.55 107.19 24.88 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.621 -0.674 . . . . 0.0 109.742 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.7 Cg_exo -70.78 -154.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 124.063 1.559 . . . . 0.0 109.932 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.412 ' HB3' HG23 ' A' ' 103' ' ' ILE . . . -85.1 39.69 0.78 Allowed 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.469 -0.769 . . . . 0.0 110.476 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 93.6 p -99.33 37.2 1.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.429 -0.795 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 83.5 tt0 -178.06 20.25 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.901 -1.124 . . . . 0.0 110.428 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.3 t -90.96 117.2 33.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.197 -0.94 . . . . 0.0 109.945 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.11 6.7 44.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.065 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 48.14 -116.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 110.023 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -60.09 139.92 57.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.929 -1.107 . . . . 0.0 110.08 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -171.47 139.91 5.62 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.542 179.292 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.266 0.555 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.49 161.57 18.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.277 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -59.97 -28.01 67.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -103.5 127.48 50.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -0.965 . . . . 0.0 110.542 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -149.91 159.99 43.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.341 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -147.09 -169.71 14.82 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.446 HG22 ' CD1' ' A' ' 34' ' ' LEU . 45.7 pt -134.82 159.99 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.228 -1.16 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.474 ' CD1' ' HB2' ' A' ' 86' ' ' LYS . 40.4 mm -98.37 116.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 110.331 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.3 pt? -139.37 -178.26 5.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.324 -0.86 . . . . 0.0 109.728 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 6.3 ptp180 -106.73 137.0 45.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 110.899 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.569 ' CG1' ' O ' ' A' ' 80' ' ' SER . 13.5 p -63.75 134.81 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.596 -0.69 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -119.79 153.47 35.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.421 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.5 tt0 -173.73 159.55 3.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.904 . . . . 0.0 110.607 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.4 170.22 12.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.996 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -69.94 -20.04 63.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.948 . . . . 0.0 110.188 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.517 ' O ' ' OG1' ' A' ' 17' ' ' THR . 23.3 t -159.43 -173.8 4.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.853 . . . . 0.0 110.293 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 16' ' ' SER . 3.5 p 57.11 -163.82 0.17 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.507 -0.745 . . . . 0.0 110.554 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.53 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 2.0 p30 37.53 62.29 3.71 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.616 -0.677 . . . . 0.0 110.53 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 13.3 Cg_exo -66.09 -175.07 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.02 1.537 . . . . 0.0 110.143 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.46 85.75 1.71 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 73' ' ' MET . 23.2 ptp -89.29 -11.92 42.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -1.143 . . . . 0.0 110.076 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.59 19.17 17.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 109.894 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.502 ' CD ' ' CZ ' ' A' ' 55' ' ' TYR . 18.1 mtt-85 -129.16 148.95 51.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 110.175 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 55' ' ' TYR . 97.6 t -117.15 122.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.502 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 1.6 ptm180 -95.64 119.33 33.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.742 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.45 HD11 ' N ' ' A' ' 31' ' ' ARG . 0.4 OUTLIER -140.69 174.85 10.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 0.0 109.513 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.1 p-10 -90.28 177.64 6.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.927 -1.108 . . . . 0.0 110.737 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.99 -41.1 91.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 108.801 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.612 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.0 t -62.77 -58.38 7.64 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.076 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.516 ' O ' HD21 ' A' ' 33' ' ' LEU . 58.4 m -49.91 -30.39 10.1 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.833 -1.167 . . . . 0.0 109.572 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.45 ' N ' HD11 ' A' ' 26' ' ' LEU . 40.3 ttm180 -81.62 -45.52 15.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 111.603 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -97.95 -10.6 24.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.267 . . . . 0.0 110.958 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.612 ' HB3' ' O ' ' A' ' 29' ' ' SER . 0.8 OUTLIER -59.94 -26.02 65.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.987 -1.07 . . . . 0.0 109.774 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 33' ' ' LEU . 54.4 mt -110.63 -75.87 0.61 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.145 -0.972 . . . . 0.0 110.277 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.534 ' HB3' ' CD ' ' A' ' 89' ' ' LYS . 9.4 t70 -168.27 -20.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.574 -0.704 . . . . 0.0 109.971 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -40.46 126.78 2.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.358 -0.839 . . . . 0.0 110.681 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.549 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.3 pt-20 -119.12 179.77 4.07 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 108.929 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' NH1' ' A' ' 31' ' ' ARG . 5.5 mm -55.81 127.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.06 . . . . 0.0 109.875 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.62 24.3 74.97 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.708 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 6.9 m-20 -89.01 169.94 11.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.754 -1.439 . . . . 0.0 109.855 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.427 HG23 ' CG2' ' A' ' 92' ' ' THR . 79.2 t -99.78 127.97 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 110.137 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 52' ' ' GLY . 2.6 m -116.02 143.71 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -113.28 143.2 44.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.735 . . . . 0.0 109.632 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -119.97 145.9 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.023 . . . . 0.0 110.198 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -151.8 88.53 1.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.062 -1.024 . . . . 0.0 111.612 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.593 ' HD3' ' CB ' ' A' ' 79' ' ' ALA . 31.0 tttm -99.23 -71.74 0.68 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 110.2 171.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.527 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.15 -34.71 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.507 -0.746 . . . . 0.0 109.409 178.06 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -141.3 -173.28 3.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.5 -0.75 . . . . 0.0 109.892 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.528 ' O ' HD22 ' A' ' 130' ' ' LEU . 2.1 mptm? -87.84 133.22 33.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 110.325 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.554 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -134.93 159.28 41.94 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.354 0.597 . . . . 0.0 110.318 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.39 162.17 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.825 . . . . 0.0 109.963 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.485 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -179.83 48.01 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.995 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.451 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 61.8 ttt180 -116.6 169.84 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 0.0 110.214 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.85 131.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 110.322 -175.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.502 ' CZ ' ' CD ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -121.3 163.67 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.551 -0.718 . . . . 0.0 110.009 175.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -90.68 124.19 34.88 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 110.134 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.459 ' HB2' ' OD1' ' A' ' 63' ' ' ASN . . . -63.22 139.25 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.565 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -58.74 -49.05 95.51 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.186 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 36.2 Cg_endo -91.06 98.78 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 108.922 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 15.7 pt-20 -73.07 35.93 0.08 Allowed 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.65 -0.657 . . . . 0.0 110.749 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.5 m-20 -148.91 -33.42 0.22 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.252 -0.905 . . . . 0.0 110.721 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.23 -26.49 28.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.987 . . . . 0.0 109.166 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.492 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 13.4 m120 -80.94 42.29 0.63 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.769 -0.582 . . . . 0.0 110.537 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 34.4 mtpt -97.79 10.0 41.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.563 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.48 28.84 0.05 OUTLIER Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.492 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.1 pt -140.59 143.88 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -1.154 . . . . 0.0 109.55 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.449 ' CB ' HD11 ' A' ' 9' ' ' LEU . 2.5 p -120.8 127.59 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.06 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.519 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 20.8 tpp180 -90.63 114.9 27.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.088 -1.008 . . . . 0.0 109.906 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 2.4 pt -130.05 161.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 21' ' ' MET . 95.3 m-20 -79.99 169.94 17.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 110.047 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.442 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 21.5 t -60.2 -36.74 78.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 110.365 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.27 -45.9 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 109.888 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 13.7 tpt -60.13 -43.45 95.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.588 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -60.0 -40.03 87.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.761 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.41 -25.94 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 73' ' ' MET . 5.4 m120 -60.12 -40.02 88.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.655 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.447 ' HB2' HG23 ' A' ' 47' ' ' VAL . 28.0 p -99.91 -38.06 8.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.985 -1.072 . . . . 0.0 110.545 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.527 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 114.79 30.85 2.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.593 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.43 169.49 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -1.131 . . . . 0.0 110.74 -174.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.569 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.7 170.96 8.19 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.341 -0.849 . . . . 0.0 109.039 174.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -63.27 140.57 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.794 -1.192 . . . . 0.0 110.429 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 11' ' ' VAL . . . 77.82 -2.95 62.31 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 172.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.568 ' HB2' HG13 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -59.64 -159.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.101 -1.235 . . . . 0.0 110.394 174.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 54.6 pttt -138.79 119.76 14.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.78 . . . . 0.0 109.836 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.564 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -123.02 161.38 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 109.895 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.474 ' HB2' ' CD1' ' A' ' 8' ' ' ILE . 20.0 ttpt -105.31 120.02 40.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 62.6 t -103.71 121.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.7 mtt180 -111.3 131.84 54.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.358 -0.839 . . . . 0.0 110.146 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.534 ' CD ' ' HB3' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -74.91 137.87 41.99 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.45 -169.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.066 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -127.99 170.98 12.27 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.427 ' CG2' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.01 159.95 16.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 111.052 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.409 ' H ' ' HA ' ' A' ' 162' ' ' VAL . 16.9 pt-20 -146.29 173.68 12.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.94 99.03 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.681 -1.262 . . . . 0.0 110.178 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 162' ' ' VAL . . . -54.09 138.79 36.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -0.803 . . . . 0.0 110.301 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.535 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -103.96 -28.25 11.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.955 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.47 ' HE3' ' OE2' ' A' ' 171' ' ' GLU . 52.5 tttp -150.04 123.08 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.761 -1.212 . . . . 0.0 110.253 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.477 HG22 HG23 ' A' ' 155' ' ' THR . 9.7 p -137.07 140.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 110.484 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 21.7 m -110.98 134.52 52.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.968 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -130.79 159.83 36.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.392 -0.817 . . . . 0.0 110.162 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.494 ' CB ' ' HD2' ' A' ' 173' ' ' ARG . . . -128.74 100.04 22.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 110.438 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -56.2 122.26 11.46 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.007 1.53 . . . . 0.0 110.039 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 49.0 mm -89.86 109.87 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.12 -0.987 . . . . 0.0 110.245 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.507 ' CD1' ' CG ' ' A' ' 108' ' ' GLN . 20.0 pt -150.09 -160.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.266 -0.896 . . . . 0.0 110.629 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.538 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . 22.6 mmt180 -112.19 157.94 20.28 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.296 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -60.05 -17.82 41.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 109.781 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.538 ' OD1' ' HB3' ' A' ' 105' ' ' ARG . 12.2 p-10 -100.73 32.72 3.02 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.553 ' OE1' ' HG ' ' A' ' 110' ' ' LEU . 1.3 pp0? -80.84 149.89 29.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.454 -0.779 . . . . 0.0 110.241 -174.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.437 ' O ' ' HE2' ' A' ' 111' ' ' LYS . 33.5 ttm180 -89.08 -13.1 39.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 110.889 -174.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.553 ' HG ' ' OE1' ' A' ' 108' ' ' GLN . 0.7 OUTLIER -98.0 77.98 2.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 0.0 110.133 -177.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -133.19 62.93 1.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.519 -0.738 . . . . 0.0 109.987 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -90.46 -56.15 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.107 -0.996 . . . . 0.0 110.616 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 74.85 -169.1 54.61 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 113' ' ' GLY . 98.8 mt-10 45.91 99.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.207 -1.172 . . . . 0.0 110.151 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.89 -23.09 11.27 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 117' ' ' GLU . 8.2 tt -59.54 -34.57 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.071 -1.252 . . . . 0.0 110.257 176.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' N ' HG22 ' A' ' 116' ' ' ILE . 97.2 mt-10 -60.03 -44.81 94.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.62 -37.25 86.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 109.594 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -60.0 -39.99 87.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.812 . . . . 0.0 109.599 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.49 ' CG1' HD11 ' A' ' 170' ' ' ILE . 79.3 t -59.99 -46.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.992 . . . . 0.0 109.371 175.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.596 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.88 -39.82 86.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 175.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.05 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.81 65.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.353 -0.842 . . . . 0.0 110.577 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 125' ' ' ILE . 86.0 mt -91.04 -9.46 45.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.834 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 3.3 tt -42.39 167.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.591 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 164' ' ' ILE . 26.1 ptt180 33.26 46.2 0.1 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.692 -0.63 . . . . 0.0 111.429 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.501 ' CG ' ' HD2' ' A' ' 128' ' ' PRO . 18.8 ttm180 -132.07 142.5 45.33 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.653 -1.28 . . . . 0.0 111.225 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.796 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.7 Cg_endo -64.6 126.34 16.62 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 124.258 1.662 . . . . 0.0 109.427 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.542 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.4 mmm -124.6 145.58 49.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.395 -1.441 . . . . 0.0 111.076 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 12.8 tp -142.55 116.67 9.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.5 pm0 -47.9 148.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.911 -1.118 . . . . 0.0 110.517 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 74.98 -2.41 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.788 -0.57 . . . . 0.0 110.871 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.56 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 2.2 p30 -69.34 -171.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.463 ' C ' HG13 ' A' ' 135' ' ' ILE . 15.1 m-80 -149.44 132.15 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.538 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.517 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -136.45 162.2 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 110.486 -178.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.0 t -134.56 148.21 50.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.672 -0.642 . . . . 0.0 110.268 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.65 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 51.9 t -133.63 -65.01 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 111.039 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 36.4 Cg_endo -70.11 122.7 9.27 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.104 1.055 . . . . 0.0 110.39 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -95.62 44.57 2.08 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.89 152.88 49.74 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.465 -1.021 . . . . 0.0 110.072 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.546 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -131.51 -171.1 2.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.096 -1.002 . . . . 0.0 110.787 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.546 ' N ' ' OG1' ' A' ' 141' ' ' THR . 87.1 mt -139.79 -123.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.683 -0.636 . . . . 0.0 109.967 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.22 -154.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.28 -0.888 . . . . 0.0 110.683 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.25 57.58 4.65 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -102.71 158.1 16.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.399 -1.059 . . . . 0.0 110.316 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.3 t -139.92 155.45 47.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.123 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.21 -91.26 0.75 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 3.4 mp 49.68 56.9 7.15 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.214 -1.168 . . . . 0.0 110.366 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 1.4 pp -140.37 166.77 23.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.348 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -93.1 120.73 33.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.952 -1.093 . . . . 0.0 110.094 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.452 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 15.3 tptm -97.77 106.35 18.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 109.725 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.56 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 2.8 t -76.64 134.47 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.995 . . . . 0.0 109.716 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.47 -20.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 110.457 -177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.5 tttm -139.58 140.42 37.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.68 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.477 HG23 HG22 ' A' ' 98' ' ' VAL . 47.0 p -139.75 161.53 37.33 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.7 -0.625 . . . . 0.0 109.602 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.69 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.55 -34.41 0.42 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 110.992 -177.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 29.4 Cg_exo -55.82 -168.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.343 1.181 . . . . 0.0 110.197 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 16.1 t -90.15 40.18 1.0 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.651 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 158' ' ' SER . 26.4 mmtp 59.97 42.31 16.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.2 m -136.07 160.06 68.64 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.533 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -49.53 120.11 5.42 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 124.09 1.574 . . . . 0.0 110.155 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 11.7 m -128.19 159.52 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.479 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -103.93 124.48 49.07 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.574 ' O ' ' N ' ' A' ' 126' ' ' ARG . 16.1 mm -72.06 153.67 7.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.817 -0.552 . . . . 0.0 110.301 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.53 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -140.8 166.67 25.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -58.14 -18.24 24.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.04 . . . . 0.0 110.29 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -89.21 -13.72 37.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.92 . . . . 0.0 110.375 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.501 ' HB ' ' OE1' ' A' ' 121' ' ' GLN . 7.2 m -62.52 150.82 39.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.014 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -98.6 153.62 18.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.27 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.59 HD12 ' HG2' ' A' ' 121' ' ' GLN . 3.6 mm -119.88 134.81 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 110.927 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.47 ' OE2' ' HE3' ' A' ' 97' ' ' LYS . 37.0 mt-10 -119.7 132.55 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.564 172.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.446 HG12 ' HG2' ' A' ' 117' ' ' GLU . 21.4 mm -127.33 122.78 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.457 -0.777 . . . . 0.0 109.748 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.494 ' HD2' ' CB ' ' A' ' 101' ' ' ALA . 13.3 ptp180 -90.07 166.36 13.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.057 -1.027 . . . . 0.0 110.506 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.502 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 28.9 tp10 -99.81 9.76 42.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 110.692 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.37 109.39 42.53 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 110.282 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.2 Cg_exo -73.08 -156.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.07 1.563 . . . . 0.0 110.545 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -77.22 54.4 1.09 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.671 -0.643 . . . . 0.0 110.068 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 1.5 m -69.49 127.27 32.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 110.125 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 178' ' ' SER . 84.0 tt0 59.99 14.64 4.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 110.723 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 62.5 t -110.04 120.07 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.992 -1.067 . . . . 0.0 110.374 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -129.17 4.2 5.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.09 -1.006 . . . . 0.0 110.283 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 181' ' ' LEU . 40.9 mt-10 59.4 13.37 3.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.351 -0.843 . . . . 0.0 111.017 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 181' ' ' LEU . 78.8 mm-40 -69.98 149.99 47.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.913 -1.117 . . . . 0.0 110.174 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.95 96.46 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.613 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.286 0.565 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -80.03 160.03 25.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 t -116.98 132.95 56.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 0.0 110.351 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -121.08 129.36 53.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.268 -0.895 . . . . 0.0 110.422 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -130.67 170.02 14.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.203 -0.936 . . . . 0.0 110.447 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.81 -166.49 11.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.594 ' CD1' HD12 ' A' ' 33' ' ' LEU . 20.5 pt -132.52 160.02 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.24 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.4 mt -100.12 117.81 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.7 pt? -136.87 -168.3 2.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.625 176.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 29.0 ptt180 -115.65 138.61 50.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.826 -1.172 . . . . 0.0 110.894 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 80' ' ' SER . 14.6 p -62.64 137.51 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.766 -0.584 . . . . 0.0 110.713 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -112.03 147.24 36.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 110.415 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -179.85 90.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.145 176.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.95 87.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.314 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -135.87 173.51 11.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.913 . . . . 0.0 110.117 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -100.0 120.2 39.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.869 . . . . 0.0 110.202 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -107.87 137.14 46.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 110.386 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.657 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -64.64 -38.76 34.19 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.883 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 24.6 Cg_exo -58.56 -169.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.621 1.327 . . . . 0.0 110.581 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' A' ' 70' ' ' ASP . . . 164.35 85.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.517 ' HG3' ' HB3' ' A' ' 23' ' ' ARG . 28.6 ptm -97.23 18.7 14.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -1.114 . . . . 0.0 110.361 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 21' ' ' MET . 22.1 p 50.01 48.32 22.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.183 -0.948 . . . . 0.0 110.407 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.517 ' HB3' ' HG3' ' A' ' 21' ' ' MET . 39.2 ptt180 -95.92 137.42 35.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 109.998 175.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 55' ' ' TYR . 75.2 t -117.15 113.56 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.02 . . . . 0.0 110.086 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.504 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 8.2 ptt180 -92.26 120.11 32.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.704 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 1.2 mp -135.38 165.75 24.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.071 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 23.1 p-10 -90.02 -176.48 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.115 -0.991 . . . . 0.0 110.584 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.1 -45.15 93.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.282 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 43.5 t -60.24 -49.25 78.36 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.165 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.628 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 74.7 m -56.68 -29.44 62.37 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.128 -0.983 . . . . 0.0 109.607 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 68.1 ttt-85 -82.5 -45.35 14.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.0 110.763 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -87.61 -0.26 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.628 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.5 pt? -52.56 -26.36 13.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.59 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 71.4 mt -142.27 -59.07 0.46 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.53 -0.731 . . . . 0.0 110.329 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.8 t0 -170.72 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 110.022 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.558 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -21.9 118.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.497 0.665 . . . . 0.0 111.373 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.502 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -107.78 176.75 5.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.8 mm -59.12 125.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.822 -1.174 . . . . 0.0 109.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.47 27.49 61.3 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.566 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 52.3 m-20 -89.49 173.29 8.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.428 . . . . 0.0 109.72 171.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.527 ' CG2' HG21 ' A' ' 92' ' ' THR . 64.7 t -99.48 131.45 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.017 -1.052 . . . . 0.0 110.269 -176.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG13 HG23 ' A' ' 54' ' ' VAL . 2.2 m -117.06 139.83 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.176 -0.953 . . . . 0.0 110.301 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -108.32 140.12 42.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.395 -0.816 . . . . 0.0 109.565 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.599 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.1 mp -122.78 145.45 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.903 -1.123 . . . . 0.0 110.592 -176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -150.13 95.19 2.25 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.834 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.536 ' CG ' HG12 ' A' ' 85' ' ' VAL . 12.6 tmtt? -97.92 -65.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.766 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG22 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.91 -36.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.457 -0.777 . . . . 0.0 109.225 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 68.2 mtp85 -127.99 -160.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.664 0.745 . . . . 0.0 110.111 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.467 ' HB3' HD21 ' A' ' 130' ' ' LEU . 3.1 mtmt -106.13 131.38 53.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 110.369 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.599 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.7 p -138.51 165.0 27.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.855 . . . . 0.0 110.112 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.559 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.39 166.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.603 -0.686 . . . . 0.0 109.913 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' C ' HG23 ' A' ' 42' ' ' VAL . . . -178.0 -174.28 44.17 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -122.07 164.96 16.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -1.083 . . . . 0.0 110.02 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.499 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -92.54 139.99 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 110.747 -172.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 24' ' ' VAL . 2.2 m-85 -125.81 162.5 24.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.52 -0.738 . . . . 0.0 110.125 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 8.7 ptp180 -89.91 124.6 34.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.34 -0.85 . . . . 0.0 109.905 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -64.5 136.4 57.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.809 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.578 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -57.85 -50.06 90.24 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 109.071 175.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 38.0 Cg_endo -92.98 98.01 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.867 1.456 . . . . 0.0 108.868 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.59 38.22 0.12 Allowed 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 59' ' ' PRO . 72.9 m-20 -143.75 -38.94 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.613 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 13.8 pt-20 -85.56 -22.39 28.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.007 . . . . 0.0 109.727 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.489 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 27.9 m-80 -81.68 37.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 110.715 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 54.4 pttt -98.43 12.25 35.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.997 -1.065 . . . . 0.0 109.547 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.82 26.53 0.05 OUTLIER Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.489 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -140.53 144.9 26.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.3 -1.117 . . . . 0.0 109.177 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 67' ' ' VAL . 6.5 p -125.83 129.91 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.029 -1.045 . . . . 0.0 110.265 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 58.8 ttt85 -89.7 119.93 30.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.539 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 3.8 pt -130.6 167.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.818 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.445 ' CB ' ' HA2' ' A' ' 20' ' ' GLY . 3.7 t0 -80.06 166.51 21.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.065 176.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.4 t -60.21 -39.98 88.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -43.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.038 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.511 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 13.3 tpt -60.06 -46.91 87.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.1 ttp85 -60.0 -39.99 87.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -70.06 -27.11 64.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.5 m-20 -60.01 -40.01 87.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.02 . . . . 0.0 110.767 -177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.479 ' HB2' HG23 ' A' ' 47' ' ' VAL . 29.5 p -99.53 -39.04 8.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.101 . . . . 0.0 110.723 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.557 ' CA ' HG22 ' A' ' 47' ' ' VAL . . . 116.13 40.73 0.8 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.61 160.73 17.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.025 -1.279 . . . . 0.0 110.659 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.554 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.9 168.88 9.14 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 176.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -53.04 139.01 11.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.034 -1.041 . . . . 0.0 110.609 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 75.65 2.58 70.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 171.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.62 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.885 -1.362 . . . . 0.0 110.228 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 22.8 pttt -131.94 109.83 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.536 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -119.97 150.24 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.955 . . . . 0.0 109.864 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 67.6 tttt -99.94 120.07 39.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.752 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.481 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.6 t -103.2 122.4 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.512 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.2 mtt180 -108.65 140.05 42.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.544 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -88.21 138.2 31.65 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.069 -1.02 . . . . 0.0 110.32 -178.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.4 m -150.17 -170.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.652 -0.655 . . . . 0.0 110.085 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.434 ' CA ' ' HB ' ' A' ' 41' ' ' VAL . 61.4 mtt180 -126.46 179.99 5.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.057 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.527 HG21 ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.76 162.73 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 111.209 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -150.03 169.13 21.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.23 97.87 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.33 -1.482 . . . . 0.0 110.3 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.54 ' CB ' HG21 ' A' ' 162' ' ' VAL . . . -56.22 138.82 49.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -0.837 . . . . 0.0 110.387 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HD2' ' CD1' ' A' ' 156' ' ' LEU . 18.6 ptpt -97.22 -27.17 14.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 111.153 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 31.5 tttt -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.82 -1.175 . . . . 0.0 110.558 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 155' ' ' THR . 5.7 p -136.13 142.53 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 171' ' ' GLU . 97.7 m -115.81 136.37 53.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.283 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -131.42 160.07 36.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.478 -0.763 . . . . 0.0 110.155 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -146.23 101.74 4.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.922 . . . . 0.0 110.883 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 15.4 Cg_exo -64.14 129.24 23.74 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.072 1.564 . . . . 0.0 110.299 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.503 HD12 ' CD1' ' A' ' 149' ' ' LEU . 80.6 mt -93.05 106.05 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.666 -178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.623 ' CD1' ' HB2' ' A' ' 108' ' ' GLN . 1.5 pt -148.17 176.87 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 173.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 95.4 mtt-85 -133.95 -131.85 0.17 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.474 -0.766 . . . . 0.0 109.737 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -60.01 -13.49 11.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.927 -1.108 . . . . 0.0 109.76 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 145' ' ' GLN . 11.7 p-10 -99.92 24.43 8.49 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.77 -0.581 . . . . 0.0 110.264 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.623 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 13.3 pt20 -83.63 106.46 15.37 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.066 -1.021 . . . . 0.0 109.947 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -100.77 -11.7 19.69 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.621 -0.674 . . . . 0.0 110.494 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 1.4 pp -99.2 52.96 0.96 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.912 . . . . 0.0 110.436 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 0.6 OUTLIER -103.25 93.09 4.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 110.128 176.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.45 ' HB2' ' CD1' ' A' ' 116' ' ' ILE . 76.4 m-85 -98.34 -75.68 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.981 . . . . 0.0 110.553 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.0 -177.33 54.36 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 46.73 86.67 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -1.182 . . . . 0.0 110.287 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.01 -1.07 89.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 112' ' ' PHE . 9.3 tp -60.39 -31.67 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -1.197 . . . . 0.0 110.194 176.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.468 ' HG2' HG12 ' A' ' 172' ' ' ILE . 98.9 mt-10 -60.01 -44.76 94.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.747 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -70.03 -40.0 75.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.839 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -59.87 -40.11 87.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.845 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 170' ' ' ILE . 49.0 t -60.05 -45.69 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.38 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.577 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 6.7 mt-30 -59.92 -47.7 84.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.609 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.51 -0.744 . . . . 0.0 110.41 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.47 ' HB1' HD22 ' A' ' 124' ' ' LEU . . . -69.35 -39.92 77.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.757 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.487 ' HB3' ' NE ' ' A' ' 127' ' ' ARG . 3.0 mm? -130.07 24.2 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 111.123 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.9 tt -48.31 176.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.094 . . . . 0.0 110.003 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 34.5 ptt180 33.96 49.14 0.27 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.527 -0.733 . . . . 0.0 111.204 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.49 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 36.9 ttp180 -128.35 142.59 45.19 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.925 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.2 Cg_endo -62.17 131.73 35.83 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.961 1.506 . . . . 0.0 110.079 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.511 ' CG ' HG12 ' A' ' 164' ' ' ILE . 96.7 mmm -123.48 140.03 53.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 110.952 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 19.7 tp -142.49 105.64 4.58 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.61 -0.681 . . . . 0.0 109.67 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.674 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.7 pt-20 -48.47 141.1 7.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.974 -1.079 . . . . 0.0 110.67 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 86.2 mm-40 79.93 -1.68 2.07 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.167 0.508 . . . . 0.0 110.498 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 1.9 p30 -69.98 -172.42 0.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.047 -1.033 . . . . 0.0 110.31 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -144.11 137.72 27.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.737 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.39 170.16 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.084 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -140.02 146.81 39.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 110.284 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.629 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 8.0 t -114.13 -68.1 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.824 . . . . 0.0 110.769 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.629 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 35.0 Cg_endo -69.62 131.87 22.35 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.222 1.117 . . . . 0.0 110.29 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -98.48 47.0 1.47 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.61 159.98 43.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.055 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -121.36 -168.29 1.65 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.614 -178.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' A' ' 141' ' ' THR . 82.5 mt -143.79 -140.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.624 -0.672 . . . . 0.0 109.756 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.09 -153.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.072 175.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.51 72.9 1.68 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 171.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.595 ' NE2' ' CD1' ' A' ' 148' ' ' LEU . 2.3 pt20 -96.62 164.96 12.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.499 -1.0 . . . . 0.0 110.08 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 t -140.07 149.72 43.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.167 -0.958 . . . . 0.0 110.686 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.407 ' O ' HD22 ' A' ' 149' ' ' LEU . . . 94.96 -92.78 1.55 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.595 ' CD1' ' NE2' ' A' ' 145' ' ' GLN . 0.2 OUTLIER 44.34 41.39 4.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.263 -1.139 . . . . 0.0 111.273 177.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.503 ' CD1' HD12 ' A' ' 103' ' ' ILE . 1.4 pp -140.46 161.21 38.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.797 -1.189 . . . . 0.0 109.83 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 3.2 m-85 -91.02 120.55 32.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 109.92 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -104.7 108.84 20.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.32 -0.862 . . . . 0.0 109.978 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.537 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 3.1 t -76.48 132.68 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.683 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 t -114.61 -30.1 2.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 111.108 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -144.75 150.2 36.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.782 -1.199 . . . . 0.0 111.272 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.493 HG22 HG23 ' A' ' 98' ' ' VAL . 72.3 p -140.33 161.32 37.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 109.427 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.654 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.64 -38.69 0.45 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.843 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.654 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 18.0 Cg_exo -58.39 -166.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.575 1.303 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.8 t -90.05 -171.09 3.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -65.33 -5.88 8.49 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.201 -0.937 . . . . 0.0 110.64 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.1 m -85.2 145.36 42.74 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.405 -0.81 . . . . 0.0 110.287 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.559 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -48.5 141.37 19.79 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.285 1.676 . . . . 0.0 110.796 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.782 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 11.2 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.493 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.4 tt0 -107.62 130.67 54.88 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.13 -0.982 . . . . 0.0 110.241 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 126' ' ' ARG . 19.0 mm -69.75 152.51 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 110.029 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.65 169.9 26.4 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -56.5 -17.97 10.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -1.117 . . . . 0.0 109.923 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.13 -25.76 18.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.567 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 91.3 m -56.57 142.3 39.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.791 . . . . 0.0 110.089 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 43.6 mmtm -91.96 154.86 18.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.856 -1.153 . . . . 0.0 110.186 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.577 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 1.4 mm -119.92 130.04 74.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.365 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 99' ' ' THR . 21.9 mt-10 -112.68 136.09 52.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 110.23 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.519 ' CD1' HG21 ' A' ' 170' ' ' ILE . 7.5 mm -124.59 134.86 65.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.608 -0.682 . . . . 0.0 109.57 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.556 ' O ' ' CD ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -88.08 148.2 24.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.344 -174.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -93.21 -14.95 26.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 109.95 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -100.01 110.21 58.71 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.384 -0.822 . . . . 0.0 109.928 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.1 -156.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.074 1.565 . . . . 0.0 110.125 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.448 ' HB1' ' CG2' ' A' ' 103' ' ' ILE . . . -90.21 42.04 1.08 Allowed 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.546 -0.722 . . . . 0.0 110.48 -174.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.514 ' C ' ' HG3' ' A' ' 179' ' ' GLU . 9.7 m -85.95 23.95 1.38 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.416 -0.803 . . . . 0.0 111.38 -177.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.514 ' HG3' ' C ' ' A' ' 178' ' ' SER . 98.4 mt-10 -154.21 12.38 0.42 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.686 -1.259 . . . . 0.0 110.307 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.51 120.0 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.237 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.19 29.89 7.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.96 -42.69 94.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.194 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -60.03 140.03 57.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 0.0 110.255 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.06 143.87 19.86 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.976 -1.458 . . . . 0.0 109.496 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HG3' ' N ' ' A' ' 2' ' ' GLU . 23.1 ptm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.124 0.488 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' A' ' 1' ' ' MET . 86.4 tt0 -131.05 126.31 35.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.093 -1.005 . . . . 0.0 110.135 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.96 38.4 16.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 110.195 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -112.19 110.06 20.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.154 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 27.7 m120 -151.4 166.27 31.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 110.47 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.493 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -149.36 -159.94 8.89 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.546 HG13 ' CD2' ' A' ' 9' ' ' LEU . 15.4 pt -138.97 163.96 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -1.188 . . . . 0.0 109.805 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.494 HD12 ' HG3' ' A' ' 86' ' ' LYS . 48.1 mm -101.0 120.49 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.299 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -140.87 -176.54 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.713 177.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 28.3 ptt180 -117.01 144.11 44.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.838 -1.164 . . . . 0.0 110.524 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.591 HG13 ' HA ' ' A' ' 81' ' ' ILE . 3.3 p -61.37 140.64 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.621 -0.674 . . . . 0.0 110.899 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -118.88 144.23 46.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 110.583 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.4 tt0 -179.04 131.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.265 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.24 -70.04 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 110.326 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 15' ' ' ASN . 6.0 p30 -164.49 84.82 0.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m 59.99 31.65 20.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.964 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.474 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 74.3 p -99.64 171.55 7.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 110.159 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 17' ' ' THR . 3.3 p30 37.24 64.68 2.74 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.629 -0.67 . . . . 0.0 110.373 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 39.8 Cg_exo -55.83 -175.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.053 1.554 . . . . 0.0 110.032 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.35 94.4 1.72 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 73' ' ' MET . 3.9 ptt? -87.58 -6.49 58.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -1.125 . . . . 0.0 109.774 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 3.6 t -100.02 6.96 45.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.848 . . . . 0.0 110.093 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.555 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 76.5 mtt85 -120.07 133.61 55.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.932 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 84.8 t -119.73 116.17 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.979 -1.076 . . . . 0.0 110.269 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.548 ' NE ' ' HG3' ' A' ' 68' ' ' ARG . 3.8 ptt180 -88.17 119.46 28.58 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.68 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.523 HD12 ' CB ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -137.95 177.42 7.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.751 -0.593 . . . . 0.0 109.684 -175.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 22.2 p-10 -103.07 179.73 4.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -59.97 -44.87 94.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.406 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 68.0 m -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.03 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.648 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 28.6 t -65.3 -28.22 69.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 27.8 ttm180 -80.86 -46.72 14.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.556 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.98 -9.62 59.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.648 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.3 pt? -47.22 -24.25 0.68 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.693 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.596 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 66.5 mt -141.27 -62.78 0.47 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.548 -0.72 . . . . 0.0 110.266 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.3 t0 -172.89 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.534 -0.729 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -31.38 141.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.463 0.649 . . . . 0.0 111.509 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -131.23 171.2 13.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.411 HD13 ' CG ' ' A' ' 56' ' ' ARG . 38.4 mm -63.47 79.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.674 -1.266 . . . . 0.0 110.208 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 37' ' ' GLU . . . 169.32 -4.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.552 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.438 ' CG ' ' NZ ' ' A' ' 89' ' ' LYS . 95.9 m-20 -111.94 168.75 9.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.384 -1.657 . . . . 0.0 110.874 -170.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 90' ' ' VAL . 72.1 t -103.65 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.107 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.4 m -110.84 145.88 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.17 -0.956 . . . . 0.0 110.592 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 86.5 tt0 -109.38 140.78 42.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.82 . . . . 0.0 109.827 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.581 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.1 mp -121.21 143.16 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.991 -1.068 . . . . 0.0 110.622 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -149.42 97.71 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.845 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HD2' ' CB ' ' A' ' 79' ' ' ALA . 8.5 tmtm? -97.98 -62.52 1.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.518 HG23 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -109.3 -36.33 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.644 0.735 . . . . 0.0 109.237 175.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 78.9 mtt85 -125.7 -172.91 2.71 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.726 -0.609 . . . . 0.0 109.59 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.489 ' HG2' HD21 ' A' ' 130' ' ' LEU . 0.3 OUTLIER -100.13 133.2 44.87 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.108 178.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.581 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.4 p -140.45 167.48 22.05 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.445 0.641 . . . . 0.0 109.679 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.662 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 3.6 m -116.46 175.75 2.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.744 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.84 -179.17 48.54 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 22' ' ' SER . 66.7 mtm180 -121.02 167.81 12.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 0.0 110.075 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.93 135.02 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.152 -0.967 . . . . 0.0 110.73 -174.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.555 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 3.6 m-85 -130.6 166.61 20.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.756 . . . . 0.0 110.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.432 ' HG2' ' NH2' ' A' ' 31' ' ' ARG . 21.5 mtt180 -89.43 124.04 34.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . . . -65.13 137.88 57.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.712 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.68 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 8.6 mmm180 -57.44 -45.89 99.84 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 109.027 174.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.68 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.0 Cg_endo -92.01 98.54 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.748 1.393 . . . . 0.0 108.853 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -75.26 35.84 0.12 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 59' ' ' PRO . 55.2 t0 -146.59 -37.28 0.23 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 110.873 -177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 16.3 pt-20 -84.8 -20.58 30.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.503 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 2.9 m-80 -81.63 36.58 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 110.719 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 58.4 pttt -98.31 17.5 18.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.952 -1.093 . . . . 0.0 109.388 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 176.84 21.38 0.03 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.503 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.11 152.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.196 -1.179 . . . . 0.0 109.191 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 HG13 ' A' ' 24' ' ' VAL . 7.9 p -130.02 129.98 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.98 -1.075 . . . . 0.0 110.131 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.548 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 22.5 mmm180 -91.33 111.74 23.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.508 HD13 ' HG2' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -136.06 171.78 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.383 -0.823 . . . . 0.0 110.553 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -81.24 166.9 20.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 0.0 110.263 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 79.5 p -69.94 -19.28 63.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.339 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.55 -47.29 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.112 -0.993 . . . . 0.0 110.483 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.491 ' CE ' ' O ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -61.33 -47.48 85.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 109.289 177.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.563 ' HD2' ' CG2' ' A' ' 11' ' ' VAL . 5.9 mmp_? -60.04 -39.94 87.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 110.245 173.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 71' ' ' SER . 47.8 t-20 -64.09 -31.82 73.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.959 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 10.7 m120 -60.01 -36.29 76.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.394 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.2 p -98.38 -38.79 9.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.059 -1.025 . . . . 0.0 110.581 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.518 ' CA ' HG23 ' A' ' 47' ' ' VAL . . . 119.79 40.05 0.63 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.553 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -120.85 166.17 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.062 -1.258 . . . . 0.0 110.611 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.532 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -118.7 176.17 5.39 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.591 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -55.84 142.58 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.074 -1.017 . . . . 0.0 110.418 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.52 ' N ' HG11 ' A' ' 11' ' ' VAL . . . 75.96 0.76 65.8 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 172.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.578 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.3 m-20 -59.82 -167.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.849 -1.383 . . . . 0.0 110.124 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.5 pttp -132.53 115.28 15.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.701 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.532 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -125.43 153.47 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 109.574 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HG3' HD12 ' A' ' 8' ' ' ILE . 60.7 tttt -99.94 121.48 41.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.095 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.485 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 65.6 t -98.99 119.99 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.956 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.493 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 87.2 mtm180 -116.2 142.53 46.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 109.807 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.438 ' NZ ' ' CG ' ' A' ' 40' ' ' ASP . 50.6 tttp -75.99 146.59 39.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.002 -1.061 . . . . 0.0 110.543 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 41' ' ' VAL . 1.9 m -149.98 -168.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.967 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -138.76 170.0 16.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.41 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.72 156.71 21.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 111.3 -175.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 163' ' ' GLU . 1.2 pm0 -150.31 169.71 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.406 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 4.5 mp -89.13 98.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.595 -1.316 . . . . 0.0 110.402 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.526 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -55.51 163.45 1.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.422 -0.798 . . . . 0.0 110.819 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.514 ' CG ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -136.16 -17.86 1.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.456 -0.778 . . . . 0.0 110.913 -178.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.567 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 32.9 tttt -149.59 119.92 7.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.887 -1.133 . . . . 0.0 110.336 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' A' ' 155' ' ' THR . 5.5 p -137.2 140.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 110.718 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.4 m -109.29 135.08 50.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -130.11 160.97 32.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 110.418 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.15 87.42 39.23 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.58 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.78 134.95 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.979 1.515 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 29.4 mm -102.15 103.77 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 110.754 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.583 HG13 ' N ' ' A' ' 105' ' ' ARG . 18.7 pt -142.89 -151.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 122.142 0.973 . . . . 0.0 109.956 171.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.583 ' N ' HG13 ' A' ' 104' ' ' ILE . 81.6 mtp180 -136.97 159.96 40.32 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.324 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -61.74 -15.53 41.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.412 -0.805 . . . . 0.0 110.174 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 34.2 p-10 -130.09 31.33 4.68 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.684 -0.635 . . . . 0.0 110.017 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.516 ' HG2' ' HB2' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -86.43 -69.99 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.101 -1.0 . . . . 0.0 110.38 -176.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.538 ' HG3' HD12 ' A' ' 110' ' ' LEU . 45.5 tpt85 -139.69 -87.92 0.2 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.11 -0.994 . . . . 0.0 110.341 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.61 ' C ' ' CD2' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -141.05 175.43 9.63 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 120.956 -1.09 . . . . 0.0 110.6 -175.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.586 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 46.1 pttt -130.75 156.01 45.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 109.492 176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.55 ' HB2' ' CD1' ' A' ' 116' ' ' ILE . 12.3 m-85 -97.85 -52.11 3.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.014 -1.053 . . . . 0.0 110.315 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 116' ' ' ILE . . . 73.82 -152.95 46.57 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -46.05 145.42 1.56 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.713 -0.875 . . . . 0.0 109.83 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.6 -16.66 34.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 112' ' ' PHE . 11.9 tt -62.39 -37.3 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.082 -1.246 . . . . 0.0 110.017 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 170' ' ' ILE . 98.9 mt-10 -59.99 -44.76 94.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.046 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -67.92 -39.97 83.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.833 . . . . 0.0 110.025 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -40.0 88.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.905 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.539 ' HB ' HG22 ' A' ' 170' ' ' ILE . 54.6 t -62.15 -44.9 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.369 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.611 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 6.3 mt-30 -59.94 -45.44 92.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.086 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.38 -41.43 93.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.487 -0.758 . . . . 0.0 109.862 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.57 -48.05 61.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 110.68 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.4 mm? -105.14 12.97 31.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.1 -1.0 . . . . 0.0 111.513 -173.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.5 tt -49.34 169.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.615 -1.303 . . . . 0.0 110.391 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 29.0 ptt180 32.98 46.07 0.08 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.599 -0.688 . . . . 0.0 111.646 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.9 mmt85 -134.76 152.44 77.54 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 120.714 -1.241 . . . . 0.0 111.358 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.757 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.1 Cg_endo -62.04 123.25 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.225 1.645 . . . . 0.0 109.684 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.482 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 15.4 mmt -137.37 137.9 39.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.554 -1.341 . . . . 0.0 110.433 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.66 ' N ' ' CD1' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.81 145.2 24.78 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.478 0.656 . . . . 0.0 110.441 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 22.0 pt-20 -55.11 152.93 7.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -0.81 . . . . 0.0 111.112 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 81.95 -12.66 0.93 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.463 0.649 . . . . 0.0 110.298 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.571 ' HB3' HD11 ' A' ' 130' ' ' LEU . 0.7 OUTLIER -69.37 -174.27 0.65 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 110.388 177.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 8.3 m-80 -147.19 160.04 42.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.89 169.92 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.203 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 t -112.52 165.15 12.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.514 -0.741 . . . . 0.0 110.605 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 139' ' ' GLY . 21.2 t -100.54 145.82 30.97 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.449 -0.782 . . . . 0.0 110.044 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 10.1 Cg_endo -57.84 67.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.028 1.541 . . . . 0.0 110.922 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 41.32 53.46 4.11 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 175.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 0.5 OUTLIER -131.4 132.61 44.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.971 -1.311 . . . . 0.0 110.266 177.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -158.7 -167.09 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 110.391 -178.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.559 ' N ' ' OG1' ' A' ' 141' ' ' THR . 0.5 OUTLIER -145.72 -127.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.591 -0.693 . . . . 0.0 109.853 178.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.91 -158.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.856 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.04 81.98 1.38 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.46 ' NE2' HD22 ' A' ' 142' ' ' LEU . 5.2 pt20 -92.48 170.04 10.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.355 -1.085 . . . . 0.0 110.183 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -136.07 150.83 49.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 110.439 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.581 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 83.68 -91.38 1.62 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.2 OUTLIER 40.03 47.14 1.92 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.585 -0.95 . . . . 0.0 110.883 175.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.24 168.47 19.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.111 -0.993 . . . . 0.0 109.834 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -99.89 129.46 45.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -115.29 113.55 24.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 110.007 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.569 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 13.2 t -77.98 135.65 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.164 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 131' ' ' GLU . 9.9 t -111.99 -28.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' OE1' ' A' ' 131' ' ' GLU . 76.2 mttt -150.63 163.88 37.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.916 -1.115 . . . . 0.0 111.281 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.542 HG22 ' CG2' ' A' ' 98' ' ' VAL . 73.8 p -149.04 169.8 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.774 -0.579 . . . . 0.0 109.491 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.624 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 1.4 tt -88.49 -41.2 0.47 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.987 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 22.1 Cg_exo -56.44 -177.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.569 1.3 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.8 t -74.5 -172.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.565 174.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -69.98 -2.25 12.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.162 -0.961 . . . . 0.0 110.376 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 m -87.54 150.46 48.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 110.41 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.662 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.47 140.55 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.292 1.68 . . . . 0.0 110.985 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.757 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 5.5 m -130.02 160.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.603 171.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 21.9 pt-20 -102.52 124.63 48.43 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.948 -1.095 . . . . 0.0 110.082 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 126' ' ' ARG . 8.0 mm -71.15 154.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.666 -0.646 . . . . 0.0 110.272 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 163.66 26.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -53.23 -20.04 3.7 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.511 -0.993 . . . . 0.0 110.311 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.5 -23.12 22.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.715 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.588 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 90.2 m -54.94 145.91 19.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.963 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 85.9 mttt -95.6 149.43 21.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 110.366 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.611 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 1.3 mm -117.07 129.97 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 110.501 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 100' ' ' LEU . 57.6 mt-10 -115.45 136.26 53.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 110.166 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 120' ' ' VAL . 5.9 mt -135.27 133.61 52.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.104 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.51 ' NE ' ' HB3' ' A' ' 175' ' ' GLU . 13.0 ptm180 -89.2 -176.72 5.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 110.315 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.491 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 81.6 mm-40 -118.15 10.13 12.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.296 -0.878 . . . . 0.0 110.471 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.51 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . 5.4 tp10 -95.6 109.22 44.61 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.904 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.3 Cg_exo -71.15 -155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.181 1.622 . . . . 0.0 110.498 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.07 52.65 0.57 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.701 -0.624 . . . . 0.0 110.174 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 23.7 t -86.36 122.46 30.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 0.0 109.963 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 82.0 tt0 60.01 19.97 9.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.52 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 182' ' ' GLU . 63.0 t -104.7 128.33 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.31 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.0 85.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.532 -0.73 . . . . 0.0 110.505 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 180' ' ' VAL . 99.1 mt-10 -60.09 -40.83 90.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.04 140.02 57.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 110.358 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -178.77 -172.81 43.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.871 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptm . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.105 0.478 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -132.81 155.13 49.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 110.367 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.12 57.82 2.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -89.65 167.18 13.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.309 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -94.6 177.6 5.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 110.461 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -146.48 -165.1 11.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 23.0 pt -130.44 160.38 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -1.2 . . . . 0.0 110.17 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.5 mt -102.14 114.03 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.288 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.5 pt? -137.23 -174.32 3.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 109.786 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 30.7 ptt180 -111.55 139.59 46.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.727 -1.233 . . . . 0.0 111.025 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 80' ' ' SER . 13.5 p -62.7 135.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -116.53 145.74 43.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 86.2 tt0 -178.85 89.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.359 173.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.35 13.64 0.43 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.051 -1.031 . . . . 0.0 111.089 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -80.06 -69.94 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.941 -1.099 . . . . 0.0 110.405 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.433 ' C ' ' OG1' ' A' ' 17' ' ' THR . 47.5 t -170.42 140.7 1.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.184 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.433 ' OG1' ' C ' ' A' ' 16' ' ' SER . 3.1 p 42.84 -161.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 109.931 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.493 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 3.2 p30 -134.96 66.24 67.64 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.138 -0.976 . . . . 0.0 110.631 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 9.2 Cg_exo -73.23 111.72 3.35 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.007 1.53 . . . . 0.0 110.632 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.413 ' C ' ' OD2' ' A' ' 70' ' ' ASP . . . 93.43 86.81 1.6 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.182 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.479 ' HA ' ' HB2' ' A' ' 70' ' ' ASP . 14.1 ptp -89.6 -12.68 39.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -1.176 . . . . 0.0 109.944 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.0 p -118.22 9.47 12.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 109.952 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.503 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 99.0 mtt180 -108.34 137.35 46.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.067 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 87.4 t -116.77 120.08 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.402 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 3.7 ptt180 -86.39 118.49 25.86 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.512 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 1.4 mp -131.4 173.08 11.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.847 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.489 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 11.6 p-10 -103.23 179.42 4.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.871 -1.143 . . . . 0.0 110.702 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 88.5 mt-10 -59.99 -41.05 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -0.871 . . . . 0.0 109.059 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.638 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -64.4 -59.67 4.08 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.123 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.499 ' O ' HD21 ' A' ' 33' ' ' LEU . 65.4 m -49.99 -31.22 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.835 -1.166 . . . . 0.0 109.08 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 40.0 ttm180 -72.29 -51.76 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.584 -0.698 . . . . 0.0 111.619 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -98.92 -3.49 35.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.742 -1.224 . . . . 0.0 111.178 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.638 ' HB3' ' O ' ' A' ' 29' ' ' SER . 0.6 OUTLIER -64.96 -24.06 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.074 . . . . 0.0 109.828 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 59.6 mt -120.62 -67.88 0.95 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.034 . . . . 0.0 110.469 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 36' ' ' ALA . 43.4 t0 -171.2 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.566 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.45 118.63 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.354 0.597 . . . . 0.0 110.72 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.8 pt-20 -106.59 -178.98 3.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.2 mm -62.3 126.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.882 -1.136 . . . . 0.0 109.803 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.35 22.94 66.55 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' CG ' ' HG2' ' A' ' 37' ' ' GLU . 77.7 m-20 -89.5 169.98 10.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.814 -1.404 . . . . 0.0 109.603 171.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.506 HG21 ' OG1' ' A' ' 92' ' ' THR . 71.8 t -99.23 136.18 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.989 -1.07 . . . . 0.0 110.087 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.4 HG22 ' C ' ' A' ' 52' ' ' GLY . 1.7 m -120.71 140.05 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.094 -1.004 . . . . 0.0 110.487 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -106.82 141.25 38.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.691 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.656 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.7 mp -124.21 143.03 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.995 -1.066 . . . . 0.0 110.582 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -149.89 97.24 2.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.534 ' HB2' HG12 ' A' ' 85' ' ' VAL . 5.5 tmtm? -97.88 -55.8 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.406 -0.809 . . . . 0.0 109.626 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.515 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.29 -34.6 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.795 0.807 . . . . 0.0 108.885 176.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.584 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -131.79 179.46 6.06 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.487 ' O ' HD23 ' A' ' 130' ' ' LEU . 12.0 mtmt -89.44 132.67 34.9 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.656 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.9 p -138.07 166.7 23.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.576 -0.702 . . . . 0.0 109.809 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.582 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.89 167.66 14.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.915 179.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.4 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.05 -175.08 44.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 68.9 ttt180 -122.45 166.16 15.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.428 -1.042 . . . . 0.0 110.334 -176.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -98.34 144.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.885 . . . . 0.0 110.513 -175.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 2.5 m-85 -138.06 168.19 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.371 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.41 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 68.1 mtm180 -88.73 121.76 31.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.74 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' ND2' ' A' ' 63' ' ' ASN . . . -62.66 140.05 58.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.711 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.596 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.84 -50.0 90.61 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.841 175.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 33.6 Cg_endo -93.06 98.41 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.841 1.443 . . . . 0.0 108.886 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.26 36.13 0.1 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.426 -0.796 . . . . 0.0 110.825 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 59' ' ' PRO . 59.2 m-20 -145.59 -34.32 0.33 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.096 -1.002 . . . . 0.0 111.058 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.559 ' OE2' ' CG ' ' A' ' 59' ' ' PRO . 14.9 pt-20 -87.19 -19.12 28.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 109.601 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.492 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 21.7 m-80 -81.21 39.64 0.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 110.622 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 pttt -97.79 13.43 30.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.492 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.6 pt -140.92 144.67 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.213 -1.169 . . . . 0.0 109.583 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.1 p -121.88 129.83 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.046 -1.034 . . . . 0.0 109.859 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -93.0 114.02 26.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 -178.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.441 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.9 pp -134.66 167.82 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 21' ' ' MET . 96.7 m-20 -79.53 168.01 20.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 110.132 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 m -59.98 -39.73 86.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.279 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.1 t -61.25 -41.58 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.151 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -61.55 -48.22 81.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.256 -0.902 . . . . 0.0 109.699 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.418 ' HD2' ' CA ' ' A' ' 80' ' ' SER . 37.7 ttp180 -60.13 -40.13 88.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.027 -1.045 . . . . 0.0 109.457 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.484 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 92.6 m-20 -64.06 -33.06 74.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 73' ' ' MET . 64.4 m-20 -57.38 -34.93 69.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.584 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 30.5 p -99.38 -40.02 8.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.991 -1.068 . . . . 0.0 110.667 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.515 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.17 41.03 1.0 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.455 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -114.4 172.4 7.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.106 -1.232 . . . . 0.0 110.508 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.539 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.58 170.28 8.54 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 109.417 177.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.531 ' HA ' HG11 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -55.57 139.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.605 178.167 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 11' ' ' VAL . . . 77.08 3.83 82.18 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -59.86 -161.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.032 -1.275 . . . . 0.0 110.575 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 23.2 pttt -134.3 110.91 9.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.487 -0.758 . . . . 0.0 110.096 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 46' ' ' LYS . 1.2 m -120.01 153.99 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 109.886 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 54.2 tttt -101.07 118.62 37.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.634 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.494 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 74.8 t -102.11 120.91 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.932 . . . . 0.0 109.897 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.487 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 76.4 mtm180 -110.39 140.88 44.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 6.1 tttt -82.48 140.25 33.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 110.662 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.404 HG23 ' CD ' ' A' ' 161' ' ' PRO . 2.4 m -148.86 -165.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.492 0.663 . . . . 0.0 109.731 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.442 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.0 mtt85 -135.66 173.39 11.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.469 -0.77 . . . . 0.0 110.42 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.506 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -103.1 161.46 13.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 111.147 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -149.93 170.03 19.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 5.1 mp -89.46 97.14 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.569 -1.332 . . . . 0.0 110.351 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.514 ' HB1' HG22 ' A' ' 162' ' ' VAL . . . -55.11 140.06 39.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -0.778 . . . . 0.0 110.219 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.574 ' HD2' ' CD2' ' A' ' 156' ' ' LEU . 3.4 ptpt -106.09 -25.75 11.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 111.558 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HE2' ' OE1' ' A' ' 171' ' ' GLU . 72.2 tttt -150.3 131.92 14.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.441 -1.412 . . . . 0.0 110.709 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.432 HG21 HG23 ' A' ' 155' ' ' THR . 8.0 p -144.33 148.0 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.894 . . . . 0.0 110.652 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 59.5 m -120.68 136.8 54.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.43 -0.793 . . . . 0.0 110.195 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.56 161.66 29.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.472 ' CB ' ' HD2' ' A' ' 173' ' ' ARG . . . -139.09 89.58 12.47 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.456 -0.778 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo -58.28 135.58 69.06 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.988 1.52 . . . . 0.0 110.627 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 82.2 mt -89.89 94.32 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.334 -0.854 . . . . 0.0 110.09 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -150.99 -170.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.825 . . . . 0.0 110.841 179.227 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.569 ' O ' HD13 ' A' ' 104' ' ' ILE . 71.1 mtp180 -89.83 169.08 11.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.287 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.97 -24.49 64.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 111.117 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 35.7 p-10 -116.83 29.97 7.61 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.87 -176.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.534 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 11.4 mm-40 -91.36 -79.97 0.36 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.91 -1.119 . . . . 0.0 111.064 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' NE ' HG23 ' A' ' 104' ' ' ILE . 44.4 mtt180 -115.06 -12.81 11.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.87 -1.144 . . . . 0.0 110.041 -176.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.511 ' CD2' ' CD1' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -97.72 55.69 1.23 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.957 -177.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.22 64.73 1.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.55 -0.719 . . . . 0.0 110.014 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -137.07 -64.06 0.58 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 110.165 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.29 -175.64 52.56 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.11 82.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.138 -1.213 . . . . 0.0 110.434 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.27 4.67 83.59 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 20.9 tt -60.1 -39.92 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -1.181 . . . . 0.0 110.256 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 41.7 mt-10 -68.96 -41.3 78.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.963 -1.086 . . . . 0.0 110.313 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.97 -32.81 71.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 122' ' ' ARG . 18.7 t80 -59.86 -39.51 85.45 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.521 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.529 ' CG1' HD11 ' A' ' 170' ' ' ILE . 78.8 t -60.0 -46.63 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.206 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.649 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -60.0 -39.74 86.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 174.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 27.4 tpt180 -60.0 -43.87 94.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.333 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 -40.55 46.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 79.1 mt -92.91 -7.58 45.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.071 -1.018 . . . . 0.0 110.58 -173.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.9 tt -42.71 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 164' ' ' ILE . 33.4 ptt180 30.4 52.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.659 -0.65 . . . . 0.0 111.262 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 30.9 ttm180 -132.71 142.96 46.7 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.047 -1.033 . . . . 0.0 110.895 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.729 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -65.59 123.94 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 124.007 1.53 . . . . 0.0 109.498 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.515 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 89.2 mmm -120.21 140.62 50.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.377 -1.452 . . . . 0.0 111.126 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 17.0 tp -141.15 107.29 5.21 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.713 -0.617 . . . . 0.0 109.649 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.601 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -45.0 140.78 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 110.905 -175.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.601 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 82.11 -2.95 1.49 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.409 0.624 . . . . 0.0 110.271 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 3.8 p-10 -68.63 -172.99 0.4 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.512 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -144.83 144.21 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.492 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.3 160.69 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.828 -1.17 . . . . 0.0 110.837 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 t -141.0 143.32 34.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.665 -0.647 . . . . 0.0 109.97 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 8.4 t -110.1 -65.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.989 -1.069 . . . . 0.0 111.063 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 43.4 Cg_endo -73.11 154.37 52.25 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.201 1.106 . . . . 0.0 110.492 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -113.18 54.88 0.53 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -139.93 162.94 33.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -1.079 . . . . 0.0 110.072 -178.246 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.58 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 0.1 OUTLIER -125.28 -170.65 2.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.011 -1.056 . . . . 0.0 110.856 -176.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.543 ' N ' ' OG1' ' A' ' 141' ' ' THR . 83.1 mt -141.74 -150.23 0.31 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.307 0.575 . . . . 0.0 110.222 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.08 66.17 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 110.562 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.85 66.97 2.45 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -176.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -93.25 168.51 11.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.873 -1.369 . . . . 0.0 110.245 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -133.44 153.73 51.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.218 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.545 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 74.71 -83.77 0.79 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.47 40.15 1.24 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.461 -1.023 . . . . 0.0 111.085 176.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.4 pp -140.53 170.44 15.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.08 -1.012 . . . . 0.0 109.754 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 40.0 m-85 -89.31 121.59 31.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 109.749 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -103.29 103.86 13.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.529 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 2.7 t -75.34 139.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.8 t -130.62 -24.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.022 -1.049 . . . . 0.0 111.443 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.485 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 5.8 tttp -139.36 125.31 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 110.926 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.441 HG21 ' CB ' ' A' ' 131' ' ' GLU . 69.2 p -128.09 163.95 23.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.456 -0.777 . . . . 0.0 109.433 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.653 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 1.1 tt -89.57 -38.2 0.42 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 110.97 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 15.4 Cg_exo -60.57 -176.06 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.485 1.255 . . . . 0.0 110.237 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.43 -162.7 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -69.59 -4.51 19.52 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.303 -0.873 . . . . 0.0 110.564 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.463 ' O ' HG21 ' A' ' 160' ' ' VAL . 35.9 m -86.37 140.5 34.18 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.059 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.582 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.7 Cg_endo -47.61 141.65 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.14 1.6 . . . . 0.0 110.48 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 5.6 m -128.3 158.18 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.785 173.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -105.9 124.15 49.12 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.885 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 126' ' ' ARG . 13.8 mm -70.14 152.37 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.743 -0.598 . . . . 0.0 109.53 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.602 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.06 166.89 26.2 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -58.0 -14.11 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.957 . . . . 0.0 110.287 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -90.13 -18.07 26.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.516 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 28.0 m -62.24 153.87 29.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 110.049 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 96' ' ' LYS . 44.8 mttt -103.6 155.6 18.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 0.0 110.014 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.529 HD11 ' CG1' ' A' ' 120' ' ' VAL . 6.5 mm -119.14 137.86 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 110.975 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.435 ' OE1' ' HE2' ' A' ' 97' ' ' LYS . 12.8 mt-10 -119.94 127.14 52.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 110.514 172.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 39.5 mm -123.34 123.83 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.175 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.472 ' HD2' ' CB ' ' A' ' 101' ' ' ALA . 4.3 ptp180 -93.19 156.83 16.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 110.559 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.419 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 81.3 mm-40 -95.61 6.9 47.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.351 -0.843 . . . . 0.0 110.03 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.76 109.99 57.49 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.317 -0.864 . . . . 0.0 110.031 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 16.4 Cg_exo -68.48 -152.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.006 1.529 . . . . 0.0 109.975 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.97 47.45 0.27 Allowed 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.415 -0.803 . . . . 0.0 110.597 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 2.0 m -75.83 -70.48 0.43 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.214 -0.929 . . . . 0.0 111.184 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.88 -21.65 64.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.841 -1.162 . . . . 0.0 110.233 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 87.8 t -63.85 132.08 29.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.707 -0.621 . . . . 0.0 110.091 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.456 ' O ' ' CG ' ' A' ' 181' ' ' LEU . 0.9 OUTLIER -112.36 56.66 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 110.414 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -61.27 130.79 47.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 109.905 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.21 140.18 57.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.157 -0.964 . . . . 0.0 110.48 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 70.19 18.18 74.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 118.0 -1.444 . . . . 0.0 109.5 179.744 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.278 0.561 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -99.98 125.63 46.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.102 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.1 m -66.63 -80.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.933 . . . . 0.0 110.242 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -151.11 140.31 21.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.332 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -157.73 157.38 33.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.049 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -153.54 -167.81 16.4 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.494 ' CG2' HD11 ' A' ' 33' ' ' LEU . 22.8 pt -135.03 160.01 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -1.078 . . . . 0.0 109.651 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.5 mt -100.62 115.85 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.2 pt? -135.54 -170.86 2.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 109.562 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 49.8 ptt85 -114.79 139.99 49.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.739 -1.225 . . . . 0.0 110.855 -174.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.566 ' CG1' ' O ' ' A' ' 80' ' ' SER . 7.9 p -62.16 140.55 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.63 -0.669 . . . . 0.0 110.552 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -118.68 143.66 46.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 110.624 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 49.0 tp10 -179.79 98.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.795 . . . . 0.0 110.091 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.17 -27.08 10.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 110.309 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -110.72 128.65 55.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.93 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -108.36 35.95 2.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.197 -0.939 . . . . 0.0 110.298 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.47 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 8.8 p -111.65 170.44 8.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.279 -0.888 . . . . 0.0 110.44 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 5.0 p-10 38.05 63.41 3.69 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.589 -0.694 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 38.8 Cg_exo -56.51 -174.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.104 1.581 . . . . 0.0 110.635 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.3 20.59 37.91 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.459 ' CG ' ' HB2' ' A' ' 70' ' ' ASP . 25.5 ptp -88.26 47.99 1.58 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.119 -1.224 . . . . 0.0 109.475 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.1 p -63.82 -3.03 2.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.493 -0.755 . . . . 0.0 110.82 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.579 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 62.6 mmt-85 -88.27 145.72 25.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 109.555 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 53' ' ' ARG . 90.4 t -101.73 115.44 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.007 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.459 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 6.2 ptt180 -93.53 120.01 33.29 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.985 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' CD2' ' CB ' ' A' ' 30' ' ' SER . 2.1 mt -138.68 173.18 11.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.568 -0.708 . . . . 0.0 110.105 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.2 p-10 -95.06 -177.18 4.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -175.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.99 -49.27 78.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.506 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 23.2 t -60.36 -41.31 93.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.159 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.651 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 48.5 m -60.38 -31.11 70.04 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 175.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.471 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 66.8 ttt180 -83.43 -46.04 12.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 111.191 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -81.93 -6.04 58.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.903 -1.123 . . . . 0.0 110.235 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.651 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.7 pt? -44.33 -27.69 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.44 -0.787 . . . . 0.0 109.727 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.563 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 78.8 mt -143.67 -63.77 0.39 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 176.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -173.38 13.4 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.281 -0.887 . . . . 0.0 110.739 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.544 ' CB ' ' HE2' ' A' ' 89' ' ' LYS . . . -47.59 119.75 2.92 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.986 -1.071 . . . . 0.0 110.01 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.504 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.18 174.44 5.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.3 mm -62.47 122.22 12.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.885 -1.134 . . . . 0.0 109.672 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.424 ' CA ' ' NH2' ' A' ' 53' ' ' ARG . . . 77.46 32.06 48.53 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 19.6 m-20 -88.75 170.78 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.926 -1.338 . . . . 0.0 109.308 170.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.549 HG23 ' CG2' ' A' ' 92' ' ' THR . 69.9 t -99.14 129.61 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.02 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.7 m -115.33 136.37 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.057 -1.027 . . . . 0.0 110.471 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -109.52 143.93 38.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 109.781 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.595 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.5 mp -120.81 145.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.001 -1.062 . . . . 0.0 110.266 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.2 tt0 -152.4 87.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.906 -1.121 . . . . 0.0 111.321 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.597 ' HD3' ' CB ' ' A' ' 79' ' ' ALA . 33.8 tttp -98.99 -80.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 172.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.543 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -84.55 -36.18 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.778 . . . . 0.0 109.55 175.144 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.546 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 92.0 mtt-85 -139.54 -176.01 4.4 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.56 -0.713 . . . . 0.0 109.532 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.559 ' HG2' ' CD2' ' A' ' 130' ' ' LEU . 1.2 ttpm? -89.96 139.06 30.97 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -141.64 165.47 27.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.255 -174.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.571 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -128.44 163.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.365 -0.835 . . . . 0.0 110.283 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' C ' HG23 ' A' ' 42' ' ' VAL . . . -175.9 179.99 46.71 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 173.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.493 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 57.2 ttt85 -118.87 171.16 8.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -1.122 . . . . 0.0 110.07 -177.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.548 ' CG2' ' HE3' ' A' ' 89' ' ' LYS . 0.3 OUTLIER -101.3 132.44 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.829 -1.169 . . . . 0.0 111.416 -171.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.579 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -130.27 162.85 28.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.752 . . . . 0.0 110.392 171.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -91.43 128.6 37.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.548 -0.72 . . . . 0.0 110.305 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.42 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . . . -65.06 140.77 58.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 110.047 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.572 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.12 -50.26 88.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.09 175.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.572 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 52.7 Cg_endo -92.21 97.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.892 1.469 . . . . 0.0 108.988 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.94 41.21 0.16 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.6 -0.687 . . . . 0.0 110.377 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 59' ' ' PRO . 27.3 m-20 -143.45 -38.58 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.294 -0.879 . . . . 0.0 110.807 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.11 -22.84 28.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.942 -1.099 . . . . 0.0 109.839 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.485 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 10.6 m-80 -81.71 38.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 110.758 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 61' ' ' ASP . 11.6 ptpt -98.46 13.05 33.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.72 25.48 0.05 OUTLIER Glycine 0 N--CA 1.481 1.647 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.485 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.8 pt -140.81 140.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.431 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.3 p -119.95 127.6 75.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 25.2 ttt85 -89.59 113.69 25.16 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.757 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.416 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 1.7 pp -129.11 170.54 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.422 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' HB2' ' CG ' ' A' ' 21' ' ' MET . 8.0 t0 -79.19 164.47 24.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.991 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.4 m -59.91 -39.95 87.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 110.488 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.496 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.3 t -64.97 -44.43 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -175.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.487 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -60.8 -45.94 92.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.64 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -60.06 -40.04 88.1 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.58 -21.79 61.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.384 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 5.3 m120 -59.89 -39.77 86.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 110.711 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 27.8 p -98.49 -31.04 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.039 -1.038 . . . . 0.0 110.392 -176.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.543 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.09 29.08 3.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.597 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.29 156.14 17.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.205 -1.174 . . . . 0.0 110.505 -175.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.566 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -111.78 166.01 11.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 175.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.536 ' HA ' HG11 ' A' ' 11' ' ' VAL . 0.9 OUTLIER -54.32 139.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.418 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.18 68.72 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 1.1 m-20 -60.15 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.84 -1.388 . . . . 0.0 110.451 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 11.6 pttt -134.5 112.35 10.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 110.122 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -118.76 148.98 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -0.893 . . . . 0.0 109.791 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -95.3 116.09 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.658 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.457 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 95.4 t -102.23 122.62 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.5 mtm180 -110.11 142.5 41.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HE3' ' CG2' ' A' ' 54' ' ' VAL . 1.4 tptm -95.94 129.57 43.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 110.239 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.55 -163.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.668 0.746 . . . . 0.0 110.095 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.467 ' CA ' ' HB ' ' A' ' 41' ' ' VAL . 35.5 mtp180 -127.04 179.59 5.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 110.349 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.549 ' CG2' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.18 169.13 8.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 111.258 -176.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -149.49 169.54 20.68 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.7 mm -89.61 99.81 9.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.486 -1.384 . . . . 0.0 110.337 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.53 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -55.28 139.29 43.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.279 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HD2' ' HG ' ' A' ' 156' ' ' LEU . 17.7 ptpt -101.8 -28.37 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 111.055 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -150.25 120.21 7.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.752 -1.217 . . . . 0.0 110.741 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.479 HG23 ' CG2' ' A' ' 155' ' ' THR . 8.7 p -131.75 140.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 110.764 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.409 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 98.6 m -113.09 143.8 43.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.393 -0.817 . . . . 0.0 110.098 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.4 OUTLIER -143.14 170.15 16.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -177.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.48 ' HB3' ' HD2' ' A' ' 173' ' ' ARG . . . -142.38 97.78 6.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 110.896 -175.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -55.89 131.95 49.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 109.912 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 148' ' ' LEU . 35.1 mm -98.64 106.35 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 110.287 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.519 ' HB ' ' HG3' ' A' ' 108' ' ' GLN . 28.9 pt -150.01 -161.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.508 175.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.505 ' HB2' ' HG2' ' A' ' 108' ' ' GLN . 24.9 mmm180 -110.35 152.33 26.36 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.926 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -59.71 -14.36 13.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.28 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' A' ' 105' ' ' ARG . 9.0 p-10 -104.72 22.66 14.71 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.559 -0.713 . . . . 0.0 110.642 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.519 ' HG3' ' HB ' ' A' ' 104' ' ' ILE . 5.3 mm100 -90.53 154.57 19.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.964 -1.085 . . . . 0.0 110.866 -177.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 109' ' ' ARG . 51.4 ttt180 -89.53 -8.06 53.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.534 -0.729 . . . . 0.0 110.78 -175.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -96.82 51.99 1.16 Allowed 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 -177.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -131.52 133.92 45.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -140.57 -59.46 0.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.022 -1.049 . . . . 0.0 110.609 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 77.26 -179.22 50.67 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 113' ' ' GLY . 98.9 mt-10 47.56 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.092 -1.24 . . . . 0.0 109.786 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.13 -14.04 58.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 117' ' ' GLU . 7.3 tp -60.12 -36.46 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -1.223 . . . . 0.0 110.206 174.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.467 ' HG2' HG12 ' A' ' 172' ' ' ILE . 96.8 mt-10 -60.11 -42.84 95.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.082 -1.011 . . . . 0.0 109.432 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.54 -40.15 92.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.495 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.541 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 52.4 t80 -60.09 -40.92 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.193 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.529 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.4 t -63.84 -45.18 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.957 -1.089 . . . . 0.0 109.743 177.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 2.5 mt-30 -60.67 -44.7 96.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.663 -0.648 . . . . 0.0 110.472 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 1.9 ptm85 -69.6 -36.43 76.21 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.064 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -72.52 -42.95 64.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.681 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -102.27 1.09 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 110.998 -174.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.9 tt -43.19 171.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.042 . . . . 0.0 110.74 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.522 ' HG2' ' CG2' ' A' ' 125' ' ' ILE . 51.4 ptt85 32.57 53.8 0.34 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.634 -0.666 . . . . 0.0 111.504 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -139.71 151.28 65.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.917 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.812 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 21.1 Cg_endo -67.1 132.2 27.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.137 1.599 . . . . 0.0 109.81 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.569 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.7 mmm -128.43 146.71 50.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.34 -1.475 . . . . 0.0 111.195 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.559 ' CD2' ' HG2' ' A' ' 49' ' ' LYS . 12.7 tp -149.45 112.44 4.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.612 -0.68 . . . . 0.0 109.587 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 5.6 pt-20 -49.23 144.36 5.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.93 -1.106 . . . . 0.0 111.022 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 83.8 -8.45 1.04 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.429 0.633 . . . . 0.0 110.316 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.1 p30 -69.97 -170.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 110.617 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.406 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 13.9 m-80 -142.29 150.07 40.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.065 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.2 169.97 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.821 -1.175 . . . . 0.0 110.64 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.5 t -132.49 143.35 49.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.555 -0.716 . . . . 0.0 110.342 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 139' ' ' GLY . 94.6 t -129.07 150.51 75.56 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 121.623 -0.673 . . . . 0.0 109.185 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 1.3 Cg_endo -47.96 82.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.841 1.443 . . . . 0.0 110.056 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . -146.1 100.78 0.23 Allowed Glycine 0 C--N 1.298 -1.57 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.607 ' CD2' ' C ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -85.36 160.66 19.73 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.437 -1.037 . . . . 0.0 110.032 -176.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.522 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -85.96 -175.25 5.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.633 -1.292 . . . . 0.0 111.234 -170.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.646 ' CD1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -149.28 -115.97 0.06 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.161 178.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.581 ' N ' ' CD2' ' A' ' 142' ' ' LEU . . . -54.82 -155.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.102 -0.999 . . . . 0.0 110.39 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.2 77.22 2.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.8 164.04 11.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.449 -1.03 . . . . 0.0 110.068 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 t -139.54 150.78 45.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 110.539 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 96.24 -88.82 1.05 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 42.17 39.51 1.42 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.523 -0.987 . . . . 0.0 111.378 178.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.52 163.79 31.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.84 -1.163 . . . . 0.0 109.799 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -96.47 127.71 42.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.028 -1.045 . . . . 0.0 109.913 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.5 112.11 23.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 4.0 t -78.46 135.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.8 t -115.81 -30.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 110.953 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -145.6 149.48 34.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.863 -1.148 . . . . 0.0 110.935 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 131' ' ' GLU . 75.2 p -139.23 167.49 21.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.631 -0.668 . . . . 0.0 109.39 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.03 -39.1 0.44 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.123 -0.986 . . . . 0.0 110.872 -176.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 16.2 Cg_exo -59.01 -170.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.58 1.305 . . . . 0.0 110.162 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.8 t -90.25 -165.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -69.18 -2.98 11.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.715 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.64 143.78 34.33 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 110.415 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.571 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.1 Cg_endo -48.49 141.5 19.49 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.244 1.655 . . . . 0.0 110.964 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.812 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 9.1 m -130.07 159.95 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.035 . . . . 0.0 109.868 173.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -107.48 129.92 54.9 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.35 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.569 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 16.7 mm -72.03 154.11 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.624 -0.672 . . . . 0.0 110.381 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.95 171.46 26.12 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -55.04 -24.85 26.8 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.343 -1.092 . . . . 0.0 110.359 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.28 -17.17 27.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.17 -0.956 . . . . 0.0 110.851 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.54 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 85.3 m -58.45 140.56 53.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 0.0 110.16 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 70.9 mmtt -94.84 162.31 13.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.954 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.529 HD12 ' CG1' ' A' ' 120' ' ' VAL . 2.1 mt -139.37 160.23 28.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 111.12 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.413 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 26.2 mt-10 -137.99 132.78 32.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.467 HG12 ' HG2' ' A' ' 117' ' ' GLU . 43.6 mm -120.07 123.51 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.426 -0.796 . . . . 0.0 110.02 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.48 ' HD2' ' HB3' ' A' ' 101' ' ' ALA . 11.1 ptp180 -88.64 156.23 19.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.016 -1.053 . . . . 0.0 110.463 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 174' ' ' GLU . 41.2 tt0 -96.37 9.3 41.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 110.184 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -96.77 109.66 49.65 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 110.185 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.1 Cg_exo -71.74 -155.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.123 1.591 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.38 53.8 0.54 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.796 -0.565 . . . . 0.0 110.116 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 21.8 p -65.01 125.97 26.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 109.975 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 178' ' ' SER . 81.3 tt0 60.02 13.79 3.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 110.662 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 66.5 t -105.19 111.55 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.051 -1.031 . . . . 0.0 110.12 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 pp -132.32 -22.78 2.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.911 . . . . 0.0 110.627 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -113.28 120.12 40.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.215 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.05 -39.87 87.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.163 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -177.14 -178.62 46.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.532 -179.891 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.215 0.531 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -99.63 139.43 35.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.021 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -60.02 -40.04 87.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -115.21 116.98 29.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.126 -0.984 . . . . 0.0 110.228 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 49.4 p30 -148.25 160.1 43.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 110.032 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -155.53 -166.48 15.71 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.098 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.568 ' CG2' HD12 ' A' ' 33' ' ' LEU . 40.0 pt -134.78 159.93 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.344 -1.092 . . . . 0.0 109.421 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 36.5 mt -98.57 124.33 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.005 . . . . 0.0 110.28 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -141.1 -172.68 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 110.478 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.555 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 25.5 ttp-105 -103.89 128.79 51.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 110.947 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 83' ' ' ASP . 7.1 p -63.02 137.87 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.558 -0.714 . . . . 0.0 110.5 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -127.48 160.15 32.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.288 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 85.1 tt0 -175.05 147.12 0.91 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.306 -0.871 . . . . 0.0 110.555 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.8 147.05 51.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.261 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -73.67 -11.77 60.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.398 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.2 m -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 110.25 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -128.51 137.73 51.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.451 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.66 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -94.09 -36.4 0.31 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.317 -0.864 . . . . 0.0 111.332 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 35.0 Cg_exo -56.14 -176.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.386 1.203 . . . . 0.0 110.829 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.449 ' HA2' ' HG2' ' A' ' 23' ' ' ARG . . . 91.38 32.23 8.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.5 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 27.6 ptm -88.4 1.89 53.78 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.279 -1.13 . . . . 0.0 109.481 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.28 16.34 2.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.355 -0.841 . . . . 0.0 110.803 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.449 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 11.0 ptp180 -140.02 146.12 38.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.0 110.394 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' TYR . 55.2 t -119.95 119.14 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.807 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 5.9 ptt180 -88.38 119.53 28.9 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.837 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.54 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 1.2 mp -138.81 164.77 28.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.672 -0.643 . . . . 0.0 109.843 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.6 p-10 -89.59 -179.79 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.036 -1.04 . . . . 0.0 110.702 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.265 -175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.0 t -67.12 -40.01 86.75 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.098 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.642 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 43.7 m -64.06 -27.94 69.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.224 -0.922 . . . . 0.0 109.496 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 61.1 ttt180 -85.12 -45.17 12.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.749 -0.594 . . . . 0.0 110.834 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 22.5 tpt180 -79.59 -9.96 59.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.812 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.642 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -41.12 -30.04 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.661 0.743 . . . . 0.0 109.859 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.584 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 80.5 mt -140.54 -60.57 0.51 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.706 -0.622 . . . . 0.0 110.56 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.7 t0 -171.06 -29.42 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.193 -0.942 . . . . 0.0 110.487 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.587 ' CB ' ' HG3' ' A' ' 89' ' ' LYS . . . -21.35 123.98 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.354 0.597 . . . . 0.0 111.469 -176.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.4 pt-20 -101.12 178.98 4.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.08 123.38 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.928 -1.107 . . . . 0.0 109.765 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' N ' HG11 ' A' ' 54' ' ' VAL . . . 73.9 30.59 61.22 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 175.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.411 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 6.3 m-20 -88.84 -179.87 6.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.326 . . . . 0.0 109.514 172.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.529 ' CG1' ' HG2' ' A' ' 161' ' ' PRO . 80.1 t -99.26 127.76 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.02 -1.05 . . . . 0.0 110.467 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.3 m -119.96 142.95 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 -177.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -110.54 142.91 41.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.489 -0.757 . . . . 0.0 109.812 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.575 ' O ' ' OG1' ' A' ' 50' ' ' THR . 3.7 mp -120.02 149.33 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.221 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.0 tt0 -151.88 94.45 1.97 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 110.845 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.542 ' CG ' HG13 ' A' ' 85' ' ' VAL . 12.7 tmtt? -98.6 -66.8 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.538 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.48 -35.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.645 0.736 . . . . 0.0 109.202 175.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 1.6 mmt85 -134.12 -167.83 2.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.61 -0.681 . . . . 0.0 109.625 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.489 ' O ' HD23 ' A' ' 130' ' ' LEU . 21.9 mttm -89.72 137.32 32.43 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.803 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.6 157.44 46.76 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.251 0.548 . . . . 0.0 110.2 178.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.568 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.3 160.82 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 109.967 177.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -178.72 -178.54 48.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.79 157.46 24.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.475 -1.014 . . . . 0.0 109.922 -176.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -85.03 135.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.962 -1.086 . . . . 0.0 110.216 -175.112 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -127.7 163.15 24.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.063 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -90.01 121.82 32.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 110.098 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.449 ' HB2' ' CG ' ' A' ' 63' ' ' ASN . . . -63.45 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.926 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.645 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 5.4 mtm180 -56.16 -45.77 99.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.045 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 40.8 Cg_endo -92.65 97.54 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.882 1.464 . . . . 0.0 109.004 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.1 pt-20 -75.29 36.06 0.12 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.562 -0.711 . . . . 0.0 110.681 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.9 m-20 -147.33 -37.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 110.558 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -84.73 -24.3 28.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.492 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 1.0 OUTLIER -81.14 38.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.71 -0.619 . . . . 0.0 110.526 177.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.484 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.4 pttt -98.81 15.48 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -0.999 . . . . 0.0 109.406 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.09 24.34 0.03 OUTLIER Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.542 HG21 ' NH2' ' A' ' 10' ' ' ARG . 46.1 pt -140.77 156.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 109.046 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG23 HG13 ' A' ' 24' ' ' VAL . 3.4 p -135.38 131.48 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.908 -1.12 . . . . 0.0 110.144 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.521 ' NE ' ' HD3' ' A' ' 25' ' ' ARG . 42.9 ttp180 -92.76 118.66 31.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 110.123 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.488 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 2.6 pt -132.09 166.45 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.473 -0.767 . . . . 0.0 110.379 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 21' ' ' MET . 21.4 p-10 -83.66 177.66 8.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 110.138 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t -63.48 -35.22 79.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.0 110.92 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 66.5 t -64.18 -46.16 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 110.123 -174.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.495 ' HB2' ' OD1' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -60.38 -43.72 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.554 177.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 6.8 ttm180 -59.95 -40.87 90.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.893 174.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -69.97 -25.91 63.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.291 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 5.4 m120 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 110.618 -175.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.476 ' HB2' HG23 ' A' ' 47' ' ' VAL . 29.1 p -99.1 -37.19 9.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.042 . . . . 0.0 110.425 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.538 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 116.4 21.92 4.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.462 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . . . -99.22 169.62 9.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.169 -1.194 . . . . 0.0 110.332 -175.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.26 171.14 7.73 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.351 -0.843 . . . . 0.0 109.366 178.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.481 ' HA ' HG11 ' A' ' 11' ' ' VAL . 0.8 OUTLIER -60.16 140.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 0.0 109.981 177.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.555 ' HA2' ' CG ' ' A' ' 10' ' ' ARG . . . 79.61 -4.79 63.11 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 171.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.542 ' HB2' HG13 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.04 -166.42 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.815 -1.403 . . . . 0.0 110.115 174.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 33.6 pttt -127.83 112.8 15.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.224 -0.922 . . . . 0.0 109.831 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.542 HG13 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.33 151.64 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 48.9 tttp -101.09 126.59 47.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.891 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.505 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.2 t -102.97 121.98 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.584 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 77.8 mtt85 -106.74 128.19 54.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.587 ' HG3' ' CB ' ' A' ' 36' ' ' ALA . 13.8 tmtt? -78.75 135.99 37.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.15 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -150.04 -169.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.49 -0.757 . . . . 0.0 110.234 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -126.6 173.3 9.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.494 -0.754 . . . . 0.0 109.671 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.466 ' OG1' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.0 162.5 12.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 110.953 -176.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' CG ' HG13 ' A' ' 162' ' ' VAL . 14.7 pt-20 -150.23 169.92 20.19 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.04 98.85 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.594 -1.316 . . . . 0.0 110.319 -176.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -57.48 139.7 52.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.538 ' CD ' HD22 ' A' ' 156' ' ' LEU . 13.0 ptpt -107.13 -24.62 11.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 111.292 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.454 ' HD3' HD13 ' A' ' 156' ' ' LEU . 63.6 tttp -149.97 119.62 7.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.706 -1.246 . . . . 0.0 110.619 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.526 ' CG2' HG23 ' A' ' 155' ' ' THR . 10.0 p -136.23 140.76 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 0.0 110.692 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 171' ' ' GLU . 99.7 m -111.97 142.1 44.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.081 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -134.04 165.86 24.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.614 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.07 89.5 11.11 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.795 . . . . 0.0 110.315 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo -58.56 131.73 44.21 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.061 1.559 . . . . 0.0 110.752 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.471 HG23 ' HB3' ' A' ' 177' ' ' ALA . 57.4 mt -89.71 90.47 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.005 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.558 HD11 ' CD2' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -151.76 -166.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.495 -0.753 . . . . 0.0 110.471 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.514 ' O ' HD12 ' A' ' 104' ' ' ILE . 9.5 mpt_? -92.91 164.4 13.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.835 . . . . 0.0 110.149 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HA ' HD22 ' A' ' 110' ' ' LEU . 39.0 pttt -59.91 -14.75 17.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.153 -0.967 . . . . 0.0 110.578 -175.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 35.7 p-10 -117.77 25.0 10.69 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.502 -0.749 . . . . 0.0 110.914 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.543 ' HB2' ' HB ' ' A' ' 104' ' ' ILE . 43.8 mm-40 -104.7 -82.58 0.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.065 -1.022 . . . . 0.0 110.818 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.483 ' HG2' HG22 ' A' ' 104' ' ' ILE . 26.7 mmm180 -93.68 -27.65 16.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.887 . . . . 0.0 109.852 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.558 ' CD2' HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -98.59 52.37 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.054 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 6.3 ptmt -131.26 60.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.392 -0.818 . . . . 0.0 110.105 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -141.08 -61.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.962 . . . . 0.0 110.239 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 76.13 -179.81 47.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 113' ' ' GLY . 98.9 mt-10 43.78 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.134 -1.215 . . . . 0.0 110.346 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.38 4.83 89.22 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -60.59 -39.94 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.235 -1.156 . . . . 0.0 109.948 177.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.575 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -62.43 -40.05 95.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.714 176.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -29.09 66.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.0 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.04 -40.01 87.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.542 ' CG1' ' CD1' ' A' ' 170' ' ' ILE . 54.5 t -65.01 -49.97 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.4 mt-30 -60.06 -44.58 94.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.813 . . . . 0.0 110.024 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -60.01 -44.09 94.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.647 -0.658 . . . . 0.0 110.211 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.05 -43.8 70.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -0.789 . . . . 0.0 110.544 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 3.5 mm? -99.05 2.81 46.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.4 tt -46.2 169.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.887 -1.133 . . . . 0.0 110.241 -175.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 28.8 ptt180 33.13 46.09 0.09 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.513 -0.742 . . . . 0.0 111.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -132.26 149.9 74.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.784 -1.198 . . . . 0.0 110.866 176.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.756 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.4 Cg_endo -63.83 133.41 38.91 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.182 1.622 . . . . 0.0 110.264 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.491 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 81.5 mmm -127.0 143.05 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.592 -1.317 . . . . 0.0 111.279 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.515 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 10.8 tp -148.27 110.7 4.68 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.729 -0.607 . . . . 0.0 109.442 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.2 pm0 -43.02 143.28 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.944 -1.097 . . . . 0.0 110.526 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.97 -2.48 2.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.873 -0.517 . . . . 0.0 110.429 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.534 ' OD1' ' CB ' ' A' ' 152' ' ' VAL . 3.6 p-10 -69.93 169.86 12.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.243 -0.911 . . . . 0.0 110.107 175.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 5.4 m120 -128.54 145.28 51.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.25 165.51 23.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.944 -1.097 . . . . 0.0 110.108 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.7 t -140.31 149.8 43.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.479 -0.763 . . . . 0.0 110.75 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.586 ' CG1' ' HD2' ' A' ' 138' ' ' PRO . 87.3 t -140.06 151.53 65.27 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 0.0 109.203 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.586 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 1.7 Cg_endo -44.3 86.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.701 1.369 . . . . 0.0 110.307 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . -144.92 102.58 0.27 Allowed Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 pp -86.6 135.92 33.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.431 -1.041 . . . . 0.0 109.834 -175.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -69.84 -171.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 111.099 -171.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.615 ' N ' ' CD2' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -127.75 -103.08 0.33 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.116 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.49 -158.26 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.252 -0.905 . . . . 0.0 110.382 176.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.37 52.55 4.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.586 ' NE2' ' CD2' ' A' ' 142' ' ' LEU . 11.6 pt20 -94.84 155.93 16.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.136 . . . . 0.0 110.167 176.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.2 t -134.13 150.22 51.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.354 -0.842 . . . . 0.0 110.317 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.74 -90.91 0.54 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER 46.62 49.47 13.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.148 -1.207 . . . . 0.0 110.631 177.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' A' ' 103' ' ' ILE . 2.3 pp -140.32 167.55 21.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.815 -1.178 . . . . 0.0 109.905 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 62.6 m-85 -91.19 121.77 33.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 110.216 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.423 ' HD2' ' ND2' ' A' ' 134' ' ' ASN . 32.0 tptt -103.26 104.77 14.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.845 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.534 ' CB ' ' OD1' ' A' ' 133' ' ' ASP . 2.2 t -76.65 139.26 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 109.851 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.26 -29.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 0.0 111.059 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 98' ' ' VAL . 38.4 ttpt -139.52 144.94 38.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.815 -1.178 . . . . 0.0 111.017 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.526 HG23 ' CG2' ' A' ' 98' ' ' VAL . 58.0 p -140.01 153.02 46.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.71 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.8 OUTLIER -89.82 -30.62 0.36 Allowed Pre-proline 0 C--N 1.297 -1.696 0 O-C-N 121.282 -0.886 . . . . 0.0 111.425 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 14.2 Cg_exo -58.63 -164.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.216 1.114 . . . . 0.0 109.921 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.3 t -89.98 -178.41 5.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 175.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -62.27 -8.47 5.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 110.469 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.7 m -84.76 146.25 45.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 110.238 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.568 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.45 141.3 14.66 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.255 1.661 . . . . 0.0 110.747 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 7.0 m -129.89 159.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 109.575 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.89 128.1 54.32 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.205 -0.934 . . . . 0.0 110.079 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 126' ' ' ARG . 11.9 mm -70.58 154.68 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 110.055 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.61 172.33 24.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.419 ' HG2' ' CD1' ' A' ' 125' ' ' ILE . 96.6 mt-10 -58.2 -26.26 62.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.898 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -87.38 -17.98 31.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.592 -176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.546 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 30.7 m -58.47 152.48 17.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 110.302 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' LYS . 23.0 mmtt -105.89 158.77 16.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.062 . . . . 0.0 109.875 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.542 ' CD1' ' CG1' ' A' ' 120' ' ' VAL . 1.8 mt -136.68 161.8 35.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 111.164 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.469 ' O ' HD22 ' A' ' 100' ' ' LEU . 12.0 mt-10 -139.06 131.66 28.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.756 -0.59 . . . . 0.0 110.219 175.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.9 mp -119.91 128.89 75.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -88.31 154.58 20.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 110.233 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.496 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 49.8 mt-10 -89.98 -0.2 57.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.321 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.77 108.3 45.02 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.934 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 11.4 Cg_exo -72.55 -155.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.026 1.54 . . . . 0.0 110.29 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.471 ' HB3' HG23 ' A' ' 103' ' ' ILE . . . -79.67 54.51 1.81 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.001 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 68.9 m -109.66 123.21 49.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.826 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 178' ' ' SER . 82.6 tt0 59.95 19.36 8.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.984 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.54 139.2 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.351 -0.843 . . . . 0.0 110.263 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.465 ' N ' ' CD2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -124.08 70.71 1.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.16 -0.962 . . . . 0.0 110.3 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.13 139.66 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.985 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 183' ' ' GLU . 8.4 mm-40 -59.93 -40.07 87.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.355 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 65.93 -107.7 2.06 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.583 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.316 0.579 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -130.35 159.96 35.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 110.157 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 p -78.75 163.95 24.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 110.133 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' O ' HD13 ' A' ' 34' ' ' LEU . 45.8 t-20 -88.79 -32.03 18.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 110.198 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 t30 45.03 -163.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -0.911 . . . . 0.0 110.388 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -151.0 -153.7 6.25 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.564 ' CG2' HD21 ' A' ' 33' ' ' LEU . 11.9 pt -138.63 167.75 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -1.15 . . . . 0.0 109.412 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 85.4 mt -109.89 127.84 66.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.117 -0.989 . . . . 0.0 110.337 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.597 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -148.49 -179.04 6.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.511 -0.743 . . . . 0.0 109.962 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 2.8 ptt180 -104.74 138.89 40.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.939 -1.101 . . . . 0.0 110.601 -173.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.556 HG11 ' N ' ' A' ' 82' ' ' GLY . 11.2 p -63.07 130.43 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 110.356 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -110.93 153.5 25.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.909 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 86.4 tt0 -176.77 134.99 0.22 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.071 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.4 130.55 56.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -59.94 -38.54 82.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 110.061 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.5 t -59.96 -39.98 87.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 110.347 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 p -116.32 107.65 15.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.003 . . . . 0.0 110.333 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.737 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -96.84 -24.05 0.24 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.344 -0.848 . . . . 0.0 112.332 -178.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 52.0 Cg_exo -47.02 144.11 8.94 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 122.913 0.954 . . . . 0.0 111.049 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.25 61.28 0.94 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.527 ' HA ' ' CB ' ' A' ' 70' ' ' ASP . 25.0 ptt? -90.01 -0.99 57.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -1.141 . . . . 0.0 110.06 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 22.6 p -138.86 9.41 2.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 110.029 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.405 ' HG2' ' HD2' ' A' ' 53' ' ' ARG . 82.2 mtt180 -107.25 131.62 53.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.819 . . . . 0.0 109.936 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' TYR . 78.1 t -105.3 114.02 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.987 -1.071 . . . . 0.0 110.053 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 8.9 ptt180 -93.5 119.95 33.19 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.563 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.583 ' CD2' ' O ' ' A' ' 55' ' ' TYR . 1.0 OUTLIER -139.84 171.94 13.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.682 -176.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.508 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 19.8 p-10 -95.43 -172.58 2.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.897 -1.127 . . . . 0.0 110.785 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.03 -46.97 87.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.578 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 18.2 m -65.24 -41.75 94.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.129 -175.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.584 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 64.3 m -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.155 -0.966 . . . . 0.0 109.558 175.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 41.1 ttm180 -73.27 -44.04 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 111.163 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -91.73 -7.82 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.919 -1.113 . . . . 0.0 111.201 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -52.23 -26.58 12.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.149 . . . . 0.0 109.329 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 41.9 mt -132.65 -66.01 0.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 110.785 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 28.8 t0 -171.82 -2.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.955 -1.091 . . . . 0.0 111.52 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -44.97 128.01 6.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.827 -1.17 . . . . 0.0 110.449 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.543 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 1.2 pt-20 -116.85 176.57 5.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.6 mm -57.96 122.41 7.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.812 -1.18 . . . . 0.0 109.855 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' H ' HG11 ' A' ' 54' ' ' VAL . . . 72.88 33.42 59.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.161 -1.018 . . . . 0.0 110.663 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 18.9 m-20 -89.2 176.23 7.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.667 -1.49 . . . . 0.0 109.596 172.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.477 HG23 HG21 ' A' ' 92' ' ' THR . 73.6 t -99.07 127.78 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.084 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 52' ' ' GLY . 4.6 m -120.0 151.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 110.229 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -122.99 142.9 50.33 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.716 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -119.9 147.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' OE1' ' CZ ' ' A' ' 88' ' ' ARG . 82.5 tt0 -151.29 93.14 1.87 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.931 -1.106 . . . . 0.0 110.846 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.538 ' HB2' HG13 ' A' ' 85' ' ' VAL . 8.9 tmtm? -97.94 -58.85 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.646 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.73 -31.51 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.676 0.75 . . . . 0.0 109.129 176.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 98.3 mtt180 -139.53 -172.57 3.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.642 -0.662 . . . . 0.0 109.747 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -88.41 130.32 35.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.177 -0.952 . . . . 0.0 110.825 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -131.03 154.31 48.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.805 -0.56 . . . . 0.0 110.26 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.637 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -117.91 164.36 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.517 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -176.77 179.0 47.96 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 18.2 ptp180 -111.53 -172.04 1.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -1.112 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.24 137.66 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.026 -1.046 . . . . 0.0 110.632 -175.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -127.89 164.13 22.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 110.194 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.27 123.67 33.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . . . -63.33 140.05 58.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.622 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 4.6 mmt180 -56.08 -49.55 92.48 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.903 -1.123 . . . . 0.0 108.877 174.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 18.7 Cg_endo -91.68 98.36 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.715 1.376 . . . . 0.0 108.831 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 11.1 pt-20 -74.97 35.29 0.1 Allowed 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 110.917 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 79.5 m-20 -145.43 -32.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.056 -1.027 . . . . 0.0 110.796 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.99 -25.55 24.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.513 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 4.1 m-80 -81.13 39.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 110.573 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.3 pttt -99.02 17.48 19.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 109.575 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.56 23.98 0.03 OUTLIER Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.513 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 44.5 pt -140.68 158.59 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.52 -0.988 . . . . 0.0 109.221 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 9' ' ' LEU . 3.4 p -129.98 137.13 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.087 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.504 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -97.31 118.02 32.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.05 -1.031 . . . . 0.0 110.1 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.554 HD12 ' CG2' ' A' ' 11' ' ' VAL . 1.1 pt -134.36 173.04 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.749 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.527 ' CB ' ' HA ' ' A' ' 21' ' ' MET . 29.7 t0 -91.23 173.61 7.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.564 -0.71 . . . . 0.0 109.857 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 58.5 p -63.12 -25.29 68.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.438 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.7 t -68.49 -47.45 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.513 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -60.07 -42.81 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 109.768 176.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.02 -40.27 88.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 174.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -71.04 -26.86 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.395 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.4 m-20 -60.07 -39.9 87.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 110.808 -176.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.462 ' HB2' HG23 ' A' ' 47' ' ' VAL . 28.5 p -98.47 -36.53 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.965 -1.084 . . . . 0.0 110.657 -175.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 117.18 22.83 4.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 74' ' ' ARG . . . -102.65 171.75 7.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -1.202 . . . . 0.0 110.311 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.515 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.91 179.05 4.08 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.509 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -65.22 140.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.053 -1.03 . . . . 0.0 110.423 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.556 ' N ' HG11 ' A' ' 11' ' ' VAL . . . 76.03 -3.21 52.72 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 173.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.547 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.52 -158.83 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.054 -1.262 . . . . 0.0 110.211 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 52.6 pttt -137.07 116.92 13.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 110.097 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 46' ' ' LYS . 1.3 m -125.81 160.07 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.433 -0.792 . . . . 0.0 109.823 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 33.0 ttmt -104.08 123.99 48.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.476 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 63.8 t -99.55 125.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.546 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtm180 -117.23 149.49 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 61.7 tttm -91.15 139.85 30.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.862 -1.149 . . . . 0.0 110.371 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 41' ' ' VAL . 2.3 m -138.84 -168.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 175.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 38.8 ptt180 -137.46 171.26 14.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.477 HG21 HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.26 159.55 16.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 0.0 111.193 -175.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.32 171.17 17.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.7 mm -88.62 98.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.287 -1.508 . . . . 0.0 110.096 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.563 ' HB3' ' CG2' ' A' ' 162' ' ' VAL . . . -58.62 139.96 55.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.392 -0.818 . . . . 0.0 110.365 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.579 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 1.4 pttt -97.46 -29.7 13.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.081 -1.012 . . . . 0.0 111.11 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -150.91 121.98 7.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 0.0 110.915 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 155' ' ' THR . 9.9 p -132.24 143.54 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.006 -1.059 . . . . 0.0 110.955 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.524 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 91.1 m -114.96 140.26 49.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 0.0 110.044 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -136.3 165.28 26.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.374 -177.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -136.33 82.11 35.56 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 111.033 -176.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.524 ' HD2' ' CD ' ' A' ' 173' ' ' ARG . 17.4 Cg_exo -58.15 128.07 27.33 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.869 1.458 . . . . 0.0 109.883 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.463 HG21 ' HB2' ' A' ' 177' ' ' ALA . 71.6 mt -95.61 103.31 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.042 -1.036 . . . . 0.0 110.549 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.502 HG13 ' N ' ' A' ' 105' ' ' ARG . 16.8 pt -150.83 -153.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 122.148 0.975 . . . . 0.0 110.615 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.502 ' N ' HG13 ' A' ' 104' ' ' ILE . 28.9 mmt85 -130.56 156.73 44.34 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.102 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.04 -18.58 47.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 109.89 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.441 ' OD1' ' CB ' ' A' ' 105' ' ' ARG . 35.6 p-10 -103.6 24.18 11.53 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.825 -0.547 . . . . 0.0 110.532 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.501 ' HG3' ' HB ' ' A' ' 104' ' ' ILE . 24.4 mm-40 -90.74 173.94 7.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.065 -1.022 . . . . 0.0 110.46 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -88.45 -22.02 23.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 110.521 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.448 ' O ' HD13 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -98.03 45.23 1.02 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 0.0 110.084 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -105.64 140.68 38.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.551 -0.718 . . . . 0.0 109.696 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -138.83 -38.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.028 . . . . 0.0 110.733 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.515 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 78.15 -156.93 44.21 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 113' ' ' GLY . 21.9 pt-20 -30.17 142.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.946 -0.738 . . . . 0.0 110.833 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.01 -11.82 55.95 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.9 tp -63.91 -34.18 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 110.113 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' HG2' HG12 ' A' ' 172' ' ' ILE . 94.8 mt-10 -59.99 -46.81 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 109.516 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.39 -39.89 92.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -64.27 -39.99 95.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.475 -0.766 . . . . 0.0 109.942 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.503 ' CG1' ' CD1' ' A' ' 170' ' ' ILE . 58.4 t -60.59 -49.97 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.4 mt-30 -61.21 -41.82 97.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.645 -0.66 . . . . 0.0 110.238 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.1 -48.93 79.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.438 -0.789 . . . . 0.0 109.97 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.01 -40.73 75.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.719 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.6 mm? -94.91 -1.74 51.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.138 -175.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.526 ' HA ' HG21 ' A' ' 164' ' ' ILE . 2.6 tt -46.95 166.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.931 -1.105 . . . . 0.0 110.109 -175.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.6 ptt180 33.76 49.56 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 0.0 111.458 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.43 ' O ' ' HG2' ' A' ' 129' ' ' MET . 6.8 tpt180 -135.07 140.95 36.36 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.899 -1.126 . . . . 0.0 111.373 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.683 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.1 Cg_exo -59.69 130.68 36.26 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 124.095 1.576 . . . . 0.0 109.734 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.533 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 15.4 mmt -134.9 141.78 46.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.409 -1.432 . . . . 0.0 110.972 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.502 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -146.42 130.0 16.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -51.32 145.63 8.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -175.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 76.51 -2.06 2.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.818 -0.551 . . . . 0.0 110.548 178.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.524 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 1.6 p30 -67.59 -171.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.196 -0.94 . . . . 0.0 109.874 173.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -150.37 159.02 44.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.34 -0.85 . . . . 0.0 109.532 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.27 168.44 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 110.122 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.5 t -117.43 163.61 16.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.445 -0.784 . . . . 0.0 110.601 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 139' ' ' GLY . 2.6 t -99.44 145.58 30.31 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.326 -0.858 . . . . 0.0 109.704 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.542 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 10.3 Cg_endo -60.43 66.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.03 1.542 . . . . 0.0 110.459 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 45.38 58.99 4.91 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.522 ' CD2' ' CG1' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -129.71 128.31 42.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.894 -1.356 . . . . 0.0 110.348 175.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -162.78 -169.73 2.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.294 -0.879 . . . . 0.0 110.137 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.552 ' N ' ' OG1' ' A' ' 141' ' ' THR . 0.3 OUTLIER -147.69 -122.41 0.06 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 109.964 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.88 -160.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.041 -1.037 . . . . 0.0 109.907 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.27 81.43 1.44 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.433 ' OE1' ' CB ' ' A' ' 141' ' ' THR . 4.4 pt20 -92.43 169.87 10.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.344 -1.092 . . . . 0.0 109.955 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -135.89 149.95 49.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.141 -0.974 . . . . 0.0 110.619 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.499 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 90.52 -92.85 1.8 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 40.1 40.74 0.82 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.492 -1.005 . . . . 0.0 111.024 176.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.424 ' CG ' HD11 ' A' ' 103' ' ' ILE . 2.2 pp -140.45 165.17 28.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.903 -1.123 . . . . 0.0 109.895 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.5 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 20.4 m-85 -104.76 128.66 52.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 110.211 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -119.95 109.98 16.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 3.9 t -74.97 139.38 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.06 -24.52 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 111.021 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -146.2 136.65 23.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.662 -1.274 . . . . 0.0 110.841 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.534 ' CG2' HG22 ' A' ' 98' ' ' VAL . 44.5 p -134.7 168.7 18.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.498 -0.752 . . . . 0.0 109.355 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.01 -35.98 0.42 Allowed Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.929 -178.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 22.9 Cg_exo -58.46 -174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.384 1.202 . . . . 0.0 110.531 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -156.36 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.59 -11.35 52.88 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 160' ' ' VAL . 33.1 m -87.11 139.45 32.43 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.637 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 9.3 Cg_endo -59.72 164.1 12.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.131 1.595 . . . . 0.0 111.002 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 14.8 m -140.37 166.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.561 -0.712 . . . . 0.0 110.101 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -103.02 126.48 50.22 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.833 -1.167 . . . . 0.0 109.954 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 126' ' ' ARG . 10.9 mm -70.11 153.73 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.588 -0.695 . . . . 0.0 109.661 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.49 168.25 25.9 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -56.62 -20.78 22.86 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -1.084 . . . . 0.0 110.033 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -91.35 -18.22 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.724 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.564 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 28.6 m -58.37 144.65 40.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 99.4 mttt -95.45 150.54 20.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 109.507 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.503 ' CD1' ' CG1' ' A' ' 120' ' ' VAL . 1.9 mt -129.95 160.05 41.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.83 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.524 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 65.2 mt-10 -135.62 145.32 46.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.566 -0.709 . . . . 0.0 110.295 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.496 HG12 ' HG2' ' A' ' 117' ' ' GLU . 30.9 mm -122.59 141.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.517 -0.739 . . . . 0.0 109.934 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.561 ' O ' ' CD ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -86.66 144.25 27.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -176.008 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.48 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 47.1 mt-10 -90.21 -9.53 47.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.103 -0.998 . . . . 0.0 110.566 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -98.58 108.53 48.64 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 110.097 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.1 Cg_exo -71.79 -154.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.103 1.581 . . . . 0.0 110.348 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.463 ' HB2' HG21 ' A' ' 103' ' ' ILE . . . -86.85 51.19 2.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.626 -0.672 . . . . 0.0 110.163 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.9 -81.22 0.29 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.35 -0.844 . . . . 0.0 110.661 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.21 7.87 10.24 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.945 -1.097 . . . . 0.0 110.169 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.9 119.55 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.41 -34.21 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.82 . . . . 0.0 110.465 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -148.93 112.7 5.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 110.085 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.95 149.95 47.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.352 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.93 46.8 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.522 -179.797 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.181 0.515 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -60.74 -40.04 90.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.963 . . . . 0.0 109.901 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -139.43 102.24 4.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.373 -0.83 . . . . 0.0 109.967 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -145.79 107.94 4.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 110.097 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -119.08 30.07 7.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.079 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 87' ' ' VAL . . . -151.8 -179.48 27.48 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 33.5 pt -134.8 159.18 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.879 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 85.5 mt -95.79 118.43 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.537 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.5 pt? -134.91 -169.28 2.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.344 -0.848 . . . . 0.0 110.382 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.514 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 38.1 ttp180 -103.91 130.15 51.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 110.965 -175.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 83' ' ' ASP . 10.5 p -61.1 137.95 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 110.277 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -122.72 149.82 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.502 ' OE1' ' HD3' ' A' ' 74' ' ' ARG . 86.5 tt0 -176.57 159.95 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.73 167.89 23.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.97 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -60.01 130.01 44.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 110.026 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.47 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 94.2 p -158.3 159.48 35.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.312 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.1 p -98.92 -64.49 1.03 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 110.293 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.684 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -94.95 -32.71 0.28 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 111.696 -176.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 52.8 Cg_exo -50.63 166.57 0.32 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.143 1.075 . . . . 0.0 110.687 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.543 ' CA ' ' HB3' ' A' ' 70' ' ' ASP . . . 94.54 60.01 1.12 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.477 ' SD ' ' HD3' ' A' ' 23' ' ' ARG . 22.0 ptm -98.45 24.4 7.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -1.113 . . . . 0.0 110.467 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 21' ' ' MET . 0.3 OUTLIER 68.3 33.48 4.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 -178.142 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 33.7 ptt180 -101.75 137.12 40.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.507 -0.745 . . . . 0.0 109.815 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 55' ' ' TYR . 53.6 t -99.96 110.1 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.065 . . . . 0.0 110.023 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -99.76 119.98 39.0 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.003 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -133.66 -169.43 2.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.525 -0.735 . . . . 0.0 110.375 -177.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 26.6 p-10 -106.85 -179.15 3.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 0.0 110.816 -175.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -60.04 -40.07 88.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.242 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 46.6 t -59.95 -49.69 76.7 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.083 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.662 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 75.4 m -59.97 -40.09 87.87 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.099 -1.001 . . . . 0.0 109.682 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 32.2 ttp180 -60.19 -46.29 90.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 172.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -67.31 -39.97 85.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 110.415 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.662 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 4.4 pp -74.84 -28.4 60.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 111.088 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD13 ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -99.48 -8.36 24.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.731 -1.231 . . . . 0.0 110.15 175.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 34' ' ' LEU . 12.4 t70 59.77 14.87 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.818 . . . . 0.0 109.82 -174.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -58.95 120.71 9.57 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -99.48 173.34 6.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -58.52 127.75 18.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.35 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.7 73.4 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.578 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.487 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 90.2 m-20 -88.33 166.46 14.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.478 -1.601 . . . . 0.0 108.756 169.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 92' ' ' THR . 93.7 t -98.75 129.33 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.737 -1.227 . . . . 0.0 110.1 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 52' ' ' GLY . 2.3 m -115.48 138.01 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.353 -177.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 83.0 tt0 -108.67 139.77 43.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.441 -0.787 . . . . 0.0 109.396 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -120.3 145.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 110.332 -176.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.9 tt0 -147.42 99.51 3.14 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 110.772 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.547 ' CG ' HG12 ' A' ' 85' ' ' VAL . 9.5 tmtt? -98.29 -65.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.67 173.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.576 HG22 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.26 -33.38 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.257 174.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 69.5 mtt85 -135.56 -178.31 5.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.761 -0.587 . . . . 0.0 109.479 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.488 ' HD3' ' OE2' ' A' ' 43' ' ' GLU . 24.3 mttt -89.3 136.95 32.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.547 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.545 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 1.8 p -141.42 168.71 19.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 110.1 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.565 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.6 164.14 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.54 -0.725 . . . . 0.0 110.379 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -177.61 -172.76 42.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.405 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.9 ptp85 -113.98 -174.87 2.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.536 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -113.59 139.46 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.609 -173.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.504 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 1.1 m-85 -132.65 164.6 26.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.894 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -98.91 126.92 44.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.436 -0.79 . . . . 0.0 110.079 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -66.31 140.58 58.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.215 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.557 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -56.5 -49.02 95.94 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 118.899 -1.121 . . . . 0.0 108.834 172.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 30.7 Cg_endo -91.72 97.24 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.864 1.455 . . . . 0.0 108.954 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.13 35.83 0.14 Allowed 'General case' 0 C--N 1.289 -2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 110.984 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 36.1 p-10 -143.08 -36.11 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 110.964 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 15.5 pt-20 -84.83 -20.43 30.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.936 -1.102 . . . . 0.0 109.585 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.492 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 4.7 m-80 -81.42 38.66 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.48 -0.762 . . . . 0.0 110.531 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.414 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 26.2 pttm -98.82 11.9 37.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.63 26.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.492 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.8 pt -140.15 143.03 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.311 -1.111 . . . . 0.0 109.358 175.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.472 ' HB ' HD13 ' A' ' 9' ' ' LEU . 7.5 p -122.48 129.62 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.309 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.536 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 38.7 mmm-85 -90.01 116.62 28.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.243 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.441 HD13 ' CG2' ' A' ' 11' ' ' VAL . 2.9 pt -136.84 169.15 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 110.599 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.543 ' HB3' ' CA ' ' A' ' 20' ' ' GLY . 32.9 p-10 -78.5 169.29 18.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.57 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 79.6 p -70.04 -23.49 63.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' HB ' ' OD2' ' A' ' 70' ' ' ASP . 54.5 t -70.06 -43.98 78.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.979 -1.076 . . . . 0.0 110.186 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.507 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 9.7 tpt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.084 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 71' ' ' SER . 43.7 ptt85 -61.38 -35.56 77.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.806 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.462 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 64.1 t30 -71.88 -26.45 62.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.11 -0.994 . . . . 0.0 110.495 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.6 m-20 -60.01 -35.66 75.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.466 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.452 ' HB2' HG23 ' A' ' 47' ' ' VAL . 26.1 p -97.95 -36.61 10.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.281 -0.887 . . . . 0.0 110.202 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.576 ' CA ' HG22 ' A' ' 47' ' ' VAL . . . 122.34 28.22 1.51 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.435 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -110.81 161.05 16.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -1.113 . . . . 0.0 110.476 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.476 ' O ' HG12 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.77 179.02 4.09 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 178.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.453 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -60.44 139.73 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.926 -1.109 . . . . 0.0 110.646 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.533 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . 78.24 -3.51 62.01 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.534 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.95 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.024 -1.28 . . . . 0.0 110.088 174.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 54.7 pttt -133.07 113.56 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 110.073 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.547 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -119.94 166.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.312 -0.867 . . . . 0.0 110.028 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 84.6 tttt -114.21 127.57 55.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 109.973 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.543 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 92.8 t -107.55 122.81 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.099 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.483 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 12.3 mtt180 -109.67 140.5 43.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 34' ' ' LEU . 53.5 tttm -82.13 140.76 33.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.094 -1.004 . . . . 0.0 110.701 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.432 HG23 HG11 ' A' ' 41' ' ' VAL . 2.3 m -150.17 -170.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.78 -0.575 . . . . 0.0 109.688 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.42 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.5 mtp180 -132.48 163.41 28.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.713 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.548 ' CG2' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -94.67 161.31 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.977 0.894 . . . . 0.0 111.418 -174.277 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' CG ' HG11 ' A' ' 162' ' ' VAL . 13.6 pt-20 -150.09 170.33 19.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.437 HG21 ' OE2' ' A' ' 167' ' ' GLU . 37.6 mm -89.07 101.11 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.625 -1.297 . . . . 0.0 110.461 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -58.69 139.98 55.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 110.31 177.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.567 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -101.84 -26.5 13.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 111.04 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.567 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 23.3 tttt -150.33 128.64 12.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 110.221 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' A' ' 155' ' ' THR . 7.2 p -140.8 144.98 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.996 -1.065 . . . . 0.0 110.616 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.541 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.3 m -116.51 133.42 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.827 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -131.94 160.81 34.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 110.371 -176.399 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.47 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -133.65 81.31 54.0 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 110.848 -176.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . 17.4 Cg_exo -62.03 127.9 22.59 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.933 1.491 . . . . 0.0 110.083 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.523 HG22 ' CB ' ' A' ' 177' ' ' ALA . 80.7 mt -89.98 98.42 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.072 -1.018 . . . . 0.0 110.389 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.566 HD13 ' O ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -151.92 -166.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 110.451 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.566 ' O ' HD13 ' A' ' 104' ' ' ILE . 98.6 mtt180 -88.77 156.93 18.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.421 -0.799 . . . . 0.0 109.696 174.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -58.34 -12.55 3.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.123 -0.986 . . . . 0.0 111.09 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 111' ' ' LYS . 35.4 p-10 -129.17 30.64 4.99 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.5 -0.75 . . . . 0.0 110.358 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.55 ' HG2' ' HB2' ' A' ' 105' ' ' ARG . 6.0 mm-40 -94.78 -94.41 0.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.982 -1.074 . . . . 0.0 111.229 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -89.3 -43.7 10.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.736 -1.227 . . . . 0.0 110.519 -171.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 110' ' ' LEU . 0.7 OUTLIER -103.1 51.05 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 110.232 -179.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 6.2 ptmt -99.37 46.76 0.97 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.259 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.31 -54.46 2.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.42 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 75.08 179.73 43.96 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -176.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 113' ' ' GLY . 37.7 mt-10 42.13 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.253 -1.145 . . . . 0.0 110.212 177.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.2 2.59 90.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.472 HD12 HD11 ' A' ' 110' ' ' LEU . 19.1 tt -59.98 -40.11 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.169 -1.194 . . . . 0.0 110.304 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.432 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 95.9 mt-10 -60.53 -40.06 90.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.957 . . . . 0.0 109.955 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -70.02 -35.94 74.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -60.04 -39.74 86.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.768 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' A' ' 170' ' ' ILE . 54.6 t -60.14 -45.32 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.611 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -60.04 -41.2 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.014 173.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -60.03 -39.9 87.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 124' ' ' LEU . . . -82.39 -42.69 18.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.845 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.483 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 4.6 mm? -94.83 0.84 55.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.019 -1.051 . . . . 0.0 111.156 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 0.5 OUTLIER -44.04 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.03 -1.044 . . . . 0.0 110.554 -176.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.99 52.63 0.48 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.577 -0.702 . . . . 0.0 111.589 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 124' ' ' LEU . 13.7 mmt180 -134.36 149.99 72.7 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.997 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.683 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.8 Cg_exo -66.11 132.32 29.57 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.975 1.513 . . . . 0.0 109.93 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.555 ' CG ' HG12 ' A' ' 164' ' ' ILE . 93.9 mmm -125.19 132.19 53.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.604 -1.31 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.589 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 19.7 tp -133.38 108.18 8.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.69 -0.631 . . . . 0.0 109.433 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.8 pt-20 -45.7 136.12 6.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.69 -1.256 . . . . 0.0 110.163 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.583 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 80.01 -2.6 2.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.947 -0.471 . . . . 0.0 110.326 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.589 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.4 p30 -69.37 -169.97 0.25 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.297 -0.877 . . . . 0.0 110.414 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 11.5 m-80 -144.96 159.17 43.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.3 OUTLIER -140.02 170.02 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 110.516 -175.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.436 ' CB ' HG12 ' A' ' 72' ' ' VAL . 47.6 t -133.37 146.75 51.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.593 -0.692 . . . . 0.0 110.12 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.538 ' CG1' ' HD2' ' A' ' 138' ' ' PRO . 55.7 t -127.24 150.02 71.24 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.48 -0.762 . . . . 0.0 109.833 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.538 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 5.3 Cg_endo -52.73 -168.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.919 1.484 . . . . 0.0 110.136 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 58.94 93.61 0.01 OUTLIER Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.552 HD22 ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -87.04 163.19 17.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.088 -1.242 . . . . 0.0 110.7 -172.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.587 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -55.4 -167.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.775 -1.203 . . . . 0.0 111.13 -167.14 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.587 ' N ' ' OG1' ' A' ' 141' ' ' THR . 0.1 OUTLIER -148.03 -102.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.567 -0.708 . . . . 0.0 109.991 -176.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.91 -159.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.42 -0.8 . . . . 0.0 110.297 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.1 62.58 4.56 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.491 ' OE1' ' CA ' ' A' ' 141' ' ' THR . 5.1 pt20 -96.33 162.87 13.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.345 -1.091 . . . . 0.0 110.022 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.7 t -140.04 151.46 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.488 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.47 ' HA3' HG23 ' A' ' 103' ' ' ILE . . . 96.39 -93.6 1.53 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.447 ' N ' ' CD2' ' A' ' 148' ' ' LEU . 2.6 mm? 42.06 41.2 1.9 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.265 -1.138 . . . . 0.0 110.732 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.48 ' HG ' HD11 ' A' ' 103' ' ' ILE . 4.5 pp -140.49 166.02 25.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.009 -1.057 . . . . 0.0 109.938 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 58.8 m-85 -100.68 130.22 46.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 110.099 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 110.03 16.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.034 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 132' ' ' GLN . 3.1 t -76.23 136.72 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 36.6 t -116.72 -30.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 110.618 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.4 tptt -140.07 135.07 32.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 0.0 110.935 -177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.523 HG22 ' CG2' ' A' ' 98' ' ' VAL . 69.6 p -129.95 166.21 20.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.397 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.661 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.1 OUTLIER -88.8 -38.2 0.44 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.035 . . . . 0.0 110.81 -178.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 22.7 Cg_exo -57.8 -171.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.551 1.29 . . . . 0.0 110.497 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.95 -167.82 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 110.013 176.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.53 -9.45 8.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.181 -0.949 . . . . 0.0 110.695 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.21 144.51 41.12 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.478 -0.764 . . . . 0.0 110.628 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.565 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -47.9 141.63 16.4 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.885 1.723 . . . . 0.0 111.252 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 8.9 m -130.23 159.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 109.946 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 88.0 tt0 -109.32 130.56 55.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.237 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.574 ' CG2' ' OE1' ' A' ' 121' ' ' GLN . 12.8 mm -71.2 152.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.518 -176.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.59 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.85 169.8 25.48 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.565 ' HG2' ' CD1' ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.87 -23.61 45.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -1.142 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.437 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.5 pt-20 -87.06 -12.53 46.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.555 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 13.5 m -62.94 144.76 56.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.5 mttt -93.91 154.64 17.59 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 109.897 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.565 ' CG1' ' CG ' ' A' ' 121' ' ' GLN . 1.8 mm -116.87 136.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 111.038 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.541 ' CB ' ' OG1' ' A' ' 99' ' ' THR . 18.7 mt-10 -120.33 130.68 54.53 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 110.198 172.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 171' ' ' GLU . 34.9 mm -120.17 140.37 44.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.529 -0.732 . . . . 0.0 110.301 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.537 ' O ' ' CZ ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -87.14 156.49 19.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.301 -176.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 96.1 mt-10 -93.55 -12.7 28.97 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.184 -0.947 . . . . 0.0 110.7 -174.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -96.59 109.12 46.59 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.147 -0.971 . . . . 0.0 110.048 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 11.5 Cg_exo -72.91 -156.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 O-C-N 124.088 1.573 . . . . 0.0 110.537 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.523 ' CB ' HG22 ' A' ' 103' ' ' ILE . . . -80.21 54.43 1.97 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.708 -0.62 . . . . 0.0 110.039 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 20.3 m -104.88 121.85 44.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.95 177.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 178' ' ' SER . 50.4 mm-40 59.95 19.98 9.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.91 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 181' ' ' LEU . 62.7 t -105.68 119.99 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.463 -0.773 . . . . 0.0 110.264 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.54 ' CD1' ' O ' ' A' ' 181' ' ' LEU . 2.5 pp 178.57 54.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -87.95 142.97 27.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 50.07 42.72 25.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.239 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.75 150.02 50.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.471 179.99 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.57 ' O ' ' N ' ' A' ' 3' ' ' SER . 60.0 ttm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.034 0.445 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 1' ' ' MET . 86.2 tt0 38.78 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.427 -0.796 . . . . 0.0 110.873 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 1' ' ' MET . 45.0 p -139.93 153.17 46.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 110.282 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -118.29 119.46 34.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.92 . . . . 0.0 110.204 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.45 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 27.3 t30 -111.45 30.07 7.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 109.987 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.516 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -155.47 -169.27 19.7 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.575 ' CG2' HD13 ' A' ' 33' ' ' LEU . 41.0 pt -133.29 162.86 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -1.14 . . . . 0.0 109.663 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.429 HG12 ' HD3' ' A' ' 86' ' ' LYS . 92.8 mt -107.62 126.55 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 85' ' ' VAL . 1.6 pt? -143.78 -165.49 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.657 -0.652 . . . . 0.0 109.447 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.553 ' NH2' HG23 ' A' ' 66' ' ' ILE . 19.9 ptt-85 -115.0 140.25 49.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 0.0 110.464 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 81' ' ' ILE . 13.6 p -60.75 137.75 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 110.635 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -115.3 139.97 49.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 110.56 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 179.57 100.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 109.918 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -157.47 160.0 37.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.123 -0.986 . . . . 0.0 110.455 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.435 ' O ' ' OG ' ' A' ' 16' ' ' SER . 64.7 t30 50.07 40.12 20.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 110.388 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.502 ' HB3' ' HG3' ' A' ' 19' ' ' PRO . 3.4 m -164.08 158.54 19.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 110.056 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 15.3 p -78.27 -49.33 13.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.948 . . . . 0.0 110.337 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.522 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 4.5 p-10 -175.12 60.44 0.21 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.151 -0.968 . . . . 0.0 110.82 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 14.1 Cg_exo -64.64 108.52 1.06 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.648 1.341 . . . . 0.0 110.353 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . 91.27 90.12 1.38 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.502 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 26.5 ptm -88.36 -18.25 28.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -1.174 . . . . 0.0 109.535 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -154.57 20.2 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.576 -0.703 . . . . 0.0 109.52 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.586 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 39.8 mtm180 -128.71 149.12 50.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.457 -0.777 . . . . 0.0 110.139 -176.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.511 ' CG1' HG21 ' A' ' 67' ' ' VAL . 83.4 t -112.44 120.56 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.511 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 1.2 ptm180 -95.74 119.88 35.02 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.602 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.531 ' CG ' ' HB3' ' A' ' 30' ' ' SER . 1.1 mp -136.36 173.72 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.7 -175.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.513 ' OD2' ' HA ' ' A' ' 64' ' ' LYS . 10.2 p-10 -95.71 -172.65 2.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 111.004 -176.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.491 ' OE2' ' NH1' ' A' ' 56' ' ' ARG . 49.7 mm-40 -59.73 -50.04 75.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 109.763 -175.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.533 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.5 t -64.1 -40.53 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.219 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.618 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 68.6 m -60.05 -29.34 68.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 70.9 ttt180 -87.35 -46.99 9.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.659 -0.651 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 33' ' ' LEU . 87.0 mtm180 -79.94 -6.94 58.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.801 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.618 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -42.03 -30.51 0.28 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.526 -0.734 . . . . 0.0 109.788 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.59 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 79.3 mt -141.53 -61.65 0.47 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 0.0 110.592 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' C ' ' A' ' 36' ' ' ALA . 26.8 t0 -172.46 -29.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.2 -0.937 . . . . 0.0 110.03 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.566 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -23.52 116.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.514 0.674 . . . . 0.0 111.357 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -109.5 168.38 9.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.279 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -46.08 125.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.063 -1.023 . . . . 0.0 109.806 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.48 21.32 67.11 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.609 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 81.3 m-20 -89.21 173.91 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.721 -1.458 . . . . 0.0 109.359 171.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.505 ' CG1' ' HG2' ' A' ' 161' ' ' PRO . 59.7 t -99.39 134.16 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.958 . . . . 0.0 110.144 -175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 42' ' ' VAL . 3.5 m -123.28 146.15 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.71 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -114.17 140.58 48.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.733 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.65 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.1 mp -124.81 138.94 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.687 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 87.6 tt0 -140.64 99.99 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 110.265 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HD2' ' CB ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -98.75 -66.47 0.9 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.618 -0.676 . . . . 0.0 109.401 177.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.531 HG23 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -111.3 -30.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.417 -0.802 . . . . 0.0 109.063 172.024 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.552 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 95.3 mtt180 -131.86 -179.82 5.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.619 173.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' C ' HG22 ' A' ' 50' ' ' THR . 35.0 mttt -89.17 138.34 31.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 111.011 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.65 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 5.5 p -142.57 167.7 21.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.55 0.69 . . . . 0.0 109.801 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -121.23 167.79 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -179.59 -168.46 38.49 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.467 ' N ' HG21 ' A' ' 42' ' ' VAL . 67.1 ttt180 -125.45 165.09 19.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.981 . . . . 0.0 110.592 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -94.23 136.08 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.269 -175.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.586 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 1.3 m-85 -133.61 163.69 28.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.472 175.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 43.0 ttt85 -92.3 125.96 37.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.936 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB2' ' HD2' ' A' ' 59' ' ' PRO . . . -63.29 139.27 58.75 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.37 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.565 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 1.6 mtp180 -56.24 -48.57 96.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.763 174.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 34.2 Cg_endo -91.65 97.18 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.095 1.576 . . . . 0.0 108.965 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.12 35.93 0.11 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.547 -0.721 . . . . 0.0 110.737 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.2 p-10 -143.59 -31.85 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.45 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.62 -28.76 24.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.185 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.484 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 3.5 m-80 -80.98 39.81 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.474 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.513 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 14.2 pttm -98.79 9.41 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -0.923 . . . . 0.0 109.683 177.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -176.36 28.08 0.07 OUTLIER Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.553 HG23 ' NH2' ' A' ' 10' ' ' ARG . 44.6 pt -140.58 143.13 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.213 -1.169 . . . . 0.0 109.473 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.548 ' N ' HD13 ' A' ' 9' ' ' LEU . 3.9 p -119.34 124.48 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.045 -1.034 . . . . 0.0 109.898 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 1.7 mtp85 -91.39 117.22 29.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.285 -0.885 . . . . 0.0 110.074 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.53 ' CD1' HG22 ' A' ' 11' ' ' VAL . 1.4 pt -129.69 162.96 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.632 -0.668 . . . . 0.0 110.264 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 26.0 p-10 -76.78 177.55 7.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.851 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 10.4 m -68.87 -19.0 64.23 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.52 ' HB ' ' OD2' ' A' ' 70' ' ' ASP . 86.3 t -69.9 -48.37 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.989 -1.069 . . . . 0.0 110.331 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.493 ' HE1' ' OG1' ' A' ' 50' ' ' THR . 88.8 mmm -62.8 -40.27 96.83 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.548 174.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.07 -40.66 90.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 173.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 71' ' ' SER . 8.0 t30 -78.34 -32.58 49.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 110.577 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.377 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 20.9 p -99.91 -38.28 8.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.726 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.531 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 111.05 23.7 5.73 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.716 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -111.05 -178.07 3.37 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.008 -1.29 . . . . 0.0 111.295 -171.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -128.74 170.15 13.66 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 174.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.586 ' HA ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -56.37 154.54 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 110.156 178.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 74.84 -5.45 31.46 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 80' ' ' SER . 1.9 m-20 -56.27 -164.64 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.039 -1.271 . . . . 0.0 110.513 176.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 22.2 pttm -134.55 115.92 14.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 109.554 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.559 HG23 HD21 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -125.75 159.22 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.126 -177.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.6 ttpm? -111.72 121.04 44.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.77 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.5 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.3 t -99.65 120.06 48.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 4.6 mtt180 -112.11 139.38 47.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.826 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -86.14 138.59 31.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 89' ' ' LYS . 2.2 m -147.07 -169.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.501 -0.749 . . . . 0.0 110.221 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -127.51 166.48 17.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.822 . . . . 0.0 109.631 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.499 ' OG1' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -99.42 162.13 13.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 0.0 111.057 -176.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.424 ' CG ' HG11 ' A' ' 162' ' ' VAL . 13.7 pt-20 -150.33 169.3 21.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 94' ' ' ILE . 30.7 mm -89.93 98.28 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.603 -1.311 . . . . 0.0 110.469 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.551 ' CB ' HG21 ' A' ' 162' ' ' VAL . . . -56.82 141.03 46.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.308 -0.87 . . . . 0.0 110.361 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 169' ' ' LYS . 5.5 pttt -108.25 -22.01 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.193 -0.942 . . . . 0.0 111.14 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HB3' HD13 ' A' ' 156' ' ' LEU . 62.6 tttp -150.7 117.22 5.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.613 -1.305 . . . . 0.0 110.485 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.515 ' CG1' HG12 ' A' ' 170' ' ' ILE . 9.9 p -134.74 140.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.04 . . . . 0.0 110.588 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.7 m -108.02 140.31 41.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.078 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -134.71 165.09 26.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.105 -178.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.64 82.88 11.02 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.141 -0.974 . . . . 0.0 111.037 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 32.5 Cg_exo -50.19 143.95 24.29 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.921 1.485 . . . . 0.0 110.394 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.519 HG21 ' HA3' ' A' ' 147' ' ' GLY . 36.9 mm -107.39 92.64 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.093 -1.005 . . . . 0.0 110.634 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.611 HG12 ' HB2' ' A' ' 108' ' ' GLN . 0.6 OUTLIER -151.3 176.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 172.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' A' ' 108' ' ' GLN . 96.9 mtt180 -117.05 -146.86 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.506 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -60.01 -12.18 7.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.962 -1.086 . . . . 0.0 110.259 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 36.9 p-10 -99.43 29.19 4.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.513 -0.742 . . . . 0.0 109.826 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.611 ' HB2' HG12 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -81.03 164.08 22.76 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.216 -0.928 . . . . 0.0 110.681 -174.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -94.8 -14.79 24.34 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.635 -0.666 . . . . 0.0 110.267 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.36 64.18 1.33 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 0.0 110.573 -175.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.462 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 1.5 ptpt -109.66 50.3 0.8 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.428 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.531 ' HB2' ' CD1' ' A' ' 116' ' ' ILE . 97.1 m-85 -97.53 -57.03 2.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 0.0 110.463 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 77.51 -177.42 52.82 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 113' ' ' GLY . 8.5 pt-20 32.66 97.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.528 -0.984 . . . . 0.0 110.704 178.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.48 -3.78 86.73 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 112' ' ' PHE . 9.0 tp -58.62 -30.0 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -1.229 . . . . 0.0 109.723 175.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.527 ' HG2' ' CD1' ' A' ' 172' ' ' ILE . 99.0 mt-10 -59.97 -45.32 93.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -70.02 -32.95 71.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 110.582 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -60.07 -39.98 87.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.139 -0.976 . . . . 0.0 109.062 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.593 ' CG1' ' CD1' ' A' ' 170' ' ' ILE . 53.9 t -60.52 -49.11 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.677 174.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.528 ' HG3' HG13 ' A' ' 170' ' ' ILE . 3.3 mt-30 -59.99 -42.65 94.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.0 -45.61 92.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 110.157 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 124' ' ' LEU . . . -69.95 -43.4 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.1 mm? -99.79 6.17 45.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.977 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 126' ' ' ARG . 1.6 tt -47.98 165.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.76 -1.212 . . . . 0.0 109.821 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 11.6 ptp180 35.3 47.7 0.33 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.445 -0.785 . . . . 0.0 111.387 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.538 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 7.4 mmt85 -129.37 150.88 76.78 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.791 -1.193 . . . . 0.0 110.965 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.3 Cg_endo -68.71 128.55 17.19 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 124.233 1.649 . . . . 0.0 109.716 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.482 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.9 mmm -124.76 139.84 53.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.446 -1.409 . . . . 0.0 110.885 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.488 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 16.7 tp -141.34 104.38 4.59 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.639 -0.663 . . . . 0.0 109.558 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.0 pt-20 -43.41 139.43 2.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.617 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.61 -7.01 0.98 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.184 0.516 . . . . 0.0 110.334 -177.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.49 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 3.3 p-10 -70.08 174.96 4.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 29.9 m-80 -141.38 149.72 41.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.03 169.37 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 110.108 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.54 135.96 46.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 0.0 110.423 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.623 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 12.0 t -115.08 -66.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.496 -0.752 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.623 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 43.7 Cg_endo -71.74 115.75 4.43 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.273 1.144 . . . . 0.0 110.483 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -88.74 41.64 3.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.64 160.57 39.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.448 -1.031 . . . . 0.0 110.147 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -136.17 -169.41 2.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.169 -0.957 . . . . 0.0 110.551 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.558 ' N ' ' OG1' ' A' ' 141' ' ' THR . 58.5 mt -143.1 -128.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.757 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.1 -155.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.947 . . . . 0.0 110.348 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.25 61.06 4.21 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.464 ' OE1' ' HB2' ' A' ' 142' ' ' LEU . 14.2 pt20 -96.78 159.95 14.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.398 -1.06 . . . . 0.0 110.214 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -139.22 159.51 41.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.927 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.532 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 105.3 -93.05 0.88 Allowed Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.9 OUTLIER 38.46 40.01 0.34 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.429 -1.041 . . . . 0.0 111.078 177.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 pp -140.58 165.07 28.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.682 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 28.6 m-85 -93.3 133.28 36.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.039 -1.038 . . . . 0.0 110.229 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.52 108.48 15.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.92 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.49 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 3.3 t -77.16 140.02 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.816 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.4 t -120.51 -30.95 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.129 -0.982 . . . . 0.0 110.785 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -143.09 149.55 38.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.772 -1.205 . . . . 0.0 111.59 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.508 ' CG2' HG22 ' A' ' 98' ' ' VAL . 55.1 p -140.54 164.39 30.28 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.9 OUTLIER -88.42 -39.15 0.46 Allowed Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.893 . . . . 0.0 110.692 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 19.3 Cg_exo -58.56 -172.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.556 1.293 . . . . 0.0 110.38 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 -167.68 1.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.465 -0.772 . . . . 0.0 109.821 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -65.79 -4.88 7.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.219 -0.925 . . . . 0.0 110.983 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.7 145.26 41.26 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.424 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.569 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -49.35 141.31 25.09 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.221 1.643 . . . . 0.0 110.545 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 4.6 m -129.88 157.9 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 109.942 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 53.7 tt0 -106.91 128.01 53.94 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 110.2 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 126' ' ' ARG . 11.2 mm -70.85 156.48 7.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 110.275 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.74 169.73 25.96 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.458 ' HG2' ' CD1' ' A' ' 125' ' ' ILE . 98.9 mt-10 -57.85 -21.45 42.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 0.0 110.209 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -88.35 -21.6 24.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.884 . . . . 0.0 109.575 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 95' ' ' ALA . 26.6 m -56.89 162.07 2.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.514 -0.741 . . . . 0.0 110.231 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' LYS . 46.8 mtmt -121.02 149.82 42.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.464 176.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.593 ' CD1' ' CG1' ' A' ' 120' ' ' VAL . 1.2 mt -127.99 162.95 32.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 110.95 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.453 ' O ' HD22 ' A' ' 100' ' ' LEU . 35.8 mt-10 -138.35 137.29 37.2 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.521 0.676 . . . . 0.0 110.11 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 117' ' ' GLU . 4.3 mp -121.68 137.72 54.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.887 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.577 ' NE ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -87.27 150.07 24.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 0.0 110.096 -174.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.48 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 96.7 mt-10 -90.66 -12.64 36.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 110.272 -175.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.33 109.23 41.49 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.744 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.2 Cg_exo -71.06 -154.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.161 1.611 . . . . 0.0 110.322 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.465 ' CB ' HG23 ' A' ' 103' ' ' ILE . . . -79.19 51.08 1.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.617 -0.677 . . . . 0.0 110.118 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 27.3 t -65.11 -72.31 0.16 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.296 -0.877 . . . . 0.0 110.779 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -61.95 -10.28 9.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.021 -1.049 . . . . 0.0 110.608 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.49 117.84 31.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.495 -0.753 . . . . 0.0 110.199 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 182' ' ' GLU . 0.7 OUTLIER -170.0 -21.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.379 -0.826 . . . . 0.0 110.903 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.501 ' N ' ' HG ' ' A' ' 181' ' ' LEU . 98.9 mt-10 -127.17 50.14 2.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.003 -1.06 . . . . 0.0 110.511 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.81 -39.93 86.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.159 -0.963 . . . . 0.0 110.082 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.53 163.87 26.43 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.003 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.259 0.552 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -120.13 140.0 51.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 110.122 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.88 91.1 7.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 110.086 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -149.94 98.62 2.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 110.139 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -137.57 122.81 19.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.338 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.508 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -152.18 -161.88 10.48 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.447 HG23 HD12 ' A' ' 33' ' ' LEU . 42.5 pt -136.07 157.92 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -1.204 . . . . 0.0 110.0 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 mm -101.5 113.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.026 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 0.9 OUTLIER -139.81 -173.8 3.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.885 -178.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 24.1 ptt-85 -115.77 139.81 49.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.943 -1.098 . . . . 0.0 110.619 -175.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 80' ' ' SER . 14.5 p -61.8 132.55 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.538 -0.726 . . . . 0.0 110.634 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -108.78 145.33 35.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.63 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.556 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 84.8 tt0 -177.98 94.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.874 175.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.43 42.34 3.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.33 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -139.65 144.92 37.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.918 . . . . 0.0 110.181 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.0 t -60.08 -44.01 95.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.322 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -92.11 157.69 16.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 110.11 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.503 ' HB2' ' OD1' ' A' ' 70' ' ' ASP . 12.5 p-10 -135.04 71.3 69.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 110.272 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -67.33 112.47 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.963 1.507 . . . . 0.0 110.774 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.53 83.3 1.67 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.571 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 24.7 ptp -90.01 -9.87 47.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -1.167 . . . . 0.0 110.081 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 80.9 p -113.74 9.02 17.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 110.342 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 24.9 mmt85 -119.96 144.03 47.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.233 -0.917 . . . . 0.0 109.846 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.473 HG12 HG21 ' A' ' 67' ' ' VAL . 85.6 t -110.45 119.98 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 0.0 110.195 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 5.1 ptt180 -90.25 116.66 28.4 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.753 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.523 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 1.1 mp -128.24 174.91 8.87 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 3.5 p-10 -91.67 177.54 6.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.84 -1.162 . . . . 0.0 110.404 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -60.04 -39.99 87.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 -176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.586 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -67.74 -58.33 4.82 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.107 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.533 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 68.3 m -49.99 -30.04 9.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 109.629 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -81.73 -47.95 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 111.261 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -93.91 -16.86 23.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.767 -1.208 . . . . 0.0 111.199 -171.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.586 ' HB3' ' O ' ' A' ' 29' ' ' SER . 1.1 pt? -60.0 -28.77 67.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.131 . . . . 0.0 110.24 -176.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 61.4 mt -101.91 -73.37 0.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 109.97 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' ALA . 12.6 t0 -170.02 -27.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -36.23 122.36 0.72 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.327 0.584 . . . . 0.0 110.933 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.575 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -115.65 179.32 4.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.2 mm -54.64 128.27 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.985 -1.072 . . . . 0.0 109.897 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.62 18.36 75.75 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.575 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 79.5 m-20 -89.17 161.86 16.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.649 -1.501 . . . . 0.0 109.635 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.442 HG22 ' OG1' ' A' ' 92' ' ' THR . 94.0 t -99.62 135.92 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.058 -1.026 . . . . 0.0 110.499 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 42' ' ' VAL . 3.5 m -119.98 153.12 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.861 . . . . 0.0 110.571 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -118.88 139.93 50.82 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.348 -0.845 . . . . 0.0 110.009 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.588 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 2.8 mp -119.98 145.11 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.049 . . . . 0.0 110.754 -177.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.49 95.28 2.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.353 -0.842 . . . . 0.0 111.023 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HG3' HG11 ' A' ' 85' ' ' VAL . 9.7 tmtm? -97.85 -59.19 1.82 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.995 . . . . 0.0 109.852 173.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG23 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -113.21 -33.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.58 -0.7 . . . . 0.0 109.22 175.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 78.9 mtm-85 -136.56 178.42 7.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 174.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.49 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.1 132.26 34.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.163 -0.96 . . . . 0.0 110.386 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.588 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.1 p -139.69 168.13 20.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.468 0.651 . . . . 0.0 109.695 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.676 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 2.8 m -115.24 175.16 2.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.55 -0.719 . . . . 0.0 110.66 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -177.78 179.75 48.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 174.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.49 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 51.1 mtp180 -125.82 176.13 7.16 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.274 -1.133 . . . . 0.0 110.027 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -99.15 127.07 52.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.351 -175.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.52 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -117.6 164.81 14.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 175.01 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -89.87 121.74 32.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.439 -0.788 . . . . 0.0 109.803 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -62.82 132.4 52.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.604 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.604 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.4 mtt-85 -57.11 -47.4 99.13 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.708 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.76 97.17 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.96 1.505 . . . . 0.0 108.975 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -75.56 33.51 0.11 Allowed 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.429 -0.794 . . . . 0.0 110.977 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 59' ' ' PRO . 72.6 m-20 -145.73 -28.54 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.055 -1.028 . . . . 0.0 110.631 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -87.03 -25.76 24.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 109.129 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 57' ' ' ALA . 18.3 m120 -81.1 42.33 0.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.639 -0.663 . . . . 0.0 110.269 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.528 ' CD ' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.73 9.52 43.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 0.0 109.788 176.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.89 27.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.577 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.456 ' CG2' ' NH2' ' A' ' 10' ' ' ARG . 45.8 pt -140.78 141.71 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.272 -1.134 . . . . 0.0 109.653 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.527 ' CB ' HD11 ' A' ' 9' ' ' LEU . 2.4 p -117.01 128.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.848 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.538 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 78.7 ttt180 -90.82 119.38 30.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.493 HD12 ' CG2' ' A' ' 11' ' ' VAL . 1.6 pp -133.31 165.03 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 110.473 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.571 ' OD2' ' N ' ' A' ' 21' ' ' MET . 89.2 m-20 -80.01 169.2 18.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.734 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.2 m -60.04 -39.95 87.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.413 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.1 -46.6 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.927 . . . . 0.0 110.161 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 51' ' ' VAL . 16.8 tpt -60.06 -42.81 95.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.582 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -39.97 93.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.691 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -69.98 -23.41 63.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.443 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 73' ' ' MET . 75.3 m-20 -60.1 -39.99 88.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.033 -1.042 . . . . 0.0 110.641 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.509 ' O ' ' NH2' ' A' ' 48' ' ' ARG . 29.1 p -98.96 -37.09 9.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.901 -1.124 . . . . 0.0 110.577 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.509 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 114.92 33.18 1.72 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.451 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -109.99 162.79 14.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -1.212 . . . . 0.0 110.401 -177.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.529 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 169.96 8.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.349 -0.844 . . . . 0.0 109.26 177.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.556 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -52.79 144.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.194 177.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.454 ' N ' HG11 ' A' ' 11' ' ' VAL . . . 74.99 0.34 60.15 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 173.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.0 m-20 -58.89 -162.83 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.801 -1.411 . . . . 0.0 110.36 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.3 ptpt -135.13 113.64 11.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.477 -0.764 . . . . 0.0 109.77 176.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.549 HG11 ' HG3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -123.74 156.37 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.629 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -102.9 119.79 39.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.813 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.503 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 45.6 t -102.04 119.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.55 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 84.4 mtm-85 -116.76 140.48 49.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.998 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 24.0 tttm -72.34 145.33 47.85 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 110.879 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -147.4 -167.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.651 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -134.06 168.61 18.5 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 109.653 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -112.21 159.26 18.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.077 -1.015 . . . . 0.0 111.149 -174.295 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -150.08 170.54 18.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.3 96.49 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.467 -1.396 . . . . 0.0 110.219 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.52 ' HB3' ' CG2' ' A' ' 162' ' ' VAL . . . -56.58 147.81 21.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.508 -0.745 . . . . 0.0 110.643 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 169' ' ' LYS . 9.7 ptmt -115.69 -24.9 8.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.805 . . . . 0.0 111.01 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.429 ' HE3' ' OE1' ' A' ' 171' ' ' GLU . 42.7 tttp -149.99 125.84 10.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.759 -1.213 . . . . 0.0 110.691 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.546 ' CG1' HG12 ' A' ' 170' ' ' ILE . 7.3 p -139.46 146.96 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.176 -0.953 . . . . 0.0 110.293 176.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 95.4 m -119.56 138.37 53.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.601 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -140.01 174.17 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.47 ' CB ' ' HD2' ' A' ' 173' ' ' ARG . . . -143.95 102.38 4.88 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 110.752 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -56.15 128.88 32.0 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.0 110.048 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.496 HD11 ' CD1' ' A' ' 149' ' ' LEU . 74.8 mt -95.94 104.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 110.282 -177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.519 HD13 ' NE2' ' A' ' 108' ' ' GLN . 15.2 pt -140.83 -160.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.867 . . . . 0.0 109.933 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.539 ' CB ' ' OD1' ' A' ' 107' ' ' ASP . 41.5 mmt180 -110.3 155.54 21.93 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.421 178.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -58.45 -16.01 13.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.68 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.539 ' OD1' ' CB ' ' A' ' 105' ' ' ARG . 33.5 p-10 -104.09 34.06 3.21 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.79 -0.569 . . . . 0.0 109.596 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.519 ' NE2' HD13 ' A' ' 104' ' ' ILE . 1.6 pp0? -81.42 144.33 31.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.133 -0.98 . . . . 0.0 110.277 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 33.6 ttm180 -96.04 -11.15 26.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.495 -0.753 . . . . 0.0 111.011 -175.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.03 53.58 1.09 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 110.017 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.499 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 10.8 ptmt -100.59 140.37 34.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 109.809 176.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.06 -70.38 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.413 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 116' ' ' ILE . . . 76.42 -170.95 54.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 113' ' ' GLY . 46.1 mt-10 42.37 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.212 -1.169 . . . . 0.0 110.278 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.05 -10.13 69.69 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 9.7 tp -64.05 -40.06 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -1.173 . . . . 0.0 110.13 176.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 41.3 tt0 -59.93 -42.75 94.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.857 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.67 -37.3 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.872 . . . . 0.0 109.817 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -59.99 -39.36 85.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.833 . . . . 0.0 109.684 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.548 ' CG1' HD13 ' A' ' 170' ' ' ILE . 67.3 t -60.03 -47.25 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.55 ' HA ' ' CD2' ' A' ' 124' ' ' LEU . 2.5 mt-30 -60.04 -41.37 92.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -60.11 -41.53 92.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 110.293 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.71 -48.58 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.919 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.55 ' CD2' ' HA ' ' A' ' 121' ' ' GLN . 0.3 OUTLIER -96.28 3.69 52.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.005 -1.06 . . . . 0.0 110.905 -172.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.544 ' HA ' ' CG2' ' A' ' 164' ' ' ILE . 3.4 tt -41.58 165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 110.492 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.95 47.43 0.18 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 111.319 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.7 OUTLIER -133.61 135.06 24.33 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.949 -1.094 . . . . 0.0 111.051 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.776 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 7.4 Cg_endo -54.33 119.76 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.815 1.429 . . . . 0.0 109.498 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG2' ' O ' ' A' ' 127' ' ' ARG . 93.5 mmm -133.26 141.94 48.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.586 -1.321 . . . . 0.0 110.738 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.688 ' N ' ' CD1' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.67 145.93 25.42 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.703 0.763 . . . . 0.0 110.752 175.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.572 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -53.47 158.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.594 -0.691 . . . . 0.0 111.085 -174.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.572 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.6 -6.17 1.84 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.83 -0.544 . . . . 0.0 110.798 177.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.571 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 1.3 p30 -70.22 169.15 14.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -136.01 138.95 42.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -140.35 169.97 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.986 -1.071 . . . . 0.0 110.338 -177.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.2 t -140.43 143.54 35.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.909 . . . . 0.0 110.257 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.649 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 13.3 t -118.99 -69.4 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 0.0 110.776 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.649 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 43.2 Cg_endo -71.88 130.78 17.26 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.176 1.093 . . . . 0.0 110.277 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -97.0 47.25 1.65 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.5 159.08 36.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -1.111 . . . . 0.0 110.386 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -132.91 -168.9 2.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.187 -0.946 . . . . 0.0 110.545 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' A' ' 141' ' ' THR . 83.7 mt -143.94 -132.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 109.937 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.72 -151.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 110.428 176.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.29 60.06 3.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.64 161.02 13.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.447 -1.031 . . . . 0.0 110.243 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.9 t -139.95 156.62 46.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.322 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.582 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 101.74 -87.96 0.67 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 43.37 49.14 6.04 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.557 -0.966 . . . . 0.0 111.244 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.496 ' CD1' HD11 ' A' ' 103' ' ' ILE . 2.4 pp -140.24 169.56 17.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.854 -1.154 . . . . 0.0 109.836 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -92.35 129.19 38.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.036 -1.04 . . . . 0.0 110.094 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -108.6 108.39 19.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.571 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 2.2 t -79.72 136.22 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.036 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.89 -22.74 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 110.784 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -150.01 151.24 32.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.843 -1.161 . . . . 0.0 110.976 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 131' ' ' GLU . 34.5 p -141.66 169.39 17.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 109.389 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.649 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.44 -40.27 0.46 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.698 -178.197 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 17.1 Cg_exo -58.99 -164.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.718 1.378 . . . . 0.0 110.425 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.6 t -89.98 -171.36 3.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.804 175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -67.44 -6.09 17.78 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.165 -0.959 . . . . 0.0 110.498 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.8 m -87.59 148.3 43.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.405 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.676 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.23 143.34 7.86 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.267 1.667 . . . . 0.0 110.628 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.776 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 9.1 m -130.04 159.37 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.58 122.43 44.96 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.838 -1.163 . . . . 0.0 110.13 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 126' ' ' ARG . 8.0 mm -69.54 158.31 6.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.68 -0.638 . . . . 0.0 110.196 -176.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.462 ' N ' ' OG1' ' A' ' 168' ' ' THR . . . -142.64 167.08 26.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.53 -23.09 57.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -1.043 . . . . 0.0 110.248 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.99 -12.07 39.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.152 -0.967 . . . . 0.0 110.087 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 95' ' ' ALA . 5.6 m -57.75 179.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.129 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 96' ' ' LYS . 50.0 mtpt -140.54 159.66 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.548 HD13 ' CG1' ' A' ' 120' ' ' VAL . 4.3 mt -140.02 168.0 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 110.834 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.529 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 13.5 mt-10 -139.17 131.73 28.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.609 -0.682 . . . . 0.0 110.195 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.497 ' CD1' HD12 ' A' ' 100' ' ' LEU . 37.2 mm -119.97 119.94 61.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.87 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.47 ' HD2' ' CB ' ' A' ' 101' ' ' ALA . 6.1 ptp180 -89.12 163.15 15.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.23 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.51 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 96.5 mt-10 -100.03 12.88 35.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.339 -0.85 . . . . 0.0 110.575 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 3.8 tt0 -94.08 109.21 40.76 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.929 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.2 Cg_exo -72.22 -155.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.115 1.587 . . . . 0.0 110.322 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -85.57 44.98 1.15 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.495 0.664 . . . . 0.0 110.217 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 47.4 t -54.11 -59.27 4.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.526 -0.734 . . . . 0.0 110.643 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -84.73 3.99 34.81 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.998 -1.064 . . . . 0.0 110.136 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 62.6 t -111.0 129.93 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 110.055 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.531 ' N ' ' CD2' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -119.42 -44.89 2.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.479 -179.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -152.52 160.7 43.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 110.404 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -59.9 -30.0 68.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 0.0 110.222 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.06 -166.83 52.06 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.427 179.617 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 57.1 ttm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.296 0.57 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 1' ' ' MET . 96.9 mt-10 54.49 40.04 31.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 110.088 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.3 t -60.11 -40.01 88.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.948 . . . . 0.0 110.187 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.485 ' OD1' ' HD3' ' A' ' 88' ' ' ARG . 18.3 t-20 -142.36 116.75 9.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.458 ' O ' HD13 ' A' ' 34' ' ' LEU . 32.2 m120 -139.39 152.99 47.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 110.086 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.01 -166.2 13.85 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.592 ' CD1' HD13 ' A' ' 33' ' ' LEU . 37.3 pt -135.75 159.98 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -1.179 . . . . 0.0 109.811 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.7 mt -101.26 118.64 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.409 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.7 pt? -139.2 -170.78 2.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.7 ptp180 -107.9 135.45 49.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.818 -1.176 . . . . 0.0 110.802 -173.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.575 ' CG1' ' O ' ' A' ' 80' ' ' SER . 14.3 p -62.97 131.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.702 . . . . 0.0 110.774 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -113.91 152.97 30.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.522 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.4 tt0 -174.89 109.58 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 110.246 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.52 -65.09 1.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 110.412 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -115.11 128.22 56.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.228 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 t -140.22 101.17 4.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.215 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -93.22 -14.35 27.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.052 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 46.1 p-10 -139.05 70.02 41.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.174 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' HB3' ' A' ' 70' ' ' ASP . 27.7 Cg_exo -57.62 140.9 94.92 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.068 1.562 . . . . 0.0 110.557 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.42 30.95 10.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.535 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 27.7 ptt? -88.12 0.02 56.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.146 -1.208 . . . . 0.0 109.105 174.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.6 m 49.98 40.15 20.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.372 -0.83 . . . . 0.0 110.487 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 21' ' ' MET . 69.4 mtp180 -118.23 135.58 54.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.111 -0.993 . . . . 0.0 110.486 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 97.5 t -120.0 124.28 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.102 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HD3' ' CD ' ' A' ' 68' ' ' ARG . 7.2 ptt180 -92.27 120.05 32.45 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.786 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HB3' ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -134.05 164.81 26.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.574 -0.704 . . . . 0.0 109.825 -176.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -93.54 -177.34 4.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.004 -1.06 . . . . 0.0 110.555 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.02 -47.33 86.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.672 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 58.1 m -66.32 -43.74 85.33 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.45 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.613 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 55.8 p -60.81 -26.89 67.63 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 53.3 ttp180 -88.35 -45.93 9.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.584 -0.697 . . . . 0.0 110.89 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 99.5 mtt180 -76.59 -10.04 59.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 0.0 109.896 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.613 ' CD2' ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -41.25 -30.03 0.15 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.607 0.718 . . . . 0.0 109.948 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.586 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 73.8 mt -139.98 -61.18 0.53 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.574 -0.704 . . . . 0.0 110.63 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 16.2 t0 -169.98 -28.73 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.551 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.559 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -23.71 118.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.558 0.694 . . . . 0.0 111.457 -175.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.4 pt-20 -104.63 177.59 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.5 mm -58.1 122.59 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.963 -1.086 . . . . 0.0 109.933 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.51 30.14 60.67 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.509 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 33.8 m-20 -89.28 174.4 7.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.832 -1.393 . . . . 0.0 109.411 170.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.497 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 96.6 t -99.38 124.69 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.238 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.5 m -111.82 140.04 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.27 -0.893 . . . . 0.0 110.489 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -108.1 143.91 36.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.764 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.605 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -119.8 144.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.068 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -151.51 87.69 1.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.833 -1.167 . . . . 0.0 111.604 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.607 ' HD3' ' CB ' ' A' ' 79' ' ' ALA . 38.5 tttp -98.57 -75.95 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 110.287 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.497 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -91.78 -33.81 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.481 -0.762 . . . . 0.0 109.62 177.424 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 91.6 mtt180 -143.93 -172.31 3.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.49 ' O ' HD22 ' A' ' 130' ' ' LEU . 14.2 mptt -87.95 132.19 34.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.679 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -133.95 158.78 42.62 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.293 0.568 . . . . 0.0 110.226 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.12 161.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 110.174 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.46 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -176.92 179.39 47.89 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.82 -178.78 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.248 -1.148 . . . . 0.0 109.981 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -110.47 135.3 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 110.373 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -128.02 167.67 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.285 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 35.2 ptt180 -89.32 124.9 34.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.078 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' A' ' 63' ' ' ASN . . . -61.84 131.54 50.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.946 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.648 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 11.5 mtt180 -59.51 -42.09 90.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 C-N-CA 119.101 -1.039 . . . . 0.0 109.367 175.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 29.3 Cg_endo -94.33 99.83 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.886 1.467 . . . . 0.0 108.998 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 12.0 pt-20 -72.77 32.61 0.07 Allowed 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.392 -0.817 . . . . 0.0 110.859 -175.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.6 m-20 -148.58 -26.66 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 0.0 110.701 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 66' ' ' ILE . 52.9 mt-10 -86.26 -28.48 23.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 109.109 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.51 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 43.5 m-80 -81.12 42.22 0.64 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.361 0.6 . . . . 0.0 110.375 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HD3' ' OD2' ' A' ' 27' ' ' ASP . 37.2 mmtt -96.76 6.32 48.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.287 177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.4 29.55 0.05 OUTLIER Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.482 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -140.78 145.12 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.224 -1.162 . . . . 0.0 109.525 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.505 ' N ' HD13 ' A' ' 9' ' ' LEU . 2.6 p -123.17 130.0 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.827 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.535 ' CD ' ' HD3' ' A' ' 25' ' ' ARG . 71.3 ttt180 -91.6 114.62 27.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 110.131 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.57 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 1.6 pt -130.16 159.98 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.679 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 19' ' ' PRO . 95.8 m-20 -81.09 169.57 17.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 110.227 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -57.86 -22.55 48.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.07 -48.84 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.437 ' HE2' ' HB ' ' A' ' 50' ' ' THR . 97.0 mmm -60.03 -43.91 94.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.953 . . . . 0.0 109.6 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -59.98 -40.49 89.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.25 -0.906 . . . . 0.0 110.04 174.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -69.49 -35.87 75.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' HB3' HG22 ' A' ' 50' ' ' THR . 20.6 m120 -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.269 -0.894 . . . . 0.0 110.372 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.7 p -98.36 -35.79 10.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 110.607 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.497 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 109.92 28.05 4.34 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.607 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -100.39 177.63 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.242 . . . . 0.0 111.016 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.575 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -122.81 172.24 8.6 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -0.853 . . . . 0.0 109.196 175.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -62.19 142.23 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.717 -1.239 . . . . 0.0 110.561 179.239 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.539 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 74.55 -0.61 55.15 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 173.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.547 ' HB2' HG11 ' A' ' 11' ' ' VAL . 0.3 OUTLIER -59.65 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.097 -1.237 . . . . 0.0 110.33 175.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 19.1 pttp -133.2 116.33 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.575 -0.703 . . . . 0.0 109.904 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.587 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -122.12 160.12 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 110.023 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 40.1 tttt -107.4 120.66 42.77 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.503 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 72.3 t -103.96 122.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 0.0 109.998 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.536 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 96.1 mtt180 -110.0 148.03 32.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.629 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.516 ' HG3' ' CA ' ' A' ' 36' ' ' ALA . 2.4 tmtt? -93.86 136.01 34.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.056 -1.027 . . . . 0.0 110.53 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.1 m -149.81 -170.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.927 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 52.7 mtt180 -132.85 164.41 26.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 110.41 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.487 ' CG2' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.45 159.39 17.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 111.224 -176.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' OE2' ' CG2' ' A' ' 160' ' ' VAL . 12.8 pt-20 -150.42 169.99 20.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.17 101.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.827 -1.17 . . . . 0.0 110.264 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.483 ' HB1' HG23 ' A' ' 162' ' ' VAL . . . -56.38 135.46 53.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.266 -0.896 . . . . 0.0 110.184 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.547 ' HD2' ' CD1' ' A' ' 156' ' ' LEU . 7.1 ptpp? -97.24 -29.75 13.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -0.973 . . . . 0.0 111.112 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 169' ' ' LYS . 47.3 tttm -151.27 126.66 10.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 110.789 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.488 HG21 ' CG2' ' A' ' 155' ' ' THR . 9.2 p -136.53 145.98 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.122 . . . . 0.0 110.881 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -119.74 139.45 52.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.051 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -134.55 166.09 23.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.505 -177.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.491 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . . . -139.51 89.65 11.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.33 -0.857 . . . . 0.0 110.466 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.0 Cg_exo -59.65 128.74 28.09 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.997 1.525 . . . . 0.0 110.434 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.506 HG21 ' HB1' ' A' ' 177' ' ' ALA . 56.7 mt -89.9 93.69 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 178.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.496 HG13 ' CD2' ' A' ' 110' ' ' LEU . 11.8 pt -150.72 -166.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.629 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.489 ' HB2' ' HG3' ' A' ' 108' ' ' GLN . 20.8 mmm180 -93.71 153.09 18.53 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.669 173.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HA ' HD23 ' A' ' 110' ' ' LEU . 48.2 mtmt -59.23 -18.62 38.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 110.192 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -103.95 9.97 36.44 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 111.155 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.489 ' HG3' ' HB2' ' A' ' 105' ' ' ARG . 40.0 mt-30 -92.26 -79.97 0.37 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.884 -1.135 . . . . 0.0 110.927 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.459 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . 34.0 ttm180 -118.76 -16.75 9.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 110.97 -175.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -98.32 46.56 1.0 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.054 -176.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -137.63 64.01 1.53 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.576 -0.703 . . . . 0.0 110.184 179.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -140.87 -60.16 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.091 -1.006 . . . . 0.0 110.508 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.52 -173.43 54.33 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 47.39 87.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.19 -1.182 . . . . 0.0 110.494 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.74 -2.73 87.29 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.478 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.2 tp -64.19 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -1.189 . . . . 0.0 110.257 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -67.31 -39.98 85.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.905 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.04 -31.46 69.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.05 -41.69 92.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 110.076 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.545 ' CG1' HD13 ' A' ' 170' ' ' ILE . 55.0 t -60.08 -45.92 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.565 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.2 mt-30 -60.0 -42.74 94.93 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 110.273 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.13 -47.94 83.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.481 -0.762 . . . . 0.0 110.151 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.17 75.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.532 -0.73 . . . . 0.0 110.318 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 51.5 mt -93.76 -5.72 47.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.416 -176.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.597 ' HA ' ' CG2' ' A' ' 164' ' ' ILE . 2.5 tt -45.91 167.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.926 -1.109 . . . . 0.0 110.207 -172.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 164' ' ' ILE . 32.0 ptt180 33.82 48.24 0.21 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.672 -0.642 . . . . 0.0 111.768 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 9.3 mmt85 -136.57 148.98 65.93 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 120.533 -1.355 . . . . 0.0 111.83 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.784 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -66.19 130.6 24.52 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.24 1.652 . . . . 0.0 109.653 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.496 ' SD ' HG13 ' A' ' 164' ' ' ILE . 39.9 mtp -130.58 150.06 51.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.44 -1.412 . . . . 0.0 111.207 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.508 ' HB2' HG11 ' A' ' 51' ' ' VAL . 16.5 tp -144.44 107.93 4.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.663 -0.648 . . . . 0.0 109.637 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.2 pm0 -44.71 142.9 1.55 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.359 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.571 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 80.39 -0.85 1.96 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.125 0.488 . . . . 0.0 110.259 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.522 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 4.2 p-10 -70.0 179.4 2.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 109.85 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.504 ' OD1' ' HD2' ' A' ' 151' ' ' LYS . 13.4 m-80 -150.17 136.1 18.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.632 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -139.99 162.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.008 -1.057 . . . . 0.0 110.303 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.3 t -141.03 144.04 34.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.459 -0.776 . . . . 0.0 110.282 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.681 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 34.8 t -127.45 -69.35 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 110.938 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.681 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 38.2 Cg_endo -70.42 124.08 10.48 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.073 1.038 . . . . 0.0 110.386 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -96.07 46.87 1.84 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pp -126.85 153.03 46.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.438 -1.037 . . . . 0.0 110.33 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -141.71 -167.67 2.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.209 -0.932 . . . . 0.0 110.506 -179.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.577 ' N ' ' OG1' ' A' ' 141' ' ' THR . 84.4 mt -136.23 -109.92 0.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.604 -0.685 . . . . 0.0 109.909 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.49 -159.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.38 177.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.66 56.25 4.74 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -101.26 159.05 15.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.393 -1.063 . . . . 0.0 110.375 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.3 t -139.99 155.69 46.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.034 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.544 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 119.95 -84.58 0.37 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 148' ' ' LEU . 0.5 OUTLIER 43.17 49.6 5.63 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.426 -1.044 . . . . 0.0 110.995 177.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 1.6 pp -140.02 166.69 23.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.907 -1.121 . . . . 0.0 110.026 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 30.0 m-85 -92.52 129.6 38.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.504 ' HD2' ' OD1' ' A' ' 134' ' ' ASN . 19.3 tptp -112.31 103.63 11.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.873 . . . . 0.0 109.75 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.522 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 2.1 t -77.44 140.01 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.14 -25.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 111.372 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.521 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 45.0 tptt -140.24 129.93 24.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.587 -1.321 . . . . 0.0 110.885 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.488 ' CG2' HG21 ' A' ' 98' ' ' VAL . 59.7 p -129.99 166.31 20.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.389 -0.82 . . . . 0.0 109.164 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.681 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.1 OUTLIER -89.05 -35.47 0.42 Allowed Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.084 -1.01 . . . . 0.0 110.98 -176.58 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 31.6 Cg_exo -53.1 -179.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.4 1.211 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -84.83 49.76 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.516 -179.238 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.6 mmtm 59.99 20.03 9.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 158' ' ' SER . 11.5 m -109.41 159.74 30.3 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.411 -0.806 . . . . 0.0 110.326 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.557 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 5.1 Cg_endo -53.87 123.29 13.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.198 1.631 . . . . 0.0 110.2 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 5.0 m -129.78 158.46 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.879 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -103.2 128.1 50.29 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.009 177.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.597 ' CG2' ' HA ' ' A' ' 125' ' ' ILE . 10.7 mm -70.26 154.22 8.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.636 -0.665 . . . . 0.0 110.036 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 164' ' ' ILE . . . -142.07 170.98 24.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.482 ' HG2' ' CD1' ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.88 -21.27 28.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -1.088 . . . . 0.0 110.074 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.45 -21.42 21.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 109.791 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.559 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 69.3 m -54.85 138.83 41.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.012 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.1 mttt -93.08 149.52 21.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.133 -0.979 . . . . 0.0 109.59 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.545 HD13 ' CG1' ' A' ' 120' ' ' VAL . 2.1 mt -130.0 160.52 40.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.935 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.513 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 30.8 mt-10 -135.19 136.12 41.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.637 -0.665 . . . . 0.0 110.173 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.423 ' CD1' HD11 ' A' ' 100' ' ' LEU . 40.6 mm -119.98 122.27 68.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.67 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.491 ' NE ' ' HB3' ' A' ' 101' ' ' ALA . 6.4 ptp180 -88.43 149.98 23.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 110.148 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 75.2 mm-40 -90.28 -0.56 57.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.945 . . . . 0.0 110.418 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 0.9 OUTLIER -98.44 108.7 49.2 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.981 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.3 Cg_exo -71.34 -154.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.241 1.653 . . . . 0.0 110.59 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 103' ' ' ILE . . . -72.82 54.91 0.38 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.72 -0.612 . . . . 0.0 109.883 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 52.9 m -96.32 120.04 35.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 110.002 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 178' ' ' SER . 81.4 tt0 60.12 19.91 9.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.893 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.26 138.98 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.778 . . . . 0.0 110.239 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.18 70.52 0.81 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.465 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 45.7 mt-10 -59.99 -40.02 87.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.087 177.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 182' ' ' GLU . 96.9 mt-10 58.74 39.99 23.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.437 -0.79 . . . . 0.0 110.297 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.94 98.68 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -178.943 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.348 0.594 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.03 -39.98 87.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 110.133 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.2 m -70.1 151.39 45.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 0.0 110.489 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -89.58 127.57 35.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.384 -0.823 . . . . 0.0 110.281 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -146.11 169.07 19.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.467 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -150.72 -155.24 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 12.2 pt -131.08 159.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.13 . . . . 0.0 109.193 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 92.2 mt -100.64 122.5 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.011 -1.055 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.608 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -139.62 -175.81 4.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.596 177.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 33.5 ptt180 -110.68 139.72 45.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.869 -1.145 . . . . 0.0 110.964 -175.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 80' ' ' SER . 14.6 p -61.82 130.05 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.661 -0.649 . . . . 0.0 110.755 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.569 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -107.84 151.62 25.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 110.423 177.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.431 ' HB3' ' CG1' ' A' ' 81' ' ' ILE . 86.4 tt0 -176.86 155.42 1.25 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -167.29 -72.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 110.272 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -141.92 114.04 8.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.312 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.0 p -159.99 164.42 33.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.116 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.477 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 69.7 p -70.35 159.8 33.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.107 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.642 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -54.66 -40.2 81.58 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.786 -176.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 13.1 Cg_exo -67.16 171.36 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.57 1.3 . . . . 0.0 110.496 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.03 20.25 36.93 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -86.81 3.17 46.33 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.368 -1.078 . . . . 0.0 109.267 176.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.5 m -117.86 12.84 13.94 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.459 -0.776 . . . . 0.0 110.385 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -124.1 140.04 53.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.291 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 78.7 t -119.46 118.46 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 3.2 ptt180 -88.6 117.36 27.5 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.431 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 55' ' ' TYR . 1.2 pt? -136.63 169.09 18.28 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.672 -0.642 . . . . 0.0 109.353 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 7.6 p-10 -97.12 -171.96 2.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.806 -1.184 . . . . 0.0 111.17 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -59.8 -49.22 78.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.49 -0.757 . . . . 0.0 109.476 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.8 t -62.03 -47.39 84.97 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.409 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.646 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 25.1 t -57.59 -29.64 64.64 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.173 -0.955 . . . . 0.0 109.545 178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 60.0 ttp85 -85.89 -45.47 11.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -80.09 -4.85 54.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.008 -1.058 . . . . 0.0 110.111 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.646 ' CD2' ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -47.49 -27.92 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.788 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 71.6 mt -139.9 -60.04 0.54 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.659 -0.65 . . . . 0.0 110.377 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' C ' ' A' ' 36' ' ' ALA . 44.1 t0 -170.75 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.905 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.583 ' HA ' ' HE2' ' A' ' 89' ' ' LYS . . . -19.94 124.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.563 0.697 . . . . 0.0 111.824 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 54' ' ' VAL . 1.3 pt-20 -116.88 -179.76 3.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.7 mm -59.99 130.1 23.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.777 -1.202 . . . . 0.0 109.689 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.75 19.13 73.92 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.942 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 85.1 m-20 -90.24 171.9 9.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.595 -1.532 . . . . 0.0 109.779 172.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' A' ' 92' ' ' THR . 61.1 t -98.91 138.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 0.0 110.522 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.526 HG12 ' NZ ' ' A' ' 89' ' ' LYS . 1.9 m -126.46 139.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -107.41 145.3 33.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.595 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.578 ' O ' ' OG1' ' A' ' 50' ' ' THR . 3.6 mp -120.02 148.29 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 110.446 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -151.45 94.17 1.98 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.977 . . . . 0.0 110.779 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.538 ' CG ' HG13 ' A' ' 85' ' ' VAL . 8.8 tmtm? -98.84 -66.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.703 173.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.53 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -106.72 -32.78 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.481 175.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 74.6 mtt85 -136.87 -172.64 3.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.469 ' O ' HD23 ' A' ' 130' ' ' LEU . 36.7 mttt -88.83 139.28 30.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.984 -1.073 . . . . 0.0 111.05 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.69 160.18 39.94 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.299 0.571 . . . . 0.0 110.221 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.584 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.13 161.22 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.269 -0.894 . . . . 0.0 109.977 178.018 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' O ' HG21 ' A' ' 42' ' ' VAL . . . -177.62 -179.78 47.93 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 51.9 ttp180 -121.69 169.37 10.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -1.028 . . . . 0.0 110.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.44 ' N ' ' CG ' ' A' ' 53' ' ' ARG . 0.4 OUTLIER -91.48 138.86 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 111.014 -172.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -128.55 162.66 26.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.502 -0.749 . . . . 0.0 109.887 174.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -89.01 123.63 33.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.891 . . . . 0.0 110.128 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -64.19 139.13 58.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.576 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -59.99 -48.91 93.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.15 174.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.4 Cg_endo -91.67 99.1 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.866 1.456 . . . . 0.0 108.993 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -73.91 36.34 0.09 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.585 -0.697 . . . . 0.0 111.126 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 59' ' ' PRO . 61.6 t0 -145.39 -36.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.073 -1.017 . . . . 0.0 111.165 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.8 pt-20 -85.87 -24.43 26.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.905 -1.122 . . . . 0.0 110.172 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.591 ' HB2' ' HB3' ' A' ' 27' ' ' ASP . 31.6 m120 -82.3 37.82 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 110.695 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 49.1 pttt -98.49 18.17 17.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 109.641 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.79 20.85 0.03 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.519 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -141.61 157.01 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -1.068 . . . . 0.0 109.191 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.417 HG23 ' CG1' ' A' ' 24' ' ' VAL . 4.6 p -135.57 131.11 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.863 -1.148 . . . . 0.0 109.86 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.569 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 34.6 ttm180 -96.99 118.16 32.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.974 -1.079 . . . . 0.0 110.24 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 pt -131.69 172.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.639 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 17' ' ' THR . 7.6 t70 -78.61 170.08 17.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.371 -0.831 . . . . 0.0 109.978 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.2 p -65.34 -27.56 68.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 110.01 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.44 -46.12 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 12.7 tpt -60.33 -44.69 95.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.457 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 43.6 ttp180 -60.17 -40.03 88.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 0.0 109.721 174.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -71.48 -22.99 61.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.578 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 73' ' ' MET . 59.3 m-20 -60.01 -36.88 78.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 0.0 110.272 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.463 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.2 p -98.4 -38.82 9.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 0.0 110.319 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.53 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 117.21 36.36 1.03 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 177.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -110.45 167.93 9.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -1.204 . . . . 0.0 110.475 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.55 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.72 169.77 8.74 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.241 -0.912 . . . . 0.0 109.226 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.431 ' CG1' ' HB3' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -54.58 139.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.924 -1.11 . . . . 0.0 110.767 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.55 2.2 79.45 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 172.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -58.8 -162.88 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.023 -1.281 . . . . 0.0 110.445 175.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 21.9 pttm -133.61 113.48 12.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 109.981 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.538 HG13 ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -125.09 160.12 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.389 -0.82 . . . . 0.0 109.586 178.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.5 tttt -110.24 125.4 53.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 110.048 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.562 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 66.1 t -99.25 119.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 110.009 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.485 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 84.4 mtt85 -103.19 145.2 30.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.832 . . . . 0.0 109.234 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 36' ' ' ALA . 29.8 tptt -99.74 135.42 41.19 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.94 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.481 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 3.1 m -150.08 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.575 0.702 . . . . 0.0 110.132 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.426 ' CA ' ' HB ' ' A' ' 41' ' ' VAL . 33.1 mtp85 -127.87 172.41 10.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.598 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.542 ' CG2' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.46 163.42 12.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 111.172 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -150.22 169.94 20.14 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.3 mm -89.01 100.62 10.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.474 ' CB ' HG21 ' A' ' 162' ' ' VAL . . . -53.89 139.94 32.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.315 -0.866 . . . . 0.0 110.173 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.544 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 17.8 ptpt -95.56 -28.75 14.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.203 -0.936 . . . . 0.0 110.999 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 21.6 ttpt -150.6 120.0 6.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.707 -1.246 . . . . 0.0 110.616 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.424 HG21 HG23 ' A' ' 155' ' ' THR . 8.2 p -130.03 140.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.01 . . . . 0.0 111.022 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 171' ' ' GLU . 38.2 m -116.68 148.75 40.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.07 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.637 ' CD1' ' N ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -150.7 179.94 7.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 0.0 110.678 178.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HB1' ' CD ' ' A' ' 173' ' ' ARG . . . -144.45 101.14 4.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 111.117 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 150' ' ' PHE . 13.0 Cg_exo -65.52 129.52 22.7 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.038 1.547 . . . . 0.0 110.035 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.47 HD11 ' CD1' ' A' ' 149' ' ' LEU . 69.0 mt -90.95 110.27 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.135 -0.978 . . . . 0.0 110.366 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.438 HD11 ' CB ' ' A' ' 108' ' ' GLN . 18.0 pt -147.58 -156.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 122.08 0.943 . . . . 0.0 110.462 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.484 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 67.0 mtp85 -130.07 162.41 28.84 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.419 0.628 . . . . 0.0 110.902 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -57.37 -17.08 10.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.813 . . . . 0.0 110.087 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 105' ' ' ARG . 34.4 p-10 -102.87 32.67 3.57 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.444 0.64 . . . . 0.0 109.444 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.507 ' OE1' ' HG ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -81.04 147.02 30.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.805 . . . . 0.0 109.97 -176.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -89.3 -12.54 40.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.432 -0.793 . . . . 0.0 110.76 -174.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.507 ' HG ' ' OE1' ' A' ' 108' ' ' GLN . 1.3 pp -98.52 51.56 1.0 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.026 -1.047 . . . . 0.0 110.206 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 16.5 ptmt -105.17 96.77 6.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.373 -0.829 . . . . 0.0 109.862 174.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -101.77 -61.99 1.31 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.933 -1.104 . . . . 0.0 110.386 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.83 174.02 35.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.094 -1.603 . . . . 0.0 109.094 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 48.15 94.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.043 -1.269 . . . . 0.0 110.02 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.85 -6.62 80.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 20.8 tt -60.13 -38.28 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.192 -1.181 . . . . 0.0 110.259 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 98.0 mt-10 -60.22 -41.9 94.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.117 -0.99 . . . . 0.0 109.763 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -68.91 -36.05 77.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.16 -41.15 92.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.401 -0.812 . . . . 0.0 109.714 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 170' ' ' ILE . 58.5 t -60.27 -45.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.275 174.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.1 mt-30 -59.85 -41.8 92.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.576 -0.703 . . . . 0.0 110.319 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -60.18 -49.83 76.08 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.342 -0.849 . . . . 0.0 109.835 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.29 -40.29 70.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -0.753 . . . . 0.0 110.722 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.489 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.4 mm? -93.36 -0.87 56.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.956 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.548 ' HA ' HG21 ' A' ' 164' ' ' ILE . 2.2 tt -47.96 165.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.97 -1.081 . . . . 0.0 110.075 -177.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ILE . 9.7 ptm180 32.23 46.28 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.537 -0.727 . . . . 0.0 111.37 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.469 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -128.07 133.6 25.31 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.997 -1.064 . . . . 0.0 110.667 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.748 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.6 Cg_exo -58.49 139.35 90.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.995 1.524 . . . . 0.0 109.756 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.514 ' N ' ' O ' ' A' ' 162' ' ' VAL . 92.2 mmm -133.66 146.92 51.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.373 -1.455 . . . . 0.0 110.891 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.585 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 14.5 tp -147.8 112.12 5.24 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.564 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.3 pm0 -46.69 139.51 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.625 -1.297 . . . . 0.0 110.108 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.564 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 79.71 -3.14 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.254 0.549 . . . . 0.0 110.468 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.585 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.3 p30 -68.47 -169.96 0.18 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 175.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.408 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 23.5 m-80 -147.01 155.52 42.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.704 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -140.35 169.92 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.074 -1.016 . . . . 0.0 109.937 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.4 t -131.08 147.85 52.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.405 -0.809 . . . . 0.0 110.609 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.552 ' CG1' ' HD2' ' A' ' 138' ' ' PRO . 84.7 t -102.76 148.27 35.3 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.521 -0.737 . . . . 0.0 109.756 178.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.552 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 1.6 Cg_endo -44.73 166.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.971 1.511 . . . . 0.0 110.598 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.93 79.87 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -132.51 155.36 48.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -1.115 . . . . 0.0 110.028 178.678 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -179.85 -169.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.07 -1.019 . . . . 0.0 110.924 -177.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.548 ' N ' ' OG1' ' A' ' 141' ' ' THR . 0.3 OUTLIER -145.41 -116.67 0.08 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.696 -0.628 . . . . 0.0 109.596 178.066 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -56.58 -157.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 0.0 110.03 175.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -83.04 81.17 1.76 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' A' ' 141' ' ' THR . 1.9 pt20 -96.43 165.45 12.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.443 -1.033 . . . . 0.0 110.114 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -140.02 154.47 47.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.277 -0.889 . . . . 0.0 110.401 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.566 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 84.62 -88.63 1.57 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 43.7 49.4 6.7 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.7 -0.882 . . . . 0.0 111.098 177.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.47 ' CD1' HD11 ' A' ' 103' ' ' ILE . 1.2 pp -134.8 160.97 36.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.031 -1.043 . . . . 0.0 109.522 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 37.4 m-85 -98.13 130.57 44.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.965 . . . . 0.0 110.372 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 133' ' ' ASP . 18.6 tptm -115.13 108.79 17.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.666 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 132' ' ' GLN . 10.6 t -75.23 131.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.104 -0.998 . . . . 0.0 110.091 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.2 t -113.0 -25.44 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.216 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.31 151.16 34.9 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.707 -1.246 . . . . 0.0 111.12 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 157' ' ' PRO . 82.4 p -142.54 162.27 35.92 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.673 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.9 -34.19 0.41 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.283 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.673 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 35.4 Cg_exo -54.39 -171.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.285 1.15 . . . . 0.0 110.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 15.7 t -88.19 43.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 0.0 110.35 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 158' ' ' SER . 33.1 mmtp 61.27 20.0 10.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.427 HG12 ' HB3' ' A' ' 158' ' ' SER . 18.2 m -105.58 154.75 38.95 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.584 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.61 119.89 4.67 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.08 1.568 . . . . 0.0 110.131 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.748 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 6.3 m -129.54 159.97 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.138 175.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.408 ' HG3' HG23 ' A' ' 92' ' ' THR . 75.7 mt-10 -110.01 136.72 48.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.104 177.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.548 HG21 ' HA ' ' A' ' 125' ' ' ILE . 14.7 mm -71.11 154.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.692 -0.63 . . . . 0.0 110.225 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.63 170.02 24.37 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 175.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -58.05 -23.11 53.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -1.119 . . . . 0.0 110.264 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -94.04 -15.61 24.63 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.135 -0.978 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 91.9 m -58.43 144.02 43.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 23.0 mttp -97.51 154.32 17.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.889 -1.132 . . . . 0.0 109.763 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 171' ' ' GLU . 2.7 mt -130.09 164.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 0.0 111.04 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.501 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 16.7 mt-10 -138.16 137.47 37.68 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.34 0.59 . . . . 0.0 110.147 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.513 HD12 HD22 ' A' ' 100' ' ' LEU . 31.8 mm -122.16 129.29 75.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.443 -0.785 . . . . 0.0 109.797 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.429 ' NE ' ' HB2' ' A' ' 175' ' ' GLU . 6.8 ptm180 -89.28 174.22 7.96 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.081 -1.012 . . . . 0.0 110.275 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.511 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 67.1 mm-40 -116.21 4.02 13.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 111.293 -174.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.429 ' HB2' ' NE ' ' A' ' 173' ' ' ARG . 2.6 mt-10 -98.77 107.45 43.22 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.967 -1.083 . . . . 0.0 110.464 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.0 Cg_exo -72.52 -156.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.109 1.583 . . . . 0.0 110.772 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -85.02 56.43 3.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.8 -0.563 . . . . 0.0 110.07 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 39.5 m -66.65 124.33 22.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.022 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 178' ' ' SER . 79.8 tt0 60.07 14.91 4.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 0.0 110.869 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.0 t -98.25 113.83 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 109.992 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.19 84.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 110.366 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.16 -40.21 89.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 109.965 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -63.48 140.0 58.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 110.195 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 158.22 160.21 10.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.197 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 54.7 ttm . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.189 0.519 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 1' ' ' MET . 96.8 mt-10 55.82 39.96 30.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.229 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -84.23 139.73 32.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.354 -0.841 . . . . 0.0 110.169 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -108.25 129.57 55.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 0.0 110.392 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -149.99 159.98 43.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.107 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.538 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.89 -168.22 16.57 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.542 ' CD1' HD12 ' A' ' 33' ' ' LEU . 26.6 pt -134.16 166.77 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.386 -1.067 . . . . 0.0 109.861 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 HD12 ' HD3' ' A' ' 86' ' ' LYS . 35.2 mm -103.22 115.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 110.341 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.7 pt? -138.19 -172.75 3.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.088 -1.008 . . . . 0.0 109.7 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.6 ptt180 -112.19 138.0 49.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.838 -1.164 . . . . 0.0 110.765 -174.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.597 ' CG2' ' CD1' ' A' ' 69' ' ' ILE . 8.4 p -62.03 134.61 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.531 -0.73 . . . . 0.0 110.54 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -111.6 166.64 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 0.0 110.89 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.564 ' HB3' ' CG1' ' A' ' 81' ' ' ILE . 51.5 tp10 -172.43 110.06 0.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 174.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 15' ' ' ASN . . . -109.08 157.03 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 109.849 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 90.3 m-20 53.68 -167.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -0.984 . . . . 0.0 109.659 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 17' ' ' THR . 2.8 t -167.79 178.98 4.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.097 -1.002 . . . . 0.0 110.561 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 16' ' ' SER . 1.2 p 60.8 26.3 16.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.392 -0.817 . . . . 0.0 110.331 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.593 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 14.6 p-10 -149.92 58.31 3.15 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 110.809 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 11.8 Cg_exo -68.9 118.37 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.684 1.36 . . . . 0.0 109.893 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.17 -93.94 0.05 OUTLIER Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.575 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.0 ptp -157.69 -37.1 0.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.709 -0.877 . . . . 0.0 109.28 175.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 21' ' ' MET . 0.4 OUTLIER 161.6 60.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.252 0.549 . . . . 0.0 109.958 -177.304 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -120.06 141.11 50.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.142 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.491 HG11 HG22 ' A' ' 67' ' ' VAL . 53.0 t -110.13 119.89 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.486 ' HD3' ' CD ' ' A' ' 68' ' ' ARG . 4.6 ptt180 -89.27 121.67 31.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.787 -1.196 . . . . 0.0 109.524 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -137.32 166.81 22.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.761 -174.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' N ' ' HB3' ' A' ' 63' ' ' ASN . 6.4 p-10 -101.49 -170.39 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.906 -1.121 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.1 -44.41 94.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.539 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 44.9 t -65.98 -49.9 66.2 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.346 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 58.1 m -56.38 -27.33 55.87 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 49.2 ttp180 -85.58 -48.29 9.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.87 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -83.08 -6.06 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.038 . . . . 0.0 110.011 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.592 ' CD2' ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -44.12 -28.16 0.47 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.621 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.573 ' HG ' ' HG ' ' A' ' 33' ' ' LEU . 82.9 mt -143.8 -59.98 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.517 -0.74 . . . . 0.0 110.617 176.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.3 t0 -170.88 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.302 -0.873 . . . . 0.0 110.852 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -30.77 127.56 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 110.915 -175.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.518 ' O ' HG11 ' A' ' 54' ' ' VAL . 2.3 pt-20 -112.51 -178.08 3.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 38' ' ' ILE . 34.7 mm -59.98 120.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.945 -1.097 . . . . 0.0 109.976 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' N ' HG13 ' A' ' 54' ' ' VAL . . . 72.8 33.55 60.13 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 174.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 2.2 m-20 -89.52 178.86 6.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.806 -1.408 . . . . 0.0 109.556 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.484 HG22 ' OG1' ' A' ' 92' ' ' THR . 79.5 t -99.26 129.58 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.203 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 42' ' ' VAL . 7.5 m -123.57 147.2 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -0.792 . . . . 0.0 110.625 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 88' ' ' ARG . 86.0 tt0 -115.62 139.95 49.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.61 ' HB ' ' OG1' ' A' ' 50' ' ' THR . 3.1 mp -122.78 147.61 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 0.0 110.566 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.4 tt0 -150.08 97.61 2.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 110.633 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' HD2' HG22 ' A' ' 47' ' ' VAL . 14.3 tmtt? -98.62 -67.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.566 HG23 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -102.32 -35.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.162 173.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 92.9 mtt-85 -127.63 -168.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.31 0.576 . . . . 0.0 109.736 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.536 ' HG2' ' CD2' ' A' ' 130' ' ' LEU . 1.3 ttpm? -103.73 137.2 42.1 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.36 -0.838 . . . . 0.0 110.212 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.61 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 8.7 p -142.8 170.53 15.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 110.254 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -122.84 167.76 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.521 -0.737 . . . . 0.0 109.902 177.185 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.472 ' O ' HG21 ' A' ' 42' ' ' VAL . . . -177.7 179.05 48.42 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -117.0 163.97 15.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.505 -0.997 . . . . 0.0 110.139 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -97.35 137.5 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.07 -1.018 . . . . 0.0 110.45 -172.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -122.12 166.48 14.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 110.116 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -89.65 124.44 34.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 110.328 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.427 ' HB2' ' CG ' ' A' ' 63' ' ' ASN . . . -64.33 132.58 50.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.097 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.74 -46.04 99.59 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.984 -1.072 . . . . 0.0 109.296 173.496 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 14.7 Cg_endo -89.89 99.18 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.022 1.538 . . . . 0.0 109.055 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.11 33.62 0.07 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.557 -0.715 . . . . 0.0 110.866 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 59' ' ' PRO . 52.8 t0 -148.78 -29.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 110.703 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.69 -29.22 22.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.438 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.462 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 4.7 m120 -80.94 39.35 0.49 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.699 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 11.3 ptpt -98.54 10.71 40.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.606 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.436 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.4 pt -141.05 142.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.304 -1.115 . . . . 0.0 109.436 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.491 HG22 HG11 ' A' ' 24' ' ' VAL . 1.8 p -119.47 125.89 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.117 -0.99 . . . . 0.0 109.995 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 70.4 ttt180 -90.05 113.04 24.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.597 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 3.0 pt -126.17 163.04 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.793 . . . . 0.0 110.77 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 21' ' ' MET . 91.6 m-20 -69.92 158.67 35.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.81 . . . . 0.0 109.932 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.581 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 79.9 p -61.7 -24.64 66.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.59 -42.88 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 110.323 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -59.92 -49.98 75.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 109.929 178.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.581 ' NE ' ' HA ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -63.87 -33.44 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.682 176.238 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.484 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 60.4 t-20 -68.08 -32.57 72.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.962 . . . . 0.0 109.933 175.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 73' ' ' MET . 98.5 m-20 -60.03 -40.01 87.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.877 . . . . 0.0 110.535 -178.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.448 ' HB2' HG21 ' A' ' 47' ' ' VAL . 27.6 p -98.34 -38.52 9.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.602 -176.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.566 ' CA ' HG23 ' A' ' 47' ' ' VAL . . . 120.16 40.63 0.58 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.449 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -116.03 158.44 23.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.944 -1.327 . . . . 0.0 110.726 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.565 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -112.44 166.84 10.94 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 175.536 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.564 ' CG1' ' HB3' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -51.33 139.96 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.989 -1.069 . . . . 0.0 110.505 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 77.28 0.61 72.05 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 171.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.18 -160.12 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.876 -1.367 . . . . 0.0 110.225 174.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 40.1 pttt -132.62 113.32 12.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.549 -0.719 . . . . 0.0 109.813 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.535 HG13 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -124.35 159.67 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.201 -0.937 . . . . 0.0 109.898 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.6 ttpt -105.21 127.96 53.18 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.218 -0.927 . . . . 0.0 109.868 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.502 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 63.3 t -109.84 121.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 109.714 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.538 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 84.4 mtm180 -110.23 140.03 44.78 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.456 -0.777 . . . . 0.0 109.552 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.483 ' HD2' ' HB3' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -91.22 136.69 32.92 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.069 -1.02 . . . . 0.0 110.001 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 m -150.01 -171.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.539 -0.725 . . . . 0.0 110.212 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . 1.6 ptm85 -126.8 170.07 12.57 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.643 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.484 ' OG1' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.47 165.34 11.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.054 -1.029 . . . . 0.0 111.078 -175.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.4 pt-20 -149.96 167.72 25.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm -89.57 97.78 7.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.542 -1.349 . . . . 0.0 110.336 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -54.88 161.8 1.47 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 110.663 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.516 ' HG3' HD12 ' A' ' 156' ' ' LEU . 25.0 pttt -125.44 -24.71 3.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 110.493 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.554 ' CB ' HD12 ' A' ' 156' ' ' LEU . 15.7 tttp -150.92 127.81 11.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.843 -1.16 . . . . 0.0 110.394 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.482 HG22 HG21 ' A' ' 155' ' ' THR . 7.4 p -139.94 144.65 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.351 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 171' ' ' GLU . 94.2 m -118.52 132.27 56.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 110.253 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.55 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.09 160.02 33.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.375 -178.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.474 ' CB ' ' HG2' ' A' ' 173' ' ' ARG . . . -138.83 93.69 10.55 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 34.7 Cg_exo -54.53 134.48 62.05 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.264 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.483 HD11 ' CD1' ' A' ' 149' ' ' LEU . 75.3 mt -90.0 107.69 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.359 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.614 ' CD1' ' HG2' ' A' ' 108' ' ' GLN . 15.5 pt -146.55 -158.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.769 0.795 . . . . 0.0 109.731 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' A' ' 108' ' ' GLN . 75.9 mtp180 -110.19 155.76 21.55 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.498 178.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -59.33 -14.93 13.37 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.929 0.871 . . . . 0.0 109.868 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.492 ' OD1' ' HB3' ' A' ' 105' ' ' ARG . 12.2 p-10 -112.19 40.48 2.19 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.736 -0.602 . . . . 0.0 109.581 176.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.614 ' HG2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -79.02 168.4 19.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.452 -173.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -109.09 -17.57 13.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.136 -0.977 . . . . 0.0 111.023 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.578 ' C ' ' CD2' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -99.17 53.22 0.96 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.875 -1.141 . . . . 0.0 111.229 -174.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.525 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 7.3 ptmt -97.83 119.97 37.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.12 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -100.12 -78.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 0.0 110.463 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.09 -178.08 54.12 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 47.2 87.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.204 -1.174 . . . . 0.0 110.169 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.78 -2.65 88.0 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 117' ' ' GLU . 9.5 tp -60.17 -37.62 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -1.221 . . . . 0.0 110.314 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 170' ' ' ILE . 96.7 mt-10 -59.92 -42.79 94.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.112 -0.992 . . . . 0.0 109.997 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.84 -37.49 76.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -59.96 -39.23 84.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.559 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.534 ' CG1' HD13 ' A' ' 170' ' ' ILE . 54.5 t -60.07 -47.8 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.674 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.587 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.39 -40.03 92.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 177.481 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.05 -46.43 89.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.61 -41.29 65.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.547 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.6 mm? -94.31 -4.3 48.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.168 -0.957 . . . . 0.0 111.227 -174.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.5 tt -44.49 167.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.774 -1.203 . . . . 0.0 110.267 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 164' ' ' ILE . 52.9 ptt85 33.3 51.21 0.3 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.666 -0.646 . . . . 0.0 111.788 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -137.79 150.22 67.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.833 -1.167 . . . . 0.0 111.074 175.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 18.2 Cg_endo -65.56 130.35 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.042 1.549 . . . . 0.0 110.026 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.551 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 88.1 mmm -125.0 139.17 54.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.515 -1.366 . . . . 0.0 111.052 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.567 ' CD2' ' CA ' ' A' ' 50' ' ' THR . 11.6 tp -144.15 113.59 7.02 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.636 -0.665 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 7.3 pm0 -47.47 143.87 3.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.116 . . . . 0.0 110.359 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.657 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 88.4 mm-40 81.33 -6.09 1.57 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.111 0.482 . . . . 0.0 110.334 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.536 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 2.1 p30 -69.88 173.78 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.149 -0.969 . . . . 0.0 109.903 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -137.72 146.9 44.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.802 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -140.47 170.04 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.085 -1.009 . . . . 0.0 110.144 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.24 135.82 34.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.346 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.672 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 37.4 t -128.95 -68.54 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 110.815 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.672 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 37.7 Cg_endo -70.49 126.37 12.76 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.112 1.059 . . . . 0.0 110.33 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -98.32 47.19 1.48 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.4 pp -126.3 156.81 39.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -1.084 . . . . 0.0 110.273 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -139.84 -169.43 2.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.14 -0.975 . . . . 0.0 110.596 -179.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.562 ' N ' ' OG1' ' A' ' 141' ' ' THR . 83.4 mt -141.97 -126.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.638 -0.664 . . . . 0.0 109.927 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.9 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.72 59.32 4.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.465 ' OE1' ' HB2' ' A' ' 142' ' ' LEU . 14.0 pt20 -97.61 164.07 12.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.415 -1.05 . . . . 0.0 110.162 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 t -139.48 159.81 41.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.226 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.99 -88.21 0.68 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.6 mt 49.48 45.49 23.95 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.187 -1.184 . . . . 0.0 111.002 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 1.9 pp -140.46 169.59 17.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.871 -1.143 . . . . 0.0 109.862 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 29.4 m-85 -92.09 120.31 32.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.079 -1.013 . . . . 0.0 110.236 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -104.87 110.63 23.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.072 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 3.5 t -76.37 138.86 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 t -117.38 -28.39 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.194 -0.941 . . . . 0.0 111.047 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.445 ' C ' HG23 ' A' ' 155' ' ' THR . 42.9 tttp -148.59 151.51 35.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.767 -1.208 . . . . 0.0 111.173 -177.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.482 HG21 HG22 ' A' ' 98' ' ' VAL . 63.8 p -139.75 158.29 44.34 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.704 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.4 OUTLIER -89.1 -34.01 0.4 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.867 -176.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 16.5 Cg_exo -56.99 -161.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.269 1.141 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.3 t -90.13 179.09 6.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 109.869 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.408 ' HE2' ' NZ ' ' A' ' 49' ' ' LYS . 13.9 tttt -61.31 -10.12 6.47 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.863 . . . . 0.0 110.425 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.6 m -84.66 153.13 61.04 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.467 -0.77 . . . . 0.0 110.159 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.539 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -48.87 142.76 18.68 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.248 1.657 . . . . 0.0 110.613 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 13.7 m -130.02 160.0 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -108.71 127.51 54.05 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.022 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.556 ' CG2' ' HA ' ' A' ' 125' ' ' ILE . 12.9 mm -71.08 153.05 8.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 121.434 0.635 . . . . 0.0 110.334 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.546 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.94 166.91 26.15 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -56.95 -19.81 20.12 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.369 -1.077 . . . . 0.0 110.197 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.16 -14.03 39.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.872 . . . . 0.0 110.326 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.525 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 21.0 m -62.04 147.8 46.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 109.856 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mttm -94.46 157.5 15.98 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.929 -1.107 . . . . 0.0 110.256 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.538 HD11 ' HG2' ' A' ' 121' ' ' GLN . 3.4 mm -118.93 129.91 74.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.363 -0.835 . . . . 0.0 110.691 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 99' ' ' THR . 20.1 mt-10 -110.96 130.08 55.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 110.225 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.465 HD13 HG21 ' A' ' 120' ' ' VAL . 33.5 mm -125.8 125.74 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.884 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.581 ' NE ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -89.29 167.26 13.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 0.0 110.713 -177.144 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.442 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 99.1 mt-10 -106.07 -9.56 16.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.928 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.406 ' O ' ' HD3' ' A' ' 173' ' ' ARG . 2.5 tp10 -98.53 109.36 52.54 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.382 -0.824 . . . . 0.0 109.901 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.463 ' HB3' HG12 ' A' ' 104' ' ' ILE . 12.8 Cg_exo -71.37 -155.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.14 1.6 . . . . 0.0 110.504 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.462 ' HB3' HG23 ' A' ' 103' ' ' ILE . . . -79.79 53.12 1.57 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.45 0.643 . . . . 0.0 110.046 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 43.0 t -101.8 120.57 40.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 110.037 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 178' ' ' SER . 83.0 tt0 59.97 19.96 9.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.091 -1.005 . . . . 0.0 109.847 -177.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.75 155.85 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.533 -0.73 . . . . 0.0 110.29 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 pp -70.02 -5.9 29.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.83 . . . . 0.0 110.66 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.05 -42.83 95.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.09 -1.006 . . . . 0.0 110.397 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -64.02 140.02 58.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.277 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 114.88 -153.35 17.69 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.513 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 95.9 mtp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.07 0.462 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 4' ' ' ASN . 99.9 mt-10 56.31 169.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 110.086 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 3.8 m 57.75 -79.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.466 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 2' ' ' GLU . 39.0 t30 -97.01 120.88 38.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.225 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -135.51 -179.99 5.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.383 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.563 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -148.33 -161.04 9.35 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.53 ' CG2' HD23 ' A' ' 33' ' ' LEU . 47.6 pt -131.01 160.01 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.936 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.1 mt -99.55 114.46 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 110.239 -178.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 2.2 pt? -137.86 -172.39 3.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 109.96 178.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.8 ptp180 -115.55 139.05 50.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.785 -1.197 . . . . 0.0 110.714 -172.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 81' ' ' ILE . 4.6 p -61.17 137.91 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.505 -0.747 . . . . 0.0 110.115 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -120.97 155.6 33.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 110.478 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 86.5 tt0 -176.31 -91.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 175.032 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 50.01 -140.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.015 -1.053 . . . . 0.0 109.835 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -79.94 113.97 18.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 110.02 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.1 p -144.04 151.14 39.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 110.166 179.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -108.81 14.36 24.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 109.946 178.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 18.2 p30 -130.04 71.43 82.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.469 -0.77 . . . . 0.0 110.206 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -61.79 166.01 12.85 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.046 1.551 . . . . 0.0 110.17 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.54 93.6 0.1 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.0 ptp -86.66 -17.33 34.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -1.145 . . . . 0.0 109.487 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.3 m -102.41 0.02 33.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 109.958 174.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.563 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 95.6 mtt180 -122.45 138.55 54.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.456 -0.778 . . . . 0.0 109.945 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 55' ' ' TYR . 92.8 t -116.6 120.03 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 110.237 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.485 ' NE ' ' HG3' ' A' ' 68' ' ' ARG . 0.9 OUTLIER -92.41 119.97 32.46 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.757 -1.177 . . . . 0.0 109.945 177.814 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.464 HD11 ' O ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -134.41 173.32 11.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.675 -177.06 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 30' ' ' SER . 17.5 p-10 -93.2 179.76 5.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.83 -1.169 . . . . 0.0 110.481 -178.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -59.97 -43.19 95.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.378 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.486 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 63.3 m -65.08 -44.56 88.52 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.545 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.589 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 59.4 m -60.0 -40.06 87.93 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.951 -1.093 . . . . 0.0 109.193 176.083 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 59.3 ttt180 -71.37 -44.4 65.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.876 -0.515 . . . . 0.0 111.734 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -93.34 -6.18 47.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.755 -1.216 . . . . 0.0 111.199 -169.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.591 HD11 ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -59.2 -31.37 68.96 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.584 -178.527 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.591 ' N ' HD11 ' A' ' 33' ' ' LEU . 31.6 mt -116.57 -66.4 1.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.111 -0.993 . . . . 0.0 110.674 175.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 36' ' ' ALA . 17.1 t0 -171.84 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.191 -0.943 . . . . 0.0 110.244 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.57 ' HA ' ' CE ' ' A' ' 89' ' ' LYS . . . -23.92 120.14 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.579 0.704 . . . . 0.0 111.408 -176.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.527 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -105.24 175.25 5.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.938 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.5 mm -56.69 127.15 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 120.966 -1.084 . . . . 0.0 109.663 178.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 54' ' ' VAL . . . 76.06 24.49 68.9 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.39 174.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 4.2 m-20 -88.81 174.0 8.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.724 -1.456 . . . . 0.0 109.247 171.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.525 ' CG1' ' HG2' ' A' ' 161' ' ' PRO . 92.6 t -102.59 130.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.995 -1.066 . . . . 0.0 110.432 -174.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG21 ' C ' ' A' ' 52' ' ' GLY . 2.2 m -115.02 137.31 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.34 141.67 38.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.435 -0.79 . . . . 0.0 109.847 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -120.99 148.2 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.024 -1.047 . . . . 0.0 110.182 -176.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -152.37 92.32 1.68 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 111.288 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.627 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 59.6 tttp -97.83 -77.05 0.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 0.0 110.123 172.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG22 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.0 -29.97 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.638 0.732 . . . . 0.0 109.688 176.76 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.6 mtt85 -141.34 -172.7 3.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.463 176.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' O ' HD21 ' A' ' 130' ' ' LEU . 18.3 mttt -88.78 141.06 28.82 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.813 -177.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -140.37 156.47 46.4 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.388 0.614 . . . . 0.0 110.111 -179.103 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.603 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -126.07 160.15 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.142 -179.657 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.451 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -176.88 -177.45 45.84 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 96.0 mtt-85 -117.05 -179.01 3.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -1.071 . . . . 0.0 109.761 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -109.31 135.9 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.023 . . . . 0.0 110.681 -175.003 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.563 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -127.16 168.98 13.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.569 -0.707 . . . . 0.0 110.057 176.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -93.59 124.15 37.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 110.152 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -64.4 139.37 58.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.884 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.648 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.8 mtt-85 -57.31 -49.63 92.79 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.953 -1.092 . . . . 0.0 108.993 174.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 57.4 Cg_endo -93.08 98.51 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 109.034 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.54 37.07 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 121.593 -0.692 . . . . 0.0 110.482 -177.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 59' ' ' PRO . 68.3 m-20 -144.16 -33.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 110.461 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -85.62 -28.92 24.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.474 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 14.7 m120 -81.31 38.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.649 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.48 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 31.9 pttt -98.9 12.64 35.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.059 -1.026 . . . . 0.0 109.759 176.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.76 24.88 0.04 OUTLIER Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.474 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.07 142.87 29.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.336 -1.097 . . . . 0.0 109.28 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.461 HG22 HG11 ' A' ' 24' ' ' VAL . 2.9 p -119.97 126.05 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.024 -1.048 . . . . 0.0 109.894 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 31.9 mmt180 -89.95 102.33 15.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.009 . . . . 0.0 110.153 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.517 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 3.3 pt -125.26 169.93 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.408 -0.808 . . . . 0.0 110.68 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.09 161.68 26.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.41 -0.806 . . . . 0.0 109.992 177.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 43.8 m -63.16 -16.8 61.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -0.907 . . . . 0.0 110.324 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 63.8 t -71.16 -49.16 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.322 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.529 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -59.97 -49.5 77.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.907 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 71' ' ' SER . 3.7 ppt_? -64.08 -28.73 69.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.085 -1.009 . . . . 0.0 109.653 175.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.484 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 19.6 t-20 -73.08 -30.28 63.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.959 -1.088 . . . . 0.0 110.388 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 73' ' ' MET . 13.9 m120 -60.04 -40.02 87.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 110.87 -173.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 25.9 p -99.3 -37.23 9.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 0.0 110.605 -177.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.554 ' CA ' HG22 ' A' ' 47' ' ' VAL . . . 126.87 33.53 0.64 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.605 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.36 140.04 34.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -1.078 . . . . 0.0 110.179 -177.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.539 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -103.26 162.57 12.87 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.14 -0.975 . . . . 0.0 108.981 174.156 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.585 ' HA ' HG11 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -52.84 135.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.013 -1.054 . . . . 0.0 110.649 -177.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.93 -0.25 66.98 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 172.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 80' ' ' SER . 0.2 OUTLIER -57.79 -160.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.982 -1.305 . . . . 0.0 110.427 176.683 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 0.5 OUTLIER -134.7 114.91 13.17 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.0 177.17 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.627 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 1.7 m -124.67 160.07 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.828 178.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.6 tttt -105.12 124.97 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.916 176.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.546 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 65.8 t -109.93 123.72 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.148 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.563 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.2 mtt85 -103.46 151.62 22.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 178.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.57 ' CE ' ' HA ' ' A' ' 36' ' ' ALA . 8.0 tmtt? -98.11 133.16 42.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.21 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.529 ' N ' ' HD3' ' A' ' 89' ' ' LYS . 2.3 m -150.3 -167.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.45 0.643 . . . . 0.0 109.975 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.516 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 27.5 mtp180 -129.29 178.11 6.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.807 . . . . 0.0 110.27 176.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.493 HG21 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.24 161.15 14.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 111.233 -175.888 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 157' ' ' PRO . 18.2 pt-20 -148.22 164.78 32.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.439 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 5.0 mp -88.86 97.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.47 -1.394 . . . . 0.0 110.22 -175.207 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.549 ' CB ' HG23 ' A' ' 162' ' ' VAL . . . -54.53 139.14 38.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 110.141 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.505 ' CD ' ' HG ' ' A' ' 156' ' ' LEU . 15.1 ptpt -100.09 -27.69 13.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.991 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 79.2 tttt -149.97 121.52 7.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.954 -1.091 . . . . 0.0 110.449 -176.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.443 HG23 ' CG2' ' A' ' 155' ' ' THR . 7.5 p -135.69 143.23 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 110.383 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 90.4 m -117.81 133.54 55.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 110.066 -177.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -132.35 164.9 25.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 110.223 -178.061 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.532 ' CB ' ' HG2' ' A' ' 173' ' ' ARG . . . -138.91 83.57 18.47 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.804 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.2 Cg_exo -58.74 125.5 18.48 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.94 1.495 . . . . 0.0 110.173 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 103' ' ' ILE . 35.2 mm -90.28 108.17 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.227 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.561 ' HB ' ' CB ' ' A' ' 108' ' ' GLN . 1.1 pp -150.7 -171.73 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.159 -0.963 . . . . 0.0 110.798 179.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.533 ' O ' HD11 ' A' ' 104' ' ' ILE . 83.8 mtp180 -91.19 166.23 13.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.466 -0.771 . . . . 0.0 110.04 176.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.446 ' HA ' HD21 ' A' ' 110' ' ' LEU . 8.5 ptpt -59.26 -15.42 15.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.052 -1.03 . . . . 0.0 110.891 -174.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 34.3 p-10 -122.76 25.81 8.51 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.561 -0.712 . . . . 0.0 110.659 -177.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.561 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 2.6 mm-40 -98.0 -81.27 0.44 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.027 -1.045 . . . . 0.0 111.198 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.492 ' HB3' HG12 ' A' ' 104' ' ' ILE . 37.1 ttm-85 -106.62 -14.56 15.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 111.47 -172.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.531 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 1.2 pp -98.31 56.68 1.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.951 -1.093 . . . . 0.0 110.154 -176.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.528 ' HD3' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -140.95 68.22 1.35 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.784 . . . . 0.0 110.028 177.112 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -138.18 -39.48 0.54 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 110.472 -177.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 78.95 -159.83 46.01 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 113' ' ' GLY . 19.3 pt-20 -31.22 141.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.931 -0.747 . . . . 0.0 111.086 -177.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.14 -10.0 72.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 175.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 16.2 tt -69.06 -40.53 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -1.173 . . . . 0.0 110.387 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.488 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 98.6 mt-10 -69.95 -39.95 75.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.093 -1.004 . . . . 0.0 110.049 175.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.03 -30.69 69.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 176.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.504 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 64.8 t80 -59.86 -37.78 80.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 109.53 176.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.544 ' CG1' HD13 ' A' ' 170' ' ' ILE . 54.4 t -59.88 -49.98 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 109.878 176.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.6 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 4.9 mt-30 -59.96 -44.11 94.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 110.312 177.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.567 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -63.58 -34.33 77.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 110.024 -175.825 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.567 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -84.22 -41.81 16.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.676 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.4 mm? -96.02 2.29 53.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 111.394 -174.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.4 tt -47.95 165.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.797 -1.189 . . . . 0.0 110.209 -175.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.537 ' HG2' ' CG2' ' A' ' 125' ' ' ILE . 9.7 ptp85 34.97 49.57 0.41 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.499 -0.75 . . . . 0.0 111.464 -178.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -132.5 136.47 27.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.782 -1.199 . . . . 0.0 110.907 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.762 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -60.07 129.78 31.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.041 1.548 . . . . 0.0 109.892 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.532 ' SD ' ' CG1' ' A' ' 164' ' ' ILE . 16.4 mtt -125.22 146.2 49.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.428 -1.42 . . . . 0.0 110.875 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.524 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 14.4 tp -144.18 105.59 4.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.616 -0.677 . . . . 0.0 109.6 -176.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.7 pm0 -43.11 143.86 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.345 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.534 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.15 -0.72 2.88 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.163 0.506 . . . . 0.0 110.392 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.533 ' OD1' ' CG2' ' A' ' 152' ' ' VAL . 3.9 p-10 -69.93 -179.46 1.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 174.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.404 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 18.4 m-80 -145.73 141.89 28.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.488 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 135' ' ' ILE . 0.7 OUTLIER -140.01 164.73 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.94 -1.1 . . . . 0.0 110.31 -179.307 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.2 t -140.72 149.96 42.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.475 -0.766 . . . . 0.0 110.359 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.668 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 40.1 t -130.19 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 111.154 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.668 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 41.3 Cg_endo -71.02 138.87 34.72 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.115 1.06 . . . . 0.0 110.672 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -111.67 52.23 0.65 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.65 178.82 4.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -1.207 . . . . 0.0 110.111 179.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -130.12 -174.24 3.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 111.089 -179.157 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.558 HD12 ' NE2' ' A' ' 145' ' ' GLN . 88.1 mt -144.9 -153.54 0.48 Allowed 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.263 0.554 . . . . 0.0 109.889 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.42 81.67 6.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.175 -0.953 . . . . 0.0 110.31 179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 54.99 60.22 9.12 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.269 -176.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.558 ' NE2' HD12 ' A' ' 142' ' ' LEU . 6.5 pt20 -96.45 168.02 10.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.722 -1.457 . . . . 0.0 110.218 178.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -140.03 152.37 46.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.873 . . . . 0.0 110.322 177.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.24 -86.99 0.8 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 177.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.511 ' CD1' ' CD ' ' A' ' 145' ' ' GLN . 11.2 mt 49.5 30.64 3.54 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.23 -1.159 . . . . 0.0 111.782 176.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 150' ' ' PHE . 3.1 pp -141.51 169.92 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.601 -1.312 . . . . 0.0 110.107 177.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 17.6 m-85 -89.53 137.8 32.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.244 -0.91 . . . . 0.0 109.94 176.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.404 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 33.4 tptt -121.12 102.22 8.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 109.874 178.14 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.533 ' CG2' ' OD1' ' A' ' 133' ' ' ASP . 2.2 t -77.06 140.73 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.6 t -131.23 -26.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 111.22 -176.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 6.4 tptm -140.04 134.54 31.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.843 -1.161 . . . . 0.0 110.591 -177.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 131' ' ' GLU . 48.8 p -134.02 165.54 24.79 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.54 -0.725 . . . . 0.0 109.396 176.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.66 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.45 -39.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.646 -176.927 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 17.2 Cg_exo -59.43 -170.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.639 1.336 . . . . 0.0 109.984 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.46 -158.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.27 -0.894 . . . . 0.0 109.998 177.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -70.19 -7.83 45.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 110.669 -177.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.1 149.5 45.4 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 110.931 -175.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.603 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.02 140.75 31.39 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.367 1.719 . . . . 0.0 110.811 179.761 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 4.6 m -130.08 157.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.022 -1.049 . . . . 0.0 109.96 172.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -103.61 130.0 50.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.314 -0.866 . . . . 0.0 110.37 177.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.532 ' CG1' ' SD ' ' A' ' 129' ' ' MET . 19.1 mm -71.34 150.23 9.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 178.135 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.92 170.13 24.65 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 175.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -53.77 -24.76 16.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.354 -1.086 . . . . 0.0 110.169 -176.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -89.67 -18.4 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.899 . . . . 0.0 111.025 -175.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.561 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 95.7 m -56.94 147.23 24.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.178 -0.951 . . . . 0.0 110.078 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' LYS . 74.1 mmtt -95.77 161.24 14.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.839 -1.163 . . . . 0.0 110.36 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.6 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 24.4 mm -119.97 130.63 74.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 110.696 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 99' ' ' THR . 21.7 mt-10 -113.97 126.2 54.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 110.368 171.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.537 HD11 ' CG2' ' A' ' 170' ' ' ILE . 32.1 mm -123.17 132.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.019 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -88.43 149.17 23.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.995 . . . . 0.0 110.387 -176.631 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.9 mt-10 -93.52 -1.04 56.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.269 -0.895 . . . . 0.0 110.785 -176.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.533 ' O ' ' CD ' ' A' ' 173' ' ' ARG . 85.9 tt0 -96.93 108.38 43.12 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 178.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 11.1 Cg_exo -73.14 -155.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.021 1.538 . . . . 0.0 110.79 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.7 56.27 3.31 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.72 -0.612 . . . . 0.0 109.93 176.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.53 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 48.0 t -100.11 122.97 43.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.93 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 178' ' ' SER . 95.0 mt-10 60.08 19.98 9.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.433 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.501 HG21 ' O ' ' A' ' 178' ' ' SER . 63.7 t -108.22 120.53 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 0.0 110.142 177.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 182' ' ' GLU . 0.8 OUTLIER -126.14 19.92 7.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.493 -178.53 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 181' ' ' LEU . 47.1 tt0 39.99 -130.02 0.34 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.317 -0.864 . . . . 0.0 110.234 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.95 150.07 47.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.992 -1.068 . . . . 0.0 110.509 -178.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 110.65 -7.16 29.86 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.425 ' N ' HD11 ' A' ' 181' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.314 0.578 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.428 ' O ' ' ND2' ' A' ' 5' ' ' ASN . 14.8 pt-20 -67.89 -19.47 65.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 110.301 -179.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -59.96 -40.01 87.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 110.331 -179.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 23.4 t-20 -95.37 100.67 12.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 110.367 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 4' ' ' ASN . 98.6 m-20 -141.52 165.07 28.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.966 177.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.6 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -146.33 -166.96 12.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.527 ' CD1' ' CD2' ' A' ' 33' ' ' LEU . 9.1 pt -136.28 159.96 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.439 -1.036 . . . . 0.0 109.418 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 96.7 mt -101.47 121.06 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.003 -1.061 . . . . 0.0 110.216 -179.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -136.96 -171.25 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 110.557 178.576 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HB3' HG21 ' A' ' 66' ' ' ILE . 53.0 ttp180 -107.51 132.85 52.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 111.099 -172.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 80' ' ' SER . 13.2 p -61.67 138.36 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.77 . . . . 0.0 110.314 176.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -123.05 145.01 48.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 110.597 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 81' ' ' ILE . 86.5 tt0 -178.56 96.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 174.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.61 77.31 1.33 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.334 -0.854 . . . . 0.0 110.364 -178.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.6 167.23 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.155 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.3 m -59.99 -40.09 88.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.905 178.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 p -131.24 138.73 49.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 110.017 175.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 1.3 p30 -131.63 73.19 79.57 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.423 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -65.15 168.33 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.968 1.51 . . . . 0.0 110.192 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.78 75.07 1.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.431 ' HA ' ' CG ' ' A' ' 70' ' ' ASP . 20.7 ptt? -86.44 -9.91 55.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -1.19 . . . . 0.0 109.895 177.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.4 m -134.35 13.04 3.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.83 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 97.3 mtt180 -114.38 137.28 52.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.994 -177.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.468 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 87.9 t -119.44 120.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 -179.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 4.9 ptt180 -92.36 119.54 32.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.7 176.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -134.73 -172.31 3.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 0.0 110.179 179.836 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.9 p-10 -106.9 -179.93 4.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.046 . . . . 0.0 110.539 -178.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.01 -44.46 94.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.579 -177.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -59.9 -46.7 88.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.535 -0.728 . . . . 0.0 110.211 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.602 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 59.9 m -59.97 -36.5 77.26 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.062 -1.024 . . . . 0.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.545 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 35.0 ttp180 -70.06 -44.54 68.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.186 178.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -90.26 -10.36 44.52 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.838 -1.164 . . . . 0.0 111.687 -171.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -50.17 -27.06 5.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.711 -1.243 . . . . 0.0 109.135 -178.566 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 33' ' ' LEU . 59.0 mt -130.11 -69.24 0.67 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.511 -0.743 . . . . 0.0 110.583 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -172.63 11.19 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.948 -1.095 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.545 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -52.02 133.6 32.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.921 -1.112 . . . . 0.0 110.199 -176.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.533 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 1.1 pt-20 -118.32 174.32 6.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.408 HD11 HG23 ' A' ' 38' ' ' ILE . 28.2 mm -58.95 119.65 3.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 120.814 -1.179 . . . . 0.0 109.722 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.4 35.54 56.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.629 174.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 33.6 m-20 -89.1 178.93 6.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.633 -1.51 . . . . 0.0 109.718 172.348 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG21 ' OG1' ' A' ' 92' ' ' THR . 76.7 t -99.39 123.54 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 110.585 -176.086 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.412 HG21 ' C ' ' A' ' 52' ' ' GLY . 3.8 m -122.08 147.28 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.618 -0.676 . . . . 0.0 110.518 -177.029 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' OE2' ' HD2' ' A' ' 49' ' ' LYS . 85.3 tt0 -111.19 137.09 49.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.746 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -117.63 140.87 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.0 -1.063 . . . . 0.0 110.55 -176.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -151.59 96.67 2.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.611 -1.306 . . . . 0.0 112.106 -174.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.693 ' HD2' ' CB ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -98.43 -80.24 0.46 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.52 -1.362 . . . . 0.0 110.443 168.014 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.63 -36.67 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.717 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.679 ' CG ' ' HA ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -135.33 -155.5 0.65 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 109.388 172.067 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 48' ' ' ARG . 3.9 mtmm -114.85 133.81 55.65 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.072 0.939 . . . . 0.0 112.271 -177.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.626 ' OG1' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -119.5 179.88 4.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.311 177.5 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.589 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -136.09 160.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.871 170.646 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.412 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -179.66 -168.96 39.32 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.35 -168.25 1.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -1.048 . . . . 0.0 109.752 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.72 130.0 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 -178.534 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.466 ' O ' HD11 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -116.95 164.92 13.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 110.427 178.592 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.64 119.74 30.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.437 -0.79 . . . . 0.0 110.132 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -64.37 140.08 58.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.838 179.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.588 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.13 -50.64 86.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 118.876 -1.129 . . . . 0.0 108.919 175.294 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 50.9 Cg_endo -93.45 97.43 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.753 1.396 . . . . 0.0 108.946 178.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.21 38.73 0.14 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 110.711 -174.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 30.6 p-10 -142.32 -37.89 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.124 -0.985 . . . . 0.0 110.833 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.538 ' OE2' ' CG ' ' A' ' 59' ' ' PRO . 19.5 pt-20 -86.75 -18.9 30.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.003 -1.06 . . . . 0.0 109.676 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.497 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 9.8 m-80 -81.72 35.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.459 -0.775 . . . . 0.0 110.78 177.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.488 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.5 pttt -98.86 16.62 21.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 0.0 109.614 176.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.21 23.26 0.03 OUTLIER Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.497 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -140.39 156.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.149 174.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.445 HG21 HG13 ' A' ' 24' ' ' VAL . 2.8 p -136.36 131.05 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 54.1 ttp85 -91.05 118.55 30.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.0 -1.063 . . . . 0.0 110.009 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 pt -130.17 167.71 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 110.717 178.075 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 34.9 p-10 -80.02 170.71 16.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.1 178.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.441 ' OG ' ' OE2' ' A' ' 13' ' ' GLU . 58.3 m -59.98 -31.88 70.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 110.417 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.463 ' HB ' ' OD2' ' A' ' 70' ' ' ASP . 54.5 t -68.05 -46.5 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.703 -175.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.7 ttt -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.513 179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -60.06 -42.89 95.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.12 172.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -71.75 -25.09 61.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.137 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.461 ' C ' ' NH1' ' A' ' 48' ' ' ARG . 94.3 m-20 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.569 -177.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.679 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 16.7 p -97.88 -37.93 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.791 -1.193 . . . . 0.0 110.92 -175.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 77' ' ' CYS . . . 112.58 31.48 2.55 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.693 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -115.07 178.11 4.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.289 . . . . 0.0 111.763 -170.197 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.538 ' O ' HG12 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -126.79 170.02 12.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.071 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -59.47 150.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.77 -1.206 . . . . 0.0 110.198 178.789 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 10' ' ' ARG . . . 75.56 -3.52 48.33 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 174.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.485 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.0 m-20 -58.58 -162.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.033 -1.275 . . . . 0.0 110.378 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 60.1 pttt -134.8 116.96 15.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.454 -0.779 . . . . 0.0 109.82 177.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.619 ' CG1' ' HE3' ' A' ' 46' ' ' LYS . 1.2 m -117.34 143.39 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 109.532 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 78.6 tttt -93.59 119.04 32.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 175.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.421 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 85.8 t -99.38 123.3 52.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.304 -0.873 . . . . 0.0 109.678 -178.144 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.6 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.6 mtt180 -110.0 146.16 35.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.659 179.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.543 ' CE ' ' HB3' ' A' ' 40' ' ' ASP . 27.1 tptt -96.65 134.8 39.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.056 -1.028 . . . . 0.0 110.152 -177.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.7 m -147.61 -170.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 110.125 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.446 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 14.2 ptm180 -127.24 171.21 11.66 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 177.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.496 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -97.86 162.92 13.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.966 -1.084 . . . . 0.0 111.019 -176.153 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.478 ' CG ' HG13 ' A' ' 162' ' ' VAL . 12.4 pt-20 -150.72 161.88 41.79 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.16 97.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.6 -1.312 . . . . 0.0 110.261 -176.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -54.92 165.0 0.7 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.372 178.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 169' ' ' LYS . 2.1 pttt -134.9 -19.25 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.364 -0.835 . . . . 0.0 110.632 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 77.4 tttt -150.74 119.99 6.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.895 -1.128 . . . . 0.0 110.558 176.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.484 HG23 ' CG2' ' A' ' 155' ' ' THR . 8.8 p -138.76 142.65 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.958 -1.089 . . . . 0.0 110.669 178.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 96.3 m -117.17 142.65 46.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.116 -179.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -139.8 172.64 12.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.337 -0.852 . . . . 0.0 110.334 -178.54 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 173' ' ' ARG . . . -143.99 94.04 5.95 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 0.0 111.021 -175.127 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 14.7 Cg_exo -64.31 126.84 17.79 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.001 1.527 . . . . 0.0 110.056 179.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 77.5 mt -93.11 119.93 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.17 -0.956 . . . . 0.0 110.52 -177.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.6 ' CD1' ' HG2' ' A' ' 108' ' ' GLN . 16.9 pt -149.31 -157.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.962 0.887 . . . . 0.0 110.629 178.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 108' ' ' GLN . 23.5 mmm180 -110.08 153.39 24.72 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.341 0.591 . . . . 0.0 110.399 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -59.8 -14.24 13.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.268 -0.895 . . . . 0.0 109.992 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 11.9 p-10 -122.62 42.3 3.21 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.827 -0.546 . . . . 0.0 109.808 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.6 ' HG2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -81.22 176.61 9.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 110.481 -174.558 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -96.7 -16.45 20.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 111.096 -176.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 110' ' ' LEU . 1.1 pp -99.52 70.5 1.69 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.513 -176.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.531 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 1.7 ptmt -119.96 125.91 49.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 0.0 110.032 175.43 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -144.19 -62.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 110.519 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.49 -169.22 54.28 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -177.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 45.46 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.26 -1.141 . . . . 0.0 110.085 176.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.1 -13.05 60.52 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 175.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 117' ' ' GLU . 12.8 tt -59.99 -39.42 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.118 -1.225 . . . . 0.0 110.078 176.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.501 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -59.96 -41.31 91.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 178.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.02 -33.33 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.741 175.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -60.0 -40.05 87.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.688 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.523 ' CG1' HD12 ' A' ' 170' ' ' ILE . 55.9 t -60.04 -45.65 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.963 175.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 168' ' ' THR . 2.7 mt-30 -60.03 -44.79 94.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.81 178.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -62.63 -42.48 99.62 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.492 -0.755 . . . . 0.0 110.144 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.28 -41.79 63.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 110.506 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.473 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.4 mm? -95.45 0.04 52.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.192 -0.943 . . . . 0.0 110.983 -176.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.5 ' HA ' HG23 ' A' ' 164' ' ' ILE . 2.9 tt -44.82 163.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.925 -1.109 . . . . 0.0 110.095 -177.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 32.6 ptt-85 33.78 48.33 0.21 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.54 -0.725 . . . . 0.0 111.281 -178.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.484 ' HG2' ' HD2' ' A' ' 128' ' ' PRO . 0.2 OUTLIER -134.04 137.76 29.05 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.854 -1.154 . . . . 0.0 111.195 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.794 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 32.5 Cg_exo -54.87 127.48 26.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.003 1.528 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.555 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.9 mmm -126.21 140.83 52.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.495 -1.378 . . . . 0.0 110.79 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.573 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 7.8 tp -139.69 112.02 7.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 -177.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.4 pt-20 -48.6 145.33 3.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.695 -1.253 . . . . 0.0 110.144 -177.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.557 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 74.58 -1.71 3.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.815 -178.744 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.573 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.9 p30 -68.81 -170.4 0.22 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.986 -1.071 . . . . 0.0 110.206 175.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -146.92 157.12 43.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.57 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.93 169.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.084 -1.01 . . . . 0.0 110.016 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.5 t -118.17 152.14 36.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.48 -0.763 . . . . 0.0 110.645 -176.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.478 HG12 ' HD2' ' A' ' 138' ' ' PRO . 23.9 t -99.88 148.26 34.56 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.424 -0.797 . . . . 0.0 109.894 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.478 ' HD2' HG12 ' A' ' 137' ' ' VAL . 3.3 Cg_endo -49.89 -175.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.009 1.531 . . . . 0.0 110.517 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.05 58.82 1.43 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -177.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -122.32 139.76 53.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -1.185 . . . . 0.0 110.104 178.325 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -150.6 -168.89 3.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.286 -0.884 . . . . 0.0 110.629 -179.055 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.548 ' N ' ' OG1' ' A' ' 141' ' ' THR . 86.4 mt -140.69 -154.77 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.652 -0.655 . . . . 0.0 110.306 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.7 77.99 5.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 110.446 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.89 62.05 6.75 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.17 -176.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.524 ' NE2' HD12 ' A' ' 142' ' ' LEU . 7.9 pt20 -94.81 -179.37 4.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.828 -1.395 . . . . 0.0 109.949 178.41 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -138.78 152.13 47.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.408 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.559 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 93.61 -88.79 1.25 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.2 OUTLIER 41.57 41.89 1.8 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.524 -0.986 . . . . 0.0 111.265 177.23 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 pp -140.75 164.82 29.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.877 -1.14 . . . . 0.0 109.946 176.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 14.1 m-85 -100.54 132.32 45.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.112 -0.993 . . . . 0.0 110.089 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.443 ' CE ' HG21 ' A' ' 153' ' ' VAL . 2.9 tmtm? -118.67 108.32 14.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 110.086 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.546 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -77.45 138.6 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 109.868 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.443 HG21 ' CE ' ' A' ' 151' ' ' LYS . 32.9 t -117.18 -32.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 110.915 -177.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 131' ' ' GLU . 60.9 tttm -148.38 149.29 31.5 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.363 -178.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.484 ' CG2' HG23 ' A' ' 98' ' ' VAL . 82.2 p -133.2 170.46 15.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.65 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.47 -37.64 0.45 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.031 . . . . 0.0 110.907 -177.746 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 23.8 Cg_exo -55.61 -171.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.415 1.218 . . . . 0.0 110.284 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 -158.35 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 110.077 176.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -85.4 42.58 0.96 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.221 -0.924 . . . . 0.0 110.269 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.3 m -140.03 158.73 66.6 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.957 . . . . 0.0 110.562 -177.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.589 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.48 136.58 40.54 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.267 1.667 . . . . 0.0 110.957 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 9.2 m -132.07 159.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 109.835 173.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -105.54 127.52 53.07 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.176 -0.953 . . . . 0.0 110.281 175.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.555 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 9.0 mm -71.21 157.39 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.653 -0.655 . . . . 0.0 110.376 -177.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.34 167.03 25.36 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -22.29 61.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.41 -1.053 . . . . 0.0 110.48 -177.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -88.72 -14.18 37.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.273 -178.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.542 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 10.0 m -58.16 155.39 11.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.489 -0.757 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.8 mttt -109.22 148.56 30.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 178.5 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.523 HD12 ' CG1' ' A' ' 120' ' ' VAL . 2.2 mt -130.23 160.0 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 111.254 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.414 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 10.2 mt-10 -133.5 132.16 40.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.671 -0.643 . . . . 0.0 110.02 175.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.459 HD13 ' HG ' ' A' ' 100' ' ' LEU . 48.5 mm -120.01 122.97 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.389 -0.819 . . . . 0.0 109.956 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.457 ' HD2' ' HB3' ' A' ' 101' ' ' ALA . 8.8 ptp180 -88.5 154.38 20.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.006 -1.059 . . . . 0.0 110.469 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 174' ' ' GLU . 86.5 tt0 -99.78 9.94 42.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.291 -0.88 . . . . 0.0 110.332 -175.086 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 10.6 tt0 -91.27 109.96 39.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 109.816 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.7 Cg_exo -72.24 -156.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.146 1.603 . . . . 0.0 110.649 -179.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.44 ' HA ' HG23 ' A' ' 180' ' ' VAL . . . -77.23 53.27 0.99 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.675 -0.64 . . . . 0.0 110.054 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 18.7 m -107.19 120.04 41.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 109.962 177.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 81.9 tt0 59.91 19.95 8.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.465 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.44 HG23 ' HA ' ' A' ' 177' ' ' ALA . 25.2 t -62.67 135.62 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.176 -0.953 . . . . 0.0 109.987 178.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 pp -69.94 -19.94 63.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 0.0 110.266 -177.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.425 ' OE1' ' HE2' ' A' ' 151' ' ' LYS . 46.0 mt-10 -88.17 123.6 32.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.234 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -60.06 -39.92 87.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 110.287 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 152.54 -178.57 29.63 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 CA-C-O 118.013 -1.437 . . . . 0.0 109.529 179.749 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.128 0.489 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -40.17 88.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.299 -178.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m -61.55 141.43 57.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.385 -0.822 . . . . 0.0 110.381 179.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -89.87 116.79 28.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.218 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -152.85 168.16 26.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 110.005 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.1 -160.04 8.91 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 14.7 pt -136.91 168.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.137 . . . . 0.0 109.51 178.403 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 93.2 mt -104.29 125.72 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.649 -177.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.609 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -147.44 178.61 8.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.645 -0.659 . . . . 0.0 109.694 178.279 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 11.7 ptp180 -104.22 137.83 41.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 110.768 -173.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 80' ' ' SER . 8.4 p -61.98 130.63 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 110.547 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -111.38 162.85 14.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 177.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 81.5 tt0 -178.93 -115.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 175.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.521 ' N ' HD12 ' A' ' 81' ' ' ILE . . . 59.97 46.26 11.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.885 -1.134 . . . . 0.0 110.202 -178.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -129.12 165.51 21.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 110.394 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 17' ' ' THR . 13.5 m -71.62 159.94 33.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 -178.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.445 ' C ' ' HD3' ' A' ' 19' ' ' PRO . 74.0 p 41.66 -153.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.898 . . . . 0.0 110.307 179.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.541 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 8.2 p-10 -135.46 61.94 46.82 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.15 -0.969 . . . . 0.0 110.759 -178.404 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 12.0 Cg_exo -69.34 117.04 4.81 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.863 1.454 . . . . 0.0 110.411 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.9 63.69 0.88 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 176.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.6 ptm -89.92 -1.71 58.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.309 -1.112 . . . . 0.0 110.011 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.4 p -148.93 16.48 0.96 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.521 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.595 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 45.5 mtm180 -128.29 147.22 50.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.575 ' CG2' HG22 ' A' ' 42' ' ' VAL . 85.2 t -117.95 122.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.942 -1.099 . . . . 0.0 110.494 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.514 ' HD2' ' HD2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -98.01 120.46 38.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.037 177.598 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -139.95 172.82 12.22 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.233 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -89.94 178.91 6.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.611 -1.306 . . . . 0.0 110.883 -175.156 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -59.91 -40.03 87.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.258 -178.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -50.07 55.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.311 -178.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.61 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 11.3 p -55.49 -34.63 64.75 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.145 -0.972 . . . . 0.0 109.566 177.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 40.0 ttm180 -81.18 -44.2 18.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.507 -0.746 . . . . 0.0 111.302 179.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -85.29 -10.02 56.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 110.81 -172.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.61 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 1.3 pp -57.01 -31.8 65.48 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.318 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 15.4 mt -105.68 -79.83 0.56 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 172.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.41 16.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.559 -0.713 . . . . 0.0 110.31 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB1' ' HG3' ' A' ' 31' ' ' ARG . . . -66.61 141.5 57.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.982 -1.074 . . . . 0.0 111.072 -171.032 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -133.63 -178.91 5.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.176 174.782 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.0 mm -74.5 74.72 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.854 -1.154 . . . . 0.0 110.279 178.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.419 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 172.23 -6.16 0.03 OUTLIER Glycine 0 N--CA 1.483 1.803 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.836 -169.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -107.96 159.95 16.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.292 -1.711 . . . . 0.0 110.773 -172.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 92' ' ' THR . 69.2 t -99.62 133.01 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.407 -0.808 . . . . 0.0 109.821 179.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.575 HG22 ' CG2' ' A' ' 24' ' ' VAL . 5.1 m -109.72 143.56 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 -175.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HB2' HG22 ' A' ' 90' ' ' VAL . 87.9 tt0 -111.75 141.44 45.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.676 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.576 ' O ' ' OG1' ' A' ' 50' ' ' THR . 4.1 mp -119.97 147.12 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 110.442 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.2 tt0 -151.16 94.51 2.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.022 -1.049 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG3' ' CG1' ' A' ' 85' ' ' VAL . 8.7 tmtt? -98.88 -66.21 0.91 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 173.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.53 HG22 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -107.09 -33.99 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 175.928 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 51.5 mtt85 -133.21 -168.23 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.591 -0.693 . . . . 0.0 109.445 175.091 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.522 ' O ' HD22 ' A' ' 130' ' ' LEU . 5.9 mtmt -91.52 138.43 31.58 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.597 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.98 158.11 45.2 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.26 0.552 . . . . 0.0 109.963 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.66 160.99 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.004 178.475 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' C ' HG21 ' A' ' 42' ' ' VAL . . . -174.05 176.38 46.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 172.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 34.6 ttm180 -111.78 171.32 7.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -1.047 . . . . 0.0 110.139 -178.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 5.4 p -89.55 126.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.046 -1.034 . . . . 0.0 110.91 -172.051 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.595 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -123.32 167.22 14.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 175.523 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -99.25 126.38 45.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 110.088 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -64.16 137.45 57.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 178.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.664 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 6.2 mtt180 -59.05 -45.22 99.51 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 109.082 174.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 32.9 Cg_endo -92.97 98.39 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.794 1.418 . . . . 0.0 108.887 178.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 14.7 pt-20 -75.57 36.78 0.13 Allowed 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.485 -0.759 . . . . 0.0 110.855 -173.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 74.1 m-20 -144.65 -38.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.855 -177.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.2 pt-20 -84.21 -22.23 30.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.517 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 17.4 m-80 -81.65 39.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.542 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.525 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 61.2 mtpt -98.64 14.38 28.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.464 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.49 24.69 0.03 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.517 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 46.9 pt -141.82 157.16 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -1.048 . . . . 0.0 109.246 175.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 67' ' ' VAL . 2.8 p -131.55 129.98 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.037 -1.039 . . . . 0.0 109.935 178.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.575 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 81.6 mtt180 -96.78 120.11 36.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.054 -1.029 . . . . 0.0 110.681 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.43 168.28 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.613 -0.68 . . . . 0.0 110.533 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 18' ' ' ASP . 26.2 p-10 -78.95 174.97 10.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.425 -0.797 . . . . 0.0 110.193 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.441 ' CA ' ' OE2' ' A' ' 13' ' ' GLU . 83.3 p -62.69 -38.52 90.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.714 -177.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.9 -43.38 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.134 -0.979 . . . . 0.0 110.359 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.478 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 7.6 tpt -59.99 -47.86 84.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.64 178.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 63.5 ttp85 -60.17 -40.11 88.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 109.964 174.143 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.35 -24.62 62.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 93.9 m-20 -60.13 -39.57 86.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -177.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.441 ' HB2' HG23 ' A' ' 47' ' ' VAL . 29.1 p -98.27 -37.85 9.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -176.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.53 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 118.07 36.56 0.94 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.437 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -112.5 161.26 16.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -1.205 . . . . 0.0 110.367 -176.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.573 ' O ' HG13 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -109.65 166.01 11.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.263 -0.898 . . . . 0.0 109.296 176.622 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -51.09 138.16 8.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.04 -1.038 . . . . 0.0 110.553 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 78.46 0.21 78.02 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 171.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -56.05 -158.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.119 -1.224 . . . . 0.0 110.423 174.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 49.5 pttt -136.05 109.64 8.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.515 -0.741 . . . . 0.0 110.139 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.548 ' CG1' ' HG3' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -124.51 154.88 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.9 . . . . 0.0 109.883 179.68 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 34.3 ttmt -100.65 125.51 47.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 177.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.523 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 74.1 t -99.51 120.79 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.991 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.499 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 99.4 mtt180 -109.67 157.48 19.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 110.007 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -100.03 137.09 38.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 110.619 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.442 HG22 ' CG ' ' A' ' 161' ' ' PRO . 2.2 m -150.38 -169.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 110.369 177.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.41 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 34.7 mtp180 -133.75 179.98 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.826 . . . . 0.0 110.426 177.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.451 HG21 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.19 156.92 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.131 -177.259 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.435 ' H ' ' HA ' ' A' ' 162' ' ' VAL . 13.5 pt-20 -150.26 169.94 20.17 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.18 98.63 8.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 110.398 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 162' ' ' VAL . . . -56.02 135.41 52.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 110.262 178.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 169' ' ' LYS . 1.0 OUTLIER -98.09 -27.79 14.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 111.105 -178.809 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 14.4 ttpt -150.16 130.96 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.811 -1.181 . . . . 0.0 110.248 178.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.507 HG23 ' CG2' ' A' ' 155' ' ' THR . 9.4 p -138.31 140.06 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 110.95 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 90.3 m -106.1 133.94 50.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.53 -0.731 . . . . 0.0 110.02 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.545 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -128.34 160.0 33.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 110.502 -178.28 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.5 84.02 24.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 110.466 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 29.2 Cg_exo -55.98 127.23 25.22 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.884 1.465 . . . . 0.0 110.356 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.519 HG22 ' HA3' ' A' ' 147' ' ' GLY . 72.7 mt -96.11 89.86 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.047 -1.033 . . . . 0.0 110.856 -177.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 103' ' ' ILE . 18.4 pt -152.59 -152.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.984 0.897 . . . . 0.0 110.424 172.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.54 ' HB2' ' CG ' ' A' ' 108' ' ' GLN . 54.7 mmm-85 -132.0 162.67 30.16 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.745 173.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -59.39 -22.57 61.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.1 -179.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 35.8 p-10 -118.91 28.68 8.14 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.677 -0.639 . . . . 0.0 110.473 -178.505 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.54 ' CG ' ' HB2' ' A' ' 105' ' ' ARG . 4.0 mm-40 -90.0 -80.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.032 -1.043 . . . . 0.0 110.294 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.434 ' NH1' ' HG2' ' A' ' 138' ' ' PRO . 31.2 mtm180 -107.9 -76.66 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 110.151 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -130.34 160.04 35.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.954 . . . . 0.0 110.667 -176.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -92.12 171.65 8.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.691 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.682 ' CA ' HG13 ' A' ' 116' ' ' ILE . 13.3 m-30 -90.6 -62.74 1.39 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.134 -0.979 . . . . 0.0 109.824 -178.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 116' ' ' ILE . . . 90.16 165.0 40.29 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 173.061 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.05 139.94 54.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.511 -0.993 . . . . 0.0 109.576 179.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.35 5.62 77.82 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -175.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.682 HG13 ' CA ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -59.79 -32.45 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -1.181 . . . . 0.0 109.627 176.866 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 170' ' ' ILE . 98.8 mt-10 -60.02 -43.76 95.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.97 . . . . 0.0 109.968 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -66.28 -34.26 77.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 109.69 175.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -37.26 78.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.626 177.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.551 ' CG1' HD13 ' A' ' 170' ' ' ILE . 54.5 t -60.16 -47.83 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 109.888 174.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.601 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 109.849 177.631 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -59.93 -41.25 91.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.119 179.035 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.83 -40.09 23.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.672 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 3.7 mm? -93.16 -0.88 56.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.109 -0.995 . . . . 0.0 111.091 -175.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.2 tt -47.92 168.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.861 -1.149 . . . . 0.0 110.242 -176.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.7 ptt-85 32.96 48.29 0.13 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 178.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.4 mmt180 -137.96 148.42 60.32 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.387 -1.446 . . . . 0.0 111.806 175.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.786 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.6 Cg_exo -62.9 132.69 38.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.321 1.695 . . . . 0.0 109.931 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.517 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.4 mmm -131.09 148.06 52.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.533 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 15.0 tp -145.7 115.06 7.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.581 -0.699 . . . . 0.0 109.772 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.9 pt-20 -49.32 136.38 15.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.114 . . . . 0.0 110.401 -176.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.615 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.14 -3.94 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.2 0.524 . . . . 0.0 110.273 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.538 ' OD2' ' CG2' ' A' ' 152' ' ' VAL . 1.4 p30 -68.04 -170.98 0.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.314 175.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.488 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 9.7 m-80 -150.94 134.46 16.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.476 -0.765 . . . . 0.0 109.445 178.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -140.28 165.7 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 0.0 110.713 -177.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.8 t -140.69 145.84 37.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.413 -0.804 . . . . 0.0 110.365 176.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.704 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 4.8 t -104.97 -48.39 0.13 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.339 -0.851 . . . . 0.0 111.065 179.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.704 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 73.8 Cg_endo -87.55 143.27 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.352 1.185 . . . . 0.0 110.222 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -101.1 46.52 1.29 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.91 156.47 48.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.306 -1.114 . . . . 0.0 110.371 -177.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 1.1 t -122.18 -162.19 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.126 -0.984 . . . . 0.0 110.594 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.554 ' N ' ' OG1' ' A' ' 141' ' ' THR . 89.3 mt -138.28 -154.67 0.54 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.788 -0.57 . . . . 0.0 110.097 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.92 64.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.49 -176.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 142' ' ' LEU . . . 57.75 66.19 3.01 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -176.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.416 ' NE2' ' CB ' ' A' ' 148' ' ' LEU . 5.0 pt20 -101.26 179.71 4.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.816 -1.402 . . . . 0.0 109.97 178.33 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -133.89 153.14 51.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -0.999 . . . . 0.0 110.639 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.538 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 82.6 -86.41 1.47 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.181 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 40.19 36.29 0.31 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.477 -1.013 . . . . 0.0 111.078 176.916 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.95 167.89 21.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.985 -1.072 . . . . 0.0 109.399 176.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.4 m-85 -89.69 118.62 29.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.927 -1.108 . . . . 0.0 109.721 177.404 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 109.95 22.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 132' ' ' GLN . 3.4 t -75.96 135.64 26.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.705 179.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.8 -32.14 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.069 -1.02 . . . . 0.0 110.932 -176.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -148.35 139.22 23.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 110.673 -177.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.507 ' CG2' HG23 ' A' ' 98' ' ' VAL . 58.8 p -129.16 169.54 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.635 176.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.701 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.16 -32.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 111.18 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 24.6 Cg_exo -56.29 -165.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.372 1.196 . . . . 0.0 110.237 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 13.0 t -89.76 41.21 1.03 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.251 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 158' ' ' SER . 64.6 mttt 60.74 18.05 8.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.767 . . . . 0.0 109.657 -177.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.485 HG11 ' O ' ' A' ' 158' ' ' SER . 14.9 m -108.18 160.0 28.58 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 110.089 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.557 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.1 Cg_endo -50.18 121.15 7.14 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.167 1.614 . . . . 0.0 110.266 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 6.2 m -129.73 159.45 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.619 176.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -105.93 127.63 53.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.135 -0.978 . . . . 0.0 109.993 178.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.593 ' CG2' ' HA ' ' A' ' 125' ' ' ILE . 11.2 mm -71.85 153.09 8.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.678 -0.639 . . . . 0.0 110.285 -176.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.86 167.52 25.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -57.7 -19.62 28.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -1.047 . . . . 0.0 110.322 -176.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -90.0 -9.99 46.63 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 110.023 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.515 ' CG2' HD12 ' A' ' 164' ' ' ILE . 46.8 m -63.76 151.65 41.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 176.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 96' ' ' LYS . 38.6 mmtm -96.64 163.05 13.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 109.767 178.111 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.551 HD13 ' CG1' ' A' ' 120' ' ' VAL . 18.4 mm -122.66 132.59 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.297 -0.877 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.516 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 58.4 mt-10 -124.17 133.27 53.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.577 172.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 117' ' ' GLU . 6.1 mt -137.46 139.37 43.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.517 -0.739 . . . . 0.0 110.306 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -88.86 159.46 17.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 110.304 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.489 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 99.1 mt-10 -98.16 7.25 46.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 110.365 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -96.76 109.03 46.6 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.861 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.4 Cg_exo -71.67 -155.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.171 1.616 . . . . 0.0 110.403 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.505 ' CB ' HG21 ' A' ' 103' ' ' ILE . . . -88.41 55.24 3.33 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.701 -0.624 . . . . 0.0 110.18 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 5.1 m -92.0 104.67 17.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 178' ' ' SER . 77.3 mm-40 57.43 19.89 5.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 109.934 177.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 177' ' ' ALA . 58.4 t -69.99 -21.84 24.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.264 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 182' ' ' GLU . 2.7 pp -60.02 -44.04 94.86 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.407 -177.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.448 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 88.6 tt0 -62.61 -51.03 68.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.0 110.318 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.06 -39.95 87.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.135 -0.978 . . . . 0.0 110.404 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.74 151.03 33.49 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -178.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.507 -179.534 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 74.6 mtm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.237 0.542 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 1' ' ' MET . 97.7 mt-10 56.18 39.74 30.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.4 t -62.26 -40.07 94.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.238 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 89' ' ' LYS . 4.4 t-20 -112.3 121.06 43.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 110.259 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -121.03 142.58 49.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.253 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -144.95 179.14 22.28 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 177.039 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 44.4 pt -135.34 159.04 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -1.177 . . . . 0.0 109.994 -179.402 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 96.8 mt -101.17 120.01 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.354 -178.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD22 HG23 ' A' ' 85' ' ' VAL . 2.0 pt? -138.36 -171.8 3.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.516 ' HG3' ' HA2' ' A' ' 82' ' ' GLY . 32.6 ttp180 -101.65 133.39 46.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.915 -174.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 82' ' ' GLY . 11.1 p -62.82 129.83 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 110.257 176.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . . . -112.14 148.84 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 110.34 179.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 86.5 tt0 -179.21 140.02 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 176.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 15' ' ' ASN . . . -110.31 -0.53 17.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.403 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 87.0 m-20 56.48 38.97 30.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.315 -178.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 p -122.68 12.32 9.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.3 p -130.01 140.18 50.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 0.0 110.538 -178.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.725 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -91.05 -29.0 0.32 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.301 -0.874 . . . . 0.0 111.725 -178.47 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 34.3 Cg_exo -52.56 -168.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.132 1.069 . . . . 0.0 110.75 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.5 ' HA2' ' OD2' ' A' ' 70' ' ' ASP . . . 162.97 68.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.48 ' HG3' ' HB3' ' A' ' 23' ' ' ARG . 21.2 ptp -97.63 14.78 25.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -1.13 . . . . 0.0 110.273 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.04 40.01 19.15 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.273 -0.892 . . . . 0.0 110.212 -177.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.48 ' HB3' ' HG3' ' A' ' 21' ' ' MET . 33.1 ptt180 -91.54 137.71 32.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.306 -0.871 . . . . 0.0 109.863 176.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 90.1 t -110.08 117.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.09 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.481 ' O ' ' OD1' ' A' ' 63' ' ' ASN . 1.3 ptm180 -96.81 120.56 37.37 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.981 -1.075 . . . . 0.0 109.909 178.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 55' ' ' TYR . 1.2 pt? -136.38 175.27 9.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.664 -0.648 . . . . 0.0 109.542 -175.39 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.558 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.4 p-10 -92.04 179.73 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.743 -175.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.08 -42.19 94.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 109.24 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 54.2 m -65.84 -55.89 14.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.074 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.558 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 23.3 t -49.91 -30.21 9.73 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.739 -1.225 . . . . 0.0 109.564 177.235 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.486 ' HA ' HD13 ' A' ' 26' ' ' LEU . 63.3 ttp85 -80.57 -48.86 12.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 111.327 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -94.42 -14.66 25.02 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.712 -1.242 . . . . 0.0 111.611 -173.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.601 ' HB3' ' O ' ' A' ' 29' ' ' SER . 1.1 pt? -60.05 -28.71 68.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 77.1 mt -103.36 -75.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.074 -1.016 . . . . 0.0 110.186 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.481 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 5.6 t70 -169.58 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.605 0.717 . . . . 0.0 109.176 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.531 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.52 119.38 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.4 0.619 . . . . 0.0 110.772 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -105.1 178.27 4.61 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.246 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.0 mm -60.22 127.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.872 -1.143 . . . . 0.0 110.074 177.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.55 23.36 67.78 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.717 172.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 81.8 m-20 -89.16 171.69 9.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.719 -1.459 . . . . 0.0 109.639 172.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.467 HG13 HG22 ' A' ' 92' ' ' THR . 76.4 t -98.92 129.3 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.09 -176.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 52' ' ' GLY . 1.7 m -117.06 141.12 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 -175.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -109.78 141.74 42.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 177.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.55 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 4.1 mp -120.46 151.29 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.816 -1.177 . . . . 0.0 110.559 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -150.71 93.11 1.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.353 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.74 ' HD2' ' CB ' ' A' ' 79' ' ' ALA . 9.1 ttpt -98.44 -65.13 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.703 174.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -111.82 -30.94 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.637 0.732 . . . . 0.0 109.264 176.112 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.4 mtt85 -136.64 -171.52 2.93 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.714 -0.616 . . . . 0.0 109.372 174.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' O ' HD21 ' A' ' 130' ' ' LEU . 7.0 mttm -88.31 136.94 32.74 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.986 -1.072 . . . . 0.0 110.459 -177.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.549 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -135.85 156.88 48.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.349 0.595 . . . . 0.0 110.296 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.58 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.52 160.59 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.868 . . . . 0.0 109.793 176.999 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 42' ' ' VAL . . . 178.88 179.72 48.68 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.387 -1.387 . . . . 0.0 109.714 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -113.91 165.45 12.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -1.046 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -89.33 139.99 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.016 . . . . 0.0 110.693 -173.576 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -125.29 161.38 27.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.748 . . . . 0.0 110.443 175.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 56' ' ' ARG . 24.8 ttp-105 -93.62 127.02 39.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -0.835 . . . . 0.0 110.314 177.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.456 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -65.9 140.0 58.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.574 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 4.4 mmm180 -56.78 -46.76 99.82 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.969 -1.082 . . . . 0.0 109.127 173.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 32.0 Cg_endo -91.57 98.33 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.997 1.525 . . . . 0.0 109.127 178.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.56 35.68 0.1 Allowed 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.641 -0.662 . . . . 0.0 110.765 -175.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 59' ' ' PRO . 51.6 t0 -148.46 -34.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.37 -24.66 27.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.197 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.503 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -81.29 41.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.718 -0.614 . . . . 0.0 110.318 176.204 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 pttt -98.59 9.76 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 178.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.84 26.75 0.06 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 176.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 66' ' ' ILE . 46.0 pt -140.13 141.22 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -1.189 . . . . 0.0 109.645 175.036 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' HB ' HD13 ' A' ' 9' ' ' LEU . 2.6 p -120.02 121.93 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.567 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 73.5 ttt180 -91.95 118.16 30.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.24 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 pp -130.01 160.04 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 110.41 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' OD2' ' HA2' ' A' ' 20' ' ' GLY . 96.1 m-20 -75.78 159.99 30.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 177.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.4 t -53.45 -29.95 38.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.913 -175.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.55 -48.53 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 110.121 -175.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.444 ' CE ' HD12 ' A' ' 44' ' ' ILE . 3.5 tpt -60.0 -45.14 93.72 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.707 177.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 77' ' ' CYS . 66.9 ttp85 -60.01 -40.09 88.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.778 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -69.93 -27.43 64.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.152 -0.968 . . . . 0.0 110.384 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -21.79 63.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 110.825 -175.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 74' ' ' ARG . 18.6 p -101.78 -25.84 13.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.99 -1.069 . . . . 0.0 110.854 -178.009 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.474 ' C ' HG23 ' A' ' 47' ' ' VAL . . . 98.0 23.47 13.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 176.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.74 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -109.02 -168.82 1.39 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.045 -1.268 . . . . 0.0 110.933 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.61 170.17 12.95 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.461 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -61.49 144.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 0.0 110.324 177.164 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.543 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . 77.74 -1.92 65.72 Favored Glycine 0 C--N 1.297 -1.638 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 172.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.532 ' HB2' HG12 ' A' ' 11' ' ' VAL . 2.3 m-20 -56.62 -167.2 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.035 -1.274 . . . . 0.0 110.189 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 44.1 pttt -127.16 113.33 16.24 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.392 -0.817 . . . . 0.0 109.753 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.57 ' CG1' ' HB2' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -121.15 158.13 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -177.122 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 85.2 tttt -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.729 175.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.527 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 62.8 t -104.22 122.03 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.945 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.529 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 89.4 mtt180 -110.34 140.22 44.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 109.429 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 11.0 tttt -84.77 138.95 32.3 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.077 -1.014 . . . . 0.0 110.237 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.0 m -150.05 -169.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 176.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -128.39 172.21 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.464 177.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.467 HG22 HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.06 163.15 12.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.004 -1.06 . . . . 0.0 111.018 -175.773 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' OE2' HG13 ' A' ' 162' ' ' VAL . 19.1 pt-20 -150.04 169.57 20.92 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.028 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.81 99.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.723 -1.236 . . . . 0.0 110.373 -176.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.566 ' HA ' ' HG3' ' A' ' 157' ' ' PRO . . . -57.25 140.77 48.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -0.837 . . . . 0.0 110.564 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.517 ' HG3' HD21 ' A' ' 156' ' ' LEU . 29.3 pttt -105.36 -26.08 12.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 111.316 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.55 ' CB ' HD21 ' A' ' 156' ' ' LEU . 22.0 tttp -148.16 128.56 13.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.687 -1.258 . . . . 0.0 110.623 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.56 HG23 ' CG2' ' A' ' 155' ' ' THR . 7.5 p -140.86 148.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.371 -0.83 . . . . 0.0 110.558 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -120.04 132.11 55.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.131 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -123.71 159.3 29.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.534 -178.53 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.402 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . . . -141.07 93.78 8.05 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.385 -0.822 . . . . 0.0 110.354 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.7 Cg_exo -58.78 129.83 34.04 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.057 1.556 . . . . 0.0 110.32 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 104' ' ' ILE . 88.4 mt -91.14 106.34 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.2 -0.938 . . . . 0.0 110.328 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.62 ' CD1' ' HB2' ' A' ' 108' ' ' GLN . 4.6 pt -142.87 -161.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 110.065 177.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.485 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 18.8 mmm180 -140.59 -161.62 1.23 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.361 176.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -59.47 -12.31 6.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.817 176.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 105' ' ' ARG . 36.6 p-10 -99.61 28.43 4.67 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.846 -0.534 . . . . 0.0 109.956 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.62 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 15.5 pt20 -78.1 126.14 30.38 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.061 -1.024 . . . . 0.0 110.346 -175.091 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 109' ' ' ARG . 12.2 tpt180 -95.16 -11.26 28.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.579 -0.701 . . . . 0.0 110.252 -179.035 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.422 HD21 HG21 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -97.97 67.5 1.94 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 109.914 -175.785 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 10.5 ptmt -129.64 127.03 39.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.53 -0.731 . . . . 0.0 109.508 176.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -146.46 -55.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.131 -0.98 . . . . 0.0 110.657 -176.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.496 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 75.72 -166.89 54.69 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -177.311 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 11.6 pt-20 34.64 97.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.649 -0.913 . . . . 0.0 110.624 178.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.85 -6.64 77.75 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 177.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 9.8 tp -59.99 -39.06 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -1.171 . . . . 0.0 110.11 177.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 96.8 mt-10 -59.97 -41.74 92.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -35.21 74.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 175.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.392 -0.818 . . . . 0.0 110.2 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.544 ' CG1' HD13 ' A' ' 170' ' ' ILE . 54.6 t -60.52 -45.17 97.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 175.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.612 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 5.9 mt-30 -60.01 -42.8 95.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 110.335 175.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -59.98 -46.56 89.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.405 -0.81 . . . . 0.0 109.953 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.524 ' HB1' ' CD2' ' A' ' 124' ' ' LEU . . . -70.17 -46.71 64.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.516 -0.74 . . . . 0.0 110.741 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.524 ' CD2' ' HB1' ' A' ' 123' ' ' ALA . 4.6 mm? -100.76 8.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.075 -1.015 . . . . 0.0 111.827 -173.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.577 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.2 tt -49.12 165.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.56 -1.337 . . . . 0.0 109.852 -176.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 31.9 ptt180 33.31 45.98 0.09 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.428 -0.795 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -128.46 134.24 26.06 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.044 -1.035 . . . . 0.0 110.589 179.046 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.772 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 6.6 Cg_endo -54.2 129.42 34.38 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.881 1.464 . . . . 0.0 109.942 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.532 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.8 mmm -126.53 143.13 51.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.568 -1.333 . . . . 0.0 110.929 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.523 HD21 ' O ' ' A' ' 49' ' ' LYS . 13.6 tp -142.95 107.56 4.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 0.0 109.645 -177.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.606 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.2 pt-20 -46.24 140.34 4.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 0.0 110.822 -174.638 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.606 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.2 -3.37 1.24 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.256 0.55 . . . . 0.0 110.343 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.51 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 2.1 p30 -69.86 -171.02 0.37 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.302 -0.874 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.49 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 15.6 m-80 -142.48 156.53 45.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.067 176.435 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -136.84 170.69 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.328 -177.612 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.8 t -102.91 164.24 11.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 110.308 -176.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 139' ' ' GLY . 53.2 t -99.55 146.87 32.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.5 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 10.9 Cg_endo -59.6 66.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.256 1.661 . . . . 0.0 110.622 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 42.68 57.6 3.87 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 176.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -139.37 139.05 37.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.009 -1.289 . . . . 0.0 110.264 176.668 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.557 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -160.97 -169.04 2.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.847 . . . . 0.0 110.231 -179.51 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.557 ' N ' ' OG1' ' A' ' 141' ' ' THR . 82.6 mt -144.02 -135.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.473 -0.767 . . . . 0.0 110.004 -178.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.63 -155.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 109.902 175.206 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.25 78.79 1.4 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 173.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -93.54 157.09 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -1.079 . . . . 0.0 109.919 178.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.9 t -119.53 146.19 45.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.945 . . . . 0.0 110.429 -178.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 86.88 -88.69 1.59 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -178.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.5 OUTLIER 42.15 48.01 4.09 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.48 -1.012 . . . . 0.0 110.942 176.864 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.495 ' CD1' HD13 ' A' ' 103' ' ' ILE . 1.2 pp -139.99 168.99 18.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.939 -1.101 . . . . 0.0 109.742 177.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.9 m-85 -93.96 129.37 40.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.161 -0.962 . . . . 0.0 110.116 -178.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.49 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 24.4 tptm -114.72 107.81 15.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.944 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 2.9 t -76.15 135.93 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 109.647 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.7 t -121.62 -27.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.934 -177.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 22.0 tttt -139.53 143.49 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.794 -1.191 . . . . 0.0 110.923 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.56 ' CG2' HG23 ' A' ' 98' ' ' VAL . 46.5 p -139.95 157.2 46.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.605 -0.685 . . . . 0.0 109.503 174.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.696 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 3.2 tp -88.97 -33.96 0.41 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 111.069 -177.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 15.3 Cg_exo -57.57 -165.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.38 1.2 . . . . 0.0 109.971 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 160' ' ' VAL . 6.4 t -90.09 179.71 5.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.222 -0.924 . . . . 0.0 109.901 175.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -60.28 -7.68 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 110.903 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 158' ' ' SER . 19.1 m -85.39 152.78 58.37 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.498 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.58 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.24 141.77 30.52 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.402 1.738 . . . . 0.0 110.933 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.772 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 6.2 m -129.98 158.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 172.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.9 tt0 -106.66 128.68 54.37 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.048 176.115 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.532 ' CG1' ' HG3' ' A' ' 129' ' ' MET . 13.3 mm -70.23 156.25 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 110.125 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 171.2 24.49 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.532 ' HG2' ' CD1' ' A' ' 125' ' ' ILE . 98.9 mt-10 -59.01 -25.7 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.264 -1.139 . . . . 0.0 110.118 -178.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.68 -11.2 40.47 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.151 -0.968 . . . . 0.0 110.494 -176.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.543 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 92.1 m -59.0 145.71 40.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.093 -1.004 . . . . 0.0 110.343 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 79.0 mttt -93.59 147.29 23.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.956 -1.09 . . . . 0.0 109.945 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.612 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 1.0 OUTLIER -121.61 141.35 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -178.184 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.411 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 44.7 mt-10 -124.9 128.88 49.33 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 171.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 170' ' ' ILE . 2.7 mp -123.26 119.95 58.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.562 -0.711 . . . . 0.0 110.052 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.402 ' NE ' ' HB3' ' A' ' 101' ' ' ALA . 8.5 ptp180 -89.08 159.67 17.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 174' ' ' GLU . 58.7 mp0 -99.98 10.0 42.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.993 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -95.52 109.92 48.15 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.407 -0.808 . . . . 0.0 109.833 179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 17.1 Cg_exo -68.51 -152.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.298 -2.09 0 O-C-N 124.202 1.632 . . . . 0.0 110.275 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.88 49.33 0.41 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.551 -0.718 . . . . 0.0 110.435 -177.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 41.5 t -59.93 -65.59 0.65 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.307 -0.87 . . . . 0.0 110.75 -178.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -62.29 -11.65 16.27 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.031 -1.043 . . . . 0.0 110.499 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.1 t -90.16 110.06 21.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.513 -0.742 . . . . 0.0 110.106 -178.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 182' ' ' GLU . 0.7 OUTLIER -147.76 46.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -178.878 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 181' ' ' LEU . 69.9 mm-40 57.6 171.42 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.341 178.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -60.04 140.18 56.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.287 -0.883 . . . . 0.0 110.421 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -149.66 177.24 27.95 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 178.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.504 -179.961 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 75.3 mtm . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.234 0.54 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 1' ' ' MET . 99.3 mt-10 55.23 40.04 31.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.07 179.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -81.08 169.97 16.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.422 -0.799 . . . . 0.0 110.35 -179.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -89.47 109.98 20.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.273 -178.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.42 ' O ' HD13 ' A' ' 34' ' ' LEU . 98.6 m-20 -132.82 167.46 20.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 110.298 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.78 -169.99 14.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 177.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 86' ' ' LYS . 21.4 pt -132.54 154.38 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -1.133 . . . . 0.0 109.952 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.0 mt -94.91 119.17 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 1.4 pt? -136.03 -168.85 2.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.221 -0.924 . . . . 0.0 110.314 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.508 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 20.2 ttp180 -106.55 130.01 54.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 110.957 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 82' ' ' GLY . 11.5 p -62.53 137.71 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 110.461 175.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 68' ' ' ARG . . . -120.91 156.58 31.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.245 177.418 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 86.4 tt0 -177.44 136.88 0.2 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.368 177.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 13' ' ' GLU . . . 179.98 74.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 16' ' ' SER . 38.2 t-20 -161.57 164.96 29.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.445 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.478 ' O ' ' OG1' ' A' ' 17' ' ' THR . 60.3 p -70.8 166.4 21.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 178.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 16' ' ' SER . 74.6 p 44.65 -156.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.043 -177.244 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.4 p30 -132.77 65.85 75.19 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.118 -0.989 . . . . 0.0 110.768 -178.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 12.1 Cg_exo -68.42 128.48 17.36 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.916 1.482 . . . . 0.0 110.476 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.54 60.7 1.09 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.505 ' SD ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -90.6 -1.03 57.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -1.16 . . . . 0.0 110.156 176.974 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.505 ' N ' ' SD ' ' A' ' 21' ' ' MET . 21.9 p -153.1 13.79 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.7 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.601 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 26.1 mmt180 -120.06 141.39 49.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -0.984 . . . . 0.0 110.476 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 55' ' ' TYR . 95.8 t -114.52 119.99 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 177.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -97.41 119.92 36.84 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.959 -1.088 . . . . 0.0 110.035 177.403 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.525 ' CD2' ' CB ' ' A' ' 30' ' ' SER . 1.8 mt -140.78 177.75 7.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.154 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 28.1 p-10 -93.65 179.35 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.833 -177.281 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.99 -40.97 90.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.349 -177.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.522 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -68.83 -42.68 76.84 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.308 -177.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.593 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 57.7 m -59.95 -40.84 90.36 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.031 -1.043 . . . . 0.0 109.573 177.008 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.568 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 52.3 ttp180 -74.19 -44.21 54.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 111.469 177.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -88.63 -11.61 44.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.88 -1.138 . . . . 0.0 111.07 -170.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 30' ' ' SER . 1.1 pp -57.73 -32.59 67.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.775 -1.203 . . . . 0.0 109.559 -177.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 33' ' ' LEU . 17.1 mt -106.44 -72.65 0.71 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.122 -0.986 . . . . 0.0 110.475 175.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 36' ' ' ALA . 6.8 t0 -170.04 -27.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.717 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -28.68 124.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.383 0.611 . . . . 0.0 111.455 -178.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.469 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 2.6 pt-20 -113.48 -175.16 2.61 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.233 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 38' ' ' ILE . 19.3 mm -60.53 134.14 25.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.947 -1.096 . . . . 0.0 109.61 174.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' H ' ' CG1' ' A' ' 54' ' ' VAL . . . 79.77 14.62 80.74 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.237 172.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' CE ' ' A' ' 89' ' ' LYS . 87.0 m-20 -88.97 167.29 13.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.301 -1.705 . . . . 0.0 110.033 173.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.4 HG21 ' OG1' ' A' ' 92' ' ' THR . 50.1 t -99.71 129.08 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.046 -1.034 . . . . 0.0 110.454 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG13 ' CD ' ' A' ' 89' ' ' LYS . 1.4 m -114.59 146.09 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.903 . . . . 0.0 110.527 -178.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.5 tt0 -112.22 144.27 41.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.41 -0.806 . . . . 0.0 109.35 177.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 4.2 mp -117.18 148.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.948 -1.095 . . . . 0.0 110.586 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -151.06 90.6 1.62 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 111.178 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.552 ' CG ' ' CG1' ' A' ' 85' ' ' VAL . 13.4 tmtt? -98.21 -59.64 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.031 . . . . 0.0 109.86 172.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.541 HG21 ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -114.26 -35.52 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 109.069 177.532 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 83.9 mtm-85 -133.06 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.504 ' O ' HD23 ' A' ' 130' ' ' LEU . 9.3 mttp -88.34 130.71 35.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.075 -1.016 . . . . 0.0 110.175 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.522 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -129.96 168.11 17.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.643 -0.66 . . . . 0.0 110.391 -178.703 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -125.81 162.55 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.392 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.455 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.29 -176.97 47.41 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 176.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 54.9 mtp180 -123.38 -168.47 1.77 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -1.086 . . . . 0.0 109.977 -178.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -111.09 131.61 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.06 -1.025 . . . . 0.0 111.202 -174.03 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.601 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -125.65 162.76 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 0.0 110.467 175.146 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -90.0 125.87 35.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.496 -0.753 . . . . 0.0 110.061 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -64.62 139.75 58.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.075 -1.016 . . . . 0.0 110.035 178.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.63 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.2 mtp180 -58.51 -49.84 91.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 109.275 174.071 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 17.9 Cg_endo -91.53 99.46 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.812 1.427 . . . . 0.0 108.885 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.6 34.16 0.07 Allowed 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.527 -0.733 . . . . 0.0 110.857 -174.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -149.8 -30.77 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.674 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.47 -25.26 29.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.157 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 10.2 m-80 -81.25 40.07 0.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.774 -0.579 . . . . 0.0 110.554 179.082 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -97.81 11.71 36.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.041 . . . . 0.0 109.553 177.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.49 25.6 0.05 OUTLIER Glycine 0 N--CA 1.48 1.611 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 176.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.422 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 44.9 pt -140.11 141.21 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -1.217 . . . . 0.0 109.508 174.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.462 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 7.6 p -120.38 129.04 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.996 . . . . 0.0 110.16 -179.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.519 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 28.5 ttm180 -94.26 112.8 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.253 -177.043 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.4 pt -131.33 168.5 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.731 . . . . 0.0 110.632 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' OD1' ' HB2' ' A' ' 73' ' ' MET . 31.6 p-10 -81.8 176.15 9.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 177.626 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -70.01 -29.1 66.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.272 -0.893 . . . . 0.0 110.671 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.7 -47.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 0.0 110.42 -176.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.543 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -60.62 -43.45 97.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.515 178.965 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.428 ' NH1' HG13 ' A' ' 81' ' ' ILE . 45.3 ttp180 -60.02 -41.08 91.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.935 173.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.95 -24.29 63.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.543 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 95.6 m-20 -60.0 -37.46 79.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.011 . . . . 0.0 110.633 -177.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.47 ' HB2' HG23 ' A' ' 47' ' ' VAL . 30.0 p -98.26 -33.36 11.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 110.439 -177.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.528 ' C ' HG22 ' A' ' 47' ' ' VAL . . . 113.94 26.75 3.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.423 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . . . -103.58 168.54 9.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -1.14 . . . . 0.0 110.275 -176.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.478 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -115.72 177.97 4.48 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.569 179.273 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.474 ' HA ' HG12 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -64.32 140.27 19.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.028 -1.045 . . . . 0.0 110.532 178.414 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.518 ' N ' HG13 ' A' ' 11' ' ' VAL . . . 77.15 -3.35 58.3 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 173.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.513 ' HB2' HG11 ' A' ' 11' ' ' VAL . 1.1 m-20 -58.08 -167.44 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.913 -1.345 . . . . 0.0 110.303 175.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 19.1 pttp -128.36 111.58 13.5 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.885 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.552 ' CG1' ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -118.37 155.42 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.7 ttmt -100.24 123.6 44.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -0.968 . . . . 0.0 109.837 176.055 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.476 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 80.3 t -102.28 123.65 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.933 178.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.551 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtt180 -111.97 148.2 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.581 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.545 ' CD ' ' HB3' ' A' ' 36' ' ' ALA . 10.5 tptt -100.0 130.04 46.12 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.049 -179.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.06 -166.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.596 -0.69 . . . . 0.0 110.15 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -129.12 171.46 12.38 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.543 -0.723 . . . . 0.0 109.67 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -107.43 159.97 16.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 111.117 -174.618 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' OE2' ' HB3' ' A' ' 157' ' ' PRO . 19.6 pt-20 -147.8 173.46 12.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.5 mm -89.2 105.73 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.821 -1.175 . . . . 0.0 110.267 -175.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.485 ' CB ' HG21 ' A' ' 162' ' ' VAL . . . -57.2 139.24 53.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.537 ' HG3' ' CD2' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -101.34 -30.48 11.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.7 178.212 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 23.6 tttt -150.03 128.76 12.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.878 -1.139 . . . . 0.0 110.493 -179.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.459 HG21 ' CG2' ' A' ' 155' ' ' THR . 9.9 p -139.92 143.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 110.384 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 54.6 m -114.79 138.36 50.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.127 -178.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -133.42 165.43 24.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.484 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . . . -144.16 99.97 4.96 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 110.605 -177.112 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HD2' ' NH1' ' A' ' 173' ' ' ARG . 28.3 Cg_exo -56.1 138.25 82.15 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.887 1.467 . . . . 0.0 110.239 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.426 HD12 HG23 ' A' ' 103' ' ' ILE . 38.5 mm -99.06 102.81 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.152 -0.967 . . . . 0.0 110.762 -177.147 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 108' ' ' GLN . 4.1 pt -144.62 173.46 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.059 -1.026 . . . . 0.0 110.244 171.417 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 95.2 mtt180 -129.41 -138.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.994 -178.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -58.62 -12.34 4.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.932 -1.105 . . . . 0.0 109.735 175.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -98.3 26.23 5.58 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.634 -0.666 . . . . 0.0 110.062 177.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.576 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -83.06 95.6 8.1 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.072 -1.018 . . . . 0.0 109.563 177.986 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 109' ' ' ARG . 14.0 ttp180 -107.06 -8.54 16.5 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.438 0.637 . . . . 0.0 109.974 -178.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.7 61.98 1.63 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.392 -0.817 . . . . 0.0 109.661 -176.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.517 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 10.9 ptmt -97.33 120.91 38.56 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.58 -0.7 . . . . 0.0 109.41 176.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.51 ' HB2' ' CD1' ' A' ' 116' ' ' ILE . 11.0 m-85 -95.93 -41.53 8.75 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.115 -0.991 . . . . 0.0 110.42 -174.062 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.449 ' O ' ' HB ' ' A' ' 116' ' ' ILE . . . 77.97 -157.8 45.6 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 113' ' ' GLY . 21.9 pt-20 -39.1 142.16 0.25 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.719 -0.871 . . . . 0.0 110.15 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.43 -16.03 42.19 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 178.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.51 ' CD1' ' HB2' ' A' ' 112' ' ' PHE . 20.9 tt -61.83 -39.45 83.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.107 -1.231 . . . . 0.0 110.096 174.276 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 170' ' ' ILE . 95.6 mt-10 -60.01 -42.82 95.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -65.86 -40.02 91.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.843 . . . . 0.0 109.607 174.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -60.57 -39.97 89.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.471 -0.768 . . . . 0.0 109.916 178.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' A' ' 170' ' ' ILE . 54.6 t -60.09 -47.67 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.889 176.076 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.627 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 5.3 mt-30 -60.02 -43.78 95.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 176.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -59.99 -43.28 95.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.887 -176.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.59 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.56 -0.712 . . . . 0.0 110.597 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 47.9 mt -94.33 -4.7 48.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.021 . . . . 0.0 110.928 -171.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 2.4 tt -45.51 166.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.883 -1.136 . . . . 0.0 109.962 -172.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 164' ' ' ILE . 35.6 ptt180 33.45 46.72 0.12 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.7 -0.625 . . . . 0.0 111.578 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 9.0 tpp180 -134.13 135.3 24.02 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.73 -1.231 . . . . 0.0 111.547 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -59.51 124.19 14.96 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.989 1.521 . . . . 0.0 109.526 178.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.435 ' SD ' HG13 ' A' ' 164' ' ' ILE . 20.0 mtp -132.1 147.44 52.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.361 -1.462 . . . . 0.0 111.269 -177.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 49' ' ' LYS . 2.1 tp -148.36 115.95 6.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.649 -0.657 . . . . 0.0 109.23 -176.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -40.43 156.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.052 -1.03 . . . . 0.0 110.514 -174.412 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 70.58 -3.49 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.812 -0.555 . . . . 0.0 111.202 179.483 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD1' ' CB ' ' A' ' 152' ' ' VAL . 3.9 p-10 -70.18 178.64 2.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.925 -1.109 . . . . 0.0 109.882 173.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.455 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 20.0 m-80 -145.26 140.96 28.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 109.807 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -139.97 161.76 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 110.432 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.0 t -140.62 146.57 38.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.583 -0.698 . . . . 0.0 110.227 178.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.63 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 18.2 t -119.34 -67.67 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 111.088 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.63 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 42.3 Cg_endo -71.83 147.12 49.45 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.192 1.101 . . . . 0.0 110.559 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -117.92 54.93 0.59 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.1 pp -129.97 156.18 44.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -1.224 . . . . 0.0 110.335 -178.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -146.11 -169.52 3.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.945 . . . . 0.0 110.795 -179.44 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.551 ' N ' ' OG1' ' A' ' 141' ' ' THR . 0.3 OUTLIER -143.63 -111.15 0.11 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.805 -0.56 . . . . 0.0 110.144 179.122 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.5 52.37 0.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.0 110.548 -177.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.71 71.4 0.78 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -177.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.481 ' NE2' HD22 ' A' ' 142' ' ' LEU . 2.0 pt20 -94.85 169.96 9.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.857 -1.378 . . . . 0.0 110.238 178.026 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -138.48 151.03 47.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.322 -0.861 . . . . 0.0 110.476 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.566 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 101.05 -95.8 1.44 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.2 OUTLIER 39.76 40.2 0.64 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.556 -0.967 . . . . 0.0 110.913 175.727 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 4.2 pp -140.52 169.73 17.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -0.95 . . . . 0.0 109.538 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -90.27 128.25 36.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.021 -1.049 . . . . 0.0 109.904 178.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.455 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 29.0 tptp -109.3 106.52 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.529 ' CB ' ' OD1' ' A' ' 133' ' ' ASP . 2.8 t -76.75 140.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 109.918 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.41 -23.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 111.242 -176.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.479 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 49.2 tptt -149.07 142.04 24.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.743 -1.223 . . . . 0.0 110.684 -176.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.512 HG23 ' CB ' ' A' ' 131' ' ' GLU . 72.5 p -140.02 160.01 40.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.497 -0.752 . . . . 0.0 109.372 176.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.72 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 10.8 tp -89.48 -29.17 0.35 Allowed Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.163 -0.96 . . . . 0.0 111.44 -175.422 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.72 ' CD ' ' N ' ' A' ' 156' ' ' LEU . 35.5 Cg_exo -53.78 -170.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.086 1.045 . . . . 0.0 110.5 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -89.85 41.35 1.04 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 110.433 -178.254 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 158' ' ' SER . 37.1 mttt 62.31 19.95 11.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.452 -0.78 . . . . 0.0 109.851 -177.3 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 162' ' ' VAL . 20.0 m -110.37 160.04 29.89 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.495 -0.753 . . . . 0.0 110.057 178.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.505 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 5.3 Cg_endo -53.1 122.24 10.79 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.123 1.591 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.778 ' O ' ' HA ' ' A' ' 128' ' ' PRO . 3.9 m -127.07 155.26 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 110.437 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -100.47 126.21 46.87 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.282 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.568 ' CG2' ' HA ' ' A' ' 125' ' ' ILE . 12.8 mm -70.39 153.21 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 110.005 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.412 ' N ' HG21 ' A' ' 164' ' ' ILE . . . -142.98 168.79 25.9 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 176.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -57.13 -21.77 34.94 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.231 -1.158 . . . . 0.0 110.229 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.53 -10.74 42.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.715 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.551 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 93.5 m -59.81 143.45 51.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.057 -1.027 . . . . 0.0 110.241 -179.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 86.4 mttt -90.02 149.22 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.032 -1.043 . . . . 0.0 109.892 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.593 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 4.5 mm -115.42 130.06 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.846 -177.271 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.462 ' O ' HD12 ' A' ' 172' ' ' ILE . 20.8 mt-10 -111.92 128.38 56.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.165 -0.96 . . . . 0.0 110.316 171.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 171' ' ' GLU . 39.2 mm -123.37 127.86 74.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.194 -177.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.603 ' CD ' ' O ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -89.58 152.38 21.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.136 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 98.9 mt-10 -97.4 0.51 47.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.7 -178.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.603 ' O ' ' CD ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -97.88 107.8 42.42 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 0.0 109.938 179.137 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 20.6 Cg_exo -66.84 -155.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.944 0 O-C-N 123.837 1.44 . . . . 0.0 110.821 -179.287 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -83.96 54.98 3.1 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.766 -0.584 . . . . 0.0 110.047 -178.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 31.0 p -98.57 120.16 38.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.424 -0.797 . . . . 0.0 110.062 178.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 178' ' ' SER . 97.8 mt-10 59.97 20.0 9.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.445 -0.785 . . . . 0.0 110.111 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 94.4 t -99.84 -3.78 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.445 -0.784 . . . . 0.0 110.509 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.12 60.11 3.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 0.0 110.005 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.24 -11.06 59.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.335 -179.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -59.99 140.07 57.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 109.944 -177.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.82 -168.54 21.07 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.588 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 5' ' ' ASN . 7.6 p30 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.506 0.67 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 87' ' ' VAL . . . -154.12 -169.98 19.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.654 HD13 HD21 ' A' ' 33' ' ' LEU . 48.1 pt -131.2 159.92 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.05 -1.265 . . . . 0.0 110.195 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.56 115.98 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.01 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.7 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.2 pt? -141.1 -175.13 4.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.672 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 3.7 ptt-85 -109.6 133.71 52.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.763 -1.211 . . . . 0.0 110.844 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.968 ' CG2' HD11 ' A' ' 69' ' ' ILE . 12.6 p -61.84 129.75 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 110.544 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -110.36 159.66 17.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.337 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.964 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.138 -0.976 . . . . 0.0 110.689 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 69.0 mtt85 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.015 0.436 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.926 HG13 HG23 ' A' ' 67' ' ' VAL . 84.4 t -110.39 119.9 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.972 -1.08 . . . . 0.0 109.948 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 3.0 ptt180 -93.09 118.12 30.85 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.491 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.962 HD22 ' HB3' ' A' ' 30' ' ' SER . 2.7 mt -136.58 -179.27 5.59 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.728 -0.607 . . . . 0.0 109.958 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 1.4 p-10 -103.06 176.24 5.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.697 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 79.6 mt-10 -59.78 -44.48 93.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.344 -0.847 . . . . 0.0 109.25 -174.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.545 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 72.1 m -68.41 -43.32 77.46 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.014 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.962 ' HB3' HD22 ' A' ' 26' ' ' LEU . 58.1 m -60.09 -40.02 88.17 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.122 -0.986 . . . . 0.0 109.713 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 26.1 ttp180 -86.66 -33.92 19.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.732 -0.605 . . . . 0.0 111.135 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 62.2 ttt180 -89.39 -12.6 39.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.909 -1.119 . . . . 0.0 110.814 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.4 pp -59.76 -32.45 70.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.935 -1.103 . . . . 0.0 109.702 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.079 ' N ' HD12 ' A' ' 33' ' ' LEU . 12.2 mt -101.65 -74.51 0.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 36' ' ' ALA . 33.7 t0 -170.24 -23.81 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.687 -0.633 . . . . 0.0 109.604 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -34.71 121.27 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.436 0.636 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.514 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.07 -179.34 3.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.437 HD13 ' NH1' ' A' ' 31' ' ' ARG . 32.5 mm -60.07 126.15 17.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.575 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.65 23.87 63.8 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.07 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -88.54 171.29 10.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.655 -1.497 . . . . 0.0 109.91 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.777 HG21 ' OG1' ' A' ' 92' ' ' THR . 84.8 t -99.2 130.15 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.264 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.508 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -117.96 139.95 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.813 . . . . 0.0 110.437 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 88.7 tt0 -108.59 142.83 38.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -119.91 150.5 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.924 -1.11 . . . . 0.0 110.703 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -152.57 93.48 1.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 111.124 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.015 ' CG ' HG12 ' A' ' 85' ' ' VAL . 4.1 tmtm? -99.06 -66.95 0.87 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.933 -1.104 . . . . 0.0 109.748 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.52 -34.58 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 109.407 176.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 85.9 mtt180 -131.59 -174.12 3.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.583 -0.698 . . . . 0.0 109.246 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.723 ' C ' HD21 ' A' ' 130' ' ' LEU . 35.5 mttt -89.14 139.44 30.47 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.351 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.566 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.54 159.81 40.91 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.431 0.634 . . . . 0.0 110.154 -177.381 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.15 161.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.035 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.474 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.87 179.85 48.76 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.678 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 59.2 ttt180 -117.17 164.46 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.503 -0.998 . . . . 0.0 110.237 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -94.05 141.79 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.463 -176.037 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.546 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.4 m-85 -137.62 166.37 24.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.508 -0.745 . . . . 0.0 110.496 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.408 ' NH2' HD11 ' A' ' 38' ' ' ILE . 58.3 ttm-85 -89.23 121.94 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 110.084 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.45 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -62.96 140.01 58.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.002 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.69 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.1 mmt85 -56.15 -49.68 91.82 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.055 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.69 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.16 98.74 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.726 1.382 . . . . 0.0 108.923 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 37.18 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.3 p-10 -147.71 -29.2 0.33 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -85.04 -28.51 25.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 109.106 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.448 ' C ' ' HB3' ' A' ' 27' ' ' ASP . 4.8 m-80 -81.13 41.51 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.857 -0.527 . . . . 0.0 110.636 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HA ' ' HG ' ' A' ' 30' ' ' SER . 20.7 pttt -97.83 8.97 43.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.9 27.08 0.05 OUTLIER Glycine 0 N--CA 1.479 1.552 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.489 HG21 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -141.11 142.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.25 -1.147 . . . . 0.0 109.561 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.926 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -119.97 127.47 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.044 -1.035 . . . . 0.0 109.973 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 33.9 ttm180 -92.86 118.46 31.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.968 HD11 ' CG2' ' A' ' 11' ' ' VAL . 2.5 pt -129.34 166.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.775 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.09 168.89 18.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.5 p -60.82 -29.65 69.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.65 -46.41 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.161 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.761 ' CE ' HD13 ' A' ' 44' ' ' ILE . 13.5 tpt -60.04 -44.38 94.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.587 ' NH1' HD13 ' A' ' 81' ' ' ILE . 61.8 ttt180 -60.03 -40.14 88.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.849 173.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -66.43 -31.24 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' MET . 99.7 m-20 -59.98 -39.85 87.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.762 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.498 ' C ' HG23 ' A' ' 47' ' ' VAL . 28.5 p -99.36 -39.64 8.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.846 -1.159 . . . . 0.0 110.801 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.586 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 110.2 30.72 3.29 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -104.54 167.91 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.13 -1.217 . . . . 0.0 110.36 -177.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.625 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 165.53 11.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.173 176.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.964 HD11 ' HB3' ' A' ' 13' ' ' GLU . 1.1 mp -53.83 139.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.995 -1.065 . . . . 0.0 110.203 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.54 2.08 73.55 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -58.23 -160.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 O-C-N 120.91 -1.347 . . . . 0.0 110.509 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 15.9 ptpt -130.88 108.93 10.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.015 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -118.87 155.2 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.128 -0.983 . . . . 0.0 110.052 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -106.6 119.96 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.199 -0.938 . . . . 0.0 109.908 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.71 HG22 HG23 ' A' ' 44' ' ' ILE . 95.0 t -105.1 121.78 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.501 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 87.7 mtm-85 -112.38 140.35 47.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.995 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.624 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 41.1 tttm -72.33 143.01 48.81 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.533 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.516 HG21 ' CG ' ' A' ' 161' ' ' PRO . 1.9 m -150.22 -169.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.511 -0.743 . . . . 0.0 109.909 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.24 169.05 17.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.777 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.98 156.2 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.625 ' HG2' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -150.26 174.47 12.8 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.558 HG21 ' OE2' ' A' ' 167' ' ' GLU . 49.4 mm -89.28 102.96 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.867 -1.146 . . . . 0.0 110.031 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.759 ' HB2' ' CG2' ' A' ' 162' ' ' VAL . . . -52.84 132.46 36.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.306 -0.871 . . . . 0.0 110.163 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.786 ' HE2' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -96.06 -28.66 14.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.996 . . . . 0.0 110.995 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HB3' HD23 ' A' ' 156' ' ' LEU . 46.2 tttp -150.05 119.9 7.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.831 -1.168 . . . . 0.0 110.281 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.617 HG23 HG22 ' A' ' 155' ' ' THR . 9.3 p -132.45 137.63 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.87 -1.144 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 171' ' ' GLU . 28.1 m -107.77 145.76 33.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.666 ' N ' HD23 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -147.66 169.76 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.144 -0.973 . . . . 0.0 110.864 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.579 ' HB1' ' CZ ' ' A' ' 173' ' ' ARG . . . -141.4 86.05 11.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 110.924 -175.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 22.0 Cg_exo . . . . . 0 C--N 1.305 -1.763 0 O-C-N 123.881 1.464 . . . . 0.0 109.834 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.065 0.459 . . . . 0.0 109.903 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.507 ' N ' HG23 ' A' ' 116' ' ' ILE . 46.7 mt-10 -61.77 -40.26 94.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -70.0 -31.43 69.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.718 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -59.89 -39.76 86.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.551 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.665 ' CG1' HD12 ' A' ' 124' ' ' LEU . 69.6 t -60.2 -46.27 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.148 -0.97 . . . . 0.0 109.238 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.6 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.17 -40.03 92.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 110.267 175.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -60.0 -41.87 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.3 -39.83 28.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -0.793 . . . . 0.0 110.586 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.665 HD12 ' CG1' ' A' ' 120' ' ' VAL . 92.0 mt -91.04 -8.39 49.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.884 -174.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 166' ' ' GLU . 3.7 tt -41.96 166.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.582 ' HG2' HG23 ' A' ' 125' ' ' ILE . 30.9 ptt-85 34.2 54.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.449 -0.782 . . . . 0.0 111.607 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 6.6 mtt-85 -135.17 150.2 72.16 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.89 -1.131 . . . . 0.0 111.163 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.9 Cg_endo -69.02 133.11 26.06 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 124.096 1.577 . . . . 0.0 109.618 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.56 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 90.4 mmm -128.54 145.67 51.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.485 -1.384 . . . . 0.0 111.607 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.723 HD21 ' C ' ' A' ' 49' ' ' LYS . 13.6 tp -149.77 114.4 5.29 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.703 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.0 pm0 -49.11 139.67 10.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 0.0 110.573 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.703 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 94.5 mm-40 79.73 -1.33 2.13 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.066 0.46 . . . . 0.0 110.593 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.669 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.1 p30 -69.02 -171.05 0.28 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.126 -0.984 . . . . 0.0 110.41 175.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 12.6 m120 -149.97 158.8 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.42 ' CG1' ' HB2' ' A' ' 150' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.092 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 45.7 m-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.276 0.56 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.39 109.78 16.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.993 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.669 HG21 ' OD2' ' A' ' 133' ' ' ASP . 5.9 t -76.54 139.98 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.241 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.3 t -120.47 -24.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.121 -0.987 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.505 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 87.6 tttt -143.11 151.08 40.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.872 -1.143 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.617 HG22 HG23 ' A' ' 98' ' ' VAL . 39.2 p -141.6 154.62 45.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.626 -0.672 . . . . 0.0 109.626 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.786 HD12 ' HE2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -89.5 -33.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 111.235 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.918 ' CG ' HG11 ' A' ' 162' ' ' VAL . 26.5 Cg_exo -55.54 -165.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.314 1.165 . . . . 0.0 110.165 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.643 ' O ' HG13 ' A' ' 160' ' ' VAL . 8.6 t -88.64 40.94 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.8 mttt 59.99 18.76 7.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.843 ' O ' HG13 ' A' ' 162' ' ' VAL . 16.3 m -106.32 160.28 26.79 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.508 -0.745 . . . . 0.0 109.813 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.528 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.71 122.24 9.37 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 124.024 1.539 . . . . 0.0 110.064 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.918 HG11 ' CG ' ' A' ' 157' ' ' PRO . 12.1 m -129.87 159.9 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.0 tt0 -108.15 128.55 54.8 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.219 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.811 HD12 HG21 ' A' ' 168' ' ' THR . 20.1 mm -72.22 153.74 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.68 -0.637 . . . . 0.0 110.425 -175.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.552 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.09 167.04 26.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.746 ' HB3' HD11 ' A' ' 125' ' ' ILE . 21.2 pt-20 -57.57 -20.07 29.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -1.088 . . . . 0.0 110.352 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.558 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.4 pt-20 -88.87 -14.0 37.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.246 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.811 HG21 HD12 ' A' ' 164' ' ' ILE . 64.1 m -60.41 141.7 56.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 86.5 mttt -96.05 145.92 25.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.04 . . . . 0.0 109.985 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.651 ' CD1' HG12 ' A' ' 120' ' ' VAL . 1.5 mt -125.21 157.85 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.192 -0.943 . . . . 0.0 110.853 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.612 ' HB3' HG23 ' A' ' 99' ' ' THR . 21.6 mt-10 -131.76 133.56 44.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.651 -0.655 . . . . 0.0 110.114 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 120' ' ' VAL . 40.7 mm -115.07 131.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.598 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.579 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.137 -176.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.166 0.507 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -148.81 -161.75 9.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.71 HG21 HD22 ' A' ' 33' ' ' LEU . 39.1 pt -129.99 160.09 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -1.107 . . . . 0.0 109.43 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.9 mt -108.48 120.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.294 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.943 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.6 pt? -144.48 -171.66 3.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.477 -0.765 . . . . 0.0 109.648 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.63 ' NH1' HG22 ' A' ' 66' ' ' ILE . 9.5 ptp85 -106.93 135.73 47.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.81 -1.181 . . . . 0.0 110.948 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.965 HG23 HD11 ' A' ' 69' ' ' ILE . 14.4 p -62.39 131.06 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.629 -0.669 . . . . 0.0 110.738 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -114.23 146.21 40.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.863 . . . . 0.0 110.561 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 1.014 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 tt0 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.0 110.321 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 53' ' ' ARG . 25.1 mmt85 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.841 HG13 HG23 ' A' ' 67' ' ' VAL . 89.8 t -109.98 119.66 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.062 . . . . 0.0 110.347 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.636 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.1 ptm180 -100.56 121.25 41.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.92 -1.113 . . . . 0.0 110.135 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.695 HD12 ' CB ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -134.06 176.8 8.25 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.35 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 25.9 p-10 -89.56 179.85 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.753 -1.217 . . . . 0.0 110.416 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 87.0 mt-10 -60.05 -40.21 88.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.362 -0.836 . . . . 0.0 109.169 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 22.9 t -70.0 -44.4 69.42 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.529 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.695 ' CB ' HD12 ' A' ' 26' ' ' LEU . 58.1 m -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.923 -1.111 . . . . 0.0 109.401 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 56.4 ttp85 -74.76 -43.04 56.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.694 -0.629 . . . . 0.0 111.623 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -88.77 -12.97 40.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 111.212 -170.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.083 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.2 pp -56.76 -32.63 65.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 109.505 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.083 ' N ' HD12 ' A' ' 33' ' ' LEU . 12.7 mt -105.27 -75.01 0.64 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.189 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' A' ' 36' ' ' ALA . 13.0 t0 -170.12 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.637 . . . . 0.0 109.676 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -26.77 118.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.539 0.685 . . . . 0.0 111.264 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.73 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -104.96 177.32 4.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.81 123.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.93 -1.106 . . . . 0.0 109.86 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.551 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.03 29.06 59.41 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 32.8 m-20 -89.12 176.44 6.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.71 -1.465 . . . . 0.0 109.296 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.796 HG21 HG23 ' A' ' 92' ' ' THR . 89.8 t -99.32 129.25 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.074 -1.016 . . . . 0.0 110.373 -176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -119.58 147.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.791 . . . . 0.0 110.319 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.55 142.16 45.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.423 -0.798 . . . . 0.0 109.606 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.792 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.3 mp -114.23 148.04 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.036 -1.04 . . . . 0.0 110.22 -177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 89.1 tt0 -150.21 89.44 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.02 -1.05 . . . . 0.0 111.222 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.099 ' CG ' HG12 ' A' ' 85' ' ' VAL . 14.4 tmtt? -98.37 -66.39 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 173.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.05 -38.82 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.708 0.766 . . . . 0.0 109.162 177.062 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.607 ' CG ' ' HA ' ' A' ' 77' ' ' CYS . 19.7 ptp180 -142.38 -163.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.46 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.638 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -88.69 130.51 35.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 111.132 -174.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.547 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -130.69 162.59 29.1 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.246 0.546 . . . . 0.0 110.339 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -124.6 160.82 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.378 -0.826 . . . . 0.0 110.609 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.92 -179.73 48.71 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 62.0 mtp180 -111.03 175.2 5.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -1.205 . . . . 0.0 109.876 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -99.64 133.54 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.075 -1.016 . . . . 0.0 110.167 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -117.44 166.82 11.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 176.642 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 38.7 ptt180 -97.16 125.65 41.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.027 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.629 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -64.2 133.05 52.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.81 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.578 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.03 -46.85 99.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.986 174.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 23.7 Cg_endo -91.64 98.61 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.549 . . . . 0.0 109.028 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.04 33.81 0.09 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.595 -0.69 . . . . 0.0 110.91 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -147.53 -29.08 0.35 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.187 -0.945 . . . . 0.0 110.705 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.55 -28.43 26.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.543 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 11.0 m120 -81.25 42.08 0.64 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.706 -0.621 . . . . 0.0 110.284 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 35.6 tttt -98.42 9.38 43.25 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.278 -0.889 . . . . 0.0 109.582 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.64 26.47 0.05 OUTLIER Glycine 0 N--CA 1.482 1.724 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 176.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.63 HG22 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -140.12 142.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.273 -1.133 . . . . 0.0 109.448 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.943 ' HB ' HD11 ' A' ' 9' ' ' LEU . 12.7 p -120.05 119.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.666 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.557 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 77.7 mtt180 -90.08 111.14 22.15 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 11' ' ' VAL . 1.1 pt -127.69 161.3 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.608 -0.682 . . . . 0.0 110.355 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -80.01 169.59 17.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.522 -0.736 . . . . 0.0 109.795 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 80.0 p -62.39 -16.03 52.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.2 -49.2 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 110.363 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.655 ' HE1' HD13 ' A' ' 44' ' ' ILE . 97.8 mmm -63.73 -40.13 95.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 0.0 109.361 176.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttp180 -60.32 -42.19 95.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 109.997 173.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -70.23 -33.56 71.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.235 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -60.11 -40.0 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.607 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 31.7 p -99.06 -39.38 8.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.021 -1.049 . . . . 0.0 110.694 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.603 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.75 47.85 0.56 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.821 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -122.87 168.54 12.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.071 -1.252 . . . . 0.0 110.75 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.813 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.93 170.93 8.11 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.014 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -58.09 140.11 16.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.925 -1.109 . . . . 0.0 110.644 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.582 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.61 -0.29 65.48 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 172.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -58.55 -160.81 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.032 -1.275 . . . . 0.0 110.211 175.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.59 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.3 pttt -130.02 115.54 17.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 109.809 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.099 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.4 m -123.04 157.65 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.0 ttpt -110.04 120.44 42.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 110.005 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.509 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 69.1 t -99.63 123.81 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.893 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.534 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 38.3 mtp85 -109.98 157.75 18.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.791 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -102.26 138.42 39.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 110.153 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.619 HG23 HG12 ' A' ' 41' ' ' VAL . 2.5 m -150.12 -169.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.443 -0.786 . . . . 0.0 110.324 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -127.48 172.81 10.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.629 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.796 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.04 163.23 12.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 111.086 -176.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.707 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.9 pt-20 -150.01 168.11 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 mm -89.64 99.81 9.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.556 -1.34 . . . . 0.0 110.466 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.898 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.2 136.62 56.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 110.226 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 6.2 pttt -106.05 -24.21 12.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.074 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.524 ' HB3' HD23 ' A' ' 156' ' ' LEU . 83.3 tttt -147.0 119.92 8.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.904 -1.123 . . . . 0.0 110.434 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.775 HG23 HG22 ' A' ' 155' ' ' THR . 8.2 p -138.09 140.28 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 110.492 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.589 ' C ' HD23 ' A' ' 100' ' ' LEU . 94.4 m -117.97 135.81 53.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -0.885 . . . . 0.0 110.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.805 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -141.27 167.74 21.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -178.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . . . -132.94 103.12 13.1 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.384 -0.822 . . . . 0.0 110.562 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.4 Cg_exo . . . . . 0 C--N 1.305 -1.736 0 O-C-N 124.106 1.582 . . . . 0.0 110.132 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 8.5 tp . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.252 0.548 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.492 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 95.0 mt-10 -60.08 -43.92 95.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 109.831 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.68 -35.57 78.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -38.3 82.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.385 -0.822 . . . . 0.0 109.817 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.657 ' CG1' HD12 ' A' ' 170' ' ' ILE . 62.4 t -60.03 -49.02 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.673 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.646 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 5.3 mt-30 -60.06 -41.17 91.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.872 . . . . 0.0 110.045 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -60.05 -39.99 87.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 110.444 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.97 -41.2 19.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 120' ' ' VAL . 52.3 mt -95.27 -3.43 47.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.059 -1.025 . . . . 0.0 110.972 -173.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.673 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.7 tt -43.43 163.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -174.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.609 ' HG2' HG23 ' A' ' 125' ' ' ILE . 34.0 ptt180 33.84 49.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.492 -0.755 . . . . 0.0 111.371 -177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 10.8 ttt85 -132.11 143.34 48.53 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.966 -1.084 . . . . 0.0 111.105 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.828 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 17.4 Cg_endo -63.76 127.24 19.17 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.062 1.559 . . . . 0.0 109.811 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.573 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 93.4 mmm -123.52 140.02 53.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.402 -1.436 . . . . 0.0 110.926 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.638 HD21 ' O ' ' A' ' 49' ' ' LYS . 19.1 tp -139.59 112.37 7.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.577 -0.702 . . . . 0.0 109.7 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.0 pt-20 -46.68 142.05 3.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.012 -1.055 . . . . 0.0 110.435 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 20.5 mm100 82.43 -2.74 1.41 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.228 0.537 . . . . 0.0 110.42 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.543 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.6 p-10 -70.21 -178.96 1.8 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 110.115 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.547 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 14.8 m-80 -148.29 129.54 14.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.086 . . . . 0.0 110.718 -177.528 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.736 ' HD2' HD12 ' A' ' 100' ' ' LEU . 28.2 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.202 0.525 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.547 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 21.2 tptm -99.92 106.72 18.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.543 HG21 ' OD1' ' A' ' 133' ' ' ASP . 2.1 t -79.37 134.37 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -0.965 . . . . 0.0 109.898 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.98 -23.19 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.157 -0.964 . . . . 0.0 110.737 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.478 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 8.6 tptp -140.2 127.12 20.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.85 -1.156 . . . . 0.0 110.609 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.775 HG22 HG23 ' A' ' 98' ' ' VAL . 33.8 p -126.79 170.01 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.586 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -88.82 -41.56 0.45 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.531 -178.025 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.998 ' CG ' HG11 ' A' ' 162' ' ' VAL . 16.4 Cg_exo -61.75 -176.3 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.631 1.332 . . . . 0.0 110.179 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -90.25 -156.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.964 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -71.77 -2.58 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.271 -0.893 . . . . 0.0 110.38 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.87 138.7 32.96 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.374 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.557 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.99 142.38 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.224 1.644 . . . . 0.0 110.51 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.998 HG11 ' CG ' ' A' ' 157' ' ' PRO . 10.8 m -129.92 159.47 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 109.516 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.2 tt0 -106.17 127.2 53.04 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.138 -0.976 . . . . 0.0 110.063 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.881 ' CD1' HG21 ' A' ' 168' ' ' THR . 12.2 mm -69.73 156.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.624 -0.673 . . . . 0.0 109.862 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.01 166.65 27.02 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.61 -24.42 21.31 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.437 -1.037 . . . . 0.0 109.993 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -88.55 -16.92 31.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.588 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.881 HG21 ' CD1' ' A' ' 164' ' ' ILE . 80.3 m -56.82 153.13 11.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.0 109.989 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 68.4 mttm -100.7 152.94 19.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 110.032 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.657 HD12 ' CG1' ' A' ' 120' ' ' VAL . 19.7 mm -114.65 131.56 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 110.927 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.687 ' O ' HD13 ' A' ' 172' ' ' ILE . 23.6 mt-10 -114.24 129.55 56.63 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.162 -0.962 . . . . 0.0 110.109 170.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 171' ' ' GLU . 38.1 mm -130.92 140.0 49.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.042 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 178.982 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.414 0.626 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.13 -163.99 10.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.031 HG23 HD11 ' A' ' 34' ' ' LEU . 34.8 pt -137.56 158.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -1.186 . . . . 0.0 110.096 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.6 mt -102.21 115.55 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.15 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.789 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.6 pt? -140.0 -171.86 3.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.791 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.2 ptt180 -111.4 140.57 45.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.829 -1.169 . . . . 0.0 110.797 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.027 HG23 HD11 ' A' ' 69' ' ' ILE . 11.7 p -61.75 136.23 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 110.58 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -115.99 152.17 34.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.172 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.925 ' HB3' HD11 ' A' ' 81' ' ' ILE . 85.5 tt0 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 96.2 mtt180 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.236 0.541 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.048 HG13 HG23 ' A' ' 67' ' ' VAL . 67.0 t -113.21 120.61 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.283 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -95.09 120.54 35.48 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.467 175.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.081 HD22 ' CB ' ' A' ' 30' ' ' SER . 3.6 mt -134.93 171.32 14.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.554 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 5.3 p-10 -89.02 170.42 10.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.335 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HA ' ' NH1' ' A' ' 31' ' ' ARG . 46.7 mt-10 -56.16 -40.03 73.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.95 . . . . 0.0 109.019 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 5.2 t -65.29 -58.81 5.01 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.213 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.081 ' CB ' HD22 ' A' ' 26' ' ' LEU . 61.7 m -49.6 -30.02 8.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.593 -1.317 . . . . 0.0 109.635 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.588 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.9 ttp-105 -81.0 -49.46 10.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 111.136 178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 38.4 mtm105 -93.45 -14.36 26.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 0.0 111.43 -171.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.961 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -60.84 -28.7 69.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.907 -1.121 . . . . 0.0 110.195 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.031 HD11 HG23 ' A' ' 7' ' ' ILE . 55.7 mt -103.66 -73.69 0.66 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.142 -0.974 . . . . 0.0 109.996 175.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 36' ' ' ALA . 30.4 t0 -168.65 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.451 0.643 . . . . 0.0 109.442 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 31' ' ' ARG . . . -33.31 118.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.419 0.628 . . . . 0.0 110.961 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.57 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -104.42 175.92 5.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 38' ' ' ILE . 33.1 mm -60.0 123.95 13.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.908 -1.12 . . . . 0.0 109.785 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.48 28.19 60.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 65.7 m-20 -89.29 171.07 10.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.703 -1.469 . . . . 0.0 109.503 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.622 HG21 HG23 ' A' ' 92' ' ' THR . 73.7 t -99.15 129.95 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 0.0 110.06 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.593 HG11 HG23 ' A' ' 54' ' ' VAL . 2.7 m -118.21 144.71 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.388 -0.82 . . . . 0.0 110.358 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.0 tt0 -112.41 140.21 47.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.934 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.2 mp -122.74 143.97 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.041 -1.037 . . . . 0.0 110.395 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.8 tt0 -150.49 100.03 2.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.134 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.829 ' HD2' ' HB2' ' A' ' 79' ' ' ALA . 9.1 tmtm? -98.31 -66.99 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.017 . . . . 0.0 109.956 173.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.576 HG23 ' C ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -101.63 -34.54 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.388 174.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.556 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 90.0 mtt-85 -134.59 -179.68 5.74 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.5 -0.75 . . . . 0.0 109.486 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.526 ' HB3' HD21 ' A' ' 130' ' ' LEU . 24.3 mttp -89.19 141.87 28.14 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.181 -0.95 . . . . 0.0 110.843 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 130' ' ' LEU . 9.3 p -143.41 169.98 16.65 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.471 0.653 . . . . 0.0 109.901 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.42 167.35 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.447 -0.783 . . . . 0.0 110.079 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.41 -172.36 41.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -122.78 164.56 18.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -1.137 . . . . 0.0 110.329 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.593 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -96.81 137.69 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 110.419 -173.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.6 m-85 -128.12 165.53 20.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.493 -0.754 . . . . 0.0 110.262 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -89.73 122.68 33.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.972 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.773 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -62.29 134.1 56.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.564 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -57.8 -48.75 96.61 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.031 174.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.564 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.3 Cg_endo -92.42 98.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.91 1.479 . . . . 0.0 109.013 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.53 36.32 0.09 Allowed 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.527 -0.733 . . . . 0.0 110.692 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 59' ' ' PRO . 70.7 m-20 -143.67 -30.62 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.157 -0.965 . . . . 0.0 110.446 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 66' ' ' ILE . 21.1 mt-10 -87.14 -28.28 22.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 0.0 109.27 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.773 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 23.6 m120 -81.13 40.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.758 -0.589 . . . . 0.0 110.492 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 4.82 47.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.22 30.18 0.07 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 9' ' ' LEU . 46.3 pt -140.62 146.96 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.518 -0.989 . . . . 0.0 109.257 174.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.048 HG23 HG13 ' A' ' 24' ' ' VAL . 2.7 p -120.01 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.783 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HG2' ' HD2' ' A' ' 25' ' ' ARG . 15.2 tpp180 -90.09 110.28 21.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.126 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.027 HD11 HG23 ' A' ' 11' ' ' VAL . 1.5 pt -130.82 166.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 110.516 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.02 171.1 15.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -63.91 -21.94 66.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.77 -49.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.934 ' CE ' HD13 ' A' ' 44' ' ' ILE . 1.3 mmt -60.72 -43.28 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 66.0 ttp85 -59.99 -40.53 89.49 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.925 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -70.38 -29.0 65.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.34 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 98.5 m-20 -59.97 -39.15 84.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.576 ' C ' HG23 ' A' ' 47' ' ' VAL . 26.9 p -98.14 -37.76 9.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 110.51 -175.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.529 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 115.56 35.38 1.3 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.829 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -113.08 165.24 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.095 -1.238 . . . . 0.0 110.54 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.737 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.43 170.62 8.11 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.358 -0.839 . . . . 0.0 109.339 178.14 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.925 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -53.41 141.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.929 -1.107 . . . . 0.0 110.382 178.471 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.414 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 75.42 1.55 65.44 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 172.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 1.8 m-20 -59.51 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.853 -1.381 . . . . 0.0 110.572 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.522 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.2 pttt -132.89 108.81 9.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.824 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.1 m -121.22 153.0 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.5 tttt -103.08 124.74 49.12 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 44' ' ' ILE . 73.2 t -107.21 123.97 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.799 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.5 mtt180 -113.65 136.89 52.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.548 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 27.5 tttt -72.24 143.53 48.76 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.952 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.524 HG23 HG12 ' A' ' 41' ' ' VAL . 1.9 m -148.07 -169.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 109.832 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 174.32 10.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.698 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.622 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.55 159.24 17.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.967 -1.083 . . . . 0.0 111.229 -174.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.59 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -150.34 176.38 10.95 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.401 ' HA ' HD13 ' A' ' 94' ' ' ILE . 25.2 mm -93.18 99.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.341 -1.474 . . . . 0.0 110.867 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.821 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.67 139.79 49.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 0.0 110.297 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.97 -27.18 10.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 111.147 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.698 ' HB3' HD23 ' A' ' 156' ' ' LEU . 79.0 tttt -150.0 124.77 9.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.838 -1.163 . . . . 0.0 110.283 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.939 HG23 HG22 ' A' ' 155' ' ' THR . 9.1 p -138.92 148.97 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.585 ' C ' HD23 ' A' ' 100' ' ' LEU . 88.9 m -120.03 130.69 54.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.819 . . . . 0.0 109.762 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.734 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -136.43 169.22 18.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.767 -176.284 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -130.42 88.82 46.18 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.863 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.589 ' HD3' HG23 ' A' ' 172' ' ' ILE . 17.3 Cg_exo . . . . . 0 C--N 1.304 -1.799 0 O-C-N 124.125 1.592 . . . . 0.0 110.385 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.7 tp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.15 0.5 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.596 ' N ' HG23 ' A' ' 116' ' ' ILE . 47.0 mt-10 -69.91 -40.11 75.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.505 ' OE1' ' NE2' ' A' ' 121' ' ' GLN . 53.1 tp10 -67.07 -30.85 71.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -59.99 -40.88 90.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.601 ' CG1' HD12 ' A' ' 170' ' ' ILE . 44.7 t -61.17 -43.37 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.62 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 0.8 OUTLIER -60.07 -44.52 94.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.116 -0.99 . . . . 0.0 110.114 175.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -60.01 -46.7 88.62 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.526 -0.734 . . . . 0.0 109.837 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.466 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -73.66 -42.47 61.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.614 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 124' ' ' LEU . 4.6 mm? -98.56 6.9 46.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.592 ' HA ' HG22 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -48.67 166.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 120.77 -1.206 . . . . 0.0 109.735 -177.387 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.572 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 32.9 ptt180 33.01 45.14 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.465 -0.772 . . . . 0.0 111.412 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.528 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -127.26 138.53 32.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.805 -1.185 . . . . 0.0 111.113 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.86 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 9.3 Cg_endo -57.51 129.06 31.92 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 124.031 1.543 . . . . 0.0 110.176 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.576 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.6 mmm -125.96 137.82 53.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.601 -1.312 . . . . 0.0 110.608 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 50' ' ' THR . 12.7 tp -137.48 115.01 11.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pt-20 -48.78 143.63 5.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.981 -1.075 . . . . 0.0 110.655 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.04 -10.63 0.9 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.366 0.603 . . . . 0.0 110.374 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.572 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -70.38 178.3 2.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 176.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.553 ' OD1' ' CG ' ' A' ' 151' ' ' LYS . 1.1 m-80 -148.64 129.4 14.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.326 -0.859 . . . . 0.0 109.124 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.708 ' HB ' ' CE1' ' A' ' 150' ' ' PHE . 1.6 mt . . . . . 0 N--CA 1.491 1.617 0 C-N-CA 118.211 -1.396 . . . . 0.0 111.459 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.708 ' CE1' ' HB ' ' A' ' 135' ' ' ILE . 7.4 p90 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.759 0.79 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.553 ' CG ' ' OD1' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -100.32 113.88 26.93 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.829 -0.544 . . . . 0.0 109.737 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.572 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -76.1 135.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.684 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.416 HG23 ' CD ' ' A' ' 151' ' ' LYS . 18.9 t -123.58 -26.7 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 110.697 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -144.38 131.6 20.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 110.443 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.939 HG22 HG23 ' A' ' 98' ' ' VAL . 37.3 p -130.0 169.38 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 109.775 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -89.04 -39.88 0.44 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.822 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 1.02 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.0 Cg_exo -61.52 -175.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.583 1.307 . . . . 0.0 110.727 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.1 t -90.5 -163.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.81 . . . . 0.0 110.258 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -68.11 -6.43 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.64 141.68 34.22 Favored Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.388 -0.82 . . . . 0.0 110.125 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.548 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.93 144.69 11.4 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.177 1.619 . . . . 0.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 1.02 HG11 ' CB ' ' A' ' 157' ' ' PRO . 10.9 m -129.91 159.27 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.089 -1.007 . . . . 0.0 109.545 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 67.4 tt0 -107.36 127.66 53.77 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.27 -0.894 . . . . 0.0 109.957 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.748 HD12 HG21 ' A' ' 168' ' ' THR . 9.1 mm -69.36 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.917 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.9 167.66 25.56 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.44 -21.19 35.27 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.416 -1.05 . . . . 0.0 110.32 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.55 -17.72 26.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 110.74 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.748 HG21 HD12 ' A' ' 164' ' ' ILE . 30.2 m -57.59 156.72 7.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.906 . . . . 0.0 110.364 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -103.97 154.53 19.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 110.277 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.62 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 2.1 mm -120.0 129.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.772 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.512 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 53.4 mt-10 -117.83 130.02 56.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.12 -0.988 . . . . 0.0 110.419 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.589 HG23 ' HD3' ' A' ' 102' ' ' PRO . 37.1 mt -135.62 135.22 51.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.309 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.276 -178.206 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.161 0.505 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 88' ' ' ARG . . . -147.41 -159.74 8.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.904 HD13 HD21 ' A' ' 33' ' ' LEU . 43.6 pt -139.58 152.05 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -1.141 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.42 119.67 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.797 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.761 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.2 pt? -135.91 -168.34 2.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.291 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.563 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 26.4 ttm105 -106.03 130.66 53.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 111.059 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.858 HG11 ' O ' ' A' ' 80' ' ' SER . 14.4 p -61.65 139.02 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.379 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -120.24 153.55 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.487 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.597 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.321 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.577 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 84.2 mtt85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.005 0.431 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.908 HG13 HG23 ' A' ' 67' ' ' VAL . 77.4 t -109.98 115.43 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.011 -1.056 . . . . 0.0 109.987 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.579 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -88.09 117.4 26.94 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.683 178.43 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.776 HD13 HG12 ' A' ' 24' ' ' VAL . 1.2 mp -129.11 172.64 11.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 109.551 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 7.0 p-10 -92.76 176.64 6.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.863 -1.148 . . . . 0.0 110.022 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -40.06 87.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.449 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.58 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.5 t -69.51 -44.98 69.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 110.57 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.66 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.7 m -59.98 -39.99 87.6 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.102 -0.999 . . . . 0.0 109.608 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 36.9 ttp180 -74.7 -43.4 55.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.772 -0.58 . . . . 0.0 111.444 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -91.41 -11.53 37.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.821 -1.174 . . . . 0.0 111.201 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.092 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.3 pp -58.65 -32.88 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.855 -1.153 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.092 ' N ' HD12 ' A' ' 33' ' ' LEU . 13.0 mt -105.21 -74.07 0.66 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.927 . . . . 0.0 110.316 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 45.6 t0 -170.16 -24.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.691 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -24.61 119.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.557 0.694 . . . . 0.0 111.407 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.694 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -105.69 175.14 5.59 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.419 HD11 ' NH1' ' A' ' 31' ' ' ARG . 26.2 mm -58.16 120.75 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.917 -1.114 . . . . 0.0 109.813 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.58 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.72 33.82 54.78 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 174.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.2 m-20 -89.11 177.1 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.458 . . . . 0.0 109.477 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 92' ' ' THR . 70.6 t -99.08 121.64 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.09 . . . . 0.0 110.166 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.482 HG22 ' C ' ' A' ' 52' ' ' GLY . 1.5 m -116.8 139.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.489 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.8 141.36 38.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 109.863 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.871 HD13 ' CE ' ' A' ' 73' ' ' MET . 2.1 mp -120.48 146.63 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.013 -1.054 . . . . 0.0 110.296 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.0 tt0 -150.95 97.16 2.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.961 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.03 ' CG ' HG12 ' A' ' 85' ' ' VAL . 1.7 tmtt? -98.41 -67.36 0.85 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.825 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.591 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.01 -35.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.16 174.296 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 71.9 mtt85 -135.46 -178.74 5.25 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.776 -0.578 . . . . 0.0 109.571 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.574 ' C ' HD21 ' A' ' 130' ' ' LEU . 28.0 mttt -89.04 137.14 32.58 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.655 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.724 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 10.9 p -140.56 166.78 23.8 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.394 0.616 . . . . 0.0 109.834 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -122.98 166.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.448 -0.782 . . . . 0.0 110.196 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.482 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.99 -169.54 39.73 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -129.94 162.8 27.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.186 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -89.03 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 0.0 110.426 -173.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.577 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 2.2 m-85 -134.68 166.31 23.23 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.504 -0.747 . . . . 0.0 110.251 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 51.9 ptt85 -90.69 128.36 36.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.572 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -65.9 139.98 58.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.609 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -54.74 -49.58 90.73 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.881 -1.137 . . . . 0.0 108.868 175.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.4 Cg_endo -92.71 98.79 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.904 1.476 . . . . 0.0 108.893 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.47 34.37 0.08 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.41 -0.806 . . . . 0.0 110.918 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -146.26 -27.51 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 110.769 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -86.12 -28.2 24.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.258 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.572 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 11.0 m120 -81.75 43.56 0.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.676 -0.64 . . . . 0.0 110.312 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 30.3 pttt -97.43 8.96 43.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.404 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.88 27.13 0.05 OUTLIER Glycine 0 N--CA 1.479 1.541 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.5 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 43.5 pt -140.24 142.87 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -1.083 . . . . 0.0 109.4 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.908 HG23 HG13 ' A' ' 24' ' ' VAL . 3.1 p -119.94 121.12 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.005 -1.059 . . . . 0.0 110.058 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.575 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 97.3 mtt180 -89.87 116.02 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.679 HD11 HG23 ' A' ' 11' ' ' VAL . 4.5 pt -126.75 171.72 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.66 -0.65 . . . . 0.0 110.645 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -80.01 168.05 19.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.881 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 m -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.316 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.82 -43.62 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.871 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.0 -46.52 89.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.628 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.417 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 6.4 ttp-105 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.554 174.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -69.99 -23.84 63.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.483 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 73' ' ' MET . 69.1 m-20 -60.07 -39.1 84.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.08 -1.013 . . . . 0.0 110.352 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.535 ' C ' HG23 ' A' ' 47' ' ' VAL . 31.4 p -98.27 -35.03 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.047 -1.033 . . . . 0.0 110.532 -175.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.591 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 112.47 26.63 4.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.46 169.97 8.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -1.166 . . . . 0.0 110.309 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.858 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.47 178.73 4.2 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 178.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -64.74 141.25 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.388 177.48 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.811 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 78.69 -3.85 62.58 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 172.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -57.3 -167.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.98 -1.306 . . . . 0.0 110.098 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 50.7 pttt -127.01 114.65 18.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.12 -0.987 . . . . 0.0 109.748 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.03 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.1 m -119.33 155.57 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 83.6 tttt -105.61 125.44 50.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.659 HG23 HD21 ' A' ' 9' ' ' LEU . 76.0 t -106.85 121.4 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.481 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 41.3 mtm180 -110.63 135.61 51.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 19.4 tttt -83.81 138.64 33.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.529 HG23 HG12 ' A' ' 41' ' ' VAL . 2.3 m -150.04 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.088 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -126.48 168.99 13.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.907 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.535 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.73 163.47 12.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.093 -1.005 . . . . 0.0 111.05 -175.173 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.63 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.5 pt-20 -150.08 169.46 21.21 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.62 100.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.923 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.85 138.19 53.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.29 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.544 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -96.66 -29.34 13.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 110.981 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HB3' HD23 ' A' ' 156' ' ' LEU . 16.1 tttp -150.66 124.63 9.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.731 -1.231 . . . . 0.0 110.842 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.065 HG23 HG22 ' A' ' 155' ' ' THR . 5.4 p -134.34 142.05 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 0.0 110.653 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 86.8 m -118.54 141.7 48.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.329 -0.857 . . . . 0.0 110.109 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -139.24 169.79 17.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.709 -178.069 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.706 ' HB2' ' HD2' ' A' ' 173' ' ' ARG . . . -141.12 99.7 6.53 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.615 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo . . . . . 0 C--N 1.304 -1.786 0 O-C-N 123.878 1.462 . . . . 0.0 110.17 179.786 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 117' ' ' GLU . 10.4 tp . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.139 0.495 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 116' ' ' ILE . 43.5 mt-10 -59.98 -40.55 89.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.966 . . . . 0.0 109.693 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -68.69 -38.94 80.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 109.943 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.413 ' HD2' HD12 ' A' ' 116' ' ' ILE . 1.6 t80 -60.08 -39.99 88.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.251 -0.905 . . . . 0.0 109.341 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 172' ' ' ILE . 54.8 t -67.02 -45.93 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 109.89 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.558 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 1.7 mt-30 -59.98 -44.41 94.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.97 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -60.07 -48.6 81.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.441 0.639 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.566 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.05 -40.1 75.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.46 -0.775 . . . . 0.0 110.535 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.657 HD22 ' N ' ' A' ' 124' ' ' LEU . 3.9 mm? -97.53 -0.06 46.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.883 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.647 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.5 tt -47.3 166.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 110.171 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 164' ' ' ILE . 34.1 ptt180 33.08 46.68 0.1 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.659 -0.651 . . . . 0.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 7.6 mmt180 -129.79 150.42 75.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.676 -1.265 . . . . 0.0 111.192 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.79 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 22.2 Cg_endo -67.22 130.72 23.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 124.192 1.627 . . . . 0.0 109.876 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.554 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 87.8 mmm -127.13 137.58 53.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.556 -1.34 . . . . 0.0 111.077 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.63 HD23 ' HA ' ' A' ' 50' ' ' THR . 10.9 tp -140.21 113.67 8.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.622 -0.674 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -45.22 146.68 0.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.172 . . . . 0.0 110.394 -176.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.85 -0.53 3.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.741 -0.599 . . . . 0.0 110.627 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.568 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.2 p30 -69.91 -176.19 1.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.054 174.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 17.1 m-80 -145.94 150.06 35.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.592 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.313 0.577 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -122.39 101.9 7.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.603 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.568 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.3 t -77.47 138.79 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.68 -21.94 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 111.09 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.551 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 10.5 tptm -139.84 129.83 24.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.678 -1.264 . . . . 0.0 110.965 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.065 HG22 HG23 ' A' ' 98' ' ' VAL . 66.7 p -130.49 164.59 24.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.244 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.666 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.29 -36.67 0.42 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 110.916 -176.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.989 ' CG ' HG11 ' A' ' 162' ' ' VAL . 31.4 Cg_exo -53.1 -174.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.363 1.191 . . . . 0.0 110.401 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 4.9 t -86.84 41.44 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.28 -0.887 . . . . 0.0 110.264 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 158' ' ' SER . 40.7 mmtm 61.41 19.56 10.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.747 . . . . 0.0 109.901 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.778 ' O ' HG13 ' A' ' 162' ' ' VAL . 23.5 m -102.29 159.92 27.9 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.392 -0.818 . . . . 0.0 109.712 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.536 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.4 Cg_endo -53.81 119.66 6.61 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.059 1.557 . . . . 0.0 110.217 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.989 HG11 ' CG ' ' A' ' 157' ' ' PRO . 5.2 m -126.61 158.3 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -104.56 128.71 52.61 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.152 -0.967 . . . . 0.0 110.052 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.834 ' CD1' HG21 ' A' ' 168' ' ' THR . 12.8 mm -71.08 152.65 8.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.827 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.06 168.32 25.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.37 -20.87 21.34 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.975 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -90.99 -18.57 24.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 110.684 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.834 HG21 ' CD1' ' A' ' 164' ' ' ILE . 30.5 m -57.89 148.41 25.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 110.473 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 49.6 mttp -96.35 147.19 24.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.004 . . . . 0.0 109.702 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.747 HD13 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mt -130.03 160.03 41.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.093 -1.004 . . . . 0.0 110.982 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 99' ' ' THR . 25.3 mt-10 -137.78 133.6 34.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.754 -0.591 . . . . 0.0 110.231 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 120' ' ' VAL . 39.5 mm -120.02 120.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.341 -0.85 . . . . 0.0 109.39 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.706 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 4.7 ptp85 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 110.439 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 122.005 0.907 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.11 -166.84 13.41 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.808 ' CG2' HD12 ' A' ' 33' ' ' LEU . 41.3 pt -131.89 160.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -1.138 . . . . 0.0 109.535 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.18 117.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.5 pt? -139.58 -172.39 3.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.603 ' NE ' HG22 ' A' ' 66' ' ' ILE . 33.1 ptt180 -111.12 140.51 45.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.597 -1.314 . . . . 0.0 110.93 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 81' ' ' ILE . 9.6 p -62.29 138.09 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.497 -0.752 . . . . 0.0 110.675 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -119.06 144.71 46.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.944 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.524 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.565 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 80.8 mtt180 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.384 0.611 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.005 HG13 HG23 ' A' ' 67' ' ' VAL . 53.0 t -120.09 121.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.885 . . . . 0.0 110.303 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.758 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.8 ptt180 -91.27 120.71 32.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.7 -1.25 . . . . 0.0 109.881 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -135.49 169.15 17.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 109.821 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.0 p-10 -94.48 -170.05 2.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.941 -1.1 . . . . 0.0 111.069 -175.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -0.76 . . . . 0.0 109.904 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.61 -43.66 93.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.752 . . . . 0.0 110.105 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.127 ' O ' HD22 ' A' ' 33' ' ' LEU . 54.6 m -58.64 -32.14 68.79 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.464 -0.773 . . . . 0.0 109.44 177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 70.6 ttt180 -84.57 -44.31 13.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.704 -0.622 . . . . 0.0 110.887 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 33' ' ' LEU . 75.9 mtp85 -77.44 -11.14 59.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.171 -0.956 . . . . 0.0 110.127 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.127 HD22 ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -40.87 -29.36 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.888 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.799 ' H ' HD23 ' A' ' 33' ' ' LEU . 84.0 mt -141.15 -61.44 0.48 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 110.107 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.9 t0 -169.62 -36.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.529 -0.732 . . . . 0.0 109.498 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.728 ' HB2' ' HE3' ' A' ' 89' ' ' LYS . . . 9.99 114.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.263 0.554 . . . . 0.0 112.101 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.642 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.84 173.03 6.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.647 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 33.2 mm -60.08 120.23 5.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.949 -1.094 . . . . 0.0 109.825 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.583 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.27 34.36 46.22 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.466 173.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.472 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.9 m-20 -88.88 174.91 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.819 -1.4 . . . . 0.0 109.492 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.66 HG12 HG23 ' A' ' 90' ' ' VAL . 71.7 t -99.15 126.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.888 -1.132 . . . . 0.0 110.479 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.603 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -119.61 146.08 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.819 . . . . 0.0 110.572 -177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.12 140.7 46.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 109.677 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.898 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.3 mp -125.85 143.67 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.944 -1.097 . . . . 0.0 110.512 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.14 98.97 2.76 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.054 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.937 ' CG ' HG12 ' A' ' 85' ' ' VAL . 5.8 tmtm? -98.56 -66.46 0.9 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.226 -0.921 . . . . 0.0 109.695 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.557 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.77 -37.12 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 174.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.598 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -129.88 -178.97 4.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.757 -0.589 . . . . 0.0 109.826 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.624 ' HB3' HD21 ' A' ' 130' ' ' LEU . 12.8 mttp -91.86 134.66 34.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.605 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.8 p -139.56 165.05 28.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.499 -0.751 . . . . 0.0 110.129 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.575 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.82 162.71 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.59 -0.694 . . . . 0.0 110.339 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.603 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.86 -171.38 42.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.21 177.14 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -1.134 . . . . 0.0 110.371 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -103.0 133.13 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 110.548 -175.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.565 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -125.54 165.93 17.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.432 -0.792 . . . . 0.0 110.658 176.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -91.52 125.03 36.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.738 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -65.67 137.78 57.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.881 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.577 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.24 -48.6 96.73 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.903 -1.123 . . . . 0.0 109.105 173.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 39.9 Cg_endo -91.86 97.99 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.838 1.441 . . . . 0.0 109.108 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.474 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 19.5 pt-20 -74.64 36.46 0.11 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.519 -0.738 . . . . 0.0 110.699 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 82.2 m-20 -144.3 -34.93 0.36 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.154 -0.966 . . . . 0.0 110.649 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -85.1 -28.6 25.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 109.241 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.524 ' HA ' HG12 ' A' ' 66' ' ' ILE . 3.2 m-80 -81.03 39.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.8 -0.563 . . . . 0.0 110.697 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 3.0 pttp -98.24 12.85 33.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.665 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.02 25.95 0.06 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.603 HG22 ' NE ' ' A' ' 10' ' ' ARG . 45.6 pt -140.66 142.62 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.492 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.005 HG23 HG13 ' A' ' 24' ' ' VAL . 2.2 p -120.33 121.75 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.969 -1.082 . . . . 0.0 109.922 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.512 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 77.4 mtt180 -89.43 117.72 28.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.94 -1.1 . . . . 0.0 110.176 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.659 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.5 pp -127.23 172.36 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.428 0.632 . . . . 0.0 110.361 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 34.0 p-10 -76.41 168.74 19.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 0.0 109.773 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -67.11 -27.85 67.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG12 HD21 ' A' ' 76' ' ' ASN . 53.0 t -70.0 -43.66 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.965 . . . . 0.0 110.486 -176.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.898 ' CE ' HD13 ' A' ' 44' ' ' ILE . 3.1 tpt -60.02 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.072 -1.018 . . . . 0.0 109.683 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.591 ' HG3' HG21 ' A' ' 11' ' ' VAL . 6.9 ttm180 -59.99 -40.01 87.72 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 0.0 109.853 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -72.2 -25.99 61.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.465 HD21 HG12 ' A' ' 72' ' ' VAL . 88.6 m-20 -68.55 -29.13 67.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.022 . . . . 0.0 110.625 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 31.0 p -99.26 -37.01 9.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 110.496 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.557 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 112.98 23.84 5.11 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.589 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.22 167.43 9.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -1.183 . . . . 0.0 110.351 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.613 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -116.75 166.42 12.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 178.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.944 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -51.4 140.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.486 178.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 77.27 -0.67 67.42 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 172.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.1 m-20 -56.31 -160.99 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 12.7 pttm -135.51 112.19 10.07 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.489 -0.757 . . . . 0.0 109.861 175.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.937 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.49 158.94 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.749 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 55.5 tttp -110.75 123.57 50.3 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.188 -0.945 . . . . 0.0 109.955 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.674 HG22 HG23 ' A' ' 44' ' ' ILE . 62.8 t -105.59 123.64 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 109.873 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.439 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.7 mtt180 -112.42 139.32 48.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.733 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HE3' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -79.06 141.06 37.72 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 110.437 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.66 HG23 HG12 ' A' ' 41' ' ' VAL . 2.0 m -150.01 -168.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 109.999 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.512 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 47.1 ptt85 -139.59 171.04 14.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.566 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.41 158.7 16.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.995 -1.066 . . . . 0.0 111.309 -173.484 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.68 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.4 pt-20 -150.86 175.23 12.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.24 101.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.663 -1.273 . . . . 0.0 110.587 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.841 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.05 137.44 55.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.541 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 19.5 ptpt -101.12 -26.4 13.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 110.814 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.663 ' HB3' HD23 ' A' ' 156' ' ' LEU . 83.7 tttt -150.8 119.95 6.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.897 -1.127 . . . . 0.0 110.584 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.933 HG23 HG22 ' A' ' 155' ' ' THR . 7.4 p -135.19 140.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.871 -1.143 . . . . 0.0 110.977 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 171' ' ' GLU . 29.9 m -112.21 144.37 41.73 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.346 -0.846 . . . . 0.0 109.962 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.745 HD21 HG23 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -141.87 165.74 26.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.179 -0.95 . . . . 0.0 110.941 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.95 90.72 10.65 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 110.368 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 37.9 Cg_exo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.955 1.503 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 117' ' ' GLU . 6.7 tp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.204 0.526 . . . . 0.0 110.066 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.431 ' N ' HG23 ' A' ' 116' ' ' ILE . 47.5 mt-10 -60.02 -43.12 95.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.675 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.43 -39.8 89.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.756 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.02 -40.03 87.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.815 . . . . 0.0 109.669 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.76 HG12 ' CD1' ' A' ' 170' ' ' ILE . 54.4 t -60.02 -47.25 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.571 ' NE2' ' O ' ' A' ' 168' ' ' THR . 4.1 mt-30 -59.95 -44.51 94.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.511 -0.743 . . . . 0.0 110.06 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -60.11 -44.04 95.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.57 -0.706 . . . . 0.0 110.19 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -74.6 -42.09 59.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.5 mm? -95.92 0.68 52.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.172 -0.955 . . . . 0.0 111.205 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.635 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.6 tt -46.04 166.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.851 -1.155 . . . . 0.0 110.261 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.9 ptm180 32.63 49.31 0.15 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.603 -0.686 . . . . 0.0 111.237 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.537 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -129.1 134.68 26.58 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.029 -1.044 . . . . 0.0 110.955 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.812 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.7 Cg_exo -59.75 125.73 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.931 1.49 . . . . 0.0 109.785 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.537 ' HG2' ' O ' ' A' ' 127' ' ' ARG . 99.7 mmm -124.35 140.46 52.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.445 -1.409 . . . . 0.0 111.031 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 49' ' ' LYS . 12.6 tp -140.99 111.6 6.94 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.58 -0.7 . . . . 0.0 109.503 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pm0 -47.07 137.42 7.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 110.612 -173.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.59 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 4.5 tp60 80.41 -3.39 1.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.243 0.545 . . . . 0.0 110.358 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.617 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.4 p30 -69.12 -173.59 0.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 175.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.465 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 7.9 m-80 -146.32 140.3 26.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 O-C-N 120.969 -1.082 . . . . 0.0 110.447 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 67.7 m-85 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.188 0.518 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.441 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 23.7 tptm -97.14 103.68 15.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.303 -0.873 . . . . 0.0 109.882 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.617 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.9 t -74.87 134.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.539 HG21 ' NH2' ' A' ' 173' ' ' ARG . 37.9 t -115.18 -30.17 2.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 110.751 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.485 ' C ' HG23 ' A' ' 155' ' ' THR . 68.5 mttt -143.4 160.0 41.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 0.0 111.163 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.933 HG22 HG23 ' A' ' 98' ' ' VAL . 81.5 p -150.0 162.55 40.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.83 -38.69 0.44 Allowed Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.994 ' CG ' HG11 ' A' ' 162' ' ' VAL . 21.4 Cg_exo -57.68 -166.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.535 1.282 . . . . 0.0 110.139 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.48 ' HB3' HG22 ' A' ' 160' ' ' VAL . 4.6 t -89.69 -169.23 2.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.913 . . . . 0.0 109.671 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -64.16 -7.9 10.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 110.605 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 158' ' ' SER . 32.1 m -83.38 152.13 63.73 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 121.416 -0.803 . . . . 0.0 110.578 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.575 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 4.6 Cg_endo -52.98 142.57 52.92 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.303 1.686 . . . . 0.0 110.952 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.994 HG11 ' CG ' ' A' ' 157' ' ' PRO . 7.2 m -132.46 158.11 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 110.033 171.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 83.2 tt0 -105.36 126.32 51.97 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 110.213 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.768 ' CD1' HG21 ' A' ' 168' ' ' THR . 13.1 mm -69.77 159.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 110.438 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.65 167.84 26.52 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.633 ' HB3' HD11 ' A' ' 125' ' ' ILE . 19.2 pt-20 -58.58 -19.95 42.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.336 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.63 -22.03 20.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.768 HG21 ' CD1' ' A' ' 164' ' ' ILE . 94.2 m -54.99 147.32 15.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.635 -0.666 . . . . 0.0 110.283 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.7 mmtm -95.52 156.72 16.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.937 -1.102 . . . . 0.0 110.014 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.76 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.4 mt -135.68 164.25 33.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.992 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 99' ' ' THR . 37.0 mt-10 -139.26 137.01 35.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.621 -0.675 . . . . 0.0 110.276 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 120' ' ' VAL . 47.1 mm -119.95 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.937 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.719 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 3.4 ptp180 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 0.0 110.29 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.563 0.697 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -144.32 -160.47 8.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.918 HG21 HD22 ' A' ' 33' ' ' LEU . 46.2 pt -132.98 147.76 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -1.145 . . . . 0.0 109.815 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.8 mt -96.24 119.08 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.802 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.7 pt? -136.61 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 110.287 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.509 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 24.0 ttp180 -106.08 130.38 53.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.419 -0.801 . . . . 0.0 110.998 -174.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.967 HG11 ' O ' ' A' ' 80' ' ' SER . 10.2 p -61.21 139.55 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.523 -0.735 . . . . 0.0 110.416 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -125.79 153.33 44.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.467 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.929 ' HB3' HD11 ' A' ' 81' ' ' ILE . 46.2 tt0 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.93 . . . . 0.0 110.062 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.556 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 98.1 mtt180 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.218 0.532 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.853 HG13 HG23 ' A' ' 67' ' ' VAL . 92.8 t -116.14 120.01 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.206 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.827 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.1 ptm180 -93.54 119.97 33.25 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.852 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.827 HD22 ' O ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -138.43 178.6 7.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.547 -0.72 . . . . 0.0 109.737 -176.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 15.2 p-10 -94.2 177.01 6.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.815 -1.178 . . . . 0.0 110.635 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 86.3 mt-10 -60.0 -44.74 94.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.3 t -60.49 -43.13 97.33 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.264 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.653 ' CB ' HD12 ' A' ' 26' ' ' LEU . 47.0 t -59.97 -41.15 91.34 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.257 176.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.607 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 67.4 ttt180 -68.98 -44.17 73.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.662 . . . . 0.0 111.363 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 33' ' ' LEU . 25.4 tpt180 -90.32 -20.69 22.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.859 -1.15 . . . . 0.0 111.74 -170.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.083 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -47.84 -30.36 3.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.73 -1.231 . . . . 0.0 108.988 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.083 ' N ' HD12 ' A' ' 33' ' ' LEU . 18.0 mt -115.67 -78.16 0.58 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.798 . . . . 0.0 110.393 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -172.23 11.65 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.473 -0.767 . . . . 0.0 110.515 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -50.03 127.75 17.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.094 -1.004 . . . . 0.0 110.337 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.681 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -112.61 176.31 5.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.435 ' HA ' HD13 ' A' ' 38' ' ' ILE . 28.5 mm -59.66 119.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.828 -1.17 . . . . 0.0 109.83 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.61 36.83 47.62 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.26 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 25.6 m-20 -87.97 169.19 12.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.752 -1.44 . . . . 0.0 109.228 170.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 54.3 t -98.78 120.36 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.858 -1.151 . . . . 0.0 110.15 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.659 HG12 ' CE ' ' A' ' 89' ' ' LYS . 2.8 m -116.85 139.79 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.554 -0.716 . . . . 0.0 110.101 -176.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 85.9 tt0 -106.55 138.34 42.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.872 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.982 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.6 mp -116.97 140.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.147 -0.97 . . . . 0.0 109.859 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 84.4 tt0 -150.16 96.29 2.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.087 -1.008 . . . . 0.0 111.186 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.761 ' HB2' HG12 ' A' ' 85' ' ' VAL . 37.9 tttp -99.53 -71.07 0.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 172.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.16 -34.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.47 175.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.552 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 87.3 mtt-85 -139.77 179.71 6.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.051 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HD3' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -89.04 134.14 34.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 110.781 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.534 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 1.7 p -138.48 172.06 13.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.679 . . . . 0.0 109.322 174.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.808 ' CG2' HD21 ' A' ' 130' ' ' LEU . 3.0 m -127.93 168.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.415 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.45 -175.9 45.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 40.8 ttm180 -121.71 165.75 15.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.439 -1.036 . . . . 0.0 109.975 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.681 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -94.57 135.85 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 110.553 -172.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.556 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -130.5 167.27 18.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 110.509 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -89.6 125.97 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.429 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.585 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -65.23 140.08 58.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.847 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.589 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -55.45 -49.96 89.54 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.947 174.452 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 33.9 Cg_endo -92.81 98.56 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.873 1.46 . . . . 0.0 108.974 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -73.64 35.13 0.08 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.561 -0.712 . . . . 0.0 110.91 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -145.91 -29.77 0.41 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.152 -0.968 . . . . 0.0 110.531 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.12 -27.25 26.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.167 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.585 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 10.7 m120 -81.22 41.15 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.775 -0.578 . . . . 0.0 110.386 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.43 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -98.2 7.96 45.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.37 26.32 0.05 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 66' ' ' ILE . 45.6 pt -140.02 141.34 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.252 -1.146 . . . . 0.0 109.411 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.853 HG23 HG13 ' A' ' 24' ' ' VAL . 10.2 p -121.51 125.85 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.053 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.558 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 77.8 mtt180 -89.52 116.32 27.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.941 -1.099 . . . . 0.0 110.107 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.4 pp -129.97 170.07 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.209 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -79.83 164.24 23.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.945 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -68.01 -18.79 64.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.09 -50.02 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 110.313 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.982 ' CE ' HD13 ' A' ' 44' ' ' ILE . 19.3 ttt -59.98 -45.7 91.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.443 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.508 ' HD3' ' CD1' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.991 174.162 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -62.03 -36.42 81.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 109.84 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -67.79 -26.37 66.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 110.755 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 24.3 p -99.36 -30.99 11.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.022 -1.049 . . . . 0.0 110.547 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.49 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 106.75 19.73 9.47 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.628 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.23 169.34 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.243 . . . . 0.0 110.838 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.967 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -120.31 178.53 4.61 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.475 -0.765 . . . . 0.0 109.458 177.013 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.929 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -66.4 142.26 16.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 110.35 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.707 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.36 -4.78 54.23 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 172.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.539 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.89 -162.08 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.053 -1.263 . . . . 0.0 110.067 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 16.4 pttp -137.2 116.15 12.36 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -119.55 160.72 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 82.8 tttt -109.37 120.62 43.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.025 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.519 HG23 HD21 ' A' ' 9' ' ' LEU . 87.3 t -101.67 123.69 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 0.0 110.204 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.52 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 93.9 mtt180 -106.88 151.4 25.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 109.763 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.659 ' CE ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -99.07 132.44 44.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.049 -1.032 . . . . 0.0 110.215 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.3 m -149.91 -168.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.561 -0.712 . . . . 0.0 110.125 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 40.1 ptt180 -129.07 171.67 12.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.636 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.74 164.72 12.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 111.023 -175.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.594 ' CG ' HG12 ' A' ' 162' ' ' VAL . 18.8 pt-20 -150.04 169.51 21.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 109.421 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 163' ' ' GLU . 40.0 mm -90.66 99.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.843 -1.161 . . . . 0.0 110.607 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.866 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.27 140.07 50.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 110.423 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.661 ' HE3' HD12 ' A' ' 156' ' ' LEU . 1.5 ptpt -101.68 -29.03 12.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.536 ' HB3' HD23 ' A' ' 156' ' ' LEU . 40.2 ttmt -150.79 129.35 12.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.367 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.083 HG23 HG22 ' A' ' 155' ' ' THR . 9.7 p -139.67 139.99 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.009 -1.057 . . . . 0.0 110.782 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 171' ' ' GLU . 14.5 m -102.71 138.67 39.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.873 . . . . 0.0 110.042 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.545 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -132.03 159.96 37.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.696 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . . . -135.18 81.82 43.39 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.432 -0.793 . . . . 0.0 110.396 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 19.7 Cg_exo . . . . . 0 C--N 1.304 -1.775 0 O-C-N 123.936 1.493 . . . . 0.0 110.33 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 117' ' ' GLU . 7.2 tp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.124 0.488 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 97.2 mt-10 -61.48 -42.58 99.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -70.04 -30.12 67.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.93 -39.93 83.07 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.783 ' O ' HD22 ' A' ' 124' ' ' LEU . 56.0 t -60.07 -43.79 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.316 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.608 ' NE2' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -59.63 -45.06 93.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.987 -1.07 . . . . 0.0 109.575 175.505 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -59.94 -40.09 87.77 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.22 -22.18 38.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.165 -0.959 . . . . 0.0 110.938 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -130.03 7.22 5.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.94 -1.1 . . . . 0.0 110.674 -174.268 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.698 ' N ' HD23 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -44.26 173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.311 -0.868 . . . . 0.0 110.883 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.7 ptm180 34.9 46.63 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.498 -0.751 . . . . 0.0 111.29 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.437 ' H ' ' HB ' ' A' ' 164' ' ' ILE . 8.9 ttt180 -123.33 129.7 24.81 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.87 -1.144 . . . . 0.0 111.19 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.846 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.5 Cg_endo -66.26 125.9 14.8 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.954 1.502 . . . . 0.0 109.647 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.98 ' O ' HD13 ' A' ' 130' ' ' LEU . 97.6 mtp -140.01 151.62 45.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.27 -1.519 . . . . 0.0 112.092 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.98 HD13 ' O ' ' A' ' 129' ' ' MET . 0.5 OUTLIER -126.03 146.16 50.01 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.443 0.639 . . . . 0.0 109.975 172.23 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.4 pm0 -57.18 140.02 50.83 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 172.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 75.2 -0.75 3.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.75 -0.594 . . . . 0.0 110.262 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.801 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -67.81 -172.81 0.3 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 109.942 176.347 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 17.1 m-80 -141.18 149.72 41.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.016 -1.052 . . . . 0.0 110.493 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 66.5 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.416 0.627 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 32.3 tptt -118.05 102.21 8.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.922 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.801 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.5 t -74.93 135.73 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.791 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.42 -31.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 110.669 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 54.7 tttm -139.39 148.76 43.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.954 -1.091 . . . . 0.0 110.953 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.083 HG22 HG23 ' A' ' 98' ' ' VAL . 24.4 p -145.07 159.7 42.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.76 -0.588 . . . . 0.0 109.836 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.674 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -90.46 -38.05 0.4 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.344 -0.847 . . . . 0.0 111.015 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 1.1 ' CB ' HG11 ' A' ' 162' ' ' VAL . 12.6 Cg_exo -60.15 -173.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.434 1.228 . . . . 0.0 110.911 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 159' ' ' LYS . 5.4 t -90.17 -168.47 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 158' ' ' SER . 8.7 ptpt -66.3 -6.01 12.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.437 ' H ' HG22 ' A' ' 160' ' ' VAL . 33.7 m -86.36 152.33 54.97 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.599 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.636 ' HB3' HG11 ' A' ' 51' ' ' VAL . 1.6 Cg_endo -51.52 132.42 40.38 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.289 1.678 . . . . 0.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 1.1 HG11 ' CB ' ' A' ' 157' ' ' PRO . 3.5 m -121.96 152.92 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.609 -1.237 . . . . 0.0 110.269 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.598 ' HG3' HD13 ' A' ' 94' ' ' ILE . 18.1 pt-20 -103.47 127.93 50.75 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.879 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 1.008 HD12 HG21 ' A' ' 168' ' ' THR . 19.3 mm -71.04 153.4 8.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.136 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.608 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -143.69 167.29 26.7 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.563 ' HA ' HD11 ' A' ' 125' ' ' ILE . 99.0 mt-10 -56.61 -20.58 21.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -1.062 . . . . 0.0 110.397 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.94 -9.91 47.04 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.667 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.008 HG21 HD12 ' A' ' 164' ' ' ILE . 95.6 m -62.44 146.65 50.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.167 -0.958 . . . . 0.0 109.886 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.5 mttt -97.43 143.97 27.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 109.64 176.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.586 HD11 ' HG2' ' A' ' 121' ' ' GLN . 2.1 mm -106.84 129.45 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 99' ' ' THR . 64.7 mt-10 -116.31 135.2 54.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 110.156 172.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.458 HG12 ' HG ' ' A' ' 100' ' ' LEU . 41.3 mt -140.1 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.873 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 173' ' ' ARG . 3.5 ptm85 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.228 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.586 ' ND2' HD22 ' A' ' 34' ' ' LEU . 31.9 p30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.139 0.495 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.71 -159.13 8.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.911 ' CG2' HD12 ' A' ' 33' ' ' LEU . 20.6 pt -137.2 169.35 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -112.51 120.51 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.011 -1.056 . . . . 0.0 110.444 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 87' ' ' VAL . 1.7 pt? -139.41 -167.66 2.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.776 . . . . 0.0 109.747 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 34.9 ptt180 -118.88 140.02 50.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.794 -1.191 . . . . 0.0 110.715 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.938 HG11 ' O ' ' A' ' 80' ' ' SER . 4.6 p -62.35 147.7 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -122.3 147.66 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.903 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.811 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.516 ' HG3' ' CG ' ' A' ' 55' ' ' TYR . 59.8 ttt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.171 0.51 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.071 HG13 HG23 ' A' ' 67' ' ' VAL . 55.5 t -112.56 112.53 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 0.0 110.271 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.793 ' O ' HD12 ' A' ' 26' ' ' LEU . 7.4 ptt180 -84.24 117.37 23.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.689 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.929 HD13 HG12 ' A' ' 24' ' ' VAL . 1.8 mp -134.83 170.62 15.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.993 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.0 p-10 -105.57 -175.18 2.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 110.507 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -59.91 -42.09 93.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.184 -0.947 . . . . 0.0 109.643 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -67.4 -49.56 63.29 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.3 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.114 ' O ' HD22 ' A' ' 33' ' ' LEU . 72.4 m -57.9 -27.44 63.31 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.119 -0.988 . . . . 0.0 109.56 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 39.9 ttm180 -86.43 -46.08 10.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.822 -0.549 . . . . 0.0 110.957 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -79.71 -8.58 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.114 HD22 ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -43.85 -28.7 0.47 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -0.779 . . . . 0.0 110.136 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.716 ' H ' HD23 ' A' ' 33' ' ' LEU . 83.2 mt -141.76 -59.43 0.47 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 110.272 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.602 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.4 t0 -170.56 -30.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.424 -0.798 . . . . 0.0 110.066 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.602 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -15.35 120.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.437 0.637 . . . . 0.0 111.581 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.597 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -105.87 -177.51 3.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.0 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.422 HD12 HG23 ' A' ' 38' ' ' ILE . 28.5 mm -63.73 119.4 7.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.062 -1.024 . . . . 0.0 110.135 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.608 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.25 35.95 56.3 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.81 178.3 6.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.056 -1.261 . . . . 0.0 109.499 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.616 HG21 ' OG1' ' A' ' 92' ' ' THR . 97.0 t -99.65 127.76 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.015 -1.053 . . . . 0.0 110.301 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG11 HG23 ' A' ' 54' ' ' VAL . 3.1 m -120.95 149.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.514 -0.741 . . . . 0.0 110.683 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -111.93 140.8 46.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.594 -0.691 . . . . 0.0 109.982 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.849 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.5 mp -124.92 144.01 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.926 -1.109 . . . . 0.0 110.731 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -150.21 98.79 2.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 110.827 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.946 ' CG ' HG12 ' A' ' 85' ' ' VAL . 9.2 tmtm? -97.94 -64.36 1.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.559 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.569 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.17 -36.94 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.817 0.818 . . . . 0.0 109.098 175.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 70.5 mtt85 -128.95 -173.47 2.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.538 ' HB3' HD21 ' A' ' 130' ' ' LEU . 29.3 mttt -96.18 141.75 29.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.122 -0.986 . . . . 0.0 110.902 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.637 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.5 p -145.0 168.2 20.84 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.374 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.57 162.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -171.66 41.39 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.216 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.403 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 70.2 ttt180 -121.72 166.44 14.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.458 -1.025 . . . . 0.0 110.165 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -99.94 149.69 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.004 . . . . 0.0 110.412 -175.37 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.0 m-85 -139.16 167.84 21.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.511 -0.743 . . . . 0.0 110.339 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -88.62 122.77 32.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.844 . . . . 0.0 110.052 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.834 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.3 138.3 58.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.734 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 2.4 mtp180 -58.35 -47.21 99.21 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.309 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 56.2 Cg_endo -93.51 98.96 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.675 1.355 . . . . 0.0 108.69 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.423 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.5 pt-20 -73.28 35.65 0.08 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.587 -0.696 . . . . 0.0 110.784 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.3 m-20 -146.07 -30.79 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.96 -28.78 25.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.433 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.834 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 5.3 m120 -80.53 39.64 0.48 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.723 -0.61 . . . . 0.0 110.64 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -98.96 13.34 33.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.072 -1.017 . . . . 0.0 109.663 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.72 26.42 0.05 OUTLIER Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.55 149.04 20.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.371 -1.076 . . . . 0.0 108.933 175.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.071 HG23 HG13 ' A' ' 24' ' ' VAL . 7.6 p -126.55 131.81 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.928 -1.108 . . . . 0.0 110.348 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 3.5 ttt180 -89.59 116.24 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 110.325 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.877 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.7 pp -135.36 168.58 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.318 -0.864 . . . . 0.0 111.036 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.06 155.54 25.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.282 -0.886 . . . . 0.0 110.201 174.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' ' CG ' ' A' ' 75' ' ' ASN . 60.1 p -60.12 -23.37 63.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 110.147 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.6 t -68.09 -42.94 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 110.232 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.849 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.95 -50.91 71.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 109.974 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.633 ' HD2' HG21 ' A' ' 11' ' ' VAL . 13.2 mmp_? -60.14 -39.85 87.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 173.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 78.2 m-20 -60.12 -37.77 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 73' ' ' MET . 93.8 m-20 -59.94 -36.25 76.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 110.648 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 30.2 p -98.15 -39.33 8.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.105 -0.997 . . . . 0.0 110.531 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.569 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 119.18 36.17 0.89 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.806 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -116.48 170.2 8.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.327 . . . . 0.0 110.38 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.938 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.99 -176.83 3.43 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.811 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -66.57 143.42 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.487 178.178 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.759 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.13 0.95 67.16 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.3 m-20 -61.33 -165.4 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.071 -1.253 . . . . 0.0 110.581 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.512 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 15.0 pttt -130.64 112.94 13.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 0.0 109.945 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.946 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -122.68 161.15 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 109.995 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 26.4 ttmt -104.96 125.67 51.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.011 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.818 HG23 HD21 ' A' ' 9' ' ' LEU . 62.0 t -108.28 121.25 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.507 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.6 mtt180 -111.39 147.13 35.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.419 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 36' ' ' ALA . 6.5 tttt -92.51 139.57 30.45 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.255 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.69 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.413 -0.804 . . . . 0.0 110.26 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -132.25 172.28 12.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.466 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.616 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.49 159.59 16.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.974 -1.079 . . . . 0.0 111.204 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.555 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.1 pt-20 -150.02 169.97 19.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 94' ' ' ILE . 4.6 mp -89.56 99.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.731 -1.231 . . . . 0.0 110.241 -178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.806 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.0 138.04 44.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.772 . . . . 0.0 110.353 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.697 ' CG ' HD13 ' A' ' 156' ' ' LEU . 15.5 ptmt -98.39 -30.01 12.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.34 -0.85 . . . . 0.0 110.849 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.549 ' HB3' HD12 ' A' ' 156' ' ' LEU . 14.7 tttp -151.06 125.61 9.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.85 -1.156 . . . . 0.0 110.803 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.063 HG23 HG22 ' A' ' 155' ' ' THR . 8.6 p -137.52 147.17 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.065 . . . . 0.0 111.044 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.758 HG23 ' HB3' ' A' ' 171' ' ' GLU . 38.0 m -119.14 142.82 47.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.111 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.686 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -138.54 169.03 18.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.847 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.38 93.84 4.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.415 -0.803 . . . . 0.0 110.489 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.7 Cg_exo . . . . . 0 C--N 1.303 -1.864 0 O-C-N 124.201 1.632 . . . . 0.0 110.417 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.5 tp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.091 0.472 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.7 mt-10 -60.03 -42.12 93.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.27 -37.51 83.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 109.6 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -59.97 -42.42 94.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.589 HG12 ' CD1' ' A' ' 170' ' ' ILE . 53.1 t -60.26 -45.01 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 175.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.583 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.1 mt-30 -59.89 -43.97 94.5 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.568 -0.707 . . . . 0.0 109.951 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.31 -46.01 91.4 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.819 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.9 68.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 110.921 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 2.9 mm? -99.89 5.33 45.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.025 -1.047 . . . . 0.0 111.171 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.706 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.7 tt -48.71 170.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 36.6 ptt180 33.66 49.12 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.628 -0.67 . . . . 0.0 111.516 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 0.7 OUTLIER -132.37 149.93 74.51 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.711 -1.243 . . . . 0.0 111.232 176.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.834 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.1 Cg_endo -68.73 128.19 16.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 124.174 1.618 . . . . 0.0 109.971 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.7 mmm -123.07 140.95 52.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.321 -1.487 . . . . 0.0 110.983 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 50' ' ' THR . 20.2 tp -139.24 104.19 4.94 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.695 -0.628 . . . . 0.0 109.386 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.642 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.5 pt-20 -45.24 137.09 4.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.046 -1.034 . . . . 0.0 110.7 -174.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 86.01 -6.06 0.8 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.27 0.557 . . . . 0.0 110.283 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.561 ' OD2' ' HB ' ' A' ' 152' ' ' VAL . 2.8 p30 -69.49 -178.31 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 110.359 177.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -147.1 153.09 39.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.941 -1.099 . . . . 0.0 110.65 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.7 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.188 0.518 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -112.4 111.95 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.561 ' HB ' ' OD2' ' A' ' 133' ' ' ASP . 2.7 t -78.15 137.57 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.89 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.48 -31.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.257 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -143.43 146.98 33.91 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.411 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.063 HG22 HG23 ' A' ' 98' ' ' VAL . 56.0 p -140.0 161.68 37.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.697 HD13 ' CG ' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -89.26 -35.91 0.42 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.96 -1.087 . . . . 0.0 111.103 -177.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.942 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.3 Cg_exo -58.61 -167.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.327 1.172 . . . . 0.0 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 160' ' ' VAL . 29.1 t -87.68 -173.88 4.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.792 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -67.9 -1.84 6.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.176 -0.953 . . . . 0.0 110.567 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' A' ' 158' ' ' SER . 33.1 m -85.79 147.73 46.76 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.146 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.585 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.8 Cg_endo -47.45 139.07 17.74 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 O-C-N 124.358 1.715 . . . . 0.0 110.975 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.942 HG11 ' CB ' ' A' ' 157' ' ' PRO . 11.1 m -130.02 159.21 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 109.442 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.3 tt0 -106.61 127.23 53.17 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.048 -1.032 . . . . 0.0 110.229 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.84 ' CD1' HG21 ' A' ' 168' ' ' THR . 16.6 mm -70.43 154.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.667 -0.646 . . . . 0.0 110.213 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.24 175.4 23.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.706 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -58.75 -26.05 63.61 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.341 -1.094 . . . . 0.0 109.992 -178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.36 -17.76 28.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 0.0 110.737 -176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.84 HG21 ' CD1' ' A' ' 164' ' ' ILE . 53.3 m -58.73 146.37 36.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 98.6 mttt -100.01 153.14 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.955 -1.091 . . . . 0.0 109.467 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.637 HG23 HD21 ' A' ' 100' ' ' LEU . 2.1 mt -129.92 159.4 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.001 -1.062 . . . . 0.0 111.185 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.758 ' HB3' HG23 ' A' ' 99' ' ' THR . 10.4 mt-10 -130.35 130.91 45.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.029 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 120' ' ' VAL . 50.5 mm -119.91 127.18 75.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.32 -0.863 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 2.9 ptp180 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 67.3 t30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.122 0.487 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -147.09 -169.71 14.82 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.008 HG23 HD11 ' A' ' 34' ' ' LEU . 45.7 pt -134.82 159.99 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.228 -1.16 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 86' ' ' LYS . 40.4 mm -98.37 116.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 110.331 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.3 pt? -139.37 -178.26 5.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.324 -0.86 . . . . 0.0 109.728 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.73 ' HG2' HG22 ' A' ' 66' ' ' ILE . 6.3 ptp180 -106.73 137.0 45.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 110.899 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.048 HG23 HD11 ' A' ' 69' ' ' ILE . 13.5 p -63.75 134.81 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.596 -0.69 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -119.79 153.47 35.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.421 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.874 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.904 . . . . 0.0 110.607 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.517 ' HD3' ' CE1' ' A' ' 55' ' ' TYR . 18.1 mtt-85 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.364 0.602 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.082 HG13 HG23 ' A' ' 67' ' ' VAL . 97.6 t -117.15 122.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.502 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 1.6 ptm180 -95.64 119.33 33.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.742 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.571 ' C ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -140.69 174.85 10.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 0.0 109.513 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.1 p-10 -90.28 177.64 6.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.927 -1.108 . . . . 0.0 110.737 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.99 -41.1 91.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 108.801 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.0 t -62.77 -58.38 7.64 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.076 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.666 ' O ' HD22 ' A' ' 33' ' ' LEU . 58.4 m -49.91 -30.39 10.1 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.833 -1.167 . . . . 0.0 109.572 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.478 ' N ' HD12 ' A' ' 26' ' ' LEU . 40.3 ttm180 -81.62 -45.52 15.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 111.603 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -97.95 -10.6 24.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.267 . . . . 0.0 110.958 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.991 HD23 ' H ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -59.94 -26.02 65.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.987 -1.07 . . . . 0.0 109.774 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.008 HD11 HG23 ' A' ' 7' ' ' ILE . 54.4 mt -110.63 -75.87 0.61 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.145 -0.972 . . . . 0.0 110.277 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.535 ' HB3' ' CD ' ' A' ' 89' ' ' LYS . 9.4 t70 -168.27 -20.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.574 -0.704 . . . . 0.0 109.971 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.594 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -40.46 126.78 2.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.358 -0.839 . . . . 0.0 110.681 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.705 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.3 pt-20 -119.12 179.77 4.07 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 108.929 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 38' ' ' ILE . 5.5 mm -55.81 127.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.06 . . . . 0.0 109.875 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.62 24.3 74.97 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.708 174.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 6.9 m-20 -89.01 169.94 11.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.754 -1.439 . . . . 0.0 109.855 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.741 HG21 ' OG1' ' A' ' 92' ' ' THR . 79.2 t -99.78 127.97 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 110.137 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.604 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.6 m -116.02 143.71 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 86.3 tt0 -113.28 143.2 44.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.735 . . . . 0.0 109.632 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.817 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.8 mp -119.97 145.9 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.023 . . . . 0.0 110.198 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.7 tt0 -151.8 88.53 1.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.062 -1.024 . . . . 0.0 111.612 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 85' ' ' VAL . 31.0 tttm -99.23 -71.74 0.68 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 110.2 171.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.539 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.15 -34.71 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.507 -0.746 . . . . 0.0 109.409 178.06 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 49.8 mtm180 -141.3 -173.28 3.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.5 -0.75 . . . . 0.0 109.892 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.668 ' C ' HD21 ' A' ' 130' ' ' LEU . 2.1 mptm? -87.84 133.22 33.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 110.325 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -134.93 159.28 41.94 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.354 0.597 . . . . 0.0 110.318 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.39 162.17 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.825 . . . . 0.0 109.963 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.604 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -179.83 48.01 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.995 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 61.8 ttt180 -116.6 169.84 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 0.0 110.214 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.85 131.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 110.322 -175.63 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.517 ' CE1' ' HD3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -121.3 163.67 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.551 -0.718 . . . . 0.0 110.009 175.724 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -90.68 124.19 34.88 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 110.134 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -63.22 139.25 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.568 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -58.74 -49.05 95.51 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.186 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.2 Cg_endo -91.06 98.78 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 108.922 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 15.7 pt-20 -73.07 35.93 0.08 Allowed 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.65 -0.657 . . . . 0.0 110.749 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.5 m-20 -148.91 -33.42 0.22 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.252 -0.905 . . . . 0.0 110.721 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.23 -26.49 28.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.987 . . . . 0.0 109.166 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.846 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 13.4 m120 -80.94 42.29 0.63 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.769 -0.582 . . . . 0.0 110.537 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 34.4 mtpt -97.79 10.0 41.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.563 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.48 28.84 0.05 OUTLIER Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.73 HG22 ' HG2' ' A' ' 10' ' ' ARG . 45.1 pt -140.59 143.88 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -1.154 . . . . 0.0 109.55 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.082 HG23 HG13 ' A' ' 24' ' ' VAL . 2.5 p -120.8 127.59 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.06 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.421 ' HB3' ' HD2' ' A' ' 25' ' ' ARG . 20.8 tpp180 -90.63 114.9 27.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.088 -1.008 . . . . 0.0 109.906 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.048 HD11 HG23 ' A' ' 11' ' ' VAL . 2.4 pt -130.05 161.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.99 169.94 17.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 110.047 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.442 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 21.5 t -60.2 -36.74 78.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 110.365 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.27 -45.9 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 109.888 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.817 ' HE1' HD13 ' A' ' 44' ' ' ILE . 13.7 tpt -60.13 -43.45 95.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.588 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -60.0 -40.03 87.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.761 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.41 -25.94 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 78.6 m-20 -60.12 -40.02 88.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.655 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.0 p -99.91 -38.06 8.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.985 -1.072 . . . . 0.0 110.545 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.539 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.79 30.85 2.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.598 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.43 169.49 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -1.131 . . . . 0.0 110.74 -174.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.94 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.7 170.96 8.19 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.341 -0.849 . . . . 0.0 109.039 174.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.874 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -63.27 140.57 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.794 -1.192 . . . . 0.0 110.429 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.633 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.82 -2.95 62.31 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 172.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -59.64 -159.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.101 -1.235 . . . . 0.0 110.394 174.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 54.6 pttt -138.79 119.76 14.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.78 . . . . 0.0 109.836 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.731 HG12 ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -123.02 161.38 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 109.895 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.464 ' HB2' ' CD1' ' A' ' 8' ' ' ILE . 20.0 ttpt -105.31 120.02 40.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.498 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.6 t -103.71 121.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.7 mtt180 -111.3 131.84 54.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.358 -0.839 . . . . 0.0 110.146 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.535 ' CD ' ' HB3' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -74.91 137.87 41.99 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 41' ' ' VAL . 2.2 m -149.45 -169.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.066 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -127.99 170.98 12.27 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.741 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.01 159.95 16.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 111.052 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.584 ' HG2' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -146.29 173.68 12.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.94 99.03 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.681 -1.262 . . . . 0.0 110.178 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.854 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.09 138.79 36.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -0.803 . . . . 0.0 110.301 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.543 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -103.96 -28.25 11.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.955 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.73 ' HB3' HD23 ' A' ' 156' ' ' LEU . 52.5 tttp -150.04 123.08 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.761 -1.212 . . . . 0.0 110.253 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.707 HG23 HG22 ' A' ' 155' ' ' THR . 9.7 p -137.07 140.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 110.484 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.54 HG23 ' HB3' ' A' ' 171' ' ' GLU . 21.7 m -110.98 134.52 52.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.968 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.681 HD11 HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -130.79 159.83 36.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.392 -0.817 . . . . 0.0 110.162 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -128.74 100.04 22.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 110.438 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 124.007 1.53 . . . . 0.0 110.039 179.67 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 8.2 tt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.067 0.46 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.479 ' HG2' HG12 ' A' ' 172' ' ' ILE . 97.2 mt-10 -60.03 -44.81 94.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.62 -37.25 86.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 109.594 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -60.0 -39.99 87.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.812 . . . . 0.0 109.599 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.681 HG11 HD11 ' A' ' 100' ' ' LEU . 79.3 t -59.99 -46.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.992 . . . . 0.0 109.371 175.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.681 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -59.88 -39.82 86.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 175.435 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.05 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.81 65.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.353 -0.842 . . . . 0.0 110.577 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.611 HD12 ' CG1' ' A' ' 120' ' ' VAL . 86.0 mt -91.04 -9.46 45.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.834 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 164' ' ' ILE . 3.3 tt -42.39 167.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.591 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 164' ' ' ILE . 26.1 ptt180 33.26 46.2 0.1 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.692 -0.63 . . . . 0.0 111.429 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.502 ' CG ' ' HD2' ' A' ' 128' ' ' PRO . 18.8 ttm180 -132.07 142.5 45.33 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.653 -1.28 . . . . 0.0 111.225 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.855 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.7 Cg_endo -64.6 126.34 16.62 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 124.258 1.662 . . . . 0.0 109.427 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.569 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.4 mmm -124.6 145.58 49.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.395 -1.441 . . . . 0.0 111.076 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.668 HD21 ' C ' ' A' ' 49' ' ' LYS . 12.8 tp -142.55 116.67 9.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.5 pm0 -47.9 148.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.911 -1.118 . . . . 0.0 110.517 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.622 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 74.98 -2.41 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.788 -0.57 . . . . 0.0 110.871 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.624 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.2 p30 -69.34 -171.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.454 ' C ' HG13 ' A' ' 135' ' ' ILE . 15.1 m-80 -149.44 132.15 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.538 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.705 HD11 ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 110.486 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.692 ' O ' HD12 ' A' ' 135' ' ' ILE . 77.9 m-85 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.326 0.584 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 15.3 tptm -97.77 106.35 18.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 109.725 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.705 ' CG2' HD11 ' A' ' 135' ' ' ILE . 2.8 t -76.64 134.47 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.995 . . . . 0.0 109.716 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.466 HG11 HH22 ' A' ' 173' ' ' ARG . 2.8 t -129.47 -20.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 110.457 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.5 tttm -139.58 140.42 37.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.68 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.707 HG22 HG23 ' A' ' 98' ' ' VAL . 47.0 p -139.75 161.53 37.33 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.7 -0.625 . . . . 0.0 109.602 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.55 -34.41 0.42 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 110.992 -177.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.927 ' CG ' HG11 ' A' ' 162' ' ' VAL . 29.4 Cg_exo -55.82 -168.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.343 1.181 . . . . 0.0 110.197 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 160' ' ' VAL . 16.1 t -90.15 40.18 1.0 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.651 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 158' ' ' SER . 26.4 mmtp 59.97 42.31 16.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.804 ' O ' HG13 ' A' ' 162' ' ' VAL . 33.2 m -136.07 160.06 68.64 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.517 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -49.53 120.11 5.42 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 124.09 1.574 . . . . 0.0 110.155 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.927 HG11 ' CG ' ' A' ' 157' ' ' PRO . 11.7 m -128.19 159.52 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.479 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -103.93 124.48 49.07 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 125' ' ' ILE . 16.1 mm -72.06 153.67 7.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.817 -0.552 . . . . 0.0 110.301 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.53 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -140.8 166.67 25.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.69 ' HB3' HD11 ' A' ' 125' ' ' ILE . 19.1 pt-20 -58.14 -18.24 24.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.04 . . . . 0.0 110.29 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -89.21 -13.72 37.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.92 . . . . 0.0 110.375 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 95' ' ' ALA . 7.2 m -62.52 150.82 39.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.014 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -98.6 153.62 18.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.27 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.681 HD11 ' HG2' ' A' ' 121' ' ' GLN . 3.6 mm -119.88 134.81 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 110.927 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.669 ' O ' HD13 ' A' ' 172' ' ' ILE . 37.0 mt-10 -119.7 132.55 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.564 172.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.669 HD13 ' O ' ' A' ' 171' ' ' GLU . 21.4 mm -127.33 122.78 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.457 -0.777 . . . . 0.0 109.748 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.49 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 13.3 ptp180 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.057 -1.027 . . . . 0.0 110.506 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.549 ' O ' HD13 ' A' ' 34' ' ' LEU . 16.7 m120 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.252 0.549 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -145.81 -166.49 11.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.975 ' CG2' HD12 ' A' ' 33' ' ' LEU . 20.5 pt -132.52 160.02 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.24 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.4 mt -100.12 117.81 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.711 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.7 pt? -136.87 -168.3 2.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.625 176.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 29.0 ptt180 -115.65 138.61 50.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.826 -1.172 . . . . 0.0 110.894 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.034 ' CG2' HD11 ' A' ' 69' ' ' ILE . 14.6 p -62.64 137.51 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.766 -0.584 . . . . 0.0 110.713 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -112.03 147.24 36.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 110.415 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.878 ' CB ' HD11 ' A' ' 81' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.145 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.05 0.452 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.043 HG13 HG23 ' A' ' 67' ' ' VAL . 75.2 t -117.15 113.56 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.02 . . . . 0.0 110.086 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.758 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.2 ptt180 -92.26 120.11 32.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.704 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -135.38 165.75 24.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.071 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 23.1 p-10 -90.02 -176.48 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.115 -0.991 . . . . 0.0 110.584 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.1 -45.15 93.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.282 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 43.5 t -60.24 -49.25 78.36 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.165 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.161 ' O ' HD22 ' A' ' 33' ' ' LEU . 74.7 m -56.68 -29.44 62.37 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.128 -0.983 . . . . 0.0 109.607 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 68.1 ttt-85 -82.5 -45.35 14.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.0 110.763 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -87.61 -0.26 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.161 HD22 ' O ' ' A' ' 30' ' ' SER . 1.5 pt? -52.56 -26.36 13.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.854 ' H ' HD23 ' A' ' 33' ' ' LEU . 71.4 mt -142.27 -59.07 0.46 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.53 -0.731 . . . . 0.0 110.329 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.8 t0 -170.72 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 110.022 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.558 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -21.9 118.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.497 0.665 . . . . 0.0 111.373 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.493 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -107.78 176.75 5.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.126 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.8 mm -59.12 125.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.822 -1.174 . . . . 0.0 109.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.47 27.49 61.3 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.566 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -89.49 173.29 8.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.428 . . . . 0.0 109.72 171.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.963 HG21 HG23 ' A' ' 92' ' ' THR . 64.7 t -99.48 131.45 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.017 -1.052 . . . . 0.0 110.269 -176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.606 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -117.06 139.83 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.176 -0.953 . . . . 0.0 110.301 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -108.32 140.12 42.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.395 -0.816 . . . . 0.0 109.565 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.807 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -122.78 145.45 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.903 -1.123 . . . . 0.0 110.592 -176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -150.13 95.19 2.25 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.834 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.027 ' CG ' HG12 ' A' ' 85' ' ' VAL . 12.6 tmtt? -97.92 -65.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.766 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.567 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.91 -36.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.457 -0.777 . . . . 0.0 109.225 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 68.2 mtp85 -127.99 -160.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.664 0.745 . . . . 0.0 110.111 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.491 ' HB3' HD21 ' A' ' 130' ' ' LEU . 3.1 mtmt -106.13 131.38 53.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 110.369 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.61 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.7 p -138.51 165.0 27.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.855 . . . . 0.0 110.112 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.39 166.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.603 -0.686 . . . . 0.0 109.913 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.0 -174.28 44.17 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -122.07 164.96 16.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -1.083 . . . . 0.0 110.02 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -92.54 139.99 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 110.747 -172.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 24' ' ' VAL . 2.2 m-85 -125.81 162.5 24.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.52 -0.738 . . . . 0.0 110.125 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 8.7 ptp180 -89.91 124.6 34.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.34 -0.85 . . . . 0.0 109.905 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.57 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -64.5 136.4 57.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.809 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.579 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -57.85 -50.06 90.24 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 109.071 175.054 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 38.0 Cg_endo -92.98 98.01 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.867 1.456 . . . . 0.0 108.868 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.59 38.22 0.12 Allowed 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -143.75 -38.94 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.613 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 13.8 pt-20 -85.56 -22.39 28.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.007 . . . . 0.0 109.727 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.512 ' HA ' HG12 ' A' ' 66' ' ' ILE . 8.0 m120 -81.68 37.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 110.715 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CA ' ' OD2' ' A' ' 27' ' ' ASP . 54.4 pttt -98.43 12.25 35.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.997 -1.065 . . . . 0.0 109.547 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.82 26.53 0.05 OUTLIER Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -140.53 144.9 26.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.3 -1.117 . . . . 0.0 109.177 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.043 HG23 HG13 ' A' ' 24' ' ' VAL . 6.5 p -125.83 129.91 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.029 -1.045 . . . . 0.0 110.265 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.539 ' HD3' ' HD3' ' A' ' 25' ' ' ARG . 58.8 ttt85 -89.7 119.93 30.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.034 HD11 ' CG2' ' A' ' 11' ' ' VAL . 3.8 pt -130.6 167.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.818 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -80.06 166.51 21.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.065 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.4 t -60.21 -39.98 88.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -43.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.038 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.807 ' CE ' HD13 ' A' ' 44' ' ' ILE . 13.3 tpt -60.06 -46.91 87.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.1 ttp85 -60.0 -39.99 87.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -70.06 -27.11 64.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.5 m-20 -60.01 -40.01 87.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.02 . . . . 0.0 110.767 -177.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.518 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.5 p -99.53 -39.04 8.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.101 . . . . 0.0 110.723 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.567 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 116.13 40.73 0.8 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -112.61 160.73 17.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.025 -1.279 . . . . 0.0 110.659 -176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.695 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.9 168.88 9.14 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 176.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.878 HD11 ' CB ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -53.04 139.01 11.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.034 -1.041 . . . . 0.0 110.609 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.65 2.58 70.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 171.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.62 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.885 -1.362 . . . . 0.0 110.228 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 22.8 pttt -131.94 109.83 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.027 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -119.97 150.24 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.955 . . . . 0.0 109.864 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 67.6 tttt -99.94 120.07 39.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.752 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.687 HG23 HD21 ' A' ' 9' ' ' LEU . 62.6 t -103.2 122.4 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.483 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.2 mtt180 -108.65 140.05 42.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.544 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.507 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -88.21 138.2 31.65 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.069 -1.02 . . . . 0.0 110.32 -178.224 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.506 HG23 HG12 ' A' ' 41' ' ' VAL . 2.4 m -150.17 -170.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.652 -0.655 . . . . 0.0 110.085 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.441 ' CA ' ' HB ' ' A' ' 41' ' ' VAL . 61.4 mtt180 -126.46 179.99 5.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.057 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.963 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.76 162.73 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 111.209 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.546 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.1 pt-20 -150.03 169.13 21.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.23 97.87 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.33 -1.482 . . . . 0.0 110.3 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.22 138.82 49.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -0.837 . . . . 0.0 110.387 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.513 ' HD2' ' CD1' ' A' ' 156' ' ' LEU . 18.6 ptpt -97.22 -27.17 14.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 111.153 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.739 ' HB3' HD23 ' A' ' 156' ' ' LEU . 31.5 tttt -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.82 -1.175 . . . . 0.0 110.558 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.95 HG23 HG22 ' A' ' 155' ' ' THR . 5.7 p -136.13 142.53 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.434 ' HA ' ' HB2' ' A' ' 171' ' ' GLU . 97.7 m -115.81 136.37 53.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.283 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.586 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -131.42 160.07 36.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.478 -0.763 . . . . 0.0 110.155 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -146.23 101.74 4.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.922 . . . . 0.0 110.883 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 15.4 Cg_exo . . . . . 0 C--N 1.305 -1.732 0 O-C-N 124.072 1.564 . . . . 0.0 110.299 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 120' ' ' VAL . 9.3 tp . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.177 0.513 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.507 ' HG2' HG12 ' A' ' 172' ' ' ILE . 98.9 mt-10 -60.01 -44.76 94.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.747 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -70.03 -40.0 75.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.839 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -59.87 -40.11 87.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.845 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.71 ' CG1' HD12 ' A' ' 170' ' ' ILE . 49.0 t -60.05 -45.69 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.38 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.692 ' HG3' HD11 ' A' ' 170' ' ' ILE . 6.7 mt-30 -59.92 -47.7 84.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.609 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.51 -0.744 . . . . 0.0 110.41 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.953 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.35 -39.92 77.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.757 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.953 HD22 ' C ' ' A' ' 123' ' ' ALA . 3.0 mm? -130.07 24.2 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 111.123 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.9 tt -48.31 176.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.094 . . . . 0.0 110.003 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.564 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 34.5 ptt180 33.96 49.14 0.27 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.527 -0.733 . . . . 0.0 111.204 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 36.9 ttp180 -128.35 142.59 45.19 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.925 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.836 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.2 Cg_endo -62.17 131.73 35.83 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.961 1.506 . . . . 0.0 110.079 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.567 ' HG3' HD11 ' A' ' 164' ' ' ILE . 96.7 mmm -123.48 140.03 53.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 110.952 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.544 HD23 ' HA ' ' A' ' 50' ' ' THR . 19.7 tp -142.49 105.64 4.58 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.61 -0.681 . . . . 0.0 109.67 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.7 pt-20 -48.47 141.1 7.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.974 -1.079 . . . . 0.0 110.67 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.676 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 86.2 mm-40 79.93 -1.68 2.07 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.167 0.508 . . . . 0.0 110.498 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.607 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.9 p30 -69.98 -172.42 0.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.047 -1.033 . . . . 0.0 110.31 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -144.11 137.72 27.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.737 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.084 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 3.2 m-85 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.239 0.542 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -104.7 108.84 20.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.32 -0.862 . . . . 0.0 109.978 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.607 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.1 t -76.48 132.68 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.683 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 t -114.61 -30.1 2.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 111.108 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -144.75 150.2 36.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.782 -1.199 . . . . 0.0 111.272 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.95 HG22 HG23 ' A' ' 98' ' ' VAL . 72.3 p -140.33 161.32 37.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 109.427 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.64 -38.69 0.45 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.843 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.989 ' CB ' HG11 ' A' ' 162' ' ' VAL . 18.0 Cg_exo -58.39 -166.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.575 1.303 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.56 ' HB3' HG22 ' A' ' 160' ' ' VAL . 20.8 t -90.05 -171.09 3.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -65.33 -5.88 8.49 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.201 -0.937 . . . . 0.0 110.64 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 158' ' ' SER . 33.1 m -85.2 145.36 42.74 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.405 -0.81 . . . . 0.0 110.287 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.547 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -48.5 141.37 19.79 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.285 1.676 . . . . 0.0 110.796 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.989 HG11 ' CB ' ' A' ' 157' ' ' PRO . 11.2 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.493 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.4 tt0 -107.62 130.67 54.88 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.13 -0.982 . . . . 0.0 110.241 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.83 ' CD1' HG21 ' A' ' 168' ' ' THR . 19.0 mm -69.75 152.51 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 110.029 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.65 169.9 26.4 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.44 ' CA ' HD11 ' A' ' 125' ' ' ILE . 15.7 pt-20 -56.5 -17.97 10.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -1.117 . . . . 0.0 109.923 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.13 -25.76 18.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.83 HG21 ' CD1' ' A' ' 164' ' ' ILE . 91.3 m -56.57 142.3 39.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.791 . . . . 0.0 110.089 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 43.6 mmtm -91.96 154.86 18.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.856 -1.153 . . . . 0.0 110.186 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.83 HG22 HD11 ' A' ' 172' ' ' ILE . 1.4 mm -119.92 130.04 74.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.365 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.648 ' O ' HD13 ' A' ' 172' ' ' ILE . 21.9 mt-10 -112.68 136.09 52.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 110.23 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.83 HD11 HG22 ' A' ' 170' ' ' ILE . 7.5 mm -124.59 134.86 65.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.608 -0.682 . . . . 0.0 109.57 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.344 -174.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 27.7 m120 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.316 0.579 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.36 -159.94 8.89 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.012 ' CG2' HD12 ' A' ' 33' ' ' LEU . 15.4 pt -138.97 163.96 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -1.188 . . . . 0.0 109.805 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.618 ' C ' HD23 ' A' ' 9' ' ' LEU . 48.1 mm -101.0 120.49 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.299 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.867 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -140.87 -176.54 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.713 177.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HG2' HG22 ' A' ' 66' ' ' ILE . 28.3 ptt180 -117.01 144.11 44.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.838 -1.164 . . . . 0.0 110.524 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.905 HG11 ' O ' ' A' ' 80' ' ' SER . 3.3 p -61.37 140.64 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.621 -0.674 . . . . 0.0 110.899 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.487 ' HB1' ' CD ' ' A' ' 68' ' ' ARG . . . -118.88 144.23 46.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 110.583 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.974 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.265 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.544 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 76.5 mtt85 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.139 HG12 HD23 ' A' ' 26' ' ' LEU . 84.8 t -119.73 116.17 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.979 -1.076 . . . . 0.0 110.269 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.859 ' O ' HD22 ' A' ' 26' ' ' LEU . 3.8 ptt180 -88.17 119.46 28.58 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.68 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.139 HD23 HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -137.95 177.42 7.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.751 -0.593 . . . . 0.0 109.684 -175.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 22.2 p-10 -103.07 179.73 4.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 60.8 mt-10 -59.97 -44.87 94.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.406 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 68.0 m -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.03 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.171 ' O ' HD22 ' A' ' 33' ' ' LEU . 28.6 t -65.3 -28.22 69.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 27.8 ttm180 -80.86 -46.72 14.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.556 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.98 -9.62 59.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.171 HD22 ' O ' ' A' ' 30' ' ' SER . 1.3 pt? -47.22 -24.25 0.68 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.693 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 33' ' ' LEU . 66.5 mt -141.27 -62.78 0.47 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.548 -0.72 . . . . 0.0 110.266 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.3 t0 -172.89 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.534 -0.729 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -31.38 141.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.463 0.649 . . . . 0.0 111.509 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -131.23 171.2 13.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 56' ' ' ARG . 38.4 mm -63.47 79.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.674 -1.266 . . . . 0.0 110.208 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 37' ' ' GLU . . . 169.32 -4.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.552 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.438 ' CG ' ' NZ ' ' A' ' 89' ' ' LYS . 95.9 m-20 -111.94 168.75 9.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.384 -1.657 . . . . 0.0 110.874 -170.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.488 HG21 ' OG1' ' A' ' 92' ' ' THR . 72.1 t -103.65 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.107 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.4 m -110.84 145.88 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.17 -0.956 . . . . 0.0 110.592 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 86.5 tt0 -109.38 140.78 42.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.82 . . . . 0.0 109.827 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.913 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -121.21 143.16 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.991 -1.068 . . . . 0.0 110.622 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -149.42 97.71 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.845 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.908 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.5 tmtm? -97.98 -62.52 1.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.525 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -109.3 -36.33 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.644 0.735 . . . . 0.0 109.237 175.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 78.9 mtt85 -125.7 -172.91 2.71 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.726 -0.609 . . . . 0.0 109.59 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.3 OUTLIER -100.13 133.2 44.87 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.108 178.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.591 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.4 p -140.45 167.48 22.05 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.445 0.641 . . . . 0.0 109.679 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.66 HG13 ' HG ' ' A' ' 130' ' ' LEU . 3.6 m -116.46 175.75 2.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.744 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.485 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.84 -179.17 48.54 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -121.02 167.81 12.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 0.0 110.075 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.93 135.02 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.152 -0.967 . . . . 0.0 110.73 -174.128 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.544 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 3.6 m-85 -130.6 166.61 20.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.756 . . . . 0.0 110.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.445 ' HG2' ' NH2' ' A' ' 31' ' ' ARG . 21.5 mtt180 -89.43 124.04 34.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -65.13 137.88 57.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.712 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.697 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 8.6 mmm180 -57.44 -45.89 99.84 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 109.027 174.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.697 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.0 Cg_endo -92.01 98.54 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.748 1.393 . . . . 0.0 108.853 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -75.26 35.84 0.12 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -146.59 -37.28 0.23 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 110.873 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.481 ' HG3' HD11 ' A' ' 66' ' ' ILE . 16.3 pt-20 -84.8 -20.58 30.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.505 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 2.9 m-80 -81.63 36.58 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 110.719 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 58.4 pttt -98.31 17.5 18.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.952 -1.093 . . . . 0.0 109.388 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 176.84 21.38 0.03 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.505 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.11 152.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.196 -1.179 . . . . 0.0 109.191 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.948 HG23 HG13 ' A' ' 24' ' ' VAL . 7.9 p -130.02 129.98 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.98 -1.075 . . . . 0.0 110.131 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.564 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 22.5 mmm180 -91.33 111.74 23.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.641 HD11 ' NH1' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -136.06 171.78 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.383 -0.823 . . . . 0.0 110.553 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -81.24 166.9 20.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 0.0 110.263 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 79.5 p -69.94 -19.28 63.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.339 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.55 -47.29 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.112 -0.993 . . . . 0.0 110.483 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.913 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -61.33 -47.48 85.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 109.289 177.014 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.69 ' HG3' HG21 ' A' ' 11' ' ' VAL . 5.9 mmp_? -60.04 -39.94 87.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 110.245 173.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' SER . 47.8 t-20 -64.09 -31.82 73.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.959 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.584 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 96.7 m-20 -60.01 -36.29 76.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.394 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.2 p -98.38 -38.79 9.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.059 -1.025 . . . . 0.0 110.581 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.525 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 119.79 40.05 0.63 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.888 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -120.85 166.17 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.062 -1.258 . . . . 0.0 110.611 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.905 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -118.7 176.17 5.39 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.974 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -55.84 142.58 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.074 -1.017 . . . . 0.0 110.418 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.76 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 75.96 0.76 65.8 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 172.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.3 m-20 -59.82 -167.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.849 -1.383 . . . . 0.0 110.124 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.5 pttp -132.53 115.28 15.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.701 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.908 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -125.43 153.47 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 109.574 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 60.7 tttt -99.94 121.48 41.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.095 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 9' ' ' LEU . 65.6 t -98.99 119.99 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.956 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 87.2 mtm180 -116.2 142.53 46.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 109.807 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.438 ' NZ ' ' CG ' ' A' ' 40' ' ' ASP . 50.6 tttp -75.99 146.59 39.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.002 -1.061 . . . . 0.0 110.543 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.439 HG23 HG12 ' A' ' 41' ' ' VAL . 1.9 m -149.98 -168.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.967 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -138.76 170.0 16.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.488 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.72 156.71 21.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 111.3 -175.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.859 ' OE2' HG12 ' A' ' 162' ' ' VAL . 1.2 pm0 -150.31 169.71 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 94' ' ' ILE . 4.5 mp -89.13 98.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.595 -1.316 . . . . 0.0 110.402 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.89 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.51 163.45 1.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.422 -0.798 . . . . 0.0 110.819 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 1.033 ' HG3' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -136.16 -17.86 1.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.456 -0.778 . . . . 0.0 110.913 -178.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 1.005 ' CB ' HD12 ' A' ' 156' ' ' LEU . 32.9 tttt -149.59 119.92 7.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.887 -1.133 . . . . 0.0 110.336 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.044 HG23 HG22 ' A' ' 155' ' ' THR . 5.5 p -137.2 140.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 110.718 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.4 m -109.29 135.08 50.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.624 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -130.11 160.97 32.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 110.418 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.15 87.42 39.23 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.58 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--N 1.307 -1.649 0 O-C-N 123.979 1.515 . . . . 0.0 110.218 179.786 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.671 HG23 HD12 ' A' ' 172' ' ' ILE . 11.9 tt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.218 0.533 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 170' ' ' ILE . 98.9 mt-10 -59.99 -44.76 94.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.046 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -67.92 -39.97 83.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.833 . . . . 0.0 110.025 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -40.0 88.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.905 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.633 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -62.15 -44.9 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.369 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.648 ' HG3' HD11 ' A' ' 170' ' ' ILE . 6.3 mt-30 -59.94 -45.44 92.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.086 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.38 -41.43 93.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.487 -0.758 . . . . 0.0 109.862 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.599 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.57 -48.05 61.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 110.68 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 123' ' ' ALA . 4.4 mm? -105.14 12.97 31.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.1 -1.0 . . . . 0.0 111.513 -173.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.5 tt -49.34 169.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.615 -1.303 . . . . 0.0 110.391 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 29.0 ptt180 32.98 46.07 0.08 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.599 -0.688 . . . . 0.0 111.646 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.9 mmt85 -134.76 152.44 77.54 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 120.714 -1.241 . . . . 0.0 111.358 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.83 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.1 Cg_endo -62.04 123.25 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.225 1.645 . . . . 0.0 109.684 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.791 ' O ' HG22 ' A' ' 162' ' ' VAL . 15.4 mmt -137.37 137.9 39.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.554 -1.341 . . . . 0.0 110.433 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.779 ' H ' HD13 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.81 145.2 24.78 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.478 0.656 . . . . 0.0 110.441 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 22.0 pt-20 -55.11 152.93 7.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -0.81 . . . . 0.0 111.112 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 81.95 -12.66 0.93 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.463 0.649 . . . . 0.0 110.298 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.694 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -69.37 -174.27 0.65 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 110.388 177.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -147.19 160.04 42.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.203 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.209 0.528 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -115.29 113.55 24.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 110.007 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.694 HG21 ' OD2' ' A' ' 133' ' ' ASP . 13.2 t -77.98 135.65 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.164 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.734 HG12 ' HG3' ' A' ' 154' ' ' LYS . 9.9 t -111.99 -28.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.734 ' HG3' HG12 ' A' ' 153' ' ' VAL . 76.2 mttt -150.63 163.88 37.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.916 -1.115 . . . . 0.0 111.281 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.044 HG22 HG23 ' A' ' 98' ' ' VAL . 73.8 p -149.04 169.8 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.774 -0.579 . . . . 0.0 109.491 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 1.033 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.4 tt -88.49 -41.2 0.47 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.987 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 1.017 ' CB ' HG11 ' A' ' 162' ' ' VAL . 22.1 Cg_exo -56.44 -177.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.569 1.3 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.473 ' HB3' HG22 ' A' ' 160' ' ' VAL . 15.8 t -74.5 -172.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.565 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -69.98 -2.25 12.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.162 -0.961 . . . . 0.0 110.376 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.535 HG23 ' OE2' ' A' ' 93' ' ' GLU . 21.4 m -87.54 150.46 48.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 110.41 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.652 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.47 140.55 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.292 1.68 . . . . 0.0 110.985 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 1.017 HG11 ' CB ' ' A' ' 157' ' ' PRO . 5.5 m -130.02 160.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.603 171.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 21.9 pt-20 -102.52 124.63 48.43 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.948 -1.095 . . . . 0.0 110.082 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.841 ' CD1' HG21 ' A' ' 168' ' ' THR . 8.0 mm -71.15 154.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.666 -0.646 . . . . 0.0 110.272 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 163.66 26.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -53.23 -20.04 3.7 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.511 -0.993 . . . . 0.0 110.311 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.5 -23.12 22.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.715 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.841 HG21 ' CD1' ' A' ' 164' ' ' ILE . 90.2 m -54.94 145.91 19.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.963 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 85.9 mttt -95.6 149.43 21.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 110.366 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.648 HD11 ' HG3' ' A' ' 121' ' ' GLN . 1.3 mm -117.07 129.97 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 110.501 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.445 ' OE2' ' HE2' ' A' ' 97' ' ' LYS . 57.6 mt-10 -115.45 136.26 53.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 110.166 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.671 HD12 HG23 ' A' ' 116' ' ' ILE . 5.9 mt -135.27 133.61 52.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.104 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 110.315 -178.619 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.19 0.519 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' A' ' 34' ' ' LEU . . . -146.48 -165.1 11.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.01 HG21 HD11 ' A' ' 33' ' ' LEU . 23.0 pt -130.44 160.38 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -1.2 . . . . 0.0 110.17 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.5 mt -102.14 114.03 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.288 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.5 pt? -137.23 -174.32 3.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 109.786 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 30.7 ptt180 -111.55 139.59 46.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.727 -1.233 . . . . 0.0 111.025 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.786 ' CG2' HD11 ' A' ' 69' ' ' ILE . 13.5 p -62.7 135.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -116.53 145.74 43.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.773 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 tt0 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.359 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 99.0 mtt180 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.251 0.548 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.039 HG13 HG23 ' A' ' 67' ' ' VAL . 87.4 t -116.77 120.08 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.402 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.64 ' O ' HD12 ' A' ' 26' ' ' LEU . 3.7 ptt180 -86.39 118.49 25.86 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.512 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.025 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mp -131.4 173.08 11.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.847 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 11.6 p-10 -103.23 179.42 4.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.871 -1.143 . . . . 0.0 110.702 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 88.5 mt-10 -59.99 -41.05 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -0.871 . . . . 0.0 109.059 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.645 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -64.4 -59.67 4.08 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.123 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.81 ' O ' HD22 ' A' ' 33' ' ' LEU . 65.4 m -49.99 -31.22 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.835 -1.166 . . . . 0.0 109.08 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 40.0 ttm180 -72.29 -51.76 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.584 -0.698 . . . . 0.0 111.619 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -98.92 -3.49 35.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.742 -1.224 . . . . 0.0 111.178 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -64.96 -24.06 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.074 . . . . 0.0 109.828 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.987 ' N ' HD23 ' A' ' 33' ' ' LEU . 59.6 mt -120.62 -67.88 0.95 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.034 . . . . 0.0 110.469 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 36' ' ' ALA . 43.4 t0 -171.2 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.566 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.548 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.45 118.63 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.354 0.597 . . . . 0.0 110.72 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.8 pt-20 -106.59 -178.98 3.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 38' ' ' ILE . 24.2 mm -62.3 126.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.882 -1.136 . . . . 0.0 109.803 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.35 22.94 66.55 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 173.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' CG ' ' HG2' ' A' ' 37' ' ' GLU . 77.7 m-20 -89.5 169.98 10.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.814 -1.404 . . . . 0.0 109.603 171.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.523 HG21 ' OG1' ' A' ' 92' ' ' THR . 71.8 t -99.23 136.18 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.989 -1.07 . . . . 0.0 110.087 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.504 HG11 HG23 ' A' ' 54' ' ' VAL . 1.7 m -120.71 140.05 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.094 -1.004 . . . . 0.0 110.487 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 44' ' ' ILE . 85.4 tt0 -106.82 141.25 38.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.691 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.831 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -124.21 143.03 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.995 -1.066 . . . . 0.0 110.582 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -149.89 97.24 2.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.895 ' HG3' HG12 ' A' ' 85' ' ' VAL . 5.5 tmtm? -97.88 -55.8 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.406 -0.809 . . . . 0.0 109.626 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.547 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.29 -34.6 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.795 0.807 . . . . 0.0 108.885 176.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.622 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -131.79 179.46 6.06 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.562 ' HB3' HD21 ' A' ' 130' ' ' LEU . 12.0 mtmt -89.44 132.67 34.9 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.668 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.9 p -138.07 166.7 23.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.576 -0.702 . . . . 0.0 109.809 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.89 167.66 14.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.915 179.392 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.05 -175.08 44.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 68.9 ttt180 -122.45 166.16 15.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.428 -1.042 . . . . 0.0 110.334 -176.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -98.34 144.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.885 . . . . 0.0 110.513 -175.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 2.5 m-85 -138.06 168.19 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.371 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -88.73 121.76 31.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.74 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.705 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -62.66 140.05 58.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.711 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.63 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.84 -50.0 90.61 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.841 175.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 33.6 Cg_endo -93.06 98.41 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.841 1.443 . . . . 0.0 108.886 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.26 36.13 0.1 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.426 -0.796 . . . . 0.0 110.825 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -145.59 -34.32 0.33 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.096 -1.002 . . . . 0.0 111.058 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.559 ' OE2' ' CG ' ' A' ' 59' ' ' PRO . 14.9 pt-20 -87.19 -19.12 28.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 109.601 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.705 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 21.7 m-80 -81.21 39.64 0.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 110.622 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 pttt -97.79 13.43 30.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 63' ' ' ASN . 45.6 pt -140.92 144.67 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.213 -1.169 . . . . 0.0 109.583 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.039 HG23 HG13 ' A' ' 24' ' ' VAL . 3.1 p -121.88 129.83 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.046 -1.034 . . . . 0.0 109.859 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.408 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -93.0 114.02 26.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 -178.57 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.786 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.9 pp -134.66 167.82 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -79.53 168.01 20.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 110.132 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 m -59.98 -39.73 86.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.279 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.1 t -61.25 -41.58 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.151 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.765 ' HE1' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -61.55 -48.22 81.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.256 -0.902 . . . . 0.0 109.699 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 80' ' ' SER . 37.7 ttp180 -60.13 -40.13 88.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.027 -1.045 . . . . 0.0 109.457 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.547 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 92.6 m-20 -64.06 -33.06 74.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 73' ' ' MET . 64.4 m-20 -57.38 -34.93 69.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.65 ' HB3' HG21 ' A' ' 50' ' ' THR . 30.5 p -99.38 -40.02 8.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.991 -1.068 . . . . 0.0 110.667 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.547 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.17 41.03 1.0 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.759 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -114.4 172.4 7.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.106 -1.232 . . . . 0.0 110.508 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.719 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.58 170.28 8.54 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 109.417 177.647 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.773 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -55.57 139.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.605 178.167 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.436 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.08 3.83 82.18 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -59.86 -161.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.032 -1.275 . . . . 0.0 110.575 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 23.2 pttt -134.3 110.91 9.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.487 -0.758 . . . . 0.0 110.096 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.895 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.2 m -120.01 153.99 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 109.886 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 54.2 tttt -101.07 118.62 37.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.634 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.512 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 74.8 t -102.11 120.91 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.932 . . . . 0.0 109.897 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HG2' ' N ' ' A' ' 6' ' ' GLY . 76.4 mtm180 -110.39 140.88 44.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 6.1 tttt -82.48 140.25 33.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 110.662 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.446 HG21 ' CD ' ' A' ' 161' ' ' PRO . 2.4 m -148.86 -165.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.492 0.663 . . . . 0.0 109.731 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.484 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.0 mtt85 -135.66 173.39 11.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.469 -0.77 . . . . 0.0 110.42 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.523 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -103.1 161.46 13.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 111.147 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.624 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.8 pt-20 -149.93 170.03 19.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 94' ' ' ILE . 5.1 mp -89.46 97.14 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.569 -1.332 . . . . 0.0 110.351 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.776 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.11 140.06 39.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -0.778 . . . . 0.0 110.219 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HD2' HD22 ' A' ' 156' ' ' LEU . 3.4 ptpt -106.09 -25.75 11.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 111.558 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.649 ' HB3' HD12 ' A' ' 156' ' ' LEU . 72.2 tttt -150.3 131.92 14.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.441 -1.412 . . . . 0.0 110.709 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.013 HG23 HG22 ' A' ' 155' ' ' THR . 8.0 p -144.33 148.0 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.894 . . . . 0.0 110.652 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.624 HG23 ' HB3' ' A' ' 171' ' ' GLU . 59.5 m -120.68 136.8 54.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.43 -0.793 . . . . 0.0 110.195 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.652 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.56 161.66 29.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.09 89.58 12.47 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.456 -0.778 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo . . . . . 0 C--N 1.304 -1.766 0 O-C-N 123.988 1.52 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 117' ' ' GLU . 20.9 tt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.062 0.458 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 116' ' ' ILE . 41.7 mt-10 -68.96 -41.3 78.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.963 -1.086 . . . . 0.0 110.313 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.97 -32.81 71.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.417 ' O ' ' HB3' ' A' ' 122' ' ' ARG . 18.7 t80 -59.86 -39.51 85.45 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.521 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.634 HG12 HD12 ' A' ' 124' ' ' LEU . 78.8 t -60.0 -46.63 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.206 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.687 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -60.0 -39.74 86.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 174.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 27.4 tpt180 -60.0 -43.87 94.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.333 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 -40.55 46.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.634 HD12 HG12 ' A' ' 120' ' ' VAL . 79.1 mt -92.91 -7.58 45.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.071 -1.018 . . . . 0.0 110.58 -173.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.717 ' HA ' HG22 ' A' ' 164' ' ' ILE . 1.9 tt -42.71 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 164' ' ' ILE . 33.4 ptt180 30.4 52.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.659 -0.65 . . . . 0.0 111.262 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 30.9 ttm180 -132.71 142.96 46.7 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.047 -1.033 . . . . 0.0 110.895 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.8 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -65.59 123.94 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 124.007 1.53 . . . . 0.0 109.498 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.542 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 89.2 mmm -120.21 140.62 50.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.377 -1.452 . . . . 0.0 111.126 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 50' ' ' THR . 17.0 tp -141.15 107.29 5.21 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.713 -0.617 . . . . 0.0 109.649 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.601 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -45.0 140.78 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 110.905 -175.333 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.601 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 82.11 -2.95 1.49 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.409 0.624 . . . . 0.0 110.271 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 3.8 p-10 -68.63 -172.99 0.4 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.512 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 21.4 m-80 -144.83 144.21 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.492 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.828 -1.17 . . . . 0.0 110.837 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 40.0 m-85 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.185 0.516 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -103.29 103.86 13.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.537 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 2.7 t -75.34 139.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.8 t -130.62 -24.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.022 -1.049 . . . . 0.0 111.443 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 5.8 tttp -139.36 125.31 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 110.926 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.013 HG22 HG23 ' A' ' 98' ' ' VAL . 69.2 p -128.09 163.95 23.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.456 -0.777 . . . . 0.0 109.433 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.68 HD22 ' HD2' ' A' ' 96' ' ' LYS . 1.1 tt -89.57 -38.2 0.42 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 110.97 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.96 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.4 Cg_exo -60.57 -176.06 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.485 1.255 . . . . 0.0 110.237 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.43 -162.7 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -69.59 -4.51 19.52 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.303 -0.873 . . . . 0.0 110.564 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.9 m -86.37 140.5 34.18 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.059 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.574 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.7 Cg_endo -47.61 141.65 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.14 1.6 . . . . 0.0 110.48 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.96 HG11 ' CB ' ' A' ' 157' ' ' PRO . 5.6 m -128.3 158.18 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.785 173.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -105.9 124.15 49.12 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.885 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.821 HD12 HG21 ' A' ' 168' ' ' THR . 13.8 mm -70.14 152.37 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.743 -0.598 . . . . 0.0 109.53 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.602 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.06 166.89 26.2 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.538 ' HB3' HD11 ' A' ' 125' ' ' ILE . 18.6 pt-20 -58.0 -14.11 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.957 . . . . 0.0 110.287 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -90.13 -18.07 26.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.821 HG21 HD12 ' A' ' 164' ' ' ILE . 28.0 m -62.24 153.87 29.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 110.049 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 96' ' ' LYS . 44.8 mttt -103.6 155.6 18.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 0.0 110.014 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.687 HD11 ' HG2' ' A' ' 121' ' ' GLN . 6.5 mm -119.14 137.86 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 110.975 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.624 ' HB3' HG23 ' A' ' 99' ' ' THR . 12.8 mt-10 -119.94 127.14 52.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 110.514 172.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.496 ' CD1' HD11 ' A' ' 100' ' ' LEU . 39.5 mm -123.34 123.83 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.175 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.622 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 4.3 ptp180 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 110.559 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.424 ' OD1' HD21 ' A' ' 34' ' ' LEU . 15.1 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.217 0.532 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -153.54 -167.81 16.4 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.884 ' CG2' HD12 ' A' ' 33' ' ' LEU . 22.8 pt -135.03 160.01 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -1.078 . . . . 0.0 109.651 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.5 mt -100.62 115.85 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.2 pt? -135.54 -170.86 2.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 109.562 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.58 ' NE ' HG22 ' A' ' 66' ' ' ILE . 49.8 ptt85 -114.79 139.99 49.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.739 -1.225 . . . . 0.0 110.855 -174.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.689 HG13 ' HA ' ' A' ' 81' ' ' ILE . 7.9 p -62.16 140.55 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.63 -0.669 . . . . 0.0 110.552 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -118.68 143.66 46.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 110.624 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.982 ' HB3' HD11 ' A' ' 81' ' ' ILE . 49.0 tp10 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.795 . . . . 0.0 110.091 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 62.6 mmt-85 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.985 HG13 HG23 ' A' ' 67' ' ' VAL . 90.4 t -101.73 115.44 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.007 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.459 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 6.2 ptt180 -93.53 120.01 33.29 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.985 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.891 HD22 ' CB ' ' A' ' 30' ' ' SER . 2.1 mt -138.68 173.18 11.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.568 -0.708 . . . . 0.0 110.105 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.2 p-10 -95.06 -177.18 4.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -175.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.99 -49.27 78.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.506 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 23.2 t -60.36 -41.31 93.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.159 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.117 ' O ' HD22 ' A' ' 33' ' ' LEU . 48.5 m -60.38 -31.11 70.04 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 175.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 66.8 ttt180 -83.43 -46.04 12.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 111.191 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -81.93 -6.04 58.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.903 -1.123 . . . . 0.0 110.235 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.117 HD22 ' O ' ' A' ' 30' ' ' SER . 1.7 pt? -44.33 -27.69 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.44 -0.787 . . . . 0.0 109.727 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.842 ' H ' HD23 ' A' ' 33' ' ' LEU . 78.8 mt -143.67 -63.77 0.39 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 176.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -173.38 13.4 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.281 -0.887 . . . . 0.0 110.739 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.536 ' CB ' ' HE2' ' A' ' 89' ' ' LYS . . . -47.59 119.75 2.92 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.986 -1.071 . . . . 0.0 110.01 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.537 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.18 174.44 5.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.248 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.759 HD11 ' HD3' ' A' ' 56' ' ' ARG . 11.3 mm -62.47 122.22 12.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.885 -1.134 . . . . 0.0 109.672 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.516 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 77.46 32.06 48.53 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -88.75 170.78 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.926 -1.338 . . . . 0.0 109.308 170.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 92' ' ' THR . 69.9 t -99.14 129.61 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.02 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.744 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.7 m -115.33 136.37 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.057 -1.027 . . . . 0.0 110.471 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' C ' HD12 ' A' ' 44' ' ' ILE . 86.3 tt0 -109.52 143.93 38.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 109.781 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.85 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.5 mp -120.81 145.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.001 -1.062 . . . . 0.0 110.266 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.2 tt0 -152.4 87.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.906 -1.121 . . . . 0.0 111.321 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HB2' HG12 ' A' ' 85' ' ' VAL . 33.8 tttp -98.99 -80.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 172.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.585 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -84.55 -36.18 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.778 . . . . 0.0 109.55 175.144 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.578 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 92.0 mtt-85 -139.54 -176.01 4.4 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.56 -0.713 . . . . 0.0 109.532 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.89 ' HG2' HD21 ' A' ' 130' ' ' LEU . 1.2 ttpm? -89.96 139.06 30.97 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -141.64 165.47 27.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.255 -174.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -128.44 163.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.365 -0.835 . . . . 0.0 110.283 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -175.9 179.99 46.71 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 173.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 57.2 ttt85 -118.87 171.16 8.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -1.122 . . . . 0.0 110.07 -177.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.552 ' CG2' ' HE3' ' A' ' 89' ' ' LYS . 0.3 OUTLIER -101.3 132.44 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.829 -1.169 . . . . 0.0 111.416 -171.323 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.587 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -130.27 162.85 28.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.752 . . . . 0.0 110.392 171.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.759 ' HD3' HD11 ' A' ' 38' ' ' ILE . 87.8 mtm180 -91.43 128.6 37.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.548 -0.72 . . . . 0.0 110.305 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -65.06 140.77 58.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 110.047 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.574 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.12 -50.26 88.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.09 175.054 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 52.7 Cg_endo -92.21 97.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.892 1.469 . . . . 0.0 108.988 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.94 41.21 0.16 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.6 -0.687 . . . . 0.0 110.377 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 27.3 m-20 -143.45 -38.58 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.294 -0.879 . . . . 0.0 110.807 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.11 -22.84 28.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.942 -1.099 . . . . 0.0 109.839 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.491 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 10.6 m-80 -81.71 38.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 110.758 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 61' ' ' ASP . 11.6 ptpt -98.46 13.05 33.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.72 25.48 0.05 OUTLIER Glycine 0 N--CA 1.481 1.647 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.58 HG22 ' NE ' ' A' ' 10' ' ' ARG . 45.8 pt -140.81 140.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.985 HG23 HG13 ' A' ' 24' ' ' VAL . 3.3 p -119.95 127.6 75.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.456 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 25.2 ttt85 -89.59 113.69 25.16 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.757 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.736 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.7 pp -129.11 170.54 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.422 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -79.19 164.47 24.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.991 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.4 m -59.91 -39.95 87.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 110.488 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.97 -44.43 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.786 ' HE1' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.8 -45.94 92.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.64 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -60.06 -40.04 88.1 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.58 -21.79 61.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.384 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.591 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 79.9 m-20 -59.89 -39.77 86.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 110.711 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 27.8 p -98.49 -31.04 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.039 -1.038 . . . . 0.0 110.392 -176.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.585 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.09 29.08 3.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.597 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.29 156.14 17.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.205 -1.174 . . . . 0.0 110.505 -175.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.665 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -111.78 166.01 11.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 175.77 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.982 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -54.32 139.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.418 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.18 68.72 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 1.1 m-20 -60.15 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.84 -1.388 . . . . 0.0 110.451 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 11.6 pttt -134.5 112.35 10.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 110.122 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.716 HG12 ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -118.76 148.98 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -0.893 . . . . 0.0 109.791 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 71.2 tttt -95.3 116.09 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.658 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.695 ' CG2' HD21 ' A' ' 9' ' ' LEU . 95.4 t -102.23 122.62 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.5 mtm180 -110.11 142.5 41.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.744 ' CD ' HG12 ' A' ' 42' ' ' VAL . 1.4 tptm -95.94 129.57 43.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 110.239 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.55 -163.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.668 0.746 . . . . 0.0 110.095 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 35.5 mtp180 -127.04 179.59 5.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 110.349 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.614 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.18 169.13 8.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 111.258 -176.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.633 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.7 pt-20 -149.49 169.54 20.68 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.608 HG21 ' OE2' ' A' ' 167' ' ' GLU . 48.7 mm -89.61 99.81 9.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.486 -1.384 . . . . 0.0 110.337 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.806 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.28 139.29 43.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.279 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.489 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 17.7 ptpt -101.8 -28.37 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 111.055 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.516 ' HB3' HD23 ' A' ' 156' ' ' LEU . 87.2 tttt -150.25 120.21 7.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.752 -1.217 . . . . 0.0 110.741 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.025 HG23 HG22 ' A' ' 155' ' ' THR . 8.7 p -131.75 140.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 110.764 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 98.6 m -113.09 143.8 43.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.393 -0.817 . . . . 0.0 110.098 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.646 HD21 HG23 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -143.14 170.15 16.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -177.55 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.637 ' HB2' ' NE ' ' A' ' 173' ' ' ARG . . . -142.38 97.78 6.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 110.896 -175.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 109.912 179.492 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 117' ' ' GLU . 7.3 tp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.118 0.485 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 172' ' ' ILE . 96.8 mt-10 -60.11 -42.84 95.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.082 -1.011 . . . . 0.0 109.432 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.54 -40.15 92.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.495 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.57 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 52.4 t80 -60.09 -40.92 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.193 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.689 ' O ' HD22 ' A' ' 124' ' ' LEU . 54.4 t -63.84 -45.18 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.957 -1.089 . . . . 0.0 109.743 177.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.584 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 1.7 mt-30 -60.67 -44.7 96.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.663 -0.648 . . . . 0.0 110.472 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.577 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 1.9 ptm85 -69.6 -36.43 76.21 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.064 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.577 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -72.52 -42.95 64.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.681 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -102.27 1.09 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 110.998 -174.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.9 tt -43.19 171.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.042 . . . . 0.0 110.74 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HG2' ' CG2' ' A' ' 125' ' ' ILE . 51.4 ptt85 32.57 53.8 0.34 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.634 -0.666 . . . . 0.0 111.504 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -139.71 151.28 65.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.917 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.867 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 21.1 Cg_endo -67.1 132.2 27.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.137 1.599 . . . . 0.0 109.81 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.596 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.7 mmm -128.43 146.71 50.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.34 -1.475 . . . . 0.0 111.195 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.89 HD21 ' HG2' ' A' ' 49' ' ' LYS . 12.7 tp -149.45 112.44 4.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.612 -0.68 . . . . 0.0 109.587 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 5.6 pt-20 -49.23 144.36 5.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.93 -1.106 . . . . 0.0 111.022 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 83.8 -8.45 1.04 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.429 0.633 . . . . 0.0 110.316 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.523 ' OD2' ' HB ' ' A' ' 152' ' ' VAL . 1.1 p30 -69.97 -170.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 110.617 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -142.29 150.07 40.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.065 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.547 HD11 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.821 -1.175 . . . . 0.0 110.64 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.208 0.528 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.5 112.11 23.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 4.0 t -78.46 135.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.855 HG21 ' NH2' ' A' ' 173' ' ' ARG . 40.8 t -115.81 -30.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 110.953 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 131' ' ' GLU . 14.9 tttp -145.6 149.48 34.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.863 -1.148 . . . . 0.0 110.935 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.025 HG22 HG23 ' A' ' 98' ' ' VAL . 75.2 p -139.23 167.49 21.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.631 -0.668 . . . . 0.0 109.39 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.03 -39.1 0.44 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.123 -0.986 . . . . 0.0 110.872 -176.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.915 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.2 Cg_exo -59.01 -170.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.58 1.305 . . . . 0.0 110.162 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.463 ' HB3' HG22 ' A' ' 160' ' ' VAL . 26.8 t -90.25 -165.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -69.18 -2.98 11.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.715 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 158' ' ' SER . 34.3 m -87.64 143.78 34.33 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 110.415 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.561 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.1 Cg_endo -48.49 141.5 19.49 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.244 1.655 . . . . 0.0 110.964 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.915 HG11 ' CB ' ' A' ' 157' ' ' PRO . 9.1 m -130.07 159.95 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.035 . . . . 0.0 109.868 173.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.4 tt0 -107.48 129.92 54.9 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.35 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.834 ' CD1' HG21 ' A' ' 168' ' ' THR . 16.7 mm -72.03 154.11 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.624 -0.672 . . . . 0.0 110.381 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.95 171.46 26.12 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -55.04 -24.85 26.8 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.343 -1.092 . . . . 0.0 110.359 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.608 ' OE2' HG21 ' A' ' 94' ' ' ILE . 18.5 pt-20 -90.28 -17.17 27.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.17 -0.956 . . . . 0.0 110.851 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.834 HG21 ' CD1' ' A' ' 164' ' ' ILE . 85.3 m -58.45 140.56 53.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 0.0 110.16 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 70.9 mmtt -94.84 162.31 13.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.954 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.646 HG23 HD21 ' A' ' 100' ' ' LEU . 2.1 mt -139.37 160.23 28.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 111.12 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.413 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 26.2 mt-10 -137.99 132.78 32.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.612 ' CD1' HD11 ' A' ' 100' ' ' LEU . 43.6 mm -120.07 123.51 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.426 -0.796 . . . . 0.0 110.02 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.855 ' NH2' HG21 ' A' ' 153' ' ' VAL . 11.1 ptp180 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.016 -1.053 . . . . 0.0 110.463 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.822 ' OD1' HD13 ' A' ' 34' ' ' LEU . 49.4 p30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.085 0.469 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -155.53 -166.48 15.71 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.098 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.722 HG13 HD22 ' A' ' 9' ' ' LEU . 40.0 pt -134.78 159.93 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.344 -1.092 . . . . 0.0 109.421 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.63 ' C ' HD23 ' A' ' 9' ' ' LEU . 36.5 mt -98.57 124.33 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.005 . . . . 0.0 110.28 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.84 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -141.1 -172.68 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 110.478 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.642 ' NH2' HG21 ' A' ' 66' ' ' ILE . 25.5 ttp-105 -103.89 128.79 51.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 110.947 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.933 HG23 HD11 ' A' ' 69' ' ' ILE . 7.1 p -63.02 137.87 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.558 -0.714 . . . . 0.0 110.5 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -127.48 160.15 32.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.288 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.792 ' HB3' HD11 ' A' ' 81' ' ' ILE . 85.1 tt0 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.306 -0.871 . . . . 0.0 110.555 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 11.0 ptp180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.33 0.586 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 55.2 t -119.95 119.14 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.807 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.768 ' O ' HD12 ' A' ' 26' ' ' LEU . 5.9 ptt180 -88.38 119.53 28.9 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.837 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -138.81 164.77 28.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.672 -0.643 . . . . 0.0 109.843 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.6 p-10 -89.59 -179.79 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.036 -1.04 . . . . 0.0 110.702 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.265 -175.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.0 t -67.12 -40.01 86.75 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.098 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.16 ' O ' HD22 ' A' ' 33' ' ' LEU . 43.7 m -64.06 -27.94 69.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.224 -0.922 . . . . 0.0 109.496 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 61.1 ttt180 -85.12 -45.17 12.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.749 -0.594 . . . . 0.0 110.834 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 22.5 tpt180 -79.59 -9.96 59.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.812 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.16 HD22 ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -41.12 -30.04 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.661 0.743 . . . . 0.0 109.859 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.822 HD13 ' OD1' ' A' ' 5' ' ' ASN . 80.5 mt -140.54 -60.57 0.51 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.706 -0.622 . . . . 0.0 110.56 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.7 t0 -171.06 -29.42 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.193 -0.942 . . . . 0.0 110.487 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.869 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -21.35 123.98 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.354 0.597 . . . . 0.0 111.469 -176.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.62 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.4 pt-20 -101.12 178.98 4.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 38' ' ' ILE . 32.6 mm -60.08 123.38 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.928 -1.107 . . . . 0.0 109.765 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.9 30.59 61.22 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 175.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -88.84 -179.87 6.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.326 . . . . 0.0 109.514 172.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.806 HG21 HG23 ' A' ' 92' ' ' THR . 80.1 t -99.26 127.76 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.02 -1.05 . . . . 0.0 110.467 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.681 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -119.96 142.95 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 -177.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -110.54 142.91 41.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.489 -0.757 . . . . 0.0 109.812 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -120.02 149.33 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.221 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.0 tt0 -151.88 94.45 1.97 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 110.845 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.068 ' CG ' HG12 ' A' ' 85' ' ' VAL . 12.7 tmtt? -98.6 -66.8 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.568 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.48 -35.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.645 0.736 . . . . 0.0 109.202 175.366 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 1.6 mmt85 -134.12 -167.83 2.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.61 -0.681 . . . . 0.0 109.625 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.739 ' C ' HD21 ' A' ' 130' ' ' LEU . 21.9 mttm -89.72 137.32 32.43 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.803 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.583 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.6 157.44 46.76 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.251 0.548 . . . . 0.0 110.2 178.077 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.3 160.82 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 109.967 177.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.56 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.72 -178.54 48.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -115.79 157.46 24.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.475 -1.014 . . . . 0.0 109.922 -176.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.681 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -85.03 135.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.962 -1.086 . . . . 0.0 110.216 -175.112 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -127.7 163.15 24.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.063 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -90.01 121.82 32.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 110.098 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -63.45 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.926 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.672 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 5.4 mtm180 -56.16 -45.77 99.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.045 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 40.8 Cg_endo -92.65 97.54 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.882 1.464 . . . . 0.0 109.004 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.1 pt-20 -75.29 36.06 0.12 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.562 -0.711 . . . . 0.0 110.681 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.9 m-20 -147.33 -37.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 110.558 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -84.73 -24.3 28.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.523 ' HA ' HG12 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -81.14 38.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.71 -0.619 . . . . 0.0 110.526 177.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.496 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.4 pttt -98.81 15.48 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -0.999 . . . . 0.0 109.406 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.09 24.34 0.03 OUTLIER Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.642 HG21 ' NH2' ' A' ' 10' ' ' ARG . 46.1 pt -140.77 156.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 109.046 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 3.4 p -135.38 131.48 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.908 -1.12 . . . . 0.0 110.144 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.536 ' NE ' ' HD3' ' A' ' 25' ' ' ARG . 42.9 ttp180 -92.76 118.66 31.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 110.123 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.933 HD11 HG23 ' A' ' 11' ' ' VAL . 2.6 pt -132.09 166.45 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.473 -0.767 . . . . 0.0 110.379 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.507 ' OD1' ' HB2' ' A' ' 73' ' ' MET . 21.4 p-10 -83.66 177.66 8.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 110.138 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t -63.48 -35.22 79.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.0 110.92 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.18 -46.16 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 110.123 -174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.728 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.38 -43.72 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.554 177.432 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 6.8 ttm180 -59.95 -40.87 90.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.893 174.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -69.97 -25.91 63.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.291 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 79.7 m-20 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 110.618 -175.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.46 ' HB2' HG23 ' A' ' 47' ' ' VAL . 29.1 p -99.1 -37.19 9.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.042 . . . . 0.0 110.425 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.568 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 116.4 21.92 4.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -99.22 169.62 9.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.169 -1.194 . . . . 0.0 110.332 -175.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.845 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.26 171.14 7.73 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.351 -0.843 . . . . 0.0 109.366 178.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.792 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -60.16 140.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 0.0 109.981 177.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.704 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 79.61 -4.79 63.11 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 171.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.546 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.04 -166.42 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.815 -1.403 . . . . 0.0 110.115 174.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 33.6 pttt -127.83 112.8 15.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.224 -0.922 . . . . 0.0 109.831 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.068 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.33 151.64 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 48.9 tttp -101.09 126.59 47.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.891 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.527 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.2 t -102.97 121.98 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.565 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 77.8 mtt85 -106.74 128.19 54.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.869 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 13.8 tmtt? -78.75 135.99 37.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.15 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.438 HG21 ' HD2' ' A' ' 161' ' ' PRO . 2.2 m -150.04 -169.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.49 -0.757 . . . . 0.0 110.234 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -126.6 173.3 9.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.494 -0.754 . . . . 0.0 109.671 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.806 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.0 162.5 12.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 110.953 -176.12 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.666 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.7 pt-20 -150.23 169.92 20.19 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.577 HG21 ' OE2' ' A' ' 167' ' ' GLU . 50.8 mm -90.04 98.85 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.594 -1.316 . . . . 0.0 110.319 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.861 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.48 139.7 52.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.65 ' CD ' HD23 ' A' ' 156' ' ' LEU . 13.0 ptpt -107.13 -24.62 11.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 111.292 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.636 ' HD3' HD13 ' A' ' 156' ' ' LEU . 63.6 tttp -149.97 119.62 7.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.706 -1.246 . . . . 0.0 110.619 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.888 HG23 HG22 ' A' ' 155' ' ' THR . 10.0 p -136.23 140.76 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 0.0 110.692 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.491 ' C ' HD23 ' A' ' 100' ' ' LEU . 99.7 m -111.97 142.1 44.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.081 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.891 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.04 165.86 24.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.614 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -140.07 89.5 11.11 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.795 . . . . 0.0 110.315 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo . . . . . 0 C--N 1.305 -1.754 0 O-C-N 124.061 1.559 . . . . 0.0 110.752 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.748 HD13 ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.08 0.467 . . . . 0.0 109.948 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -62.43 -40.05 95.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.714 176.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -29.09 66.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.0 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.04 -40.01 87.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.769 HG12 ' CD1' ' A' ' 170' ' ' ILE . 54.5 t -65.01 -49.97 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.4 mt-30 -60.06 -44.58 94.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.813 . . . . 0.0 110.024 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -60.01 -44.09 94.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.647 -0.658 . . . . 0.0 110.211 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.527 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.05 -43.8 70.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -0.789 . . . . 0.0 110.544 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.74 HD22 ' N ' ' A' ' 124' ' ' LEU . 3.5 mm? -99.05 2.81 46.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.738 HD11 ' HG2' ' A' ' 166' ' ' GLU . 2.4 tt -46.2 169.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.887 -1.133 . . . . 0.0 110.241 -175.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 28.8 ptt180 33.13 46.09 0.09 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.513 -0.742 . . . . 0.0 111.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -132.26 149.9 74.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.784 -1.198 . . . . 0.0 110.866 176.689 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.81 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.4 Cg_endo -63.83 133.41 38.91 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.182 1.622 . . . . 0.0 110.264 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.522 ' HE2' HG21 ' A' ' 98' ' ' VAL . 81.5 mmm -127.0 143.05 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.592 -1.317 . . . . 0.0 111.279 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.739 HD21 ' C ' ' A' ' 49' ' ' LYS . 10.8 tp -148.27 110.7 4.68 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.729 -0.607 . . . . 0.0 109.442 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.2 pm0 -43.02 143.28 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.944 -1.097 . . . . 0.0 110.526 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.97 -2.48 2.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.873 -0.517 . . . . 0.0 110.429 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.7 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.6 p-10 -69.93 169.86 12.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.243 -0.911 . . . . 0.0 110.107 175.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 5.4 m120 -128.54 145.28 51.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.524 0 O-C-N 120.944 -1.097 . . . . 0.0 110.108 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 62.6 m-85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.397 0.618 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.437 ' HD2' ' ND2' ' A' ' 134' ' ' ASN . 32.0 tptt -103.26 104.77 14.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.845 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.7 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.2 t -76.65 139.26 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 109.851 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.26 -29.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 0.0 111.059 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 38.4 ttpt -139.52 144.94 38.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.815 -1.178 . . . . 0.0 111.017 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.888 HG22 HG23 ' A' ' 98' ' ' VAL . 58.0 p -140.01 153.02 46.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.71 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.8 OUTLIER -89.82 -30.62 0.36 Allowed Pre-proline 0 C--N 1.297 -1.696 0 O-C-N 121.282 -0.886 . . . . 0.0 111.425 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.974 ' CB ' HG11 ' A' ' 162' ' ' VAL . 14.2 Cg_exo -58.63 -164.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.216 1.114 . . . . 0.0 109.921 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.678 ' HB3' HG22 ' A' ' 160' ' ' VAL . 15.3 t -89.98 -178.41 5.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 175.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -62.27 -8.47 5.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 110.469 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.678 HG22 ' HB3' ' A' ' 158' ' ' SER . 20.7 m -84.76 146.25 45.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 110.238 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.555 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.45 141.3 14.66 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.255 1.661 . . . . 0.0 110.747 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.974 HG11 ' CB ' ' A' ' 157' ' ' PRO . 7.0 m -129.89 159.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 109.575 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.89 128.1 54.32 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.205 -0.934 . . . . 0.0 110.079 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.769 ' CD1' HG21 ' A' ' 168' ' ' THR . 11.9 mm -70.58 154.68 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 110.055 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.61 172.33 24.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.738 ' HG2' HD11 ' A' ' 125' ' ' ILE . 96.6 mt-10 -58.2 -26.26 62.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.898 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.577 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.4 pt-20 -87.38 -17.98 31.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.592 -176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 95' ' ' ALA . 30.7 m -58.47 152.48 17.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 110.302 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' LYS . 23.0 mmtt -105.89 158.77 16.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.062 . . . . 0.0 109.875 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.891 HG23 HD21 ' A' ' 100' ' ' LEU . 1.8 mt -136.68 161.8 35.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 111.164 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.474 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 12.0 mt-10 -139.06 131.66 28.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.756 -0.59 . . . . 0.0 110.219 175.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.9 mp -119.91 128.89 75.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.465 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 5.5 ptp180 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 110.233 -178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 t30 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.52 0.676 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -151.0 -153.7 6.25 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.022 HG21 HD22 ' A' ' 33' ' ' LEU . 11.9 pt -138.63 167.75 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -1.15 . . . . 0.0 109.412 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.771 ' C ' HD23 ' A' ' 9' ' ' LEU . 85.4 mt -109.89 127.84 66.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.117 -0.989 . . . . 0.0 110.337 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.837 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -148.49 -179.04 6.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.511 -0.743 . . . . 0.0 109.962 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 2.8 ptt180 -104.74 138.89 40.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.939 -1.101 . . . . 0.0 110.601 -173.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 80' ' ' SER . 11.2 p -63.07 130.43 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 110.356 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -110.93 153.5 25.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.909 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.518 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.071 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HG2' ' HD2' ' A' ' 53' ' ' ARG . 82.2 mtt180 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.95 0.405 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 67' ' ' VAL . 78.1 t -105.3 114.02 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.987 -1.071 . . . . 0.0 110.053 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 8.9 ptt180 -93.5 119.95 33.19 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.563 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.628 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -139.84 171.94 13.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.682 -176.464 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 19.8 p-10 -95.43 -172.58 2.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.897 -1.127 . . . . 0.0 110.785 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.03 -46.97 87.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.578 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.474 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 18.2 m -65.24 -41.75 94.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.129 -175.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.667 ' HA ' HD23 ' A' ' 33' ' ' LEU . 64.3 m -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.155 -0.966 . . . . 0.0 109.558 175.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 41.1 ttm180 -73.27 -44.04 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 111.163 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -91.73 -7.82 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.919 -1.113 . . . . 0.0 111.201 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.041 HD12 ' N ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -52.23 -26.58 12.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.149 . . . . 0.0 109.329 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.041 ' N ' HD12 ' A' ' 33' ' ' LEU . 41.9 mt -132.65 -66.01 0.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 110.785 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 28.8 t0 -171.82 -2.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.955 -1.091 . . . . 0.0 111.52 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -44.97 128.01 6.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.827 -1.17 . . . . 0.0 110.449 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.585 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.2 pt-20 -116.85 176.57 5.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 38' ' ' ILE . 21.6 mm -57.96 122.41 7.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.812 -1.18 . . . . 0.0 109.855 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.504 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 72.88 33.42 59.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.161 -1.018 . . . . 0.0 110.663 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 18.9 m-20 -89.2 176.23 7.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.667 -1.49 . . . . 0.0 109.596 172.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.079 HG12 HG23 ' A' ' 90' ' ' VAL . 73.6 t -99.07 127.78 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.084 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 52' ' ' GLY . 4.6 m -120.0 151.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 110.229 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' C ' HD12 ' A' ' 44' ' ' ILE . 86.5 tt0 -122.99 142.9 50.33 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.716 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -119.9 147.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' OE1' ' CZ ' ' A' ' 88' ' ' ARG . 82.5 tt0 -151.29 93.14 1.87 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.931 -1.106 . . . . 0.0 110.846 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.035 ' HG3' HG12 ' A' ' 85' ' ' VAL . 8.9 tmtm? -97.94 -58.85 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.646 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.73 -31.51 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.676 0.75 . . . . 0.0 109.129 176.677 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 98.3 mtt180 -139.53 -172.57 3.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.642 -0.662 . . . . 0.0 109.747 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -88.41 130.32 35.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.177 -0.952 . . . . 0.0 110.825 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -131.03 154.31 48.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.805 -0.56 . . . . 0.0 110.26 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.056 HG11 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -117.91 164.36 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.945 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -176.77 179.0 47.96 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 18.2 ptp180 -111.53 -172.04 1.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -1.112 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.585 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.24 137.66 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.026 -1.046 . . . . 0.0 110.632 -175.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -127.89 164.13 22.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 110.194 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.27 123.67 33.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -63.33 140.05 58.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.653 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 4.6 mmt180 -56.08 -49.55 92.48 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.903 -1.123 . . . . 0.0 108.877 174.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 18.7 Cg_endo -91.68 98.36 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.715 1.376 . . . . 0.0 108.831 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 11.1 pt-20 -74.97 35.29 0.1 Allowed 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 110.917 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 79.5 m-20 -145.43 -32.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.056 -1.027 . . . . 0.0 110.796 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.99 -25.55 24.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.563 ' HA ' HG12 ' A' ' 66' ' ' ILE . 4.1 m-80 -81.13 39.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 110.573 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.3 pttt -99.02 17.48 19.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 109.575 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.56 23.98 0.03 OUTLIER Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.563 HG12 ' HA ' ' A' ' 63' ' ' ASN . 44.5 pt -140.68 158.59 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.52 -0.988 . . . . 0.0 109.221 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.976 HG23 HG13 ' A' ' 24' ' ' VAL . 3.4 p -129.98 137.13 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.087 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -97.31 118.02 32.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.05 -1.031 . . . . 0.0 110.1 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.857 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.1 pt -134.36 173.04 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.749 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 71' ' ' SER . 29.7 t0 -91.23 173.61 7.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.564 -0.71 . . . . 0.0 109.857 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 58.5 p -63.12 -25.29 68.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.438 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.7 t -68.49 -47.45 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.689 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.07 -42.81 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 109.768 176.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.02 -40.27 88.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 174.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -71.04 -26.86 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.395 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.4 m-20 -60.07 -39.9 87.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 110.808 -176.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.524 ' C ' HG23 ' A' ' 47' ' ' VAL . 28.5 p -98.47 -36.53 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.965 -1.084 . . . . 0.0 110.657 -175.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 117.18 22.83 4.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.79 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -102.65 171.75 7.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -1.202 . . . . 0.0 110.311 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.962 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.91 179.05 4.08 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -65.22 140.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.053 -1.03 . . . . 0.0 110.423 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.88 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.03 -3.21 52.72 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 173.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.586 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.52 -158.83 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.054 -1.262 . . . . 0.0 110.211 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 52.6 pttt -137.07 116.92 13.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 110.097 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.035 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.3 m -125.81 160.07 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.433 -0.792 . . . . 0.0 109.823 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 33.0 ttmt -104.08 123.99 48.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.508 HG21 HD11 ' A' ' 9' ' ' LEU . 63.8 t -99.55 125.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtm180 -117.23 149.49 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 61.7 tttm -91.15 139.85 30.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.862 -1.149 . . . . 0.0 110.371 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.079 HG23 HG12 ' A' ' 41' ' ' VAL . 2.3 m -138.84 -168.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 175.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.481 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 38.8 ptt180 -137.46 171.26 14.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.26 159.55 16.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 0.0 111.193 -175.01 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.648 ' CG ' HG12 ' A' ' 162' ' ' VAL . 11.7 pt-20 -150.32 171.17 17.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.761 HG21 ' OE2' ' A' ' 167' ' ' GLU . 39.7 mm -88.62 98.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.287 -1.508 . . . . 0.0 110.096 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.992 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -58.62 139.96 55.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.392 -0.818 . . . . 0.0 110.365 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.587 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 1.4 pttt -97.46 -29.7 13.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.081 -1.012 . . . . 0.0 111.11 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.564 ' HB3' HD23 ' A' ' 156' ' ' LEU . 80.4 tttt -150.91 121.98 7.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 0.0 110.915 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.017 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -132.24 143.54 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.006 -1.059 . . . . 0.0 110.955 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.524 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 91.1 m -114.96 140.26 49.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 0.0 110.044 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 170' ' ' ILE . 0.1 OUTLIER -136.3 165.28 26.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.374 -177.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.576 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -136.33 82.11 35.56 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 111.033 -176.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.53 ' HD2' ' CD ' ' A' ' 173' ' ' ARG . 17.4 Cg_exo . . . . . 0 C--N 1.305 -1.754 0 O-C-N 123.869 1.458 . . . . 0.0 109.883 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 120' ' ' VAL . 5.9 tp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.076 0.465 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.541 ' HG2' HG12 ' A' ' 172' ' ' ILE . 94.8 mt-10 -59.99 -46.81 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 109.516 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.39 -39.89 92.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.457 ' HB3' HD12 ' A' ' 116' ' ' ILE . 36.8 t80 -64.27 -39.99 95.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.475 -0.766 . . . . 0.0 109.942 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.73 HG12 ' CD1' ' A' ' 170' ' ' ILE . 58.4 t -60.59 -49.97 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.512 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 1.9 mt-30 -61.21 -41.82 97.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.645 -0.66 . . . . 0.0 110.238 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.1 -48.93 79.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.438 -0.789 . . . . 0.0 109.97 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.402 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.01 -40.73 75.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.719 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.573 HD12 ' HE3' ' A' ' 129' ' ' MET . 4.6 mm? -94.91 -1.74 51.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.138 -175.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.712 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.6 tt -46.95 166.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.931 -1.105 . . . . 0.0 110.109 -175.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.6 ptt180 33.76 49.56 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 0.0 111.458 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.464 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 6.8 tpt180 -135.07 140.95 36.36 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.899 -1.126 . . . . 0.0 111.373 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.1 Cg_exo -59.69 130.68 36.26 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 124.095 1.576 . . . . 0.0 109.734 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.573 ' HE3' HD12 ' A' ' 124' ' ' LEU . 15.4 mmt -134.9 141.78 46.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.409 -1.432 . . . . 0.0 110.972 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -146.42 130.0 16.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -51.32 145.63 8.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -175.525 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 76.51 -2.06 2.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.818 -0.551 . . . . 0.0 110.548 178.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.801 ' HB3' HD23 ' A' ' 130' ' ' LEU . 1.6 p30 -67.59 -171.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.196 -0.94 . . . . 0.0 109.874 173.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -150.37 159.02 44.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.34 -0.85 . . . . 0.0 109.532 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.423 HD12 ' CB ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 110.122 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.511 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 20.4 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.188 0.518 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -119.95 109.98 16.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.558 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.9 t -74.97 139.38 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.06 -24.52 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 111.021 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -146.2 136.65 23.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.662 -1.274 . . . . 0.0 110.841 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.017 HG22 HG23 ' A' ' 98' ' ' VAL . 44.5 p -134.7 168.7 18.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.498 -0.752 . . . . 0.0 109.355 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.01 -35.98 0.42 Allowed Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.929 -178.11 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 1.062 ' CG ' HG11 ' A' ' 162' ' ' VAL . 22.9 Cg_exo -58.46 -174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.384 1.202 . . . . 0.0 110.531 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -156.36 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.59 -11.35 52.88 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 160' ' ' VAL . 33.1 m -87.11 139.45 32.43 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 1.056 ' HB3' HG11 ' A' ' 51' ' ' VAL . 9.3 Cg_endo -59.72 164.1 12.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.131 1.595 . . . . 0.0 111.002 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 1.062 HG11 ' CG ' ' A' ' 157' ' ' PRO . 14.8 m -140.37 166.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.561 -0.712 . . . . 0.0 110.101 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -103.02 126.48 50.22 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.833 -1.167 . . . . 0.0 109.954 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.813 ' CD1' HG21 ' A' ' 168' ' ' THR . 10.9 mm -70.11 153.73 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.588 -0.695 . . . . 0.0 109.661 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.49 168.25 25.9 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -56.62 -20.78 22.86 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -1.084 . . . . 0.0 110.033 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.761 ' OE2' HG21 ' A' ' 94' ' ' ILE . 21.3 pt-20 -91.35 -18.22 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.724 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.813 HG21 ' CD1' ' A' ' 164' ' ' ILE . 28.6 m -58.37 144.65 40.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.4 mttt -95.45 150.54 20.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 109.507 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.818 HG23 HD21 ' A' ' 100' ' ' LEU . 1.9 mt -129.95 160.05 41.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.83 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.524 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 65.2 mt-10 -135.62 145.32 46.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.566 -0.709 . . . . 0.0 110.295 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.685 HD11 HG21 ' A' ' 120' ' ' VAL . 30.9 mm -122.59 141.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.517 -0.739 . . . . 0.0 109.934 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.576 ' HD2' ' HA ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -176.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.922 0.867 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.891 ' HA2' HD11 ' A' ' 34' ' ' LEU . . . -151.8 -179.48 27.48 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.733 HG21 HD13 ' A' ' 33' ' ' LEU . 33.5 pt -134.8 159.18 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.879 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 85.5 mt -95.79 118.43 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.875 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.5 pt? -134.91 -169.28 2.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.344 -0.848 . . . . 0.0 110.382 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 38.1 ttp180 -103.91 130.15 51.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 110.965 -175.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.028 HG23 HD11 ' A' ' 69' ' ' ILE . 10.5 p -61.1 137.95 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 110.277 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -122.72 149.82 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' OE1' ' HD3' ' A' ' 74' ' ' ARG . 86.5 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 33.7 ptt180 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.984 HG13 HG23 ' A' ' 67' ' ' VAL . 53.6 t -99.96 110.1 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.065 . . . . 0.0 110.023 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -99.76 119.98 39.0 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.003 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -133.66 -169.43 2.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.525 -0.735 . . . . 0.0 110.375 -177.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' N ' ' HB3' ' A' ' 63' ' ' ASN . 26.6 p-10 -106.85 -179.15 3.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 0.0 110.816 -175.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 84.2 mt-10 -60.04 -40.07 88.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.242 -178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 46.6 t -59.95 -49.69 76.7 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.083 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.814 ' HA ' HD21 ' A' ' 33' ' ' LEU . 75.4 m -59.97 -40.09 87.87 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.099 -1.001 . . . . 0.0 109.682 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 32.2 ttp180 -60.19 -46.29 90.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 172.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -67.31 -39.97 85.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 110.415 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.951 ' CD1' HD13 ' A' ' 34' ' ' LEU . 4.4 pp -74.84 -28.4 60.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 111.088 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.951 HD13 ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -99.48 -8.36 24.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.731 -1.231 . . . . 0.0 110.15 175.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 34' ' ' LEU . 12.4 t70 59.77 14.87 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.818 . . . . 0.0 109.82 -174.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.934 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -58.95 120.71 9.57 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.593 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -99.48 173.34 6.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -58.52 127.75 18.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.35 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.7 73.4 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.578 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.42 ' CG ' ' HG2' ' A' ' 37' ' ' GLU . 90.2 m-20 -88.33 166.46 14.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.478 -1.601 . . . . 0.0 108.756 169.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 92' ' ' THR . 93.7 t -98.75 129.33 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.737 -1.227 . . . . 0.0 110.1 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.763 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -115.48 138.01 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.353 -177.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 83.0 tt0 -108.67 139.77 43.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.441 -0.787 . . . . 0.0 109.396 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.97 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.6 mp -120.3 145.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 110.332 -176.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.9 tt0 -147.42 99.51 3.14 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 110.772 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.043 ' CG ' HG12 ' A' ' 85' ' ' VAL . 9.5 tmtt? -98.29 -65.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.67 173.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.557 HG21 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.26 -33.38 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.257 174.252 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 69.5 mtt85 -135.56 -178.31 5.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.761 -0.587 . . . . 0.0 109.479 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.538 ' HB3' HD21 ' A' ' 130' ' ' LEU . 24.3 mttt -89.3 136.95 32.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.547 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.689 ' HA ' HD23 ' A' ' 130' ' ' LEU . 1.8 p -141.42 168.71 19.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 110.1 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.558 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.6 164.14 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.54 -0.725 . . . . 0.0 110.379 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.61 -172.76 42.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.9 ptp85 -113.98 -174.87 2.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.934 HG21 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -113.59 139.46 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.609 -173.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 1.1 m-85 -132.65 164.6 26.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.894 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -98.91 126.92 44.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.436 -0.79 . . . . 0.0 110.079 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -66.31 140.58 58.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.215 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.58 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -56.5 -49.02 95.94 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 118.899 -1.121 . . . . 0.0 108.834 172.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 30.7 Cg_endo -91.72 97.24 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.864 1.455 . . . . 0.0 108.954 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.13 35.83 0.14 Allowed 'General case' 0 C--N 1.289 -2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 110.984 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 36.1 p-10 -143.08 -36.11 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 110.964 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 15.5 pt-20 -84.83 -20.43 30.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.936 -1.102 . . . . 0.0 109.585 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.496 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 4.7 m-80 -81.42 38.66 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.48 -0.762 . . . . 0.0 110.531 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 26.2 pttm -98.82 11.9 37.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.63 26.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.496 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.8 pt -140.15 143.03 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.311 -1.111 . . . . 0.0 109.358 175.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.984 HG23 HG13 ' A' ' 24' ' ' VAL . 7.5 p -122.48 129.62 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.309 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 38.7 mmm-85 -90.01 116.62 28.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.243 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.028 HD11 HG23 ' A' ' 11' ' ' VAL . 2.9 pt -136.84 169.15 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 110.599 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.462 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 32.9 p-10 -78.5 169.29 18.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.601 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 79.6 p -70.04 -23.49 63.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.462 ' HB ' ' OD2' ' A' ' 70' ' ' ASP . 54.5 t -70.06 -43.98 78.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.979 -1.076 . . . . 0.0 110.186 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.97 ' CE ' HD13 ' A' ' 44' ' ' ILE . 9.7 tpt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.084 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 71' ' ' SER . 43.7 ptt85 -61.38 -35.56 77.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.806 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.476 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 64.1 t30 -71.88 -26.45 62.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.11 -0.994 . . . . 0.0 110.495 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.6 m-20 -60.01 -35.66 75.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.466 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.509 ' C ' HG23 ' A' ' 47' ' ' VAL . 26.1 p -97.95 -36.61 10.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.281 -0.887 . . . . 0.0 110.202 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.557 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 122.34 28.22 1.51 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.718 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -110.81 161.05 16.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -1.113 . . . . 0.0 110.476 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.849 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.77 179.02 4.09 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 178.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -60.44 139.73 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.926 -1.109 . . . . 0.0 110.646 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.836 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 78.24 -3.51 62.01 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.57 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.95 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.024 -1.28 . . . . 0.0 110.088 174.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 54.7 pttt -133.07 113.56 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 110.073 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.043 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -119.94 166.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.312 -0.867 . . . . 0.0 110.028 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 84.6 tttt -114.21 127.57 55.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 109.973 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.595 HG23 HD21 ' A' ' 9' ' ' LEU . 92.8 t -107.55 122.81 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.099 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.486 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 12.3 mtt180 -109.67 140.5 43.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 34' ' ' LEU . 53.5 tttm -82.13 140.76 33.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.094 -1.004 . . . . 0.0 110.701 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.481 HG21 ' CG ' ' A' ' 161' ' ' PRO . 2.3 m -150.17 -170.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.78 -0.575 . . . . 0.0 109.688 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.5 mtp180 -132.48 163.41 28.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.713 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.675 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -94.67 161.31 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.977 0.894 . . . . 0.0 111.418 -174.277 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.673 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.6 pt-20 -150.09 170.33 19.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.848 HG21 ' OE2' ' A' ' 167' ' ' GLU . 37.6 mm -89.07 101.11 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.625 -1.297 . . . . 0.0 110.461 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.828 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -58.69 139.98 55.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 110.31 177.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -101.84 -26.5 13.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 111.04 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.741 ' HB3' HD23 ' A' ' 156' ' ' LEU . 23.3 tttt -150.33 128.64 12.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 110.221 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.944 HG23 HG22 ' A' ' 155' ' ' THR . 7.2 p -140.8 144.98 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.996 -1.065 . . . . 0.0 110.616 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.541 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.3 m -116.51 133.42 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.827 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.944 HD11 HG11 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -131.94 160.81 34.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 110.371 -176.399 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -133.65 81.31 54.0 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 110.848 -176.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.515 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . 17.4 Cg_exo . . . . . 0 C--N 1.306 -1.704 0 O-C-N 123.933 1.491 . . . . 0.0 110.083 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.55 HG23 ' N ' ' A' ' 117' ' ' GLU . 19.1 tt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 121.162 0.506 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.55 ' N ' HG23 ' A' ' 116' ' ' ILE . 95.9 mt-10 -60.53 -40.06 90.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.957 . . . . 0.0 109.955 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -70.02 -35.94 74.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -60.04 -39.74 86.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.768 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.944 HG11 HD11 ' A' ' 100' ' ' LEU . 54.6 t -60.14 -45.32 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -60.04 -41.2 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.014 173.029 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -60.03 -39.9 87.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.39 -42.69 18.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.845 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 4.6 mm? -94.83 0.84 55.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.019 -1.051 . . . . 0.0 111.156 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.833 HD11 ' HG2' ' A' ' 166' ' ' GLU . 0.5 OUTLIER -44.04 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.03 -1.044 . . . . 0.0 110.554 -176.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.99 52.63 0.48 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.577 -0.702 . . . . 0.0 111.589 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 13.7 mmt180 -134.36 149.99 72.7 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.997 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.755 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.8 Cg_exo -66.11 132.32 29.57 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.975 1.513 . . . . 0.0 109.93 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.839 ' HE2' HG21 ' A' ' 98' ' ' VAL . 93.9 mmm -125.19 132.19 53.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.604 -1.31 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 50' ' ' THR . 19.7 tp -133.38 108.18 8.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.69 -0.631 . . . . 0.0 109.433 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.8 pt-20 -45.7 136.12 6.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.69 -1.256 . . . . 0.0 110.163 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.583 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 80.01 -2.6 2.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.947 -0.471 . . . . 0.0 110.326 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.4 p30 -69.37 -169.97 0.25 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.297 -0.877 . . . . 0.0 110.414 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 10.7 m120 -144.96 159.17 43.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 110.516 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.515 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 58.8 m-85 . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.261 0.553 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 110.03 16.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.034 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 132' ' ' GLN . 3.1 t -76.23 136.72 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 36.6 t -116.72 -30.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 110.618 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.4 tptt -140.07 135.07 32.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 0.0 110.935 -177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.944 HG22 HG23 ' A' ' 98' ' ' VAL . 69.6 p -129.95 166.21 20.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.397 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -88.8 -38.2 0.44 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.035 . . . . 0.0 110.81 -178.272 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 1.008 ' CG ' HG11 ' A' ' 162' ' ' VAL . 22.7 Cg_exo -57.8 -171.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.551 1.29 . . . . 0.0 110.497 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.95 -167.82 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 110.013 176.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.53 -9.45 8.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.181 -0.949 . . . . 0.0 110.695 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.21 144.51 41.12 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.478 -0.764 . . . . 0.0 110.628 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.558 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -47.9 141.63 16.4 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.885 1.723 . . . . 0.0 111.252 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 1.008 HG11 ' CG ' ' A' ' 157' ' ' PRO . 8.9 m -130.23 159.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 109.946 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 88.0 tt0 -109.32 130.56 55.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.237 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.912 HD12 HG21 ' A' ' 168' ' ' THR . 12.8 mm -71.2 152.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.518 -176.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.59 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.85 169.8 25.48 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.833 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.87 -23.61 45.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -1.142 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.848 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.5 pt-20 -87.06 -12.53 46.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.912 HG21 HD12 ' A' ' 164' ' ' ILE . 13.5 m -62.94 144.76 56.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.5 mttt -93.91 154.64 17.59 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 109.897 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.68 HD12 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mm -116.87 136.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 111.038 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.541 ' CB ' ' OG1' ' A' ' 99' ' ' THR . 18.7 mt-10 -120.33 130.68 54.53 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 110.198 172.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 170' ' ' ILE . 34.9 mm -120.17 140.37 44.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.529 -0.732 . . . . 0.0 110.301 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.537 ' CZ ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.301 -176.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.48 ' O ' HD13 ' A' ' 34' ' ' LEU . 27.3 t30 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.081 0.943 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.525 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -155.47 -169.27 19.7 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.927 ' CG2' HD12 ' A' ' 33' ' ' LEU . 41.0 pt -133.29 162.86 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -1.14 . . . . 0.0 109.663 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 ' HD3' ' A' ' 86' ' ' LYS . 92.8 mt -107.62 126.55 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.806 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.6 pt? -143.78 -165.49 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.657 -0.652 . . . . 0.0 109.447 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.515 ' CZ ' HG22 ' A' ' 66' ' ' ILE . 19.9 ptt-85 -115.0 140.25 49.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 0.0 110.464 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.063 HG23 HD11 ' A' ' 69' ' ' ILE . 13.6 p -60.75 137.75 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 110.635 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -115.3 139.97 49.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 110.56 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.937 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 109.918 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.613 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 39.8 mtm180 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.257 0.551 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 67' ' ' VAL . 83.4 t -112.44 120.56 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.75 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.2 ptm180 -95.74 119.88 35.02 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.602 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.1 mp -136.36 173.72 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.7 -175.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.466 ' OD1' ' OG ' ' A' ' 30' ' ' SER . 10.2 p-10 -95.71 -172.65 2.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 111.004 -176.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.491 ' OE2' ' NH1' ' A' ' 56' ' ' ARG . 49.7 mm-40 -59.73 -50.04 75.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 109.763 -175.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.54 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.5 t -64.1 -40.53 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.219 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.131 ' O ' HD22 ' A' ' 33' ' ' LEU . 68.6 m -60.05 -29.34 68.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 70.9 ttt180 -87.35 -46.99 9.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.659 -0.651 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 33' ' ' LEU . 87.0 mtm180 -79.94 -6.94 58.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.801 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.131 HD22 ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -42.03 -30.51 0.28 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.526 -0.734 . . . . 0.0 109.788 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 33' ' ' LEU . 79.3 mt -141.53 -61.65 0.47 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 0.0 110.592 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' C ' ' A' ' 36' ' ' ALA . 26.8 t0 -172.46 -29.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.2 -0.937 . . . . 0.0 110.03 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -23.52 116.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.514 0.674 . . . . 0.0 111.357 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.634 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -109.5 168.38 9.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.279 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -46.08 125.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.063 -1.023 . . . . 0.0 109.806 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 79.48 21.32 67.11 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.609 171.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 81.3 m-20 -89.21 173.91 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.721 -1.458 . . . . 0.0 109.359 171.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.521 ' CG1' ' HG2' ' A' ' 161' ' ' PRO . 59.7 t -99.39 134.16 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.958 . . . . 0.0 110.144 -175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.72 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -123.28 146.15 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.71 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -114.17 140.58 48.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.733 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.1 mp -124.81 138.94 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.687 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 87.6 tt0 -140.64 99.99 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 110.265 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.928 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -98.75 -66.47 0.9 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.618 -0.676 . . . . 0.0 109.401 177.138 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -111.3 -30.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.417 -0.802 . . . . 0.0 109.063 172.024 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.591 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 95.3 mtt180 -131.86 -179.82 5.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.619 173.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.51 ' HB3' HD21 ' A' ' 130' ' ' LEU . 35.0 mttt -89.17 138.34 31.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 111.011 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.663 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 5.5 p -142.57 167.7 21.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.55 0.69 . . . . 0.0 109.801 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -121.23 167.79 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.72 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.59 -168.46 38.49 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' HG22 ' A' ' 42' ' ' VAL . 67.1 ttt180 -125.45 165.09 19.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.981 . . . . 0.0 110.592 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.841 HG21 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -94.23 136.08 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.269 -175.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.613 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 1.3 m-85 -133.61 163.69 28.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.472 175.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 43.0 ttt85 -92.3 125.96 37.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.936 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -63.29 139.27 58.75 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.37 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.574 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.6 mtp180 -56.24 -48.57 96.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.763 174.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 34.2 Cg_endo -91.65 97.18 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.095 1.576 . . . . 0.0 108.965 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.12 35.93 0.11 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.547 -0.721 . . . . 0.0 110.737 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -143.59 -31.85 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.45 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.62 -28.76 24.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.185 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.489 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 3.5 m-80 -80.98 39.81 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.474 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 14.2 pttm -98.79 9.41 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -0.923 . . . . 0.0 109.683 177.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -176.36 28.08 0.07 OUTLIER Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.515 HG22 ' CZ ' ' A' ' 10' ' ' ARG . 44.6 pt -140.58 143.13 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.213 -1.169 . . . . 0.0 109.473 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.947 HG23 HG13 ' A' ' 24' ' ' VAL . 3.9 p -119.34 124.48 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.045 -1.034 . . . . 0.0 109.898 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 1.7 mtp85 -91.39 117.22 29.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.285 -0.885 . . . . 0.0 110.074 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.063 HD11 HG23 ' A' ' 11' ' ' VAL . 1.4 pt -129.69 162.96 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.632 -0.668 . . . . 0.0 110.264 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.53 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 26.0 p-10 -76.78 177.55 7.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.851 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 10.4 m -68.87 -19.0 64.23 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.613 HG12 ' ND2' ' A' ' 76' ' ' ASN . 86.3 t -69.9 -48.37 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.989 -1.069 . . . . 0.0 110.331 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.752 ' HE1' HD13 ' A' ' 44' ' ' ILE . 88.8 mmm -62.8 -40.27 96.83 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.548 174.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.898 ' NH1' HD13 ' A' ' 81' ' ' ILE . 72.7 ttt180 -60.07 -40.66 90.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 173.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' SER . 8.0 t30 -78.34 -32.58 49.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 110.577 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.613 ' ND2' HG12 ' A' ' 72' ' ' VAL . 98.6 m-20 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.377 -175.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 20.9 p -99.91 -38.28 8.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.726 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.58 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 111.05 23.7 5.73 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.928 ' HB1' ' HD2' ' A' ' 46' ' ' LYS . . . -111.05 -178.07 3.37 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.008 -1.29 . . . . 0.0 111.295 -171.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.553 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -128.74 170.15 13.66 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 174.128 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.937 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -56.37 154.54 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 110.156 178.337 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 74.84 -5.45 31.46 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.669 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.9 m-20 -56.27 -164.64 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.039 -1.271 . . . . 0.0 110.513 176.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 22.2 pttm -134.55 115.92 14.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 109.554 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.74 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -125.75 159.22 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.126 -177.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.6 ttpm? -111.72 121.04 44.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.77 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.524 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.3 t -99.65 120.06 48.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 4.6 mtt180 -112.11 139.38 47.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.826 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -86.14 138.59 31.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.486 HG21 ' CD ' ' A' ' 161' ' ' PRO . 2.2 m -147.07 -169.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.501 -0.749 . . . . 0.0 110.221 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -127.51 166.48 17.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.822 . . . . 0.0 109.631 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.51 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -99.42 162.13 13.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 0.0 111.057 -176.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.594 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.7 pt-20 -150.33 169.3 21.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.7 mm -89.93 98.28 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.603 -1.311 . . . . 0.0 110.469 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.927 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.82 141.03 46.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.308 -0.87 . . . . 0.0 110.361 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.749 ' HG2' HD22 ' A' ' 156' ' ' LEU . 5.5 pttt -108.25 -22.01 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.193 -0.942 . . . . 0.0 111.14 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 169' ' ' LYS . 62.6 tttp -150.7 117.22 5.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.613 -1.305 . . . . 0.0 110.485 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.08 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -134.74 140.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.04 . . . . 0.0 110.588 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.478 ' C ' HD23 ' A' ' 100' ' ' LEU . 41.7 m -108.02 140.31 41.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.078 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.927 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.71 165.09 26.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.105 -178.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.64 82.88 11.02 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.141 -0.974 . . . . 0.0 111.037 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 32.5 Cg_exo . . . . . 0 C--N 1.306 -1.662 0 O-C-N 123.921 1.485 . . . . 0.0 110.394 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.304 0.573 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.709 ' HA ' HD11 ' A' ' 172' ' ' ILE . 99.0 mt-10 -59.97 -45.32 93.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -70.02 -32.95 71.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 110.582 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -60.07 -39.98 87.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.139 -0.976 . . . . 0.0 109.062 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.878 HG12 ' CD1' ' A' ' 170' ' ' ILE . 53.9 t -60.52 -49.11 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.677 174.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.628 ' NE2' ' O ' ' A' ' 168' ' ' THR . 2.5 mt-30 -59.99 -42.65 94.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.0 -45.61 92.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 110.157 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.538 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.95 -43.4 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.644 HD22 ' N ' ' A' ' 124' ' ' LEU . 4.1 mm? -99.79 6.17 45.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.977 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.737 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.6 tt -47.98 165.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.76 -1.212 . . . . 0.0 109.821 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 11.6 ptp180 35.3 47.7 0.33 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.445 -0.785 . . . . 0.0 111.387 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 7.4 mmt85 -129.37 150.88 76.78 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.791 -1.193 . . . . 0.0 110.965 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.784 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.3 Cg_endo -68.71 128.55 17.19 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 124.233 1.649 . . . . 0.0 109.716 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.505 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.9 mmm -124.76 139.84 53.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.446 -1.409 . . . . 0.0 110.885 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 50' ' ' THR . 16.7 tp -141.34 104.38 4.59 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.639 -0.663 . . . . 0.0 109.558 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.0 pt-20 -43.41 139.43 2.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.617 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.61 -7.01 0.98 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.184 0.516 . . . . 0.0 110.334 -177.618 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.54 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.3 p-10 -70.08 174.96 4.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 29.9 m-80 -141.38 149.72 41.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 110.108 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 28.6 m-85 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.339 0.59 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.52 108.48 15.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.92 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.54 HG21 ' OD1' ' A' ' 133' ' ' ASP . 3.3 t -77.16 140.02 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.816 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.4 t -120.51 -30.95 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.129 -0.982 . . . . 0.0 110.785 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -143.09 149.55 38.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.772 -1.205 . . . . 0.0 111.59 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.08 HG22 HG23 ' A' ' 98' ' ' VAL . 55.1 p -140.54 164.39 30.28 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.749 HD22 ' HG2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -88.42 -39.15 0.46 Allowed Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.893 . . . . 0.0 110.692 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.977 ' CB ' HG11 ' A' ' 162' ' ' VAL . 19.3 Cg_exo -58.56 -172.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.556 1.293 . . . . 0.0 110.38 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 -167.68 1.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.465 -0.772 . . . . 0.0 109.821 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -65.79 -4.88 7.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.219 -0.925 . . . . 0.0 110.983 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.7 145.26 41.26 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.424 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.56 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -49.35 141.31 25.09 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.221 1.643 . . . . 0.0 110.545 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.977 HG11 ' CB ' ' A' ' 157' ' ' PRO . 4.6 m -129.88 157.9 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 109.942 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 53.7 tt0 -106.91 128.01 53.94 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 110.2 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.804 HD12 HG21 ' A' ' 168' ' ' THR . 11.2 mm -70.85 156.48 7.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 110.275 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.74 169.73 25.96 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.737 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -57.85 -21.45 42.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 0.0 110.209 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -88.35 -21.6 24.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.884 . . . . 0.0 109.575 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.804 HG21 HD12 ' A' ' 164' ' ' ILE . 26.6 m -56.89 162.07 2.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.514 -0.741 . . . . 0.0 110.231 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' LYS . 46.8 mtmt -121.02 149.82 42.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.464 176.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.927 HG23 HD21 ' A' ' 100' ' ' LEU . 1.2 mt -127.99 162.95 32.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 110.95 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 35.8 mt-10 -138.35 137.29 37.2 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.521 0.676 . . . . 0.0 110.11 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.709 HD11 ' HA ' ' A' ' 117' ' ' GLU . 4.3 mp -121.68 137.72 54.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.887 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.577 ' O ' ' NE ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 0.0 110.096 -174.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.357 0.599 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.526 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -152.18 -161.88 10.48 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.709 HG23 HD11 ' A' ' 34' ' ' LEU . 42.5 pt -136.07 157.92 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -1.204 . . . . 0.0 110.0 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 mm -101.5 113.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.026 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.714 HD11 ' HB ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -139.81 -173.8 3.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.885 -178.565 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 24.1 ptt-85 -115.77 139.81 49.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.943 -1.098 . . . . 0.0 110.619 -175.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.762 HG13 ' HA ' ' A' ' 81' ' ' ILE . 14.5 p -61.8 132.55 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.538 -0.726 . . . . 0.0 110.634 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -108.78 145.33 35.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.63 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.957 ' HB3' HD11 ' A' ' 81' ' ' ILE . 84.8 tt0 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.874 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 53' ' ' ARG . 24.9 mmt85 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.089 0.471 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.118 HG13 HG23 ' A' ' 67' ' ' VAL . 85.6 t -110.45 119.98 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 0.0 110.195 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 26' ' ' LEU . 5.1 ptt180 -90.25 116.66 28.4 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.753 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.922 HD13 HG12 ' A' ' 24' ' ' VAL . 1.1 mp -128.24 174.91 8.87 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 3.5 p-10 -91.67 177.54 6.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.84 -1.162 . . . . 0.0 110.404 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 87.0 mt-10 -60.04 -39.99 87.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.59 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -67.74 -58.33 4.82 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.107 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.583 ' C ' HD22 ' A' ' 33' ' ' LEU . 68.3 m -49.99 -30.04 9.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 109.629 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 51.6 ttp180 -81.73 -47.95 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 111.261 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -93.91 -16.86 23.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.767 -1.208 . . . . 0.0 111.199 -171.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.926 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.1 pt? -60.0 -28.77 67.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.131 . . . . 0.0 110.24 -176.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.926 ' H ' HD23 ' A' ' 33' ' ' LEU . 61.4 mt -101.91 -73.37 0.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 109.97 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' ALA . 12.6 t0 -170.02 -27.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -36.23 122.36 0.72 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.327 0.584 . . . . 0.0 110.933 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.716 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -115.65 179.32 4.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.003 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 38' ' ' ILE . 28.2 mm -54.64 128.27 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.985 -1.072 . . . . 0.0 109.897 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.62 18.36 75.75 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.575 172.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' OD1' ' OE2' ' A' ' 37' ' ' GLU . 79.5 m-20 -89.17 161.86 16.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.649 -1.501 . . . . 0.0 109.635 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.838 HG21 ' OG1' ' A' ' 92' ' ' THR . 94.0 t -99.62 135.92 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.058 -1.026 . . . . 0.0 110.499 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.736 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -119.98 153.12 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.861 . . . . 0.0 110.571 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 86.5 tt0 -118.88 139.93 50.82 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.348 -0.845 . . . . 0.0 110.009 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.8 mp -119.98 145.11 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.049 . . . . 0.0 110.754 -177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.49 95.28 2.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.353 -0.842 . . . . 0.0 111.023 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.999 ' HG3' HG12 ' A' ' 85' ' ' VAL . 9.7 tmtm? -97.85 -59.19 1.82 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.995 . . . . 0.0 109.852 173.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.58 HG23 ' C ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -113.21 -33.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.58 -0.7 . . . . 0.0 109.22 175.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 78.9 mtm-85 -136.56 178.42 7.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 174.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.607 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.1 132.26 34.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.163 -0.96 . . . . 0.0 110.386 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.598 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.1 p -139.69 168.13 20.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.468 0.651 . . . . 0.0 109.695 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.755 HG13 ' HG ' ' A' ' 130' ' ' LEU . 2.8 m -115.24 175.16 2.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.55 -0.719 . . . . 0.0 110.66 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.736 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.78 179.75 48.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 174.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.535 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 51.1 mtp180 -125.82 176.13 7.16 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.274 -1.133 . . . . 0.0 110.027 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -99.15 127.07 52.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.351 -175.21 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -117.6 164.81 14.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 175.01 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -89.87 121.74 32.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.439 -0.788 . . . . 0.0 109.803 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.791 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -62.82 132.4 52.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.604 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.4 mtt-85 -57.11 -47.4 99.13 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.708 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.76 97.17 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.96 1.505 . . . . 0.0 108.975 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -75.56 33.51 0.11 Allowed 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.429 -0.794 . . . . 0.0 110.977 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -145.73 -28.54 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.055 -1.028 . . . . 0.0 110.631 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -87.03 -25.76 24.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 109.129 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.791 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 18.3 m120 -81.1 42.33 0.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.639 -0.663 . . . . 0.0 110.269 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.528 ' CD ' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.73 9.52 43.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 0.0 109.788 176.625 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.89 27.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.577 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.465 HG22 ' CZ ' ' A' ' 10' ' ' ARG . 45.8 pt -140.78 141.71 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.272 -1.134 . . . . 0.0 109.653 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.118 HG23 HG13 ' A' ' 24' ' ' VAL . 2.4 p -117.01 128.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.848 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HD3' ' HD3' ' A' ' 25' ' ' ARG . 78.7 ttt180 -90.82 119.38 30.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.759 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.6 pp -133.31 165.03 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 110.473 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -80.01 169.2 18.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.734 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.2 m -60.04 -39.95 87.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.413 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.1 -46.6 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.927 . . . . 0.0 110.161 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.756 ' CE ' HD13 ' A' ' 44' ' ' ILE . 16.8 tpt -60.06 -42.81 95.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.582 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.427 ' HD2' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -61.75 -39.97 93.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.691 173.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -69.98 -23.41 63.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.443 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 73' ' ' MET . 75.3 m-20 -60.1 -39.99 88.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.033 -1.042 . . . . 0.0 110.641 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.58 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.1 p -98.96 -37.09 9.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.901 -1.124 . . . . 0.0 110.577 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.92 33.18 1.72 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.776 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -109.99 162.79 14.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -1.212 . . . . 0.0 110.401 -177.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.633 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 169.96 8.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.349 -0.844 . . . . 0.0 109.26 177.318 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.957 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -52.79 144.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.194 177.291 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.99 0.34 60.15 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.0 m-20 -58.89 -162.83 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.801 -1.411 . . . . 0.0 110.36 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 15.3 ptpt -135.13 113.64 11.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.477 -0.764 . . . . 0.0 109.77 176.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.999 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -123.74 156.37 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.629 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -102.9 119.79 39.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.813 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.526 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 45.6 t -102.04 119.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.55 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 84.4 mtm-85 -116.76 140.48 49.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.998 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 24.0 tttm -72.34 145.33 47.85 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 110.879 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.555 HG23 HG12 ' A' ' 41' ' ' VAL . 2.2 m -147.4 -167.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.651 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -134.06 168.61 18.5 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 109.653 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.838 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -112.21 159.26 18.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.077 -1.015 . . . . 0.0 111.149 -174.295 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' H ' ' HA ' ' A' ' 162' ' ' VAL . 7.4 pt-20 -150.08 170.54 18.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.3 96.49 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.467 -1.396 . . . . 0.0 110.219 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.928 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.58 147.81 21.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.508 -0.745 . . . . 0.0 110.643 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 169' ' ' LYS . 9.7 ptmt -115.69 -24.9 8.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.805 . . . . 0.0 111.01 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.748 ' HB3' HD23 ' A' ' 156' ' ' LEU . 42.7 tttp -149.99 125.84 10.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.759 -1.213 . . . . 0.0 110.691 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.007 HG23 HG22 ' A' ' 155' ' ' THR . 7.3 p -139.46 146.96 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.176 -0.953 . . . . 0.0 110.293 176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.604 ' C ' HD23 ' A' ' 100' ' ' LEU . 95.4 m -119.56 138.37 53.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.829 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -140.01 174.17 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -143.95 102.38 4.88 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 110.752 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.0 110.048 179.524 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.545 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.7 tp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.235 0.541 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 116' ' ' ILE . 41.3 tt0 -59.93 -42.75 94.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.857 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.67 -37.3 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.872 . . . . 0.0 109.817 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -59.99 -39.36 85.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.833 . . . . 0.0 109.684 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 170' ' ' ILE . 67.3 t -60.03 -47.25 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.58 ' HA ' ' CD2' ' A' ' 124' ' ' LEU . 2.7 mt-30 -60.04 -41.37 92.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -60.11 -41.53 92.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 110.293 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.71 -48.58 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.919 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.3 OUTLIER -96.28 3.69 52.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.005 -1.06 . . . . 0.0 110.905 -172.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.618 ' HA ' HG22 ' A' ' 164' ' ' ILE . 3.4 tt -41.58 165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 110.492 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.95 47.43 0.18 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 111.319 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.7 OUTLIER -133.61 135.06 24.33 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.949 -1.094 . . . . 0.0 111.051 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.844 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 7.4 Cg_endo -54.33 119.76 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.815 1.429 . . . . 0.0 109.498 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.672 ' O ' HG22 ' A' ' 162' ' ' VAL . 93.5 mmm -133.26 141.94 48.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.586 -1.321 . . . . 0.0 110.738 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.773 ' H ' HD13 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.67 145.93 25.42 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.703 0.763 . . . . 0.0 110.752 175.338 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -53.47 158.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.594 -0.691 . . . . 0.0 111.085 -174.307 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.6 -6.17 1.84 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.83 -0.544 . . . . 0.0 110.798 177.372 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.735 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.3 p30 -70.22 169.15 14.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -136.01 138.95 42.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 120.986 -1.071 . . . . 0.0 110.338 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.262 0.553 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -108.6 108.39 19.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.735 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.2 t -79.72 136.22 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.036 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.89 -22.74 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 110.784 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -150.01 151.24 32.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.843 -1.161 . . . . 0.0 110.976 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.007 HG22 HG23 ' A' ' 98' ' ' VAL . 34.5 p -141.66 169.39 17.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 109.389 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.44 -40.27 0.46 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.698 -178.197 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.973 ' CB ' HG11 ' A' ' 162' ' ' VAL . 17.1 Cg_exo -58.99 -164.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.718 1.378 . . . . 0.0 110.425 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.518 ' HB3' HG22 ' A' ' 160' ' ' VAL . 23.6 t -89.98 -171.36 3.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.804 175.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -67.44 -6.09 17.78 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.165 -0.959 . . . . 0.0 110.498 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 158' ' ' SER . 23.8 m -87.59 148.3 43.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.405 -177.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.665 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.23 143.34 7.86 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.267 1.667 . . . . 0.0 110.628 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.973 HG11 ' CB ' ' A' ' 157' ' ' PRO . 9.1 m -130.04 159.37 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.58 122.43 44.96 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.838 -1.163 . . . . 0.0 110.13 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.756 ' CD1' HG21 ' A' ' 168' ' ' THR . 8.0 mm -69.54 158.31 6.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.68 -0.638 . . . . 0.0 110.196 -176.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.64 167.08 26.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.53 -23.09 57.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -1.043 . . . . 0.0 110.248 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.99 -12.07 39.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.152 -0.967 . . . . 0.0 110.087 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 95' ' ' ALA . 5.6 m -57.75 179.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.129 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 168' ' ' THR . 50.0 mtpt -140.54 159.66 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.812 HG23 HD21 ' A' ' 100' ' ' LEU . 4.3 mt -140.02 168.0 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 110.834 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.529 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 13.5 mt-10 -139.17 131.73 28.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.609 -0.682 . . . . 0.0 110.195 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.501 HD13 ' HG ' ' A' ' 100' ' ' LEU . 37.2 mm -119.97 119.94 61.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.87 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.475 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 6.1 ptp180 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.23 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.445 ' O ' HD13 ' A' ' 34' ' ' LEU . 32.2 m120 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.177 0.513 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -152.01 -166.2 13.85 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.017 ' CG2' HD12 ' A' ' 33' ' ' LEU . 37.3 pt -135.75 159.98 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -1.179 . . . . 0.0 109.811 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.7 mt -101.26 118.64 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.409 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.838 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.7 pt? -139.2 -170.78 2.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.7 ptp180 -107.9 135.45 49.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.818 -1.176 . . . . 0.0 110.802 -173.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.02 ' CG2' HD11 ' A' ' 69' ' ' ILE . 14.3 p -62.97 131.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.702 . . . . 0.0 110.774 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -113.91 152.97 30.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.928 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 110.246 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.492 ' NH2' ' CE2' ' A' ' 55' ' ' TYR . 69.4 mtp180 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.242 0.544 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.094 HG13 HG23 ' A' ' 67' ' ' VAL . 97.5 t -120.0 124.28 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.102 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.548 ' O ' HD12 ' A' ' 26' ' ' LEU . 7.2 ptt180 -92.27 120.05 32.45 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.786 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.767 HD13 HG12 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -134.05 164.81 26.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.574 -0.704 . . . . 0.0 109.825 -176.433 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -93.54 -177.34 4.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.004 -1.06 . . . . 0.0 110.555 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.02 -47.33 86.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.672 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 58.1 m -66.32 -43.74 85.33 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.45 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.114 ' O ' HD22 ' A' ' 33' ' ' LEU . 55.8 p -60.81 -26.89 67.63 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 53.3 ttp180 -88.35 -45.93 9.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.584 -0.697 . . . . 0.0 110.89 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 99.5 mtt180 -76.59 -10.04 59.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 0.0 109.896 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.114 HD22 ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -41.25 -30.03 0.15 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.607 0.718 . . . . 0.0 109.948 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.762 ' H ' HD23 ' A' ' 33' ' ' LEU . 73.8 mt -139.98 -61.18 0.53 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.574 -0.704 . . . . 0.0 110.63 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 16.2 t0 -169.98 -28.73 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.551 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.619 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -23.71 118.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.558 0.694 . . . . 0.0 111.457 -175.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.659 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.4 pt-20 -104.63 177.59 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 38' ' ' ILE . 26.5 mm -58.1 122.59 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.963 -1.086 . . . . 0.0 109.933 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.562 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.51 30.14 60.67 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.451 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 33.8 m-20 -89.28 174.4 7.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.832 -1.393 . . . . 0.0 109.411 170.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.637 HG21 ' N ' ' A' ' 92' ' ' THR . 96.6 t -99.38 124.69 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.238 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.67 HG11 HG23 ' A' ' 54' ' ' VAL . 2.5 m -111.82 140.04 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.27 -0.893 . . . . 0.0 110.489 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' C ' HD12 ' A' ' 44' ' ' ILE . 41.7 tt0 -108.1 143.91 36.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.764 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.905 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.8 mp -119.8 144.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.068 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -151.51 87.69 1.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.833 -1.167 . . . . 0.0 111.604 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.761 ' HB2' HG12 ' A' ' 85' ' ' VAL . 38.5 tttp -98.57 -75.95 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 110.287 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.51 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -91.78 -33.81 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.481 -0.762 . . . . 0.0 109.62 177.424 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 91.6 mtt180 -143.93 -172.31 3.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.686 ' C ' HD21 ' A' ' 130' ' ' LEU . 14.2 mptt -87.95 132.19 34.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.679 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.554 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -133.95 158.78 42.62 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.293 0.568 . . . . 0.0 110.226 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.12 161.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 110.174 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.575 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -176.92 179.39 47.89 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.82 -178.78 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.248 -1.148 . . . . 0.0 109.981 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.67 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -110.47 135.3 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 110.373 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -128.02 167.67 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.285 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 35.2 ptt180 -89.32 124.9 34.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.078 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.8 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -61.84 131.54 50.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.946 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.644 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 11.5 mtt180 -59.51 -42.09 90.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 C-N-CA 119.101 -1.039 . . . . 0.0 109.367 175.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.644 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 29.3 Cg_endo -94.33 99.83 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.886 1.467 . . . . 0.0 108.998 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 12.0 pt-20 -72.77 32.61 0.07 Allowed 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.392 -0.817 . . . . 0.0 110.859 -175.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.6 m-20 -148.58 -26.66 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 0.0 110.701 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 66' ' ' ILE . 52.9 mt-10 -86.26 -28.48 23.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 109.109 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.8 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 43.5 m-80 -81.12 42.22 0.64 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.361 0.6 . . . . 0.0 110.375 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HD3' ' OD2' ' A' ' 27' ' ' ASP . 37.2 mmtt -96.76 6.32 48.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.287 177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.4 29.55 0.05 OUTLIER Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 9' ' ' LEU . 45.7 pt -140.78 145.12 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.224 -1.162 . . . . 0.0 109.525 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.094 HG23 HG13 ' A' ' 24' ' ' VAL . 2.6 p -123.17 130.0 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.827 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.539 ' CD ' ' HD3' ' A' ' 25' ' ' ARG . 71.3 ttt180 -91.6 114.62 27.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 110.131 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.02 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.6 pt -130.16 159.98 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.679 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -81.09 169.57 17.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 110.227 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -57.86 -22.55 48.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.07 -48.84 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.905 ' HE1' HD13 ' A' ' 44' ' ' ILE . 97.0 mmm -60.03 -43.91 94.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.953 . . . . 0.0 109.6 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -59.98 -40.49 89.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.25 -0.906 . . . . 0.0 110.04 174.402 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -69.49 -35.87 75.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.532 ' HB3' HG22 ' A' ' 50' ' ' THR . 20.6 m120 -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.269 -0.894 . . . . 0.0 110.372 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.6 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.7 p -98.36 -35.79 10.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 110.607 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.51 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 109.92 28.05 4.34 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.603 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -100.39 177.63 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.242 . . . . 0.0 111.016 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.903 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -122.81 172.24 8.6 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -0.853 . . . . 0.0 109.196 175.392 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.928 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -62.19 142.23 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.717 -1.239 . . . . 0.0 110.561 179.239 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.566 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 74.55 -0.61 55.15 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 173.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -59.65 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.097 -1.237 . . . . 0.0 110.33 175.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 19.1 pttp -133.2 116.33 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.575 -0.703 . . . . 0.0 109.904 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -122.12 160.12 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 110.023 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 40.1 tttt -107.4 120.66 42.77 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.523 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 72.3 t -103.96 122.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 0.0 109.998 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.507 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 96.1 mtt180 -110.0 148.03 32.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.629 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.619 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 2.4 tmtt? -93.86 136.01 34.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.056 -1.027 . . . . 0.0 110.53 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.1 m -149.81 -170.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.927 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 52.7 mtt180 -132.85 164.41 26.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 110.41 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.637 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.45 159.39 17.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 111.224 -176.13 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.653 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.8 pt-20 -150.42 169.99 20.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 94' ' ' ILE . 48.5 mm -89.17 101.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.827 -1.17 . . . . 0.0 110.264 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.918 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.38 135.46 53.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.266 -0.896 . . . . 0.0 110.184 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.552 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 7.1 ptpp? -97.24 -29.75 13.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -0.973 . . . . 0.0 111.112 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.682 ' HB3' HD23 ' A' ' 156' ' ' LEU . 47.3 tttm -151.27 126.66 10.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 110.789 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.037 HG23 HG22 ' A' ' 155' ' ' THR . 9.2 p -136.53 145.98 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.122 . . . . 0.0 110.881 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -119.74 139.45 52.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.051 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.746 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.55 166.09 23.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.505 -177.669 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.51 89.65 11.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.33 -0.857 . . . . 0.0 110.466 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.0 Cg_exo . . . . . 0 C--N 1.305 -1.718 0 O-C-N 123.997 1.525 . . . . 0.0 110.434 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.2 tp . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.12 0.486 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.557 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -67.31 -39.98 85.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.905 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.04 -31.46 69.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.05 -41.69 92.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 110.076 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.759 HG12 ' CD1' ' A' ' 170' ' ' ILE . 55.0 t -60.08 -45.92 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.57 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.2 mt-30 -60.0 -42.74 94.93 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 110.273 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.13 -47.94 83.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.481 -0.762 . . . . 0.0 110.151 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.17 75.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.532 -0.73 . . . . 0.0 110.318 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.524 HD12 ' CG1' ' A' ' 120' ' ' VAL . 51.5 mt -93.76 -5.72 47.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.416 -176.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.846 HD11 ' HG2' ' A' ' 166' ' ' GLU . 2.5 tt -45.91 167.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.926 -1.109 . . . . 0.0 110.207 -172.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 164' ' ' ILE . 32.0 ptt180 33.82 48.24 0.21 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.672 -0.642 . . . . 0.0 111.768 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 9.3 mmt85 -136.57 148.98 65.93 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 120.533 -1.355 . . . . 0.0 111.83 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.838 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -66.19 130.6 24.52 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.24 1.652 . . . . 0.0 109.653 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.522 ' SD ' HG13 ' A' ' 164' ' ' ILE . 39.9 mtp -130.58 150.06 51.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.44 -1.412 . . . . 0.0 111.207 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.686 HD21 ' C ' ' A' ' 49' ' ' LYS . 16.5 tp -144.44 107.93 4.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.663 -0.648 . . . . 0.0 109.637 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.2 pm0 -44.71 142.9 1.55 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.359 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.571 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.6 OUTLIER 80.39 -0.85 1.96 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.125 0.488 . . . . 0.0 110.259 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.603 ' OD2' HG21 ' A' ' 152' ' ' VAL . 4.2 p-10 -70.0 179.4 2.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 109.85 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.525 ' OD1' ' HD2' ' A' ' 151' ' ' LYS . 13.4 m-80 -150.17 136.1 18.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.632 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.008 -1.057 . . . . 0.0 110.303 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 30.0 m-85 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.337 0.589 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.525 ' HD2' ' OD1' ' A' ' 134' ' ' ASN . 19.3 tptp -112.31 103.63 11.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.873 . . . . 0.0 109.75 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.603 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.1 t -77.44 140.01 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.14 -25.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 111.372 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 45.0 tptt -140.24 129.93 24.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.587 -1.321 . . . . 0.0 110.885 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.037 HG22 HG23 ' A' ' 98' ' ' VAL . 59.7 p -129.99 166.31 20.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.389 -0.82 . . . . 0.0 109.164 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -89.05 -35.47 0.42 Allowed Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.084 -1.01 . . . . 0.0 110.98 -176.58 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 1.048 ' CG ' HG11 ' A' ' 162' ' ' VAL . 31.6 Cg_exo -53.1 -179.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.4 1.211 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.709 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -84.83 49.76 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.516 -179.238 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.6 mmtm 59.99 20.03 9.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.731 ' O ' HG13 ' A' ' 162' ' ' VAL . 11.5 m -109.41 159.74 30.3 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.411 -0.806 . . . . 0.0 110.326 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.555 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.1 Cg_endo -53.87 123.29 13.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.198 1.631 . . . . 0.0 110.2 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 1.048 HG11 ' CG ' ' A' ' 157' ' ' PRO . 5.0 m -129.78 158.46 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.879 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -103.2 128.1 50.29 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.009 177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.945 HD12 HG21 ' A' ' 168' ' ' THR . 10.7 mm -70.26 154.22 8.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.636 -0.665 . . . . 0.0 110.036 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.07 170.98 24.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.846 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.88 -21.27 28.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -1.088 . . . . 0.0 110.074 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.45 -21.42 21.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 109.791 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.945 HG21 HD12 ' A' ' 164' ' ' ILE . 69.3 m -54.85 138.83 41.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.012 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.1 mttt -93.08 149.52 21.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.133 -0.979 . . . . 0.0 109.59 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.759 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.1 mt -130.0 160.52 40.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.935 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.496 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 30.8 mt-10 -135.19 136.12 41.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.637 -0.665 . . . . 0.0 110.173 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.59 HD11 HG21 ' A' ' 120' ' ' VAL . 40.6 mm -119.98 122.27 68.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.67 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.613 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 6.4 ptp180 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 110.148 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.71 HD21 ' N ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.486 0.66 . . . . 0.0 110.467 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -150.72 -155.24 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.965 ' CG2' HD12 ' A' ' 33' ' ' LEU . 12.2 pt -131.08 159.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.13 . . . . 0.0 109.193 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.614 ' C ' HD23 ' A' ' 9' ' ' LEU . 92.2 mt -100.64 122.5 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.011 -1.055 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.857 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -139.62 -175.81 4.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.596 177.128 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 33.5 ptt180 -110.68 139.72 45.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.869 -1.145 . . . . 0.0 110.964 -175.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.972 HG23 HD11 ' A' ' 69' ' ' ILE . 14.6 p -61.82 130.05 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.661 -0.649 . . . . 0.0 110.755 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.648 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -107.84 151.62 25.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 110.423 177.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.569 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.145 0.498 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.074 HG13 HG23 ' A' ' 67' ' ' VAL . 78.7 t -119.46 118.46 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 3.2 ptt180 -88.6 117.36 27.5 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.431 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.2 pt? -136.63 169.09 18.28 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.672 -0.642 . . . . 0.0 109.353 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 7.6 p-10 -97.12 -171.96 2.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.806 -1.184 . . . . 0.0 111.17 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -59.8 -49.22 78.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.49 -0.757 . . . . 0.0 109.476 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.8 t -62.03 -47.39 84.97 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.409 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.115 ' O ' HD22 ' A' ' 33' ' ' LEU . 25.1 t -57.59 -29.64 64.64 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.173 -0.955 . . . . 0.0 109.545 178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 60.0 ttp85 -85.89 -45.47 11.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -80.09 -4.85 54.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.008 -1.058 . . . . 0.0 110.111 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.115 HD22 ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -47.49 -27.92 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.788 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 33' ' ' LEU . 71.6 mt -139.9 -60.04 0.54 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.659 -0.65 . . . . 0.0 110.377 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' C ' ' A' ' 36' ' ' ALA . 44.1 t0 -170.75 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.905 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB2' ' HD3' ' A' ' 89' ' ' LYS . . . -19.94 124.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.563 0.697 . . . . 0.0 111.824 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.3 pt-20 -116.88 -179.76 3.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 29.7 mm -59.99 130.1 23.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.777 -1.202 . . . . 0.0 109.689 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.518 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.75 19.13 73.92 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.942 173.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.544 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 85.1 m-20 -90.24 171.9 9.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.595 -1.532 . . . . 0.0 109.779 172.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.696 HG21 ' N ' ' A' ' 92' ' ' THR . 61.1 t -98.91 138.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 0.0 110.522 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.618 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.9 m -126.46 139.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -107.41 145.3 33.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.595 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.805 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.6 mp -120.02 148.29 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 110.446 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 40.9 tt0 -151.45 94.17 1.98 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.977 . . . . 0.0 110.779 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.992 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.8 tmtm? -98.84 -66.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.703 173.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.574 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -106.72 -32.78 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.481 175.364 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 74.6 mtt85 -136.87 -172.64 3.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.674 ' HB3' HD21 ' A' ' 130' ' ' LEU . 36.7 mttt -88.83 139.28 30.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.984 -1.073 . . . . 0.0 111.05 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.579 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.69 160.18 39.94 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.299 0.571 . . . . 0.0 110.221 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.676 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.13 161.22 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.269 -0.894 . . . . 0.0 109.977 178.018 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.62 -179.78 47.93 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 51.9 ttp180 -121.69 169.37 10.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -1.028 . . . . 0.0 110.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -91.48 138.86 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 111.014 -172.658 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -128.55 162.66 26.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.502 -0.749 . . . . 0.0 109.887 174.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -89.01 123.63 33.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.891 . . . . 0.0 110.128 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.809 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.19 139.13 58.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.603 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -59.99 -48.91 93.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.15 174.09 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.4 Cg_endo -91.67 99.1 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.866 1.456 . . . . 0.0 108.993 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -73.91 36.34 0.09 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.585 -0.697 . . . . 0.0 111.126 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -145.39 -36.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.073 -1.017 . . . . 0.0 111.165 -178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.8 pt-20 -85.87 -24.43 26.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.905 -1.122 . . . . 0.0 110.172 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.809 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 31.6 m120 -82.3 37.82 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 110.695 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 49.1 pttt -98.49 18.17 17.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 109.641 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.79 20.85 0.03 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.522 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -141.61 157.01 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -1.068 . . . . 0.0 109.191 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.074 HG23 HG13 ' A' ' 24' ' ' VAL . 4.6 p -135.57 131.11 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.863 -1.148 . . . . 0.0 109.86 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.648 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 34.6 ttm180 -96.99 118.16 32.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.974 -1.079 . . . . 0.0 110.24 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.972 HD11 HG23 ' A' ' 11' ' ' VAL . 3.7 pt -131.69 172.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.639 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -78.61 170.08 17.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.371 -0.831 . . . . 0.0 109.978 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.2 p -65.34 -27.56 68.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 110.01 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.44 -46.12 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.805 ' HE1' HD13 ' A' ' 44' ' ' ILE . 12.7 tpt -60.33 -44.69 95.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.457 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 43.6 ttp180 -60.17 -40.03 88.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 0.0 109.721 174.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -71.48 -22.99 61.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.578 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 73' ' ' MET . 59.3 m-20 -60.01 -36.88 78.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 0.0 110.272 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.544 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.2 p -98.4 -38.82 9.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 0.0 110.319 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.574 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 117.21 36.36 1.03 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 177.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.82 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -110.45 167.93 9.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -1.204 . . . . 0.0 110.475 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.663 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.72 169.77 8.74 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.241 -0.912 . . . . 0.0 109.226 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -54.58 139.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.924 -1.11 . . . . 0.0 110.767 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.55 2.2 79.45 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 172.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -58.8 -162.88 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.023 -1.281 . . . . 0.0 110.445 175.694 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 21.9 pttm -133.61 113.48 12.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 109.981 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.992 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -125.09 160.12 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.389 -0.82 . . . . 0.0 109.586 178.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.5 tttt -110.24 125.4 53.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 110.048 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.584 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 66.1 t -99.25 119.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 110.009 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.479 ' NH2' ' HD3' ' A' ' 86' ' ' LYS . 84.4 mtt85 -103.19 145.2 30.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.832 . . . . 0.0 109.234 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 36' ' ' ALA . 29.8 tptt -99.74 135.42 41.19 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.94 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.488 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 3.1 m -150.08 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.575 0.702 . . . . 0.0 110.132 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.457 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 33.1 mtp85 -127.87 172.41 10.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.598 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.696 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.46 163.42 12.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 111.172 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.61 ' HG2' HG12 ' A' ' 162' ' ' VAL . 14.9 pt-20 -150.22 169.94 20.14 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.3 mm -89.01 100.62 10.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.909 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -53.89 139.94 32.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.315 -0.866 . . . . 0.0 110.173 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.549 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 17.8 ptpt -95.56 -28.75 14.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.203 -0.936 . . . . 0.0 110.999 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 21.6 ttpt -150.6 120.0 6.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.707 -1.246 . . . . 0.0 110.616 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.927 HG23 HG22 ' A' ' 155' ' ' THR . 8.2 p -130.03 140.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.01 . . . . 0.0 111.022 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.742 HG23 ' HB3' ' A' ' 171' ' ' GLU . 38.2 m -116.68 148.75 40.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.07 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.886 HD13 ' N ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -150.7 179.94 7.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 0.0 110.678 178.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB2' ' HD2' ' A' ' 173' ' ' ARG . . . -144.45 101.14 4.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 111.117 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.483 ' HG3' ' CE2' ' A' ' 150' ' ' PHE . 13.0 Cg_exo . . . . . 0 C--N 1.306 -1.696 0 O-C-N 124.038 1.547 . . . . 0.0 110.035 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.496 HG23 ' N ' ' A' ' 117' ' ' GLU . 20.8 tt . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.186 0.517 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.0 mt-10 -60.22 -41.9 94.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.117 -0.99 . . . . 0.0 109.763 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -68.91 -36.05 77.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.16 -41.15 92.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.401 -0.812 . . . . 0.0 109.714 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 170' ' ' ILE . 58.5 t -60.27 -45.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.275 174.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.1 mt-30 -59.85 -41.8 92.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.576 -0.703 . . . . 0.0 110.319 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -60.18 -49.83 76.08 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.342 -0.849 . . . . 0.0 109.835 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.29 -40.29 70.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -0.753 . . . . 0.0 110.722 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 124' ' ' LEU . 4.4 mm? -93.36 -0.87 56.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.956 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.2 tt -47.96 165.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.97 -1.081 . . . . 0.0 110.075 -177.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ILE . 9.7 ptm180 32.23 46.28 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.537 -0.727 . . . . 0.0 111.37 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.483 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -128.07 133.6 25.31 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.997 -1.064 . . . . 0.0 110.667 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.6 Cg_exo -58.49 139.35 90.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.995 1.524 . . . . 0.0 109.756 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.532 ' HG3' HG12 ' A' ' 164' ' ' ILE . 92.2 mmm -133.66 146.92 51.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.373 -1.455 . . . . 0.0 110.891 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 49' ' ' LYS . 14.5 tp -147.8 112.12 5.24 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.3 pm0 -46.69 139.51 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.625 -1.297 . . . . 0.0 110.108 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.575 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 79.71 -3.14 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.254 0.549 . . . . 0.0 110.468 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.3 p30 -68.47 -169.96 0.18 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 175.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.408 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 23.5 m-80 -147.01 155.52 42.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.704 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.074 -1.016 . . . . 0.0 109.937 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.483 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 37.4 m-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.311 0.576 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 133' ' ' ASP . 18.6 tptm -115.13 108.79 17.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.666 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 132' ' ' GLN . 10.6 t -75.23 131.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.104 -0.998 . . . . 0.0 110.091 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.2 t -113.0 -25.44 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.216 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.31 151.16 34.9 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.707 -1.246 . . . . 0.0 111.12 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.927 HG22 HG23 ' A' ' 98' ' ' VAL . 82.4 p -142.54 162.27 35.92 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.673 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.9 -34.19 0.41 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.283 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.969 ' CG ' HG11 ' A' ' 162' ' ' VAL . 35.4 Cg_exo -54.39 -171.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.285 1.15 . . . . 0.0 110.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.562 ' O ' HG13 ' A' ' 160' ' ' VAL . 15.7 t -88.19 43.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 0.0 110.35 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 158' ' ' SER . 33.1 mmtp 61.27 20.0 10.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.856 ' O ' HG13 ' A' ' 162' ' ' VAL . 18.2 m -105.58 154.75 38.95 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.676 ' HB3' HG12 ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.61 119.89 4.67 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.08 1.568 . . . . 0.0 110.131 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.969 HG11 ' CG ' ' A' ' 157' ' ' PRO . 6.3 m -129.54 159.97 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.138 175.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -110.01 136.72 48.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.104 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.78 ' CD1' HG21 ' A' ' 168' ' ' THR . 14.7 mm -71.11 154.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.692 -0.63 . . . . 0.0 110.225 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.63 170.02 24.37 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 175.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -58.05 -23.11 53.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -1.119 . . . . 0.0 110.264 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -94.04 -15.61 24.63 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.135 -0.978 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.78 HG21 ' CD1' ' A' ' 164' ' ' ILE . 91.9 m -58.43 144.02 43.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 23.0 mttp -97.51 154.32 17.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.889 -1.132 . . . . 0.0 109.763 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.672 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.7 mt -130.09 164.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 0.0 111.04 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.742 ' HB3' HG23 ' A' ' 99' ' ' THR . 16.7 mt-10 -138.16 137.47 37.68 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.34 0.59 . . . . 0.0 110.147 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.641 HD13 HD21 ' A' ' 100' ' ' LEU . 31.8 mm -122.16 129.29 75.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.443 -0.785 . . . . 0.0 109.797 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.439 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 6.8 ptm180 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.081 -1.012 . . . . 0.0 110.275 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.255 0.55 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.89 -168.22 16.57 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.838 ' CG2' HD12 ' A' ' 33' ' ' LEU . 26.6 pt -134.16 166.77 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.386 -1.067 . . . . 0.0 109.861 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.492 HD11 ' HD3' ' A' ' 86' ' ' LYS . 35.2 mm -103.22 115.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 110.341 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 9' ' ' LEU . 1.7 pt? -138.19 -172.75 3.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.088 -1.008 . . . . 0.0 109.7 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.6 ptt180 -112.19 138.0 49.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.838 -1.164 . . . . 0.0 110.765 -174.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.087 ' CG2' HD11 ' A' ' 69' ' ' ILE . 8.4 p -62.03 134.61 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.531 -0.73 . . . . 0.0 110.54 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -111.6 166.64 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 0.0 110.89 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.774 ' CB ' HD11 ' A' ' 81' ' ' ILE . 51.5 tp10 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.19 0.519 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 53.0 t -110.13 119.89 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HD3' ' HD3' ' A' ' 68' ' ' ARG . 4.6 ptt180 -89.27 121.67 31.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.787 -1.196 . . . . 0.0 109.524 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.928 HD21 HG22 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -137.32 166.81 22.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.761 -174.75 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.487 ' N ' ' HB3' ' A' ' 63' ' ' ASN . 6.4 p-10 -101.49 -170.39 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.906 -1.121 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.1 -44.41 94.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.539 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 44.9 t -65.98 -49.9 66.2 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.346 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.068 ' O ' HD22 ' A' ' 33' ' ' LEU . 58.1 m -56.38 -27.33 55.87 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 49.2 ttp180 -85.58 -48.29 9.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.87 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -83.08 -6.06 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.038 . . . . 0.0 110.011 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.068 HD22 ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -44.12 -28.16 0.47 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.621 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.837 ' H ' HD23 ' A' ' 33' ' ' LEU . 82.9 mt -143.8 -59.98 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.517 -0.74 . . . . 0.0 110.617 176.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.3 t0 -170.88 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.302 -0.873 . . . . 0.0 110.852 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -30.77 127.56 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 110.915 -175.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.66 ' O ' HG11 ' A' ' 54' ' ' VAL . 2.3 pt-20 -112.51 -178.08 3.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 38' ' ' ILE . 34.7 mm -59.98 120.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.945 -1.097 . . . . 0.0 109.976 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.597 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 72.8 33.55 60.13 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 174.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 2.2 m-20 -89.52 178.86 6.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.806 -1.408 . . . . 0.0 109.556 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 92' ' ' THR . 79.5 t -99.26 129.58 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.203 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 52' ' ' GLY . 7.5 m -123.57 147.2 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -0.792 . . . . 0.0 110.625 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 88' ' ' ARG . 86.0 tt0 -115.62 139.95 49.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.928 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -122.78 147.61 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 0.0 110.566 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.4 tt0 -150.08 97.61 2.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 110.633 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.024 ' CG ' HG12 ' A' ' 85' ' ' VAL . 14.3 tmtt? -98.62 -67.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.566 HG22 ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -102.32 -35.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.162 173.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 92.9 mtt-85 -127.63 -168.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.31 0.576 . . . . 0.0 109.736 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.975 ' HG2' HD21 ' A' ' 130' ' ' LEU . 1.3 ttpm? -103.73 137.2 42.1 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.36 -0.838 . . . . 0.0 110.212 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.763 ' HA ' HD23 ' A' ' 130' ' ' LEU . 8.7 p -142.8 170.53 15.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 110.254 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -122.84 167.76 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.521 -0.737 . . . . 0.0 109.902 177.185 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.818 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -177.7 179.05 48.42 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -117.0 163.97 15.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.505 -0.997 . . . . 0.0 110.139 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.928 HG22 HD21 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -97.35 137.5 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.07 -1.018 . . . . 0.0 110.45 -172.008 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -122.12 166.48 14.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 110.116 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -89.65 124.44 34.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 110.328 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.709 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.33 132.58 50.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.097 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.74 -46.04 99.59 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.984 -1.072 . . . . 0.0 109.296 173.496 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 14.7 Cg_endo -89.89 99.18 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.022 1.538 . . . . 0.0 109.055 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.11 33.62 0.07 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.557 -0.715 . . . . 0.0 110.866 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 59' ' ' PRO . 52.8 t0 -148.78 -29.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 110.703 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.69 -29.22 22.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.438 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.709 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 4.7 m120 -80.94 39.35 0.49 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.699 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 11.3 ptpt -98.54 10.71 40.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.606 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.442 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.4 pt -141.05 142.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.304 -1.115 . . . . 0.0 109.436 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 1.8 p -119.47 125.89 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.117 -0.99 . . . . 0.0 109.995 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.509 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 70.4 ttt180 -90.05 113.04 24.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.087 HD11 ' CG2' ' A' ' 11' ' ' VAL . 3.0 pt -126.17 163.04 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.793 . . . . 0.0 110.77 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.92 158.67 35.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.81 . . . . 0.0 109.932 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.592 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 79.9 p -61.7 -24.64 66.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.59 -42.88 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 110.323 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.928 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -59.92 -49.98 75.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 109.929 178.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -63.87 -33.44 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.682 176.238 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.501 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 60.4 t-20 -68.08 -32.57 72.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.962 . . . . 0.0 109.933 175.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.439 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 98.5 m-20 -60.03 -40.01 87.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.877 . . . . 0.0 110.535 -178.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.458 ' HB2' ' H ' ' A' ' 48' ' ' ARG . 27.6 p -98.34 -38.52 9.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.602 -176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.564 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 120.16 40.63 0.58 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.765 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -116.03 158.44 23.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.944 -1.327 . . . . 0.0 110.726 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.613 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -112.44 166.84 10.94 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 175.536 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.774 HD11 ' CB ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -51.33 139.96 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.989 -1.069 . . . . 0.0 110.505 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.28 0.61 72.05 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 171.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.18 -160.12 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.876 -1.367 . . . . 0.0 110.225 174.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 40.1 pttt -132.62 113.32 12.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.549 -0.719 . . . . 0.0 109.813 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.024 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -124.35 159.67 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.201 -0.937 . . . . 0.0 109.898 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.6 ttpt -105.21 127.96 53.18 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.218 -0.927 . . . . 0.0 109.868 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.502 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 63.3 t -109.84 121.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 109.714 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' NH2' ' OE2' ' A' ' 43' ' ' GLU . 84.4 mtm180 -110.23 140.03 44.78 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.456 -0.777 . . . . 0.0 109.552 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.59 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.22 136.69 32.92 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.069 -1.02 . . . . 0.0 110.001 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 41' ' ' VAL . 2.7 m -150.01 -171.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.539 -0.725 . . . . 0.0 110.212 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.515 ' NH1' ' HB2' ' A' ' 91' ' ' ARG . 1.6 ptm85 -126.8 170.07 12.57 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.643 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.47 165.34 11.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.054 -1.029 . . . . 0.0 111.078 -175.192 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.566 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.4 pt-20 -149.96 167.72 25.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm -89.57 97.78 7.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.542 -1.349 . . . . 0.0 110.336 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.88 161.8 1.47 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 110.663 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.907 ' HE3' HD22 ' A' ' 156' ' ' LEU . 25.0 pttt -125.44 -24.71 3.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 110.493 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.959 ' CB ' HD12 ' A' ' 156' ' ' LEU . 15.7 tttp -150.92 127.81 11.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.843 -1.16 . . . . 0.0 110.394 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.993 HG23 HG22 ' A' ' 155' ' ' THR . 7.4 p -139.94 144.65 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.351 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.458 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.2 m -118.52 132.27 56.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 110.253 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.763 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.09 160.02 33.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.375 -178.356 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HB2' ' HG2' ' A' ' 173' ' ' ARG . . . -138.83 93.69 10.55 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 34.7 Cg_exo . . . . . 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.264 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.5 tp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.178 0.513 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.461 ' N ' HG23 ' A' ' 116' ' ' ILE . 96.7 mt-10 -59.92 -42.79 94.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.112 -0.992 . . . . 0.0 109.997 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.84 -37.49 76.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -59.96 -39.23 84.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.559 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.79 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.5 t -60.07 -47.8 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.674 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.74 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -61.39 -40.03 92.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 177.481 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.05 -46.43 89.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.61 -41.29 65.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.547 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.6 mm? -94.31 -4.3 48.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.168 -0.957 . . . . 0.0 111.227 -174.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.758 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.5 tt -44.49 167.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.774 -1.203 . . . . 0.0 110.267 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 164' ' ' ILE . 52.9 ptt85 33.3 51.21 0.3 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.666 -0.646 . . . . 0.0 111.788 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -137.79 150.22 67.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.833 -1.167 . . . . 0.0 111.074 175.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.841 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 18.2 Cg_endo -65.56 130.35 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.042 1.549 . . . . 0.0 110.026 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.577 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 88.1 mmm -125.0 139.17 54.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.515 -1.366 . . . . 0.0 111.052 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.975 HD21 ' HG2' ' A' ' 49' ' ' LYS . 11.6 tp -144.15 113.59 7.02 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.636 -0.665 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 7.3 pm0 -47.47 143.87 3.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.116 . . . . 0.0 110.359 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 88.4 mm-40 81.33 -6.09 1.57 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.111 0.482 . . . . 0.0 110.334 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.618 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.1 p30 -69.88 173.78 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.149 -0.969 . . . . 0.0 109.903 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -137.72 146.9 44.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.802 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.085 -1.009 . . . . 0.0 110.144 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 29.4 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.242 0.544 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -104.87 110.63 23.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.072 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.618 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.5 t -76.37 138.86 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 t -117.38 -28.39 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.194 -0.941 . . . . 0.0 111.047 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -148.59 151.51 35.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.767 -1.208 . . . . 0.0 111.173 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.993 HG22 HG23 ' A' ' 98' ' ' VAL . 63.8 p -139.75 158.29 44.34 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.959 HD12 ' CB ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -89.1 -34.01 0.4 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.867 -176.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.988 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.5 Cg_exo -56.99 -161.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.269 1.141 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.432 ' HB3' HG22 ' A' ' 160' ' ' VAL . 13.3 t -90.13 179.09 6.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 109.869 176.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.418 ' HE2' ' NZ ' ' A' ' 49' ' ' LYS . 13.9 tttt -61.31 -10.12 6.47 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.863 . . . . 0.0 110.425 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 158' ' ' SER . 13.6 m -84.66 153.13 61.04 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.467 -0.77 . . . . 0.0 110.159 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.529 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -48.87 142.76 18.68 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.248 1.657 . . . . 0.0 110.613 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.988 HG11 ' CB ' ' A' ' 157' ' ' PRO . 13.7 m -130.02 160.0 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.1 tt0 -108.71 127.51 54.05 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.022 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.836 HD12 HG21 ' A' ' 168' ' ' THR . 12.9 mm -71.08 153.05 8.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 121.434 0.635 . . . . 0.0 110.334 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.546 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.94 166.91 26.15 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 125' ' ' ILE . 13.6 pt-20 -56.95 -19.81 20.12 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.369 -1.077 . . . . 0.0 110.197 -177.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.16 -14.03 39.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.872 . . . . 0.0 110.326 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.836 HG21 HD12 ' A' ' 164' ' ' ILE . 21.0 m -62.04 147.8 46.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 109.856 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mttm -94.46 157.5 15.98 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.929 -1.107 . . . . 0.0 110.256 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.79 HD12 ' CG1' ' A' ' 120' ' ' VAL . 3.4 mm -118.93 129.91 74.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.363 -0.835 . . . . 0.0 110.691 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.58 ' O ' HD13 ' A' ' 172' ' ' ILE . 20.1 mt-10 -110.96 130.08 55.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 110.225 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.58 HD13 ' O ' ' A' ' 171' ' ' GLU . 33.5 mm -125.8 125.74 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.884 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.581 ' O ' ' NE ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 0.0 110.713 -177.144 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.303 0.573 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -148.33 -161.04 9.35 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.969 HG21 HD22 ' A' ' 33' ' ' LEU . 47.6 pt -131.01 160.01 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.936 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.1 mt -99.55 114.46 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 110.239 -178.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.2 pt? -137.86 -172.39 3.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 109.96 178.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.8 ptp180 -115.55 139.05 50.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.785 -1.197 . . . . 0.0 110.714 -172.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.95 HG23 HD11 ' A' ' 69' ' ' ILE . 4.6 p -61.17 137.91 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.505 -0.747 . . . . 0.0 110.115 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -120.97 155.6 33.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 110.478 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.541 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 175.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 95.6 mtt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.083 0.468 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 92.8 t -116.6 120.03 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 110.237 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.649 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -92.41 119.97 32.46 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.757 -1.177 . . . . 0.0 109.945 177.814 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.927 HD23 HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -134.41 173.32 11.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.675 -177.06 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.482 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 17.5 p-10 -93.2 179.76 5.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.83 -1.169 . . . . 0.0 110.481 -178.47 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -59.97 -43.19 95.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.378 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.492 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 63.3 m -65.08 -44.56 88.52 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.545 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.711 ' CB ' HD12 ' A' ' 26' ' ' LEU . 59.4 m -60.0 -40.06 87.93 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.951 -1.093 . . . . 0.0 109.193 176.083 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 59.3 ttt180 -71.37 -44.4 65.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.876 -0.515 . . . . 0.0 111.734 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -93.34 -6.18 47.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.755 -1.216 . . . . 0.0 111.199 -169.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.032 HD12 ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -59.2 -31.37 68.96 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.584 -178.527 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.032 ' N ' HD12 ' A' ' 33' ' ' LEU . 31.6 mt -116.57 -66.4 1.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.111 -0.993 . . . . 0.0 110.674 175.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 36' ' ' ALA . 17.1 t0 -171.84 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.191 -0.943 . . . . 0.0 110.244 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.72 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -23.92 120.14 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.579 0.704 . . . . 0.0 111.408 -176.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.649 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -105.24 175.25 5.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.938 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.407 HG12 ' NH2' ' A' ' 31' ' ' ARG . 45.5 mm -56.69 127.15 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 120.966 -1.084 . . . . 0.0 109.663 178.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.06 24.49 68.9 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.39 174.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.81 174.0 8.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.724 -1.456 . . . . 0.0 109.247 171.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 92.6 t -102.59 130.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.995 -1.066 . . . . 0.0 110.432 -174.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.593 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -115.02 137.31 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.34 141.67 38.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.435 -0.79 . . . . 0.0 109.847 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -120.99 148.2 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.024 -1.047 . . . . 0.0 110.182 -176.442 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 39.3 tt0 -152.37 92.32 1.68 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 111.288 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.726 ' HD2' HG12 ' A' ' 85' ' ' VAL . 59.6 tttp -97.83 -77.05 0.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 0.0 110.123 172.43 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.609 HG21 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.0 -29.97 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.638 0.732 . . . . 0.0 109.688 176.76 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.447 ' H ' ' HB2' ' A' ' 77' ' ' CYS . 71.6 mtt85 -141.34 -172.7 3.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.463 176.401 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.712 ' C ' HD21 ' A' ' 130' ' ' LEU . 18.3 mttt -88.78 141.06 28.82 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.813 -177.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.568 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -140.37 156.47 46.4 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.388 0.614 . . . . 0.0 110.111 -179.103 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.596 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -126.07 160.15 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.142 -179.657 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.451 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -176.88 -177.45 45.84 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.413 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 96.0 mtt-85 -117.05 -179.01 3.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -1.071 . . . . 0.0 109.761 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.649 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -109.31 135.9 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.023 . . . . 0.0 110.681 -175.003 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.543 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -127.16 168.98 13.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.569 -0.707 . . . . 0.0 110.057 176.101 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -93.59 124.15 37.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 110.152 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.746 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.4 139.37 58.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.884 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.673 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.8 mtt-85 -57.31 -49.63 92.79 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.953 -1.092 . . . . 0.0 108.993 174.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.673 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 57.4 Cg_endo -93.08 98.51 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 109.034 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.54 37.07 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 121.593 -0.692 . . . . 0.0 110.482 -177.168 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 59' ' ' PRO . 68.3 m-20 -144.16 -33.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 110.461 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 66' ' ' ILE . 48.7 mt-10 -85.62 -28.92 24.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.746 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 14.7 m120 -81.31 38.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.649 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 31.9 pttt -98.9 12.64 35.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.059 -1.026 . . . . 0.0 109.759 176.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.76 24.88 0.04 OUTLIER Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.478 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.07 142.87 29.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.336 -1.097 . . . . 0.0 109.28 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 2.9 p -119.97 126.05 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.024 -1.048 . . . . 0.0 109.894 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 31.9 mmt180 -89.95 102.33 15.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.009 . . . . 0.0 110.153 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.95 HD11 HG23 ' A' ' 11' ' ' VAL . 3.3 pt -125.26 169.93 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.408 -0.808 . . . . 0.0 110.68 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.09 161.68 26.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.41 -0.806 . . . . 0.0 109.992 177.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.629 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 43.8 m -63.16 -16.8 61.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -0.907 . . . . 0.0 110.324 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 63.8 t -71.16 -49.16 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.322 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.721 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -59.97 -49.5 77.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.907 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.629 ' HG2' ' HA ' ' A' ' 71' ' ' SER . 3.7 ppt_? -64.08 -28.73 69.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.085 -1.009 . . . . 0.0 109.653 175.163 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.472 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 19.6 t-20 -73.08 -30.28 63.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.959 -1.088 . . . . 0.0 110.388 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 73' ' ' MET . 13.9 m120 -60.04 -40.02 87.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 110.87 -173.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.447 ' HB2' ' H ' ' A' ' 48' ' ' ARG . 25.9 p -99.3 -37.23 9.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 0.0 110.605 -177.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.609 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 126.87 33.53 0.64 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.705 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . . . -99.36 140.04 34.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -1.078 . . . . 0.0 110.179 -177.426 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.607 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -103.26 162.57 12.87 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.14 -0.975 . . . . 0.0 108.981 174.156 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.71 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -52.84 135.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.013 -1.054 . . . . 0.0 110.649 -177.975 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.93 -0.25 66.98 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 172.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 80' ' ' SER . 0.2 OUTLIER -57.79 -160.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.982 -1.305 . . . . 0.0 110.427 176.683 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -134.7 114.91 13.17 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.0 177.17 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.726 HG12 ' HD2' ' A' ' 46' ' ' LYS . 1.7 m -124.67 160.07 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.828 178.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.6 tttt -105.12 124.97 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.916 176.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.635 ' CG2' HD21 ' A' ' 9' ' ' LEU . 65.8 t -109.93 123.72 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.148 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.545 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.2 mtt85 -103.46 151.62 22.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 178.276 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.72 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 8.0 tmtt? -98.11 133.16 42.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.21 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.547 ' N ' ' HD3' ' A' ' 89' ' ' LYS . 2.3 m -150.3 -167.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.45 0.643 . . . . 0.0 109.975 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.552 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 27.5 mtp180 -129.29 178.11 6.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.807 . . . . 0.0 110.27 176.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.534 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.24 161.15 14.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 111.233 -175.888 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.546 ' CG ' HG12 ' A' ' 162' ' ' VAL . 18.2 pt-20 -148.22 164.78 32.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 94' ' ' ILE . 5.0 mp -88.86 97.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.47 -1.394 . . . . 0.0 110.22 -175.207 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.93 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.53 139.14 38.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 110.141 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.51 ' CD ' ' HG ' ' A' ' 156' ' ' LEU . 15.1 ptpt -100.09 -27.69 13.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.991 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.815 ' HB3' HD23 ' A' ' 156' ' ' LEU . 79.2 tttt -149.97 121.52 7.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.954 -1.091 . . . . 0.0 110.449 -176.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.097 HG23 HG22 ' A' ' 155' ' ' THR . 7.5 p -135.69 143.23 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 110.383 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 90.4 m -117.81 133.54 55.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 110.066 -177.699 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.703 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -132.35 164.9 25.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 110.223 -178.061 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 173' ' ' ARG . . . -138.91 83.57 18.47 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.804 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.2 Cg_exo . . . . . 0 C--N 1.305 -1.727 0 O-C-N 123.94 1.495 . . . . 0.0 110.173 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 117' ' ' GLU . 16.2 tt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.025 0.44 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.6 mt-10 -69.95 -39.95 75.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.093 -1.004 . . . . 0.0 110.049 175.71 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.03 -30.69 69.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 176.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 64.8 t80 -59.86 -37.78 80.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 109.53 176.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.764 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.4 t -59.88 -49.98 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 109.878 176.103 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.649 ' HG3' HD11 ' A' ' 170' ' ' ILE . 4.9 mt-30 -59.96 -44.11 94.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 110.312 177.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -63.58 -34.33 77.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 110.024 -175.825 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -84.22 -41.81 16.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.676 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.4 mm? -96.02 2.29 53.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 111.394 -174.097 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.628 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.4 tt -47.95 165.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.797 -1.189 . . . . 0.0 110.209 -175.328 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HG2' ' CG2' ' A' ' 125' ' ' ILE . 9.7 ptp85 34.97 49.57 0.41 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.499 -0.75 . . . . 0.0 111.464 -178.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -132.5 136.47 27.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.782 -1.199 . . . . 0.0 110.907 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.818 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -60.07 129.78 31.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.041 1.548 . . . . 0.0 109.892 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.678 ' SD ' HD11 ' A' ' 164' ' ' ILE . 16.4 mtt -125.22 146.2 49.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.428 -1.42 . . . . 0.0 110.875 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.712 HD21 ' C ' ' A' ' 49' ' ' LYS . 14.4 tp -144.18 105.59 4.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.616 -0.677 . . . . 0.0 109.6 -176.11 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.7 pm0 -43.11 143.86 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.345 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.15 -0.72 2.88 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.163 0.506 . . . . 0.0 110.392 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.606 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.9 p-10 -69.93 -179.46 1.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 174.436 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 151' ' ' LYS . 18.4 m-80 -145.73 141.89 28.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.488 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 120.94 -1.1 . . . . 0.0 110.31 -179.307 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 17.6 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.125 0.488 . . . . 0.0 109.94 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.422 ' HD2' ' OD1' ' A' ' 134' ' ' ASN . 33.4 tptt -121.12 102.22 8.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 109.874 178.14 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.606 HG21 ' OD1' ' A' ' 133' ' ' ASP . 2.2 t -77.06 140.73 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.6 t -131.23 -26.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 111.22 -176.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.54 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 6.4 tptm -140.04 134.54 31.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.843 -1.161 . . . . 0.0 110.591 -177.034 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.097 HG22 HG23 ' A' ' 98' ' ' VAL . 48.8 p -134.02 165.54 24.79 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.54 -0.725 . . . . 0.0 109.396 176.177 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.45 -39.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.646 -176.927 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.972 ' CB ' HG11 ' A' ' 162' ' ' VAL . 17.2 Cg_exo -59.43 -170.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.639 1.336 . . . . 0.0 109.984 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.46 -158.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.27 -0.894 . . . . 0.0 109.998 177.148 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -70.19 -7.83 45.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 110.669 -177.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 160' ' ' VAL . 34.3 m -88.1 149.5 45.4 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 110.931 -175.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.596 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.02 140.75 31.39 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.367 1.719 . . . . 0.0 110.811 179.761 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.972 HG11 ' CB ' ' A' ' 157' ' ' PRO . 4.6 m -130.08 157.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.022 -1.049 . . . . 0.0 109.96 172.192 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -103.61 130.0 50.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.314 -0.866 . . . . 0.0 110.37 177.056 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.892 ' CD1' HG21 ' A' ' 168' ' ' THR . 19.1 mm -71.34 150.23 9.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 178.135 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.92 170.13 24.65 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 175.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -53.77 -24.76 16.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.354 -1.086 . . . . 0.0 110.169 -176.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.634 ' OE2' HG21 ' A' ' 94' ' ' ILE . 18.0 pt-20 -89.67 -18.4 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.899 . . . . 0.0 111.025 -175.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.892 HG21 ' CD1' ' A' ' 164' ' ' ILE . 95.7 m -56.94 147.23 24.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.178 -0.951 . . . . 0.0 110.078 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' LYS . 74.1 mmtt -95.77 161.24 14.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.839 -1.163 . . . . 0.0 110.36 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.764 HD12 ' CG1' ' A' ' 120' ' ' VAL . 24.4 mm -119.97 130.63 74.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 110.696 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.476 ' OE1' ' HE2' ' A' ' 97' ' ' LYS . 21.7 mt-10 -113.97 126.2 54.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 110.368 171.275 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 120' ' ' VAL . 32.1 mm -123.17 132.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.019 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.542 ' HG2' ' CB ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.995 . . . . 0.0 110.387 -176.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.233 0.54 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -146.33 -166.96 12.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.024 HG21 HD22 ' A' ' 33' ' ' LEU . 9.1 pt -136.28 159.96 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.439 -1.036 . . . . 0.0 109.418 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.61 ' C ' HD23 ' A' ' 9' ' ' LEU . 96.7 mt -101.47 121.06 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.003 -1.061 . . . . 0.0 110.216 -179.012 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.809 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -136.96 -171.25 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 110.557 178.576 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.487 ' HB3' HG22 ' A' ' 66' ' ' ILE . 53.0 ttp180 -107.51 132.85 52.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 111.099 -172.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.937 HG23 HD11 ' A' ' 69' ' ' ILE . 13.2 p -61.67 138.36 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.77 . . . . 0.0 110.314 176.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -123.05 145.01 48.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 110.597 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.961 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 174.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.47 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 97.3 mtt180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.159 0.504 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.083 HG13 HG23 ' A' ' 67' ' ' VAL . 87.9 t -119.44 120.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 -179.018 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 4.9 ptt180 -92.36 119.54 32.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.7 176.302 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -134.73 -172.31 3.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 0.0 110.179 179.836 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.501 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.9 p-10 -106.9 -179.93 4.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.046 . . . . 0.0 110.539 -178.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.01 -44.46 94.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.579 -177.563 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -59.9 -46.7 88.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.535 -0.728 . . . . 0.0 110.211 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.59 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 59.9 m -59.97 -36.5 77.26 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.062 -1.024 . . . . 0.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.675 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 35.0 ttp180 -70.06 -44.54 68.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.186 178.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -90.26 -10.36 44.52 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.838 -1.164 . . . . 0.0 111.687 -171.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.024 HD22 HG21 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -50.17 -27.06 5.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.711 -1.243 . . . . 0.0 109.135 -178.566 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.003 ' N ' HD12 ' A' ' 33' ' ' LEU . 59.0 mt -130.11 -69.24 0.67 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.511 -0.743 . . . . 0.0 110.583 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -172.63 11.19 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.948 -1.095 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . . . -52.02 133.6 32.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.921 -1.112 . . . . 0.0 110.199 -176.154 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.679 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -118.32 174.32 6.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.415 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 38' ' ' ILE . 28.2 mm -58.95 119.65 3.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 120.814 -1.179 . . . . 0.0 109.722 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.4 35.54 56.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.629 174.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.572 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 33.6 m-20 -89.1 178.93 6.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.633 -1.51 . . . . 0.0 109.718 172.348 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.737 HG21 HG23 ' A' ' 92' ' ' THR . 76.7 t -99.39 123.54 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 110.585 -176.086 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' HD2' ' A' ' 89' ' ' LYS . 3.8 m -122.08 147.28 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.618 -0.676 . . . . 0.0 110.518 -177.029 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' OE2' ' HD2' ' A' ' 49' ' ' LYS . 85.3 tt0 -111.19 137.09 49.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.746 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -117.63 140.87 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.0 -1.063 . . . . 0.0 110.55 -176.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -151.59 96.67 2.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.611 -1.306 . . . . 0.0 112.106 -174.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.105 ' HE3' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -98.43 -80.24 0.46 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.52 -1.362 . . . . 0.0 110.443 168.014 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.63 -36.67 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.717 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.015 ' CZ ' HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -135.33 -155.5 0.65 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 109.388 172.067 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 48' ' ' ARG . 3.9 mtmm -114.85 133.81 55.65 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.072 0.939 . . . . 0.0 112.271 -177.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . 1.015 HG23 ' CZ ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -119.5 179.88 4.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.311 177.5 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.576 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -136.09 160.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.871 170.646 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.66 -168.96 39.32 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.35 -168.25 1.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -1.048 . . . . 0.0 109.752 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.72 130.0 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 -178.534 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.47 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -116.95 164.92 13.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 110.427 178.592 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.64 119.74 30.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.437 -0.79 . . . . 0.0 110.132 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -64.37 140.08 58.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.838 179.174 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.13 -50.64 86.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 118.876 -1.129 . . . . 0.0 108.919 175.294 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 50.9 Cg_endo -93.45 97.43 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.753 1.396 . . . . 0.0 108.946 178.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.21 38.73 0.14 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 110.711 -174.335 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 30.6 p-10 -142.32 -37.89 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.124 -0.985 . . . . 0.0 110.833 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.554 ' HG3' HD11 ' A' ' 66' ' ' ILE . 19.5 pt-20 -86.75 -18.9 30.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.003 -1.06 . . . . 0.0 109.676 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.503 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 9.8 m-80 -81.72 35.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.459 -0.775 . . . . 0.0 110.78 177.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.501 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.5 pttt -98.86 16.62 21.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 0.0 109.614 176.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.21 23.26 0.03 OUTLIER Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.554 HD11 ' HG3' ' A' ' 62' ' ' GLU . 45.7 pt -140.39 156.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.149 174.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.083 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -136.36 131.05 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.463 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 54.1 ttp85 -91.05 118.55 30.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.0 -1.063 . . . . 0.0 110.009 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.937 HD11 HG23 ' A' ' 11' ' ' VAL . 3.2 pt -130.17 167.71 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 110.717 178.075 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 34.9 p-10 -80.02 170.71 16.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.1 178.428 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.3 m -59.98 -31.88 70.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 110.417 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.5 HG12 HD21 ' A' ' 76' ' ' ASN . 54.5 t -68.05 -46.5 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.703 -175.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.601 ' CE ' HD13 ' A' ' 44' ' ' ILE . 4.7 ttt -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.513 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.754 ' NH1' HD13 ' A' ' 81' ' ' ILE . 58.0 ttt180 -60.06 -42.89 95.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.12 172.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -71.75 -25.09 61.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.137 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.5 HD21 HG12 ' A' ' 72' ' ' VAL . 94.3 m-20 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.569 -177.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.709 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 16.7 p -97.88 -37.93 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.791 -1.193 . . . . 0.0 110.92 -175.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 77' ' ' CYS . . . 112.58 31.48 2.55 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.706 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -115.07 178.11 4.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.289 . . . . 0.0 111.763 -170.197 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.587 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -126.79 170.02 12.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.071 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.961 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -59.47 150.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.77 -1.206 . . . . 0.0 110.198 178.789 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' A' ' 10' ' ' ARG . . . 75.56 -3.52 48.33 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 174.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.521 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 2.0 m-20 -58.58 -162.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.033 -1.275 . . . . 0.0 110.378 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 60.1 pttt -134.8 116.96 15.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.454 -0.779 . . . . 0.0 109.82 177.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.105 HG12 ' HE3' ' A' ' 46' ' ' LYS . 1.2 m -117.34 143.39 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 109.532 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 78.6 tttt -93.59 119.04 32.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 175.695 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.631 HG21 HD11 ' A' ' 9' ' ' LEU . 85.8 t -99.38 123.3 52.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.304 -0.873 . . . . 0.0 109.678 -178.144 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.583 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.6 mtt180 -110.0 146.16 35.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.659 179.568 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.673 ' HD3' ' HB2' ' A' ' 36' ' ' ALA . 27.1 tptt -96.65 134.8 39.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.056 -1.028 . . . . 0.0 110.152 -177.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.573 HG23 HG12 ' A' ' 41' ' ' VAL . 2.7 m -147.61 -170.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 110.125 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 14.2 ptm180 -127.24 171.21 11.66 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 177.566 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.737 HG23 HG21 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -97.86 162.92 13.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.966 -1.084 . . . . 0.0 111.019 -176.153 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.77 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.4 pt-20 -150.72 161.88 41.79 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 94' ' ' ILE . 4.3 mp -89.16 97.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.6 -1.312 . . . . 0.0 110.261 -176.439 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.742 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.92 165.0 0.7 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.372 178.425 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 169' ' ' LYS . 2.1 pttt -134.9 -19.25 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.364 -0.835 . . . . 0.0 110.632 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.832 ' HB3' HD23 ' A' ' 156' ' ' LEU . 77.4 tttt -150.74 119.99 6.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.895 -1.128 . . . . 0.0 110.558 176.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.103 HG23 HG22 ' A' ' 155' ' ' THR . 8.8 p -138.76 142.65 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.958 -1.089 . . . . 0.0 110.669 178.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.489 ' C ' HD23 ' A' ' 100' ' ' LEU . 96.3 m -117.17 142.65 46.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.116 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.72 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -139.8 172.64 12.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.337 -0.852 . . . . 0.0 110.334 -178.54 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' HG2' ' A' ' 173' ' ' ARG . . . -143.99 94.04 5.95 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 0.0 111.021 -175.127 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 14.7 Cg_exo . . . . . 0 C--N 1.304 -1.768 0 O-C-N 124.001 1.527 . . . . 0.0 110.056 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 117' ' ' GLU . 12.8 tt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.29 0.567 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -59.96 -41.31 91.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 178.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.02 -33.33 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.741 175.299 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -60.0 -40.05 87.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.688 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.634 HG12 ' CD1' ' A' ' 170' ' ' ILE . 55.9 t -60.04 -45.65 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.963 175.008 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 168' ' ' THR . 2.7 mt-30 -60.03 -44.79 94.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.81 178.058 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -62.63 -42.48 99.62 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.492 -0.755 . . . . 0.0 110.144 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.412 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -73.28 -41.79 63.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 110.506 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 124' ' ' LEU . 4.4 mm? -95.45 0.04 52.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.192 -0.943 . . . . 0.0 110.983 -176.383 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.9 tt -44.82 163.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.925 -1.109 . . . . 0.0 110.095 -177.013 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 32.6 ptt-85 33.78 48.33 0.21 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.54 -0.725 . . . . 0.0 111.281 -178.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.495 ' HG2' ' HD2' ' A' ' 128' ' ' PRO . 0.2 OUTLIER -134.04 137.76 29.05 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.854 -1.154 . . . . 0.0 111.195 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.852 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 32.5 Cg_exo -54.87 127.48 26.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.003 1.528 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.581 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.9 mmm -126.21 140.83 52.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.495 -1.378 . . . . 0.0 110.79 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 7.8 tp -139.69 112.02 7.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 -177.092 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.4 pt-20 -48.6 145.33 3.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.695 -1.253 . . . . 0.0 110.144 -177.499 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 74.58 -1.71 3.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.815 -178.744 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.612 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.9 p30 -68.81 -170.4 0.22 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.986 -1.071 . . . . 0.0 110.206 175.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -146.92 157.12 43.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.57 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.084 -1.01 . . . . 0.0 110.016 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 14.1 m-85 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.232 0.539 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.446 ' HD3' HG23 ' A' ' 153' ' ' VAL . 2.9 tmtm? -118.67 108.32 14.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 110.086 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.612 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -77.45 138.6 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 109.868 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.446 HG23 ' HD3' ' A' ' 151' ' ' LYS . 32.9 t -117.18 -32.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 110.915 -177.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 131' ' ' GLU . 60.9 tttm -148.38 149.29 31.5 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.363 -178.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.103 HG22 HG23 ' A' ' 98' ' ' VAL . 82.2 p -133.2 170.46 15.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.832 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.47 -37.64 0.45 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.031 . . . . 0.0 110.907 -177.746 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.916 ' CG ' HG11 ' A' ' 162' ' ' VAL . 23.8 Cg_exo -55.61 -171.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.415 1.218 . . . . 0.0 110.284 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 -158.35 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 110.077 176.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -85.4 42.58 0.96 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.221 -0.924 . . . . 0.0 110.269 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 162' ' ' VAL . 33.3 m -140.03 158.73 66.6 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.957 . . . . 0.0 110.562 -177.354 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.576 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.48 136.58 40.54 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.267 1.667 . . . . 0.0 110.957 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.916 HG11 ' CG ' ' A' ' 157' ' ' PRO . 9.2 m -132.07 159.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 109.835 173.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.4 tt0 -105.54 127.52 53.07 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.176 -0.953 . . . . 0.0 110.281 175.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.79 ' CD1' HG21 ' A' ' 168' ' ' THR . 9.0 mm -71.21 157.39 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.653 -0.655 . . . . 0.0 110.376 -177.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.34 167.03 25.36 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.355 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.545 ' HB3' HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.31 -22.29 61.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.41 -1.053 . . . . 0.0 110.48 -177.161 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -88.72 -14.18 37.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.273 -178.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.79 HG21 ' CD1' ' A' ' 164' ' ' ILE . 10.0 m -58.16 155.39 11.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.489 -0.757 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.8 mttt -109.22 148.56 30.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 178.5 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.701 HG23 HD21 ' A' ' 100' ' ' LEU . 2.2 mt -130.23 160.0 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 111.254 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.45 ' HB3' HG23 ' A' ' 99' ' ' THR . 10.2 mt-10 -133.5 132.16 40.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.671 -0.643 . . . . 0.0 110.02 175.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.483 HD13 ' HG ' ' A' ' 100' ' ' LEU . 48.5 mm -120.01 122.97 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.389 -0.819 . . . . 0.0 109.956 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 101' ' ' ALA . 8.8 ptp180 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.006 -1.059 . . . . 0.0 110.469 -179.084 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.0 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.148 0.499 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.1 -160.04 8.91 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.924 HD13 ' CD2' ' A' ' 33' ' ' LEU . 14.7 pt -136.91 168.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.137 . . . . 0.0 109.51 178.403 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.757 ' C ' HD23 ' A' ' 9' ' ' LEU . 93.2 mt -104.29 125.72 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.649 -177.056 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.844 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -147.44 178.61 8.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.645 -0.659 . . . . 0.0 109.694 178.279 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.795 ' HG2' HG22 ' A' ' 66' ' ' ILE . 11.7 ptp180 -104.22 137.83 41.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 110.768 -173.152 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.955 HG23 HD11 ' A' ' 69' ' ' ILE . 8.4 p -61.98 130.63 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 110.547 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -111.38 162.85 14.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 177.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 81.5 tt0 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 175.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.627 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 45.5 mtm180 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.046 0.45 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.978 HG13 HG23 ' A' ' 67' ' ' VAL . 85.2 t -117.95 122.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.942 -1.099 . . . . 0.0 110.494 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -98.01 120.46 38.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.037 177.598 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -139.95 172.82 12.22 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.233 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -89.94 178.91 6.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.611 -1.306 . . . . 0.0 110.883 -175.156 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 86.9 mt-10 -59.91 -40.03 87.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.258 -178.043 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -50.07 55.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.311 -178.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.687 ' HA ' HD23 ' A' ' 33' ' ' LEU . 11.3 p -55.49 -34.63 64.75 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.145 -0.972 . . . . 0.0 109.566 177.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.54 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 40.0 ttm180 -81.18 -44.2 18.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.507 -0.746 . . . . 0.0 111.302 179.088 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -85.29 -10.02 56.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 110.81 -172.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.121 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.3 pp -57.01 -31.8 65.48 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.318 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.121 ' N ' HD12 ' A' ' 33' ' ' LEU . 15.4 mt -105.68 -79.83 0.56 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 172.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.41 16.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.559 -0.713 . . . . 0.0 110.31 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.54 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -66.61 141.5 57.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.982 -1.074 . . . . 0.0 111.072 -171.032 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.841 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -133.63 -178.91 5.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.176 174.782 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 38' ' ' ILE . 38.0 mm -74.5 74.72 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.854 -1.154 . . . . 0.0 110.279 178.299 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.428 ' H ' HG11 ' A' ' 54' ' ' VAL . . . 172.23 -6.16 0.03 OUTLIER Glycine 0 N--CA 1.483 1.803 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.836 -169.171 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -107.96 159.95 16.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.292 -1.711 . . . . 0.0 110.773 -172.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.612 HG11 ' HB2' ' A' ' 161' ' ' PRO . 69.2 t -99.62 133.01 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.407 -0.808 . . . . 0.0 109.821 179.583 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 52' ' ' GLY . 5.1 m -109.72 143.56 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 -175.411 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.456 ' C ' HD12 ' A' ' 44' ' ' ILE . 87.9 tt0 -111.75 141.44 45.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.676 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.826 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.1 mp -119.97 147.12 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 110.442 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.2 tt0 -151.16 94.51 2.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.022 -1.049 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.012 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.7 tmtt? -98.88 -66.21 0.91 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 173.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.566 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -107.09 -33.99 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 175.928 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 51.5 mtt85 -133.21 -168.23 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.591 -0.693 . . . . 0.0 109.445 175.091 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.72 ' C ' HD21 ' A' ' 130' ' ' LEU . 5.9 mtmt -91.52 138.43 31.58 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.597 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.567 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.98 158.11 45.2 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.26 0.552 . . . . 0.0 109.963 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.543 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.66 160.99 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.004 178.475 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.653 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -174.05 176.38 46.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 172.231 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 34.6 ttm180 -111.78 171.32 7.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -1.047 . . . . 0.0 110.139 -178.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.841 HG11 ' O ' ' A' ' 37' ' ' GLU . 5.4 p -89.55 126.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.046 -1.034 . . . . 0.0 110.91 -172.051 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.627 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -123.32 167.22 14.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 175.523 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -99.25 126.38 45.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 110.088 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -64.16 137.45 57.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 178.141 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.674 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 6.2 mtt180 -59.05 -45.22 99.51 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 109.082 174.481 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.674 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 32.9 Cg_endo -92.97 98.39 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.794 1.418 . . . . 0.0 108.887 178.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 14.7 pt-20 -75.57 36.78 0.13 Allowed 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.485 -0.759 . . . . 0.0 110.855 -173.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 74.1 m-20 -144.65 -38.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.855 -177.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.2 pt-20 -84.21 -22.23 30.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.524 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 5.3 m120 -81.65 39.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.542 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.549 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 61.2 mtpt -98.64 14.38 28.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.464 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.49 24.69 0.03 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.795 HG22 ' HG2' ' A' ' 10' ' ' ARG . 46.9 pt -141.82 157.16 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -1.048 . . . . 0.0 109.246 175.508 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.978 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -131.55 129.98 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.037 -1.039 . . . . 0.0 109.935 178.058 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 25' ' ' ARG . 81.6 mtt180 -96.78 120.11 36.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.054 -1.029 . . . . 0.0 110.681 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.955 HD11 HG23 ' A' ' 11' ' ' VAL . 3.0 pt -134.43 168.28 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.613 -0.68 . . . . 0.0 110.533 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -78.95 174.97 10.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.425 -0.797 . . . . 0.0 110.193 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.441 ' CA ' ' OE2' ' A' ' 13' ' ' GLU . 83.3 p -62.69 -38.52 90.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.714 -177.628 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.9 -43.38 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.134 -0.979 . . . . 0.0 110.359 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.533 ' CE ' HD13 ' A' ' 44' ' ' ILE . 7.6 tpt -59.99 -47.86 84.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.64 178.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 63.5 ttp85 -60.17 -40.11 88.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 109.964 174.143 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.35 -24.62 62.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 93.9 m-20 -60.13 -39.57 86.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -177.53 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.505 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.1 p -98.27 -37.85 9.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -176.323 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.566 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 118.07 36.56 0.94 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.316 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -112.5 161.26 16.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -1.205 . . . . 0.0 110.367 -176.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.608 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -109.65 166.01 11.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.263 -0.898 . . . . 0.0 109.296 176.622 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.437 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -51.09 138.16 8.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.04 -1.038 . . . . 0.0 110.553 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 78.46 0.21 78.02 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 171.6 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -56.05 -158.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.119 -1.224 . . . . 0.0 110.423 174.567 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 49.5 pttt -136.05 109.64 8.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.515 -0.741 . . . . 0.0 110.139 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.012 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -124.51 154.88 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.9 . . . . 0.0 109.883 179.68 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 34.3 ttmt -100.65 125.51 47.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 177.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.601 HG21 HD11 ' A' ' 9' ' ' LEU . 74.1 t -99.51 120.79 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.991 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.48 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 99.4 mtt180 -109.67 157.48 19.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 110.007 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.401 ' O ' HG13 ' A' ' 90' ' ' VAL . 59.5 tttm -100.03 137.09 38.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 110.619 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.513 HG21 ' CG ' ' A' ' 161' ' ' PRO . 2.2 m -150.38 -169.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 110.369 177.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 34.7 mtp180 -133.75 179.98 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.826 . . . . 0.0 110.426 177.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.61 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.19 156.92 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.131 -177.259 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.618 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.5 pt-20 -150.26 169.94 20.17 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.18 98.63 8.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 110.398 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.99 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.02 135.41 52.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 110.262 178.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.533 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 1.0 OUTLIER -98.09 -27.79 14.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 111.105 -178.809 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.527 ' HB3' HD23 ' A' ' 156' ' ' LEU . 14.4 ttpt -150.16 130.96 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.811 -1.181 . . . . 0.0 110.248 178.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.999 HG23 HG22 ' A' ' 155' ' ' THR . 9.4 p -138.31 140.06 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 110.95 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 90.3 m -106.1 133.94 50.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.53 -0.731 . . . . 0.0 110.02 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.55 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -128.34 160.0 33.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 110.502 -178.28 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.5 84.02 24.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 110.466 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 150' ' ' PHE . 29.2 Cg_exo . . . . . 0 C--N 1.307 -1.654 0 O-C-N 123.884 1.465 . . . . 0.0 110.356 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 170' ' ' ILE . 98.8 mt-10 -60.02 -43.76 95.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.97 . . . . 0.0 109.968 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -66.28 -34.26 77.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 109.69 175.293 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -37.26 78.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.626 177.019 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.716 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.5 t -60.16 -47.83 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 109.888 174.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.762 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 109.849 177.631 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -59.93 -41.25 91.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.119 179.035 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.83 -40.09 23.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.672 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.639 HD22 ' N ' ' A' ' 124' ' ' LEU . 3.7 mm? -93.16 -0.88 56.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.109 -0.995 . . . . 0.0 111.091 -175.431 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.805 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.2 tt -47.92 168.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.861 -1.149 . . . . 0.0 110.242 -176.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.7 ptt-85 32.96 48.29 0.13 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 178.423 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.4 mmt180 -137.96 148.42 60.32 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.387 -1.446 . . . . 0.0 111.806 175.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.849 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.6 Cg_exo -62.9 132.69 38.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.321 1.695 . . . . 0.0 109.931 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.4 mmm -131.09 148.06 52.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.72 HD21 ' C ' ' A' ' 49' ' ' LYS . 15.0 tp -145.7 115.06 7.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.581 -0.699 . . . . 0.0 109.772 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.9 pt-20 -49.32 136.38 15.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.114 . . . . 0.0 110.401 -176.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.615 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.14 -3.94 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.2 0.524 . . . . 0.0 110.273 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.555 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.4 p30 -68.04 -170.98 0.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.314 175.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -150.94 134.46 16.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.476 -0.765 . . . . 0.0 109.445 178.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 0.0 110.713 -177.269 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 10.4 m-85 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.293 0.568 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 109.95 22.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.555 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.4 t -75.96 135.64 26.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.705 179.026 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.531 HG21 ' NH2' ' A' ' 173' ' ' ARG . 43.2 t -114.8 -32.14 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.069 -1.02 . . . . 0.0 110.932 -176.254 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -148.35 139.22 23.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 110.673 -177.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.999 HG22 HG23 ' A' ' 98' ' ' VAL . 58.8 p -129.16 169.54 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.635 176.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.701 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.16 -32.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 111.18 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.907 ' CG ' HG11 ' A' ' 162' ' ' VAL . 24.6 Cg_exo -56.29 -165.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.372 1.196 . . . . 0.0 110.237 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.723 ' O ' HG13 ' A' ' 160' ' ' VAL . 13.0 t -89.76 41.21 1.03 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.251 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 158' ' ' SER . 64.6 mttt 60.74 18.05 8.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.767 . . . . 0.0 109.657 -177.297 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.854 ' O ' HG13 ' A' ' 162' ' ' VAL . 14.9 m -108.18 160.0 28.58 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 110.089 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.612 ' HB2' HG11 ' A' ' 41' ' ' VAL . 1.1 Cg_endo -50.18 121.15 7.14 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.167 1.614 . . . . 0.0 110.266 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.99 HG21 ' HB2' ' A' ' 95' ' ' ALA . 6.2 m -129.73 159.45 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.619 176.632 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 43.7 tt0 -105.93 127.63 53.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.135 -0.978 . . . . 0.0 109.993 178.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.975 HD12 HG21 ' A' ' 168' ' ' THR . 11.2 mm -71.85 153.09 8.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.678 -0.639 . . . . 0.0 110.285 -176.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.86 167.52 25.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.476 ' HB3' HD11 ' A' ' 125' ' ' ILE . 21.9 pt-20 -57.7 -19.62 28.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -1.047 . . . . 0.0 110.322 -176.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -90.0 -9.99 46.63 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 110.023 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.975 HG21 HD12 ' A' ' 164' ' ' ILE . 46.8 m -63.76 151.65 41.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 176.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 96' ' ' LYS . 38.6 mmtm -96.64 163.05 13.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 109.767 178.111 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.762 HD11 ' HG2' ' A' ' 121' ' ' GLN . 18.4 mm -122.66 132.59 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.297 -0.877 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.516 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 58.4 mt-10 -124.17 133.27 53.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.577 172.436 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 120' ' ' VAL . 6.1 mt -137.46 139.37 43.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.517 -0.739 . . . . 0.0 110.306 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.531 ' NH2' HG21 ' A' ' 153' ' ' VAL . 10.1 ptp180 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 110.304 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.689 ' HB3' HD22 ' A' ' 34' ' ' LEU . 96.0 m-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.268 0.556 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 87' ' ' VAL . . . -144.95 179.14 22.28 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 177.039 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.015 HG23 HD11 ' A' ' 34' ' ' LEU . 44.4 pt -135.34 159.04 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -1.177 . . . . 0.0 109.994 -179.402 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -101.17 120.01 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.354 -178.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.0 pt? -138.36 -171.8 3.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.522 ' HG3' ' HA2' ' A' ' 82' ' ' GLY . 32.6 ttp180 -101.65 133.39 46.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.915 -174.518 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.861 HG13 ' H ' ' A' ' 82' ' ' GLY . 11.1 p -62.82 129.83 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 110.257 176.107 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -112.14 148.84 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 110.34 179.401 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.656 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 176.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 33.1 ptt180 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.147 0.499 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.15 HG13 HG23 ' A' ' 67' ' ' VAL . 90.1 t -110.08 117.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.09 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.481 ' O ' ' OD1' ' A' ' 63' ' ' ASN . 1.3 ptm180 -96.81 120.56 37.37 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.981 -1.075 . . . . 0.0 109.909 178.157 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.671 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.2 pt? -136.38 175.27 9.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.664 -0.648 . . . . 0.0 109.542 -175.39 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.558 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.4 p-10 -92.04 179.73 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.743 -175.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.08 -42.19 94.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 109.24 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 54.2 m -65.84 -55.89 14.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.074 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.603 ' C ' HD22 ' A' ' 33' ' ' LEU . 23.3 t -49.91 -30.21 9.73 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.739 -1.225 . . . . 0.0 109.564 177.235 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HA ' HD11 ' A' ' 26' ' ' LEU . 63.3 ttp85 -80.57 -48.86 12.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 111.327 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -94.42 -14.66 25.02 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.712 -1.242 . . . . 0.0 111.611 -173.096 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.936 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.1 pt? -60.05 -28.71 68.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 7' ' ' ILE . 77.1 mt -103.36 -75.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.074 -1.016 . . . . 0.0 110.186 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 5.6 t70 -169.58 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.605 0.717 . . . . 0.0 109.176 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.52 119.38 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.4 0.619 . . . . 0.0 110.772 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.473 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -105.1 178.27 4.61 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.246 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 38' ' ' ILE . 19.0 mm -60.22 127.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.872 -1.143 . . . . 0.0 110.074 177.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.533 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 77.55 23.36 67.78 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.717 172.578 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.451 ' OD1' ' OE2' ' A' ' 37' ' ' GLU . 81.8 m-20 -89.16 171.69 9.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.719 -1.459 . . . . 0.0 109.639 172.728 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.471 HG21 ' OG1' ' A' ' 92' ' ' THR . 76.4 t -98.92 129.3 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.09 -176.608 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.608 HG11 HG23 ' A' ' 54' ' ' VAL . 1.7 m -117.06 141.12 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 -175.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.415 ' C ' HD12 ' A' ' 44' ' ' ILE . 41.0 tt0 -109.78 141.74 42.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 177.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.873 HD13 ' HE1' ' A' ' 73' ' ' MET . 4.1 mp -120.46 151.29 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.816 -1.177 . . . . 0.0 110.559 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -150.71 93.11 1.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.353 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.022 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 9.1 ttpt -98.44 -65.13 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.703 174.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.017 ' CG2' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -111.82 -30.94 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.637 0.732 . . . . 0.0 109.264 176.112 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 32.4 mtt85 -136.64 -171.52 2.93 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.714 -0.616 . . . . 0.0 109.372 174.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.736 ' HB3' HD21 ' A' ' 130' ' ' LEU . 7.0 mttm -88.31 136.94 32.74 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.986 -1.072 . . . . 0.0 110.459 -177.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.553 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -135.85 156.88 48.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.349 0.595 . . . . 0.0 110.296 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.52 160.59 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.868 . . . . 0.0 109.793 176.999 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' O ' HG22 ' A' ' 42' ' ' VAL . . . 178.88 179.72 48.68 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.387 -1.387 . . . . 0.0 109.714 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -113.91 165.45 12.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -1.046 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -89.33 139.99 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.016 . . . . 0.0 110.693 -173.576 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -125.29 161.38 27.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.748 . . . . 0.0 110.443 175.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 56' ' ' ARG . 24.8 ttp-105 -93.62 127.02 39.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -0.835 . . . . 0.0 110.314 177.208 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -65.9 140.0 58.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.578 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 4.4 mmm180 -56.78 -46.76 99.82 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.969 -1.082 . . . . 0.0 109.127 173.371 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 32.0 Cg_endo -91.57 98.33 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.997 1.525 . . . . 0.0 109.127 178.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.56 35.68 0.1 Allowed 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.641 -0.662 . . . . 0.0 110.765 -175.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -148.46 -34.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.37 -24.66 27.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.197 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.521 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -81.29 41.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.718 -0.614 . . . . 0.0 110.318 176.204 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 pttt -98.59 9.76 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 178.533 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.84 26.75 0.06 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 176.609 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 66' ' ' ILE . 46.0 pt -140.13 141.22 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -1.189 . . . . 0.0 109.645 175.036 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.15 HG23 HG13 ' A' ' 24' ' ' VAL . 2.6 p -120.02 121.93 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 73.5 ttt180 -91.95 118.16 30.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.24 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.726 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.5 pp -130.01 160.04 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 110.41 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -75.78 159.99 30.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 177.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.4 t -53.45 -29.95 38.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.913 -175.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.55 -48.53 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 110.121 -175.545 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.873 ' HE1' HD13 ' A' ' 44' ' ' ILE . 3.5 tpt -60.0 -45.14 93.72 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.707 177.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.438 ' O ' ' SG ' ' A' ' 77' ' ' CYS . 66.9 ttp85 -60.01 -40.09 88.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.778 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -69.93 -27.43 64.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.152 -0.968 . . . . 0.0 110.384 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -21.79 63.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 110.825 -175.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.493 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 18.6 p -101.78 -25.84 13.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.99 -1.069 . . . . 0.0 110.854 -178.009 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.547 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 98.0 23.47 13.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 176.416 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 1.022 ' HB1' ' HD2' ' A' ' 46' ' ' LYS . . . -109.02 -168.82 1.39 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.045 -1.268 . . . . 0.0 110.933 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.575 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -127.61 170.17 12.95 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.656 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -61.49 144.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 0.0 110.324 177.164 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.861 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.74 -1.92 65.72 Favored Glycine 0 C--N 1.297 -1.638 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 172.186 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.512 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.3 m-20 -56.62 -167.2 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.035 -1.274 . . . . 0.0 110.189 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 44.1 pttt -127.16 113.33 16.24 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.392 -0.817 . . . . 0.0 109.753 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.71 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -121.15 158.13 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -177.122 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 85.2 tttt -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.729 175.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.527 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 62.8 t -104.22 122.03 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.945 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 89.4 mtt180 -110.34 140.22 44.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 109.429 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 11.0 tttt -84.77 138.95 32.3 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.077 -1.014 . . . . 0.0 110.237 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.0 m -150.05 -169.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 176.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 48.0 ptt85 -128.39 172.21 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.464 177.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.471 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.06 163.15 12.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.004 -1.06 . . . . 0.0 111.018 -175.773 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.554 ' CG ' HG12 ' A' ' 162' ' ' VAL . 19.1 pt-20 -150.04 169.57 20.92 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.028 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.81 99.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.723 -1.236 . . . . 0.0 110.373 -176.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.83 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.25 140.77 48.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -0.837 . . . . 0.0 110.564 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.71 ' CD ' HD23 ' A' ' 156' ' ' LEU . 29.3 pttt -105.36 -26.08 12.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 111.316 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.891 ' CB ' HD22 ' A' ' 156' ' ' LEU . 22.0 tttp -148.16 128.56 13.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.687 -1.258 . . . . 0.0 110.623 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.114 HG23 HG22 ' A' ' 155' ' ' THR . 7.5 p -140.86 148.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.371 -0.83 . . . . 0.0 110.558 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -120.04 132.11 55.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.131 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.74 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -123.71 159.3 29.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.534 -178.53 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -141.07 93.78 8.05 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.385 -0.822 . . . . 0.0 110.354 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.7 Cg_exo . . . . . 0 C--N 1.303 -1.83 0 O-C-N 124.057 1.556 . . . . 0.0 110.32 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.8 tp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.184 0.516 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HA ' HD11 ' A' ' 172' ' ' ILE . 96.8 mt-10 -59.97 -41.74 92.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -35.21 74.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 175.319 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.392 -0.818 . . . . 0.0 110.2 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.611 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -60.52 -45.17 97.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 175.567 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.624 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 0.8 OUTLIER -60.01 -42.8 95.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 110.335 175.887 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -59.98 -46.56 89.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.405 -0.81 . . . . 0.0 109.953 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.529 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.17 -46.71 64.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.516 -0.74 . . . . 0.0 110.741 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 124' ' ' LEU . 4.6 mm? -100.76 8.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.075 -1.015 . . . . 0.0 111.827 -173.564 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.891 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.2 tt -49.12 165.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.56 -1.337 . . . . 0.0 109.852 -176.43 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.549 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 31.9 ptt180 33.31 45.98 0.09 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.428 -0.795 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -128.46 134.24 26.06 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.044 -1.035 . . . . 0.0 110.589 179.046 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.829 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 6.6 Cg_endo -54.2 129.42 34.38 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.881 1.464 . . . . 0.0 109.942 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.56 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.8 mmm -126.53 143.13 51.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.568 -1.333 . . . . 0.0 110.929 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' A' ' 49' ' ' LYS . 13.6 tp -142.95 107.56 4.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 0.0 109.645 -177.312 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.606 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.2 pt-20 -46.24 140.34 4.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 0.0 110.822 -174.638 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.606 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.2 -3.37 1.24 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.256 0.55 . . . . 0.0 110.343 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.1 p30 -69.86 -171.02 0.37 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.302 -0.874 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.49 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 15.6 m-80 -142.48 156.53 45.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.067 176.435 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.328 -177.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.463 ' O ' HG13 ' A' ' 135' ' ' ILE . 10.9 m-85 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.305 0.574 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.49 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 24.4 tptm -114.72 107.81 15.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.944 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.529 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.9 t -76.15 135.93 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 109.647 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.7 t -121.62 -27.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.934 -177.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 22.0 tttt -139.53 143.49 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.794 -1.191 . . . . 0.0 110.923 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.114 HG22 HG23 ' A' ' 98' ' ' VAL . 46.5 p -139.95 157.2 46.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.605 -0.685 . . . . 0.0 109.503 174.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.891 HD22 ' CB ' ' A' ' 97' ' ' LYS . 3.2 tp -88.97 -33.96 0.41 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 111.069 -177.258 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 1.048 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.3 Cg_exo -57.57 -165.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.38 1.2 . . . . 0.0 109.971 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 t -90.09 179.71 5.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.222 -0.924 . . . . 0.0 109.901 175.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -60.28 -7.68 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 110.903 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.39 152.78 58.37 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.498 -179.434 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.569 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.24 141.77 30.52 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.402 1.738 . . . . 0.0 110.933 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 1.048 HG11 ' CB ' ' A' ' 157' ' ' PRO . 6.2 m -129.98 158.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 172.432 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.9 tt0 -106.66 128.68 54.37 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.048 176.115 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.862 ' CD1' HG21 ' A' ' 168' ' ' THR . 13.3 mm -70.23 156.25 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 110.125 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 171.2 24.49 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.891 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -59.01 -25.7 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.264 -1.139 . . . . 0.0 110.118 -178.084 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.68 -11.2 40.47 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.151 -0.968 . . . . 0.0 110.494 -176.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.862 HG21 ' CD1' ' A' ' 164' ' ' ILE . 92.1 m -59.0 145.71 40.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.093 -1.004 . . . . 0.0 110.343 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 79.0 mttt -93.59 147.29 23.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.956 -1.09 . . . . 0.0 109.945 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.624 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 1.0 OUTLIER -121.61 141.35 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -178.184 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.411 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 44.7 mt-10 -124.9 128.88 49.33 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 171.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 117' ' ' GLU . 2.7 mp -123.26 119.95 58.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.562 -0.711 . . . . 0.0 110.052 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.5 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 8.5 ptp180 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.522 ' O ' HD13 ' A' ' 34' ' ' LEU . 98.6 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.324 0.583 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.78 -169.99 14.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 177.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.869 HD13 ' CD2' ' A' ' 33' ' ' LEU . 21.4 pt -132.54 154.38 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -1.133 . . . . 0.0 109.952 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.0 mt -94.91 119.17 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.814 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.4 pt? -136.03 -168.85 2.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.221 -0.924 . . . . 0.0 110.314 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 20.2 ttp180 -106.55 130.01 54.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 110.957 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.973 HG23 HD11 ' A' ' 69' ' ' ILE . 11.5 p -62.53 137.71 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 110.461 175.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -120.91 156.58 31.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.245 177.418 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.53 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.368 177.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.588 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 26.1 mmt180 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.293 0.568 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.873 HG13 HG23 ' A' ' 67' ' ' VAL . 95.8 t -114.52 119.99 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 177.333 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -97.41 119.92 36.84 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.959 -1.088 . . . . 0.0 110.035 177.403 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.027 HD22 ' CB ' ' A' ' 30' ' ' SER . 1.8 mt -140.78 177.75 7.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.154 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 28.1 p-10 -93.65 179.35 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.833 -177.281 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.99 -40.97 90.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.349 -177.605 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -68.83 -42.68 76.84 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.308 -177.058 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.027 ' CB ' HD22 ' A' ' 26' ' ' LEU . 57.7 m -59.95 -40.84 90.36 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.031 -1.043 . . . . 0.0 109.573 177.008 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.568 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 52.3 ttp180 -74.19 -44.21 54.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 111.469 177.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -88.63 -11.61 44.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.88 -1.138 . . . . 0.0 111.07 -170.369 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.086 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.1 pp -57.73 -32.59 67.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.775 -1.203 . . . . 0.0 109.559 -177.552 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.086 ' N ' HD12 ' A' ' 33' ' ' LEU . 17.1 mt -106.44 -72.65 0.71 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.122 -0.986 . . . . 0.0 110.475 175.226 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 36' ' ' ALA . 6.8 t0 -170.04 -27.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.717 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.789 ' HB1' ' NZ ' ' A' ' 89' ' ' LYS . . . -28.68 124.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.383 0.611 . . . . 0.0 111.455 -178.421 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.55 ' O ' HG11 ' A' ' 54' ' ' VAL . 2.6 pt-20 -113.48 -175.16 2.61 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.233 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 38' ' ' ILE . 19.3 mm -60.53 134.14 25.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.947 -1.096 . . . . 0.0 109.61 174.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.55 ' H ' ' CG1' ' A' ' 54' ' ' VAL . . . 79.77 14.62 80.74 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.237 172.016 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' CE ' ' A' ' 89' ' ' LYS . 87.0 m-20 -88.97 167.29 13.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.301 -1.705 . . . . 0.0 110.033 173.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.582 HG21 ' OG1' ' A' ' 92' ' ' THR . 50.1 t -99.71 129.08 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.046 -1.034 . . . . 0.0 110.454 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.689 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.4 m -114.59 146.09 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.903 . . . . 0.0 110.527 -178.505 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.5 tt0 -112.22 144.27 41.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.41 -0.806 . . . . 0.0 109.35 177.384 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.2 mp -117.18 148.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.948 -1.095 . . . . 0.0 110.586 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -151.06 90.6 1.62 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 111.178 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.083 ' CG ' HG12 ' A' ' 85' ' ' VAL . 13.4 tmtt? -98.21 -59.64 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.031 . . . . 0.0 109.86 172.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.551 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -114.26 -35.52 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 109.069 177.532 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 83.9 mtm-85 -133.06 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.416 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.657 ' C ' HD21 ' A' ' 130' ' ' LEU . 9.3 mttp -88.34 130.71 35.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.075 -1.016 . . . . 0.0 110.175 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.526 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -129.96 168.11 17.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.643 -0.66 . . . . 0.0 110.391 -178.703 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -125.81 162.55 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.392 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.561 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.29 -176.97 47.41 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 176.215 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 54.9 mtp180 -123.38 -168.47 1.77 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -1.086 . . . . 0.0 109.977 -178.66 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -111.09 131.61 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.06 -1.025 . . . . 0.0 111.202 -174.03 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.588 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -125.65 162.76 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 0.0 110.467 175.146 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -90.0 125.87 35.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.496 -0.753 . . . . 0.0 110.061 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -64.62 139.75 58.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.075 -1.016 . . . . 0.0 110.035 178.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.662 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.2 mtp180 -58.51 -49.84 91.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 109.275 174.071 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 17.9 Cg_endo -91.53 99.46 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.812 1.427 . . . . 0.0 108.885 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.6 34.16 0.07 Allowed 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.527 -0.733 . . . . 0.0 110.857 -174.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -149.8 -30.77 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.674 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.47 -25.26 29.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.157 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.452 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 4.3 m120 -81.25 40.07 0.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.774 -0.579 . . . . 0.0 110.554 179.082 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -97.81 11.71 36.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.041 . . . . 0.0 109.553 177.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.49 25.6 0.05 OUTLIER Glycine 0 N--CA 1.48 1.611 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 176.632 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.426 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 44.9 pt -140.11 141.21 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -1.217 . . . . 0.0 109.508 174.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.873 HG23 HG13 ' A' ' 24' ' ' VAL . 7.6 p -120.38 129.04 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.996 . . . . 0.0 110.16 -179.462 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 28.5 ttm180 -94.26 112.8 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.253 -177.043 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.973 HD11 HG23 ' A' ' 11' ' ' VAL . 2.4 pt -131.33 168.5 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.731 . . . . 0.0 110.632 -179.191 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.506 ' OD1' ' HB2' ' A' ' 73' ' ' MET . 31.6 p-10 -81.8 176.15 9.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 177.626 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -70.01 -29.1 66.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.272 -0.893 . . . . 0.0 110.671 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.7 -47.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 0.0 110.42 -176.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.709 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.62 -43.45 97.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.515 178.965 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' NH1' HG13 ' A' ' 81' ' ' ILE . 45.3 ttp180 -60.02 -41.08 91.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.935 173.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.95 -24.29 63.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 95.6 m-20 -60.0 -37.46 79.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.011 . . . . 0.0 110.633 -177.295 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.479 ' C ' HG23 ' A' ' 47' ' ' VAL . 30.0 p -98.26 -33.36 11.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 110.439 -177.396 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.551 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.94 26.75 3.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.626 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.58 168.54 9.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -1.14 . . . . 0.0 110.275 -176.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.917 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -115.72 177.97 4.48 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.569 179.273 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.53 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -64.32 140.27 19.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.028 -1.045 . . . . 0.0 110.532 178.414 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.15 -3.35 58.3 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 173.091 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.548 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.1 m-20 -58.08 -167.44 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.913 -1.345 . . . . 0.0 110.303 175.794 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 19.1 pttp -128.36 111.58 13.5 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.885 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -118.37 155.42 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.7 ttmt -100.24 123.6 44.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -0.968 . . . . 0.0 109.837 176.055 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.795 HG23 HD21 ' A' ' 9' ' ' LEU . 80.3 t -102.28 123.65 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.933 178.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.524 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtt180 -111.97 148.2 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.581 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.789 ' NZ ' ' HB1' ' A' ' 36' ' ' ALA . 10.5 tptt -100.0 130.04 46.12 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.049 -179.086 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.06 -166.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.596 -0.69 . . . . 0.0 110.15 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -129.12 171.46 12.38 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.543 -0.723 . . . . 0.0 109.67 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.582 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.43 159.97 16.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 111.117 -174.618 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 157' ' ' PRO . 19.6 pt-20 -147.8 173.46 12.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.01 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.5 mm -89.2 105.73 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.821 -1.175 . . . . 0.0 110.267 -175.725 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.2 139.24 53.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.974 ' CG ' HD23 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -101.34 -30.48 11.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.7 178.212 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.769 ' HB3' HD22 ' A' ' 156' ' ' LEU . 23.6 tttt -150.03 128.76 12.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.878 -1.139 . . . . 0.0 110.493 -179.471 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.043 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -139.92 143.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 110.384 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.628 HG23 ' HB3' ' A' ' 171' ' ' GLU . 54.6 m -114.79 138.36 50.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.127 -178.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.617 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -133.42 165.43 24.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HB2' ' HG2' ' A' ' 173' ' ' ARG . . . -144.16 99.97 4.96 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 110.605 -177.112 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.478 ' HD2' ' NH1' ' A' ' 173' ' ' ARG . 28.3 Cg_exo . . . . . 0 C--N 1.307 -1.622 0 O-C-N 123.887 1.467 . . . . 0.0 110.239 179.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 117' ' ' GLU . 20.9 tt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.27 0.557 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.657 ' HA ' HG21 ' A' ' 170' ' ' ILE . 95.6 mt-10 -60.01 -42.82 95.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -65.86 -40.02 91.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.843 . . . . 0.0 109.607 174.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -60.57 -39.97 89.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.471 -0.768 . . . . 0.0 109.916 178.743 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.686 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -60.09 -47.67 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.889 176.076 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.656 ' HG3' HD11 ' A' ' 170' ' ' ILE . 0.7 OUTLIER -60.02 -43.78 95.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 176.419 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -59.99 -43.28 95.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.887 -176.289 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.59 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.56 -0.712 . . . . 0.0 110.597 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 47.9 mt -94.33 -4.7 48.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.021 . . . . 0.0 110.928 -171.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.741 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.4 tt -45.51 166.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.883 -1.136 . . . . 0.0 109.962 -172.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 164' ' ' ILE . 35.6 ptt180 33.45 46.72 0.12 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.7 -0.625 . . . . 0.0 111.578 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.489 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 9.0 tpp180 -134.13 135.3 24.02 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.73 -1.231 . . . . 0.0 111.547 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.841 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -59.51 124.19 14.96 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.989 1.521 . . . . 0.0 109.526 178.79 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.458 ' SD ' HG13 ' A' ' 164' ' ' ILE . 20.0 mtp -132.1 147.44 52.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.361 -1.462 . . . . 0.0 111.269 -177.444 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.657 HD21 ' C ' ' A' ' 49' ' ' LYS . 2.1 tp -148.36 115.95 6.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.649 -0.657 . . . . 0.0 109.23 -176.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.598 ' HB3' HG23 ' A' ' 155' ' ' THR . 0.7 OUTLIER -40.43 156.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.052 -1.03 . . . . 0.0 110.514 -174.412 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 70.58 -3.49 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.812 -0.555 . . . . 0.0 111.202 179.483 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.656 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.9 p-10 -70.18 178.64 2.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.925 -1.109 . . . . 0.0 109.882 173.753 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.455 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 20.0 m-80 -145.26 140.96 28.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 109.807 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 110.432 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.157 0.503 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.455 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 29.0 tptp -109.3 106.52 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.656 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.8 t -76.75 140.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 109.918 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.41 -23.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 111.242 -176.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 49.2 tptt -149.07 142.04 24.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.743 -1.223 . . . . 0.0 110.684 -176.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' THR . . . . . 1.043 HG22 HG23 ' A' ' 98' ' ' VAL . 72.5 p -140.02 160.01 40.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.497 -0.752 . . . . 0.0 109.372 176.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.974 HD23 ' CG ' ' A' ' 96' ' ' LYS . 10.8 tp -89.48 -29.17 0.35 Allowed Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.163 -0.96 . . . . 0.0 111.44 -175.422 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.944 ' CG ' HG11 ' A' ' 162' ' ' VAL . 35.5 Cg_exo -53.78 -170.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.086 1.045 . . . . 0.0 110.5 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.601 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -89.85 41.35 1.04 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 110.433 -178.254 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 158' ' ' SER . 37.1 mttt 62.31 19.95 11.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.452 -0.78 . . . . 0.0 109.851 -177.3 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.781 ' O ' HG13 ' A' ' 162' ' ' VAL . 20.0 m -110.37 160.04 29.89 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.495 -0.753 . . . . 0.0 110.057 178.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.541 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.3 Cg_endo -53.1 122.24 10.79 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.123 1.591 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.944 HG11 ' CG ' ' A' ' 157' ' ' PRO . 3.9 m -127.07 155.26 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 110.437 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -100.47 126.21 46.87 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.282 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.919 HD12 HG21 ' A' ' 168' ' ' THR . 12.8 mm -70.39 153.21 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 110.005 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.98 168.79 25.9 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 176.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -57.13 -21.77 34.94 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.231 -1.158 . . . . 0.0 110.229 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.53 -10.74 42.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.715 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.919 HG21 HD12 ' A' ' 164' ' ' ILE . 93.5 m -59.81 143.45 51.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.057 -1.027 . . . . 0.0 110.241 -179.642 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 86.4 mttt -90.02 149.22 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.032 -1.043 . . . . 0.0 109.892 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.686 HD12 ' CG1' ' A' ' 120' ' ' VAL . 4.5 mm -115.42 130.06 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.846 -177.271 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.628 ' HB3' HG23 ' A' ' 99' ' ' THR . 20.8 mt-10 -111.92 128.38 56.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.165 -0.96 . . . . 0.0 110.316 171.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.477 HD11 HG21 ' A' ' 120' ' ' VAL . 39.2 mm -123.37 127.86 74.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.194 -177.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.51 ' HG2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.344 0.592 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -59.98 -41.41 91.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 110.652 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.9 t -149.58 140.44 22.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 110.183 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -148.45 92.55 2.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 110.122 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 5' ' ' ASN . 7.6 p30 -136.44 109.03 7.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 110.582 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 87' ' ' VAL . . . -154.12 -169.98 19.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.654 HD13 HD21 ' A' ' 33' ' ' LEU . 48.1 pt -131.2 159.92 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.05 -1.265 . . . . 0.0 110.195 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.56 115.98 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.01 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.7 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.2 pt? -141.1 -175.13 4.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.672 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 3.7 ptt-85 -109.6 133.71 52.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.763 -1.211 . . . . 0.0 110.844 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.968 ' CG2' HD11 ' A' ' 69' ' ' ILE . 12.6 p -61.84 129.75 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 110.544 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -110.36 159.66 17.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.337 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.964 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 -175.74 142.18 0.53 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.138 -0.976 . . . . 0.0 110.689 176.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.68 171.38 17.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.386 -0.821 . . . . 0.0 110.038 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -59.93 133.1 55.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.113 -0.992 . . . . 0.0 110.128 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 p -175.4 -158.45 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.875 . . . . 0.0 110.084 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 43.2 p -71.54 159.26 34.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.682 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -69.89 -36.67 6.72 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.371 -0.831 . . . . 0.0 111.256 -177.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 16.9 Cg_exo -63.38 -175.01 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.515 1.271 . . . . 0.0 110.849 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.59 17.72 44.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.9 ptm -88.31 5.41 42.01 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.224 -1.162 . . . . 0.0 109.269 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -134.33 11.72 3.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 110.386 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 69.0 mtt85 -127.29 134.37 50.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 0.0 109.844 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.926 HG13 HG23 ' A' ' 67' ' ' VAL . 84.4 t -110.39 119.9 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.972 -1.08 . . . . 0.0 109.948 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 3.0 ptt180 -93.09 118.12 30.85 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.491 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.962 HD22 ' HB3' ' A' ' 30' ' ' SER . 2.7 mt -136.58 -179.27 5.59 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.728 -0.607 . . . . 0.0 109.958 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 1.4 p-10 -103.06 176.24 5.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.697 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 79.6 mt-10 -59.78 -44.48 93.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.344 -0.847 . . . . 0.0 109.25 -174.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.545 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 72.1 m -68.41 -43.32 77.46 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.014 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.962 ' HB3' HD22 ' A' ' 26' ' ' LEU . 58.1 m -60.09 -40.02 88.17 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.122 -0.986 . . . . 0.0 109.713 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 26.1 ttp180 -86.66 -33.92 19.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.732 -0.605 . . . . 0.0 111.135 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 62.2 ttt180 -89.39 -12.6 39.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.909 -1.119 . . . . 0.0 110.814 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.4 pp -59.76 -32.45 70.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.935 -1.103 . . . . 0.0 109.702 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.079 ' N ' HD12 ' A' ' 33' ' ' LEU . 12.2 mt -101.65 -74.51 0.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 36' ' ' ALA . 33.7 t0 -170.24 -23.81 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.687 -0.633 . . . . 0.0 109.604 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -34.71 121.27 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.436 0.636 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.514 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.07 -179.34 3.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.437 HD13 ' NH1' ' A' ' 31' ' ' ARG . 32.5 mm -60.07 126.15 17.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.575 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.65 23.87 63.8 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.07 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -88.54 171.29 10.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.655 -1.497 . . . . 0.0 109.91 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.777 HG21 ' OG1' ' A' ' 92' ' ' THR . 84.8 t -99.2 130.15 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.264 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.508 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -117.96 139.95 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.813 . . . . 0.0 110.437 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 88.7 tt0 -108.59 142.83 38.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -119.91 150.5 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.924 -1.11 . . . . 0.0 110.703 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -152.57 93.48 1.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 111.124 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.015 ' CG ' HG12 ' A' ' 85' ' ' VAL . 4.1 tmtm? -99.06 -66.95 0.87 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.933 -1.104 . . . . 0.0 109.748 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.52 -34.58 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 109.407 176.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 85.9 mtt180 -131.59 -174.12 3.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.583 -0.698 . . . . 0.0 109.246 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.723 ' C ' HD21 ' A' ' 130' ' ' LEU . 35.5 mttt -89.14 139.44 30.47 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.351 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.566 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.54 159.81 40.91 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.431 0.634 . . . . 0.0 110.154 -177.381 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.15 161.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.035 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.474 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.87 179.85 48.76 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.678 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 59.2 ttt180 -117.17 164.46 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.503 -0.998 . . . . 0.0 110.237 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -94.05 141.79 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.463 -176.037 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.546 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.4 m-85 -137.62 166.37 24.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.508 -0.745 . . . . 0.0 110.496 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.408 ' NH2' HD11 ' A' ' 38' ' ' ILE . 58.3 ttm-85 -89.23 121.94 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 110.084 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.45 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -62.96 140.01 58.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.002 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.69 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.1 mmt85 -56.15 -49.68 91.82 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.055 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.69 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.16 98.74 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.726 1.382 . . . . 0.0 108.923 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 37.18 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.3 p-10 -147.71 -29.2 0.33 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -85.04 -28.51 25.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 109.106 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.448 ' C ' ' HB3' ' A' ' 27' ' ' ASP . 4.8 m-80 -81.13 41.51 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.857 -0.527 . . . . 0.0 110.636 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HA ' ' HG ' ' A' ' 30' ' ' SER . 20.7 pttt -97.83 8.97 43.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.9 27.08 0.05 OUTLIER Glycine 0 N--CA 1.479 1.552 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.489 HG21 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -141.11 142.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.25 -1.147 . . . . 0.0 109.561 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.926 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -119.97 127.47 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.044 -1.035 . . . . 0.0 109.973 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 33.9 ttm180 -92.86 118.46 31.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.968 HD11 ' CG2' ' A' ' 11' ' ' VAL . 2.5 pt -129.34 166.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.775 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.4 ' OD2' ' O ' ' A' ' 18' ' ' ASP . 3.8 t70 -80.09 168.89 18.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.5 p -60.82 -29.65 69.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.65 -46.41 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.161 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.761 ' CE ' HD13 ' A' ' 44' ' ' ILE . 13.5 tpt -60.04 -44.38 94.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.587 ' NH1' HD13 ' A' ' 81' ' ' ILE . 61.8 ttt180 -60.03 -40.14 88.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.849 173.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -66.43 -31.24 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' MET . 99.7 m-20 -59.98 -39.85 87.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.762 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.498 ' C ' HG23 ' A' ' 47' ' ' VAL . 28.5 p -99.36 -39.64 8.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.846 -1.159 . . . . 0.0 110.801 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.586 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 110.2 30.72 3.29 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -104.54 167.91 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.13 -1.217 . . . . 0.0 110.36 -177.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.625 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 165.53 11.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.173 176.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.964 HD11 ' HB3' ' A' ' 13' ' ' GLU . 1.1 mp -53.83 139.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.995 -1.065 . . . . 0.0 110.203 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.54 2.08 73.55 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -58.23 -160.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 O-C-N 120.91 -1.347 . . . . 0.0 110.509 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 15.9 ptpt -130.88 108.93 10.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.015 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -118.87 155.2 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.128 -0.983 . . . . 0.0 110.052 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -106.6 119.96 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.199 -0.938 . . . . 0.0 109.908 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.71 HG22 HG23 ' A' ' 44' ' ' ILE . 95.0 t -105.1 121.78 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.501 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 87.7 mtm-85 -112.38 140.35 47.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.995 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.624 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 41.1 tttm -72.33 143.01 48.81 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.533 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.516 HG21 ' CG ' ' A' ' 161' ' ' PRO . 1.9 m -150.22 -169.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.511 -0.743 . . . . 0.0 109.909 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.24 169.05 17.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.777 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.98 156.2 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.625 ' HG2' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -150.26 174.47 12.8 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.558 HG21 ' OE2' ' A' ' 167' ' ' GLU . 49.4 mm -89.28 102.96 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.867 -1.146 . . . . 0.0 110.031 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.759 ' HB2' ' CG2' ' A' ' 162' ' ' VAL . . . -52.84 132.46 36.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.306 -0.871 . . . . 0.0 110.163 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.786 ' HE2' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -96.06 -28.66 14.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.996 . . . . 0.0 110.995 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HB3' HD23 ' A' ' 156' ' ' LEU . 46.2 tttp -150.05 119.9 7.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.831 -1.168 . . . . 0.0 110.281 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.617 HG23 HG22 ' A' ' 155' ' ' THR . 9.3 p -132.45 137.63 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.87 -1.144 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 171' ' ' GLU . 28.1 m -107.77 145.76 33.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.666 ' N ' HD23 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -147.66 169.76 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.144 -0.973 . . . . 0.0 110.864 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.579 ' HB1' ' CZ ' ' A' ' 173' ' ' ARG . . . -141.4 86.05 11.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 110.924 -175.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 22.0 Cg_exo -60.01 126.09 19.37 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.881 1.464 . . . . 0.0 109.834 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.947 HG23 ' HB2' ' A' ' 177' ' ' ALA . 76.2 mt -89.44 95.14 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.004 . . . . 0.0 110.149 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.561 HD12 ' H ' ' A' ' 109' ' ' ARG . 8.8 pt -150.79 -168.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.49 -0.756 . . . . 0.0 110.453 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.512 ' HB2' ' HG3' ' A' ' 108' ' ' GLN . 33.0 mmt180 -93.87 156.64 16.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.541 -0.725 . . . . 0.0 110.005 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -55.6 -22.52 22.73 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.118 -0.989 . . . . 0.0 110.14 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 36.2 p-10 -110.02 20.03 18.38 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 111.095 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.656 ' CG ' HD11 ' A' ' 142' ' ' LEU . 1.6 mt-30 -90.54 -80.07 0.34 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.837 -1.164 . . . . 0.0 110.795 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.561 ' H ' HD12 ' A' ' 104' ' ' ILE . 47.3 ttm-85 -119.83 -17.34 8.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.038 -1.039 . . . . 0.0 111.065 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -97.99 43.12 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.044 -1.035 . . . . 0.0 110.523 -177.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -110.41 47.88 0.94 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.589 -0.694 . . . . 0.0 110.578 176.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -111.49 -62.78 1.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 110.543 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 78.18 169.95 35.51 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 113' ' ' GLY . 96.1 mt-10 44.4 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.267 -1.137 . . . . 0.0 110.234 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.3 0.94 89.55 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -60.91 -39.97 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -1.166 . . . . 0.0 109.903 177.018 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.507 ' N ' HG23 ' A' ' 116' ' ' ILE . 46.7 mt-10 -61.77 -40.26 94.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -70.0 -31.43 69.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.718 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -59.89 -39.76 86.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.551 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.665 ' CG1' HD12 ' A' ' 124' ' ' LEU . 69.6 t -60.2 -46.27 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.148 -0.97 . . . . 0.0 109.238 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.6 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.17 -40.03 92.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 110.267 175.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -60.0 -41.87 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.3 -39.83 28.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -0.793 . . . . 0.0 110.586 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.665 HD12 ' CG1' ' A' ' 120' ' ' VAL . 92.0 mt -91.04 -8.39 49.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.884 -174.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 166' ' ' GLU . 3.7 tt -41.96 166.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.582 ' HG2' HG23 ' A' ' 125' ' ' ILE . 30.9 ptt-85 34.2 54.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.449 -0.782 . . . . 0.0 111.607 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 6.6 mtt-85 -135.17 150.2 72.16 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.89 -1.131 . . . . 0.0 111.163 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.9 Cg_endo -69.02 133.11 26.06 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 124.096 1.577 . . . . 0.0 109.618 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.56 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 90.4 mmm -128.54 145.67 51.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.485 -1.384 . . . . 0.0 111.607 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.723 HD21 ' C ' ' A' ' 49' ' ' LYS . 13.6 tp -149.77 114.4 5.29 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.703 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.0 pm0 -49.11 139.67 10.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 0.0 110.573 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.703 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 94.5 mm-40 79.73 -1.33 2.13 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.066 0.46 . . . . 0.0 110.593 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.669 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.1 p30 -69.02 -171.05 0.28 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.126 -0.984 . . . . 0.0 110.41 175.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 12.6 m120 -149.97 158.8 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.42 ' CG1' ' HB2' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -140.38 171.7 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.092 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.9 t -116.51 158.59 23.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.327 -0.858 . . . . 0.0 110.684 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.748 ' HB ' HD22 ' A' ' 140' ' ' LEU . 2.5 t -113.55 148.67 40.21 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.481 -0.762 . . . . 0.0 109.546 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.605 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 4.8 Cg_endo -51.78 76.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.845 1.445 . . . . 0.0 111.302 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 38.13 63.16 0.96 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.907 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -123.59 153.99 39.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -1.19 . . . . 0.0 110.004 176.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -180.0 -167.14 0.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.2 -0.938 . . . . 0.0 110.38 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.656 HD11 ' CG ' ' A' ' 108' ' ' GLN . 83.7 mt -141.86 -131.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.656 -0.652 . . . . 0.0 109.923 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.52 -151.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 110.501 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.46 62.63 4.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -97.36 169.12 9.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.46 -1.024 . . . . 0.0 110.035 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -135.31 158.46 44.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.245 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.561 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 101.49 -91.5 0.93 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.06 44.33 2.05 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.457 -1.025 . . . . 0.0 111.021 177.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 103' ' ' ILE . 2.9 pp -140.45 163.27 33.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.014 -1.054 . . . . 0.0 109.735 177.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 45.7 m-85 -90.71 131.92 36.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.02 . . . . 0.0 110.17 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.39 109.78 16.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.993 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.669 HG21 ' OD2' ' A' ' 133' ' ' ASP . 5.9 t -76.54 139.98 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.241 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.3 t -120.47 -24.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.121 -0.987 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.505 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 87.6 tttt -143.11 151.08 40.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.872 -1.143 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.617 HG22 HG23 ' A' ' 98' ' ' VAL . 39.2 p -141.6 154.62 45.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.626 -0.672 . . . . 0.0 109.626 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.786 HD12 ' HE2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -89.5 -33.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 111.235 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.918 ' CG ' HG11 ' A' ' 162' ' ' VAL . 26.5 Cg_exo -55.54 -165.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.314 1.165 . . . . 0.0 110.165 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.643 ' O ' HG13 ' A' ' 160' ' ' VAL . 8.6 t -88.64 40.94 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.8 mttt 59.99 18.76 7.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.843 ' O ' HG13 ' A' ' 162' ' ' VAL . 16.3 m -106.32 160.28 26.79 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.508 -0.745 . . . . 0.0 109.813 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.528 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.71 122.24 9.37 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 124.024 1.539 . . . . 0.0 110.064 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.918 HG11 ' CG ' ' A' ' 157' ' ' PRO . 12.1 m -129.87 159.9 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.0 tt0 -108.15 128.55 54.8 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.219 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.811 HD12 HG21 ' A' ' 168' ' ' THR . 20.1 mm -72.22 153.74 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.68 -0.637 . . . . 0.0 110.425 -175.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.552 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.09 167.04 26.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.746 ' HB3' HD11 ' A' ' 125' ' ' ILE . 21.2 pt-20 -57.57 -20.07 29.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -1.088 . . . . 0.0 110.352 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.558 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.4 pt-20 -88.87 -14.0 37.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.246 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.811 HG21 HD12 ' A' ' 164' ' ' ILE . 64.1 m -60.41 141.7 56.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 86.5 mttt -96.05 145.92 25.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.04 . . . . 0.0 109.985 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.651 ' CD1' HG12 ' A' ' 120' ' ' VAL . 1.5 mt -125.21 157.85 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.192 -0.943 . . . . 0.0 110.853 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.612 ' HB3' HG23 ' A' ' 99' ' ' THR . 21.6 mt-10 -131.76 133.56 44.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.651 -0.655 . . . . 0.0 110.114 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 120' ' ' VAL . 40.7 mm -115.07 131.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.598 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.579 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -86.91 149.6 24.69 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.137 -176.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 174' ' ' GLU . 85.5 tt0 -90.25 10.07 26.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.318 -0.864 . . . . 0.0 110.327 -174.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -122.08 74.57 38.79 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.481 ' HD3' ' C ' ' A' ' 174' ' ' GLU . 21.0 Cg_exo -64.64 -149.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.023 1.539 . . . . 0.0 110.418 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.947 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -73.73 53.11 0.43 Allowed 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.257 0.551 . . . . 0.0 110.237 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 180' ' ' VAL . 25.5 t -107.36 113.86 27.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 178' ' ' SER . 81.0 tt0 60.0 19.74 8.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 178' ' ' SER . 17.6 t -101.74 112.44 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 110.105 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 181' ' ' LEU . 1.4 pt? -147.44 29.01 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 110.247 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 181' ' ' LEU . 99.1 mt-10 55.38 37.72 29.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -0.878 . . . . 0.0 110.118 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.07 -29.94 68.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.932 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.94 173.94 16.78 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.022 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.291 0.567 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -139.97 156.51 46.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.085 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 m -97.49 148.98 22.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -99.84 138.04 37.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 110.38 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -139.43 154.35 47.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 110.102 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -148.81 -161.75 9.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.71 HG21 HD22 ' A' ' 33' ' ' LEU . 39.1 pt -129.99 160.09 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -1.107 . . . . 0.0 109.43 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.9 mt -108.48 120.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.294 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.943 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.6 pt? -144.48 -171.66 3.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.477 -0.765 . . . . 0.0 109.648 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.63 ' NH1' HG22 ' A' ' 66' ' ' ILE . 9.5 ptp85 -106.93 135.73 47.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.81 -1.181 . . . . 0.0 110.948 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.965 HG23 HD11 ' A' ' 69' ' ' ILE . 14.4 p -62.39 131.06 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.629 -0.669 . . . . 0.0 110.738 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -114.23 146.21 40.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.863 . . . . 0.0 110.561 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 1.014 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 tt0 -177.96 86.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.0 110.321 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.91 -26.93 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.902 . . . . 0.0 110.544 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -59.99 -49.06 79.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.094 -1.004 . . . . 0.0 110.51 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.423 ' OG ' ' HG2' ' A' ' 19' ' ' PRO . 87.5 p -154.95 151.28 28.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.347 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.2 p -118.44 -16.84 9.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 110.393 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.681 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -68.48 -35.75 7.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 111.302 -176.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 22.9 Cg_exo -60.3 -170.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.547 1.288 . . . . 0.0 110.666 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.511 ' N ' ' OD2' ' A' ' 70' ' ' ASP . . . 159.97 57.69 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.514 ' HG3' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -90.02 2.39 55.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -1.1 . . . . 0.0 110.032 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.46 39.89 27.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.368 -0.832 . . . . 0.0 110.346 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.514 ' CG ' ' HG3' ' A' ' 21' ' ' MET . 25.1 mmt85 -113.91 147.83 37.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.813 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.841 HG13 HG23 ' A' ' 67' ' ' VAL . 89.8 t -109.98 119.66 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.062 . . . . 0.0 110.347 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.636 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.1 ptm180 -100.56 121.25 41.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.92 -1.113 . . . . 0.0 110.135 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.695 HD12 ' CB ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -134.06 176.8 8.25 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 25.9 p-10 -89.56 179.85 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.753 -1.217 . . . . 0.0 110.416 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 87.0 mt-10 -60.05 -40.21 88.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.362 -0.836 . . . . 0.0 109.169 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 22.9 t -70.0 -44.4 69.42 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.529 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.695 ' CB ' HD12 ' A' ' 26' ' ' LEU . 58.1 m -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.923 -1.111 . . . . 0.0 109.401 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 56.4 ttp85 -74.76 -43.04 56.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.694 -0.629 . . . . 0.0 111.623 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -88.77 -12.97 40.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 111.212 -170.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.083 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.2 pp -56.76 -32.63 65.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 109.505 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.083 ' N ' HD12 ' A' ' 33' ' ' LEU . 12.7 mt -105.27 -75.01 0.64 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.189 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' A' ' 36' ' ' ALA . 13.0 t0 -170.12 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.637 . . . . 0.0 109.676 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -26.77 118.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.539 0.685 . . . . 0.0 111.264 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.73 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -104.96 177.32 4.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.81 123.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.93 -1.106 . . . . 0.0 109.86 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.03 29.06 59.41 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 32.8 m-20 -89.12 176.44 6.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.71 -1.465 . . . . 0.0 109.296 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.796 HG21 HG23 ' A' ' 92' ' ' THR . 89.8 t -99.32 129.25 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.074 -1.016 . . . . 0.0 110.373 -176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -119.58 147.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.791 . . . . 0.0 110.319 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.55 142.16 45.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.423 -0.798 . . . . 0.0 109.606 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.792 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.3 mp -114.23 148.04 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.036 -1.04 . . . . 0.0 110.22 -177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 89.1 tt0 -150.21 89.44 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.02 -1.05 . . . . 0.0 111.222 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.099 ' CG ' HG12 ' A' ' 85' ' ' VAL . 14.4 tmtt? -98.37 -66.39 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 173.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.05 -38.82 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.708 0.766 . . . . 0.0 109.162 177.062 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.607 ' CG ' ' HA ' ' A' ' 77' ' ' CYS . 19.7 ptp180 -142.38 -163.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.46 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.638 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -88.69 130.51 35.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 111.132 -174.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.547 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -130.69 162.59 29.1 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.246 0.546 . . . . 0.0 110.339 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -124.6 160.82 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.378 -0.826 . . . . 0.0 110.609 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.92 -179.73 48.71 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 62.0 mtp180 -111.03 175.2 5.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -1.205 . . . . 0.0 109.876 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -99.64 133.54 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.075 -1.016 . . . . 0.0 110.167 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -117.44 166.82 11.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 176.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 38.7 ptt180 -97.16 125.65 41.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.027 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.629 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -64.2 133.05 52.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.81 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.578 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.03 -46.85 99.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.986 174.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 23.7 Cg_endo -91.64 98.61 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.549 . . . . 0.0 109.028 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.04 33.81 0.09 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.595 -0.69 . . . . 0.0 110.91 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -147.53 -29.08 0.35 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.187 -0.945 . . . . 0.0 110.705 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.55 -28.43 26.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.543 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 11.0 m120 -81.25 42.08 0.64 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.706 -0.621 . . . . 0.0 110.284 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 35.6 tttt -98.42 9.38 43.25 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.278 -0.889 . . . . 0.0 109.582 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.64 26.47 0.05 OUTLIER Glycine 0 N--CA 1.482 1.724 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 176.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.63 HG22 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -140.12 142.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.273 -1.133 . . . . 0.0 109.448 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.943 ' HB ' HD11 ' A' ' 9' ' ' LEU . 12.7 p -120.05 119.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.666 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.557 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 77.7 mtt180 -90.08 111.14 22.15 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 11' ' ' VAL . 1.1 pt -127.69 161.3 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.608 -0.682 . . . . 0.0 110.355 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.511 ' OD2' ' N ' ' A' ' 20' ' ' GLY . 90.0 m-20 -80.01 169.59 17.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.522 -0.736 . . . . 0.0 109.795 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 80.0 p -62.39 -16.03 52.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.2 -49.2 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 110.363 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.655 ' HE1' HD13 ' A' ' 44' ' ' ILE . 97.8 mmm -63.73 -40.13 95.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 0.0 109.361 176.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttp180 -60.32 -42.19 95.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 109.997 173.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -70.23 -33.56 71.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.235 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -60.11 -40.0 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.607 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 31.7 p -99.06 -39.38 8.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.021 -1.049 . . . . 0.0 110.694 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.603 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.75 47.85 0.56 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.821 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -122.87 168.54 12.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.071 -1.252 . . . . 0.0 110.75 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.813 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.93 170.93 8.11 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.014 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -58.09 140.11 16.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.925 -1.109 . . . . 0.0 110.644 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.582 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.61 -0.29 65.48 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 172.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -58.55 -160.81 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.032 -1.275 . . . . 0.0 110.211 175.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.59 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.3 pttt -130.02 115.54 17.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 109.809 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.099 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.4 m -123.04 157.65 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.0 ttpt -110.04 120.44 42.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 110.005 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.509 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 69.1 t -99.63 123.81 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.893 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.534 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 38.3 mtp85 -109.98 157.75 18.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.791 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -102.26 138.42 39.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 110.153 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.619 HG23 HG12 ' A' ' 41' ' ' VAL . 2.5 m -150.12 -169.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.443 -0.786 . . . . 0.0 110.324 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -127.48 172.81 10.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.629 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.796 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.04 163.23 12.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 111.086 -176.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.707 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.9 pt-20 -150.01 168.11 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 mm -89.64 99.81 9.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.556 -1.34 . . . . 0.0 110.466 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.898 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.2 136.62 56.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 110.226 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 6.2 pttt -106.05 -24.21 12.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.074 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.524 ' HB3' HD23 ' A' ' 156' ' ' LEU . 83.3 tttt -147.0 119.92 8.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.904 -1.123 . . . . 0.0 110.434 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.775 HG23 HG22 ' A' ' 155' ' ' THR . 8.2 p -138.09 140.28 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 110.492 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.589 ' C ' HD23 ' A' ' 100' ' ' LEU . 94.4 m -117.97 135.81 53.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -0.885 . . . . 0.0 110.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.805 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -141.27 167.74 21.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -178.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . . . -132.94 103.12 13.1 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.384 -0.822 . . . . 0.0 110.562 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.4 Cg_exo -65.35 120.2 7.37 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.106 1.582 . . . . 0.0 110.132 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 81.3 mt -89.72 95.96 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.038 . . . . 0.0 110.249 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.993 HG21 HD21 ' A' ' 110' ' ' LEU . 15.0 pt -150.32 -164.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.29 -0.881 . . . . 0.0 110.744 178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.546 ' HB2' ' HG2' ' A' ' 108' ' ' GLN . 6.7 mmm180 -90.4 148.1 23.02 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.81 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -60.0 -14.51 16.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 0.0 110.241 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -122.53 37.78 4.31 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.841 -0.537 . . . . 0.0 110.257 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.546 ' HG2' ' HB2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -86.77 -163.2 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.223 -0.923 . . . . 0.0 110.241 -178.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -88.95 -25.16 22.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.024 -1.048 . . . . 0.0 110.956 -173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.993 HD21 HG21 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -99.78 57.37 1.0 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.053 -1.029 . . . . 0.0 110.46 -177.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.524 ' HD2' ' O ' ' A' ' 108' ' ' GLN . 0.2 OUTLIER -139.91 129.95 24.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.154 -0.966 . . . . 0.0 109.64 173.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -143.75 -86.44 0.13 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.411 -0.806 . . . . 0.0 110.131 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 115' ' ' GLY . . . 170.92 -159.79 32.01 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.147 -175.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -43.87 82.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.102 -0.646 . . . . 0.0 110.949 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 113' ' ' GLY . . . 161.71 -32.36 0.34 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -170.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 8.5 tp -59.98 -39.02 79.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.757 -0.849 . . . . 0.0 109.565 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.492 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 95.0 mt-10 -60.08 -43.92 95.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 109.831 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.68 -35.57 78.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -38.3 82.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.385 -0.822 . . . . 0.0 109.817 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.657 ' CG1' HD12 ' A' ' 170' ' ' ILE . 62.4 t -60.03 -49.02 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.673 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.646 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 5.3 mt-30 -60.06 -41.17 91.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.872 . . . . 0.0 110.045 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -60.05 -39.99 87.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 110.444 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.97 -41.2 19.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 120' ' ' VAL . 52.3 mt -95.27 -3.43 47.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.059 -1.025 . . . . 0.0 110.972 -173.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.673 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.7 tt -43.43 163.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -174.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.609 ' HG2' HG23 ' A' ' 125' ' ' ILE . 34.0 ptt180 33.84 49.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.492 -0.755 . . . . 0.0 111.371 -177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 10.8 ttt85 -132.11 143.34 48.53 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.966 -1.084 . . . . 0.0 111.105 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.828 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 17.4 Cg_endo -63.76 127.24 19.17 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.062 1.559 . . . . 0.0 109.811 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.573 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 93.4 mmm -123.52 140.02 53.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.402 -1.436 . . . . 0.0 110.926 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.638 HD21 ' O ' ' A' ' 49' ' ' LYS . 19.1 tp -139.59 112.37 7.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.577 -0.702 . . . . 0.0 109.7 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.0 pt-20 -46.68 142.05 3.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.012 -1.055 . . . . 0.0 110.435 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 20.5 mm100 82.43 -2.74 1.41 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.228 0.537 . . . . 0.0 110.42 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.543 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.6 p-10 -70.21 -178.96 1.8 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 110.115 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.547 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 14.8 m-80 -148.29 129.54 14.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 1.3 mt -139.96 162.26 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.086 . . . . 0.0 110.718 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.0 t -140.97 147.4 38.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.459 -0.775 . . . . 0.0 110.251 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.621 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 11.4 t -106.61 -62.91 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 39.1 Cg_endo -71.82 153.37 58.8 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.286 1.15 . . . . 0.0 110.524 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -113.16 52.93 0.61 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.058 HD22 ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -141.71 160.89 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -1.155 . . . . 0.0 110.457 -178.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 1.058 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -144.89 -165.46 2.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.444 -177.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.573 ' N ' ' OG1' ' A' ' 141' ' ' THR . 85.1 mt -130.54 -125.06 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.618 -0.676 . . . . 0.0 109.919 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.01 -157.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.31 55.79 4.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.433 ' OE1' ' HB2' ' A' ' 142' ' ' LEU . 14.5 pt20 -97.43 161.68 13.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.475 -1.015 . . . . 0.0 110.216 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.583 HG23 HD12 ' A' ' 181' ' ' LEU . 9.0 t -137.48 151.48 48.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 110.112 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.685 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 118.19 -91.35 0.52 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.685 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 41.49 44.28 2.47 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.322 -1.105 . . . . 0.0 111.016 177.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 3.6 pp -140.23 169.96 16.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.019 -1.05 . . . . 0.0 109.921 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.736 ' HD2' HD12 ' A' ' 100' ' ' LEU . 28.2 m-85 -91.57 125.89 36.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 110.067 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.547 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 21.2 tptm -99.92 106.72 18.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.543 HG21 ' OD1' ' A' ' 133' ' ' ASP . 2.1 t -79.37 134.37 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -0.965 . . . . 0.0 109.898 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.98 -23.19 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.157 -0.964 . . . . 0.0 110.737 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.478 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 8.6 tptp -140.2 127.12 20.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.85 -1.156 . . . . 0.0 110.609 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.775 HG22 HG23 ' A' ' 98' ' ' VAL . 33.8 p -126.79 170.01 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.586 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -88.82 -41.56 0.45 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.531 -178.025 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.998 ' CG ' HG11 ' A' ' 162' ' ' VAL . 16.4 Cg_exo -61.75 -176.3 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.631 1.332 . . . . 0.0 110.179 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -90.25 -156.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.964 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -71.77 -2.58 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.271 -0.893 . . . . 0.0 110.38 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.87 138.7 32.96 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.374 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.557 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.99 142.38 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.224 1.644 . . . . 0.0 110.51 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.998 HG11 ' CG ' ' A' ' 157' ' ' PRO . 10.8 m -129.92 159.47 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 109.516 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.2 tt0 -106.17 127.2 53.04 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.138 -0.976 . . . . 0.0 110.063 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.881 ' CD1' HG21 ' A' ' 168' ' ' THR . 12.2 mm -69.73 156.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.624 -0.673 . . . . 0.0 109.862 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.01 166.65 27.02 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.61 -24.42 21.31 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.437 -1.037 . . . . 0.0 109.993 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -88.55 -16.92 31.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.588 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.881 HG21 ' CD1' ' A' ' 164' ' ' ILE . 80.3 m -56.82 153.13 11.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.0 109.989 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 68.4 mttm -100.7 152.94 19.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 110.032 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.657 HD12 ' CG1' ' A' ' 120' ' ' VAL . 19.7 mm -114.65 131.56 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 110.927 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.687 ' O ' HD13 ' A' ' 172' ' ' ILE . 23.6 mt-10 -114.24 129.55 56.63 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.162 -0.962 . . . . 0.0 110.109 170.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 171' ' ' GLU . 38.1 mm -130.92 140.0 49.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.042 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.487 ' NE ' ' HB3' ' A' ' 175' ' ' GLU . 7.8 ptm180 -88.03 173.79 8.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 174' ' ' GLU . 58.5 mp0 -111.31 -2.46 15.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -0.956 . . . . 0.0 110.779 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.487 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . 8.6 tt0 -99.41 107.93 47.7 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 110.336 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 11.9 Cg_exo -72.3 -154.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.089 1.573 . . . . 0.0 110.018 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.73 53.66 0.45 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.554 -0.716 . . . . 0.0 109.993 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.659 ' O ' HG23 ' A' ' 180' ' ' VAL . 20.1 t -81.1 125.05 29.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.313 -0.867 . . . . 0.0 109.782 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 178' ' ' SER . 90.4 mt-10 60.05 19.9 9.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.435 -0.791 . . . . 0.0 109.982 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 178' ' ' SER . 62.3 t -109.96 120.02 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.59 ' C ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER 15.73 72.37 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.273 0.559 . . . . 0.0 111.747 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 184' ' ' GLY . 21.4 pt-20 -140.71 160.25 40.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.864 . . . . 0.0 110.096 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -59.93 -30.08 68.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.144 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 182' ' ' GLU . . . -93.28 -176.27 40.51 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.618 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.268 0.556 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.99 -39.97 87.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.204 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 m -98.05 144.76 27.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.223 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -129.6 163.45 25.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.027 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -127.16 160.37 31.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.965 . . . . 0.0 110.602 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.13 -163.99 10.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.031 HG23 HD11 ' A' ' 34' ' ' LEU . 34.8 pt -137.56 158.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -1.186 . . . . 0.0 110.096 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.6 mt -102.21 115.55 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.15 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.789 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.6 pt? -140.0 -171.86 3.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.791 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.2 ptt180 -111.4 140.57 45.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.829 -1.169 . . . . 0.0 110.797 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.027 HG23 HD11 ' A' ' 69' ' ' ILE . 11.7 p -61.75 136.23 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 110.58 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -115.99 152.17 34.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.172 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.925 ' HB3' HD11 ' A' ' 81' ' ' ILE . 85.5 tt0 -175.27 114.42 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 15' ' ' ASN . . . -100.02 3.43 44.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.146 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 28.3 m120 58.4 32.06 21.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.41 -0.806 . . . . 0.0 110.338 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.4 t -68.89 -47.98 64.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 65.2 p -140.03 151.83 45.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.152 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.69 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -76.05 -33.19 1.23 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.922 . . . . 0.0 111.52 -177.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 14.5 Cg_exo -65.52 159.02 49.93 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.347 1.183 . . . . 0.0 110.605 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.79 39.34 4.66 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 73' ' ' MET . 0.0 OUTLIER -89.37 2.24 54.69 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.305 -1.115 . . . . 0.0 109.438 176.559 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.4 p -135.19 15.02 3.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.0 110.51 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 96.2 mtt180 -119.95 140.04 51.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.136 -0.978 . . . . 0.0 110.38 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.048 HG13 HG23 ' A' ' 67' ' ' VAL . 67.0 t -113.21 120.61 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.283 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -95.09 120.54 35.48 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.467 175.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.081 HD22 ' CB ' ' A' ' 30' ' ' SER . 3.6 mt -134.93 171.32 14.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.554 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 5.3 p-10 -89.02 170.42 10.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.335 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HA ' ' NH1' ' A' ' 31' ' ' ARG . 46.7 mt-10 -56.16 -40.03 73.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.95 . . . . 0.0 109.019 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 5.2 t -65.29 -58.81 5.01 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.213 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.081 ' CB ' HD22 ' A' ' 26' ' ' LEU . 61.7 m -49.6 -30.02 8.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.593 -1.317 . . . . 0.0 109.635 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.588 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.9 ttp-105 -81.0 -49.46 10.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 111.136 178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 38.4 mtm105 -93.45 -14.36 26.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 0.0 111.43 -171.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.961 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -60.84 -28.7 69.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.907 -1.121 . . . . 0.0 110.195 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.031 HD11 HG23 ' A' ' 7' ' ' ILE . 55.7 mt -103.66 -73.69 0.66 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.142 -0.974 . . . . 0.0 109.996 175.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 36' ' ' ALA . 30.4 t0 -168.65 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.451 0.643 . . . . 0.0 109.442 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 31' ' ' ARG . . . -33.31 118.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.419 0.628 . . . . 0.0 110.961 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.57 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -104.42 175.92 5.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 38' ' ' ILE . 33.1 mm -60.0 123.95 13.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.908 -1.12 . . . . 0.0 109.785 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.48 28.19 60.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 65.7 m-20 -89.29 171.07 10.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.703 -1.469 . . . . 0.0 109.503 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.622 HG21 HG23 ' A' ' 92' ' ' THR . 73.7 t -99.15 129.95 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 0.0 110.06 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.593 HG11 HG23 ' A' ' 54' ' ' VAL . 2.7 m -118.21 144.71 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.388 -0.82 . . . . 0.0 110.358 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.0 tt0 -112.41 140.21 47.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.934 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.2 mp -122.74 143.97 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.041 -1.037 . . . . 0.0 110.395 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.8 tt0 -150.49 100.03 2.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.134 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.829 ' HD2' ' HB2' ' A' ' 79' ' ' ALA . 9.1 tmtm? -98.31 -66.99 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.017 . . . . 0.0 109.956 173.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.576 HG23 ' C ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -101.63 -34.54 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.388 174.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.556 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 90.0 mtt-85 -134.59 -179.68 5.74 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.5 -0.75 . . . . 0.0 109.486 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.526 ' HB3' HD21 ' A' ' 130' ' ' LEU . 24.3 mttp -89.19 141.87 28.14 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.181 -0.95 . . . . 0.0 110.843 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 130' ' ' LEU . 9.3 p -143.41 169.98 16.65 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.471 0.653 . . . . 0.0 109.901 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.42 167.35 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.447 -0.783 . . . . 0.0 110.079 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.41 -172.36 41.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -122.78 164.56 18.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -1.137 . . . . 0.0 110.329 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.593 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -96.81 137.69 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 110.419 -173.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.6 m-85 -128.12 165.53 20.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.493 -0.754 . . . . 0.0 110.262 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -89.73 122.68 33.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.972 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.773 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -62.29 134.1 56.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.564 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -57.8 -48.75 96.61 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.031 174.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.564 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.3 Cg_endo -92.42 98.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.91 1.479 . . . . 0.0 109.013 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.53 36.32 0.09 Allowed 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.527 -0.733 . . . . 0.0 110.692 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 59' ' ' PRO . 70.7 m-20 -143.67 -30.62 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.157 -0.965 . . . . 0.0 110.446 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 66' ' ' ILE . 21.1 mt-10 -87.14 -28.28 22.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 0.0 109.27 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.773 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 23.6 m120 -81.13 40.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.758 -0.589 . . . . 0.0 110.492 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 4.82 47.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.22 30.18 0.07 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 9' ' ' LEU . 46.3 pt -140.62 146.96 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.518 -0.989 . . . . 0.0 109.257 174.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.048 HG23 HG13 ' A' ' 24' ' ' VAL . 2.7 p -120.01 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.783 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HG2' ' HD2' ' A' ' 25' ' ' ARG . 15.2 tpp180 -90.09 110.28 21.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.126 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.027 HD11 HG23 ' A' ' 11' ' ' VAL . 1.5 pt -130.82 166.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 110.516 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 18' ' ' ASP . 11.5 t70 -80.02 171.1 15.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 176.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -63.91 -21.94 66.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.77 -49.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.934 ' CE ' HD13 ' A' ' 44' ' ' ILE . 1.3 mmt -60.72 -43.28 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 66.0 ttp85 -59.99 -40.53 89.49 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.925 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -70.38 -29.0 65.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.34 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 98.5 m-20 -59.97 -39.15 84.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.576 ' C ' HG23 ' A' ' 47' ' ' VAL . 26.9 p -98.14 -37.76 9.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 110.51 -175.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.529 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 115.56 35.38 1.3 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.829 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -113.08 165.24 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.095 -1.238 . . . . 0.0 110.54 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.737 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.43 170.62 8.11 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.358 -0.839 . . . . 0.0 109.339 178.14 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.925 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -53.41 141.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.929 -1.107 . . . . 0.0 110.382 178.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.414 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 75.42 1.55 65.44 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 172.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 1.8 m-20 -59.51 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.853 -1.381 . . . . 0.0 110.572 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.522 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.2 pttt -132.89 108.81 9.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.824 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.1 m -121.22 153.0 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.5 tttt -103.08 124.74 49.12 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 44' ' ' ILE . 73.2 t -107.21 123.97 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.799 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.5 mtt180 -113.65 136.89 52.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.548 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 27.5 tttt -72.24 143.53 48.76 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.952 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.524 HG23 HG12 ' A' ' 41' ' ' VAL . 1.9 m -148.07 -169.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 109.832 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 174.32 10.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.698 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.622 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.55 159.24 17.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.967 -1.083 . . . . 0.0 111.229 -174.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.59 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -150.34 176.38 10.95 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' HA ' HD13 ' A' ' 94' ' ' ILE . 25.2 mm -93.18 99.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.341 -1.474 . . . . 0.0 110.867 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.821 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.67 139.79 49.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 0.0 110.297 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.97 -27.18 10.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 111.147 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.698 ' HB3' HD23 ' A' ' 156' ' ' LEU . 79.0 tttt -150.0 124.77 9.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.838 -1.163 . . . . 0.0 110.283 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.939 HG23 HG22 ' A' ' 155' ' ' THR . 9.1 p -138.92 148.97 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.585 ' C ' HD23 ' A' ' 100' ' ' LEU . 88.9 m -120.03 130.69 54.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.819 . . . . 0.0 109.762 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.734 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -136.43 169.22 18.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.767 -176.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -130.42 88.82 46.18 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.863 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.589 ' HD3' HG23 ' A' ' 172' ' ' ILE . 17.3 Cg_exo -61.66 124.34 14.41 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.125 1.592 . . . . 0.0 110.385 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.781 HG23 ' HB2' ' A' ' 177' ' ' ALA . 71.7 mt -97.61 106.35 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 110.314 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.689 HD11 HD13 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -150.99 -164.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 110.551 178.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 104' ' ' ILE . 27.1 mmm180 -88.52 158.87 18.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.475 -0.765 . . . . 0.0 109.984 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -57.71 -15.81 9.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.99 -1.069 . . . . 0.0 110.739 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -124.86 27.83 6.66 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.603 -0.686 . . . . 0.0 110.387 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.537 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 2.0 mm-40 -94.54 -80.09 0.41 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.062 -1.024 . . . . 0.0 110.542 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 102' ' ' PRO . 36.5 ttp180 -113.39 -20.31 11.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 111.017 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.689 HD13 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -97.74 41.93 1.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.904 -1.122 . . . . 0.0 110.636 -174.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.93 62.81 1.59 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.252 -0.905 . . . . 0.0 110.495 174.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' HB2' HD13 ' A' ' 116' ' ' ILE . 45.3 m-85 -146.52 -58.24 0.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.995 -1.066 . . . . 0.0 110.442 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.63 177.86 42.3 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 49.0 95.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.164 -1.198 . . . . 0.0 110.071 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.54 -9.92 73.86 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.7 tp -62.42 -43.04 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -1.185 . . . . 0.0 110.103 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.596 ' N ' HG23 ' A' ' 116' ' ' ILE . 47.0 mt-10 -69.91 -40.11 75.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.505 ' OE1' ' NE2' ' A' ' 121' ' ' GLN . 53.1 tp10 -67.07 -30.85 71.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -59.99 -40.88 90.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.601 ' CG1' HD12 ' A' ' 170' ' ' ILE . 44.7 t -61.17 -43.37 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.62 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 0.8 OUTLIER -60.07 -44.52 94.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.116 -0.99 . . . . 0.0 110.114 175.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -60.01 -46.7 88.62 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.526 -0.734 . . . . 0.0 109.837 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.752 ' HB1' HG11 ' A' ' 137' ' ' VAL . . . -73.66 -42.47 61.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.614 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 124' ' ' LEU . 4.6 mm? -98.56 6.9 46.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.592 ' HA ' HG22 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -48.67 166.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 120.77 -1.206 . . . . 0.0 109.735 -177.387 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.572 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 32.9 ptt180 33.01 45.14 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.465 -0.772 . . . . 0.0 111.412 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.528 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -127.26 138.53 32.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.805 -1.185 . . . . 0.0 111.113 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.86 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 9.3 Cg_endo -57.51 129.06 31.92 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 124.031 1.543 . . . . 0.0 110.176 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.576 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.6 mmm -125.96 137.82 53.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.601 -1.312 . . . . 0.0 110.608 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 50' ' ' THR . 12.7 tp -137.48 115.01 11.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pt-20 -48.78 143.63 5.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.981 -1.075 . . . . 0.0 110.655 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.04 -10.63 0.9 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.366 0.603 . . . . 0.0 110.374 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.572 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -70.38 178.3 2.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 176.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.553 ' OD1' ' CG ' ' A' ' 151' ' ' LYS . 1.1 m-80 -148.64 129.4 14.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.326 -0.859 . . . . 0.0 109.124 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.708 ' HB ' ' CE1' ' A' ' 150' ' ' PHE . 1.6 mt -140.05 164.85 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.211 -1.396 . . . . 0.0 111.459 -173.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 149' ' ' LEU . 10.2 t -138.13 149.97 46.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.721 -0.612 . . . . 0.0 109.822 175.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.967 HG12 ' CD ' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -99.98 -171.81 0.25 Allowed Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.967 ' CD ' HG12 ' A' ' 137' ' ' VAL . 1.9 Cg_endo -69.25 58.06 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.148 1.078 . . . . 0.0 109.907 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . -115.61 108.38 1.87 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 141' ' ' THR . 1.7 pp -87.64 144.5 26.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -1.085 . . . . 0.0 109.843 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.6 OUTLIER -65.45 -166.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 111.054 -171.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.564 ' N ' ' OG1' ' A' ' 141' ' ' THR . 77.3 mt -140.1 -109.95 0.15 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.84 -0.538 . . . . 0.0 109.631 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.74 -155.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.156 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.34 55.89 4.97 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 145' ' ' GLN . 14.2 pt20 -98.89 162.56 13.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.361 -1.082 . . . . 0.0 110.259 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.9 t -139.9 155.89 46.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 110.232 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.674 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 112.17 -86.53 0.43 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.674 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 40.04 26.11 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.32 -1.106 . . . . 0.0 111.474 177.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 3.3 pp -140.43 166.11 25.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.894 -1.129 . . . . 0.0 108.866 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.708 ' CE1' ' HB ' ' A' ' 135' ' ' ILE . 7.4 p90 -113.17 140.39 47.96 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.244 -1.382 . . . . 0.0 111.169 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.553 ' CG ' ' OD1' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -100.32 113.88 26.93 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.829 -0.544 . . . . 0.0 109.737 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.572 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -76.1 135.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.684 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.416 HG23 ' CD ' ' A' ' 151' ' ' LYS . 18.9 t -123.58 -26.7 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 110.697 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -144.38 131.6 20.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 110.443 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.939 HG22 HG23 ' A' ' 98' ' ' VAL . 37.3 p -130.0 169.38 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 109.775 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -89.04 -39.88 0.44 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.822 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 1.02 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.0 Cg_exo -61.52 -175.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.583 1.307 . . . . 0.0 110.727 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.1 t -90.5 -163.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.81 . . . . 0.0 110.258 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -68.11 -6.43 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.64 141.68 34.22 Favored Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.388 -0.82 . . . . 0.0 110.125 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.548 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.93 144.69 11.4 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.177 1.619 . . . . 0.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 1.02 HG11 ' CB ' ' A' ' 157' ' ' PRO . 10.9 m -129.91 159.27 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.089 -1.007 . . . . 0.0 109.545 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 67.4 tt0 -107.36 127.66 53.77 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.27 -0.894 . . . . 0.0 109.957 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.748 HD12 HG21 ' A' ' 168' ' ' THR . 9.1 mm -69.36 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.917 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.9 167.66 25.56 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.44 -21.19 35.27 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.416 -1.05 . . . . 0.0 110.32 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.55 -17.72 26.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 110.74 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.748 HG21 HD12 ' A' ' 164' ' ' ILE . 30.2 m -57.59 156.72 7.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.906 . . . . 0.0 110.364 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -103.97 154.53 19.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 110.277 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.62 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 2.1 mm -120.0 129.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.772 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.512 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 53.4 mt-10 -117.83 130.02 56.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.12 -0.988 . . . . 0.0 110.419 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.589 HG23 ' HD3' ' A' ' 102' ' ' PRO . 37.1 mt -135.62 135.22 51.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.309 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.417 ' HD3' ' HB3' ' A' ' 175' ' ' GLU . 13.1 ptp180 -88.82 164.98 14.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.276 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 98.3 mt-10 -98.83 11.5 38.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . 0.9 OUTLIER -94.71 109.72 45.23 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.955 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 14.7 Cg_exo -71.01 -154.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.159 1.61 . . . . 0.0 110.696 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.781 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -69.53 53.21 0.11 Allowed 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.727 -0.608 . . . . 0.0 110.17 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 82.0 p -83.03 120.45 25.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.301 -0.874 . . . . 0.0 110.18 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 178' ' ' SER . 83.8 tt0 60.06 18.72 7.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.364 -0.835 . . . . 0.0 110.422 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 180' ' ' VAL . 92.1 t -92.75 4.29 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.362 -0.836 . . . . 0.0 110.03 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.07 66.81 1.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 0.0 110.186 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -148.44 160.57 42.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.275 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.0 139.98 57.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.291 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.428 ' O ' ' OXT' ' A' ' 185' ' ' GLY . . . 90.05 -2.19 81.31 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.428 ' OXT' ' O ' ' A' ' 184' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 118.025 -1.43 . . . . 0.0 109.551 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mtp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.257 0.551 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 4' ' ' ASN . 85.8 tt0 -59.94 -40.06 87.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.03 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m 51.86 49.9 19.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.285 -0.885 . . . . 0.0 110.301 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.421 ' HB2' ' HG2' ' A' ' 2' ' ' GLU . 11.4 t-20 -93.5 120.19 33.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -148.14 -170.74 3.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.961 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 88' ' ' ARG . . . -147.41 -159.74 8.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.904 HD13 HD21 ' A' ' 33' ' ' LEU . 43.6 pt -139.58 152.05 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -1.141 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.42 119.67 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.797 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.761 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.2 pt? -135.91 -168.34 2.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.291 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.563 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 26.4 ttm105 -106.03 130.66 53.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 111.059 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.858 HG11 ' O ' ' A' ' 80' ' ' SER . 14.4 p -61.65 139.02 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.379 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -120.24 153.55 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.487 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.597 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -176.43 148.47 0.75 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.321 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.38 159.98 35.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.837 . . . . 0.0 110.341 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -52.08 -27.0 12.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 60.2 p -59.95 159.87 8.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.172 -0.955 . . . . 0.0 110.061 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 18' ' ' ASP . 82.0 p -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.935 . . . . 0.0 110.39 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 4.7 p-10 36.44 59.97 3.36 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.457 -0.777 . . . . 0.0 110.54 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 17.3 Cg_exo -62.0 167.4 10.66 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.915 1.482 . . . . 0.0 110.55 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.7 83.33 1.67 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.7 ptm -89.79 -10.01 47.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.303 -1.116 . . . . 0.0 110.107 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.1 p -99.39 1.89 44.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.577 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 84.2 mtt85 -110.84 129.47 55.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.461 -0.774 . . . . 0.0 109.909 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.908 HG13 HG23 ' A' ' 67' ' ' VAL . 77.4 t -109.98 115.43 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.011 -1.056 . . . . 0.0 109.987 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.579 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -88.09 117.4 26.94 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.683 178.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.776 HD13 HG12 ' A' ' 24' ' ' VAL . 1.2 mp -129.11 172.64 11.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 109.551 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 7.0 p-10 -92.76 176.64 6.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.863 -1.148 . . . . 0.0 110.022 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -40.06 87.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.449 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.58 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.5 t -69.51 -44.98 69.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 110.57 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.66 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.7 m -59.98 -39.99 87.6 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.102 -0.999 . . . . 0.0 109.608 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 36.9 ttp180 -74.7 -43.4 55.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.772 -0.58 . . . . 0.0 111.444 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -91.41 -11.53 37.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.821 -1.174 . . . . 0.0 111.201 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.092 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.3 pp -58.65 -32.88 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.855 -1.153 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.092 ' N ' HD12 ' A' ' 33' ' ' LEU . 13.0 mt -105.21 -74.07 0.66 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.927 . . . . 0.0 110.316 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 45.6 t0 -170.16 -24.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.691 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -24.61 119.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.557 0.694 . . . . 0.0 111.407 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.694 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -105.69 175.14 5.59 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.419 HD11 ' NH1' ' A' ' 31' ' ' ARG . 26.2 mm -58.16 120.75 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.917 -1.114 . . . . 0.0 109.813 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.58 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.72 33.82 54.78 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 174.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.2 m-20 -89.11 177.1 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.458 . . . . 0.0 109.477 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 92' ' ' THR . 70.6 t -99.08 121.64 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.09 . . . . 0.0 110.166 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.482 HG22 ' C ' ' A' ' 52' ' ' GLY . 1.5 m -116.8 139.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.489 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.8 141.36 38.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 109.863 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.871 HD13 ' CE ' ' A' ' 73' ' ' MET . 2.1 mp -120.48 146.63 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.013 -1.054 . . . . 0.0 110.296 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.0 tt0 -150.95 97.16 2.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.961 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.03 ' CG ' HG12 ' A' ' 85' ' ' VAL . 1.7 tmtt? -98.41 -67.36 0.85 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.825 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.591 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.01 -35.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.16 174.296 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 71.9 mtt85 -135.46 -178.74 5.25 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.776 -0.578 . . . . 0.0 109.571 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.574 ' C ' HD21 ' A' ' 130' ' ' LEU . 28.0 mttt -89.04 137.14 32.58 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.655 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.724 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 10.9 p -140.56 166.78 23.8 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.394 0.616 . . . . 0.0 109.834 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -122.98 166.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.448 -0.782 . . . . 0.0 110.196 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.482 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.99 -169.54 39.73 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -129.94 162.8 27.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.186 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -89.03 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 0.0 110.426 -173.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.577 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 2.2 m-85 -134.68 166.31 23.23 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.504 -0.747 . . . . 0.0 110.251 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 51.9 ptt85 -90.69 128.36 36.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.572 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -65.9 139.98 58.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.609 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -54.74 -49.58 90.73 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.881 -1.137 . . . . 0.0 108.868 175.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.4 Cg_endo -92.71 98.79 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.904 1.476 . . . . 0.0 108.893 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.47 34.37 0.08 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.41 -0.806 . . . . 0.0 110.918 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -146.26 -27.51 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 110.769 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -86.12 -28.2 24.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.258 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.572 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 11.0 m120 -81.75 43.56 0.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.676 -0.64 . . . . 0.0 110.312 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 30.3 pttt -97.43 8.96 43.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.404 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.88 27.13 0.05 OUTLIER Glycine 0 N--CA 1.479 1.541 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.5 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 43.5 pt -140.24 142.87 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -1.083 . . . . 0.0 109.4 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.908 HG23 HG13 ' A' ' 24' ' ' VAL . 3.1 p -119.94 121.12 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.005 -1.059 . . . . 0.0 110.058 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.575 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 97.3 mtt180 -89.87 116.02 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.679 HD11 HG23 ' A' ' 11' ' ' VAL . 4.5 pt -126.75 171.72 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.66 -0.65 . . . . 0.0 110.645 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -80.01 168.05 19.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.881 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 m -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.316 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.506 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.5 t -62.82 -43.62 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.871 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.0 -46.52 89.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.628 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.417 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 6.4 ttp-105 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.554 174.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -69.99 -23.84 63.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.483 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 4.2 m120 -60.07 -39.1 84.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.08 -1.013 . . . . 0.0 110.352 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.535 ' C ' HG23 ' A' ' 47' ' ' VAL . 31.4 p -98.27 -35.03 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.047 -1.033 . . . . 0.0 110.532 -175.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.591 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 112.47 26.63 4.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.46 169.97 8.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -1.166 . . . . 0.0 110.309 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.858 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.47 178.73 4.2 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 178.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -64.74 141.25 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.388 177.48 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.811 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 78.69 -3.85 62.58 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 172.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -57.3 -167.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.98 -1.306 . . . . 0.0 110.098 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 50.7 pttt -127.01 114.65 18.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.12 -0.987 . . . . 0.0 109.748 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.03 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.1 m -119.33 155.57 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 83.6 tttt -105.61 125.44 50.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.659 HG23 HD21 ' A' ' 9' ' ' LEU . 76.0 t -106.85 121.4 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.481 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 41.3 mtm180 -110.63 135.61 51.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 19.4 tttt -83.81 138.64 33.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.529 HG23 HG12 ' A' ' 41' ' ' VAL . 2.3 m -150.04 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.088 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -126.48 168.99 13.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.907 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.535 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.73 163.47 12.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.093 -1.005 . . . . 0.0 111.05 -175.173 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.63 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.5 pt-20 -150.08 169.46 21.21 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.62 100.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.923 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.85 138.19 53.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.29 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.544 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -96.66 -29.34 13.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 110.981 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HB3' HD23 ' A' ' 156' ' ' LEU . 16.1 tttp -150.66 124.63 9.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.731 -1.231 . . . . 0.0 110.842 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.065 HG23 HG22 ' A' ' 155' ' ' THR . 5.4 p -134.34 142.05 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 0.0 110.653 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 86.8 m -118.54 141.7 48.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.329 -0.857 . . . . 0.0 110.109 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -139.24 169.79 17.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.709 -178.069 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.706 ' HB2' ' HD2' ' A' ' 173' ' ' ARG . . . -141.12 99.7 6.53 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.615 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.727 ' HB3' HD11 ' A' ' 110' ' ' LEU . 22.6 Cg_exo -60.33 125.98 18.86 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.878 1.462 . . . . 0.0 110.17 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.012 HG23 ' HB2' ' A' ' 177' ' ' ALA . 83.4 mt -91.95 106.38 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -0.957 . . . . 0.0 110.821 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.76 HD12 ' HB2' ' A' ' 108' ' ' GLN . 1.9 pt -150.52 -173.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 82.4 mtp180 -140.66 -135.55 0.11 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.516 -0.74 . . . . 0.0 109.848 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -59.88 -13.56 11.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.89 -1.131 . . . . 0.0 109.48 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 145' ' ' GLN . 54.2 p-10 -99.82 28.79 4.52 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.284 0.564 . . . . 0.0 109.833 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.76 ' HB2' HD12 ' A' ' 104' ' ' ILE . 12.8 pt20 -82.88 109.77 17.3 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.272 -0.893 . . . . 0.0 109.975 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.1 ttt85 -111.73 -13.46 13.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.619 -0.676 . . . . 0.0 110.123 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' ' 102' ' ' PRO . 0.8 OUTLIER -99.22 52.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 110.023 -178.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.423 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -140.03 135.04 32.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.866 176.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.511 ' HB2' HD13 ' A' ' 116' ' ' ILE . 10.0 m-85 -142.74 -40.04 0.33 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.961 . . . . 0.0 110.501 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 75.88 -176.23 51.3 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 113' ' ' GLY . 75.1 mm-40 41.46 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.169 -1.195 . . . . 0.0 109.994 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.15 -7.43 75.38 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' A' ' 112' ' ' PHE . 10.4 tp -60.04 -35.9 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 110.127 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 116' ' ' ILE . 43.5 mt-10 -59.98 -40.55 89.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.966 . . . . 0.0 109.693 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -68.69 -38.94 80.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 109.943 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.413 ' HD2' HD12 ' A' ' 116' ' ' ILE . 1.6 t80 -60.08 -39.99 88.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.251 -0.905 . . . . 0.0 109.341 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 172' ' ' ILE . 54.8 t -67.02 -45.93 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 109.89 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.558 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 1.7 mt-30 -59.98 -44.41 94.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.97 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -60.07 -48.6 81.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.441 0.639 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.566 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.05 -40.1 75.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.46 -0.775 . . . . 0.0 110.535 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.657 HD22 ' N ' ' A' ' 124' ' ' LEU . 3.9 mm? -97.53 -0.06 46.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.883 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.647 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.5 tt -47.3 166.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 110.171 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 164' ' ' ILE . 34.1 ptt180 33.08 46.68 0.1 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.659 -0.651 . . . . 0.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 7.6 mmt180 -129.79 150.42 75.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.676 -1.265 . . . . 0.0 111.192 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.79 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 22.2 Cg_endo -67.22 130.72 23.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 124.192 1.627 . . . . 0.0 109.876 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.554 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 87.8 mmm -127.13 137.58 53.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.556 -1.34 . . . . 0.0 111.077 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.63 HD23 ' HA ' ' A' ' 50' ' ' THR . 10.9 tp -140.21 113.67 8.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.622 -0.674 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -45.22 146.68 0.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.172 . . . . 0.0 110.394 -176.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.85 -0.53 3.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.741 -0.599 . . . . 0.0 110.627 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.568 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.2 p30 -69.91 -176.19 1.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.054 174.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 17.1 m-80 -145.94 150.06 35.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.592 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -134.34 170.35 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 t -136.44 165.82 24.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 0.0 110.57 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.58 ' CG1' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t -112.05 147.82 37.72 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.586 ' O ' HD12 ' A' ' 140' ' ' LEU . 1.4 Cg_endo -46.55 177.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.856 1.45 . . . . 0.0 110.532 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.21 68.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.927 ' C ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -130.03 154.78 47.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -1.198 . . . . 0.0 111.03 179.271 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.748 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER 177.0 -167.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.039 . . . . 0.0 110.242 -178.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.697 HD21 ' NE2' ' A' ' 145' ' ' GLN . 0.5 OUTLIER -146.07 -122.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.522 -0.736 . . . . 0.0 109.847 178.183 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.521 ' H ' HD12 ' A' ' 142' ' ' LEU . . . -52.88 -161.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 109.973 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.0 79.99 1.54 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.697 ' NE2' HD21 ' A' ' 142' ' ' LEU . 1.9 pt20 -94.89 165.17 12.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.384 -1.069 . . . . 0.0 110.096 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -140.03 153.76 46.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.418 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.711 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 80.18 -90.48 1.31 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.711 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 42.47 48.54 4.56 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.541 -0.976 . . . . 0.0 110.832 176.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.706 HD11 HD12 ' A' ' 103' ' ' ILE . 2.6 pp -137.14 164.44 28.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.995 -1.066 . . . . 0.0 109.585 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -91.58 137.7 32.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.112 -0.993 . . . . 0.0 110.247 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.504 ' HB2' HD11 ' A' ' 103' ' ' ILE . 27.4 tptp -122.39 101.9 7.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.603 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.568 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.3 t -77.47 138.79 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.68 -21.94 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 111.09 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.551 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 10.5 tptm -139.84 129.83 24.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.678 -1.264 . . . . 0.0 110.965 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.065 HG22 HG23 ' A' ' 98' ' ' VAL . 66.7 p -130.49 164.59 24.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.244 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.666 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.29 -36.67 0.42 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 110.916 -176.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.989 ' CG ' HG11 ' A' ' 162' ' ' VAL . 31.4 Cg_exo -53.1 -174.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.363 1.191 . . . . 0.0 110.401 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 4.9 t -86.84 41.44 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.28 -0.887 . . . . 0.0 110.264 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 158' ' ' SER . 40.7 mmtm 61.41 19.56 10.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.747 . . . . 0.0 109.901 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.778 ' O ' HG13 ' A' ' 162' ' ' VAL . 23.5 m -102.29 159.92 27.9 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.392 -0.818 . . . . 0.0 109.712 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.536 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.4 Cg_endo -53.81 119.66 6.61 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.059 1.557 . . . . 0.0 110.217 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.989 HG11 ' CG ' ' A' ' 157' ' ' PRO . 5.2 m -126.61 158.3 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -104.56 128.71 52.61 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.152 -0.967 . . . . 0.0 110.052 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.834 ' CD1' HG21 ' A' ' 168' ' ' THR . 12.8 mm -71.08 152.65 8.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.827 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.06 168.32 25.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.37 -20.87 21.34 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.975 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -90.99 -18.57 24.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 110.684 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.834 HG21 ' CD1' ' A' ' 164' ' ' ILE . 30.5 m -57.89 148.41 25.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 110.473 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 49.6 mttp -96.35 147.19 24.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.004 . . . . 0.0 109.702 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.747 HD13 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mt -130.03 160.03 41.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.093 -1.004 . . . . 0.0 110.982 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 99' ' ' THR . 25.3 mt-10 -137.78 133.6 34.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.754 -0.591 . . . . 0.0 110.231 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 120' ' ' VAL . 39.5 mm -120.02 120.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.341 -0.85 . . . . 0.0 109.39 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.706 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 4.7 ptp85 -93.5 163.8 13.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 110.439 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.9 mt-10 -101.83 13.08 35.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.852 . . . . 0.0 110.392 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . 1.3 tt0 -93.07 109.91 42.65 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.375 -0.828 . . . . 0.0 109.702 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.6 Cg_exo -71.9 -156.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.165 1.613 . . . . 0.0 110.68 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.012 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -80.46 52.96 1.73 Allowed 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.084 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.62 ' O ' HG23 ' A' ' 180' ' ' VAL . 13.5 t -80.69 127.99 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.986 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 178' ' ' SER . 84.1 tt0 60.05 15.53 5.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.852 . . . . 0.0 110.404 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.772 ' C ' HD23 ' A' ' 181' ' ' LEU . 63.1 t -117.96 123.78 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.206 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.772 HD23 ' C ' ' A' ' 180' ' ' VAL . 0.1 OUTLIER -141.63 79.85 1.7 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -0.95 . . . . 0.0 110.054 177.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -61.73 144.09 55.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 183' ' ' GLU . 12.1 mt-10 -60.0 139.98 57.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.234 -0.916 . . . . 0.0 110.08 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 147.51 69.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.945 -1.475 . . . . 0.0 109.481 -179.465 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -120.23 140.29 51.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.902 . . . . 0.0 110.116 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -61.06 157.16 16.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.973 . . . . 0.0 110.25 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.402 ' OD1' ' CE ' ' A' ' 86' ' ' LYS . 65.0 t-20 -130.15 105.68 8.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 110.19 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -128.27 34.87 4.49 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.005 0.907 . . . . 0.0 109.836 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.11 -166.84 13.41 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.808 ' CG2' HD12 ' A' ' 33' ' ' LEU . 41.3 pt -131.89 160.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -1.138 . . . . 0.0 109.535 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.18 117.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.5 pt? -139.58 -172.39 3.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.603 ' NE ' HG22 ' A' ' 66' ' ' ILE . 33.1 ptt180 -111.12 140.51 45.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.597 -1.314 . . . . 0.0 110.93 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 81' ' ' ILE . 9.6 p -62.29 138.09 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.497 -0.752 . . . . 0.0 110.675 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -119.06 144.71 46.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.944 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 -179.0 100.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.524 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.4 -40.13 9.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 109.797 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -156.45 156.3 33.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.827 . . . . 0.0 109.711 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.55 165.77 25.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.601 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' ASP . 66.2 p -131.35 154.84 48.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.435 -0.79 . . . . 0.0 109.903 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' THR . 5.5 p-10 38.06 72.12 0.94 Allowed Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.516 -0.74 . . . . 0.0 109.92 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.83 151.31 33.3 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.325 1.697 . . . . 0.0 110.688 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.514 ' N ' ' OD2' ' A' ' 70' ' ' ASP . . . 95.44 40.04 4.3 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.484 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 25.0 ptp -89.47 -0.01 57.19 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.273 -1.133 . . . . 0.0 109.414 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 21' ' ' MET . 1.0 OUTLIER 42.74 45.86 4.26 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.392 -0.817 . . . . 0.0 110.438 176.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.565 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 80.8 mtt180 -136.41 141.77 43.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.115 -0.99 . . . . 0.0 110.56 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.005 HG13 HG23 ' A' ' 67' ' ' VAL . 53.0 t -120.09 121.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.885 . . . . 0.0 110.303 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.758 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.8 ptt180 -91.27 120.71 32.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.7 -1.25 . . . . 0.0 109.881 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -135.49 169.15 17.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 109.821 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.0 p-10 -94.48 -170.05 2.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.941 -1.1 . . . . 0.0 111.069 -175.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -0.76 . . . . 0.0 109.904 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.61 -43.66 93.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.752 . . . . 0.0 110.105 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.127 ' O ' HD22 ' A' ' 33' ' ' LEU . 54.6 m -58.64 -32.14 68.79 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.464 -0.773 . . . . 0.0 109.44 177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 70.6 ttt180 -84.57 -44.31 13.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.704 -0.622 . . . . 0.0 110.887 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 33' ' ' LEU . 75.9 mtp85 -77.44 -11.14 59.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.171 -0.956 . . . . 0.0 110.127 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.127 HD22 ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -40.87 -29.36 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.888 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.799 ' H ' HD23 ' A' ' 33' ' ' LEU . 84.0 mt -141.15 -61.44 0.48 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 110.107 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.9 t0 -169.62 -36.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.529 -0.732 . . . . 0.0 109.498 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.728 ' HB2' ' HE3' ' A' ' 89' ' ' LYS . . . 9.99 114.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.263 0.554 . . . . 0.0 112.101 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.642 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.84 173.03 6.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.647 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 33.2 mm -60.08 120.23 5.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.949 -1.094 . . . . 0.0 109.825 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.583 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.27 34.36 46.22 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.466 173.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.472 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.9 m-20 -88.88 174.91 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.819 -1.4 . . . . 0.0 109.492 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.66 HG12 HG23 ' A' ' 90' ' ' VAL . 71.7 t -99.15 126.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.888 -1.132 . . . . 0.0 110.479 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.603 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -119.61 146.08 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.819 . . . . 0.0 110.572 -177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.12 140.7 46.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 109.677 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.898 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.3 mp -125.85 143.67 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.944 -1.097 . . . . 0.0 110.512 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.14 98.97 2.76 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.054 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.937 ' CG ' HG12 ' A' ' 85' ' ' VAL . 5.8 tmtm? -98.56 -66.46 0.9 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.226 -0.921 . . . . 0.0 109.695 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.77 -37.12 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 174.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.598 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -129.88 -178.97 4.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.757 -0.589 . . . . 0.0 109.826 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.624 ' HB3' HD21 ' A' ' 130' ' ' LEU . 12.8 mttp -91.86 134.66 34.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.605 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.8 p -139.56 165.05 28.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.499 -0.751 . . . . 0.0 110.129 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.575 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.82 162.71 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.59 -0.694 . . . . 0.0 110.339 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.603 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.86 -171.38 42.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.21 177.14 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -1.134 . . . . 0.0 110.371 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -103.0 133.13 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 110.548 -175.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.565 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -125.54 165.93 17.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.432 -0.792 . . . . 0.0 110.658 176.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -91.52 125.03 36.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.738 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -65.67 137.78 57.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.881 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.577 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.24 -48.6 96.73 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.903 -1.123 . . . . 0.0 109.105 173.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 39.9 Cg_endo -91.86 97.99 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.838 1.441 . . . . 0.0 109.108 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.474 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 19.5 pt-20 -74.64 36.46 0.11 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.519 -0.738 . . . . 0.0 110.699 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 82.2 m-20 -144.3 -34.93 0.36 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.154 -0.966 . . . . 0.0 110.649 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -85.1 -28.6 25.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 109.241 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.524 ' HA ' HG12 ' A' ' 66' ' ' ILE . 3.2 m-80 -81.03 39.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.8 -0.563 . . . . 0.0 110.697 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 3.0 pttp -98.24 12.85 33.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.665 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.02 25.95 0.06 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.603 HG22 ' NE ' ' A' ' 10' ' ' ARG . 45.6 pt -140.66 142.62 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.492 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.005 HG23 HG13 ' A' ' 24' ' ' VAL . 2.2 p -120.33 121.75 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.969 -1.082 . . . . 0.0 109.922 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.512 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 77.4 mtt180 -89.43 117.72 28.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.94 -1.1 . . . . 0.0 110.176 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.659 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.5 pp -127.23 172.36 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.428 0.632 . . . . 0.0 110.361 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' OD2' ' N ' ' A' ' 20' ' ' GLY . 34.0 p-10 -76.41 168.74 19.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 0.0 109.773 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -67.11 -27.85 67.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG12 HD21 ' A' ' 76' ' ' ASN . 53.0 t -70.0 -43.66 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.965 . . . . 0.0 110.486 -176.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.898 ' CE ' HD13 ' A' ' 44' ' ' ILE . 3.1 tpt -60.02 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.072 -1.018 . . . . 0.0 109.683 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.591 ' HG3' HG21 ' A' ' 11' ' ' VAL . 6.9 ttm180 -59.99 -40.01 87.72 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 0.0 109.853 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -72.2 -25.99 61.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.465 HD21 HG12 ' A' ' 72' ' ' VAL . 88.6 m-20 -68.55 -29.13 67.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.022 . . . . 0.0 110.625 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 31.0 p -99.26 -37.01 9.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 110.496 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.557 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 112.98 23.84 5.11 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.589 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.22 167.43 9.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -1.183 . . . . 0.0 110.351 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.613 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -116.75 166.42 12.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 178.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.944 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -51.4 140.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.486 178.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 77.27 -0.67 67.42 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 172.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.1 m-20 -56.31 -160.99 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 12.7 pttm -135.51 112.19 10.07 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.489 -0.757 . . . . 0.0 109.861 175.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.937 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.49 158.94 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.749 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 55.5 tttp -110.75 123.57 50.3 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.188 -0.945 . . . . 0.0 109.955 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.674 HG22 HG23 ' A' ' 44' ' ' ILE . 62.8 t -105.59 123.64 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 109.873 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.439 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.7 mtt180 -112.42 139.32 48.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.733 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HE3' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -79.06 141.06 37.72 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 110.437 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.66 HG23 HG12 ' A' ' 41' ' ' VAL . 2.0 m -150.01 -168.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 109.999 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.512 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 47.1 ptt85 -139.59 171.04 14.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.566 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.41 158.7 16.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.995 -1.066 . . . . 0.0 111.309 -173.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.68 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.4 pt-20 -150.86 175.23 12.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.24 101.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.663 -1.273 . . . . 0.0 110.587 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.841 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.05 137.44 55.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 19.5 ptpt -101.12 -26.4 13.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 110.814 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.663 ' HB3' HD23 ' A' ' 156' ' ' LEU . 83.7 tttt -150.8 119.95 6.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.897 -1.127 . . . . 0.0 110.584 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.933 HG23 HG22 ' A' ' 155' ' ' THR . 7.4 p -135.19 140.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.871 -1.143 . . . . 0.0 110.977 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 171' ' ' GLU . 29.9 m -112.21 144.37 41.73 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.346 -0.846 . . . . 0.0 109.962 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.745 HD21 HG23 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -141.87 165.74 26.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.179 -0.95 . . . . 0.0 110.941 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.95 90.72 10.65 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 110.368 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 37.9 Cg_exo -55.15 129.84 37.46 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.955 1.503 . . . . 0.0 110.547 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.103 HG23 ' HB2' ' A' ' 177' ' ' ALA . 41.8 mm -89.98 88.68 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.174 -0.954 . . . . 0.0 110.244 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.589 ' HB ' ' CB ' ' A' ' 108' ' ' GLN . 1.0 OUTLIER -152.27 -167.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.885 176.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 104' ' ' ILE . 79.3 mmt-85 -92.39 165.26 13.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.477 -0.765 . . . . 0.0 110.091 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -59.89 -15.24 19.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.112 -0.993 . . . . 0.0 110.885 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 36.5 p-10 -122.98 25.44 8.57 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.59 -0.693 . . . . 0.0 110.623 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.589 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 1.2 mt-30 -93.51 -79.97 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 110.609 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.738 HH22 HD12 ' A' ' 148' ' ' LEU . 78.4 mtt180 -108.85 -27.28 9.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 109.824 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -97.64 41.35 1.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.537 -174.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 2.7 pttt -97.44 43.84 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.935 . . . . 0.0 110.347 174.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.641 ' HB2' HD13 ' A' ' 116' ' ' ILE . 21.5 m-85 -107.98 -40.73 5.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.523 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 77.81 -161.05 49.24 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' GLY . 19.2 pt-20 -32.14 144.83 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.878 -0.778 . . . . 0.0 110.723 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.4 -10.99 59.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 112' ' ' PHE . 6.7 tp -63.99 -37.14 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 110.066 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.431 ' N ' HG23 ' A' ' 116' ' ' ILE . 47.5 mt-10 -60.02 -43.12 95.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.675 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.43 -39.8 89.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.756 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.02 -40.03 87.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.815 . . . . 0.0 109.669 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.76 HG12 ' CD1' ' A' ' 170' ' ' ILE . 54.4 t -60.02 -47.25 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.571 ' NE2' ' O ' ' A' ' 168' ' ' THR . 4.1 mt-30 -59.95 -44.51 94.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.511 -0.743 . . . . 0.0 110.06 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -60.11 -44.04 95.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.57 -0.706 . . . . 0.0 110.19 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -74.6 -42.09 59.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.5 mm? -95.92 0.68 52.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.172 -0.955 . . . . 0.0 111.205 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.635 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.6 tt -46.04 166.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.851 -1.155 . . . . 0.0 110.261 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.9 ptm180 32.63 49.31 0.15 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.603 -0.686 . . . . 0.0 111.237 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.537 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -129.1 134.68 26.58 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.029 -1.044 . . . . 0.0 110.955 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.812 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.7 Cg_exo -59.75 125.73 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.931 1.49 . . . . 0.0 109.785 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.537 ' HG2' ' O ' ' A' ' 127' ' ' ARG . 99.7 mmm -124.35 140.46 52.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.445 -1.409 . . . . 0.0 111.031 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 49' ' ' LYS . 12.6 tp -140.99 111.6 6.94 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.58 -0.7 . . . . 0.0 109.503 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pm0 -47.07 137.42 7.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 110.612 -173.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.59 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 4.5 tp60 80.41 -3.39 1.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.243 0.545 . . . . 0.0 110.358 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.617 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.4 p30 -69.12 -173.59 0.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 175.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.657 ' HB3' HD13 ' A' ' 149' ' ' LEU . 7.9 m-80 -146.32 140.3 26.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -139.95 165.57 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.969 -1.082 . . . . 0.0 110.447 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 t -140.7 137.99 33.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 110.205 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.651 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 10.8 t -109.9 -68.08 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.66 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.651 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 34.2 Cg_endo -69.72 136.22 32.53 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.199 1.105 . . . . 0.0 110.162 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -98.62 46.77 1.48 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.512 HD12 ' C ' ' A' ' 140' ' ' LEU . 1.7 pp -123.97 143.44 50.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -1.094 . . . . 0.0 110.314 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -118.78 -168.63 1.58 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.187 -0.946 . . . . 0.0 110.5 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' A' ' 141' ' ' THR . 83.4 mt -142.3 -138.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.541 -0.724 . . . . 0.0 109.8 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.03 -154.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 110.1 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.18 68.04 2.68 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -94.3 168.89 10.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.484 -1.009 . . . . 0.0 110.153 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.3 t -140.0 159.04 43.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.229 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.731 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 80.66 -83.88 1.42 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.738 HD12 HH22 ' A' ' 109' ' ' ARG . 0.4 OUTLIER 41.81 42.74 2.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.436 -1.038 . . . . 0.0 110.981 178.014 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' ' 134' ' ' ASN . 4.4 pp -140.04 173.37 11.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.023 -1.048 . . . . 0.0 109.686 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 67.7 m-85 -89.55 120.06 30.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.441 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 23.7 tptm -97.14 103.68 15.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.303 -0.873 . . . . 0.0 109.882 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.617 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.9 t -74.87 134.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.539 HG21 ' NH2' ' A' ' 173' ' ' ARG . 37.9 t -115.18 -30.17 2.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 110.751 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.485 ' C ' HG23 ' A' ' 155' ' ' THR . 68.5 mttt -143.4 160.0 41.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 0.0 111.163 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.933 HG22 HG23 ' A' ' 98' ' ' VAL . 81.5 p -150.0 162.55 40.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.83 -38.69 0.44 Allowed Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.994 ' CG ' HG11 ' A' ' 162' ' ' VAL . 21.4 Cg_exo -57.68 -166.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.535 1.282 . . . . 0.0 110.139 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.48 ' HB3' HG22 ' A' ' 160' ' ' VAL . 4.6 t -89.69 -169.23 2.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.913 . . . . 0.0 109.671 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -64.16 -7.9 10.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 110.605 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 158' ' ' SER . 32.1 m -83.38 152.13 63.73 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 121.416 -0.803 . . . . 0.0 110.578 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.575 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 4.6 Cg_endo -52.98 142.57 52.92 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.303 1.686 . . . . 0.0 110.952 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.994 HG11 ' CG ' ' A' ' 157' ' ' PRO . 7.2 m -132.46 158.11 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 110.033 171.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 83.2 tt0 -105.36 126.32 51.97 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 110.213 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.768 ' CD1' HG21 ' A' ' 168' ' ' THR . 13.1 mm -69.77 159.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 110.438 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.65 167.84 26.52 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.633 ' HB3' HD11 ' A' ' 125' ' ' ILE . 19.2 pt-20 -58.58 -19.95 42.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.336 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.63 -22.03 20.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.768 HG21 ' CD1' ' A' ' 164' ' ' ILE . 94.2 m -54.99 147.32 15.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.635 -0.666 . . . . 0.0 110.283 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.7 mmtm -95.52 156.72 16.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.937 -1.102 . . . . 0.0 110.014 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.76 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.4 mt -135.68 164.25 33.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.992 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 99' ' ' THR . 37.0 mt-10 -139.26 137.01 35.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.621 -0.675 . . . . 0.0 110.276 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 120' ' ' VAL . 47.1 mm -119.95 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.937 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.719 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 3.4 ptp180 -88.64 152.02 22.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 0.0 110.29 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.4 mt-10 -89.79 -3.58 58.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 110.319 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -98.97 109.49 54.12 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.022 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.9 Cg_exo -70.59 -154.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.11 1.584 . . . . 0.0 110.568 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.103 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -76.92 53.3 0.92 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.345 0.593 . . . . 0.0 110.043 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 180' ' ' VAL . 96.5 p -79.33 119.53 22.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.283 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 178' ' ' SER . 84.0 tt0 59.99 18.26 7.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.855 . . . . 0.0 110.655 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.523 ' O ' HD23 ' A' ' 181' ' ' LEU . 96.3 t -108.68 112.01 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.12 -0.988 . . . . 0.0 110.204 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 180' ' ' VAL . 0.5 OUTLIER 167.71 -42.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.438 -0.789 . . . . 0.0 110.108 177.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.462 ' HG3' ' CD1' ' A' ' 181' ' ' LEU . 98.9 mt-10 -60.5 -40.04 89.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.39 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -59.95 140.0 57.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.19 -31.14 29.11 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.428 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttm . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.207 0.527 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.77 136.34 45.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.435 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 t -61.13 -39.99 92.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 110.359 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 5' ' ' ASN . 42.5 t30 -89.77 -80.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 110.242 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 1.4 t-20 65.92 -159.93 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.936 -1.102 . . . . 0.0 110.362 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -144.32 -160.47 8.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.918 HG21 HD22 ' A' ' 33' ' ' LEU . 46.2 pt -132.98 147.76 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -1.145 . . . . 0.0 109.815 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.8 mt -96.24 119.08 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.802 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.7 pt? -136.61 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 110.287 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 24.0 ttp180 -106.08 130.38 53.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.419 -0.801 . . . . 0.0 110.998 -174.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.967 HG11 ' O ' ' A' ' 80' ' ' SER . 10.2 p -61.21 139.55 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.523 -0.735 . . . . 0.0 110.416 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -125.79 153.33 44.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.467 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.929 ' HB3' HD11 ' A' ' 81' ' ' ILE . 46.2 tt0 -179.35 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.93 . . . . 0.0 110.062 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.59 -20.32 5.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.528 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 17' ' ' THR . 54.1 t-20 -119.97 129.88 54.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.123 -0.986 . . . . 0.0 110.257 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.8 p -92.17 0.65 57.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.362 -0.836 . . . . 0.0 110.344 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 80.9 p -77.47 165.81 23.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.208 -0.933 . . . . 0.0 110.41 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 17' ' ' THR . 5.5 p-10 37.25 69.56 1.33 Allowed Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.65 -0.656 . . . . 0.0 110.205 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -56.74 165.77 4.45 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.101 1.58 . . . . 0.0 110.476 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.93 88.65 0.07 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.7 ptp -89.8 -10.2 46.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -1.162 . . . . 0.0 110.165 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.5 p -93.07 2.5 56.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 110.042 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.556 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 98.1 mtt180 -119.85 135.78 54.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.007 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.853 HG13 HG23 ' A' ' 67' ' ' VAL . 92.8 t -116.14 120.01 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.206 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.827 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.1 ptm180 -93.54 119.97 33.25 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.852 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.827 HD22 ' O ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -138.43 178.6 7.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.547 -0.72 . . . . 0.0 109.737 -176.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 15.2 p-10 -94.2 177.01 6.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.815 -1.178 . . . . 0.0 110.635 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 86.3 mt-10 -60.0 -44.74 94.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.3 t -60.49 -43.13 97.33 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.264 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.653 ' CB ' HD12 ' A' ' 26' ' ' LEU . 47.0 t -59.97 -41.15 91.34 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.257 176.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.607 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 67.4 ttt180 -68.98 -44.17 73.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.662 . . . . 0.0 111.363 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 33' ' ' LEU . 25.4 tpt180 -90.32 -20.69 22.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.859 -1.15 . . . . 0.0 111.74 -170.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.083 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -47.84 -30.36 3.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.73 -1.231 . . . . 0.0 108.988 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.083 ' N ' HD12 ' A' ' 33' ' ' LEU . 18.0 mt -115.67 -78.16 0.58 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.798 . . . . 0.0 110.393 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -172.23 11.65 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.473 -0.767 . . . . 0.0 110.515 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -50.03 127.75 17.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.094 -1.004 . . . . 0.0 110.337 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.681 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -112.61 176.31 5.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.435 ' HA ' HD13 ' A' ' 38' ' ' ILE . 28.5 mm -59.66 119.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.828 -1.17 . . . . 0.0 109.83 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.61 36.83 47.62 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.26 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 25.6 m-20 -87.97 169.19 12.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.752 -1.44 . . . . 0.0 109.228 170.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 54.3 t -98.78 120.36 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.858 -1.151 . . . . 0.0 110.15 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.659 HG12 ' CE ' ' A' ' 89' ' ' LYS . 2.8 m -116.85 139.79 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.554 -0.716 . . . . 0.0 110.101 -176.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 85.9 tt0 -106.55 138.34 42.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.872 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.982 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.6 mp -116.97 140.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.147 -0.97 . . . . 0.0 109.859 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 84.4 tt0 -150.16 96.29 2.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.087 -1.008 . . . . 0.0 111.186 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.761 ' HB2' HG12 ' A' ' 85' ' ' VAL . 37.9 tttp -99.53 -71.07 0.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 172.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.16 -34.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.47 175.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.552 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 87.3 mtt-85 -139.77 179.71 6.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.051 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HD3' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -89.04 134.14 34.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 110.781 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.534 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 1.7 p -138.48 172.06 13.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.679 . . . . 0.0 109.322 174.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.808 ' CG2' HD21 ' A' ' 130' ' ' LEU . 3.0 m -127.93 168.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.415 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.45 -175.9 45.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 40.8 ttm180 -121.71 165.75 15.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.439 -1.036 . . . . 0.0 109.975 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.681 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -94.57 135.85 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 110.553 -172.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.556 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -130.5 167.27 18.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 110.509 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -89.6 125.97 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.429 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.585 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -65.23 140.08 58.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.847 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.589 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -55.45 -49.96 89.54 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.947 174.452 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 33.9 Cg_endo -92.81 98.56 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.873 1.46 . . . . 0.0 108.974 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -73.64 35.13 0.08 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.561 -0.712 . . . . 0.0 110.91 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -145.91 -29.77 0.41 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.152 -0.968 . . . . 0.0 110.531 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.12 -27.25 26.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.167 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.585 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 10.7 m120 -81.22 41.15 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.775 -0.578 . . . . 0.0 110.386 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -98.2 7.96 45.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.37 26.32 0.05 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 66' ' ' ILE . 45.6 pt -140.02 141.34 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.252 -1.146 . . . . 0.0 109.411 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.853 HG23 HG13 ' A' ' 24' ' ' VAL . 10.2 p -121.51 125.85 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.053 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.558 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 77.8 mtt180 -89.52 116.32 27.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.941 -1.099 . . . . 0.0 110.107 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.4 pp -129.97 170.07 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.209 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -79.83 164.24 23.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.945 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -68.01 -18.79 64.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.09 -50.02 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 110.313 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.982 ' CE ' HD13 ' A' ' 44' ' ' ILE . 19.3 ttt -59.98 -45.7 91.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.443 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.508 ' HD3' ' CD1' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.991 174.162 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -62.03 -36.42 81.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 109.84 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -67.79 -26.37 66.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 110.755 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 24.3 p -99.36 -30.99 11.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.022 -1.049 . . . . 0.0 110.547 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.49 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 106.75 19.73 9.47 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.628 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.23 169.34 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.243 . . . . 0.0 110.838 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.967 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -120.31 178.53 4.61 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.475 -0.765 . . . . 0.0 109.458 177.013 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.929 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -66.4 142.26 16.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 110.35 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.707 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.36 -4.78 54.23 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 172.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.539 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.89 -162.08 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.053 -1.263 . . . . 0.0 110.067 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 16.4 pttp -137.2 116.15 12.36 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -119.55 160.72 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 82.8 tttt -109.37 120.62 43.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.025 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.519 HG23 HD21 ' A' ' 9' ' ' LEU . 87.3 t -101.67 123.69 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 0.0 110.204 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.52 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 93.9 mtt180 -106.88 151.4 25.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 109.763 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.659 ' CE ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -99.07 132.44 44.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.049 -1.032 . . . . 0.0 110.215 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.3 m -149.91 -168.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.561 -0.712 . . . . 0.0 110.125 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 40.1 ptt180 -129.07 171.67 12.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.636 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.74 164.72 12.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 111.023 -175.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.594 ' CG ' HG12 ' A' ' 162' ' ' VAL . 18.8 pt-20 -150.04 169.51 21.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 109.421 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 163' ' ' GLU . 40.0 mm -90.66 99.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.843 -1.161 . . . . 0.0 110.607 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.866 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.27 140.07 50.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 110.423 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.661 ' HE3' HD12 ' A' ' 156' ' ' LEU . 1.5 ptpt -101.68 -29.03 12.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.536 ' HB3' HD23 ' A' ' 156' ' ' LEU . 40.2 ttmt -150.79 129.35 12.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.367 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.083 HG23 HG22 ' A' ' 155' ' ' THR . 9.7 p -139.67 139.99 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.009 -1.057 . . . . 0.0 110.782 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 171' ' ' GLU . 14.5 m -102.71 138.67 39.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.873 . . . . 0.0 110.042 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.545 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -132.03 159.96 37.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.696 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . . . -135.18 81.82 43.39 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.432 -0.793 . . . . 0.0 110.396 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 19.7 Cg_exo -60.54 132.96 45.95 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.936 1.493 . . . . 0.0 110.33 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.905 HG23 ' HB2' ' A' ' 177' ' ' ALA . 46.3 mm -91.88 95.39 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.206 -0.934 . . . . 0.0 110.054 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -151.9 -166.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.38 -0.825 . . . . 0.0 110.726 178.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.58 ' HB2' ' HG2' ' A' ' 108' ' ' GLN . 28.8 mmm180 -88.99 156.91 18.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.467 -0.771 . . . . 0.0 109.587 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -57.52 -14.14 4.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 110.725 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 35.5 p-10 -127.9 32.13 4.99 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 121.619 -0.676 . . . . 0.0 110.437 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.58 ' HG2' ' HB2' ' A' ' 105' ' ' ARG . 4.8 mm-40 -89.95 -79.99 0.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.946 -1.096 . . . . 0.0 110.78 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -103.28 -32.35 9.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.01 -1.056 . . . . 0.0 110.876 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.771 ' O ' HD12 ' A' ' 110' ' ' LEU . 1.4 pp -99.62 50.14 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 110.179 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -102.83 49.04 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.442 -0.787 . . . . 0.0 110.089 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.452 ' HB2' HD13 ' A' ' 116' ' ' ILE . 57.8 m-85 -124.55 -51.03 1.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.59 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 75.34 175.86 37.75 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 113' ' ' GLY . 96.0 mt-10 43.76 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.148 -1.207 . . . . 0.0 110.507 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.3 -2.91 87.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 117' ' ' GLU . 7.2 tp -59.98 -39.98 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -1.205 . . . . 0.0 110.18 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 97.2 mt-10 -61.48 -42.58 99.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -70.04 -30.12 67.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.93 -39.93 83.07 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.783 ' O ' HD22 ' A' ' 124' ' ' LEU . 56.0 t -60.07 -43.79 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.316 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.608 ' NE2' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -59.63 -45.06 93.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.987 -1.07 . . . . 0.0 109.575 175.505 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -59.94 -40.09 87.77 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.22 -22.18 38.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.165 -0.959 . . . . 0.0 110.938 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -130.03 7.22 5.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.94 -1.1 . . . . 0.0 110.674 -174.268 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.698 ' N ' HD23 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -44.26 173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.311 -0.868 . . . . 0.0 110.883 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.7 ptm180 34.9 46.63 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.498 -0.751 . . . . 0.0 111.29 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.437 ' H ' ' HB ' ' A' ' 164' ' ' ILE . 8.9 ttt180 -123.33 129.7 24.81 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.87 -1.144 . . . . 0.0 111.19 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.846 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.5 Cg_endo -66.26 125.9 14.8 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.954 1.502 . . . . 0.0 109.647 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.98 ' O ' HD13 ' A' ' 130' ' ' LEU . 97.6 mtp -140.01 151.62 45.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.27 -1.519 . . . . 0.0 112.092 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.98 HD13 ' O ' ' A' ' 129' ' ' MET . 0.5 OUTLIER -126.03 146.16 50.01 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.443 0.639 . . . . 0.0 109.975 172.23 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.4 pm0 -57.18 140.02 50.83 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 172.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 75.2 -0.75 3.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.75 -0.594 . . . . 0.0 110.262 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.801 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -67.81 -172.81 0.3 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 109.942 176.347 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 17.1 m-80 -141.18 149.72 41.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.0 165.48 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.016 -1.052 . . . . 0.0 110.493 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 t -140.66 149.36 42.16 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.363 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.724 HG13 ' HD2' ' A' ' 138' ' ' PRO . 77.5 t -135.63 149.93 70.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.706 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.724 ' HD2' HG13 ' A' ' 137' ' ' VAL . 1.4 Cg_endo -46.76 83.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.931 1.49 . . . . 0.0 110.136 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . -139.84 101.58 0.31 Allowed Glycine 0 N--CA 1.482 1.734 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 141' ' ' THR . 1.4 pp -87.14 146.45 26.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.428 -1.043 . . . . 0.0 109.784 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 1.036 ' C ' HD13 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -60.82 -170.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.083 -1.01 . . . . 0.0 110.89 -171.253 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.036 HD13 ' C ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -143.61 -100.58 0.12 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.837 -0.539 . . . . 0.0 110.237 178.458 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.527 ' H ' HD23 ' A' ' 142' ' ' LEU . . . -78.54 50.18 0.94 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.325 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.64 68.01 1.86 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 142' ' ' LEU . 17.2 pt20 -104.56 172.74 6.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.773 -1.427 . . . . 0.0 109.883 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -137.52 153.24 50.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.397 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.738 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 100.37 -90.72 0.93 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.738 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.5 OUTLIER 41.88 47.32 3.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.415 -1.05 . . . . 0.0 111.122 177.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.8 pp -140.1 167.86 21.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.961 -1.087 . . . . 0.0 110.073 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 66.5 m-85 -101.89 134.61 44.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.043 . . . . 0.0 110.665 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 32.3 tptt -118.05 102.21 8.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.922 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.801 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.5 t -74.93 135.73 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.791 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.42 -31.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 110.669 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 54.7 tttm -139.39 148.76 43.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.954 -1.091 . . . . 0.0 110.953 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.083 HG22 HG23 ' A' ' 98' ' ' VAL . 24.4 p -145.07 159.7 42.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.76 -0.588 . . . . 0.0 109.836 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.674 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -90.46 -38.05 0.4 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.344 -0.847 . . . . 0.0 111.015 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 1.1 ' CB ' HG11 ' A' ' 162' ' ' VAL . 12.6 Cg_exo -60.15 -173.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.434 1.228 . . . . 0.0 110.911 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 159' ' ' LYS . 5.4 t -90.17 -168.47 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 158' ' ' SER . 8.7 ptpt -66.3 -6.01 12.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.437 ' H ' HG22 ' A' ' 160' ' ' VAL . 33.7 m -86.36 152.33 54.97 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.599 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.636 ' HB3' HG11 ' A' ' 51' ' ' VAL . 1.6 Cg_endo -51.52 132.42 40.38 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.289 1.678 . . . . 0.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 1.1 HG11 ' CB ' ' A' ' 157' ' ' PRO . 3.5 m -121.96 152.92 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.609 -1.237 . . . . 0.0 110.269 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.598 ' HG3' HD13 ' A' ' 94' ' ' ILE . 18.1 pt-20 -103.47 127.93 50.75 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.879 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 1.008 HD12 HG21 ' A' ' 168' ' ' THR . 19.3 mm -71.04 153.4 8.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.136 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.608 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -143.69 167.29 26.7 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.563 ' HA ' HD11 ' A' ' 125' ' ' ILE . 99.0 mt-10 -56.61 -20.58 21.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -1.062 . . . . 0.0 110.397 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.94 -9.91 47.04 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.667 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.008 HG21 HD12 ' A' ' 164' ' ' ILE . 95.6 m -62.44 146.65 50.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.167 -0.958 . . . . 0.0 109.886 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.5 mttt -97.43 143.97 27.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 109.64 176.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.586 HD11 ' HG2' ' A' ' 121' ' ' GLN . 2.1 mm -106.84 129.45 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 99' ' ' THR . 64.7 mt-10 -116.31 135.2 54.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 110.156 172.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.458 HG12 ' HG ' ' A' ' 100' ' ' LEU . 41.3 mt -140.1 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.873 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 173' ' ' ARG . 3.5 ptm85 -87.9 -175.52 5.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.228 -175.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 24.5 pt-20 -120.32 -16.57 8.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.345 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.4 109.96 45.94 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.545 -0.722 . . . . 0.0 109.662 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.652 ' O ' HG21 ' A' ' 180' ' ' VAL . 14.8 Cg_exo -69.97 -154.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.14 1.6 . . . . 0.0 110.599 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.905 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -76.88 51.48 0.79 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.694 -0.629 . . . . 0.0 110.207 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 180' ' ' VAL . 36.6 t -110.72 111.49 22.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.995 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 178' ' ' SER . 79.7 tt0 59.89 19.98 8.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.439 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.652 HG21 ' O ' ' A' ' 176' ' ' PRO . 23.1 t -101.31 139.72 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.173 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER 39.83 42.83 1.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.562 -0.711 . . . . 0.0 110.561 -178.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -60.84 130.04 44.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.187 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.95 -30.07 68.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 110.221 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 62.95 -131.62 42.95 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 117.989 -1.451 . . . . 0.0 109.481 179.82 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 mmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.38 0.609 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -60.29 -39.7 87.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 110.225 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -60.13 -39.98 88.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.274 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.404 ' ND2' ' HD2' ' A' ' 159' ' ' LYS . 40.6 t-20 -101.01 113.47 26.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.225 -0.922 . . . . 0.0 110.309 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.586 ' ND2' HD22 ' A' ' 34' ' ' LEU . 31.9 p30 -160.46 154.93 23.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.078 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.71 -159.13 8.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.911 ' CG2' HD12 ' A' ' 33' ' ' LEU . 20.6 pt -137.2 169.35 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -112.51 120.51 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.011 -1.056 . . . . 0.0 110.444 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 87' ' ' VAL . 1.7 pt? -139.41 -167.66 2.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.776 . . . . 0.0 109.747 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 34.9 ptt180 -118.88 140.02 50.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.794 -1.191 . . . . 0.0 110.715 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.938 HG11 ' O ' ' A' ' 80' ' ' SER . 4.6 p -62.35 147.7 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -122.3 147.66 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.903 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.811 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 -177.2 129.13 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 173.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.08 -52.91 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.179 -0.951 . . . . 0.0 110.295 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -149.64 99.47 2.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.274 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.1 p -151.55 159.83 43.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.217 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 75.2 p -75.69 156.89 34.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.942 . . . . 0.0 109.885 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.643 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -59.91 -40.66 80.14 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 110.68 -177.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 13.4 Cg_exo -67.05 149.73 82.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.66 1.347 . . . . 0.0 110.228 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.471 ' C ' ' OD2' ' A' ' 70' ' ' ASP . . . 96.05 43.96 3.17 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.401 ' O ' ' HG3' ' A' ' 73' ' ' MET . 27.1 ptt? -86.53 -0.42 56.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.428 -1.042 . . . . 0.0 109.485 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.8 p -100.53 5.74 44.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -0.86 . . . . 0.0 110.069 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.516 ' HG3' ' CG ' ' A' ' 55' ' ' TYR . 59.8 ttt180 -99.99 113.94 26.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.821 . . . . 0.0 110.091 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.071 HG13 HG23 ' A' ' 67' ' ' VAL . 55.5 t -112.56 112.53 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 0.0 110.271 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.793 ' O ' HD12 ' A' ' 26' ' ' LEU . 7.4 ptt180 -84.24 117.37 23.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.689 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.929 HD13 HG12 ' A' ' 24' ' ' VAL . 1.8 mp -134.83 170.62 15.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.993 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.0 p-10 -105.57 -175.18 2.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 110.507 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -59.91 -42.09 93.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.184 -0.947 . . . . 0.0 109.643 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -67.4 -49.56 63.29 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.3 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.114 ' O ' HD22 ' A' ' 33' ' ' LEU . 72.4 m -57.9 -27.44 63.31 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.119 -0.988 . . . . 0.0 109.56 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 39.9 ttm180 -86.43 -46.08 10.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.822 -0.549 . . . . 0.0 110.957 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -79.71 -8.58 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.114 HD22 ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -43.85 -28.7 0.47 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -0.779 . . . . 0.0 110.136 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.716 ' H ' HD23 ' A' ' 33' ' ' LEU . 83.2 mt -141.76 -59.43 0.47 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 110.272 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.602 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.4 t0 -170.56 -30.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.424 -0.798 . . . . 0.0 110.066 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.602 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -15.35 120.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.437 0.637 . . . . 0.0 111.581 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.597 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -105.87 -177.51 3.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.0 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.422 HD12 HG23 ' A' ' 38' ' ' ILE . 28.5 mm -63.73 119.4 7.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.062 -1.024 . . . . 0.0 110.135 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.608 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.25 35.95 56.3 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.81 178.3 6.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.056 -1.261 . . . . 0.0 109.499 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.616 HG21 ' OG1' ' A' ' 92' ' ' THR . 97.0 t -99.65 127.76 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.015 -1.053 . . . . 0.0 110.301 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG11 HG23 ' A' ' 54' ' ' VAL . 3.1 m -120.95 149.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.514 -0.741 . . . . 0.0 110.683 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -111.93 140.8 46.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.594 -0.691 . . . . 0.0 109.982 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.849 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.5 mp -124.92 144.01 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.926 -1.109 . . . . 0.0 110.731 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -150.21 98.79 2.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 110.827 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.946 ' CG ' HG12 ' A' ' 85' ' ' VAL . 9.2 tmtm? -97.94 -64.36 1.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.559 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.569 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.17 -36.94 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.817 0.818 . . . . 0.0 109.098 175.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 70.5 mtt85 -128.95 -173.47 2.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.538 ' HB3' HD21 ' A' ' 130' ' ' LEU . 29.3 mttt -96.18 141.75 29.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.122 -0.986 . . . . 0.0 110.902 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.637 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.5 p -145.0 168.2 20.84 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.374 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.57 162.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -171.66 41.39 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.216 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.403 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 70.2 ttt180 -121.72 166.44 14.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.458 -1.025 . . . . 0.0 110.165 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -99.94 149.69 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.004 . . . . 0.0 110.412 -175.37 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.0 m-85 -139.16 167.84 21.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.511 -0.743 . . . . 0.0 110.339 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -88.62 122.77 32.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.844 . . . . 0.0 110.052 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.834 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.3 138.3 58.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.734 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 2.4 mtp180 -58.35 -47.21 99.21 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.309 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 56.2 Cg_endo -93.51 98.96 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.675 1.355 . . . . 0.0 108.69 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.423 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.5 pt-20 -73.28 35.65 0.08 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.587 -0.696 . . . . 0.0 110.784 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.3 m-20 -146.07 -30.79 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.96 -28.78 25.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.433 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.834 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 5.3 m120 -80.53 39.64 0.48 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.723 -0.61 . . . . 0.0 110.64 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -98.96 13.34 33.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.072 -1.017 . . . . 0.0 109.663 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.72 26.42 0.05 OUTLIER Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.55 149.04 20.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.371 -1.076 . . . . 0.0 108.933 175.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.071 HG23 HG13 ' A' ' 24' ' ' VAL . 7.6 p -126.55 131.81 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.928 -1.108 . . . . 0.0 110.348 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 3.5 ttt180 -89.59 116.24 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 110.325 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.877 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.7 pp -135.36 168.58 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.318 -0.864 . . . . 0.0 111.036 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' OD2' ' C ' ' A' ' 20' ' ' GLY . 78.0 m-20 -82.06 155.54 25.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.282 -0.886 . . . . 0.0 110.201 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' ' CG ' ' A' ' 75' ' ' ASN . 60.1 p -60.12 -23.37 63.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 110.147 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.6 t -68.09 -42.94 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 110.232 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.849 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.95 -50.91 71.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 109.974 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.633 ' HD2' HG21 ' A' ' 11' ' ' VAL . 13.2 mmp_? -60.14 -39.85 87.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 173.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 78.2 m-20 -60.12 -37.77 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 73' ' ' MET . 93.8 m-20 -59.94 -36.25 76.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 110.648 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 30.2 p -98.15 -39.33 8.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.105 -0.997 . . . . 0.0 110.531 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.569 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 119.18 36.17 0.89 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.806 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -116.48 170.2 8.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.327 . . . . 0.0 110.38 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.938 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.99 -176.83 3.43 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.811 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -66.57 143.42 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.487 178.178 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.759 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.13 0.95 67.16 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.3 m-20 -61.33 -165.4 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.071 -1.253 . . . . 0.0 110.581 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.512 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 15.0 pttt -130.64 112.94 13.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 0.0 109.945 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.946 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -122.68 161.15 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 109.995 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 26.4 ttmt -104.96 125.67 51.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.011 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.818 HG23 HD21 ' A' ' 9' ' ' LEU . 62.0 t -108.28 121.25 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.507 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.6 mtt180 -111.39 147.13 35.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.419 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 36' ' ' ALA . 6.5 tttt -92.51 139.57 30.45 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.255 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.69 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.413 -0.804 . . . . 0.0 110.26 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -132.25 172.28 12.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.466 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.616 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.49 159.59 16.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.974 -1.079 . . . . 0.0 111.204 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.555 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.1 pt-20 -150.02 169.97 19.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 94' ' ' ILE . 4.6 mp -89.56 99.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.731 -1.231 . . . . 0.0 110.241 -178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.806 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.0 138.04 44.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.772 . . . . 0.0 110.353 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.697 ' CG ' HD13 ' A' ' 156' ' ' LEU . 15.5 ptmt -98.39 -30.01 12.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.34 -0.85 . . . . 0.0 110.849 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.549 ' HB3' HD12 ' A' ' 156' ' ' LEU . 14.7 tttp -151.06 125.61 9.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.85 -1.156 . . . . 0.0 110.803 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.063 HG23 HG22 ' A' ' 155' ' ' THR . 8.6 p -137.52 147.17 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.065 . . . . 0.0 111.044 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.758 HG23 ' HB3' ' A' ' 171' ' ' GLU . 38.0 m -119.14 142.82 47.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.111 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.686 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -138.54 169.03 18.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.847 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.38 93.84 4.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.415 -0.803 . . . . 0.0 110.489 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.7 Cg_exo -65.57 128.9 21.1 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.201 1.632 . . . . 0.0 110.417 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.971 HG23 ' HB2' ' A' ' 177' ' ' ALA . 91.3 mt -90.02 96.41 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 110.151 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.792 HD13 ' HB3' ' A' ' 108' ' ' GLN . 0.8 OUTLIER -150.01 -175.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.352 -0.842 . . . . 0.0 110.5 176.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -135.23 -134.18 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 109.575 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -60.68 -17.2 46.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.997 -1.064 . . . . 0.0 109.925 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -98.93 26.23 5.95 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.42 0.629 . . . . 0.0 110.015 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.792 ' HB3' HD13 ' A' ' 104' ' ' ILE . 28.5 pt20 -83.7 151.63 25.15 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.444 -0.785 . . . . 0.0 110.107 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -88.54 -14.9 36.58 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.385 -0.822 . . . . 0.0 110.174 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.493 HD22 ' HG2' ' A' ' 102' ' ' PRO . 0.6 OUTLIER -99.64 57.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 110.32 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -105.11 54.85 0.7 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.903 . . . . 0.0 110.405 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -131.27 -53.42 1.03 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 110.578 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 74.41 174.23 31.5 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -176.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.49 ' O ' ' O ' ' A' ' 113' ' ' GLY . 98.2 mt-10 47.79 102.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.083 -1.245 . . . . 0.0 110.089 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.55 57.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.5 tp -60.14 -36.44 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -1.203 . . . . 0.0 110.064 175.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.7 mt-10 -60.03 -42.12 93.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.27 -37.51 83.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 109.6 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -59.97 -42.42 94.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.589 HG12 ' CD1' ' A' ' 170' ' ' ILE . 53.1 t -60.26 -45.01 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 175.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.583 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.1 mt-30 -59.89 -43.97 94.5 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.568 -0.707 . . . . 0.0 109.951 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.31 -46.01 91.4 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.819 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.9 68.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 110.921 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 2.9 mm? -99.89 5.33 45.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.025 -1.047 . . . . 0.0 111.171 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.706 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.7 tt -48.71 170.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 36.6 ptt180 33.66 49.12 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.628 -0.67 . . . . 0.0 111.516 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 0.7 OUTLIER -132.37 149.93 74.51 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.711 -1.243 . . . . 0.0 111.232 176.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.834 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.1 Cg_endo -68.73 128.19 16.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 124.174 1.618 . . . . 0.0 109.971 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.7 mmm -123.07 140.95 52.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.321 -1.487 . . . . 0.0 110.983 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 50' ' ' THR . 20.2 tp -139.24 104.19 4.94 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.695 -0.628 . . . . 0.0 109.386 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.642 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.5 pt-20 -45.24 137.09 4.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.046 -1.034 . . . . 0.0 110.7 -174.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 86.01 -6.06 0.8 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.27 0.557 . . . . 0.0 110.283 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.561 ' OD2' ' HB ' ' A' ' 152' ' ' VAL . 2.8 p30 -69.49 -178.31 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 110.359 177.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -147.1 153.09 39.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.03 160.64 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.941 -1.099 . . . . 0.0 110.65 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.0 t -140.51 157.18 45.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.671 -0.643 . . . . 0.0 110.355 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.888 ' HB ' HD22 ' A' ' 140' ' ' LEU . 91.2 t -99.55 148.39 34.65 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 109.942 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.69 ' HD2' HG13 ' A' ' 137' ' ' VAL . 1.9 Cg_endo -44.94 87.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.977 1.514 . . . . 0.0 110.995 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 46.0 60.31 4.55 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.912 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -110.57 153.0 25.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.027 -1.278 . . . . 0.0 109.482 176.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -176.17 -171.83 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.067 -1.021 . . . . 0.0 110.749 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.55 ' N ' ' OG1' ' A' ' 141' ' ' THR . 82.7 mt -146.76 -127.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.891 -0.506 . . . . 0.0 109.796 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -58.4 -153.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.026 . . . . 0.0 110.176 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.29 75.63 2.18 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.794 ' OE1' HD13 ' A' ' 148' ' ' LEU . 4.0 pt20 -96.33 170.07 9.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.476 -1.014 . . . . 0.0 110.385 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 t -135.99 154.16 51.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.968 . . . . 0.0 110.216 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.707 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 69.7 -84.31 0.28 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.794 HD13 ' OE1' ' A' ' 145' ' ' GLN . 0.4 OUTLIER 43.68 49.7 6.65 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.584 -0.951 . . . . 0.0 110.946 178.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 pp -140.39 163.77 31.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.979 -1.075 . . . . 0.0 109.803 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.7 m-85 -91.02 126.49 36.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.078 -1.014 . . . . 0.0 110.049 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -112.4 111.95 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.561 ' HB ' ' OD2' ' A' ' 133' ' ' ASP . 2.7 t -78.15 137.57 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.89 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.48 -31.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.257 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -143.43 146.98 33.91 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.411 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.063 HG22 HG23 ' A' ' 98' ' ' VAL . 56.0 p -140.0 161.68 37.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.697 HD13 ' CG ' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -89.26 -35.91 0.42 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.96 -1.087 . . . . 0.0 111.103 -177.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.942 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.3 Cg_exo -58.61 -167.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.327 1.172 . . . . 0.0 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 160' ' ' VAL . 29.1 t -87.68 -173.88 4.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.792 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.404 ' HD2' ' ND2' ' A' ' 4' ' ' ASN . 12.3 ptpt -67.9 -1.84 6.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.176 -0.953 . . . . 0.0 110.567 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' A' ' 158' ' ' SER . 33.1 m -85.79 147.73 46.76 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.146 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.585 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.8 Cg_endo -47.45 139.07 17.74 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 O-C-N 124.358 1.715 . . . . 0.0 110.975 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.942 HG11 ' CB ' ' A' ' 157' ' ' PRO . 11.1 m -130.02 159.21 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 109.442 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.3 tt0 -106.61 127.23 53.17 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.048 -1.032 . . . . 0.0 110.229 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.84 ' CD1' HG21 ' A' ' 168' ' ' THR . 16.6 mm -70.43 154.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.667 -0.646 . . . . 0.0 110.213 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.24 175.4 23.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.706 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -58.75 -26.05 63.61 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.341 -1.094 . . . . 0.0 109.992 -178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.36 -17.76 28.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 0.0 110.737 -176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.84 HG21 ' CD1' ' A' ' 164' ' ' ILE . 53.3 m -58.73 146.37 36.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 98.6 mttt -100.01 153.14 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.955 -1.091 . . . . 0.0 109.467 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.637 HG23 HD21 ' A' ' 100' ' ' LEU . 2.1 mt -129.92 159.4 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.001 -1.062 . . . . 0.0 111.185 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.758 ' HB3' HG23 ' A' ' 99' ' ' THR . 10.4 mt-10 -130.35 130.91 45.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.029 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 120' ' ' VAL . 50.5 mm -119.91 127.18 75.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.32 -0.863 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 2.9 ptp180 -88.6 144.51 26.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.545 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 85.6 tt0 -89.97 0.06 57.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 110.108 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 3.4 tm-20 -93.55 107.19 24.88 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.621 -0.674 . . . . 0.0 109.742 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.7 Cg_exo -70.78 -154.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 124.063 1.559 . . . . 0.0 109.932 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.971 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -85.1 39.69 0.78 Allowed 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.469 -0.769 . . . . 0.0 110.476 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 93.6 p -99.33 37.2 1.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.429 -0.795 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 83.5 tt0 -178.06 20.25 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.901 -1.124 . . . . 0.0 110.428 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.3 t -90.96 117.2 33.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.197 -0.94 . . . . 0.0 109.945 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.11 6.7 44.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.065 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 48.14 -116.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 110.023 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -60.09 139.92 57.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.929 -1.107 . . . . 0.0 110.08 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -171.47 139.91 5.62 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.542 179.292 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.266 0.555 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.49 161.57 18.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.277 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -59.97 -28.01 67.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -103.5 127.48 50.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -0.965 . . . . 0.0 110.542 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -149.91 159.99 43.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.341 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -147.09 -169.71 14.82 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.008 HG23 HD11 ' A' ' 34' ' ' LEU . 45.7 pt -134.82 159.99 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.228 -1.16 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 86' ' ' LYS . 40.4 mm -98.37 116.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 110.331 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.3 pt? -139.37 -178.26 5.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.324 -0.86 . . . . 0.0 109.728 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.73 ' HG2' HG22 ' A' ' 66' ' ' ILE . 6.3 ptp180 -106.73 137.0 45.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 110.899 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.048 HG23 HD11 ' A' ' 69' ' ' ILE . 13.5 p -63.75 134.81 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.596 -0.69 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -119.79 153.47 35.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.421 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.874 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -173.73 159.55 3.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.904 . . . . 0.0 110.607 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB3' ' OD2' ' A' ' 18' ' ' ASP . . . -126.4 170.22 12.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.996 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -69.94 -20.04 63.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.948 . . . . 0.0 110.188 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' OG1' ' A' ' 17' ' ' THR . 23.3 t -159.43 -173.8 4.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.853 . . . . 0.0 110.293 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.474 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 3.5 p 57.11 -163.82 0.17 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.507 -0.745 . . . . 0.0 110.554 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.585 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 2.0 p30 37.53 62.29 3.71 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.616 -0.677 . . . . 0.0 110.53 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 13.3 Cg_exo -66.09 -175.07 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.02 1.537 . . . . 0.0 110.143 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.46 85.75 1.71 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 73' ' ' MET . 23.2 ptp -89.29 -11.92 42.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -1.143 . . . . 0.0 110.076 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.59 19.17 17.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 109.894 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.517 ' HD3' ' CE1' ' A' ' 55' ' ' TYR . 18.1 mtt-85 -129.16 148.95 51.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 110.175 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.082 HG13 HG23 ' A' ' 67' ' ' VAL . 97.6 t -117.15 122.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.502 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 1.6 ptm180 -95.64 119.33 33.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.742 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.571 ' C ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -140.69 174.85 10.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 0.0 109.513 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.1 p-10 -90.28 177.64 6.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.927 -1.108 . . . . 0.0 110.737 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.99 -41.1 91.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 108.801 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.0 t -62.77 -58.38 7.64 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.076 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.666 ' O ' HD22 ' A' ' 33' ' ' LEU . 58.4 m -49.91 -30.39 10.1 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.833 -1.167 . . . . 0.0 109.572 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.478 ' N ' HD12 ' A' ' 26' ' ' LEU . 40.3 ttm180 -81.62 -45.52 15.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 111.603 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -97.95 -10.6 24.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.267 . . . . 0.0 110.958 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.991 HD23 ' H ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -59.94 -26.02 65.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.987 -1.07 . . . . 0.0 109.774 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.008 HD11 HG23 ' A' ' 7' ' ' ILE . 54.4 mt -110.63 -75.87 0.61 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.145 -0.972 . . . . 0.0 110.277 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.535 ' HB3' ' CD ' ' A' ' 89' ' ' LYS . 9.4 t70 -168.27 -20.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.574 -0.704 . . . . 0.0 109.971 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.594 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -40.46 126.78 2.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.358 -0.839 . . . . 0.0 110.681 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.705 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.3 pt-20 -119.12 179.77 4.07 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 108.929 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 38' ' ' ILE . 5.5 mm -55.81 127.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.06 . . . . 0.0 109.875 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.62 24.3 74.97 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.708 174.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 6.9 m-20 -89.01 169.94 11.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.754 -1.439 . . . . 0.0 109.855 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.741 HG21 ' OG1' ' A' ' 92' ' ' THR . 79.2 t -99.78 127.97 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 110.137 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.604 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.6 m -116.02 143.71 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 86.3 tt0 -113.28 143.2 44.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.735 . . . . 0.0 109.632 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.817 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.8 mp -119.97 145.9 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.023 . . . . 0.0 110.198 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.7 tt0 -151.8 88.53 1.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.062 -1.024 . . . . 0.0 111.612 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 85' ' ' VAL . 31.0 tttm -99.23 -71.74 0.68 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 110.2 171.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.539 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.15 -34.71 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.507 -0.746 . . . . 0.0 109.409 178.06 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 49.8 mtm180 -141.3 -173.28 3.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.5 -0.75 . . . . 0.0 109.892 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.668 ' C ' HD21 ' A' ' 130' ' ' LEU . 2.1 mptm? -87.84 133.22 33.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 110.325 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -134.93 159.28 41.94 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.354 0.597 . . . . 0.0 110.318 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.39 162.17 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.825 . . . . 0.0 109.963 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.604 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -179.83 48.01 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.995 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 61.8 ttt180 -116.6 169.84 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 0.0 110.214 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.85 131.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 110.322 -175.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.517 ' CE1' ' HD3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -121.3 163.67 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.551 -0.718 . . . . 0.0 110.009 175.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -90.68 124.19 34.88 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 110.134 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -63.22 139.25 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.568 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -58.74 -49.05 95.51 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.186 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.2 Cg_endo -91.06 98.78 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 108.922 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 15.7 pt-20 -73.07 35.93 0.08 Allowed 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.65 -0.657 . . . . 0.0 110.749 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.5 m-20 -148.91 -33.42 0.22 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.252 -0.905 . . . . 0.0 110.721 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.23 -26.49 28.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.987 . . . . 0.0 109.166 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.846 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 13.4 m120 -80.94 42.29 0.63 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.769 -0.582 . . . . 0.0 110.537 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 34.4 mtpt -97.79 10.0 41.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.563 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.48 28.84 0.05 OUTLIER Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.73 HG22 ' HG2' ' A' ' 10' ' ' ARG . 45.1 pt -140.59 143.88 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -1.154 . . . . 0.0 109.55 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.082 HG23 HG13 ' A' ' 24' ' ' VAL . 2.5 p -120.8 127.59 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.06 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.421 ' HB3' ' HD2' ' A' ' 25' ' ' ARG . 20.8 tpp180 -90.63 114.9 27.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.088 -1.008 . . . . 0.0 109.906 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.048 HD11 HG23 ' A' ' 11' ' ' VAL . 2.4 pt -130.05 161.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.99 169.94 17.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 110.047 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.442 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 21.5 t -60.2 -36.74 78.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 110.365 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.27 -45.9 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 109.888 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.817 ' HE1' HD13 ' A' ' 44' ' ' ILE . 13.7 tpt -60.13 -43.45 95.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.588 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -60.0 -40.03 87.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.761 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.41 -25.94 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 78.6 m-20 -60.12 -40.02 88.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.655 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.0 p -99.91 -38.06 8.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.985 -1.072 . . . . 0.0 110.545 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.539 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.79 30.85 2.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.598 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.43 169.49 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -1.131 . . . . 0.0 110.74 -174.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.94 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.7 170.96 8.19 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.341 -0.849 . . . . 0.0 109.039 174.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.874 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -63.27 140.57 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.794 -1.192 . . . . 0.0 110.429 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.633 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.82 -2.95 62.31 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 172.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -59.64 -159.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.101 -1.235 . . . . 0.0 110.394 174.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 54.6 pttt -138.79 119.76 14.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.78 . . . . 0.0 109.836 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.731 HG12 ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -123.02 161.38 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 109.895 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.464 ' HB2' ' CD1' ' A' ' 8' ' ' ILE . 20.0 ttpt -105.31 120.02 40.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.498 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.6 t -103.71 121.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.7 mtt180 -111.3 131.84 54.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.358 -0.839 . . . . 0.0 110.146 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.535 ' CD ' ' HB3' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -74.91 137.87 41.99 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 41' ' ' VAL . 2.2 m -149.45 -169.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.066 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -127.99 170.98 12.27 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.741 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.01 159.95 16.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 111.052 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.584 ' HG2' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -146.29 173.68 12.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.94 99.03 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.681 -1.262 . . . . 0.0 110.178 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.854 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.09 138.79 36.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -0.803 . . . . 0.0 110.301 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.543 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -103.96 -28.25 11.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.955 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.73 ' HB3' HD23 ' A' ' 156' ' ' LEU . 52.5 tttp -150.04 123.08 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.761 -1.212 . . . . 0.0 110.253 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.707 HG23 HG22 ' A' ' 155' ' ' THR . 9.7 p -137.07 140.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 110.484 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.54 HG23 ' HB3' ' A' ' 171' ' ' GLU . 21.7 m -110.98 134.52 52.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.968 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.681 HD11 HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -130.79 159.83 36.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.392 -0.817 . . . . 0.0 110.162 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -128.74 100.04 22.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 110.438 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -56.2 122.26 11.46 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.007 1.53 . . . . 0.0 110.039 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.744 HG23 ' HB2' ' A' ' 177' ' ' ALA . 49.0 mm -89.86 109.87 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.12 -0.987 . . . . 0.0 110.245 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.857 HD12 ' CG ' ' A' ' 108' ' ' GLN . 20.0 pt -150.09 -160.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.266 -0.896 . . . . 0.0 110.629 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.57 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . 22.6 mmt180 -112.19 157.94 20.28 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.296 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -60.05 -17.82 41.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 109.781 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.57 ' OD1' ' HB3' ' A' ' 105' ' ' ARG . 12.2 p-10 -100.73 32.72 3.02 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.857 ' CG ' HD12 ' A' ' 104' ' ' ILE . 1.3 pp0? -80.84 149.89 29.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.454 -0.779 . . . . 0.0 110.241 -174.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.752 ' HB3' HD11 ' A' ' 142' ' ' LEU . 33.5 ttm180 -89.08 -13.1 39.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 110.889 -174.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.565 ' HG ' ' OE1' ' A' ' 108' ' ' GLN . 0.7 OUTLIER -98.0 77.98 2.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 0.0 110.133 -177.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.526 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -133.19 62.93 1.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.519 -0.738 . . . . 0.0 109.987 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -90.46 -56.15 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.107 -0.996 . . . . 0.0 110.616 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 74.85 -169.1 54.61 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 113' ' ' GLY . 98.8 mt-10 45.91 99.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.207 -1.172 . . . . 0.0 110.151 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.89 -23.09 11.27 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.442 HG21 ' HA2' ' A' ' 113' ' ' GLY . 8.2 tt -59.54 -34.57 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.071 -1.252 . . . . 0.0 110.257 176.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' HG2' HG12 ' A' ' 172' ' ' ILE . 97.2 mt-10 -60.03 -44.81 94.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.62 -37.25 86.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 109.594 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -60.0 -39.99 87.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.812 . . . . 0.0 109.599 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.681 HG11 HD11 ' A' ' 100' ' ' LEU . 79.3 t -59.99 -46.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.992 . . . . 0.0 109.371 175.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.681 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -59.88 -39.82 86.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 175.435 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.05 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.81 65.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.353 -0.842 . . . . 0.0 110.577 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.611 HD12 ' CG1' ' A' ' 120' ' ' VAL . 86.0 mt -91.04 -9.46 45.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.834 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 164' ' ' ILE . 3.3 tt -42.39 167.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.591 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 164' ' ' ILE . 26.1 ptt180 33.26 46.2 0.1 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.692 -0.63 . . . . 0.0 111.429 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.502 ' CG ' ' HD2' ' A' ' 128' ' ' PRO . 18.8 ttm180 -132.07 142.5 45.33 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.653 -1.28 . . . . 0.0 111.225 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.855 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.7 Cg_endo -64.6 126.34 16.62 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 124.258 1.662 . . . . 0.0 109.427 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.569 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.4 mmm -124.6 145.58 49.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.395 -1.441 . . . . 0.0 111.076 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.668 HD21 ' C ' ' A' ' 49' ' ' LYS . 12.8 tp -142.55 116.67 9.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.5 pm0 -47.9 148.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.911 -1.118 . . . . 0.0 110.517 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.622 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 74.98 -2.41 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.788 -0.57 . . . . 0.0 110.871 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.624 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.2 p30 -69.34 -171.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.454 ' C ' HG13 ' A' ' 135' ' ' ILE . 15.1 m-80 -149.44 132.15 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.538 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.705 HD11 ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -136.45 162.2 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 110.486 -178.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.0 t -134.56 148.21 50.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.672 -0.642 . . . . 0.0 110.268 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.709 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 51.9 t -133.63 -65.01 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 111.039 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 36.4 Cg_endo -70.11 122.7 9.27 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.104 1.055 . . . . 0.0 110.39 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -95.62 44.57 2.08 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.441 HD12 ' C ' ' A' ' 140' ' ' LEU . 1.4 pp -130.89 152.88 49.74 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.465 -1.021 . . . . 0.0 110.072 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.546 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -131.51 -171.1 2.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.096 -1.002 . . . . 0.0 110.787 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 109' ' ' ARG . 87.1 mt -139.79 -123.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.683 -0.636 . . . . 0.0 109.967 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.22 -154.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.28 -0.888 . . . . 0.0 110.683 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.25 57.58 4.65 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.57 ' NE2' HD11 ' A' ' 148' ' ' LEU . 14.6 pt20 -102.71 158.1 16.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.399 -1.059 . . . . 0.0 110.316 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.3 t -139.92 155.45 47.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.123 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.21 -91.26 0.75 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.57 HD11 ' NE2' ' A' ' 145' ' ' GLN . 3.4 mp 49.68 56.9 7.15 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.214 -1.168 . . . . 0.0 110.366 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 1.4 pp -140.37 166.77 23.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.348 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.692 ' O ' HD12 ' A' ' 135' ' ' ILE . 77.9 m-85 -93.1 120.73 33.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.952 -1.093 . . . . 0.0 110.094 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 15.3 tptm -97.77 106.35 18.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 109.725 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.705 ' CG2' HD11 ' A' ' 135' ' ' ILE . 2.8 t -76.64 134.47 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.995 . . . . 0.0 109.716 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.466 HG11 HH22 ' A' ' 173' ' ' ARG . 2.8 t -129.47 -20.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 110.457 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.5 tttm -139.58 140.42 37.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.68 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.707 HG22 HG23 ' A' ' 98' ' ' VAL . 47.0 p -139.75 161.53 37.33 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.7 -0.625 . . . . 0.0 109.602 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.55 -34.41 0.42 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 110.992 -177.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.927 ' CG ' HG11 ' A' ' 162' ' ' VAL . 29.4 Cg_exo -55.82 -168.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.343 1.181 . . . . 0.0 110.197 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 160' ' ' VAL . 16.1 t -90.15 40.18 1.0 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.651 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 158' ' ' SER . 26.4 mmtp 59.97 42.31 16.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.804 ' O ' HG13 ' A' ' 162' ' ' VAL . 33.2 m -136.07 160.06 68.64 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.517 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -49.53 120.11 5.42 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 124.09 1.574 . . . . 0.0 110.155 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.927 HG11 ' CG ' ' A' ' 157' ' ' PRO . 11.7 m -128.19 159.52 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.479 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -103.93 124.48 49.07 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 125' ' ' ILE . 16.1 mm -72.06 153.67 7.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.817 -0.552 . . . . 0.0 110.301 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.53 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -140.8 166.67 25.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.69 ' HB3' HD11 ' A' ' 125' ' ' ILE . 19.1 pt-20 -58.14 -18.24 24.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.04 . . . . 0.0 110.29 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -89.21 -13.72 37.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.92 . . . . 0.0 110.375 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 95' ' ' ALA . 7.2 m -62.52 150.82 39.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.014 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -98.6 153.62 18.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.27 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.681 HD11 ' HG2' ' A' ' 121' ' ' GLN . 3.6 mm -119.88 134.81 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 110.927 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.669 ' O ' HD13 ' A' ' 172' ' ' ILE . 37.0 mt-10 -119.7 132.55 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.564 172.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.669 HD13 ' O ' ' A' ' 171' ' ' GLU . 21.4 mm -127.33 122.78 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.457 -0.777 . . . . 0.0 109.748 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.49 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 13.3 ptp180 -90.07 166.36 13.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.057 -1.027 . . . . 0.0 110.506 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.494 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 28.9 tp10 -99.81 9.76 42.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 110.692 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.37 109.39 42.53 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 110.282 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.2 Cg_exo -73.08 -156.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.07 1.563 . . . . 0.0 110.545 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.744 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -77.22 54.4 1.09 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.671 -0.643 . . . . 0.0 110.068 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.565 ' O ' HG23 ' A' ' 180' ' ' VAL . 1.5 m -69.49 127.27 32.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 110.125 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 178' ' ' SER . 84.0 tt0 59.99 14.64 4.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 110.723 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 178' ' ' SER . 62.5 t -110.04 120.07 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.992 -1.067 . . . . 0.0 110.374 177.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.973 HD12 ' CG ' ' A' ' 183' ' ' GLU . 0.2 OUTLIER -129.17 4.2 5.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.09 -1.006 . . . . 0.0 110.283 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 181' ' ' LEU . 40.9 mt-10 59.4 13.37 3.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.351 -0.843 . . . . 0.0 111.017 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.973 ' CG ' HD12 ' A' ' 181' ' ' LEU . 78.8 mm-40 -69.98 149.99 47.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.913 -1.117 . . . . 0.0 110.174 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.95 96.46 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.613 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.286 0.565 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -80.03 160.03 25.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 t -116.98 132.95 56.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 0.0 110.351 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -121.08 129.36 53.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.268 -0.895 . . . . 0.0 110.422 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.549 ' O ' HD13 ' A' ' 34' ' ' LEU . 16.7 m120 -130.67 170.02 14.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.203 -0.936 . . . . 0.0 110.447 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -145.81 -166.49 11.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.975 ' CG2' HD12 ' A' ' 33' ' ' LEU . 20.5 pt -132.52 160.02 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.24 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.4 mt -100.12 117.81 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.711 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.7 pt? -136.87 -168.3 2.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.625 176.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 29.0 ptt180 -115.65 138.61 50.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.826 -1.172 . . . . 0.0 110.894 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.034 ' CG2' HD11 ' A' ' 69' ' ' ILE . 14.6 p -62.64 137.51 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.766 -0.584 . . . . 0.0 110.713 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -112.03 147.24 36.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 110.415 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.878 ' CB ' HD11 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -179.85 90.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.145 176.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.95 87.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.314 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -135.87 173.51 11.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.913 . . . . 0.0 110.117 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -100.0 120.2 39.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.869 . . . . 0.0 110.202 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -107.87 137.14 46.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 110.386 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.657 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -64.64 -38.76 34.19 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.883 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 24.6 Cg_exo -58.56 -169.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.621 1.327 . . . . 0.0 110.581 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA2' ' CB ' ' A' ' 70' ' ' ASP . . . 164.35 85.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.52 ' HG3' ' HB3' ' A' ' 23' ' ' ARG . 28.6 ptm -97.23 18.7 14.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -1.114 . . . . 0.0 110.361 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 p 50.01 48.32 22.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.183 -0.948 . . . . 0.0 110.407 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB3' ' HG3' ' A' ' 21' ' ' MET . 39.2 ptt180 -95.92 137.42 35.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 109.998 175.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.043 HG13 HG23 ' A' ' 67' ' ' VAL . 75.2 t -117.15 113.56 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.02 . . . . 0.0 110.086 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.758 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.2 ptt180 -92.26 120.11 32.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.704 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -135.38 165.75 24.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.071 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 23.1 p-10 -90.02 -176.48 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.115 -0.991 . . . . 0.0 110.584 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.1 -45.15 93.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.282 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 43.5 t -60.24 -49.25 78.36 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.165 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.161 ' O ' HD22 ' A' ' 33' ' ' LEU . 74.7 m -56.68 -29.44 62.37 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.128 -0.983 . . . . 0.0 109.607 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 68.1 ttt-85 -82.5 -45.35 14.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.0 110.763 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -87.61 -0.26 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.161 HD22 ' O ' ' A' ' 30' ' ' SER . 1.5 pt? -52.56 -26.36 13.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.854 ' H ' HD23 ' A' ' 33' ' ' LEU . 71.4 mt -142.27 -59.07 0.46 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.53 -0.731 . . . . 0.0 110.329 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.8 t0 -170.72 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 110.022 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.558 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -21.9 118.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.497 0.665 . . . . 0.0 111.373 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.493 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -107.78 176.75 5.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.8 mm -59.12 125.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.822 -1.174 . . . . 0.0 109.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.47 27.49 61.3 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.566 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -89.49 173.29 8.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.428 . . . . 0.0 109.72 171.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.963 HG21 HG23 ' A' ' 92' ' ' THR . 64.7 t -99.48 131.45 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.017 -1.052 . . . . 0.0 110.269 -176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.606 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -117.06 139.83 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.176 -0.953 . . . . 0.0 110.301 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -108.32 140.12 42.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.395 -0.816 . . . . 0.0 109.565 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.807 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -122.78 145.45 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.903 -1.123 . . . . 0.0 110.592 -176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -150.13 95.19 2.25 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.834 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.027 ' CG ' HG12 ' A' ' 85' ' ' VAL . 12.6 tmtt? -97.92 -65.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.766 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.567 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.91 -36.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.457 -0.777 . . . . 0.0 109.225 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 68.2 mtp85 -127.99 -160.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.664 0.745 . . . . 0.0 110.111 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.491 ' HB3' HD21 ' A' ' 130' ' ' LEU . 3.1 mtmt -106.13 131.38 53.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 110.369 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.61 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.7 p -138.51 165.0 27.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.855 . . . . 0.0 110.112 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.39 166.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.603 -0.686 . . . . 0.0 109.913 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.0 -174.28 44.17 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -122.07 164.96 16.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -1.083 . . . . 0.0 110.02 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -92.54 139.99 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 110.747 -172.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 24' ' ' VAL . 2.2 m-85 -125.81 162.5 24.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.52 -0.738 . . . . 0.0 110.125 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 8.7 ptp180 -89.91 124.6 34.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.34 -0.85 . . . . 0.0 109.905 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.57 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -64.5 136.4 57.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.809 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.579 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -57.85 -50.06 90.24 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 109.071 175.054 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 38.0 Cg_endo -92.98 98.01 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.867 1.456 . . . . 0.0 108.868 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.59 38.22 0.12 Allowed 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -143.75 -38.94 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.613 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 13.8 pt-20 -85.56 -22.39 28.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.007 . . . . 0.0 109.727 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.512 ' HA ' HG12 ' A' ' 66' ' ' ILE . 8.0 m120 -81.68 37.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 110.715 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CA ' ' OD2' ' A' ' 27' ' ' ASP . 54.4 pttt -98.43 12.25 35.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.997 -1.065 . . . . 0.0 109.547 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.82 26.53 0.05 OUTLIER Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -140.53 144.9 26.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.3 -1.117 . . . . 0.0 109.177 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.043 HG23 HG13 ' A' ' 24' ' ' VAL . 6.5 p -125.83 129.91 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.029 -1.045 . . . . 0.0 110.265 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.539 ' HD3' ' HD3' ' A' ' 25' ' ' ARG . 58.8 ttt85 -89.7 119.93 30.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.034 HD11 ' CG2' ' A' ' 11' ' ' VAL . 3.8 pt -130.6 167.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.818 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' CB ' ' HA2' ' A' ' 20' ' ' GLY . 3.7 t0 -80.06 166.51 21.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.065 176.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.4 t -60.21 -39.98 88.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -43.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.038 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.807 ' CE ' HD13 ' A' ' 44' ' ' ILE . 13.3 tpt -60.06 -46.91 87.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.1 ttp85 -60.0 -39.99 87.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -70.06 -27.11 64.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.5 m-20 -60.01 -40.01 87.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.02 . . . . 0.0 110.767 -177.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.518 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.5 p -99.53 -39.04 8.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.101 . . . . 0.0 110.723 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.567 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 116.13 40.73 0.8 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -112.61 160.73 17.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.025 -1.279 . . . . 0.0 110.659 -176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.695 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.9 168.88 9.14 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 176.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.878 HD11 ' CB ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -53.04 139.01 11.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.034 -1.041 . . . . 0.0 110.609 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.65 2.58 70.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 171.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.62 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.885 -1.362 . . . . 0.0 110.228 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 22.8 pttt -131.94 109.83 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.027 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -119.97 150.24 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.955 . . . . 0.0 109.864 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 67.6 tttt -99.94 120.07 39.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.752 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.687 HG23 HD21 ' A' ' 9' ' ' LEU . 62.6 t -103.2 122.4 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.483 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.2 mtt180 -108.65 140.05 42.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.544 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.507 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -88.21 138.2 31.65 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.069 -1.02 . . . . 0.0 110.32 -178.224 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.506 HG23 HG12 ' A' ' 41' ' ' VAL . 2.4 m -150.17 -170.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.652 -0.655 . . . . 0.0 110.085 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.441 ' CA ' ' HB ' ' A' ' 41' ' ' VAL . 61.4 mtt180 -126.46 179.99 5.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.057 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.963 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.76 162.73 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 111.209 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.546 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.1 pt-20 -150.03 169.13 21.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.23 97.87 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.33 -1.482 . . . . 0.0 110.3 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.22 138.82 49.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -0.837 . . . . 0.0 110.387 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.513 ' HD2' ' CD1' ' A' ' 156' ' ' LEU . 18.6 ptpt -97.22 -27.17 14.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 111.153 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.739 ' HB3' HD23 ' A' ' 156' ' ' LEU . 31.5 tttt -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.82 -1.175 . . . . 0.0 110.558 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.95 HG23 HG22 ' A' ' 155' ' ' THR . 5.7 p -136.13 142.53 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.434 ' HA ' ' HB2' ' A' ' 171' ' ' GLU . 97.7 m -115.81 136.37 53.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.283 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.586 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -131.42 160.07 36.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.478 -0.763 . . . . 0.0 110.155 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -146.23 101.74 4.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.922 . . . . 0.0 110.883 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 15.4 Cg_exo -64.14 129.24 23.74 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.072 1.564 . . . . 0.0 110.299 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.887 HG23 ' CB ' ' A' ' 177' ' ' ALA . 80.6 mt -93.05 106.05 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.666 -178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.765 HD12 ' HB2' ' A' ' 108' ' ' GLN . 1.5 pt -148.17 176.87 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 173.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 95.4 mtt-85 -133.95 -131.85 0.17 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.474 -0.766 . . . . 0.0 109.737 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -60.01 -13.49 11.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.927 -1.108 . . . . 0.0 109.76 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 145' ' ' GLN . 11.7 p-10 -99.92 24.43 8.49 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.77 -0.581 . . . . 0.0 110.264 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.765 ' HB2' HD12 ' A' ' 104' ' ' ILE . 13.3 pt20 -83.63 106.46 15.37 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.066 -1.021 . . . . 0.0 109.947 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -100.77 -11.7 19.69 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.621 -0.674 . . . . 0.0 110.494 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.758 ' O ' HD12 ' A' ' 110' ' ' LEU . 1.4 pp -99.2 52.96 0.96 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.912 . . . . 0.0 110.436 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 0.6 OUTLIER -103.25 93.09 4.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 110.128 176.034 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.913 ' HB2' HD13 ' A' ' 116' ' ' ILE . 76.4 m-85 -98.34 -75.68 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.981 . . . . 0.0 110.553 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.0 -177.33 54.36 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 46.73 86.67 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -1.182 . . . . 0.0 110.287 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.01 -1.07 89.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.913 HD13 ' HB2' ' A' ' 112' ' ' PHE . 9.3 tp -60.39 -31.67 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -1.197 . . . . 0.0 110.194 176.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.507 ' HG2' HG12 ' A' ' 172' ' ' ILE . 98.9 mt-10 -60.01 -44.76 94.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.747 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -70.03 -40.0 75.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.839 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -59.87 -40.11 87.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.845 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.71 ' CG1' HD12 ' A' ' 170' ' ' ILE . 49.0 t -60.05 -45.69 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.38 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.692 ' HG3' HD11 ' A' ' 170' ' ' ILE . 6.7 mt-30 -59.92 -47.7 84.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.609 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.51 -0.744 . . . . 0.0 110.41 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.953 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.35 -39.92 77.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.757 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.953 HD22 ' C ' ' A' ' 123' ' ' ALA . 3.0 mm? -130.07 24.2 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 111.123 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.9 tt -48.31 176.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.094 . . . . 0.0 110.003 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.564 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 34.5 ptt180 33.96 49.14 0.27 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.527 -0.733 . . . . 0.0 111.204 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 36.9 ttp180 -128.35 142.59 45.19 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.925 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.836 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.2 Cg_endo -62.17 131.73 35.83 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.961 1.506 . . . . 0.0 110.079 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.567 ' HG3' HD11 ' A' ' 164' ' ' ILE . 96.7 mmm -123.48 140.03 53.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 110.952 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.544 HD23 ' HA ' ' A' ' 50' ' ' THR . 19.7 tp -142.49 105.64 4.58 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.61 -0.681 . . . . 0.0 109.67 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.7 pt-20 -48.47 141.1 7.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.974 -1.079 . . . . 0.0 110.67 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.676 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 86.2 mm-40 79.93 -1.68 2.07 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.167 0.508 . . . . 0.0 110.498 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.607 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.9 p30 -69.98 -172.42 0.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.047 -1.033 . . . . 0.0 110.31 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -144.11 137.72 27.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.737 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.39 170.16 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.084 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -140.02 146.81 39.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 110.284 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.644 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 8.0 t -114.13 -68.1 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.824 . . . . 0.0 110.769 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.644 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 35.0 Cg_endo -69.62 131.87 22.35 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.222 1.117 . . . . 0.0 110.29 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -98.48 47.0 1.47 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.524 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -147.61 159.98 43.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.055 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -121.36 -168.29 1.65 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.614 -178.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.629 HD12 HE22 ' A' ' 145' ' ' GLN . 82.5 mt -143.79 -140.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.624 -0.672 . . . . 0.0 109.756 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.09 -153.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.072 175.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.51 72.9 1.68 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 171.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.629 HE22 HD12 ' A' ' 142' ' ' LEU . 2.3 pt20 -96.62 164.96 12.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.499 -1.0 . . . . 0.0 110.08 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 t -140.07 149.72 43.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.167 -0.958 . . . . 0.0 110.686 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.96 -92.78 1.55 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.608 HD13 ' CD ' ' A' ' 145' ' ' GLN . 0.2 OUTLIER 44.34 41.39 4.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.263 -1.139 . . . . 0.0 111.273 177.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.576 HD11 HD12 ' A' ' 103' ' ' ILE . 1.4 pp -140.46 161.21 38.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.797 -1.189 . . . . 0.0 109.83 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 3.2 m-85 -91.02 120.55 32.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 109.92 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.515 ' HB2' HD11 ' A' ' 103' ' ' ILE . 19.2 tptm -104.7 108.84 20.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.32 -0.862 . . . . 0.0 109.978 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.607 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.1 t -76.48 132.68 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.683 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 t -114.61 -30.1 2.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 111.108 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -144.75 150.2 36.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.782 -1.199 . . . . 0.0 111.272 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.95 HG22 HG23 ' A' ' 98' ' ' VAL . 72.3 p -140.33 161.32 37.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 109.427 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.64 -38.69 0.45 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.843 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.989 ' CB ' HG11 ' A' ' 162' ' ' VAL . 18.0 Cg_exo -58.39 -166.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.575 1.303 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.56 ' HB3' HG22 ' A' ' 160' ' ' VAL . 20.8 t -90.05 -171.09 3.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -65.33 -5.88 8.49 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.201 -0.937 . . . . 0.0 110.64 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 158' ' ' SER . 33.1 m -85.2 145.36 42.74 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.405 -0.81 . . . . 0.0 110.287 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.547 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -48.5 141.37 19.79 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.285 1.676 . . . . 0.0 110.796 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.989 HG11 ' CB ' ' A' ' 157' ' ' PRO . 11.2 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.493 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.4 tt0 -107.62 130.67 54.88 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.13 -0.982 . . . . 0.0 110.241 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.83 ' CD1' HG21 ' A' ' 168' ' ' THR . 19.0 mm -69.75 152.51 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 110.029 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.65 169.9 26.4 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.44 ' CA ' HD11 ' A' ' 125' ' ' ILE . 15.7 pt-20 -56.5 -17.97 10.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -1.117 . . . . 0.0 109.923 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.13 -25.76 18.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.83 HG21 ' CD1' ' A' ' 164' ' ' ILE . 91.3 m -56.57 142.3 39.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.791 . . . . 0.0 110.089 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 43.6 mmtm -91.96 154.86 18.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.856 -1.153 . . . . 0.0 110.186 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.83 HG22 HD11 ' A' ' 172' ' ' ILE . 1.4 mm -119.92 130.04 74.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.365 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.648 ' O ' HD13 ' A' ' 172' ' ' ILE . 21.9 mt-10 -112.68 136.09 52.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 110.23 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.83 HD11 HG22 ' A' ' 170' ' ' ILE . 7.5 mm -124.59 134.86 65.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.608 -0.682 . . . . 0.0 109.57 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -88.08 148.2 24.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.344 -174.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -93.21 -14.95 26.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 109.95 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -100.01 110.21 58.71 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.384 -0.822 . . . . 0.0 109.928 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.1 -156.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.074 1.565 . . . . 0.0 110.125 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.887 ' CB ' HG23 ' A' ' 103' ' ' ILE . . . -90.21 42.04 1.08 Allowed 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.546 -0.722 . . . . 0.0 110.48 -174.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.531 ' C ' ' HG3' ' A' ' 179' ' ' GLU . 9.7 m -85.95 23.95 1.38 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.416 -0.803 . . . . 0.0 111.38 -177.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.531 ' HG3' ' C ' ' A' ' 178' ' ' SER . 98.4 mt-10 -154.21 12.38 0.42 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.686 -1.259 . . . . 0.0 110.307 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.51 120.0 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.237 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.19 29.89 7.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.96 -42.69 94.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.194 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -60.03 140.03 57.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 0.0 110.255 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.06 143.87 19.86 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.976 -1.458 . . . . 0.0 109.496 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HG3' ' N ' ' A' ' 2' ' ' GLU . 23.1 ptm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.124 0.488 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 1' ' ' MET . 86.4 tt0 -131.05 126.31 35.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.093 -1.005 . . . . 0.0 110.135 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.96 38.4 16.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 110.195 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -112.19 110.06 20.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.154 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 27.7 m120 -151.4 166.27 31.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 110.47 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.36 -159.94 8.89 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.012 ' CG2' HD12 ' A' ' 33' ' ' LEU . 15.4 pt -138.97 163.96 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -1.188 . . . . 0.0 109.805 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.618 ' C ' HD23 ' A' ' 9' ' ' LEU . 48.1 mm -101.0 120.49 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.299 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.867 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -140.87 -176.54 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.713 177.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HG2' HG22 ' A' ' 66' ' ' ILE . 28.3 ptt180 -117.01 144.11 44.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.838 -1.164 . . . . 0.0 110.524 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.905 HG11 ' O ' ' A' ' 80' ' ' SER . 3.3 p -61.37 140.64 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.621 -0.674 . . . . 0.0 110.899 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.487 ' HB1' ' CD ' ' A' ' 68' ' ' ARG . . . -118.88 144.23 46.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 110.583 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.974 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 -179.04 131.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.265 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.24 -70.04 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 110.326 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.42 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 6.0 p30 -164.49 84.82 0.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m 59.99 31.65 20.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.964 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.474 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 74.3 p -99.64 171.55 7.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 110.159 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 17' ' ' THR . 3.3 p30 37.24 64.68 2.74 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.629 -0.67 . . . . 0.0 110.373 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 39.8 Cg_exo -55.83 -175.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.053 1.554 . . . . 0.0 110.032 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.35 94.4 1.72 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.478 ' O ' ' HG3' ' A' ' 73' ' ' MET . 3.9 ptt? -87.58 -6.49 58.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -1.125 . . . . 0.0 109.774 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.6 t -100.02 6.96 45.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.848 . . . . 0.0 110.093 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.544 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 76.5 mtt85 -120.07 133.61 55.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.932 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.139 HG12 HD23 ' A' ' 26' ' ' LEU . 84.8 t -119.73 116.17 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.979 -1.076 . . . . 0.0 110.269 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.859 ' O ' HD22 ' A' ' 26' ' ' LEU . 3.8 ptt180 -88.17 119.46 28.58 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.68 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.139 HD23 HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -137.95 177.42 7.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.751 -0.593 . . . . 0.0 109.684 -175.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 22.2 p-10 -103.07 179.73 4.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 60.8 mt-10 -59.97 -44.87 94.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.406 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 68.0 m -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.03 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.171 ' O ' HD22 ' A' ' 33' ' ' LEU . 28.6 t -65.3 -28.22 69.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 27.8 ttm180 -80.86 -46.72 14.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.556 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.98 -9.62 59.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.171 HD22 ' O ' ' A' ' 30' ' ' SER . 1.3 pt? -47.22 -24.25 0.68 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.693 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 33' ' ' LEU . 66.5 mt -141.27 -62.78 0.47 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.548 -0.72 . . . . 0.0 110.266 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.3 t0 -172.89 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.534 -0.729 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -31.38 141.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.463 0.649 . . . . 0.0 111.509 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -131.23 171.2 13.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 56' ' ' ARG . 38.4 mm -63.47 79.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.674 -1.266 . . . . 0.0 110.208 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 37' ' ' GLU . . . 169.32 -4.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.552 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.438 ' CG ' ' NZ ' ' A' ' 89' ' ' LYS . 95.9 m-20 -111.94 168.75 9.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.384 -1.657 . . . . 0.0 110.874 -170.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.488 HG21 ' OG1' ' A' ' 92' ' ' THR . 72.1 t -103.65 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.107 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.4 m -110.84 145.88 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.17 -0.956 . . . . 0.0 110.592 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 86.5 tt0 -109.38 140.78 42.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.82 . . . . 0.0 109.827 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.913 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -121.21 143.16 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.991 -1.068 . . . . 0.0 110.622 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -149.42 97.71 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.845 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.908 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.5 tmtm? -97.98 -62.52 1.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.525 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -109.3 -36.33 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.644 0.735 . . . . 0.0 109.237 175.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 78.9 mtt85 -125.7 -172.91 2.71 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.726 -0.609 . . . . 0.0 109.59 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.3 OUTLIER -100.13 133.2 44.87 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.108 178.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.591 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.4 p -140.45 167.48 22.05 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.445 0.641 . . . . 0.0 109.679 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.66 HG13 ' HG ' ' A' ' 130' ' ' LEU . 3.6 m -116.46 175.75 2.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.744 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.485 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.84 -179.17 48.54 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -121.02 167.81 12.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 0.0 110.075 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.93 135.02 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.152 -0.967 . . . . 0.0 110.73 -174.128 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.544 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 3.6 m-85 -130.6 166.61 20.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.756 . . . . 0.0 110.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.445 ' HG2' ' NH2' ' A' ' 31' ' ' ARG . 21.5 mtt180 -89.43 124.04 34.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -65.13 137.88 57.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.712 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.697 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 8.6 mmm180 -57.44 -45.89 99.84 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 109.027 174.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.697 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.0 Cg_endo -92.01 98.54 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.748 1.393 . . . . 0.0 108.853 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -75.26 35.84 0.12 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -146.59 -37.28 0.23 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 110.873 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.481 ' HG3' HD11 ' A' ' 66' ' ' ILE . 16.3 pt-20 -84.8 -20.58 30.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.505 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 2.9 m-80 -81.63 36.58 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 110.719 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 58.4 pttt -98.31 17.5 18.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.952 -1.093 . . . . 0.0 109.388 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 176.84 21.38 0.03 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.505 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.11 152.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.196 -1.179 . . . . 0.0 109.191 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.948 HG23 HG13 ' A' ' 24' ' ' VAL . 7.9 p -130.02 129.98 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.98 -1.075 . . . . 0.0 110.131 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.564 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 22.5 mmm180 -91.33 111.74 23.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.641 HD11 ' NH1' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -136.06 171.78 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.383 -0.823 . . . . 0.0 110.553 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -81.24 166.9 20.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 0.0 110.263 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 79.5 p -69.94 -19.28 63.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.339 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.55 -47.29 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.112 -0.993 . . . . 0.0 110.483 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.913 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -61.33 -47.48 85.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 109.289 177.014 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.69 ' HG3' HG21 ' A' ' 11' ' ' VAL . 5.9 mmp_? -60.04 -39.94 87.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 110.245 173.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' SER . 47.8 t-20 -64.09 -31.82 73.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.959 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.584 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 96.7 m-20 -60.01 -36.29 76.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.394 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.2 p -98.38 -38.79 9.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.059 -1.025 . . . . 0.0 110.581 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.525 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 119.79 40.05 0.63 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.888 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -120.85 166.17 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.062 -1.258 . . . . 0.0 110.611 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.905 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -118.7 176.17 5.39 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.974 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -55.84 142.58 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.074 -1.017 . . . . 0.0 110.418 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.76 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 75.96 0.76 65.8 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 172.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.3 m-20 -59.82 -167.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.849 -1.383 . . . . 0.0 110.124 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 10.5 pttp -132.53 115.28 15.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.701 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.908 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -125.43 153.47 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 109.574 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 60.7 tttt -99.94 121.48 41.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.095 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 9' ' ' LEU . 65.6 t -98.99 119.99 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.956 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 87.2 mtm180 -116.2 142.53 46.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 109.807 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.438 ' NZ ' ' CG ' ' A' ' 40' ' ' ASP . 50.6 tttp -75.99 146.59 39.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.002 -1.061 . . . . 0.0 110.543 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.439 HG23 HG12 ' A' ' 41' ' ' VAL . 1.9 m -149.98 -168.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.967 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -138.76 170.0 16.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.488 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.72 156.71 21.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 111.3 -175.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.859 ' OE2' HG12 ' A' ' 162' ' ' VAL . 1.2 pm0 -150.31 169.71 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 94' ' ' ILE . 4.5 mp -89.13 98.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.595 -1.316 . . . . 0.0 110.402 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.89 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.51 163.45 1.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.422 -0.798 . . . . 0.0 110.819 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 1.033 ' HG3' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -136.16 -17.86 1.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.456 -0.778 . . . . 0.0 110.913 -178.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 1.005 ' CB ' HD12 ' A' ' 156' ' ' LEU . 32.9 tttt -149.59 119.92 7.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.887 -1.133 . . . . 0.0 110.336 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.044 HG23 HG22 ' A' ' 155' ' ' THR . 5.5 p -137.2 140.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 110.718 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.4 m -109.29 135.08 50.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.624 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -130.11 160.97 32.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 110.418 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.15 87.42 39.23 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.58 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.78 134.95 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.979 1.515 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 177' ' ' ALA . 29.4 mm -102.15 103.77 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 110.754 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.578 HG13 ' N ' ' A' ' 105' ' ' ARG . 18.7 pt -142.89 -151.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 122.142 0.973 . . . . 0.0 109.956 171.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.622 ' H ' ' HB2' ' A' ' 108' ' ' GLN . 81.6 mtp180 -136.97 159.96 40.32 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.324 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -61.74 -15.53 41.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.412 -0.805 . . . . 0.0 110.174 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 34.2 p-10 -130.09 31.33 4.68 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.684 -0.635 . . . . 0.0 110.017 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.622 ' HB2' ' H ' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -86.43 -69.99 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.101 -1.0 . . . . 0.0 110.38 -176.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.518 ' HB2' HD22 ' A' ' 142' ' ' LEU . 45.5 tpt85 -139.69 -87.92 0.2 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.11 -0.994 . . . . 0.0 110.341 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.944 HD22 ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -141.05 175.43 9.63 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 120.956 -1.09 . . . . 0.0 110.6 -175.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.944 ' N ' HD22 ' A' ' 110' ' ' LEU . 46.1 pttt -130.75 156.01 45.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 109.492 176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.787 ' HB2' HD12 ' A' ' 116' ' ' ILE . 12.3 m-85 -97.85 -52.11 3.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.014 -1.053 . . . . 0.0 110.315 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 116' ' ' ILE . . . 73.82 -152.95 46.57 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -46.05 145.42 1.56 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.713 -0.875 . . . . 0.0 109.83 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.6 -16.66 34.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.787 HD12 ' HB2' ' A' ' 112' ' ' PHE . 11.9 tt -62.39 -37.3 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.082 -1.246 . . . . 0.0 110.017 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 170' ' ' ILE . 98.9 mt-10 -59.99 -44.76 94.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.046 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -67.92 -39.97 83.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.833 . . . . 0.0 110.025 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -40.0 88.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.905 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.633 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -62.15 -44.9 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.369 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.648 ' HG3' HD11 ' A' ' 170' ' ' ILE . 6.3 mt-30 -59.94 -45.44 92.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.086 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.38 -41.43 93.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.487 -0.758 . . . . 0.0 109.862 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.599 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.57 -48.05 61.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 110.68 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 123' ' ' ALA . 4.4 mm? -105.14 12.97 31.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.1 -1.0 . . . . 0.0 111.513 -173.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.5 tt -49.34 169.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.615 -1.303 . . . . 0.0 110.391 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 29.0 ptt180 32.98 46.07 0.08 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.599 -0.688 . . . . 0.0 111.646 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.9 mmt85 -134.76 152.44 77.54 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 120.714 -1.241 . . . . 0.0 111.358 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.83 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.1 Cg_endo -62.04 123.25 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.225 1.645 . . . . 0.0 109.684 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.791 ' O ' HG22 ' A' ' 162' ' ' VAL . 15.4 mmt -137.37 137.9 39.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.554 -1.341 . . . . 0.0 110.433 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.779 ' H ' HD13 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.81 145.2 24.78 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.478 0.656 . . . . 0.0 110.441 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 22.0 pt-20 -55.11 152.93 7.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -0.81 . . . . 0.0 111.112 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 81.95 -12.66 0.93 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.463 0.649 . . . . 0.0 110.298 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.694 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -69.37 -174.27 0.65 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 110.388 177.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -147.19 160.04 42.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.89 169.92 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.203 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 t -112.52 165.15 12.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.514 -0.741 . . . . 0.0 110.605 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 139' ' ' GLY . 21.2 t -100.54 145.82 30.97 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.449 -0.782 . . . . 0.0 110.044 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.544 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 10.1 Cg_endo -57.84 67.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.028 1.541 . . . . 0.0 110.922 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 41.32 53.46 4.11 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 175.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.618 HD12 ' C ' ' A' ' 140' ' ' LEU . 0.5 OUTLIER -131.4 132.61 44.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.971 -1.311 . . . . 0.0 110.266 177.176 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -158.7 -167.09 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 110.391 -178.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.753 HD21 ' NE2' ' A' ' 145' ' ' GLN . 0.5 OUTLIER -145.72 -127.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.591 -0.693 . . . . 0.0 109.853 178.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.91 -158.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.856 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.04 81.98 1.38 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.753 ' NE2' HD21 ' A' ' 142' ' ' LEU . 5.2 pt20 -92.48 170.04 10.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.355 -1.085 . . . . 0.0 110.183 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -136.07 150.83 49.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 110.439 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.59 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 83.68 -91.38 1.62 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.2 OUTLIER 40.03 47.14 1.92 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.585 -0.95 . . . . 0.0 110.883 175.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.412 ' H ' ' HB ' ' A' ' 103' ' ' ILE . 3.1 pp -140.24 168.47 19.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.111 -0.993 . . . . 0.0 109.834 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -99.89 129.46 45.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -115.29 113.55 24.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 110.007 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.694 HG21 ' OD2' ' A' ' 133' ' ' ASP . 13.2 t -77.98 135.65 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.164 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.734 HG12 ' HG3' ' A' ' 154' ' ' LYS . 9.9 t -111.99 -28.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.734 ' HG3' HG12 ' A' ' 153' ' ' VAL . 76.2 mttt -150.63 163.88 37.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.916 -1.115 . . . . 0.0 111.281 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.044 HG22 HG23 ' A' ' 98' ' ' VAL . 73.8 p -149.04 169.8 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.774 -0.579 . . . . 0.0 109.491 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.033 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.4 tt -88.49 -41.2 0.47 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.987 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 1.017 ' CB ' HG11 ' A' ' 162' ' ' VAL . 22.1 Cg_exo -56.44 -177.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.569 1.3 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.473 ' HB3' HG22 ' A' ' 160' ' ' VAL . 15.8 t -74.5 -172.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.565 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -69.98 -2.25 12.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.162 -0.961 . . . . 0.0 110.376 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.535 HG23 ' OE2' ' A' ' 93' ' ' GLU . 21.4 m -87.54 150.46 48.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 110.41 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.652 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.47 140.55 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.292 1.68 . . . . 0.0 110.985 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 1.017 HG11 ' CB ' ' A' ' 157' ' ' PRO . 5.5 m -130.02 160.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.603 171.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 21.9 pt-20 -102.52 124.63 48.43 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.948 -1.095 . . . . 0.0 110.082 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.841 ' CD1' HG21 ' A' ' 168' ' ' THR . 8.0 mm -71.15 154.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.666 -0.646 . . . . 0.0 110.272 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 163.66 26.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -53.23 -20.04 3.7 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.511 -0.993 . . . . 0.0 110.311 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.5 -23.12 22.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.715 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.841 HG21 ' CD1' ' A' ' 164' ' ' ILE . 90.2 m -54.94 145.91 19.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.963 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 85.9 mttt -95.6 149.43 21.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 110.366 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.648 HD11 ' HG3' ' A' ' 121' ' ' GLN . 1.3 mm -117.07 129.97 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 110.501 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.445 ' OE2' ' HE2' ' A' ' 97' ' ' LYS . 57.6 mt-10 -115.45 136.26 53.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 110.166 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.671 HD12 HG23 ' A' ' 116' ' ' ILE . 5.9 mt -135.27 133.61 52.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.104 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.535 ' NE ' ' HB3' ' A' ' 175' ' ' GLU . 13.0 ptm180 -89.2 -176.72 5.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 110.315 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 81.6 mm-40 -118.15 10.13 12.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.296 -0.878 . . . . 0.0 110.471 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.535 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . 5.4 tp10 -95.6 109.22 44.61 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.904 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.3 Cg_exo -71.15 -155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.181 1.622 . . . . 0.0 110.498 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.487 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -75.07 52.65 0.57 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.701 -0.624 . . . . 0.0 110.174 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 180' ' ' VAL . 23.7 t -86.36 122.46 30.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 0.0 109.963 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 178' ' ' SER . 82.0 tt0 60.01 19.97 9.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.52 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 178' ' ' SER . 63.0 t -104.7 128.33 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.31 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 181' ' ' LEU . 0.7 OUTLIER -50.0 85.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.532 -0.73 . . . . 0.0 110.505 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 180' ' ' VAL . 99.1 mt-10 -60.09 -40.83 90.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.04 140.02 57.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 110.358 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -178.77 -172.81 43.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.871 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptm . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.105 0.478 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -132.81 155.13 49.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 110.367 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.12 57.82 2.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -89.65 167.18 13.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.309 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -94.6 177.6 5.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 110.461 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' A' ' 34' ' ' LEU . . . -146.48 -165.1 11.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.01 HG21 HD11 ' A' ' 33' ' ' LEU . 23.0 pt -130.44 160.38 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -1.2 . . . . 0.0 110.17 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.5 mt -102.14 114.03 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.288 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.5 pt? -137.23 -174.32 3.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 109.786 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 30.7 ptt180 -111.55 139.59 46.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.727 -1.233 . . . . 0.0 111.025 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.786 ' CG2' HD11 ' A' ' 69' ' ' ILE . 13.5 p -62.7 135.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -116.53 145.74 43.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.773 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 tt0 -178.85 89.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.359 173.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.35 13.64 0.43 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.051 -1.031 . . . . 0.0 111.089 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -80.06 -69.94 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.941 -1.099 . . . . 0.0 110.405 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.433 ' C ' ' OG1' ' A' ' 17' ' ' THR . 47.5 t -170.42 140.7 1.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.184 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.438 ' C ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 p 42.84 -161.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 109.931 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.486 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 3.2 p30 -134.96 66.24 67.64 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.138 -0.976 . . . . 0.0 110.631 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 9.2 Cg_exo -73.23 111.72 3.35 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.007 1.53 . . . . 0.0 110.632 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.413 ' C ' ' OD2' ' A' ' 70' ' ' ASP . . . 93.43 86.81 1.6 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.182 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.461 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 14.1 ptp -89.6 -12.68 39.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -1.176 . . . . 0.0 109.944 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.0 p -118.22 9.47 12.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 109.952 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 99.0 mtt180 -108.34 137.35 46.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.067 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.039 HG13 HG23 ' A' ' 67' ' ' VAL . 87.4 t -116.77 120.08 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.402 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.64 ' O ' HD12 ' A' ' 26' ' ' LEU . 3.7 ptt180 -86.39 118.49 25.86 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.512 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.025 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mp -131.4 173.08 11.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.847 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 11.6 p-10 -103.23 179.42 4.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.871 -1.143 . . . . 0.0 110.702 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 88.5 mt-10 -59.99 -41.05 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -0.871 . . . . 0.0 109.059 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.645 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -64.4 -59.67 4.08 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.123 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.81 ' O ' HD22 ' A' ' 33' ' ' LEU . 65.4 m -49.99 -31.22 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.835 -1.166 . . . . 0.0 109.08 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 40.0 ttm180 -72.29 -51.76 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.584 -0.698 . . . . 0.0 111.619 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -98.92 -3.49 35.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.742 -1.224 . . . . 0.0 111.178 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -64.96 -24.06 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.074 . . . . 0.0 109.828 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.987 ' N ' HD23 ' A' ' 33' ' ' LEU . 59.6 mt -120.62 -67.88 0.95 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.034 . . . . 0.0 110.469 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 36' ' ' ALA . 43.4 t0 -171.2 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.566 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.548 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.45 118.63 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.354 0.597 . . . . 0.0 110.72 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.8 pt-20 -106.59 -178.98 3.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 38' ' ' ILE . 24.2 mm -62.3 126.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.882 -1.136 . . . . 0.0 109.803 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.35 22.94 66.55 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 173.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.441 ' CG ' ' HG2' ' A' ' 37' ' ' GLU . 77.7 m-20 -89.5 169.98 10.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.814 -1.404 . . . . 0.0 109.603 171.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.523 HG21 ' OG1' ' A' ' 92' ' ' THR . 71.8 t -99.23 136.18 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.989 -1.07 . . . . 0.0 110.087 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.504 HG11 HG23 ' A' ' 54' ' ' VAL . 1.7 m -120.71 140.05 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.094 -1.004 . . . . 0.0 110.487 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 44' ' ' ILE . 85.4 tt0 -106.82 141.25 38.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.691 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.831 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -124.21 143.03 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.995 -1.066 . . . . 0.0 110.582 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -149.89 97.24 2.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.895 ' HG3' HG12 ' A' ' 85' ' ' VAL . 5.5 tmtm? -97.88 -55.8 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.406 -0.809 . . . . 0.0 109.626 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.547 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.29 -34.6 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.795 0.807 . . . . 0.0 108.885 176.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.622 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -131.79 179.46 6.06 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.562 ' HB3' HD21 ' A' ' 130' ' ' LEU . 12.0 mtmt -89.44 132.67 34.9 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.668 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.9 p -138.07 166.7 23.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.576 -0.702 . . . . 0.0 109.809 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.89 167.66 14.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.915 179.392 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.05 -175.08 44.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 68.9 ttt180 -122.45 166.16 15.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.428 -1.042 . . . . 0.0 110.334 -176.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -98.34 144.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.885 . . . . 0.0 110.513 -175.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 2.5 m-85 -138.06 168.19 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.371 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -88.73 121.76 31.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.74 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.705 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -62.66 140.05 58.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.711 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.63 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.84 -50.0 90.61 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.841 175.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 33.6 Cg_endo -93.06 98.41 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.841 1.443 . . . . 0.0 108.886 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.26 36.13 0.1 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.426 -0.796 . . . . 0.0 110.825 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -145.59 -34.32 0.33 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.096 -1.002 . . . . 0.0 111.058 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.559 ' OE2' ' CG ' ' A' ' 59' ' ' PRO . 14.9 pt-20 -87.19 -19.12 28.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 109.601 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.705 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 21.7 m-80 -81.21 39.64 0.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 110.622 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 pttt -97.79 13.43 30.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 63' ' ' ASN . 45.6 pt -140.92 144.67 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.213 -1.169 . . . . 0.0 109.583 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.039 HG23 HG13 ' A' ' 24' ' ' VAL . 3.1 p -121.88 129.83 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.046 -1.034 . . . . 0.0 109.859 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.408 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -93.0 114.02 26.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 -178.57 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.786 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.9 pp -134.66 167.82 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' OD2' ' N ' ' A' ' 21' ' ' MET . 96.7 m-20 -79.53 168.01 20.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 110.132 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 m -59.98 -39.73 86.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.279 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.1 t -61.25 -41.58 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.151 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.765 ' HE1' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -61.55 -48.22 81.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.256 -0.902 . . . . 0.0 109.699 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 80' ' ' SER . 37.7 ttp180 -60.13 -40.13 88.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.027 -1.045 . . . . 0.0 109.457 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.547 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 92.6 m-20 -64.06 -33.06 74.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 73' ' ' MET . 64.4 m-20 -57.38 -34.93 69.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.65 ' HB3' HG21 ' A' ' 50' ' ' THR . 30.5 p -99.38 -40.02 8.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.991 -1.068 . . . . 0.0 110.667 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.547 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.17 41.03 1.0 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.759 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -114.4 172.4 7.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.106 -1.232 . . . . 0.0 110.508 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.719 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.58 170.28 8.54 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 109.417 177.647 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.773 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -55.57 139.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.605 178.167 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.436 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.08 3.83 82.18 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -59.86 -161.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.032 -1.275 . . . . 0.0 110.575 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 23.2 pttt -134.3 110.91 9.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.487 -0.758 . . . . 0.0 110.096 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.895 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.2 m -120.01 153.99 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 109.886 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 54.2 tttt -101.07 118.62 37.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.634 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.512 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 74.8 t -102.11 120.91 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.932 . . . . 0.0 109.897 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HG2' ' N ' ' A' ' 6' ' ' GLY . 76.4 mtm180 -110.39 140.88 44.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 6.1 tttt -82.48 140.25 33.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 110.662 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.446 HG21 ' CD ' ' A' ' 161' ' ' PRO . 2.4 m -148.86 -165.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.492 0.663 . . . . 0.0 109.731 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.484 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.0 mtt85 -135.66 173.39 11.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.469 -0.77 . . . . 0.0 110.42 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.523 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -103.1 161.46 13.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 111.147 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.624 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.8 pt-20 -149.93 170.03 19.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.646 ' N ' HD12 ' A' ' 94' ' ' ILE . 5.1 mp -89.46 97.14 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.569 -1.332 . . . . 0.0 110.351 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.776 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.11 140.06 39.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -0.778 . . . . 0.0 110.219 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HD2' HD22 ' A' ' 156' ' ' LEU . 3.4 ptpt -106.09 -25.75 11.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 111.558 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.649 ' HB3' HD12 ' A' ' 156' ' ' LEU . 72.2 tttt -150.3 131.92 14.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.441 -1.412 . . . . 0.0 110.709 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.013 HG23 HG22 ' A' ' 155' ' ' THR . 8.0 p -144.33 148.0 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.894 . . . . 0.0 110.652 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.624 HG23 ' HB3' ' A' ' 171' ' ' GLU . 59.5 m -120.68 136.8 54.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.43 -0.793 . . . . 0.0 110.195 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.652 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.56 161.66 29.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.09 89.58 12.47 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.456 -0.778 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo -58.28 135.58 69.06 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.988 1.52 . . . . 0.0 110.627 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.016 HG23 ' HB2' ' A' ' 177' ' ' ALA . 82.2 mt -89.89 94.32 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.334 -0.854 . . . . 0.0 110.09 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.672 HD11 HD22 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -150.99 -170.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.825 . . . . 0.0 110.841 179.227 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.63 ' O ' HD21 ' A' ' 110' ' ' LEU . 71.1 mtp180 -89.83 169.08 11.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.287 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.97 -24.49 64.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 111.117 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -116.83 29.97 7.61 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.87 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.54 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 11.4 mm-40 -91.36 -79.97 0.36 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.91 -1.119 . . . . 0.0 111.064 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HG3' ' HB3' ' A' ' 108' ' ' GLN . 44.4 mtt180 -115.06 -12.81 11.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.87 -1.144 . . . . 0.0 110.041 -176.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.672 HD22 HD11 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -97.72 55.69 1.23 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.957 -177.149 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.22 64.73 1.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.55 -0.719 . . . . 0.0 110.014 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -137.07 -64.06 0.58 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 110.165 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.717 ' H ' HD12 ' A' ' 116' ' ' ILE . . . 76.29 -175.64 52.56 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.11 82.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.138 -1.213 . . . . 0.0 110.434 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.27 4.67 83.59 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.717 HD12 ' H ' ' A' ' 113' ' ' GLY . 20.9 tt -60.1 -39.92 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -1.181 . . . . 0.0 110.256 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 116' ' ' ILE . 41.7 mt-10 -68.96 -41.3 78.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.963 -1.086 . . . . 0.0 110.313 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.97 -32.81 71.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.417 ' O ' ' HB3' ' A' ' 122' ' ' ARG . 18.7 t80 -59.86 -39.51 85.45 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.521 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.634 HG12 HD12 ' A' ' 124' ' ' LEU . 78.8 t -60.0 -46.63 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.206 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.687 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -60.0 -39.74 86.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 174.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 27.4 tpt180 -60.0 -43.87 94.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.333 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 -40.55 46.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.634 HD12 HG12 ' A' ' 120' ' ' VAL . 79.1 mt -92.91 -7.58 45.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.071 -1.018 . . . . 0.0 110.58 -173.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.717 ' HA ' HG22 ' A' ' 164' ' ' ILE . 1.9 tt -42.71 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 164' ' ' ILE . 33.4 ptt180 30.4 52.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.659 -0.65 . . . . 0.0 111.262 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 30.9 ttm180 -132.71 142.96 46.7 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.047 -1.033 . . . . 0.0 110.895 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.8 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -65.59 123.94 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 124.007 1.53 . . . . 0.0 109.498 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.542 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 89.2 mmm -120.21 140.62 50.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.377 -1.452 . . . . 0.0 111.126 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 50' ' ' THR . 17.0 tp -141.15 107.29 5.21 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.713 -0.617 . . . . 0.0 109.649 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.601 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -45.0 140.78 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 110.905 -175.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.601 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 82.11 -2.95 1.49 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.409 0.624 . . . . 0.0 110.271 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 3.8 p-10 -68.63 -172.99 0.4 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.512 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.621 ' HB3' HD13 ' A' ' 149' ' ' LEU . 21.4 m-80 -144.83 144.21 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.492 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.3 160.69 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.828 -1.17 . . . . 0.0 110.837 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 t -141.0 143.32 34.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.665 -0.647 . . . . 0.0 109.97 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.657 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 8.4 t -110.1 -65.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.989 -1.069 . . . . 0.0 111.063 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 43.4 Cg_endo -73.11 154.37 52.25 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.201 1.106 . . . . 0.0 110.492 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -113.18 54.88 0.53 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.045 HD22 ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -139.93 162.94 33.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -1.079 . . . . 0.0 110.072 -178.246 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 1.045 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -125.28 -170.65 2.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.011 -1.056 . . . . 0.0 110.856 -176.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.628 HD12 ' OE1' ' A' ' 145' ' ' GLN . 83.1 mt -141.74 -150.23 0.31 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.307 0.575 . . . . 0.0 110.222 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.08 66.17 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 110.562 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.85 66.97 2.45 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -176.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.628 ' OE1' HD12 ' A' ' 142' ' ' LEU . 28.8 pt20 -93.25 168.51 11.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.873 -1.369 . . . . 0.0 110.245 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -133.44 153.73 51.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.218 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.552 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 74.71 -83.77 0.79 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.47 40.15 1.24 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.461 -1.023 . . . . 0.0 111.085 176.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.686 ' HG ' HD12 ' A' ' 103' ' ' ILE . 3.4 pp -140.53 170.44 15.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.08 -1.012 . . . . 0.0 109.754 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 40.0 m-85 -89.31 121.59 31.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 109.749 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -103.29 103.86 13.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.537 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 2.7 t -75.34 139.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.8 t -130.62 -24.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.022 -1.049 . . . . 0.0 111.443 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 5.8 tttp -139.36 125.31 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 110.926 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.013 HG22 HG23 ' A' ' 98' ' ' VAL . 69.2 p -128.09 163.95 23.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.456 -0.777 . . . . 0.0 109.433 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.68 HD22 ' HD2' ' A' ' 96' ' ' LYS . 1.1 tt -89.57 -38.2 0.42 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 110.97 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.96 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.4 Cg_exo -60.57 -176.06 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.485 1.255 . . . . 0.0 110.237 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.43 -162.7 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -69.59 -4.51 19.52 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.303 -0.873 . . . . 0.0 110.564 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.9 m -86.37 140.5 34.18 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.059 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.574 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.7 Cg_endo -47.61 141.65 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.14 1.6 . . . . 0.0 110.48 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.96 HG11 ' CB ' ' A' ' 157' ' ' PRO . 5.6 m -128.3 158.18 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.785 173.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -105.9 124.15 49.12 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.885 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.821 HD12 HG21 ' A' ' 168' ' ' THR . 13.8 mm -70.14 152.37 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.743 -0.598 . . . . 0.0 109.53 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.602 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.06 166.89 26.2 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.538 ' HB3' HD11 ' A' ' 125' ' ' ILE . 18.6 pt-20 -58.0 -14.11 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.957 . . . . 0.0 110.287 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -90.13 -18.07 26.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.821 HG21 HD12 ' A' ' 164' ' ' ILE . 28.0 m -62.24 153.87 29.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 110.049 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 96' ' ' LYS . 44.8 mttt -103.6 155.6 18.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 0.0 110.014 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.687 HD11 ' HG2' ' A' ' 121' ' ' GLN . 6.5 mm -119.14 137.86 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 110.975 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.624 ' HB3' HG23 ' A' ' 99' ' ' THR . 12.8 mt-10 -119.94 127.14 52.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 110.514 172.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.496 ' CD1' HD11 ' A' ' 100' ' ' LEU . 39.5 mm -123.34 123.83 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.175 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.622 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 4.3 ptp180 -93.19 156.83 16.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 110.559 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 81.3 mm-40 -95.61 6.9 47.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.351 -0.843 . . . . 0.0 110.03 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.76 109.99 57.49 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.317 -0.864 . . . . 0.0 110.031 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.439 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 16.4 Cg_exo -68.48 -152.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.006 1.529 . . . . 0.0 109.975 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.016 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -73.97 47.45 0.27 Allowed 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.415 -0.803 . . . . 0.0 110.597 -177.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 2.0 m -75.83 -70.48 0.43 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.214 -0.929 . . . . 0.0 111.184 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.88 -21.65 64.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.841 -1.162 . . . . 0.0 110.233 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 87.8 t -63.85 132.08 29.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.707 -0.621 . . . . 0.0 110.091 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -112.36 56.66 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 110.414 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -61.27 130.79 47.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 109.905 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.21 140.18 57.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.157 -0.964 . . . . 0.0 110.48 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 70.19 18.18 74.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 118.0 -1.444 . . . . 0.0 109.5 179.744 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.278 0.561 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -99.98 125.63 46.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.102 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.1 m -66.63 -80.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.933 . . . . 0.0 110.242 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -151.11 140.31 21.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.332 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.424 ' OD1' HD21 ' A' ' 34' ' ' LEU . 15.1 t-20 -157.73 157.38 33.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.049 177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -153.54 -167.81 16.4 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.884 ' CG2' HD12 ' A' ' 33' ' ' LEU . 22.8 pt -135.03 160.01 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -1.078 . . . . 0.0 109.651 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.5 mt -100.62 115.85 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.2 pt? -135.54 -170.86 2.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 109.562 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.58 ' NE ' HG22 ' A' ' 66' ' ' ILE . 49.8 ptt85 -114.79 139.99 49.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.739 -1.225 . . . . 0.0 110.855 -174.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.689 HG13 ' HA ' ' A' ' 81' ' ' ILE . 7.9 p -62.16 140.55 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.63 -0.669 . . . . 0.0 110.552 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -118.68 143.66 46.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 110.624 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.982 ' HB3' HD11 ' A' ' 81' ' ' ILE . 49.0 tp10 -179.79 98.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.795 . . . . 0.0 110.091 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.17 -27.08 10.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 110.309 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -110.72 128.65 55.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.93 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -108.36 35.95 2.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.197 -0.939 . . . . 0.0 110.298 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.47 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 8.8 p -111.65 170.44 8.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.279 -0.888 . . . . 0.0 110.44 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 5.0 p-10 38.05 63.41 3.69 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.589 -0.694 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 38.8 Cg_exo -56.51 -174.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.104 1.581 . . . . 0.0 110.635 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.3 20.59 37.91 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.449 ' CG ' ' HB2' ' A' ' 70' ' ' ASP . 25.5 ptp -88.26 47.99 1.58 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.119 -1.224 . . . . 0.0 109.475 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.1 p -63.82 -3.03 2.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.493 -0.755 . . . . 0.0 110.82 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 62.6 mmt-85 -88.27 145.72 25.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 109.555 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.985 HG13 HG23 ' A' ' 67' ' ' VAL . 90.4 t -101.73 115.44 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.007 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.459 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 6.2 ptt180 -93.53 120.01 33.29 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.985 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.891 HD22 ' CB ' ' A' ' 30' ' ' SER . 2.1 mt -138.68 173.18 11.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.568 -0.708 . . . . 0.0 110.105 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.2 p-10 -95.06 -177.18 4.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -175.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.99 -49.27 78.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.506 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 23.2 t -60.36 -41.31 93.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.159 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.117 ' O ' HD22 ' A' ' 33' ' ' LEU . 48.5 m -60.38 -31.11 70.04 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 175.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 66.8 ttt180 -83.43 -46.04 12.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 111.191 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -81.93 -6.04 58.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.903 -1.123 . . . . 0.0 110.235 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.117 HD22 ' O ' ' A' ' 30' ' ' SER . 1.7 pt? -44.33 -27.69 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.44 -0.787 . . . . 0.0 109.727 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.842 ' H ' HD23 ' A' ' 33' ' ' LEU . 78.8 mt -143.67 -63.77 0.39 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 176.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -173.38 13.4 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.281 -0.887 . . . . 0.0 110.739 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.536 ' CB ' ' HE2' ' A' ' 89' ' ' LYS . . . -47.59 119.75 2.92 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.986 -1.071 . . . . 0.0 110.01 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.537 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.18 174.44 5.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.248 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.759 HD11 ' HD3' ' A' ' 56' ' ' ARG . 11.3 mm -62.47 122.22 12.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.885 -1.134 . . . . 0.0 109.672 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.516 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 77.46 32.06 48.53 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -88.75 170.78 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.926 -1.338 . . . . 0.0 109.308 170.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 92' ' ' THR . 69.9 t -99.14 129.61 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.02 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.744 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.7 m -115.33 136.37 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.057 -1.027 . . . . 0.0 110.471 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' C ' HD12 ' A' ' 44' ' ' ILE . 86.3 tt0 -109.52 143.93 38.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 109.781 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.85 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.5 mp -120.81 145.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.001 -1.062 . . . . 0.0 110.266 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.2 tt0 -152.4 87.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.906 -1.121 . . . . 0.0 111.321 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HB2' HG12 ' A' ' 85' ' ' VAL . 33.8 tttp -98.99 -80.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 172.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.585 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -84.55 -36.18 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.778 . . . . 0.0 109.55 175.144 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.578 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 92.0 mtt-85 -139.54 -176.01 4.4 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.56 -0.713 . . . . 0.0 109.532 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.89 ' HG2' HD21 ' A' ' 130' ' ' LEU . 1.2 ttpm? -89.96 139.06 30.97 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -141.64 165.47 27.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.255 -174.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -128.44 163.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.365 -0.835 . . . . 0.0 110.283 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -175.9 179.99 46.71 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 173.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 57.2 ttt85 -118.87 171.16 8.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -1.122 . . . . 0.0 110.07 -177.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.552 ' CG2' ' HE3' ' A' ' 89' ' ' LYS . 0.3 OUTLIER -101.3 132.44 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.829 -1.169 . . . . 0.0 111.416 -171.323 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.587 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -130.27 162.85 28.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.752 . . . . 0.0 110.392 171.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.759 ' HD3' HD11 ' A' ' 38' ' ' ILE . 87.8 mtm180 -91.43 128.6 37.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.548 -0.72 . . . . 0.0 110.305 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -65.06 140.77 58.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 110.047 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.574 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.12 -50.26 88.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.09 175.054 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 52.7 Cg_endo -92.21 97.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.892 1.469 . . . . 0.0 108.988 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.94 41.21 0.16 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.6 -0.687 . . . . 0.0 110.377 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 27.3 m-20 -143.45 -38.58 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.294 -0.879 . . . . 0.0 110.807 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.11 -22.84 28.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.942 -1.099 . . . . 0.0 109.839 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.491 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 10.6 m-80 -81.71 38.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 110.758 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 61' ' ' ASP . 11.6 ptpt -98.46 13.05 33.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.72 25.48 0.05 OUTLIER Glycine 0 N--CA 1.481 1.647 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.58 HG22 ' NE ' ' A' ' 10' ' ' ARG . 45.8 pt -140.81 140.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.985 HG23 HG13 ' A' ' 24' ' ' VAL . 3.3 p -119.95 127.6 75.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.456 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 25.2 ttt85 -89.59 113.69 25.16 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.757 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.736 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.7 pp -129.11 170.54 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.422 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' HB2' ' CG ' ' A' ' 21' ' ' MET . 8.0 t0 -79.19 164.47 24.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.991 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.4 m -59.91 -39.95 87.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 110.488 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.97 -44.43 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.786 ' HE1' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.8 -45.94 92.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.64 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -60.06 -40.04 88.1 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.58 -21.79 61.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.384 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.591 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 79.9 m-20 -59.89 -39.77 86.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 110.711 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 27.8 p -98.49 -31.04 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.039 -1.038 . . . . 0.0 110.392 -176.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.585 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.09 29.08 3.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.597 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.29 156.14 17.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.205 -1.174 . . . . 0.0 110.505 -175.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.665 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -111.78 166.01 11.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 175.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.982 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -54.32 139.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.418 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.18 68.72 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 1.1 m-20 -60.15 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.84 -1.388 . . . . 0.0 110.451 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 11.6 pttt -134.5 112.35 10.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 110.122 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.716 HG12 ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -118.76 148.98 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -0.893 . . . . 0.0 109.791 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 71.2 tttt -95.3 116.09 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.658 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.695 ' CG2' HD21 ' A' ' 9' ' ' LEU . 95.4 t -102.23 122.62 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.5 mtm180 -110.11 142.5 41.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.744 ' CD ' HG12 ' A' ' 42' ' ' VAL . 1.4 tptm -95.94 129.57 43.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 110.239 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.55 -163.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.668 0.746 . . . . 0.0 110.095 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 35.5 mtp180 -127.04 179.59 5.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 110.349 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.614 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.18 169.13 8.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 111.258 -176.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.633 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.7 pt-20 -149.49 169.54 20.68 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.608 HG21 ' OE2' ' A' ' 167' ' ' GLU . 48.7 mm -89.61 99.81 9.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.486 -1.384 . . . . 0.0 110.337 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.806 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.28 139.29 43.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.279 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.489 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 17.7 ptpt -101.8 -28.37 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 111.055 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.516 ' HB3' HD23 ' A' ' 156' ' ' LEU . 87.2 tttt -150.25 120.21 7.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.752 -1.217 . . . . 0.0 110.741 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.025 HG23 HG22 ' A' ' 155' ' ' THR . 8.7 p -131.75 140.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 110.764 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 98.6 m -113.09 143.8 43.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.393 -0.817 . . . . 0.0 110.098 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.646 HD21 HG23 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -143.14 170.15 16.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -177.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.637 ' HB2' ' NE ' ' A' ' 173' ' ' ARG . . . -142.38 97.78 6.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 110.896 -175.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -55.89 131.95 49.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 109.912 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 148' ' ' LEU . 35.1 mm -98.64 106.35 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 110.287 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.79 HG21 HD11 ' A' ' 110' ' ' LEU . 28.9 pt -150.01 -161.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.508 175.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.524 ' HB2' ' HG2' ' A' ' 108' ' ' GLN . 24.9 mmm180 -110.35 152.33 26.36 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.926 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -59.71 -14.36 13.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.28 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 105' ' ' ARG . 9.0 p-10 -104.72 22.66 14.71 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.559 -0.713 . . . . 0.0 110.642 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.533 ' HG3' ' HB ' ' A' ' 104' ' ' ILE . 27.1 mm-40 -90.53 154.57 19.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.964 -1.085 . . . . 0.0 110.866 -177.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 109' ' ' ARG . 51.4 ttt180 -89.53 -8.06 53.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.534 -0.729 . . . . 0.0 110.78 -175.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.79 HD11 HG21 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -96.82 51.99 1.16 Allowed 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 -177.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -131.52 133.92 45.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -140.57 -59.46 0.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.022 -1.049 . . . . 0.0 110.609 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 77.26 -179.22 50.67 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 113' ' ' GLY . 98.9 mt-10 47.56 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.092 -1.24 . . . . 0.0 109.786 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.13 -14.04 58.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 117' ' ' GLU . 7.3 tp -60.12 -36.46 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -1.223 . . . . 0.0 110.206 174.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 172' ' ' ILE . 96.8 mt-10 -60.11 -42.84 95.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.082 -1.011 . . . . 0.0 109.432 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.54 -40.15 92.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.495 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.57 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 52.4 t80 -60.09 -40.92 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.193 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.689 ' O ' HD22 ' A' ' 124' ' ' LEU . 54.4 t -63.84 -45.18 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.957 -1.089 . . . . 0.0 109.743 177.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.584 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 1.7 mt-30 -60.67 -44.7 96.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.663 -0.648 . . . . 0.0 110.472 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.577 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 1.9 ptm85 -69.6 -36.43 76.21 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.064 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.577 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -72.52 -42.95 64.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.681 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -102.27 1.09 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 110.998 -174.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.9 tt -43.19 171.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.042 . . . . 0.0 110.74 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HG2' ' CG2' ' A' ' 125' ' ' ILE . 51.4 ptt85 32.57 53.8 0.34 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.634 -0.666 . . . . 0.0 111.504 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -139.71 151.28 65.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.917 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.867 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 21.1 Cg_endo -67.1 132.2 27.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.137 1.599 . . . . 0.0 109.81 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.596 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.7 mmm -128.43 146.71 50.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.34 -1.475 . . . . 0.0 111.195 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.89 HD21 ' HG2' ' A' ' 49' ' ' LYS . 12.7 tp -149.45 112.44 4.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.612 -0.68 . . . . 0.0 109.587 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 5.6 pt-20 -49.23 144.36 5.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.93 -1.106 . . . . 0.0 111.022 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 83.8 -8.45 1.04 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.429 0.633 . . . . 0.0 110.316 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.523 ' OD2' ' HB ' ' A' ' 152' ' ' VAL . 1.1 p30 -69.97 -170.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 110.617 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -142.29 150.07 40.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.065 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.547 HD11 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -136.2 169.97 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.821 -1.175 . . . . 0.0 110.64 -177.421 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.5 t -132.49 143.35 49.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.555 -0.716 . . . . 0.0 110.342 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.678 HG13 ' HD2' ' A' ' 138' ' ' PRO . 94.6 t -129.07 150.51 75.56 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 121.623 -0.673 . . . . 0.0 109.185 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.678 ' HD2' HG13 ' A' ' 137' ' ' VAL . 1.3 Cg_endo -47.96 82.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.841 1.443 . . . . 0.0 110.056 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . -146.1 100.78 0.23 Allowed Glycine 0 C--N 1.298 -1.57 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.79 HD13 ' H ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -85.36 160.66 19.73 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.437 -1.037 . . . . 0.0 110.032 -176.129 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.87 ' C ' HD13 ' A' ' 142' ' ' LEU . 0.8 OUTLIER -85.96 -175.25 5.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.633 -1.292 . . . . 0.0 111.234 -170.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.899 HD13 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -149.28 -115.97 0.06 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.161 178.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.664 ' N ' HD23 ' A' ' 142' ' ' LEU . . . -54.82 -155.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.102 -0.999 . . . . 0.0 110.39 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.2 77.22 2.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.474 ' HG2' HD22 ' A' ' 142' ' ' LEU . 2.7 pt20 -102.8 164.04 11.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.449 -1.03 . . . . 0.0 110.068 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 t -139.54 150.78 45.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 110.539 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.719 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 96.24 -88.82 1.05 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.719 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 42.17 39.51 1.42 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.523 -0.987 . . . . 0.0 111.378 178.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.52 163.79 31.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.84 -1.163 . . . . 0.0 109.799 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -96.47 127.71 42.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.028 -1.045 . . . . 0.0 109.913 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.5 112.11 23.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 4.0 t -78.46 135.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.855 HG21 ' NH2' ' A' ' 173' ' ' ARG . 40.8 t -115.81 -30.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 110.953 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 131' ' ' GLU . 14.9 tttp -145.6 149.48 34.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.863 -1.148 . . . . 0.0 110.935 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.025 HG22 HG23 ' A' ' 98' ' ' VAL . 75.2 p -139.23 167.49 21.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.631 -0.668 . . . . 0.0 109.39 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.03 -39.1 0.44 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.123 -0.986 . . . . 0.0 110.872 -176.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.915 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.2 Cg_exo -59.01 -170.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.58 1.305 . . . . 0.0 110.162 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.463 ' HB3' HG22 ' A' ' 160' ' ' VAL . 26.8 t -90.25 -165.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -69.18 -2.98 11.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.715 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 158' ' ' SER . 34.3 m -87.64 143.78 34.33 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 110.415 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.561 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.1 Cg_endo -48.49 141.5 19.49 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.244 1.655 . . . . 0.0 110.964 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.915 HG11 ' CB ' ' A' ' 157' ' ' PRO . 9.1 m -130.07 159.95 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.035 . . . . 0.0 109.868 173.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.4 tt0 -107.48 129.92 54.9 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.35 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.834 ' CD1' HG21 ' A' ' 168' ' ' THR . 16.7 mm -72.03 154.11 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.624 -0.672 . . . . 0.0 110.381 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.95 171.46 26.12 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -55.04 -24.85 26.8 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.343 -1.092 . . . . 0.0 110.359 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.608 ' OE2' HG21 ' A' ' 94' ' ' ILE . 18.5 pt-20 -90.28 -17.17 27.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.17 -0.956 . . . . 0.0 110.851 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.834 HG21 ' CD1' ' A' ' 164' ' ' ILE . 85.3 m -58.45 140.56 53.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 0.0 110.16 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 70.9 mmtt -94.84 162.31 13.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.954 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.646 HG23 HD21 ' A' ' 100' ' ' LEU . 2.1 mt -139.37 160.23 28.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 111.12 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.413 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 26.2 mt-10 -137.99 132.78 32.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.612 ' CD1' HD11 ' A' ' 100' ' ' LEU . 43.6 mm -120.07 123.51 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.426 -0.796 . . . . 0.0 110.02 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.855 ' NH2' HG21 ' A' ' 153' ' ' VAL . 11.1 ptp180 -88.64 156.23 19.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.016 -1.053 . . . . 0.0 110.463 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 174' ' ' GLU . 41.2 tt0 -96.37 9.3 41.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 110.184 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -96.77 109.66 49.65 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 110.185 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.1 Cg_exo -71.74 -155.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.123 1.591 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.38 53.8 0.54 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.796 -0.565 . . . . 0.0 110.116 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 21.8 p -65.01 125.97 26.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 109.975 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 178' ' ' SER . 81.3 tt0 60.02 13.79 3.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 110.662 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 66.5 t -105.19 111.55 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.051 -1.031 . . . . 0.0 110.12 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 pp -132.32 -22.78 2.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.911 . . . . 0.0 110.627 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -113.28 120.12 40.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.215 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.05 -39.87 87.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.163 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -177.14 -178.62 46.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.532 -179.891 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.215 0.531 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -99.63 139.43 35.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.021 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -60.02 -40.04 87.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -115.21 116.98 29.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.126 -0.984 . . . . 0.0 110.228 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.822 ' OD1' HD13 ' A' ' 34' ' ' LEU . 49.4 p30 -148.25 160.1 43.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 110.032 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -155.53 -166.48 15.71 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.098 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.722 HG13 HD22 ' A' ' 9' ' ' LEU . 40.0 pt -134.78 159.93 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.344 -1.092 . . . . 0.0 109.421 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.63 ' C ' HD23 ' A' ' 9' ' ' LEU . 36.5 mt -98.57 124.33 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.005 . . . . 0.0 110.28 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.84 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -141.1 -172.68 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 110.478 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.642 ' NH2' HG21 ' A' ' 66' ' ' ILE . 25.5 ttp-105 -103.89 128.79 51.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 110.947 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.933 HG23 HD11 ' A' ' 69' ' ' ILE . 7.1 p -63.02 137.87 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.558 -0.714 . . . . 0.0 110.5 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -127.48 160.15 32.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.288 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.792 ' HB3' HD11 ' A' ' 81' ' ' ILE . 85.1 tt0 -175.05 147.12 0.91 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.306 -0.871 . . . . 0.0 110.555 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.8 147.05 51.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.261 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -73.67 -11.77 60.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.398 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.2 m -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 110.25 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -128.51 137.73 51.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.451 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.66 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -94.09 -36.4 0.31 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.317 -0.864 . . . . 0.0 111.332 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 35.0 Cg_exo -56.14 -176.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.386 1.203 . . . . 0.0 110.829 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.461 ' HA2' ' HG2' ' A' ' 23' ' ' ARG . . . 91.38 32.23 8.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.516 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 27.6 ptm -88.4 1.89 53.78 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.279 -1.13 . . . . 0.0 109.481 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.28 16.34 2.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.355 -0.841 . . . . 0.0 110.803 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 11.0 ptp180 -140.02 146.12 38.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.0 110.394 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 55.2 t -119.95 119.14 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.807 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.768 ' O ' HD12 ' A' ' 26' ' ' LEU . 5.9 ptt180 -88.38 119.53 28.9 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.837 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -138.81 164.77 28.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.672 -0.643 . . . . 0.0 109.843 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.6 p-10 -89.59 -179.79 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.036 -1.04 . . . . 0.0 110.702 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.265 -175.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.0 t -67.12 -40.01 86.75 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.098 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.16 ' O ' HD22 ' A' ' 33' ' ' LEU . 43.7 m -64.06 -27.94 69.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.224 -0.922 . . . . 0.0 109.496 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 61.1 ttt180 -85.12 -45.17 12.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.749 -0.594 . . . . 0.0 110.834 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 22.5 tpt180 -79.59 -9.96 59.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.812 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.16 HD22 ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -41.12 -30.04 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.661 0.743 . . . . 0.0 109.859 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.822 HD13 ' OD1' ' A' ' 5' ' ' ASN . 80.5 mt -140.54 -60.57 0.51 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.706 -0.622 . . . . 0.0 110.56 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.7 t0 -171.06 -29.42 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.193 -0.942 . . . . 0.0 110.487 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.869 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -21.35 123.98 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.354 0.597 . . . . 0.0 111.469 -176.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.62 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.4 pt-20 -101.12 178.98 4.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 38' ' ' ILE . 32.6 mm -60.08 123.38 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.928 -1.107 . . . . 0.0 109.765 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.9 30.59 61.22 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 175.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -88.84 -179.87 6.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.326 . . . . 0.0 109.514 172.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.806 HG21 HG23 ' A' ' 92' ' ' THR . 80.1 t -99.26 127.76 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.02 -1.05 . . . . 0.0 110.467 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.681 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -119.96 142.95 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 -177.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -110.54 142.91 41.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.489 -0.757 . . . . 0.0 109.812 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -120.02 149.33 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.221 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.0 tt0 -151.88 94.45 1.97 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 110.845 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.068 ' CG ' HG12 ' A' ' 85' ' ' VAL . 12.7 tmtt? -98.6 -66.8 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.568 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.48 -35.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.645 0.736 . . . . 0.0 109.202 175.366 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 1.6 mmt85 -134.12 -167.83 2.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.61 -0.681 . . . . 0.0 109.625 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.739 ' C ' HD21 ' A' ' 130' ' ' LEU . 21.9 mttm -89.72 137.32 32.43 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.803 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.583 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.6 157.44 46.76 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.251 0.548 . . . . 0.0 110.2 178.077 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.3 160.82 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 109.967 177.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.56 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.72 -178.54 48.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -115.79 157.46 24.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.475 -1.014 . . . . 0.0 109.922 -176.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.681 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -85.03 135.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.962 -1.086 . . . . 0.0 110.216 -175.112 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -127.7 163.15 24.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.063 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -90.01 121.82 32.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 110.098 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -63.45 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.926 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.672 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 5.4 mtm180 -56.16 -45.77 99.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.045 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 40.8 Cg_endo -92.65 97.54 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.882 1.464 . . . . 0.0 109.004 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.1 pt-20 -75.29 36.06 0.12 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.562 -0.711 . . . . 0.0 110.681 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.9 m-20 -147.33 -37.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 110.558 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -84.73 -24.3 28.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.523 ' HA ' HG12 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -81.14 38.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.71 -0.619 . . . . 0.0 110.526 177.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.496 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.4 pttt -98.81 15.48 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -0.999 . . . . 0.0 109.406 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.09 24.34 0.03 OUTLIER Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.642 HG21 ' NH2' ' A' ' 10' ' ' ARG . 46.1 pt -140.77 156.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 109.046 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 3.4 p -135.38 131.48 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.908 -1.12 . . . . 0.0 110.144 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.536 ' NE ' ' HD3' ' A' ' 25' ' ' ARG . 42.9 ttp180 -92.76 118.66 31.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 110.123 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.933 HD11 HG23 ' A' ' 11' ' ' VAL . 2.6 pt -132.09 166.45 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.473 -0.767 . . . . 0.0 110.379 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' OD2' ' HB3' ' A' ' 21' ' ' MET . 21.4 p-10 -83.66 177.66 8.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 110.138 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t -63.48 -35.22 79.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.0 110.92 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.18 -46.16 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 110.123 -174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.728 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.38 -43.72 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.554 177.432 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 6.8 ttm180 -59.95 -40.87 90.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.893 174.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -69.97 -25.91 63.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.291 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 79.7 m-20 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 110.618 -175.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.46 ' HB2' HG23 ' A' ' 47' ' ' VAL . 29.1 p -99.1 -37.19 9.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.042 . . . . 0.0 110.425 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.568 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 116.4 21.92 4.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -99.22 169.62 9.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.169 -1.194 . . . . 0.0 110.332 -175.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.845 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.26 171.14 7.73 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.351 -0.843 . . . . 0.0 109.366 178.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.792 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -60.16 140.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 0.0 109.981 177.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.704 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 79.61 -4.79 63.11 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 171.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.546 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.04 -166.42 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.815 -1.403 . . . . 0.0 110.115 174.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 33.6 pttt -127.83 112.8 15.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.224 -0.922 . . . . 0.0 109.831 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.068 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.33 151.64 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 48.9 tttp -101.09 126.59 47.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.891 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.527 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.2 t -102.97 121.98 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.565 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 77.8 mtt85 -106.74 128.19 54.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.869 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 13.8 tmtt? -78.75 135.99 37.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.15 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.438 HG21 ' HD2' ' A' ' 161' ' ' PRO . 2.2 m -150.04 -169.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.49 -0.757 . . . . 0.0 110.234 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -126.6 173.3 9.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.494 -0.754 . . . . 0.0 109.671 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.806 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.0 162.5 12.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 110.953 -176.12 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.666 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.7 pt-20 -150.23 169.92 20.19 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.577 HG21 ' OE2' ' A' ' 167' ' ' GLU . 50.8 mm -90.04 98.85 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.594 -1.316 . . . . 0.0 110.319 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.861 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.48 139.7 52.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.65 ' CD ' HD23 ' A' ' 156' ' ' LEU . 13.0 ptpt -107.13 -24.62 11.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 111.292 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.636 ' HD3' HD13 ' A' ' 156' ' ' LEU . 63.6 tttp -149.97 119.62 7.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.706 -1.246 . . . . 0.0 110.619 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.888 HG23 HG22 ' A' ' 155' ' ' THR . 10.0 p -136.23 140.76 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 0.0 110.692 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.491 ' C ' HD23 ' A' ' 100' ' ' LEU . 99.7 m -111.97 142.1 44.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.081 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.891 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.04 165.86 24.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.614 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -140.07 89.5 11.11 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.795 . . . . 0.0 110.315 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo -58.56 131.73 44.21 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.061 1.559 . . . . 0.0 110.752 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.971 HG23 ' HB2' ' A' ' 177' ' ' ALA . 57.4 mt -89.71 90.47 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.005 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.741 HG21 ' CG ' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -151.76 -166.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.495 -0.753 . . . . 0.0 110.471 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.574 ' O ' HD13 ' A' ' 104' ' ' ILE . 9.5 mpt_? -92.91 164.4 13.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.835 . . . . 0.0 110.149 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.832 ' HA ' HD21 ' A' ' 110' ' ' LEU . 39.0 pttt -59.91 -14.75 17.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.153 -0.967 . . . . 0.0 110.578 -175.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.442 ' O ' ' HD2' ' A' ' 111' ' ' LYS . 35.7 p-10 -117.77 25.0 10.69 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.502 -0.749 . . . . 0.0 110.914 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 104' ' ' ILE . 43.8 mm-40 -104.7 -82.58 0.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.065 -1.022 . . . . 0.0 110.818 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.741 ' CG ' HG21 ' A' ' 104' ' ' ILE . 26.7 mmm180 -93.68 -27.65 16.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.887 . . . . 0.0 109.852 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.832 HD21 ' HA ' ' A' ' 106' ' ' LYS . 0.8 OUTLIER -98.59 52.37 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.054 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 107' ' ' ASP . 6.3 ptmt -131.26 60.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.392 -0.818 . . . . 0.0 110.105 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -141.08 -61.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.962 . . . . 0.0 110.239 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 76.13 -179.81 47.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 113' ' ' GLY . 98.9 mt-10 43.78 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.134 -1.215 . . . . 0.0 110.346 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.38 4.83 89.22 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.748 HD13 ' C ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -60.59 -39.94 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.235 -1.156 . . . . 0.0 109.948 177.407 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -62.43 -40.05 95.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.714 176.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -29.09 66.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.0 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.04 -40.01 87.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.769 HG12 ' CD1' ' A' ' 170' ' ' ILE . 54.5 t -65.01 -49.97 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.4 mt-30 -60.06 -44.58 94.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.813 . . . . 0.0 110.024 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -60.01 -44.09 94.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.647 -0.658 . . . . 0.0 110.211 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.527 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.05 -43.8 70.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -0.789 . . . . 0.0 110.544 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.74 HD22 ' N ' ' A' ' 124' ' ' LEU . 3.5 mm? -99.05 2.81 46.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.738 HD11 ' HG2' ' A' ' 166' ' ' GLU . 2.4 tt -46.2 169.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.887 -1.133 . . . . 0.0 110.241 -175.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 28.8 ptt180 33.13 46.09 0.09 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.513 -0.742 . . . . 0.0 111.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -132.26 149.9 74.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.784 -1.198 . . . . 0.0 110.866 176.689 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.81 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.4 Cg_endo -63.83 133.41 38.91 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.182 1.622 . . . . 0.0 110.264 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.522 ' HE2' HG21 ' A' ' 98' ' ' VAL . 81.5 mmm -127.0 143.05 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.592 -1.317 . . . . 0.0 111.279 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.739 HD21 ' C ' ' A' ' 49' ' ' LYS . 10.8 tp -148.27 110.7 4.68 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.729 -0.607 . . . . 0.0 109.442 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.2 pm0 -43.02 143.28 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.944 -1.097 . . . . 0.0 110.526 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.97 -2.48 2.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.873 -0.517 . . . . 0.0 110.429 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.7 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.6 p-10 -69.93 169.86 12.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.243 -0.911 . . . . 0.0 110.107 175.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 5.4 m120 -128.54 145.28 51.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.25 165.51 23.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.944 -1.097 . . . . 0.0 110.108 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.7 t -140.31 149.8 43.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.479 -0.763 . . . . 0.0 110.75 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.715 HG13 ' HD2' ' A' ' 138' ' ' PRO . 87.3 t -140.06 151.53 65.27 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 0.0 109.203 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.715 ' HD2' HG13 ' A' ' 137' ' ' VAL . 1.7 Cg_endo -44.3 86.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.701 1.369 . . . . 0.0 110.307 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.633 ' O ' HD22 ' A' ' 148' ' ' LEU . . . -144.92 102.58 0.27 Allowed Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 141' ' ' THR . 3.8 pp -86.6 135.92 33.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.431 -1.041 . . . . 0.0 109.834 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . 1.089 ' O ' HD13 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -69.84 -171.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 111.099 -171.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.089 HD13 ' O ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -127.75 -103.08 0.33 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.116 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.49 -158.26 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.252 -0.905 . . . . 0.0 110.382 176.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.37 52.55 4.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.54 ' CG ' ' OG1' ' A' ' 141' ' ' THR . 4.2 pt20 -94.84 155.93 16.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.136 . . . . 0.0 110.167 176.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.2 t -134.13 150.22 51.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.354 -0.842 . . . . 0.0 110.317 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.74 -90.91 0.54 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.633 HD22 ' O ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER 46.62 49.47 13.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.148 -1.207 . . . . 0.0 110.631 177.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 103' ' ' ILE . 2.3 pp -140.32 167.55 21.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.815 -1.178 . . . . 0.0 109.905 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 62.6 m-85 -91.19 121.77 33.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 110.216 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.437 ' HD2' ' ND2' ' A' ' 134' ' ' ASN . 32.0 tptt -103.26 104.77 14.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.845 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.7 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.2 t -76.65 139.26 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 109.851 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.26 -29.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 0.0 111.059 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 38.4 ttpt -139.52 144.94 38.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.815 -1.178 . . . . 0.0 111.017 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.888 HG22 HG23 ' A' ' 98' ' ' VAL . 58.0 p -140.01 153.02 46.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.71 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.8 OUTLIER -89.82 -30.62 0.36 Allowed Pre-proline 0 C--N 1.297 -1.696 0 O-C-N 121.282 -0.886 . . . . 0.0 111.425 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.974 ' CB ' HG11 ' A' ' 162' ' ' VAL . 14.2 Cg_exo -58.63 -164.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.216 1.114 . . . . 0.0 109.921 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.678 ' HB3' HG22 ' A' ' 160' ' ' VAL . 15.3 t -89.98 -178.41 5.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 175.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -62.27 -8.47 5.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 110.469 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.678 HG22 ' HB3' ' A' ' 158' ' ' SER . 20.7 m -84.76 146.25 45.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 110.238 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.555 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.45 141.3 14.66 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.255 1.661 . . . . 0.0 110.747 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.974 HG11 ' CB ' ' A' ' 157' ' ' PRO . 7.0 m -129.89 159.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 109.575 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.89 128.1 54.32 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.205 -0.934 . . . . 0.0 110.079 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.769 ' CD1' HG21 ' A' ' 168' ' ' THR . 11.9 mm -70.58 154.68 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 110.055 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.61 172.33 24.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.738 ' HG2' HD11 ' A' ' 125' ' ' ILE . 96.6 mt-10 -58.2 -26.26 62.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.898 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.577 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.4 pt-20 -87.38 -17.98 31.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.592 -176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 95' ' ' ALA . 30.7 m -58.47 152.48 17.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 110.302 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' LYS . 23.0 mmtt -105.89 158.77 16.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.062 . . . . 0.0 109.875 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.891 HG23 HD21 ' A' ' 100' ' ' LEU . 1.8 mt -136.68 161.8 35.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 111.164 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.474 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 12.0 mt-10 -139.06 131.66 28.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.756 -0.59 . . . . 0.0 110.219 175.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.9 mp -119.91 128.89 75.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.465 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 5.5 ptp180 -88.31 154.58 20.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 110.233 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 49.8 mt-10 -89.98 -0.2 57.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.321 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.77 108.3 45.02 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.934 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.4 Cg_exo -72.55 -155.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.026 1.54 . . . . 0.0 110.29 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.971 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -79.67 54.51 1.81 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.001 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 68.9 m -109.66 123.21 49.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.826 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 178' ' ' SER . 82.6 tt0 59.95 19.36 8.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.984 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.54 139.2 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.351 -0.843 . . . . 0.0 110.263 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.623 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -124.08 70.71 1.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.16 -0.962 . . . . 0.0 110.3 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.13 139.66 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.985 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.93 -40.07 87.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.355 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 65.93 -107.7 2.06 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.583 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.316 0.579 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -130.35 159.96 35.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 110.157 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 p -78.75 163.95 24.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 110.133 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -88.79 -32.03 18.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 110.198 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 t30 45.03 -163.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -0.911 . . . . 0.0 110.388 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -151.0 -153.7 6.25 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.022 HG21 HD22 ' A' ' 33' ' ' LEU . 11.9 pt -138.63 167.75 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -1.15 . . . . 0.0 109.412 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.771 ' C ' HD23 ' A' ' 9' ' ' LEU . 85.4 mt -109.89 127.84 66.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.117 -0.989 . . . . 0.0 110.337 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.837 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -148.49 -179.04 6.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.511 -0.743 . . . . 0.0 109.962 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 2.8 ptt180 -104.74 138.89 40.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.939 -1.101 . . . . 0.0 110.601 -173.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 80' ' ' SER . 11.2 p -63.07 130.43 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 110.356 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -110.93 153.5 25.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.909 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 -176.77 134.99 0.22 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.071 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.4 130.55 56.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -59.94 -38.54 82.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 110.061 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.5 t -59.96 -39.98 87.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 110.347 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 p -116.32 107.65 15.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.003 . . . . 0.0 110.333 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.737 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -96.84 -24.05 0.24 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.344 -0.848 . . . . 0.0 112.332 -178.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 52.0 Cg_exo -47.02 144.11 8.94 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 122.913 0.954 . . . . 0.0 111.049 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.25 61.28 0.94 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.491 ' HA ' ' CB ' ' A' ' 70' ' ' ASP . 25.0 ptt? -90.01 -0.99 57.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -1.141 . . . . 0.0 110.06 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 22.6 p -138.86 9.41 2.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 110.029 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HG2' ' HD2' ' A' ' 53' ' ' ARG . 82.2 mtt180 -107.25 131.62 53.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.819 . . . . 0.0 109.936 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 67' ' ' VAL . 78.1 t -105.3 114.02 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.987 -1.071 . . . . 0.0 110.053 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 8.9 ptt180 -93.5 119.95 33.19 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.563 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.628 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -139.84 171.94 13.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.682 -176.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 19.8 p-10 -95.43 -172.58 2.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.897 -1.127 . . . . 0.0 110.785 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.03 -46.97 87.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.578 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.474 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 18.2 m -65.24 -41.75 94.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.129 -175.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.667 ' HA ' HD23 ' A' ' 33' ' ' LEU . 64.3 m -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.155 -0.966 . . . . 0.0 109.558 175.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 41.1 ttm180 -73.27 -44.04 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 111.163 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -91.73 -7.82 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.919 -1.113 . . . . 0.0 111.201 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.041 HD12 ' N ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -52.23 -26.58 12.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.149 . . . . 0.0 109.329 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.041 ' N ' HD12 ' A' ' 33' ' ' LEU . 41.9 mt -132.65 -66.01 0.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 110.785 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 28.8 t0 -171.82 -2.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.955 -1.091 . . . . 0.0 111.52 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -44.97 128.01 6.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.827 -1.17 . . . . 0.0 110.449 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.585 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.2 pt-20 -116.85 176.57 5.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 38' ' ' ILE . 21.6 mm -57.96 122.41 7.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.812 -1.18 . . . . 0.0 109.855 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.504 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 72.88 33.42 59.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.161 -1.018 . . . . 0.0 110.663 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 18.9 m-20 -89.2 176.23 7.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.667 -1.49 . . . . 0.0 109.596 172.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.079 HG12 HG23 ' A' ' 90' ' ' VAL . 73.6 t -99.07 127.78 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.084 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 52' ' ' GLY . 4.6 m -120.0 151.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 110.229 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' C ' HD12 ' A' ' 44' ' ' ILE . 86.5 tt0 -122.99 142.9 50.33 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.716 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -119.9 147.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' OE1' ' CZ ' ' A' ' 88' ' ' ARG . 82.5 tt0 -151.29 93.14 1.87 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.931 -1.106 . . . . 0.0 110.846 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.035 ' HG3' HG12 ' A' ' 85' ' ' VAL . 8.9 tmtm? -97.94 -58.85 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.646 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.73 -31.51 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.676 0.75 . . . . 0.0 109.129 176.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 98.3 mtt180 -139.53 -172.57 3.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.642 -0.662 . . . . 0.0 109.747 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -88.41 130.32 35.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.177 -0.952 . . . . 0.0 110.825 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -131.03 154.31 48.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.805 -0.56 . . . . 0.0 110.26 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.056 HG11 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -117.91 164.36 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.945 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -176.77 179.0 47.96 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 18.2 ptp180 -111.53 -172.04 1.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -1.112 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.585 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.24 137.66 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.026 -1.046 . . . . 0.0 110.632 -175.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -127.89 164.13 22.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 110.194 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.27 123.67 33.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -63.33 140.05 58.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.653 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 4.6 mmt180 -56.08 -49.55 92.48 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.903 -1.123 . . . . 0.0 108.877 174.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 18.7 Cg_endo -91.68 98.36 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.715 1.376 . . . . 0.0 108.831 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 11.1 pt-20 -74.97 35.29 0.1 Allowed 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 110.917 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 79.5 m-20 -145.43 -32.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.056 -1.027 . . . . 0.0 110.796 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.99 -25.55 24.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.563 ' HA ' HG12 ' A' ' 66' ' ' ILE . 4.1 m-80 -81.13 39.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 110.573 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.3 pttt -99.02 17.48 19.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 109.575 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.56 23.98 0.03 OUTLIER Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.563 HG12 ' HA ' ' A' ' 63' ' ' ASN . 44.5 pt -140.68 158.59 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.52 -0.988 . . . . 0.0 109.221 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.976 HG23 HG13 ' A' ' 24' ' ' VAL . 3.4 p -129.98 137.13 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.087 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -97.31 118.02 32.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.05 -1.031 . . . . 0.0 110.1 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.857 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.1 pt -134.36 173.04 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.749 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' CB ' ' HA ' ' A' ' 21' ' ' MET . 29.7 t0 -91.23 173.61 7.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.564 -0.71 . . . . 0.0 109.857 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 58.5 p -63.12 -25.29 68.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.438 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.7 t -68.49 -47.45 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.689 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.07 -42.81 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 109.768 176.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.02 -40.27 88.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 174.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -71.04 -26.86 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.395 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.4 m-20 -60.07 -39.9 87.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 110.808 -176.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.524 ' C ' HG23 ' A' ' 47' ' ' VAL . 28.5 p -98.47 -36.53 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.965 -1.084 . . . . 0.0 110.657 -175.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 117.18 22.83 4.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.79 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -102.65 171.75 7.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -1.202 . . . . 0.0 110.311 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.962 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.91 179.05 4.08 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -65.22 140.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.053 -1.03 . . . . 0.0 110.423 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.88 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.03 -3.21 52.72 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 173.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.586 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.52 -158.83 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.054 -1.262 . . . . 0.0 110.211 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 52.6 pttt -137.07 116.92 13.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 110.097 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.035 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.3 m -125.81 160.07 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.433 -0.792 . . . . 0.0 109.823 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 33.0 ttmt -104.08 123.99 48.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.508 HG21 HD11 ' A' ' 9' ' ' LEU . 63.8 t -99.55 125.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtm180 -117.23 149.49 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 61.7 tttm -91.15 139.85 30.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.862 -1.149 . . . . 0.0 110.371 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.079 HG23 HG12 ' A' ' 41' ' ' VAL . 2.3 m -138.84 -168.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 175.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.481 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 38.8 ptt180 -137.46 171.26 14.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.26 159.55 16.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 0.0 111.193 -175.01 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.648 ' CG ' HG12 ' A' ' 162' ' ' VAL . 11.7 pt-20 -150.32 171.17 17.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.761 HG21 ' OE2' ' A' ' 167' ' ' GLU . 39.7 mm -88.62 98.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.287 -1.508 . . . . 0.0 110.096 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.992 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -58.62 139.96 55.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.392 -0.818 . . . . 0.0 110.365 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.587 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 1.4 pttt -97.46 -29.7 13.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.081 -1.012 . . . . 0.0 111.11 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.564 ' HB3' HD23 ' A' ' 156' ' ' LEU . 80.4 tttt -150.91 121.98 7.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 0.0 110.915 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.017 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -132.24 143.54 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.006 -1.059 . . . . 0.0 110.955 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.524 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 91.1 m -114.96 140.26 49.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 0.0 110.044 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 170' ' ' ILE . 0.1 OUTLIER -136.3 165.28 26.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.374 -177.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.576 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -136.33 82.11 35.56 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 111.033 -176.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.53 ' HD2' ' CD ' ' A' ' 173' ' ' ARG . 17.4 Cg_exo -58.15 128.07 27.33 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.869 1.458 . . . . 0.0 109.883 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.775 ' CG2' ' HB2' ' A' ' 177' ' ' ALA . 71.6 mt -95.61 103.31 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.042 -1.036 . . . . 0.0 110.549 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.664 HG21 HD21 ' A' ' 110' ' ' LEU . 16.8 pt -150.83 -153.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 122.148 0.975 . . . . 0.0 110.615 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.496 ' N ' HG13 ' A' ' 104' ' ' ILE . 28.9 mmt85 -130.56 156.73 44.34 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.102 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.04 -18.58 47.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 109.89 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.441 ' OD1' ' CB ' ' A' ' 105' ' ' ARG . 35.6 p-10 -103.6 24.18 11.53 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.825 -0.547 . . . . 0.0 110.532 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.623 ' OE1' HD21 ' A' ' 142' ' ' LEU . 24.4 mm-40 -90.74 173.94 7.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.065 -1.022 . . . . 0.0 110.46 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -88.45 -22.02 23.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 110.521 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.664 HD21 HG21 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -98.03 45.23 1.02 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 0.0 110.084 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -105.64 140.68 38.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.551 -0.718 . . . . 0.0 109.696 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -138.83 -38.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.028 . . . . 0.0 110.733 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.515 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 78.15 -156.93 44.21 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 113' ' ' GLY . 21.9 pt-20 -30.17 142.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.946 -0.738 . . . . 0.0 110.833 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.01 -11.82 55.95 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 120' ' ' VAL . 5.9 tp -63.91 -34.18 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 110.113 175.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.541 ' HG2' HG12 ' A' ' 172' ' ' ILE . 94.8 mt-10 -59.99 -46.81 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 109.516 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.39 -39.89 92.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.457 ' HB3' HD12 ' A' ' 116' ' ' ILE . 36.8 t80 -64.27 -39.99 95.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.475 -0.766 . . . . 0.0 109.942 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.73 HG12 ' CD1' ' A' ' 170' ' ' ILE . 58.4 t -60.59 -49.97 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.512 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 1.9 mt-30 -61.21 -41.82 97.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.645 -0.66 . . . . 0.0 110.238 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.1 -48.93 79.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.438 -0.789 . . . . 0.0 109.97 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.01 -40.73 75.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.719 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.573 HD12 ' HE3' ' A' ' 129' ' ' MET . 4.6 mm? -94.91 -1.74 51.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.138 -175.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.712 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.6 tt -46.95 166.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.931 -1.105 . . . . 0.0 110.109 -175.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.6 ptt180 33.76 49.56 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 0.0 111.458 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.464 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 6.8 tpt180 -135.07 140.95 36.36 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.899 -1.126 . . . . 0.0 111.373 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.1 Cg_exo -59.69 130.68 36.26 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 124.095 1.576 . . . . 0.0 109.734 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.573 ' HE3' HD12 ' A' ' 124' ' ' LEU . 15.4 mmt -134.9 141.78 46.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.409 -1.432 . . . . 0.0 110.972 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -146.42 130.0 16.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -51.32 145.63 8.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -175.525 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 76.51 -2.06 2.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.818 -0.551 . . . . 0.0 110.548 178.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.801 ' HB3' HD23 ' A' ' 130' ' ' LEU . 1.6 p30 -67.59 -171.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.196 -0.94 . . . . 0.0 109.874 173.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -150.37 159.02 44.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.34 -0.85 . . . . 0.0 109.532 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.423 HD12 ' CB ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -137.27 168.44 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 110.122 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.5 t -117.43 163.61 16.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.445 -0.784 . . . . 0.0 110.601 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.598 HG12 HD23 ' A' ' 140' ' ' LEU . 2.6 t -99.44 145.58 30.31 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.326 -0.858 . . . . 0.0 109.704 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 10.3 Cg_endo -60.43 66.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.03 1.542 . . . . 0.0 110.459 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 45.38 58.99 4.91 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.72 HD12 ' C ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -129.71 128.31 42.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.894 -1.356 . . . . 0.0 110.348 175.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -162.78 -169.73 2.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.294 -0.879 . . . . 0.0 110.137 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.623 HD21 ' OE1' ' A' ' 108' ' ' GLN . 0.3 OUTLIER -147.69 -122.41 0.06 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 109.964 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.88 -160.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.041 -1.037 . . . . 0.0 109.907 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.27 81.43 1.44 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.433 ' OE1' ' CB ' ' A' ' 141' ' ' THR . 4.4 pt20 -92.43 169.87 10.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.344 -1.092 . . . . 0.0 109.955 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -135.89 149.95 49.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.141 -0.974 . . . . 0.0 110.619 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.641 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 90.52 -92.85 1.8 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 40.1 40.74 0.82 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.492 -1.005 . . . . 0.0 111.024 176.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.633 HD11 HD12 ' A' ' 103' ' ' ILE . 2.2 pp -140.45 165.17 28.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.903 -1.123 . . . . 0.0 109.895 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.511 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 20.4 m-85 -104.76 128.66 52.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 110.211 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -119.95 109.98 16.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.558 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.9 t -74.97 139.38 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.06 -24.52 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 111.021 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -146.2 136.65 23.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.662 -1.274 . . . . 0.0 110.841 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.017 HG22 HG23 ' A' ' 98' ' ' VAL . 44.5 p -134.7 168.7 18.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.498 -0.752 . . . . 0.0 109.355 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.01 -35.98 0.42 Allowed Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.929 -178.11 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 1.062 ' CG ' HG11 ' A' ' 162' ' ' VAL . 22.9 Cg_exo -58.46 -174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.384 1.202 . . . . 0.0 110.531 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -156.36 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.59 -11.35 52.88 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 160' ' ' VAL . 33.1 m -87.11 139.45 32.43 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 1.056 ' HB3' HG11 ' A' ' 51' ' ' VAL . 9.3 Cg_endo -59.72 164.1 12.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.131 1.595 . . . . 0.0 111.002 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 1.062 HG11 ' CG ' ' A' ' 157' ' ' PRO . 14.8 m -140.37 166.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.561 -0.712 . . . . 0.0 110.101 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -103.02 126.48 50.22 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.833 -1.167 . . . . 0.0 109.954 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.813 ' CD1' HG21 ' A' ' 168' ' ' THR . 10.9 mm -70.11 153.73 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.588 -0.695 . . . . 0.0 109.661 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.49 168.25 25.9 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -56.62 -20.78 22.86 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -1.084 . . . . 0.0 110.033 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.761 ' OE2' HG21 ' A' ' 94' ' ' ILE . 21.3 pt-20 -91.35 -18.22 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.724 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.813 HG21 ' CD1' ' A' ' 164' ' ' ILE . 28.6 m -58.37 144.65 40.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.4 mttt -95.45 150.54 20.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 109.507 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.818 HG23 HD21 ' A' ' 100' ' ' LEU . 1.9 mt -129.95 160.05 41.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.83 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.524 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 65.2 mt-10 -135.62 145.32 46.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.566 -0.709 . . . . 0.0 110.295 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.685 HD11 HG21 ' A' ' 120' ' ' VAL . 30.9 mm -122.59 141.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.517 -0.739 . . . . 0.0 109.934 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.576 ' HD2' ' HA ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -86.66 144.25 27.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -176.008 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 47.1 mt-10 -90.21 -9.53 47.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.103 -0.998 . . . . 0.0 110.566 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 6.5 mt-10 -98.58 108.53 48.64 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 110.097 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.1 Cg_exo -71.79 -154.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.103 1.581 . . . . 0.0 110.348 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.775 ' HB2' ' CG2' ' A' ' 103' ' ' ILE . . . -86.85 51.19 2.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.626 -0.672 . . . . 0.0 110.163 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.9 -81.22 0.29 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.35 -0.844 . . . . 0.0 110.661 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.21 7.87 10.24 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.945 -1.097 . . . . 0.0 110.169 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.9 119.55 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.41 -34.21 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.82 . . . . 0.0 110.465 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -148.93 112.7 5.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 110.085 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.95 149.95 47.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.352 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.93 46.8 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.522 -179.797 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.181 0.515 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 58.8 mp0 -60.74 -40.04 90.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.963 . . . . 0.0 109.901 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -139.43 102.24 4.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.373 -0.83 . . . . 0.0 109.967 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -145.79 107.94 4.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 110.097 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -119.08 30.07 7.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.079 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.891 ' HA2' HD11 ' A' ' 34' ' ' LEU . . . -151.8 -179.48 27.48 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.733 HG21 HD13 ' A' ' 33' ' ' LEU . 33.5 pt -134.8 159.18 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.879 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 85.5 mt -95.79 118.43 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.875 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.5 pt? -134.91 -169.28 2.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.344 -0.848 . . . . 0.0 110.382 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 38.1 ttp180 -103.91 130.15 51.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 110.965 -175.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.028 HG23 HD11 ' A' ' 69' ' ' ILE . 10.5 p -61.1 137.95 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 110.277 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -122.72 149.82 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' OE1' ' HD3' ' A' ' 74' ' ' ARG . 86.5 tt0 -176.57 159.95 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' N ' ' HG2' ' A' ' 13' ' ' GLU . . . -147.73 167.89 23.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.97 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -60.01 130.01 44.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 110.026 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.478 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 94.2 p -158.3 159.48 35.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.312 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.1 p -98.92 -64.49 1.03 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 110.293 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.684 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -94.95 -32.71 0.28 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 111.696 -176.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 52.8 Cg_exo -50.63 166.57 0.32 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.143 1.075 . . . . 0.0 110.687 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.562 ' CA ' ' HB3' ' A' ' 70' ' ' ASP . . . 94.54 60.01 1.12 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.493 ' SD ' ' HD3' ' A' ' 23' ' ' ARG . 22.0 ptm -98.45 24.4 7.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -1.113 . . . . 0.0 110.467 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 21' ' ' MET . 0.3 OUTLIER 68.3 33.48 4.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 -178.142 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 33.7 ptt180 -101.75 137.12 40.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.507 -0.745 . . . . 0.0 109.815 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.984 HG13 HG23 ' A' ' 67' ' ' VAL . 53.6 t -99.96 110.1 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.065 . . . . 0.0 110.023 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -99.76 119.98 39.0 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.003 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -133.66 -169.43 2.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.525 -0.735 . . . . 0.0 110.375 -177.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' N ' ' HB3' ' A' ' 63' ' ' ASN . 26.6 p-10 -106.85 -179.15 3.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 0.0 110.816 -175.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 84.2 mt-10 -60.04 -40.07 88.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.242 -178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 46.6 t -59.95 -49.69 76.7 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.083 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.814 ' HA ' HD21 ' A' ' 33' ' ' LEU . 75.4 m -59.97 -40.09 87.87 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.099 -1.001 . . . . 0.0 109.682 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 32.2 ttp180 -60.19 -46.29 90.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 172.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -67.31 -39.97 85.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 110.415 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.951 ' CD1' HD13 ' A' ' 34' ' ' LEU . 4.4 pp -74.84 -28.4 60.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 111.088 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.951 HD13 ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -99.48 -8.36 24.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.731 -1.231 . . . . 0.0 110.15 175.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 34' ' ' LEU . 12.4 t70 59.77 14.87 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.818 . . . . 0.0 109.82 -174.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.934 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -58.95 120.71 9.57 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.593 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -99.48 173.34 6.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -58.52 127.75 18.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.35 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.7 73.4 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.578 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.42 ' CG ' ' HG2' ' A' ' 37' ' ' GLU . 90.2 m-20 -88.33 166.46 14.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.478 -1.601 . . . . 0.0 108.756 169.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 92' ' ' THR . 93.7 t -98.75 129.33 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.737 -1.227 . . . . 0.0 110.1 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.763 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -115.48 138.01 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.353 -177.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 83.0 tt0 -108.67 139.77 43.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.441 -0.787 . . . . 0.0 109.396 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.97 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.6 mp -120.3 145.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 110.332 -176.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.9 tt0 -147.42 99.51 3.14 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 110.772 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.043 ' CG ' HG12 ' A' ' 85' ' ' VAL . 9.5 tmtt? -98.29 -65.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.67 173.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG21 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.26 -33.38 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.257 174.252 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 69.5 mtt85 -135.56 -178.31 5.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.761 -0.587 . . . . 0.0 109.479 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.538 ' HB3' HD21 ' A' ' 130' ' ' LEU . 24.3 mttt -89.3 136.95 32.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.547 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.689 ' HA ' HD23 ' A' ' 130' ' ' LEU . 1.8 p -141.42 168.71 19.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 110.1 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.558 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.6 164.14 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.54 -0.725 . . . . 0.0 110.379 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.61 -172.76 42.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.9 ptp85 -113.98 -174.87 2.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.934 HG21 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -113.59 139.46 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.609 -173.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 1.1 m-85 -132.65 164.6 26.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.894 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -98.91 126.92 44.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.436 -0.79 . . . . 0.0 110.079 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -66.31 140.58 58.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.215 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.58 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -56.5 -49.02 95.94 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 118.899 -1.121 . . . . 0.0 108.834 172.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 30.7 Cg_endo -91.72 97.24 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.864 1.455 . . . . 0.0 108.954 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.13 35.83 0.14 Allowed 'General case' 0 C--N 1.289 -2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 110.984 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 36.1 p-10 -143.08 -36.11 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 110.964 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 15.5 pt-20 -84.83 -20.43 30.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.936 -1.102 . . . . 0.0 109.585 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.496 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 4.7 m-80 -81.42 38.66 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.48 -0.762 . . . . 0.0 110.531 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 26.2 pttm -98.82 11.9 37.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.63 26.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.496 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.8 pt -140.15 143.03 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.311 -1.111 . . . . 0.0 109.358 175.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.984 HG23 HG13 ' A' ' 24' ' ' VAL . 7.5 p -122.48 129.62 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.309 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 38.7 mmm-85 -90.01 116.62 28.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.243 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.028 HD11 HG23 ' A' ' 11' ' ' VAL . 2.9 pt -136.84 169.15 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 110.599 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.562 ' HB3' ' CA ' ' A' ' 20' ' ' GLY . 32.9 p-10 -78.5 169.29 18.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.601 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 79.6 p -70.04 -23.49 63.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.462 ' HB ' ' OD2' ' A' ' 70' ' ' ASP . 54.5 t -70.06 -43.98 78.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.979 -1.076 . . . . 0.0 110.186 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.97 ' CE ' HD13 ' A' ' 44' ' ' ILE . 9.7 tpt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.084 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 71' ' ' SER . 43.7 ptt85 -61.38 -35.56 77.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.806 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.476 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 64.1 t30 -71.88 -26.45 62.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.11 -0.994 . . . . 0.0 110.495 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.6 m-20 -60.01 -35.66 75.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.466 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.509 ' C ' HG23 ' A' ' 47' ' ' VAL . 26.1 p -97.95 -36.61 10.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.281 -0.887 . . . . 0.0 110.202 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.557 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 122.34 28.22 1.51 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.718 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -110.81 161.05 16.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -1.113 . . . . 0.0 110.476 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.849 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.77 179.02 4.09 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 178.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -60.44 139.73 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.926 -1.109 . . . . 0.0 110.646 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.836 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 78.24 -3.51 62.01 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.57 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.95 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.024 -1.28 . . . . 0.0 110.088 174.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 54.7 pttt -133.07 113.56 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 110.073 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.043 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -119.94 166.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.312 -0.867 . . . . 0.0 110.028 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 84.6 tttt -114.21 127.57 55.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 109.973 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.595 HG23 HD21 ' A' ' 9' ' ' LEU . 92.8 t -107.55 122.81 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.099 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.486 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 12.3 mtt180 -109.67 140.5 43.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 34' ' ' LEU . 53.5 tttm -82.13 140.76 33.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.094 -1.004 . . . . 0.0 110.701 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.481 HG21 ' CG ' ' A' ' 161' ' ' PRO . 2.3 m -150.17 -170.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.78 -0.575 . . . . 0.0 109.688 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.5 mtp180 -132.48 163.41 28.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.713 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.675 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -94.67 161.31 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.977 0.894 . . . . 0.0 111.418 -174.277 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.673 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.6 pt-20 -150.09 170.33 19.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.848 HG21 ' OE2' ' A' ' 167' ' ' GLU . 37.6 mm -89.07 101.11 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.625 -1.297 . . . . 0.0 110.461 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.828 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -58.69 139.98 55.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 110.31 177.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -101.84 -26.5 13.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 111.04 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.741 ' HB3' HD23 ' A' ' 156' ' ' LEU . 23.3 tttt -150.33 128.64 12.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 110.221 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.944 HG23 HG22 ' A' ' 155' ' ' THR . 7.2 p -140.8 144.98 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.996 -1.065 . . . . 0.0 110.616 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.541 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.3 m -116.51 133.42 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.827 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.944 HD11 HG11 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -131.94 160.81 34.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 110.371 -176.399 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -133.65 81.31 54.0 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 110.848 -176.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.515 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . 17.4 Cg_exo -62.03 127.9 22.59 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.933 1.491 . . . . 0.0 110.083 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.635 ' CG2' ' HB2' ' A' ' 177' ' ' ALA . 80.7 mt -89.98 98.42 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.072 -1.018 . . . . 0.0 110.389 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.605 HD13 ' O ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -151.92 -166.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 110.451 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.605 ' O ' HD13 ' A' ' 104' ' ' ILE . 98.6 mtt180 -88.77 156.93 18.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.421 -0.799 . . . . 0.0 109.696 174.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -58.34 -12.55 3.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.123 -0.986 . . . . 0.0 111.09 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 111' ' ' LYS . 35.4 p-10 -129.17 30.64 4.99 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.5 -0.75 . . . . 0.0 110.358 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.58 ' HG2' ' HB2' ' A' ' 105' ' ' ARG . 6.0 mm-40 -94.78 -94.41 0.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.982 -1.074 . . . . 0.0 111.229 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -89.3 -43.7 10.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.736 -1.227 . . . . 0.0 110.519 -171.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -103.1 51.05 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 110.232 -179.021 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 6.2 ptmt -99.37 46.76 0.97 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.259 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.31 -54.46 2.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.42 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.762 ' H ' HD12 ' A' ' 116' ' ' ILE . . . 75.08 179.73 43.96 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -176.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 113' ' ' GLY . 37.7 mt-10 42.13 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.253 -1.145 . . . . 0.0 110.212 177.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.2 2.59 90.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.762 HD12 ' H ' ' A' ' 113' ' ' GLY . 19.1 tt -59.98 -40.11 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.169 -1.194 . . . . 0.0 110.304 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.55 ' N ' HG23 ' A' ' 116' ' ' ILE . 95.9 mt-10 -60.53 -40.06 90.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.957 . . . . 0.0 109.955 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -70.02 -35.94 74.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -60.04 -39.74 86.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.768 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.944 HG11 HD11 ' A' ' 100' ' ' LEU . 54.6 t -60.14 -45.32 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -60.04 -41.2 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.014 173.029 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -60.03 -39.9 87.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.39 -42.69 18.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.845 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 4.6 mm? -94.83 0.84 55.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.019 -1.051 . . . . 0.0 111.156 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.833 HD11 ' HG2' ' A' ' 166' ' ' GLU . 0.5 OUTLIER -44.04 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.03 -1.044 . . . . 0.0 110.554 -176.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.99 52.63 0.48 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.577 -0.702 . . . . 0.0 111.589 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 13.7 mmt180 -134.36 149.99 72.7 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.997 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.755 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.8 Cg_exo -66.11 132.32 29.57 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.975 1.513 . . . . 0.0 109.93 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.839 ' HE2' HG21 ' A' ' 98' ' ' VAL . 93.9 mmm -125.19 132.19 53.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.604 -1.31 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 50' ' ' THR . 19.7 tp -133.38 108.18 8.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.69 -0.631 . . . . 0.0 109.433 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.8 pt-20 -45.7 136.12 6.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.69 -1.256 . . . . 0.0 110.163 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.583 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 80.01 -2.6 2.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.947 -0.471 . . . . 0.0 110.326 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.4 p30 -69.37 -169.97 0.25 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.297 -0.877 . . . . 0.0 110.414 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 76' ' ' ASN . 10.7 m120 -144.96 159.17 43.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.3 OUTLIER -140.02 170.02 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 110.516 -175.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.436 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 47.6 t -133.37 146.75 51.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.593 -0.692 . . . . 0.0 110.12 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.779 HG13 ' HD2' ' A' ' 138' ' ' PRO . 55.7 t -127.24 150.02 71.24 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.48 -0.762 . . . . 0.0 109.833 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.779 ' HD2' HG13 ' A' ' 137' ' ' VAL . 5.3 Cg_endo -52.73 -168.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.919 1.484 . . . . 0.0 110.136 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 58.94 93.61 0.01 OUTLIER Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.771 ' C ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -87.04 163.19 17.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.088 -1.242 . . . . 0.0 110.7 -172.475 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.635 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -55.4 -167.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.775 -1.203 . . . . 0.0 111.13 -167.14 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.587 ' N ' ' OG1' ' A' ' 141' ' ' THR . 0.1 OUTLIER -148.03 -102.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.567 -0.708 . . . . 0.0 109.991 -176.029 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.91 -159.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.42 -0.8 . . . . 0.0 110.297 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.1 62.58 4.56 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 141' ' ' THR . 5.1 pt20 -96.33 162.87 13.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.345 -1.091 . . . . 0.0 110.022 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.7 t -140.04 151.46 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.488 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 148' ' ' LEU . . . 96.39 -93.6 1.53 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.447 ' N ' ' CD2' ' A' ' 148' ' ' LEU . 2.6 mm? 42.06 41.2 1.9 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.265 -1.138 . . . . 0.0 110.732 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.624 ' C ' HD12 ' A' ' 149' ' ' LEU . 4.5 pp -140.49 166.02 25.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.009 -1.057 . . . . 0.0 109.938 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.637 ' CE1' HG21 ' A' ' 137' ' ' VAL . 58.8 m-85 -100.68 130.22 46.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 110.099 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 110.03 16.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.034 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 132' ' ' GLN . 3.1 t -76.23 136.72 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 36.6 t -116.72 -30.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 110.618 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.4 tptt -140.07 135.07 32.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 0.0 110.935 -177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.944 HG22 HG23 ' A' ' 98' ' ' VAL . 69.6 p -129.95 166.21 20.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.397 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -88.8 -38.2 0.44 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.035 . . . . 0.0 110.81 -178.272 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 1.008 ' CG ' HG11 ' A' ' 162' ' ' VAL . 22.7 Cg_exo -57.8 -171.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.551 1.29 . . . . 0.0 110.497 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.95 -167.82 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 110.013 176.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.53 -9.45 8.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.181 -0.949 . . . . 0.0 110.695 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.21 144.51 41.12 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.478 -0.764 . . . . 0.0 110.628 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.558 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -47.9 141.63 16.4 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.885 1.723 . . . . 0.0 111.252 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 1.008 HG11 ' CG ' ' A' ' 157' ' ' PRO . 8.9 m -130.23 159.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 109.946 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 88.0 tt0 -109.32 130.56 55.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.237 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.912 HD12 HG21 ' A' ' 168' ' ' THR . 12.8 mm -71.2 152.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.518 -176.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.59 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.85 169.8 25.48 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.833 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.87 -23.61 45.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -1.142 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.848 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.5 pt-20 -87.06 -12.53 46.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.912 HG21 HD12 ' A' ' 164' ' ' ILE . 13.5 m -62.94 144.76 56.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.5 mttt -93.91 154.64 17.59 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 109.897 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.68 HD12 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mm -116.87 136.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 111.038 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.541 ' CB ' ' OG1' ' A' ' 99' ' ' THR . 18.7 mt-10 -120.33 130.68 54.53 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 110.198 172.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 170' ' ' ILE . 34.9 mm -120.17 140.37 44.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.529 -0.732 . . . . 0.0 110.301 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.537 ' CZ ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -87.14 156.49 19.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.301 -176.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 96.1 mt-10 -93.55 -12.7 28.97 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.184 -0.947 . . . . 0.0 110.7 -174.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 55.9 tt0 -96.59 109.12 46.59 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.147 -0.971 . . . . 0.0 110.048 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 11.5 Cg_exo -72.91 -156.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 O-C-N 124.088 1.573 . . . . 0.0 110.537 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.635 ' HB2' ' CG2' ' A' ' 103' ' ' ILE . . . -80.21 54.43 1.97 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.708 -0.62 . . . . 0.0 110.039 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.681 ' O ' HG23 ' A' ' 180' ' ' VAL . 20.3 m -104.88 121.85 44.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.95 177.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 178' ' ' SER . 50.4 mm-40 59.95 19.98 9.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.91 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 178' ' ' SER . 62.7 t -105.68 119.99 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.463 -0.773 . . . . 0.0 110.264 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.876 ' O ' HD12 ' A' ' 181' ' ' LEU . 2.5 pp 178.57 54.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -87.95 142.97 27.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 50.07 42.72 25.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.239 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.75 150.02 50.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.471 179.99 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.57 ' O ' ' N ' ' A' ' 3' ' ' SER . 60.0 ttm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.034 0.445 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 1' ' ' MET . 86.2 tt0 38.78 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.427 -0.796 . . . . 0.0 110.873 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 1' ' ' MET . 45.0 p -139.93 153.17 46.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 110.282 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -118.29 119.46 34.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.92 . . . . 0.0 110.204 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.48 ' O ' HD13 ' A' ' 34' ' ' LEU . 27.3 t30 -111.45 30.07 7.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 109.987 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.525 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -155.47 -169.27 19.7 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.927 ' CG2' HD12 ' A' ' 33' ' ' LEU . 41.0 pt -133.29 162.86 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -1.14 . . . . 0.0 109.663 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 ' HD3' ' A' ' 86' ' ' LYS . 92.8 mt -107.62 126.55 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.806 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.6 pt? -143.78 -165.49 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.657 -0.652 . . . . 0.0 109.447 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.515 ' CZ ' HG22 ' A' ' 66' ' ' ILE . 19.9 ptt-85 -115.0 140.25 49.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 0.0 110.464 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.063 HG23 HD11 ' A' ' 69' ' ' ILE . 13.6 p -60.75 137.75 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 110.635 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -115.3 139.97 49.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 110.56 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.937 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 179.57 100.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 109.918 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -157.47 160.0 37.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.123 -0.986 . . . . 0.0 110.455 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.435 ' O ' ' OG ' ' A' ' 16' ' ' SER . 64.7 t30 50.07 40.12 20.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 110.388 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.544 ' HB3' ' HG3' ' A' ' 19' ' ' PRO . 3.4 m -164.08 158.54 19.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 110.056 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 15.3 p -78.27 -49.33 13.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.948 . . . . 0.0 110.337 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.523 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 4.5 p-10 -175.12 60.44 0.21 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.151 -0.968 . . . . 0.0 110.82 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HG3' ' HB3' ' A' ' 16' ' ' SER . 14.1 Cg_exo -64.64 108.52 1.06 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.648 1.341 . . . . 0.0 110.353 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . 91.27 90.12 1.38 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.528 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 26.5 ptm -88.36 -18.25 28.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -1.174 . . . . 0.0 109.535 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -154.57 20.2 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.576 -0.703 . . . . 0.0 109.52 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.613 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 39.8 mtm180 -128.71 149.12 50.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.457 -0.777 . . . . 0.0 110.139 -176.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 67' ' ' VAL . 83.4 t -112.44 120.56 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.75 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.2 ptm180 -95.74 119.88 35.02 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.602 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.1 mp -136.36 173.72 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.7 -175.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' OD1' ' OG ' ' A' ' 30' ' ' SER . 10.2 p-10 -95.71 -172.65 2.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 111.004 -176.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.491 ' OE2' ' NH1' ' A' ' 56' ' ' ARG . 49.7 mm-40 -59.73 -50.04 75.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 109.763 -175.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.54 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.5 t -64.1 -40.53 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.219 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.131 ' O ' HD22 ' A' ' 33' ' ' LEU . 68.6 m -60.05 -29.34 68.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 70.9 ttt180 -87.35 -46.99 9.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.659 -0.651 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 33' ' ' LEU . 87.0 mtm180 -79.94 -6.94 58.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.801 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.131 HD22 ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -42.03 -30.51 0.28 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.526 -0.734 . . . . 0.0 109.788 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 33' ' ' LEU . 79.3 mt -141.53 -61.65 0.47 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 0.0 110.592 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' C ' ' A' ' 36' ' ' ALA . 26.8 t0 -172.46 -29.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.2 -0.937 . . . . 0.0 110.03 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -23.52 116.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.514 0.674 . . . . 0.0 111.357 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.634 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -109.5 168.38 9.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.279 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -46.08 125.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.063 -1.023 . . . . 0.0 109.806 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 79.48 21.32 67.11 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.609 171.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 81.3 m-20 -89.21 173.91 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.721 -1.458 . . . . 0.0 109.359 171.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.521 ' CG1' ' HG2' ' A' ' 161' ' ' PRO . 59.7 t -99.39 134.16 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.958 . . . . 0.0 110.144 -175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.72 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -123.28 146.15 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.71 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -114.17 140.58 48.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.733 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.1 mp -124.81 138.94 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.687 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 87.6 tt0 -140.64 99.99 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 110.265 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.928 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -98.75 -66.47 0.9 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.618 -0.676 . . . . 0.0 109.401 177.138 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -111.3 -30.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.417 -0.802 . . . . 0.0 109.063 172.024 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.591 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 95.3 mtt180 -131.86 -179.82 5.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.619 173.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.51 ' HB3' HD21 ' A' ' 130' ' ' LEU . 35.0 mttt -89.17 138.34 31.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 111.011 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.663 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 5.5 p -142.57 167.7 21.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.55 0.69 . . . . 0.0 109.801 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -121.23 167.79 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.72 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.59 -168.46 38.49 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' HG22 ' A' ' 42' ' ' VAL . 67.1 ttt180 -125.45 165.09 19.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.981 . . . . 0.0 110.592 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.841 HG21 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -94.23 136.08 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.269 -175.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.613 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 1.3 m-85 -133.61 163.69 28.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.472 175.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 43.0 ttt85 -92.3 125.96 37.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.936 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -63.29 139.27 58.75 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.37 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.574 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.6 mtp180 -56.24 -48.57 96.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.763 174.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 34.2 Cg_endo -91.65 97.18 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.095 1.576 . . . . 0.0 108.965 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.12 35.93 0.11 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.547 -0.721 . . . . 0.0 110.737 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -143.59 -31.85 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.45 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.62 -28.76 24.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.185 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.489 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 3.5 m-80 -80.98 39.81 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.474 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 14.2 pttm -98.79 9.41 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -0.923 . . . . 0.0 109.683 177.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -176.36 28.08 0.07 OUTLIER Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.515 HG22 ' CZ ' ' A' ' 10' ' ' ARG . 44.6 pt -140.58 143.13 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.213 -1.169 . . . . 0.0 109.473 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.947 HG23 HG13 ' A' ' 24' ' ' VAL . 3.9 p -119.34 124.48 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.045 -1.034 . . . . 0.0 109.898 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 1.7 mtp85 -91.39 117.22 29.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.285 -0.885 . . . . 0.0 110.074 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.063 HD11 HG23 ' A' ' 11' ' ' VAL . 1.4 pt -129.69 162.96 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.632 -0.668 . . . . 0.0 110.264 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.53 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 26.0 p-10 -76.78 177.55 7.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.851 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 10.4 m -68.87 -19.0 64.23 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.613 HG12 ' ND2' ' A' ' 76' ' ' ASN . 86.3 t -69.9 -48.37 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.989 -1.069 . . . . 0.0 110.331 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.752 ' HE1' HD13 ' A' ' 44' ' ' ILE . 88.8 mmm -62.8 -40.27 96.83 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.548 174.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.898 ' NH1' HD13 ' A' ' 81' ' ' ILE . 72.7 ttt180 -60.07 -40.66 90.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 173.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' SER . 8.0 t30 -78.34 -32.58 49.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 110.577 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.613 ' ND2' HG12 ' A' ' 72' ' ' VAL . 98.6 m-20 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.377 -175.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 20.9 p -99.91 -38.28 8.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.726 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.58 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 111.05 23.7 5.73 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.928 ' HB1' ' HD2' ' A' ' 46' ' ' LYS . . . -111.05 -178.07 3.37 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.008 -1.29 . . . . 0.0 111.295 -171.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.553 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -128.74 170.15 13.66 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 174.128 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.937 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -56.37 154.54 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 110.156 178.337 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 74.84 -5.45 31.46 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.669 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.9 m-20 -56.27 -164.64 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.039 -1.271 . . . . 0.0 110.513 176.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 22.2 pttm -134.55 115.92 14.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 109.554 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.74 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -125.75 159.22 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.126 -177.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.6 ttpm? -111.72 121.04 44.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.77 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.524 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.3 t -99.65 120.06 48.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 4.6 mtt180 -112.11 139.38 47.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.826 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -86.14 138.59 31.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.486 HG21 ' CD ' ' A' ' 161' ' ' PRO . 2.2 m -147.07 -169.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.501 -0.749 . . . . 0.0 110.221 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -127.51 166.48 17.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.822 . . . . 0.0 109.631 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.51 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -99.42 162.13 13.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 0.0 111.057 -176.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.594 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.7 pt-20 -150.33 169.3 21.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.7 mm -89.93 98.28 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.603 -1.311 . . . . 0.0 110.469 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.927 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.82 141.03 46.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.308 -0.87 . . . . 0.0 110.361 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.749 ' HG2' HD22 ' A' ' 156' ' ' LEU . 5.5 pttt -108.25 -22.01 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.193 -0.942 . . . . 0.0 111.14 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 169' ' ' LYS . 62.6 tttp -150.7 117.22 5.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.613 -1.305 . . . . 0.0 110.485 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.08 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -134.74 140.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.04 . . . . 0.0 110.588 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.478 ' C ' HD23 ' A' ' 100' ' ' LEU . 41.7 m -108.02 140.31 41.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.078 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.927 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.71 165.09 26.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.105 -178.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.64 82.88 11.02 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.141 -0.974 . . . . 0.0 111.037 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 32.5 Cg_exo -50.19 143.95 24.29 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.921 1.485 . . . . 0.0 110.394 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.761 HG23 ' HB2' ' A' ' 177' ' ' ALA . 36.9 mm -107.39 92.64 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.093 -1.005 . . . . 0.0 110.634 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.813 HD13 ' HB3' ' A' ' 108' ' ' GLN . 0.6 OUTLIER -151.3 176.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 172.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' A' ' 108' ' ' GLN . 96.9 mtt180 -117.05 -146.86 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.506 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -60.01 -12.18 7.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.962 -1.086 . . . . 0.0 110.259 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 36.9 p-10 -99.43 29.19 4.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.513 -0.742 . . . . 0.0 109.826 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.813 ' HB3' HD13 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -81.03 164.08 22.76 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.216 -0.928 . . . . 0.0 110.681 -174.348 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -94.8 -14.79 24.34 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.635 -0.666 . . . . 0.0 110.267 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.474 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -99.36 64.18 1.33 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 0.0 110.573 -175.536 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 111' ' ' LYS . 1.5 ptpt -109.66 50.3 0.8 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.428 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 1.014 ' HB2' HD13 ' A' ' 116' ' ' ILE . 97.1 m-85 -97.53 -57.03 2.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 0.0 110.463 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 77.51 -177.42 52.82 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 113' ' ' GLY . 8.5 pt-20 32.66 97.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.528 -0.984 . . . . 0.0 110.704 178.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.48 -3.78 86.73 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 1.014 HD13 ' HB2' ' A' ' 112' ' ' PHE . 9.0 tp -58.62 -30.0 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -1.229 . . . . 0.0 109.723 175.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.709 ' HA ' HD11 ' A' ' 172' ' ' ILE . 99.0 mt-10 -59.97 -45.32 93.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -70.02 -32.95 71.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 110.582 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -60.07 -39.98 87.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.139 -0.976 . . . . 0.0 109.062 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.878 HG12 ' CD1' ' A' ' 170' ' ' ILE . 53.9 t -60.52 -49.11 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.677 174.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.628 ' NE2' ' O ' ' A' ' 168' ' ' THR . 2.5 mt-30 -59.99 -42.65 94.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.0 -45.61 92.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 110.157 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.538 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.95 -43.4 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.644 HD22 ' N ' ' A' ' 124' ' ' LEU . 4.1 mm? -99.79 6.17 45.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.977 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.737 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.6 tt -47.98 165.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.76 -1.212 . . . . 0.0 109.821 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 11.6 ptp180 35.3 47.7 0.33 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.445 -0.785 . . . . 0.0 111.387 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 7.4 mmt85 -129.37 150.88 76.78 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.791 -1.193 . . . . 0.0 110.965 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.784 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.3 Cg_endo -68.71 128.55 17.19 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 124.233 1.649 . . . . 0.0 109.716 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.505 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.9 mmm -124.76 139.84 53.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.446 -1.409 . . . . 0.0 110.885 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 50' ' ' THR . 16.7 tp -141.34 104.38 4.59 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.639 -0.663 . . . . 0.0 109.558 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.0 pt-20 -43.41 139.43 2.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.617 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.61 -7.01 0.98 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.184 0.516 . . . . 0.0 110.334 -177.618 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.54 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.3 p-10 -70.08 174.96 4.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 29.9 m-80 -141.38 149.72 41.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.03 169.37 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 110.108 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.54 135.96 46.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 0.0 110.423 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.641 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 12.0 t -115.08 -66.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.496 -0.752 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 43.7 Cg_endo -71.74 115.75 4.43 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.273 1.144 . . . . 0.0 110.483 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -88.74 41.64 3.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.64 160.57 39.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.448 -1.031 . . . . 0.0 110.147 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.758 ' O ' HD23 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -136.17 -169.41 2.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.169 -0.957 . . . . 0.0 110.551 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 141' ' ' THR . 58.5 mt -143.1 -128.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.757 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.1 -155.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.947 . . . . 0.0 110.348 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.25 61.06 4.21 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.465 ' OE1' ' HB2' ' A' ' 142' ' ' LEU . 14.2 pt20 -96.78 159.95 14.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.398 -1.06 . . . . 0.0 110.214 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -139.22 159.51 41.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.927 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.869 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 105.3 -93.05 0.88 Allowed Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.869 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.9 OUTLIER 38.46 40.01 0.34 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.429 -1.041 . . . . 0.0 111.078 177.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 149' ' ' LEU . 3.7 pp -140.58 165.07 28.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.682 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 28.6 m-85 -93.3 133.28 36.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.039 -1.038 . . . . 0.0 110.229 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.52 108.48 15.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.92 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.54 HG21 ' OD1' ' A' ' 133' ' ' ASP . 3.3 t -77.16 140.02 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.816 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.4 t -120.51 -30.95 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.129 -0.982 . . . . 0.0 110.785 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -143.09 149.55 38.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.772 -1.205 . . . . 0.0 111.59 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.08 HG22 HG23 ' A' ' 98' ' ' VAL . 55.1 p -140.54 164.39 30.28 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.749 HD22 ' HG2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -88.42 -39.15 0.46 Allowed Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.893 . . . . 0.0 110.692 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.977 ' CB ' HG11 ' A' ' 162' ' ' VAL . 19.3 Cg_exo -58.56 -172.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.556 1.293 . . . . 0.0 110.38 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 -167.68 1.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.465 -0.772 . . . . 0.0 109.821 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -65.79 -4.88 7.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.219 -0.925 . . . . 0.0 110.983 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.7 145.26 41.26 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.424 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.56 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -49.35 141.31 25.09 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.221 1.643 . . . . 0.0 110.545 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.977 HG11 ' CB ' ' A' ' 157' ' ' PRO . 4.6 m -129.88 157.9 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 109.942 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 53.7 tt0 -106.91 128.01 53.94 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 110.2 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.804 HD12 HG21 ' A' ' 168' ' ' THR . 11.2 mm -70.85 156.48 7.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 110.275 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.74 169.73 25.96 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.737 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -57.85 -21.45 42.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 0.0 110.209 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -88.35 -21.6 24.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.884 . . . . 0.0 109.575 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.804 HG21 HD12 ' A' ' 164' ' ' ILE . 26.6 m -56.89 162.07 2.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.514 -0.741 . . . . 0.0 110.231 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' LYS . 46.8 mtmt -121.02 149.82 42.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.464 176.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.927 HG23 HD21 ' A' ' 100' ' ' LEU . 1.2 mt -127.99 162.95 32.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 110.95 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 35.8 mt-10 -138.35 137.29 37.2 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.521 0.676 . . . . 0.0 110.11 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.709 HD11 ' HA ' ' A' ' 117' ' ' GLU . 4.3 mp -121.68 137.72 54.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.887 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.577 ' O ' ' NE ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -87.27 150.07 24.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 0.0 110.096 -174.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 96.7 mt-10 -90.66 -12.64 36.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 110.272 -175.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.33 109.23 41.49 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.744 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.2 Cg_exo -71.06 -154.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.161 1.611 . . . . 0.0 110.322 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.761 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -79.19 51.08 1.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.617 -0.677 . . . . 0.0 110.118 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 27.3 t -65.11 -72.31 0.16 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.296 -0.877 . . . . 0.0 110.779 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.639 ' O ' HD23 ' A' ' 181' ' ' LEU . 86.5 tt0 -61.95 -10.28 9.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.021 -1.049 . . . . 0.0 110.608 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.49 117.84 31.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.495 -0.753 . . . . 0.0 110.199 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 179' ' ' GLU . 0.7 OUTLIER -170.0 -21.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.379 -0.826 . . . . 0.0 110.903 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.507 ' N ' ' HG ' ' A' ' 181' ' ' LEU . 98.9 mt-10 -127.17 50.14 2.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.003 -1.06 . . . . 0.0 110.511 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.81 -39.93 86.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.159 -0.963 . . . . 0.0 110.082 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.53 163.87 26.43 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.003 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.259 0.552 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -120.13 140.0 51.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 110.122 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.88 91.1 7.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 110.086 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -149.94 98.62 2.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 110.139 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -137.57 122.81 19.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.338 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.526 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -152.18 -161.88 10.48 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.709 HG23 HD11 ' A' ' 34' ' ' LEU . 42.5 pt -136.07 157.92 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -1.204 . . . . 0.0 110.0 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 mm -101.5 113.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.026 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.714 HD11 ' HB ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -139.81 -173.8 3.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.885 -178.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 24.1 ptt-85 -115.77 139.81 49.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.943 -1.098 . . . . 0.0 110.619 -175.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.762 HG13 ' HA ' ' A' ' 81' ' ' ILE . 14.5 p -61.8 132.55 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.538 -0.726 . . . . 0.0 110.634 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -108.78 145.33 35.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.63 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.957 ' HB3' HD11 ' A' ' 81' ' ' ILE . 84.8 tt0 -177.98 94.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.874 175.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.43 42.34 3.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.33 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -139.65 144.92 37.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.918 . . . . 0.0 110.181 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.0 t -60.08 -44.01 95.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.322 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -92.11 157.69 16.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 110.11 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.499 ' HB2' ' OD1' ' A' ' 70' ' ' ASP . 12.5 p-10 -135.04 71.3 69.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 110.272 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -67.33 112.47 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.963 1.507 . . . . 0.0 110.774 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.53 83.3 1.67 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.571 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 24.7 ptp -90.01 -9.87 47.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -1.167 . . . . 0.0 110.081 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 80.9 p -113.74 9.02 17.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 110.342 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 53' ' ' ARG . 24.9 mmt85 -119.96 144.03 47.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.233 -0.917 . . . . 0.0 109.846 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.118 HG13 HG23 ' A' ' 67' ' ' VAL . 85.6 t -110.45 119.98 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 0.0 110.195 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 26' ' ' LEU . 5.1 ptt180 -90.25 116.66 28.4 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.753 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.922 HD13 HG12 ' A' ' 24' ' ' VAL . 1.1 mp -128.24 174.91 8.87 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 3.5 p-10 -91.67 177.54 6.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.84 -1.162 . . . . 0.0 110.404 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 87.0 mt-10 -60.04 -39.99 87.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.59 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -67.74 -58.33 4.82 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.107 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.583 ' C ' HD22 ' A' ' 33' ' ' LEU . 68.3 m -49.99 -30.04 9.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 109.629 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 51.6 ttp180 -81.73 -47.95 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 111.261 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -93.91 -16.86 23.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.767 -1.208 . . . . 0.0 111.199 -171.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.926 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.1 pt? -60.0 -28.77 67.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.131 . . . . 0.0 110.24 -176.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.926 ' H ' HD23 ' A' ' 33' ' ' LEU . 61.4 mt -101.91 -73.37 0.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 109.97 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' ALA . 12.6 t0 -170.02 -27.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -36.23 122.36 0.72 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.327 0.584 . . . . 0.0 110.933 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.716 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -115.65 179.32 4.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.003 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 38' ' ' ILE . 28.2 mm -54.64 128.27 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.985 -1.072 . . . . 0.0 109.897 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.62 18.36 75.75 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.575 172.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.441 ' OD1' ' OE2' ' A' ' 37' ' ' GLU . 79.5 m-20 -89.17 161.86 16.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.649 -1.501 . . . . 0.0 109.635 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.838 HG21 ' OG1' ' A' ' 92' ' ' THR . 94.0 t -99.62 135.92 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.058 -1.026 . . . . 0.0 110.499 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.736 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -119.98 153.12 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.861 . . . . 0.0 110.571 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 86.5 tt0 -118.88 139.93 50.82 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.348 -0.845 . . . . 0.0 110.009 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.8 mp -119.98 145.11 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.049 . . . . 0.0 110.754 -177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.49 95.28 2.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.353 -0.842 . . . . 0.0 111.023 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.999 ' HG3' HG12 ' A' ' 85' ' ' VAL . 9.7 tmtm? -97.85 -59.19 1.82 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.995 . . . . 0.0 109.852 173.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.58 HG23 ' C ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -113.21 -33.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.58 -0.7 . . . . 0.0 109.22 175.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 78.9 mtm-85 -136.56 178.42 7.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 174.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.607 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.1 132.26 34.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.163 -0.96 . . . . 0.0 110.386 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.598 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.1 p -139.69 168.13 20.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.468 0.651 . . . . 0.0 109.695 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.755 HG13 ' HG ' ' A' ' 130' ' ' LEU . 2.8 m -115.24 175.16 2.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.55 -0.719 . . . . 0.0 110.66 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.736 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.78 179.75 48.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 174.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.535 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 51.1 mtp180 -125.82 176.13 7.16 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.274 -1.133 . . . . 0.0 110.027 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -99.15 127.07 52.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.351 -175.21 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -117.6 164.81 14.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 175.01 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -89.87 121.74 32.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.439 -0.788 . . . . 0.0 109.803 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.791 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -62.82 132.4 52.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.604 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.4 mtt-85 -57.11 -47.4 99.13 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.708 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.76 97.17 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.96 1.505 . . . . 0.0 108.975 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -75.56 33.51 0.11 Allowed 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.429 -0.794 . . . . 0.0 110.977 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -145.73 -28.54 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.055 -1.028 . . . . 0.0 110.631 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -87.03 -25.76 24.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 109.129 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.791 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 18.3 m120 -81.1 42.33 0.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.639 -0.663 . . . . 0.0 110.269 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.528 ' CD ' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.73 9.52 43.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 0.0 109.788 176.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.89 27.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.577 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.465 HG22 ' CZ ' ' A' ' 10' ' ' ARG . 45.8 pt -140.78 141.71 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.272 -1.134 . . . . 0.0 109.653 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.118 HG23 HG13 ' A' ' 24' ' ' VAL . 2.4 p -117.01 128.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.848 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HD3' ' HD3' ' A' ' 25' ' ' ARG . 78.7 ttt180 -90.82 119.38 30.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.759 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.6 pp -133.31 165.03 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 110.473 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.571 ' OD2' ' N ' ' A' ' 21' ' ' MET . 89.2 m-20 -80.01 169.2 18.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.734 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.2 m -60.04 -39.95 87.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.413 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.1 -46.6 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.927 . . . . 0.0 110.161 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.756 ' CE ' HD13 ' A' ' 44' ' ' ILE . 16.8 tpt -60.06 -42.81 95.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.582 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.427 ' HD2' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -61.75 -39.97 93.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.691 173.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -69.98 -23.41 63.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.443 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 73' ' ' MET . 75.3 m-20 -60.1 -39.99 88.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.033 -1.042 . . . . 0.0 110.641 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.58 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.1 p -98.96 -37.09 9.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.901 -1.124 . . . . 0.0 110.577 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.92 33.18 1.72 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.776 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -109.99 162.79 14.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -1.212 . . . . 0.0 110.401 -177.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.633 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 169.96 8.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.349 -0.844 . . . . 0.0 109.26 177.318 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.957 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -52.79 144.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.194 177.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.99 0.34 60.15 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.0 m-20 -58.89 -162.83 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.801 -1.411 . . . . 0.0 110.36 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 15.3 ptpt -135.13 113.64 11.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.477 -0.764 . . . . 0.0 109.77 176.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.999 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -123.74 156.37 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.629 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -102.9 119.79 39.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.813 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.526 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 45.6 t -102.04 119.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.55 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 84.4 mtm-85 -116.76 140.48 49.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.998 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 24.0 tttm -72.34 145.33 47.85 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 110.879 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.555 HG23 HG12 ' A' ' 41' ' ' VAL . 2.2 m -147.4 -167.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.651 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -134.06 168.61 18.5 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 109.653 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.838 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -112.21 159.26 18.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.077 -1.015 . . . . 0.0 111.149 -174.295 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.423 ' H ' ' HA ' ' A' ' 162' ' ' VAL . 7.4 pt-20 -150.08 170.54 18.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.3 96.49 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.467 -1.396 . . . . 0.0 110.219 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.928 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.58 147.81 21.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.508 -0.745 . . . . 0.0 110.643 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 169' ' ' LYS . 9.7 ptmt -115.69 -24.9 8.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.805 . . . . 0.0 111.01 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.748 ' HB3' HD23 ' A' ' 156' ' ' LEU . 42.7 tttp -149.99 125.84 10.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.759 -1.213 . . . . 0.0 110.691 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.007 HG23 HG22 ' A' ' 155' ' ' THR . 7.3 p -139.46 146.96 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.176 -0.953 . . . . 0.0 110.293 176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.604 ' C ' HD23 ' A' ' 100' ' ' LEU . 95.4 m -119.56 138.37 53.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.829 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -140.01 174.17 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -143.95 102.38 4.88 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 110.752 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -56.15 128.88 32.0 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.0 110.048 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.094 HG23 ' HB2' ' A' ' 177' ' ' ALA . 74.8 mt -95.94 104.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 110.282 -177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.856 HD12 ' CG ' ' A' ' 108' ' ' GLN . 15.2 pt -140.83 -160.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.867 . . . . 0.0 109.933 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.539 ' CB ' ' OD1' ' A' ' 107' ' ' ASP . 41.5 mmt180 -110.3 155.54 21.93 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.421 178.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -58.45 -16.01 13.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.68 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.539 ' OD1' ' CB ' ' A' ' 105' ' ' ARG . 33.5 p-10 -104.09 34.06 3.21 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.79 -0.569 . . . . 0.0 109.596 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.856 ' CG ' HD12 ' A' ' 104' ' ' ILE . 1.6 pp0? -81.42 144.33 31.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.133 -0.98 . . . . 0.0 110.277 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.491 ' H ' HD11 ' A' ' 142' ' ' LEU . 33.6 ttm180 -96.04 -11.15 26.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.495 -0.753 . . . . 0.0 111.011 -175.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -98.03 53.58 1.09 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 110.017 -175.016 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.515 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 10.8 ptmt -100.59 140.37 34.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 109.809 176.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.06 -70.38 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.413 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 76.42 -170.95 54.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 113' ' ' GLY . 46.1 mt-10 42.37 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.212 -1.169 . . . . 0.0 110.278 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.05 -10.13 69.69 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.545 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.7 tp -64.05 -40.06 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -1.173 . . . . 0.0 110.13 176.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 116' ' ' ILE . 41.3 tt0 -59.93 -42.75 94.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.857 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.67 -37.3 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.872 . . . . 0.0 109.817 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -59.99 -39.36 85.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.833 . . . . 0.0 109.684 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 170' ' ' ILE . 67.3 t -60.03 -47.25 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.58 ' HA ' ' CD2' ' A' ' 124' ' ' LEU . 2.7 mt-30 -60.04 -41.37 92.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -60.11 -41.53 92.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 110.293 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.71 -48.58 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.919 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.3 OUTLIER -96.28 3.69 52.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.005 -1.06 . . . . 0.0 110.905 -172.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.618 ' HA ' HG22 ' A' ' 164' ' ' ILE . 3.4 tt -41.58 165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 110.492 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.95 47.43 0.18 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 111.319 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.7 OUTLIER -133.61 135.06 24.33 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.949 -1.094 . . . . 0.0 111.051 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.844 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 7.4 Cg_endo -54.33 119.76 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.815 1.429 . . . . 0.0 109.498 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.672 ' O ' HG22 ' A' ' 162' ' ' VAL . 93.5 mmm -133.26 141.94 48.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.586 -1.321 . . . . 0.0 110.738 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.773 ' H ' HD13 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.67 145.93 25.42 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.703 0.763 . . . . 0.0 110.752 175.338 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -53.47 158.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.594 -0.691 . . . . 0.0 111.085 -174.307 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.6 -6.17 1.84 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.83 -0.544 . . . . 0.0 110.798 177.372 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.735 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.3 p30 -70.22 169.15 14.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -136.01 138.95 42.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -140.35 169.97 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.986 -1.071 . . . . 0.0 110.338 -177.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.2 t -140.43 143.54 35.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.909 . . . . 0.0 110.257 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.666 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 13.3 t -118.99 -69.4 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 0.0 110.776 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.666 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 43.2 Cg_endo -71.88 130.78 17.26 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.176 1.093 . . . . 0.0 110.277 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -97.0 47.25 1.65 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -128.5 159.08 36.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -1.111 . . . . 0.0 110.386 -178.263 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -132.91 -168.9 2.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.187 -0.946 . . . . 0.0 110.545 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' A' ' 141' ' ' THR . 83.7 mt -143.94 -132.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 109.937 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.72 -151.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 110.428 176.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.29 60.06 3.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.64 161.02 13.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.447 -1.031 . . . . 0.0 110.243 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.9 t -139.95 156.62 46.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.322 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.595 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 101.74 -87.96 0.67 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 43.37 49.14 6.04 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.557 -0.966 . . . . 0.0 111.244 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.734 ' HG ' HD12 ' A' ' 103' ' ' ILE . 2.4 pp -140.24 169.56 17.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.854 -1.154 . . . . 0.0 109.836 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -92.35 129.19 38.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.036 -1.04 . . . . 0.0 110.094 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.743 ' HB2' HD11 ' A' ' 103' ' ' ILE . 57.8 tptt -108.6 108.39 19.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.735 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.2 t -79.72 136.22 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.036 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.89 -22.74 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 110.784 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -150.01 151.24 32.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.843 -1.161 . . . . 0.0 110.976 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.007 HG22 HG23 ' A' ' 98' ' ' VAL . 34.5 p -141.66 169.39 17.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 109.389 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.44 -40.27 0.46 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.698 -178.197 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.973 ' CB ' HG11 ' A' ' 162' ' ' VAL . 17.1 Cg_exo -58.99 -164.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.718 1.378 . . . . 0.0 110.425 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.518 ' HB3' HG22 ' A' ' 160' ' ' VAL . 23.6 t -89.98 -171.36 3.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.804 175.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -67.44 -6.09 17.78 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.165 -0.959 . . . . 0.0 110.498 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 158' ' ' SER . 23.8 m -87.59 148.3 43.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.405 -177.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.665 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.23 143.34 7.86 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.267 1.667 . . . . 0.0 110.628 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.973 HG11 ' CB ' ' A' ' 157' ' ' PRO . 9.1 m -130.04 159.37 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.58 122.43 44.96 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.838 -1.163 . . . . 0.0 110.13 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.756 ' CD1' HG21 ' A' ' 168' ' ' THR . 8.0 mm -69.54 158.31 6.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.68 -0.638 . . . . 0.0 110.196 -176.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.64 167.08 26.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.53 -23.09 57.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -1.043 . . . . 0.0 110.248 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.99 -12.07 39.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.152 -0.967 . . . . 0.0 110.087 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 95' ' ' ALA . 5.6 m -57.75 179.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.129 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 168' ' ' THR . 50.0 mtpt -140.54 159.66 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.812 HG23 HD21 ' A' ' 100' ' ' LEU . 4.3 mt -140.02 168.0 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 110.834 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.529 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 13.5 mt-10 -139.17 131.73 28.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.609 -0.682 . . . . 0.0 110.195 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.501 HD13 ' HG ' ' A' ' 100' ' ' LEU . 37.2 mm -119.97 119.94 61.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.87 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.475 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 6.1 ptp180 -89.12 163.15 15.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.23 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.507 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 96.5 mt-10 -100.03 12.88 35.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.339 -0.85 . . . . 0.0 110.575 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 3.8 tt0 -94.08 109.21 40.76 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.929 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.2 Cg_exo -72.22 -155.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.115 1.587 . . . . 0.0 110.322 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.094 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -85.57 44.98 1.15 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.495 0.664 . . . . 0.0 110.217 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 47.4 t -54.11 -59.27 4.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.526 -0.734 . . . . 0.0 110.643 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -84.73 3.99 34.81 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.998 -1.064 . . . . 0.0 110.136 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.414 ' C ' HD23 ' A' ' 181' ' ' LEU . 62.6 t -111.0 129.93 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 110.055 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.697 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -119.42 -44.89 2.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.479 -179.583 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -152.52 160.7 43.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 110.404 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -59.9 -30.0 68.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 0.0 110.222 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.06 -166.83 52.06 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.427 179.617 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 57.1 ttm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.296 0.57 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 1' ' ' MET . 96.9 mt-10 54.49 40.04 31.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 110.088 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.3 t -60.11 -40.01 88.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.948 . . . . 0.0 110.187 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' OD1' ' HD3' ' A' ' 88' ' ' ARG . 18.3 t-20 -142.36 116.75 9.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.445 ' O ' HD13 ' A' ' 34' ' ' LEU . 32.2 m120 -139.39 152.99 47.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 110.086 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -152.01 -166.2 13.85 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.017 ' CG2' HD12 ' A' ' 33' ' ' LEU . 37.3 pt -135.75 159.98 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -1.179 . . . . 0.0 109.811 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.7 mt -101.26 118.64 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.409 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.838 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.7 pt? -139.2 -170.78 2.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.7 ptp180 -107.9 135.45 49.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.818 -1.176 . . . . 0.0 110.802 -173.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.02 ' CG2' HD11 ' A' ' 69' ' ' ILE . 14.3 p -62.97 131.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.702 . . . . 0.0 110.774 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -113.91 152.97 30.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.928 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 -174.89 109.58 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 110.246 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.52 -65.09 1.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 110.412 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -115.11 128.22 56.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.228 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 t -140.22 101.17 4.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.215 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -93.22 -14.35 27.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.052 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 46.1 p-10 -139.05 70.02 41.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.174 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.468 ' HA ' ' CB ' ' A' ' 70' ' ' ASP . 27.7 Cg_exo -57.62 140.9 94.92 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.068 1.562 . . . . 0.0 110.557 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.42 30.95 10.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.541 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 27.7 ptt? -88.12 0.02 56.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.146 -1.208 . . . . 0.0 109.105 174.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.6 m 49.98 40.15 20.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.372 -0.83 . . . . 0.0 110.487 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 21' ' ' MET . 69.4 mtp180 -118.23 135.58 54.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.111 -0.993 . . . . 0.0 110.486 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.094 HG13 HG23 ' A' ' 67' ' ' VAL . 97.5 t -120.0 124.28 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.102 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.548 ' O ' HD12 ' A' ' 26' ' ' LEU . 7.2 ptt180 -92.27 120.05 32.45 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.786 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.767 HD13 HG12 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -134.05 164.81 26.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.574 -0.704 . . . . 0.0 109.825 -176.433 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -93.54 -177.34 4.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.004 -1.06 . . . . 0.0 110.555 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.02 -47.33 86.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.672 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 58.1 m -66.32 -43.74 85.33 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.45 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.114 ' O ' HD22 ' A' ' 33' ' ' LEU . 55.8 p -60.81 -26.89 67.63 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 53.3 ttp180 -88.35 -45.93 9.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.584 -0.697 . . . . 0.0 110.89 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 99.5 mtt180 -76.59 -10.04 59.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 0.0 109.896 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.114 HD22 ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -41.25 -30.03 0.15 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.607 0.718 . . . . 0.0 109.948 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.762 ' H ' HD23 ' A' ' 33' ' ' LEU . 73.8 mt -139.98 -61.18 0.53 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.574 -0.704 . . . . 0.0 110.63 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 16.2 t0 -169.98 -28.73 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.551 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.619 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -23.71 118.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.558 0.694 . . . . 0.0 111.457 -175.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.659 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.4 pt-20 -104.63 177.59 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 38' ' ' ILE . 26.5 mm -58.1 122.59 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.963 -1.086 . . . . 0.0 109.933 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.562 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.51 30.14 60.67 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 33.8 m-20 -89.28 174.4 7.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.832 -1.393 . . . . 0.0 109.411 170.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.637 HG21 ' N ' ' A' ' 92' ' ' THR . 96.6 t -99.38 124.69 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.238 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.67 HG11 HG23 ' A' ' 54' ' ' VAL . 2.5 m -111.82 140.04 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.27 -0.893 . . . . 0.0 110.489 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' C ' HD12 ' A' ' 44' ' ' ILE . 41.7 tt0 -108.1 143.91 36.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.764 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.905 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.8 mp -119.8 144.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.068 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -151.51 87.69 1.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.833 -1.167 . . . . 0.0 111.604 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.761 ' HB2' HG12 ' A' ' 85' ' ' VAL . 38.5 tttp -98.57 -75.95 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 110.287 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.51 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -91.78 -33.81 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.481 -0.762 . . . . 0.0 109.62 177.424 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 91.6 mtt180 -143.93 -172.31 3.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.686 ' C ' HD21 ' A' ' 130' ' ' LEU . 14.2 mptt -87.95 132.19 34.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.679 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.554 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -133.95 158.78 42.62 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.293 0.568 . . . . 0.0 110.226 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.12 161.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 110.174 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.575 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -176.92 179.39 47.89 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.82 -178.78 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.248 -1.148 . . . . 0.0 109.981 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.67 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -110.47 135.3 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 110.373 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -128.02 167.67 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.285 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 35.2 ptt180 -89.32 124.9 34.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.078 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.8 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -61.84 131.54 50.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.946 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.644 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 11.5 mtt180 -59.51 -42.09 90.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 C-N-CA 119.101 -1.039 . . . . 0.0 109.367 175.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.644 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 29.3 Cg_endo -94.33 99.83 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.886 1.467 . . . . 0.0 108.998 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 12.0 pt-20 -72.77 32.61 0.07 Allowed 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.392 -0.817 . . . . 0.0 110.859 -175.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.6 m-20 -148.58 -26.66 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 0.0 110.701 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 66' ' ' ILE . 52.9 mt-10 -86.26 -28.48 23.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 109.109 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.8 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 43.5 m-80 -81.12 42.22 0.64 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.361 0.6 . . . . 0.0 110.375 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HD3' ' OD2' ' A' ' 27' ' ' ASP . 37.2 mmtt -96.76 6.32 48.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.287 177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.4 29.55 0.05 OUTLIER Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 9' ' ' LEU . 45.7 pt -140.78 145.12 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.224 -1.162 . . . . 0.0 109.525 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.094 HG23 HG13 ' A' ' 24' ' ' VAL . 2.6 p -123.17 130.0 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.827 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.539 ' CD ' ' HD3' ' A' ' 25' ' ' ARG . 71.3 ttt180 -91.6 114.62 27.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 110.131 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.02 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.6 pt -130.16 159.98 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.679 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 95.8 m-20 -81.09 169.57 17.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 110.227 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -57.86 -22.55 48.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.07 -48.84 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.905 ' HE1' HD13 ' A' ' 44' ' ' ILE . 97.0 mmm -60.03 -43.91 94.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.953 . . . . 0.0 109.6 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -59.98 -40.49 89.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.25 -0.906 . . . . 0.0 110.04 174.402 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -69.49 -35.87 75.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.532 ' HB3' HG22 ' A' ' 50' ' ' THR . 20.6 m120 -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.269 -0.894 . . . . 0.0 110.372 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.6 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.7 p -98.36 -35.79 10.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 110.607 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.51 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 109.92 28.05 4.34 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.603 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -100.39 177.63 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.242 . . . . 0.0 111.016 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.903 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -122.81 172.24 8.6 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -0.853 . . . . 0.0 109.196 175.392 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.928 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -62.19 142.23 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.717 -1.239 . . . . 0.0 110.561 179.239 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.566 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 74.55 -0.61 55.15 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 173.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -59.65 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.097 -1.237 . . . . 0.0 110.33 175.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 19.1 pttp -133.2 116.33 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.575 -0.703 . . . . 0.0 109.904 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -122.12 160.12 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 110.023 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 40.1 tttt -107.4 120.66 42.77 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.523 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 72.3 t -103.96 122.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 0.0 109.998 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.521 ' HD3' ' OD1' ' A' ' 4' ' ' ASN . 96.1 mtt180 -110.0 148.03 32.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.629 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.619 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 2.4 tmtt? -93.86 136.01 34.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.056 -1.027 . . . . 0.0 110.53 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.1 m -149.81 -170.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.927 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 52.7 mtt180 -132.85 164.41 26.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 110.41 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.637 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.45 159.39 17.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 111.224 -176.13 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.653 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.8 pt-20 -150.42 169.99 20.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 94' ' ' ILE . 48.5 mm -89.17 101.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.827 -1.17 . . . . 0.0 110.264 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.918 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.38 135.46 53.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.266 -0.896 . . . . 0.0 110.184 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.552 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 7.1 ptpp? -97.24 -29.75 13.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -0.973 . . . . 0.0 111.112 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.682 ' HB3' HD23 ' A' ' 156' ' ' LEU . 47.3 tttm -151.27 126.66 10.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 110.789 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.037 HG23 HG22 ' A' ' 155' ' ' THR . 9.2 p -136.53 145.98 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.122 . . . . 0.0 110.881 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -119.74 139.45 52.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.051 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.746 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.55 166.09 23.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.505 -177.669 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.51 89.65 11.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.33 -0.857 . . . . 0.0 110.466 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.0 Cg_exo -59.65 128.74 28.09 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.997 1.525 . . . . 0.0 110.434 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.049 HG23 ' HB2' ' A' ' 177' ' ' ALA . 56.7 mt -89.9 93.69 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 178.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.626 HG13 HD23 ' A' ' 110' ' ' LEU . 11.8 pt -150.72 -166.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.629 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.491 ' HB2' ' HG3' ' A' ' 108' ' ' GLN . 20.8 mmm180 -93.71 153.09 18.53 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.669 173.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.667 ' HA ' HD21 ' A' ' 110' ' ' LEU . 48.2 mtmt -59.23 -18.62 38.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 110.192 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -103.95 9.97 36.44 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 111.155 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.491 ' HG3' ' HB2' ' A' ' 105' ' ' ARG . 40.0 mt-30 -92.26 -79.97 0.37 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.884 -1.135 . . . . 0.0 110.927 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.567 ' H ' HD12 ' A' ' 104' ' ' ILE . 34.0 ttm180 -118.76 -16.75 9.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 110.97 -175.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.667 HD21 ' HA ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -98.32 46.56 1.0 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.054 -176.534 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -137.63 64.01 1.53 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.576 -0.703 . . . . 0.0 110.184 179.172 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -140.87 -60.16 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.091 -1.006 . . . . 0.0 110.508 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.52 -173.43 54.33 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 47.39 87.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.19 -1.182 . . . . 0.0 110.494 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.74 -2.73 87.29 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.2 tp -64.19 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -1.189 . . . . 0.0 110.257 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.557 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -67.31 -39.98 85.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.905 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.04 -31.46 69.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.05 -41.69 92.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 110.076 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.759 HG12 ' CD1' ' A' ' 170' ' ' ILE . 55.0 t -60.08 -45.92 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.57 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.2 mt-30 -60.0 -42.74 94.93 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 110.273 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.13 -47.94 83.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.481 -0.762 . . . . 0.0 110.151 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.17 75.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.532 -0.73 . . . . 0.0 110.318 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.524 HD12 ' CG1' ' A' ' 120' ' ' VAL . 51.5 mt -93.76 -5.72 47.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.416 -176.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.846 HD11 ' HG2' ' A' ' 166' ' ' GLU . 2.5 tt -45.91 167.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.926 -1.109 . . . . 0.0 110.207 -172.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 164' ' ' ILE . 32.0 ptt180 33.82 48.24 0.21 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.672 -0.642 . . . . 0.0 111.768 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 9.3 mmt85 -136.57 148.98 65.93 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 120.533 -1.355 . . . . 0.0 111.83 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.838 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -66.19 130.6 24.52 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.24 1.652 . . . . 0.0 109.653 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.522 ' SD ' HG13 ' A' ' 164' ' ' ILE . 39.9 mtp -130.58 150.06 51.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.44 -1.412 . . . . 0.0 111.207 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.686 HD21 ' C ' ' A' ' 49' ' ' LYS . 16.5 tp -144.44 107.93 4.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.663 -0.648 . . . . 0.0 109.637 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.2 pm0 -44.71 142.9 1.55 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.359 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.571 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.6 OUTLIER 80.39 -0.85 1.96 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.125 0.488 . . . . 0.0 110.259 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.603 ' OD2' HG21 ' A' ' 152' ' ' VAL . 4.2 p-10 -70.0 179.4 2.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 109.85 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.525 ' OD1' ' HD2' ' A' ' 151' ' ' LYS . 13.4 m-80 -150.17 136.1 18.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.632 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -139.99 162.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.008 -1.057 . . . . 0.0 110.303 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.3 t -141.03 144.04 34.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.459 -0.776 . . . . 0.0 110.282 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.7 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 34.8 t -127.45 -69.35 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 110.938 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.7 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 38.2 Cg_endo -70.42 124.08 10.48 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.073 1.038 . . . . 0.0 110.386 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -96.07 46.87 1.84 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pp -126.85 153.03 46.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.438 -1.037 . . . . 0.0 110.33 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -141.71 -167.67 2.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.209 -0.932 . . . . 0.0 110.506 -179.374 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.577 ' N ' ' OG1' ' A' ' 141' ' ' THR . 84.4 mt -136.23 -109.92 0.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.604 -0.685 . . . . 0.0 109.909 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.49 -159.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.38 177.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.66 56.25 4.74 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 145' ' ' GLN . 13.7 pt20 -101.26 159.05 15.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.393 -1.063 . . . . 0.0 110.375 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.3 t -139.99 155.69 46.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.034 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.775 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 119.95 -84.58 0.37 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.775 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.5 OUTLIER 43.17 49.6 5.63 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.426 -1.044 . . . . 0.0 110.995 177.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.502 ' HG ' HD12 ' A' ' 103' ' ' ILE . 1.6 pp -140.02 166.69 23.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.907 -1.121 . . . . 0.0 110.026 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 30.0 m-85 -92.52 129.6 38.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.525 ' HD2' ' OD1' ' A' ' 134' ' ' ASN . 19.3 tptp -112.31 103.63 11.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.873 . . . . 0.0 109.75 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.603 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.1 t -77.44 140.01 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.14 -25.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 111.372 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 45.0 tptt -140.24 129.93 24.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.587 -1.321 . . . . 0.0 110.885 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.037 HG22 HG23 ' A' ' 98' ' ' VAL . 59.7 p -129.99 166.31 20.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.389 -0.82 . . . . 0.0 109.164 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -89.05 -35.47 0.42 Allowed Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.084 -1.01 . . . . 0.0 110.98 -176.58 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 1.048 ' CG ' HG11 ' A' ' 162' ' ' VAL . 31.6 Cg_exo -53.1 -179.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.4 1.211 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.709 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -84.83 49.76 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.516 -179.238 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.6 mmtm 59.99 20.03 9.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.731 ' O ' HG13 ' A' ' 162' ' ' VAL . 11.5 m -109.41 159.74 30.3 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.411 -0.806 . . . . 0.0 110.326 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.555 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.1 Cg_endo -53.87 123.29 13.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.198 1.631 . . . . 0.0 110.2 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 1.048 HG11 ' CG ' ' A' ' 157' ' ' PRO . 5.0 m -129.78 158.46 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.879 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -103.2 128.1 50.29 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.009 177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.945 HD12 HG21 ' A' ' 168' ' ' THR . 10.7 mm -70.26 154.22 8.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.636 -0.665 . . . . 0.0 110.036 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.07 170.98 24.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.846 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.88 -21.27 28.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -1.088 . . . . 0.0 110.074 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.45 -21.42 21.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 109.791 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.945 HG21 HD12 ' A' ' 164' ' ' ILE . 69.3 m -54.85 138.83 41.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.012 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.1 mttt -93.08 149.52 21.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.133 -0.979 . . . . 0.0 109.59 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.759 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.1 mt -130.0 160.52 40.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.935 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.496 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 30.8 mt-10 -135.19 136.12 41.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.637 -0.665 . . . . 0.0 110.173 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.59 HD11 HG21 ' A' ' 120' ' ' VAL . 40.6 mm -119.98 122.27 68.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.67 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.613 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 6.4 ptp180 -88.43 149.98 23.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 110.148 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.479 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 75.2 mm-40 -90.28 -0.56 57.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.945 . . . . 0.0 110.418 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 0.9 OUTLIER -98.44 108.7 49.2 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.981 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.3 Cg_exo -71.34 -154.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.241 1.653 . . . . 0.0 110.59 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.049 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -72.82 54.91 0.38 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.72 -0.612 . . . . 0.0 109.883 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 52.9 m -96.32 120.04 35.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 110.002 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 178' ' ' SER . 81.4 tt0 60.12 19.91 9.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.893 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.26 138.98 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.778 . . . . 0.0 110.239 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -118.18 70.52 0.81 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.465 -177.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 45.7 mt-10 -59.99 -40.02 87.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.087 177.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 182' ' ' GLU . 96.9 mt-10 58.74 39.99 23.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.437 -0.79 . . . . 0.0 110.297 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.94 98.68 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -178.943 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.348 0.594 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.03 -39.98 87.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 110.133 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.2 m -70.1 151.39 45.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 0.0 110.489 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -89.58 127.57 35.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.384 -0.823 . . . . 0.0 110.281 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -146.11 169.07 19.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.467 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -150.72 -155.24 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.965 ' CG2' HD12 ' A' ' 33' ' ' LEU . 12.2 pt -131.08 159.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.13 . . . . 0.0 109.193 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.614 ' C ' HD23 ' A' ' 9' ' ' LEU . 92.2 mt -100.64 122.5 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.011 -1.055 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.857 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -139.62 -175.81 4.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.596 177.128 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 33.5 ptt180 -110.68 139.72 45.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.869 -1.145 . . . . 0.0 110.964 -175.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.972 HG23 HD11 ' A' ' 69' ' ' ILE . 14.6 p -61.82 130.05 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.661 -0.649 . . . . 0.0 110.755 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.648 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -107.84 151.62 25.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 110.423 177.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.569 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 -176.86 155.42 1.25 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -167.29 -72.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 110.272 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -141.92 114.04 8.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.312 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.0 p -159.99 164.42 33.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.116 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.494 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 69.7 p -70.35 159.8 33.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.107 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.642 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -54.66 -40.2 81.58 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.786 -176.469 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 13.1 Cg_exo -67.16 171.36 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.57 1.3 . . . . 0.0 110.496 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.03 20.25 36.93 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.453 ' SD ' HG11 ' A' ' 72' ' ' VAL . 25.5 ptt? -86.81 3.17 46.33 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.368 -1.078 . . . . 0.0 109.267 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.5 m -117.86 12.84 13.94 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.459 -0.776 . . . . 0.0 110.385 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -124.1 140.04 53.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.291 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.074 HG13 HG23 ' A' ' 67' ' ' VAL . 78.7 t -119.46 118.46 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 3.2 ptt180 -88.6 117.36 27.5 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.431 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.2 pt? -136.63 169.09 18.28 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.672 -0.642 . . . . 0.0 109.353 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 7.6 p-10 -97.12 -171.96 2.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.806 -1.184 . . . . 0.0 111.17 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -59.8 -49.22 78.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.49 -0.757 . . . . 0.0 109.476 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.8 t -62.03 -47.39 84.97 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.409 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.115 ' O ' HD22 ' A' ' 33' ' ' LEU . 25.1 t -57.59 -29.64 64.64 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.173 -0.955 . . . . 0.0 109.545 178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 60.0 ttp85 -85.89 -45.47 11.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -80.09 -4.85 54.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.008 -1.058 . . . . 0.0 110.111 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.115 HD22 ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -47.49 -27.92 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.788 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 33' ' ' LEU . 71.6 mt -139.9 -60.04 0.54 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.659 -0.65 . . . . 0.0 110.377 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' C ' ' A' ' 36' ' ' ALA . 44.1 t0 -170.75 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.905 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB2' ' HD3' ' A' ' 89' ' ' LYS . . . -19.94 124.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.563 0.697 . . . . 0.0 111.824 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.3 pt-20 -116.88 -179.76 3.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 29.7 mm -59.99 130.1 23.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.777 -1.202 . . . . 0.0 109.689 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.518 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.75 19.13 73.92 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.942 173.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.544 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 85.1 m-20 -90.24 171.9 9.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.595 -1.532 . . . . 0.0 109.779 172.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.696 HG21 ' N ' ' A' ' 92' ' ' THR . 61.1 t -98.91 138.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 0.0 110.522 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.618 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.9 m -126.46 139.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -107.41 145.3 33.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.595 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.805 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.6 mp -120.02 148.29 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 110.446 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 40.9 tt0 -151.45 94.17 1.98 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.977 . . . . 0.0 110.779 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.992 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.8 tmtm? -98.84 -66.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.703 173.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.574 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -106.72 -32.78 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.481 175.364 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 74.6 mtt85 -136.87 -172.64 3.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.674 ' HB3' HD21 ' A' ' 130' ' ' LEU . 36.7 mttt -88.83 139.28 30.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.984 -1.073 . . . . 0.0 111.05 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.579 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.69 160.18 39.94 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.299 0.571 . . . . 0.0 110.221 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.676 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.13 161.22 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.269 -0.894 . . . . 0.0 109.977 178.018 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.62 -179.78 47.93 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 51.9 ttp180 -121.69 169.37 10.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -1.028 . . . . 0.0 110.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -91.48 138.86 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 111.014 -172.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -128.55 162.66 26.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.502 -0.749 . . . . 0.0 109.887 174.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -89.01 123.63 33.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.891 . . . . 0.0 110.128 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.809 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.19 139.13 58.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.603 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -59.99 -48.91 93.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.15 174.09 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.4 Cg_endo -91.67 99.1 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.866 1.456 . . . . 0.0 108.993 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -73.91 36.34 0.09 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.585 -0.697 . . . . 0.0 111.126 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -145.39 -36.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.073 -1.017 . . . . 0.0 111.165 -178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.8 pt-20 -85.87 -24.43 26.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.905 -1.122 . . . . 0.0 110.172 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.809 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 31.6 m120 -82.3 37.82 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 110.695 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 49.1 pttt -98.49 18.17 17.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 109.641 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.79 20.85 0.03 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.522 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -141.61 157.01 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -1.068 . . . . 0.0 109.191 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.074 HG23 HG13 ' A' ' 24' ' ' VAL . 4.6 p -135.57 131.11 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.863 -1.148 . . . . 0.0 109.86 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.648 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 34.6 ttm180 -96.99 118.16 32.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.974 -1.079 . . . . 0.0 110.24 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.972 HD11 HG23 ' A' ' 11' ' ' VAL . 3.7 pt -131.69 172.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.639 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 17' ' ' THR . 7.6 t70 -78.61 170.08 17.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.371 -0.831 . . . . 0.0 109.978 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.2 p -65.34 -27.56 68.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 110.01 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.453 HG11 ' SD ' ' A' ' 21' ' ' MET . 54.4 t -68.44 -46.12 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.805 ' HE1' HD13 ' A' ' 44' ' ' ILE . 12.7 tpt -60.33 -44.69 95.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.457 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 43.6 ttp180 -60.17 -40.03 88.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 0.0 109.721 174.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -71.48 -22.99 61.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.578 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 73' ' ' MET . 59.3 m-20 -60.01 -36.88 78.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 0.0 110.272 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.544 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.2 p -98.4 -38.82 9.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 0.0 110.319 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.574 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 117.21 36.36 1.03 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 177.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.82 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -110.45 167.93 9.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -1.204 . . . . 0.0 110.475 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.663 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.72 169.77 8.74 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.241 -0.912 . . . . 0.0 109.226 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -54.58 139.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.924 -1.11 . . . . 0.0 110.767 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.55 2.2 79.45 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 172.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -58.8 -162.88 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.023 -1.281 . . . . 0.0 110.445 175.694 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 21.9 pttm -133.61 113.48 12.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 109.981 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.992 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -125.09 160.12 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.389 -0.82 . . . . 0.0 109.586 178.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.5 tttt -110.24 125.4 53.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 110.048 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.584 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 66.1 t -99.25 119.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 110.009 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.479 ' NH2' ' HD3' ' A' ' 86' ' ' LYS . 84.4 mtt85 -103.19 145.2 30.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.832 . . . . 0.0 109.234 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 36' ' ' ALA . 29.8 tptt -99.74 135.42 41.19 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.94 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.488 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 3.1 m -150.08 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.575 0.702 . . . . 0.0 110.132 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.457 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 33.1 mtp85 -127.87 172.41 10.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.598 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.696 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.46 163.42 12.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 111.172 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.61 ' HG2' HG12 ' A' ' 162' ' ' VAL . 14.9 pt-20 -150.22 169.94 20.14 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.3 mm -89.01 100.62 10.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.909 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -53.89 139.94 32.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.315 -0.866 . . . . 0.0 110.173 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 17.8 ptpt -95.56 -28.75 14.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.203 -0.936 . . . . 0.0 110.999 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 21.6 ttpt -150.6 120.0 6.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.707 -1.246 . . . . 0.0 110.616 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.927 HG23 HG22 ' A' ' 155' ' ' THR . 8.2 p -130.03 140.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.01 . . . . 0.0 111.022 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.742 HG23 ' HB3' ' A' ' 171' ' ' GLU . 38.2 m -116.68 148.75 40.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.07 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.886 HD13 ' N ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -150.7 179.94 7.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 0.0 110.678 178.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB2' ' HD2' ' A' ' 173' ' ' ARG . . . -144.45 101.14 4.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 111.117 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.483 ' HG3' ' CE2' ' A' ' 150' ' ' PHE . 13.0 Cg_exo -65.52 129.52 22.7 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.038 1.547 . . . . 0.0 110.035 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.991 HG23 ' HB2' ' A' ' 177' ' ' ALA . 69.0 mt -90.95 110.27 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.135 -0.978 . . . . 0.0 110.366 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.811 HD12 ' CG ' ' A' ' 108' ' ' GLN . 18.0 pt -147.58 -156.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 122.08 0.943 . . . . 0.0 110.462 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.51 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 67.0 mtp85 -130.07 162.41 28.84 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.419 0.628 . . . . 0.0 110.902 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -57.37 -17.08 10.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.813 . . . . 0.0 110.087 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.51 ' OD1' ' HB2' ' A' ' 105' ' ' ARG . 34.4 p-10 -102.87 32.67 3.57 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.444 0.64 . . . . 0.0 109.444 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.811 ' CG ' HD12 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -81.04 147.02 30.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.805 . . . . 0.0 109.97 -176.23 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.881 ' HB3' HD22 ' A' ' 142' ' ' LEU . 5.3 ttt85 -89.3 -12.54 40.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.432 -0.793 . . . . 0.0 110.76 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 110' ' ' LEU . 1.3 pp -98.52 51.56 1.0 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.026 -1.047 . . . . 0.0 110.206 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 16.5 ptmt -105.17 96.77 6.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.373 -0.829 . . . . 0.0 109.862 174.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -101.77 -61.99 1.31 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.933 -1.104 . . . . 0.0 110.386 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.734 ' H ' HD12 ' A' ' 116' ' ' ILE . . . 75.83 174.02 35.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.094 -1.603 . . . . 0.0 109.094 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 48.15 94.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.043 -1.269 . . . . 0.0 110.02 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.85 -6.62 80.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.734 HD12 ' H ' ' A' ' 113' ' ' GLY . 20.8 tt -60.13 -38.28 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.192 -1.181 . . . . 0.0 110.259 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.0 mt-10 -60.22 -41.9 94.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.117 -0.99 . . . . 0.0 109.763 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -68.91 -36.05 77.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.16 -41.15 92.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.401 -0.812 . . . . 0.0 109.714 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 170' ' ' ILE . 58.5 t -60.27 -45.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.275 174.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.1 mt-30 -59.85 -41.8 92.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.576 -0.703 . . . . 0.0 110.319 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -60.18 -49.83 76.08 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.342 -0.849 . . . . 0.0 109.835 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.29 -40.29 70.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -0.753 . . . . 0.0 110.722 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 124' ' ' LEU . 4.4 mm? -93.36 -0.87 56.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.956 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.2 tt -47.96 165.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.97 -1.081 . . . . 0.0 110.075 -177.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ILE . 9.7 ptm180 32.23 46.28 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.537 -0.727 . . . . 0.0 111.37 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.483 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -128.07 133.6 25.31 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.997 -1.064 . . . . 0.0 110.667 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.6 Cg_exo -58.49 139.35 90.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.995 1.524 . . . . 0.0 109.756 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.532 ' HG3' HG12 ' A' ' 164' ' ' ILE . 92.2 mmm -133.66 146.92 51.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.373 -1.455 . . . . 0.0 110.891 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 49' ' ' LYS . 14.5 tp -147.8 112.12 5.24 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.3 pm0 -46.69 139.51 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.625 -1.297 . . . . 0.0 110.108 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.575 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 79.71 -3.14 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.254 0.549 . . . . 0.0 110.468 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.3 p30 -68.47 -169.96 0.18 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 175.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.408 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 23.5 m-80 -147.01 155.52 42.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.704 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.35 169.92 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.074 -1.016 . . . . 0.0 109.937 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.4 t -131.08 147.85 52.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.405 -0.809 . . . . 0.0 110.609 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.658 HG13 ' HD2' ' A' ' 138' ' ' PRO . 84.7 t -102.76 148.27 35.3 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.521 -0.737 . . . . 0.0 109.756 178.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.658 ' HD2' HG13 ' A' ' 137' ' ' VAL . 1.6 Cg_endo -44.73 166.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.971 1.511 . . . . 0.0 110.598 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.93 79.87 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.085 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -132.51 155.36 48.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -1.115 . . . . 0.0 110.028 178.678 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.997 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -179.85 -169.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.07 -1.019 . . . . 0.0 110.924 -177.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.881 HD22 ' HB3' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -145.41 -116.67 0.08 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.696 -0.628 . . . . 0.0 109.596 178.066 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -56.58 -157.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 0.0 110.03 175.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -83.04 81.17 1.76 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.528 ' NE2' HD21 ' A' ' 142' ' ' LEU . 1.9 pt20 -96.43 165.45 12.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.443 -1.033 . . . . 0.0 110.114 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -140.02 154.47 47.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.277 -0.889 . . . . 0.0 110.401 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.638 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 84.62 -88.63 1.57 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 43.7 49.4 6.7 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.7 -0.882 . . . . 0.0 111.098 177.643 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.759 ' CG ' HD12 ' A' ' 103' ' ' ILE . 1.2 pp -134.8 160.97 36.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.031 -1.043 . . . . 0.0 109.522 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.483 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 37.4 m-85 -98.13 130.57 44.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.965 . . . . 0.0 110.372 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 133' ' ' ASP . 18.6 tptm -115.13 108.79 17.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.666 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 132' ' ' GLN . 10.6 t -75.23 131.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.104 -0.998 . . . . 0.0 110.091 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.2 t -113.0 -25.44 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.216 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.31 151.16 34.9 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.707 -1.246 . . . . 0.0 111.12 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.927 HG22 HG23 ' A' ' 98' ' ' VAL . 82.4 p -142.54 162.27 35.92 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.673 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.9 -34.19 0.41 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.283 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.969 ' CG ' HG11 ' A' ' 162' ' ' VAL . 35.4 Cg_exo -54.39 -171.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.285 1.15 . . . . 0.0 110.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.562 ' O ' HG13 ' A' ' 160' ' ' VAL . 15.7 t -88.19 43.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 0.0 110.35 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 158' ' ' SER . 33.1 mmtp 61.27 20.0 10.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.856 ' O ' HG13 ' A' ' 162' ' ' VAL . 18.2 m -105.58 154.75 38.95 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.676 ' HB3' HG12 ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.61 119.89 4.67 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.08 1.568 . . . . 0.0 110.131 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.969 HG11 ' CG ' ' A' ' 157' ' ' PRO . 6.3 m -129.54 159.97 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.138 175.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -110.01 136.72 48.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.104 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.78 ' CD1' HG21 ' A' ' 168' ' ' THR . 14.7 mm -71.11 154.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.692 -0.63 . . . . 0.0 110.225 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.63 170.02 24.37 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 175.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -58.05 -23.11 53.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -1.119 . . . . 0.0 110.264 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -94.04 -15.61 24.63 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.135 -0.978 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.78 HG21 ' CD1' ' A' ' 164' ' ' ILE . 91.9 m -58.43 144.02 43.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 23.0 mttp -97.51 154.32 17.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.889 -1.132 . . . . 0.0 109.763 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.672 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.7 mt -130.09 164.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 0.0 111.04 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.742 ' HB3' HG23 ' A' ' 99' ' ' THR . 16.7 mt-10 -138.16 137.47 37.68 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.34 0.59 . . . . 0.0 110.147 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.641 HD13 HD21 ' A' ' 100' ' ' LEU . 31.8 mm -122.16 129.29 75.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.443 -0.785 . . . . 0.0 109.797 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.445 ' NE ' ' HB2' ' A' ' 175' ' ' GLU . 6.8 ptm180 -89.28 174.22 7.96 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.081 -1.012 . . . . 0.0 110.275 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.512 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 67.1 mm-40 -116.21 4.02 13.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 111.293 -174.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.445 ' HB2' ' NE ' ' A' ' 173' ' ' ARG . 2.6 mt-10 -98.77 107.45 43.22 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.967 -1.083 . . . . 0.0 110.464 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.0 Cg_exo -72.52 -156.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.109 1.583 . . . . 0.0 110.772 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.991 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -85.02 56.43 3.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.8 -0.563 . . . . 0.0 110.07 178.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 39.5 m -66.65 124.33 22.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.022 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 178' ' ' SER . 79.8 tt0 60.07 14.91 4.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 0.0 110.869 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.0 t -98.25 113.83 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 109.992 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 181' ' ' LEU . 0.5 OUTLIER -175.19 84.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 110.366 -179.427 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.16 -40.21 89.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 109.965 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -63.48 140.0 58.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 110.195 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 158.22 160.21 10.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.197 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 54.7 ttm . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.189 0.519 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 1' ' ' MET . 96.8 mt-10 55.82 39.96 30.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.229 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -84.23 139.73 32.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.354 -0.841 . . . . 0.0 110.169 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -108.25 129.57 55.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 0.0 110.392 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -149.99 159.98 43.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.107 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.89 -168.22 16.57 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.838 ' CG2' HD12 ' A' ' 33' ' ' LEU . 26.6 pt -134.16 166.77 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.386 -1.067 . . . . 0.0 109.861 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.492 HD11 ' HD3' ' A' ' 86' ' ' LYS . 35.2 mm -103.22 115.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 110.341 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 9' ' ' LEU . 1.7 pt? -138.19 -172.75 3.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.088 -1.008 . . . . 0.0 109.7 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.6 ptt180 -112.19 138.0 49.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.838 -1.164 . . . . 0.0 110.765 -174.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.087 ' CG2' HD11 ' A' ' 69' ' ' ILE . 8.4 p -62.03 134.61 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.531 -0.73 . . . . 0.0 110.54 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -111.6 166.64 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 0.0 110.89 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.774 ' CB ' HD11 ' A' ' 81' ' ' ILE . 51.5 tp10 -172.43 110.06 0.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 174.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 15' ' ' ASN . . . -109.08 157.03 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 109.849 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 90.3 m-20 53.68 -167.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -0.984 . . . . 0.0 109.659 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.685 ' C ' HG23 ' A' ' 17' ' ' THR . 2.8 t -167.79 178.98 4.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.097 -1.002 . . . . 0.0 110.561 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.685 HG23 ' C ' ' A' ' 16' ' ' SER . 1.2 p 60.8 26.3 16.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.392 -0.817 . . . . 0.0 110.331 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.592 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 14.6 p-10 -149.92 58.31 3.15 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 110.809 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 11.8 Cg_exo -68.9 118.37 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.684 1.36 . . . . 0.0 109.893 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.17 -93.94 0.05 OUTLIER Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.575 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.0 ptp -157.69 -37.1 0.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.709 -0.877 . . . . 0.0 109.28 175.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 21' ' ' MET . 0.4 OUTLIER 161.6 60.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.252 0.549 . . . . 0.0 109.958 -177.304 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -120.06 141.11 50.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.142 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 53.0 t -110.13 119.89 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HD3' ' HD3' ' A' ' 68' ' ' ARG . 4.6 ptt180 -89.27 121.67 31.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.787 -1.196 . . . . 0.0 109.524 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.928 HD21 HG22 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -137.32 166.81 22.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.761 -174.75 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' N ' ' HB3' ' A' ' 63' ' ' ASN . 6.4 p-10 -101.49 -170.39 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.906 -1.121 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.1 -44.41 94.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.539 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 44.9 t -65.98 -49.9 66.2 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.346 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.068 ' O ' HD22 ' A' ' 33' ' ' LEU . 58.1 m -56.38 -27.33 55.87 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 49.2 ttp180 -85.58 -48.29 9.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.87 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -83.08 -6.06 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.038 . . . . 0.0 110.011 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.068 HD22 ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -44.12 -28.16 0.47 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.621 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.837 ' H ' HD23 ' A' ' 33' ' ' LEU . 82.9 mt -143.8 -59.98 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.517 -0.74 . . . . 0.0 110.617 176.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.3 t0 -170.88 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.302 -0.873 . . . . 0.0 110.852 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -30.77 127.56 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 110.915 -175.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.66 ' O ' HG11 ' A' ' 54' ' ' VAL . 2.3 pt-20 -112.51 -178.08 3.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 38' ' ' ILE . 34.7 mm -59.98 120.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.945 -1.097 . . . . 0.0 109.976 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.597 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 72.8 33.55 60.13 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 174.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 2.2 m-20 -89.52 178.86 6.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.806 -1.408 . . . . 0.0 109.556 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 92' ' ' THR . 79.5 t -99.26 129.58 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.203 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 52' ' ' GLY . 7.5 m -123.57 147.2 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -0.792 . . . . 0.0 110.625 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 88' ' ' ARG . 86.0 tt0 -115.62 139.95 49.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.928 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -122.78 147.61 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 0.0 110.566 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.4 tt0 -150.08 97.61 2.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 110.633 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.024 ' CG ' HG12 ' A' ' 85' ' ' VAL . 14.3 tmtt? -98.62 -67.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.566 HG22 ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -102.32 -35.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.162 173.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 92.9 mtt-85 -127.63 -168.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.31 0.576 . . . . 0.0 109.736 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.975 ' HG2' HD21 ' A' ' 130' ' ' LEU . 1.3 ttpm? -103.73 137.2 42.1 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.36 -0.838 . . . . 0.0 110.212 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.763 ' HA ' HD23 ' A' ' 130' ' ' LEU . 8.7 p -142.8 170.53 15.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 110.254 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -122.84 167.76 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.521 -0.737 . . . . 0.0 109.902 177.185 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.818 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -177.7 179.05 48.42 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -117.0 163.97 15.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.505 -0.997 . . . . 0.0 110.139 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.928 HG22 HD21 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -97.35 137.5 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.07 -1.018 . . . . 0.0 110.45 -172.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -122.12 166.48 14.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 110.116 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -89.65 124.44 34.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 110.328 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.709 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.33 132.58 50.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.097 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.74 -46.04 99.59 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.984 -1.072 . . . . 0.0 109.296 173.496 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 14.7 Cg_endo -89.89 99.18 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.022 1.538 . . . . 0.0 109.055 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.11 33.62 0.07 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.557 -0.715 . . . . 0.0 110.866 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 59' ' ' PRO . 52.8 t0 -148.78 -29.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 110.703 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.69 -29.22 22.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.438 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.709 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 4.7 m120 -80.94 39.35 0.49 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.699 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 11.3 ptpt -98.54 10.71 40.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.606 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.442 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.4 pt -141.05 142.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.304 -1.115 . . . . 0.0 109.436 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 1.8 p -119.47 125.89 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.117 -0.99 . . . . 0.0 109.995 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.509 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 70.4 ttt180 -90.05 113.04 24.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.087 HD11 ' CG2' ' A' ' 11' ' ' VAL . 3.0 pt -126.17 163.04 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.793 . . . . 0.0 110.77 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 21' ' ' MET . 91.6 m-20 -69.92 158.67 35.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.81 . . . . 0.0 109.932 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.592 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 79.9 p -61.7 -24.64 66.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.59 -42.88 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 110.323 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.928 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -59.92 -49.98 75.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 109.929 178.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -63.87 -33.44 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.682 176.238 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.501 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 60.4 t-20 -68.08 -32.57 72.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.962 . . . . 0.0 109.933 175.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.439 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 98.5 m-20 -60.03 -40.01 87.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.877 . . . . 0.0 110.535 -178.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.458 ' HB2' ' H ' ' A' ' 48' ' ' ARG . 27.6 p -98.34 -38.52 9.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.602 -176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.564 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 120.16 40.63 0.58 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.765 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -116.03 158.44 23.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.944 -1.327 . . . . 0.0 110.726 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.613 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -112.44 166.84 10.94 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 175.536 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.774 HD11 ' CB ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -51.33 139.96 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.989 -1.069 . . . . 0.0 110.505 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.28 0.61 72.05 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 171.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.18 -160.12 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.876 -1.367 . . . . 0.0 110.225 174.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 40.1 pttt -132.62 113.32 12.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.549 -0.719 . . . . 0.0 109.813 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.024 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -124.35 159.67 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.201 -0.937 . . . . 0.0 109.898 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.6 ttpt -105.21 127.96 53.18 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.218 -0.927 . . . . 0.0 109.868 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.502 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 63.3 t -109.84 121.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 109.714 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' NH2' ' OE2' ' A' ' 43' ' ' GLU . 84.4 mtm180 -110.23 140.03 44.78 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.456 -0.777 . . . . 0.0 109.552 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.59 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.22 136.69 32.92 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.069 -1.02 . . . . 0.0 110.001 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 41' ' ' VAL . 2.7 m -150.01 -171.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.539 -0.725 . . . . 0.0 110.212 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.515 ' NH1' ' HB2' ' A' ' 91' ' ' ARG . 1.6 ptm85 -126.8 170.07 12.57 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.643 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.47 165.34 11.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.054 -1.029 . . . . 0.0 111.078 -175.192 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.566 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.4 pt-20 -149.96 167.72 25.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm -89.57 97.78 7.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.542 -1.349 . . . . 0.0 110.336 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.88 161.8 1.47 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 110.663 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.907 ' HE3' HD22 ' A' ' 156' ' ' LEU . 25.0 pttt -125.44 -24.71 3.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 110.493 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.959 ' CB ' HD12 ' A' ' 156' ' ' LEU . 15.7 tttp -150.92 127.81 11.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.843 -1.16 . . . . 0.0 110.394 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.993 HG23 HG22 ' A' ' 155' ' ' THR . 7.4 p -139.94 144.65 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.351 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.458 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.2 m -118.52 132.27 56.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 110.253 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.763 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.09 160.02 33.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.375 -178.356 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HB2' ' HG2' ' A' ' 173' ' ' ARG . . . -138.83 93.69 10.55 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 34.7 Cg_exo -54.53 134.48 62.05 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.264 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.009 HG23 ' CB ' ' A' ' 177' ' ' ALA . 75.3 mt -90.0 107.69 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.359 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.96 HD12 ' HG2' ' A' ' 108' ' ' GLN . 15.5 pt -146.55 -158.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.769 0.795 . . . . 0.0 109.731 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 108' ' ' GLN . 75.9 mtp180 -110.19 155.76 21.55 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.498 178.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -59.33 -14.93 13.37 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.929 0.871 . . . . 0.0 109.868 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.519 ' OD1' ' HB3' ' A' ' 105' ' ' ARG . 12.2 p-10 -112.19 40.48 2.19 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.736 -0.602 . . . . 0.0 109.581 176.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.96 ' HG2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -79.02 168.4 19.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.452 -173.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -109.09 -17.57 13.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.136 -0.977 . . . . 0.0 111.023 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.695 ' H ' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -99.17 53.22 0.96 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.875 -1.141 . . . . 0.0 111.229 -174.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.525 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 7.3 ptmt -97.83 119.97 37.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.12 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.831 ' HB2' HD13 ' A' ' 116' ' ' ILE . 17.2 m-85 -100.12 -78.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 0.0 110.463 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.09 -178.08 54.12 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 47.2 87.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.204 -1.174 . . . . 0.0 110.169 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.78 -2.65 88.0 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.831 HD13 ' HB2' ' A' ' 112' ' ' PHE . 9.5 tp -60.17 -37.62 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -1.221 . . . . 0.0 110.314 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.461 ' N ' HG23 ' A' ' 116' ' ' ILE . 96.7 mt-10 -59.92 -42.79 94.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.112 -0.992 . . . . 0.0 109.997 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.84 -37.49 76.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -59.96 -39.23 84.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.559 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.79 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.5 t -60.07 -47.8 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.674 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.74 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -61.39 -40.03 92.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 177.481 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.05 -46.43 89.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.61 -41.29 65.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.547 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.6 mm? -94.31 -4.3 48.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.168 -0.957 . . . . 0.0 111.227 -174.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.758 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.5 tt -44.49 167.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.774 -1.203 . . . . 0.0 110.267 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 164' ' ' ILE . 52.9 ptt85 33.3 51.21 0.3 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.666 -0.646 . . . . 0.0 111.788 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -137.79 150.22 67.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.833 -1.167 . . . . 0.0 111.074 175.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.841 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 18.2 Cg_endo -65.56 130.35 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.042 1.549 . . . . 0.0 110.026 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.577 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 88.1 mmm -125.0 139.17 54.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.515 -1.366 . . . . 0.0 111.052 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.975 HD21 ' HG2' ' A' ' 49' ' ' LYS . 11.6 tp -144.15 113.59 7.02 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.636 -0.665 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 7.3 pm0 -47.47 143.87 3.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.116 . . . . 0.0 110.359 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 88.4 mm-40 81.33 -6.09 1.57 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.111 0.482 . . . . 0.0 110.334 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.618 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.1 p30 -69.88 173.78 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.149 -0.969 . . . . 0.0 109.903 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.468 ' HB3' HD13 ' A' ' 149' ' ' LEU . 16.3 m120 -137.72 146.9 44.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.802 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -140.47 170.04 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.085 -1.009 . . . . 0.0 110.144 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.24 135.82 34.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.346 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.694 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 37.4 t -128.95 -68.54 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 110.815 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.694 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 37.7 Cg_endo -70.49 126.37 12.76 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.112 1.059 . . . . 0.0 110.33 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -98.32 47.19 1.48 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.474 HD11 HD12 ' A' ' 110' ' ' LEU . 1.4 pp -126.3 156.81 39.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -1.084 . . . . 0.0 110.273 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -139.84 -169.43 2.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.14 -0.975 . . . . 0.0 110.596 -179.404 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.562 ' N ' ' OG1' ' A' ' 141' ' ' THR . 83.4 mt -141.97 -126.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.638 -0.664 . . . . 0.0 109.927 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.9 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.72 59.32 4.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.778 ' NE2' HD21 ' A' ' 148' ' ' LEU . 14.0 pt20 -97.61 164.07 12.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.415 -1.05 . . . . 0.0 110.162 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 t -139.48 159.81 41.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.226 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.99 -88.21 0.68 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.778 HD21 ' NE2' ' A' ' 145' ' ' GLN . 80.6 mt 49.48 45.49 23.95 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.187 -1.184 . . . . 0.0 111.002 176.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.893 ' HG ' HD12 ' A' ' 103' ' ' ILE . 1.9 pp -140.46 169.59 17.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.871 -1.143 . . . . 0.0 109.862 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 29.4 m-85 -92.09 120.31 32.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.079 -1.013 . . . . 0.0 110.236 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -104.87 110.63 23.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.072 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.618 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.5 t -76.37 138.86 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 t -117.38 -28.39 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.194 -0.941 . . . . 0.0 111.047 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -148.59 151.51 35.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.767 -1.208 . . . . 0.0 111.173 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.993 HG22 HG23 ' A' ' 98' ' ' VAL . 63.8 p -139.75 158.29 44.34 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.959 HD12 ' CB ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -89.1 -34.01 0.4 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.867 -176.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.988 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.5 Cg_exo -56.99 -161.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.269 1.141 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.432 ' HB3' HG22 ' A' ' 160' ' ' VAL . 13.3 t -90.13 179.09 6.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 109.869 176.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.418 ' HE2' ' NZ ' ' A' ' 49' ' ' LYS . 13.9 tttt -61.31 -10.12 6.47 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.863 . . . . 0.0 110.425 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 158' ' ' SER . 13.6 m -84.66 153.13 61.04 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.467 -0.77 . . . . 0.0 110.159 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.529 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -48.87 142.76 18.68 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.248 1.657 . . . . 0.0 110.613 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.988 HG11 ' CB ' ' A' ' 157' ' ' PRO . 13.7 m -130.02 160.0 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.1 tt0 -108.71 127.51 54.05 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.022 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.836 HD12 HG21 ' A' ' 168' ' ' THR . 12.9 mm -71.08 153.05 8.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 121.434 0.635 . . . . 0.0 110.334 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.546 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.94 166.91 26.15 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 125' ' ' ILE . 13.6 pt-20 -56.95 -19.81 20.12 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.369 -1.077 . . . . 0.0 110.197 -177.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.16 -14.03 39.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.872 . . . . 0.0 110.326 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.836 HG21 HD12 ' A' ' 164' ' ' ILE . 21.0 m -62.04 147.8 46.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 109.856 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mttm -94.46 157.5 15.98 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.929 -1.107 . . . . 0.0 110.256 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.79 HD12 ' CG1' ' A' ' 120' ' ' VAL . 3.4 mm -118.93 129.91 74.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.363 -0.835 . . . . 0.0 110.691 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.58 ' O ' HD13 ' A' ' 172' ' ' ILE . 20.1 mt-10 -110.96 130.08 55.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 110.225 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.58 HD13 ' O ' ' A' ' 171' ' ' GLU . 33.5 mm -125.8 125.74 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.884 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.581 ' O ' ' NE ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -89.29 167.26 13.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 0.0 110.713 -177.144 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 99.1 mt-10 -106.07 -9.56 16.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.928 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' A' ' 173' ' ' ARG . 2.5 tp10 -98.53 109.36 52.54 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.382 -0.824 . . . . 0.0 109.901 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.492 ' HB3' HG12 ' A' ' 104' ' ' ILE . 12.8 Cg_exo -71.37 -155.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.14 1.6 . . . . 0.0 110.504 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.009 ' CB ' HG23 ' A' ' 103' ' ' ILE . . . -79.79 53.12 1.57 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.45 0.643 . . . . 0.0 110.046 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 43.0 t -101.8 120.57 40.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 110.037 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 178' ' ' SER . 83.0 tt0 59.97 19.96 9.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.091 -1.005 . . . . 0.0 109.847 -177.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.469 HG13 ' HB2' ' A' ' 182' ' ' GLU . 10.4 p -73.75 155.85 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.533 -0.73 . . . . 0.0 110.29 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 pp -70.02 -5.9 29.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.83 . . . . 0.0 110.66 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.469 ' HB2' HG13 ' A' ' 180' ' ' VAL . 98.9 mt-10 -60.05 -42.83 95.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.09 -1.006 . . . . 0.0 110.397 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -64.02 140.02 58.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.277 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 114.88 -153.35 17.69 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.513 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 95.9 mtp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.07 0.462 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 4' ' ' ASN . 99.9 mt-10 56.31 169.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 110.086 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 3.8 m 57.75 -79.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.466 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 2' ' ' GLU . 39.0 t30 -97.01 120.88 38.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.225 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -135.51 -179.99 5.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.383 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -148.33 -161.04 9.35 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.969 HG21 HD22 ' A' ' 33' ' ' LEU . 47.6 pt -131.01 160.01 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.936 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.1 mt -99.55 114.46 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 110.239 -178.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.2 pt? -137.86 -172.39 3.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 109.96 178.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.8 ptp180 -115.55 139.05 50.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.785 -1.197 . . . . 0.0 110.714 -172.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.95 HG23 HD11 ' A' ' 69' ' ' ILE . 4.6 p -61.17 137.91 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.505 -0.747 . . . . 0.0 110.115 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -120.97 155.6 33.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 110.478 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.541 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -176.31 -91.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 175.032 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.714 ' H ' HD11 ' A' ' 81' ' ' ILE . . . 50.01 -140.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.015 -1.053 . . . . 0.0 109.835 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -79.94 113.97 18.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 110.02 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.1 p -144.04 151.14 39.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 110.166 179.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -108.81 14.36 24.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 109.946 178.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 18.2 p30 -130.04 71.43 82.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.469 -0.77 . . . . 0.0 110.206 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -61.79 166.01 12.85 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.046 1.551 . . . . 0.0 110.17 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.54 93.6 0.1 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.0 ptp -86.66 -17.33 34.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -1.145 . . . . 0.0 109.487 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.3 m -102.41 0.02 33.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 109.958 174.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 95.6 mtt180 -122.45 138.55 54.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.456 -0.778 . . . . 0.0 109.945 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 92.8 t -116.6 120.03 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 110.237 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.649 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -92.41 119.97 32.46 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.757 -1.177 . . . . 0.0 109.945 177.814 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.927 HD23 HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -134.41 173.32 11.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.675 -177.06 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.482 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 17.5 p-10 -93.2 179.76 5.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.83 -1.169 . . . . 0.0 110.481 -178.47 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -59.97 -43.19 95.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.378 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.492 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 63.3 m -65.08 -44.56 88.52 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.545 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.711 ' CB ' HD12 ' A' ' 26' ' ' LEU . 59.4 m -60.0 -40.06 87.93 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.951 -1.093 . . . . 0.0 109.193 176.083 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 59.3 ttt180 -71.37 -44.4 65.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.876 -0.515 . . . . 0.0 111.734 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -93.34 -6.18 47.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.755 -1.216 . . . . 0.0 111.199 -169.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.032 HD12 ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -59.2 -31.37 68.96 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.584 -178.527 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.032 ' N ' HD12 ' A' ' 33' ' ' LEU . 31.6 mt -116.57 -66.4 1.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.111 -0.993 . . . . 0.0 110.674 175.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 36' ' ' ALA . 17.1 t0 -171.84 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.191 -0.943 . . . . 0.0 110.244 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.72 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -23.92 120.14 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.579 0.704 . . . . 0.0 111.408 -176.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.649 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -105.24 175.25 5.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.938 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.407 HG12 ' NH2' ' A' ' 31' ' ' ARG . 45.5 mm -56.69 127.15 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 120.966 -1.084 . . . . 0.0 109.663 178.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.06 24.49 68.9 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.39 174.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.81 174.0 8.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.724 -1.456 . . . . 0.0 109.247 171.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 92.6 t -102.59 130.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.995 -1.066 . . . . 0.0 110.432 -174.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.593 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -115.02 137.31 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.34 141.67 38.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.435 -0.79 . . . . 0.0 109.847 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -120.99 148.2 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.024 -1.047 . . . . 0.0 110.182 -176.442 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 39.3 tt0 -152.37 92.32 1.68 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 111.288 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.726 ' HD2' HG12 ' A' ' 85' ' ' VAL . 59.6 tttp -97.83 -77.05 0.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 0.0 110.123 172.43 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.609 HG21 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.0 -29.97 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.638 0.732 . . . . 0.0 109.688 176.76 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.447 ' H ' ' HB2' ' A' ' 77' ' ' CYS . 71.6 mtt85 -141.34 -172.7 3.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.463 176.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.712 ' C ' HD21 ' A' ' 130' ' ' LEU . 18.3 mttt -88.78 141.06 28.82 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.813 -177.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.568 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -140.37 156.47 46.4 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.388 0.614 . . . . 0.0 110.111 -179.103 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.596 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -126.07 160.15 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.142 -179.657 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.451 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -176.88 -177.45 45.84 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.413 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 96.0 mtt-85 -117.05 -179.01 3.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -1.071 . . . . 0.0 109.761 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.649 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -109.31 135.9 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.023 . . . . 0.0 110.681 -175.003 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.543 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -127.16 168.98 13.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.569 -0.707 . . . . 0.0 110.057 176.101 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -93.59 124.15 37.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 110.152 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.746 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.4 139.37 58.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.884 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.673 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.8 mtt-85 -57.31 -49.63 92.79 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.953 -1.092 . . . . 0.0 108.993 174.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.673 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 57.4 Cg_endo -93.08 98.51 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 109.034 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.54 37.07 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 121.593 -0.692 . . . . 0.0 110.482 -177.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 59' ' ' PRO . 68.3 m-20 -144.16 -33.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 110.461 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 66' ' ' ILE . 48.7 mt-10 -85.62 -28.92 24.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.746 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 14.7 m120 -81.31 38.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.649 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 31.9 pttt -98.9 12.64 35.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.059 -1.026 . . . . 0.0 109.759 176.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.76 24.88 0.04 OUTLIER Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.478 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.07 142.87 29.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.336 -1.097 . . . . 0.0 109.28 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 2.9 p -119.97 126.05 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.024 -1.048 . . . . 0.0 109.894 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 31.9 mmt180 -89.95 102.33 15.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.009 . . . . 0.0 110.153 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.95 HD11 HG23 ' A' ' 11' ' ' VAL . 3.3 pt -125.26 169.93 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.408 -0.808 . . . . 0.0 110.68 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.09 161.68 26.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.41 -0.806 . . . . 0.0 109.992 177.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.629 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 43.8 m -63.16 -16.8 61.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -0.907 . . . . 0.0 110.324 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 63.8 t -71.16 -49.16 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.322 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.721 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -59.97 -49.5 77.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.907 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.629 ' HG2' ' HA ' ' A' ' 71' ' ' SER . 3.7 ppt_? -64.08 -28.73 69.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.085 -1.009 . . . . 0.0 109.653 175.163 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.472 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 19.6 t-20 -73.08 -30.28 63.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.959 -1.088 . . . . 0.0 110.388 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 73' ' ' MET . 13.9 m120 -60.04 -40.02 87.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 110.87 -173.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.447 ' HB2' ' H ' ' A' ' 48' ' ' ARG . 25.9 p -99.3 -37.23 9.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 0.0 110.605 -177.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.609 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 126.87 33.53 0.64 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.705 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . . . -99.36 140.04 34.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -1.078 . . . . 0.0 110.179 -177.426 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.607 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -103.26 162.57 12.87 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.14 -0.975 . . . . 0.0 108.981 174.156 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.714 HD11 ' H ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -52.84 135.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.013 -1.054 . . . . 0.0 110.649 -177.975 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.93 -0.25 66.98 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 172.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 80' ' ' SER . 0.2 OUTLIER -57.79 -160.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.982 -1.305 . . . . 0.0 110.427 176.683 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -134.7 114.91 13.17 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.0 177.17 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.726 HG12 ' HD2' ' A' ' 46' ' ' LYS . 1.7 m -124.67 160.07 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.828 178.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.6 tttt -105.12 124.97 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.916 176.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.635 ' CG2' HD21 ' A' ' 9' ' ' LEU . 65.8 t -109.93 123.72 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.148 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.545 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.2 mtt85 -103.46 151.62 22.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 178.276 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.72 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 8.0 tmtt? -98.11 133.16 42.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.21 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.547 ' N ' ' HD3' ' A' ' 89' ' ' LYS . 2.3 m -150.3 -167.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.45 0.643 . . . . 0.0 109.975 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.552 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 27.5 mtp180 -129.29 178.11 6.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.807 . . . . 0.0 110.27 176.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.534 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.24 161.15 14.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 111.233 -175.888 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.546 ' CG ' HG12 ' A' ' 162' ' ' VAL . 18.2 pt-20 -148.22 164.78 32.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 94' ' ' ILE . 5.0 mp -88.86 97.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.47 -1.394 . . . . 0.0 110.22 -175.207 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.93 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.53 139.14 38.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 110.141 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' CD ' ' HG ' ' A' ' 156' ' ' LEU . 15.1 ptpt -100.09 -27.69 13.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.991 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.815 ' HB3' HD23 ' A' ' 156' ' ' LEU . 79.2 tttt -149.97 121.52 7.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.954 -1.091 . . . . 0.0 110.449 -176.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.097 HG23 HG22 ' A' ' 155' ' ' THR . 7.5 p -135.69 143.23 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 110.383 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 90.4 m -117.81 133.54 55.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 110.066 -177.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.703 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -132.35 164.9 25.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 110.223 -178.061 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 173' ' ' ARG . . . -138.91 83.57 18.47 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.804 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.2 Cg_exo -58.74 125.5 18.48 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.94 1.495 . . . . 0.0 110.173 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.759 HG23 ' HB2' ' A' ' 177' ' ' ALA . 35.2 mm -90.28 108.17 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.227 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.628 ' CD1' HD23 ' A' ' 110' ' ' LEU . 1.1 pp -150.7 -171.73 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.159 -0.963 . . . . 0.0 110.798 179.286 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.732 ' HD3' HD13 ' A' ' 142' ' ' LEU . 83.8 mtp180 -91.19 166.23 13.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.466 -0.771 . . . . 0.0 110.04 176.329 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.671 ' HA ' HD21 ' A' ' 110' ' ' LEU . 8.5 ptpt -59.26 -15.42 15.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.052 -1.03 . . . . 0.0 110.891 -174.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 34.3 p-10 -122.76 25.81 8.51 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.561 -0.712 . . . . 0.0 110.659 -177.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.568 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -98.0 -81.27 0.44 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.027 -1.045 . . . . 0.0 111.198 179.51 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.513 ' HB3' HG12 ' A' ' 104' ' ' ILE . 37.1 ttm-85 -106.62 -14.56 15.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 111.47 -172.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.797 ' O ' HD12 ' A' ' 110' ' ' LEU . 1.2 pp -98.31 56.68 1.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.951 -1.093 . . . . 0.0 110.154 -176.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.52 ' O ' ' HD3' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -140.95 68.22 1.35 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.784 . . . . 0.0 110.028 177.112 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.628 ' HB2' HD12 ' A' ' 116' ' ' ILE . 12.0 m-85 -138.18 -39.48 0.54 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 110.472 -177.562 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 78.95 -159.83 46.01 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 113' ' ' GLY . 19.3 pt-20 -31.22 141.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.931 -0.747 . . . . 0.0 111.086 -177.329 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.14 -10.0 72.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 175.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.628 HD12 ' HB2' ' A' ' 112' ' ' PHE . 16.2 tt -69.06 -40.53 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -1.173 . . . . 0.0 110.387 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.6 mt-10 -69.95 -39.95 75.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.093 -1.004 . . . . 0.0 110.049 175.71 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.03 -30.69 69.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 176.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 64.8 t80 -59.86 -37.78 80.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 109.53 176.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.764 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.4 t -59.88 -49.98 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 109.878 176.103 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.649 ' HG3' HD11 ' A' ' 170' ' ' ILE . 4.9 mt-30 -59.96 -44.11 94.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 110.312 177.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -63.58 -34.33 77.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 110.024 -175.825 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -84.22 -41.81 16.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.676 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.4 mm? -96.02 2.29 53.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 111.394 -174.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.628 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.4 tt -47.95 165.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.797 -1.189 . . . . 0.0 110.209 -175.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HG2' ' CG2' ' A' ' 125' ' ' ILE . 9.7 ptp85 34.97 49.57 0.41 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.499 -0.75 . . . . 0.0 111.464 -178.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -132.5 136.47 27.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.782 -1.199 . . . . 0.0 110.907 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.818 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -60.07 129.78 31.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.041 1.548 . . . . 0.0 109.892 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.678 ' SD ' HD11 ' A' ' 164' ' ' ILE . 16.4 mtt -125.22 146.2 49.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.428 -1.42 . . . . 0.0 110.875 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.712 HD21 ' C ' ' A' ' 49' ' ' LYS . 14.4 tp -144.18 105.59 4.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.616 -0.677 . . . . 0.0 109.6 -176.11 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.7 pm0 -43.11 143.86 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.345 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.15 -0.72 2.88 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.163 0.506 . . . . 0.0 110.392 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.606 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.9 p-10 -69.93 -179.46 1.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 174.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 151' ' ' LYS . 18.4 m-80 -145.73 141.89 28.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.488 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.01 164.73 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.94 -1.1 . . . . 0.0 110.31 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.2 t -140.72 149.96 42.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.475 -0.766 . . . . 0.0 110.359 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.691 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 40.1 t -130.19 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 111.154 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.691 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 41.3 Cg_endo -71.02 138.87 34.72 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.115 1.06 . . . . 0.0 110.672 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -111.67 52.23 0.65 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 141' ' ' THR . 0.7 OUTLIER -122.65 178.82 4.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -1.207 . . . . 0.0 110.111 179.063 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.12 -174.24 3.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 111.089 -179.157 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.975 HD12 ' NE2' ' A' ' 145' ' ' GLN . 88.1 mt -144.9 -153.54 0.48 Allowed 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.263 0.554 . . . . 0.0 109.889 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.42 81.67 6.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.175 -0.953 . . . . 0.0 110.31 179.351 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 54.99 60.22 9.12 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.269 -176.347 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.975 ' NE2' HD12 ' A' ' 142' ' ' LEU . 6.5 pt20 -96.45 168.02 10.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.722 -1.457 . . . . 0.0 110.218 178.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -140.03 152.37 46.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.873 . . . . 0.0 110.322 177.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.24 -86.99 0.8 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 177.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.88 HD11 ' CD ' ' A' ' 145' ' ' GLN . 11.2 mt 49.5 30.64 3.54 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.23 -1.159 . . . . 0.0 111.782 176.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.612 HD12 ' C ' ' A' ' 150' ' ' PHE . 3.1 pp -141.51 169.92 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.601 -1.312 . . . . 0.0 110.107 177.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.612 ' C ' HD12 ' A' ' 149' ' ' LEU . 17.6 m-85 -89.53 137.8 32.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.244 -0.91 . . . . 0.0 109.94 176.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.422 ' HD2' ' OD1' ' A' ' 134' ' ' ASN . 33.4 tptt -121.12 102.22 8.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 109.874 178.14 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.606 HG21 ' OD1' ' A' ' 133' ' ' ASP . 2.2 t -77.06 140.73 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.6 t -131.23 -26.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 111.22 -176.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.54 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 6.4 tptm -140.04 134.54 31.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.843 -1.161 . . . . 0.0 110.591 -177.034 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.097 HG22 HG23 ' A' ' 98' ' ' VAL . 48.8 p -134.02 165.54 24.79 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.54 -0.725 . . . . 0.0 109.396 176.177 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.45 -39.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.646 -176.927 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.972 ' CB ' HG11 ' A' ' 162' ' ' VAL . 17.2 Cg_exo -59.43 -170.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.639 1.336 . . . . 0.0 109.984 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.46 -158.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.27 -0.894 . . . . 0.0 109.998 177.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -70.19 -7.83 45.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 110.669 -177.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 160' ' ' VAL . 34.3 m -88.1 149.5 45.4 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 110.931 -175.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.596 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.02 140.75 31.39 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.367 1.719 . . . . 0.0 110.811 179.761 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.972 HG11 ' CB ' ' A' ' 157' ' ' PRO . 4.6 m -130.08 157.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.022 -1.049 . . . . 0.0 109.96 172.192 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -103.61 130.0 50.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.314 -0.866 . . . . 0.0 110.37 177.056 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.892 ' CD1' HG21 ' A' ' 168' ' ' THR . 19.1 mm -71.34 150.23 9.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 178.135 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.92 170.13 24.65 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 175.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -53.77 -24.76 16.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.354 -1.086 . . . . 0.0 110.169 -176.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.634 ' OE2' HG21 ' A' ' 94' ' ' ILE . 18.0 pt-20 -89.67 -18.4 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.899 . . . . 0.0 111.025 -175.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.892 HG21 ' CD1' ' A' ' 164' ' ' ILE . 95.7 m -56.94 147.23 24.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.178 -0.951 . . . . 0.0 110.078 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' LYS . 74.1 mmtt -95.77 161.24 14.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.839 -1.163 . . . . 0.0 110.36 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.764 HD12 ' CG1' ' A' ' 120' ' ' VAL . 24.4 mm -119.97 130.63 74.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 110.696 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.476 ' OE1' ' HE2' ' A' ' 97' ' ' LYS . 21.7 mt-10 -113.97 126.2 54.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 110.368 171.275 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 120' ' ' VAL . 32.1 mm -123.17 132.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.019 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.542 ' HG2' ' CB ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -88.43 149.17 23.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.995 . . . . 0.0 110.387 -176.631 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.9 mt-10 -93.52 -1.04 56.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.269 -0.895 . . . . 0.0 110.785 -176.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.533 ' O ' ' CD ' ' A' ' 173' ' ' ARG . 85.9 tt0 -96.93 108.38 43.12 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 178.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 11.1 Cg_exo -73.14 -155.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.021 1.538 . . . . 0.0 110.79 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.759 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -82.7 56.27 3.31 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.72 -0.612 . . . . 0.0 109.93 176.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 48.0 t -100.11 122.97 43.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.93 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 178' ' ' SER . 95.0 mt-10 60.08 19.98 9.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.433 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 178' ' ' SER . 63.7 t -108.22 120.53 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 0.0 110.142 177.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.737 HD11 ' HA3' ' A' ' 185' ' ' GLY . 0.8 OUTLIER -126.14 19.92 7.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.493 -178.53 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 181' ' ' LEU . 47.1 tt0 39.99 -130.02 0.34 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.317 -0.864 . . . . 0.0 110.234 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.95 150.07 47.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.992 -1.068 . . . . 0.0 110.509 -178.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 110.65 -7.16 29.86 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.737 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.314 0.578 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.428 ' O ' ' ND2' ' A' ' 5' ' ' ASN . 14.8 pt-20 -67.89 -19.47 65.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 110.301 -179.097 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -59.96 -40.01 87.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 110.331 -179.111 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 23.4 t-20 -95.37 100.67 12.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 110.367 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 4' ' ' ASN . 98.6 m-20 -141.52 165.07 28.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.966 177.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -146.33 -166.96 12.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.024 HG21 HD22 ' A' ' 33' ' ' LEU . 9.1 pt -136.28 159.96 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.439 -1.036 . . . . 0.0 109.418 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.61 ' C ' HD23 ' A' ' 9' ' ' LEU . 96.7 mt -101.47 121.06 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.003 -1.061 . . . . 0.0 110.216 -179.012 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.809 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -136.96 -171.25 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 110.557 178.576 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.487 ' HB3' HG22 ' A' ' 66' ' ' ILE . 53.0 ttp180 -107.51 132.85 52.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 111.099 -172.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.937 HG23 HD11 ' A' ' 69' ' ' ILE . 13.2 p -61.67 138.36 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.77 . . . . 0.0 110.314 176.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -123.05 145.01 48.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 110.597 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.961 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -178.56 96.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 174.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.61 77.31 1.33 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.334 -0.854 . . . . 0.0 110.364 -178.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.6 167.23 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.155 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.3 m -59.99 -40.09 88.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.905 178.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 p -131.24 138.73 49.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 110.017 175.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 1.3 p30 -131.63 73.19 79.57 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.423 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -65.15 168.33 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.968 1.51 . . . . 0.0 110.192 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.78 75.07 1.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.017 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.419 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 20.7 ptt? -86.44 -9.91 55.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -1.19 . . . . 0.0 109.895 177.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.4 m -134.35 13.04 3.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.83 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.47 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 97.3 mtt180 -114.38 137.28 52.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.994 -177.515 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.083 HG13 HG23 ' A' ' 67' ' ' VAL . 87.9 t -119.44 120.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 -179.018 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 25' ' ' ARG . 4.9 ptt180 -92.36 119.54 32.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.7 176.302 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -134.73 -172.31 3.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 0.0 110.179 179.836 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.501 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.9 p-10 -106.9 -179.93 4.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.046 . . . . 0.0 110.539 -178.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.01 -44.46 94.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.579 -177.563 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -59.9 -46.7 88.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.535 -0.728 . . . . 0.0 110.211 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.59 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 59.9 m -59.97 -36.5 77.26 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.062 -1.024 . . . . 0.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.675 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 35.0 ttp180 -70.06 -44.54 68.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.186 178.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -90.26 -10.36 44.52 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.838 -1.164 . . . . 0.0 111.687 -171.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.024 HD22 HG21 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -50.17 -27.06 5.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.711 -1.243 . . . . 0.0 109.135 -178.566 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.003 ' N ' HD12 ' A' ' 33' ' ' LEU . 59.0 mt -130.11 -69.24 0.67 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.511 -0.743 . . . . 0.0 110.583 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -172.63 11.19 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.948 -1.095 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . . . -52.02 133.6 32.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.921 -1.112 . . . . 0.0 110.199 -176.154 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.679 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -118.32 174.32 6.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.415 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 38' ' ' ILE . 28.2 mm -58.95 119.65 3.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 120.814 -1.179 . . . . 0.0 109.722 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.4 35.54 56.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.629 174.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.572 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 33.6 m-20 -89.1 178.93 6.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.633 -1.51 . . . . 0.0 109.718 172.348 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.737 HG21 HG23 ' A' ' 92' ' ' THR . 76.7 t -99.39 123.54 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 110.585 -176.086 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' HD2' ' A' ' 89' ' ' LYS . 3.8 m -122.08 147.28 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.618 -0.676 . . . . 0.0 110.518 -177.029 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' OE2' ' HD2' ' A' ' 49' ' ' LYS . 85.3 tt0 -111.19 137.09 49.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.746 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -117.63 140.87 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.0 -1.063 . . . . 0.0 110.55 -176.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -151.59 96.67 2.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.611 -1.306 . . . . 0.0 112.106 -174.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.105 ' HE3' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -98.43 -80.24 0.46 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.52 -1.362 . . . . 0.0 110.443 168.014 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.63 -36.67 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.717 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.015 ' CZ ' HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -135.33 -155.5 0.65 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 109.388 172.067 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 48' ' ' ARG . 3.9 mtmm -114.85 133.81 55.65 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.072 0.939 . . . . 0.0 112.271 -177.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . 1.015 HG23 ' CZ ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -119.5 179.88 4.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.311 177.5 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.576 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -136.09 160.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.871 170.646 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.66 -168.96 39.32 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.35 -168.25 1.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -1.048 . . . . 0.0 109.752 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.72 130.0 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 -178.534 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.47 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -116.95 164.92 13.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 110.427 178.592 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.64 119.74 30.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.437 -0.79 . . . . 0.0 110.132 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -64.37 140.08 58.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.838 179.174 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.13 -50.64 86.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 118.876 -1.129 . . . . 0.0 108.919 175.294 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 50.9 Cg_endo -93.45 97.43 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.753 1.396 . . . . 0.0 108.946 178.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.21 38.73 0.14 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 110.711 -174.335 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 30.6 p-10 -142.32 -37.89 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.124 -0.985 . . . . 0.0 110.833 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.554 ' HG3' HD11 ' A' ' 66' ' ' ILE . 19.5 pt-20 -86.75 -18.9 30.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.003 -1.06 . . . . 0.0 109.676 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.503 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 9.8 m-80 -81.72 35.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.459 -0.775 . . . . 0.0 110.78 177.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.501 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.5 pttt -98.86 16.62 21.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 0.0 109.614 176.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.21 23.26 0.03 OUTLIER Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.554 HD11 ' HG3' ' A' ' 62' ' ' GLU . 45.7 pt -140.39 156.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.149 174.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.083 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -136.36 131.05 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 54.1 ttp85 -91.05 118.55 30.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.0 -1.063 . . . . 0.0 110.009 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.937 HD11 HG23 ' A' ' 11' ' ' VAL . 3.2 pt -130.17 167.71 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 110.717 178.075 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 34.9 p-10 -80.02 170.71 16.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.1 178.428 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.3 m -59.98 -31.88 70.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 110.417 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.5 HG12 HD21 ' A' ' 76' ' ' ASN . 54.5 t -68.05 -46.5 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.703 -175.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.601 ' CE ' HD13 ' A' ' 44' ' ' ILE . 4.7 ttt -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.513 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.754 ' NH1' HD13 ' A' ' 81' ' ' ILE . 58.0 ttt180 -60.06 -42.89 95.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.12 172.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -71.75 -25.09 61.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.137 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.5 HD21 HG12 ' A' ' 72' ' ' VAL . 94.3 m-20 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.569 -177.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.709 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 16.7 p -97.88 -37.93 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.791 -1.193 . . . . 0.0 110.92 -175.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 77' ' ' CYS . . . 112.58 31.48 2.55 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.706 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -115.07 178.11 4.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.289 . . . . 0.0 111.763 -170.197 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.587 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -126.79 170.02 12.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.071 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.961 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -59.47 150.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.77 -1.206 . . . . 0.0 110.198 178.789 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' A' ' 10' ' ' ARG . . . 75.56 -3.52 48.33 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 174.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.521 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 2.0 m-20 -58.58 -162.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.033 -1.275 . . . . 0.0 110.378 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 60.1 pttt -134.8 116.96 15.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.454 -0.779 . . . . 0.0 109.82 177.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.105 HG12 ' HE3' ' A' ' 46' ' ' LYS . 1.2 m -117.34 143.39 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 109.532 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 78.6 tttt -93.59 119.04 32.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 175.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.631 HG21 HD11 ' A' ' 9' ' ' LEU . 85.8 t -99.38 123.3 52.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.304 -0.873 . . . . 0.0 109.678 -178.144 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.583 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.6 mtt180 -110.0 146.16 35.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.659 179.568 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.673 ' HD3' ' HB2' ' A' ' 36' ' ' ALA . 27.1 tptt -96.65 134.8 39.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.056 -1.028 . . . . 0.0 110.152 -177.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.573 HG23 HG12 ' A' ' 41' ' ' VAL . 2.7 m -147.61 -170.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 110.125 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 14.2 ptm180 -127.24 171.21 11.66 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 177.566 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.737 HG23 HG21 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -97.86 162.92 13.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.966 -1.084 . . . . 0.0 111.019 -176.153 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.77 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.4 pt-20 -150.72 161.88 41.79 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 94' ' ' ILE . 4.3 mp -89.16 97.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.6 -1.312 . . . . 0.0 110.261 -176.439 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.742 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.92 165.0 0.7 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.372 178.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 169' ' ' LYS . 2.1 pttt -134.9 -19.25 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.364 -0.835 . . . . 0.0 110.632 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.832 ' HB3' HD23 ' A' ' 156' ' ' LEU . 77.4 tttt -150.74 119.99 6.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.895 -1.128 . . . . 0.0 110.558 176.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.103 HG23 HG22 ' A' ' 155' ' ' THR . 8.8 p -138.76 142.65 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.958 -1.089 . . . . 0.0 110.669 178.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.489 ' C ' HD23 ' A' ' 100' ' ' LEU . 96.3 m -117.17 142.65 46.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.116 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.72 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -139.8 172.64 12.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.337 -0.852 . . . . 0.0 110.334 -178.54 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' HG2' ' A' ' 173' ' ' ARG . . . -143.99 94.04 5.95 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 0.0 111.021 -175.127 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 14.7 Cg_exo -64.31 126.84 17.79 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.001 1.527 . . . . 0.0 110.056 179.264 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.641 ' CG2' ' HB2' ' A' ' 177' ' ' ALA . 77.5 mt -93.11 119.93 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.17 -0.956 . . . . 0.0 110.52 -177.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.143 HD12 ' HG2' ' A' ' 108' ' ' GLN . 16.9 pt -149.31 -157.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.962 0.887 . . . . 0.0 110.629 178.398 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.55 ' O ' ' HG3' ' A' ' 108' ' ' GLN . 23.5 mmm180 -110.08 153.39 24.72 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.341 0.591 . . . . 0.0 110.399 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -59.8 -14.24 13.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.268 -0.895 . . . . 0.0 109.992 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 11.9 p-10 -122.62 42.3 3.21 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.827 -0.546 . . . . 0.0 109.808 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 1.143 ' HG2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -81.22 176.61 9.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 110.481 -174.558 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.676 ' HB3' HD21 ' A' ' 142' ' ' LEU . 34.4 ttm180 -96.7 -16.45 20.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 111.096 -176.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 110' ' ' LEU . 1.1 pp -99.52 70.5 1.69 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.513 -176.563 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 1.7 ptmt -119.96 125.91 49.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 0.0 110.032 175.43 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -144.19 -62.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 110.519 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.49 -169.22 54.28 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -177.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 45.46 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.26 -1.141 . . . . 0.0 110.085 176.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.1 -13.05 60.52 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 175.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 117' ' ' GLU . 12.8 tt -59.99 -39.42 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.118 -1.225 . . . . 0.0 110.078 176.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -59.96 -41.31 91.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 178.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.02 -33.33 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.741 175.299 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -60.0 -40.05 87.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.688 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.634 HG12 ' CD1' ' A' ' 170' ' ' ILE . 55.9 t -60.04 -45.65 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.963 175.008 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 168' ' ' THR . 2.7 mt-30 -60.03 -44.79 94.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.81 178.058 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -62.63 -42.48 99.62 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.492 -0.755 . . . . 0.0 110.144 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.412 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -73.28 -41.79 63.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 110.506 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 124' ' ' LEU . 4.4 mm? -95.45 0.04 52.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.192 -0.943 . . . . 0.0 110.983 -176.383 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.9 tt -44.82 163.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.925 -1.109 . . . . 0.0 110.095 -177.013 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 126' ' ' ARG . 32.6 ptt-85 33.78 48.33 0.21 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.54 -0.725 . . . . 0.0 111.281 -178.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.495 ' HG2' ' HD2' ' A' ' 128' ' ' PRO . 0.2 OUTLIER -134.04 137.76 29.05 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.854 -1.154 . . . . 0.0 111.195 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.852 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 32.5 Cg_exo -54.87 127.48 26.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.003 1.528 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.581 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.9 mmm -126.21 140.83 52.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.495 -1.378 . . . . 0.0 110.79 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 7.8 tp -139.69 112.02 7.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 -177.092 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.4 pt-20 -48.6 145.33 3.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.695 -1.253 . . . . 0.0 110.144 -177.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 74.58 -1.71 3.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.815 -178.744 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.612 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.9 p30 -68.81 -170.4 0.22 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.986 -1.071 . . . . 0.0 110.206 175.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -146.92 157.12 43.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.57 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.93 169.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.084 -1.01 . . . . 0.0 110.016 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.5 t -118.17 152.14 36.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.48 -0.763 . . . . 0.0 110.645 -176.047 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.674 HG13 ' HD2' ' A' ' 138' ' ' PRO . 23.9 t -99.88 148.26 34.56 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.424 -0.797 . . . . 0.0 109.894 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.674 ' HD2' HG13 ' A' ' 137' ' ' VAL . 3.3 Cg_endo -49.89 -175.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.009 1.531 . . . . 0.0 110.517 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.05 58.82 1.43 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -177.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 141' ' ' THR . 0.2 OUTLIER -122.32 139.76 53.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -1.185 . . . . 0.0 110.104 178.325 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.593 ' N ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -150.6 -168.89 3.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.286 -0.884 . . . . 0.0 110.629 -179.055 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.867 HD12 ' NE2' ' A' ' 145' ' ' GLN . 86.4 mt -140.69 -154.77 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.652 -0.655 . . . . 0.0 110.306 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.7 77.99 5.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 110.446 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.89 62.05 6.75 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.17 -176.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.867 ' NE2' HD12 ' A' ' 142' ' ' LEU . 7.9 pt20 -94.81 -179.37 4.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.828 -1.395 . . . . 0.0 109.949 178.41 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -138.78 152.13 47.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.408 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.606 ' O ' HD23 ' A' ' 149' ' ' LEU . . . 93.61 -88.79 1.25 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.2 OUTLIER 41.57 41.89 1.8 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.524 -0.986 . . . . 0.0 111.265 177.23 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 103' ' ' ILE . 1.3 pp -140.75 164.82 29.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.877 -1.14 . . . . 0.0 109.946 176.615 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 14.1 m-85 -100.54 132.32 45.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.112 -0.993 . . . . 0.0 110.089 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.446 ' HD3' HG23 ' A' ' 153' ' ' VAL . 2.9 tmtm? -118.67 108.32 14.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 110.086 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.612 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -77.45 138.6 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 109.868 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.446 HG23 ' HD3' ' A' ' 151' ' ' LYS . 32.9 t -117.18 -32.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 110.915 -177.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 131' ' ' GLU . 60.9 tttm -148.38 149.29 31.5 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.363 -178.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.103 HG22 HG23 ' A' ' 98' ' ' VAL . 82.2 p -133.2 170.46 15.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.832 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.47 -37.64 0.45 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.031 . . . . 0.0 110.907 -177.746 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.916 ' CG ' HG11 ' A' ' 162' ' ' VAL . 23.8 Cg_exo -55.61 -171.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.415 1.218 . . . . 0.0 110.284 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 -158.35 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 110.077 176.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -85.4 42.58 0.96 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.221 -0.924 . . . . 0.0 110.269 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 162' ' ' VAL . 33.3 m -140.03 158.73 66.6 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.957 . . . . 0.0 110.562 -177.354 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.576 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.48 136.58 40.54 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.267 1.667 . . . . 0.0 110.957 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.916 HG11 ' CG ' ' A' ' 157' ' ' PRO . 9.2 m -132.07 159.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 109.835 173.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.4 tt0 -105.54 127.52 53.07 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.176 -0.953 . . . . 0.0 110.281 175.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.79 ' CD1' HG21 ' A' ' 168' ' ' THR . 9.0 mm -71.21 157.39 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.653 -0.655 . . . . 0.0 110.376 -177.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.34 167.03 25.36 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.355 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.545 ' HB3' HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.31 -22.29 61.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.41 -1.053 . . . . 0.0 110.48 -177.161 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -88.72 -14.18 37.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.273 -178.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.79 HG21 ' CD1' ' A' ' 164' ' ' ILE . 10.0 m -58.16 155.39 11.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.489 -0.757 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.8 mttt -109.22 148.56 30.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 178.5 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.701 HG23 HD21 ' A' ' 100' ' ' LEU . 2.2 mt -130.23 160.0 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 111.254 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.45 ' HB3' HG23 ' A' ' 99' ' ' THR . 10.2 mt-10 -133.5 132.16 40.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.671 -0.643 . . . . 0.0 110.02 175.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.483 HD13 ' HG ' ' A' ' 100' ' ' LEU . 48.5 mm -120.01 122.97 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.389 -0.819 . . . . 0.0 109.956 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 101' ' ' ALA . 8.8 ptp180 -88.5 154.38 20.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.006 -1.059 . . . . 0.0 110.469 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 174' ' ' GLU . 86.5 tt0 -99.78 9.94 42.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.291 -0.88 . . . . 0.0 110.332 -175.086 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 10.6 tt0 -91.27 109.96 39.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 109.816 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.7 Cg_exo -72.24 -156.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.146 1.603 . . . . 0.0 110.649 -179.515 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.641 ' HB2' ' CG2' ' A' ' 103' ' ' ILE . . . -77.23 53.27 0.99 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.675 -0.64 . . . . 0.0 110.054 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 18.7 m -107.19 120.04 41.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 109.962 177.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 81.9 tt0 59.91 19.95 8.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.465 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 182' ' ' GLU . 25.2 t -62.67 135.62 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.176 -0.953 . . . . 0.0 109.987 178.394 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 pp -69.94 -19.94 63.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 0.0 110.266 -177.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 180' ' ' VAL . 46.0 mt-10 -88.17 123.6 32.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.234 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -60.06 -39.92 87.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 110.287 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 152.54 -178.57 29.63 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 CA-C-O 118.013 -1.437 . . . . 0.0 109.529 179.749 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.128 0.489 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -40.17 88.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.299 -178.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m -61.55 141.43 57.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.385 -0.822 . . . . 0.0 110.381 179.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -89.87 116.79 28.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.218 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -152.85 168.16 26.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 110.005 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.1 -160.04 8.91 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.924 HD13 ' CD2' ' A' ' 33' ' ' LEU . 14.7 pt -136.91 168.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.137 . . . . 0.0 109.51 178.403 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.757 ' C ' HD23 ' A' ' 9' ' ' LEU . 93.2 mt -104.29 125.72 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.649 -177.056 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.844 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -147.44 178.61 8.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.645 -0.659 . . . . 0.0 109.694 178.279 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.795 ' HG2' HG22 ' A' ' 66' ' ' ILE . 11.7 ptp180 -104.22 137.83 41.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 110.768 -173.152 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.955 HG23 HD11 ' A' ' 69' ' ' ILE . 8.4 p -61.98 130.63 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 110.547 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -111.38 162.85 14.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 177.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.565 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 81.5 tt0 -178.93 -115.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 175.579 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 13' ' ' GLU . . . 59.97 46.26 11.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.885 -1.134 . . . . 0.0 110.202 -178.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -129.12 165.51 21.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 110.394 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 17' ' ' THR . 13.5 m -71.62 159.94 33.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 -178.598 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.463 ' C ' ' HD3' ' A' ' 19' ' ' PRO . 74.0 p 41.66 -153.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.898 . . . . 0.0 110.307 179.305 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.542 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 8.2 p-10 -135.46 61.94 46.82 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.15 -0.969 . . . . 0.0 110.759 -178.404 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 12.0 Cg_exo -69.34 117.04 4.81 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.863 1.454 . . . . 0.0 110.411 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.9 63.69 0.88 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 176.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.6 ptm -89.92 -1.71 58.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.309 -1.112 . . . . 0.0 110.011 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.4 p -148.93 16.48 0.96 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.521 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.627 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 45.5 mtm180 -128.29 147.22 50.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.978 HG13 HG23 ' A' ' 67' ' ' VAL . 85.2 t -117.95 122.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.942 -1.099 . . . . 0.0 110.494 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -98.01 120.46 38.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.037 177.598 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -139.95 172.82 12.22 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.233 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -89.94 178.91 6.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.611 -1.306 . . . . 0.0 110.883 -175.156 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 86.9 mt-10 -59.91 -40.03 87.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.258 -178.043 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -50.07 55.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.311 -178.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.687 ' HA ' HD23 ' A' ' 33' ' ' LEU . 11.3 p -55.49 -34.63 64.75 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.145 -0.972 . . . . 0.0 109.566 177.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.54 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 40.0 ttm180 -81.18 -44.2 18.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.507 -0.746 . . . . 0.0 111.302 179.088 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -85.29 -10.02 56.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 110.81 -172.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.121 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.3 pp -57.01 -31.8 65.48 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.318 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.121 ' N ' HD12 ' A' ' 33' ' ' LEU . 15.4 mt -105.68 -79.83 0.56 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 172.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.41 16.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.559 -0.713 . . . . 0.0 110.31 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.54 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -66.61 141.5 57.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.982 -1.074 . . . . 0.0 111.072 -171.032 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.841 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -133.63 -178.91 5.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.176 174.782 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 38' ' ' ILE . 38.0 mm -74.5 74.72 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.854 -1.154 . . . . 0.0 110.279 178.299 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.428 ' H ' HG11 ' A' ' 54' ' ' VAL . . . 172.23 -6.16 0.03 OUTLIER Glycine 0 N--CA 1.483 1.803 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.836 -169.171 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -107.96 159.95 16.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.292 -1.711 . . . . 0.0 110.773 -172.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.612 HG11 ' HB2' ' A' ' 161' ' ' PRO . 69.2 t -99.62 133.01 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.407 -0.808 . . . . 0.0 109.821 179.583 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 52' ' ' GLY . 5.1 m -109.72 143.56 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 -175.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' C ' HD12 ' A' ' 44' ' ' ILE . 87.9 tt0 -111.75 141.44 45.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.676 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.826 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.1 mp -119.97 147.12 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 110.442 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.2 tt0 -151.16 94.51 2.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.022 -1.049 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.012 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.7 tmtt? -98.88 -66.21 0.91 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 173.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.566 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -107.09 -33.99 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 175.928 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 51.5 mtt85 -133.21 -168.23 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.591 -0.693 . . . . 0.0 109.445 175.091 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.72 ' C ' HD21 ' A' ' 130' ' ' LEU . 5.9 mtmt -91.52 138.43 31.58 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.597 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.567 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.98 158.11 45.2 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.26 0.552 . . . . 0.0 109.963 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.543 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.66 160.99 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.004 178.475 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.653 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -174.05 176.38 46.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 172.231 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 34.6 ttm180 -111.78 171.32 7.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -1.047 . . . . 0.0 110.139 -178.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.841 HG11 ' O ' ' A' ' 37' ' ' GLU . 5.4 p -89.55 126.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.046 -1.034 . . . . 0.0 110.91 -172.051 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.627 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -123.32 167.22 14.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 175.523 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -99.25 126.38 45.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 110.088 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -64.16 137.45 57.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 178.141 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.674 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 6.2 mtt180 -59.05 -45.22 99.51 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 109.082 174.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.674 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 32.9 Cg_endo -92.97 98.39 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.794 1.418 . . . . 0.0 108.887 178.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 14.7 pt-20 -75.57 36.78 0.13 Allowed 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.485 -0.759 . . . . 0.0 110.855 -173.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 74.1 m-20 -144.65 -38.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.855 -177.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.2 pt-20 -84.21 -22.23 30.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.524 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 5.3 m120 -81.65 39.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.542 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.549 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 61.2 mtpt -98.64 14.38 28.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.464 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.49 24.69 0.03 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.795 HG22 ' HG2' ' A' ' 10' ' ' ARG . 46.9 pt -141.82 157.16 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -1.048 . . . . 0.0 109.246 175.508 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.978 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -131.55 129.98 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.037 -1.039 . . . . 0.0 109.935 178.058 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 25' ' ' ARG . 81.6 mtt180 -96.78 120.11 36.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.054 -1.029 . . . . 0.0 110.681 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.955 HD11 HG23 ' A' ' 11' ' ' VAL . 3.0 pt -134.43 168.28 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.613 -0.68 . . . . 0.0 110.533 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 18' ' ' ASP . 26.2 p-10 -78.95 174.97 10.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.425 -0.797 . . . . 0.0 110.193 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.441 ' CA ' ' OE2' ' A' ' 13' ' ' GLU . 83.3 p -62.69 -38.52 90.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.714 -177.628 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.9 -43.38 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.134 -0.979 . . . . 0.0 110.359 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.533 ' CE ' HD13 ' A' ' 44' ' ' ILE . 7.6 tpt -59.99 -47.86 84.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.64 178.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 63.5 ttp85 -60.17 -40.11 88.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 109.964 174.143 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.35 -24.62 62.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 93.9 m-20 -60.13 -39.57 86.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -177.53 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.505 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.1 p -98.27 -37.85 9.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -176.323 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.566 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 118.07 36.56 0.94 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.316 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -112.5 161.26 16.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -1.205 . . . . 0.0 110.367 -176.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.608 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -109.65 166.01 11.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.263 -0.898 . . . . 0.0 109.296 176.622 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -51.09 138.16 8.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.04 -1.038 . . . . 0.0 110.553 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 78.46 0.21 78.02 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 171.6 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -56.05 -158.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.119 -1.224 . . . . 0.0 110.423 174.567 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 49.5 pttt -136.05 109.64 8.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.515 -0.741 . . . . 0.0 110.139 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.012 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -124.51 154.88 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.9 . . . . 0.0 109.883 179.68 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 34.3 ttmt -100.65 125.51 47.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 177.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.601 HG21 HD11 ' A' ' 9' ' ' LEU . 74.1 t -99.51 120.79 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.991 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.48 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 99.4 mtt180 -109.67 157.48 19.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 110.007 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' O ' HG13 ' A' ' 90' ' ' VAL . 59.5 tttm -100.03 137.09 38.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 110.619 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.513 HG21 ' CG ' ' A' ' 161' ' ' PRO . 2.2 m -150.38 -169.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 110.369 177.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 34.7 mtp180 -133.75 179.98 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.826 . . . . 0.0 110.426 177.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.61 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.19 156.92 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.131 -177.259 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.618 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.5 pt-20 -150.26 169.94 20.17 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.18 98.63 8.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 110.398 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.99 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.02 135.41 52.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 110.262 178.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.533 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 1.0 OUTLIER -98.09 -27.79 14.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 111.105 -178.809 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.527 ' HB3' HD23 ' A' ' 156' ' ' LEU . 14.4 ttpt -150.16 130.96 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.811 -1.181 . . . . 0.0 110.248 178.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.999 HG23 HG22 ' A' ' 155' ' ' THR . 9.4 p -138.31 140.06 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 110.95 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 90.3 m -106.1 133.94 50.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.53 -0.731 . . . . 0.0 110.02 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.55 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -128.34 160.0 33.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 110.502 -178.28 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.5 84.02 24.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 110.466 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 150' ' ' PHE . 29.2 Cg_exo -55.98 127.23 25.22 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.884 1.465 . . . . 0.0 110.356 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.749 HG23 ' HB2' ' A' ' 177' ' ' ALA . 72.7 mt -96.11 89.86 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.047 -1.033 . . . . 0.0 110.856 -177.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.509 HG23 ' C ' ' A' ' 103' ' ' ILE . 18.4 pt -152.59 -152.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.984 0.897 . . . . 0.0 110.424 172.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.533 ' HB2' ' CG ' ' A' ' 108' ' ' GLN . 54.7 mmm-85 -132.0 162.67 30.16 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.745 173.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -59.39 -22.57 61.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.1 -179.028 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 35.8 p-10 -118.91 28.68 8.14 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.677 -0.639 . . . . 0.0 110.473 -178.505 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.615 ' OE1' HD12 ' A' ' 142' ' ' LEU . 4.0 mm-40 -90.0 -80.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.032 -1.043 . . . . 0.0 110.294 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.852 ' HG2' HD11 ' A' ' 142' ' ' LEU . 31.2 mtm180 -107.9 -76.66 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 110.151 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 110' ' ' LEU . 2.1 pt? -130.34 160.04 35.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.954 . . . . 0.0 110.667 -176.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -92.12 171.65 8.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.691 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.701 ' CA ' HG13 ' A' ' 116' ' ' ILE . 13.3 m-30 -90.6 -62.74 1.39 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.134 -0.979 . . . . 0.0 109.824 -178.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 116' ' ' ILE . . . 90.16 165.0 40.29 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 173.061 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.05 139.94 54.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.511 -0.993 . . . . 0.0 109.576 179.397 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.35 5.62 77.82 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -175.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.701 HG13 ' CA ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -59.79 -32.45 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -1.181 . . . . 0.0 109.627 176.866 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 170' ' ' ILE . 98.8 mt-10 -60.02 -43.76 95.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.97 . . . . 0.0 109.968 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -66.28 -34.26 77.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 109.69 175.293 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -37.26 78.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.626 177.019 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.716 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.5 t -60.16 -47.83 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 109.888 174.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.762 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 109.849 177.631 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -59.93 -41.25 91.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.119 179.035 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.83 -40.09 23.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.672 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.639 HD22 ' N ' ' A' ' 124' ' ' LEU . 3.7 mm? -93.16 -0.88 56.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.109 -0.995 . . . . 0.0 111.091 -175.431 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.805 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.2 tt -47.92 168.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.861 -1.149 . . . . 0.0 110.242 -176.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.7 ptt-85 32.96 48.29 0.13 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 178.423 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.4 mmt180 -137.96 148.42 60.32 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.387 -1.446 . . . . 0.0 111.806 175.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.849 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.6 Cg_exo -62.9 132.69 38.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.321 1.695 . . . . 0.0 109.931 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.4 mmm -131.09 148.06 52.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.72 HD21 ' C ' ' A' ' 49' ' ' LYS . 15.0 tp -145.7 115.06 7.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.581 -0.699 . . . . 0.0 109.772 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.9 pt-20 -49.32 136.38 15.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.114 . . . . 0.0 110.401 -176.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.615 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.14 -3.94 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.2 0.524 . . . . 0.0 110.273 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.555 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.4 p30 -68.04 -170.98 0.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.314 175.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.565 ' HB3' HD13 ' A' ' 149' ' ' LEU . 9.8 m120 -150.94 134.46 16.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.476 -0.765 . . . . 0.0 109.445 178.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -140.28 165.7 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 0.0 110.713 -177.269 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.8 t -140.69 145.84 37.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.413 -0.804 . . . . 0.0 110.365 176.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.724 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 4.8 t -104.97 -48.39 0.13 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.339 -0.851 . . . . 0.0 111.065 179.169 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.724 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 73.8 Cg_endo -87.55 143.27 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.352 1.185 . . . . 0.0 110.222 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -101.1 46.52 1.29 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.91 156.47 48.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.306 -1.114 . . . . 0.0 110.371 -177.318 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 1.1 t -122.18 -162.19 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.126 -0.984 . . . . 0.0 110.594 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.852 HD11 ' HG2' ' A' ' 109' ' ' ARG . 89.3 mt -138.28 -154.67 0.54 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.788 -0.57 . . . . 0.0 110.097 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.92 64.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.49 -176.438 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 142' ' ' LEU . . . 57.75 66.19 3.01 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -176.355 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.416 ' NE2' ' CB ' ' A' ' 148' ' ' LEU . 5.0 pt20 -101.26 179.71 4.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.816 -1.402 . . . . 0.0 109.97 178.33 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -133.89 153.14 51.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -0.999 . . . . 0.0 110.639 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 82.6 -86.41 1.47 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.181 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 40.19 36.29 0.31 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.477 -1.013 . . . . 0.0 111.078 176.916 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.565 HD13 ' HB3' ' A' ' 134' ' ' ASN . 3.3 pp -140.95 167.89 21.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.985 -1.072 . . . . 0.0 109.399 176.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 10.4 m-85 -89.69 118.62 29.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.927 -1.108 . . . . 0.0 109.721 177.404 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 109.95 22.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.555 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.4 t -75.96 135.64 26.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.705 179.026 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.531 HG21 ' NH2' ' A' ' 173' ' ' ARG . 43.2 t -114.8 -32.14 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.069 -1.02 . . . . 0.0 110.932 -176.254 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -148.35 139.22 23.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 110.673 -177.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.999 HG22 HG23 ' A' ' 98' ' ' VAL . 58.8 p -129.16 169.54 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.635 176.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.701 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.16 -32.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 111.18 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.907 ' CG ' HG11 ' A' ' 162' ' ' VAL . 24.6 Cg_exo -56.29 -165.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.372 1.196 . . . . 0.0 110.237 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.723 ' O ' HG13 ' A' ' 160' ' ' VAL . 13.0 t -89.76 41.21 1.03 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.251 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 158' ' ' SER . 64.6 mttt 60.74 18.05 8.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.767 . . . . 0.0 109.657 -177.297 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.854 ' O ' HG13 ' A' ' 162' ' ' VAL . 14.9 m -108.18 160.0 28.58 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 110.089 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.612 ' HB2' HG11 ' A' ' 41' ' ' VAL . 1.1 Cg_endo -50.18 121.15 7.14 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.167 1.614 . . . . 0.0 110.266 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.99 HG21 ' HB2' ' A' ' 95' ' ' ALA . 6.2 m -129.73 159.45 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.619 176.632 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 43.7 tt0 -105.93 127.63 53.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.135 -0.978 . . . . 0.0 109.993 178.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.975 HD12 HG21 ' A' ' 168' ' ' THR . 11.2 mm -71.85 153.09 8.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.678 -0.639 . . . . 0.0 110.285 -176.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.86 167.52 25.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.476 ' HB3' HD11 ' A' ' 125' ' ' ILE . 21.9 pt-20 -57.7 -19.62 28.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -1.047 . . . . 0.0 110.322 -176.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -90.0 -9.99 46.63 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 110.023 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.975 HG21 HD12 ' A' ' 164' ' ' ILE . 46.8 m -63.76 151.65 41.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 176.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 96' ' ' LYS . 38.6 mmtm -96.64 163.05 13.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 109.767 178.111 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.762 HD11 ' HG2' ' A' ' 121' ' ' GLN . 18.4 mm -122.66 132.59 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.297 -0.877 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.516 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 58.4 mt-10 -124.17 133.27 53.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.577 172.436 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 120' ' ' VAL . 6.1 mt -137.46 139.37 43.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.517 -0.739 . . . . 0.0 110.306 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.531 ' NH2' HG21 ' A' ' 153' ' ' VAL . 10.1 ptp180 -88.86 159.46 17.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 110.304 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.486 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 99.1 mt-10 -98.16 7.25 46.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 110.365 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -96.76 109.03 46.6 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.861 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.4 Cg_exo -71.67 -155.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.171 1.616 . . . . 0.0 110.403 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -88.41 55.24 3.33 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.701 -0.624 . . . . 0.0 110.18 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 5.1 m -92.0 104.67 17.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 178' ' ' SER . 77.3 mm-40 57.43 19.89 5.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 109.934 177.149 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.99 -21.84 24.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.264 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 182' ' ' GLU . 2.7 pp -60.02 -44.04 94.86 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.407 -177.407 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.731 ' N ' HD12 ' A' ' 181' ' ' LEU . 88.6 tt0 -62.61 -51.03 68.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.0 110.318 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.06 -39.95 87.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.135 -0.978 . . . . 0.0 110.404 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.74 151.03 33.49 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -178.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.507 -179.534 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 74.6 mtm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.237 0.542 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 1' ' ' MET . 97.7 mt-10 56.18 39.74 30.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.4 t -62.26 -40.07 94.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.238 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -112.3 121.06 43.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 110.259 179.336 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.689 ' HB3' HD22 ' A' ' 34' ' ' LEU . 96.0 m-20 -121.03 142.58 49.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.253 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 87' ' ' VAL . . . -144.95 179.14 22.28 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 177.039 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.015 HG23 HD11 ' A' ' 34' ' ' LEU . 44.4 pt -135.34 159.04 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -1.177 . . . . 0.0 109.994 -179.402 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -101.17 120.01 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.354 -178.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.0 pt? -138.36 -171.8 3.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.522 ' HG3' ' HA2' ' A' ' 82' ' ' GLY . 32.6 ttp180 -101.65 133.39 46.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.915 -174.518 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.861 HG13 ' H ' ' A' ' 82' ' ' GLY . 11.1 p -62.82 129.83 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 110.257 176.107 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -112.14 148.84 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 110.34 179.401 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.656 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -179.21 140.02 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 176.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 15' ' ' ASN . . . -110.31 -0.53 17.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.403 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 87.0 m-20 56.48 38.97 30.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.315 -178.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 p -122.68 12.32 9.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.3 p -130.01 140.18 50.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 0.0 110.538 -178.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.725 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -91.05 -29.0 0.32 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.301 -0.874 . . . . 0.0 111.725 -178.47 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 34.3 Cg_exo -52.56 -168.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.132 1.069 . . . . 0.0 110.75 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.494 ' HA2' ' OD2' ' A' ' 70' ' ' ASP . . . 162.97 68.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.499 ' SD ' ' HD3' ' A' ' 23' ' ' ARG . 21.2 ptp -97.63 14.78 25.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -1.13 . . . . 0.0 110.273 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.04 40.01 19.15 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.273 -0.892 . . . . 0.0 110.212 -177.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HD3' ' SD ' ' A' ' 21' ' ' MET . 33.1 ptt180 -91.54 137.71 32.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.306 -0.871 . . . . 0.0 109.863 176.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.15 HG13 HG23 ' A' ' 67' ' ' VAL . 90.1 t -110.08 117.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.09 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.481 ' O ' ' OD1' ' A' ' 63' ' ' ASN . 1.3 ptm180 -96.81 120.56 37.37 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.981 -1.075 . . . . 0.0 109.909 178.157 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.671 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.2 pt? -136.38 175.27 9.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.664 -0.648 . . . . 0.0 109.542 -175.39 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.558 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.4 p-10 -92.04 179.73 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.743 -175.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.08 -42.19 94.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 109.24 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 54.2 m -65.84 -55.89 14.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.074 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.603 ' C ' HD22 ' A' ' 33' ' ' LEU . 23.3 t -49.91 -30.21 9.73 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.739 -1.225 . . . . 0.0 109.564 177.235 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HA ' HD11 ' A' ' 26' ' ' LEU . 63.3 ttp85 -80.57 -48.86 12.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 111.327 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -94.42 -14.66 25.02 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.712 -1.242 . . . . 0.0 111.611 -173.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.936 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.1 pt? -60.05 -28.71 68.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 7' ' ' ILE . 77.1 mt -103.36 -75.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.074 -1.016 . . . . 0.0 110.186 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 5.6 t70 -169.58 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.605 0.717 . . . . 0.0 109.176 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.52 119.38 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.4 0.619 . . . . 0.0 110.772 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.473 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -105.1 178.27 4.61 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.246 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 38' ' ' ILE . 19.0 mm -60.22 127.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.872 -1.143 . . . . 0.0 110.074 177.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.533 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 77.55 23.36 67.78 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.717 172.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' OD1' ' OE2' ' A' ' 37' ' ' GLU . 81.8 m-20 -89.16 171.69 9.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.719 -1.459 . . . . 0.0 109.639 172.728 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.471 HG21 ' OG1' ' A' ' 92' ' ' THR . 76.4 t -98.92 129.3 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.09 -176.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.608 HG11 HG23 ' A' ' 54' ' ' VAL . 1.7 m -117.06 141.12 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 -175.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' C ' HD12 ' A' ' 44' ' ' ILE . 41.0 tt0 -109.78 141.74 42.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 177.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.873 HD13 ' HE1' ' A' ' 73' ' ' MET . 4.1 mp -120.46 151.29 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.816 -1.177 . . . . 0.0 110.559 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -150.71 93.11 1.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.353 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.022 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 9.1 ttpt -98.44 -65.13 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.703 174.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.017 ' CG2' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -111.82 -30.94 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.637 0.732 . . . . 0.0 109.264 176.112 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 32.4 mtt85 -136.64 -171.52 2.93 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.714 -0.616 . . . . 0.0 109.372 174.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.736 ' HB3' HD21 ' A' ' 130' ' ' LEU . 7.0 mttm -88.31 136.94 32.74 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.986 -1.072 . . . . 0.0 110.459 -177.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.553 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -135.85 156.88 48.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.349 0.595 . . . . 0.0 110.296 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.52 160.59 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.868 . . . . 0.0 109.793 176.999 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' O ' HG22 ' A' ' 42' ' ' VAL . . . 178.88 179.72 48.68 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.387 -1.387 . . . . 0.0 109.714 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -113.91 165.45 12.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -1.046 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -89.33 139.99 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.016 . . . . 0.0 110.693 -173.576 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -125.29 161.38 27.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.748 . . . . 0.0 110.443 175.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 56' ' ' ARG . 24.8 ttp-105 -93.62 127.02 39.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -0.835 . . . . 0.0 110.314 177.208 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -65.9 140.0 58.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.578 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 4.4 mmm180 -56.78 -46.76 99.82 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.969 -1.082 . . . . 0.0 109.127 173.371 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 32.0 Cg_endo -91.57 98.33 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.997 1.525 . . . . 0.0 109.127 178.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.56 35.68 0.1 Allowed 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.641 -0.662 . . . . 0.0 110.765 -175.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -148.46 -34.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.37 -24.66 27.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.197 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.521 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -81.29 41.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.718 -0.614 . . . . 0.0 110.318 176.204 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 pttt -98.59 9.76 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 178.533 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.84 26.75 0.06 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 176.609 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 66' ' ' ILE . 46.0 pt -140.13 141.22 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -1.189 . . . . 0.0 109.645 175.036 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.15 HG23 HG13 ' A' ' 24' ' ' VAL . 2.6 p -120.02 121.93 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 73.5 ttt180 -91.95 118.16 30.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.24 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.726 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.5 pp -130.01 160.04 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 110.41 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.494 ' OD2' ' HA2' ' A' ' 20' ' ' GLY . 96.1 m-20 -75.78 159.99 30.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 177.291 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.4 t -53.45 -29.95 38.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.913 -175.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.55 -48.53 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 110.121 -175.545 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.873 ' HE1' HD13 ' A' ' 44' ' ' ILE . 3.5 tpt -60.0 -45.14 93.72 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.707 177.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' O ' ' SG ' ' A' ' 77' ' ' CYS . 66.9 ttp85 -60.01 -40.09 88.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.778 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -69.93 -27.43 64.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.152 -0.968 . . . . 0.0 110.384 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -21.79 63.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 110.825 -175.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.493 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 18.6 p -101.78 -25.84 13.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.99 -1.069 . . . . 0.0 110.854 -178.009 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.547 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 98.0 23.47 13.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 176.416 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 1.022 ' HB1' ' HD2' ' A' ' 46' ' ' LYS . . . -109.02 -168.82 1.39 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.045 -1.268 . . . . 0.0 110.933 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.575 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -127.61 170.17 12.95 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.656 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -61.49 144.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 0.0 110.324 177.164 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.861 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.74 -1.92 65.72 Favored Glycine 0 C--N 1.297 -1.638 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 172.186 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.512 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.3 m-20 -56.62 -167.2 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.035 -1.274 . . . . 0.0 110.189 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 44.1 pttt -127.16 113.33 16.24 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.392 -0.817 . . . . 0.0 109.753 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.71 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -121.15 158.13 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -177.122 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 85.2 tttt -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.729 175.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.527 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 62.8 t -104.22 122.03 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.945 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 89.4 mtt180 -110.34 140.22 44.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 109.429 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 11.0 tttt -84.77 138.95 32.3 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.077 -1.014 . . . . 0.0 110.237 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.0 m -150.05 -169.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 176.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 48.0 ptt85 -128.39 172.21 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.464 177.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.471 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.06 163.15 12.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.004 -1.06 . . . . 0.0 111.018 -175.773 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.554 ' CG ' HG12 ' A' ' 162' ' ' VAL . 19.1 pt-20 -150.04 169.57 20.92 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.028 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.81 99.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.723 -1.236 . . . . 0.0 110.373 -176.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.83 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.25 140.77 48.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -0.837 . . . . 0.0 110.564 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.71 ' CD ' HD23 ' A' ' 156' ' ' LEU . 29.3 pttt -105.36 -26.08 12.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 111.316 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.891 ' CB ' HD22 ' A' ' 156' ' ' LEU . 22.0 tttp -148.16 128.56 13.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.687 -1.258 . . . . 0.0 110.623 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.114 HG23 HG22 ' A' ' 155' ' ' THR . 7.5 p -140.86 148.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.371 -0.83 . . . . 0.0 110.558 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -120.04 132.11 55.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.131 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.74 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -123.71 159.3 29.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.534 -178.53 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -141.07 93.78 8.05 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.385 -0.822 . . . . 0.0 110.354 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.7 Cg_exo -58.78 129.83 34.04 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.057 1.556 . . . . 0.0 110.32 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.09 HG23 ' HB2' ' A' ' 177' ' ' ALA . 88.4 mt -91.14 106.34 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.2 -0.938 . . . . 0.0 110.328 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.087 HG21 HD21 ' A' ' 110' ' ' LEU . 4.6 pt -142.87 -161.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 110.065 177.033 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.486 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 18.8 mmm180 -140.59 -161.62 1.23 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.361 176.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -59.47 -12.31 6.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.817 176.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.561 ' O ' HD12 ' A' ' 142' ' ' LEU . 36.6 p-10 -99.61 28.43 4.67 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.846 -0.534 . . . . 0.0 109.956 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 1.081 ' CB ' HD12 ' A' ' 104' ' ' ILE . 15.5 pt20 -78.1 126.14 30.38 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.061 -1.024 . . . . 0.0 110.346 -175.091 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.72 ' HB2' HD11 ' A' ' 142' ' ' LEU . 12.2 tpt180 -95.16 -11.26 28.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.579 -0.701 . . . . 0.0 110.252 -179.035 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.087 HD21 HG21 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -97.97 67.5 1.94 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 109.914 -175.785 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 10.5 ptmt -129.64 127.03 39.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.53 -0.731 . . . . 0.0 109.508 176.742 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.622 ' HB2' HD13 ' A' ' 116' ' ' ILE . 28.7 m-85 -146.46 -55.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.131 -0.98 . . . . 0.0 110.657 -176.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 114' ' ' GLU . . . 75.72 -166.89 54.69 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -177.311 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 11.6 pt-20 34.64 97.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.649 -0.913 . . . . 0.0 110.624 178.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.85 -6.64 77.75 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 177.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.622 HD13 ' HB2' ' A' ' 112' ' ' PHE . 9.8 tp -59.99 -39.06 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -1.171 . . . . 0.0 110.11 177.431 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HA ' HD11 ' A' ' 172' ' ' ILE . 96.8 mt-10 -59.97 -41.74 92.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -35.21 74.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 175.319 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.392 -0.818 . . . . 0.0 110.2 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.611 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -60.52 -45.17 97.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 175.567 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.624 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 0.8 OUTLIER -60.01 -42.8 95.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 110.335 175.887 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -59.98 -46.56 89.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.405 -0.81 . . . . 0.0 109.953 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.529 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.17 -46.71 64.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.516 -0.74 . . . . 0.0 110.741 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 124' ' ' LEU . 4.6 mm? -100.76 8.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.075 -1.015 . . . . 0.0 111.827 -173.564 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.891 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.2 tt -49.12 165.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.56 -1.337 . . . . 0.0 109.852 -176.43 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.549 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 31.9 ptt180 33.31 45.98 0.09 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.428 -0.795 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -128.46 134.24 26.06 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.044 -1.035 . . . . 0.0 110.589 179.046 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.829 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 6.6 Cg_endo -54.2 129.42 34.38 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.881 1.464 . . . . 0.0 109.942 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.56 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.8 mmm -126.53 143.13 51.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.568 -1.333 . . . . 0.0 110.929 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' A' ' 49' ' ' LYS . 13.6 tp -142.95 107.56 4.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 0.0 109.645 -177.312 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.606 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.2 pt-20 -46.24 140.34 4.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 0.0 110.822 -174.638 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.606 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.2 -3.37 1.24 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.256 0.55 . . . . 0.0 110.343 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.1 p30 -69.86 -171.02 0.37 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.302 -0.874 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.49 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 15.6 m-80 -142.48 156.53 45.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.067 176.435 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -136.84 170.69 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.328 -177.612 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.8 t -102.91 164.24 11.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 110.308 -176.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.736 HG13 ' HD2' ' A' ' 138' ' ' PRO . 53.2 t -99.55 146.87 32.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.736 ' HD2' HG13 ' A' ' 137' ' ' VAL . 10.9 Cg_endo -59.6 66.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.256 1.661 . . . . 0.0 110.622 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 42.68 57.6 3.87 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 176.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -139.37 139.05 37.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.009 -1.289 . . . . 0.0 110.264 176.668 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.557 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -160.97 -169.04 2.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.847 . . . . 0.0 110.231 -179.51 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' A' ' 109' ' ' ARG . 82.6 mt -144.02 -135.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.473 -0.767 . . . . 0.0 110.004 -178.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.63 -155.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 109.902 175.206 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.25 78.79 1.4 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 173.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -93.54 157.09 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -1.079 . . . . 0.0 109.919 178.194 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.9 t -119.53 146.19 45.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.945 . . . . 0.0 110.429 -178.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.748 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 86.88 -88.69 1.59 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -178.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.748 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.5 OUTLIER 42.15 48.01 4.09 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.48 -1.012 . . . . 0.0 110.942 176.864 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.614 ' CG ' HD12 ' A' ' 103' ' ' ILE . 1.2 pp -139.99 168.99 18.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.939 -1.101 . . . . 0.0 109.742 177.34 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.463 ' O ' HG13 ' A' ' 135' ' ' ILE . 10.9 m-85 -93.96 129.37 40.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.161 -0.962 . . . . 0.0 110.116 -178.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.49 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 24.4 tptm -114.72 107.81 15.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.944 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.529 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.9 t -76.15 135.93 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 109.647 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.7 t -121.62 -27.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.934 -177.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 22.0 tttt -139.53 143.49 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.794 -1.191 . . . . 0.0 110.923 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.114 HG22 HG23 ' A' ' 98' ' ' VAL . 46.5 p -139.95 157.2 46.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.605 -0.685 . . . . 0.0 109.503 174.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.891 HD22 ' CB ' ' A' ' 97' ' ' LYS . 3.2 tp -88.97 -33.96 0.41 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 111.069 -177.258 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 1.048 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.3 Cg_exo -57.57 -165.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.38 1.2 . . . . 0.0 109.971 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 t -90.09 179.71 5.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.222 -0.924 . . . . 0.0 109.901 175.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -60.28 -7.68 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 110.903 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.39 152.78 58.37 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.498 -179.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.569 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.24 141.77 30.52 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.402 1.738 . . . . 0.0 110.933 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 1.048 HG11 ' CB ' ' A' ' 157' ' ' PRO . 6.2 m -129.98 158.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 172.432 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.9 tt0 -106.66 128.68 54.37 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.048 176.115 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.862 ' CD1' HG21 ' A' ' 168' ' ' THR . 13.3 mm -70.23 156.25 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 110.125 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 171.2 24.49 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.891 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -59.01 -25.7 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.264 -1.139 . . . . 0.0 110.118 -178.084 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.68 -11.2 40.47 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.151 -0.968 . . . . 0.0 110.494 -176.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.862 HG21 ' CD1' ' A' ' 164' ' ' ILE . 92.1 m -59.0 145.71 40.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.093 -1.004 . . . . 0.0 110.343 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 79.0 mttt -93.59 147.29 23.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.956 -1.09 . . . . 0.0 109.945 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.624 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 1.0 OUTLIER -121.61 141.35 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -178.184 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.411 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 44.7 mt-10 -124.9 128.88 49.33 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 171.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 117' ' ' GLU . 2.7 mp -123.26 119.95 58.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.562 -0.711 . . . . 0.0 110.052 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.5 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 8.5 ptp180 -89.08 159.67 17.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 174' ' ' GLU . 58.7 mp0 -99.98 10.0 42.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.993 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . 11.1 tt0 -95.52 109.92 48.15 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.407 -0.808 . . . . 0.0 109.833 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 17.1 Cg_exo -68.51 -152.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.298 -2.09 0 O-C-N 124.202 1.632 . . . . 0.0 110.275 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.09 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -74.88 49.33 0.41 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.551 -0.718 . . . . 0.0 110.435 -177.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 41.5 t -59.93 -65.59 0.65 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.307 -0.87 . . . . 0.0 110.75 -178.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -62.29 -11.65 16.27 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.031 -1.043 . . . . 0.0 110.499 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.572 ' HB ' ' HB1' ' A' ' 177' ' ' ALA . 39.1 t -90.16 110.06 21.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.513 -0.742 . . . . 0.0 110.106 -178.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 182' ' ' GLU . 0.7 OUTLIER -147.76 46.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -178.878 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 181' ' ' LEU . 69.9 mm-40 57.6 171.42 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.341 178.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -60.04 140.18 56.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.287 -0.883 . . . . 0.0 110.421 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -149.66 177.24 27.95 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 178.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.504 -179.961 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 75.3 mtm . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.234 0.54 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 1' ' ' MET . 99.3 mt-10 55.23 40.04 31.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.07 179.652 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -81.08 169.97 16.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.422 -0.799 . . . . 0.0 110.35 -179.26 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -89.47 109.98 20.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.273 -178.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.522 ' O ' HD13 ' A' ' 34' ' ' LEU . 98.6 m-20 -132.82 167.46 20.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 110.298 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.78 -169.99 14.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 177.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.869 HD13 ' CD2' ' A' ' 33' ' ' LEU . 21.4 pt -132.54 154.38 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -1.133 . . . . 0.0 109.952 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.0 mt -94.91 119.17 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.814 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.4 pt? -136.03 -168.85 2.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.221 -0.924 . . . . 0.0 110.314 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 20.2 ttp180 -106.55 130.01 54.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 110.957 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.973 HG23 HD11 ' A' ' 69' ' ' ILE . 11.5 p -62.53 137.71 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 110.461 175.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -120.91 156.58 31.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.245 177.418 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.53 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 -177.44 136.88 0.2 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.368 177.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 13' ' ' GLU . . . 179.98 74.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 16' ' ' SER . 38.2 t-20 -161.57 164.96 29.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.445 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.467 ' C ' ' HG1' ' A' ' 17' ' ' THR . 60.3 p -70.8 166.4 21.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 178.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.467 ' HG1' ' C ' ' A' ' 16' ' ' SER . 74.6 p 44.65 -156.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.043 -177.244 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.4 p30 -132.77 65.85 75.19 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.118 -0.989 . . . . 0.0 110.768 -178.225 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 17' ' ' THR . 12.1 Cg_exo -68.42 128.48 17.36 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.916 1.482 . . . . 0.0 110.476 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.54 60.7 1.09 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.505 ' SD ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -90.6 -1.03 57.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -1.16 . . . . 0.0 110.156 176.974 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.505 ' N ' ' SD ' ' A' ' 21' ' ' MET . 21.9 p -153.1 13.79 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.7 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.588 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 26.1 mmt180 -120.06 141.39 49.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -0.984 . . . . 0.0 110.476 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.873 HG13 HG23 ' A' ' 67' ' ' VAL . 95.8 t -114.52 119.99 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 177.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -97.41 119.92 36.84 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.959 -1.088 . . . . 0.0 110.035 177.403 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.027 HD22 ' CB ' ' A' ' 30' ' ' SER . 1.8 mt -140.78 177.75 7.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.154 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 28.1 p-10 -93.65 179.35 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.833 -177.281 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.99 -40.97 90.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.349 -177.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -68.83 -42.68 76.84 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.308 -177.058 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.027 ' CB ' HD22 ' A' ' 26' ' ' LEU . 57.7 m -59.95 -40.84 90.36 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.031 -1.043 . . . . 0.0 109.573 177.008 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.568 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 52.3 ttp180 -74.19 -44.21 54.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 111.469 177.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -88.63 -11.61 44.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.88 -1.138 . . . . 0.0 111.07 -170.369 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.086 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.1 pp -57.73 -32.59 67.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.775 -1.203 . . . . 0.0 109.559 -177.552 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.086 ' N ' HD12 ' A' ' 33' ' ' LEU . 17.1 mt -106.44 -72.65 0.71 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.122 -0.986 . . . . 0.0 110.475 175.226 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 36' ' ' ALA . 6.8 t0 -170.04 -27.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.717 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.789 ' HB1' ' NZ ' ' A' ' 89' ' ' LYS . . . -28.68 124.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.383 0.611 . . . . 0.0 111.455 -178.421 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.55 ' O ' HG11 ' A' ' 54' ' ' VAL . 2.6 pt-20 -113.48 -175.16 2.61 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.233 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 38' ' ' ILE . 19.3 mm -60.53 134.14 25.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.947 -1.096 . . . . 0.0 109.61 174.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.55 ' H ' ' CG1' ' A' ' 54' ' ' VAL . . . 79.77 14.62 80.74 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.237 172.016 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' CE ' ' A' ' 89' ' ' LYS . 87.0 m-20 -88.97 167.29 13.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.301 -1.705 . . . . 0.0 110.033 173.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.582 HG21 ' OG1' ' A' ' 92' ' ' THR . 50.1 t -99.71 129.08 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.046 -1.034 . . . . 0.0 110.454 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.689 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.4 m -114.59 146.09 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.903 . . . . 0.0 110.527 -178.505 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.5 tt0 -112.22 144.27 41.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.41 -0.806 . . . . 0.0 109.35 177.384 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.2 mp -117.18 148.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.948 -1.095 . . . . 0.0 110.586 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -151.06 90.6 1.62 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 111.178 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.083 ' CG ' HG12 ' A' ' 85' ' ' VAL . 13.4 tmtt? -98.21 -59.64 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.031 . . . . 0.0 109.86 172.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.551 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -114.26 -35.52 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 109.069 177.532 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 83.9 mtm-85 -133.06 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.657 ' C ' HD21 ' A' ' 130' ' ' LEU . 9.3 mttp -88.34 130.71 35.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.075 -1.016 . . . . 0.0 110.175 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.526 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -129.96 168.11 17.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.643 -0.66 . . . . 0.0 110.391 -178.703 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -125.81 162.55 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.392 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.561 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.29 -176.97 47.41 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 176.215 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 54.9 mtp180 -123.38 -168.47 1.77 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -1.086 . . . . 0.0 109.977 -178.66 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -111.09 131.61 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.06 -1.025 . . . . 0.0 111.202 -174.03 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.588 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -125.65 162.76 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 0.0 110.467 175.146 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -90.0 125.87 35.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.496 -0.753 . . . . 0.0 110.061 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -64.62 139.75 58.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.075 -1.016 . . . . 0.0 110.035 178.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.662 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.2 mtp180 -58.51 -49.84 91.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 109.275 174.071 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 17.9 Cg_endo -91.53 99.46 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.812 1.427 . . . . 0.0 108.885 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.6 34.16 0.07 Allowed 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.527 -0.733 . . . . 0.0 110.857 -174.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -149.8 -30.77 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.674 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.47 -25.26 29.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.157 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.452 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 4.3 m120 -81.25 40.07 0.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.774 -0.579 . . . . 0.0 110.554 179.082 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -97.81 11.71 36.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.041 . . . . 0.0 109.553 177.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.49 25.6 0.05 OUTLIER Glycine 0 N--CA 1.48 1.611 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 176.632 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.426 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 44.9 pt -140.11 141.21 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -1.217 . . . . 0.0 109.508 174.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.873 HG23 HG13 ' A' ' 24' ' ' VAL . 7.6 p -120.38 129.04 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.996 . . . . 0.0 110.16 -179.462 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 28.5 ttm180 -94.26 112.8 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.253 -177.043 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.973 HD11 HG23 ' A' ' 11' ' ' VAL . 2.4 pt -131.33 168.5 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.731 . . . . 0.0 110.632 -179.191 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.506 ' OD1' ' HB2' ' A' ' 73' ' ' MET . 31.6 p-10 -81.8 176.15 9.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 177.626 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -70.01 -29.1 66.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.272 -0.893 . . . . 0.0 110.671 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.7 -47.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 0.0 110.42 -176.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.709 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.62 -43.45 97.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.515 178.965 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' NH1' HG13 ' A' ' 81' ' ' ILE . 45.3 ttp180 -60.02 -41.08 91.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.935 173.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.95 -24.29 63.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 95.6 m-20 -60.0 -37.46 79.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.011 . . . . 0.0 110.633 -177.295 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.479 ' C ' HG23 ' A' ' 47' ' ' VAL . 30.0 p -98.26 -33.36 11.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 110.439 -177.396 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.551 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.94 26.75 3.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.626 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.58 168.54 9.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -1.14 . . . . 0.0 110.275 -176.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.917 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -115.72 177.97 4.48 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.569 179.273 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.53 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -64.32 140.27 19.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.028 -1.045 . . . . 0.0 110.532 178.414 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.15 -3.35 58.3 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 173.091 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.548 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.1 m-20 -58.08 -167.44 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.913 -1.345 . . . . 0.0 110.303 175.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 19.1 pttp -128.36 111.58 13.5 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.885 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -118.37 155.42 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.7 ttmt -100.24 123.6 44.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -0.968 . . . . 0.0 109.837 176.055 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.795 HG23 HD21 ' A' ' 9' ' ' LEU . 80.3 t -102.28 123.65 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.933 178.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.524 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtt180 -111.97 148.2 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.581 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.789 ' NZ ' ' HB1' ' A' ' 36' ' ' ALA . 10.5 tptt -100.0 130.04 46.12 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.049 -179.086 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.06 -166.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.596 -0.69 . . . . 0.0 110.15 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -129.12 171.46 12.38 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.543 -0.723 . . . . 0.0 109.67 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.582 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.43 159.97 16.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 111.117 -174.618 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 157' ' ' PRO . 19.6 pt-20 -147.8 173.46 12.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.01 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.5 mm -89.2 105.73 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.821 -1.175 . . . . 0.0 110.267 -175.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.2 139.24 53.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.974 ' CG ' HD23 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -101.34 -30.48 11.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.7 178.212 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.769 ' HB3' HD22 ' A' ' 156' ' ' LEU . 23.6 tttt -150.03 128.76 12.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.878 -1.139 . . . . 0.0 110.493 -179.471 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.043 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -139.92 143.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 110.384 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.628 HG23 ' HB3' ' A' ' 171' ' ' GLU . 54.6 m -114.79 138.36 50.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.127 -178.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.617 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -133.42 165.43 24.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HB2' ' HG2' ' A' ' 173' ' ' ARG . . . -144.16 99.97 4.96 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 110.605 -177.112 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.478 ' HD2' ' NH1' ' A' ' 173' ' ' ARG . 28.3 Cg_exo -56.1 138.25 82.15 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.887 1.467 . . . . 0.0 110.239 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.5 mm -99.06 102.81 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.152 -0.967 . . . . 0.0 110.762 -177.147 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.848 HD12 ' CB ' ' A' ' 108' ' ' GLN . 4.1 pt -144.62 173.46 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.059 -1.026 . . . . 0.0 110.244 171.417 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.545 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 95.2 mtt180 -129.41 -138.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.994 -178.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -58.62 -12.34 4.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.932 -1.105 . . . . 0.0 109.735 175.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -98.3 26.23 5.58 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.634 -0.666 . . . . 0.0 110.062 177.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.848 ' CB ' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -83.06 95.6 8.1 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.072 -1.018 . . . . 0.0 109.563 177.986 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 109' ' ' ARG . 14.0 ttp180 -107.06 -8.54 16.5 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.438 0.637 . . . . 0.0 109.974 -178.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.84 HD21 HG21 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -97.7 61.98 1.63 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.392 -0.817 . . . . 0.0 109.661 -176.13 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 10.9 ptmt -97.33 120.91 38.56 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.58 -0.7 . . . . 0.0 109.41 176.598 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.729 ' HB2' HD12 ' A' ' 116' ' ' ILE . 11.0 m-85 -95.93 -41.53 8.75 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.115 -0.991 . . . . 0.0 110.42 -174.062 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.448 ' O ' ' HB ' ' A' ' 116' ' ' ILE . . . 77.97 -157.8 45.6 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 113' ' ' GLY . 21.9 pt-20 -39.1 142.16 0.25 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.719 -0.871 . . . . 0.0 110.15 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.43 -16.03 42.19 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 178.1 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' A' ' 112' ' ' PHE . 20.9 tt -61.83 -39.45 83.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.107 -1.231 . . . . 0.0 110.096 174.276 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.657 ' HA ' HG21 ' A' ' 170' ' ' ILE . 95.6 mt-10 -60.01 -42.82 95.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -65.86 -40.02 91.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.843 . . . . 0.0 109.607 174.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -60.57 -39.97 89.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.471 -0.768 . . . . 0.0 109.916 178.743 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.686 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -60.09 -47.67 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.889 176.076 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.656 ' HG3' HD11 ' A' ' 170' ' ' ILE . 0.7 OUTLIER -60.02 -43.78 95.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 176.419 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -59.99 -43.28 95.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.887 -176.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.59 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.56 -0.712 . . . . 0.0 110.597 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 47.9 mt -94.33 -4.7 48.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.021 . . . . 0.0 110.928 -171.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.741 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.4 tt -45.51 166.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.883 -1.136 . . . . 0.0 109.962 -172.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 164' ' ' ILE . 35.6 ptt180 33.45 46.72 0.12 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.7 -0.625 . . . . 0.0 111.578 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.489 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 9.0 tpp180 -134.13 135.3 24.02 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.73 -1.231 . . . . 0.0 111.547 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.841 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -59.51 124.19 14.96 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.989 1.521 . . . . 0.0 109.526 178.79 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.458 ' SD ' HG13 ' A' ' 164' ' ' ILE . 20.0 mtp -132.1 147.44 52.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.361 -1.462 . . . . 0.0 111.269 -177.444 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.657 HD21 ' C ' ' A' ' 49' ' ' LYS . 2.1 tp -148.36 115.95 6.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.649 -0.657 . . . . 0.0 109.23 -176.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.598 ' HB3' HG23 ' A' ' 155' ' ' THR . 0.7 OUTLIER -40.43 156.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.052 -1.03 . . . . 0.0 110.514 -174.412 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 70.58 -3.49 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.812 -0.555 . . . . 0.0 111.202 179.483 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.656 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.9 p-10 -70.18 178.64 2.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.925 -1.109 . . . . 0.0 109.882 173.753 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.455 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 20.0 m-80 -145.26 140.96 28.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 109.807 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -139.97 161.76 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 110.432 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.0 t -140.62 146.57 38.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.583 -0.698 . . . . 0.0 110.227 178.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.648 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 18.2 t -119.34 -67.67 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 111.088 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.648 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 42.3 Cg_endo -71.83 147.12 49.45 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.192 1.101 . . . . 0.0 110.559 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -117.92 54.93 0.59 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.1 pp -129.97 156.18 44.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -1.224 . . . . 0.0 110.335 -178.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -146.11 -169.52 3.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.945 . . . . 0.0 110.795 -179.44 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.762 HD21 ' NE2' ' A' ' 145' ' ' GLN . 0.3 OUTLIER -143.63 -111.15 0.11 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.805 -0.56 . . . . 0.0 110.144 179.122 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.5 52.37 0.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.0 110.548 -177.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.71 71.4 0.78 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -177.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.762 ' NE2' HD21 ' A' ' 142' ' ' LEU . 2.0 pt20 -94.85 169.96 9.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.857 -1.378 . . . . 0.0 110.238 178.026 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -138.48 151.03 47.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.322 -0.861 . . . . 0.0 110.476 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.576 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 101.05 -95.8 1.44 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.2 OUTLIER 39.76 40.2 0.64 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.556 -0.967 . . . . 0.0 110.913 175.727 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.535 ' C ' HD12 ' A' ' 149' ' ' LEU . 4.2 pp -140.52 169.73 17.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -0.95 . . . . 0.0 109.538 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -90.27 128.25 36.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.021 -1.049 . . . . 0.0 109.904 178.199 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.455 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 29.0 tptp -109.3 106.52 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.656 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.8 t -76.75 140.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 109.918 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.41 -23.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 111.242 -176.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 49.2 tptt -149.07 142.04 24.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.743 -1.223 . . . . 0.0 110.684 -176.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' THR . . . . . 1.043 HG22 HG23 ' A' ' 98' ' ' VAL . 72.5 p -140.02 160.01 40.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.497 -0.752 . . . . 0.0 109.372 176.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.974 HD23 ' CG ' ' A' ' 96' ' ' LYS . 10.8 tp -89.48 -29.17 0.35 Allowed Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.163 -0.96 . . . . 0.0 111.44 -175.422 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.944 ' CG ' HG11 ' A' ' 162' ' ' VAL . 35.5 Cg_exo -53.78 -170.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.086 1.045 . . . . 0.0 110.5 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.601 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -89.85 41.35 1.04 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 110.433 -178.254 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 158' ' ' SER . 37.1 mttt 62.31 19.95 11.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.452 -0.78 . . . . 0.0 109.851 -177.3 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.781 ' O ' HG13 ' A' ' 162' ' ' VAL . 20.0 m -110.37 160.04 29.89 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.495 -0.753 . . . . 0.0 110.057 178.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.541 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.3 Cg_endo -53.1 122.24 10.79 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.123 1.591 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.944 HG11 ' CG ' ' A' ' 157' ' ' PRO . 3.9 m -127.07 155.26 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 110.437 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -100.47 126.21 46.87 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.282 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.919 HD12 HG21 ' A' ' 168' ' ' THR . 12.8 mm -70.39 153.21 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 110.005 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.98 168.79 25.9 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 176.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -57.13 -21.77 34.94 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.231 -1.158 . . . . 0.0 110.229 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.53 -10.74 42.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.715 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.919 HG21 HD12 ' A' ' 164' ' ' ILE . 93.5 m -59.81 143.45 51.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.057 -1.027 . . . . 0.0 110.241 -179.642 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 86.4 mttt -90.02 149.22 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.032 -1.043 . . . . 0.0 109.892 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.686 HD12 ' CG1' ' A' ' 120' ' ' VAL . 4.5 mm -115.42 130.06 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.846 -177.271 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.628 ' HB3' HG23 ' A' ' 99' ' ' THR . 20.8 mt-10 -111.92 128.38 56.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.165 -0.96 . . . . 0.0 110.316 171.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.477 HD11 HG21 ' A' ' 120' ' ' VAL . 39.2 mm -123.37 127.86 74.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.194 -177.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.603 ' CD ' ' O ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -89.58 152.38 21.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.136 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 98.9 mt-10 -97.4 0.51 47.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.7 -178.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.603 ' O ' ' CD ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -97.88 107.8 42.42 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 0.0 109.938 179.137 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 20.6 Cg_exo -66.84 -155.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.944 0 O-C-N 123.837 1.44 . . . . 0.0 110.821 -179.287 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.96 54.98 3.1 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.766 -0.584 . . . . 0.0 110.047 -178.218 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 31.0 p -98.57 120.16 38.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.424 -0.797 . . . . 0.0 110.062 178.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 178' ' ' SER . 97.8 mt-10 59.97 20.0 9.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.445 -0.785 . . . . 0.0 110.111 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 178' ' ' SER . 94.4 t -99.84 -3.78 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.445 -0.784 . . . . 0.0 110.509 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.688 ' O ' HD12 ' A' ' 181' ' ' LEU . 1.1 pp -80.12 60.11 3.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 0.0 110.005 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.24 -11.06 59.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.335 -179.083 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -59.99 140.07 57.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 109.944 -177.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.82 -168.54 21.07 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.588 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 7.6 p30 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.506 0.67 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 87' ' ' VAL . . . -154.12 -169.98 19.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.654 HD13 HD21 ' A' ' 33' ' ' LEU . 48.1 pt -131.2 159.92 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.05 -1.265 . . . . 0.0 110.195 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.56 115.98 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.01 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.7 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.2 pt? -141.1 -175.13 4.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.672 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 3.7 ptt-85 -109.6 133.71 52.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.763 -1.211 . . . . 0.0 110.844 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.968 ' CG2' HD11 ' A' ' 69' ' ' ILE . 12.6 p -61.84 129.75 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 110.544 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -110.36 159.66 17.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.337 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.964 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.138 -0.976 . . . . 0.0 110.689 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 69.0 mtt85 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.015 0.436 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.926 HG13 HG23 ' A' ' 67' ' ' VAL . 84.4 t -110.39 119.9 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.972 -1.08 . . . . 0.0 109.948 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 3.0 ptt180 -93.09 118.12 30.85 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.491 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.962 HD22 ' HB3' ' A' ' 30' ' ' SER . 2.7 mt -136.58 -179.27 5.59 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.728 -0.607 . . . . 0.0 109.958 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 1.4 p-10 -103.06 176.24 5.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.697 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 79.6 mt-10 -59.78 -44.48 93.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.344 -0.847 . . . . 0.0 109.25 -174.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.545 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 72.1 m -68.41 -43.32 77.46 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.014 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.962 ' HB3' HD22 ' A' ' 26' ' ' LEU . 58.1 m -60.09 -40.02 88.17 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.122 -0.986 . . . . 0.0 109.713 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 26.1 ttp180 -86.66 -33.92 19.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.732 -0.605 . . . . 0.0 111.135 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 62.2 ttt180 -89.39 -12.6 39.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.909 -1.119 . . . . 0.0 110.814 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.4 pp -59.76 -32.45 70.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.935 -1.103 . . . . 0.0 109.702 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.079 ' N ' HD12 ' A' ' 33' ' ' LEU . 12.2 mt -101.65 -74.51 0.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 36' ' ' ALA . 33.7 t0 -170.24 -23.81 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.687 -0.633 . . . . 0.0 109.604 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -34.71 121.27 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.436 0.636 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.514 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.07 -179.34 3.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.437 HD13 ' NH1' ' A' ' 31' ' ' ARG . 32.5 mm -60.07 126.15 17.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.575 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.65 23.87 63.8 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.07 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -88.54 171.29 10.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.655 -1.497 . . . . 0.0 109.91 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.777 HG21 ' OG1' ' A' ' 92' ' ' THR . 84.8 t -99.2 130.15 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.264 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.508 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -117.96 139.95 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.813 . . . . 0.0 110.437 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 88.7 tt0 -108.59 142.83 38.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -119.91 150.5 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.924 -1.11 . . . . 0.0 110.703 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -152.57 93.48 1.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 111.124 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.015 ' CG ' HG12 ' A' ' 85' ' ' VAL . 4.1 tmtm? -99.06 -66.95 0.87 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.933 -1.104 . . . . 0.0 109.748 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.52 -34.58 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 109.407 176.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 85.9 mtt180 -131.59 -174.12 3.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.583 -0.698 . . . . 0.0 109.246 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.723 ' C ' HD21 ' A' ' 130' ' ' LEU . 35.5 mttt -89.14 139.44 30.47 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.351 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.566 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.54 159.81 40.91 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.431 0.634 . . . . 0.0 110.154 -177.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.15 161.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.035 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.474 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.87 179.85 48.76 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.678 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 59.2 ttt180 -117.17 164.46 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.503 -0.998 . . . . 0.0 110.237 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -94.05 141.79 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.463 -176.037 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.546 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.4 m-85 -137.62 166.37 24.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.508 -0.745 . . . . 0.0 110.496 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.408 ' NH2' HD11 ' A' ' 38' ' ' ILE . 58.3 ttm-85 -89.23 121.94 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 110.084 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.45 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -62.96 140.01 58.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.002 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.69 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.1 mmt85 -56.15 -49.68 91.82 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.055 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.69 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.16 98.74 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.726 1.382 . . . . 0.0 108.923 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 37.18 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.3 p-10 -147.71 -29.2 0.33 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -85.04 -28.51 25.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 109.106 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.448 ' C ' ' HB3' ' A' ' 27' ' ' ASP . 4.8 m-80 -81.13 41.51 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.857 -0.527 . . . . 0.0 110.636 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HA ' ' HG ' ' A' ' 30' ' ' SER . 20.7 pttt -97.83 8.97 43.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.9 27.08 0.05 OUTLIER Glycine 0 N--CA 1.479 1.552 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.489 HG21 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -141.11 142.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.25 -1.147 . . . . 0.0 109.561 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.926 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -119.97 127.47 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.044 -1.035 . . . . 0.0 109.973 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 33.9 ttm180 -92.86 118.46 31.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.968 HD11 ' CG2' ' A' ' 11' ' ' VAL . 2.5 pt -129.34 166.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.775 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.09 168.89 18.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.5 p -60.82 -29.65 69.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.65 -46.41 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.161 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.761 ' CE ' HD13 ' A' ' 44' ' ' ILE . 13.5 tpt -60.04 -44.38 94.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.587 ' NH1' HD13 ' A' ' 81' ' ' ILE . 61.8 ttt180 -60.03 -40.14 88.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.849 173.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -66.43 -31.24 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' MET . 99.7 m-20 -59.98 -39.85 87.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.762 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.498 ' C ' HG23 ' A' ' 47' ' ' VAL . 28.5 p -99.36 -39.64 8.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.846 -1.159 . . . . 0.0 110.801 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.586 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 110.2 30.72 3.29 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -104.54 167.91 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.13 -1.217 . . . . 0.0 110.36 -177.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.625 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 165.53 11.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.173 176.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.964 HD11 ' HB3' ' A' ' 13' ' ' GLU . 1.1 mp -53.83 139.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.995 -1.065 . . . . 0.0 110.203 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.54 2.08 73.55 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -58.23 -160.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 O-C-N 120.91 -1.347 . . . . 0.0 110.509 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.9 ptpt -130.88 108.93 10.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.015 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -118.87 155.2 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.128 -0.983 . . . . 0.0 110.052 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -106.6 119.96 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.199 -0.938 . . . . 0.0 109.908 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.71 HG22 HG23 ' A' ' 44' ' ' ILE . 95.0 t -105.1 121.78 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.501 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 87.7 mtm-85 -112.38 140.35 47.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.995 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.624 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 41.1 tttm -72.33 143.01 48.81 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.533 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.516 HG21 ' CG ' ' A' ' 161' ' ' PRO . 1.9 m -150.22 -169.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.511 -0.743 . . . . 0.0 109.909 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.24 169.05 17.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.777 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.98 156.2 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.625 ' HG2' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -150.26 174.47 12.8 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.558 HG21 ' OE2' ' A' ' 167' ' ' GLU . 49.4 mm -89.28 102.96 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.867 -1.146 . . . . 0.0 110.031 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.759 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -52.84 132.46 36.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.306 -0.871 . . . . 0.0 110.163 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.786 ' HE2' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -96.06 -28.66 14.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.996 . . . . 0.0 110.995 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HB3' HD23 ' A' ' 156' ' ' LEU . 46.2 tttp -150.05 119.9 7.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.831 -1.168 . . . . 0.0 110.281 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.617 HG23 HG22 ' A' ' 155' ' ' THR . 9.3 p -132.45 137.63 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.87 -1.144 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 171' ' ' GLU . 28.1 m -107.77 145.76 33.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 100' ' ' LEU . 1.0 OUTLIER -147.66 169.76 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.144 -0.973 . . . . 0.0 110.864 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.579 ' HB1' ' CZ ' ' A' ' 173' ' ' ARG . . . -141.4 86.05 11.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 110.924 -175.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 22.0 Cg_exo . . . . . 0 C--N 1.305 -1.763 0 O-C-N 123.881 1.464 . . . . 0.0 109.834 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.065 0.459 . . . . 0.0 109.903 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.507 ' N ' HG23 ' A' ' 116' ' ' ILE . 46.7 mt-10 -61.77 -40.26 94.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -70.0 -31.43 69.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.718 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -59.89 -39.76 86.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.551 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.665 ' CG1' HD12 ' A' ' 124' ' ' LEU . 69.6 t -60.2 -46.27 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.148 -0.97 . . . . 0.0 109.238 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.6 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.17 -40.03 92.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 110.267 175.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -60.0 -41.87 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.3 -39.83 28.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -0.793 . . . . 0.0 110.586 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.665 HD12 ' CG1' ' A' ' 120' ' ' VAL . 92.0 mt -91.04 -8.39 49.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.884 -174.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 166' ' ' GLU . 3.7 tt -41.96 166.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.582 ' HG2' HG23 ' A' ' 125' ' ' ILE . 30.9 ptt-85 34.2 54.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.449 -0.782 . . . . 0.0 111.607 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 6.6 mtt-85 -135.17 150.2 72.16 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.89 -1.131 . . . . 0.0 111.163 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.9 Cg_endo -69.02 133.11 26.06 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 124.096 1.577 . . . . 0.0 109.618 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.56 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 90.4 mmm -128.54 145.67 51.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.485 -1.384 . . . . 0.0 111.607 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.723 HD21 ' C ' ' A' ' 49' ' ' LYS . 13.6 tp -149.77 114.4 5.29 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.703 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.0 pm0 -49.11 139.67 10.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 0.0 110.573 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.703 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 94.5 mm-40 79.73 -1.33 2.13 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.066 0.46 . . . . 0.0 110.593 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.669 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.1 p30 -69.02 -171.05 0.28 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.126 -0.984 . . . . 0.0 110.41 175.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 22.2 m-80 -149.97 158.8 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.42 ' CG1' ' HB2' ' A' ' 150' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.092 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 45.7 m-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.276 0.56 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.39 109.78 16.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.993 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.669 HG21 ' OD2' ' A' ' 133' ' ' ASP . 5.9 t -76.54 139.98 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.241 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.3 t -120.47 -24.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.121 -0.987 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.505 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 87.6 tttt -143.11 151.08 40.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.872 -1.143 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.617 HG22 HG23 ' A' ' 98' ' ' VAL . 39.2 p -141.6 154.62 45.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.626 -0.672 . . . . 0.0 109.626 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.786 HD12 ' HE2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -89.5 -33.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 111.235 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.918 ' CG ' HG11 ' A' ' 162' ' ' VAL . 26.5 Cg_exo -55.54 -165.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.314 1.165 . . . . 0.0 110.165 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.643 ' O ' HG13 ' A' ' 160' ' ' VAL . 8.6 t -88.64 40.94 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.8 mttt 59.99 18.76 7.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.843 ' O ' HG13 ' A' ' 162' ' ' VAL . 16.3 m -106.32 160.28 26.79 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.508 -0.745 . . . . 0.0 109.813 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.528 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.71 122.24 9.37 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 124.024 1.539 . . . . 0.0 110.064 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.918 HG11 ' CG ' ' A' ' 157' ' ' PRO . 12.1 m -129.87 159.9 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.0 tt0 -108.15 128.55 54.8 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.219 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.811 HD12 HG21 ' A' ' 168' ' ' THR . 20.1 mm -72.22 153.74 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.68 -0.637 . . . . 0.0 110.425 -175.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.552 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.09 167.04 26.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.746 ' HB3' HD11 ' A' ' 125' ' ' ILE . 21.2 pt-20 -57.57 -20.07 29.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -1.088 . . . . 0.0 110.352 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.558 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.4 pt-20 -88.87 -14.0 37.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.246 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.811 HG21 HD12 ' A' ' 164' ' ' ILE . 64.1 m -60.41 141.7 56.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 86.5 mttt -96.05 145.92 25.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.04 . . . . 0.0 109.985 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.651 ' CD1' HG12 ' A' ' 120' ' ' VAL . 1.5 mt -125.21 157.85 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.192 -0.943 . . . . 0.0 110.853 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.612 ' HB3' HG23 ' A' ' 99' ' ' THR . 21.6 mt-10 -131.76 133.56 44.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.651 -0.655 . . . . 0.0 110.114 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 120' ' ' VAL . 40.7 mm -115.07 131.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.598 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.579 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.137 -176.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.166 0.507 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -148.81 -161.75 9.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.71 HG21 HD22 ' A' ' 33' ' ' LEU . 39.1 pt -129.99 160.09 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -1.107 . . . . 0.0 109.43 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.9 mt -108.48 120.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.294 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.943 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.6 pt? -144.48 -171.66 3.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.477 -0.765 . . . . 0.0 109.648 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.63 ' NH1' HG22 ' A' ' 66' ' ' ILE . 9.5 ptp85 -106.93 135.73 47.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.81 -1.181 . . . . 0.0 110.948 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.965 HG23 HD11 ' A' ' 69' ' ' ILE . 14.4 p -62.39 131.06 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.629 -0.669 . . . . 0.0 110.738 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -114.23 146.21 40.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.863 . . . . 0.0 110.561 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 1.014 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 tt0 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.0 110.321 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 53' ' ' ARG . 25.1 mmt85 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.841 HG13 HG23 ' A' ' 67' ' ' VAL . 89.8 t -109.98 119.66 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.062 . . . . 0.0 110.347 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.636 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.1 ptm180 -100.56 121.25 41.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.92 -1.113 . . . . 0.0 110.135 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.695 HD12 ' CB ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -134.06 176.8 8.25 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 25.9 p-10 -89.56 179.85 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.753 -1.217 . . . . 0.0 110.416 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 87.0 mt-10 -60.05 -40.21 88.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.362 -0.836 . . . . 0.0 109.169 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 22.9 t -70.0 -44.4 69.42 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.529 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.695 ' CB ' HD12 ' A' ' 26' ' ' LEU . 58.1 m -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.923 -1.111 . . . . 0.0 109.401 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 56.4 ttp85 -74.76 -43.04 56.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.694 -0.629 . . . . 0.0 111.623 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -88.77 -12.97 40.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 111.212 -170.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.083 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.2 pp -56.76 -32.63 65.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 109.505 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.083 ' N ' HD12 ' A' ' 33' ' ' LEU . 12.7 mt -105.27 -75.01 0.64 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.189 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' A' ' 36' ' ' ALA . 13.0 t0 -170.12 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.637 . . . . 0.0 109.676 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -26.77 118.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.539 0.685 . . . . 0.0 111.264 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.73 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -104.96 177.32 4.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.81 123.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.93 -1.106 . . . . 0.0 109.86 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.551 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.03 29.06 59.41 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 32.8 m-20 -89.12 176.44 6.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.71 -1.465 . . . . 0.0 109.296 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.796 HG21 HG23 ' A' ' 92' ' ' THR . 89.8 t -99.32 129.25 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.074 -1.016 . . . . 0.0 110.373 -176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -119.58 147.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.791 . . . . 0.0 110.319 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.55 142.16 45.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.423 -0.798 . . . . 0.0 109.606 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.792 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.3 mp -114.23 148.04 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.036 -1.04 . . . . 0.0 110.22 -177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 89.1 tt0 -150.21 89.44 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.02 -1.05 . . . . 0.0 111.222 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.099 ' CG ' HG12 ' A' ' 85' ' ' VAL . 14.4 tmtt? -98.37 -66.39 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 173.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.05 -38.82 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.708 0.766 . . . . 0.0 109.162 177.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.607 ' CG ' ' HA ' ' A' ' 77' ' ' CYS . 19.7 ptp180 -142.38 -163.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.46 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.638 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -88.69 130.51 35.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 111.132 -174.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.547 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -130.69 162.59 29.1 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.246 0.546 . . . . 0.0 110.339 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -124.6 160.82 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.378 -0.826 . . . . 0.0 110.609 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.92 -179.73 48.71 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 62.0 mtp180 -111.03 175.2 5.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -1.205 . . . . 0.0 109.876 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -99.64 133.54 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.075 -1.016 . . . . 0.0 110.167 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -117.44 166.82 11.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 176.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 38.7 ptt180 -97.16 125.65 41.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.027 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.693 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -64.2 133.05 52.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.81 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.578 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.03 -46.85 99.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.986 174.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 23.7 Cg_endo -91.64 98.61 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.549 . . . . 0.0 109.028 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.04 33.81 0.09 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.595 -0.69 . . . . 0.0 110.91 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -147.53 -29.08 0.35 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.187 -0.945 . . . . 0.0 110.705 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.55 -28.43 26.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.693 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 37.8 m-80 -81.25 42.08 0.64 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.706 -0.621 . . . . 0.0 110.284 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 35.6 tttt -98.42 9.38 43.25 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.278 -0.889 . . . . 0.0 109.582 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.64 26.47 0.05 OUTLIER Glycine 0 N--CA 1.482 1.724 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 176.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.63 HG22 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -140.12 142.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.273 -1.133 . . . . 0.0 109.448 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.943 ' HB ' HD11 ' A' ' 9' ' ' LEU . 12.7 p -120.05 119.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.666 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.557 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 77.7 mtt180 -90.08 111.14 22.15 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 11' ' ' VAL . 1.1 pt -127.69 161.3 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.608 -0.682 . . . . 0.0 110.355 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -80.01 169.59 17.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.522 -0.736 . . . . 0.0 109.795 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 80.0 p -62.39 -16.03 52.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.2 -49.2 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 110.363 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.655 ' HE1' HD13 ' A' ' 44' ' ' ILE . 97.8 mmm -63.73 -40.13 95.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 0.0 109.361 176.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttp180 -60.32 -42.19 95.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 109.997 173.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -70.23 -33.56 71.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.235 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -60.11 -40.0 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.607 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 31.7 p -99.06 -39.38 8.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.021 -1.049 . . . . 0.0 110.694 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.603 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.75 47.85 0.56 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.821 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -122.87 168.54 12.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.071 -1.252 . . . . 0.0 110.75 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.813 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.93 170.93 8.11 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.014 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -58.09 140.11 16.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.925 -1.109 . . . . 0.0 110.644 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.582 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.61 -0.29 65.48 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 172.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -58.55 -160.81 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.032 -1.275 . . . . 0.0 110.211 175.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.3 pttt -130.02 115.54 17.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 109.809 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.099 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.4 m -123.04 157.65 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.0 ttpt -110.04 120.44 42.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 110.005 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.509 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 69.1 t -99.63 123.81 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.893 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.534 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 38.3 mtp85 -109.98 157.75 18.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.791 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -102.26 138.42 39.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 110.153 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.619 HG23 HG12 ' A' ' 41' ' ' VAL . 2.5 m -150.12 -169.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.443 -0.786 . . . . 0.0 110.324 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -127.48 172.81 10.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.629 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.796 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.04 163.23 12.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 111.086 -176.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.707 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.9 pt-20 -150.01 168.11 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 mm -89.64 99.81 9.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.556 -1.34 . . . . 0.0 110.466 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.898 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.2 136.62 56.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 110.226 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 6.2 pttt -106.05 -24.21 12.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.074 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.524 ' HB3' HD23 ' A' ' 156' ' ' LEU . 83.3 tttt -147.0 119.92 8.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.904 -1.123 . . . . 0.0 110.434 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.775 HG23 HG22 ' A' ' 155' ' ' THR . 8.2 p -138.09 140.28 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 110.492 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.589 ' C ' HD23 ' A' ' 100' ' ' LEU . 94.4 m -117.97 135.81 53.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -0.885 . . . . 0.0 110.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -141.27 167.74 21.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -178.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . . . -132.94 103.12 13.1 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.384 -0.822 . . . . 0.0 110.562 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.4 Cg_exo . . . . . 0 C--N 1.305 -1.736 0 O-C-N 124.106 1.582 . . . . 0.0 110.132 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 8.5 tp . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.252 0.548 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.492 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 95.0 mt-10 -60.08 -43.92 95.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 109.831 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.68 -35.57 78.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -38.3 82.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.385 -0.822 . . . . 0.0 109.817 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.657 ' CG1' HD12 ' A' ' 170' ' ' ILE . 62.4 t -60.03 -49.02 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.673 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.646 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 5.3 mt-30 -60.06 -41.17 91.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.872 . . . . 0.0 110.045 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -60.05 -39.99 87.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 110.444 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.97 -41.2 19.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 120' ' ' VAL . 52.3 mt -95.27 -3.43 47.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.059 -1.025 . . . . 0.0 110.972 -173.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.673 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.7 tt -43.43 163.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -174.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.609 ' HG2' HG23 ' A' ' 125' ' ' ILE . 34.0 ptt180 33.84 49.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.492 -0.755 . . . . 0.0 111.371 -177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 10.8 ttt85 -132.11 143.34 48.53 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.966 -1.084 . . . . 0.0 111.105 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.828 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 17.4 Cg_endo -63.76 127.24 19.17 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.062 1.559 . . . . 0.0 109.811 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.573 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 93.4 mmm -123.52 140.02 53.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.402 -1.436 . . . . 0.0 110.926 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.638 HD21 ' O ' ' A' ' 49' ' ' LYS . 19.1 tp -139.59 112.37 7.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.577 -0.702 . . . . 0.0 109.7 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.0 pt-20 -46.68 142.05 3.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.012 -1.055 . . . . 0.0 110.435 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 85.4 mm-40 82.43 -2.74 1.41 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.228 0.537 . . . . 0.0 110.42 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.543 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.6 p-10 -70.21 -178.96 1.8 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 110.115 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.547 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 14.8 m-80 -148.29 129.54 14.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.086 . . . . 0.0 110.718 -177.528 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.736 ' HD2' HD12 ' A' ' 100' ' ' LEU . 28.2 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.202 0.525 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.547 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 21.2 tptm -99.92 106.72 18.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.543 HG21 ' OD1' ' A' ' 133' ' ' ASP . 2.1 t -79.37 134.37 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -0.965 . . . . 0.0 109.898 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.41 ' HA ' ' NE2' ' A' ' 132' ' ' GLN . 2.9 t -128.98 -23.19 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.157 -0.964 . . . . 0.0 110.737 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.478 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 8.6 tptp -140.2 127.12 20.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.85 -1.156 . . . . 0.0 110.609 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.775 HG22 HG23 ' A' ' 98' ' ' VAL . 33.8 p -126.79 170.01 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.586 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -88.82 -41.56 0.45 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.531 -178.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.998 ' CG ' HG11 ' A' ' 162' ' ' VAL . 16.4 Cg_exo -61.75 -176.3 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.631 1.332 . . . . 0.0 110.179 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -90.25 -156.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.964 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -71.77 -2.58 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.271 -0.893 . . . . 0.0 110.38 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.87 138.7 32.96 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.374 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.557 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.99 142.38 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.224 1.644 . . . . 0.0 110.51 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.998 HG11 ' CG ' ' A' ' 157' ' ' PRO . 10.8 m -129.92 159.47 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 109.516 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.2 tt0 -106.17 127.2 53.04 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.138 -0.976 . . . . 0.0 110.063 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.881 ' CD1' HG21 ' A' ' 168' ' ' THR . 12.2 mm -69.73 156.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.624 -0.673 . . . . 0.0 109.862 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.01 166.65 27.02 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.61 -24.42 21.31 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.437 -1.037 . . . . 0.0 109.993 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -88.55 -16.92 31.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.588 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.881 HG21 ' CD1' ' A' ' 164' ' ' ILE . 80.3 m -56.82 153.13 11.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.0 109.989 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 68.4 mttm -100.7 152.94 19.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 110.032 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.657 HD12 ' CG1' ' A' ' 120' ' ' VAL . 19.7 mm -114.65 131.56 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 110.927 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.687 ' O ' HD13 ' A' ' 172' ' ' ILE . 23.6 mt-10 -114.24 129.55 56.63 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.162 -0.962 . . . . 0.0 110.109 170.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 171' ' ' GLU . 38.1 mm -130.92 140.0 49.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.042 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 178.982 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.414 0.626 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.13 -163.99 10.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.031 HG23 HD11 ' A' ' 34' ' ' LEU . 34.8 pt -137.56 158.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -1.186 . . . . 0.0 110.096 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.6 mt -102.21 115.55 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.15 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.789 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.6 pt? -140.0 -171.86 3.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.791 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.2 ptt180 -111.4 140.57 45.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.829 -1.169 . . . . 0.0 110.797 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.027 HG23 HD11 ' A' ' 69' ' ' ILE . 11.7 p -61.75 136.23 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 110.58 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -115.99 152.17 34.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.172 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.925 ' HB3' HD11 ' A' ' 81' ' ' ILE . 85.5 tt0 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 96.2 mtt180 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.236 0.541 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.048 HG13 HG23 ' A' ' 67' ' ' VAL . 67.0 t -113.21 120.61 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.283 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -95.09 120.54 35.48 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.467 175.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.081 HD22 ' CB ' ' A' ' 30' ' ' SER . 3.6 mt -134.93 171.32 14.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.554 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 5.3 p-10 -89.02 170.42 10.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.335 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HA ' ' NH1' ' A' ' 31' ' ' ARG . 46.7 mt-10 -56.16 -40.03 73.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.95 . . . . 0.0 109.019 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 5.2 t -65.29 -58.81 5.01 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.213 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.081 ' CB ' HD22 ' A' ' 26' ' ' LEU . 61.7 m -49.6 -30.02 8.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.593 -1.317 . . . . 0.0 109.635 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.588 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.9 ttp-105 -81.0 -49.46 10.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 111.136 178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 32' ' ' ARG . 38.4 mtm105 -93.45 -14.36 26.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 0.0 111.43 -171.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.961 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -60.84 -28.7 69.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.907 -1.121 . . . . 0.0 110.195 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.031 HD11 HG23 ' A' ' 7' ' ' ILE . 55.7 mt -103.66 -73.69 0.66 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.142 -0.974 . . . . 0.0 109.996 175.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 36' ' ' ALA . 30.4 t0 -168.65 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.451 0.643 . . . . 0.0 109.442 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 31' ' ' ARG . . . -33.31 118.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.419 0.628 . . . . 0.0 110.961 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.57 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -104.42 175.92 5.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 38' ' ' ILE . 33.1 mm -60.0 123.95 13.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.908 -1.12 . . . . 0.0 109.785 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.48 28.19 60.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 65.7 m-20 -89.29 171.07 10.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.703 -1.469 . . . . 0.0 109.503 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.622 HG21 HG23 ' A' ' 92' ' ' THR . 73.7 t -99.15 129.95 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 0.0 110.06 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.593 HG11 HG23 ' A' ' 54' ' ' VAL . 2.7 m -118.21 144.71 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.388 -0.82 . . . . 0.0 110.358 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.0 tt0 -112.41 140.21 47.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.934 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.2 mp -122.74 143.97 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.041 -1.037 . . . . 0.0 110.395 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.8 tt0 -150.49 100.03 2.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.134 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.829 ' HD2' ' HB2' ' A' ' 79' ' ' ALA . 9.1 tmtm? -98.31 -66.99 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.017 . . . . 0.0 109.956 173.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.576 HG23 ' C ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -101.63 -34.54 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.388 174.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.556 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 90.0 mtt-85 -134.59 -179.68 5.74 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.5 -0.75 . . . . 0.0 109.486 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.526 ' HB3' HD21 ' A' ' 130' ' ' LEU . 24.3 mttp -89.19 141.87 28.14 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.181 -0.95 . . . . 0.0 110.843 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 130' ' ' LEU . 9.3 p -143.41 169.98 16.65 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.471 0.653 . . . . 0.0 109.901 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.42 167.35 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.447 -0.783 . . . . 0.0 110.079 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.41 -172.36 41.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -122.78 164.56 18.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -1.137 . . . . 0.0 110.329 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.593 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -96.81 137.69 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 110.419 -173.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.6 m-85 -128.12 165.53 20.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.493 -0.754 . . . . 0.0 110.262 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -89.73 122.68 33.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.972 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.773 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -62.29 134.1 56.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.564 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -57.8 -48.75 96.61 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.031 174.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.564 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.3 Cg_endo -92.42 98.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.91 1.479 . . . . 0.0 109.013 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.53 36.32 0.09 Allowed 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.527 -0.733 . . . . 0.0 110.692 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 59' ' ' PRO . 70.7 m-20 -143.67 -30.62 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.157 -0.965 . . . . 0.0 110.446 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 66' ' ' ILE . 21.1 mt-10 -87.14 -28.28 22.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 0.0 109.27 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.773 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 23.6 m120 -81.13 40.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.758 -0.589 . . . . 0.0 110.492 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 4.82 47.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.22 30.18 0.07 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 9' ' ' LEU . 46.3 pt -140.62 146.96 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.518 -0.989 . . . . 0.0 109.257 174.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.048 HG23 HG13 ' A' ' 24' ' ' VAL . 2.7 p -120.01 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.783 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HG2' ' HD2' ' A' ' 25' ' ' ARG . 15.2 tpp180 -90.09 110.28 21.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.126 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.027 HD11 HG23 ' A' ' 11' ' ' VAL . 1.5 pt -130.82 166.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 110.516 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.02 171.1 15.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -63.91 -21.94 66.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.77 -49.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.934 ' CE ' HD13 ' A' ' 44' ' ' ILE . 1.3 mmt -60.72 -43.28 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 66.0 ttp85 -59.99 -40.53 89.49 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.925 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -70.38 -29.0 65.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.34 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 98.5 m-20 -59.97 -39.15 84.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.576 ' C ' HG23 ' A' ' 47' ' ' VAL . 26.9 p -98.14 -37.76 9.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 110.51 -175.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.529 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 115.56 35.38 1.3 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.829 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -113.08 165.24 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.095 -1.238 . . . . 0.0 110.54 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.737 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.43 170.62 8.11 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.358 -0.839 . . . . 0.0 109.339 178.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.925 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -53.41 141.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.929 -1.107 . . . . 0.0 110.382 178.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.414 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 75.42 1.55 65.44 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 172.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 1.8 m-20 -59.51 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.853 -1.381 . . . . 0.0 110.572 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.2 pttt -132.89 108.81 9.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.824 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.1 m -121.22 153.0 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.5 tttt -103.08 124.74 49.12 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 44' ' ' ILE . 73.2 t -107.21 123.97 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.799 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.5 mtt180 -113.65 136.89 52.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.548 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 27.5 tttt -72.24 143.53 48.76 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.952 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.524 HG23 HG12 ' A' ' 41' ' ' VAL . 1.9 m -148.07 -169.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 109.832 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 174.32 10.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.698 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.622 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.55 159.24 17.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.967 -1.083 . . . . 0.0 111.229 -174.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.59 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -150.34 176.38 10.95 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.401 ' HA ' HD13 ' A' ' 94' ' ' ILE . 25.2 mm -93.18 99.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.341 -1.474 . . . . 0.0 110.867 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.821 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.67 139.79 49.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 0.0 110.297 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.97 -27.18 10.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 111.147 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.698 ' HB3' HD23 ' A' ' 156' ' ' LEU . 79.0 tttt -150.0 124.77 9.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.838 -1.163 . . . . 0.0 110.283 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.939 HG23 HG22 ' A' ' 155' ' ' THR . 9.1 p -138.92 148.97 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.585 ' C ' HD23 ' A' ' 100' ' ' LEU . 88.9 m -120.03 130.69 54.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.819 . . . . 0.0 109.762 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -136.43 169.22 18.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.767 -176.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -130.42 88.82 46.18 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.863 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.589 ' HD3' HG23 ' A' ' 172' ' ' ILE . 17.3 Cg_exo . . . . . 0 C--N 1.304 -1.799 0 O-C-N 124.125 1.592 . . . . 0.0 110.385 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.7 tp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.15 0.5 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.596 ' N ' HG23 ' A' ' 116' ' ' ILE . 47.0 mt-10 -69.91 -40.11 75.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.07 -30.85 71.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -59.99 -40.88 90.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.601 ' CG1' HD12 ' A' ' 170' ' ' ILE . 44.7 t -61.17 -43.37 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.62 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 4.6 mt-30 -60.07 -44.52 94.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.116 -0.99 . . . . 0.0 110.114 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -60.01 -46.7 88.62 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.526 -0.734 . . . . 0.0 109.837 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.466 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -73.66 -42.47 61.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.614 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 124' ' ' LEU . 4.6 mm? -98.56 6.9 46.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.592 ' HA ' HG22 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -48.67 166.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 120.77 -1.206 . . . . 0.0 109.735 -177.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.572 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 32.9 ptt180 33.01 45.14 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.465 -0.772 . . . . 0.0 111.412 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.528 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -127.26 138.53 32.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.805 -1.185 . . . . 0.0 111.113 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.86 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 9.3 Cg_endo -57.51 129.06 31.92 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 124.031 1.543 . . . . 0.0 110.176 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.576 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.6 mmm -125.96 137.82 53.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.601 -1.312 . . . . 0.0 110.608 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 50' ' ' THR . 12.7 tp -137.48 115.01 11.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pt-20 -48.78 143.63 5.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.981 -1.075 . . . . 0.0 110.655 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.04 -10.63 0.9 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.366 0.603 . . . . 0.0 110.374 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.572 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -70.38 178.3 2.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 176.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.553 ' OD1' ' CG ' ' A' ' 151' ' ' LYS . 1.1 m-80 -148.64 129.4 14.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.326 -0.859 . . . . 0.0 109.124 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.708 ' HB ' ' CE1' ' A' ' 150' ' ' PHE . 1.6 mt . . . . . 0 N--CA 1.491 1.617 0 C-N-CA 118.211 -1.396 . . . . 0.0 111.459 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.708 ' CE1' ' HB ' ' A' ' 135' ' ' ILE . 7.4 p90 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.759 0.79 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.553 ' CG ' ' OD1' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -100.32 113.88 26.93 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.829 -0.544 . . . . 0.0 109.737 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.572 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -76.1 135.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.684 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.416 HG23 ' CD ' ' A' ' 151' ' ' LYS . 18.9 t -123.58 -26.7 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 110.697 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -144.38 131.6 20.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 110.443 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.939 HG22 HG23 ' A' ' 98' ' ' VAL . 37.3 p -130.0 169.38 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 109.775 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -89.04 -39.88 0.44 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.822 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 1.02 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.0 Cg_exo -61.52 -175.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.583 1.307 . . . . 0.0 110.727 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.1 t -90.5 -163.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.81 . . . . 0.0 110.258 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -68.11 -6.43 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.64 141.68 34.22 Favored Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.388 -0.82 . . . . 0.0 110.125 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.548 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.93 144.69 11.4 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.177 1.619 . . . . 0.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 1.02 HG11 ' CB ' ' A' ' 157' ' ' PRO . 10.9 m -129.91 159.27 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.089 -1.007 . . . . 0.0 109.545 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 67.4 tt0 -107.36 127.66 53.77 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.27 -0.894 . . . . 0.0 109.957 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.748 HD12 HG21 ' A' ' 168' ' ' THR . 9.1 mm -69.36 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.917 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -140.9 167.66 25.56 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.44 -21.19 35.27 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.416 -1.05 . . . . 0.0 110.32 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.55 -17.72 26.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 110.74 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.748 HG21 HD12 ' A' ' 164' ' ' ILE . 30.2 m -57.59 156.72 7.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.906 . . . . 0.0 110.364 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -103.97 154.53 19.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 110.277 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.62 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 2.1 mm -120.0 129.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.772 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.512 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 53.4 mt-10 -117.83 130.02 56.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.12 -0.988 . . . . 0.0 110.419 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.589 HG23 ' HD3' ' A' ' 102' ' ' PRO . 37.1 mt -135.62 135.22 51.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.309 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.276 -178.206 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.161 0.505 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 88' ' ' ARG . . . -147.41 -159.74 8.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.904 HD13 HD21 ' A' ' 33' ' ' LEU . 43.6 pt -139.58 152.05 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -1.141 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.42 119.67 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.797 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.761 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.2 pt? -135.91 -168.34 2.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.291 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.563 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 26.4 ttm105 -106.03 130.66 53.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 111.059 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.858 HG11 ' O ' ' A' ' 80' ' ' SER . 14.4 p -61.65 139.02 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.379 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -120.24 153.55 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.487 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.597 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.321 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.577 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 84.2 mtt85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.005 0.431 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.908 HG13 HG23 ' A' ' 67' ' ' VAL . 77.4 t -109.98 115.43 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.011 -1.056 . . . . 0.0 109.987 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.579 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -88.09 117.4 26.94 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.683 178.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.776 HD13 HG12 ' A' ' 24' ' ' VAL . 1.2 mp -129.11 172.64 11.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 109.551 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 7.0 p-10 -92.76 176.64 6.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.863 -1.148 . . . . 0.0 110.022 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -40.06 87.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.449 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.58 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.5 t -69.51 -44.98 69.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 110.57 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.66 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.7 m -59.98 -39.99 87.6 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.102 -0.999 . . . . 0.0 109.608 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 36.9 ttp180 -74.7 -43.4 55.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.772 -0.58 . . . . 0.0 111.444 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -91.41 -11.53 37.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.821 -1.174 . . . . 0.0 111.201 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.092 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.3 pp -58.65 -32.88 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.855 -1.153 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.092 ' N ' HD12 ' A' ' 33' ' ' LEU . 13.0 mt -105.21 -74.07 0.66 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.927 . . . . 0.0 110.316 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 45.6 t0 -170.16 -24.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.691 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -24.61 119.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.557 0.694 . . . . 0.0 111.407 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.694 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -105.69 175.14 5.59 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.419 HD11 ' NH1' ' A' ' 31' ' ' ARG . 26.2 mm -58.16 120.75 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.917 -1.114 . . . . 0.0 109.813 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.58 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.72 33.82 54.78 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 174.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.2 m-20 -89.11 177.1 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.458 . . . . 0.0 109.477 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 92' ' ' THR . 70.6 t -99.08 121.64 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.09 . . . . 0.0 110.166 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.482 HG22 ' C ' ' A' ' 52' ' ' GLY . 1.5 m -116.8 139.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.489 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.8 141.36 38.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 109.863 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.871 HD13 ' CE ' ' A' ' 73' ' ' MET . 2.1 mp -120.48 146.63 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.013 -1.054 . . . . 0.0 110.296 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.0 tt0 -150.95 97.16 2.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.961 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.03 ' CG ' HG12 ' A' ' 85' ' ' VAL . 1.7 tmtt? -98.41 -67.36 0.85 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.825 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.591 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.01 -35.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.16 174.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 71.9 mtt85 -135.46 -178.74 5.25 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.776 -0.578 . . . . 0.0 109.571 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.574 ' C ' HD21 ' A' ' 130' ' ' LEU . 28.0 mttt -89.04 137.14 32.58 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.655 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.724 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 10.9 p -140.56 166.78 23.8 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.394 0.616 . . . . 0.0 109.834 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -122.98 166.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.448 -0.782 . . . . 0.0 110.196 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.482 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.99 -169.54 39.73 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -129.94 162.8 27.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.186 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -89.03 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 0.0 110.426 -173.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.577 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 2.2 m-85 -134.68 166.31 23.23 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.504 -0.747 . . . . 0.0 110.251 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 51.9 ptt85 -90.69 128.36 36.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.73 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -65.9 139.98 58.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.609 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -54.74 -49.58 90.73 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.881 -1.137 . . . . 0.0 108.868 175.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.4 Cg_endo -92.71 98.79 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.904 1.476 . . . . 0.0 108.893 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.47 34.37 0.08 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.41 -0.806 . . . . 0.0 110.918 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -146.26 -27.51 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 110.769 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -86.12 -28.2 24.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.258 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.73 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 33.6 m-80 -81.75 43.56 0.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.676 -0.64 . . . . 0.0 110.312 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 30.3 pttt -97.43 8.96 43.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.404 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.88 27.13 0.05 OUTLIER Glycine 0 N--CA 1.479 1.541 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.5 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 43.5 pt -140.24 142.87 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -1.083 . . . . 0.0 109.4 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.908 HG23 HG13 ' A' ' 24' ' ' VAL . 3.1 p -119.94 121.12 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.005 -1.059 . . . . 0.0 110.058 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.575 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 97.3 mtt180 -89.87 116.02 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.679 HD11 HG23 ' A' ' 11' ' ' VAL . 4.5 pt -126.75 171.72 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.66 -0.65 . . . . 0.0 110.645 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -80.01 168.05 19.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.881 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 m -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.316 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.506 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.5 t -62.82 -43.62 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.871 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.0 -46.52 89.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.628 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.417 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 6.4 ttp-105 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.554 174.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -69.99 -23.84 63.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.483 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 4.2 m120 -60.07 -39.1 84.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.08 -1.013 . . . . 0.0 110.352 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.535 ' C ' HG23 ' A' ' 47' ' ' VAL . 31.4 p -98.27 -35.03 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.047 -1.033 . . . . 0.0 110.532 -175.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.591 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 112.47 26.63 4.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.46 169.97 8.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -1.166 . . . . 0.0 110.309 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.858 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.47 178.73 4.2 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 178.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -64.74 141.25 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.388 177.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.811 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 78.69 -3.85 62.58 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 172.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -57.3 -167.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.98 -1.306 . . . . 0.0 110.098 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 50.7 pttt -127.01 114.65 18.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.12 -0.987 . . . . 0.0 109.748 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.03 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.1 m -119.33 155.57 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 83.6 tttt -105.61 125.44 50.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.659 HG23 HD21 ' A' ' 9' ' ' LEU . 76.0 t -106.85 121.4 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.481 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 41.3 mtm180 -110.63 135.61 51.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 19.4 tttt -83.81 138.64 33.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.529 HG23 HG12 ' A' ' 41' ' ' VAL . 2.3 m -150.04 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.088 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -126.48 168.99 13.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.907 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.535 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.73 163.47 12.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.093 -1.005 . . . . 0.0 111.05 -175.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.63 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.5 pt-20 -150.08 169.46 21.21 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.62 100.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.923 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.85 138.19 53.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.29 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.544 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -96.66 -29.34 13.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 110.981 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HB3' HD23 ' A' ' 156' ' ' LEU . 16.1 tttp -150.66 124.63 9.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.731 -1.231 . . . . 0.0 110.842 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.065 HG23 HG22 ' A' ' 155' ' ' THR . 5.4 p -134.34 142.05 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 0.0 110.653 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 86.8 m -118.54 141.7 48.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.329 -0.857 . . . . 0.0 110.109 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -139.24 169.79 17.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.709 -178.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.706 ' HB2' ' HD2' ' A' ' 173' ' ' ARG . . . -141.12 99.7 6.53 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.615 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo . . . . . 0 C--N 1.304 -1.786 0 O-C-N 123.878 1.462 . . . . 0.0 110.17 179.786 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 117' ' ' GLU . 10.4 tp . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.139 0.495 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 116' ' ' ILE . 43.5 mt-10 -59.98 -40.55 89.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.966 . . . . 0.0 109.693 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -68.69 -38.94 80.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 109.943 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.413 ' HD2' HD12 ' A' ' 116' ' ' ILE . 1.6 t80 -60.08 -39.99 88.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.251 -0.905 . . . . 0.0 109.341 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 172' ' ' ILE . 54.8 t -67.02 -45.93 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 109.89 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.558 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.2 mt-30 -59.98 -44.41 94.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.97 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -60.07 -48.6 81.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.441 0.639 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.566 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.05 -40.1 75.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.46 -0.775 . . . . 0.0 110.535 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.657 ' N ' HD22 ' A' ' 124' ' ' LEU . 3.9 mm? -97.53 -0.06 46.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.883 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.647 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.5 tt -47.3 166.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 110.171 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 164' ' ' ILE . 34.1 ptt180 33.08 46.68 0.1 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.659 -0.651 . . . . 0.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 7.6 mmt180 -129.79 150.42 75.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.676 -1.265 . . . . 0.0 111.192 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.79 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 22.2 Cg_endo -67.22 130.72 23.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 124.192 1.627 . . . . 0.0 109.876 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.554 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 87.8 mmm -127.13 137.58 53.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.556 -1.34 . . . . 0.0 111.077 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.63 HD23 ' HA ' ' A' ' 50' ' ' THR . 10.9 tp -140.21 113.67 8.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.622 -0.674 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -45.22 146.68 0.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.172 . . . . 0.0 110.394 -176.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.85 -0.53 3.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.741 -0.599 . . . . 0.0 110.627 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.568 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.2 p30 -69.91 -176.19 1.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.054 174.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 17.1 m-80 -145.94 150.06 35.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.592 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.313 0.577 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -122.39 101.9 7.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.603 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.568 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.3 t -77.47 138.79 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.68 -21.94 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 111.09 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.551 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 10.5 tptm -139.84 129.83 24.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.678 -1.264 . . . . 0.0 110.965 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.065 HG22 HG23 ' A' ' 98' ' ' VAL . 66.7 p -130.49 164.59 24.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.244 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.666 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.29 -36.67 0.42 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 110.916 -176.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.989 ' CG ' HG11 ' A' ' 162' ' ' VAL . 31.4 Cg_exo -53.1 -174.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.363 1.191 . . . . 0.0 110.401 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 4.9 t -86.84 41.44 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.28 -0.887 . . . . 0.0 110.264 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 158' ' ' SER . 40.7 mmtm 61.41 19.56 10.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.747 . . . . 0.0 109.901 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.778 ' O ' HG13 ' A' ' 162' ' ' VAL . 23.5 m -102.29 159.92 27.9 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.392 -0.818 . . . . 0.0 109.712 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.536 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.4 Cg_endo -53.81 119.66 6.61 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.059 1.557 . . . . 0.0 110.217 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.989 HG11 ' CG ' ' A' ' 157' ' ' PRO . 5.2 m -126.61 158.3 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -104.56 128.71 52.61 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.152 -0.967 . . . . 0.0 110.052 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.834 ' CD1' HG21 ' A' ' 168' ' ' THR . 12.8 mm -71.08 152.65 8.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.827 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.06 168.32 25.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.37 -20.87 21.34 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.975 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -90.99 -18.57 24.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 110.684 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.834 HG21 ' CD1' ' A' ' 164' ' ' ILE . 30.5 m -57.89 148.41 25.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 110.473 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 49.6 mttp -96.35 147.19 24.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.004 . . . . 0.0 109.702 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.747 HD13 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mt -130.03 160.03 41.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.093 -1.004 . . . . 0.0 110.982 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 99' ' ' THR . 25.3 mt-10 -137.78 133.6 34.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.754 -0.591 . . . . 0.0 110.231 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 120' ' ' VAL . 39.5 mm -120.02 120.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.341 -0.85 . . . . 0.0 109.39 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.706 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 4.7 ptp85 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 110.439 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 122.005 0.907 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.11 -166.84 13.41 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.808 ' CG2' HD12 ' A' ' 33' ' ' LEU . 41.3 pt -131.89 160.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -1.138 . . . . 0.0 109.535 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.18 117.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.5 pt? -139.58 -172.39 3.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.603 ' NE ' HG22 ' A' ' 66' ' ' ILE . 33.1 ptt180 -111.12 140.51 45.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.597 -1.314 . . . . 0.0 110.93 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 81' ' ' ILE . 9.6 p -62.29 138.09 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.497 -0.752 . . . . 0.0 110.675 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -119.06 144.71 46.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.944 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.524 174.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.565 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 80.8 mtt180 . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.384 0.611 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.005 HG13 HG23 ' A' ' 67' ' ' VAL . 53.0 t -120.09 121.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.885 . . . . 0.0 110.303 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.758 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.8 ptt180 -91.27 120.71 32.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.7 -1.25 . . . . 0.0 109.881 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -135.49 169.15 17.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 109.821 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.0 p-10 -94.48 -170.05 2.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.941 -1.1 . . . . 0.0 111.069 -175.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -0.76 . . . . 0.0 109.904 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.61 -43.66 93.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.752 . . . . 0.0 110.105 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.127 ' O ' HD22 ' A' ' 33' ' ' LEU . 54.6 m -58.64 -32.14 68.79 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.464 -0.773 . . . . 0.0 109.44 177.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 70.6 ttt180 -84.57 -44.31 13.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.704 -0.622 . . . . 0.0 110.887 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 33' ' ' LEU . 75.9 mtp85 -77.44 -11.14 59.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.171 -0.956 . . . . 0.0 110.127 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.127 HD22 ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -40.87 -29.36 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.888 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.799 ' H ' HD23 ' A' ' 33' ' ' LEU . 84.0 mt -141.15 -61.44 0.48 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 110.107 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.9 t0 -169.62 -36.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.529 -0.732 . . . . 0.0 109.498 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.728 ' HB2' ' HE3' ' A' ' 89' ' ' LYS . . . 9.99 114.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.263 0.554 . . . . 0.0 112.101 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.642 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.84 173.03 6.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.647 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 33.2 mm -60.08 120.23 5.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.949 -1.094 . . . . 0.0 109.825 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.583 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.27 34.36 46.22 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.466 173.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.472 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.9 m-20 -88.88 174.91 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.819 -1.4 . . . . 0.0 109.492 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.66 HG12 HG23 ' A' ' 90' ' ' VAL . 71.7 t -99.15 126.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.888 -1.132 . . . . 0.0 110.479 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.603 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -119.61 146.08 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.819 . . . . 0.0 110.572 -177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.12 140.7 46.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 109.677 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.898 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.3 mp -125.85 143.67 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.944 -1.097 . . . . 0.0 110.512 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.14 98.97 2.76 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.054 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.937 ' CG ' HG12 ' A' ' 85' ' ' VAL . 5.8 tmtm? -98.56 -66.46 0.9 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.226 -0.921 . . . . 0.0 109.695 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.557 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.77 -37.12 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 174.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.598 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -129.88 -178.97 4.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.757 -0.589 . . . . 0.0 109.826 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.624 ' HB3' HD21 ' A' ' 130' ' ' LEU . 12.8 mttp -91.86 134.66 34.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.605 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.8 p -139.56 165.05 28.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.499 -0.751 . . . . 0.0 110.129 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.575 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.82 162.71 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.59 -0.694 . . . . 0.0 110.339 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.603 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.86 -171.38 42.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.21 177.14 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -1.134 . . . . 0.0 110.371 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -103.0 133.13 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 110.548 -175.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.565 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -125.54 165.93 17.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.432 -0.792 . . . . 0.0 110.658 176.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -91.52 125.03 36.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.738 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -65.67 137.78 57.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.881 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.577 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.24 -48.6 96.73 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.903 -1.123 . . . . 0.0 109.105 173.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 39.9 Cg_endo -91.86 97.99 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.838 1.441 . . . . 0.0 109.108 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.474 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 19.5 pt-20 -74.64 36.46 0.11 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.519 -0.738 . . . . 0.0 110.699 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 82.2 m-20 -144.3 -34.93 0.36 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.154 -0.966 . . . . 0.0 110.649 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -85.1 -28.6 25.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 109.241 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.524 ' HA ' HG12 ' A' ' 66' ' ' ILE . 3.2 m-80 -81.03 39.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.8 -0.563 . . . . 0.0 110.697 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 3.0 pttp -98.24 12.85 33.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.665 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.02 25.95 0.06 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.603 HG22 ' NE ' ' A' ' 10' ' ' ARG . 45.6 pt -140.66 142.62 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.492 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.005 HG23 HG13 ' A' ' 24' ' ' VAL . 2.2 p -120.33 121.75 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.969 -1.082 . . . . 0.0 109.922 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.512 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 77.4 mtt180 -89.43 117.72 28.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.94 -1.1 . . . . 0.0 110.176 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.659 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.5 pp -127.23 172.36 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.428 0.632 . . . . 0.0 110.361 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 34.0 p-10 -76.41 168.74 19.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 0.0 109.773 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -67.11 -27.85 67.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG12 HD21 ' A' ' 76' ' ' ASN . 53.0 t -70.0 -43.66 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.965 . . . . 0.0 110.486 -176.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.898 ' CE ' HD13 ' A' ' 44' ' ' ILE . 3.1 tpt -60.02 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.072 -1.018 . . . . 0.0 109.683 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.591 ' HG3' HG21 ' A' ' 11' ' ' VAL . 6.9 ttm180 -59.99 -40.01 87.72 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 0.0 109.853 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -72.2 -25.99 61.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.465 HD21 HG12 ' A' ' 72' ' ' VAL . 88.6 m-20 -68.55 -29.13 67.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.022 . . . . 0.0 110.625 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 31.0 p -99.26 -37.01 9.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 110.496 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.557 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 112.98 23.84 5.11 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.589 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.22 167.43 9.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -1.183 . . . . 0.0 110.351 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.613 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -116.75 166.42 12.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 178.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.944 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -51.4 140.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.486 178.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 77.27 -0.67 67.42 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 172.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.1 m-20 -56.31 -160.99 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 12.7 pttm -135.51 112.19 10.07 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.489 -0.757 . . . . 0.0 109.861 175.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.937 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.49 158.94 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.749 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 55.5 tttp -110.75 123.57 50.3 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.188 -0.945 . . . . 0.0 109.955 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.674 HG22 HG23 ' A' ' 44' ' ' ILE . 62.8 t -105.59 123.64 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 109.873 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.439 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.7 mtt180 -112.42 139.32 48.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.733 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HE3' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -79.06 141.06 37.72 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 110.437 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.66 HG23 HG12 ' A' ' 41' ' ' VAL . 2.0 m -150.01 -168.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 109.999 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.512 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 47.1 ptt85 -139.59 171.04 14.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.566 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.41 158.7 16.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.995 -1.066 . . . . 0.0 111.309 -173.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.68 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.4 pt-20 -150.86 175.23 12.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.24 101.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.663 -1.273 . . . . 0.0 110.587 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.841 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.05 137.44 55.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.541 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 19.5 ptpt -101.12 -26.4 13.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 110.814 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.663 ' HB3' HD23 ' A' ' 156' ' ' LEU . 83.7 tttt -150.8 119.95 6.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.897 -1.127 . . . . 0.0 110.584 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.933 HG23 HG22 ' A' ' 155' ' ' THR . 7.4 p -135.19 140.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.871 -1.143 . . . . 0.0 110.977 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 171' ' ' GLU . 29.9 m -112.21 144.37 41.73 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.346 -0.846 . . . . 0.0 109.962 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.745 HD21 HG23 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -141.87 165.74 26.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.179 -0.95 . . . . 0.0 110.941 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.95 90.72 10.65 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 110.368 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 37.9 Cg_exo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 123.955 1.503 . . . . 0.0 110.547 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 117' ' ' GLU . 6.7 tp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.204 0.526 . . . . 0.0 110.066 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.431 ' N ' HG23 ' A' ' 116' ' ' ILE . 47.5 mt-10 -60.02 -43.12 95.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.675 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.43 -39.8 89.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.756 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.02 -40.03 87.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.815 . . . . 0.0 109.669 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.76 HG12 ' CD1' ' A' ' 170' ' ' ILE . 54.4 t -60.02 -47.25 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.571 ' NE2' ' O ' ' A' ' 168' ' ' THR . 4.1 mt-30 -59.95 -44.51 94.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.511 -0.743 . . . . 0.0 110.06 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -60.11 -44.04 95.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.57 -0.706 . . . . 0.0 110.19 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -74.6 -42.09 59.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.5 mm? -95.92 0.68 52.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.172 -0.955 . . . . 0.0 111.205 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.635 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.6 tt -46.04 166.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.851 -1.155 . . . . 0.0 110.261 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.9 ptm180 32.63 49.31 0.15 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.603 -0.686 . . . . 0.0 111.237 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.537 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -129.1 134.68 26.58 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.029 -1.044 . . . . 0.0 110.955 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.812 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.7 Cg_exo -59.75 125.73 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.931 1.49 . . . . 0.0 109.785 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.537 ' HG2' ' O ' ' A' ' 127' ' ' ARG . 99.7 mmm -124.35 140.46 52.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.445 -1.409 . . . . 0.0 111.031 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 49' ' ' LYS . 12.6 tp -140.99 111.6 6.94 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.58 -0.7 . . . . 0.0 109.503 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pm0 -47.07 137.42 7.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 110.612 -173.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.59 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 1.3 tp-100 80.41 -3.39 1.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.243 0.545 . . . . 0.0 110.358 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.617 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.4 p30 -69.12 -173.59 0.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 175.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.465 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 7.9 m-80 -146.32 140.3 26.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 O-C-N 120.969 -1.082 . . . . 0.0 110.447 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 67.7 m-85 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.188 0.518 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.441 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 23.7 tptm -97.14 103.68 15.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.303 -0.873 . . . . 0.0 109.882 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.617 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.9 t -74.87 134.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.539 HG21 ' NH2' ' A' ' 173' ' ' ARG . 37.9 t -115.18 -30.17 2.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 110.751 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.485 ' C ' HG23 ' A' ' 155' ' ' THR . 68.5 mttt -143.4 160.0 41.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 0.0 111.163 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.933 HG22 HG23 ' A' ' 98' ' ' VAL . 81.5 p -150.0 162.55 40.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.83 -38.69 0.44 Allowed Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.994 ' CG ' HG11 ' A' ' 162' ' ' VAL . 21.4 Cg_exo -57.68 -166.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.535 1.282 . . . . 0.0 110.139 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.48 ' HB3' HG22 ' A' ' 160' ' ' VAL . 4.6 t -89.69 -169.23 2.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.913 . . . . 0.0 109.671 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -64.16 -7.9 10.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 110.605 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 158' ' ' SER . 32.1 m -83.38 152.13 63.73 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 121.416 -0.803 . . . . 0.0 110.578 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.575 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 4.6 Cg_endo -52.98 142.57 52.92 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.303 1.686 . . . . 0.0 110.952 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.994 HG11 ' CG ' ' A' ' 157' ' ' PRO . 7.2 m -132.46 158.11 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 110.033 171.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 83.2 tt0 -105.36 126.32 51.97 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 110.213 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.768 ' CD1' HG21 ' A' ' 168' ' ' THR . 13.1 mm -69.77 159.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 110.438 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.65 167.84 26.52 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.633 ' HB3' HD11 ' A' ' 125' ' ' ILE . 19.2 pt-20 -58.58 -19.95 42.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.336 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.63 -22.03 20.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.768 HG21 ' CD1' ' A' ' 164' ' ' ILE . 94.2 m -54.99 147.32 15.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.635 -0.666 . . . . 0.0 110.283 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.7 mmtm -95.52 156.72 16.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.937 -1.102 . . . . 0.0 110.014 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.76 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.4 mt -135.68 164.25 33.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.992 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 99' ' ' THR . 37.0 mt-10 -139.26 137.01 35.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.621 -0.675 . . . . 0.0 110.276 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 120' ' ' VAL . 47.1 mm -119.95 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.937 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.719 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 3.4 ptp180 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 0.0 110.29 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.563 0.697 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -144.32 -160.47 8.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.918 HG21 HD22 ' A' ' 33' ' ' LEU . 46.2 pt -132.98 147.76 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -1.145 . . . . 0.0 109.815 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.8 mt -96.24 119.08 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.802 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.7 pt? -136.61 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 110.287 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.509 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 24.0 ttp180 -106.08 130.38 53.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.419 -0.801 . . . . 0.0 110.998 -174.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.967 HG11 ' O ' ' A' ' 80' ' ' SER . 10.2 p -61.21 139.55 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.523 -0.735 . . . . 0.0 110.416 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -125.79 153.33 44.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.467 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.929 ' HB3' HD11 ' A' ' 81' ' ' ILE . 46.2 tt0 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.93 . . . . 0.0 110.062 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.556 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 98.1 mtt180 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.218 0.532 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.853 HG13 HG23 ' A' ' 67' ' ' VAL . 92.8 t -116.14 120.01 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.206 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.827 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.1 ptm180 -93.54 119.97 33.25 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.852 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.827 HD22 ' O ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -138.43 178.6 7.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.547 -0.72 . . . . 0.0 109.737 -176.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 15.2 p-10 -94.2 177.01 6.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.815 -1.178 . . . . 0.0 110.635 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 86.3 mt-10 -60.0 -44.74 94.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.3 t -60.49 -43.13 97.33 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.264 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.653 ' CB ' HD12 ' A' ' 26' ' ' LEU . 47.0 t -59.97 -41.15 91.34 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.257 176.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.607 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 67.4 ttt180 -68.98 -44.17 73.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.662 . . . . 0.0 111.363 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 33' ' ' LEU . 25.4 tpt180 -90.32 -20.69 22.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.859 -1.15 . . . . 0.0 111.74 -170.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.083 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -47.84 -30.36 3.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.73 -1.231 . . . . 0.0 108.988 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.083 ' N ' HD12 ' A' ' 33' ' ' LEU . 18.0 mt -115.67 -78.16 0.58 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.798 . . . . 0.0 110.393 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -172.23 11.65 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.473 -0.767 . . . . 0.0 110.515 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -50.03 127.75 17.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.094 -1.004 . . . . 0.0 110.337 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.681 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -112.61 176.31 5.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.435 ' HA ' HD13 ' A' ' 38' ' ' ILE . 28.5 mm -59.66 119.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.828 -1.17 . . . . 0.0 109.83 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.61 36.83 47.62 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.26 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 25.6 m-20 -87.97 169.19 12.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.752 -1.44 . . . . 0.0 109.228 170.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 54.3 t -98.78 120.36 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.858 -1.151 . . . . 0.0 110.15 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.659 HG12 ' CE ' ' A' ' 89' ' ' LYS . 2.8 m -116.85 139.79 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.554 -0.716 . . . . 0.0 110.101 -176.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 85.9 tt0 -106.55 138.34 42.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.872 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.982 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.6 mp -116.97 140.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.147 -0.97 . . . . 0.0 109.859 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 84.4 tt0 -150.16 96.29 2.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.087 -1.008 . . . . 0.0 111.186 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.761 ' HB2' HG12 ' A' ' 85' ' ' VAL . 37.9 tttp -99.53 -71.07 0.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 172.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.16 -34.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.47 175.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.552 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 87.3 mtt-85 -139.77 179.71 6.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.051 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HD3' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -89.04 134.14 34.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 110.781 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.534 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 1.7 p -138.48 172.06 13.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.679 . . . . 0.0 109.322 174.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.808 ' CG2' HD21 ' A' ' 130' ' ' LEU . 3.0 m -127.93 168.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.415 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.45 -175.9 45.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 40.8 ttm180 -121.71 165.75 15.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.439 -1.036 . . . . 0.0 109.975 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.681 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -94.57 135.85 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 110.553 -172.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.556 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -130.5 167.27 18.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 110.509 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -89.6 125.97 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.429 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.74 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -65.23 140.08 58.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.847 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.589 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -55.45 -49.96 89.54 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.947 174.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 33.9 Cg_endo -92.81 98.56 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.873 1.46 . . . . 0.0 108.974 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -73.64 35.13 0.08 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.561 -0.712 . . . . 0.0 110.91 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -145.91 -29.77 0.41 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.152 -0.968 . . . . 0.0 110.531 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.12 -27.25 26.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.167 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.74 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 31.5 m-80 -81.22 41.15 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.775 -0.578 . . . . 0.0 110.386 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.43 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -98.2 7.96 45.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.37 26.32 0.05 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 66' ' ' ILE . 45.6 pt -140.02 141.34 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.252 -1.146 . . . . 0.0 109.411 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.853 HG23 HG13 ' A' ' 24' ' ' VAL . 10.2 p -121.51 125.85 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.053 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.558 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 77.8 mtt180 -89.52 116.32 27.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.941 -1.099 . . . . 0.0 110.107 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.4 pp -129.97 170.07 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.209 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -79.83 164.24 23.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.945 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -68.01 -18.79 64.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.09 -50.02 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 110.313 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.982 ' CE ' HD13 ' A' ' 44' ' ' ILE . 19.3 ttt -59.98 -45.7 91.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.443 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.508 ' HD3' ' CD1' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.991 174.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -62.03 -36.42 81.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 109.84 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -67.79 -26.37 66.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 110.755 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 24.3 p -99.36 -30.99 11.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.022 -1.049 . . . . 0.0 110.547 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.49 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 106.75 19.73 9.47 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.628 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.23 169.34 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.243 . . . . 0.0 110.838 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.967 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -120.31 178.53 4.61 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.475 -0.765 . . . . 0.0 109.458 177.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.929 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -66.4 142.26 16.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 110.35 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.707 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.36 -4.78 54.23 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 172.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.539 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.89 -162.08 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.053 -1.263 . . . . 0.0 110.067 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 16.4 pttp -137.2 116.15 12.36 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -119.55 160.72 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 82.8 tttt -109.37 120.62 43.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.025 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.519 HG23 HD21 ' A' ' 9' ' ' LEU . 87.3 t -101.67 123.69 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 0.0 110.204 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.52 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 93.9 mtt180 -106.88 151.4 25.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 109.763 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.659 ' CE ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -99.07 132.44 44.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.049 -1.032 . . . . 0.0 110.215 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.3 m -149.91 -168.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.561 -0.712 . . . . 0.0 110.125 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 40.1 ptt180 -129.07 171.67 12.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.636 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.74 164.72 12.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 111.023 -175.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.594 ' CG ' HG12 ' A' ' 162' ' ' VAL . 18.8 pt-20 -150.04 169.51 21.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 109.421 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 163' ' ' GLU . 40.0 mm -90.66 99.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.843 -1.161 . . . . 0.0 110.607 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.866 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.27 140.07 50.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 110.423 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.661 ' HE3' HD12 ' A' ' 156' ' ' LEU . 1.5 ptpt -101.68 -29.03 12.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.536 ' HB3' HD23 ' A' ' 156' ' ' LEU . 40.2 ttmt -150.79 129.35 12.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.367 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.083 HG23 HG22 ' A' ' 155' ' ' THR . 9.7 p -139.67 139.99 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.009 -1.057 . . . . 0.0 110.782 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 171' ' ' GLU . 14.5 m -102.71 138.67 39.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.873 . . . . 0.0 110.042 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.545 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -132.03 159.96 37.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.696 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . . . -135.18 81.82 43.39 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.432 -0.793 . . . . 0.0 110.396 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 19.7 Cg_exo . . . . . 0 C--N 1.304 -1.775 0 O-C-N 123.936 1.493 . . . . 0.0 110.33 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 117' ' ' GLU . 7.2 tp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.124 0.488 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 97.2 mt-10 -61.48 -42.58 99.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -70.04 -30.12 67.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.93 -39.93 83.07 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.783 ' O ' HD22 ' A' ' 124' ' ' LEU . 56.0 t -60.07 -43.79 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.316 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.608 ' NE2' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -59.63 -45.06 93.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.987 -1.07 . . . . 0.0 109.575 175.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -59.94 -40.09 87.77 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.22 -22.18 38.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.165 -0.959 . . . . 0.0 110.938 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -130.03 7.22 5.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.94 -1.1 . . . . 0.0 110.674 -174.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.698 ' N ' HD23 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -44.26 173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.311 -0.868 . . . . 0.0 110.883 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.7 ptm180 34.9 46.63 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.498 -0.751 . . . . 0.0 111.29 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.437 ' H ' ' HB ' ' A' ' 164' ' ' ILE . 8.9 ttt180 -123.33 129.7 24.81 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.87 -1.144 . . . . 0.0 111.19 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.846 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.5 Cg_endo -66.26 125.9 14.8 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.954 1.502 . . . . 0.0 109.647 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.98 ' O ' HD13 ' A' ' 130' ' ' LEU . 97.6 mtp -140.01 151.62 45.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.27 -1.519 . . . . 0.0 112.092 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.98 HD13 ' O ' ' A' ' 129' ' ' MET . 0.5 OUTLIER -126.03 146.16 50.01 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.443 0.639 . . . . 0.0 109.975 172.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.4 pm0 -57.18 140.02 50.83 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 172.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 75.2 -0.75 3.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.75 -0.594 . . . . 0.0 110.262 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.801 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -67.81 -172.81 0.3 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 109.942 176.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 17.1 m-80 -141.18 149.72 41.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.016 -1.052 . . . . 0.0 110.493 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 66.5 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.416 0.627 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 32.3 tptt -118.05 102.21 8.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.922 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.801 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.5 t -74.93 135.73 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.791 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.42 -31.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 110.669 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 54.7 tttm -139.39 148.76 43.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.954 -1.091 . . . . 0.0 110.953 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.083 HG22 HG23 ' A' ' 98' ' ' VAL . 24.4 p -145.07 159.7 42.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.76 -0.588 . . . . 0.0 109.836 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.674 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -90.46 -38.05 0.4 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.344 -0.847 . . . . 0.0 111.015 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 1.1 ' CB ' HG11 ' A' ' 162' ' ' VAL . 12.6 Cg_exo -60.15 -173.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.434 1.228 . . . . 0.0 110.911 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 159' ' ' LYS . 5.4 t -90.17 -168.47 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 158' ' ' SER . 8.7 ptpt -66.3 -6.01 12.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.437 ' H ' HG22 ' A' ' 160' ' ' VAL . 33.7 m -86.36 152.33 54.97 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.599 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.636 ' HB3' HG11 ' A' ' 51' ' ' VAL . 1.6 Cg_endo -51.52 132.42 40.38 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.289 1.678 . . . . 0.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 1.1 HG11 ' CB ' ' A' ' 157' ' ' PRO . 3.5 m -121.96 152.92 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.609 -1.237 . . . . 0.0 110.269 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.598 ' HG3' HD13 ' A' ' 94' ' ' ILE . 18.1 pt-20 -103.47 127.93 50.75 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.879 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 1.008 HD12 HG21 ' A' ' 168' ' ' THR . 19.3 mm -71.04 153.4 8.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.136 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.608 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -143.69 167.29 26.7 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.563 ' HA ' HD11 ' A' ' 125' ' ' ILE . 99.0 mt-10 -56.61 -20.58 21.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -1.062 . . . . 0.0 110.397 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.94 -9.91 47.04 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.667 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.008 HG21 HD12 ' A' ' 164' ' ' ILE . 95.6 m -62.44 146.65 50.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.167 -0.958 . . . . 0.0 109.886 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.5 mttt -97.43 143.97 27.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 109.64 176.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.586 HD11 ' HG2' ' A' ' 121' ' ' GLN . 2.1 mm -106.84 129.45 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 99' ' ' THR . 64.7 mt-10 -116.31 135.2 54.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 110.156 172.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.458 HG12 ' HG ' ' A' ' 100' ' ' LEU . 41.3 mt -140.1 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.873 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 173' ' ' ARG . 3.5 ptm85 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.228 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.586 ' ND2' HD22 ' A' ' 34' ' ' LEU . 31.9 p30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.139 0.495 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.71 -159.13 8.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.911 ' CG2' HD12 ' A' ' 33' ' ' LEU . 20.6 pt -137.2 169.35 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -112.51 120.51 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.011 -1.056 . . . . 0.0 110.444 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 87' ' ' VAL . 1.7 pt? -139.41 -167.66 2.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.776 . . . . 0.0 109.747 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 34.9 ptt180 -118.88 140.02 50.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.794 -1.191 . . . . 0.0 110.715 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.938 HG11 ' O ' ' A' ' 80' ' ' SER . 4.6 p -62.35 147.7 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -122.3 147.66 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.903 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.811 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.516 ' HG3' ' CG ' ' A' ' 55' ' ' TYR . 59.8 ttt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.171 0.51 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.071 HG13 HG23 ' A' ' 67' ' ' VAL . 55.5 t -112.56 112.53 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 0.0 110.271 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.793 ' O ' HD12 ' A' ' 26' ' ' LEU . 7.4 ptt180 -84.24 117.37 23.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.689 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.929 HD13 HG12 ' A' ' 24' ' ' VAL . 1.8 mp -134.83 170.62 15.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.993 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.0 p-10 -105.57 -175.18 2.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 110.507 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -59.91 -42.09 93.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.184 -0.947 . . . . 0.0 109.643 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -67.4 -49.56 63.29 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.3 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.114 ' O ' HD22 ' A' ' 33' ' ' LEU . 72.4 m -57.9 -27.44 63.31 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.119 -0.988 . . . . 0.0 109.56 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 39.9 ttm180 -86.43 -46.08 10.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.822 -0.549 . . . . 0.0 110.957 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -79.71 -8.58 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.114 HD22 ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -43.85 -28.7 0.47 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -0.779 . . . . 0.0 110.136 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.716 ' H ' HD23 ' A' ' 33' ' ' LEU . 83.2 mt -141.76 -59.43 0.47 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 110.272 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.602 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.4 t0 -170.56 -30.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.424 -0.798 . . . . 0.0 110.066 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.602 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -15.35 120.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.437 0.637 . . . . 0.0 111.581 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.597 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -105.87 -177.51 3.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.0 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.422 HD12 HG23 ' A' ' 38' ' ' ILE . 28.5 mm -63.73 119.4 7.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.062 -1.024 . . . . 0.0 110.135 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.608 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.25 35.95 56.3 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.81 178.3 6.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.056 -1.261 . . . . 0.0 109.499 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.616 HG21 ' OG1' ' A' ' 92' ' ' THR . 97.0 t -99.65 127.76 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.015 -1.053 . . . . 0.0 110.301 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG11 HG23 ' A' ' 54' ' ' VAL . 3.1 m -120.95 149.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.514 -0.741 . . . . 0.0 110.683 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -111.93 140.8 46.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.594 -0.691 . . . . 0.0 109.982 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.849 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.5 mp -124.92 144.01 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.926 -1.109 . . . . 0.0 110.731 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -150.21 98.79 2.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 110.827 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.946 ' CG ' HG12 ' A' ' 85' ' ' VAL . 9.2 tmtm? -97.94 -64.36 1.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.559 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.569 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.17 -36.94 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.817 0.818 . . . . 0.0 109.098 175.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 70.5 mtt85 -128.95 -173.47 2.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.538 ' HB3' HD21 ' A' ' 130' ' ' LEU . 29.3 mttt -96.18 141.75 29.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.122 -0.986 . . . . 0.0 110.902 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.637 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.5 p -145.0 168.2 20.84 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.374 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.57 162.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -171.66 41.39 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.216 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.403 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 70.2 ttt180 -121.72 166.44 14.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.458 -1.025 . . . . 0.0 110.165 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -99.94 149.69 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.004 . . . . 0.0 110.412 -175.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.0 m-85 -139.16 167.84 21.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.511 -0.743 . . . . 0.0 110.339 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -88.62 122.77 32.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.844 . . . . 0.0 110.052 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.834 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.3 138.3 58.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.734 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 2.4 mtp180 -58.35 -47.21 99.21 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.309 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 56.2 Cg_endo -93.51 98.96 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.675 1.355 . . . . 0.0 108.69 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.423 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.5 pt-20 -73.28 35.65 0.08 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.587 -0.696 . . . . 0.0 110.784 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.3 m-20 -146.07 -30.79 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.96 -28.78 25.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.433 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.834 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 5.3 m120 -80.53 39.64 0.48 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.723 -0.61 . . . . 0.0 110.64 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -98.96 13.34 33.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.072 -1.017 . . . . 0.0 109.663 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.72 26.42 0.05 OUTLIER Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.55 149.04 20.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.371 -1.076 . . . . 0.0 108.933 175.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.071 HG23 HG13 ' A' ' 24' ' ' VAL . 7.6 p -126.55 131.81 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.928 -1.108 . . . . 0.0 110.348 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 3.5 ttt180 -89.59 116.24 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 110.325 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.877 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.7 pp -135.36 168.58 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.318 -0.864 . . . . 0.0 111.036 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -82.06 155.54 25.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.282 -0.886 . . . . 0.0 110.201 174.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' ' CG ' ' A' ' 75' ' ' ASN . 60.1 p -60.12 -23.37 63.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 110.147 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.6 t -68.09 -42.94 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 110.232 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.849 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.95 -50.91 71.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 109.974 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.633 ' HD2' HG21 ' A' ' 11' ' ' VAL . 13.2 mmp_? -60.14 -39.85 87.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 173.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 78.2 m-20 -60.12 -37.77 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 73' ' ' MET . 93.8 m-20 -59.94 -36.25 76.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 110.648 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 30.2 p -98.15 -39.33 8.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.105 -0.997 . . . . 0.0 110.531 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.569 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 119.18 36.17 0.89 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.806 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -116.48 170.2 8.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.327 . . . . 0.0 110.38 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.938 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.99 -176.83 3.43 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.811 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -66.57 143.42 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.487 178.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.759 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.13 0.95 67.16 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.3 m-20 -61.33 -165.4 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.071 -1.253 . . . . 0.0 110.581 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.0 pttt -130.64 112.94 13.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 0.0 109.945 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.946 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -122.68 161.15 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 109.995 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 26.4 ttmt -104.96 125.67 51.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.011 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.818 HG23 HD21 ' A' ' 9' ' ' LEU . 62.0 t -108.28 121.25 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.507 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.6 mtt180 -111.39 147.13 35.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.419 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 36' ' ' ALA . 6.5 tttt -92.51 139.57 30.45 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.255 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.69 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.413 -0.804 . . . . 0.0 110.26 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -132.25 172.28 12.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.466 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.616 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.49 159.59 16.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.974 -1.079 . . . . 0.0 111.204 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.555 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.1 pt-20 -150.02 169.97 19.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.657 HD12 ' N ' ' A' ' 94' ' ' ILE . 4.6 mp -89.56 99.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.731 -1.231 . . . . 0.0 110.241 -178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.806 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.0 138.04 44.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.772 . . . . 0.0 110.353 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.697 ' CG ' HD13 ' A' ' 156' ' ' LEU . 15.5 ptmt -98.39 -30.01 12.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.34 -0.85 . . . . 0.0 110.849 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.549 ' HB3' HD12 ' A' ' 156' ' ' LEU . 14.7 tttp -151.06 125.61 9.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.85 -1.156 . . . . 0.0 110.803 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.063 HG23 HG22 ' A' ' 155' ' ' THR . 8.6 p -137.52 147.17 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.065 . . . . 0.0 111.044 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.758 HG23 ' HB3' ' A' ' 171' ' ' GLU . 38.0 m -119.14 142.82 47.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.111 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.686 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -138.54 169.03 18.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.847 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.38 93.84 4.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.415 -0.803 . . . . 0.0 110.489 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.7 Cg_exo . . . . . 0 C--N 1.303 -1.864 0 O-C-N 124.201 1.632 . . . . 0.0 110.417 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.5 tp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.091 0.472 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.7 mt-10 -60.03 -42.12 93.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.27 -37.51 83.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 109.6 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -59.97 -42.42 94.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.589 HG12 ' CD1' ' A' ' 170' ' ' ILE . 53.1 t -60.26 -45.01 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 175.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.583 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.1 mt-30 -59.89 -43.97 94.5 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.568 -0.707 . . . . 0.0 109.951 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.31 -46.01 91.4 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.819 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.9 68.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 110.921 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 2.9 mm? -99.89 5.33 45.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.025 -1.047 . . . . 0.0 111.171 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.706 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.7 tt -48.71 170.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 36.6 ptt180 33.66 49.12 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.628 -0.67 . . . . 0.0 111.516 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 0.7 OUTLIER -132.37 149.93 74.51 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.711 -1.243 . . . . 0.0 111.232 176.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.834 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.1 Cg_endo -68.73 128.19 16.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 124.174 1.618 . . . . 0.0 109.971 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.7 mmm -123.07 140.95 52.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.321 -1.487 . . . . 0.0 110.983 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 50' ' ' THR . 20.2 tp -139.24 104.19 4.94 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.695 -0.628 . . . . 0.0 109.386 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.642 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.5 pt-20 -45.24 137.09 4.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.046 -1.034 . . . . 0.0 110.7 -174.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 86.01 -6.06 0.8 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.27 0.557 . . . . 0.0 110.283 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.561 ' OD2' ' HB ' ' A' ' 152' ' ' VAL . 2.8 p30 -69.49 -178.31 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 110.359 177.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -147.1 153.09 39.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.941 -1.099 . . . . 0.0 110.65 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.7 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.188 0.518 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -112.4 111.95 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.561 ' HB ' ' OD2' ' A' ' 133' ' ' ASP . 2.7 t -78.15 137.57 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.89 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.48 -31.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.257 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -143.43 146.98 33.91 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.411 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.063 HG22 HG23 ' A' ' 98' ' ' VAL . 56.0 p -140.0 161.68 37.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.697 HD13 ' CG ' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -89.26 -35.91 0.42 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.96 -1.087 . . . . 0.0 111.103 -177.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.942 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.3 Cg_exo -58.61 -167.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.327 1.172 . . . . 0.0 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 160' ' ' VAL . 29.1 t -87.68 -173.88 4.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.792 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -67.9 -1.84 6.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.176 -0.953 . . . . 0.0 110.567 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' A' ' 158' ' ' SER . 33.1 m -85.79 147.73 46.76 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.146 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.585 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.8 Cg_endo -47.45 139.07 17.74 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 O-C-N 124.358 1.715 . . . . 0.0 110.975 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.942 HG11 ' CB ' ' A' ' 157' ' ' PRO . 11.1 m -130.02 159.21 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 109.442 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.3 tt0 -106.61 127.23 53.17 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.048 -1.032 . . . . 0.0 110.229 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.84 ' CD1' HG21 ' A' ' 168' ' ' THR . 16.6 mm -70.43 154.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.667 -0.646 . . . . 0.0 110.213 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.24 175.4 23.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.706 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -58.75 -26.05 63.61 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.341 -1.094 . . . . 0.0 109.992 -178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.36 -17.76 28.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 0.0 110.737 -176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.84 HG21 ' CD1' ' A' ' 164' ' ' ILE . 53.3 m -58.73 146.37 36.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 98.6 mttt -100.01 153.14 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.955 -1.091 . . . . 0.0 109.467 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.637 HG23 HD21 ' A' ' 100' ' ' LEU . 2.1 mt -129.92 159.4 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.001 -1.062 . . . . 0.0 111.185 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.758 ' HB3' HG23 ' A' ' 99' ' ' THR . 10.4 mt-10 -130.35 130.91 45.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.029 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 120' ' ' VAL . 50.5 mm -119.91 127.18 75.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.32 -0.863 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 2.9 ptp180 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 67.3 t30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.122 0.487 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -147.09 -169.71 14.82 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.008 HG23 HD11 ' A' ' 34' ' ' LEU . 45.7 pt -134.82 159.99 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.228 -1.16 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 86' ' ' LYS . 40.4 mm -98.37 116.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 110.331 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.3 pt? -139.37 -178.26 5.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.324 -0.86 . . . . 0.0 109.728 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.73 ' HG2' HG22 ' A' ' 66' ' ' ILE . 6.3 ptp180 -106.73 137.0 45.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 110.899 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.048 HG23 HD11 ' A' ' 69' ' ' ILE . 13.5 p -63.75 134.81 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.596 -0.69 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -119.79 153.47 35.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.421 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.874 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.904 . . . . 0.0 110.607 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.517 ' HD3' ' CE1' ' A' ' 55' ' ' TYR . 18.1 mtt-85 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.364 0.602 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.082 HG13 HG23 ' A' ' 67' ' ' VAL . 97.6 t -117.15 122.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.502 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 1.6 ptm180 -95.64 119.33 33.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.742 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.571 ' C ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -140.69 174.85 10.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 0.0 109.513 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.1 p-10 -90.28 177.64 6.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.927 -1.108 . . . . 0.0 110.737 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.99 -41.1 91.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 108.801 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.0 t -62.77 -58.38 7.64 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.076 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.666 ' O ' HD22 ' A' ' 33' ' ' LEU . 58.4 m -49.91 -30.39 10.1 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.833 -1.167 . . . . 0.0 109.572 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.478 ' N ' HD12 ' A' ' 26' ' ' LEU . 40.3 ttm180 -81.62 -45.52 15.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 111.603 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -97.95 -10.6 24.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.267 . . . . 0.0 110.958 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.991 HD23 ' H ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -59.94 -26.02 65.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.987 -1.07 . . . . 0.0 109.774 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.008 HD11 HG23 ' A' ' 7' ' ' ILE . 54.4 mt -110.63 -75.87 0.61 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.145 -0.972 . . . . 0.0 110.277 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.535 ' HB3' ' CD ' ' A' ' 89' ' ' LYS . 9.4 t70 -168.27 -20.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.574 -0.704 . . . . 0.0 109.971 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.594 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -40.46 126.78 2.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.358 -0.839 . . . . 0.0 110.681 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.705 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.3 pt-20 -119.12 179.77 4.07 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 108.929 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.434 ' HA ' HD13 ' A' ' 38' ' ' ILE . 5.5 mm -55.81 127.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.06 . . . . 0.0 109.875 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.62 24.3 74.97 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.708 174.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 6.9 m-20 -89.01 169.94 11.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.754 -1.439 . . . . 0.0 109.855 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.741 HG21 ' OG1' ' A' ' 92' ' ' THR . 79.2 t -99.78 127.97 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 110.137 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.604 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.6 m -116.02 143.71 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 86.3 tt0 -113.28 143.2 44.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.735 . . . . 0.0 109.632 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.817 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.8 mp -119.97 145.9 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.023 . . . . 0.0 110.198 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.7 tt0 -151.8 88.53 1.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.062 -1.024 . . . . 0.0 111.612 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 85' ' ' VAL . 31.0 tttm -99.23 -71.74 0.68 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 110.2 171.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.539 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.15 -34.71 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.507 -0.746 . . . . 0.0 109.409 178.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 49.8 mtm180 -141.3 -173.28 3.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.5 -0.75 . . . . 0.0 109.892 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.668 ' C ' HD21 ' A' ' 130' ' ' LEU . 2.1 mptm? -87.84 133.22 33.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 110.325 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -134.93 159.28 41.94 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.354 0.597 . . . . 0.0 110.318 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.39 162.17 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.825 . . . . 0.0 109.963 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.604 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -179.83 48.01 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.995 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 61.8 ttt180 -116.6 169.84 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 0.0 110.214 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.85 131.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 110.322 -175.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.517 ' CE1' ' HD3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -121.3 163.67 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.551 -0.718 . . . . 0.0 110.009 175.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -90.68 124.19 34.88 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 110.134 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -63.22 139.25 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.568 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -58.74 -49.05 95.51 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.186 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.2 Cg_endo -91.06 98.78 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 108.922 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 15.7 pt-20 -73.07 35.93 0.08 Allowed 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.65 -0.657 . . . . 0.0 110.749 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.5 m-20 -148.91 -33.42 0.22 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.252 -0.905 . . . . 0.0 110.721 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.23 -26.49 28.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.987 . . . . 0.0 109.166 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.846 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 13.4 m120 -80.94 42.29 0.63 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.769 -0.582 . . . . 0.0 110.537 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 34.4 mtpt -97.79 10.0 41.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.563 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.48 28.84 0.05 OUTLIER Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.73 HG22 ' HG2' ' A' ' 10' ' ' ARG . 45.1 pt -140.59 143.88 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -1.154 . . . . 0.0 109.55 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.082 HG23 HG13 ' A' ' 24' ' ' VAL . 2.5 p -120.8 127.59 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.06 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.421 ' HB3' ' HD2' ' A' ' 25' ' ' ARG . 20.8 tpp180 -90.63 114.9 27.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.088 -1.008 . . . . 0.0 109.906 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.048 HD11 HG23 ' A' ' 11' ' ' VAL . 2.4 pt -130.05 161.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.99 169.94 17.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 110.047 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.442 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 21.5 t -60.2 -36.74 78.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 110.365 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.27 -45.9 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 109.888 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.817 ' HE1' HD13 ' A' ' 44' ' ' ILE . 13.7 tpt -60.13 -43.45 95.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.588 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -60.0 -40.03 87.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.761 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.41 -25.94 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' MET . 5.4 m120 -60.12 -40.02 88.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.655 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.0 p -99.91 -38.06 8.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.985 -1.072 . . . . 0.0 110.545 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.539 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.79 30.85 2.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.598 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.43 169.49 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -1.131 . . . . 0.0 110.74 -174.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.94 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.7 170.96 8.19 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.341 -0.849 . . . . 0.0 109.039 174.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.874 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -63.27 140.57 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.794 -1.192 . . . . 0.0 110.429 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.633 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.82 -2.95 62.31 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 172.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -59.64 -159.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.101 -1.235 . . . . 0.0 110.394 174.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 54.6 pttt -138.79 119.76 14.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.78 . . . . 0.0 109.836 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.731 HG12 ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -123.02 161.38 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 109.895 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.464 ' HB2' ' CD1' ' A' ' 8' ' ' ILE . 20.0 ttpt -105.31 120.02 40.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.498 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.6 t -103.71 121.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.7 mtt180 -111.3 131.84 54.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.358 -0.839 . . . . 0.0 110.146 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.535 ' CD ' ' HB3' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -74.91 137.87 41.99 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 41' ' ' VAL . 2.2 m -149.45 -169.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.066 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -127.99 170.98 12.27 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.741 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.01 159.95 16.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 111.052 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.584 ' HG2' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -146.29 173.68 12.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.94 99.03 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.681 -1.262 . . . . 0.0 110.178 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.854 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.09 138.79 36.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -0.803 . . . . 0.0 110.301 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.543 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -103.96 -28.25 11.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.955 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.73 ' HB3' HD23 ' A' ' 156' ' ' LEU . 52.5 tttp -150.04 123.08 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.761 -1.212 . . . . 0.0 110.253 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.707 HG23 HG22 ' A' ' 155' ' ' THR . 9.7 p -137.07 140.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 110.484 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.54 HG23 ' HB3' ' A' ' 171' ' ' GLU . 21.7 m -110.98 134.52 52.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.968 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.681 HD11 HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -130.79 159.83 36.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.392 -0.817 . . . . 0.0 110.162 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -128.74 100.04 22.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 110.438 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 124.007 1.53 . . . . 0.0 110.039 179.67 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 8.2 tt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.067 0.46 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.479 ' HG2' HG12 ' A' ' 172' ' ' ILE . 97.2 mt-10 -60.03 -44.81 94.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.62 -37.25 86.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 109.594 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -60.0 -39.99 87.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.812 . . . . 0.0 109.599 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.681 HG11 HD11 ' A' ' 100' ' ' LEU . 79.3 t -59.99 -46.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.992 . . . . 0.0 109.371 175.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.681 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -59.88 -39.82 86.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 175.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.05 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.81 65.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.353 -0.842 . . . . 0.0 110.577 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.611 HD12 ' CG1' ' A' ' 120' ' ' VAL . 86.0 mt -91.04 -9.46 45.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.834 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 164' ' ' ILE . 3.3 tt -42.39 167.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.591 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 164' ' ' ILE . 26.1 ptt180 33.26 46.2 0.1 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.692 -0.63 . . . . 0.0 111.429 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.502 ' CG ' ' HD2' ' A' ' 128' ' ' PRO . 18.8 ttm180 -132.07 142.5 45.33 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.653 -1.28 . . . . 0.0 111.225 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.855 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.7 Cg_endo -64.6 126.34 16.62 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 124.258 1.662 . . . . 0.0 109.427 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.569 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.4 mmm -124.6 145.58 49.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.395 -1.441 . . . . 0.0 111.076 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.668 HD21 ' C ' ' A' ' 49' ' ' LYS . 12.8 tp -142.55 116.67 9.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.5 pm0 -47.9 148.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.911 -1.118 . . . . 0.0 110.517 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.622 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 74.98 -2.41 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.788 -0.57 . . . . 0.0 110.871 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.624 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.2 p30 -69.34 -171.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.454 ' C ' HG13 ' A' ' 135' ' ' ILE . 15.1 m-80 -149.44 132.15 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.538 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.705 HD11 ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 110.486 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.692 ' O ' HD12 ' A' ' 135' ' ' ILE . 77.9 m-85 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.326 0.584 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 15.3 tptm -97.77 106.35 18.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 109.725 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.705 ' CG2' HD11 ' A' ' 135' ' ' ILE . 2.8 t -76.64 134.47 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.995 . . . . 0.0 109.716 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.466 HG11 HH22 ' A' ' 173' ' ' ARG . 2.8 t -129.47 -20.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 110.457 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.5 tttm -139.58 140.42 37.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.68 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.707 HG22 HG23 ' A' ' 98' ' ' VAL . 47.0 p -139.75 161.53 37.33 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.7 -0.625 . . . . 0.0 109.602 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.55 -34.41 0.42 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 110.992 -177.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.927 ' CG ' HG11 ' A' ' 162' ' ' VAL . 29.4 Cg_exo -55.82 -168.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.343 1.181 . . . . 0.0 110.197 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 160' ' ' VAL . 16.1 t -90.15 40.18 1.0 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.651 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 158' ' ' SER . 26.4 mmtp 59.97 42.31 16.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.804 ' O ' HG13 ' A' ' 162' ' ' VAL . 33.2 m -136.07 160.06 68.64 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.517 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -49.53 120.11 5.42 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 124.09 1.574 . . . . 0.0 110.155 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.927 HG11 ' CG ' ' A' ' 157' ' ' PRO . 11.7 m -128.19 159.52 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.479 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -103.93 124.48 49.07 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 125' ' ' ILE . 16.1 mm -72.06 153.67 7.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.817 -0.552 . . . . 0.0 110.301 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.53 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -140.8 166.67 25.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.69 ' HB3' HD11 ' A' ' 125' ' ' ILE . 19.1 pt-20 -58.14 -18.24 24.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.04 . . . . 0.0 110.29 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -89.21 -13.72 37.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.92 . . . . 0.0 110.375 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 95' ' ' ALA . 7.2 m -62.52 150.82 39.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.014 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -98.6 153.62 18.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.27 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.681 HD11 ' HG2' ' A' ' 121' ' ' GLN . 3.6 mm -119.88 134.81 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 110.927 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.669 ' O ' HD13 ' A' ' 172' ' ' ILE . 37.0 mt-10 -119.7 132.55 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.564 172.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.669 HD13 ' O ' ' A' ' 171' ' ' GLU . 21.4 mm -127.33 122.78 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.457 -0.777 . . . . 0.0 109.748 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.49 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 13.3 ptp180 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.057 -1.027 . . . . 0.0 110.506 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.549 ' O ' HD13 ' A' ' 34' ' ' LEU . 16.7 m120 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.252 0.549 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -145.81 -166.49 11.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.975 ' CG2' HD12 ' A' ' 33' ' ' LEU . 20.5 pt -132.52 160.02 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.24 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.4 mt -100.12 117.81 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.711 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.7 pt? -136.87 -168.3 2.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.625 176.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 29.0 ptt180 -115.65 138.61 50.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.826 -1.172 . . . . 0.0 110.894 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.034 ' CG2' HD11 ' A' ' 69' ' ' ILE . 14.6 p -62.64 137.51 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.766 -0.584 . . . . 0.0 110.713 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -112.03 147.24 36.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 110.415 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.878 ' CB ' HD11 ' A' ' 81' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.145 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.05 0.452 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.043 HG13 HG23 ' A' ' 67' ' ' VAL . 75.2 t -117.15 113.56 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.02 . . . . 0.0 110.086 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.758 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.2 ptt180 -92.26 120.11 32.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.704 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -135.38 165.75 24.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.071 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 23.1 p-10 -90.02 -176.48 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.115 -0.991 . . . . 0.0 110.584 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.1 -45.15 93.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.282 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 43.5 t -60.24 -49.25 78.36 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.165 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.161 ' O ' HD22 ' A' ' 33' ' ' LEU . 74.7 m -56.68 -29.44 62.37 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.128 -0.983 . . . . 0.0 109.607 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 68.1 ttt-85 -82.5 -45.35 14.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.0 110.763 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -87.61 -0.26 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.161 HD22 ' O ' ' A' ' 30' ' ' SER . 1.5 pt? -52.56 -26.36 13.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.854 ' H ' HD23 ' A' ' 33' ' ' LEU . 71.4 mt -142.27 -59.07 0.46 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.53 -0.731 . . . . 0.0 110.329 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.8 t0 -170.72 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 110.022 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.558 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -21.9 118.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.497 0.665 . . . . 0.0 111.373 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.493 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -107.78 176.75 5.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.8 mm -59.12 125.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.822 -1.174 . . . . 0.0 109.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.47 27.49 61.3 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.566 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -89.49 173.29 8.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.428 . . . . 0.0 109.72 171.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.963 HG21 HG23 ' A' ' 92' ' ' THR . 64.7 t -99.48 131.45 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.017 -1.052 . . . . 0.0 110.269 -176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.606 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -117.06 139.83 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.176 -0.953 . . . . 0.0 110.301 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -108.32 140.12 42.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.395 -0.816 . . . . 0.0 109.565 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.807 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -122.78 145.45 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.903 -1.123 . . . . 0.0 110.592 -176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -150.13 95.19 2.25 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.834 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.027 ' CG ' HG12 ' A' ' 85' ' ' VAL . 12.6 tmtt? -97.92 -65.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.766 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.567 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.91 -36.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.457 -0.777 . . . . 0.0 109.225 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 68.2 mtp85 -127.99 -160.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.664 0.745 . . . . 0.0 110.111 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.491 ' HB3' HD21 ' A' ' 130' ' ' LEU . 3.1 mtmt -106.13 131.38 53.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 110.369 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.61 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.7 p -138.51 165.0 27.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.855 . . . . 0.0 110.112 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.39 166.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.603 -0.686 . . . . 0.0 109.913 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.0 -174.28 44.17 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -122.07 164.96 16.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -1.083 . . . . 0.0 110.02 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -92.54 139.99 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 110.747 -172.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 24' ' ' VAL . 2.2 m-85 -125.81 162.5 24.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.52 -0.738 . . . . 0.0 110.125 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 8.7 ptp180 -89.91 124.6 34.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.34 -0.85 . . . . 0.0 109.905 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.651 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -64.5 136.4 57.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.809 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.579 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -57.85 -50.06 90.24 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 109.071 175.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 38.0 Cg_endo -92.98 98.01 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.867 1.456 . . . . 0.0 108.868 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.59 38.22 0.12 Allowed 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -143.75 -38.94 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.613 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 13.8 pt-20 -85.56 -22.39 28.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.007 . . . . 0.0 109.727 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.651 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 27.9 m-80 -81.68 37.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 110.715 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CA ' ' OD2' ' A' ' 27' ' ' ASP . 54.4 pttt -98.43 12.25 35.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.997 -1.065 . . . . 0.0 109.547 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.82 26.53 0.05 OUTLIER Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -140.53 144.9 26.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.3 -1.117 . . . . 0.0 109.177 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.043 HG23 HG13 ' A' ' 24' ' ' VAL . 6.5 p -125.83 129.91 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.029 -1.045 . . . . 0.0 110.265 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.539 ' HD3' ' HD3' ' A' ' 25' ' ' ARG . 58.8 ttt85 -89.7 119.93 30.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.034 HD11 ' CG2' ' A' ' 11' ' ' VAL . 3.8 pt -130.6 167.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.818 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -80.06 166.51 21.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.065 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.4 t -60.21 -39.98 88.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -43.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.038 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.807 ' CE ' HD13 ' A' ' 44' ' ' ILE . 13.3 tpt -60.06 -46.91 87.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.1 ttp85 -60.0 -39.99 87.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -70.06 -27.11 64.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.5 m-20 -60.01 -40.01 87.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.02 . . . . 0.0 110.767 -177.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.518 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.5 p -99.53 -39.04 8.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.101 . . . . 0.0 110.723 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.567 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 116.13 40.73 0.8 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -112.61 160.73 17.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.025 -1.279 . . . . 0.0 110.659 -176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.695 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.9 168.88 9.14 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 176.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.878 HD11 ' CB ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -53.04 139.01 11.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.034 -1.041 . . . . 0.0 110.609 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.65 2.58 70.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 171.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.62 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.885 -1.362 . . . . 0.0 110.228 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 22.8 pttt -131.94 109.83 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.027 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -119.97 150.24 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.955 . . . . 0.0 109.864 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 67.6 tttt -99.94 120.07 39.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.752 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.687 HG23 HD21 ' A' ' 9' ' ' LEU . 62.6 t -103.2 122.4 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.483 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.2 mtt180 -108.65 140.05 42.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.544 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.507 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -88.21 138.2 31.65 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.069 -1.02 . . . . 0.0 110.32 -178.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.506 HG23 HG12 ' A' ' 41' ' ' VAL . 2.4 m -150.17 -170.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.652 -0.655 . . . . 0.0 110.085 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.441 ' CA ' ' HB ' ' A' ' 41' ' ' VAL . 61.4 mtt180 -126.46 179.99 5.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.057 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.963 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.76 162.73 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 111.209 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.546 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.1 pt-20 -150.03 169.13 21.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.23 97.87 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.33 -1.482 . . . . 0.0 110.3 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.22 138.82 49.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -0.837 . . . . 0.0 110.387 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.513 ' HD2' ' CD1' ' A' ' 156' ' ' LEU . 18.6 ptpt -97.22 -27.17 14.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 111.153 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.739 ' HB3' HD23 ' A' ' 156' ' ' LEU . 31.5 tttt -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.82 -1.175 . . . . 0.0 110.558 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.95 HG23 HG22 ' A' ' 155' ' ' THR . 5.7 p -136.13 142.53 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.434 ' HA ' ' HB2' ' A' ' 171' ' ' GLU . 97.7 m -115.81 136.37 53.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.283 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -131.42 160.07 36.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.478 -0.763 . . . . 0.0 110.155 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -146.23 101.74 4.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.922 . . . . 0.0 110.883 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 15.4 Cg_exo . . . . . 0 C--N 1.305 -1.732 0 O-C-N 124.072 1.564 . . . . 0.0 110.299 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 120' ' ' VAL . 9.3 tp . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.177 0.513 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.507 ' HG2' HG12 ' A' ' 172' ' ' ILE . 98.9 mt-10 -60.01 -44.76 94.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.747 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -70.03 -40.0 75.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.839 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -59.87 -40.11 87.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.845 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.71 ' CG1' HD12 ' A' ' 170' ' ' ILE . 49.0 t -60.05 -45.69 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.38 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.692 ' HG3' HD11 ' A' ' 170' ' ' ILE . 6.7 mt-30 -59.92 -47.7 84.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.609 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.51 -0.744 . . . . 0.0 110.41 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.953 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.35 -39.92 77.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.757 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.953 HD22 ' C ' ' A' ' 123' ' ' ALA . 3.0 mm? -130.07 24.2 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 111.123 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.9 tt -48.31 176.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.094 . . . . 0.0 110.003 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.564 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 34.5 ptt180 33.96 49.14 0.27 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.527 -0.733 . . . . 0.0 111.204 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 36.9 ttp180 -128.35 142.59 45.19 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.925 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.836 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.2 Cg_endo -62.17 131.73 35.83 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.961 1.506 . . . . 0.0 110.079 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.567 ' HG3' HD11 ' A' ' 164' ' ' ILE . 96.7 mmm -123.48 140.03 53.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 110.952 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.544 HD23 ' HA ' ' A' ' 50' ' ' THR . 19.7 tp -142.49 105.64 4.58 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.61 -0.681 . . . . 0.0 109.67 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.7 pt-20 -48.47 141.1 7.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.974 -1.079 . . . . 0.0 110.67 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.676 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 86.2 mm-40 79.93 -1.68 2.07 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.167 0.508 . . . . 0.0 110.498 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.607 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.9 p30 -69.98 -172.42 0.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.047 -1.033 . . . . 0.0 110.31 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -144.11 137.72 27.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.737 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.084 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 3.2 m-85 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.239 0.542 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -104.7 108.84 20.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.32 -0.862 . . . . 0.0 109.978 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.607 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.1 t -76.48 132.68 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.683 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 t -114.61 -30.1 2.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 111.108 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -144.75 150.2 36.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.782 -1.199 . . . . 0.0 111.272 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.95 HG22 HG23 ' A' ' 98' ' ' VAL . 72.3 p -140.33 161.32 37.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 109.427 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.64 -38.69 0.45 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.843 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.989 ' CB ' HG11 ' A' ' 162' ' ' VAL . 18.0 Cg_exo -58.39 -166.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.575 1.303 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.56 ' HB3' HG22 ' A' ' 160' ' ' VAL . 20.8 t -90.05 -171.09 3.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -65.33 -5.88 8.49 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.201 -0.937 . . . . 0.0 110.64 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 158' ' ' SER . 33.1 m -85.2 145.36 42.74 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.405 -0.81 . . . . 0.0 110.287 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.547 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -48.5 141.37 19.79 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.285 1.676 . . . . 0.0 110.796 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.989 HG11 ' CB ' ' A' ' 157' ' ' PRO . 11.2 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.493 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.4 tt0 -107.62 130.67 54.88 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.13 -0.982 . . . . 0.0 110.241 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.83 ' CD1' HG21 ' A' ' 168' ' ' THR . 19.0 mm -69.75 152.51 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 110.029 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.65 169.9 26.4 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.44 ' CA ' HD11 ' A' ' 125' ' ' ILE . 15.7 pt-20 -56.5 -17.97 10.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -1.117 . . . . 0.0 109.923 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.13 -25.76 18.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.83 HG21 ' CD1' ' A' ' 164' ' ' ILE . 91.3 m -56.57 142.3 39.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.791 . . . . 0.0 110.089 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 43.6 mmtm -91.96 154.86 18.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.856 -1.153 . . . . 0.0 110.186 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.83 HG22 HD11 ' A' ' 172' ' ' ILE . 1.4 mm -119.92 130.04 74.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.365 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.648 ' O ' HD13 ' A' ' 172' ' ' ILE . 21.9 mt-10 -112.68 136.09 52.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 110.23 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.83 HD11 HG22 ' A' ' 170' ' ' ILE . 7.5 mm -124.59 134.86 65.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.608 -0.682 . . . . 0.0 109.57 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.344 -174.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 27.7 m120 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.316 0.579 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.36 -159.94 8.89 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.012 ' CG2' HD12 ' A' ' 33' ' ' LEU . 15.4 pt -138.97 163.96 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -1.188 . . . . 0.0 109.805 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.618 ' C ' HD23 ' A' ' 9' ' ' LEU . 48.1 mm -101.0 120.49 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.299 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.867 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -140.87 -176.54 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.713 177.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HG2' HG22 ' A' ' 66' ' ' ILE . 28.3 ptt180 -117.01 144.11 44.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.838 -1.164 . . . . 0.0 110.524 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.905 HG11 ' O ' ' A' ' 80' ' ' SER . 3.3 p -61.37 140.64 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.621 -0.674 . . . . 0.0 110.899 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.487 ' HB1' ' CD ' ' A' ' 68' ' ' ARG . . . -118.88 144.23 46.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 110.583 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.974 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.265 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.544 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 76.5 mtt85 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.139 HG12 HD23 ' A' ' 26' ' ' LEU . 84.8 t -119.73 116.17 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.979 -1.076 . . . . 0.0 110.269 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.859 ' O ' HD22 ' A' ' 26' ' ' LEU . 3.8 ptt180 -88.17 119.46 28.58 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.68 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.139 HD23 HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -137.95 177.42 7.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.751 -0.593 . . . . 0.0 109.684 -175.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 22.2 p-10 -103.07 179.73 4.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 60.8 mt-10 -59.97 -44.87 94.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.406 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 68.0 m -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.03 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.171 ' O ' HD22 ' A' ' 33' ' ' LEU . 28.6 t -65.3 -28.22 69.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 27.8 ttm180 -80.86 -46.72 14.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.556 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.98 -9.62 59.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.171 HD22 ' O ' ' A' ' 30' ' ' SER . 1.3 pt? -47.22 -24.25 0.68 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.693 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 33' ' ' LEU . 66.5 mt -141.27 -62.78 0.47 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.548 -0.72 . . . . 0.0 110.266 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.3 t0 -172.89 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.534 -0.729 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -31.38 141.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.463 0.649 . . . . 0.0 111.509 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -131.23 171.2 13.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 56' ' ' ARG . 38.4 mm -63.47 79.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.674 -1.266 . . . . 0.0 110.208 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 37' ' ' GLU . . . 169.32 -4.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.552 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.438 ' CG ' ' NZ ' ' A' ' 89' ' ' LYS . 95.9 m-20 -111.94 168.75 9.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.384 -1.657 . . . . 0.0 110.874 -170.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.488 HG21 ' OG1' ' A' ' 92' ' ' THR . 72.1 t -103.65 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.107 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.4 m -110.84 145.88 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.17 -0.956 . . . . 0.0 110.592 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 86.5 tt0 -109.38 140.78 42.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.82 . . . . 0.0 109.827 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.913 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -121.21 143.16 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.991 -1.068 . . . . 0.0 110.622 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -149.42 97.71 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.845 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.908 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.5 tmtm? -97.98 -62.52 1.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.525 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -109.3 -36.33 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.644 0.735 . . . . 0.0 109.237 175.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 78.9 mtt85 -125.7 -172.91 2.71 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.726 -0.609 . . . . 0.0 109.59 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.3 OUTLIER -100.13 133.2 44.87 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.108 178.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.591 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.4 p -140.45 167.48 22.05 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.445 0.641 . . . . 0.0 109.679 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.66 HG13 ' HG ' ' A' ' 130' ' ' LEU . 3.6 m -116.46 175.75 2.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.744 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.485 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.84 -179.17 48.54 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -121.02 167.81 12.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 0.0 110.075 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.93 135.02 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.152 -0.967 . . . . 0.0 110.73 -174.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.544 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 3.6 m-85 -130.6 166.61 20.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.756 . . . . 0.0 110.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.445 ' HG2' ' NH2' ' A' ' 31' ' ' ARG . 21.5 mtt180 -89.43 124.04 34.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -65.13 137.88 57.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.712 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.697 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 8.6 mmm180 -57.44 -45.89 99.84 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 109.027 174.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.697 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.0 Cg_endo -92.01 98.54 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.748 1.393 . . . . 0.0 108.853 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -75.26 35.84 0.12 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -146.59 -37.28 0.23 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 110.873 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.481 ' HG3' HD11 ' A' ' 66' ' ' ILE . 16.3 pt-20 -84.8 -20.58 30.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.505 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 2.9 m-80 -81.63 36.58 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 110.719 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 58.4 pttt -98.31 17.5 18.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.952 -1.093 . . . . 0.0 109.388 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 176.84 21.38 0.03 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.505 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.11 152.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.196 -1.179 . . . . 0.0 109.191 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.948 HG23 HG13 ' A' ' 24' ' ' VAL . 7.9 p -130.02 129.98 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.98 -1.075 . . . . 0.0 110.131 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.564 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 22.5 mmm180 -91.33 111.74 23.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.641 HD11 ' NH1' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -136.06 171.78 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.383 -0.823 . . . . 0.0 110.553 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -81.24 166.9 20.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 0.0 110.263 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 79.5 p -69.94 -19.28 63.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.339 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.55 -47.29 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.112 -0.993 . . . . 0.0 110.483 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.913 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -61.33 -47.48 85.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 109.289 177.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.69 ' HG3' HG21 ' A' ' 11' ' ' VAL . 5.9 mmp_? -60.04 -39.94 87.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 110.245 173.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' SER . 47.8 t-20 -64.09 -31.82 73.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.959 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 10.7 m120 -60.01 -36.29 76.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.394 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.2 p -98.38 -38.79 9.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.059 -1.025 . . . . 0.0 110.581 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.525 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 119.79 40.05 0.63 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.888 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -120.85 166.17 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.062 -1.258 . . . . 0.0 110.611 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.905 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -118.7 176.17 5.39 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.974 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -55.84 142.58 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.074 -1.017 . . . . 0.0 110.418 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.76 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 75.96 0.76 65.8 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 172.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.3 m-20 -59.82 -167.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.849 -1.383 . . . . 0.0 110.124 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.5 pttp -132.53 115.28 15.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.701 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.908 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -125.43 153.47 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 109.574 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 60.7 tttt -99.94 121.48 41.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.095 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 9' ' ' LEU . 65.6 t -98.99 119.99 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.956 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 87.2 mtm180 -116.2 142.53 46.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 109.807 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.438 ' NZ ' ' CG ' ' A' ' 40' ' ' ASP . 50.6 tttp -75.99 146.59 39.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.002 -1.061 . . . . 0.0 110.543 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.439 HG23 HG12 ' A' ' 41' ' ' VAL . 1.9 m -149.98 -168.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.967 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -138.76 170.0 16.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.488 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.72 156.71 21.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 111.3 -175.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.859 ' OE2' HG12 ' A' ' 162' ' ' VAL . 1.2 pm0 -150.31 169.71 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 94' ' ' ILE . 4.5 mp -89.13 98.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.595 -1.316 . . . . 0.0 110.402 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.89 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.51 163.45 1.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.422 -0.798 . . . . 0.0 110.819 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 1.033 ' HG3' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -136.16 -17.86 1.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.456 -0.778 . . . . 0.0 110.913 -178.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 1.005 ' CB ' HD12 ' A' ' 156' ' ' LEU . 32.9 tttt -149.59 119.92 7.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.887 -1.133 . . . . 0.0 110.336 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.044 HG23 HG22 ' A' ' 155' ' ' THR . 5.5 p -137.2 140.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 110.718 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.4 m -109.29 135.08 50.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -130.11 160.97 32.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 110.418 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.15 87.42 39.23 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.58 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--N 1.307 -1.649 0 O-C-N 123.979 1.515 . . . . 0.0 110.218 179.786 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.671 HG23 HD12 ' A' ' 172' ' ' ILE . 11.9 tt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.218 0.533 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 170' ' ' ILE . 98.9 mt-10 -59.99 -44.76 94.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.046 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -67.92 -39.97 83.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.833 . . . . 0.0 110.025 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -40.0 88.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.905 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.633 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -62.15 -44.9 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.369 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.648 ' HG3' HD11 ' A' ' 170' ' ' ILE . 6.3 mt-30 -59.94 -45.44 92.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.086 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.38 -41.43 93.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.487 -0.758 . . . . 0.0 109.862 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.599 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.57 -48.05 61.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 110.68 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 123' ' ' ALA . 4.4 mm? -105.14 12.97 31.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.1 -1.0 . . . . 0.0 111.513 -173.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.5 tt -49.34 169.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.615 -1.303 . . . . 0.0 110.391 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 29.0 ptt180 32.98 46.07 0.08 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.599 -0.688 . . . . 0.0 111.646 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.9 mmt85 -134.76 152.44 77.54 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 120.714 -1.241 . . . . 0.0 111.358 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.83 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.1 Cg_endo -62.04 123.25 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.225 1.645 . . . . 0.0 109.684 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.791 ' O ' HG22 ' A' ' 162' ' ' VAL . 15.4 mmt -137.37 137.9 39.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.554 -1.341 . . . . 0.0 110.433 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.779 ' H ' HD13 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.81 145.2 24.78 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.478 0.656 . . . . 0.0 110.441 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 22.0 pt-20 -55.11 152.93 7.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -0.81 . . . . 0.0 111.112 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 81.95 -12.66 0.93 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.463 0.649 . . . . 0.0 110.298 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.694 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -69.37 -174.27 0.65 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 110.388 177.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 8.3 m-80 -147.19 160.04 42.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.203 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.209 0.528 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -115.29 113.55 24.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 110.007 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.694 HG21 ' OD2' ' A' ' 133' ' ' ASP . 13.2 t -77.98 135.65 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.164 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.734 HG12 ' HG3' ' A' ' 154' ' ' LYS . 9.9 t -111.99 -28.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.734 ' HG3' HG12 ' A' ' 153' ' ' VAL . 76.2 mttt -150.63 163.88 37.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.916 -1.115 . . . . 0.0 111.281 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.044 HG22 HG23 ' A' ' 98' ' ' VAL . 73.8 p -149.04 169.8 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.774 -0.579 . . . . 0.0 109.491 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 1.033 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.4 tt -88.49 -41.2 0.47 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.987 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 1.017 ' CB ' HG11 ' A' ' 162' ' ' VAL . 22.1 Cg_exo -56.44 -177.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.569 1.3 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.473 ' HB3' HG22 ' A' ' 160' ' ' VAL . 15.8 t -74.5 -172.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.565 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -69.98 -2.25 12.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.162 -0.961 . . . . 0.0 110.376 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.535 HG23 ' OE2' ' A' ' 93' ' ' GLU . 21.4 m -87.54 150.46 48.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 110.41 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.652 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.47 140.55 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.292 1.68 . . . . 0.0 110.985 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 1.017 HG11 ' CB ' ' A' ' 157' ' ' PRO . 5.5 m -130.02 160.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.603 171.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 21.9 pt-20 -102.52 124.63 48.43 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.948 -1.095 . . . . 0.0 110.082 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.841 ' CD1' HG21 ' A' ' 168' ' ' THR . 8.0 mm -71.15 154.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.666 -0.646 . . . . 0.0 110.272 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 163.66 26.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -53.23 -20.04 3.7 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.511 -0.993 . . . . 0.0 110.311 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.5 -23.12 22.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.715 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.841 HG21 ' CD1' ' A' ' 164' ' ' ILE . 90.2 m -54.94 145.91 19.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.963 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 85.9 mttt -95.6 149.43 21.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 110.366 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.648 HD11 ' HG3' ' A' ' 121' ' ' GLN . 1.3 mm -117.07 129.97 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 110.501 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.445 ' OE2' ' HE2' ' A' ' 97' ' ' LYS . 57.6 mt-10 -115.45 136.26 53.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 110.166 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.671 HD12 HG23 ' A' ' 116' ' ' ILE . 5.9 mt -135.27 133.61 52.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.104 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 110.315 -178.619 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.19 0.519 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' A' ' 34' ' ' LEU . . . -146.48 -165.1 11.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.01 HG21 HD11 ' A' ' 33' ' ' LEU . 23.0 pt -130.44 160.38 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -1.2 . . . . 0.0 110.17 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.5 mt -102.14 114.03 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.288 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.775 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -137.23 -174.32 3.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 109.786 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 30.7 ptt180 -111.55 139.59 46.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.727 -1.233 . . . . 0.0 111.025 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.786 ' CG2' HD11 ' A' ' 69' ' ' ILE . 13.5 p -62.7 135.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -116.53 145.74 43.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.773 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 tt0 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.359 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 99.0 mtt180 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.251 0.548 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.039 HG13 HG23 ' A' ' 67' ' ' VAL . 87.4 t -116.77 120.08 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.402 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.64 ' O ' HD12 ' A' ' 26' ' ' LEU . 3.7 ptt180 -86.39 118.49 25.86 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.512 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.025 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mp -131.4 173.08 11.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.847 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 11.6 p-10 -103.23 179.42 4.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.871 -1.143 . . . . 0.0 110.702 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 88.5 mt-10 -59.99 -41.05 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -0.871 . . . . 0.0 109.059 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.645 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -64.4 -59.67 4.08 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.123 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.81 ' O ' HD22 ' A' ' 33' ' ' LEU . 65.4 m -49.99 -31.22 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.835 -1.166 . . . . 0.0 109.08 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 40.0 ttm180 -72.29 -51.76 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.584 -0.698 . . . . 0.0 111.619 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -98.92 -3.49 35.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.742 -1.224 . . . . 0.0 111.178 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -64.96 -24.06 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.074 . . . . 0.0 109.828 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.987 ' N ' HD23 ' A' ' 33' ' ' LEU . 59.6 mt -120.62 -67.88 0.95 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.034 . . . . 0.0 110.469 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 36' ' ' ALA . 43.4 t0 -171.2 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.566 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.548 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.45 118.63 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.354 0.597 . . . . 0.0 110.72 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.8 pt-20 -106.59 -178.98 3.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 38' ' ' ILE . 24.2 mm -62.3 126.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.882 -1.136 . . . . 0.0 109.803 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.35 22.94 66.55 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 173.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' CG ' ' HG2' ' A' ' 37' ' ' GLU . 77.7 m-20 -89.5 169.98 10.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.814 -1.404 . . . . 0.0 109.603 171.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.523 HG21 ' OG1' ' A' ' 92' ' ' THR . 71.8 t -99.23 136.18 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.989 -1.07 . . . . 0.0 110.087 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.504 HG11 HG23 ' A' ' 54' ' ' VAL . 1.7 m -120.71 140.05 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.094 -1.004 . . . . 0.0 110.487 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 44' ' ' ILE . 85.4 tt0 -106.82 141.25 38.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.691 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.831 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -124.21 143.03 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.995 -1.066 . . . . 0.0 110.582 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -149.89 97.24 2.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.895 ' HG3' HG12 ' A' ' 85' ' ' VAL . 5.5 tmtm? -97.88 -55.8 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.406 -0.809 . . . . 0.0 109.626 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.547 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.29 -34.6 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.795 0.807 . . . . 0.0 108.885 176.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.622 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -131.79 179.46 6.06 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.562 ' HB3' HD21 ' A' ' 130' ' ' LEU . 12.0 mtmt -89.44 132.67 34.9 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.668 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.9 p -138.07 166.7 23.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.576 -0.702 . . . . 0.0 109.809 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.89 167.66 14.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.915 179.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.05 -175.08 44.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 68.9 ttt180 -122.45 166.16 15.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.428 -1.042 . . . . 0.0 110.334 -176.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -98.34 144.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.885 . . . . 0.0 110.513 -175.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 2.5 m-85 -138.06 168.19 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.371 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -88.73 121.76 31.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.74 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.705 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -62.66 140.05 58.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.711 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.63 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.84 -50.0 90.61 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.841 175.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 33.6 Cg_endo -93.06 98.41 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.841 1.443 . . . . 0.0 108.886 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.26 36.13 0.1 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.426 -0.796 . . . . 0.0 110.825 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -145.59 -34.32 0.33 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.096 -1.002 . . . . 0.0 111.058 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.559 ' OE2' ' CG ' ' A' ' 59' ' ' PRO . 14.9 pt-20 -87.19 -19.12 28.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 109.601 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.705 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 21.7 m-80 -81.21 39.64 0.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 110.622 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 pttt -97.79 13.43 30.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 63' ' ' ASN . 45.6 pt -140.92 144.67 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.213 -1.169 . . . . 0.0 109.583 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.039 HG23 HG13 ' A' ' 24' ' ' VAL . 3.1 p -121.88 129.83 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.046 -1.034 . . . . 0.0 109.859 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.408 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -93.0 114.02 26.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 -178.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.786 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.9 pp -134.66 167.82 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -79.53 168.01 20.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 110.132 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 m -59.98 -39.73 86.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.279 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.1 t -61.25 -41.58 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.151 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.765 ' HE1' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -61.55 -48.22 81.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.256 -0.902 . . . . 0.0 109.699 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 80' ' ' SER . 37.7 ttp180 -60.13 -40.13 88.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.027 -1.045 . . . . 0.0 109.457 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.547 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 92.6 m-20 -64.06 -33.06 74.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 73' ' ' MET . 64.4 m-20 -57.38 -34.93 69.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.65 ' HB3' HG21 ' A' ' 50' ' ' THR . 30.5 p -99.38 -40.02 8.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.991 -1.068 . . . . 0.0 110.667 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.547 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.17 41.03 1.0 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.759 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -114.4 172.4 7.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.106 -1.232 . . . . 0.0 110.508 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.719 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.58 170.28 8.54 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 109.417 177.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.773 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -55.57 139.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.605 178.167 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.436 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.08 3.83 82.18 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -59.86 -161.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.032 -1.275 . . . . 0.0 110.575 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 23.2 pttt -134.3 110.91 9.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.487 -0.758 . . . . 0.0 110.096 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.895 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.2 m -120.01 153.99 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 109.886 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 54.2 tttt -101.07 118.62 37.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.634 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.512 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 74.8 t -102.11 120.91 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.932 . . . . 0.0 109.897 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HG2' ' N ' ' A' ' 6' ' ' GLY . 76.4 mtm180 -110.39 140.88 44.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 6.1 tttt -82.48 140.25 33.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 110.662 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.446 HG21 ' CD ' ' A' ' 161' ' ' PRO . 2.4 m -148.86 -165.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.492 0.663 . . . . 0.0 109.731 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.484 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.0 mtt85 -135.66 173.39 11.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.469 -0.77 . . . . 0.0 110.42 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.523 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -103.1 161.46 13.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 111.147 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.624 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.8 pt-20 -149.93 170.03 19.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.646 HD12 ' N ' ' A' ' 94' ' ' ILE . 5.1 mp -89.46 97.14 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.569 -1.332 . . . . 0.0 110.351 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.776 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.11 140.06 39.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -0.778 . . . . 0.0 110.219 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HD2' HD22 ' A' ' 156' ' ' LEU . 3.4 ptpt -106.09 -25.75 11.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 111.558 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.649 ' HB3' HD12 ' A' ' 156' ' ' LEU . 72.2 tttt -150.3 131.92 14.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.441 -1.412 . . . . 0.0 110.709 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.013 HG23 HG22 ' A' ' 155' ' ' THR . 8.0 p -144.33 148.0 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.894 . . . . 0.0 110.652 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.624 HG23 ' HB3' ' A' ' 171' ' ' GLU . 59.5 m -120.68 136.8 54.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.43 -0.793 . . . . 0.0 110.195 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.652 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.56 161.66 29.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.09 89.58 12.47 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.456 -0.778 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo . . . . . 0 C--N 1.304 -1.766 0 O-C-N 123.988 1.52 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 117' ' ' GLU . 20.9 tt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.062 0.458 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 116' ' ' ILE . 41.7 mt-10 -68.96 -41.3 78.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.963 -1.086 . . . . 0.0 110.313 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.97 -32.81 71.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.417 ' O ' ' HB3' ' A' ' 122' ' ' ARG . 18.7 t80 -59.86 -39.51 85.45 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.521 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.634 HG12 HD12 ' A' ' 124' ' ' LEU . 78.8 t -60.0 -46.63 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.206 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.687 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -60.0 -39.74 86.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 174.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 27.4 tpt180 -60.0 -43.87 94.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.333 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 -40.55 46.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.634 HD12 HG12 ' A' ' 120' ' ' VAL . 79.1 mt -92.91 -7.58 45.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.071 -1.018 . . . . 0.0 110.58 -173.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.717 ' HA ' HG22 ' A' ' 164' ' ' ILE . 1.9 tt -42.71 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 164' ' ' ILE . 33.4 ptt180 30.4 52.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.659 -0.65 . . . . 0.0 111.262 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 30.9 ttm180 -132.71 142.96 46.7 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.047 -1.033 . . . . 0.0 110.895 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.8 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -65.59 123.94 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 124.007 1.53 . . . . 0.0 109.498 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.542 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 89.2 mmm -120.21 140.62 50.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.377 -1.452 . . . . 0.0 111.126 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 50' ' ' THR . 17.0 tp -141.15 107.29 5.21 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.713 -0.617 . . . . 0.0 109.649 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.601 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -45.0 140.78 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 110.905 -175.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.601 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 82.11 -2.95 1.49 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.409 0.624 . . . . 0.0 110.271 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 3.8 p-10 -68.63 -172.99 0.4 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.512 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 21.4 m-80 -144.83 144.21 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.492 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.828 -1.17 . . . . 0.0 110.837 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 40.0 m-85 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.185 0.516 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -103.29 103.86 13.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.537 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 2.7 t -75.34 139.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.8 t -130.62 -24.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.022 -1.049 . . . . 0.0 111.443 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 5.8 tttp -139.36 125.31 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 110.926 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.013 HG22 HG23 ' A' ' 98' ' ' VAL . 69.2 p -128.09 163.95 23.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.456 -0.777 . . . . 0.0 109.433 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.68 HD22 ' HD2' ' A' ' 96' ' ' LYS . 1.1 tt -89.57 -38.2 0.42 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 110.97 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.96 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.4 Cg_exo -60.57 -176.06 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.485 1.255 . . . . 0.0 110.237 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.43 -162.7 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -69.59 -4.51 19.52 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.303 -0.873 . . . . 0.0 110.564 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.9 m -86.37 140.5 34.18 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.059 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.574 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.7 Cg_endo -47.61 141.65 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.14 1.6 . . . . 0.0 110.48 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.96 HG11 ' CB ' ' A' ' 157' ' ' PRO . 5.6 m -128.3 158.18 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.785 173.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -105.9 124.15 49.12 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.885 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.821 HD12 HG21 ' A' ' 168' ' ' THR . 13.8 mm -70.14 152.37 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.743 -0.598 . . . . 0.0 109.53 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.602 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.06 166.89 26.2 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.538 ' HB3' HD11 ' A' ' 125' ' ' ILE . 18.6 pt-20 -58.0 -14.11 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.957 . . . . 0.0 110.287 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -90.13 -18.07 26.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.821 HG21 HD12 ' A' ' 164' ' ' ILE . 28.0 m -62.24 153.87 29.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 110.049 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 96' ' ' LYS . 44.8 mttt -103.6 155.6 18.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 0.0 110.014 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.687 HD11 ' HG2' ' A' ' 121' ' ' GLN . 6.5 mm -119.14 137.86 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 110.975 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.624 ' HB3' HG23 ' A' ' 99' ' ' THR . 12.8 mt-10 -119.94 127.14 52.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 110.514 172.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.496 ' CD1' HD11 ' A' ' 100' ' ' LEU . 39.5 mm -123.34 123.83 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.175 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.622 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 4.3 ptp180 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 110.559 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.424 ' OD1' HD21 ' A' ' 34' ' ' LEU . 15.1 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.217 0.532 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -153.54 -167.81 16.4 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.884 ' CG2' HD12 ' A' ' 33' ' ' LEU . 22.8 pt -135.03 160.01 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -1.078 . . . . 0.0 109.651 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.5 mt -100.62 115.85 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.2 pt? -135.54 -170.86 2.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 109.562 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.58 ' NE ' HG22 ' A' ' 66' ' ' ILE . 49.8 ptt85 -114.79 139.99 49.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.739 -1.225 . . . . 0.0 110.855 -174.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.689 HG13 ' HA ' ' A' ' 81' ' ' ILE . 7.9 p -62.16 140.55 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.63 -0.669 . . . . 0.0 110.552 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -118.68 143.66 46.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 110.624 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.982 ' HB3' HD11 ' A' ' 81' ' ' ILE . 49.0 tp10 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.795 . . . . 0.0 110.091 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 62.6 mmt-85 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.985 HG13 HG23 ' A' ' 67' ' ' VAL . 90.4 t -101.73 115.44 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.007 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.459 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 6.2 ptt180 -93.53 120.01 33.29 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.985 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.891 HD22 ' CB ' ' A' ' 30' ' ' SER . 2.1 mt -138.68 173.18 11.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.568 -0.708 . . . . 0.0 110.105 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.2 p-10 -95.06 -177.18 4.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -175.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.99 -49.27 78.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.506 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 23.2 t -60.36 -41.31 93.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.159 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.117 ' O ' HD22 ' A' ' 33' ' ' LEU . 48.5 m -60.38 -31.11 70.04 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 175.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 66.8 ttt180 -83.43 -46.04 12.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 111.191 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -81.93 -6.04 58.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.903 -1.123 . . . . 0.0 110.235 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.117 HD22 ' O ' ' A' ' 30' ' ' SER . 1.7 pt? -44.33 -27.69 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.44 -0.787 . . . . 0.0 109.727 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.842 ' H ' HD23 ' A' ' 33' ' ' LEU . 78.8 mt -143.67 -63.77 0.39 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 176.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -173.38 13.4 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.281 -0.887 . . . . 0.0 110.739 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.536 ' CB ' ' HE2' ' A' ' 89' ' ' LYS . . . -47.59 119.75 2.92 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.986 -1.071 . . . . 0.0 110.01 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.537 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.18 174.44 5.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.759 HD11 ' HD3' ' A' ' 56' ' ' ARG . 11.3 mm -62.47 122.22 12.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.885 -1.134 . . . . 0.0 109.672 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.516 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 77.46 32.06 48.53 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -88.75 170.78 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.926 -1.338 . . . . 0.0 109.308 170.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 92' ' ' THR . 69.9 t -99.14 129.61 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.02 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.744 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.7 m -115.33 136.37 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.057 -1.027 . . . . 0.0 110.471 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.403 ' C ' HD12 ' A' ' 44' ' ' ILE . 86.3 tt0 -109.52 143.93 38.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 109.781 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.85 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.5 mp -120.81 145.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.001 -1.062 . . . . 0.0 110.266 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.2 tt0 -152.4 87.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.906 -1.121 . . . . 0.0 111.321 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HB2' HG12 ' A' ' 85' ' ' VAL . 33.8 tttp -98.99 -80.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 172.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.585 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -84.55 -36.18 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.778 . . . . 0.0 109.55 175.144 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.578 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 92.0 mtt-85 -139.54 -176.01 4.4 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.56 -0.713 . . . . 0.0 109.532 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.89 ' HG2' HD21 ' A' ' 130' ' ' LEU . 1.2 ttpm? -89.96 139.06 30.97 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -141.64 165.47 27.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.255 -174.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -128.44 163.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.365 -0.835 . . . . 0.0 110.283 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -175.9 179.99 46.71 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 173.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 57.2 ttt85 -118.87 171.16 8.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -1.122 . . . . 0.0 110.07 -177.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.552 ' CG2' ' HE3' ' A' ' 89' ' ' LYS . 0.3 OUTLIER -101.3 132.44 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.829 -1.169 . . . . 0.0 111.416 -171.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.587 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -130.27 162.85 28.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.752 . . . . 0.0 110.392 171.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.759 ' HD3' HD11 ' A' ' 38' ' ' ILE . 87.8 mtm180 -91.43 128.6 37.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.548 -0.72 . . . . 0.0 110.305 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -65.06 140.77 58.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 110.047 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.574 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.12 -50.26 88.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.09 175.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 52.7 Cg_endo -92.21 97.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.892 1.469 . . . . 0.0 108.988 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.94 41.21 0.16 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.6 -0.687 . . . . 0.0 110.377 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 27.3 m-20 -143.45 -38.58 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.294 -0.879 . . . . 0.0 110.807 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.11 -22.84 28.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.942 -1.099 . . . . 0.0 109.839 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.491 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 10.6 m-80 -81.71 38.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 110.758 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 61' ' ' ASP . 11.6 ptpt -98.46 13.05 33.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.72 25.48 0.05 OUTLIER Glycine 0 N--CA 1.481 1.647 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.58 HG22 ' NE ' ' A' ' 10' ' ' ARG . 45.8 pt -140.81 140.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.985 HG23 HG13 ' A' ' 24' ' ' VAL . 3.3 p -119.95 127.6 75.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.456 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 25.2 ttt85 -89.59 113.69 25.16 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.757 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.736 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.7 pp -129.11 170.54 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.422 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -79.19 164.47 24.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.991 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.4 m -59.91 -39.95 87.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 110.488 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.496 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.3 t -64.97 -44.43 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -175.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.786 ' HE1' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.8 -45.94 92.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.64 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -60.06 -40.04 88.1 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.58 -21.79 61.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.384 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 5.3 m120 -59.89 -39.77 86.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 110.711 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 27.8 p -98.49 -31.04 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.039 -1.038 . . . . 0.0 110.392 -176.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.585 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.09 29.08 3.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.597 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.29 156.14 17.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.205 -1.174 . . . . 0.0 110.505 -175.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.665 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -111.78 166.01 11.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 175.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.982 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -54.32 139.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.418 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.18 68.72 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 1.1 m-20 -60.15 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.84 -1.388 . . . . 0.0 110.451 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 11.6 pttt -134.5 112.35 10.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 110.122 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.716 HG12 ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -118.76 148.98 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -0.893 . . . . 0.0 109.791 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 71.2 tttt -95.3 116.09 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.658 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.695 ' CG2' HD21 ' A' ' 9' ' ' LEU . 95.4 t -102.23 122.62 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.5 mtm180 -110.11 142.5 41.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.744 ' CD ' HG12 ' A' ' 42' ' ' VAL . 1.4 tptm -95.94 129.57 43.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 110.239 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.55 -163.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.668 0.746 . . . . 0.0 110.095 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 35.5 mtp180 -127.04 179.59 5.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 110.349 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.614 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.18 169.13 8.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 111.258 -176.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.633 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.7 pt-20 -149.49 169.54 20.68 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.608 HG21 ' OE2' ' A' ' 167' ' ' GLU . 48.7 mm -89.61 99.81 9.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.486 -1.384 . . . . 0.0 110.337 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.806 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.28 139.29 43.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.279 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.489 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 17.7 ptpt -101.8 -28.37 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 111.055 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.516 ' HB3' HD23 ' A' ' 156' ' ' LEU . 87.2 tttt -150.25 120.21 7.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.752 -1.217 . . . . 0.0 110.741 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.025 HG23 HG22 ' A' ' 155' ' ' THR . 8.7 p -131.75 140.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 110.764 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 98.6 m -113.09 143.8 43.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.393 -0.817 . . . . 0.0 110.098 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.646 HD21 HG23 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -143.14 170.15 16.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -177.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.637 ' HB2' ' NE ' ' A' ' 173' ' ' ARG . . . -142.38 97.78 6.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 110.896 -175.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 109.912 179.492 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 117' ' ' GLU . 7.3 tp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.118 0.485 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 172' ' ' ILE . 96.8 mt-10 -60.11 -42.84 95.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.082 -1.011 . . . . 0.0 109.432 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.54 -40.15 92.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.495 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.57 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 52.4 t80 -60.09 -40.92 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.193 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.689 ' O ' HD22 ' A' ' 124' ' ' LEU . 54.4 t -63.84 -45.18 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.957 -1.089 . . . . 0.0 109.743 177.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.584 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 2.5 mt-30 -60.67 -44.7 96.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.663 -0.648 . . . . 0.0 110.472 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.577 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 1.9 ptm85 -69.6 -36.43 76.21 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.064 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.577 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -72.52 -42.95 64.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.681 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -102.27 1.09 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 110.998 -174.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.9 tt -43.19 171.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.042 . . . . 0.0 110.74 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HG2' ' CG2' ' A' ' 125' ' ' ILE . 51.4 ptt85 32.57 53.8 0.34 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.634 -0.666 . . . . 0.0 111.504 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -139.71 151.28 65.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.917 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.867 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 21.1 Cg_endo -67.1 132.2 27.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.137 1.599 . . . . 0.0 109.81 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.596 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.7 mmm -128.43 146.71 50.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.34 -1.475 . . . . 0.0 111.195 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.89 HD21 ' HG2' ' A' ' 49' ' ' LYS . 12.7 tp -149.45 112.44 4.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.612 -0.68 . . . . 0.0 109.587 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 5.6 pt-20 -49.23 144.36 5.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.93 -1.106 . . . . 0.0 111.022 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 83.8 -8.45 1.04 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.429 0.633 . . . . 0.0 110.316 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.523 ' OD2' ' HB ' ' A' ' 152' ' ' VAL . 1.1 p30 -69.97 -170.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 110.617 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.412 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 13.9 m-80 -142.29 150.07 40.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.065 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.547 HD11 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.821 -1.175 . . . . 0.0 110.64 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.208 0.528 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.5 112.11 23.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 4.0 t -78.46 135.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.855 HG21 ' NH2' ' A' ' 173' ' ' ARG . 40.8 t -115.81 -30.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 110.953 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 131' ' ' GLU . 14.9 tttp -145.6 149.48 34.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.863 -1.148 . . . . 0.0 110.935 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.025 HG22 HG23 ' A' ' 98' ' ' VAL . 75.2 p -139.23 167.49 21.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.631 -0.668 . . . . 0.0 109.39 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.03 -39.1 0.44 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.123 -0.986 . . . . 0.0 110.872 -176.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.915 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.2 Cg_exo -59.01 -170.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.58 1.305 . . . . 0.0 110.162 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.463 ' HB3' HG22 ' A' ' 160' ' ' VAL . 26.8 t -90.25 -165.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -69.18 -2.98 11.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.715 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 158' ' ' SER . 34.3 m -87.64 143.78 34.33 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 110.415 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.561 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.1 Cg_endo -48.49 141.5 19.49 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.244 1.655 . . . . 0.0 110.964 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.915 HG11 ' CB ' ' A' ' 157' ' ' PRO . 9.1 m -130.07 159.95 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.035 . . . . 0.0 109.868 173.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.4 tt0 -107.48 129.92 54.9 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.35 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.834 ' CD1' HG21 ' A' ' 168' ' ' THR . 16.7 mm -72.03 154.11 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.624 -0.672 . . . . 0.0 110.381 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.95 171.46 26.12 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -55.04 -24.85 26.8 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.343 -1.092 . . . . 0.0 110.359 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.608 ' OE2' HG21 ' A' ' 94' ' ' ILE . 18.5 pt-20 -90.28 -17.17 27.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.17 -0.956 . . . . 0.0 110.851 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.834 HG21 ' CD1' ' A' ' 164' ' ' ILE . 85.3 m -58.45 140.56 53.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 0.0 110.16 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 70.9 mmtt -94.84 162.31 13.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.954 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.646 HG23 HD21 ' A' ' 100' ' ' LEU . 2.1 mt -139.37 160.23 28.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 111.12 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.413 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 26.2 mt-10 -137.99 132.78 32.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.612 ' CD1' HD11 ' A' ' 100' ' ' LEU . 43.6 mm -120.07 123.51 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.426 -0.796 . . . . 0.0 110.02 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.855 ' NH2' HG21 ' A' ' 153' ' ' VAL . 11.1 ptp180 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.016 -1.053 . . . . 0.0 110.463 -178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.822 ' OD1' HD13 ' A' ' 34' ' ' LEU . 49.4 p30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.085 0.469 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -155.53 -166.48 15.71 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.098 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.722 HG13 HD22 ' A' ' 9' ' ' LEU . 40.0 pt -134.78 159.93 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.344 -1.092 . . . . 0.0 109.421 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.63 ' C ' HD23 ' A' ' 9' ' ' LEU . 36.5 mt -98.57 124.33 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.005 . . . . 0.0 110.28 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.84 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -141.1 -172.68 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 110.478 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.642 ' NH2' HG21 ' A' ' 66' ' ' ILE . 25.5 ttp-105 -103.89 128.79 51.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 110.947 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.933 HG23 HD11 ' A' ' 69' ' ' ILE . 7.1 p -63.02 137.87 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.558 -0.714 . . . . 0.0 110.5 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -127.48 160.15 32.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.288 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.792 ' HB3' HD11 ' A' ' 81' ' ' ILE . 85.1 tt0 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.306 -0.871 . . . . 0.0 110.555 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 11.0 ptp180 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.33 0.586 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 55.2 t -119.95 119.14 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.807 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.768 ' O ' HD12 ' A' ' 26' ' ' LEU . 5.9 ptt180 -88.38 119.53 28.9 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.837 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -138.81 164.77 28.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.672 -0.643 . . . . 0.0 109.843 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.6 p-10 -89.59 -179.79 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.036 -1.04 . . . . 0.0 110.702 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.265 -175.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.0 t -67.12 -40.01 86.75 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.098 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.16 ' O ' HD22 ' A' ' 33' ' ' LEU . 43.7 m -64.06 -27.94 69.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.224 -0.922 . . . . 0.0 109.496 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 61.1 ttt180 -85.12 -45.17 12.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.749 -0.594 . . . . 0.0 110.834 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 22.5 tpt180 -79.59 -9.96 59.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.812 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.16 HD22 ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -41.12 -30.04 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.661 0.743 . . . . 0.0 109.859 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.822 HD13 ' OD1' ' A' ' 5' ' ' ASN . 80.5 mt -140.54 -60.57 0.51 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.706 -0.622 . . . . 0.0 110.56 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.7 t0 -171.06 -29.42 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.193 -0.942 . . . . 0.0 110.487 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.869 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -21.35 123.98 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.354 0.597 . . . . 0.0 111.469 -176.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.62 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.4 pt-20 -101.12 178.98 4.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 38' ' ' ILE . 32.6 mm -60.08 123.38 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.928 -1.107 . . . . 0.0 109.765 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.9 30.59 61.22 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 175.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -88.84 -179.87 6.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.326 . . . . 0.0 109.514 172.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.806 HG21 HG23 ' A' ' 92' ' ' THR . 80.1 t -99.26 127.76 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.02 -1.05 . . . . 0.0 110.467 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.681 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -119.96 142.95 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 -177.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -110.54 142.91 41.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.489 -0.757 . . . . 0.0 109.812 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -120.02 149.33 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.221 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.0 tt0 -151.88 94.45 1.97 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 110.845 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.068 ' CG ' HG12 ' A' ' 85' ' ' VAL . 12.7 tmtt? -98.6 -66.8 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.568 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.48 -35.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.645 0.736 . . . . 0.0 109.202 175.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 1.6 mmt85 -134.12 -167.83 2.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.61 -0.681 . . . . 0.0 109.625 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.739 ' C ' HD21 ' A' ' 130' ' ' LEU . 21.9 mttm -89.72 137.32 32.43 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.803 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.583 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.6 157.44 46.76 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.251 0.548 . . . . 0.0 110.2 178.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.3 160.82 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 109.967 177.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.56 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.72 -178.54 48.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -115.79 157.46 24.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.475 -1.014 . . . . 0.0 109.922 -176.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.681 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -85.03 135.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.962 -1.086 . . . . 0.0 110.216 -175.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -127.7 163.15 24.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.063 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -90.01 121.82 32.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 110.098 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -63.45 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.926 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.672 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 5.4 mtm180 -56.16 -45.77 99.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.045 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 40.8 Cg_endo -92.65 97.54 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.882 1.464 . . . . 0.0 109.004 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.1 pt-20 -75.29 36.06 0.12 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.562 -0.711 . . . . 0.0 110.681 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.9 m-20 -147.33 -37.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 110.558 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -84.73 -24.3 28.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.523 ' HA ' HG12 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -81.14 38.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.71 -0.619 . . . . 0.0 110.526 177.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.496 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.4 pttt -98.81 15.48 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -0.999 . . . . 0.0 109.406 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.09 24.34 0.03 OUTLIER Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.642 HG21 ' NH2' ' A' ' 10' ' ' ARG . 46.1 pt -140.77 156.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 109.046 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 3.4 p -135.38 131.48 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.908 -1.12 . . . . 0.0 110.144 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.536 ' NE ' ' HD3' ' A' ' 25' ' ' ARG . 42.9 ttp180 -92.76 118.66 31.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 110.123 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.933 HD11 HG23 ' A' ' 11' ' ' VAL . 2.6 pt -132.09 166.45 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.473 -0.767 . . . . 0.0 110.379 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.507 ' OD1' ' HB2' ' A' ' 73' ' ' MET . 21.4 p-10 -83.66 177.66 8.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 110.138 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t -63.48 -35.22 79.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.0 110.92 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 66.5 t -64.18 -46.16 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 110.123 -174.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.728 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.38 -43.72 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.554 177.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 6.8 ttm180 -59.95 -40.87 90.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.893 174.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -69.97 -25.91 63.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.291 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 5.4 m120 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 110.618 -175.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.46 ' HB2' HG23 ' A' ' 47' ' ' VAL . 29.1 p -99.1 -37.19 9.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.042 . . . . 0.0 110.425 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.568 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 116.4 21.92 4.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -99.22 169.62 9.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.169 -1.194 . . . . 0.0 110.332 -175.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.845 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.26 171.14 7.73 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.351 -0.843 . . . . 0.0 109.366 178.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.792 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -60.16 140.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 0.0 109.981 177.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.704 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 79.61 -4.79 63.11 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 171.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.546 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.04 -166.42 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.815 -1.403 . . . . 0.0 110.115 174.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 33.6 pttt -127.83 112.8 15.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.224 -0.922 . . . . 0.0 109.831 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.068 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.33 151.64 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 48.9 tttp -101.09 126.59 47.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.891 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.527 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.2 t -102.97 121.98 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.565 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 77.8 mtt85 -106.74 128.19 54.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.869 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 13.8 tmtt? -78.75 135.99 37.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.15 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.438 HG21 ' HD2' ' A' ' 161' ' ' PRO . 2.2 m -150.04 -169.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.49 -0.757 . . . . 0.0 110.234 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -126.6 173.3 9.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.494 -0.754 . . . . 0.0 109.671 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.806 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.0 162.5 12.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 110.953 -176.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.666 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.7 pt-20 -150.23 169.92 20.19 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.577 HG21 ' OE2' ' A' ' 167' ' ' GLU . 50.8 mm -90.04 98.85 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.594 -1.316 . . . . 0.0 110.319 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.861 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.48 139.7 52.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.65 ' CD ' HD23 ' A' ' 156' ' ' LEU . 13.0 ptpt -107.13 -24.62 11.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 111.292 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.636 ' HD3' HD13 ' A' ' 156' ' ' LEU . 63.6 tttp -149.97 119.62 7.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.706 -1.246 . . . . 0.0 110.619 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.888 HG23 HG22 ' A' ' 155' ' ' THR . 10.0 p -136.23 140.76 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 0.0 110.692 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.491 ' C ' HD23 ' A' ' 100' ' ' LEU . 99.7 m -111.97 142.1 44.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.081 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.891 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.04 165.86 24.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.614 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -140.07 89.5 11.11 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.795 . . . . 0.0 110.315 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo . . . . . 0 C--N 1.305 -1.754 0 O-C-N 124.061 1.559 . . . . 0.0 110.752 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.748 ' C ' HD13 ' A' ' 116' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 121.08 0.467 . . . . 0.0 109.948 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -62.43 -40.05 95.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.714 176.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -29.09 66.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.0 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.04 -40.01 87.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.769 HG12 ' CD1' ' A' ' 170' ' ' ILE . 54.5 t -65.01 -49.97 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.4 mt-30 -60.06 -44.58 94.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.813 . . . . 0.0 110.024 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -60.01 -44.09 94.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.647 -0.658 . . . . 0.0 110.211 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.527 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.05 -43.8 70.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -0.789 . . . . 0.0 110.544 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.74 ' N ' HD22 ' A' ' 124' ' ' LEU . 3.5 mm? -99.05 2.81 46.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.738 HD11 ' HG2' ' A' ' 166' ' ' GLU . 2.4 tt -46.2 169.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.887 -1.133 . . . . 0.0 110.241 -175.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 28.8 ptt180 33.13 46.09 0.09 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.513 -0.742 . . . . 0.0 111.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -132.26 149.9 74.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.784 -1.198 . . . . 0.0 110.866 176.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.81 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.4 Cg_endo -63.83 133.41 38.91 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.182 1.622 . . . . 0.0 110.264 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.522 ' HE2' HG21 ' A' ' 98' ' ' VAL . 81.5 mmm -127.0 143.05 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.592 -1.317 . . . . 0.0 111.279 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.739 HD21 ' C ' ' A' ' 49' ' ' LYS . 10.8 tp -148.27 110.7 4.68 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.729 -0.607 . . . . 0.0 109.442 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.2 pm0 -43.02 143.28 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.944 -1.097 . . . . 0.0 110.526 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.97 -2.48 2.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.873 -0.517 . . . . 0.0 110.429 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.7 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.6 p-10 -69.93 169.86 12.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.243 -0.911 . . . . 0.0 110.107 175.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 5.4 m120 -128.54 145.28 51.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.524 0 O-C-N 120.944 -1.097 . . . . 0.0 110.108 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 62.6 m-85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.397 0.618 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.437 ' HD2' ' ND2' ' A' ' 134' ' ' ASN . 32.0 tptt -103.26 104.77 14.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.845 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.7 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.2 t -76.65 139.26 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 109.851 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.26 -29.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 0.0 111.059 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 38.4 ttpt -139.52 144.94 38.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.815 -1.178 . . . . 0.0 111.017 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.888 HG22 HG23 ' A' ' 98' ' ' VAL . 58.0 p -140.01 153.02 46.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.71 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.8 OUTLIER -89.82 -30.62 0.36 Allowed Pre-proline 0 C--N 1.297 -1.696 0 O-C-N 121.282 -0.886 . . . . 0.0 111.425 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.974 ' CB ' HG11 ' A' ' 162' ' ' VAL . 14.2 Cg_exo -58.63 -164.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.216 1.114 . . . . 0.0 109.921 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.678 ' HB3' HG22 ' A' ' 160' ' ' VAL . 15.3 t -89.98 -178.41 5.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 175.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -62.27 -8.47 5.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 110.469 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.678 HG22 ' HB3' ' A' ' 158' ' ' SER . 20.7 m -84.76 146.25 45.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 110.238 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.555 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.45 141.3 14.66 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.255 1.661 . . . . 0.0 110.747 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.974 HG11 ' CB ' ' A' ' 157' ' ' PRO . 7.0 m -129.89 159.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 109.575 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.89 128.1 54.32 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.205 -0.934 . . . . 0.0 110.079 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.769 ' CD1' HG21 ' A' ' 168' ' ' THR . 11.9 mm -70.58 154.68 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 110.055 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.61 172.33 24.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.738 ' HG2' HD11 ' A' ' 125' ' ' ILE . 96.6 mt-10 -58.2 -26.26 62.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.898 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.577 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.4 pt-20 -87.38 -17.98 31.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.592 -176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 95' ' ' ALA . 30.7 m -58.47 152.48 17.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 110.302 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' LYS . 23.0 mmtt -105.89 158.77 16.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.062 . . . . 0.0 109.875 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.891 HG23 HD21 ' A' ' 100' ' ' LEU . 1.8 mt -136.68 161.8 35.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 111.164 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.474 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 12.0 mt-10 -139.06 131.66 28.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.756 -0.59 . . . . 0.0 110.219 175.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.9 mp -119.91 128.89 75.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.465 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 5.5 ptp180 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 110.233 -178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 t30 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.52 0.676 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -151.0 -153.7 6.25 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.022 HG21 HD22 ' A' ' 33' ' ' LEU . 11.9 pt -138.63 167.75 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -1.15 . . . . 0.0 109.412 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.771 ' C ' HD23 ' A' ' 9' ' ' LEU . 85.4 mt -109.89 127.84 66.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.117 -0.989 . . . . 0.0 110.337 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.837 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -148.49 -179.04 6.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.511 -0.743 . . . . 0.0 109.962 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 2.8 ptt180 -104.74 138.89 40.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.939 -1.101 . . . . 0.0 110.601 -173.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 80' ' ' SER . 11.2 p -63.07 130.43 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 110.356 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -110.93 153.5 25.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.909 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.518 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.071 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HG2' ' HD2' ' A' ' 53' ' ' ARG . 82.2 mtt180 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.95 0.405 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 67' ' ' VAL . 78.1 t -105.3 114.02 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.987 -1.071 . . . . 0.0 110.053 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 8.9 ptt180 -93.5 119.95 33.19 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.563 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.628 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -139.84 171.94 13.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.682 -176.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 19.8 p-10 -95.43 -172.58 2.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.897 -1.127 . . . . 0.0 110.785 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.03 -46.97 87.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.578 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.474 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 18.2 m -65.24 -41.75 94.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.129 -175.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.667 ' HA ' HD23 ' A' ' 33' ' ' LEU . 64.3 m -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.155 -0.966 . . . . 0.0 109.558 175.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 41.1 ttm180 -73.27 -44.04 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 111.163 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -91.73 -7.82 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.919 -1.113 . . . . 0.0 111.201 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.041 HD12 ' N ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -52.23 -26.58 12.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.149 . . . . 0.0 109.329 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.041 ' N ' HD12 ' A' ' 33' ' ' LEU . 41.9 mt -132.65 -66.01 0.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 110.785 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 28.8 t0 -171.82 -2.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.955 -1.091 . . . . 0.0 111.52 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -44.97 128.01 6.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.827 -1.17 . . . . 0.0 110.449 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.585 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.2 pt-20 -116.85 176.57 5.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 38' ' ' ILE . 21.6 mm -57.96 122.41 7.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.812 -1.18 . . . . 0.0 109.855 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.504 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 72.88 33.42 59.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.161 -1.018 . . . . 0.0 110.663 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 18.9 m-20 -89.2 176.23 7.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.667 -1.49 . . . . 0.0 109.596 172.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.079 HG12 HG23 ' A' ' 90' ' ' VAL . 73.6 t -99.07 127.78 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.084 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 52' ' ' GLY . 4.6 m -120.0 151.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 110.229 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' C ' HD12 ' A' ' 44' ' ' ILE . 86.5 tt0 -122.99 142.9 50.33 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.716 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -119.9 147.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' OE1' ' CZ ' ' A' ' 88' ' ' ARG . 82.5 tt0 -151.29 93.14 1.87 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.931 -1.106 . . . . 0.0 110.846 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.035 ' HG3' HG12 ' A' ' 85' ' ' VAL . 8.9 tmtm? -97.94 -58.85 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.646 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.73 -31.51 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.676 0.75 . . . . 0.0 109.129 176.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 98.3 mtt180 -139.53 -172.57 3.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.642 -0.662 . . . . 0.0 109.747 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -88.41 130.32 35.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.177 -0.952 . . . . 0.0 110.825 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -131.03 154.31 48.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.805 -0.56 . . . . 0.0 110.26 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.056 HG11 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -117.91 164.36 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.945 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -176.77 179.0 47.96 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 18.2 ptp180 -111.53 -172.04 1.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -1.112 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.585 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.24 137.66 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.026 -1.046 . . . . 0.0 110.632 -175.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -127.89 164.13 22.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 110.194 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.27 123.67 33.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -63.33 140.05 58.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.653 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 4.6 mmt180 -56.08 -49.55 92.48 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.903 -1.123 . . . . 0.0 108.877 174.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 18.7 Cg_endo -91.68 98.36 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.715 1.376 . . . . 0.0 108.831 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 11.1 pt-20 -74.97 35.29 0.1 Allowed 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 110.917 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 79.5 m-20 -145.43 -32.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.056 -1.027 . . . . 0.0 110.796 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.99 -25.55 24.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.563 ' HA ' HG12 ' A' ' 66' ' ' ILE . 4.1 m-80 -81.13 39.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 110.573 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.3 pttt -99.02 17.48 19.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 109.575 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.56 23.98 0.03 OUTLIER Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.563 HG12 ' HA ' ' A' ' 63' ' ' ASN . 44.5 pt -140.68 158.59 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.52 -0.988 . . . . 0.0 109.221 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.976 HG23 HG13 ' A' ' 24' ' ' VAL . 3.4 p -129.98 137.13 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.087 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -97.31 118.02 32.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.05 -1.031 . . . . 0.0 110.1 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.857 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.1 pt -134.36 173.04 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.749 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 71' ' ' SER . 29.7 t0 -91.23 173.61 7.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.564 -0.71 . . . . 0.0 109.857 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 58.5 p -63.12 -25.29 68.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.438 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.7 t -68.49 -47.45 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.689 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.07 -42.81 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 109.768 176.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.02 -40.27 88.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 174.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -71.04 -26.86 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.395 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.4 m-20 -60.07 -39.9 87.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 110.808 -176.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.524 ' C ' HG23 ' A' ' 47' ' ' VAL . 28.5 p -98.47 -36.53 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.965 -1.084 . . . . 0.0 110.657 -175.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 117.18 22.83 4.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.79 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -102.65 171.75 7.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -1.202 . . . . 0.0 110.311 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.962 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.91 179.05 4.08 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -65.22 140.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.053 -1.03 . . . . 0.0 110.423 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.88 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.03 -3.21 52.72 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 173.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.586 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.52 -158.83 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.054 -1.262 . . . . 0.0 110.211 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 52.6 pttt -137.07 116.92 13.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 110.097 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.035 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.3 m -125.81 160.07 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.433 -0.792 . . . . 0.0 109.823 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 33.0 ttmt -104.08 123.99 48.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.508 HG21 HD11 ' A' ' 9' ' ' LEU . 63.8 t -99.55 125.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtm180 -117.23 149.49 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 61.7 tttm -91.15 139.85 30.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.862 -1.149 . . . . 0.0 110.371 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.079 HG23 HG12 ' A' ' 41' ' ' VAL . 2.3 m -138.84 -168.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 175.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.481 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 38.8 ptt180 -137.46 171.26 14.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.26 159.55 16.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 0.0 111.193 -175.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.648 ' CG ' HG12 ' A' ' 162' ' ' VAL . 11.7 pt-20 -150.32 171.17 17.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.761 HG21 ' OE2' ' A' ' 167' ' ' GLU . 39.7 mm -88.62 98.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.287 -1.508 . . . . 0.0 110.096 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.992 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -58.62 139.96 55.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.392 -0.818 . . . . 0.0 110.365 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.587 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 1.4 pttt -97.46 -29.7 13.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.081 -1.012 . . . . 0.0 111.11 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.564 ' HB3' HD23 ' A' ' 156' ' ' LEU . 80.4 tttt -150.91 121.98 7.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 0.0 110.915 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.017 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -132.24 143.54 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.006 -1.059 . . . . 0.0 110.955 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.524 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 91.1 m -114.96 140.26 49.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 0.0 110.044 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 170' ' ' ILE . 0.1 OUTLIER -136.3 165.28 26.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.374 -177.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.576 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -136.33 82.11 35.56 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 111.033 -176.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.53 ' HD2' ' CD ' ' A' ' 173' ' ' ARG . 17.4 Cg_exo . . . . . 0 C--N 1.305 -1.754 0 O-C-N 123.869 1.458 . . . . 0.0 109.883 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 120' ' ' VAL . 5.9 tp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.076 0.465 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.541 ' HG2' HG12 ' A' ' 172' ' ' ILE . 94.8 mt-10 -59.99 -46.81 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 109.516 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.39 -39.89 92.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.457 ' HB3' HD12 ' A' ' 116' ' ' ILE . 36.8 t80 -64.27 -39.99 95.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.475 -0.766 . . . . 0.0 109.942 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.73 HG12 ' CD1' ' A' ' 170' ' ' ILE . 58.4 t -60.59 -49.97 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.4 mt-30 -61.21 -41.82 97.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.645 -0.66 . . . . 0.0 110.238 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.1 -48.93 79.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.438 -0.789 . . . . 0.0 109.97 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.402 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.01 -40.73 75.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.719 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.573 HD12 ' HE3' ' A' ' 129' ' ' MET . 4.6 mm? -94.91 -1.74 51.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.138 -175.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.712 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.6 tt -46.95 166.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.931 -1.105 . . . . 0.0 110.109 -175.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.6 ptt180 33.76 49.56 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 0.0 111.458 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.464 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 6.8 tpt180 -135.07 140.95 36.36 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.899 -1.126 . . . . 0.0 111.373 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.1 Cg_exo -59.69 130.68 36.26 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 124.095 1.576 . . . . 0.0 109.734 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.573 ' HE3' HD12 ' A' ' 124' ' ' LEU . 15.4 mmt -134.9 141.78 46.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.409 -1.432 . . . . 0.0 110.972 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -146.42 130.0 16.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -51.32 145.63 8.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -175.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.541 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 76.51 -2.06 2.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.818 -0.551 . . . . 0.0 110.548 178.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.801 ' HB3' HD23 ' A' ' 130' ' ' LEU . 1.6 p30 -67.59 -171.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.196 -0.94 . . . . 0.0 109.874 173.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -150.37 159.02 44.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.34 -0.85 . . . . 0.0 109.532 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.423 HD12 ' CB ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 110.122 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.511 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 20.4 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.188 0.518 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -119.95 109.98 16.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.558 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.9 t -74.97 139.38 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.06 -24.52 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 111.021 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -146.2 136.65 23.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.662 -1.274 . . . . 0.0 110.841 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.017 HG22 HG23 ' A' ' 98' ' ' VAL . 44.5 p -134.7 168.7 18.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.498 -0.752 . . . . 0.0 109.355 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.01 -35.98 0.42 Allowed Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.929 -178.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 1.062 ' CG ' HG11 ' A' ' 162' ' ' VAL . 22.9 Cg_exo -58.46 -174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.384 1.202 . . . . 0.0 110.531 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -156.36 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.59 -11.35 52.88 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 160' ' ' VAL . 33.1 m -87.11 139.45 32.43 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 1.056 ' HB3' HG11 ' A' ' 51' ' ' VAL . 9.3 Cg_endo -59.72 164.1 12.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.131 1.595 . . . . 0.0 111.002 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 1.062 HG11 ' CG ' ' A' ' 157' ' ' PRO . 14.8 m -140.37 166.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.561 -0.712 . . . . 0.0 110.101 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -103.02 126.48 50.22 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.833 -1.167 . . . . 0.0 109.954 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.813 ' CD1' HG21 ' A' ' 168' ' ' THR . 10.9 mm -70.11 153.73 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.588 -0.695 . . . . 0.0 109.661 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.49 168.25 25.9 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -56.62 -20.78 22.86 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -1.084 . . . . 0.0 110.033 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.761 ' OE2' HG21 ' A' ' 94' ' ' ILE . 21.3 pt-20 -91.35 -18.22 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.724 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.813 HG21 ' CD1' ' A' ' 164' ' ' ILE . 28.6 m -58.37 144.65 40.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.4 mttt -95.45 150.54 20.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 109.507 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.818 HG23 HD21 ' A' ' 100' ' ' LEU . 1.9 mt -129.95 160.05 41.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.83 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.524 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 65.2 mt-10 -135.62 145.32 46.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.566 -0.709 . . . . 0.0 110.295 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.685 HD11 HG21 ' A' ' 120' ' ' VAL . 30.9 mm -122.59 141.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.517 -0.739 . . . . 0.0 109.934 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.576 ' HD2' ' HA ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -176.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.922 0.867 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.891 ' HA2' HD11 ' A' ' 34' ' ' LEU . . . -151.8 -179.48 27.48 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.733 HG21 HD13 ' A' ' 33' ' ' LEU . 33.5 pt -134.8 159.18 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.879 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 85.5 mt -95.79 118.43 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.875 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.5 pt? -134.91 -169.28 2.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.344 -0.848 . . . . 0.0 110.382 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 38.1 ttp180 -103.91 130.15 51.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 110.965 -175.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.028 HG23 HD11 ' A' ' 69' ' ' ILE . 10.5 p -61.1 137.95 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 110.277 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -122.72 149.82 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' OE1' ' HD3' ' A' ' 74' ' ' ARG . 86.5 tt0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 33.7 ptt180 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.984 HG13 HG23 ' A' ' 67' ' ' VAL . 53.6 t -99.96 110.1 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.065 . . . . 0.0 110.023 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -99.76 119.98 39.0 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.003 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -133.66 -169.43 2.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.525 -0.735 . . . . 0.0 110.375 -177.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' N ' ' HB3' ' A' ' 63' ' ' ASN . 26.6 p-10 -106.85 -179.15 3.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 0.0 110.816 -175.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 84.2 mt-10 -60.04 -40.07 88.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.242 -178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 46.6 t -59.95 -49.69 76.7 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.083 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.814 ' HA ' HD21 ' A' ' 33' ' ' LEU . 75.4 m -59.97 -40.09 87.87 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.099 -1.001 . . . . 0.0 109.682 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 32.2 ttp180 -60.19 -46.29 90.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 172.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -67.31 -39.97 85.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 110.415 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.951 ' CD1' HD13 ' A' ' 34' ' ' LEU . 4.4 pp -74.84 -28.4 60.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 111.088 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.951 HD13 ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -99.48 -8.36 24.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.731 -1.231 . . . . 0.0 110.15 175.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 34' ' ' LEU . 12.4 t70 59.77 14.87 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.818 . . . . 0.0 109.82 -174.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.934 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -58.95 120.71 9.57 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.593 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -99.48 173.34 6.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -58.52 127.75 18.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.35 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.7 73.4 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.578 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.42 ' CG ' ' HG2' ' A' ' 37' ' ' GLU . 90.2 m-20 -88.33 166.46 14.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.478 -1.601 . . . . 0.0 108.756 169.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 92' ' ' THR . 93.7 t -98.75 129.33 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.737 -1.227 . . . . 0.0 110.1 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.763 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -115.48 138.01 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.353 -177.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 83.0 tt0 -108.67 139.77 43.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.441 -0.787 . . . . 0.0 109.396 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.97 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.6 mp -120.3 145.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 110.332 -176.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.9 tt0 -147.42 99.51 3.14 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 110.772 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.043 ' CG ' HG12 ' A' ' 85' ' ' VAL . 9.5 tmtt? -98.29 -65.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.67 173.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.557 HG21 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.26 -33.38 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.257 174.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 69.5 mtt85 -135.56 -178.31 5.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.761 -0.587 . . . . 0.0 109.479 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.538 ' HB3' HD21 ' A' ' 130' ' ' LEU . 24.3 mttt -89.3 136.95 32.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.547 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.689 ' HA ' HD23 ' A' ' 130' ' ' LEU . 1.8 p -141.42 168.71 19.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 110.1 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.558 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.6 164.14 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.54 -0.725 . . . . 0.0 110.379 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.61 -172.76 42.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.9 ptp85 -113.98 -174.87 2.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.934 HG21 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -113.59 139.46 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.609 -173.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 1.1 m-85 -132.65 164.6 26.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.894 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -98.91 126.92 44.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.436 -0.79 . . . . 0.0 110.079 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -66.31 140.58 58.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.215 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.58 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -56.5 -49.02 95.94 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 118.899 -1.121 . . . . 0.0 108.834 172.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 30.7 Cg_endo -91.72 97.24 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.864 1.455 . . . . 0.0 108.954 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.13 35.83 0.14 Allowed 'General case' 0 C--N 1.289 -2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 110.984 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 36.1 p-10 -143.08 -36.11 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 110.964 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 15.5 pt-20 -84.83 -20.43 30.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.936 -1.102 . . . . 0.0 109.585 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.496 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 4.7 m-80 -81.42 38.66 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.48 -0.762 . . . . 0.0 110.531 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 26.2 pttm -98.82 11.9 37.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.63 26.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.496 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.8 pt -140.15 143.03 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.311 -1.111 . . . . 0.0 109.358 175.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.984 HG23 HG13 ' A' ' 24' ' ' VAL . 7.5 p -122.48 129.62 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.309 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 38.7 mmm-85 -90.01 116.62 28.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.243 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.028 HD11 HG23 ' A' ' 11' ' ' VAL . 2.9 pt -136.84 169.15 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 110.599 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.462 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 32.9 p-10 -78.5 169.29 18.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.601 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 79.6 p -70.04 -23.49 63.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.462 ' HB ' ' OD2' ' A' ' 70' ' ' ASP . 54.5 t -70.06 -43.98 78.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.979 -1.076 . . . . 0.0 110.186 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.97 ' CE ' HD13 ' A' ' 44' ' ' ILE . 9.7 tpt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.084 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 71' ' ' SER . 43.7 ptt85 -61.38 -35.56 77.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.806 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.476 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 64.1 t30 -71.88 -26.45 62.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.11 -0.994 . . . . 0.0 110.495 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.6 m-20 -60.01 -35.66 75.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.466 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.509 ' C ' HG23 ' A' ' 47' ' ' VAL . 26.1 p -97.95 -36.61 10.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.281 -0.887 . . . . 0.0 110.202 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.557 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 122.34 28.22 1.51 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.718 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -110.81 161.05 16.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -1.113 . . . . 0.0 110.476 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.849 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.77 179.02 4.09 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 178.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -60.44 139.73 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.926 -1.109 . . . . 0.0 110.646 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.836 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 78.24 -3.51 62.01 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.57 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.95 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.024 -1.28 . . . . 0.0 110.088 174.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 54.7 pttt -133.07 113.56 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 110.073 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.043 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -119.94 166.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.312 -0.867 . . . . 0.0 110.028 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 84.6 tttt -114.21 127.57 55.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 109.973 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.595 HG23 HD21 ' A' ' 9' ' ' LEU . 92.8 t -107.55 122.81 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.099 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.486 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 12.3 mtt180 -109.67 140.5 43.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 34' ' ' LEU . 53.5 tttm -82.13 140.76 33.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.094 -1.004 . . . . 0.0 110.701 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.481 HG21 ' CG ' ' A' ' 161' ' ' PRO . 2.3 m -150.17 -170.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.78 -0.575 . . . . 0.0 109.688 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.5 mtp180 -132.48 163.41 28.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.713 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.675 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -94.67 161.31 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.977 0.894 . . . . 0.0 111.418 -174.277 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.673 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.6 pt-20 -150.09 170.33 19.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.848 HG21 ' OE2' ' A' ' 167' ' ' GLU . 37.6 mm -89.07 101.11 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.625 -1.297 . . . . 0.0 110.461 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.828 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -58.69 139.98 55.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 110.31 177.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -101.84 -26.5 13.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 111.04 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.741 ' HB3' HD23 ' A' ' 156' ' ' LEU . 23.3 tttt -150.33 128.64 12.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 110.221 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.944 HG23 HG22 ' A' ' 155' ' ' THR . 7.2 p -140.8 144.98 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.996 -1.065 . . . . 0.0 110.616 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.541 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.3 m -116.51 133.42 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.827 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.944 HD11 HG11 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -131.94 160.81 34.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 110.371 -176.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -133.65 81.31 54.0 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 110.848 -176.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.515 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . 17.4 Cg_exo . . . . . 0 C--N 1.306 -1.704 0 O-C-N 123.933 1.491 . . . . 0.0 110.083 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.55 HG23 ' N ' ' A' ' 117' ' ' GLU . 19.1 tt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 121.162 0.506 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.55 ' N ' HG23 ' A' ' 116' ' ' ILE . 95.9 mt-10 -60.53 -40.06 90.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.957 . . . . 0.0 109.955 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -70.02 -35.94 74.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -60.04 -39.74 86.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.768 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.944 HG11 HD11 ' A' ' 100' ' ' LEU . 54.6 t -60.14 -45.32 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -60.04 -41.2 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.014 173.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -60.03 -39.9 87.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.39 -42.69 18.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.845 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 4.6 mm? -94.83 0.84 55.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.019 -1.051 . . . . 0.0 111.156 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.833 HD11 ' HG2' ' A' ' 166' ' ' GLU . 0.5 OUTLIER -44.04 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.03 -1.044 . . . . 0.0 110.554 -176.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.99 52.63 0.48 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.577 -0.702 . . . . 0.0 111.589 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 13.7 mmt180 -134.36 149.99 72.7 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.997 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.755 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.8 Cg_exo -66.11 132.32 29.57 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.975 1.513 . . . . 0.0 109.93 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.839 ' HE2' HG21 ' A' ' 98' ' ' VAL . 93.9 mmm -125.19 132.19 53.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.604 -1.31 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 50' ' ' THR . 19.7 tp -133.38 108.18 8.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.69 -0.631 . . . . 0.0 109.433 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.8 pt-20 -45.7 136.12 6.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.69 -1.256 . . . . 0.0 110.163 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.583 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 80.01 -2.6 2.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.947 -0.471 . . . . 0.0 110.326 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.4 p30 -69.37 -169.97 0.25 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.297 -0.877 . . . . 0.0 110.414 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 11.5 m-80 -144.96 159.17 43.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 110.516 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.515 ' CE2' ' HB3' ' A' ' 102' ' ' PRO . 58.8 m-85 . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.261 0.553 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 110.03 16.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.034 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 132' ' ' GLN . 3.1 t -76.23 136.72 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 36.6 t -116.72 -30.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 110.618 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.4 tptt -140.07 135.07 32.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 0.0 110.935 -177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.944 HG22 HG23 ' A' ' 98' ' ' VAL . 69.6 p -129.95 166.21 20.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.397 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -88.8 -38.2 0.44 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.035 . . . . 0.0 110.81 -178.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 1.008 ' CG ' HG11 ' A' ' 162' ' ' VAL . 22.7 Cg_exo -57.8 -171.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.551 1.29 . . . . 0.0 110.497 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.95 -167.82 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 110.013 176.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.53 -9.45 8.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.181 -0.949 . . . . 0.0 110.695 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.21 144.51 41.12 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.478 -0.764 . . . . 0.0 110.628 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.558 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -47.9 141.63 16.4 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.885 1.723 . . . . 0.0 111.252 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 1.008 HG11 ' CG ' ' A' ' 157' ' ' PRO . 8.9 m -130.23 159.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 109.946 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 88.0 tt0 -109.32 130.56 55.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.237 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.912 HD12 HG21 ' A' ' 168' ' ' THR . 12.8 mm -71.2 152.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.518 -176.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.59 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.85 169.8 25.48 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.833 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.87 -23.61 45.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -1.142 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.848 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.5 pt-20 -87.06 -12.53 46.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.912 HG21 HD12 ' A' ' 164' ' ' ILE . 13.5 m -62.94 144.76 56.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.5 mttt -93.91 154.64 17.59 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 109.897 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.68 HD12 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mm -116.87 136.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 111.038 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.541 ' CB ' ' OG1' ' A' ' 99' ' ' THR . 18.7 mt-10 -120.33 130.68 54.53 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 110.198 172.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 170' ' ' ILE . 34.9 mm -120.17 140.37 44.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.529 -0.732 . . . . 0.0 110.301 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.537 ' O ' ' CZ ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.301 -176.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.48 ' O ' HD13 ' A' ' 34' ' ' LEU . 27.3 t30 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.081 0.943 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.525 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -155.47 -169.27 19.7 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.927 ' CG2' HD12 ' A' ' 33' ' ' LEU . 41.0 pt -133.29 162.86 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -1.14 . . . . 0.0 109.663 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 ' HD3' ' A' ' 86' ' ' LYS . 92.8 mt -107.62 126.55 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.806 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.6 pt? -143.78 -165.49 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.657 -0.652 . . . . 0.0 109.447 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.515 ' CZ ' HG22 ' A' ' 66' ' ' ILE . 19.9 ptt-85 -115.0 140.25 49.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 0.0 110.464 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.063 HG23 HD11 ' A' ' 69' ' ' ILE . 13.6 p -60.75 137.75 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 110.635 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -115.3 139.97 49.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 110.56 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.937 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 109.918 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.613 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 39.8 mtm180 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.257 0.551 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 67' ' ' VAL . 83.4 t -112.44 120.56 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.75 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.2 ptm180 -95.74 119.88 35.02 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.602 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.1 mp -136.36 173.72 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.7 -175.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.466 ' OD1' ' OG ' ' A' ' 30' ' ' SER . 10.2 p-10 -95.71 -172.65 2.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 111.004 -176.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.491 ' OE2' ' NH1' ' A' ' 56' ' ' ARG . 49.7 mm-40 -59.73 -50.04 75.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 109.763 -175.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.54 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.5 t -64.1 -40.53 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.219 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.131 ' O ' HD22 ' A' ' 33' ' ' LEU . 68.6 m -60.05 -29.34 68.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 70.9 ttt180 -87.35 -46.99 9.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.659 -0.651 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 33' ' ' LEU . 87.0 mtm180 -79.94 -6.94 58.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.801 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.131 HD22 ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -42.03 -30.51 0.28 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.526 -0.734 . . . . 0.0 109.788 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 33' ' ' LEU . 79.3 mt -141.53 -61.65 0.47 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 0.0 110.592 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' C ' ' A' ' 36' ' ' ALA . 26.8 t0 -172.46 -29.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.2 -0.937 . . . . 0.0 110.03 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -23.52 116.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.514 0.674 . . . . 0.0 111.357 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.634 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -109.5 168.38 9.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.279 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -46.08 125.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.063 -1.023 . . . . 0.0 109.806 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 79.48 21.32 67.11 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.609 171.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 81.3 m-20 -89.21 173.91 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.721 -1.458 . . . . 0.0 109.359 171.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.521 ' CG1' ' HG2' ' A' ' 161' ' ' PRO . 59.7 t -99.39 134.16 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.958 . . . . 0.0 110.144 -175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.72 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -123.28 146.15 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.71 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -114.17 140.58 48.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.733 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.1 mp -124.81 138.94 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.687 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 87.6 tt0 -140.64 99.99 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 110.265 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.928 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -98.75 -66.47 0.9 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.618 -0.676 . . . . 0.0 109.401 177.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -111.3 -30.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.417 -0.802 . . . . 0.0 109.063 172.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.591 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 95.3 mtt180 -131.86 -179.82 5.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.619 173.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.51 ' HB3' HD21 ' A' ' 130' ' ' LEU . 35.0 mttt -89.17 138.34 31.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 111.011 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.663 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 5.5 p -142.57 167.7 21.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.55 0.69 . . . . 0.0 109.801 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -121.23 167.79 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.72 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.59 -168.46 38.49 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' HG22 ' A' ' 42' ' ' VAL . 67.1 ttt180 -125.45 165.09 19.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.981 . . . . 0.0 110.592 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.841 HG21 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -94.23 136.08 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.269 -175.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.613 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 1.3 m-85 -133.61 163.69 28.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.472 175.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 43.0 ttt85 -92.3 125.96 37.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.936 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -63.29 139.27 58.75 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.37 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.574 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.6 mtp180 -56.24 -48.57 96.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.763 174.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 34.2 Cg_endo -91.65 97.18 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.095 1.576 . . . . 0.0 108.965 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.12 35.93 0.11 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.547 -0.721 . . . . 0.0 110.737 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -143.59 -31.85 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.45 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.62 -28.76 24.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.185 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.489 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 3.5 m-80 -80.98 39.81 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.474 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 14.2 pttm -98.79 9.41 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -0.923 . . . . 0.0 109.683 177.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -176.36 28.08 0.07 OUTLIER Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.515 HG22 ' CZ ' ' A' ' 10' ' ' ARG . 44.6 pt -140.58 143.13 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.213 -1.169 . . . . 0.0 109.473 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.947 HG23 HG13 ' A' ' 24' ' ' VAL . 3.9 p -119.34 124.48 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.045 -1.034 . . . . 0.0 109.898 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 1.7 mtp85 -91.39 117.22 29.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.285 -0.885 . . . . 0.0 110.074 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.063 HD11 HG23 ' A' ' 11' ' ' VAL . 1.4 pt -129.69 162.96 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.632 -0.668 . . . . 0.0 110.264 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.53 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 26.0 p-10 -76.78 177.55 7.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.851 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 10.4 m -68.87 -19.0 64.23 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.613 HG12 ' ND2' ' A' ' 76' ' ' ASN . 86.3 t -69.9 -48.37 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.989 -1.069 . . . . 0.0 110.331 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.752 ' HE1' HD13 ' A' ' 44' ' ' ILE . 88.8 mmm -62.8 -40.27 96.83 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.548 174.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.898 ' NH1' HD13 ' A' ' 81' ' ' ILE . 72.7 ttt180 -60.07 -40.66 90.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 173.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' SER . 8.0 t30 -78.34 -32.58 49.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 110.577 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.613 ' ND2' HG12 ' A' ' 72' ' ' VAL . 98.6 m-20 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.377 -175.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 20.9 p -99.91 -38.28 8.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.726 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.58 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 111.05 23.7 5.73 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.928 ' HB1' ' HD2' ' A' ' 46' ' ' LYS . . . -111.05 -178.07 3.37 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.008 -1.29 . . . . 0.0 111.295 -171.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.553 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -128.74 170.15 13.66 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 174.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.937 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -56.37 154.54 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 110.156 178.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 74.84 -5.45 31.46 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.669 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.9 m-20 -56.27 -164.64 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.039 -1.271 . . . . 0.0 110.513 176.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 22.2 pttm -134.55 115.92 14.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 109.554 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.74 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -125.75 159.22 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.126 -177.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.6 ttpm? -111.72 121.04 44.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.77 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.524 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.3 t -99.65 120.06 48.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 4.6 mtt180 -112.11 139.38 47.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.826 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -86.14 138.59 31.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.486 HG21 ' CD ' ' A' ' 161' ' ' PRO . 2.2 m -147.07 -169.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.501 -0.749 . . . . 0.0 110.221 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -127.51 166.48 17.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.822 . . . . 0.0 109.631 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.51 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -99.42 162.13 13.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 0.0 111.057 -176.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.594 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.7 pt-20 -150.33 169.3 21.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.7 mm -89.93 98.28 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.603 -1.311 . . . . 0.0 110.469 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.927 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.82 141.03 46.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.308 -0.87 . . . . 0.0 110.361 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.749 ' HG2' HD22 ' A' ' 156' ' ' LEU . 5.5 pttt -108.25 -22.01 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.193 -0.942 . . . . 0.0 111.14 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 169' ' ' LYS . 62.6 tttp -150.7 117.22 5.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.613 -1.305 . . . . 0.0 110.485 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.08 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -134.74 140.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.04 . . . . 0.0 110.588 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.478 ' C ' HD23 ' A' ' 100' ' ' LEU . 41.7 m -108.02 140.31 41.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.078 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.927 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.71 165.09 26.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.105 -178.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.64 82.88 11.02 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.141 -0.974 . . . . 0.0 111.037 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 32.5 Cg_exo . . . . . 0 C--N 1.306 -1.662 0 O-C-N 123.921 1.485 . . . . 0.0 110.394 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.304 0.573 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.709 ' HA ' HD11 ' A' ' 172' ' ' ILE . 99.0 mt-10 -59.97 -45.32 93.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -70.02 -32.95 71.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 110.582 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -60.07 -39.98 87.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.139 -0.976 . . . . 0.0 109.062 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.878 HG12 ' CD1' ' A' ' 170' ' ' ILE . 53.9 t -60.52 -49.11 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.677 174.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.543 ' HG3' HG13 ' A' ' 170' ' ' ILE . 3.3 mt-30 -59.99 -42.65 94.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.0 -45.61 92.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 110.157 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.538 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.95 -43.4 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.644 ' N ' HD22 ' A' ' 124' ' ' LEU . 4.1 mm? -99.79 6.17 45.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.977 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.737 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.6 tt -47.98 165.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.76 -1.212 . . . . 0.0 109.821 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 11.6 ptp180 35.3 47.7 0.33 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.445 -0.785 . . . . 0.0 111.387 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 7.4 mmt85 -129.37 150.88 76.78 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.791 -1.193 . . . . 0.0 110.965 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.784 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.3 Cg_endo -68.71 128.55 17.19 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 124.233 1.649 . . . . 0.0 109.716 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.505 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.9 mmm -124.76 139.84 53.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.446 -1.409 . . . . 0.0 110.885 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 50' ' ' THR . 16.7 tp -141.34 104.38 4.59 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.639 -0.663 . . . . 0.0 109.558 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.0 pt-20 -43.41 139.43 2.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.617 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.61 -7.01 0.98 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.184 0.516 . . . . 0.0 110.334 -177.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.54 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.3 p-10 -70.08 174.96 4.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 29.9 m-80 -141.38 149.72 41.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 110.108 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 28.6 m-85 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.339 0.59 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.52 108.48 15.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.92 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.54 HG21 ' OD1' ' A' ' 133' ' ' ASP . 3.3 t -77.16 140.02 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.816 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.4 t -120.51 -30.95 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.129 -0.982 . . . . 0.0 110.785 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -143.09 149.55 38.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.772 -1.205 . . . . 0.0 111.59 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.08 HG22 HG23 ' A' ' 98' ' ' VAL . 55.1 p -140.54 164.39 30.28 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.749 HD22 ' HG2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -88.42 -39.15 0.46 Allowed Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.893 . . . . 0.0 110.692 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.977 ' CB ' HG11 ' A' ' 162' ' ' VAL . 19.3 Cg_exo -58.56 -172.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.556 1.293 . . . . 0.0 110.38 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 -167.68 1.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.465 -0.772 . . . . 0.0 109.821 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -65.79 -4.88 7.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.219 -0.925 . . . . 0.0 110.983 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.7 145.26 41.26 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.424 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.56 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -49.35 141.31 25.09 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.221 1.643 . . . . 0.0 110.545 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.977 HG11 ' CB ' ' A' ' 157' ' ' PRO . 4.6 m -129.88 157.9 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 109.942 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 53.7 tt0 -106.91 128.01 53.94 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 110.2 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.804 HD12 HG21 ' A' ' 168' ' ' THR . 11.2 mm -70.85 156.48 7.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 110.275 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.74 169.73 25.96 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.737 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -57.85 -21.45 42.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 0.0 110.209 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -88.35 -21.6 24.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.884 . . . . 0.0 109.575 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.804 HG21 HD12 ' A' ' 164' ' ' ILE . 26.6 m -56.89 162.07 2.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.514 -0.741 . . . . 0.0 110.231 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' LYS . 46.8 mtmt -121.02 149.82 42.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.464 176.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.927 HG23 HD21 ' A' ' 100' ' ' LEU . 1.2 mt -127.99 162.95 32.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 110.95 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 35.8 mt-10 -138.35 137.29 37.2 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.521 0.676 . . . . 0.0 110.11 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.709 HD11 ' HA ' ' A' ' 117' ' ' GLU . 4.3 mp -121.68 137.72 54.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.887 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.577 ' NE ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 0.0 110.096 -174.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.357 0.599 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -152.18 -161.88 10.48 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.709 HG23 HD11 ' A' ' 34' ' ' LEU . 42.5 pt -136.07 157.92 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -1.204 . . . . 0.0 110.0 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 mm -101.5 113.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.026 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.714 HD11 ' HB ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -139.81 -173.8 3.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.885 -178.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 24.1 ptt-85 -115.77 139.81 49.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.943 -1.098 . . . . 0.0 110.619 -175.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.762 HG13 ' HA ' ' A' ' 81' ' ' ILE . 14.5 p -61.8 132.55 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.538 -0.726 . . . . 0.0 110.634 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -108.78 145.33 35.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.63 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.957 ' HB3' HD11 ' A' ' 81' ' ' ILE . 84.8 tt0 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.874 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 53' ' ' ARG . 24.9 mmt85 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.089 0.471 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.118 HG13 HG23 ' A' ' 67' ' ' VAL . 85.6 t -110.45 119.98 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 0.0 110.195 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 26' ' ' LEU . 5.1 ptt180 -90.25 116.66 28.4 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.753 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.922 HD13 HG12 ' A' ' 24' ' ' VAL . 1.1 mp -128.24 174.91 8.87 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 3.5 p-10 -91.67 177.54 6.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.84 -1.162 . . . . 0.0 110.404 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 87.0 mt-10 -60.04 -39.99 87.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.59 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -67.74 -58.33 4.82 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.107 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.583 ' C ' HD22 ' A' ' 33' ' ' LEU . 68.3 m -49.99 -30.04 9.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 109.629 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 51.6 ttp180 -81.73 -47.95 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 111.261 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -93.91 -16.86 23.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.767 -1.208 . . . . 0.0 111.199 -171.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.926 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.1 pt? -60.0 -28.77 67.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.131 . . . . 0.0 110.24 -176.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.926 ' H ' HD23 ' A' ' 33' ' ' LEU . 61.4 mt -101.91 -73.37 0.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 109.97 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' ALA . 12.6 t0 -170.02 -27.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -36.23 122.36 0.72 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.327 0.584 . . . . 0.0 110.933 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.716 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -115.65 179.32 4.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 38' ' ' ILE . 28.2 mm -54.64 128.27 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.985 -1.072 . . . . 0.0 109.897 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.62 18.36 75.75 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.575 172.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' OD1' ' OE2' ' A' ' 37' ' ' GLU . 79.5 m-20 -89.17 161.86 16.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.649 -1.501 . . . . 0.0 109.635 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.838 HG21 ' OG1' ' A' ' 92' ' ' THR . 94.0 t -99.62 135.92 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.058 -1.026 . . . . 0.0 110.499 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.736 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -119.98 153.12 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.861 . . . . 0.0 110.571 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 86.5 tt0 -118.88 139.93 50.82 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.348 -0.845 . . . . 0.0 110.009 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.8 mp -119.98 145.11 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.049 . . . . 0.0 110.754 -177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.49 95.28 2.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.353 -0.842 . . . . 0.0 111.023 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.999 ' HG3' HG12 ' A' ' 85' ' ' VAL . 9.7 tmtm? -97.85 -59.19 1.82 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.995 . . . . 0.0 109.852 173.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.58 HG23 ' C ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -113.21 -33.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.58 -0.7 . . . . 0.0 109.22 175.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 78.9 mtm-85 -136.56 178.42 7.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 174.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.607 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.1 132.26 34.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.163 -0.96 . . . . 0.0 110.386 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.598 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.1 p -139.69 168.13 20.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.468 0.651 . . . . 0.0 109.695 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.755 HG13 ' HG ' ' A' ' 130' ' ' LEU . 2.8 m -115.24 175.16 2.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.55 -0.719 . . . . 0.0 110.66 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.736 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.78 179.75 48.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 174.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.535 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 51.1 mtp180 -125.82 176.13 7.16 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.274 -1.133 . . . . 0.0 110.027 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -99.15 127.07 52.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.351 -175.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -117.6 164.81 14.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 175.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -89.87 121.74 32.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.439 -0.788 . . . . 0.0 109.803 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.791 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -62.82 132.4 52.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.604 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.4 mtt-85 -57.11 -47.4 99.13 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.708 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.76 97.17 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.96 1.505 . . . . 0.0 108.975 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -75.56 33.51 0.11 Allowed 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.429 -0.794 . . . . 0.0 110.977 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -145.73 -28.54 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.055 -1.028 . . . . 0.0 110.631 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -87.03 -25.76 24.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 109.129 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.791 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 18.3 m120 -81.1 42.33 0.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.639 -0.663 . . . . 0.0 110.269 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.528 ' CD ' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.73 9.52 43.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 0.0 109.788 176.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.89 27.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.577 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.465 HG22 ' CZ ' ' A' ' 10' ' ' ARG . 45.8 pt -140.78 141.71 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.272 -1.134 . . . . 0.0 109.653 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.118 HG23 HG13 ' A' ' 24' ' ' VAL . 2.4 p -117.01 128.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.848 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HD3' ' HD3' ' A' ' 25' ' ' ARG . 78.7 ttt180 -90.82 119.38 30.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.759 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.6 pp -133.31 165.03 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 110.473 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -80.01 169.2 18.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.734 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.2 m -60.04 -39.95 87.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.413 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.1 -46.6 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.927 . . . . 0.0 110.161 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.756 ' CE ' HD13 ' A' ' 44' ' ' ILE . 16.8 tpt -60.06 -42.81 95.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.582 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.427 ' HD2' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -61.75 -39.97 93.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.691 173.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -69.98 -23.41 63.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.443 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 73' ' ' MET . 75.3 m-20 -60.1 -39.99 88.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.033 -1.042 . . . . 0.0 110.641 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.58 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.1 p -98.96 -37.09 9.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.901 -1.124 . . . . 0.0 110.577 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.92 33.18 1.72 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.776 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -109.99 162.79 14.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -1.212 . . . . 0.0 110.401 -177.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.633 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 169.96 8.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.349 -0.844 . . . . 0.0 109.26 177.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.957 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -52.79 144.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.194 177.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.99 0.34 60.15 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.0 m-20 -58.89 -162.83 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.801 -1.411 . . . . 0.0 110.36 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.3 ptpt -135.13 113.64 11.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.477 -0.764 . . . . 0.0 109.77 176.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.999 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -123.74 156.37 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.629 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -102.9 119.79 39.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.813 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.526 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 45.6 t -102.04 119.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.55 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 84.4 mtm-85 -116.76 140.48 49.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.998 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 24.0 tttm -72.34 145.33 47.85 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 110.879 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.555 HG23 HG12 ' A' ' 41' ' ' VAL . 2.2 m -147.4 -167.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.651 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -134.06 168.61 18.5 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 109.653 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.838 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -112.21 159.26 18.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.077 -1.015 . . . . 0.0 111.149 -174.295 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' H ' ' HA ' ' A' ' 162' ' ' VAL . 7.4 pt-20 -150.08 170.54 18.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.3 96.49 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.467 -1.396 . . . . 0.0 110.219 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.928 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.58 147.81 21.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.508 -0.745 . . . . 0.0 110.643 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 169' ' ' LYS . 9.7 ptmt -115.69 -24.9 8.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.805 . . . . 0.0 111.01 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.748 ' HB3' HD23 ' A' ' 156' ' ' LEU . 42.7 tttp -149.99 125.84 10.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.759 -1.213 . . . . 0.0 110.691 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.007 HG23 HG22 ' A' ' 155' ' ' THR . 7.3 p -139.46 146.96 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.176 -0.953 . . . . 0.0 110.293 176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.604 ' C ' HD23 ' A' ' 100' ' ' LEU . 95.4 m -119.56 138.37 53.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.829 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -140.01 174.17 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -143.95 102.38 4.88 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 110.752 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.0 110.048 179.524 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.545 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.7 tp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.235 0.541 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 116' ' ' ILE . 41.3 tt0 -59.93 -42.75 94.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.857 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.67 -37.3 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.872 . . . . 0.0 109.817 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -59.99 -39.36 85.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.833 . . . . 0.0 109.684 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 170' ' ' ILE . 67.3 t -60.03 -47.25 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.58 ' HA ' ' CD2' ' A' ' 124' ' ' LEU . 2.5 mt-30 -60.04 -41.37 92.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -60.11 -41.53 92.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 110.293 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.71 -48.58 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.919 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.3 OUTLIER -96.28 3.69 52.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.005 -1.06 . . . . 0.0 110.905 -172.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.618 ' HA ' HG22 ' A' ' 164' ' ' ILE . 3.4 tt -41.58 165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 110.492 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.95 47.43 0.18 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 111.319 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.7 OUTLIER -133.61 135.06 24.33 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.949 -1.094 . . . . 0.0 111.051 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.844 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 7.4 Cg_endo -54.33 119.76 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.815 1.429 . . . . 0.0 109.498 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.672 ' O ' HG22 ' A' ' 162' ' ' VAL . 93.5 mmm -133.26 141.94 48.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.586 -1.321 . . . . 0.0 110.738 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.773 ' H ' HD13 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.67 145.93 25.42 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.703 0.763 . . . . 0.0 110.752 175.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -53.47 158.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.594 -0.691 . . . . 0.0 111.085 -174.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.6 -6.17 1.84 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.83 -0.544 . . . . 0.0 110.798 177.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.735 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.3 p30 -70.22 169.15 14.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -136.01 138.95 42.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 120.986 -1.071 . . . . 0.0 110.338 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.262 0.553 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -108.6 108.39 19.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.735 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.2 t -79.72 136.22 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.036 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.89 -22.74 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 110.784 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -150.01 151.24 32.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.843 -1.161 . . . . 0.0 110.976 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.007 HG22 HG23 ' A' ' 98' ' ' VAL . 34.5 p -141.66 169.39 17.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 109.389 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.44 -40.27 0.46 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.698 -178.197 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.973 ' CB ' HG11 ' A' ' 162' ' ' VAL . 17.1 Cg_exo -58.99 -164.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.718 1.378 . . . . 0.0 110.425 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.518 ' HB3' HG22 ' A' ' 160' ' ' VAL . 23.6 t -89.98 -171.36 3.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.804 175.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -67.44 -6.09 17.78 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.165 -0.959 . . . . 0.0 110.498 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 158' ' ' SER . 23.8 m -87.59 148.3 43.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.405 -177.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.665 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.23 143.34 7.86 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.267 1.667 . . . . 0.0 110.628 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.973 HG11 ' CB ' ' A' ' 157' ' ' PRO . 9.1 m -130.04 159.37 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.58 122.43 44.96 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.838 -1.163 . . . . 0.0 110.13 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.756 ' CD1' HG21 ' A' ' 168' ' ' THR . 8.0 mm -69.54 158.31 6.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.68 -0.638 . . . . 0.0 110.196 -176.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.64 167.08 26.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.53 -23.09 57.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -1.043 . . . . 0.0 110.248 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.99 -12.07 39.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.152 -0.967 . . . . 0.0 110.087 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 95' ' ' ALA . 5.6 m -57.75 179.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.129 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 168' ' ' THR . 50.0 mtpt -140.54 159.66 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.812 HG23 HD21 ' A' ' 100' ' ' LEU . 4.3 mt -140.02 168.0 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 110.834 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.529 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 13.5 mt-10 -139.17 131.73 28.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.609 -0.682 . . . . 0.0 110.195 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.501 HD13 ' HG ' ' A' ' 100' ' ' LEU . 37.2 mm -119.97 119.94 61.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.87 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.475 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 6.1 ptp180 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.23 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.445 ' O ' HD13 ' A' ' 34' ' ' LEU . 32.2 m120 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.177 0.513 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -152.01 -166.2 13.85 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.017 ' CG2' HD12 ' A' ' 33' ' ' LEU . 37.3 pt -135.75 159.98 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -1.179 . . . . 0.0 109.811 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.7 mt -101.26 118.64 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.409 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.838 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.7 pt? -139.2 -170.78 2.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.7 ptp180 -107.9 135.45 49.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.818 -1.176 . . . . 0.0 110.802 -173.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.02 ' CG2' HD11 ' A' ' 69' ' ' ILE . 14.3 p -62.97 131.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.702 . . . . 0.0 110.774 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -113.91 152.97 30.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.928 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 110.246 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.492 ' NH2' ' CE2' ' A' ' 55' ' ' TYR . 69.4 mtp180 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.242 0.544 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.094 HG13 HG23 ' A' ' 67' ' ' VAL . 97.5 t -120.0 124.28 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.102 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.548 ' O ' HD12 ' A' ' 26' ' ' LEU . 7.2 ptt180 -92.27 120.05 32.45 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.786 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.767 HD13 HG12 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -134.05 164.81 26.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.574 -0.704 . . . . 0.0 109.825 -176.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -93.54 -177.34 4.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.004 -1.06 . . . . 0.0 110.555 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.02 -47.33 86.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.672 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 58.1 m -66.32 -43.74 85.33 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.45 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.114 ' O ' HD22 ' A' ' 33' ' ' LEU . 55.8 p -60.81 -26.89 67.63 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 53.3 ttp180 -88.35 -45.93 9.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.584 -0.697 . . . . 0.0 110.89 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 99.5 mtt180 -76.59 -10.04 59.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 0.0 109.896 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.114 HD22 ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -41.25 -30.03 0.15 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.607 0.718 . . . . 0.0 109.948 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.762 ' H ' HD23 ' A' ' 33' ' ' LEU . 73.8 mt -139.98 -61.18 0.53 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.574 -0.704 . . . . 0.0 110.63 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 16.2 t0 -169.98 -28.73 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.551 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.619 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -23.71 118.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.558 0.694 . . . . 0.0 111.457 -175.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.659 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.4 pt-20 -104.63 177.59 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 38' ' ' ILE . 26.5 mm -58.1 122.59 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.963 -1.086 . . . . 0.0 109.933 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.562 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.51 30.14 60.67 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.451 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 33.8 m-20 -89.28 174.4 7.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.832 -1.393 . . . . 0.0 109.411 170.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.637 HG21 ' N ' ' A' ' 92' ' ' THR . 96.6 t -99.38 124.69 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.238 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.67 HG11 HG23 ' A' ' 54' ' ' VAL . 2.5 m -111.82 140.04 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.27 -0.893 . . . . 0.0 110.489 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' C ' HD12 ' A' ' 44' ' ' ILE . 41.7 tt0 -108.1 143.91 36.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.764 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.905 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.8 mp -119.8 144.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.068 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -151.51 87.69 1.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.833 -1.167 . . . . 0.0 111.604 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.761 ' HB2' HG12 ' A' ' 85' ' ' VAL . 38.5 tttp -98.57 -75.95 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 110.287 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.51 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -91.78 -33.81 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.481 -0.762 . . . . 0.0 109.62 177.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 91.6 mtt180 -143.93 -172.31 3.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.686 ' C ' HD21 ' A' ' 130' ' ' LEU . 14.2 mptt -87.95 132.19 34.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.679 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.554 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -133.95 158.78 42.62 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.293 0.568 . . . . 0.0 110.226 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.12 161.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 110.174 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.575 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -176.92 179.39 47.89 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.82 -178.78 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.248 -1.148 . . . . 0.0 109.981 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.67 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -110.47 135.3 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 110.373 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -128.02 167.67 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.285 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 35.2 ptt180 -89.32 124.9 34.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.078 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.8 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -61.84 131.54 50.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.946 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.644 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 11.5 mtt180 -59.51 -42.09 90.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 C-N-CA 119.101 -1.039 . . . . 0.0 109.367 175.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.644 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 29.3 Cg_endo -94.33 99.83 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.886 1.467 . . . . 0.0 108.998 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 12.0 pt-20 -72.77 32.61 0.07 Allowed 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.392 -0.817 . . . . 0.0 110.859 -175.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.6 m-20 -148.58 -26.66 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 0.0 110.701 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 66' ' ' ILE . 52.9 mt-10 -86.26 -28.48 23.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 109.109 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.8 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 43.5 m-80 -81.12 42.22 0.64 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.361 0.6 . . . . 0.0 110.375 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HD3' ' OD2' ' A' ' 27' ' ' ASP . 37.2 mmtt -96.76 6.32 48.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.287 177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.4 29.55 0.05 OUTLIER Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 9' ' ' LEU . 45.7 pt -140.78 145.12 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.224 -1.162 . . . . 0.0 109.525 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.094 HG23 HG13 ' A' ' 24' ' ' VAL . 2.6 p -123.17 130.0 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.827 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.539 ' CD ' ' HD3' ' A' ' 25' ' ' ARG . 71.3 ttt180 -91.6 114.62 27.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 110.131 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.02 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.6 pt -130.16 159.98 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.679 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -81.09 169.57 17.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 110.227 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -57.86 -22.55 48.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.07 -48.84 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.905 ' HE1' HD13 ' A' ' 44' ' ' ILE . 97.0 mmm -60.03 -43.91 94.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.953 . . . . 0.0 109.6 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -59.98 -40.49 89.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.25 -0.906 . . . . 0.0 110.04 174.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -69.49 -35.87 75.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.532 ' HB3' HG22 ' A' ' 50' ' ' THR . 20.6 m120 -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.269 -0.894 . . . . 0.0 110.372 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.6 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.7 p -98.36 -35.79 10.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 110.607 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.51 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 109.92 28.05 4.34 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.603 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -100.39 177.63 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.242 . . . . 0.0 111.016 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.903 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -122.81 172.24 8.6 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -0.853 . . . . 0.0 109.196 175.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.928 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -62.19 142.23 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.717 -1.239 . . . . 0.0 110.561 179.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.566 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 74.55 -0.61 55.15 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 173.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -59.65 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.097 -1.237 . . . . 0.0 110.33 175.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 19.1 pttp -133.2 116.33 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.575 -0.703 . . . . 0.0 109.904 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -122.12 160.12 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 110.023 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 40.1 tttt -107.4 120.66 42.77 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.523 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 72.3 t -103.96 122.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 0.0 109.998 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.507 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 96.1 mtt180 -110.0 148.03 32.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.629 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.619 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 2.4 tmtt? -93.86 136.01 34.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.056 -1.027 . . . . 0.0 110.53 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.1 m -149.81 -170.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.927 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 52.7 mtt180 -132.85 164.41 26.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 110.41 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.637 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.45 159.39 17.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 111.224 -176.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.653 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.8 pt-20 -150.42 169.99 20.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 94' ' ' ILE . 48.5 mm -89.17 101.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.827 -1.17 . . . . 0.0 110.264 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.918 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.38 135.46 53.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.266 -0.896 . . . . 0.0 110.184 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.552 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 7.1 ptpp? -97.24 -29.75 13.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -0.973 . . . . 0.0 111.112 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.682 ' HB3' HD23 ' A' ' 156' ' ' LEU . 47.3 tttm -151.27 126.66 10.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 110.789 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.037 HG23 HG22 ' A' ' 155' ' ' THR . 9.2 p -136.53 145.98 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.122 . . . . 0.0 110.881 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -119.74 139.45 52.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.051 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.746 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.55 166.09 23.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.505 -177.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.51 89.65 11.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.33 -0.857 . . . . 0.0 110.466 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.0 Cg_exo . . . . . 0 C--N 1.305 -1.718 0 O-C-N 123.997 1.525 . . . . 0.0 110.434 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.2 tp . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.12 0.486 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.557 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -67.31 -39.98 85.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.905 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.04 -31.46 69.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.05 -41.69 92.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 110.076 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.759 HG12 ' CD1' ' A' ' 170' ' ' ILE . 55.0 t -60.08 -45.92 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.57 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.2 mt-30 -60.0 -42.74 94.93 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 110.273 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.13 -47.94 83.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.481 -0.762 . . . . 0.0 110.151 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.17 75.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.532 -0.73 . . . . 0.0 110.318 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.524 HD12 ' CG1' ' A' ' 120' ' ' VAL . 51.5 mt -93.76 -5.72 47.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.416 -176.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.846 HD11 ' HG2' ' A' ' 166' ' ' GLU . 2.5 tt -45.91 167.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.926 -1.109 . . . . 0.0 110.207 -172.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 164' ' ' ILE . 32.0 ptt180 33.82 48.24 0.21 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.672 -0.642 . . . . 0.0 111.768 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 9.3 mmt85 -136.57 148.98 65.93 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 120.533 -1.355 . . . . 0.0 111.83 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.838 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -66.19 130.6 24.52 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.24 1.652 . . . . 0.0 109.653 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.522 ' SD ' HG13 ' A' ' 164' ' ' ILE . 39.9 mtp -130.58 150.06 51.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.44 -1.412 . . . . 0.0 111.207 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.686 HD21 ' C ' ' A' ' 49' ' ' LYS . 16.5 tp -144.44 107.93 4.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.663 -0.648 . . . . 0.0 109.637 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.2 pm0 -44.71 142.9 1.55 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.359 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.571 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 80.39 -0.85 1.96 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.125 0.488 . . . . 0.0 110.259 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.603 ' OD2' HG21 ' A' ' 152' ' ' VAL . 4.2 p-10 -70.0 179.4 2.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 109.85 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.525 ' OD1' ' HD2' ' A' ' 151' ' ' LYS . 13.4 m-80 -150.17 136.1 18.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.632 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.008 -1.057 . . . . 0.0 110.303 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 30.0 m-85 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.337 0.589 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.525 ' HD2' ' OD1' ' A' ' 134' ' ' ASN . 19.3 tptp -112.31 103.63 11.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.873 . . . . 0.0 109.75 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.603 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.1 t -77.44 140.01 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.14 -25.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 111.372 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 45.0 tptt -140.24 129.93 24.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.587 -1.321 . . . . 0.0 110.885 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.037 HG22 HG23 ' A' ' 98' ' ' VAL . 59.7 p -129.99 166.31 20.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.389 -0.82 . . . . 0.0 109.164 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -89.05 -35.47 0.42 Allowed Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.084 -1.01 . . . . 0.0 110.98 -176.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 1.048 ' CG ' HG11 ' A' ' 162' ' ' VAL . 31.6 Cg_exo -53.1 -179.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.4 1.211 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.709 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -84.83 49.76 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.516 -179.238 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.6 mmtm 59.99 20.03 9.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.731 ' O ' HG13 ' A' ' 162' ' ' VAL . 11.5 m -109.41 159.74 30.3 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.411 -0.806 . . . . 0.0 110.326 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.555 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.1 Cg_endo -53.87 123.29 13.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.198 1.631 . . . . 0.0 110.2 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 1.048 HG11 ' CG ' ' A' ' 157' ' ' PRO . 5.0 m -129.78 158.46 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.879 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -103.2 128.1 50.29 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.009 177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.945 HD12 HG21 ' A' ' 168' ' ' THR . 10.7 mm -70.26 154.22 8.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.636 -0.665 . . . . 0.0 110.036 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.07 170.98 24.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.846 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.88 -21.27 28.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -1.088 . . . . 0.0 110.074 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.45 -21.42 21.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 109.791 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.945 HG21 HD12 ' A' ' 164' ' ' ILE . 69.3 m -54.85 138.83 41.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.012 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.1 mttt -93.08 149.52 21.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.133 -0.979 . . . . 0.0 109.59 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.759 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.1 mt -130.0 160.52 40.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.935 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.496 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 30.8 mt-10 -135.19 136.12 41.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.637 -0.665 . . . . 0.0 110.173 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.59 HD11 HG21 ' A' ' 120' ' ' VAL . 40.6 mm -119.98 122.27 68.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.67 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.613 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 6.4 ptp180 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 110.148 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.486 0.66 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -150.72 -155.24 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.965 ' CG2' HD12 ' A' ' 33' ' ' LEU . 12.2 pt -131.08 159.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.13 . . . . 0.0 109.193 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.614 ' C ' HD23 ' A' ' 9' ' ' LEU . 92.2 mt -100.64 122.5 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.011 -1.055 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.857 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -139.62 -175.81 4.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.596 177.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 33.5 ptt180 -110.68 139.72 45.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.869 -1.145 . . . . 0.0 110.964 -175.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.972 HG23 HD11 ' A' ' 69' ' ' ILE . 14.6 p -61.82 130.05 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.661 -0.649 . . . . 0.0 110.755 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.648 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -107.84 151.62 25.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 110.423 177.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.569 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.145 0.498 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.074 HG13 HG23 ' A' ' 67' ' ' VAL . 78.7 t -119.46 118.46 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 3.2 ptt180 -88.6 117.36 27.5 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.431 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.2 pt? -136.63 169.09 18.28 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.672 -0.642 . . . . 0.0 109.353 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 7.6 p-10 -97.12 -171.96 2.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.806 -1.184 . . . . 0.0 111.17 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -59.8 -49.22 78.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.49 -0.757 . . . . 0.0 109.476 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.8 t -62.03 -47.39 84.97 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.409 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.115 ' O ' HD22 ' A' ' 33' ' ' LEU . 25.1 t -57.59 -29.64 64.64 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.173 -0.955 . . . . 0.0 109.545 178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 60.0 ttp85 -85.89 -45.47 11.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -80.09 -4.85 54.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.008 -1.058 . . . . 0.0 110.111 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.115 HD22 ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -47.49 -27.92 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.788 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 33' ' ' LEU . 71.6 mt -139.9 -60.04 0.54 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.659 -0.65 . . . . 0.0 110.377 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' C ' ' A' ' 36' ' ' ALA . 44.1 t0 -170.75 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.905 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB2' ' HD3' ' A' ' 89' ' ' LYS . . . -19.94 124.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.563 0.697 . . . . 0.0 111.824 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.3 pt-20 -116.88 -179.76 3.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 29.7 mm -59.99 130.1 23.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.777 -1.202 . . . . 0.0 109.689 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.518 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.75 19.13 73.92 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.942 173.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.544 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 85.1 m-20 -90.24 171.9 9.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.595 -1.532 . . . . 0.0 109.779 172.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.696 HG21 ' N ' ' A' ' 92' ' ' THR . 61.1 t -98.91 138.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 0.0 110.522 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.618 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.9 m -126.46 139.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -107.41 145.3 33.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.595 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.805 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.6 mp -120.02 148.29 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 110.446 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 40.9 tt0 -151.45 94.17 1.98 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.977 . . . . 0.0 110.779 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.992 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.8 tmtm? -98.84 -66.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.703 173.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.574 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -106.72 -32.78 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.481 175.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 74.6 mtt85 -136.87 -172.64 3.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.674 ' HB3' HD21 ' A' ' 130' ' ' LEU . 36.7 mttt -88.83 139.28 30.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.984 -1.073 . . . . 0.0 111.05 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.579 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.69 160.18 39.94 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.299 0.571 . . . . 0.0 110.221 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.676 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.13 161.22 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.269 -0.894 . . . . 0.0 109.977 178.018 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.62 -179.78 47.93 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 51.9 ttp180 -121.69 169.37 10.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -1.028 . . . . 0.0 110.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -91.48 138.86 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 111.014 -172.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -128.55 162.66 26.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.502 -0.749 . . . . 0.0 109.887 174.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -89.01 123.63 33.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.891 . . . . 0.0 110.128 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.809 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.19 139.13 58.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.603 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -59.99 -48.91 93.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.15 174.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.4 Cg_endo -91.67 99.1 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.866 1.456 . . . . 0.0 108.993 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -73.91 36.34 0.09 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.585 -0.697 . . . . 0.0 111.126 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -145.39 -36.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.073 -1.017 . . . . 0.0 111.165 -178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.8 pt-20 -85.87 -24.43 26.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.905 -1.122 . . . . 0.0 110.172 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.809 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 31.6 m120 -82.3 37.82 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 110.695 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 49.1 pttt -98.49 18.17 17.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 109.641 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.79 20.85 0.03 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.522 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -141.61 157.01 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -1.068 . . . . 0.0 109.191 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.074 HG23 HG13 ' A' ' 24' ' ' VAL . 4.6 p -135.57 131.11 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.863 -1.148 . . . . 0.0 109.86 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.648 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 34.6 ttm180 -96.99 118.16 32.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.974 -1.079 . . . . 0.0 110.24 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.972 HD11 HG23 ' A' ' 11' ' ' VAL . 3.7 pt -131.69 172.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.639 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -78.61 170.08 17.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.371 -0.831 . . . . 0.0 109.978 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.2 p -65.34 -27.56 68.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 110.01 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.44 -46.12 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.805 ' HE1' HD13 ' A' ' 44' ' ' ILE . 12.7 tpt -60.33 -44.69 95.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.457 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 43.6 ttp180 -60.17 -40.03 88.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 0.0 109.721 174.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -71.48 -22.99 61.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.578 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 73' ' ' MET . 59.3 m-20 -60.01 -36.88 78.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 0.0 110.272 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.544 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.2 p -98.4 -38.82 9.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 0.0 110.319 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.574 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 117.21 36.36 1.03 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 177.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.82 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -110.45 167.93 9.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -1.204 . . . . 0.0 110.475 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.663 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.72 169.77 8.74 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.241 -0.912 . . . . 0.0 109.226 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -54.58 139.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.924 -1.11 . . . . 0.0 110.767 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.55 2.2 79.45 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 172.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -58.8 -162.88 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.023 -1.281 . . . . 0.0 110.445 175.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 21.9 pttm -133.61 113.48 12.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 109.981 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.992 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -125.09 160.12 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.389 -0.82 . . . . 0.0 109.586 178.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.5 tttt -110.24 125.4 53.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 110.048 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.584 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 66.1 t -99.25 119.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 110.009 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.479 ' NH2' ' HD3' ' A' ' 86' ' ' LYS . 84.4 mtt85 -103.19 145.2 30.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.832 . . . . 0.0 109.234 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 36' ' ' ALA . 29.8 tptt -99.74 135.42 41.19 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.94 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.488 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 3.1 m -150.08 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.575 0.702 . . . . 0.0 110.132 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.457 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 33.1 mtp85 -127.87 172.41 10.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.598 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.696 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.46 163.42 12.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 111.172 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.61 ' HG2' HG12 ' A' ' 162' ' ' VAL . 14.9 pt-20 -150.22 169.94 20.14 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.3 mm -89.01 100.62 10.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.909 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -53.89 139.94 32.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.315 -0.866 . . . . 0.0 110.173 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.549 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 17.8 ptpt -95.56 -28.75 14.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.203 -0.936 . . . . 0.0 110.999 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 21.6 ttpt -150.6 120.0 6.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.707 -1.246 . . . . 0.0 110.616 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.927 HG23 HG22 ' A' ' 155' ' ' THR . 8.2 p -130.03 140.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.01 . . . . 0.0 111.022 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.742 HG23 ' HB3' ' A' ' 171' ' ' GLU . 38.2 m -116.68 148.75 40.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.07 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.886 ' N ' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -150.7 179.94 7.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 0.0 110.678 178.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB2' ' HD2' ' A' ' 173' ' ' ARG . . . -144.45 101.14 4.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 111.117 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.483 ' HG3' ' CE2' ' A' ' 150' ' ' PHE . 13.0 Cg_exo . . . . . 0 C--N 1.306 -1.696 0 O-C-N 124.038 1.547 . . . . 0.0 110.035 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.496 HG23 ' N ' ' A' ' 117' ' ' GLU . 20.8 tt . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.186 0.517 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.0 mt-10 -60.22 -41.9 94.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.117 -0.99 . . . . 0.0 109.763 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -68.91 -36.05 77.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.16 -41.15 92.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.401 -0.812 . . . . 0.0 109.714 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 170' ' ' ILE . 58.5 t -60.27 -45.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.275 174.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.1 mt-30 -59.85 -41.8 92.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.576 -0.703 . . . . 0.0 110.319 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -60.18 -49.83 76.08 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.342 -0.849 . . . . 0.0 109.835 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.29 -40.29 70.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -0.753 . . . . 0.0 110.722 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.489 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.4 mm? -93.36 -0.87 56.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.956 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.2 tt -47.96 165.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.97 -1.081 . . . . 0.0 110.075 -177.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ILE . 9.7 ptm180 32.23 46.28 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.537 -0.727 . . . . 0.0 111.37 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.483 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -128.07 133.6 25.31 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.997 -1.064 . . . . 0.0 110.667 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.6 Cg_exo -58.49 139.35 90.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.995 1.524 . . . . 0.0 109.756 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.532 ' HG3' HG12 ' A' ' 164' ' ' ILE . 92.2 mmm -133.66 146.92 51.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.373 -1.455 . . . . 0.0 110.891 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 49' ' ' LYS . 14.5 tp -147.8 112.12 5.24 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.3 pm0 -46.69 139.51 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.625 -1.297 . . . . 0.0 110.108 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.575 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 79.71 -3.14 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.254 0.549 . . . . 0.0 110.468 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.3 p30 -68.47 -169.96 0.18 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 175.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.408 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 23.5 m-80 -147.01 155.52 42.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.704 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.074 -1.016 . . . . 0.0 109.937 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.483 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 37.4 m-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.311 0.576 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 133' ' ' ASP . 18.6 tptm -115.13 108.79 17.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.666 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 132' ' ' GLN . 10.6 t -75.23 131.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.104 -0.998 . . . . 0.0 110.091 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.2 t -113.0 -25.44 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.216 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.31 151.16 34.9 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.707 -1.246 . . . . 0.0 111.12 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.927 HG22 HG23 ' A' ' 98' ' ' VAL . 82.4 p -142.54 162.27 35.92 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.673 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.9 -34.19 0.41 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.283 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.969 ' CG ' HG11 ' A' ' 162' ' ' VAL . 35.4 Cg_exo -54.39 -171.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.285 1.15 . . . . 0.0 110.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.562 ' O ' HG13 ' A' ' 160' ' ' VAL . 15.7 t -88.19 43.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 0.0 110.35 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 158' ' ' SER . 33.1 mmtp 61.27 20.0 10.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.856 ' O ' HG13 ' A' ' 162' ' ' VAL . 18.2 m -105.58 154.75 38.95 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.676 ' HB3' HG12 ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.61 119.89 4.67 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.08 1.568 . . . . 0.0 110.131 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.969 HG11 ' CG ' ' A' ' 157' ' ' PRO . 6.3 m -129.54 159.97 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.138 175.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -110.01 136.72 48.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.104 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.78 ' CD1' HG21 ' A' ' 168' ' ' THR . 14.7 mm -71.11 154.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.692 -0.63 . . . . 0.0 110.225 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.63 170.02 24.37 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 175.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -58.05 -23.11 53.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -1.119 . . . . 0.0 110.264 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -94.04 -15.61 24.63 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.135 -0.978 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.78 HG21 ' CD1' ' A' ' 164' ' ' ILE . 91.9 m -58.43 144.02 43.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 23.0 mttp -97.51 154.32 17.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.889 -1.132 . . . . 0.0 109.763 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.672 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.7 mt -130.09 164.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 0.0 111.04 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.742 ' HB3' HG23 ' A' ' 99' ' ' THR . 16.7 mt-10 -138.16 137.47 37.68 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.34 0.59 . . . . 0.0 110.147 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.641 HD13 HD21 ' A' ' 100' ' ' LEU . 31.8 mm -122.16 129.29 75.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.443 -0.785 . . . . 0.0 109.797 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.439 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 6.8 ptm180 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.081 -1.012 . . . . 0.0 110.275 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.255 0.55 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.89 -168.22 16.57 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.838 ' CG2' HD12 ' A' ' 33' ' ' LEU . 26.6 pt -134.16 166.77 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.386 -1.067 . . . . 0.0 109.861 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.492 HD11 ' HD3' ' A' ' 86' ' ' LYS . 35.2 mm -103.22 115.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 110.341 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 9' ' ' LEU . 1.7 pt? -138.19 -172.75 3.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.088 -1.008 . . . . 0.0 109.7 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.6 ptt180 -112.19 138.0 49.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.838 -1.164 . . . . 0.0 110.765 -174.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.087 ' CG2' HD11 ' A' ' 69' ' ' ILE . 8.4 p -62.03 134.61 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.531 -0.73 . . . . 0.0 110.54 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -111.6 166.64 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 0.0 110.89 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.774 ' CB ' HD11 ' A' ' 81' ' ' ILE . 51.5 tp10 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.19 0.519 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 53.0 t -110.13 119.89 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HD3' ' HD3' ' A' ' 68' ' ' ARG . 4.6 ptt180 -89.27 121.67 31.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.787 -1.196 . . . . 0.0 109.524 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.928 HD21 HG22 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -137.32 166.81 22.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.761 -174.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.487 ' N ' ' HB3' ' A' ' 63' ' ' ASN . 6.4 p-10 -101.49 -170.39 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.906 -1.121 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.1 -44.41 94.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.539 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 44.9 t -65.98 -49.9 66.2 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.346 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.068 ' O ' HD22 ' A' ' 33' ' ' LEU . 58.1 m -56.38 -27.33 55.87 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 49.2 ttp180 -85.58 -48.29 9.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.87 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -83.08 -6.06 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.038 . . . . 0.0 110.011 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.068 HD22 ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -44.12 -28.16 0.47 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.621 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.837 ' H ' HD23 ' A' ' 33' ' ' LEU . 82.9 mt -143.8 -59.98 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.517 -0.74 . . . . 0.0 110.617 176.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.3 t0 -170.88 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.302 -0.873 . . . . 0.0 110.852 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -30.77 127.56 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 110.915 -175.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.66 ' O ' HG11 ' A' ' 54' ' ' VAL . 2.3 pt-20 -112.51 -178.08 3.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 38' ' ' ILE . 34.7 mm -59.98 120.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.945 -1.097 . . . . 0.0 109.976 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.597 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 72.8 33.55 60.13 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 174.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 2.2 m-20 -89.52 178.86 6.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.806 -1.408 . . . . 0.0 109.556 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 92' ' ' THR . 79.5 t -99.26 129.58 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.203 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 52' ' ' GLY . 7.5 m -123.57 147.2 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -0.792 . . . . 0.0 110.625 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 88' ' ' ARG . 86.0 tt0 -115.62 139.95 49.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.928 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -122.78 147.61 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 0.0 110.566 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.4 tt0 -150.08 97.61 2.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 110.633 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.024 ' CG ' HG12 ' A' ' 85' ' ' VAL . 14.3 tmtt? -98.62 -67.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.566 HG22 ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -102.32 -35.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.162 173.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 92.9 mtt-85 -127.63 -168.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.31 0.576 . . . . 0.0 109.736 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.975 ' HG2' HD21 ' A' ' 130' ' ' LEU . 1.3 ttpm? -103.73 137.2 42.1 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.36 -0.838 . . . . 0.0 110.212 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.763 ' HA ' HD23 ' A' ' 130' ' ' LEU . 8.7 p -142.8 170.53 15.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 110.254 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -122.84 167.76 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.521 -0.737 . . . . 0.0 109.902 177.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.818 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -177.7 179.05 48.42 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -117.0 163.97 15.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.505 -0.997 . . . . 0.0 110.139 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.928 HG22 HD21 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -97.35 137.5 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.07 -1.018 . . . . 0.0 110.45 -172.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -122.12 166.48 14.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 110.116 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -89.65 124.44 34.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 110.328 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.709 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.33 132.58 50.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.097 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.74 -46.04 99.59 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.984 -1.072 . . . . 0.0 109.296 173.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 14.7 Cg_endo -89.89 99.18 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.022 1.538 . . . . 0.0 109.055 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.11 33.62 0.07 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.557 -0.715 . . . . 0.0 110.866 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 59' ' ' PRO . 52.8 t0 -148.78 -29.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 110.703 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.69 -29.22 22.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.438 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.709 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 4.7 m120 -80.94 39.35 0.49 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.699 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 11.3 ptpt -98.54 10.71 40.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.606 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.442 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.4 pt -141.05 142.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.304 -1.115 . . . . 0.0 109.436 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 1.8 p -119.47 125.89 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.117 -0.99 . . . . 0.0 109.995 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.509 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 70.4 ttt180 -90.05 113.04 24.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.087 HD11 ' CG2' ' A' ' 11' ' ' VAL . 3.0 pt -126.17 163.04 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.793 . . . . 0.0 110.77 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.92 158.67 35.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.81 . . . . 0.0 109.932 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.592 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 79.9 p -61.7 -24.64 66.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.59 -42.88 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 110.323 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.928 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -59.92 -49.98 75.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 109.929 178.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -63.87 -33.44 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.682 176.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.501 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 60.4 t-20 -68.08 -32.57 72.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.962 . . . . 0.0 109.933 175.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.439 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 98.5 m-20 -60.03 -40.01 87.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.877 . . . . 0.0 110.535 -178.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.458 ' HB2' ' H ' ' A' ' 48' ' ' ARG . 27.6 p -98.34 -38.52 9.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.602 -176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.564 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 120.16 40.63 0.58 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.765 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -116.03 158.44 23.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.944 -1.327 . . . . 0.0 110.726 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.613 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -112.44 166.84 10.94 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 175.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.774 HD11 ' CB ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -51.33 139.96 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.989 -1.069 . . . . 0.0 110.505 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.28 0.61 72.05 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 171.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.18 -160.12 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.876 -1.367 . . . . 0.0 110.225 174.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 40.1 pttt -132.62 113.32 12.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.549 -0.719 . . . . 0.0 109.813 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.024 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -124.35 159.67 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.201 -0.937 . . . . 0.0 109.898 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.6 ttpt -105.21 127.96 53.18 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.218 -0.927 . . . . 0.0 109.868 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.502 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 63.3 t -109.84 121.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 109.714 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' NH2' ' OE2' ' A' ' 43' ' ' GLU . 84.4 mtm180 -110.23 140.03 44.78 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.456 -0.777 . . . . 0.0 109.552 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.59 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.22 136.69 32.92 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.069 -1.02 . . . . 0.0 110.001 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 41' ' ' VAL . 2.7 m -150.01 -171.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.539 -0.725 . . . . 0.0 110.212 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.515 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . 1.6 ptm85 -126.8 170.07 12.57 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.643 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.47 165.34 11.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.054 -1.029 . . . . 0.0 111.078 -175.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.566 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.4 pt-20 -149.96 167.72 25.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm -89.57 97.78 7.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.542 -1.349 . . . . 0.0 110.336 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.88 161.8 1.47 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 110.663 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.907 ' HE3' HD22 ' A' ' 156' ' ' LEU . 25.0 pttt -125.44 -24.71 3.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 110.493 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.959 ' CB ' HD12 ' A' ' 156' ' ' LEU . 15.7 tttp -150.92 127.81 11.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.843 -1.16 . . . . 0.0 110.394 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.993 HG23 HG22 ' A' ' 155' ' ' THR . 7.4 p -139.94 144.65 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.351 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.458 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.2 m -118.52 132.27 56.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 110.253 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.763 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.09 160.02 33.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.375 -178.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HB2' ' HG2' ' A' ' 173' ' ' ARG . . . -138.83 93.69 10.55 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 34.7 Cg_exo . . . . . 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.264 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.5 tp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.178 0.513 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.461 ' N ' HG23 ' A' ' 116' ' ' ILE . 96.7 mt-10 -59.92 -42.79 94.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.112 -0.992 . . . . 0.0 109.997 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.84 -37.49 76.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -59.96 -39.23 84.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.559 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.79 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.5 t -60.07 -47.8 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.674 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.74 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -61.39 -40.03 92.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 177.481 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.05 -46.43 89.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.61 -41.29 65.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.547 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.6 mm? -94.31 -4.3 48.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.168 -0.957 . . . . 0.0 111.227 -174.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.758 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.5 tt -44.49 167.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.774 -1.203 . . . . 0.0 110.267 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 164' ' ' ILE . 52.9 ptt85 33.3 51.21 0.3 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.666 -0.646 . . . . 0.0 111.788 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -137.79 150.22 67.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.833 -1.167 . . . . 0.0 111.074 175.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.841 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 18.2 Cg_endo -65.56 130.35 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.042 1.549 . . . . 0.0 110.026 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.577 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 88.1 mmm -125.0 139.17 54.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.515 -1.366 . . . . 0.0 111.052 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.975 HD21 ' HG2' ' A' ' 49' ' ' LYS . 11.6 tp -144.15 113.59 7.02 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.636 -0.665 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 7.3 pm0 -47.47 143.87 3.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.116 . . . . 0.0 110.359 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 88.4 mm-40 81.33 -6.09 1.57 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.111 0.482 . . . . 0.0 110.334 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.618 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.1 p30 -69.88 173.78 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.149 -0.969 . . . . 0.0 109.903 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -137.72 146.9 44.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.802 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.085 -1.009 . . . . 0.0 110.144 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 29.4 m-85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.242 0.544 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -104.87 110.63 23.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.072 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.618 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.5 t -76.37 138.86 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 t -117.38 -28.39 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.194 -0.941 . . . . 0.0 111.047 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -148.59 151.51 35.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.767 -1.208 . . . . 0.0 111.173 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.993 HG22 HG23 ' A' ' 98' ' ' VAL . 63.8 p -139.75 158.29 44.34 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.959 HD12 ' CB ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -89.1 -34.01 0.4 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.867 -176.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.988 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.5 Cg_exo -56.99 -161.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.269 1.141 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.432 ' HB3' HG22 ' A' ' 160' ' ' VAL . 13.3 t -90.13 179.09 6.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 109.869 176.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.418 ' HE2' ' NZ ' ' A' ' 49' ' ' LYS . 13.9 tttt -61.31 -10.12 6.47 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.863 . . . . 0.0 110.425 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 158' ' ' SER . 13.6 m -84.66 153.13 61.04 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.467 -0.77 . . . . 0.0 110.159 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.529 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -48.87 142.76 18.68 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.248 1.657 . . . . 0.0 110.613 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.988 HG11 ' CB ' ' A' ' 157' ' ' PRO . 13.7 m -130.02 160.0 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.1 tt0 -108.71 127.51 54.05 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.022 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.836 HD12 HG21 ' A' ' 168' ' ' THR . 12.9 mm -71.08 153.05 8.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 121.434 0.635 . . . . 0.0 110.334 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.546 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.94 166.91 26.15 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 125' ' ' ILE . 13.6 pt-20 -56.95 -19.81 20.12 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.369 -1.077 . . . . 0.0 110.197 -177.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.16 -14.03 39.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.872 . . . . 0.0 110.326 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.836 HG21 HD12 ' A' ' 164' ' ' ILE . 21.0 m -62.04 147.8 46.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 109.856 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mttm -94.46 157.5 15.98 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.929 -1.107 . . . . 0.0 110.256 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.79 HD12 ' CG1' ' A' ' 120' ' ' VAL . 3.4 mm -118.93 129.91 74.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.363 -0.835 . . . . 0.0 110.691 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.58 ' O ' HD13 ' A' ' 172' ' ' ILE . 20.1 mt-10 -110.96 130.08 55.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 110.225 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.58 HD13 ' O ' ' A' ' 171' ' ' GLU . 33.5 mm -125.8 125.74 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.884 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.581 ' NE ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 0.0 110.713 -177.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.303 0.573 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -148.33 -161.04 9.35 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.969 HG21 HD22 ' A' ' 33' ' ' LEU . 47.6 pt -131.01 160.01 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.936 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.1 mt -99.55 114.46 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 110.239 -178.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.2 pt? -137.86 -172.39 3.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 109.96 178.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.8 ptp180 -115.55 139.05 50.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.785 -1.197 . . . . 0.0 110.714 -172.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.95 HG23 HD11 ' A' ' 69' ' ' ILE . 4.6 p -61.17 137.91 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.505 -0.747 . . . . 0.0 110.115 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -120.97 155.6 33.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 110.478 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.541 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 175.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 95.6 mtt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.083 0.468 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 92.8 t -116.6 120.03 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 110.237 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.649 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -92.41 119.97 32.46 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.757 -1.177 . . . . 0.0 109.945 177.814 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.927 HD23 HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -134.41 173.32 11.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.675 -177.06 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.482 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 17.5 p-10 -93.2 179.76 5.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.83 -1.169 . . . . 0.0 110.481 -178.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -59.97 -43.19 95.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.378 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.492 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 63.3 m -65.08 -44.56 88.52 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.545 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.711 ' CB ' HD12 ' A' ' 26' ' ' LEU . 59.4 m -60.0 -40.06 87.93 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.951 -1.093 . . . . 0.0 109.193 176.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 59.3 ttt180 -71.37 -44.4 65.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.876 -0.515 . . . . 0.0 111.734 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -93.34 -6.18 47.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.755 -1.216 . . . . 0.0 111.199 -169.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.032 HD12 ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -59.2 -31.37 68.96 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.584 -178.527 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.032 ' N ' HD12 ' A' ' 33' ' ' LEU . 31.6 mt -116.57 -66.4 1.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.111 -0.993 . . . . 0.0 110.674 175.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 36' ' ' ALA . 17.1 t0 -171.84 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.191 -0.943 . . . . 0.0 110.244 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.72 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -23.92 120.14 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.579 0.704 . . . . 0.0 111.408 -176.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.649 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -105.24 175.25 5.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.938 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.407 HG12 ' NH2' ' A' ' 31' ' ' ARG . 45.5 mm -56.69 127.15 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 120.966 -1.084 . . . . 0.0 109.663 178.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.06 24.49 68.9 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.39 174.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.81 174.0 8.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.724 -1.456 . . . . 0.0 109.247 171.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 92.6 t -102.59 130.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.995 -1.066 . . . . 0.0 110.432 -174.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.593 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -115.02 137.31 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.34 141.67 38.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.435 -0.79 . . . . 0.0 109.847 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -120.99 148.2 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.024 -1.047 . . . . 0.0 110.182 -176.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 39.3 tt0 -152.37 92.32 1.68 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 111.288 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.726 ' HD2' HG12 ' A' ' 85' ' ' VAL . 59.6 tttp -97.83 -77.05 0.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 0.0 110.123 172.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.609 HG21 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.0 -29.97 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.638 0.732 . . . . 0.0 109.688 176.76 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.447 ' H ' ' HB2' ' A' ' 77' ' ' CYS . 71.6 mtt85 -141.34 -172.7 3.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.463 176.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.712 ' C ' HD21 ' A' ' 130' ' ' LEU . 18.3 mttt -88.78 141.06 28.82 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.813 -177.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.568 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -140.37 156.47 46.4 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.388 0.614 . . . . 0.0 110.111 -179.103 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.596 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -126.07 160.15 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.142 -179.657 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.451 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -176.88 -177.45 45.84 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.413 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 96.0 mtt-85 -117.05 -179.01 3.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -1.071 . . . . 0.0 109.761 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.649 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -109.31 135.9 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.023 . . . . 0.0 110.681 -175.003 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.543 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -127.16 168.98 13.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.569 -0.707 . . . . 0.0 110.057 176.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -93.59 124.15 37.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 110.152 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.746 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.4 139.37 58.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.884 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.673 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.8 mtt-85 -57.31 -49.63 92.79 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.953 -1.092 . . . . 0.0 108.993 174.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.673 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 57.4 Cg_endo -93.08 98.51 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 109.034 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.54 37.07 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 121.593 -0.692 . . . . 0.0 110.482 -177.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 59' ' ' PRO . 68.3 m-20 -144.16 -33.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 110.461 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 66' ' ' ILE . 48.7 mt-10 -85.62 -28.92 24.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.746 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 14.7 m120 -81.31 38.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.649 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 31.9 pttt -98.9 12.64 35.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.059 -1.026 . . . . 0.0 109.759 176.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.76 24.88 0.04 OUTLIER Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.478 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.07 142.87 29.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.336 -1.097 . . . . 0.0 109.28 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 2.9 p -119.97 126.05 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.024 -1.048 . . . . 0.0 109.894 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 31.9 mmt180 -89.95 102.33 15.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.009 . . . . 0.0 110.153 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.95 HD11 HG23 ' A' ' 11' ' ' VAL . 3.3 pt -125.26 169.93 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.408 -0.808 . . . . 0.0 110.68 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.09 161.68 26.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.41 -0.806 . . . . 0.0 109.992 177.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.629 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 43.8 m -63.16 -16.8 61.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -0.907 . . . . 0.0 110.324 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 63.8 t -71.16 -49.16 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.322 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.721 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -59.97 -49.5 77.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.907 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.629 ' HG2' ' HA ' ' A' ' 71' ' ' SER . 3.7 ppt_? -64.08 -28.73 69.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.085 -1.009 . . . . 0.0 109.653 175.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.472 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 19.6 t-20 -73.08 -30.28 63.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.959 -1.088 . . . . 0.0 110.388 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 73' ' ' MET . 13.9 m120 -60.04 -40.02 87.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 110.87 -173.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.447 ' HB2' ' H ' ' A' ' 48' ' ' ARG . 25.9 p -99.3 -37.23 9.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 0.0 110.605 -177.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.609 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 126.87 33.53 0.64 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.705 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . . . -99.36 140.04 34.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -1.078 . . . . 0.0 110.179 -177.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.607 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -103.26 162.57 12.87 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.14 -0.975 . . . . 0.0 108.981 174.156 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.71 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -52.84 135.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.013 -1.054 . . . . 0.0 110.649 -177.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.93 -0.25 66.98 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 172.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 80' ' ' SER . 0.2 OUTLIER -57.79 -160.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.982 -1.305 . . . . 0.0 110.427 176.683 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -134.7 114.91 13.17 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.0 177.17 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.726 HG12 ' HD2' ' A' ' 46' ' ' LYS . 1.7 m -124.67 160.07 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.828 178.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.6 tttt -105.12 124.97 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.916 176.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.635 ' CG2' HD21 ' A' ' 9' ' ' LEU . 65.8 t -109.93 123.72 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.148 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.545 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.2 mtt85 -103.46 151.62 22.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 178.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.72 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 8.0 tmtt? -98.11 133.16 42.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.21 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.547 ' N ' ' HD3' ' A' ' 89' ' ' LYS . 2.3 m -150.3 -167.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.45 0.643 . . . . 0.0 109.975 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.552 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 27.5 mtp180 -129.29 178.11 6.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.807 . . . . 0.0 110.27 176.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.534 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.24 161.15 14.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 111.233 -175.888 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.546 ' CG ' HG12 ' A' ' 162' ' ' VAL . 18.2 pt-20 -148.22 164.78 32.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 94' ' ' ILE . 5.0 mp -88.86 97.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.47 -1.394 . . . . 0.0 110.22 -175.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.93 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.53 139.14 38.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 110.141 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.51 ' CD ' ' HG ' ' A' ' 156' ' ' LEU . 15.1 ptpt -100.09 -27.69 13.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.991 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.815 ' HB3' HD23 ' A' ' 156' ' ' LEU . 79.2 tttt -149.97 121.52 7.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.954 -1.091 . . . . 0.0 110.449 -176.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.097 HG23 HG22 ' A' ' 155' ' ' THR . 7.5 p -135.69 143.23 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 110.383 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 90.4 m -117.81 133.54 55.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 110.066 -177.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -132.35 164.9 25.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 110.223 -178.061 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 173' ' ' ARG . . . -138.91 83.57 18.47 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.804 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.2 Cg_exo . . . . . 0 C--N 1.305 -1.727 0 O-C-N 123.94 1.495 . . . . 0.0 110.173 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 117' ' ' GLU . 16.2 tt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.025 0.44 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.6 mt-10 -69.95 -39.95 75.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.093 -1.004 . . . . 0.0 110.049 175.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.03 -30.69 69.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 176.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 64.8 t80 -59.86 -37.78 80.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 109.53 176.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.764 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.4 t -59.88 -49.98 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 109.878 176.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.649 ' HG3' HD11 ' A' ' 170' ' ' ILE . 4.9 mt-30 -59.96 -44.11 94.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 110.312 177.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -63.58 -34.33 77.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 110.024 -175.825 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -84.22 -41.81 16.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.676 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.4 mm? -96.02 2.29 53.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 111.394 -174.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.628 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.4 tt -47.95 165.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.797 -1.189 . . . . 0.0 110.209 -175.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HG2' HG23 ' A' ' 125' ' ' ILE . 9.7 ptp85 34.97 49.57 0.41 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.499 -0.75 . . . . 0.0 111.464 -178.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -132.5 136.47 27.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.782 -1.199 . . . . 0.0 110.907 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.818 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -60.07 129.78 31.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.041 1.548 . . . . 0.0 109.892 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.678 ' SD ' HD11 ' A' ' 164' ' ' ILE . 16.4 mtt -125.22 146.2 49.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.428 -1.42 . . . . 0.0 110.875 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.712 HD21 ' C ' ' A' ' 49' ' ' LYS . 14.4 tp -144.18 105.59 4.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.616 -0.677 . . . . 0.0 109.6 -176.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.7 pm0 -43.11 143.86 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.345 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.15 -0.72 2.88 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.163 0.506 . . . . 0.0 110.392 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.606 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.9 p-10 -69.93 -179.46 1.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 174.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 151' ' ' LYS . 18.4 m-80 -145.73 141.89 28.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.488 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 120.94 -1.1 . . . . 0.0 110.31 -179.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 17.6 m-85 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.125 0.488 . . . . 0.0 109.94 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.422 ' HD2' ' OD1' ' A' ' 134' ' ' ASN . 33.4 tptt -121.12 102.22 8.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 109.874 178.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.606 HG21 ' OD1' ' A' ' 133' ' ' ASP . 2.2 t -77.06 140.73 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.6 t -131.23 -26.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 111.22 -176.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.54 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 6.4 tptm -140.04 134.54 31.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.843 -1.161 . . . . 0.0 110.591 -177.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.097 HG22 HG23 ' A' ' 98' ' ' VAL . 48.8 p -134.02 165.54 24.79 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.54 -0.725 . . . . 0.0 109.396 176.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.45 -39.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.646 -176.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.972 ' CB ' HG11 ' A' ' 162' ' ' VAL . 17.2 Cg_exo -59.43 -170.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.639 1.336 . . . . 0.0 109.984 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.46 -158.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.27 -0.894 . . . . 0.0 109.998 177.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -70.19 -7.83 45.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 110.669 -177.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 160' ' ' VAL . 34.3 m -88.1 149.5 45.4 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 110.931 -175.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.596 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.02 140.75 31.39 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.367 1.719 . . . . 0.0 110.811 179.761 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.972 HG11 ' CB ' ' A' ' 157' ' ' PRO . 4.6 m -130.08 157.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.022 -1.049 . . . . 0.0 109.96 172.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -103.61 130.0 50.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.314 -0.866 . . . . 0.0 110.37 177.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.892 ' CD1' HG21 ' A' ' 168' ' ' THR . 19.1 mm -71.34 150.23 9.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 178.135 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.92 170.13 24.65 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 175.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -53.77 -24.76 16.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.354 -1.086 . . . . 0.0 110.169 -176.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.634 ' OE2' HG21 ' A' ' 94' ' ' ILE . 18.0 pt-20 -89.67 -18.4 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.899 . . . . 0.0 111.025 -175.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.892 HG21 ' CD1' ' A' ' 164' ' ' ILE . 95.7 m -56.94 147.23 24.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.178 -0.951 . . . . 0.0 110.078 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' LYS . 74.1 mmtt -95.77 161.24 14.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.839 -1.163 . . . . 0.0 110.36 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.764 HD12 ' CG1' ' A' ' 120' ' ' VAL . 24.4 mm -119.97 130.63 74.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 110.696 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.476 ' OE1' ' HE2' ' A' ' 97' ' ' LYS . 21.7 mt-10 -113.97 126.2 54.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 110.368 171.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 120' ' ' VAL . 32.1 mm -123.17 132.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.019 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.542 ' HG2' ' CB ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.995 . . . . 0.0 110.387 -176.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.233 0.54 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -146.33 -166.96 12.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.024 HG21 HD22 ' A' ' 33' ' ' LEU . 9.1 pt -136.28 159.96 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.439 -1.036 . . . . 0.0 109.418 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.61 ' C ' HD23 ' A' ' 9' ' ' LEU . 96.7 mt -101.47 121.06 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.003 -1.061 . . . . 0.0 110.216 -179.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.809 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -136.96 -171.25 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 110.557 178.576 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.487 ' HB3' HG22 ' A' ' 66' ' ' ILE . 53.0 ttp180 -107.51 132.85 52.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 111.099 -172.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.937 HG23 HD11 ' A' ' 69' ' ' ILE . 13.2 p -61.67 138.36 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.77 . . . . 0.0 110.314 176.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -123.05 145.01 48.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 110.597 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.961 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 174.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.47 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 97.3 mtt180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.159 0.504 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.083 HG13 HG23 ' A' ' 67' ' ' VAL . 87.9 t -119.44 120.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 -179.018 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 4.9 ptt180 -92.36 119.54 32.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.7 176.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -134.73 -172.31 3.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 0.0 110.179 179.836 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.501 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.9 p-10 -106.9 -179.93 4.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.046 . . . . 0.0 110.539 -178.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.01 -44.46 94.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.579 -177.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -59.9 -46.7 88.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.535 -0.728 . . . . 0.0 110.211 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.59 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 59.9 m -59.97 -36.5 77.26 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.062 -1.024 . . . . 0.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.675 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 35.0 ttp180 -70.06 -44.54 68.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.186 178.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -90.26 -10.36 44.52 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.838 -1.164 . . . . 0.0 111.687 -171.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.024 HD22 HG21 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -50.17 -27.06 5.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.711 -1.243 . . . . 0.0 109.135 -178.566 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.003 ' N ' HD12 ' A' ' 33' ' ' LEU . 59.0 mt -130.11 -69.24 0.67 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.511 -0.743 . . . . 0.0 110.583 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -172.63 11.19 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.948 -1.095 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . . . -52.02 133.6 32.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.921 -1.112 . . . . 0.0 110.199 -176.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.679 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -118.32 174.32 6.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 38' ' ' ILE . 28.2 mm -58.95 119.65 3.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 120.814 -1.179 . . . . 0.0 109.722 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.4 35.54 56.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.629 174.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.572 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 33.6 m-20 -89.1 178.93 6.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.633 -1.51 . . . . 0.0 109.718 172.348 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.737 HG21 HG23 ' A' ' 92' ' ' THR . 76.7 t -99.39 123.54 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 110.585 -176.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' HD2' ' A' ' 89' ' ' LYS . 3.8 m -122.08 147.28 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.618 -0.676 . . . . 0.0 110.518 -177.029 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' OE2' ' HD2' ' A' ' 49' ' ' LYS . 85.3 tt0 -111.19 137.09 49.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.746 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -117.63 140.87 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.0 -1.063 . . . . 0.0 110.55 -176.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -151.59 96.67 2.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.611 -1.306 . . . . 0.0 112.106 -174.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.105 ' HE3' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -98.43 -80.24 0.46 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.52 -1.362 . . . . 0.0 110.443 168.014 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.63 -36.67 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.717 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.015 ' CZ ' HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -135.33 -155.5 0.65 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 109.388 172.067 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 48' ' ' ARG . 3.9 mtmm -114.85 133.81 55.65 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.072 0.939 . . . . 0.0 112.271 -177.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 1.015 HG23 ' CZ ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -119.5 179.88 4.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.311 177.5 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.576 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -136.09 160.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.871 170.646 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.66 -168.96 39.32 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.35 -168.25 1.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -1.048 . . . . 0.0 109.752 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.72 130.0 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 -178.534 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.47 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -116.95 164.92 13.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 110.427 178.592 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.64 119.74 30.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.437 -0.79 . . . . 0.0 110.132 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -64.37 140.08 58.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.838 179.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.13 -50.64 86.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 118.876 -1.129 . . . . 0.0 108.919 175.294 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 50.9 Cg_endo -93.45 97.43 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.753 1.396 . . . . 0.0 108.946 178.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.21 38.73 0.14 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 110.711 -174.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 30.6 p-10 -142.32 -37.89 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.124 -0.985 . . . . 0.0 110.833 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.554 ' HG3' HD11 ' A' ' 66' ' ' ILE . 19.5 pt-20 -86.75 -18.9 30.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.003 -1.06 . . . . 0.0 109.676 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.503 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 9.8 m-80 -81.72 35.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.459 -0.775 . . . . 0.0 110.78 177.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.501 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.5 pttt -98.86 16.62 21.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 0.0 109.614 176.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.21 23.26 0.03 OUTLIER Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.554 HD11 ' HG3' ' A' ' 62' ' ' GLU . 45.7 pt -140.39 156.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.149 174.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.083 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -136.36 131.05 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.463 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 54.1 ttp85 -91.05 118.55 30.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.0 -1.063 . . . . 0.0 110.009 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.937 HD11 HG23 ' A' ' 11' ' ' VAL . 3.2 pt -130.17 167.71 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 110.717 178.075 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 34.9 p-10 -80.02 170.71 16.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.1 178.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.3 m -59.98 -31.88 70.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 110.417 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.5 HG12 HD21 ' A' ' 76' ' ' ASN . 54.5 t -68.05 -46.5 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.703 -175.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.601 ' CE ' HD13 ' A' ' 44' ' ' ILE . 4.7 ttt -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.513 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.754 ' NH1' HD13 ' A' ' 81' ' ' ILE . 58.0 ttt180 -60.06 -42.89 95.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.12 172.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -71.75 -25.09 61.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.137 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.5 HD21 HG12 ' A' ' 72' ' ' VAL . 94.3 m-20 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.569 -177.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.709 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 16.7 p -97.88 -37.93 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.791 -1.193 . . . . 0.0 110.92 -175.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 77' ' ' CYS . . . 112.58 31.48 2.55 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.706 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -115.07 178.11 4.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.289 . . . . 0.0 111.763 -170.197 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.587 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -126.79 170.02 12.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.071 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.961 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -59.47 150.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.77 -1.206 . . . . 0.0 110.198 178.789 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' A' ' 10' ' ' ARG . . . 75.56 -3.52 48.33 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 174.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.521 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 2.0 m-20 -58.58 -162.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.033 -1.275 . . . . 0.0 110.378 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 60.1 pttt -134.8 116.96 15.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.454 -0.779 . . . . 0.0 109.82 177.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.105 HG12 ' HE3' ' A' ' 46' ' ' LYS . 1.2 m -117.34 143.39 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 109.532 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 78.6 tttt -93.59 119.04 32.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 175.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.631 HG21 HD11 ' A' ' 9' ' ' LEU . 85.8 t -99.38 123.3 52.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.304 -0.873 . . . . 0.0 109.678 -178.144 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.583 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.6 mtt180 -110.0 146.16 35.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.659 179.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.673 ' HD3' ' HB2' ' A' ' 36' ' ' ALA . 27.1 tptt -96.65 134.8 39.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.056 -1.028 . . . . 0.0 110.152 -177.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.573 HG23 HG12 ' A' ' 41' ' ' VAL . 2.7 m -147.61 -170.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 110.125 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 14.2 ptm180 -127.24 171.21 11.66 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 177.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.737 HG23 HG21 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -97.86 162.92 13.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.966 -1.084 . . . . 0.0 111.019 -176.153 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.77 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.4 pt-20 -150.72 161.88 41.79 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 94' ' ' ILE . 4.3 mp -89.16 97.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.6 -1.312 . . . . 0.0 110.261 -176.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.742 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.92 165.0 0.7 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.372 178.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 169' ' ' LYS . 2.1 pttt -134.9 -19.25 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.364 -0.835 . . . . 0.0 110.632 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.832 ' HB3' HD23 ' A' ' 156' ' ' LEU . 77.4 tttt -150.74 119.99 6.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.895 -1.128 . . . . 0.0 110.558 176.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.103 HG23 HG22 ' A' ' 155' ' ' THR . 8.8 p -138.76 142.65 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.958 -1.089 . . . . 0.0 110.669 178.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.489 ' C ' HD23 ' A' ' 100' ' ' LEU . 96.3 m -117.17 142.65 46.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.116 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.72 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -139.8 172.64 12.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.337 -0.852 . . . . 0.0 110.334 -178.54 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' HG2' ' A' ' 173' ' ' ARG . . . -143.99 94.04 5.95 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 0.0 111.021 -175.127 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 14.7 Cg_exo . . . . . 0 C--N 1.304 -1.768 0 O-C-N 124.001 1.527 . . . . 0.0 110.056 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 117' ' ' GLU . 12.8 tt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.29 0.567 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -59.96 -41.31 91.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 178.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.02 -33.33 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.741 175.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -60.0 -40.05 87.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.688 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.634 HG12 ' CD1' ' A' ' 170' ' ' ILE . 55.9 t -60.04 -45.65 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.963 175.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 168' ' ' THR . 2.7 mt-30 -60.03 -44.79 94.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.81 178.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -62.63 -42.48 99.62 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.492 -0.755 . . . . 0.0 110.144 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.412 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -73.28 -41.79 63.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 110.506 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.556 ' N ' HD22 ' A' ' 124' ' ' LEU . 4.4 mm? -95.45 0.04 52.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.192 -0.943 . . . . 0.0 110.983 -176.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.9 tt -44.82 163.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.925 -1.109 . . . . 0.0 110.095 -177.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 32.6 ptt-85 33.78 48.33 0.21 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.54 -0.725 . . . . 0.0 111.281 -178.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.495 ' HG2' ' HD2' ' A' ' 128' ' ' PRO . 0.2 OUTLIER -134.04 137.76 29.05 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.854 -1.154 . . . . 0.0 111.195 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.852 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 32.5 Cg_exo -54.87 127.48 26.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.003 1.528 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.581 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.9 mmm -126.21 140.83 52.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.495 -1.378 . . . . 0.0 110.79 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 7.8 tp -139.69 112.02 7.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 -177.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.4 pt-20 -48.6 145.33 3.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.695 -1.253 . . . . 0.0 110.144 -177.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 74.58 -1.71 3.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.815 -178.744 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.612 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.9 p30 -68.81 -170.4 0.22 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.986 -1.071 . . . . 0.0 110.206 175.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -146.92 157.12 43.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.57 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.084 -1.01 . . . . 0.0 110.016 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 14.1 m-85 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.232 0.539 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.446 ' HD3' HG23 ' A' ' 153' ' ' VAL . 2.9 tmtm? -118.67 108.32 14.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 110.086 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.612 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -77.45 138.6 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 109.868 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.446 HG23 ' HD3' ' A' ' 151' ' ' LYS . 32.9 t -117.18 -32.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 110.915 -177.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 131' ' ' GLU . 60.9 tttm -148.38 149.29 31.5 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.363 -178.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.103 HG22 HG23 ' A' ' 98' ' ' VAL . 82.2 p -133.2 170.46 15.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.832 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.47 -37.64 0.45 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.031 . . . . 0.0 110.907 -177.746 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.916 ' CG ' HG11 ' A' ' 162' ' ' VAL . 23.8 Cg_exo -55.61 -171.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.415 1.218 . . . . 0.0 110.284 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 -158.35 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 110.077 176.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -85.4 42.58 0.96 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.221 -0.924 . . . . 0.0 110.269 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 162' ' ' VAL . 33.3 m -140.03 158.73 66.6 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.957 . . . . 0.0 110.562 -177.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.576 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.48 136.58 40.54 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.267 1.667 . . . . 0.0 110.957 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.916 HG11 ' CG ' ' A' ' 157' ' ' PRO . 9.2 m -132.07 159.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 109.835 173.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.4 tt0 -105.54 127.52 53.07 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.176 -0.953 . . . . 0.0 110.281 175.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.79 ' CD1' HG21 ' A' ' 168' ' ' THR . 9.0 mm -71.21 157.39 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.653 -0.655 . . . . 0.0 110.376 -177.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.34 167.03 25.36 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.545 ' HB3' HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.31 -22.29 61.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.41 -1.053 . . . . 0.0 110.48 -177.161 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -88.72 -14.18 37.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.273 -178.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.79 HG21 ' CD1' ' A' ' 164' ' ' ILE . 10.0 m -58.16 155.39 11.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.489 -0.757 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.8 mttt -109.22 148.56 30.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 178.5 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.701 HG23 HD21 ' A' ' 100' ' ' LEU . 2.2 mt -130.23 160.0 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 111.254 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.45 ' HB3' HG23 ' A' ' 99' ' ' THR . 10.2 mt-10 -133.5 132.16 40.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.671 -0.643 . . . . 0.0 110.02 175.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.483 HD13 ' HG ' ' A' ' 100' ' ' LEU . 48.5 mm -120.01 122.97 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.389 -0.819 . . . . 0.0 109.956 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 101' ' ' ALA . 8.8 ptp180 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.006 -1.059 . . . . 0.0 110.469 -179.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.0 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.148 0.499 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.1 -160.04 8.91 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.924 HD13 ' CD2' ' A' ' 33' ' ' LEU . 14.7 pt -136.91 168.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.137 . . . . 0.0 109.51 178.403 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.757 ' C ' HD23 ' A' ' 9' ' ' LEU . 93.2 mt -104.29 125.72 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.649 -177.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.844 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -147.44 178.61 8.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.645 -0.659 . . . . 0.0 109.694 178.279 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.795 ' HG2' HG22 ' A' ' 66' ' ' ILE . 11.7 ptp180 -104.22 137.83 41.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 110.768 -173.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.955 HG23 HD11 ' A' ' 69' ' ' ILE . 8.4 p -61.98 130.63 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 110.547 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -111.38 162.85 14.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 177.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 81.5 tt0 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 175.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.627 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 45.5 mtm180 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.046 0.45 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.978 HG13 HG23 ' A' ' 67' ' ' VAL . 85.2 t -117.95 122.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.942 -1.099 . . . . 0.0 110.494 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -98.01 120.46 38.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.037 177.598 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -139.95 172.82 12.22 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.233 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -89.94 178.91 6.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.611 -1.306 . . . . 0.0 110.883 -175.156 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 86.9 mt-10 -59.91 -40.03 87.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.258 -178.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -50.07 55.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.311 -178.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.687 ' HA ' HD23 ' A' ' 33' ' ' LEU . 11.3 p -55.49 -34.63 64.75 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.145 -0.972 . . . . 0.0 109.566 177.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.54 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 40.0 ttm180 -81.18 -44.2 18.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.507 -0.746 . . . . 0.0 111.302 179.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -85.29 -10.02 56.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 110.81 -172.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.121 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.3 pp -57.01 -31.8 65.48 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.318 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.121 ' N ' HD12 ' A' ' 33' ' ' LEU . 15.4 mt -105.68 -79.83 0.56 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 172.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.41 16.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.559 -0.713 . . . . 0.0 110.31 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.54 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -66.61 141.5 57.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.982 -1.074 . . . . 0.0 111.072 -171.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.841 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -133.63 -178.91 5.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.176 174.782 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 38' ' ' ILE . 38.0 mm -74.5 74.72 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.854 -1.154 . . . . 0.0 110.279 178.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.428 ' H ' HG11 ' A' ' 54' ' ' VAL . . . 172.23 -6.16 0.03 OUTLIER Glycine 0 N--CA 1.483 1.803 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.836 -169.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -107.96 159.95 16.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.292 -1.711 . . . . 0.0 110.773 -172.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.612 HG11 ' HB2' ' A' ' 161' ' ' PRO . 69.2 t -99.62 133.01 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.407 -0.808 . . . . 0.0 109.821 179.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 52' ' ' GLY . 5.1 m -109.72 143.56 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 -175.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.456 ' C ' HD12 ' A' ' 44' ' ' ILE . 87.9 tt0 -111.75 141.44 45.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.676 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.826 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.1 mp -119.97 147.12 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 110.442 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.2 tt0 -151.16 94.51 2.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.022 -1.049 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.012 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.7 tmtt? -98.88 -66.21 0.91 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 173.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.566 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -107.09 -33.99 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 175.928 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 51.5 mtt85 -133.21 -168.23 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.591 -0.693 . . . . 0.0 109.445 175.091 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.72 ' C ' HD21 ' A' ' 130' ' ' LEU . 5.9 mtmt -91.52 138.43 31.58 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.597 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.567 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.98 158.11 45.2 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.26 0.552 . . . . 0.0 109.963 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.543 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.66 160.99 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.004 178.475 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.653 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -174.05 176.38 46.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 172.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 34.6 ttm180 -111.78 171.32 7.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -1.047 . . . . 0.0 110.139 -178.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.841 HG11 ' O ' ' A' ' 37' ' ' GLU . 5.4 p -89.55 126.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.046 -1.034 . . . . 0.0 110.91 -172.051 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.627 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -123.32 167.22 14.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 175.523 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -99.25 126.38 45.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 110.088 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.568 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -64.16 137.45 57.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 178.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.674 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 6.2 mtt180 -59.05 -45.22 99.51 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 109.082 174.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.674 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 32.9 Cg_endo -92.97 98.39 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.794 1.418 . . . . 0.0 108.887 178.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 14.7 pt-20 -75.57 36.78 0.13 Allowed 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.485 -0.759 . . . . 0.0 110.855 -173.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 74.1 m-20 -144.65 -38.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.855 -177.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.2 pt-20 -84.21 -22.23 30.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.568 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 17.4 m-80 -81.65 39.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.542 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.549 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 61.2 mtpt -98.64 14.38 28.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.464 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.49 24.69 0.03 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.795 HG22 ' HG2' ' A' ' 10' ' ' ARG . 46.9 pt -141.82 157.16 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -1.048 . . . . 0.0 109.246 175.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.978 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -131.55 129.98 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.037 -1.039 . . . . 0.0 109.935 178.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 25' ' ' ARG . 81.6 mtt180 -96.78 120.11 36.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.054 -1.029 . . . . 0.0 110.681 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.955 HD11 HG23 ' A' ' 11' ' ' VAL . 3.0 pt -134.43 168.28 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.613 -0.68 . . . . 0.0 110.533 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -78.95 174.97 10.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.425 -0.797 . . . . 0.0 110.193 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.441 ' CA ' ' OE2' ' A' ' 13' ' ' GLU . 83.3 p -62.69 -38.52 90.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.714 -177.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.9 -43.38 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.134 -0.979 . . . . 0.0 110.359 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.533 ' CE ' HD13 ' A' ' 44' ' ' ILE . 7.6 tpt -59.99 -47.86 84.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.64 178.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 63.5 ttp85 -60.17 -40.11 88.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 109.964 174.143 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.35 -24.62 62.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 93.9 m-20 -60.13 -39.57 86.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -177.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.505 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.1 p -98.27 -37.85 9.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -176.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.566 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 118.07 36.56 0.94 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -112.5 161.26 16.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -1.205 . . . . 0.0 110.367 -176.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.608 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -109.65 166.01 11.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.263 -0.898 . . . . 0.0 109.296 176.622 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.437 ' HA ' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -51.09 138.16 8.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.04 -1.038 . . . . 0.0 110.553 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 78.46 0.21 78.02 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 171.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -56.05 -158.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.119 -1.224 . . . . 0.0 110.423 174.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 49.5 pttt -136.05 109.64 8.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.515 -0.741 . . . . 0.0 110.139 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.012 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -124.51 154.88 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.9 . . . . 0.0 109.883 179.68 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 34.3 ttmt -100.65 125.51 47.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 177.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.601 HG21 HD11 ' A' ' 9' ' ' LEU . 74.1 t -99.51 120.79 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.991 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.48 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 99.4 mtt180 -109.67 157.48 19.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 110.007 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.401 ' O ' HG13 ' A' ' 90' ' ' VAL . 59.5 tttm -100.03 137.09 38.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 110.619 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.513 HG21 ' CG ' ' A' ' 161' ' ' PRO . 2.2 m -150.38 -169.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 110.369 177.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 34.7 mtp180 -133.75 179.98 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.826 . . . . 0.0 110.426 177.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.61 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.19 156.92 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.131 -177.259 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.618 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.5 pt-20 -150.26 169.94 20.17 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.18 98.63 8.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 110.398 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.99 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.02 135.41 52.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 110.262 178.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.533 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 1.0 OUTLIER -98.09 -27.79 14.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 111.105 -178.809 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.527 ' HB3' HD23 ' A' ' 156' ' ' LEU . 14.4 ttpt -150.16 130.96 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.811 -1.181 . . . . 0.0 110.248 178.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.999 HG23 HG22 ' A' ' 155' ' ' THR . 9.4 p -138.31 140.06 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 110.95 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 90.3 m -106.1 133.94 50.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.53 -0.731 . . . . 0.0 110.02 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -128.34 160.0 33.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 110.502 -178.28 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.5 84.02 24.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 110.466 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 150' ' ' PHE . 29.2 Cg_exo . . . . . 0 C--N 1.307 -1.654 0 O-C-N 123.884 1.465 . . . . 0.0 110.356 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.55 ' C ' HD13 ' A' ' 116' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 170' ' ' ILE . 98.8 mt-10 -60.02 -43.76 95.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.97 . . . . 0.0 109.968 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -66.28 -34.26 77.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 109.69 175.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -37.26 78.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.626 177.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.716 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.5 t -60.16 -47.83 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 109.888 174.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.762 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 109.849 177.631 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -59.93 -41.25 91.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.119 179.035 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.83 -40.09 23.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.672 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.639 ' N ' HD22 ' A' ' 124' ' ' LEU . 3.7 mm? -93.16 -0.88 56.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.109 -0.995 . . . . 0.0 111.091 -175.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.805 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.2 tt -47.92 168.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.861 -1.149 . . . . 0.0 110.242 -176.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.7 ptt-85 32.96 48.29 0.13 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 178.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.4 mmt180 -137.96 148.42 60.32 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.387 -1.446 . . . . 0.0 111.806 175.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.849 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.6 Cg_exo -62.9 132.69 38.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.321 1.695 . . . . 0.0 109.931 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.4 mmm -131.09 148.06 52.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.72 HD21 ' C ' ' A' ' 49' ' ' LYS . 15.0 tp -145.7 115.06 7.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.581 -0.699 . . . . 0.0 109.772 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.9 pt-20 -49.32 136.38 15.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.114 . . . . 0.0 110.401 -176.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.615 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.14 -3.94 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.2 0.524 . . . . 0.0 110.273 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.555 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.4 p30 -68.04 -170.98 0.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.314 175.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.488 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 9.7 m-80 -150.94 134.46 16.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.476 -0.765 . . . . 0.0 109.445 178.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 0.0 110.713 -177.269 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 10.4 m-85 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.293 0.568 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 109.95 22.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.555 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.4 t -75.96 135.64 26.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.705 179.026 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.531 HG21 ' NH2' ' A' ' 173' ' ' ARG . 43.2 t -114.8 -32.14 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.069 -1.02 . . . . 0.0 110.932 -176.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -148.35 139.22 23.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 110.673 -177.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.999 HG22 HG23 ' A' ' 98' ' ' VAL . 58.8 p -129.16 169.54 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.635 176.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.701 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.16 -32.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 111.18 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.907 ' CG ' HG11 ' A' ' 162' ' ' VAL . 24.6 Cg_exo -56.29 -165.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.372 1.196 . . . . 0.0 110.237 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.723 ' O ' HG13 ' A' ' 160' ' ' VAL . 13.0 t -89.76 41.21 1.03 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.251 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 158' ' ' SER . 64.6 mttt 60.74 18.05 8.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.767 . . . . 0.0 109.657 -177.297 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.854 ' O ' HG13 ' A' ' 162' ' ' VAL . 14.9 m -108.18 160.0 28.58 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 110.089 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.612 ' HB2' HG11 ' A' ' 41' ' ' VAL . 1.1 Cg_endo -50.18 121.15 7.14 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.167 1.614 . . . . 0.0 110.266 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.99 HG21 ' HB2' ' A' ' 95' ' ' ALA . 6.2 m -129.73 159.45 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.619 176.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 43.7 tt0 -105.93 127.63 53.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.135 -0.978 . . . . 0.0 109.993 178.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.975 HD12 HG21 ' A' ' 168' ' ' THR . 11.2 mm -71.85 153.09 8.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.678 -0.639 . . . . 0.0 110.285 -176.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.86 167.52 25.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.476 ' HB3' HD11 ' A' ' 125' ' ' ILE . 21.9 pt-20 -57.7 -19.62 28.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -1.047 . . . . 0.0 110.322 -176.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -90.0 -9.99 46.63 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 110.023 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.975 HG21 HD12 ' A' ' 164' ' ' ILE . 46.8 m -63.76 151.65 41.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 176.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 96' ' ' LYS . 38.6 mmtm -96.64 163.05 13.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 109.767 178.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.762 HD11 ' HG2' ' A' ' 121' ' ' GLN . 18.4 mm -122.66 132.59 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.297 -0.877 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.516 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 58.4 mt-10 -124.17 133.27 53.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.577 172.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 120' ' ' VAL . 6.1 mt -137.46 139.37 43.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.517 -0.739 . . . . 0.0 110.306 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.531 ' NH2' HG21 ' A' ' 153' ' ' VAL . 10.1 ptp180 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 110.304 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.689 ' HB3' HD22 ' A' ' 34' ' ' LEU . 96.0 m-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.268 0.556 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 87' ' ' VAL . . . -144.95 179.14 22.28 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 177.039 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.015 HG23 HD11 ' A' ' 34' ' ' LEU . 44.4 pt -135.34 159.04 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -1.177 . . . . 0.0 109.994 -179.402 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -101.17 120.01 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.354 -178.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.0 pt? -138.36 -171.8 3.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.522 ' HG3' ' HA2' ' A' ' 82' ' ' GLY . 32.6 ttp180 -101.65 133.39 46.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.915 -174.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.861 HG13 ' H ' ' A' ' 82' ' ' GLY . 11.1 p -62.82 129.83 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 110.257 176.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -112.14 148.84 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 110.34 179.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.656 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 176.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 33.1 ptt180 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.147 0.499 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.15 HG13 HG23 ' A' ' 67' ' ' VAL . 90.1 t -110.08 117.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.09 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.481 ' O ' ' OD1' ' A' ' 63' ' ' ASN . 1.3 ptm180 -96.81 120.56 37.37 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.981 -1.075 . . . . 0.0 109.909 178.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.671 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.2 pt? -136.38 175.27 9.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.664 -0.648 . . . . 0.0 109.542 -175.39 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.558 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.4 p-10 -92.04 179.73 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.743 -175.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.08 -42.19 94.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 109.24 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 54.2 m -65.84 -55.89 14.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.074 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.603 ' C ' HD22 ' A' ' 33' ' ' LEU . 23.3 t -49.91 -30.21 9.73 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.739 -1.225 . . . . 0.0 109.564 177.235 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HA ' HD11 ' A' ' 26' ' ' LEU . 63.3 ttp85 -80.57 -48.86 12.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 111.327 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -94.42 -14.66 25.02 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.712 -1.242 . . . . 0.0 111.611 -173.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.936 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.1 pt? -60.05 -28.71 68.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 7' ' ' ILE . 77.1 mt -103.36 -75.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.074 -1.016 . . . . 0.0 110.186 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 5.6 t70 -169.58 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.605 0.717 . . . . 0.0 109.176 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.52 119.38 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.4 0.619 . . . . 0.0 110.772 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.473 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -105.1 178.27 4.61 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.246 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 38' ' ' ILE . 19.0 mm -60.22 127.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.872 -1.143 . . . . 0.0 110.074 177.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.533 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 77.55 23.36 67.78 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.717 172.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.451 ' OD1' ' OE2' ' A' ' 37' ' ' GLU . 81.8 m-20 -89.16 171.69 9.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.719 -1.459 . . . . 0.0 109.639 172.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.471 HG21 ' OG1' ' A' ' 92' ' ' THR . 76.4 t -98.92 129.3 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.09 -176.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.608 HG11 HG23 ' A' ' 54' ' ' VAL . 1.7 m -117.06 141.12 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 -175.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.415 ' C ' HD12 ' A' ' 44' ' ' ILE . 41.0 tt0 -109.78 141.74 42.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 177.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.873 HD13 ' HE1' ' A' ' 73' ' ' MET . 4.1 mp -120.46 151.29 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.816 -1.177 . . . . 0.0 110.559 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -150.71 93.11 1.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.353 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.022 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 9.1 ttpt -98.44 -65.13 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.703 174.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.017 ' CG2' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -111.82 -30.94 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.637 0.732 . . . . 0.0 109.264 176.112 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 32.4 mtt85 -136.64 -171.52 2.93 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.714 -0.616 . . . . 0.0 109.372 174.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.736 ' HB3' HD21 ' A' ' 130' ' ' LEU . 7.0 mttm -88.31 136.94 32.74 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.986 -1.072 . . . . 0.0 110.459 -177.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.553 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -135.85 156.88 48.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.349 0.595 . . . . 0.0 110.296 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.52 160.59 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.868 . . . . 0.0 109.793 176.999 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' O ' HG22 ' A' ' 42' ' ' VAL . . . 178.88 179.72 48.68 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.387 -1.387 . . . . 0.0 109.714 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -113.91 165.45 12.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -1.046 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -89.33 139.99 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.016 . . . . 0.0 110.693 -173.576 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -125.29 161.38 27.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.748 . . . . 0.0 110.443 175.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 56' ' ' ARG . 24.8 ttp-105 -93.62 127.02 39.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -0.835 . . . . 0.0 110.314 177.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -65.9 140.0 58.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.578 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 4.4 mmm180 -56.78 -46.76 99.82 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.969 -1.082 . . . . 0.0 109.127 173.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 32.0 Cg_endo -91.57 98.33 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.997 1.525 . . . . 0.0 109.127 178.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.56 35.68 0.1 Allowed 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.641 -0.662 . . . . 0.0 110.765 -175.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -148.46 -34.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.37 -24.66 27.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.197 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.521 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -81.29 41.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.718 -0.614 . . . . 0.0 110.318 176.204 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 pttt -98.59 9.76 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 178.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.84 26.75 0.06 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 176.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 66' ' ' ILE . 46.0 pt -140.13 141.22 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -1.189 . . . . 0.0 109.645 175.036 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.15 HG23 HG13 ' A' ' 24' ' ' VAL . 2.6 p -120.02 121.93 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 73.5 ttt180 -91.95 118.16 30.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.24 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.726 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.5 pp -130.01 160.04 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 110.41 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -75.78 159.99 30.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 177.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.4 t -53.45 -29.95 38.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.913 -175.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.55 -48.53 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 110.121 -175.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.873 ' HE1' HD13 ' A' ' 44' ' ' ILE . 3.5 tpt -60.0 -45.14 93.72 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.707 177.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.438 ' O ' ' SG ' ' A' ' 77' ' ' CYS . 66.9 ttp85 -60.01 -40.09 88.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.778 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -69.93 -27.43 64.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.152 -0.968 . . . . 0.0 110.384 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -21.79 63.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 110.825 -175.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.493 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 18.6 p -101.78 -25.84 13.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.99 -1.069 . . . . 0.0 110.854 -178.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.547 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 98.0 23.47 13.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 176.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 1.022 ' HB1' ' HD2' ' A' ' 46' ' ' LYS . . . -109.02 -168.82 1.39 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.045 -1.268 . . . . 0.0 110.933 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.575 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -127.61 170.17 12.95 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.656 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -61.49 144.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 0.0 110.324 177.164 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.861 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.74 -1.92 65.72 Favored Glycine 0 C--N 1.297 -1.638 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 172.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.512 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.3 m-20 -56.62 -167.2 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.035 -1.274 . . . . 0.0 110.189 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 44.1 pttt -127.16 113.33 16.24 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.392 -0.817 . . . . 0.0 109.753 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.71 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -121.15 158.13 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -177.122 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 85.2 tttt -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.729 175.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.527 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 62.8 t -104.22 122.03 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.945 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 89.4 mtt180 -110.34 140.22 44.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 109.429 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 11.0 tttt -84.77 138.95 32.3 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.077 -1.014 . . . . 0.0 110.237 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.0 m -150.05 -169.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 176.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 48.0 ptt85 -128.39 172.21 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.464 177.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.471 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.06 163.15 12.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.004 -1.06 . . . . 0.0 111.018 -175.773 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.554 ' CG ' HG12 ' A' ' 162' ' ' VAL . 19.1 pt-20 -150.04 169.57 20.92 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.028 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.81 99.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.723 -1.236 . . . . 0.0 110.373 -176.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.83 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.25 140.77 48.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -0.837 . . . . 0.0 110.564 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.71 ' CD ' HD23 ' A' ' 156' ' ' LEU . 29.3 pttt -105.36 -26.08 12.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 111.316 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.891 ' CB ' HD22 ' A' ' 156' ' ' LEU . 22.0 tttp -148.16 128.56 13.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.687 -1.258 . . . . 0.0 110.623 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.114 HG23 HG22 ' A' ' 155' ' ' THR . 7.5 p -140.86 148.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.371 -0.83 . . . . 0.0 110.558 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -120.04 132.11 55.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.131 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.74 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -123.71 159.3 29.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.534 -178.53 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -141.07 93.78 8.05 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.385 -0.822 . . . . 0.0 110.354 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.7 Cg_exo . . . . . 0 C--N 1.303 -1.83 0 O-C-N 124.057 1.556 . . . . 0.0 110.32 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.8 tp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.184 0.516 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HA ' HD11 ' A' ' 172' ' ' ILE . 96.8 mt-10 -59.97 -41.74 92.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -35.21 74.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 175.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.392 -0.818 . . . . 0.0 110.2 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.611 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -60.52 -45.17 97.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 175.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.624 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 5.9 mt-30 -60.01 -42.8 95.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 110.335 175.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -59.98 -46.56 89.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.405 -0.81 . . . . 0.0 109.953 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.529 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.17 -46.71 64.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.516 -0.74 . . . . 0.0 110.741 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 124' ' ' LEU . 4.6 mm? -100.76 8.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.075 -1.015 . . . . 0.0 111.827 -173.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.891 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.2 tt -49.12 165.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.56 -1.337 . . . . 0.0 109.852 -176.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.549 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 31.9 ptt180 33.31 45.98 0.09 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.428 -0.795 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -128.46 134.24 26.06 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.044 -1.035 . . . . 0.0 110.589 179.046 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.829 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 6.6 Cg_endo -54.2 129.42 34.38 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.881 1.464 . . . . 0.0 109.942 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.56 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.8 mmm -126.53 143.13 51.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.568 -1.333 . . . . 0.0 110.929 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' A' ' 49' ' ' LYS . 13.6 tp -142.95 107.56 4.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 0.0 109.645 -177.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.606 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.2 pt-20 -46.24 140.34 4.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 0.0 110.822 -174.638 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.606 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.2 -3.37 1.24 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.256 0.55 . . . . 0.0 110.343 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.1 p30 -69.86 -171.02 0.37 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.302 -0.874 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.49 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 15.6 m-80 -142.48 156.53 45.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.067 176.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.328 -177.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.463 ' O ' HG13 ' A' ' 135' ' ' ILE . 10.9 m-85 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.305 0.574 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.49 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 24.4 tptm -114.72 107.81 15.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.944 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.529 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.9 t -76.15 135.93 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 109.647 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.7 t -121.62 -27.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.934 -177.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 22.0 tttt -139.53 143.49 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.794 -1.191 . . . . 0.0 110.923 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.114 HG22 HG23 ' A' ' 98' ' ' VAL . 46.5 p -139.95 157.2 46.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.605 -0.685 . . . . 0.0 109.503 174.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.891 HD22 ' CB ' ' A' ' 97' ' ' LYS . 3.2 tp -88.97 -33.96 0.41 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 111.069 -177.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 1.048 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.3 Cg_exo -57.57 -165.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.38 1.2 . . . . 0.0 109.971 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 t -90.09 179.71 5.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.222 -0.924 . . . . 0.0 109.901 175.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -60.28 -7.68 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 110.903 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.39 152.78 58.37 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.498 -179.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.569 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.24 141.77 30.52 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.402 1.738 . . . . 0.0 110.933 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 1.048 HG11 ' CB ' ' A' ' 157' ' ' PRO . 6.2 m -129.98 158.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 172.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.9 tt0 -106.66 128.68 54.37 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.048 176.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.862 ' CD1' HG21 ' A' ' 168' ' ' THR . 13.3 mm -70.23 156.25 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 110.125 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 171.2 24.49 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.891 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -59.01 -25.7 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.264 -1.139 . . . . 0.0 110.118 -178.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.68 -11.2 40.47 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.151 -0.968 . . . . 0.0 110.494 -176.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.862 HG21 ' CD1' ' A' ' 164' ' ' ILE . 92.1 m -59.0 145.71 40.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.093 -1.004 . . . . 0.0 110.343 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 79.0 mttt -93.59 147.29 23.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.956 -1.09 . . . . 0.0 109.945 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.624 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 1.0 OUTLIER -121.61 141.35 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -178.184 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.411 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 44.7 mt-10 -124.9 128.88 49.33 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 171.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 117' ' ' GLU . 2.7 mp -123.26 119.95 58.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.562 -0.711 . . . . 0.0 110.052 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.5 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 8.5 ptp180 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.522 ' O ' HD13 ' A' ' 34' ' ' LEU . 98.6 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.324 0.583 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.78 -169.99 14.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 177.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.869 HD13 ' CD2' ' A' ' 33' ' ' LEU . 21.4 pt -132.54 154.38 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -1.133 . . . . 0.0 109.952 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.0 mt -94.91 119.17 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.814 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.4 pt? -136.03 -168.85 2.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.221 -0.924 . . . . 0.0 110.314 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 20.2 ttp180 -106.55 130.01 54.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 110.957 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.973 HG23 HD11 ' A' ' 69' ' ' ILE . 11.5 p -62.53 137.71 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 110.461 175.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -120.91 156.58 31.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.245 177.418 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.53 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.368 177.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.588 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 26.1 mmt180 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.293 0.568 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.873 HG13 HG23 ' A' ' 67' ' ' VAL . 95.8 t -114.52 119.99 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 177.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -97.41 119.92 36.84 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.959 -1.088 . . . . 0.0 110.035 177.403 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.027 HD22 ' CB ' ' A' ' 30' ' ' SER . 1.8 mt -140.78 177.75 7.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.154 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 28.1 p-10 -93.65 179.35 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.833 -177.281 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.99 -40.97 90.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.349 -177.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -68.83 -42.68 76.84 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.308 -177.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.027 ' CB ' HD22 ' A' ' 26' ' ' LEU . 57.7 m -59.95 -40.84 90.36 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.031 -1.043 . . . . 0.0 109.573 177.008 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.568 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 52.3 ttp180 -74.19 -44.21 54.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 111.469 177.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -88.63 -11.61 44.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.88 -1.138 . . . . 0.0 111.07 -170.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.086 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.1 pp -57.73 -32.59 67.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.775 -1.203 . . . . 0.0 109.559 -177.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.086 ' N ' HD12 ' A' ' 33' ' ' LEU . 17.1 mt -106.44 -72.65 0.71 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.122 -0.986 . . . . 0.0 110.475 175.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 36' ' ' ALA . 6.8 t0 -170.04 -27.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.717 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.789 ' HB1' ' NZ ' ' A' ' 89' ' ' LYS . . . -28.68 124.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.383 0.611 . . . . 0.0 111.455 -178.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.55 ' O ' HG11 ' A' ' 54' ' ' VAL . 2.6 pt-20 -113.48 -175.16 2.61 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.233 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 38' ' ' ILE . 19.3 mm -60.53 134.14 25.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.947 -1.096 . . . . 0.0 109.61 174.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.55 ' H ' ' CG1' ' A' ' 54' ' ' VAL . . . 79.77 14.62 80.74 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.237 172.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' CE ' ' A' ' 89' ' ' LYS . 87.0 m-20 -88.97 167.29 13.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.301 -1.705 . . . . 0.0 110.033 173.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.582 HG21 ' OG1' ' A' ' 92' ' ' THR . 50.1 t -99.71 129.08 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.046 -1.034 . . . . 0.0 110.454 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.689 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.4 m -114.59 146.09 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.903 . . . . 0.0 110.527 -178.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.5 tt0 -112.22 144.27 41.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.41 -0.806 . . . . 0.0 109.35 177.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.2 mp -117.18 148.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.948 -1.095 . . . . 0.0 110.586 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -151.06 90.6 1.62 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 111.178 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.083 ' CG ' HG12 ' A' ' 85' ' ' VAL . 13.4 tmtt? -98.21 -59.64 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.031 . . . . 0.0 109.86 172.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.551 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -114.26 -35.52 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 109.069 177.532 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 83.9 mtm-85 -133.06 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.657 ' C ' HD21 ' A' ' 130' ' ' LEU . 9.3 mttp -88.34 130.71 35.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.075 -1.016 . . . . 0.0 110.175 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.526 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -129.96 168.11 17.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.643 -0.66 . . . . 0.0 110.391 -178.703 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -125.81 162.55 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.392 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.561 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.29 -176.97 47.41 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 176.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 54.9 mtp180 -123.38 -168.47 1.77 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -1.086 . . . . 0.0 109.977 -178.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -111.09 131.61 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.06 -1.025 . . . . 0.0 111.202 -174.03 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.588 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -125.65 162.76 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 0.0 110.467 175.146 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -90.0 125.87 35.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.496 -0.753 . . . . 0.0 110.061 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -64.62 139.75 58.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.075 -1.016 . . . . 0.0 110.035 178.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.662 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.2 mtp180 -58.51 -49.84 91.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 109.275 174.071 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 17.9 Cg_endo -91.53 99.46 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.812 1.427 . . . . 0.0 108.885 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.6 34.16 0.07 Allowed 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.527 -0.733 . . . . 0.0 110.857 -174.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -149.8 -30.77 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.674 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.47 -25.26 29.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.157 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.513 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 10.2 m-80 -81.25 40.07 0.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.774 -0.579 . . . . 0.0 110.554 179.082 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -97.81 11.71 36.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.041 . . . . 0.0 109.553 177.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.49 25.6 0.05 OUTLIER Glycine 0 N--CA 1.48 1.611 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 176.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.426 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 44.9 pt -140.11 141.21 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -1.217 . . . . 0.0 109.508 174.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.873 HG23 HG13 ' A' ' 24' ' ' VAL . 7.6 p -120.38 129.04 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.996 . . . . 0.0 110.16 -179.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 28.5 ttm180 -94.26 112.8 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.253 -177.043 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.973 HD11 HG23 ' A' ' 11' ' ' VAL . 2.4 pt -131.33 168.5 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.731 . . . . 0.0 110.632 -179.191 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.506 ' OD1' ' HB2' ' A' ' 73' ' ' MET . 31.6 p-10 -81.8 176.15 9.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 177.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -70.01 -29.1 66.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.272 -0.893 . . . . 0.0 110.671 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.7 -47.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 0.0 110.42 -176.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.709 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.62 -43.45 97.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.515 178.965 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' NH1' HG13 ' A' ' 81' ' ' ILE . 45.3 ttp180 -60.02 -41.08 91.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.935 173.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.95 -24.29 63.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 95.6 m-20 -60.0 -37.46 79.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.011 . . . . 0.0 110.633 -177.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.479 ' C ' HG23 ' A' ' 47' ' ' VAL . 30.0 p -98.26 -33.36 11.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 110.439 -177.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.551 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.94 26.75 3.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.626 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.58 168.54 9.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -1.14 . . . . 0.0 110.275 -176.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.917 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -115.72 177.97 4.48 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.569 179.273 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.53 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -64.32 140.27 19.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.028 -1.045 . . . . 0.0 110.532 178.414 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.15 -3.35 58.3 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 173.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.548 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.1 m-20 -58.08 -167.44 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.913 -1.345 . . . . 0.0 110.303 175.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 19.1 pttp -128.36 111.58 13.5 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.885 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -118.37 155.42 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.7 ttmt -100.24 123.6 44.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -0.968 . . . . 0.0 109.837 176.055 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.795 HG23 HD21 ' A' ' 9' ' ' LEU . 80.3 t -102.28 123.65 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.933 178.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.524 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtt180 -111.97 148.2 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.581 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.789 ' NZ ' ' HB1' ' A' ' 36' ' ' ALA . 10.5 tptt -100.0 130.04 46.12 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.049 -179.086 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.06 -166.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.596 -0.69 . . . . 0.0 110.15 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -129.12 171.46 12.38 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.543 -0.723 . . . . 0.0 109.67 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.582 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.43 159.97 16.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 111.117 -174.618 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 157' ' ' PRO . 19.6 pt-20 -147.8 173.46 12.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.5 mm -89.2 105.73 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.821 -1.175 . . . . 0.0 110.267 -175.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.2 139.24 53.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.974 ' CG ' HD23 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -101.34 -30.48 11.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.7 178.212 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.769 ' HB3' HD22 ' A' ' 156' ' ' LEU . 23.6 tttt -150.03 128.76 12.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.878 -1.139 . . . . 0.0 110.493 -179.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.043 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -139.92 143.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 110.384 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.628 HG23 ' HB3' ' A' ' 171' ' ' GLU . 54.6 m -114.79 138.36 50.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.127 -178.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -133.42 165.43 24.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HB2' ' HG2' ' A' ' 173' ' ' ARG . . . -144.16 99.97 4.96 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 110.605 -177.112 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.478 ' HD2' ' NH1' ' A' ' 173' ' ' ARG . 28.3 Cg_exo . . . . . 0 C--N 1.307 -1.622 0 O-C-N 123.887 1.467 . . . . 0.0 110.239 179.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 117' ' ' GLU . 20.9 tt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.27 0.557 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.657 ' HA ' HG21 ' A' ' 170' ' ' ILE . 95.6 mt-10 -60.01 -42.82 95.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -65.86 -40.02 91.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.843 . . . . 0.0 109.607 174.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -60.57 -39.97 89.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.471 -0.768 . . . . 0.0 109.916 178.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.686 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -60.09 -47.67 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.889 176.076 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.656 ' HG3' HD11 ' A' ' 170' ' ' ILE . 5.3 mt-30 -60.02 -43.78 95.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 176.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -59.99 -43.28 95.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.887 -176.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.59 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.56 -0.712 . . . . 0.0 110.597 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 47.9 mt -94.33 -4.7 48.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.021 . . . . 0.0 110.928 -171.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.741 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.4 tt -45.51 166.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.883 -1.136 . . . . 0.0 109.962 -172.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 164' ' ' ILE . 35.6 ptt180 33.45 46.72 0.12 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.7 -0.625 . . . . 0.0 111.578 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.489 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 9.0 tpp180 -134.13 135.3 24.02 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.73 -1.231 . . . . 0.0 111.547 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.841 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -59.51 124.19 14.96 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.989 1.521 . . . . 0.0 109.526 178.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.458 ' SD ' HG13 ' A' ' 164' ' ' ILE . 20.0 mtp -132.1 147.44 52.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.361 -1.462 . . . . 0.0 111.269 -177.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.657 HD21 ' C ' ' A' ' 49' ' ' LYS . 2.1 tp -148.36 115.95 6.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.649 -0.657 . . . . 0.0 109.23 -176.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.598 ' HB3' HG23 ' A' ' 155' ' ' THR . 0.7 OUTLIER -40.43 156.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.052 -1.03 . . . . 0.0 110.514 -174.412 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 70.58 -3.49 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.812 -0.555 . . . . 0.0 111.202 179.483 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.656 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.9 p-10 -70.18 178.64 2.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.925 -1.109 . . . . 0.0 109.882 173.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.455 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 20.0 m-80 -145.26 140.96 28.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 109.807 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 110.432 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.157 0.503 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.455 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 29.0 tptp -109.3 106.52 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.656 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.8 t -76.75 140.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 109.918 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.41 -23.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 111.242 -176.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 49.2 tptt -149.07 142.04 24.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.743 -1.223 . . . . 0.0 110.684 -176.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 1.043 HG22 HG23 ' A' ' 98' ' ' VAL . 72.5 p -140.02 160.01 40.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.497 -0.752 . . . . 0.0 109.372 176.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.974 HD23 ' CG ' ' A' ' 96' ' ' LYS . 10.8 tp -89.48 -29.17 0.35 Allowed Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.163 -0.96 . . . . 0.0 111.44 -175.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.944 ' CG ' HG11 ' A' ' 162' ' ' VAL . 35.5 Cg_exo -53.78 -170.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.086 1.045 . . . . 0.0 110.5 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.601 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -89.85 41.35 1.04 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 110.433 -178.254 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 158' ' ' SER . 37.1 mttt 62.31 19.95 11.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.452 -0.78 . . . . 0.0 109.851 -177.3 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.781 ' O ' HG13 ' A' ' 162' ' ' VAL . 20.0 m -110.37 160.04 29.89 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.495 -0.753 . . . . 0.0 110.057 178.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.541 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.3 Cg_endo -53.1 122.24 10.79 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.123 1.591 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.944 HG11 ' CG ' ' A' ' 157' ' ' PRO . 3.9 m -127.07 155.26 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 110.437 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -100.47 126.21 46.87 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.282 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.919 HD12 HG21 ' A' ' 168' ' ' THR . 12.8 mm -70.39 153.21 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 110.005 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.98 168.79 25.9 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 176.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -57.13 -21.77 34.94 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.231 -1.158 . . . . 0.0 110.229 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.53 -10.74 42.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.715 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.919 HG21 HD12 ' A' ' 164' ' ' ILE . 93.5 m -59.81 143.45 51.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.057 -1.027 . . . . 0.0 110.241 -179.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 86.4 mttt -90.02 149.22 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.032 -1.043 . . . . 0.0 109.892 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.686 HD12 ' CG1' ' A' ' 120' ' ' VAL . 4.5 mm -115.42 130.06 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.846 -177.271 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.628 ' HB3' HG23 ' A' ' 99' ' ' THR . 20.8 mt-10 -111.92 128.38 56.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.165 -0.96 . . . . 0.0 110.316 171.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.477 HD11 HG21 ' A' ' 120' ' ' VAL . 39.2 mm -123.37 127.86 74.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.194 -177.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.51 ' HG2' ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.344 0.592 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -59.98 -41.41 91.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.398 -0.814 . . . . 0.0 110.652 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.9 t -149.58 140.44 22.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 110.183 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -148.45 92.55 2.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 110.122 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 7.6 p30 -136.44 109.03 7.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 110.582 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 87' ' ' VAL . . . -154.12 -169.98 19.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.654 HD13 HD21 ' A' ' 33' ' ' LEU . 48.1 pt -131.2 159.92 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.05 -1.265 . . . . 0.0 110.195 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.4 mm -102.56 115.98 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.01 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.7 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.2 pt? -141.1 -175.13 4.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.672 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 3.7 ptt-85 -109.6 133.71 52.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.763 -1.211 . . . . 0.0 110.844 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.968 ' CG2' HD11 ' A' ' 69' ' ' ILE . 12.6 p -61.84 129.75 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 110.544 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -110.36 159.66 17.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.337 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.964 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 -175.74 142.18 0.53 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.138 -0.976 . . . . 0.0 110.689 176.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.68 171.38 17.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.386 -0.821 . . . . 0.0 110.038 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -59.93 133.1 55.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.113 -0.992 . . . . 0.0 110.128 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 p -175.4 -158.45 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.875 . . . . 0.0 110.084 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 43.2 p -71.54 159.26 34.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.682 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -69.89 -36.67 6.72 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.371 -0.831 . . . . 0.0 111.256 -177.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 16.9 Cg_exo -63.38 -175.01 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.515 1.271 . . . . 0.0 110.849 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.59 17.72 44.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.9 ptm -88.31 5.41 42.01 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.224 -1.162 . . . . 0.0 109.269 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 m -134.33 11.72 3.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.435 -0.791 . . . . 0.0 110.386 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 69.0 mtt85 -127.29 134.37 50.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 0.0 109.844 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.926 HG13 HG23 ' A' ' 67' ' ' VAL . 84.4 t -110.39 119.9 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.972 -1.08 . . . . 0.0 109.948 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 3.0 ptt180 -93.09 118.12 30.85 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.491 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.962 HD22 ' HB3' ' A' ' 30' ' ' SER . 2.7 mt -136.58 -179.27 5.59 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.728 -0.607 . . . . 0.0 109.958 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 1.4 p-10 -103.06 176.24 5.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.697 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 79.6 mt-10 -59.78 -44.48 93.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.344 -0.847 . . . . 0.0 109.25 -174.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.545 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 72.1 m -68.41 -43.32 77.46 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.014 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.962 ' HB3' HD22 ' A' ' 26' ' ' LEU . 58.1 m -60.09 -40.02 88.17 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.122 -0.986 . . . . 0.0 109.713 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 26.1 ttp180 -86.66 -33.92 19.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.732 -0.605 . . . . 0.0 111.135 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 62.2 ttt180 -89.39 -12.6 39.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.909 -1.119 . . . . 0.0 110.814 -175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.4 pp -59.76 -32.45 70.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.935 -1.103 . . . . 0.0 109.702 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.079 ' N ' HD12 ' A' ' 33' ' ' LEU . 12.2 mt -101.65 -74.51 0.62 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 36' ' ' ALA . 33.7 t0 -170.24 -23.81 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.687 -0.633 . . . . 0.0 109.604 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -34.71 121.27 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.436 0.636 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.514 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.07 -179.34 3.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.437 HD13 ' NH1' ' A' ' 31' ' ' ARG . 32.5 mm -60.07 126.15 17.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.575 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.65 23.87 63.8 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.07 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -88.54 171.29 10.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.655 -1.497 . . . . 0.0 109.91 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.777 HG21 ' OG1' ' A' ' 92' ' ' THR . 84.8 t -99.2 130.15 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 110.264 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.508 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -117.96 139.95 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.813 . . . . 0.0 110.437 -176.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 88.7 tt0 -108.59 142.83 38.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -119.91 150.5 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.924 -1.11 . . . . 0.0 110.703 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -152.57 93.48 1.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 111.124 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.015 ' CG ' HG12 ' A' ' 85' ' ' VAL . 4.1 tmtm? -99.06 -66.95 0.87 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.933 -1.104 . . . . 0.0 109.748 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.52 -34.58 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 109.407 176.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 85.9 mtt180 -131.59 -174.12 3.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.583 -0.698 . . . . 0.0 109.246 174.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.723 ' C ' HD21 ' A' ' 130' ' ' LEU . 35.5 mttt -89.14 139.44 30.47 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.351 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.566 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.54 159.81 40.91 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.431 0.634 . . . . 0.0 110.154 -177.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.15 161.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.035 178.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.474 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.87 179.85 48.76 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.678 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 59.2 ttt180 -117.17 164.46 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.503 -0.998 . . . . 0.0 110.237 -177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -94.05 141.79 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 0.0 110.463 -176.037 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.546 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.4 m-85 -137.62 166.37 24.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.508 -0.745 . . . . 0.0 110.496 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.408 ' NH2' HD11 ' A' ' 38' ' ' ILE . 58.3 ttm-85 -89.23 121.94 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -0.773 . . . . 0.0 110.084 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.45 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -62.96 140.01 58.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.002 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.69 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.1 mmt85 -56.15 -49.68 91.82 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.055 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.69 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.16 98.74 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.726 1.382 . . . . 0.0 108.923 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.59 37.18 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.3 p-10 -147.71 -29.2 0.33 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -85.04 -28.51 25.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 109.106 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.448 ' C ' ' HB3' ' A' ' 27' ' ' ASP . 4.8 m-80 -81.13 41.51 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.857 -0.527 . . . . 0.0 110.636 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' HA ' ' HG ' ' A' ' 30' ' ' SER . 20.7 pttt -97.83 8.97 43.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.9 27.08 0.05 OUTLIER Glycine 0 N--CA 1.479 1.552 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.489 HG21 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -141.11 142.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.25 -1.147 . . . . 0.0 109.561 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.926 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -119.97 127.47 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.044 -1.035 . . . . 0.0 109.973 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 33.9 ttm180 -92.86 118.46 31.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 110.077 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.968 HD11 ' CG2' ' A' ' 11' ' ' VAL . 2.5 pt -129.34 166.22 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.775 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.4 ' OD2' ' O ' ' A' ' 18' ' ' ASP . 3.8 t70 -80.09 168.89 18.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 82.5 p -60.82 -29.65 69.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.65 -46.41 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 110.161 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.761 ' CE ' HD13 ' A' ' 44' ' ' ILE . 13.5 tpt -60.04 -44.38 94.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.587 ' NH1' HD13 ' A' ' 81' ' ' ILE . 61.8 ttt180 -60.03 -40.14 88.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.849 173.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -66.43 -31.24 71.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.118 -0.989 . . . . 0.0 110.252 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' MET . 99.7 m-20 -59.98 -39.85 87.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.762 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.498 ' C ' HG23 ' A' ' 47' ' ' VAL . 28.5 p -99.36 -39.64 8.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.846 -1.159 . . . . 0.0 110.801 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.586 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 110.2 30.72 3.29 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -104.54 167.91 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.13 -1.217 . . . . 0.0 110.36 -177.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.625 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 165.53 11.66 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.214 -0.929 . . . . 0.0 109.173 176.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.964 HD11 ' HB3' ' A' ' 13' ' ' GLU . 1.1 mp -53.83 139.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.995 -1.065 . . . . 0.0 110.203 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.54 2.08 73.55 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -58.23 -160.16 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 O-C-N 120.91 -1.347 . . . . 0.0 110.509 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.9 ptpt -130.88 108.93 10.19 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.015 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -118.87 155.2 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.128 -0.983 . . . . 0.0 110.052 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -106.6 119.96 40.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.199 -0.938 . . . . 0.0 109.908 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.71 HG22 HG23 ' A' ' 44' ' ' ILE . 95.0 t -105.1 121.78 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.812 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.501 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 87.7 mtm-85 -112.38 140.35 47.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.995 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.624 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 41.1 tttm -72.33 143.01 48.81 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.533 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.516 HG21 ' CG ' ' A' ' 161' ' ' PRO . 1.9 m -150.22 -169.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.511 -0.743 . . . . 0.0 109.909 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.24 169.05 17.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.904 . . . . 0.0 109.606 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.777 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.98 156.2 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.032 -1.042 . . . . 0.0 111.404 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.625 ' HG2' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -150.26 174.47 12.8 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.558 HG21 ' OE2' ' A' ' 167' ' ' GLU . 49.4 mm -89.28 102.96 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.867 -1.146 . . . . 0.0 110.031 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.759 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -52.84 132.46 36.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.306 -0.871 . . . . 0.0 110.163 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.786 ' HE2' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -96.06 -28.66 14.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.106 -0.996 . . . . 0.0 110.995 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HB3' HD23 ' A' ' 156' ' ' LEU . 46.2 tttp -150.05 119.9 7.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.831 -1.168 . . . . 0.0 110.281 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.617 HG23 HG22 ' A' ' 155' ' ' THR . 9.3 p -132.45 137.63 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.87 -1.144 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 171' ' ' GLU . 28.1 m -107.77 145.76 33.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 100' ' ' LEU . 1.0 OUTLIER -147.66 169.76 18.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.144 -0.973 . . . . 0.0 110.864 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.579 ' HB1' ' CZ ' ' A' ' 173' ' ' ARG . . . -141.4 86.05 11.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 110.924 -175.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 22.0 Cg_exo -60.01 126.09 19.37 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.881 1.464 . . . . 0.0 109.834 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.947 HG23 ' HB2' ' A' ' 177' ' ' ALA . 76.2 mt -89.44 95.14 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.004 . . . . 0.0 110.149 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.561 HD12 ' H ' ' A' ' 109' ' ' ARG . 8.8 pt -150.79 -168.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.49 -0.756 . . . . 0.0 110.453 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.512 ' HB2' ' HG3' ' A' ' 108' ' ' GLN . 33.0 mmt180 -93.87 156.64 16.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.541 -0.725 . . . . 0.0 110.005 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -55.6 -22.52 22.73 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.118 -0.989 . . . . 0.0 110.14 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 36.2 p-10 -110.02 20.03 18.38 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.703 -0.623 . . . . 0.0 111.095 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.656 ' CG ' HD11 ' A' ' 142' ' ' LEU . 2.9 mt-30 -90.54 -80.07 0.34 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.837 -1.164 . . . . 0.0 110.795 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.561 ' H ' HD12 ' A' ' 104' ' ' ILE . 47.3 ttm-85 -119.83 -17.34 8.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.038 -1.039 . . . . 0.0 111.065 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -97.99 43.12 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.044 -1.035 . . . . 0.0 110.523 -177.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -110.41 47.88 0.94 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.589 -0.694 . . . . 0.0 110.578 176.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -111.49 -62.78 1.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 110.543 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 78.18 169.95 35.51 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 113' ' ' GLY . 96.1 mt-10 44.4 94.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.267 -1.137 . . . . 0.0 110.234 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.3 0.94 89.55 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -60.91 -39.97 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -1.166 . . . . 0.0 109.903 177.018 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.507 ' N ' HG23 ' A' ' 116' ' ' ILE . 46.7 mt-10 -61.77 -40.26 94.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -70.0 -31.43 69.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.718 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -59.89 -39.76 86.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.551 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.665 ' CG1' HD12 ' A' ' 124' ' ' LEU . 69.6 t -60.2 -46.27 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.148 -0.97 . . . . 0.0 109.238 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.6 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -61.17 -40.03 92.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 110.267 175.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -60.0 -41.87 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.161 -0.962 . . . . 0.0 109.995 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.3 -39.83 28.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.431 -0.793 . . . . 0.0 110.586 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.665 HD12 ' CG1' ' A' ' 120' ' ' VAL . 92.0 mt -91.04 -8.39 49.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -1.0 . . . . 0.0 110.884 -174.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 166' ' ' GLU . 3.7 tt -41.96 166.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.582 ' HG2' HG23 ' A' ' 125' ' ' ILE . 30.9 ptt-85 34.2 54.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.449 -0.782 . . . . 0.0 111.607 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 6.6 mtt-85 -135.17 150.2 72.16 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.89 -1.131 . . . . 0.0 111.163 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.9 Cg_endo -69.02 133.11 26.06 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 124.096 1.577 . . . . 0.0 109.618 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.56 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 90.4 mmm -128.54 145.67 51.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.485 -1.384 . . . . 0.0 111.607 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.723 HD21 ' C ' ' A' ' 49' ' ' LYS . 13.6 tp -149.77 114.4 5.29 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.703 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.0 pm0 -49.11 139.67 10.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.703 -1.248 . . . . 0.0 110.573 -174.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.703 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 94.5 mm-40 79.73 -1.33 2.13 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.066 0.46 . . . . 0.0 110.593 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.669 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.1 p30 -69.02 -171.05 0.28 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.126 -0.984 . . . . 0.0 110.41 175.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 22.2 m-80 -149.97 158.8 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 109.679 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -140.38 171.7 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.13 -0.981 . . . . 0.0 110.092 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.9 t -116.51 158.59 23.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.327 -0.858 . . . . 0.0 110.684 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.748 ' HB ' HD22 ' A' ' 140' ' ' LEU . 2.5 t -113.55 148.67 40.21 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.481 -0.762 . . . . 0.0 109.546 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.605 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 4.8 Cg_endo -51.78 76.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.845 1.445 . . . . 0.0 111.302 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 38.13 63.16 0.96 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.907 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -123.59 153.99 39.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -1.19 . . . . 0.0 110.004 176.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -180.0 -167.14 0.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.2 -0.938 . . . . 0.0 110.38 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.656 HD11 ' CG ' ' A' ' 108' ' ' GLN . 83.7 mt -141.86 -131.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.656 -0.652 . . . . 0.0 109.923 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.52 -151.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 110.501 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.46 62.63 4.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -97.36 169.12 9.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.46 -1.024 . . . . 0.0 110.035 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -135.31 158.46 44.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.245 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.561 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 101.49 -91.5 0.93 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.06 44.33 2.05 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.457 -1.025 . . . . 0.0 111.021 177.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 103' ' ' ILE . 2.9 pp -140.45 163.27 33.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.014 -1.054 . . . . 0.0 109.735 177.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 45.7 m-85 -90.71 131.92 36.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.068 -1.02 . . . . 0.0 110.17 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.39 109.78 16.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.993 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.669 HG21 ' OD2' ' A' ' 133' ' ' ASP . 5.9 t -76.54 139.98 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.241 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.3 t -120.47 -24.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.121 -0.987 . . . . 0.0 111.093 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.505 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 87.6 tttt -143.11 151.08 40.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.872 -1.143 . . . . 0.0 111.15 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.617 HG22 HG23 ' A' ' 98' ' ' VAL . 39.2 p -141.6 154.62 45.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.626 -0.672 . . . . 0.0 109.626 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.786 HD12 ' HE2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -89.5 -33.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 111.235 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.918 ' CG ' HG11 ' A' ' 162' ' ' VAL . 26.5 Cg_exo -55.54 -165.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.314 1.165 . . . . 0.0 110.165 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.643 ' O ' HG13 ' A' ' 160' ' ' VAL . 8.6 t -88.64 40.94 0.99 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.224 -0.922 . . . . 0.0 110.297 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.8 mttt 59.99 18.76 7.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.843 ' O ' HG13 ' A' ' 162' ' ' VAL . 16.3 m -106.32 160.28 26.79 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.508 -0.745 . . . . 0.0 109.813 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.528 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.71 122.24 9.37 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 124.024 1.539 . . . . 0.0 110.064 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.918 HG11 ' CG ' ' A' ' 157' ' ' PRO . 12.1 m -129.87 159.9 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.0 tt0 -108.15 128.55 54.8 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.219 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.811 HD12 HG21 ' A' ' 168' ' ' THR . 20.1 mm -72.22 153.74 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.68 -0.637 . . . . 0.0 110.425 -175.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.552 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.09 167.04 26.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.746 ' HB3' HD11 ' A' ' 125' ' ' ILE . 21.2 pt-20 -57.57 -20.07 29.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -1.088 . . . . 0.0 110.352 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.558 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.4 pt-20 -88.87 -14.0 37.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.246 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.811 HG21 HD12 ' A' ' 164' ' ' ILE . 64.1 m -60.41 141.7 56.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 86.5 mttt -96.05 145.92 25.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.036 -1.04 . . . . 0.0 109.985 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.651 ' CD1' HG12 ' A' ' 120' ' ' VAL . 1.5 mt -125.21 157.85 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.192 -0.943 . . . . 0.0 110.853 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.612 ' HB3' HG23 ' A' ' 99' ' ' THR . 21.6 mt-10 -131.76 133.56 44.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.651 -0.655 . . . . 0.0 110.114 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 120' ' ' VAL . 40.7 mm -115.07 131.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.382 -0.824 . . . . 0.0 109.598 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.579 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -86.91 149.6 24.69 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.137 -176.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 174' ' ' GLU . 85.5 tt0 -90.25 10.07 26.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.318 -0.864 . . . . 0.0 110.327 -174.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -122.08 74.57 38.79 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.481 ' HD3' ' C ' ' A' ' 174' ' ' GLU . 21.0 Cg_exo -64.64 -149.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.023 1.539 . . . . 0.0 110.418 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.947 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -73.73 53.11 0.43 Allowed 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.257 0.551 . . . . 0.0 110.237 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 180' ' ' VAL . 25.5 t -107.36 113.86 27.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 178' ' ' SER . 81.0 tt0 60.0 19.74 8.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 178' ' ' SER . 17.6 t -101.74 112.44 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 110.105 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 181' ' ' LEU . 1.4 pt? -147.44 29.01 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 110.247 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 181' ' ' LEU . 99.1 mt-10 55.38 37.72 29.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -0.878 . . . . 0.0 110.118 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.07 -29.94 68.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.932 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.94 173.94 16.78 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.022 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.291 0.567 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -139.97 156.51 46.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.085 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 m -97.49 148.98 22.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -99.84 138.04 37.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 110.38 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -139.43 154.35 47.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 110.102 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -148.81 -161.75 9.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.71 HG21 HD22 ' A' ' 33' ' ' LEU . 39.1 pt -129.99 160.09 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -1.107 . . . . 0.0 109.43 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.9 mt -108.48 120.3 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.134 -0.979 . . . . 0.0 110.294 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.943 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.6 pt? -144.48 -171.66 3.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.477 -0.765 . . . . 0.0 109.648 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.63 ' NH1' HG22 ' A' ' 66' ' ' ILE . 9.5 ptp85 -106.93 135.73 47.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.81 -1.181 . . . . 0.0 110.948 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.965 HG23 HD11 ' A' ' 69' ' ' ILE . 14.4 p -62.39 131.06 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.629 -0.669 . . . . 0.0 110.738 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -114.23 146.21 40.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.863 . . . . 0.0 110.561 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 1.014 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 tt0 -177.96 86.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.0 110.321 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.91 -26.93 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.902 . . . . 0.0 110.544 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -59.99 -49.06 79.15 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.094 -1.004 . . . . 0.0 110.51 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.423 ' OG ' ' HG2' ' A' ' 19' ' ' PRO . 87.5 p -154.95 151.28 28.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 110.347 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.2 p -118.44 -16.84 9.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 110.393 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.681 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -68.48 -35.75 7.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 111.302 -176.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 22.9 Cg_exo -60.3 -170.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.547 1.288 . . . . 0.0 110.666 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.511 ' N ' ' OD2' ' A' ' 70' ' ' ASP . . . 159.97 57.69 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.514 ' HG3' ' CG ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -90.02 2.39 55.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -1.1 . . . . 0.0 110.032 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.46 39.89 27.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.368 -0.832 . . . . 0.0 110.346 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.514 ' CG ' ' HG3' ' A' ' 21' ' ' MET . 25.1 mmt85 -113.91 147.83 37.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 109.813 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.841 HG13 HG23 ' A' ' 67' ' ' VAL . 89.8 t -109.98 119.66 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.062 . . . . 0.0 110.347 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.636 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.1 ptm180 -100.56 121.25 41.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.92 -1.113 . . . . 0.0 110.135 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.695 HD12 ' CB ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -134.06 176.8 8.25 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 25.9 p-10 -89.56 179.85 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.753 -1.217 . . . . 0.0 110.416 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 87.0 mt-10 -60.05 -40.21 88.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.362 -0.836 . . . . 0.0 109.169 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 22.9 t -70.0 -44.4 69.42 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.529 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.695 ' CB ' HD12 ' A' ' 26' ' ' LEU . 58.1 m -60.05 -40.04 88.03 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.923 -1.111 . . . . 0.0 109.401 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.491 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 56.4 ttp85 -74.76 -43.04 56.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.694 -0.629 . . . . 0.0 111.623 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -88.77 -12.97 40.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 111.212 -170.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.083 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.2 pp -56.76 -32.63 65.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 109.505 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.083 ' N ' HD12 ' A' ' 33' ' ' LEU . 12.7 mt -105.27 -75.01 0.64 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 0.0 110.189 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' A' ' 36' ' ' ALA . 13.0 t0 -170.12 -24.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.637 . . . . 0.0 109.676 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -26.77 118.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.539 0.685 . . . . 0.0 111.264 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.73 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -104.96 177.32 4.88 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.81 123.35 12.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.93 -1.106 . . . . 0.0 109.86 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.03 29.06 59.41 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 32.8 m-20 -89.12 176.44 6.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.71 -1.465 . . . . 0.0 109.296 170.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.796 HG21 HG23 ' A' ' 92' ' ' THR . 89.8 t -99.32 129.25 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.074 -1.016 . . . . 0.0 110.373 -176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.755 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -119.58 147.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.434 -0.791 . . . . 0.0 110.319 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.55 142.16 45.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.423 -0.798 . . . . 0.0 109.606 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.792 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.3 mp -114.23 148.04 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.036 -1.04 . . . . 0.0 110.22 -177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 89.1 tt0 -150.21 89.44 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.02 -1.05 . . . . 0.0 111.222 -178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.099 ' CG ' HG12 ' A' ' 85' ' ' VAL . 14.4 tmtt? -98.37 -66.39 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 173.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.05 -38.82 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.708 0.766 . . . . 0.0 109.162 177.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.607 ' CG ' ' HA ' ' A' ' 77' ' ' CYS . 19.7 ptp180 -142.38 -163.58 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.704 -0.623 . . . . 0.0 109.46 175.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.638 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -88.69 130.51 35.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.073 -1.017 . . . . 0.0 111.132 -174.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.547 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -130.69 162.59 29.1 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.246 0.546 . . . . 0.0 110.339 178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -124.6 160.82 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.378 -0.826 . . . . 0.0 110.609 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.92 -179.73 48.71 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 62.0 mtp180 -111.03 175.2 5.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -1.205 . . . . 0.0 109.876 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.755 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -99.64 133.54 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.075 -1.016 . . . . 0.0 110.167 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -117.44 166.82 11.88 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.528 -0.732 . . . . 0.0 110.378 176.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 38.7 ptt180 -97.16 125.65 41.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.027 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.693 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -64.2 133.05 52.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.81 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.578 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -57.03 -46.85 99.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.986 174.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 23.7 Cg_endo -91.64 98.61 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.044 1.549 . . . . 0.0 109.028 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.04 33.81 0.09 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.595 -0.69 . . . . 0.0 110.91 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -147.53 -29.08 0.35 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.187 -0.945 . . . . 0.0 110.705 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.55 -28.43 26.64 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.693 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 37.8 m-80 -81.25 42.08 0.64 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.706 -0.621 . . . . 0.0 110.284 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 35.6 tttt -98.42 9.38 43.25 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.278 -0.889 . . . . 0.0 109.582 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.64 26.47 0.05 OUTLIER Glycine 0 N--CA 1.482 1.724 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 176.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.63 HG22 ' NH1' ' A' ' 10' ' ' ARG . 45.6 pt -140.12 142.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.273 -1.133 . . . . 0.0 109.448 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.943 ' HB ' HD11 ' A' ' 9' ' ' LEU . 12.7 p -120.05 119.98 61.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.666 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.557 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 77.7 mtt180 -90.08 111.14 22.15 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 11' ' ' VAL . 1.1 pt -127.69 161.3 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.608 -0.682 . . . . 0.0 110.355 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.511 ' OD2' ' N ' ' A' ' 20' ' ' GLY . 90.0 m-20 -80.01 169.59 17.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.522 -0.736 . . . . 0.0 109.795 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.526 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 80.0 p -62.39 -16.03 52.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.2 -49.2 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.343 -0.848 . . . . 0.0 110.363 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.655 ' HE1' HD13 ' A' ' 44' ' ' ILE . 97.8 mmm -63.73 -40.13 95.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 0.0 109.361 176.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttp180 -60.32 -42.19 95.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 109.997 173.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -70.23 -33.56 71.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.235 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -60.11 -40.0 88.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.607 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 31.7 p -99.06 -39.38 8.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.021 -1.049 . . . . 0.0 110.694 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.603 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.75 47.85 0.56 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.821 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -122.87 168.54 12.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.071 -1.252 . . . . 0.0 110.75 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.813 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.93 170.93 8.11 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.261 -0.899 . . . . 0.0 109.362 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.014 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -58.09 140.11 16.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.925 -1.109 . . . . 0.0 110.644 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.582 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.61 -0.29 65.48 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 172.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -58.55 -160.81 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.032 -1.275 . . . . 0.0 110.211 175.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.59 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.3 pttt -130.02 115.54 17.26 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 109.809 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.099 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.4 m -123.04 157.65 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.247 -0.908 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.0 ttpt -110.04 120.44 42.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 110.005 176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.509 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 69.1 t -99.63 123.81 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 0.0 109.893 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.534 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 38.3 mtp85 -109.98 157.75 18.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.791 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -102.26 138.42 39.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 110.153 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.619 HG23 HG12 ' A' ' 41' ' ' VAL . 2.5 m -150.12 -169.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.443 -0.786 . . . . 0.0 110.324 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -127.48 172.81 10.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.629 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.796 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.04 163.23 12.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.051 . . . . 0.0 111.086 -176.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.707 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.9 pt-20 -150.01 168.11 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 mm -89.64 99.81 9.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.556 -1.34 . . . . 0.0 110.466 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.898 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.2 136.62 56.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 110.226 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 6.2 pttt -106.05 -24.21 12.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.074 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.524 ' HB3' HD23 ' A' ' 156' ' ' LEU . 83.3 tttt -147.0 119.92 8.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.904 -1.123 . . . . 0.0 110.434 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.775 HG23 HG22 ' A' ' 155' ' ' THR . 8.2 p -138.09 140.28 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.134 -0.979 . . . . 0.0 110.492 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.589 ' C ' HD23 ' A' ' 100' ' ' LEU . 94.4 m -117.97 135.81 53.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -0.885 . . . . 0.0 110.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -141.27 167.74 21.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.227 -178.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . . . -132.94 103.12 13.1 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.384 -0.822 . . . . 0.0 110.562 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.4 Cg_exo -65.35 120.2 7.37 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.106 1.582 . . . . 0.0 110.132 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 81.3 mt -89.72 95.96 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.038 . . . . 0.0 110.249 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.993 HG21 HD21 ' A' ' 110' ' ' LEU . 15.0 pt -150.32 -164.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.29 -0.881 . . . . 0.0 110.744 178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.546 ' HB2' ' HG2' ' A' ' 108' ' ' GLN . 6.7 mmm180 -90.4 148.1 23.02 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.81 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -60.0 -14.51 16.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 0.0 110.241 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -122.53 37.78 4.31 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.841 -0.537 . . . . 0.0 110.257 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.546 ' HG2' ' HB2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -86.77 -163.2 0.87 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.223 -0.923 . . . . 0.0 110.241 -178.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -88.95 -25.16 22.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.024 -1.048 . . . . 0.0 110.956 -173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.993 HD21 HG21 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -99.78 57.37 1.0 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.053 -1.029 . . . . 0.0 110.46 -177.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.524 ' HD2' ' O ' ' A' ' 108' ' ' GLN . 0.2 OUTLIER -139.91 129.95 24.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.154 -0.966 . . . . 0.0 109.64 173.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -143.75 -86.44 0.13 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.411 -0.806 . . . . 0.0 110.131 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 115' ' ' GLY . . . 170.92 -159.79 32.01 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.147 -175.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -43.87 82.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.102 -0.646 . . . . 0.0 110.949 -176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 113' ' ' GLY . . . 161.71 -32.36 0.34 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -170.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 8.5 tp -59.98 -39.02 79.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.757 -0.849 . . . . 0.0 109.565 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.492 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 95.0 mt-10 -60.08 -43.92 95.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 109.831 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.68 -35.57 78.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -38.3 82.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.385 -0.822 . . . . 0.0 109.817 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.657 ' CG1' HD12 ' A' ' 170' ' ' ILE . 62.4 t -60.03 -49.02 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.673 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.646 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 5.3 mt-30 -60.06 -41.17 91.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.872 . . . . 0.0 110.045 174.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -60.05 -39.99 87.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.379 -0.826 . . . . 0.0 110.444 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.97 -41.2 19.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.545 HD12 HG13 ' A' ' 120' ' ' VAL . 52.3 mt -95.27 -3.43 47.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.059 -1.025 . . . . 0.0 110.972 -173.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.673 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.7 tt -43.43 163.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -174.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.609 ' HG2' HG23 ' A' ' 125' ' ' ILE . 34.0 ptt180 33.84 49.97 0.3 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.492 -0.755 . . . . 0.0 111.371 -177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.524 ' CB ' ' O ' ' A' ' 124' ' ' LEU . 10.8 ttt85 -132.11 143.34 48.53 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.966 -1.084 . . . . 0.0 111.105 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.828 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 17.4 Cg_endo -63.76 127.24 19.17 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.062 1.559 . . . . 0.0 109.811 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.573 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 93.4 mmm -123.52 140.02 53.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.402 -1.436 . . . . 0.0 110.926 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.638 HD21 ' O ' ' A' ' 49' ' ' LYS . 19.1 tp -139.59 112.37 7.93 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.577 -0.702 . . . . 0.0 109.7 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.0 pt-20 -46.68 142.05 3.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.012 -1.055 . . . . 0.0 110.435 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 85.4 mm-40 82.43 -2.74 1.41 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.228 0.537 . . . . 0.0 110.42 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.543 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.6 p-10 -70.21 -178.96 1.8 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.056 -1.027 . . . . 0.0 110.115 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.547 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 14.8 m-80 -148.29 129.54 14.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 1.3 mt -139.96 162.26 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.962 -1.086 . . . . 0.0 110.718 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.0 t -140.97 147.4 38.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.459 -0.775 . . . . 0.0 110.251 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.621 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 11.4 t -106.61 -62.91 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 39.1 Cg_endo -71.82 153.37 58.8 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.286 1.15 . . . . 0.0 110.524 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -113.16 52.93 0.61 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.058 HD22 ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -141.71 160.89 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -1.155 . . . . 0.0 110.457 -178.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 1.058 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -144.89 -165.46 2.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.444 -177.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.573 ' N ' ' OG1' ' A' ' 141' ' ' THR . 85.1 mt -130.54 -125.06 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.618 -0.676 . . . . 0.0 109.919 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.01 -157.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.31 55.79 4.04 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.433 ' OE1' ' HB2' ' A' ' 142' ' ' LEU . 14.5 pt20 -97.43 161.68 13.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.475 -1.015 . . . . 0.0 110.216 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.583 HG23 HD12 ' A' ' 181' ' ' LEU . 9.0 t -137.48 151.48 48.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 110.112 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.685 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 118.19 -91.35 0.52 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.685 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 41.49 44.28 2.47 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.322 -1.105 . . . . 0.0 111.016 177.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 3.6 pp -140.23 169.96 16.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.019 -1.05 . . . . 0.0 109.921 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.736 ' HD2' HD12 ' A' ' 100' ' ' LEU . 28.2 m-85 -91.57 125.89 36.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 110.067 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.547 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 21.2 tptm -99.92 106.72 18.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.543 HG21 ' OD1' ' A' ' 133' ' ' ASP . 2.1 t -79.37 134.37 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -0.965 . . . . 0.0 109.898 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.41 ' HA ' ' NE2' ' A' ' 132' ' ' GLN . 2.9 t -128.98 -23.19 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.157 -0.964 . . . . 0.0 110.737 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.478 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 8.6 tptp -140.2 127.12 20.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.85 -1.156 . . . . 0.0 110.609 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.775 HG22 HG23 ' A' ' 98' ' ' VAL . 33.8 p -126.79 170.01 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 109.586 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.628 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.3 OUTLIER -88.82 -41.56 0.45 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.531 -178.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.998 ' CG ' HG11 ' A' ' 162' ' ' VAL . 16.4 Cg_exo -61.75 -176.3 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.631 1.332 . . . . 0.0 110.179 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -90.25 -156.49 0.43 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.964 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -71.77 -2.58 18.09 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.271 -0.893 . . . . 0.0 110.38 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.87 138.7 32.96 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.0 110.374 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.557 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.99 142.38 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.224 1.644 . . . . 0.0 110.51 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.998 HG11 ' CG ' ' A' ' 157' ' ' PRO . 10.8 m -129.92 159.47 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 109.516 173.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.2 tt0 -106.17 127.2 53.04 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.138 -0.976 . . . . 0.0 110.063 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.881 ' CD1' HG21 ' A' ' 168' ' ' THR . 12.2 mm -69.73 156.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.624 -0.673 . . . . 0.0 109.862 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.01 166.65 27.02 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.61 -24.42 21.31 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.437 -1.037 . . . . 0.0 109.993 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -88.55 -16.92 31.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.588 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.881 HG21 ' CD1' ' A' ' 164' ' ' ILE . 80.3 m -56.82 153.13 11.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.0 109.989 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 68.4 mttm -100.7 152.94 19.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.915 -1.116 . . . . 0.0 110.032 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.657 HD12 ' CG1' ' A' ' 120' ' ' VAL . 19.7 mm -114.65 131.56 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.293 -0.879 . . . . 0.0 110.927 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.687 ' O ' HD13 ' A' ' 172' ' ' ILE . 23.6 mt-10 -114.24 129.55 56.63 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.162 -0.962 . . . . 0.0 110.109 170.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 171' ' ' GLU . 38.1 mm -130.92 140.0 49.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.042 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.487 ' NE ' ' HB3' ' A' ' 175' ' ' GLU . 7.8 ptm180 -88.03 173.79 8.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' A' ' 174' ' ' GLU . 58.5 mp0 -111.31 -2.46 15.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -0.956 . . . . 0.0 110.779 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.487 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . 8.6 tt0 -99.41 107.93 47.7 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 0.0 110.336 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 11.9 Cg_exo -72.3 -154.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.089 1.573 . . . . 0.0 110.018 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -73.73 53.66 0.45 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.554 -0.716 . . . . 0.0 109.993 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.659 ' O ' HG23 ' A' ' 180' ' ' VAL . 20.1 t -81.1 125.05 29.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.313 -0.867 . . . . 0.0 109.782 177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 178' ' ' SER . 90.4 mt-10 60.05 19.9 9.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.435 -0.791 . . . . 0.0 109.982 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 178' ' ' SER . 62.3 t -109.96 120.02 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.59 ' C ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER 15.73 72.37 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.273 0.559 . . . . 0.0 111.747 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 184' ' ' GLY . 21.4 pt-20 -140.71 160.25 40.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.864 . . . . 0.0 110.096 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -59.93 -30.08 68.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.144 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 182' ' ' GLU . . . -93.28 -176.27 40.51 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.618 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.268 0.556 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.99 -39.97 87.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.204 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 m -98.05 144.76 27.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.223 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -129.6 163.45 25.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.027 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -127.16 160.37 31.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.965 . . . . 0.0 110.602 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.13 -163.99 10.42 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.031 HG23 HD11 ' A' ' 34' ' ' LEU . 34.8 pt -137.56 158.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -1.186 . . . . 0.0 110.096 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.6 mt -102.21 115.55 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.305 -0.872 . . . . 0.0 110.15 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.789 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.6 pt? -140.0 -171.86 3.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.791 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.2 ptt180 -111.4 140.57 45.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.829 -1.169 . . . . 0.0 110.797 -174.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.027 HG23 HD11 ' A' ' 69' ' ' ILE . 11.7 p -61.75 136.23 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 110.58 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -115.99 152.17 34.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.172 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.925 ' HB3' HD11 ' A' ' 81' ' ' ILE . 85.5 tt0 -175.27 114.42 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 15' ' ' ASN . . . -100.02 3.43 44.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.146 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 28.3 m120 58.4 32.06 21.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.41 -0.806 . . . . 0.0 110.338 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.4 t -68.89 -47.98 64.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 65.2 p -140.03 151.83 45.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.152 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.69 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -76.05 -33.19 1.23 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.922 . . . . 0.0 111.52 -177.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 14.5 Cg_exo -65.52 159.02 49.93 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.347 1.183 . . . . 0.0 110.605 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.79 39.34 4.66 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 73' ' ' MET . 0.0 OUTLIER -89.37 2.24 54.69 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.305 -1.115 . . . . 0.0 109.438 176.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.4 p -135.19 15.02 3.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.0 110.51 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 96.2 mtt180 -119.95 140.04 51.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.136 -0.978 . . . . 0.0 110.38 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.048 HG13 HG23 ' A' ' 67' ' ' VAL . 67.0 t -113.21 120.61 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.146 -0.971 . . . . 0.0 110.283 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -95.09 120.54 35.48 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.467 175.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.081 HD22 ' CB ' ' A' ' 30' ' ' SER . 3.6 mt -134.93 171.32 14.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.554 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 5.3 p-10 -89.02 170.42 10.67 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.335 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HA ' ' NH1' ' A' ' 31' ' ' ARG . 46.7 mt-10 -56.16 -40.03 73.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.95 . . . . 0.0 109.019 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 5.2 t -65.29 -58.81 5.01 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.213 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.081 ' CB ' HD22 ' A' ' 26' ' ' LEU . 61.7 m -49.6 -30.02 8.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.593 -1.317 . . . . 0.0 109.635 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.588 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.9 ttp-105 -81.0 -49.46 10.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.87 . . . . 0.0 111.136 178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 32' ' ' ARG . 38.4 mtm105 -93.45 -14.36 26.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.756 -1.215 . . . . 0.0 111.43 -171.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.961 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -60.84 -28.7 69.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.907 -1.121 . . . . 0.0 110.195 -177.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.031 HD11 HG23 ' A' ' 7' ' ' ILE . 55.7 mt -103.66 -73.69 0.66 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.142 -0.974 . . . . 0.0 109.996 175.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 36' ' ' ALA . 30.4 t0 -168.65 -26.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.451 0.643 . . . . 0.0 109.442 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 31' ' ' ARG . . . -33.31 118.81 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.419 0.628 . . . . 0.0 110.961 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.57 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -104.42 175.92 5.33 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 38' ' ' ILE . 33.1 mm -60.0 123.95 13.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 120.908 -1.12 . . . . 0.0 109.785 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.534 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.48 28.19 60.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 65.7 m-20 -89.29 171.07 10.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.703 -1.469 . . . . 0.0 109.503 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.622 HG21 HG23 ' A' ' 92' ' ' THR . 73.7 t -99.15 129.95 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 0.0 110.06 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.593 HG11 HG23 ' A' ' 54' ' ' VAL . 2.7 m -118.21 144.71 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.388 -0.82 . . . . 0.0 110.358 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.0 tt0 -112.41 140.21 47.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 109.897 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.934 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.2 mp -122.74 143.97 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.041 -1.037 . . . . 0.0 110.395 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.8 tt0 -150.49 100.03 2.82 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.134 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.829 ' HD2' ' HB2' ' A' ' 79' ' ' ALA . 9.1 tmtm? -98.31 -66.99 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.017 . . . . 0.0 109.956 173.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.576 HG23 ' C ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -101.63 -34.54 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.388 174.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.556 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 90.0 mtt-85 -134.59 -179.68 5.74 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.5 -0.75 . . . . 0.0 109.486 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.526 ' HB3' HD21 ' A' ' 130' ' ' LEU . 24.3 mttp -89.19 141.87 28.14 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.181 -0.95 . . . . 0.0 110.843 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 130' ' ' LEU . 9.3 p -143.41 169.98 16.65 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.471 0.653 . . . . 0.0 109.901 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.42 167.35 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.447 -0.783 . . . . 0.0 110.079 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.41 -172.36 41.86 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 174.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -122.78 164.56 18.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -1.137 . . . . 0.0 110.329 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.593 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -96.81 137.69 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 110.419 -173.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.6 m-85 -128.12 165.53 20.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.493 -0.754 . . . . 0.0 110.262 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -89.73 122.68 33.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.972 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.773 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -62.29 134.1 56.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.564 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -57.8 -48.75 96.61 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.031 174.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.564 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.3 Cg_endo -92.42 98.53 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.91 1.479 . . . . 0.0 109.013 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.53 36.32 0.09 Allowed 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.527 -0.733 . . . . 0.0 110.692 -176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 59' ' ' PRO . 70.7 m-20 -143.67 -30.62 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.157 -0.965 . . . . 0.0 110.446 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 66' ' ' ILE . 21.1 mt-10 -87.14 -28.28 22.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 0.0 109.27 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.773 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 23.6 m120 -81.13 40.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.758 -0.589 . . . . 0.0 110.492 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 4.82 47.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.666 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.22 30.18 0.07 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 9' ' ' LEU . 46.3 pt -140.62 146.96 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.518 -0.989 . . . . 0.0 109.257 174.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.048 HG23 HG13 ' A' ' 24' ' ' VAL . 2.7 p -120.01 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.783 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HG2' ' HD2' ' A' ' 25' ' ' ARG . 15.2 tpp180 -90.09 110.28 21.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.126 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.027 HD11 HG23 ' A' ' 11' ' ' VAL . 1.5 pt -130.82 166.72 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.511 -0.743 . . . . 0.0 110.516 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 18' ' ' ASP . 11.5 t70 -80.02 171.1 15.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 176.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -63.91 -21.94 66.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 110.13 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.77 -49.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.934 ' CE ' HD13 ' A' ' 44' ' ' ILE . 1.3 mmt -60.72 -43.28 98.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 66.0 ttp85 -59.99 -40.53 89.49 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.334 -0.854 . . . . 0.0 109.925 174.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -70.38 -29.0 65.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.34 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 98.5 m-20 -59.97 -39.15 84.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.576 ' C ' HG23 ' A' ' 47' ' ' VAL . 26.9 p -98.14 -37.76 9.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 110.51 -175.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.529 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 115.56 35.38 1.3 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.829 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -113.08 165.24 12.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.095 -1.238 . . . . 0.0 110.54 -177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.737 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.43 170.62 8.11 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.358 -0.839 . . . . 0.0 109.339 178.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.925 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -53.41 141.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.929 -1.107 . . . . 0.0 110.382 178.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.414 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 75.42 1.55 65.44 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 172.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 1.8 m-20 -59.51 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 120.853 -1.381 . . . . 0.0 110.572 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.2 pttt -132.89 108.81 9.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.573 -0.704 . . . . 0.0 109.903 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.824 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.1 m -121.22 153.0 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 29.5 tttt -103.08 124.74 49.12 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 44' ' ' ILE . 73.2 t -107.21 123.97 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.799 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.5 mtt180 -113.65 136.89 52.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.548 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 27.5 tttt -72.24 143.53 48.76 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.952 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.524 HG23 HG12 ' A' ' 41' ' ' VAL . 1.9 m -148.07 -169.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 109.832 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 174.32 10.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.698 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.622 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.55 159.24 17.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.967 -1.083 . . . . 0.0 111.229 -174.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.59 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -150.34 176.38 10.95 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' HA ' HD13 ' A' ' 94' ' ' ILE . 25.2 mm -93.18 99.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.341 -1.474 . . . . 0.0 110.867 -177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.821 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.67 139.79 49.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 0.0 110.297 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.97 -27.18 10.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 111.147 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.698 ' HB3' HD23 ' A' ' 156' ' ' LEU . 79.0 tttt -150.0 124.77 9.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.838 -1.163 . . . . 0.0 110.283 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.939 HG23 HG22 ' A' ' 155' ' ' THR . 9.1 p -138.92 148.97 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 0.0 110.596 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.585 ' C ' HD23 ' A' ' 100' ' ' LEU . 88.9 m -120.03 130.69 54.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.819 . . . . 0.0 109.762 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -136.43 169.22 18.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.767 -176.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -130.42 88.82 46.18 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.298 -0.876 . . . . 0.0 110.863 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.589 ' HD3' HG23 ' A' ' 172' ' ' ILE . 17.3 Cg_exo -61.66 124.34 14.41 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.125 1.592 . . . . 0.0 110.385 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.781 HG23 ' HB2' ' A' ' 177' ' ' ALA . 71.7 mt -97.61 106.35 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 110.314 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.689 HD11 HD13 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -150.99 -164.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 110.551 178.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 104' ' ' ILE . 27.1 mmm180 -88.52 158.87 18.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.475 -0.765 . . . . 0.0 109.984 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -57.71 -15.81 9.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.99 -1.069 . . . . 0.0 110.739 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -124.86 27.83 6.66 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.603 -0.686 . . . . 0.0 110.387 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.537 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 2.0 mm-40 -94.54 -80.09 0.41 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.062 -1.024 . . . . 0.0 110.542 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 102' ' ' PRO . 36.5 ttp180 -113.39 -20.31 11.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 0.0 111.017 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.689 HD13 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -97.74 41.93 1.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.904 -1.122 . . . . 0.0 110.636 -174.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.93 62.81 1.59 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.252 -0.905 . . . . 0.0 110.495 174.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' HB2' HD13 ' A' ' 116' ' ' ILE . 45.3 m-85 -146.52 -58.24 0.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.995 -1.066 . . . . 0.0 110.442 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.63 177.86 42.3 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 49.0 95.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.164 -1.198 . . . . 0.0 110.071 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.54 -9.92 73.86 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.7 tp -62.42 -43.04 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -1.185 . . . . 0.0 110.103 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.596 ' N ' HG23 ' A' ' 116' ' ' ILE . 47.0 mt-10 -69.91 -40.11 75.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.07 -30.85 71.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -59.99 -40.88 90.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.601 ' CG1' HD12 ' A' ' 170' ' ' ILE . 44.7 t -61.17 -43.37 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.62 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 4.6 mt-30 -60.07 -44.52 94.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.116 -0.99 . . . . 0.0 110.114 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -60.01 -46.7 88.62 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.526 -0.734 . . . . 0.0 109.837 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.752 ' HB1' HG11 ' A' ' 137' ' ' VAL . . . -73.66 -42.47 61.32 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.614 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 124' ' ' LEU . 4.6 mm? -98.56 6.9 46.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 111.208 -175.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.592 ' HA ' HG22 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -48.67 166.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 120.77 -1.206 . . . . 0.0 109.735 -177.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.572 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 32.9 ptt180 33.01 45.14 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.465 -0.772 . . . . 0.0 111.412 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.528 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -127.26 138.53 32.96 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 120.805 -1.185 . . . . 0.0 111.113 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.86 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 9.3 Cg_endo -57.51 129.06 31.92 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 124.031 1.543 . . . . 0.0 110.176 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.576 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.6 mmm -125.96 137.82 53.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.601 -1.312 . . . . 0.0 110.608 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 50' ' ' THR . 12.7 tp -137.48 115.01 11.17 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.419 -0.8 . . . . 0.0 109.689 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pt-20 -48.78 143.63 5.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.981 -1.075 . . . . 0.0 110.655 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.04 -10.63 0.9 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.366 0.603 . . . . 0.0 110.374 -179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.572 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -70.38 178.3 2.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 176.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.553 ' OD1' ' CG ' ' A' ' 151' ' ' LYS . 1.1 m-80 -148.64 129.4 14.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.326 -0.859 . . . . 0.0 109.124 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.708 ' HB ' ' CE1' ' A' ' 150' ' ' PHE . 1.6 mt -140.05 164.85 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 118.211 -1.396 . . . . 0.0 111.459 -173.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 149' ' ' LEU . 10.2 t -138.13 149.97 46.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.721 -0.612 . . . . 0.0 109.822 175.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.967 HG12 ' CD ' ' A' ' 138' ' ' PRO . 0.1 OUTLIER -99.98 -171.81 0.25 Allowed Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.967 ' CD ' HG12 ' A' ' 137' ' ' VAL . 1.9 Cg_endo -69.25 58.06 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.148 1.078 . . . . 0.0 109.907 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . -115.61 108.38 1.87 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 141' ' ' THR . 1.7 pp -87.64 144.5 26.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -1.085 . . . . 0.0 109.843 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.6 OUTLIER -65.45 -166.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 111.054 -171.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.564 ' N ' ' OG1' ' A' ' 141' ' ' THR . 77.3 mt -140.1 -109.95 0.15 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.84 -0.538 . . . . 0.0 109.631 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.74 -155.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.156 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.34 55.89 4.97 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 145' ' ' GLN . 14.2 pt20 -98.89 162.56 13.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.361 -1.082 . . . . 0.0 110.259 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.9 t -139.9 155.89 46.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 110.232 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.674 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 112.17 -86.53 0.43 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.674 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 40.04 26.11 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.32 -1.106 . . . . 0.0 111.474 177.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 136' ' ' SER . 3.3 pp -140.43 166.11 25.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.894 -1.129 . . . . 0.0 108.866 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.708 ' CE1' ' HB ' ' A' ' 135' ' ' ILE . 7.4 p90 -113.17 140.39 47.96 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.244 -1.382 . . . . 0.0 111.169 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.553 ' CG ' ' OD1' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -100.32 113.88 26.93 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.829 -0.544 . . . . 0.0 109.737 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.572 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -76.1 135.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.684 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.416 HG23 ' CD ' ' A' ' 151' ' ' LYS . 18.9 t -123.58 -26.7 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 110.697 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -144.38 131.6 20.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.052 -1.03 . . . . 0.0 110.443 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.939 HG22 HG23 ' A' ' 98' ' ' VAL . 37.3 p -130.0 169.38 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.459 -0.776 . . . . 0.0 109.775 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -89.04 -39.88 0.44 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 0.0 110.822 -178.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 1.02 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.0 Cg_exo -61.52 -175.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.583 1.307 . . . . 0.0 110.727 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.1 t -90.5 -163.83 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.81 . . . . 0.0 110.258 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -68.11 -6.43 22.92 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.64 141.68 34.22 Favored Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.388 -0.82 . . . . 0.0 110.125 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.548 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.93 144.69 11.4 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.177 1.619 . . . . 0.0 110.363 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 1.02 HG11 ' CB ' ' A' ' 157' ' ' PRO . 10.9 m -129.91 159.27 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.089 -1.007 . . . . 0.0 109.545 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 67.4 tt0 -107.36 127.66 53.77 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.27 -0.894 . . . . 0.0 109.957 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.748 HD12 HG21 ' A' ' 168' ' ' THR . 9.1 mm -69.36 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.537 -0.727 . . . . 0.0 109.917 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -140.9 167.66 25.56 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -57.44 -21.19 35.27 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.416 -1.05 . . . . 0.0 110.32 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.55 -17.72 26.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 110.74 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.748 HG21 HD12 ' A' ' 164' ' ' ILE . 30.2 m -57.59 156.72 7.89 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.906 . . . . 0.0 110.364 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 0.3 OUTLIER -103.97 154.53 19.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 110.277 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.62 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 2.1 mm -120.0 129.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 110.772 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.512 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 53.4 mt-10 -117.83 130.02 56.02 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.12 -0.988 . . . . 0.0 110.419 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.589 HG23 ' HD3' ' A' ' 102' ' ' PRO . 37.1 mt -135.62 135.22 51.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.309 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.417 ' HD3' ' HB3' ' A' ' 175' ' ' GLU . 13.1 ptp180 -88.82 164.98 14.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.276 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 98.3 mt-10 -98.83 11.5 38.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.891 . . . . 0.0 110.252 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.417 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . 0.9 OUTLIER -94.71 109.72 45.23 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.955 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 14.7 Cg_exo -71.01 -154.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.159 1.61 . . . . 0.0 110.696 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.781 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -69.53 53.21 0.11 Allowed 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.727 -0.608 . . . . 0.0 110.17 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 82.0 p -83.03 120.45 25.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.301 -0.874 . . . . 0.0 110.18 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 178' ' ' SER . 83.8 tt0 60.06 18.72 7.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.364 -0.835 . . . . 0.0 110.422 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 180' ' ' VAL . 92.1 t -92.75 4.29 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.362 -0.836 . . . . 0.0 110.03 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.07 66.81 1.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 0.0 110.186 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -148.44 160.57 42.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.275 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.0 139.98 57.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.291 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.428 ' O ' ' OXT' ' A' ' 185' ' ' GLY . . . 90.05 -2.19 81.31 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.428 ' OXT' ' O ' ' A' ' 184' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.296 0 CA-C-O 118.025 -1.43 . . . . 0.0 109.551 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mtp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.257 0.551 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 4' ' ' ASN . 85.8 tt0 -59.94 -40.06 87.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.03 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m 51.86 49.9 19.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.285 -0.885 . . . . 0.0 110.301 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.421 ' HB2' ' HG2' ' A' ' 2' ' ' GLU . 11.4 t-20 -93.5 120.19 33.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.305 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -148.14 -170.74 3.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.961 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 88' ' ' ARG . . . -147.41 -159.74 8.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.904 HD13 HD21 ' A' ' 33' ' ' LEU . 43.6 pt -139.58 152.05 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -1.141 . . . . 0.0 110.002 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.42 119.67 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.337 -0.852 . . . . 0.0 109.797 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.761 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.2 pt? -135.91 -168.34 2.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.291 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.563 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 26.4 ttm105 -106.03 130.66 53.91 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 111.059 -174.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.858 HG11 ' O ' ' A' ' 80' ' ' SER . 14.4 p -61.65 139.02 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.439 -0.788 . . . . 0.0 110.379 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -120.24 153.55 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.487 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.597 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -176.43 148.47 0.75 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.321 175.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.38 159.98 35.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.837 . . . . 0.0 110.341 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -52.08 -27.0 12.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 60.2 p -59.95 159.87 8.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.172 -0.955 . . . . 0.0 110.061 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 18' ' ' ASP . 82.0 p -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.935 . . . . 0.0 110.39 -176.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 4.7 p-10 36.44 59.97 3.36 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.457 -0.777 . . . . 0.0 110.54 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 17.3 Cg_exo -62.0 167.4 10.66 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.915 1.482 . . . . 0.0 110.55 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.7 83.33 1.67 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 23.7 ptm -89.79 -10.01 47.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.303 -1.116 . . . . 0.0 110.107 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.1 p -99.39 1.89 44.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.577 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 84.2 mtt85 -110.84 129.47 55.85 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.461 -0.774 . . . . 0.0 109.909 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.908 HG13 HG23 ' A' ' 67' ' ' VAL . 77.4 t -109.98 115.43 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.011 -1.056 . . . . 0.0 109.987 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.579 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -88.09 117.4 26.94 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.683 178.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.776 HD13 HG12 ' A' ' 24' ' ' VAL . 1.2 mp -129.11 172.64 11.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 109.551 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 7.0 p-10 -92.76 176.64 6.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.863 -1.148 . . . . 0.0 110.022 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -40.06 87.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.449 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.58 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.5 t -69.51 -44.98 69.95 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 110.57 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.66 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 58.7 m -59.98 -39.99 87.6 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.102 -0.999 . . . . 0.0 109.608 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 36.9 ttp180 -74.7 -43.4 55.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.772 -0.58 . . . . 0.0 111.444 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -91.41 -11.53 37.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.821 -1.174 . . . . 0.0 111.201 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.092 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.3 pp -58.65 -32.88 69.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.855 -1.153 . . . . 0.0 109.606 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.092 ' N ' HD12 ' A' ' 33' ' ' LEU . 13.0 mt -105.21 -74.07 0.66 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.927 . . . . 0.0 110.316 175.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 45.6 t0 -170.16 -24.54 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.663 -0.648 . . . . 0.0 109.909 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.691 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -24.61 119.17 0.05 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.557 0.694 . . . . 0.0 111.407 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.694 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -105.69 175.14 5.59 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.419 HD11 ' NH1' ' A' ' 31' ' ' ARG . 26.2 mm -58.16 120.75 4.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.917 -1.114 . . . . 0.0 109.813 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.58 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.72 33.82 54.78 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 174.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.459 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.2 m-20 -89.11 177.1 6.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.721 -1.458 . . . . 0.0 109.477 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.535 HG21 HG23 ' A' ' 92' ' ' THR . 70.6 t -99.08 121.64 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.957 -1.09 . . . . 0.0 110.166 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.482 HG22 ' C ' ' A' ' 52' ' ' GLY . 1.5 m -116.8 139.41 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.489 -176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.8 141.36 38.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.812 . . . . 0.0 109.863 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.871 HD13 ' CE ' ' A' ' 73' ' ' MET . 2.1 mp -120.48 146.63 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.013 -1.054 . . . . 0.0 110.296 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.0 tt0 -150.95 97.16 2.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.961 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.03 ' CG ' HG12 ' A' ' 85' ' ' VAL . 1.7 tmtt? -98.41 -67.36 0.85 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.825 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.591 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.01 -35.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.16 174.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 71.9 mtt85 -135.46 -178.74 5.25 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.776 -0.578 . . . . 0.0 109.571 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.574 ' C ' HD21 ' A' ' 130' ' ' LEU . 28.0 mttt -89.04 137.14 32.58 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.655 -177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.724 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 10.9 p -140.56 166.78 23.8 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.394 0.616 . . . . 0.0 109.834 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -122.98 166.21 18.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.448 -0.782 . . . . 0.0 110.196 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.482 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.99 -169.54 39.73 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -129.94 162.8 27.79 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.311 -1.111 . . . . 0.0 110.186 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -89.03 138.8 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 0.0 110.426 -173.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.577 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 2.2 m-85 -134.68 166.31 23.23 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.504 -0.747 . . . . 0.0 110.251 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 51.9 ptt85 -90.69 128.36 36.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 110.209 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.73 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -65.9 139.98 58.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.609 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -54.74 -49.58 90.73 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 120.881 -1.137 . . . . 0.0 108.868 175.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.4 Cg_endo -92.71 98.79 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.904 1.476 . . . . 0.0 108.893 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -73.47 34.37 0.08 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.41 -0.806 . . . . 0.0 110.918 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -146.26 -27.51 0.42 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 110.769 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -86.12 -28.2 24.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.258 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.73 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 33.6 m-80 -81.75 43.56 0.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.676 -0.64 . . . . 0.0 110.312 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 30.3 pttt -97.43 8.96 43.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.404 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.88 27.13 0.05 OUTLIER Glycine 0 N--CA 1.479 1.541 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.5 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 43.5 pt -140.24 142.87 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -1.083 . . . . 0.0 109.4 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.908 HG23 HG13 ' A' ' 24' ' ' VAL . 3.1 p -119.94 121.12 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.005 -1.059 . . . . 0.0 110.058 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.575 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 97.3 mtt180 -89.87 116.02 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.229 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.679 HD11 HG23 ' A' ' 11' ' ' VAL . 4.5 pt -126.75 171.72 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.66 -0.65 . . . . 0.0 110.645 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -80.01 168.05 19.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.881 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.0 m -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.316 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.506 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.5 t -62.82 -43.62 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.871 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.0 -46.52 89.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.628 178.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.417 ' HD3' ' OE1' ' A' ' 13' ' ' GLU . 6.4 ttp-105 -60.13 -40.01 88.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.138 -0.976 . . . . 0.0 109.554 174.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -69.99 -23.84 63.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.483 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 4.2 m120 -60.07 -39.1 84.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.08 -1.013 . . . . 0.0 110.352 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.535 ' C ' HG23 ' A' ' 47' ' ' VAL . 31.4 p -98.27 -35.03 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.047 -1.033 . . . . 0.0 110.532 -175.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.591 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 112.47 26.63 4.17 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.46 169.97 8.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -1.166 . . . . 0.0 110.309 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.858 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.47 178.73 4.2 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 178.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -64.74 141.25 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.388 177.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.811 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 78.69 -3.85 62.58 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 172.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -57.3 -167.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.98 -1.306 . . . . 0.0 110.098 175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 50.7 pttt -127.01 114.65 18.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.12 -0.987 . . . . 0.0 109.748 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.03 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.1 m -119.33 155.57 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 83.6 tttt -105.61 125.44 50.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.659 HG23 HD21 ' A' ' 9' ' ' LEU . 76.0 t -106.85 121.4 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.481 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 41.3 mtm180 -110.63 135.61 51.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.526 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 19.4 tttt -83.81 138.64 33.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 110.353 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.529 HG23 HG12 ' A' ' 41' ' ' VAL . 2.3 m -150.04 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 110.088 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -126.48 168.99 13.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.907 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.535 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -98.73 163.47 12.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.093 -1.005 . . . . 0.0 111.05 -175.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.63 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.5 pt-20 -150.08 169.46 21.21 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 mm -89.62 100.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.606 -1.309 . . . . 0.0 110.538 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.923 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.85 138.19 53.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.271 -0.893 . . . . 0.0 110.29 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.544 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -96.66 -29.34 13.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 110.981 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HB3' HD23 ' A' ' 156' ' ' LEU . 16.1 tttp -150.66 124.63 9.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.731 -1.231 . . . . 0.0 110.842 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.065 HG23 HG22 ' A' ' 155' ' ' THR . 5.4 p -134.34 142.05 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.156 -0.965 . . . . 0.0 110.653 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 86.8 m -118.54 141.7 48.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.329 -0.857 . . . . 0.0 110.109 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -139.24 169.79 17.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.258 -0.901 . . . . 0.0 110.709 -178.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.706 ' HB2' ' HD2' ' A' ' 173' ' ' ARG . . . -141.12 99.7 6.53 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.615 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.727 ' HB3' HD11 ' A' ' 110' ' ' LEU . 22.6 Cg_exo -60.33 125.98 18.86 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.878 1.462 . . . . 0.0 110.17 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.012 HG23 ' HB2' ' A' ' 177' ' ' ALA . 83.4 mt -91.95 106.38 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -0.957 . . . . 0.0 110.821 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.76 HD12 ' HB2' ' A' ' 108' ' ' GLN . 1.9 pt -150.52 -173.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 82.4 mtp180 -140.66 -135.55 0.11 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.516 -0.74 . . . . 0.0 109.848 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -59.88 -13.56 11.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.89 -1.131 . . . . 0.0 109.48 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 145' ' ' GLN . 54.2 p-10 -99.82 28.79 4.52 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.284 0.564 . . . . 0.0 109.833 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.76 ' HB2' HD12 ' A' ' 104' ' ' ILE . 12.8 pt20 -82.88 109.77 17.3 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.272 -0.893 . . . . 0.0 109.975 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.1 ttt85 -111.73 -13.46 13.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.619 -0.676 . . . . 0.0 110.123 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' ' 102' ' ' PRO . 0.8 OUTLIER -99.22 52.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 110.023 -178.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.423 ' O ' ' CD1' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -140.03 135.04 32.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.866 176.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.511 ' HB2' HD13 ' A' ' 116' ' ' ILE . 10.0 m-85 -142.74 -40.04 0.33 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.961 . . . . 0.0 110.501 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 75.88 -176.23 51.3 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 113' ' ' GLY . 75.1 mm-40 41.46 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.169 -1.195 . . . . 0.0 109.994 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.15 -7.43 75.38 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' A' ' 112' ' ' PHE . 10.4 tp -60.04 -35.9 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 110.127 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 116' ' ' ILE . 43.5 mt-10 -59.98 -40.55 89.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.966 . . . . 0.0 109.693 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -68.69 -38.94 80.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 109.943 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.413 ' HD2' HD12 ' A' ' 116' ' ' ILE . 1.6 t80 -60.08 -39.99 88.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.251 -0.905 . . . . 0.0 109.341 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 172' ' ' ILE . 54.8 t -67.02 -45.93 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 109.89 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.558 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.2 mt-30 -59.98 -44.41 94.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.454 -0.779 . . . . 0.0 109.97 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -60.07 -48.6 81.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.441 0.639 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.566 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.05 -40.1 75.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.46 -0.775 . . . . 0.0 110.535 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.657 ' N ' HD22 ' A' ' 124' ' ' LEU . 3.9 mm? -97.53 -0.06 46.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.262 -0.899 . . . . 0.0 110.883 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.647 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.5 tt -47.3 166.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 110.171 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 164' ' ' ILE . 34.1 ptt180 33.08 46.68 0.1 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.659 -0.651 . . . . 0.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 7.6 mmt180 -129.79 150.42 75.78 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.676 -1.265 . . . . 0.0 111.192 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.79 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 22.2 Cg_endo -67.22 130.72 23.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 124.192 1.627 . . . . 0.0 109.876 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.554 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 87.8 mmm -127.13 137.58 53.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.556 -1.34 . . . . 0.0 111.077 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.63 HD23 ' HA ' ' A' ' 50' ' ' THR . 10.9 tp -140.21 113.67 8.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.622 -0.674 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -45.22 146.68 0.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.172 . . . . 0.0 110.394 -176.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.85 -0.53 3.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.741 -0.599 . . . . 0.0 110.627 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.568 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.2 p30 -69.91 -176.19 1.05 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.054 174.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 17.1 m-80 -145.94 150.06 35.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.592 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -134.34 170.35 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 t -136.44 165.82 24.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 0.0 110.57 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.58 ' CG1' ' HD2' ' A' ' 138' ' ' PRO . 2.7 t -112.05 147.82 37.72 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.586 ' O ' HD12 ' A' ' 140' ' ' LEU . 1.4 Cg_endo -46.55 177.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.856 1.45 . . . . 0.0 110.532 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.21 68.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.927 ' C ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -130.03 154.78 47.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -1.198 . . . . 0.0 111.03 179.271 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.748 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER 177.0 -167.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.039 . . . . 0.0 110.242 -178.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.697 HD21 ' NE2' ' A' ' 145' ' ' GLN . 0.5 OUTLIER -146.07 -122.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.522 -0.736 . . . . 0.0 109.847 178.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.521 ' H ' HD12 ' A' ' 142' ' ' LEU . . . -52.88 -161.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 109.973 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.0 79.99 1.54 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.697 ' NE2' HD21 ' A' ' 142' ' ' LEU . 1.9 pt20 -94.89 165.17 12.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.384 -1.069 . . . . 0.0 110.096 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -140.03 153.76 46.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 110.418 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.711 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 80.18 -90.48 1.31 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.711 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 42.47 48.54 4.56 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.541 -0.976 . . . . 0.0 110.832 176.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.706 HD11 HD12 ' A' ' 103' ' ' ILE . 2.6 pp -137.14 164.44 28.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.995 -1.066 . . . . 0.0 109.585 176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -91.58 137.7 32.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.112 -0.993 . . . . 0.0 110.247 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.504 ' HB2' HD11 ' A' ' 103' ' ' ILE . 27.4 tptp -122.39 101.9 7.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.603 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.568 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.3 t -77.47 138.79 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.68 -21.94 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 111.09 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.551 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 10.5 tptm -139.84 129.83 24.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.678 -1.264 . . . . 0.0 110.965 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.065 HG22 HG23 ' A' ' 98' ' ' VAL . 66.7 p -130.49 164.59 24.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.492 -0.755 . . . . 0.0 109.244 173.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.666 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.29 -36.67 0.42 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 110.916 -176.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.989 ' CG ' HG11 ' A' ' 162' ' ' VAL . 31.4 Cg_exo -53.1 -174.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.363 1.191 . . . . 0.0 110.401 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 4.9 t -86.84 41.44 0.96 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.28 -0.887 . . . . 0.0 110.264 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 158' ' ' SER . 40.7 mmtm 61.41 19.56 10.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.504 -0.747 . . . . 0.0 109.901 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.778 ' O ' HG13 ' A' ' 162' ' ' VAL . 23.5 m -102.29 159.92 27.9 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.392 -0.818 . . . . 0.0 109.712 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.536 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.4 Cg_endo -53.81 119.66 6.61 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.059 1.557 . . . . 0.0 110.217 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.989 HG11 ' CG ' ' A' ' 157' ' ' PRO . 5.2 m -126.61 158.3 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -104.56 128.71 52.61 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.152 -0.967 . . . . 0.0 110.052 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.834 ' CD1' HG21 ' A' ' 168' ' ' THR . 12.8 mm -71.08 152.65 8.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.827 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.06 168.32 25.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.37 -20.87 21.34 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.975 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -90.99 -18.57 24.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 110.684 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.834 HG21 ' CD1' ' A' ' 164' ' ' ILE . 30.5 m -57.89 148.41 25.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.162 -0.962 . . . . 0.0 110.473 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 49.6 mttp -96.35 147.19 24.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.093 -1.004 . . . . 0.0 109.702 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.747 HD13 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mt -130.03 160.03 41.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.093 -1.004 . . . . 0.0 110.982 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 99' ' ' THR . 25.3 mt-10 -137.78 133.6 34.24 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.754 -0.591 . . . . 0.0 110.231 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 120' ' ' VAL . 39.5 mm -120.02 120.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.341 -0.85 . . . . 0.0 109.39 177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.706 ' HD2' ' HB2' ' A' ' 101' ' ' ALA . 4.7 ptp85 -93.5 163.8 13.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 110.439 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.9 mt-10 -101.83 13.08 35.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.852 . . . . 0.0 110.392 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . 1.3 tt0 -93.07 109.91 42.65 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.375 -0.828 . . . . 0.0 109.702 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.6 Cg_exo -71.9 -156.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 124.165 1.613 . . . . 0.0 110.68 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.012 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -80.46 52.96 1.73 Allowed 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.084 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.62 ' O ' HG23 ' A' ' 180' ' ' VAL . 13.5 t -80.69 127.99 33.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 109.986 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 178' ' ' SER . 84.1 tt0 60.05 15.53 5.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.852 . . . . 0.0 110.404 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.772 ' C ' HD23 ' A' ' 181' ' ' LEU . 63.1 t -117.96 123.78 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.206 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.772 HD23 ' C ' ' A' ' 180' ' ' VAL . 0.1 OUTLIER -141.63 79.85 1.7 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -0.95 . . . . 0.0 110.054 177.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -61.73 144.09 55.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.197 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 183' ' ' GLU . 12.1 mt-10 -60.0 139.98 57.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.234 -0.916 . . . . 0.0 110.08 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 147.51 69.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.945 -1.475 . . . . 0.0 109.481 -179.465 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.274 0.559 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -120.23 140.29 51.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.902 . . . . 0.0 110.116 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -61.06 157.16 16.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.973 . . . . 0.0 110.25 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.402 ' OD1' ' CE ' ' A' ' 86' ' ' LYS . 65.0 t-20 -130.15 105.68 8.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 110.19 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -128.27 34.87 4.49 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.005 0.907 . . . . 0.0 109.836 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.11 -166.84 13.41 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.808 ' CG2' HD12 ' A' ' 33' ' ' LEU . 41.3 pt -131.89 160.03 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -1.138 . . . . 0.0 109.535 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.7 mt -104.18 117.08 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.5 pt? -139.58 -172.39 3.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.533 -0.729 . . . . 0.0 109.506 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.603 ' NE ' HG22 ' A' ' 66' ' ' ILE . 33.1 ptt180 -111.12 140.51 45.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.597 -1.314 . . . . 0.0 110.93 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 81' ' ' ILE . 9.6 p -62.29 138.09 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.497 -0.752 . . . . 0.0 110.675 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -119.06 144.71 46.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.245 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.944 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 -179.0 100.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.129 -0.982 . . . . 0.0 110.524 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.4 -40.13 9.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 109.797 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -156.45 156.3 33.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.827 . . . . 0.0 109.711 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.55 165.77 25.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.601 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' ASP . 66.2 p -131.35 154.84 48.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.435 -0.79 . . . . 0.0 109.903 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' THR . 5.5 p-10 38.06 72.12 0.94 Allowed Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.516 -0.74 . . . . 0.0 109.92 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.83 151.31 33.3 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.325 1.697 . . . . 0.0 110.688 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.514 ' N ' ' OD2' ' A' ' 70' ' ' ASP . . . 95.44 40.04 4.3 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.484 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 25.0 ptp -89.47 -0.01 57.19 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.273 -1.133 . . . . 0.0 109.414 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 21' ' ' MET . 1.0 OUTLIER 42.74 45.86 4.26 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.392 -0.817 . . . . 0.0 110.438 176.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.565 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 80.8 mtt180 -136.41 141.77 43.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.115 -0.99 . . . . 0.0 110.56 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.005 HG13 HG23 ' A' ' 67' ' ' VAL . 53.0 t -120.09 121.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.285 -0.885 . . . . 0.0 110.303 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.758 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.8 ptt180 -91.27 120.71 32.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.7 -1.25 . . . . 0.0 109.881 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -135.49 169.15 17.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 109.821 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.0 p-10 -94.48 -170.05 2.18 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.941 -1.1 . . . . 0.0 111.069 -175.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -0.76 . . . . 0.0 109.904 -176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.61 -43.66 93.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.752 . . . . 0.0 110.105 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.127 ' O ' HD22 ' A' ' 33' ' ' LEU . 54.6 m -58.64 -32.14 68.79 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.464 -0.773 . . . . 0.0 109.44 177.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 70.6 ttt180 -84.57 -44.31 13.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.704 -0.622 . . . . 0.0 110.887 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 33' ' ' LEU . 75.9 mtp85 -77.44 -11.14 59.81 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.171 -0.956 . . . . 0.0 110.127 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.127 HD22 ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -40.87 -29.36 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.888 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.799 ' H ' HD23 ' A' ' 33' ' ' LEU . 84.0 mt -141.15 -61.44 0.48 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.619 -0.676 . . . . 0.0 110.107 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.9 t0 -169.62 -36.21 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.529 -0.732 . . . . 0.0 109.498 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.728 ' HB2' ' HE3' ' A' ' 89' ' ' LYS . . . 9.99 114.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.263 0.554 . . . . 0.0 112.101 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.642 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.84 173.03 6.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.238 -0.913 . . . . 0.0 108.647 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 33.2 mm -60.08 120.23 5.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.949 -1.094 . . . . 0.0 109.825 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.583 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.27 34.36 46.22 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.466 173.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.472 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 35.9 m-20 -88.88 174.91 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.819 -1.4 . . . . 0.0 109.492 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.66 HG12 HG23 ' A' ' 90' ' ' VAL . 71.7 t -99.15 126.91 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.888 -1.132 . . . . 0.0 110.479 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.603 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -119.61 146.08 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.389 -0.819 . . . . 0.0 110.572 -177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -112.12 140.7 46.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 109.677 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.898 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.3 mp -125.85 143.67 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.944 -1.097 . . . . 0.0 110.512 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.14 98.97 2.76 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.054 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.937 ' CG ' HG12 ' A' ' 85' ' ' VAL . 5.8 tmtm? -98.56 -66.46 0.9 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.226 -0.921 . . . . 0.0 109.695 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -101.77 -37.12 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.484 -0.76 . . . . 0.0 109.106 174.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.598 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -129.88 -178.97 4.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.757 -0.589 . . . . 0.0 109.826 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.624 ' HB3' HD21 ' A' ' 130' ' ' LEU . 12.8 mttp -91.86 134.66 34.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 110.386 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.605 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.8 p -139.56 165.05 28.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.499 -0.751 . . . . 0.0 110.129 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.575 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.82 162.71 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.59 -0.694 . . . . 0.0 110.339 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.603 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.86 -171.38 42.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -122.21 177.14 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -1.134 . . . . 0.0 110.371 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.642 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -103.0 133.13 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 110.548 -175.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.565 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -125.54 165.93 17.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.432 -0.792 . . . . 0.0 110.658 176.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -91.52 125.03 36.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.738 . . . . 0.0 110.499 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -65.67 137.78 57.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.881 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.577 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.24 -48.6 96.73 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.903 -1.123 . . . . 0.0 109.105 173.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 39.9 Cg_endo -91.86 97.99 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.838 1.441 . . . . 0.0 109.108 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.474 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 19.5 pt-20 -74.64 36.46 0.11 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 121.519 -0.738 . . . . 0.0 110.699 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 82.2 m-20 -144.3 -34.93 0.36 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.154 -0.966 . . . . 0.0 110.649 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -85.1 -28.6 25.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 109.241 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.524 ' HA ' HG12 ' A' ' 66' ' ' ILE . 3.2 m-80 -81.03 39.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.8 -0.563 . . . . 0.0 110.697 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 3.0 pttp -98.24 12.85 33.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.665 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.02 25.95 0.06 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.603 HG22 ' NE ' ' A' ' 10' ' ' ARG . 45.6 pt -140.66 142.62 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -1.159 . . . . 0.0 109.492 175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.005 HG23 HG13 ' A' ' 24' ' ' VAL . 2.2 p -120.33 121.75 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.969 -1.082 . . . . 0.0 109.922 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.512 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 77.4 mtt180 -89.43 117.72 28.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.94 -1.1 . . . . 0.0 110.176 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.659 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.5 pp -127.23 172.36 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 121.428 0.632 . . . . 0.0 110.361 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' OD2' ' N ' ' A' ' 20' ' ' GLY . 34.0 p-10 -76.41 168.74 19.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 0.0 109.773 176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -67.11 -27.85 67.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG12 HD21 ' A' ' 76' ' ' ASN . 53.0 t -70.0 -43.66 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.965 . . . . 0.0 110.486 -176.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.898 ' CE ' HD13 ' A' ' 44' ' ' ILE . 3.1 tpt -60.02 -48.85 80.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.072 -1.018 . . . . 0.0 109.683 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.591 ' HG3' HG21 ' A' ' 11' ' ' VAL . 6.9 ttm180 -59.99 -40.01 87.72 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.306 -0.871 . . . . 0.0 109.853 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -72.2 -25.99 61.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.465 HD21 HG12 ' A' ' 72' ' ' VAL . 88.6 m-20 -68.55 -29.13 67.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.022 . . . . 0.0 110.625 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 31.0 p -99.26 -37.01 9.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 110.496 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.557 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 112.98 23.84 5.11 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.589 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.22 167.43 9.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -1.183 . . . . 0.0 110.351 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.613 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -116.75 166.42 12.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 178.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.944 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -51.4 140.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.486 178.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 77.27 -0.67 67.42 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 172.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.1 m-20 -56.31 -160.99 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 12.7 pttm -135.51 112.19 10.07 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.489 -0.757 . . . . 0.0 109.861 175.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.937 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.49 158.94 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.749 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 55.5 tttp -110.75 123.57 50.3 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.188 -0.945 . . . . 0.0 109.955 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.674 HG22 HG23 ' A' ' 44' ' ' ILE . 62.8 t -105.59 123.64 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 109.873 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.439 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.7 mtt180 -112.42 139.32 48.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.733 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HE3' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -79.06 141.06 37.72 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 110.437 -177.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.66 HG23 HG12 ' A' ' 41' ' ' VAL . 2.0 m -150.01 -168.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.487 -0.758 . . . . 0.0 109.999 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.512 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 47.1 ptt85 -139.59 171.04 14.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.566 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.41 158.7 16.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.995 -1.066 . . . . 0.0 111.309 -173.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.68 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.4 pt-20 -150.86 175.23 12.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.24 101.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.663 -1.273 . . . . 0.0 110.587 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.841 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.05 137.44 55.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 19.5 ptpt -101.12 -26.4 13.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 110.814 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.663 ' HB3' HD23 ' A' ' 156' ' ' LEU . 83.7 tttt -150.8 119.95 6.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.897 -1.127 . . . . 0.0 110.584 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.933 HG23 HG22 ' A' ' 155' ' ' THR . 7.4 p -135.19 140.04 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 120.871 -1.143 . . . . 0.0 110.977 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 171' ' ' GLU . 29.9 m -112.21 144.37 41.73 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.346 -0.846 . . . . 0.0 109.962 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.745 HD21 HG23 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -141.87 165.74 26.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.179 -0.95 . . . . 0.0 110.941 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.95 90.72 10.65 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.483 -0.761 . . . . 0.0 110.368 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 37.9 Cg_exo -55.15 129.84 37.46 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.955 1.503 . . . . 0.0 110.547 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.103 HG23 ' HB2' ' A' ' 177' ' ' ALA . 41.8 mm -89.98 88.68 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.174 -0.954 . . . . 0.0 110.244 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.589 ' HB ' ' CB ' ' A' ' 108' ' ' GLN . 1.0 OUTLIER -152.27 -167.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.885 176.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 104' ' ' ILE . 79.3 mmt-85 -92.39 165.26 13.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.477 -0.765 . . . . 0.0 110.091 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -59.89 -15.24 19.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.112 -0.993 . . . . 0.0 110.885 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 36.5 p-10 -122.98 25.44 8.57 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.59 -0.693 . . . . 0.0 110.623 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.589 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 1.2 mt-30 -93.51 -79.97 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 110.609 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.738 HH22 HD12 ' A' ' 148' ' ' LEU . 78.4 mtt180 -108.85 -27.28 9.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 109.824 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -97.64 41.35 1.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.537 -174.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 2.7 pttt -97.44 43.84 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.203 -0.935 . . . . 0.0 110.347 174.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.641 ' HB2' HD13 ' A' ' 116' ' ' ILE . 21.5 m-85 -107.98 -40.73 5.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.523 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 77.81 -161.05 49.24 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.506 ' C ' ' O ' ' A' ' 113' ' ' GLY . 19.2 pt-20 -32.14 144.83 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.878 -0.778 . . . . 0.0 110.723 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.4 -10.99 59.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 112' ' ' PHE . 6.7 tp -63.99 -37.14 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -1.182 . . . . 0.0 110.066 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.431 ' N ' HG23 ' A' ' 116' ' ' ILE . 47.5 mt-10 -60.02 -43.12 95.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 0.0 109.675 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.43 -39.8 89.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.756 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -60.02 -40.03 87.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.395 -0.815 . . . . 0.0 109.669 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.76 HG12 ' CD1' ' A' ' 170' ' ' ILE . 54.4 t -60.02 -47.25 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.571 ' NE2' ' O ' ' A' ' 168' ' ' THR . 4.1 mt-30 -59.95 -44.51 94.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.511 -0.743 . . . . 0.0 110.06 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -60.11 -44.04 95.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.57 -0.706 . . . . 0.0 110.19 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -74.6 -42.09 59.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.859 . . . . 0.0 110.647 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.5 mm? -95.92 0.68 52.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.172 -0.955 . . . . 0.0 111.205 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.635 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.6 tt -46.04 166.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.851 -1.155 . . . . 0.0 110.261 -176.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.9 ptm180 32.63 49.31 0.15 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.603 -0.686 . . . . 0.0 111.237 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.537 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -129.1 134.68 26.58 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.029 -1.044 . . . . 0.0 110.955 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.812 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.7 Cg_exo -59.75 125.73 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.931 1.49 . . . . 0.0 109.785 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.537 ' HG2' ' O ' ' A' ' 127' ' ' ARG . 99.7 mmm -124.35 140.46 52.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.445 -1.409 . . . . 0.0 111.031 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 49' ' ' LYS . 12.6 tp -140.99 111.6 6.94 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.58 -0.7 . . . . 0.0 109.503 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.59 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.6 pm0 -47.07 137.42 7.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.569 -1.332 . . . . 0.0 110.612 -173.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.59 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 1.3 tp-100 80.41 -3.39 1.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.243 0.545 . . . . 0.0 110.358 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.617 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.4 p30 -69.12 -173.59 0.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.175 -0.953 . . . . 0.0 110.384 175.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.657 ' HB3' HD13 ' A' ' 149' ' ' LEU . 7.9 m-80 -146.32 140.3 26.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -139.95 165.57 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.969 -1.082 . . . . 0.0 110.447 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 t -140.7 137.99 33.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 110.205 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.651 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 10.8 t -109.9 -68.08 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.66 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.651 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 34.2 Cg_endo -69.72 136.22 32.53 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.199 1.105 . . . . 0.0 110.162 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -98.62 46.77 1.48 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.512 HD12 ' C ' ' A' ' 140' ' ' LEU . 1.7 pp -123.97 143.44 50.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.34 -1.094 . . . . 0.0 110.314 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -118.78 -168.63 1.58 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.187 -0.946 . . . . 0.0 110.5 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' A' ' 141' ' ' THR . 83.4 mt -142.3 -138.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.541 -0.724 . . . . 0.0 109.8 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.03 -154.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 110.1 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.18 68.04 2.68 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.513 ' NE2' HD12 ' A' ' 142' ' ' LEU . 3.7 pt20 -94.3 168.89 10.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.484 -1.009 . . . . 0.0 110.153 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.3 t -140.0 159.04 43.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.229 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.731 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 80.66 -83.88 1.42 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.738 HD12 HH22 ' A' ' 109' ' ' ARG . 0.4 OUTLIER 41.81 42.74 2.29 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.436 -1.038 . . . . 0.0 110.981 178.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.657 HD13 ' HB3' ' A' ' 134' ' ' ASN . 4.4 pp -140.04 173.37 11.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.023 -1.048 . . . . 0.0 109.686 178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 67.7 m-85 -89.55 120.06 30.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 0.0 109.773 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.441 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 23.7 tptm -97.14 103.68 15.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.303 -0.873 . . . . 0.0 109.882 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.617 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.9 t -74.87 134.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.539 HG21 ' NH2' ' A' ' 173' ' ' ARG . 37.9 t -115.18 -30.17 2.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.146 -0.971 . . . . 0.0 110.751 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.485 ' C ' HG23 ' A' ' 155' ' ' THR . 68.5 mttt -143.4 160.0 41.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.993 -1.067 . . . . 0.0 111.163 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.933 HG22 HG23 ' A' ' 98' ' ' VAL . 81.5 p -150.0 162.55 40.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.83 -38.69 0.44 Allowed Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.994 ' CG ' HG11 ' A' ' 162' ' ' VAL . 21.4 Cg_exo -57.68 -166.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.535 1.282 . . . . 0.0 110.139 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.48 ' HB3' HG22 ' A' ' 160' ' ' VAL . 4.6 t -89.69 -169.23 2.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.24 -0.913 . . . . 0.0 109.671 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -64.16 -7.9 10.54 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 110.605 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 158' ' ' SER . 32.1 m -83.38 152.13 63.73 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 121.416 -0.803 . . . . 0.0 110.578 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.575 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 4.6 Cg_endo -52.98 142.57 52.92 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.303 1.686 . . . . 0.0 110.952 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.994 HG11 ' CG ' ' A' ' 157' ' ' PRO . 7.2 m -132.46 158.11 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 110.033 171.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 83.2 tt0 -105.36 126.32 51.97 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 110.213 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.768 ' CD1' HG21 ' A' ' 168' ' ' THR . 13.1 mm -69.77 159.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.567 -0.708 . . . . 0.0 110.438 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.65 167.84 26.52 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.633 ' HB3' HD11 ' A' ' 125' ' ' ILE . 19.2 pt-20 -58.58 -19.95 42.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.336 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -91.63 -22.03 20.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.768 HG21 ' CD1' ' A' ' 164' ' ' ILE . 94.2 m -54.99 147.32 15.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.635 -0.666 . . . . 0.0 110.283 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.7 mmtm -95.52 156.72 16.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.937 -1.102 . . . . 0.0 110.014 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.76 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.4 mt -135.68 164.25 33.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.992 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 99' ' ' THR . 37.0 mt-10 -139.26 137.01 35.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.621 -0.675 . . . . 0.0 110.276 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 120' ' ' VAL . 47.1 mm -119.95 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.814 . . . . 0.0 109.937 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.719 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 3.4 ptp180 -88.64 152.02 22.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 0.0 110.29 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.4 mt-10 -89.79 -3.58 58.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 110.319 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -98.97 109.49 54.12 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.022 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.9 Cg_exo -70.59 -154.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.11 1.584 . . . . 0.0 110.568 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.103 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -76.92 53.3 0.92 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.345 0.593 . . . . 0.0 110.043 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 180' ' ' VAL . 96.5 p -79.33 119.53 22.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.283 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 178' ' ' SER . 84.0 tt0 59.99 18.26 7.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.855 . . . . 0.0 110.655 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.523 ' O ' HD23 ' A' ' 181' ' ' LEU . 96.3 t -108.68 112.01 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.12 -0.988 . . . . 0.0 110.204 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 180' ' ' VAL . 0.5 OUTLIER 167.71 -42.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.438 -0.789 . . . . 0.0 110.108 177.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.462 ' HG3' ' CD1' ' A' ' 181' ' ' LEU . 98.9 mt-10 -60.5 -40.04 89.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 0.0 110.39 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -59.95 140.0 57.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.233 -0.917 . . . . 0.0 110.246 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.19 -31.14 29.11 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.428 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttm . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.207 0.527 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.77 136.34 45.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.435 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 t -61.13 -39.99 92.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.0 110.359 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 5' ' ' ASN . 42.5 t30 -89.77 -80.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 110.242 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 1.4 t-20 65.92 -159.93 0.26 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.936 -1.102 . . . . 0.0 110.362 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -144.32 -160.47 8.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.918 HG21 HD22 ' A' ' 33' ' ' LEU . 46.2 pt -132.98 147.76 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -1.145 . . . . 0.0 109.815 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.8 mt -96.24 119.08 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -0.947 . . . . 0.0 109.986 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.802 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.7 pt? -136.61 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 110.287 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 24.0 ttp180 -106.08 130.38 53.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.419 -0.801 . . . . 0.0 110.998 -174.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.967 HG11 ' O ' ' A' ' 80' ' ' SER . 10.2 p -61.21 139.55 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.523 -0.735 . . . . 0.0 110.416 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -125.79 153.33 44.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.467 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.929 ' HB3' HD11 ' A' ' 81' ' ' ILE . 46.2 tt0 -179.35 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.93 . . . . 0.0 110.062 175.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.59 -20.32 5.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.528 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 17' ' ' THR . 54.1 t-20 -119.97 129.88 54.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.123 -0.986 . . . . 0.0 110.257 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.8 p -92.17 0.65 57.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.362 -0.836 . . . . 0.0 110.344 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 80.9 p -77.47 165.81 23.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.208 -0.933 . . . . 0.0 110.41 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' CG ' ' O ' ' A' ' 17' ' ' THR . 5.5 p-10 37.25 69.56 1.33 Allowed Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.65 -0.656 . . . . 0.0 110.205 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -56.74 165.77 4.45 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.101 1.58 . . . . 0.0 110.476 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.93 88.65 0.07 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.7 ptp -89.8 -10.2 46.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -1.162 . . . . 0.0 110.165 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.5 p -93.07 2.5 56.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 110.042 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.556 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 98.1 mtt180 -119.85 135.78 54.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.449 -0.782 . . . . 0.0 110.007 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.853 HG13 HG23 ' A' ' 67' ' ' VAL . 92.8 t -116.14 120.01 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.206 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.827 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.1 ptm180 -93.54 119.97 33.25 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.852 178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.827 HD22 ' O ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -138.43 178.6 7.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.547 -0.72 . . . . 0.0 109.737 -176.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 15.2 p-10 -94.2 177.01 6.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.815 -1.178 . . . . 0.0 110.635 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 86.3 mt-10 -60.0 -44.74 94.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 47.3 t -60.49 -43.13 97.33 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.264 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.653 ' CB ' HD12 ' A' ' 26' ' ' LEU . 47.0 t -59.97 -41.15 91.34 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.158 -0.964 . . . . 0.0 109.257 176.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.607 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 67.4 ttt180 -68.98 -44.17 73.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.641 -0.662 . . . . 0.0 111.363 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 33' ' ' LEU . 25.4 tpt180 -90.32 -20.69 22.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.859 -1.15 . . . . 0.0 111.74 -170.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.083 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -47.84 -30.36 3.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.73 -1.231 . . . . 0.0 108.988 -177.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.083 ' N ' HD12 ' A' ' 33' ' ' LEU . 18.0 mt -115.67 -78.16 0.58 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.424 -0.798 . . . . 0.0 110.393 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -172.23 11.65 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.473 -0.767 . . . . 0.0 110.515 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -50.03 127.75 17.32 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.094 -1.004 . . . . 0.0 110.337 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.681 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -112.61 176.31 5.07 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.435 ' HA ' HD13 ' A' ' 38' ' ' ILE . 28.5 mm -59.66 119.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 120.828 -1.17 . . . . 0.0 109.83 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.61 36.83 47.62 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.26 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 25.6 m-20 -87.97 169.19 12.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.752 -1.44 . . . . 0.0 109.228 170.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 54.3 t -98.78 120.36 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.858 -1.151 . . . . 0.0 110.15 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.659 HG12 ' CE ' ' A' ' 89' ' ' LYS . 2.8 m -116.85 139.79 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.554 -0.716 . . . . 0.0 110.101 -176.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 85.9 tt0 -106.55 138.34 42.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.872 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.982 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.6 mp -116.97 140.87 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.147 -0.97 . . . . 0.0 109.859 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 84.4 tt0 -150.16 96.29 2.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.087 -1.008 . . . . 0.0 111.186 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.761 ' HB2' HG12 ' A' ' 85' ' ' VAL . 37.9 tttp -99.53 -71.07 0.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 172.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.16 -34.81 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.47 175.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.552 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 87.3 mtt-85 -139.77 179.71 6.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 0.0 110.051 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HD3' ' OE2' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -89.04 134.14 34.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 110.781 -175.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.534 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 1.7 p -138.48 172.06 13.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.679 . . . . 0.0 109.322 174.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.808 ' CG2' HD21 ' A' ' 130' ' ' LEU . 3.0 m -127.93 168.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 110.79 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.415 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.45 -175.9 45.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 40.8 ttm180 -121.71 165.75 15.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.439 -1.036 . . . . 0.0 109.975 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.681 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -94.57 135.85 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 110.553 -172.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.556 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -130.5 167.27 18.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.505 -0.747 . . . . 0.0 110.509 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -89.6 125.97 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.429 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.74 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -65.23 140.08 58.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.847 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.589 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -55.45 -49.96 89.54 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 119.028 -1.069 . . . . 0.0 108.947 174.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 33.9 Cg_endo -92.81 98.56 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.873 1.46 . . . . 0.0 108.974 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -73.64 35.13 0.08 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.561 -0.712 . . . . 0.0 110.91 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -145.91 -29.77 0.41 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.152 -0.968 . . . . 0.0 110.531 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -85.12 -27.25 26.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.167 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.74 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 31.5 m-80 -81.22 41.15 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.775 -0.578 . . . . 0.0 110.386 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.43 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -98.2 7.96 45.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.37 26.32 0.05 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 66' ' ' ILE . 45.6 pt -140.02 141.34 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.252 -1.146 . . . . 0.0 109.411 174.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.853 HG23 HG13 ' A' ' 24' ' ' VAL . 10.2 p -121.51 125.85 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.053 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.558 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 77.8 mtt180 -89.52 116.32 27.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.941 -1.099 . . . . 0.0 110.107 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.4 pp -129.97 170.07 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 110.209 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -79.83 164.24 23.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.945 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -68.01 -18.79 64.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.09 -50.02 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.976 . . . . 0.0 110.313 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.982 ' CE ' HD13 ' A' ' 44' ' ' ILE . 19.3 ttt -59.98 -45.7 91.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.443 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.508 ' HD3' ' CD1' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -60.04 -40.0 87.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.991 174.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -62.03 -36.42 81.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 0.0 109.84 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -67.79 -26.37 66.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 110.755 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 24.3 p -99.36 -30.99 11.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.022 -1.049 . . . . 0.0 110.547 -178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.49 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 106.75 19.73 9.47 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.628 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.23 169.34 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.087 -1.243 . . . . 0.0 110.838 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.967 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -120.31 178.53 4.61 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.475 -0.765 . . . . 0.0 109.458 177.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.929 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -66.4 142.26 16.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 110.35 177.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.707 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.36 -4.78 54.23 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 172.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.539 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.89 -162.08 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.053 -1.263 . . . . 0.0 110.067 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 16.4 pttp -137.2 116.15 12.36 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.115 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -119.55 160.72 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.084 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 82.8 tttt -109.37 120.62 43.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 110.025 176.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.519 HG23 HD21 ' A' ' 9' ' ' LEU . 87.3 t -101.67 123.69 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 0.0 110.204 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.52 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 93.9 mtt180 -106.88 151.4 25.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 109.763 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.659 ' CE ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -99.07 132.44 44.38 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.049 -1.032 . . . . 0.0 110.215 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 2.3 m -149.91 -168.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.561 -0.712 . . . . 0.0 110.125 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 40.1 ptt180 -129.07 171.67 12.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.386 -0.821 . . . . 0.0 109.636 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.74 164.72 12.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.032 -1.042 . . . . 0.0 111.023 -175.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.594 ' CG ' HG12 ' A' ' 162' ' ' VAL . 18.8 pt-20 -150.04 169.51 21.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.643 -0.661 . . . . 0.0 109.421 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 163' ' ' GLU . 40.0 mm -90.66 99.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.843 -1.161 . . . . 0.0 110.607 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.866 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.27 140.07 50.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.151 -0.968 . . . . 0.0 110.423 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.661 ' HE3' HD12 ' A' ' 156' ' ' LEU . 1.5 ptpt -101.68 -29.03 12.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.536 ' HB3' HD23 ' A' ' 156' ' ' LEU . 40.2 ttmt -150.79 129.35 12.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.367 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.083 HG23 HG22 ' A' ' 155' ' ' THR . 9.7 p -139.67 139.99 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.009 -1.057 . . . . 0.0 110.782 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 171' ' ' GLU . 14.5 m -102.71 138.67 39.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.873 . . . . 0.0 110.042 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.545 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -132.03 159.96 37.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.696 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . . . -135.18 81.82 43.39 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.432 -0.793 . . . . 0.0 110.396 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 19.7 Cg_exo -60.54 132.96 45.95 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.936 1.493 . . . . 0.0 110.33 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.905 HG23 ' HB2' ' A' ' 177' ' ' ALA . 46.3 mm -91.88 95.39 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.206 -0.934 . . . . 0.0 110.054 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -151.9 -166.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.38 -0.825 . . . . 0.0 110.726 178.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.58 ' HB2' ' HG2' ' A' ' 108' ' ' GLN . 28.8 mmm180 -88.99 156.91 18.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.467 -0.771 . . . . 0.0 109.587 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -57.52 -14.14 4.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 0.0 110.725 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 35.5 p-10 -127.9 32.13 4.99 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 121.619 -0.676 . . . . 0.0 110.437 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.58 ' HG2' ' HB2' ' A' ' 105' ' ' ARG . 4.8 mm-40 -89.95 -79.99 0.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.946 -1.096 . . . . 0.0 110.78 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -103.28 -32.35 9.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.01 -1.056 . . . . 0.0 110.876 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.771 ' O ' HD12 ' A' ' 110' ' ' LEU . 1.4 pp -99.62 50.14 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 110.179 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -102.83 49.04 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.442 -0.787 . . . . 0.0 110.089 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.452 ' HB2' HD13 ' A' ' 116' ' ' ILE . 57.8 m-85 -124.55 -51.03 1.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.59 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 75.34 175.86 37.75 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 113' ' ' GLY . 96.0 mt-10 43.76 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.148 -1.207 . . . . 0.0 110.507 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.3 -2.91 87.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 117' ' ' GLU . 7.2 tp -59.98 -39.98 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -1.205 . . . . 0.0 110.18 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 97.2 mt-10 -61.48 -42.58 99.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -70.04 -30.12 67.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -58.93 -39.93 83.07 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.256 -0.902 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.783 ' O ' HD22 ' A' ' 124' ' ' LEU . 56.0 t -60.07 -43.79 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 110.316 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.608 ' NE2' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -59.63 -45.06 93.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.987 -1.07 . . . . 0.0 109.575 175.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -59.94 -40.09 87.77 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.22 -22.18 38.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.165 -0.959 . . . . 0.0 110.938 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -130.03 7.22 5.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.94 -1.1 . . . . 0.0 110.674 -174.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.698 ' N ' HD23 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -44.26 173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.311 -0.868 . . . . 0.0 110.883 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 164' ' ' ILE . 15.7 ptm180 34.9 46.63 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.498 -0.751 . . . . 0.0 111.29 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.437 ' H ' ' HB ' ' A' ' 164' ' ' ILE . 8.9 ttt180 -123.33 129.7 24.81 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.87 -1.144 . . . . 0.0 111.19 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.846 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.5 Cg_endo -66.26 125.9 14.8 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.954 1.502 . . . . 0.0 109.647 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.98 ' O ' HD13 ' A' ' 130' ' ' LEU . 97.6 mtp -140.01 151.62 45.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.27 -1.519 . . . . 0.0 112.092 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.98 HD13 ' O ' ' A' ' 129' ' ' MET . 0.5 OUTLIER -126.03 146.16 50.01 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.443 0.639 . . . . 0.0 109.975 172.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.4 pm0 -57.18 140.02 50.83 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.241 -0.912 . . . . 0.0 110.303 172.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 75.2 -0.75 3.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.75 -0.594 . . . . 0.0 110.262 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.801 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -67.81 -172.81 0.3 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.199 -0.938 . . . . 0.0 109.942 176.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 17.1 m-80 -141.18 149.72 41.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.0 165.48 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.016 -1.052 . . . . 0.0 110.493 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 t -140.66 149.36 42.16 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.363 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.724 HG13 ' HD2' ' A' ' 138' ' ' PRO . 77.5 t -135.63 149.93 70.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.706 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.724 ' HD2' HG13 ' A' ' 137' ' ' VAL . 1.4 Cg_endo -46.76 83.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.931 1.49 . . . . 0.0 110.136 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . -139.84 101.58 0.31 Allowed Glycine 0 N--CA 1.482 1.734 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 141' ' ' THR . 1.4 pp -87.14 146.45 26.03 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.428 -1.043 . . . . 0.0 109.784 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 1.036 ' C ' HD13 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -60.82 -170.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.083 -1.01 . . . . 0.0 110.89 -171.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.036 HD13 ' C ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -143.61 -100.58 0.12 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.837 -0.539 . . . . 0.0 110.237 178.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.527 ' H ' HD23 ' A' ' 142' ' ' LEU . . . -78.54 50.18 0.94 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.325 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.64 68.01 1.86 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 142' ' ' LEU . 17.2 pt20 -104.56 172.74 6.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.773 -1.427 . . . . 0.0 109.883 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -137.52 153.24 50.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.397 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.738 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 100.37 -90.72 0.93 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.738 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.5 OUTLIER 41.88 47.32 3.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.415 -1.05 . . . . 0.0 111.122 177.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.8 pp -140.1 167.86 21.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.961 -1.087 . . . . 0.0 110.073 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 66.5 m-85 -101.89 134.61 44.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.032 -1.043 . . . . 0.0 110.665 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 32.3 tptt -118.05 102.21 8.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.922 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.801 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.5 t -74.93 135.73 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.791 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.42 -31.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 110.669 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 54.7 tttm -139.39 148.76 43.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.954 -1.091 . . . . 0.0 110.953 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.083 HG22 HG23 ' A' ' 98' ' ' VAL . 24.4 p -145.07 159.7 42.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.76 -0.588 . . . . 0.0 109.836 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.674 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -90.46 -38.05 0.4 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.344 -0.847 . . . . 0.0 111.015 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 1.1 ' CB ' HG11 ' A' ' 162' ' ' VAL . 12.6 Cg_exo -60.15 -173.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.434 1.228 . . . . 0.0 110.911 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 159' ' ' LYS . 5.4 t -90.17 -168.47 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 0.0 110.103 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 158' ' ' SER . 8.7 ptpt -66.3 -6.01 12.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.437 ' H ' HG22 ' A' ' 160' ' ' VAL . 33.7 m -86.36 152.33 54.97 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.599 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.636 ' HB3' HG11 ' A' ' 51' ' ' VAL . 1.6 Cg_endo -51.52 132.42 40.38 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 124.289 1.678 . . . . 0.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 1.1 HG11 ' CB ' ' A' ' 157' ' ' PRO . 3.5 m -121.96 152.92 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.609 -1.237 . . . . 0.0 110.269 171.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.598 ' HG3' HD13 ' A' ' 94' ' ' ILE . 18.1 pt-20 -103.47 127.93 50.75 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.879 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 1.008 HD12 HG21 ' A' ' 168' ' ' THR . 19.3 mm -71.04 153.4 8.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.136 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.608 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -143.69 167.29 26.7 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 176.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.563 ' HA ' HD11 ' A' ' 125' ' ' ILE . 99.0 mt-10 -56.61 -20.58 21.86 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -1.062 . . . . 0.0 110.397 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -89.94 -9.91 47.04 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.256 -0.903 . . . . 0.0 109.667 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.008 HG21 HD12 ' A' ' 164' ' ' ILE . 95.6 m -62.44 146.65 50.92 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.167 -0.958 . . . . 0.0 109.886 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.5 mttt -97.43 143.97 27.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 109.64 176.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.586 HD11 ' HG2' ' A' ' 121' ' ' GLN . 2.1 mm -106.84 129.45 60.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.14 -0.975 . . . . 0.0 110.453 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 99' ' ' THR . 64.7 mt-10 -116.31 135.2 54.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 110.156 172.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.458 HG12 ' HG ' ' A' ' 100' ' ' LEU . 41.3 mt -140.1 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.873 -176.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 173' ' ' ARG . 3.5 ptm85 -87.9 -175.52 5.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 110.228 -175.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 24.5 pt-20 -120.32 -16.57 8.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.345 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.4 109.96 45.94 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.545 -0.722 . . . . 0.0 109.662 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.652 ' O ' HG21 ' A' ' 180' ' ' VAL . 14.8 Cg_exo -69.97 -154.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 124.14 1.6 . . . . 0.0 110.599 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.905 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -76.88 51.48 0.79 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.694 -0.629 . . . . 0.0 110.207 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 180' ' ' VAL . 36.6 t -110.72 111.49 22.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.995 176.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 178' ' ' SER . 79.7 tt0 59.89 19.98 8.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.439 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.652 HG21 ' O ' ' A' ' 176' ' ' PRO . 23.1 t -101.31 139.72 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.173 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER 39.83 42.83 1.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.562 -0.711 . . . . 0.0 110.561 -178.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -60.84 130.04 44.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.187 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.95 -30.07 68.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 110.221 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 62.95 -131.62 42.95 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 117.989 -1.451 . . . . 0.0 109.481 179.82 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 mmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.38 0.609 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -60.29 -39.7 87.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 110.225 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -60.13 -39.98 88.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.274 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.404 ' ND2' ' HD2' ' A' ' 159' ' ' LYS . 40.6 t-20 -101.01 113.47 26.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.225 -0.922 . . . . 0.0 110.309 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.586 ' ND2' HD22 ' A' ' 34' ' ' LEU . 31.9 p30 -160.46 154.93 23.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.078 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.71 -159.13 8.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.911 ' CG2' HD12 ' A' ' 33' ' ' LEU . 20.6 pt -137.2 169.35 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -112.51 120.51 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.011 -1.056 . . . . 0.0 110.444 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 87' ' ' VAL . 1.7 pt? -139.41 -167.66 2.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.458 -0.776 . . . . 0.0 109.747 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 34.9 ptt180 -118.88 140.02 50.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.794 -1.191 . . . . 0.0 110.715 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.938 HG11 ' O ' ' A' ' 80' ' ' SER . 4.6 p -62.35 147.7 11.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.646 -0.659 . . . . 0.0 110.943 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -122.3 147.66 45.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.903 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.811 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.1 tt0 -177.2 129.13 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 173.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.08 -52.91 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.179 -0.951 . . . . 0.0 110.295 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -149.64 99.47 2.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.274 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.1 p -151.55 159.83 43.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.217 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 75.2 p -75.69 156.89 34.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.942 . . . . 0.0 109.885 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.643 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -59.91 -40.66 80.14 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 110.68 -177.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 13.4 Cg_exo -67.05 149.73 82.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.66 1.347 . . . . 0.0 110.228 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.471 ' C ' ' OD2' ' A' ' 70' ' ' ASP . . . 96.05 43.96 3.17 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.401 ' O ' ' HG3' ' A' ' 73' ' ' MET . 27.1 ptt? -86.53 -0.42 56.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.428 -1.042 . . . . 0.0 109.485 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.8 p -100.53 5.74 44.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.324 -0.86 . . . . 0.0 110.069 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.516 ' HG3' ' CG ' ' A' ' 55' ' ' TYR . 59.8 ttt180 -99.99 113.94 26.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.821 . . . . 0.0 110.091 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.071 HG13 HG23 ' A' ' 67' ' ' VAL . 55.5 t -112.56 112.53 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 0.0 110.271 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.793 ' O ' HD12 ' A' ' 26' ' ' LEU . 7.4 ptt180 -84.24 117.37 23.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.689 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.929 HD13 HG12 ' A' ' 24' ' ' VAL . 1.8 mp -134.83 170.62 15.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.621 -0.674 . . . . 0.0 109.993 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.0 p-10 -105.57 -175.18 2.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 110.507 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -59.91 -42.09 93.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.184 -0.947 . . . . 0.0 109.643 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -67.4 -49.56 63.29 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.3 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.114 ' O ' HD22 ' A' ' 33' ' ' LEU . 72.4 m -57.9 -27.44 63.31 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.119 -0.988 . . . . 0.0 109.56 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 39.9 ttm180 -86.43 -46.08 10.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.822 -0.549 . . . . 0.0 110.957 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -79.71 -8.58 59.32 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.114 HD22 ' O ' ' A' ' 30' ' ' SER . 2.1 pt? -43.85 -28.7 0.47 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -0.779 . . . . 0.0 110.136 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.716 ' H ' HD23 ' A' ' 33' ' ' LEU . 83.2 mt -141.76 -59.43 0.47 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 110.272 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.602 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.4 t0 -170.56 -30.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.424 -0.798 . . . . 0.0 110.066 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.602 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -15.35 120.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.437 0.637 . . . . 0.0 111.581 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.597 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.5 pt-20 -105.87 -177.51 3.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.0 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.422 HD12 HG23 ' A' ' 38' ' ' ILE . 28.5 mm -63.73 119.4 7.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.062 -1.024 . . . . 0.0 110.135 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.608 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.25 35.95 56.3 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.81 178.3 6.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.056 -1.261 . . . . 0.0 109.499 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.616 HG21 ' OG1' ' A' ' 92' ' ' THR . 97.0 t -99.65 127.76 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.015 -1.053 . . . . 0.0 110.301 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG11 HG23 ' A' ' 54' ' ' VAL . 3.1 m -120.95 149.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.514 -0.741 . . . . 0.0 110.683 -177.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -111.93 140.8 46.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.594 -0.691 . . . . 0.0 109.982 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.849 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.5 mp -124.92 144.01 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 120.926 -1.109 . . . . 0.0 110.731 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -150.21 98.79 2.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 110.827 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.946 ' CG ' HG12 ' A' ' 85' ' ' VAL . 9.2 tmtm? -97.94 -64.36 1.05 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.559 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.569 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.17 -36.94 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-O 121.817 0.818 . . . . 0.0 109.098 175.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 70.5 mtt85 -128.95 -173.47 2.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.538 ' HB3' HD21 ' A' ' 130' ' ' LEU . 29.3 mttt -96.18 141.75 29.17 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.122 -0.986 . . . . 0.0 110.902 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.637 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.5 p -145.0 168.2 20.84 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.374 178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.57 162.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.662 -0.649 . . . . 0.0 110.058 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -171.66 41.39 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.216 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.403 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 70.2 ttt180 -121.72 166.44 14.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.458 -1.025 . . . . 0.0 110.165 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -99.94 149.69 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.004 . . . . 0.0 110.412 -175.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 3.0 m-85 -139.16 167.84 21.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.511 -0.743 . . . . 0.0 110.339 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -88.62 122.77 32.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.349 -0.844 . . . . 0.0 110.052 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.834 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.3 138.3 58.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.734 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 2.4 mtp180 -58.35 -47.21 99.21 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.309 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 56.2 Cg_endo -93.51 98.96 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.675 1.355 . . . . 0.0 108.69 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.423 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.5 pt-20 -73.28 35.65 0.08 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.587 -0.696 . . . . 0.0 110.784 -176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.3 m-20 -146.07 -30.79 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -84.96 -28.78 25.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.433 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.834 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 5.3 m120 -80.53 39.64 0.48 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.723 -0.61 . . . . 0.0 110.64 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -98.96 13.34 33.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.072 -1.017 . . . . 0.0 109.663 175.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.72 26.42 0.05 OUTLIER Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.55 149.04 20.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.371 -1.076 . . . . 0.0 108.933 175.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.071 HG23 HG13 ' A' ' 24' ' ' VAL . 7.6 p -126.55 131.81 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.928 -1.108 . . . . 0.0 110.348 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HD2' ' HD3' ' A' ' 25' ' ' ARG . 3.5 ttt180 -89.59 116.24 27.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.086 -1.009 . . . . 0.0 110.325 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.877 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.7 pp -135.36 168.58 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.318 -0.864 . . . . 0.0 111.036 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' OD2' ' C ' ' A' ' 20' ' ' GLY . 78.0 m-20 -82.06 155.54 25.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.282 -0.886 . . . . 0.0 110.201 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' ' CG ' ' A' ' 75' ' ' ASN . 60.1 p -60.12 -23.37 63.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 110.147 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.6 t -68.09 -42.94 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 110.232 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.849 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.95 -50.91 71.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 109.974 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.633 ' HD2' HG21 ' A' ' 11' ' ' VAL . 13.2 mmp_? -60.14 -39.85 87.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 173.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 78.2 m-20 -60.12 -37.77 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 73' ' ' MET . 93.8 m-20 -59.94 -36.25 76.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.914 . . . . 0.0 110.648 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 30.2 p -98.15 -39.33 8.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.105 -0.997 . . . . 0.0 110.531 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.569 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 119.18 36.17 0.89 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 175.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.806 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -116.48 170.2 8.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.327 . . . . 0.0 110.38 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.938 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -121.99 -176.83 3.43 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.811 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -66.57 143.42 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.487 178.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.759 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.13 0.95 67.16 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.3 m-20 -61.33 -165.4 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.071 -1.253 . . . . 0.0 110.581 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.0 pttt -130.64 112.94 13.59 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.407 -0.808 . . . . 0.0 109.945 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.946 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -122.68 161.15 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 109.995 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 26.4 ttmt -104.96 125.67 51.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.011 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.818 HG23 HD21 ' A' ' 9' ' ' LEU . 62.0 t -108.28 121.25 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.507 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.6 mtt180 -111.39 147.13 35.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.409 -0.807 . . . . 0.0 109.419 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 36' ' ' ALA . 6.5 tttt -92.51 139.57 30.45 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.061 -1.024 . . . . 0.0 110.255 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.69 -168.61 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.413 -0.804 . . . . 0.0 110.26 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -132.25 172.28 12.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 109.466 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.616 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.49 159.59 16.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.974 -1.079 . . . . 0.0 111.204 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.555 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.1 pt-20 -150.02 169.97 19.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.657 HD12 ' N ' ' A' ' 94' ' ' ILE . 4.6 mp -89.56 99.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.731 -1.231 . . . . 0.0 110.241 -178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.806 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.0 138.04 44.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.464 -0.772 . . . . 0.0 110.353 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.697 ' CG ' HD13 ' A' ' 156' ' ' LEU . 15.5 ptmt -98.39 -30.01 12.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.34 -0.85 . . . . 0.0 110.849 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.549 ' HB3' HD12 ' A' ' 156' ' ' LEU . 14.7 tttp -151.06 125.61 9.55 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.85 -1.156 . . . . 0.0 110.803 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.063 HG23 HG22 ' A' ' 155' ' ' THR . 8.6 p -137.52 147.17 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.996 -1.065 . . . . 0.0 111.044 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.758 HG23 ' HB3' ' A' ' 171' ' ' GLU . 38.0 m -119.14 142.82 47.6 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.339 -0.851 . . . . 0.0 110.111 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.686 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -138.54 169.03 18.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.06 -1.025 . . . . 0.0 110.847 -179.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.38 93.84 4.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.415 -0.803 . . . . 0.0 110.489 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 13.7 Cg_exo -65.57 128.9 21.1 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.201 1.632 . . . . 0.0 110.417 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.971 HG23 ' HB2' ' A' ' 177' ' ' ALA . 91.3 mt -90.02 96.41 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 110.151 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.792 HD13 ' HB3' ' A' ' 108' ' ' GLN . 0.8 OUTLIER -150.01 -175.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.352 -0.842 . . . . 0.0 110.5 176.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -135.23 -134.18 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 109.575 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -60.68 -17.2 46.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.997 -1.064 . . . . 0.0 109.925 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -98.93 26.23 5.95 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.42 0.629 . . . . 0.0 110.015 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.792 ' HB3' HD13 ' A' ' 104' ' ' ILE . 28.5 pt20 -83.7 151.63 25.15 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.444 -0.785 . . . . 0.0 110.107 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -88.54 -14.9 36.58 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.385 -0.822 . . . . 0.0 110.174 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.493 HD22 ' HG2' ' A' ' 102' ' ' PRO . 0.6 OUTLIER -99.64 57.15 1.01 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 110.32 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -105.11 54.85 0.7 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.903 . . . . 0.0 110.405 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -131.27 -53.42 1.03 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 110.578 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 74.41 174.23 31.5 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -176.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.49 ' O ' ' O ' ' A' ' 113' ' ' GLY . 98.2 mt-10 47.79 102.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.083 -1.245 . . . . 0.0 110.089 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.55 57.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.5 tp -60.14 -36.44 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -1.203 . . . . 0.0 110.064 175.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.7 mt-10 -60.03 -42.12 93.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.27 -37.51 83.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 109.6 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -59.97 -42.42 94.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.589 HG12 ' CD1' ' A' ' 170' ' ' ILE . 53.1 t -60.26 -45.01 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 175.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.583 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.1 mt-30 -59.89 -43.97 94.5 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.568 -0.707 . . . . 0.0 109.951 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.31 -46.01 91.4 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.819 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.9 68.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 110.921 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 2.9 mm? -99.89 5.33 45.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.025 -1.047 . . . . 0.0 111.171 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.706 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.7 tt -48.71 170.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.369 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 36.6 ptt180 33.66 49.12 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.628 -0.67 . . . . 0.0 111.516 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 0.7 OUTLIER -132.37 149.93 74.51 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.711 -1.243 . . . . 0.0 111.232 176.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.834 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.1 Cg_endo -68.73 128.19 16.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 124.174 1.618 . . . . 0.0 109.971 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.7 mmm -123.07 140.95 52.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.321 -1.487 . . . . 0.0 110.983 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 50' ' ' THR . 20.2 tp -139.24 104.19 4.94 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.695 -0.628 . . . . 0.0 109.386 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.642 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.5 pt-20 -45.24 137.09 4.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.046 -1.034 . . . . 0.0 110.7 -174.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.642 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 86.01 -6.06 0.8 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.27 0.557 . . . . 0.0 110.283 -178.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.561 ' OD2' ' HB ' ' A' ' 152' ' ' VAL . 2.8 p30 -69.49 -178.31 1.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.446 -0.784 . . . . 0.0 110.359 177.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -147.1 153.09 39.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 109.549 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.03 160.64 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.941 -1.099 . . . . 0.0 110.65 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.0 t -140.51 157.18 45.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.671 -0.643 . . . . 0.0 110.355 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.888 ' HB ' HD22 ' A' ' 140' ' ' LEU . 91.2 t -99.55 148.39 34.65 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 109.942 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.69 ' HD2' HG13 ' A' ' 137' ' ' VAL . 1.9 Cg_endo -44.94 87.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.977 1.514 . . . . 0.0 110.995 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 46.0 60.31 4.55 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.912 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -110.57 153.0 25.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.027 -1.278 . . . . 0.0 109.482 176.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -176.17 -171.83 0.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.067 -1.021 . . . . 0.0 110.749 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.55 ' N ' ' OG1' ' A' ' 141' ' ' THR . 82.7 mt -146.76 -127.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.891 -0.506 . . . . 0.0 109.796 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -58.4 -153.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.026 . . . . 0.0 110.176 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.29 75.63 2.18 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.794 ' OE1' HD13 ' A' ' 148' ' ' LEU . 4.0 pt20 -96.33 170.07 9.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.476 -1.014 . . . . 0.0 110.385 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 t -135.99 154.16 51.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.968 . . . . 0.0 110.216 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.707 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 69.7 -84.31 0.28 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.794 HD13 ' OE1' ' A' ' 145' ' ' GLN . 0.4 OUTLIER 43.68 49.7 6.65 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.584 -0.951 . . . . 0.0 110.946 178.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 pp -140.39 163.77 31.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.979 -1.075 . . . . 0.0 109.803 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.7 m-85 -91.02 126.49 36.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.078 -1.014 . . . . 0.0 110.049 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -112.4 111.95 23.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.561 ' HB ' ' OD2' ' A' ' 133' ' ' ASP . 2.7 t -78.15 137.57 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.911 . . . . 0.0 109.89 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.48 -31.44 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.257 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -143.43 146.98 33.91 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.411 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.063 HG22 HG23 ' A' ' 98' ' ' VAL . 56.0 p -140.0 161.68 37.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.697 HD13 ' CG ' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -89.26 -35.91 0.42 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.96 -1.087 . . . . 0.0 111.103 -177.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.942 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.3 Cg_exo -58.61 -167.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.327 1.172 . . . . 0.0 109.774 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 160' ' ' VAL . 29.1 t -87.68 -173.88 4.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.792 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.404 ' HD2' ' ND2' ' A' ' 4' ' ' ASN . 12.3 ptpt -67.9 -1.84 6.32 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.176 -0.953 . . . . 0.0 110.567 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' A' ' 158' ' ' SER . 33.1 m -85.79 147.73 46.76 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.146 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.585 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.8 Cg_endo -47.45 139.07 17.74 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 O-C-N 124.358 1.715 . . . . 0.0 110.975 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.942 HG11 ' CB ' ' A' ' 157' ' ' PRO . 11.1 m -130.02 159.21 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 109.442 171.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.3 tt0 -106.61 127.23 53.17 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.048 -1.032 . . . . 0.0 110.229 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.84 ' CD1' HG21 ' A' ' 168' ' ' THR . 16.6 mm -70.43 154.13 8.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.667 -0.646 . . . . 0.0 110.213 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.24 175.4 23.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.706 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -58.75 -26.05 63.61 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.341 -1.094 . . . . 0.0 109.992 -178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -89.36 -17.76 28.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 0.0 110.737 -176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.84 HG21 ' CD1' ' A' ' 164' ' ' ILE . 53.3 m -58.73 146.37 36.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 97' ' ' LYS . 98.6 mttt -100.01 153.14 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.955 -1.091 . . . . 0.0 109.467 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.637 HG23 HD21 ' A' ' 100' ' ' LEU . 2.1 mt -129.92 159.4 41.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.001 -1.062 . . . . 0.0 111.185 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.758 ' HB3' HG23 ' A' ' 99' ' ' THR . 10.4 mt-10 -130.35 130.91 45.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.029 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 120' ' ' VAL . 50.5 mm -119.91 127.18 75.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.32 -0.863 . . . . 0.0 109.905 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 2.9 ptp180 -88.6 144.51 26.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.056 -1.028 . . . . 0.0 110.262 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.545 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 85.6 tt0 -89.97 0.06 57.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 110.108 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 3.4 tm-20 -93.55 107.19 24.88 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.621 -0.674 . . . . 0.0 109.742 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.7 Cg_exo -70.78 -154.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 124.063 1.559 . . . . 0.0 109.932 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.971 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -85.1 39.69 0.78 Allowed 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.469 -0.769 . . . . 0.0 110.476 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 93.6 p -99.33 37.2 1.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.429 -0.795 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 83.5 tt0 -178.06 20.25 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.901 -1.124 . . . . 0.0 110.428 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.3 t -90.96 117.2 33.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.197 -0.94 . . . . 0.0 109.945 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.11 6.7 44.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.065 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 48.14 -116.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -0.863 . . . . 0.0 110.023 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -60.09 139.92 57.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.929 -1.107 . . . . 0.0 110.08 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -171.47 139.91 5.62 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.542 179.292 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.266 0.555 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.49 161.57 18.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.277 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -59.97 -28.01 67.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.378 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -103.5 127.48 50.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -0.965 . . . . 0.0 110.542 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -149.91 159.99 43.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.341 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -147.09 -169.71 14.82 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.008 HG23 HD11 ' A' ' 34' ' ' LEU . 45.7 pt -134.82 159.99 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.228 -1.16 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 86' ' ' LYS . 40.4 mm -98.37 116.87 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 110.331 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.3 pt? -139.37 -178.26 5.3 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.324 -0.86 . . . . 0.0 109.728 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.73 ' HG2' HG22 ' A' ' 66' ' ' ILE . 6.3 ptp180 -106.73 137.0 45.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 110.899 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.048 HG23 HD11 ' A' ' 69' ' ' ILE . 13.5 p -63.75 134.81 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.596 -0.69 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -119.79 153.47 35.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.242 -0.911 . . . . 0.0 110.421 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.874 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -173.73 159.55 3.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.253 -0.904 . . . . 0.0 110.607 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB3' ' OD2' ' A' ' 18' ' ' ASP . . . -126.4 170.22 12.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.996 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -69.94 -20.04 63.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.948 . . . . 0.0 110.188 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' OG1' ' A' ' 17' ' ' THR . 23.3 t -159.43 -173.8 4.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.853 . . . . 0.0 110.293 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.474 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 3.5 p 57.11 -163.82 0.17 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.507 -0.745 . . . . 0.0 110.554 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.585 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 2.0 p30 37.53 62.29 3.71 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.616 -0.677 . . . . 0.0 110.53 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 13.3 Cg_exo -66.09 -175.07 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.02 1.537 . . . . 0.0 110.143 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.46 85.75 1.71 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.403 ' O ' ' HB2' ' A' ' 73' ' ' MET . 23.2 ptp -89.29 -11.92 42.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -1.143 . . . . 0.0 110.076 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.59 19.17 17.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 109.894 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.517 ' HD3' ' CE1' ' A' ' 55' ' ' TYR . 18.1 mtt-85 -129.16 148.95 51.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 110.175 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.082 HG13 HG23 ' A' ' 67' ' ' VAL . 97.6 t -117.15 122.02 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.502 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 1.6 ptm180 -95.64 119.33 33.95 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.742 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.571 ' C ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -140.69 174.85 10.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.636 -0.665 . . . . 0.0 109.513 -177.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' OD2' ' HG2' ' A' ' 64' ' ' LYS . 1.1 p-10 -90.28 177.64 6.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.927 -1.108 . . . . 0.0 110.737 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -59.99 -41.1 91.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 108.801 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.0 t -62.77 -58.38 7.64 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.076 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.666 ' O ' HD22 ' A' ' 33' ' ' LEU . 58.4 m -49.91 -30.39 10.1 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.833 -1.167 . . . . 0.0 109.572 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.478 ' N ' HD12 ' A' ' 26' ' ' LEU . 40.3 ttm180 -81.62 -45.52 15.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 111.603 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -97.95 -10.6 24.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.673 -1.267 . . . . 0.0 110.958 -172.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.991 HD23 ' H ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -59.94 -26.02 65.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.987 -1.07 . . . . 0.0 109.774 179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.008 HD11 HG23 ' A' ' 7' ' ' ILE . 54.4 mt -110.63 -75.87 0.61 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.145 -0.972 . . . . 0.0 110.277 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.535 ' HB3' ' CD ' ' A' ' 89' ' ' LYS . 9.4 t70 -168.27 -20.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.574 -0.704 . . . . 0.0 109.971 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.594 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -40.46 126.78 2.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.358 -0.839 . . . . 0.0 110.681 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.705 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.3 pt-20 -119.12 179.77 4.07 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 108.929 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.434 ' HA ' HD13 ' A' ' 38' ' ' ILE . 5.5 mm -55.81 127.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.005 -1.06 . . . . 0.0 109.875 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.62 24.3 74.97 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.708 174.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 6.9 m-20 -89.01 169.94 11.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.754 -1.439 . . . . 0.0 109.855 173.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.741 HG21 ' OG1' ' A' ' 92' ' ' THR . 79.2 t -99.78 127.97 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.052 -1.03 . . . . 0.0 110.137 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.604 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.6 m -116.02 143.71 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.285 -0.884 . . . . 0.0 110.222 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 86.3 tt0 -113.28 143.2 44.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.735 . . . . 0.0 109.632 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.817 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.8 mp -119.97 145.9 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.023 . . . . 0.0 110.198 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.7 tt0 -151.8 88.53 1.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.062 -1.024 . . . . 0.0 111.612 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 85' ' ' VAL . 31.0 tttm -99.23 -71.74 0.68 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.054 -1.029 . . . . 0.0 110.2 171.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.539 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.15 -34.71 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.507 -0.746 . . . . 0.0 109.409 178.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 49.8 mtm180 -141.3 -173.28 3.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.5 -0.75 . . . . 0.0 109.892 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.668 ' C ' HD21 ' A' ' 130' ' ' LEU . 2.1 mptm? -87.84 133.22 33.93 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.097 -1.002 . . . . 0.0 110.325 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -134.93 159.28 41.94 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.354 0.597 . . . . 0.0 110.318 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -124.39 162.17 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.825 . . . . 0.0 109.963 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.604 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.71 -179.83 48.01 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.995 175.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 61.8 ttt180 -116.6 169.84 9.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 0.0 110.214 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.85 131.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 110.322 -175.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.517 ' CE1' ' HD3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -121.3 163.67 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.551 -0.718 . . . . 0.0 110.009 175.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -90.68 124.19 34.88 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.421 -0.799 . . . . 0.0 110.134 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -63.22 139.25 58.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.568 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -58.74 -49.05 95.51 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.186 174.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.2 Cg_endo -91.06 98.78 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 108.922 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 15.7 pt-20 -73.07 35.93 0.08 Allowed 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.65 -0.657 . . . . 0.0 110.749 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.5 m-20 -148.91 -33.42 0.22 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.252 -0.905 . . . . 0.0 110.721 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.23 -26.49 28.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.12 -0.987 . . . . 0.0 109.166 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.846 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 13.4 m120 -80.94 42.29 0.63 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.769 -0.582 . . . . 0.0 110.537 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 34.4 mtpt -97.79 10.0 41.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.307 -0.871 . . . . 0.0 109.563 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 179.48 28.84 0.05 OUTLIER Glycine 0 N--CA 1.48 1.62 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.73 HG22 ' HG2' ' A' ' 10' ' ' ARG . 45.1 pt -140.59 143.88 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -1.154 . . . . 0.0 109.55 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.082 HG23 HG13 ' A' ' 24' ' ' VAL . 2.5 p -120.8 127.59 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.06 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.421 ' HB3' ' HD2' ' A' ' 25' ' ' ARG . 20.8 tpp180 -90.63 114.9 27.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.088 -1.008 . . . . 0.0 109.906 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.048 HD11 HG23 ' A' ' 11' ' ' VAL . 2.4 pt -130.05 161.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.372 -0.83 . . . . 0.0 110.643 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -79.99 169.94 17.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.586 -0.696 . . . . 0.0 110.047 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.442 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 21.5 t -60.2 -36.74 78.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 110.365 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.27 -45.9 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 109.888 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.817 ' HE1' HD13 ' A' ' 44' ' ' ILE . 13.7 tpt -60.13 -43.45 95.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 109.588 176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -60.0 -40.03 87.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.761 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -69.41 -25.94 64.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' MET . 5.4 m120 -60.12 -40.02 88.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.655 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.0 p -99.91 -38.06 8.78 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.985 -1.072 . . . . 0.0 110.545 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.539 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.79 30.85 2.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.598 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.43 169.49 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -1.131 . . . . 0.0 110.74 -174.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.94 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -116.7 170.96 8.19 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.341 -0.849 . . . . 0.0 109.039 174.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.874 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -63.27 140.57 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 120.794 -1.192 . . . . 0.0 110.429 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.633 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.82 -2.95 62.31 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 172.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -59.64 -159.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.101 -1.235 . . . . 0.0 110.394 174.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 54.6 pttt -138.79 119.76 14.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.78 . . . . 0.0 109.836 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.731 HG12 ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -123.02 161.38 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 109.895 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.464 ' HB2' ' CD1' ' A' ' 8' ' ' ILE . 20.0 ttpt -105.31 120.02 40.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 110.061 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.498 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.6 t -103.71 121.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.508 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.7 mtt180 -111.3 131.84 54.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.358 -0.839 . . . . 0.0 110.146 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.535 ' CD ' ' HB3' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -74.91 137.87 41.99 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.268 -0.895 . . . . 0.0 110.302 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 41' ' ' VAL . 2.2 m -149.45 -169.5 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.066 177.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -127.99 170.98 12.27 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.484 -0.76 . . . . 0.0 109.618 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.741 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -110.01 159.95 16.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 111.052 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.584 ' HG2' HG12 ' A' ' 162' ' ' VAL . 16.9 pt-20 -146.29 173.68 12.03 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.4 mm -88.94 99.03 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.681 -1.262 . . . . 0.0 110.178 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.854 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.09 138.79 36.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.415 -0.803 . . . . 0.0 110.301 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.543 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 16.9 ptpt -103.96 -28.25 11.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.955 . . . . 0.0 111.066 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.73 ' HB3' HD23 ' A' ' 156' ' ' LEU . 52.5 tttp -150.04 123.08 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.761 -1.212 . . . . 0.0 110.253 -177.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.707 HG23 HG22 ' A' ' 155' ' ' THR . 9.7 p -137.07 140.29 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.127 -0.983 . . . . 0.0 110.484 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.54 HG23 ' HB3' ' A' ' 171' ' ' GLU . 21.7 m -110.98 134.52 52.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 109.968 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.681 HD11 HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -130.79 159.83 36.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.392 -0.817 . . . . 0.0 110.162 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -128.74 100.04 22.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 110.438 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -56.2 122.26 11.46 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.007 1.53 . . . . 0.0 110.039 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.744 HG23 ' HB2' ' A' ' 177' ' ' ALA . 49.0 mm -89.86 109.87 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.12 -0.987 . . . . 0.0 110.245 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.857 HD12 ' CG ' ' A' ' 108' ' ' GLN . 20.0 pt -150.09 -160.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.266 -0.896 . . . . 0.0 110.629 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.57 ' HB3' ' OD1' ' A' ' 107' ' ' ASP . 22.6 mmt180 -112.19 157.94 20.28 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.296 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -60.05 -17.82 41.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 109.781 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.57 ' OD1' ' HB3' ' A' ' 105' ' ' ARG . 12.2 p-10 -100.73 32.72 3.02 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.857 ' CG ' HD12 ' A' ' 104' ' ' ILE . 1.3 pp0? -80.84 149.89 29.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.454 -0.779 . . . . 0.0 110.241 -174.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.752 ' HB3' HD11 ' A' ' 142' ' ' LEU . 33.5 ttm180 -89.08 -13.1 39.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 110.889 -174.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.565 ' HG ' ' OE1' ' A' ' 108' ' ' GLN . 0.7 OUTLIER -98.0 77.98 2.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 0.0 110.133 -177.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -133.19 62.93 1.65 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.519 -0.738 . . . . 0.0 109.987 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -90.46 -56.15 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.107 -0.996 . . . . 0.0 110.616 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 74.85 -169.1 54.61 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -177.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 113' ' ' GLY . 98.8 mt-10 45.91 99.54 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.207 -1.172 . . . . 0.0 110.151 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.89 -23.09 11.27 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.442 HG21 ' HA2' ' A' ' 113' ' ' GLY . 8.2 tt -59.54 -34.57 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.071 -1.252 . . . . 0.0 110.257 176.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' HG2' HG12 ' A' ' 172' ' ' ILE . 97.2 mt-10 -60.03 -44.81 94.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.62 -37.25 86.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 109.594 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -60.0 -39.99 87.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.812 . . . . 0.0 109.599 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.681 HG11 HD11 ' A' ' 100' ' ' LEU . 79.3 t -59.99 -46.81 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.992 . . . . 0.0 109.371 175.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.681 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -59.88 -39.82 86.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 175.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -60.05 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.159 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.81 65.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.353 -0.842 . . . . 0.0 110.577 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.611 HD12 ' CG1' ' A' ' 120' ' ' VAL . 86.0 mt -91.04 -9.46 45.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.834 -173.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 164' ' ' ILE . 3.3 tt -42.39 167.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.178 -0.951 . . . . 0.0 110.591 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 164' ' ' ILE . 26.1 ptt180 33.26 46.2 0.1 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.692 -0.63 . . . . 0.0 111.429 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.502 ' CG ' ' HD2' ' A' ' 128' ' ' PRO . 18.8 ttm180 -132.07 142.5 45.33 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.653 -1.28 . . . . 0.0 111.225 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.855 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.7 Cg_endo -64.6 126.34 16.62 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 124.258 1.662 . . . . 0.0 109.427 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.569 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.4 mmm -124.6 145.58 49.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.395 -1.441 . . . . 0.0 111.076 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.668 HD21 ' C ' ' A' ' 49' ' ' LYS . 12.8 tp -142.55 116.67 9.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.694 -0.629 . . . . 0.0 109.559 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 2.5 pm0 -47.9 148.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.911 -1.118 . . . . 0.0 110.517 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.622 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 74.98 -2.41 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.788 -0.57 . . . . 0.0 110.871 179.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.624 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.2 p30 -69.34 -171.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.454 ' C ' HG13 ' A' ' 135' ' ' ILE . 15.1 m-80 -149.44 132.15 15.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.538 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.705 HD11 ' CG2' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -136.45 162.2 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.018 -1.051 . . . . 0.0 110.486 -178.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.0 t -134.56 148.21 50.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.672 -0.642 . . . . 0.0 110.268 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.709 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 51.9 t -133.63 -65.01 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 111.039 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 36.4 Cg_endo -70.11 122.7 9.27 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.104 1.055 . . . . 0.0 110.39 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -95.62 44.57 2.08 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.441 HD12 ' C ' ' A' ' 140' ' ' LEU . 1.4 pp -130.89 152.88 49.74 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.465 -1.021 . . . . 0.0 110.072 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.546 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -131.51 -171.1 2.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.096 -1.002 . . . . 0.0 110.787 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 109' ' ' ARG . 87.1 mt -139.79 -123.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.683 -0.636 . . . . 0.0 109.967 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.22 -154.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.28 -0.888 . . . . 0.0 110.683 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.25 57.58 4.65 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.57 ' NE2' HD11 ' A' ' 148' ' ' LEU . 14.6 pt20 -102.71 158.1 16.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.399 -1.059 . . . . 0.0 110.316 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.3 t -139.92 155.45 47.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 110.123 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.21 -91.26 0.75 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.57 HD11 ' NE2' ' A' ' 145' ' ' GLN . 3.4 mp 49.68 56.9 7.15 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.214 -1.168 . . . . 0.0 110.366 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 135' ' ' ILE . 1.4 pp -140.37 166.77 23.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.348 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.692 ' O ' HD12 ' A' ' 135' ' ' ILE . 77.9 m-85 -93.1 120.73 33.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.952 -1.093 . . . . 0.0 110.094 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 15.3 tptm -97.77 106.35 18.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.447 -0.783 . . . . 0.0 109.725 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.705 ' CG2' HD11 ' A' ' 135' ' ' ILE . 2.8 t -76.64 134.47 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.995 . . . . 0.0 109.716 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.466 HG11 HH22 ' A' ' 173' ' ' ARG . 2.8 t -129.47 -20.44 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 110.457 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.5 tttm -139.58 140.42 37.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.68 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.707 HG22 HG23 ' A' ' 98' ' ' VAL . 47.0 p -139.75 161.53 37.33 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.7 -0.625 . . . . 0.0 109.602 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.55 -34.41 0.42 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 110.992 -177.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.927 ' CG ' HG11 ' A' ' 162' ' ' VAL . 29.4 Cg_exo -55.82 -168.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.343 1.181 . . . . 0.0 110.197 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 160' ' ' VAL . 16.1 t -90.15 40.18 1.0 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.651 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 158' ' ' SER . 26.4 mmtp 59.97 42.31 16.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.804 ' O ' HG13 ' A' ' 162' ' ' VAL . 33.2 m -136.07 160.06 68.64 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.517 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -49.53 120.11 5.42 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 124.09 1.574 . . . . 0.0 110.155 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.927 HG11 ' CG ' ' A' ' 157' ' ' PRO . 11.7 m -128.19 159.52 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.479 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -103.93 124.48 49.07 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.235 -0.916 . . . . 0.0 110.201 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 125' ' ' ILE . 16.1 mm -72.06 153.67 7.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.817 -0.552 . . . . 0.0 110.301 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.53 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -140.8 166.67 25.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.69 ' HB3' HD11 ' A' ' 125' ' ' ILE . 19.1 pt-20 -58.14 -18.24 24.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.433 -1.04 . . . . 0.0 110.29 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -89.21 -13.72 37.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.92 . . . . 0.0 110.375 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 95' ' ' ALA . 7.2 m -62.52 150.82 39.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.014 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -98.6 153.62 18.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.27 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.681 HD11 ' HG2' ' A' ' 121' ' ' GLN . 3.6 mm -119.88 134.81 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 0.0 110.927 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.669 ' O ' HD13 ' A' ' 172' ' ' ILE . 37.0 mt-10 -119.7 132.55 55.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.112 -0.993 . . . . 0.0 110.564 172.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.669 HD13 ' O ' ' A' ' 171' ' ' GLU . 21.4 mm -127.33 122.78 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.457 -0.777 . . . . 0.0 109.748 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.49 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 13.3 ptp180 -90.07 166.36 13.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.057 -1.027 . . . . 0.0 110.506 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.494 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 28.9 tp10 -99.81 9.76 42.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 110.692 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.37 109.39 42.53 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 110.282 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.2 Cg_exo -73.08 -156.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.07 1.563 . . . . 0.0 110.545 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.744 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -77.22 54.4 1.09 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.671 -0.643 . . . . 0.0 110.068 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.565 ' O ' HG23 ' A' ' 180' ' ' VAL . 1.5 m -69.49 127.27 32.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 110.125 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 178' ' ' SER . 84.0 tt0 59.99 14.64 4.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 110.723 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 178' ' ' SER . 62.5 t -110.04 120.07 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.992 -1.067 . . . . 0.0 110.374 177.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.973 HD12 ' CG ' ' A' ' 183' ' ' GLU . 0.2 OUTLIER -129.17 4.2 5.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.09 -1.006 . . . . 0.0 110.283 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 181' ' ' LEU . 40.9 mt-10 59.4 13.37 3.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.351 -0.843 . . . . 0.0 111.017 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.973 ' CG ' HD12 ' A' ' 181' ' ' LEU . 78.8 mm-40 -69.98 149.99 47.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.913 -1.117 . . . . 0.0 110.174 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.95 96.46 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.613 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.286 0.565 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -80.03 160.03 25.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 t -116.98 132.95 56.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 0.0 110.351 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -121.08 129.36 53.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.268 -0.895 . . . . 0.0 110.422 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.549 ' O ' HD13 ' A' ' 34' ' ' LEU . 16.7 m120 -130.67 170.02 14.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.203 -0.936 . . . . 0.0 110.447 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -145.81 -166.49 11.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.975 ' CG2' HD12 ' A' ' 33' ' ' LEU . 20.5 pt -132.52 160.02 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.24 . . . . 0.0 109.887 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.4 mt -100.12 117.81 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.711 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.7 pt? -136.87 -168.3 2.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.375 -0.828 . . . . 0.0 109.625 176.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 29.0 ptt180 -115.65 138.61 50.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.826 -1.172 . . . . 0.0 110.894 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.034 ' CG2' HD11 ' A' ' 69' ' ' ILE . 14.6 p -62.64 137.51 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.766 -0.584 . . . . 0.0 110.713 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -112.03 147.24 36.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 110.415 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.878 ' CB ' HD11 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -179.85 90.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.145 176.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.95 87.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.314 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -135.87 173.51 11.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.913 . . . . 0.0 110.117 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -100.0 120.2 39.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.869 . . . . 0.0 110.202 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -107.87 137.14 46.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 110.386 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.657 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -64.64 -38.76 34.19 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.883 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 24.6 Cg_exo -58.56 -169.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.621 1.327 . . . . 0.0 110.581 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA2' ' CB ' ' A' ' 70' ' ' ASP . . . 164.35 85.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.52 ' HG3' ' HB3' ' A' ' 23' ' ' ARG . 28.6 ptm -97.23 18.7 14.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -1.114 . . . . 0.0 110.361 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.1 p 50.01 48.32 22.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.183 -0.948 . . . . 0.0 110.407 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB3' ' HG3' ' A' ' 21' ' ' MET . 39.2 ptt180 -95.92 137.42 35.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 109.998 175.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.043 HG13 HG23 ' A' ' 67' ' ' VAL . 75.2 t -117.15 113.56 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.02 . . . . 0.0 110.086 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.758 ' O ' HD12 ' A' ' 26' ' ' LEU . 8.2 ptt180 -92.26 120.11 32.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.704 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -135.38 165.75 24.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.071 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 23.1 p-10 -90.02 -176.48 4.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.115 -0.991 . . . . 0.0 110.584 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.1 -45.15 93.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.282 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 43.5 t -60.24 -49.25 78.36 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.165 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.161 ' O ' HD22 ' A' ' 33' ' ' LEU . 74.7 m -56.68 -29.44 62.37 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.128 -0.983 . . . . 0.0 109.607 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 68.1 ttt-85 -82.5 -45.35 14.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.774 . . . . 0.0 110.763 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -87.61 -0.26 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.161 HD22 ' O ' ' A' ' 30' ' ' SER . 1.5 pt? -52.56 -26.36 13.11 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.854 ' H ' HD23 ' A' ' 33' ' ' LEU . 71.4 mt -142.27 -59.07 0.46 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.53 -0.731 . . . . 0.0 110.329 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 36' ' ' ALA . 35.8 t0 -170.72 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 110.022 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.558 ' C ' ' O ' ' A' ' 35' ' ' ASP . . . -21.9 118.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.497 0.665 . . . . 0.0 111.373 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.493 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -107.78 176.75 5.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.8 mm -59.12 125.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.822 -1.174 . . . . 0.0 109.665 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.47 27.49 61.3 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.566 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -89.49 173.29 8.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.428 . . . . 0.0 109.72 171.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.963 HG21 HG23 ' A' ' 92' ' ' THR . 64.7 t -99.48 131.45 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.017 -1.052 . . . . 0.0 110.269 -176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.606 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -117.06 139.83 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.176 -0.953 . . . . 0.0 110.301 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -108.32 140.12 42.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.395 -0.816 . . . . 0.0 109.565 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.807 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -122.78 145.45 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.903 -1.123 . . . . 0.0 110.592 -176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -150.13 95.19 2.25 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.834 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.027 ' CG ' HG12 ' A' ' 85' ' ' VAL . 12.6 tmtt? -97.92 -65.49 0.96 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.766 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.567 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.91 -36.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.457 -0.777 . . . . 0.0 109.225 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 68.2 mtp85 -127.99 -160.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.664 0.745 . . . . 0.0 110.111 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.491 ' HB3' HD21 ' A' ' 130' ' ' LEU . 3.1 mtmt -106.13 131.38 53.46 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 110.369 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.61 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.7 p -138.51 165.0 27.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.855 . . . . 0.0 110.112 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.39 166.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.603 -0.686 . . . . 0.0 109.913 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.0 -174.28 44.17 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -122.07 164.96 16.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -1.083 . . . . 0.0 110.02 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -92.54 139.99 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 110.747 -172.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 24' ' ' VAL . 2.2 m-85 -125.81 162.5 24.97 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.52 -0.738 . . . . 0.0 110.125 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 8.7 ptp180 -89.91 124.6 34.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.34 -0.85 . . . . 0.0 109.905 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.651 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -64.5 136.4 57.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.084 -1.01 . . . . 0.0 109.809 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.579 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -57.85 -50.06 90.24 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 109.071 175.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 38.0 Cg_endo -92.98 98.01 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.867 1.456 . . . . 0.0 108.868 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.59 38.22 0.12 Allowed 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -143.75 -38.94 0.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.613 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 13.8 pt-20 -85.56 -22.39 28.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.007 . . . . 0.0 109.727 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.651 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 27.9 m-80 -81.68 37.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.414 -0.804 . . . . 0.0 110.715 177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' CA ' ' OD2' ' A' ' 27' ' ' ASP . 54.4 pttt -98.43 12.25 35.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.997 -1.065 . . . . 0.0 109.547 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.82 26.53 0.05 OUTLIER Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -140.53 144.9 26.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.3 -1.117 . . . . 0.0 109.177 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.043 HG23 HG13 ' A' ' 24' ' ' VAL . 6.5 p -125.83 129.91 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.029 -1.045 . . . . 0.0 110.265 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.539 ' HD3' ' HD3' ' A' ' 25' ' ' ARG . 58.8 ttt85 -89.7 119.93 30.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 110.3 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.034 HD11 ' CG2' ' A' ' 11' ' ' VAL . 3.8 pt -130.6 167.92 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.818 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' CB ' ' HA2' ' A' ' 20' ' ' GLY . 3.7 t0 -80.06 166.51 21.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.065 176.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.4 t -60.21 -39.98 88.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -43.3 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.038 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.807 ' CE ' HD13 ' A' ' 44' ' ' ILE . 13.3 tpt -60.06 -46.91 87.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.616 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.1 ttp85 -60.0 -39.99 87.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -70.06 -27.11 64.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 110.292 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.5 m-20 -60.01 -40.01 87.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.02 . . . . 0.0 110.767 -177.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.518 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.5 p -99.53 -39.04 8.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.101 . . . . 0.0 110.723 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.567 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 116.13 40.73 0.8 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 176.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -112.61 160.73 17.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.025 -1.279 . . . . 0.0 110.659 -176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.695 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.9 168.88 9.14 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 176.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.878 HD11 ' CB ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -53.04 139.01 11.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.034 -1.041 . . . . 0.0 110.609 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.65 2.58 70.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 171.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.62 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 O-C-N 120.885 -1.362 . . . . 0.0 110.228 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 22.8 pttt -131.94 109.83 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.027 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -119.97 150.24 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.955 . . . . 0.0 109.864 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 67.6 tttt -99.94 120.07 39.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.752 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.687 HG23 HD21 ' A' ' 9' ' ' LEU . 62.6 t -103.2 122.4 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.483 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 98.2 mtt180 -108.65 140.05 42.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -0.856 . . . . 0.0 109.544 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.507 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -88.21 138.2 31.65 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.069 -1.02 . . . . 0.0 110.32 -178.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.506 HG23 HG12 ' A' ' 41' ' ' VAL . 2.4 m -150.17 -170.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.652 -0.655 . . . . 0.0 110.085 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.441 ' CA ' ' HB ' ' A' ' 41' ' ' VAL . 61.4 mtt180 -126.46 179.99 5.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.057 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.963 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -108.76 162.73 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 111.209 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.546 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.1 pt-20 -150.03 169.13 21.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mm -89.23 97.87 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.33 -1.482 . . . . 0.0 110.3 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.22 138.82 49.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -0.837 . . . . 0.0 110.387 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.513 ' HD2' ' CD1' ' A' ' 156' ' ' LEU . 18.6 ptpt -97.22 -27.17 14.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 111.153 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.739 ' HB3' HD23 ' A' ' 156' ' ' LEU . 31.5 tttt -150.09 121.9 8.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.82 -1.175 . . . . 0.0 110.558 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.95 HG23 HG22 ' A' ' 155' ' ' THR . 5.7 p -136.13 142.53 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.434 ' HA ' ' HB2' ' A' ' 171' ' ' GLU . 97.7 m -115.81 136.37 53.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 0.0 110.283 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -131.42 160.07 36.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.478 -0.763 . . . . 0.0 110.155 -177.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -146.23 101.74 4.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.224 -0.922 . . . . 0.0 110.883 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 15.4 Cg_exo -64.14 129.24 23.74 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.072 1.564 . . . . 0.0 110.299 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.887 HG23 ' CB ' ' A' ' 177' ' ' ALA . 80.6 mt -93.05 106.05 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.666 -178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.765 HD12 ' HB2' ' A' ' 108' ' ' GLN . 1.5 pt -148.17 176.87 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 173.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 95.4 mtt-85 -133.95 -131.85 0.17 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.474 -0.766 . . . . 0.0 109.737 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -60.01 -13.49 11.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.927 -1.108 . . . . 0.0 109.76 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 145' ' ' GLN . 11.7 p-10 -99.92 24.43 8.49 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.77 -0.581 . . . . 0.0 110.264 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.765 ' HB2' HD12 ' A' ' 104' ' ' ILE . 13.3 pt20 -83.63 106.46 15.37 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.066 -1.021 . . . . 0.0 109.947 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -100.77 -11.7 19.69 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.621 -0.674 . . . . 0.0 110.494 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.758 ' O ' HD12 ' A' ' 110' ' ' LEU . 1.4 pp -99.2 52.96 0.96 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -0.912 . . . . 0.0 110.436 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 0.6 OUTLIER -103.25 93.09 4.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 110.128 176.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.913 ' HB2' HD13 ' A' ' 116' ' ' ILE . 76.4 m-85 -98.34 -75.68 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.981 . . . . 0.0 110.553 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.0 -177.33 54.36 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 46.73 86.67 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -1.182 . . . . 0.0 110.287 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.01 -1.07 89.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.913 HD13 ' HB2' ' A' ' 112' ' ' PHE . 9.3 tp -60.39 -31.67 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -1.197 . . . . 0.0 110.194 176.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.507 ' HG2' HG12 ' A' ' 172' ' ' ILE . 98.9 mt-10 -60.01 -44.76 94.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.148 -0.97 . . . . 0.0 109.747 178.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -70.03 -40.0 75.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.839 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -59.87 -40.11 87.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.278 -0.889 . . . . 0.0 109.845 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.71 ' CG1' HD12 ' A' ' 170' ' ' ILE . 49.0 t -60.05 -45.69 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.38 176.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.692 ' HG3' HD11 ' A' ' 170' ' ' ILE . 6.7 mt-30 -59.92 -47.7 84.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.609 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.51 -0.744 . . . . 0.0 110.41 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.953 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.35 -39.92 77.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 110.757 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.953 HD22 ' C ' ' A' ' 123' ' ' ALA . 3.0 mm? -130.07 24.2 5.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 111.123 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.9 tt -48.31 176.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.95 -1.094 . . . . 0.0 110.003 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.564 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 34.5 ptt180 33.96 49.14 0.27 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.527 -0.733 . . . . 0.0 111.204 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 36.9 ttp180 -128.35 142.59 45.19 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.925 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.836 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.2 Cg_endo -62.17 131.73 35.83 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.961 1.506 . . . . 0.0 110.079 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.567 ' HG3' HD11 ' A' ' 164' ' ' ILE . 96.7 mmm -123.48 140.03 53.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 110.952 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.544 HD23 ' HA ' ' A' ' 50' ' ' THR . 19.7 tp -142.49 105.64 4.58 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.61 -0.681 . . . . 0.0 109.67 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.7 pt-20 -48.47 141.1 7.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.974 -1.079 . . . . 0.0 110.67 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.676 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 86.2 mm-40 79.93 -1.68 2.07 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.167 0.508 . . . . 0.0 110.498 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.607 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.9 p30 -69.98 -172.42 0.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.047 -1.033 . . . . 0.0 110.31 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -144.11 137.72 27.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.737 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.39 170.16 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.074 -1.016 . . . . 0.0 110.084 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.1 t -140.02 146.81 39.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 110.284 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.644 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 8.0 t -114.13 -68.1 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.824 . . . . 0.0 110.769 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.644 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 35.0 Cg_endo -69.62 131.87 22.35 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.222 1.117 . . . . 0.0 110.29 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -98.48 47.0 1.47 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.524 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -147.61 159.98 43.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.055 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -121.36 -168.29 1.65 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.614 -178.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.629 HD12 HE22 ' A' ' 145' ' ' GLN . 82.5 mt -143.79 -140.78 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.624 -0.672 . . . . 0.0 109.756 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.09 -153.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.072 175.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.51 72.9 1.68 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 171.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.629 HE22 HD12 ' A' ' 142' ' ' LEU . 2.3 pt20 -96.62 164.96 12.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.499 -1.0 . . . . 0.0 110.08 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 t -140.07 149.72 43.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.167 -0.958 . . . . 0.0 110.686 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.96 -92.78 1.55 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.608 HD13 ' CD ' ' A' ' 145' ' ' GLN . 0.2 OUTLIER 44.34 41.39 4.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.263 -1.139 . . . . 0.0 111.273 177.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.576 HD11 HD12 ' A' ' 103' ' ' ILE . 1.4 pp -140.46 161.21 38.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.797 -1.189 . . . . 0.0 109.83 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 3.2 m-85 -91.02 120.55 32.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 109.92 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.515 ' HB2' HD11 ' A' ' 103' ' ' ILE . 19.2 tptm -104.7 108.84 20.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.32 -0.862 . . . . 0.0 109.978 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.607 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.1 t -76.48 132.68 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.95 . . . . 0.0 109.683 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 t -114.61 -30.1 2.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.036 -1.04 . . . . 0.0 111.108 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -144.75 150.2 36.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.782 -1.199 . . . . 0.0 111.272 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.95 HG22 HG23 ' A' ' 98' ' ' VAL . 72.3 p -140.33 161.32 37.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 109.427 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.64 -38.69 0.45 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.843 -177.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.989 ' CB ' HG11 ' A' ' 162' ' ' VAL . 18.0 Cg_exo -58.39 -166.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.575 1.303 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.56 ' HB3' HG22 ' A' ' 160' ' ' VAL . 20.8 t -90.05 -171.09 3.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 109.885 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -65.33 -5.88 8.49 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.201 -0.937 . . . . 0.0 110.64 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 158' ' ' SER . 33.1 m -85.2 145.36 42.74 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.405 -0.81 . . . . 0.0 110.287 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.547 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -48.5 141.37 19.79 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.285 1.676 . . . . 0.0 110.796 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.989 HG11 ' CB ' ' A' ' 157' ' ' PRO . 11.2 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.493 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.4 tt0 -107.62 130.67 54.88 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.13 -0.982 . . . . 0.0 110.241 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.83 ' CD1' HG21 ' A' ' 168' ' ' THR . 19.0 mm -69.75 152.51 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 110.029 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.65 169.9 26.4 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.44 ' CA ' HD11 ' A' ' 125' ' ' ILE . 15.7 pt-20 -56.5 -17.97 10.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.301 -1.117 . . . . 0.0 109.923 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.13 -25.76 18.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.324 -0.86 . . . . 0.0 110.014 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.83 HG21 ' CD1' ' A' ' 164' ' ' ILE . 91.3 m -56.57 142.3 39.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.435 -0.791 . . . . 0.0 110.089 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 43.6 mmtm -91.96 154.86 18.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.856 -1.153 . . . . 0.0 110.186 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.83 HG22 HD11 ' A' ' 172' ' ' ILE . 1.4 mm -119.92 130.04 74.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.365 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.648 ' O ' HD13 ' A' ' 172' ' ' ILE . 21.9 mt-10 -112.68 136.09 52.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 110.23 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.83 HD11 HG22 ' A' ' 170' ' ' ILE . 7.5 mm -124.59 134.86 65.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.608 -0.682 . . . . 0.0 109.57 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -88.08 148.2 24.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.344 -174.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -93.21 -14.95 26.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 109.95 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -100.01 110.21 58.71 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.384 -0.822 . . . . 0.0 109.928 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.1 -156.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.988 0 O-C-N 124.074 1.565 . . . . 0.0 110.125 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.887 ' CB ' HG23 ' A' ' 103' ' ' ILE . . . -90.21 42.04 1.08 Allowed 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.546 -0.722 . . . . 0.0 110.48 -174.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.531 ' C ' ' HG3' ' A' ' 179' ' ' GLU . 9.7 m -85.95 23.95 1.38 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.416 -0.803 . . . . 0.0 111.38 -177.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.531 ' HG3' ' C ' ' A' ' 178' ' ' SER . 98.4 mt-10 -154.21 12.38 0.42 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.686 -1.259 . . . . 0.0 110.307 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.51 120.0 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.237 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.19 29.89 7.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.96 -42.69 94.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.945 . . . . 0.0 110.194 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -60.03 140.03 57.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -0.84 . . . . 0.0 110.255 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -86.06 143.87 19.86 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.976 -1.458 . . . . 0.0 109.496 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HG3' ' N ' ' A' ' 2' ' ' GLU . 23.1 ptm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.124 0.488 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 1' ' ' MET . 86.4 tt0 -131.05 126.31 35.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.093 -1.005 . . . . 0.0 110.135 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.96 38.4 16.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 110.195 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -112.19 110.06 20.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.154 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.51 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 27.7 m120 -151.4 166.27 31.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 110.47 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.36 -159.94 8.89 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.012 ' CG2' HD12 ' A' ' 33' ' ' LEU . 15.4 pt -138.97 163.96 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -1.188 . . . . 0.0 109.805 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.618 ' C ' HD23 ' A' ' 9' ' ' LEU . 48.1 mm -101.0 120.49 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.299 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.867 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -140.87 -176.54 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.713 177.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HG2' HG22 ' A' ' 66' ' ' ILE . 28.3 ptt180 -117.01 144.11 44.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.838 -1.164 . . . . 0.0 110.524 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.905 HG11 ' O ' ' A' ' 80' ' ' SER . 3.3 p -61.37 140.64 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.621 -0.674 . . . . 0.0 110.899 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.487 ' HB1' ' CD ' ' A' ' 68' ' ' ARG . . . -118.88 144.23 46.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 110.583 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.974 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 -179.04 131.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.265 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.24 -70.04 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 110.326 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 15' ' ' ASN . 6.0 p30 -164.49 84.82 0.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m 59.99 31.65 20.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.964 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.474 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 74.3 p -99.64 171.55 7.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 110.159 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 17' ' ' THR . 3.3 p30 37.24 64.68 2.74 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.629 -0.67 . . . . 0.0 110.373 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 39.8 Cg_exo -55.83 -175.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.053 1.554 . . . . 0.0 110.032 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.35 94.4 1.72 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.478 ' O ' ' HG3' ' A' ' 73' ' ' MET . 3.9 ptt? -87.58 -6.49 58.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -1.125 . . . . 0.0 109.774 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.6 t -100.02 6.96 45.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.848 . . . . 0.0 110.093 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.544 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 76.5 mtt85 -120.07 133.61 55.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.932 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.139 HG12 HD23 ' A' ' 26' ' ' LEU . 84.8 t -119.73 116.17 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.979 -1.076 . . . . 0.0 110.269 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.859 ' O ' HD22 ' A' ' 26' ' ' LEU . 3.8 ptt180 -88.17 119.46 28.58 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.68 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.139 HD23 HG12 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -137.95 177.42 7.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.751 -0.593 . . . . 0.0 109.684 -175.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 22.2 p-10 -103.07 179.73 4.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 60.8 mt-10 -59.97 -44.87 94.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.406 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 68.0 m -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.03 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.171 ' O ' HD22 ' A' ' 33' ' ' LEU . 28.6 t -65.3 -28.22 69.16 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 27.8 ttm180 -80.86 -46.72 14.85 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.537 -0.727 . . . . 0.0 110.556 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -79.98 -9.62 59.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.171 HD22 ' O ' ' A' ' 30' ' ' SER . 1.3 pt? -47.22 -24.25 0.68 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.693 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.885 ' H ' HD23 ' A' ' 33' ' ' LEU . 66.5 mt -141.27 -62.78 0.47 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.548 -0.72 . . . . 0.0 110.266 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.3 t0 -172.89 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.534 -0.729 . . . . 0.0 109.437 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -31.38 141.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.463 0.649 . . . . 0.0 111.509 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -131.23 171.2 13.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 172.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 56' ' ' ARG . 38.4 mm -63.47 79.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.674 -1.266 . . . . 0.0 110.208 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 37' ' ' GLU . . . 169.32 -4.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.552 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.438 ' CG ' ' NZ ' ' A' ' 89' ' ' LYS . 95.9 m-20 -111.94 168.75 9.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.384 -1.657 . . . . 0.0 110.874 -170.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.488 HG21 ' OG1' ' A' ' 92' ' ' THR . 72.1 t -103.65 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.107 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG22 ' C ' ' A' ' 52' ' ' GLY . 2.4 m -110.84 145.88 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.17 -0.956 . . . . 0.0 110.592 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 86.5 tt0 -109.38 140.78 42.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.82 . . . . 0.0 109.827 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.913 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -121.21 143.16 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.991 -1.068 . . . . 0.0 110.622 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.2 tt0 -149.42 97.71 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.845 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.908 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.5 tmtm? -97.98 -62.52 1.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.525 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -109.3 -36.33 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.644 0.735 . . . . 0.0 109.237 175.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 78.9 mtt85 -125.7 -172.91 2.71 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.726 -0.609 . . . . 0.0 109.59 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.3 OUTLIER -100.13 133.2 44.87 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.108 178.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.591 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 2.4 p -140.45 167.48 22.05 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.445 0.641 . . . . 0.0 109.679 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.66 HG13 ' HG ' ' A' ' 130' ' ' LEU . 3.6 m -116.46 175.75 2.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.744 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.485 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.84 -179.17 48.54 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -121.02 167.81 12.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.371 -1.076 . . . . 0.0 110.075 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -95.93 135.02 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.152 -0.967 . . . . 0.0 110.73 -174.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.544 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 3.6 m-85 -130.6 166.61 20.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.756 . . . . 0.0 110.488 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.445 ' HG2' ' NH2' ' A' ' 31' ' ' ARG . 21.5 mtt180 -89.43 124.04 34.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -65.13 137.88 57.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.712 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.697 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 8.6 mmm180 -57.44 -45.89 99.84 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.825 -1.172 . . . . 0.0 109.027 174.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.697 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 35.0 Cg_endo -92.01 98.54 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.748 1.393 . . . . 0.0 108.853 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -75.26 35.84 0.12 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -146.59 -37.28 0.23 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 110.873 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.481 ' HG3' HD11 ' A' ' 66' ' ' ILE . 16.3 pt-20 -84.8 -20.58 30.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.059 -1.026 . . . . 0.0 109.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.505 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 2.9 m-80 -81.63 36.58 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 110.719 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 58.4 pttt -98.31 17.5 18.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.952 -1.093 . . . . 0.0 109.388 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 176.84 21.38 0.03 OUTLIER Glycine 0 N--CA 1.48 1.607 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.505 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.11 152.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.196 -1.179 . . . . 0.0 109.191 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.948 HG23 HG13 ' A' ' 24' ' ' VAL . 7.9 p -130.02 129.98 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.98 -1.075 . . . . 0.0 110.131 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.564 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 22.5 mmm180 -91.33 111.74 23.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.641 HD11 ' NH1' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -136.06 171.78 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.383 -0.823 . . . . 0.0 110.553 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -81.24 166.9 20.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 0.0 110.263 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 79.5 p -69.94 -19.28 63.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 110.339 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.55 -47.29 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.112 -0.993 . . . . 0.0 110.483 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.913 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -61.33 -47.48 85.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.985 -1.072 . . . . 0.0 109.289 177.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.69 ' HG3' HG21 ' A' ' 11' ' ' VAL . 5.9 mmp_? -60.04 -39.94 87.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 110.245 173.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 71' ' ' SER . 47.8 t-20 -64.09 -31.82 73.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.0 109.959 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 10.7 m120 -60.01 -36.29 76.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.394 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.2 p -98.38 -38.79 9.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.059 -1.025 . . . . 0.0 110.581 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.525 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 119.79 40.05 0.63 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.888 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -120.85 166.17 14.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.062 -1.258 . . . . 0.0 110.611 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.905 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -118.7 176.17 5.39 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.974 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -55.84 142.58 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.074 -1.017 . . . . 0.0 110.418 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.76 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 75.96 0.76 65.8 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 172.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.3 m-20 -59.82 -167.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.849 -1.383 . . . . 0.0 110.124 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 10.5 pttp -132.53 115.28 15.29 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.701 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.908 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -125.43 153.47 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 109.574 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 60.7 tttt -99.94 121.48 41.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.129 -0.982 . . . . 0.0 110.095 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 9' ' ' LEU . 65.6 t -98.99 119.99 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.956 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 87.2 mtm180 -116.2 142.53 46.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.382 -0.824 . . . . 0.0 109.807 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.438 ' NZ ' ' CG ' ' A' ' 40' ' ' ASP . 50.6 tttp -75.99 146.59 39.44 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.002 -1.061 . . . . 0.0 110.543 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.439 HG23 HG12 ' A' ' 41' ' ' VAL . 1.9 m -149.98 -168.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.515 -0.741 . . . . 0.0 109.967 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.4 ptt-85 -138.76 170.0 16.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.893 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.488 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -111.72 156.71 21.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 111.3 -175.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.859 ' OE2' HG12 ' A' ' 162' ' ' VAL . 1.2 pm0 -150.31 169.71 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 94' ' ' ILE . 4.5 mp -89.13 98.31 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.595 -1.316 . . . . 0.0 110.402 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.89 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.51 163.45 1.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.422 -0.798 . . . . 0.0 110.819 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 1.033 ' HG3' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -136.16 -17.86 1.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.456 -0.778 . . . . 0.0 110.913 -178.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 1.005 ' CB ' HD12 ' A' ' 156' ' ' LEU . 32.9 tttt -149.59 119.92 7.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.887 -1.133 . . . . 0.0 110.336 177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.044 HG23 HG22 ' A' ' 155' ' ' THR . 5.5 p -137.2 140.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.0 110.718 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.4 m -109.29 135.08 50.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -130.11 160.97 32.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 110.418 -178.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.15 87.42 39.23 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.58 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.78 134.95 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.979 1.515 . . . . 0.0 110.218 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 177' ' ' ALA . 29.4 mm -102.15 103.77 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 110.754 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.578 HG13 ' N ' ' A' ' 105' ' ' ARG . 18.7 pt -142.89 -151.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 122.142 0.973 . . . . 0.0 109.956 171.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.622 ' H ' ' HB2' ' A' ' 108' ' ' GLN . 81.6 mtp180 -136.97 159.96 40.32 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.324 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -61.74 -15.53 41.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.412 -0.805 . . . . 0.0 110.174 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 34.2 p-10 -130.09 31.33 4.68 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.684 -0.635 . . . . 0.0 110.017 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.622 ' HB2' ' H ' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -86.43 -69.99 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.101 -1.0 . . . . 0.0 110.38 -176.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.518 ' HB2' HD22 ' A' ' 142' ' ' LEU . 45.5 tpt85 -139.69 -87.92 0.2 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.11 -0.994 . . . . 0.0 110.341 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.944 HD22 ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -141.05 175.43 9.63 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 120.956 -1.09 . . . . 0.0 110.6 -175.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.944 ' N ' HD22 ' A' ' 110' ' ' LEU . 46.1 pttt -130.75 156.01 45.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 109.492 176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.787 ' HB2' HD12 ' A' ' 116' ' ' ILE . 12.3 m-85 -97.85 -52.11 3.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.014 -1.053 . . . . 0.0 110.315 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 116' ' ' ILE . . . 73.82 -152.95 46.57 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -46.05 145.42 1.56 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.713 -0.875 . . . . 0.0 109.83 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.6 -16.66 34.42 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.787 HD12 ' HB2' ' A' ' 112' ' ' PHE . 11.9 tt -62.39 -37.3 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.082 -1.246 . . . . 0.0 110.017 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 170' ' ' ILE . 98.9 mt-10 -59.99 -44.76 94.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.046 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -67.92 -39.97 83.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.833 . . . . 0.0 110.025 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -40.0 88.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.905 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.633 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -62.15 -44.9 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.369 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.648 ' HG3' HD11 ' A' ' 170' ' ' ILE . 6.3 mt-30 -59.94 -45.44 92.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.086 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -60.38 -41.43 93.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.487 -0.758 . . . . 0.0 109.862 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.599 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.57 -48.05 61.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 110.68 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 123' ' ' ALA . 4.4 mm? -105.14 12.97 31.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.1 -1.0 . . . . 0.0 111.513 -173.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 121' ' ' GLN . 1.5 tt -49.34 169.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.615 -1.303 . . . . 0.0 110.391 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 29.0 ptt180 32.98 46.07 0.08 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.599 -0.688 . . . . 0.0 111.646 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.9 mmt85 -134.76 152.44 77.54 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 120.714 -1.241 . . . . 0.0 111.358 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.83 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.1 Cg_endo -62.04 123.25 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.225 1.645 . . . . 0.0 109.684 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.791 ' O ' HG22 ' A' ' 162' ' ' VAL . 15.4 mmt -137.37 137.9 39.36 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.554 -1.341 . . . . 0.0 110.433 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.779 ' H ' HD13 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.81 145.2 24.78 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.478 0.656 . . . . 0.0 110.441 176.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 22.0 pt-20 -55.11 152.93 7.22 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -0.81 . . . . 0.0 111.112 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.585 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 81.95 -12.66 0.93 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.463 0.649 . . . . 0.0 110.298 178.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.694 ' OD2' HG21 ' A' ' 152' ' ' VAL . 0.7 OUTLIER -69.37 -174.27 0.65 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.482 -0.761 . . . . 0.0 110.388 177.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 8.3 m-80 -147.19 160.04 42.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.337 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.89 169.92 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.203 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 t -112.52 165.15 12.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.514 -0.741 . . . . 0.0 110.605 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 139' ' ' GLY . 21.2 t -100.54 145.82 30.97 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.449 -0.782 . . . . 0.0 110.044 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.544 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 10.1 Cg_endo -57.84 67.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.028 1.541 . . . . 0.0 110.922 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 41.32 53.46 4.11 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 175.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.618 HD12 ' C ' ' A' ' 140' ' ' LEU . 0.5 OUTLIER -131.4 132.61 44.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.971 -1.311 . . . . 0.0 110.266 177.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -158.7 -167.09 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 110.391 -178.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.753 HD21 ' NE2' ' A' ' 145' ' ' GLN . 0.5 OUTLIER -145.72 -127.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.591 -0.693 . . . . 0.0 109.853 178.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.91 -158.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.982 . . . . 0.0 109.856 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.04 81.98 1.38 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.753 ' NE2' HD21 ' A' ' 142' ' ' LEU . 5.2 pt20 -92.48 170.04 10.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.355 -1.085 . . . . 0.0 110.183 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -136.07 150.83 49.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 110.439 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.59 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 83.68 -91.38 1.62 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.2 OUTLIER 40.03 47.14 1.92 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.585 -0.95 . . . . 0.0 110.883 175.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.412 ' H ' ' HB ' ' A' ' 103' ' ' ILE . 3.1 pp -140.24 168.47 19.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.111 -0.993 . . . . 0.0 109.834 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -99.89 129.46 45.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.127 -0.983 . . . . 0.0 110.201 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -115.29 113.55 24.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 110.007 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.694 HG21 ' OD2' ' A' ' 133' ' ' ASP . 13.2 t -77.98 135.65 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.164 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.734 HG12 ' HG3' ' A' ' 154' ' ' LYS . 9.9 t -111.99 -28.66 2.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.734 ' HG3' HG12 ' A' ' 153' ' ' VAL . 76.2 mttt -150.63 163.88 37.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.916 -1.115 . . . . 0.0 111.281 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.044 HG22 HG23 ' A' ' 98' ' ' VAL . 73.8 p -149.04 169.8 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.774 -0.579 . . . . 0.0 109.491 177.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.033 HD13 ' HG3' ' A' ' 96' ' ' LYS . 1.4 tt -88.49 -41.2 0.47 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.987 . . . . 0.0 110.631 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 1.017 ' CB ' HG11 ' A' ' 162' ' ' VAL . 22.1 Cg_exo -56.44 -177.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.569 1.3 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.473 ' HB3' HG22 ' A' ' 160' ' ' VAL . 15.8 t -74.5 -172.89 1.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.565 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -69.98 -2.25 12.04 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.162 -0.961 . . . . 0.0 110.376 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.535 HG23 ' OE2' ' A' ' 93' ' ' GLU . 21.4 m -87.54 150.46 48.74 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 110.41 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.652 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.47 140.55 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.292 1.68 . . . . 0.0 110.985 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 1.017 HG11 ' CB ' ' A' ' 157' ' ' PRO . 5.5 m -130.02 160.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.603 171.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 21.9 pt-20 -102.52 124.63 48.43 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.948 -1.095 . . . . 0.0 110.082 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.841 ' CD1' HG21 ' A' ' 168' ' ' THR . 8.0 mm -71.15 154.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.666 -0.646 . . . . 0.0 110.272 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 163.66 26.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -53.23 -20.04 3.7 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.511 -0.993 . . . . 0.0 110.311 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -89.5 -23.12 22.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.715 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.841 HG21 ' CD1' ' A' ' 164' ' ' ILE . 90.2 m -54.94 145.91 19.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.963 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 85.9 mttt -95.6 149.43 21.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 110.366 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.648 HD11 ' HG3' ' A' ' 121' ' ' GLN . 1.3 mm -117.07 129.97 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.301 -0.874 . . . . 0.0 110.501 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.445 ' OE2' ' HE2' ' A' ' 97' ' ' LYS . 57.6 mt-10 -115.45 136.26 53.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 110.166 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.671 HD12 HG23 ' A' ' 116' ' ' ILE . 5.9 mt -135.27 133.61 52.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.104 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.535 ' NE ' ' HB3' ' A' ' 175' ' ' GLU . 13.0 ptm180 -89.2 -176.72 5.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 110.315 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 81.6 mm-40 -118.15 10.13 12.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.296 -0.878 . . . . 0.0 110.471 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.535 ' HB3' ' NE ' ' A' ' 173' ' ' ARG . 5.4 tp10 -95.6 109.22 44.61 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.904 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.3 Cg_exo -71.15 -155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.181 1.622 . . . . 0.0 110.498 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.487 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -75.07 52.65 0.57 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.701 -0.624 . . . . 0.0 110.174 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 180' ' ' VAL . 23.7 t -86.36 122.46 30.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 0.0 109.963 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 178' ' ' SER . 82.0 tt0 60.01 19.97 9.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.52 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 178' ' ' SER . 63.0 t -104.7 128.33 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.31 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 181' ' ' LEU . 0.7 OUTLIER -50.0 85.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.532 -0.73 . . . . 0.0 110.505 -177.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 180' ' ' VAL . 99.1 mt-10 -60.09 -40.83 90.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.04 140.02 57.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 110.358 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -178.77 -172.81 43.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.871 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptm . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.105 0.478 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -132.81 155.13 49.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 110.367 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.12 57.82 2.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -89.65 167.18 13.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.309 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -94.6 177.6 5.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 110.461 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.521 ' HA2' HD13 ' A' ' 34' ' ' LEU . . . -146.48 -165.1 11.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.01 HG21 HD11 ' A' ' 33' ' ' LEU . 23.0 pt -130.44 160.38 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -1.2 . . . . 0.0 110.17 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.5 mt -102.14 114.03 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.288 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.775 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -137.23 -174.32 3.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 109.786 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 30.7 ptt180 -111.55 139.59 46.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.727 -1.233 . . . . 0.0 111.025 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.786 ' CG2' HD11 ' A' ' 69' ' ' ILE . 13.5 p -62.7 135.0 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -116.53 145.74 43.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.773 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 tt0 -178.85 89.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.215 -0.928 . . . . 0.0 110.359 173.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.35 13.64 0.43 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.051 -1.031 . . . . 0.0 111.089 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -80.06 -69.94 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.941 -1.099 . . . . 0.0 110.405 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.433 ' C ' ' OG1' ' A' ' 17' ' ' THR . 47.5 t -170.42 140.7 1.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.184 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.438 ' C ' ' HD3' ' A' ' 19' ' ' PRO . 3.1 p 42.84 -161.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 109.931 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.486 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 3.2 p30 -134.96 66.24 67.64 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.138 -0.976 . . . . 0.0 110.631 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 9.2 Cg_exo -73.23 111.72 3.35 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.007 1.53 . . . . 0.0 110.632 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.413 ' C ' ' OD2' ' A' ' 70' ' ' ASP . . . 93.43 86.81 1.6 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.182 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.461 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 14.1 ptp -89.6 -12.68 39.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.201 -1.176 . . . . 0.0 109.944 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.0 p -118.22 9.47 12.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.89 . . . . 0.0 109.952 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 99.0 mtt180 -108.34 137.35 46.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 110.067 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.039 HG13 HG23 ' A' ' 67' ' ' VAL . 87.4 t -116.77 120.08 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 110.402 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.64 ' O ' HD12 ' A' ' 26' ' ' LEU . 3.7 ptt180 -86.39 118.49 25.86 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.512 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.025 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mp -131.4 173.08 11.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.622 -0.674 . . . . 0.0 109.847 -176.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 11.6 p-10 -103.23 179.42 4.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.871 -1.143 . . . . 0.0 110.702 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 88.5 mt-10 -59.99 -41.05 91.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -0.871 . . . . 0.0 109.059 -177.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.645 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -64.4 -59.67 4.08 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.123 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.81 ' O ' HD22 ' A' ' 33' ' ' LEU . 65.4 m -49.99 -31.22 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.835 -1.166 . . . . 0.0 109.08 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 40.0 ttm180 -72.29 -51.76 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.584 -0.698 . . . . 0.0 111.619 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -98.92 -3.49 35.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.742 -1.224 . . . . 0.0 111.178 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -64.96 -24.06 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.982 -1.074 . . . . 0.0 109.828 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.987 ' N ' HD23 ' A' ' 33' ' ' LEU . 59.6 mt -120.62 -67.88 0.95 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.045 -1.034 . . . . 0.0 110.469 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 36' ' ' ALA . 43.4 t0 -171.2 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.566 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.548 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.45 118.63 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.354 0.597 . . . . 0.0 110.72 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.8 pt-20 -106.59 -178.98 3.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 172.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 38' ' ' ILE . 24.2 mm -62.3 126.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.882 -1.136 . . . . 0.0 109.803 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.35 22.94 66.55 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 173.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.441 ' CG ' ' HG2' ' A' ' 37' ' ' GLU . 77.7 m-20 -89.5 169.98 10.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.814 -1.404 . . . . 0.0 109.603 171.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.523 HG21 ' OG1' ' A' ' 92' ' ' THR . 71.8 t -99.23 136.18 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.989 -1.07 . . . . 0.0 110.087 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.504 HG11 HG23 ' A' ' 54' ' ' VAL . 1.7 m -120.71 140.05 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.094 -1.004 . . . . 0.0 110.487 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 44' ' ' ILE . 85.4 tt0 -106.82 141.25 38.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.0 109.691 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.831 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -124.21 143.03 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.995 -1.066 . . . . 0.0 110.582 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.5 tt0 -149.89 97.24 2.56 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.895 ' HG3' HG12 ' A' ' 85' ' ' VAL . 5.5 tmtm? -97.88 -55.8 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.406 -0.809 . . . . 0.0 109.626 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.547 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.29 -34.6 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.795 0.807 . . . . 0.0 108.885 176.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.622 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 94.6 mtt180 -131.79 179.46 6.06 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.562 ' HB3' HD21 ' A' ' 130' ' ' LEU . 12.0 mtmt -89.44 132.67 34.9 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.468 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.668 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.9 p -138.07 166.7 23.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.576 -0.702 . . . . 0.0 109.809 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -120.89 167.66 14.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 O-C-N 121.597 -0.689 . . . . 0.0 109.915 179.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.05 -175.08 44.04 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 68.9 ttt180 -122.45 166.16 15.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.428 -1.042 . . . . 0.0 110.334 -176.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -98.34 144.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -0.885 . . . . 0.0 110.513 -175.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 2.5 m-85 -138.06 168.19 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 0.0 110.371 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -88.73 121.76 31.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.74 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.705 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -62.66 140.05 58.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.711 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.63 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.84 -50.0 90.61 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.841 175.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 33.6 Cg_endo -93.06 98.41 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.841 1.443 . . . . 0.0 108.886 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.26 36.13 0.1 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.426 -0.796 . . . . 0.0 110.825 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -145.59 -34.32 0.33 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.096 -1.002 . . . . 0.0 111.058 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.559 ' OE2' ' CG ' ' A' ' 59' ' ' PRO . 14.9 pt-20 -87.19 -19.12 28.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.063 -1.023 . . . . 0.0 109.601 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.705 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 21.7 m-80 -81.21 39.64 0.52 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.494 -0.754 . . . . 0.0 110.622 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.0 pttt -97.79 13.43 30.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 63' ' ' ASN . 45.6 pt -140.92 144.67 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.213 -1.169 . . . . 0.0 109.583 175.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.039 HG23 HG13 ' A' ' 24' ' ' VAL . 3.1 p -121.88 129.83 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.046 -1.034 . . . . 0.0 109.859 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.408 ' CB ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -93.0 114.02 26.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -0.985 . . . . 0.0 110.088 -178.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.786 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.9 pp -134.66 167.82 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' OD2' ' N ' ' A' ' 21' ' ' MET . 96.7 m-20 -79.53 168.01 20.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 110.132 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.2 m -59.98 -39.73 86.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.279 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 75' ' ' ASN . 54.1 t -61.25 -41.58 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 0.0 110.151 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.765 ' HE1' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -61.55 -48.22 81.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.256 -0.902 . . . . 0.0 109.699 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 80' ' ' SER . 37.7 ttp180 -60.13 -40.13 88.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.027 -1.045 . . . . 0.0 109.457 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.547 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 92.6 m-20 -64.06 -33.06 74.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 73' ' ' MET . 64.4 m-20 -57.38 -34.93 69.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.214 -0.929 . . . . 0.0 110.067 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.65 ' HB3' HG21 ' A' ' 50' ' ' THR . 30.5 p -99.38 -40.02 8.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.991 -1.068 . . . . 0.0 110.667 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.547 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.17 41.03 1.0 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.759 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -114.4 172.4 7.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.106 -1.232 . . . . 0.0 110.508 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.719 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -115.58 170.28 8.54 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.322 -0.861 . . . . 0.0 109.417 177.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.773 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -55.57 139.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.871 -1.143 . . . . 0.0 110.605 178.167 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.436 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.08 3.83 82.18 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -59.86 -161.46 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.032 -1.275 . . . . 0.0 110.575 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 23.2 pttt -134.3 110.91 9.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.487 -0.758 . . . . 0.0 110.096 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.895 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.2 m -120.01 153.99 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 109.886 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 54.2 tttt -101.07 118.62 37.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.634 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.512 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 74.8 t -102.11 120.91 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.932 . . . . 0.0 109.897 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HG2' ' N ' ' A' ' 6' ' ' GLY . 76.4 mtm180 -110.39 140.88 44.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 6.1 tttt -82.48 140.25 33.48 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.049 -1.032 . . . . 0.0 110.662 -176.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.446 HG21 ' CD ' ' A' ' 161' ' ' PRO . 2.4 m -148.86 -165.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 121.492 0.663 . . . . 0.0 109.731 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.484 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.0 mtt85 -135.66 173.39 11.76 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.469 -0.77 . . . . 0.0 110.42 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.523 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -103.1 161.46 13.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 111.147 -176.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.624 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.8 pt-20 -149.93 170.03 19.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.646 HD12 ' N ' ' A' ' 94' ' ' ILE . 5.1 mp -89.46 97.14 6.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 120.569 -1.332 . . . . 0.0 110.351 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.776 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.11 140.06 39.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.455 -0.778 . . . . 0.0 110.219 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.68 ' HD2' HD22 ' A' ' 156' ' ' LEU . 3.4 ptpt -106.09 -25.75 11.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 111.558 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.649 ' HB3' HD12 ' A' ' 156' ' ' LEU . 72.2 tttt -150.3 131.92 14.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.441 -1.412 . . . . 0.0 110.709 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.013 HG23 HG22 ' A' ' 155' ' ' THR . 8.0 p -144.33 148.0 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.894 . . . . 0.0 110.652 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.624 HG23 ' HB3' ' A' ' 171' ' ' GLU . 59.5 m -120.68 136.8 54.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.43 -0.793 . . . . 0.0 110.195 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.652 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.56 161.66 29.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.256 -0.903 . . . . 0.0 110.528 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.09 89.58 12.47 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.456 -0.778 . . . . 0.0 110.094 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo -58.28 135.58 69.06 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.988 1.52 . . . . 0.0 110.627 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.016 HG23 ' HB2' ' A' ' 177' ' ' ALA . 82.2 mt -89.89 94.32 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.334 -0.854 . . . . 0.0 110.09 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.672 HD11 HD22 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -150.99 -170.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.381 -0.825 . . . . 0.0 110.841 179.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.63 ' O ' HD21 ' A' ' 110' ' ' LEU . 71.1 mtp180 -89.83 169.08 11.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.287 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.97 -24.49 64.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 111.117 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -116.83 29.97 7.61 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.87 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.54 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 11.4 mm-40 -91.36 -79.97 0.36 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.91 -1.119 . . . . 0.0 111.064 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HG3' ' HB3' ' A' ' 108' ' ' GLN . 44.4 mtt180 -115.06 -12.81 11.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.87 -1.144 . . . . 0.0 110.041 -176.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.672 HD22 HD11 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -97.72 55.69 1.23 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.957 -177.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.22 64.73 1.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.55 -0.719 . . . . 0.0 110.014 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -137.07 -64.06 0.58 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 110.165 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.717 ' H ' HD12 ' A' ' 116' ' ' ILE . . . 76.29 -175.64 52.56 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.11 82.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.138 -1.213 . . . . 0.0 110.434 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.27 4.67 83.59 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.717 HD12 ' H ' ' A' ' 113' ' ' GLY . 20.9 tt -60.1 -39.92 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -1.181 . . . . 0.0 110.256 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 116' ' ' ILE . 41.7 mt-10 -68.96 -41.3 78.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.963 -1.086 . . . . 0.0 110.313 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.97 -32.81 71.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.417 ' O ' ' HB3' ' A' ' 122' ' ' ARG . 18.7 t80 -59.86 -39.51 85.45 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.521 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.634 HG12 HD12 ' A' ' 124' ' ' LEU . 78.8 t -60.0 -46.63 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.206 176.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.687 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -60.0 -39.74 86.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.886 174.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 119' ' ' TYR . 27.4 tpt180 -60.0 -43.87 94.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.333 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 -40.55 46.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -0.838 . . . . 0.0 110.664 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.634 HD12 HG12 ' A' ' 120' ' ' VAL . 79.1 mt -92.91 -7.58 45.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.071 -1.018 . . . . 0.0 110.58 -173.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.717 ' HA ' HG22 ' A' ' 164' ' ' ILE . 1.9 tt -42.71 166.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.279 -0.888 . . . . 0.0 110.43 -174.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 164' ' ' ILE . 33.4 ptt180 30.4 52.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.659 -0.65 . . . . 0.0 111.262 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 30.9 ttm180 -132.71 142.96 46.7 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.047 -1.033 . . . . 0.0 110.895 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.8 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -65.59 123.94 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 124.007 1.53 . . . . 0.0 109.498 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.542 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 89.2 mmm -120.21 140.62 50.89 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.377 -1.452 . . . . 0.0 111.126 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 50' ' ' THR . 17.0 tp -141.15 107.29 5.21 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.713 -0.617 . . . . 0.0 109.649 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.601 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -45.0 140.78 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.07 -1.019 . . . . 0.0 110.905 -175.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.601 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 82.11 -2.95 1.49 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.409 0.624 . . . . 0.0 110.271 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' OD1' ' HB ' ' A' ' 152' ' ' VAL . 3.8 p-10 -68.63 -172.99 0.4 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.512 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.621 ' HB3' HD13 ' A' ' 149' ' ' LEU . 21.4 m-80 -144.83 144.21 31.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.431 -0.793 . . . . 0.0 109.492 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.3 160.69 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.828 -1.17 . . . . 0.0 110.837 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 t -141.0 143.32 34.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.665 -0.647 . . . . 0.0 109.97 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.657 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 8.4 t -110.1 -65.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.989 -1.069 . . . . 0.0 111.063 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 43.4 Cg_endo -73.11 154.37 52.25 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 O-C-N 123.201 1.106 . . . . 0.0 110.492 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -113.18 54.88 0.53 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.045 HD22 ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -139.93 162.94 33.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -1.079 . . . . 0.0 110.072 -178.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 1.045 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -125.28 -170.65 2.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.011 -1.056 . . . . 0.0 110.856 -176.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.778 HD12 ' NE2' ' A' ' 145' ' ' GLN . 83.1 mt -141.74 -150.23 0.31 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.307 0.575 . . . . 0.0 110.222 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.08 66.17 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 110.562 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.85 66.97 2.45 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -176.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.778 ' NE2' HD12 ' A' ' 142' ' ' LEU . 2.5 pt20 -93.25 168.51 11.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.873 -1.369 . . . . 0.0 110.245 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -133.44 153.73 51.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.218 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.552 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 74.71 -83.77 0.79 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 41.47 40.15 1.24 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.461 -1.023 . . . . 0.0 111.085 176.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.686 ' HG ' HD12 ' A' ' 103' ' ' ILE . 3.4 pp -140.53 170.44 15.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.08 -1.012 . . . . 0.0 109.754 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 40.0 m-85 -89.31 121.59 31.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 109.749 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -103.29 103.86 13.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.537 ' HB ' ' OD1' ' A' ' 133' ' ' ASP . 2.7 t -75.34 139.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.8 t -130.62 -24.53 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.022 -1.049 . . . . 0.0 111.443 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 5.8 tttp -139.36 125.31 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 110.926 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.013 HG22 HG23 ' A' ' 98' ' ' VAL . 69.2 p -128.09 163.95 23.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.456 -0.777 . . . . 0.0 109.433 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.68 HD22 ' HD2' ' A' ' 96' ' ' LYS . 1.1 tt -89.57 -38.2 0.42 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 110.97 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.96 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.4 Cg_exo -60.57 -176.06 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.485 1.255 . . . . 0.0 110.237 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.43 -162.7 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -69.59 -4.51 19.52 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.303 -0.873 . . . . 0.0 110.564 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.9 m -86.37 140.5 34.18 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.059 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.574 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.7 Cg_endo -47.61 141.65 14.94 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 124.14 1.6 . . . . 0.0 110.48 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.96 HG11 ' CB ' ' A' ' 157' ' ' PRO . 5.6 m -128.3 158.18 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.785 173.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -105.9 124.15 49.12 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.885 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.821 HD12 HG21 ' A' ' 168' ' ' THR . 13.8 mm -70.14 152.37 9.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.743 -0.598 . . . . 0.0 109.53 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.602 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.06 166.89 26.2 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.538 ' HB3' HD11 ' A' ' 125' ' ' ILE . 18.6 pt-20 -58.0 -14.11 5.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.957 . . . . 0.0 110.287 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -90.13 -18.07 26.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.821 HG21 HD12 ' A' ' 164' ' ' ILE . 28.0 m -62.24 153.87 29.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.598 -0.689 . . . . 0.0 110.049 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 96' ' ' LYS . 44.8 mttt -103.6 155.6 18.42 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 0.0 110.014 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.687 HD11 ' HG2' ' A' ' 121' ' ' GLN . 6.5 mm -119.14 137.86 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 110.975 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.624 ' HB3' HG23 ' A' ' 99' ' ' THR . 12.8 mt-10 -119.94 127.14 52.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 110.514 172.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.496 ' CD1' HD11 ' A' ' 100' ' ' LEU . 39.5 mm -123.34 123.83 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.175 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.622 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 4.3 ptp180 -93.19 156.83 16.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.0 110.559 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 81.3 mm-40 -95.61 6.9 47.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.351 -0.843 . . . . 0.0 110.03 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.76 109.99 57.49 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.317 -0.864 . . . . 0.0 110.031 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.439 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 16.4 Cg_exo -68.48 -152.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.006 1.529 . . . . 0.0 109.975 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.016 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -73.97 47.45 0.27 Allowed 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.415 -0.803 . . . . 0.0 110.597 -177.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 2.0 m -75.83 -70.48 0.43 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.214 -0.929 . . . . 0.0 111.184 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.88 -21.65 64.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.841 -1.162 . . . . 0.0 110.233 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 87.8 t -63.85 132.08 29.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 121.707 -0.621 . . . . 0.0 110.091 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 181' ' ' LEU . 0.9 OUTLIER -112.36 56.66 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 110.414 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -61.27 130.79 47.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 109.905 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.21 140.18 57.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.157 -0.964 . . . . 0.0 110.48 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 70.19 18.18 74.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 118.0 -1.444 . . . . 0.0 109.5 179.744 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.278 0.561 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -99.98 125.63 46.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.102 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.1 m -66.63 -80.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.933 . . . . 0.0 110.242 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -151.11 140.31 21.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.332 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.424 ' OD1' HD21 ' A' ' 34' ' ' LEU . 15.1 t-20 -157.73 157.38 33.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.049 177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -153.54 -167.81 16.4 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.884 ' CG2' HD12 ' A' ' 33' ' ' LEU . 22.8 pt -135.03 160.01 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -1.078 . . . . 0.0 109.651 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.5 mt -100.62 115.85 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.2 pt? -135.54 -170.86 2.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.0 109.562 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.58 ' NE ' HG22 ' A' ' 66' ' ' ILE . 49.8 ptt85 -114.79 139.99 49.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.739 -1.225 . . . . 0.0 110.855 -174.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.689 HG13 ' HA ' ' A' ' 81' ' ' ILE . 7.9 p -62.16 140.55 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.63 -0.669 . . . . 0.0 110.552 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -118.68 143.66 46.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 110.624 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.982 ' HB3' HD11 ' A' ' 81' ' ' ILE . 49.0 tp10 -179.79 98.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.795 . . . . 0.0 110.091 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.17 -27.08 10.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 110.309 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -110.72 128.65 55.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.93 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -108.36 35.95 2.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.197 -0.939 . . . . 0.0 110.298 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.47 ' O ' ' CG ' ' A' ' 18' ' ' ASP . 8.8 p -111.65 170.44 8.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.279 -0.888 . . . . 0.0 110.44 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 5.0 p-10 38.05 63.41 3.69 Favored Pre-proline 0 N--CA 1.5 2.052 0 O-C-N 121.589 -0.694 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 38.8 Cg_exo -56.51 -174.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.104 1.581 . . . . 0.0 110.635 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.3 20.59 37.91 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.449 ' CG ' ' HB2' ' A' ' 70' ' ' ASP . 25.5 ptp -88.26 47.99 1.58 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.119 -1.224 . . . . 0.0 109.475 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.1 p -63.82 -3.03 2.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.493 -0.755 . . . . 0.0 110.82 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 55' ' ' TYR . 62.6 mmt-85 -88.27 145.72 25.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 109.555 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.985 HG13 HG23 ' A' ' 67' ' ' VAL . 90.4 t -101.73 115.44 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.121 -0.987 . . . . 0.0 110.007 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.459 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 6.2 ptt180 -93.53 120.01 33.29 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.985 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.891 HD22 ' CB ' ' A' ' 30' ' ' SER . 2.1 mt -138.68 173.18 11.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.568 -0.708 . . . . 0.0 110.105 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 4.2 p-10 -95.06 -177.18 4.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 111.232 -175.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -59.99 -49.27 78.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.435 -0.791 . . . . 0.0 109.506 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 23.2 t -60.36 -41.31 93.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.159 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.117 ' O ' HD22 ' A' ' 33' ' ' LEU . 48.5 m -60.38 -31.11 70.04 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.217 -0.927 . . . . 0.0 109.583 175.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 66.8 ttt180 -83.43 -46.04 12.97 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.476 -0.765 . . . . 0.0 111.191 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -81.93 -6.04 58.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.903 -1.123 . . . . 0.0 110.235 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.117 HD22 ' O ' ' A' ' 30' ' ' SER . 1.7 pt? -44.33 -27.69 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.44 -0.787 . . . . 0.0 109.727 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.842 ' H ' HD23 ' A' ' 33' ' ' LEU . 78.8 mt -143.67 -63.77 0.39 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.471 -0.768 . . . . 0.0 110.4 176.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -173.38 13.4 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.281 -0.887 . . . . 0.0 110.739 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.536 ' CB ' ' HE2' ' A' ' 89' ' ' LYS . . . -47.59 119.75 2.92 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.986 -1.071 . . . . 0.0 110.01 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.537 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -106.18 174.44 5.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.759 HD11 ' HD3' ' A' ' 56' ' ' ARG . 11.3 mm -62.47 122.22 12.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 120.885 -1.134 . . . . 0.0 109.672 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.516 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 77.46 32.06 48.53 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -88.75 170.78 10.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.926 -1.338 . . . . 0.0 109.308 170.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 92' ' ' THR . 69.9 t -99.14 129.61 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 110.02 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.744 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.7 m -115.33 136.37 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.057 -1.027 . . . . 0.0 110.471 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' C ' HD12 ' A' ' 44' ' ' ILE . 86.3 tt0 -109.52 143.93 38.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 109.781 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.85 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.5 mp -120.81 145.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.001 -1.062 . . . . 0.0 110.266 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.2 tt0 -152.4 87.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.906 -1.121 . . . . 0.0 111.321 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.716 ' HB2' HG12 ' A' ' 85' ' ' VAL . 33.8 tttp -98.99 -80.32 0.47 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 172.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.585 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -84.55 -36.18 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.778 . . . . 0.0 109.55 175.144 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.578 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 92.0 mtt-85 -139.54 -176.01 4.4 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.56 -0.713 . . . . 0.0 109.532 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.89 ' HG2' HD21 ' A' ' 130' ' ' LEU . 1.2 ttpm? -89.96 139.06 30.97 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.375 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -141.64 165.47 27.4 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.341 0.591 . . . . 0.0 110.255 -174.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -128.44 163.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.365 -0.835 . . . . 0.0 110.283 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -175.9 179.99 46.71 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 173.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 57.2 ttt85 -118.87 171.16 8.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -1.122 . . . . 0.0 110.07 -177.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.552 ' CG2' ' HE3' ' A' ' 89' ' ' LYS . 0.3 OUTLIER -101.3 132.44 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.829 -1.169 . . . . 0.0 111.416 -171.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.587 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -130.27 162.85 28.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.496 -0.752 . . . . 0.0 110.392 171.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.759 ' HD3' HD11 ' A' ' 38' ' ' ILE . 87.8 mtm180 -91.43 128.6 37.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.548 -0.72 . . . . 0.0 110.305 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -65.06 140.77 58.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.246 -0.909 . . . . 0.0 110.047 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.574 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.12 -50.26 88.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.09 175.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 58' ' ' ARG . 52.7 Cg_endo -92.21 97.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.892 1.469 . . . . 0.0 108.988 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.94 41.21 0.16 Allowed 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.6 -0.687 . . . . 0.0 110.377 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 27.3 m-20 -143.45 -38.58 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.294 -0.879 . . . . 0.0 110.807 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.11 -22.84 28.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.942 -1.099 . . . . 0.0 109.839 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.491 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 10.6 m-80 -81.71 38.81 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 0.0 110.758 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 61' ' ' ASP . 11.6 ptpt -98.46 13.05 33.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.72 25.48 0.05 OUTLIER Glycine 0 N--CA 1.481 1.647 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.58 HG22 ' NE ' ' A' ' 10' ' ' ARG . 45.8 pt -140.81 140.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.985 HG23 HG13 ' A' ' 24' ' ' VAL . 3.3 p -119.95 127.6 75.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.456 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 25.2 ttt85 -89.59 113.69 25.16 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 109.757 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.736 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.7 pp -129.11 170.54 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.422 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' HB2' ' CG ' ' A' ' 21' ' ' MET . 8.0 t0 -79.19 164.47 24.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.991 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.4 m -59.91 -39.95 87.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.416 -0.803 . . . . 0.0 110.488 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.496 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 54.3 t -64.97 -44.43 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -175.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.786 ' HE1' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.8 -45.94 92.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.64 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -60.06 -40.04 88.1 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 109.983 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -71.58 -21.79 61.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.916 . . . . 0.0 110.384 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 5.3 m120 -59.89 -39.77 86.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 110.711 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 27.8 p -98.49 -31.04 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.039 -1.038 . . . . 0.0 110.392 -176.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.585 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.09 29.08 3.14 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.597 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -99.29 156.14 17.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.205 -1.174 . . . . 0.0 110.505 -175.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.665 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -111.78 166.01 11.56 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 175.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.982 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -54.32 139.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.418 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.18 68.72 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 1.1 m-20 -60.15 -160.56 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.84 -1.388 . . . . 0.0 110.451 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 11.6 pttt -134.5 112.35 10.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 110.122 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.716 HG12 ' HB2' ' A' ' 46' ' ' LYS . 1.5 m -118.76 148.98 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -0.893 . . . . 0.0 109.791 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 71.2 tttt -95.3 116.09 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.658 177.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.695 ' CG2' HD21 ' A' ' 9' ' ' LEU . 95.4 t -102.23 122.62 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 110.088 -177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 88.5 mtm180 -110.11 142.5 41.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.744 ' CD ' HG12 ' A' ' 42' ' ' VAL . 1.4 tptm -95.94 129.57 43.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 110.239 -176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.55 -163.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.668 0.746 . . . . 0.0 110.095 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 35.5 mtp180 -127.04 179.59 5.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 110.349 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.614 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.18 169.13 8.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.28 -0.888 . . . . 0.0 111.258 -176.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.633 ' CG ' HG12 ' A' ' 162' ' ' VAL . 16.7 pt-20 -149.49 169.54 20.68 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.608 HG21 ' OE2' ' A' ' 167' ' ' GLU . 48.7 mm -89.61 99.81 9.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.486 -1.384 . . . . 0.0 110.337 -176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.806 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -55.28 139.29 43.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.279 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.489 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 17.7 ptpt -101.8 -28.37 12.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 111.055 -178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.516 ' HB3' HD23 ' A' ' 156' ' ' LEU . 87.2 tttt -150.25 120.21 7.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.752 -1.217 . . . . 0.0 110.741 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.025 HG23 HG22 ' A' ' 155' ' ' THR . 8.7 p -131.75 140.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 110.764 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 98.6 m -113.09 143.8 43.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.393 -0.817 . . . . 0.0 110.098 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.646 HD21 HG23 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -143.14 170.15 16.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -177.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.637 ' HB2' ' NE ' ' A' ' 173' ' ' ARG . . . -142.38 97.78 6.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.848 . . . . 0.0 110.896 -175.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -55.89 131.95 49.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.992 1.522 . . . . 0.0 109.912 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 148' ' ' LEU . 35.1 mm -98.64 106.35 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 110.287 -177.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.79 HG21 HD11 ' A' ' 110' ' ' LEU . 28.9 pt -150.01 -161.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.508 175.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.524 ' HB2' ' HG2' ' A' ' 108' ' ' GLN . 24.9 mmm180 -110.35 152.33 26.36 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.926 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -59.71 -14.36 13.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.28 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 105' ' ' ARG . 9.0 p-10 -104.72 22.66 14.71 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.559 -0.713 . . . . 0.0 110.642 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.533 ' HG3' ' HB ' ' A' ' 104' ' ' ILE . 5.3 mm100 -90.53 154.57 19.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.964 -1.085 . . . . 0.0 110.866 -177.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 109' ' ' ARG . 51.4 ttt180 -89.53 -8.06 53.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.534 -0.729 . . . . 0.0 110.78 -175.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.79 HD11 HG21 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -96.82 51.99 1.16 Allowed 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 -177.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -131.52 133.92 45.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -140.57 -59.46 0.52 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.022 -1.049 . . . . 0.0 110.609 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 114' ' ' GLU . . . 77.26 -179.22 50.67 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 113' ' ' GLY . 98.9 mt-10 47.56 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.092 -1.24 . . . . 0.0 109.786 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.13 -14.04 58.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 117' ' ' GLU . 7.3 tp -60.12 -36.46 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -1.223 . . . . 0.0 110.206 174.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 172' ' ' ILE . 96.8 mt-10 -60.11 -42.84 95.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.082 -1.011 . . . . 0.0 109.432 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -65.54 -40.15 92.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -0.882 . . . . 0.0 109.495 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.57 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 52.4 t80 -60.09 -40.92 91.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.193 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.689 ' O ' HD22 ' A' ' 124' ' ' LEU . 54.4 t -63.84 -45.18 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.957 -1.089 . . . . 0.0 109.743 177.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.584 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 2.5 mt-30 -60.67 -44.7 96.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.663 -0.648 . . . . 0.0 110.472 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.577 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 1.9 ptm85 -69.6 -36.43 76.21 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.064 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.577 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -72.52 -42.95 64.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.681 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -102.27 1.09 35.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 110.998 -174.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.9 tt -43.19 171.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.042 . . . . 0.0 110.74 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HG2' ' CG2' ' A' ' 125' ' ' ILE . 51.4 ptt85 32.57 53.8 0.34 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.634 -0.666 . . . . 0.0 111.504 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -139.71 151.28 65.67 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.007 -1.058 . . . . 0.0 110.917 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.867 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 21.1 Cg_endo -67.1 132.2 27.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.137 1.599 . . . . 0.0 109.81 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.596 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.7 mmm -128.43 146.71 50.72 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.34 -1.475 . . . . 0.0 111.195 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.89 HD21 ' HG2' ' A' ' 49' ' ' LYS . 12.7 tp -149.45 112.44 4.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.612 -0.68 . . . . 0.0 109.587 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.611 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 5.6 pt-20 -49.23 144.36 5.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.93 -1.106 . . . . 0.0 111.022 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.611 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 83.8 -8.45 1.04 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.429 0.633 . . . . 0.0 110.316 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.523 ' OD2' ' HB ' ' A' ' 152' ' ' VAL . 1.1 p30 -69.97 -170.03 0.31 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.448 -0.782 . . . . 0.0 110.617 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.412 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . 13.9 m-80 -142.29 150.07 40.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.065 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.547 HD11 ' CG2' ' A' ' 152' ' ' VAL . 0.3 OUTLIER -136.2 169.97 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.821 -1.175 . . . . 0.0 110.64 -177.421 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.5 t -132.49 143.35 49.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.555 -0.716 . . . . 0.0 110.342 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.678 HG13 ' HD2' ' A' ' 138' ' ' PRO . 94.6 t -129.07 150.51 75.56 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 121.623 -0.673 . . . . 0.0 109.185 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.678 ' HD2' HG13 ' A' ' 137' ' ' VAL . 1.3 Cg_endo -47.96 82.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.841 1.443 . . . . 0.0 110.056 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . -146.1 100.78 0.23 Allowed Glycine 0 C--N 1.298 -1.57 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.79 HD13 ' H ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -85.36 160.66 19.73 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.437 -1.037 . . . . 0.0 110.032 -176.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.87 ' C ' HD13 ' A' ' 142' ' ' LEU . 0.8 OUTLIER -85.96 -175.25 5.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.633 -1.292 . . . . 0.0 111.234 -170.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.899 ' N ' HD13 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -149.28 -115.97 0.06 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.161 178.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.664 ' N ' HD23 ' A' ' 142' ' ' LEU . . . -54.82 -155.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.102 -0.999 . . . . 0.0 110.39 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.2 77.22 2.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.474 ' HG2' HD22 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -102.8 164.04 11.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.449 -1.03 . . . . 0.0 110.068 177.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 t -139.54 150.78 45.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 110.539 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.719 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 96.24 -88.82 1.05 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.719 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 42.17 39.51 1.42 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.523 -0.987 . . . . 0.0 111.378 178.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.52 163.79 31.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.84 -1.163 . . . . 0.0 109.799 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -96.47 127.71 42.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.028 -1.045 . . . . 0.0 109.913 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.5 112.11 23.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 4.0 t -78.46 135.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 110.114 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.855 HG21 ' NH2' ' A' ' 173' ' ' ARG . 40.8 t -115.81 -30.61 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.189 -0.944 . . . . 0.0 110.953 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 131' ' ' GLU . 14.9 tttp -145.6 149.48 34.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.863 -1.148 . . . . 0.0 110.935 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.025 HG22 HG23 ' A' ' 98' ' ' VAL . 75.2 p -139.23 167.49 21.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.631 -0.668 . . . . 0.0 109.39 175.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.03 -39.1 0.44 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.123 -0.986 . . . . 0.0 110.872 -176.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.915 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.2 Cg_exo -59.01 -170.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.58 1.305 . . . . 0.0 110.162 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.463 ' HB3' HG22 ' A' ' 160' ' ' VAL . 26.8 t -90.25 -165.16 1.29 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -69.18 -2.98 11.75 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.715 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 158' ' ' SER . 34.3 m -87.64 143.78 34.33 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 110.415 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.561 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.1 Cg_endo -48.49 141.5 19.49 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.244 1.655 . . . . 0.0 110.964 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.915 HG11 ' CB ' ' A' ' 157' ' ' PRO . 9.1 m -130.07 159.95 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.035 . . . . 0.0 109.868 173.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.4 tt0 -107.48 129.92 54.9 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.35 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.834 ' CD1' HG21 ' A' ' 168' ' ' THR . 16.7 mm -72.03 154.11 7.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.624 -0.672 . . . . 0.0 110.381 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.95 171.46 26.12 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -55.04 -24.85 26.8 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.343 -1.092 . . . . 0.0 110.359 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.608 ' OE2' HG21 ' A' ' 94' ' ' ILE . 18.5 pt-20 -90.28 -17.17 27.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.17 -0.956 . . . . 0.0 110.851 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.834 HG21 ' CD1' ' A' ' 164' ' ' ILE . 85.3 m -58.45 140.56 53.68 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 0.0 110.16 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 70.9 mmtt -94.84 162.31 13.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.964 -1.085 . . . . 0.0 109.954 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.646 HG23 HD21 ' A' ' 100' ' ' LEU . 2.1 mt -139.37 160.23 28.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 111.12 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.413 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 26.2 mt-10 -137.99 132.78 32.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.633 -0.667 . . . . 0.0 110.413 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.612 ' CD1' HD11 ' A' ' 100' ' ' LEU . 43.6 mm -120.07 123.51 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.426 -0.796 . . . . 0.0 110.02 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.855 ' NH2' HG21 ' A' ' 153' ' ' VAL . 11.1 ptp180 -88.64 156.23 19.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.016 -1.053 . . . . 0.0 110.463 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 174' ' ' GLU . 41.2 tt0 -96.37 9.3 41.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.297 -0.877 . . . . 0.0 110.184 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -96.77 109.66 49.65 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 110.185 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.1 Cg_exo -71.74 -155.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.123 1.591 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.38 53.8 0.54 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.796 -0.565 . . . . 0.0 110.116 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 21.8 p -65.01 125.97 26.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 109.975 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 178' ' ' SER . 81.3 tt0 60.02 13.79 3.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.359 -0.838 . . . . 0.0 110.662 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 66.5 t -105.19 111.55 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.051 -1.031 . . . . 0.0 110.12 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 pp -132.32 -22.78 2.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.911 . . . . 0.0 110.627 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -113.28 120.12 40.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.026 -1.046 . . . . 0.0 110.215 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.05 -39.87 87.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.163 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -177.14 -178.62 46.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.532 -179.891 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.215 0.531 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -99.63 139.43 35.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.021 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 t -60.02 -40.04 87.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 110.183 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -115.21 116.98 29.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.126 -0.984 . . . . 0.0 110.228 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.822 ' OD1' HD13 ' A' ' 34' ' ' LEU . 49.4 p30 -148.25 160.1 43.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 110.032 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -155.53 -166.48 15.71 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.098 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.722 HG13 HD22 ' A' ' 9' ' ' LEU . 40.0 pt -134.78 159.93 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.344 -1.092 . . . . 0.0 109.421 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.63 ' C ' HD23 ' A' ' 9' ' ' LEU . 36.5 mt -98.57 124.33 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.005 . . . . 0.0 110.28 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.84 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -141.1 -172.68 3.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.394 -0.816 . . . . 0.0 110.478 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.642 ' NH2' HG21 ' A' ' 66' ' ' ILE . 25.5 ttp-105 -103.89 128.79 51.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 110.947 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.933 HG23 HD11 ' A' ' 69' ' ' ILE . 7.1 p -63.02 137.87 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.558 -0.714 . . . . 0.0 110.5 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -127.48 160.15 32.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 0.0 110.288 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.792 ' HB3' HD11 ' A' ' 81' ' ' ILE . 85.1 tt0 -175.05 147.12 0.91 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.306 -0.871 . . . . 0.0 110.555 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.8 147.05 51.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.261 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -73.67 -11.77 60.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.398 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.2 m -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 110.25 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -128.51 137.73 51.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.451 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.66 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -94.09 -36.4 0.31 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.317 -0.864 . . . . 0.0 111.332 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 35.0 Cg_exo -56.14 -176.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 123.386 1.203 . . . . 0.0 110.829 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.461 ' HA2' ' HG2' ' A' ' 23' ' ' ARG . . . 91.38 32.23 8.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.516 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 27.6 ptm -88.4 1.89 53.78 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.279 -1.13 . . . . 0.0 109.481 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.28 16.34 2.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.355 -0.841 . . . . 0.0 110.803 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 11.0 ptp180 -140.02 146.12 38.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.0 110.394 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 55.2 t -119.95 119.14 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -0.832 . . . . 0.0 109.807 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.768 ' O ' HD12 ' A' ' 26' ' ' LEU . 5.9 ptt180 -88.38 119.53 28.9 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.837 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.2 mp -138.81 164.77 28.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.672 -0.643 . . . . 0.0 109.843 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.6 p-10 -89.59 -179.79 5.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.036 -1.04 . . . . 0.0 110.702 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 109.265 -175.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.0 t -67.12 -40.01 86.75 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.098 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.16 ' O ' HD22 ' A' ' 33' ' ' LEU . 43.7 m -64.06 -27.94 69.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.224 -0.922 . . . . 0.0 109.496 175.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 61.1 ttt180 -85.12 -45.17 12.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.749 -0.594 . . . . 0.0 110.834 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 22.5 tpt180 -79.59 -9.96 59.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.812 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.16 HD22 ' O ' ' A' ' 30' ' ' SER . 1.9 pt? -41.12 -30.04 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.661 0.743 . . . . 0.0 109.859 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.822 HD13 ' OD1' ' A' ' 5' ' ' ASN . 80.5 mt -140.54 -60.57 0.51 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.706 -0.622 . . . . 0.0 110.56 176.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' C ' ' A' ' 36' ' ' ALA . 19.7 t0 -171.06 -29.42 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.193 -0.942 . . . . 0.0 110.487 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.869 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -21.35 123.98 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.354 0.597 . . . . 0.0 111.469 -176.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.62 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.4 pt-20 -101.12 178.98 4.5 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 38' ' ' ILE . 32.6 mm -60.08 123.38 12.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 120.928 -1.107 . . . . 0.0 109.765 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.9 30.59 61.22 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 175.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -88.84 -179.87 6.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.326 . . . . 0.0 109.514 172.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.806 HG21 HG23 ' A' ' 92' ' ' THR . 80.1 t -99.26 127.76 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.02 -1.05 . . . . 0.0 110.467 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.681 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -119.96 142.95 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 -177.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -110.54 142.91 41.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.489 -0.757 . . . . 0.0 109.812 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.7 mp -120.02 149.33 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.221 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.0 tt0 -151.88 94.45 1.97 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 110.845 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.068 ' CG ' HG12 ' A' ' 85' ' ' VAL . 12.7 tmtt? -98.6 -66.8 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.052 -1.03 . . . . 0.0 109.69 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.568 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -103.48 -35.53 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.645 0.736 . . . . 0.0 109.202 175.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 1.6 mmt85 -134.12 -167.83 2.02 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.61 -0.681 . . . . 0.0 109.625 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.739 ' C ' HD21 ' A' ' 130' ' ' LEU . 21.9 mttm -89.72 137.32 32.43 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.803 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.583 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.6 157.44 46.76 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.251 0.548 . . . . 0.0 110.2 178.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.3 160.82 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 109.967 177.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.56 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -178.72 -178.54 48.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -115.79 157.46 24.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.475 -1.014 . . . . 0.0 109.922 -176.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.681 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -85.03 135.51 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.962 -1.086 . . . . 0.0 110.216 -175.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -127.7 163.15 24.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.063 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -90.01 121.82 32.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 110.098 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -63.45 141.65 58.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.958 . . . . 0.0 109.926 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.672 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 5.4 mtm180 -56.16 -45.77 99.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.045 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 40.8 Cg_endo -92.65 97.54 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.882 1.464 . . . . 0.0 109.004 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.432 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 13.1 pt-20 -75.29 36.06 0.12 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.562 -0.711 . . . . 0.0 110.681 -176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.9 m-20 -147.33 -37.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.057 -1.027 . . . . 0.0 110.558 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -84.73 -24.3 28.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.094 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.523 ' HA ' HG12 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -81.14 38.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.71 -0.619 . . . . 0.0 110.526 177.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.496 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.4 pttt -98.81 15.48 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -0.999 . . . . 0.0 109.406 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.09 24.34 0.03 OUTLIER Glycine 0 N--CA 1.479 1.557 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.642 HG21 ' NH2' ' A' ' 10' ' ' ARG . 46.1 pt -140.77 156.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -1.12 . . . . 0.0 109.046 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 3.4 p -135.38 131.48 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.908 -1.12 . . . . 0.0 110.144 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.536 ' NE ' ' HD3' ' A' ' 25' ' ' ARG . 42.9 ttp180 -92.76 118.66 31.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 110.123 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.933 HD11 HG23 ' A' ' 11' ' ' VAL . 2.6 pt -132.09 166.45 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.473 -0.767 . . . . 0.0 110.379 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' OD2' ' HB3' ' A' ' 21' ' ' MET . 21.4 p-10 -83.66 177.66 8.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.406 -0.809 . . . . 0.0 110.138 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.3 t -63.48 -35.22 79.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.0 110.92 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.434 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 66.5 t -64.18 -46.16 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 110.123 -174.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.728 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.38 -43.72 96.33 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.554 177.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 6.8 ttm180 -59.95 -40.87 90.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.893 174.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -69.97 -25.91 63.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.291 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 72' ' ' VAL . 5.4 m120 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 110.618 -175.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.46 ' HB2' HG23 ' A' ' 47' ' ' VAL . 29.1 p -99.1 -37.19 9.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.034 -1.042 . . . . 0.0 110.425 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.568 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 116.4 21.92 4.62 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -99.22 169.62 9.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.169 -1.194 . . . . 0.0 110.332 -175.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.845 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.26 171.14 7.73 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.351 -0.843 . . . . 0.0 109.366 178.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.792 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -60.16 140.46 18.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.03 -1.044 . . . . 0.0 109.981 177.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.704 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 79.61 -4.79 63.11 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 171.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.546 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.2 m-20 -58.04 -166.42 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.815 -1.403 . . . . 0.0 110.115 174.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 33.6 pttt -127.83 112.8 15.15 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.224 -0.922 . . . . 0.0 109.831 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.068 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -120.33 151.64 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 48.9 tttp -101.09 126.59 47.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.891 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.527 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 62.2 t -102.97 121.98 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.963 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.565 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 77.8 mtt85 -106.74 128.19 54.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.869 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 13.8 tmtt? -78.75 135.99 37.27 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.15 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.438 HG21 ' HD2' ' A' ' 161' ' ' PRO . 2.2 m -150.04 -169.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.49 -0.757 . . . . 0.0 110.234 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -126.6 173.3 9.56 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.494 -0.754 . . . . 0.0 109.671 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.806 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.0 162.5 12.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 110.953 -176.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.666 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.7 pt-20 -150.23 169.92 20.19 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.577 HG21 ' OE2' ' A' ' 167' ' ' GLU . 50.8 mm -90.04 98.85 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.594 -1.316 . . . . 0.0 110.319 -176.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.861 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.48 139.7 52.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.234 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.65 ' CD ' HD23 ' A' ' 156' ' ' LEU . 13.0 ptpt -107.13 -24.62 11.88 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.17 -0.956 . . . . 0.0 111.292 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.636 ' HD3' HD13 ' A' ' 156' ' ' LEU . 63.6 tttp -149.97 119.62 7.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.706 -1.246 . . . . 0.0 110.619 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.888 HG23 HG22 ' A' ' 155' ' ' THR . 10.0 p -136.23 140.76 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.017 . . . . 0.0 110.692 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.491 ' C ' HD23 ' A' ' 100' ' ' LEU . 99.7 m -111.97 142.1 44.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.081 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.891 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.04 165.86 24.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.0 110.614 -178.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -140.07 89.5 11.11 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.429 -0.795 . . . . 0.0 110.315 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.5 Cg_exo -58.56 131.73 44.21 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.061 1.559 . . . . 0.0 110.752 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.971 HG23 ' HB2' ' A' ' 177' ' ' ALA . 57.4 mt -89.71 90.47 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 0.0 110.005 177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.741 HG21 ' CG ' ' A' ' 109' ' ' ARG . 1.0 OUTLIER -151.76 -166.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.495 -0.753 . . . . 0.0 110.471 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.574 ' O ' HD13 ' A' ' 104' ' ' ILE . 9.5 mpt_? -92.91 164.4 13.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.835 . . . . 0.0 110.149 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.832 ' HA ' HD21 ' A' ' 110' ' ' LEU . 39.0 pttt -59.91 -14.75 17.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.153 -0.967 . . . . 0.0 110.578 -175.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.442 ' O ' ' HD2' ' A' ' 111' ' ' LYS . 35.7 p-10 -117.77 25.0 10.69 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.502 -0.749 . . . . 0.0 110.914 -177.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 104' ' ' ILE . 43.8 mm-40 -104.7 -82.58 0.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.065 -1.022 . . . . 0.0 110.818 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.741 ' CG ' HG21 ' A' ' 104' ' ' ILE . 26.7 mmm180 -93.68 -27.65 16.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.887 . . . . 0.0 109.852 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.832 HD21 ' HA ' ' A' ' 106' ' ' LYS . 0.8 OUTLIER -98.59 52.37 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.054 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 107' ' ' ASP . 6.3 ptmt -131.26 60.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.392 -0.818 . . . . 0.0 110.105 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -141.08 -61.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.962 . . . . 0.0 110.239 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 76.13 -179.81 47.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 113' ' ' GLY . 98.9 mt-10 43.78 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.134 -1.215 . . . . 0.0 110.346 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.38 4.83 89.22 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.748 ' C ' HD13 ' A' ' 116' ' ' ILE . 0.0 OUTLIER -60.59 -39.94 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.235 -1.156 . . . . 0.0 109.948 177.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -62.43 -40.05 95.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.714 176.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.53 -29.09 66.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.0 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.04 -40.01 87.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.226 -0.921 . . . . 0.0 109.572 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.769 HG12 ' CD1' ' A' ' 170' ' ' ILE . 54.5 t -65.01 -49.97 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.4 mt-30 -60.06 -44.58 94.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.813 . . . . 0.0 110.024 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -60.01 -44.09 94.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.647 -0.658 . . . . 0.0 110.211 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.527 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.05 -43.8 70.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -0.789 . . . . 0.0 110.544 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.74 ' N ' HD22 ' A' ' 124' ' ' LEU . 3.5 mm? -99.05 2.81 46.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 111.036 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.738 HD11 ' HG2' ' A' ' 166' ' ' GLU . 2.4 tt -46.2 169.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.887 -1.133 . . . . 0.0 110.241 -175.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 28.8 ptt180 33.13 46.09 0.09 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.513 -0.742 . . . . 0.0 111.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -132.26 149.9 74.47 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.784 -1.198 . . . . 0.0 110.866 176.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.81 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 19.4 Cg_endo -63.83 133.41 38.91 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.182 1.622 . . . . 0.0 110.264 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.522 ' HE2' HG21 ' A' ' 98' ' ' VAL . 81.5 mmm -127.0 143.05 51.4 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.592 -1.317 . . . . 0.0 111.279 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.739 HD21 ' C ' ' A' ' 49' ' ' LYS . 10.8 tp -148.27 110.7 4.68 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.729 -0.607 . . . . 0.0 109.442 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.552 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 3.2 pm0 -43.02 143.28 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.944 -1.097 . . . . 0.0 110.526 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.97 -2.48 2.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.873 -0.517 . . . . 0.0 110.429 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.7 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.6 p-10 -69.93 169.86 12.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.243 -0.911 . . . . 0.0 110.107 175.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.477 ' ND2' ' C ' ' A' ' 133' ' ' ASP . 5.4 m120 -128.54 145.28 51.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.25 165.51 23.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.944 -1.097 . . . . 0.0 110.108 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.7 t -140.31 149.8 43.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.479 -0.763 . . . . 0.0 110.75 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.715 HG13 ' HD2' ' A' ' 138' ' ' PRO . 87.3 t -140.06 151.53 65.27 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 0.0 109.203 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.715 ' HD2' HG13 ' A' ' 137' ' ' VAL . 1.7 Cg_endo -44.3 86.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.701 1.369 . . . . 0.0 110.307 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.633 ' O ' HD22 ' A' ' 148' ' ' LEU . . . -144.92 102.58 0.27 Allowed Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 141' ' ' THR . 3.8 pp -86.6 135.92 33.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.431 -1.041 . . . . 0.0 109.834 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 1.089 ' O ' HD13 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -69.84 -171.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 111.099 -171.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.089 HD13 ' O ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -127.75 -103.08 0.33 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.49 -158.26 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.252 -0.905 . . . . 0.0 110.382 176.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.37 52.55 4.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.586 ' NE2' ' CD2' ' A' ' 142' ' ' LEU . 11.6 pt20 -94.84 155.93 16.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.136 . . . . 0.0 110.167 176.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.2 t -134.13 150.22 51.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.354 -0.842 . . . . 0.0 110.317 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.74 -90.91 0.54 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.633 HD22 ' O ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER 46.62 49.47 13.76 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.148 -1.207 . . . . 0.0 110.631 177.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 103' ' ' ILE . 2.3 pp -140.32 167.55 21.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.815 -1.178 . . . . 0.0 109.905 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 62.6 m-85 -91.19 121.77 33.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 110.216 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.437 ' HD2' ' ND2' ' A' ' 134' ' ' ASN . 32.0 tptt -103.26 104.77 14.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.845 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.7 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.2 t -76.65 139.26 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.19 -0.944 . . . . 0.0 109.851 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.26 -29.0 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.115 -0.99 . . . . 0.0 111.059 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 38.4 ttpt -139.52 144.94 38.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.815 -1.178 . . . . 0.0 111.017 -176.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.888 HG22 HG23 ' A' ' 98' ' ' VAL . 58.0 p -140.01 153.02 46.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.71 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.8 OUTLIER -89.82 -30.62 0.36 Allowed Pre-proline 0 C--N 1.297 -1.696 0 O-C-N 121.282 -0.886 . . . . 0.0 111.425 -177.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.974 ' CB ' HG11 ' A' ' 162' ' ' VAL . 14.2 Cg_exo -58.63 -164.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.216 1.114 . . . . 0.0 109.921 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.678 ' HB3' HG22 ' A' ' 160' ' ' VAL . 15.3 t -89.98 -178.41 5.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.776 175.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -62.27 -8.47 5.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 110.469 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.678 HG22 ' HB3' ' A' ' 158' ' ' SER . 20.7 m -84.76 146.25 45.97 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 110.238 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.555 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.4 Cg_endo -47.45 141.3 14.66 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.255 1.661 . . . . 0.0 110.747 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.974 HG11 ' CB ' ' A' ' 157' ' ' PRO . 7.0 m -129.89 159.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 109.575 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.89 128.1 54.32 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.205 -0.934 . . . . 0.0 110.079 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.769 ' CD1' HG21 ' A' ' 168' ' ' THR . 11.9 mm -70.58 154.68 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.609 -0.682 . . . . 0.0 110.055 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.61 172.33 24.0 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.738 ' HG2' HD11 ' A' ' 125' ' ' ILE . 96.6 mt-10 -58.2 -26.26 62.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.898 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.577 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.4 pt-20 -87.38 -17.98 31.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.592 -176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 95' ' ' ALA . 30.7 m -58.47 152.48 17.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 110.302 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' LYS . 23.0 mmtt -105.89 158.77 16.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.062 . . . . 0.0 109.875 177.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.891 HG23 HD21 ' A' ' 100' ' ' LEU . 1.8 mt -136.68 161.8 35.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 111.164 -178.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.474 ' HB2' ' OG1' ' A' ' 99' ' ' THR . 12.0 mt-10 -139.06 131.66 28.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.756 -0.59 . . . . 0.0 110.219 175.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.9 mp -119.91 128.89 75.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 110.135 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.465 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 5.5 ptp180 -88.31 154.58 20.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 110.233 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 49.8 mt-10 -89.98 -0.2 57.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.321 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.77 108.3 45.02 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.934 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 104' ' ' ILE . 11.4 Cg_exo -72.55 -155.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.026 1.54 . . . . 0.0 110.29 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.971 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -79.67 54.51 1.81 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.001 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 68.9 m -109.66 123.21 49.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 109.826 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 178' ' ' SER . 82.6 tt0 59.95 19.36 8.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.984 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.54 139.2 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.351 -0.843 . . . . 0.0 110.263 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.623 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -124.08 70.71 1.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.16 -0.962 . . . . 0.0 110.3 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.13 139.66 58.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.985 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.93 -40.07 87.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.355 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 65.93 -107.7 2.06 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.583 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.316 0.579 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -130.35 159.96 35.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 110.157 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 p -78.75 163.95 24.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 110.133 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -88.79 -32.03 18.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 110.198 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 t30 45.03 -163.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -0.911 . . . . 0.0 110.388 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -151.0 -153.7 6.25 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.022 HG21 HD22 ' A' ' 33' ' ' LEU . 11.9 pt -138.63 167.75 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -1.15 . . . . 0.0 109.412 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.771 ' C ' HD23 ' A' ' 9' ' ' LEU . 85.4 mt -109.89 127.84 66.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.117 -0.989 . . . . 0.0 110.337 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.837 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -148.49 -179.04 6.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.511 -0.743 . . . . 0.0 109.962 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 2.8 ptt180 -104.74 138.89 40.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.939 -1.101 . . . . 0.0 110.601 -173.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 80' ' ' SER . 11.2 p -63.07 130.43 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 110.356 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -110.93 153.5 25.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.909 175.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 -176.77 134.99 0.22 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 0.0 110.071 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.4 130.55 56.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -59.94 -38.54 82.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 110.061 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.5 t -59.96 -39.98 87.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 110.347 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 p -116.32 107.65 15.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.003 . . . . 0.0 110.333 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.737 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -96.84 -24.05 0.24 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.344 -0.848 . . . . 0.0 112.332 -178.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 52.0 Cg_exo -47.02 144.11 8.94 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 122.913 0.954 . . . . 0.0 111.049 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.25 61.28 0.94 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.491 ' HA ' ' CB ' ' A' ' 70' ' ' ASP . 25.0 ptt? -90.01 -0.99 57.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -1.141 . . . . 0.0 110.06 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 22.6 p -138.86 9.41 2.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 110.029 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HG2' ' HD2' ' A' ' 53' ' ' ARG . 82.2 mtt180 -107.25 131.62 53.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.389 -0.819 . . . . 0.0 109.936 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 67' ' ' VAL . 78.1 t -105.3 114.02 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.987 -1.071 . . . . 0.0 110.053 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.484 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 8.9 ptt180 -93.5 119.95 33.19 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.563 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.628 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -139.84 171.94 13.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.682 -176.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 19.8 p-10 -95.43 -172.58 2.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.897 -1.127 . . . . 0.0 110.785 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.03 -46.97 87.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.578 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.474 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 18.2 m -65.24 -41.75 94.06 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.129 -175.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.667 ' HA ' HD23 ' A' ' 33' ' ' LEU . 64.3 m -59.92 -40.04 87.51 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.155 -0.966 . . . . 0.0 109.558 175.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 41.1 ttm180 -73.27 -44.04 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 111.163 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -91.73 -7.82 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.919 -1.113 . . . . 0.0 111.201 -172.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.041 HD12 ' N ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -52.23 -26.58 12.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.149 . . . . 0.0 109.329 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.041 ' N ' HD12 ' A' ' 33' ' ' LEU . 41.9 mt -132.65 -66.01 0.7 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.407 -0.808 . . . . 0.0 110.785 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.472 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 28.8 t0 -171.82 -2.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.955 -1.091 . . . . 0.0 111.52 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -44.97 128.01 6.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.827 -1.17 . . . . 0.0 110.449 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.585 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.2 pt-20 -116.85 176.57 5.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 38' ' ' ILE . 21.6 mm -57.96 122.41 7.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.812 -1.18 . . . . 0.0 109.855 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.504 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 72.88 33.42 59.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 120.161 -1.018 . . . . 0.0 110.663 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 18.9 m-20 -89.2 176.23 7.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.667 -1.49 . . . . 0.0 109.596 172.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.079 HG12 HG23 ' A' ' 90' ' ' VAL . 73.6 t -99.07 127.78 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.084 -177.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 52' ' ' GLY . 4.6 m -120.0 151.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 110.229 -177.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' C ' HD12 ' A' ' 44' ' ' ILE . 86.5 tt0 -122.99 142.9 50.33 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 109.716 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -119.9 147.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' OE1' ' CZ ' ' A' ' 88' ' ' ARG . 82.5 tt0 -151.29 93.14 1.87 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.931 -1.106 . . . . 0.0 110.846 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.035 ' HG3' HG12 ' A' ' 85' ' ' VAL . 8.9 tmtm? -97.94 -58.85 1.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.646 174.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -115.73 -31.51 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.676 0.75 . . . . 0.0 109.129 176.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 98.3 mtt180 -139.53 -172.57 3.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.642 -0.662 . . . . 0.0 109.747 176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -88.41 130.32 35.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.177 -0.952 . . . . 0.0 110.825 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -131.03 154.31 48.35 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.805 -0.56 . . . . 0.0 110.26 179.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.056 HG11 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -117.91 164.36 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.131 -0.981 . . . . 0.0 110.514 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.945 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -176.77 179.0 47.96 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 18.2 ptp180 -111.53 -172.04 1.96 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -1.112 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.585 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.24 137.66 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.026 -1.046 . . . . 0.0 110.632 -175.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -127.89 164.13 22.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 110.194 176.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.27 123.67 33.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -63.33 140.05 58.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.653 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 4.6 mmt180 -56.08 -49.55 92.48 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 120.903 -1.123 . . . . 0.0 108.877 174.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 18.7 Cg_endo -91.68 98.36 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.715 1.376 . . . . 0.0 108.831 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.465 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 11.1 pt-20 -74.97 35.29 0.1 Allowed 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 110.917 -173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 79.5 m-20 -145.43 -32.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.056 -1.027 . . . . 0.0 110.796 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -86.99 -25.55 24.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.563 ' HA ' HG12 ' A' ' 66' ' ' ILE . 4.1 m-80 -81.13 39.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.641 -0.662 . . . . 0.0 110.573 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.3 pttt -99.02 17.48 19.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 0.0 109.575 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.56 23.98 0.03 OUTLIER Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.563 HG12 ' HA ' ' A' ' 63' ' ' ASN . 44.5 pt -140.68 158.59 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.52 -0.988 . . . . 0.0 109.221 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.976 HG23 HG13 ' A' ' 24' ' ' VAL . 3.4 p -129.98 137.13 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.087 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -97.31 118.02 32.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.05 -1.031 . . . . 0.0 110.1 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.857 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.1 pt -134.36 173.04 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.749 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' CB ' ' HA ' ' A' ' 21' ' ' MET . 29.7 t0 -91.23 173.61 7.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.564 -0.71 . . . . 0.0 109.857 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 58.5 p -63.12 -25.29 68.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.438 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.7 t -68.49 -47.45 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.689 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.07 -42.81 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 109.768 176.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.02 -40.27 88.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.337 -0.852 . . . . 0.0 109.993 174.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -71.04 -26.86 63.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.395 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.4 m-20 -60.07 -39.9 87.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 110.808 -176.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.524 ' C ' HG23 ' A' ' 47' ' ' VAL . 28.5 p -98.47 -36.53 9.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.965 -1.084 . . . . 0.0 110.657 -175.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 117.18 22.83 4.04 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.79 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -102.65 171.75 7.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -1.202 . . . . 0.0 110.311 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.962 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.91 179.05 4.08 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -65.22 140.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.053 -1.03 . . . . 0.0 110.423 177.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.88 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 76.03 -3.21 52.72 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 173.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.586 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.52 -158.83 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.054 -1.262 . . . . 0.0 110.211 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 52.6 pttt -137.07 116.92 13.14 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 110.097 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.035 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.3 m -125.81 160.07 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.433 -0.792 . . . . 0.0 109.823 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 33.0 ttmt -104.08 123.99 48.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.079 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.508 HG21 HD11 ' A' ' 9' ' ' LEU . 63.8 t -99.55 125.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtm180 -117.23 149.49 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 61.7 tttm -91.15 139.85 30.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.862 -1.149 . . . . 0.0 110.371 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.079 HG23 HG12 ' A' ' 41' ' ' VAL . 2.3 m -138.84 -168.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 175.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.481 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 38.8 ptt180 -137.46 171.26 14.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -109.26 159.55 16.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 0.0 111.193 -175.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.648 ' CG ' HG12 ' A' ' 162' ' ' VAL . 11.7 pt-20 -150.32 171.17 17.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.761 HG21 ' OE2' ' A' ' 167' ' ' GLU . 39.7 mm -88.62 98.87 8.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 120.287 -1.508 . . . . 0.0 110.096 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.992 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -58.62 139.96 55.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.392 -0.818 . . . . 0.0 110.365 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.587 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 1.4 pttt -97.46 -29.7 13.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.081 -1.012 . . . . 0.0 111.11 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.564 ' HB3' HD23 ' A' ' 156' ' ' LEU . 80.4 tttt -150.91 121.98 7.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.62 -1.3 . . . . 0.0 110.915 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.017 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -132.24 143.54 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.006 -1.059 . . . . 0.0 110.955 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.524 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 91.1 m -114.96 140.26 49.16 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.391 -0.818 . . . . 0.0 110.044 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 170' ' ' ILE . 0.1 OUTLIER -136.3 165.28 26.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.374 -177.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.576 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -136.33 82.11 35.56 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 111.033 -176.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.53 ' HD2' ' CD ' ' A' ' 173' ' ' ARG . 17.4 Cg_exo -58.15 128.07 27.33 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.869 1.458 . . . . 0.0 109.883 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.775 ' CG2' ' HB2' ' A' ' 177' ' ' ALA . 71.6 mt -95.61 103.31 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.042 -1.036 . . . . 0.0 110.549 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.664 HG21 HD21 ' A' ' 110' ' ' LEU . 16.8 pt -150.83 -153.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 122.148 0.975 . . . . 0.0 110.615 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.496 ' N ' HG13 ' A' ' 104' ' ' ILE . 28.9 mmt85 -130.56 156.73 44.34 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.102 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.04 -18.58 47.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 109.89 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.441 ' OD1' ' CB ' ' A' ' 105' ' ' ARG . 35.6 p-10 -103.6 24.18 11.53 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.825 -0.547 . . . . 0.0 110.532 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.623 ' OE1' HD21 ' A' ' 142' ' ' LEU . 24.4 mm-40 -90.74 173.94 7.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.065 -1.022 . . . . 0.0 110.46 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -88.45 -22.02 23.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 110.521 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.664 HD21 HG21 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -98.03 45.23 1.02 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 0.0 110.084 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -105.64 140.68 38.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.551 -0.718 . . . . 0.0 109.696 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -138.83 -38.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.028 . . . . 0.0 110.733 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.515 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 78.15 -156.93 44.21 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 113' ' ' GLY . 21.9 pt-20 -30.17 142.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.946 -0.738 . . . . 0.0 110.833 -178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.01 -11.82 55.95 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 120' ' ' VAL . 5.9 tp -63.91 -34.18 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 110.113 175.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.541 ' HG2' HG12 ' A' ' 172' ' ' ILE . 94.8 mt-10 -59.99 -46.81 88.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.235 -0.916 . . . . 0.0 109.516 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.39 -39.89 92.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.511 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.457 ' HB3' HD12 ' A' ' 116' ' ' ILE . 36.8 t80 -64.27 -39.99 95.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.475 -0.766 . . . . 0.0 109.942 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.73 HG12 ' CD1' ' A' ' 170' ' ' ILE . 58.4 t -60.59 -49.97 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.694 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.4 mt-30 -61.21 -41.82 97.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.645 -0.66 . . . . 0.0 110.238 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -60.1 -48.93 79.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.438 -0.789 . . . . 0.0 109.97 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.01 -40.73 75.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.775 . . . . 0.0 110.719 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.573 HD12 ' HE3' ' A' ' 129' ' ' MET . 4.6 mm? -94.91 -1.74 51.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.94 . . . . 0.0 111.138 -175.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.712 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.6 tt -46.95 166.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.931 -1.105 . . . . 0.0 110.109 -175.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.6 ptt180 33.76 49.56 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 0.0 111.458 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.464 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 6.8 tpt180 -135.07 140.95 36.36 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.899 -1.126 . . . . 0.0 111.373 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 25.1 Cg_exo -59.69 130.68 36.26 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 124.095 1.576 . . . . 0.0 109.734 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.573 ' HE3' HD12 ' A' ' 124' ' ' LEU . 15.4 mmt -134.9 141.78 46.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.409 -1.432 . . . . 0.0 110.972 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -146.42 130.0 16.92 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -51.32 145.63 8.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -175.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.541 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 76.51 -2.06 2.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.818 -0.551 . . . . 0.0 110.548 178.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.801 ' HB3' HD23 ' A' ' 130' ' ' LEU . 1.6 p30 -67.59 -171.21 0.18 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.196 -0.94 . . . . 0.0 109.874 173.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -150.37 159.02 44.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.34 -0.85 . . . . 0.0 109.532 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.423 HD12 ' CB ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -137.27 168.44 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 0.0 110.122 178.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.5 t -117.43 163.61 16.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.445 -0.784 . . . . 0.0 110.601 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.598 HG12 HD23 ' A' ' 140' ' ' LEU . 2.6 t -99.44 145.58 30.31 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.326 -0.858 . . . . 0.0 109.704 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 137' ' ' VAL . 10.3 Cg_endo -60.43 66.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.03 1.542 . . . . 0.0 110.459 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 45.38 58.99 4.91 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.72 HD12 ' C ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -129.71 128.31 42.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.894 -1.356 . . . . 0.0 110.348 175.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -162.78 -169.73 2.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.294 -0.879 . . . . 0.0 110.137 178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.623 HD21 ' OE1' ' A' ' 108' ' ' GLN . 0.3 OUTLIER -147.69 -122.41 0.06 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.452 -0.78 . . . . 0.0 109.964 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.88 -160.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.041 -1.037 . . . . 0.0 109.907 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.27 81.43 1.44 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.433 ' OE1' ' CB ' ' A' ' 141' ' ' THR . 4.4 pt20 -92.43 169.87 10.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.344 -1.092 . . . . 0.0 109.955 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -135.89 149.95 49.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.141 -0.974 . . . . 0.0 110.619 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.641 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 90.52 -92.85 1.8 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 40.1 40.74 0.82 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.492 -1.005 . . . . 0.0 111.024 176.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.633 HD11 HD12 ' A' ' 103' ' ' ILE . 2.2 pp -140.45 165.17 28.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.903 -1.123 . . . . 0.0 109.895 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.511 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 20.4 m-85 -104.76 128.66 52.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 110.211 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -119.95 109.98 16.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.899 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.558 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.9 t -74.97 139.38 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.06 -24.52 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 111.021 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -146.2 136.65 23.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.662 -1.274 . . . . 0.0 110.841 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.017 HG22 HG23 ' A' ' 98' ' ' VAL . 44.5 p -134.7 168.7 18.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.498 -0.752 . . . . 0.0 109.355 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.682 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.01 -35.98 0.42 Allowed Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.929 -178.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 1.062 ' CG ' HG11 ' A' ' 162' ' ' VAL . 22.9 Cg_exo -58.46 -174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.384 1.202 . . . . 0.0 110.531 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -156.36 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.407 -0.808 . . . . 0.0 110.092 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.59 -11.35 52.88 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.308 -0.87 . . . . 0.0 110.4 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 160' ' ' VAL . 33.1 m -87.11 139.45 32.43 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 1.056 ' HB3' HG11 ' A' ' 51' ' ' VAL . 9.3 Cg_endo -59.72 164.1 12.18 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.131 1.595 . . . . 0.0 111.002 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 1.062 HG11 ' CG ' ' A' ' 157' ' ' PRO . 14.8 m -140.37 166.89 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.561 -0.712 . . . . 0.0 110.101 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -103.02 126.48 50.22 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.833 -1.167 . . . . 0.0 109.954 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.813 ' CD1' HG21 ' A' ' 168' ' ' THR . 10.9 mm -70.11 153.73 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.588 -0.695 . . . . 0.0 109.661 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.49 168.25 25.9 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -56.62 -20.78 22.86 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -1.084 . . . . 0.0 110.033 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.761 ' OE2' HG21 ' A' ' 94' ' ' ILE . 21.3 pt-20 -91.35 -18.22 24.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.724 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.813 HG21 ' CD1' ' A' ' 164' ' ' ILE . 28.6 m -58.37 144.65 40.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.4 mttt -95.45 150.54 20.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.034 -1.041 . . . . 0.0 109.507 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.818 HG23 HD21 ' A' ' 100' ' ' LEU . 1.9 mt -129.95 160.05 41.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.83 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.524 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 65.2 mt-10 -135.62 145.32 46.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.566 -0.709 . . . . 0.0 110.295 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.685 HD11 HG21 ' A' ' 120' ' ' VAL . 30.9 mm -122.59 141.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.517 -0.739 . . . . 0.0 109.934 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.576 ' HD2' ' HA ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -86.66 144.25 27.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -176.008 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 47.1 mt-10 -90.21 -9.53 47.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.103 -0.998 . . . . 0.0 110.566 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 6.5 mt-10 -98.58 108.53 48.64 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 110.097 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.1 Cg_exo -71.79 -154.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.103 1.581 . . . . 0.0 110.348 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.775 ' HB2' ' CG2' ' A' ' 103' ' ' ILE . . . -86.85 51.19 2.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.626 -0.672 . . . . 0.0 110.163 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.9 -81.22 0.29 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.35 -0.844 . . . . 0.0 110.661 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.21 7.87 10.24 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.945 -1.097 . . . . 0.0 110.169 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.9 119.55 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.41 -34.21 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.82 . . . . 0.0 110.465 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -148.93 112.7 5.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 110.085 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.95 149.95 47.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.352 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.93 46.8 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.522 -179.797 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.181 0.515 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 58.8 mp0 -60.74 -40.04 90.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.963 . . . . 0.0 109.901 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -139.43 102.24 4.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.373 -0.83 . . . . 0.0 109.967 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -145.79 107.94 4.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 110.097 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -119.08 30.07 7.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.079 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.891 ' HA2' HD11 ' A' ' 34' ' ' LEU . . . -151.8 -179.48 27.48 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.733 HG21 HD13 ' A' ' 33' ' ' LEU . 33.5 pt -134.8 159.18 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -1.174 . . . . 0.0 109.879 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 85.5 mt -95.79 118.43 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.022 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.875 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.5 pt? -134.91 -169.28 2.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.344 -0.848 . . . . 0.0 110.382 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 38.1 ttp180 -103.91 130.15 51.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 110.965 -175.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.028 HG23 HD11 ' A' ' 69' ' ' ILE . 10.5 p -61.1 137.95 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 110.277 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -122.72 149.82 43.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.144 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' OE1' ' HD3' ' A' ' 74' ' ' ARG . 86.5 tt0 -176.57 159.95 1.95 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' N ' ' HG2' ' A' ' 13' ' ' GLU . . . -147.73 167.89 23.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.97 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -60.01 130.01 44.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 110.026 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.478 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 94.2 p -158.3 159.48 35.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 110.312 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.1 p -98.92 -64.49 1.03 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 110.293 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.684 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -94.95 -32.71 0.28 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 111.696 -176.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 52.8 Cg_exo -50.63 166.57 0.32 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.143 1.075 . . . . 0.0 110.687 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.562 ' CA ' ' HB3' ' A' ' 70' ' ' ASP . . . 94.54 60.01 1.12 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.493 ' SD ' ' HD3' ' A' ' 23' ' ' ARG . 22.0 ptm -98.45 24.4 7.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -1.113 . . . . 0.0 110.467 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 21' ' ' MET . 0.3 OUTLIER 68.3 33.48 4.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 -178.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 33.7 ptt180 -101.75 137.12 40.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.507 -0.745 . . . . 0.0 109.815 176.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.984 HG13 HG23 ' A' ' 67' ' ' VAL . 53.6 t -99.96 110.1 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.995 -1.065 . . . . 0.0 110.023 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -99.76 119.98 39.0 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.003 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -133.66 -169.43 2.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.525 -0.735 . . . . 0.0 110.375 -177.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' N ' ' HB3' ' A' ' 63' ' ' ASN . 26.6 p-10 -106.85 -179.15 3.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 0.0 110.816 -175.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 84.2 mt-10 -60.04 -40.07 88.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.242 -178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 46.6 t -59.95 -49.69 76.7 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.083 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.814 ' HA ' HD21 ' A' ' 33' ' ' LEU . 75.4 m -59.97 -40.09 87.87 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.099 -1.001 . . . . 0.0 109.682 177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 32.2 ttp180 -60.19 -46.29 90.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 110.448 172.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -67.31 -39.97 85.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 110.415 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.951 ' CD1' HD13 ' A' ' 34' ' ' LEU . 4.4 pp -74.84 -28.4 60.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.105 -0.997 . . . . 0.0 111.088 -176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.951 HD13 ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -99.48 -8.36 24.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.731 -1.231 . . . . 0.0 110.15 175.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 34' ' ' LEU . 12.4 t70 59.77 14.87 4.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.818 . . . . 0.0 109.82 -174.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.934 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -58.95 120.71 9.57 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.476 -0.765 . . . . 0.0 109.981 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.593 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -99.48 173.34 6.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -58.52 127.75 18.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.35 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.7 73.4 Favored Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.578 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.42 ' CG ' ' HG2' ' A' ' 37' ' ' GLU . 90.2 m-20 -88.33 166.46 14.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.478 -1.601 . . . . 0.0 108.756 169.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 92' ' ' THR . 93.7 t -98.75 129.33 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.737 -1.227 . . . . 0.0 110.1 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.763 HG11 HG23 ' A' ' 54' ' ' VAL . 2.3 m -115.48 138.01 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.353 -177.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 83.0 tt0 -108.67 139.77 43.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.441 -0.787 . . . . 0.0 109.396 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.97 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.6 mp -120.3 145.37 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.929 -1.107 . . . . 0.0 110.332 -176.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 85.9 tt0 -147.42 99.51 3.14 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 110.772 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.043 ' CG ' HG12 ' A' ' 85' ' ' VAL . 9.5 tmtt? -98.29 -65.71 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.67 173.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG21 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -105.26 -33.38 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.257 174.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 69.5 mtt85 -135.56 -178.31 5.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.761 -0.587 . . . . 0.0 109.479 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.538 ' HB3' HD21 ' A' ' 130' ' ' LEU . 24.3 mttt -89.3 136.95 32.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.94 . . . . 0.0 110.547 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.689 ' HA ' HD23 ' A' ' 130' ' ' LEU . 1.8 p -141.42 168.71 19.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.506 -0.746 . . . . 0.0 110.1 177.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.558 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -123.6 164.14 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.54 -0.725 . . . . 0.0 110.379 -178.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.61 -172.76 42.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 175.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 7.9 ptp85 -113.98 -174.87 2.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.934 HG21 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -113.59 139.46 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.609 -173.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 23' ' ' ARG . 1.1 m-85 -132.65 164.6 26.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.894 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -98.91 126.92 44.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.436 -0.79 . . . . 0.0 110.079 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -66.31 140.58 58.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.215 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.58 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -56.5 -49.02 95.94 Favored Pre-proline 0 N--CA 1.49 1.531 0 C-N-CA 118.899 -1.121 . . . . 0.0 108.834 172.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 30.7 Cg_endo -91.72 97.24 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.864 1.455 . . . . 0.0 108.954 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.13 35.83 0.14 Allowed 'General case' 0 C--N 1.289 -2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 110.984 -173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 36.1 p-10 -143.08 -36.11 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 110.964 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 15.5 pt-20 -84.83 -20.43 30.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.936 -1.102 . . . . 0.0 109.585 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.496 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 4.7 m-80 -81.42 38.66 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.48 -0.762 . . . . 0.0 110.531 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 26.2 pttm -98.82 11.9 37.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.63 26.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.646 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 176.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.496 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.8 pt -140.15 143.03 30.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.311 -1.111 . . . . 0.0 109.358 175.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.984 HG23 HG13 ' A' ' 24' ' ' VAL . 7.5 p -122.48 129.62 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 110.309 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 38.7 mmm-85 -90.01 116.62 28.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.986 . . . . 0.0 110.243 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.028 HD11 HG23 ' A' ' 11' ' ' VAL . 2.9 pt -136.84 169.15 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.489 -0.757 . . . . 0.0 110.599 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.562 ' HB3' ' CA ' ' A' ' 20' ' ' GLY . 32.9 p-10 -78.5 169.29 18.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.601 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 79.6 p -70.04 -23.49 63.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.462 ' HB ' ' OD2' ' A' ' 70' ' ' ASP . 54.5 t -70.06 -43.98 78.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.979 -1.076 . . . . 0.0 110.186 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.97 ' CE ' HD13 ' A' ' 44' ' ' ILE . 9.7 tpt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.084 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 71' ' ' SER . 43.7 ptt85 -61.38 -35.56 77.84 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.806 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.476 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 64.1 t30 -71.88 -26.45 62.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.11 -0.994 . . . . 0.0 110.495 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 99.6 m-20 -60.01 -35.66 75.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.466 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.509 ' C ' HG23 ' A' ' 47' ' ' VAL . 26.1 p -97.95 -36.61 10.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.281 -0.887 . . . . 0.0 110.202 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.557 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 122.34 28.22 1.51 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.718 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -110.81 161.05 16.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -1.113 . . . . 0.0 110.476 -175.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.849 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -112.77 179.02 4.09 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 178.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -60.44 139.73 19.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.926 -1.109 . . . . 0.0 110.646 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.836 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 78.24 -3.51 62.01 Favored Glycine 0 N--CA 1.481 1.661 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.57 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.2 m-20 -56.95 -164.43 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.024 -1.28 . . . . 0.0 110.088 174.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 54.7 pttt -133.07 113.56 12.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 110.073 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.043 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -119.94 166.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.312 -0.867 . . . . 0.0 110.028 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 84.6 tttt -114.21 127.57 55.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 109.973 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.595 HG23 HD21 ' A' ' 9' ' ' LEU . 92.8 t -107.55 122.81 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.099 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.486 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 12.3 mtt180 -109.67 140.5 43.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.529 ' CD ' ' O ' ' A' ' 34' ' ' LEU . 53.5 tttm -82.13 140.76 33.61 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.094 -1.004 . . . . 0.0 110.701 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.481 HG21 ' CG ' ' A' ' 161' ' ' PRO . 2.3 m -150.17 -170.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.78 -0.575 . . . . 0.0 109.688 176.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 31.5 mtp180 -132.48 163.41 28.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.713 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.675 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -94.67 161.31 14.24 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.977 0.894 . . . . 0.0 111.418 -174.277 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.673 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.6 pt-20 -150.09 170.33 19.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.848 HG21 ' OE2' ' A' ' 167' ' ' GLU . 37.6 mm -89.07 101.11 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.625 -1.297 . . . . 0.0 110.461 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.828 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -58.69 139.98 55.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.303 -0.873 . . . . 0.0 110.31 177.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -101.84 -26.5 13.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 111.04 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.741 ' HB3' HD23 ' A' ' 156' ' ' LEU . 23.3 tttt -150.33 128.64 12.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 110.221 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.944 HG23 HG22 ' A' ' 155' ' ' THR . 7.2 p -140.8 144.98 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.996 -1.065 . . . . 0.0 110.616 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.541 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.3 m -116.51 133.42 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.344 -0.847 . . . . 0.0 109.827 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.944 HD11 HG11 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -131.94 160.81 34.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -0.902 . . . . 0.0 110.371 -176.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.533 ' HA ' ' HD2' ' A' ' 173' ' ' ARG . . . -133.65 81.31 54.0 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 110.848 -176.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.515 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . 17.4 Cg_exo -62.03 127.9 22.59 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.933 1.491 . . . . 0.0 110.083 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.635 ' CG2' ' HB2' ' A' ' 177' ' ' ALA . 80.7 mt -89.98 98.42 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.072 -1.018 . . . . 0.0 110.389 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.605 HD13 ' O ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -151.92 -166.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.318 -0.864 . . . . 0.0 110.451 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.605 ' O ' HD13 ' A' ' 104' ' ' ILE . 98.6 mtt180 -88.77 156.93 18.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.421 -0.799 . . . . 0.0 109.696 174.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -58.34 -12.55 3.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.123 -0.986 . . . . 0.0 111.09 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 111' ' ' LYS . 35.4 p-10 -129.17 30.64 4.99 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.5 -0.75 . . . . 0.0 110.358 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.58 ' HG2' ' HB2' ' A' ' 105' ' ' ARG . 6.0 mm-40 -94.78 -94.41 0.18 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.982 -1.074 . . . . 0.0 111.229 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -89.3 -43.7 10.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.736 -1.227 . . . . 0.0 110.519 -171.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -103.1 51.05 0.8 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 110.232 -179.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 107' ' ' ASP . 6.2 ptmt -99.37 46.76 0.97 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.259 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.31 -54.46 2.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.42 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.762 ' H ' HD12 ' A' ' 116' ' ' ILE . . . 75.08 179.73 43.96 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -176.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 113' ' ' GLY . 37.7 mt-10 42.13 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.253 -1.145 . . . . 0.0 110.212 177.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.2 2.59 90.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.762 HD12 ' H ' ' A' ' 113' ' ' GLY . 19.1 tt -59.98 -40.11 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.169 -1.194 . . . . 0.0 110.304 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.55 ' N ' HG23 ' A' ' 116' ' ' ILE . 95.9 mt-10 -60.53 -40.06 90.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.957 . . . . 0.0 109.955 178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -70.02 -35.94 74.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 109.612 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -60.04 -39.74 86.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.482 -0.761 . . . . 0.0 109.768 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.944 HG11 HD11 ' A' ' 100' ' ' LEU . 54.6 t -60.14 -45.32 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.618 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -60.04 -41.2 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.014 173.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -60.03 -39.9 87.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.39 -42.69 18.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.845 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 4.6 mm? -94.83 0.84 55.2 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.019 -1.051 . . . . 0.0 111.156 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.833 HD11 ' HG2' ' A' ' 166' ' ' GLU . 0.5 OUTLIER -44.04 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.03 -1.044 . . . . 0.0 110.554 -176.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.99 52.63 0.48 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.577 -0.702 . . . . 0.0 111.589 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 163' ' ' GLU . 13.7 mmt180 -134.36 149.99 72.7 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.997 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.755 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 13.8 Cg_exo -66.11 132.32 29.57 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.975 1.513 . . . . 0.0 109.93 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.839 ' HE2' HG21 ' A' ' 98' ' ' VAL . 93.9 mmm -125.19 132.19 53.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.604 -1.31 . . . . 0.0 110.922 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 50' ' ' THR . 19.7 tp -133.38 108.18 8.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.69 -0.631 . . . . 0.0 109.433 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.8 pt-20 -45.7 136.12 6.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.69 -1.256 . . . . 0.0 110.163 -174.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.583 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 80.01 -2.6 2.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.947 -0.471 . . . . 0.0 110.326 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.4 p30 -69.37 -169.97 0.25 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.297 -0.877 . . . . 0.0 110.414 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 76' ' ' ASN . 11.5 m-80 -144.96 159.17 43.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.3 OUTLIER -140.02 170.02 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 110.516 -175.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.436 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 47.6 t -133.37 146.75 51.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.593 -0.692 . . . . 0.0 110.12 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.779 HG13 ' HD2' ' A' ' 138' ' ' PRO . 55.7 t -127.24 150.02 71.24 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.48 -0.762 . . . . 0.0 109.833 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.779 ' HD2' HG13 ' A' ' 137' ' ' VAL . 5.3 Cg_endo -52.73 -168.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.919 1.484 . . . . 0.0 110.136 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 58.94 93.61 0.01 OUTLIER Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.771 ' C ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -87.04 163.19 17.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.088 -1.242 . . . . 0.0 110.7 -172.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.635 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -55.4 -167.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.775 -1.203 . . . . 0.0 111.13 -167.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.587 ' N ' ' OG1' ' A' ' 141' ' ' THR . 0.1 OUTLIER -148.03 -102.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.567 -0.708 . . . . 0.0 109.991 -176.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.91 -159.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.42 -0.8 . . . . 0.0 110.297 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -84.1 62.58 4.56 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 141' ' ' THR . 5.1 pt20 -96.33 162.87 13.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.345 -1.091 . . . . 0.0 110.022 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.7 t -140.04 151.46 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.488 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 148' ' ' LEU . . . 96.39 -93.6 1.53 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.447 ' N ' ' CD2' ' A' ' 148' ' ' LEU . 2.6 mm? 42.06 41.2 1.9 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.265 -1.138 . . . . 0.0 110.732 175.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.624 HD12 ' C ' ' A' ' 149' ' ' LEU . 4.5 pp -140.49 166.02 25.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.009 -1.057 . . . . 0.0 109.938 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.637 ' CE1' HG21 ' A' ' 137' ' ' VAL . 58.8 m-85 -100.68 130.22 46.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 110.099 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.71 110.03 16.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.034 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 132' ' ' GLN . 3.1 t -76.23 136.72 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.884 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 36.6 t -116.72 -30.73 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 110.618 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 36.4 tptt -140.07 135.07 32.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 0.0 110.935 -177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.944 HG22 HG23 ' A' ' 98' ' ' VAL . 69.6 p -129.95 166.21 20.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.397 174.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -88.8 -38.2 0.44 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.035 . . . . 0.0 110.81 -178.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 1.008 ' CG ' HG11 ' A' ' 162' ' ' VAL . 22.7 Cg_exo -57.8 -171.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.551 1.29 . . . . 0.0 110.497 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.95 -167.82 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.388 -0.82 . . . . 0.0 110.013 176.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.53 -9.45 8.74 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.181 -0.949 . . . . 0.0 110.695 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.21 144.51 41.12 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.478 -0.764 . . . . 0.0 110.628 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.558 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -47.9 141.63 16.4 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.885 1.723 . . . . 0.0 111.252 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 1.008 HG11 ' CG ' ' A' ' 157' ' ' PRO . 8.9 m -130.23 159.96 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 109.946 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 88.0 tt0 -109.32 130.56 55.49 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.237 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.912 HD12 HG21 ' A' ' 168' ' ' THR . 12.8 mm -71.2 152.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.559 -0.713 . . . . 0.0 110.518 -176.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.59 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -142.85 169.8 25.48 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 175.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.833 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.87 -23.61 45.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -1.142 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.848 ' OE2' HG21 ' A' ' 94' ' ' ILE . 20.5 pt-20 -87.06 -12.53 46.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.912 HG21 HD12 ' A' ' 164' ' ' ILE . 13.5 m -62.94 144.76 56.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.006 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.5 mttt -93.91 154.64 17.59 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.89 -1.131 . . . . 0.0 109.897 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.68 HD12 ' CG1' ' A' ' 120' ' ' VAL . 1.8 mm -116.87 136.2 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 111.038 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.541 ' CB ' ' OG1' ' A' ' 99' ' ' THR . 18.7 mt-10 -120.33 130.68 54.53 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 110.198 172.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 170' ' ' ILE . 34.9 mm -120.17 140.37 44.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.529 -0.732 . . . . 0.0 110.301 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.537 ' O ' ' CZ ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -87.14 156.49 19.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.301 -176.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 96.1 mt-10 -93.55 -12.7 28.97 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.184 -0.947 . . . . 0.0 110.7 -174.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 55.9 tt0 -96.59 109.12 46.59 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.147 -0.971 . . . . 0.0 110.048 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 11.5 Cg_exo -72.91 -156.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 O-C-N 124.088 1.573 . . . . 0.0 110.537 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.635 ' HB2' ' CG2' ' A' ' 103' ' ' ILE . . . -80.21 54.43 1.97 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.708 -0.62 . . . . 0.0 110.039 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.681 ' O ' HG23 ' A' ' 180' ' ' VAL . 20.3 m -104.88 121.85 44.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.95 177.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 178' ' ' SER . 50.4 mm-40 59.95 19.98 9.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.91 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 178' ' ' SER . 62.7 t -105.68 119.99 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.463 -0.773 . . . . 0.0 110.264 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.876 HD12 ' O ' ' A' ' 181' ' ' LEU . 2.5 pp 178.57 54.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.199 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -87.95 142.97 27.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 50.07 42.72 25.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.314 -0.866 . . . . 0.0 110.239 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.75 150.02 50.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.471 179.99 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.57 ' O ' ' N ' ' A' ' 3' ' ' SER . 60.0 ttm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.034 0.445 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 1' ' ' MET . 86.2 tt0 38.78 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.427 -0.796 . . . . 0.0 110.873 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 1' ' ' MET . 45.0 p -139.93 153.17 46.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.123 -0.986 . . . . 0.0 110.282 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -118.29 119.46 34.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.92 . . . . 0.0 110.204 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.48 ' O ' HD13 ' A' ' 34' ' ' LEU . 27.3 t30 -111.45 30.07 7.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 109.987 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.525 ' HA3' ' HG2' ' A' ' 88' ' ' ARG . . . -155.47 -169.27 19.7 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.927 ' CG2' HD12 ' A' ' 33' ' ' LEU . 41.0 pt -133.29 162.86 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -1.14 . . . . 0.0 109.663 177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 ' HD3' ' A' ' 86' ' ' LYS . 92.8 mt -107.62 126.55 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 -178.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.806 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.6 pt? -143.78 -165.49 2.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.657 -0.652 . . . . 0.0 109.447 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.515 ' CZ ' HG22 ' A' ' 66' ' ' ILE . 19.9 ptt-85 -115.0 140.25 49.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 0.0 110.464 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.063 HG23 HD11 ' A' ' 69' ' ' ILE . 13.6 p -60.75 137.75 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.514 -0.741 . . . . 0.0 110.635 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -115.3 139.97 49.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.973 . . . . 0.0 110.56 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.937 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 179.57 100.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 109.918 173.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -157.47 160.0 37.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.123 -0.986 . . . . 0.0 110.455 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.435 ' O ' ' OG ' ' A' ' 16' ' ' SER . 64.7 t30 50.07 40.12 20.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 110.388 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.544 ' HB3' ' HG3' ' A' ' 19' ' ' PRO . 3.4 m -164.08 158.54 19.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 110.056 178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 15.3 p -78.27 -49.33 13.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.948 . . . . 0.0 110.337 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.523 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 4.5 p-10 -175.12 60.44 0.21 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.151 -0.968 . . . . 0.0 110.82 -176.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HG3' ' HB3' ' A' ' 16' ' ' SER . 14.1 Cg_exo -64.64 108.52 1.06 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.648 1.341 . . . . 0.0 110.353 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 70' ' ' ASP . . . 91.27 90.12 1.38 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.528 ' HA ' ' OD2' ' A' ' 70' ' ' ASP . 26.5 ptm -88.36 -18.25 28.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -1.174 . . . . 0.0 109.535 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -154.57 20.2 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.576 -0.703 . . . . 0.0 109.52 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.613 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 39.8 mtm180 -128.71 149.12 50.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.457 -0.777 . . . . 0.0 110.139 -176.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 67' ' ' VAL . 83.4 t -112.44 120.56 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.75 ' O ' HD12 ' A' ' 26' ' ' LEU . 1.2 ptm180 -95.74 119.88 35.02 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.602 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.75 HD12 ' O ' ' A' ' 25' ' ' ARG . 1.1 mp -136.36 173.72 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.585 -0.697 . . . . 0.0 109.7 -175.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' OD1' ' OG ' ' A' ' 30' ' ' SER . 10.2 p-10 -95.71 -172.65 2.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.854 -1.154 . . . . 0.0 111.004 -176.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.491 ' OE2' ' NH1' ' A' ' 56' ' ' ARG . 49.7 mm-40 -59.73 -50.04 75.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 109.763 -175.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.54 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.5 t -64.1 -40.53 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.219 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.131 ' O ' HD22 ' A' ' 33' ' ' LEU . 68.6 m -60.05 -29.34 68.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 70.9 ttt180 -87.35 -46.99 9.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.659 -0.651 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 33' ' ' LEU . 87.0 mtm180 -79.94 -6.94 58.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.801 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.131 HD22 ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -42.03 -30.51 0.28 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.526 -0.734 . . . . 0.0 109.788 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.812 ' H ' HD23 ' A' ' 33' ' ' LEU . 79.3 mt -141.53 -61.65 0.47 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 0.0 110.592 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.566 ' O ' ' C ' ' A' ' 36' ' ' ALA . 26.8 t0 -172.46 -29.55 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.2 -0.937 . . . . 0.0 110.03 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB1' HG21 ' A' ' 54' ' ' VAL . . . -23.52 116.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.514 0.674 . . . . 0.0 111.357 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.634 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -109.5 168.38 9.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.279 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -46.08 125.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.063 -1.023 . . . . 0.0 109.806 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 79.48 21.32 67.11 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.871 -1.157 . . . . 0.0 110.609 171.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.408 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 81.3 m-20 -89.21 173.91 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.721 -1.458 . . . . 0.0 109.359 171.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.521 ' CG1' ' HG2' ' A' ' 161' ' ' PRO . 59.7 t -99.39 134.16 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.958 . . . . 0.0 110.144 -175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.72 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -123.28 146.15 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.71 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -114.17 140.58 48.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.516 -0.74 . . . . 0.0 109.733 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.752 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.1 mp -124.81 138.94 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.687 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 87.6 tt0 -140.64 99.99 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 110.265 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.928 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -98.75 -66.47 0.9 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.618 -0.676 . . . . 0.0 109.401 177.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -111.3 -30.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.417 -0.802 . . . . 0.0 109.063 172.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.591 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 95.3 mtt180 -131.86 -179.82 5.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.619 173.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.51 ' HB3' HD21 ' A' ' 130' ' ' LEU . 35.0 mttt -89.17 138.34 31.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 111.011 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.663 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 5.5 p -142.57 167.7 21.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.55 0.69 . . . . 0.0 109.801 177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -121.23 167.79 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.72 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.59 -168.46 38.49 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' N ' HG22 ' A' ' 42' ' ' VAL . 67.1 ttt180 -125.45 165.09 19.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.532 -0.981 . . . . 0.0 110.592 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.841 HG21 ' HB1' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -94.23 136.08 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.269 -175.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.613 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 1.3 m-85 -133.61 163.69 28.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.334 -0.854 . . . . 0.0 110.472 175.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 43.0 ttt85 -92.3 125.96 37.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.936 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -63.29 139.27 58.75 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.146 -0.971 . . . . 0.0 109.37 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.574 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.6 mtp180 -56.24 -48.57 96.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.763 174.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 34.2 Cg_endo -91.65 97.18 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.095 1.576 . . . . 0.0 108.965 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -75.12 35.93 0.11 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.547 -0.721 . . . . 0.0 110.737 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -143.59 -31.85 0.46 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.45 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.62 -28.76 24.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.185 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.489 ' HA ' ' CG1' ' A' ' 66' ' ' ILE . 3.5 m-80 -80.98 39.81 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.732 -0.605 . . . . 0.0 110.474 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 14.2 pttm -98.79 9.41 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.223 -0.923 . . . . 0.0 109.683 177.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -176.36 28.08 0.07 OUTLIER Glycine 0 N--CA 1.479 1.515 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.515 HG22 ' CZ ' ' A' ' 10' ' ' ARG . 44.6 pt -140.58 143.13 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.213 -1.169 . . . . 0.0 109.473 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.947 HG23 HG13 ' A' ' 24' ' ' VAL . 3.9 p -119.34 124.48 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.045 -1.034 . . . . 0.0 109.898 178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 1.7 mtp85 -91.39 117.22 29.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.285 -0.885 . . . . 0.0 110.074 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.063 HD11 HG23 ' A' ' 11' ' ' VAL . 1.4 pt -129.69 162.96 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.632 -0.668 . . . . 0.0 110.264 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.53 ' OD2' ' HB ' ' A' ' 72' ' ' VAL . 26.0 p-10 -76.78 177.55 7.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.851 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 10.4 m -68.87 -19.0 64.23 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.0 110.549 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.613 HG12 ' ND2' ' A' ' 76' ' ' ASN . 86.3 t -69.9 -48.37 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.989 -1.069 . . . . 0.0 110.331 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.752 ' HE1' HD13 ' A' ' 44' ' ' ILE . 88.8 mmm -62.8 -40.27 96.83 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.548 174.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.898 ' NH1' HD13 ' A' ' 81' ' ' ILE . 72.7 ttt180 -60.07 -40.66 90.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.259 173.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' SER . 8.0 t30 -78.34 -32.58 49.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 110.577 -177.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.613 ' ND2' HG12 ' A' ' 72' ' ' VAL . 98.6 m-20 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.377 -175.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 20.9 p -99.91 -38.28 8.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.726 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.58 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 111.05 23.7 5.73 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.928 ' HB1' ' HD2' ' A' ' 46' ' ' LYS . . . -111.05 -178.07 3.37 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.008 -1.29 . . . . 0.0 111.295 -171.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.553 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -128.74 170.15 13.66 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.442 -0.786 . . . . 0.0 108.925 174.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.937 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -56.37 154.54 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 110.156 178.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 74.84 -5.45 31.46 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.669 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.9 m-20 -56.27 -164.64 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.039 -1.271 . . . . 0.0 110.513 176.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 22.2 pttm -134.55 115.92 14.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 109.554 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.74 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -125.75 159.22 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.116 -0.99 . . . . 0.0 110.126 -177.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.6 ttpm? -111.72 121.04 44.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.77 176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.524 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.3 t -99.65 120.06 48.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 4.6 mtt180 -112.11 139.38 47.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.826 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -86.14 138.59 31.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.486 HG21 ' CD ' ' A' ' 161' ' ' PRO . 2.2 m -147.07 -169.16 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.501 -0.749 . . . . 0.0 110.221 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -127.51 166.48 17.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.822 . . . . 0.0 109.631 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.51 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -99.42 162.13 13.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 0.0 111.057 -176.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.594 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.7 pt-20 -150.33 169.3 21.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.7 mm -89.93 98.28 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.603 -1.311 . . . . 0.0 110.469 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.927 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.82 141.03 46.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.308 -0.87 . . . . 0.0 110.361 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.749 ' HG2' HD22 ' A' ' 156' ' ' LEU . 5.5 pttt -108.25 -22.01 12.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.193 -0.942 . . . . 0.0 111.14 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 169' ' ' LYS . 62.6 tttp -150.7 117.22 5.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.613 -1.305 . . . . 0.0 110.485 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.08 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -134.74 140.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.04 . . . . 0.0 110.588 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.478 ' C ' HD23 ' A' ' 100' ' ' LEU . 41.7 m -108.02 140.31 41.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.409 -0.807 . . . . 0.0 110.078 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.927 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.71 165.09 26.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.105 -178.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.64 82.88 11.02 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.141 -0.974 . . . . 0.0 111.037 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 32.5 Cg_exo -50.19 143.95 24.29 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.921 1.485 . . . . 0.0 110.394 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.761 HG23 ' HB2' ' A' ' 177' ' ' ALA . 36.9 mm -107.39 92.64 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.093 -1.005 . . . . 0.0 110.634 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.813 HD13 ' HB3' ' A' ' 108' ' ' GLN . 0.6 OUTLIER -151.3 176.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.199 172.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' A' ' 108' ' ' GLN . 96.9 mtt180 -117.05 -146.86 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.506 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -60.01 -12.18 7.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.962 -1.086 . . . . 0.0 110.259 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 36.9 p-10 -99.43 29.19 4.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.513 -0.742 . . . . 0.0 109.826 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.813 ' HB3' HD13 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -81.03 164.08 22.76 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.216 -0.928 . . . . 0.0 110.681 -174.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -94.8 -14.79 24.34 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.635 -0.666 . . . . 0.0 110.267 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.474 ' O ' HD12 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -99.36 64.18 1.33 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 0.0 110.573 -175.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.462 ' CG ' ' O ' ' A' ' 111' ' ' LYS . 1.5 ptpt -109.66 50.3 0.8 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.428 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 1.014 ' HB2' HD13 ' A' ' 116' ' ' ILE . 97.1 m-85 -97.53 -57.03 2.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 0.0 110.463 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 77.51 -177.42 52.82 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 113' ' ' GLY . 8.5 pt-20 32.66 97.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.528 -0.984 . . . . 0.0 110.704 178.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.48 -3.78 86.73 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 1.014 HD13 ' HB2' ' A' ' 112' ' ' PHE . 9.0 tp -58.62 -30.0 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -1.229 . . . . 0.0 109.723 175.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.709 ' HA ' HD11 ' A' ' 172' ' ' ILE . 99.0 mt-10 -59.97 -45.32 93.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -70.02 -32.95 71.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -0.892 . . . . 0.0 110.582 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -60.07 -39.98 87.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.139 -0.976 . . . . 0.0 109.062 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.878 HG12 ' CD1' ' A' ' 170' ' ' ILE . 53.9 t -60.52 -49.11 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.677 174.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.543 ' HG3' HG13 ' A' ' 170' ' ' ILE . 3.3 mt-30 -59.99 -42.65 94.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -60.0 -45.61 92.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -0.801 . . . . 0.0 110.157 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.538 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -69.95 -43.4 71.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.644 ' N ' HD22 ' A' ' 124' ' ' LEU . 4.1 mm? -99.79 6.17 45.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.977 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.737 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.6 tt -47.98 165.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.76 -1.212 . . . . 0.0 109.821 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 11.6 ptp180 35.3 47.7 0.33 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.445 -0.785 . . . . 0.0 111.387 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 7.4 mmt85 -129.37 150.88 76.78 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 120.791 -1.193 . . . . 0.0 110.965 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.784 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 28.3 Cg_endo -68.71 128.55 17.19 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 124.233 1.649 . . . . 0.0 109.716 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.505 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.9 mmm -124.76 139.84 53.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.446 -1.409 . . . . 0.0 110.885 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 50' ' ' THR . 16.7 tp -141.34 104.38 4.59 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.639 -0.663 . . . . 0.0 109.558 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.617 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.0 pt-20 -43.41 139.43 2.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.617 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 84.61 -7.01 0.98 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.184 0.516 . . . . 0.0 110.334 -177.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.54 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.3 p-10 -70.08 174.96 4.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 150' ' ' PHE . 29.9 m-80 -141.38 149.72 41.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.03 169.37 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 110.108 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.54 135.96 46.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 0.0 110.423 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.641 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 12.0 t -115.08 -66.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.496 -0.752 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 43.7 Cg_endo -71.74 115.75 4.43 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.273 1.144 . . . . 0.0 110.483 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -88.74 41.64 3.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.64 160.57 39.29 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.448 -1.031 . . . . 0.0 110.147 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.758 ' O ' HD23 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -136.17 -169.41 2.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.169 -0.957 . . . . 0.0 110.551 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 141' ' ' THR . 58.5 mt -143.1 -128.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.757 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.1 -155.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.184 -0.947 . . . . 0.0 110.348 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.25 61.06 4.21 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.465 ' OE1' ' HB2' ' A' ' 142' ' ' LEU . 14.2 pt20 -96.78 159.95 14.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.398 -1.06 . . . . 0.0 110.214 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.7 t -139.22 159.51 41.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.927 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.869 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 105.3 -93.05 0.88 Allowed Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.869 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.9 OUTLIER 38.46 40.01 0.34 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.429 -1.041 . . . . 0.0 111.078 177.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.447 HD12 ' C ' ' A' ' 149' ' ' LEU . 3.7 pp -140.58 165.07 28.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.682 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 28.6 m-85 -93.3 133.28 36.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.039 -1.038 . . . . 0.0 110.229 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.52 108.48 15.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.348 -0.845 . . . . 0.0 109.92 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.54 HG21 ' OD1' ' A' ' 133' ' ' ASP . 3.3 t -77.16 140.02 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.816 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.4 t -120.51 -30.95 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.129 -0.982 . . . . 0.0 110.785 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -143.09 149.55 38.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.772 -1.205 . . . . 0.0 111.59 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.08 HG22 HG23 ' A' ' 98' ' ' VAL . 55.1 p -140.54 164.39 30.28 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.749 HD22 ' HG2' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -88.42 -39.15 0.46 Allowed Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.893 . . . . 0.0 110.692 -178.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.977 ' CB ' HG11 ' A' ' 162' ' ' VAL . 19.3 Cg_exo -58.56 -172.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.556 1.293 . . . . 0.0 110.38 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 -167.68 1.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.465 -0.772 . . . . 0.0 109.821 177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -65.79 -4.88 7.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.219 -0.925 . . . . 0.0 110.983 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.7 145.26 41.26 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.424 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.56 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.3 Cg_endo -49.35 141.31 25.09 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.221 1.643 . . . . 0.0 110.545 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.977 HG11 ' CB ' ' A' ' 157' ' ' PRO . 4.6 m -129.88 157.9 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.993 -1.067 . . . . 0.0 109.942 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 53.7 tt0 -106.91 128.01 53.94 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 110.2 176.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.804 HD12 HG21 ' A' ' 168' ' ' THR . 11.2 mm -70.85 156.48 7.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 110.275 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -143.74 169.73 25.96 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.737 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -57.85 -21.45 42.72 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.435 -1.038 . . . . 0.0 110.209 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -88.35 -21.6 24.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.884 . . . . 0.0 109.575 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.804 HG21 HD12 ' A' ' 164' ' ' ILE . 26.6 m -56.89 162.07 2.61 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.514 -0.741 . . . . 0.0 110.231 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' LYS . 46.8 mtmt -121.02 149.82 42.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.464 176.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.927 HG23 HD21 ' A' ' 100' ' ' LEU . 1.2 mt -127.99 162.95 32.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 110.95 -174.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.448 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 35.8 mt-10 -138.35 137.29 37.2 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.521 0.676 . . . . 0.0 110.11 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.709 HD11 ' HA ' ' A' ' 117' ' ' GLU . 4.3 mp -121.68 137.72 54.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.525 -0.734 . . . . 0.0 109.887 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.577 ' NE ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -87.27 150.07 24.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 0.0 110.096 -174.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 96.7 mt-10 -90.66 -12.64 36.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 110.272 -175.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.33 109.23 41.49 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.744 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.2 Cg_exo -71.06 -154.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.161 1.611 . . . . 0.0 110.322 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.761 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -79.19 51.08 1.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.617 -0.677 . . . . 0.0 110.118 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 27.3 t -65.11 -72.31 0.16 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.296 -0.877 . . . . 0.0 110.779 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.639 ' O ' HD23 ' A' ' 181' ' ' LEU . 86.5 tt0 -61.95 -10.28 9.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.021 -1.049 . . . . 0.0 110.608 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.49 117.84 31.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.495 -0.753 . . . . 0.0 110.199 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 179' ' ' GLU . 0.7 OUTLIER -170.0 -21.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.379 -0.826 . . . . 0.0 110.903 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.507 ' N ' ' HG ' ' A' ' 181' ' ' LEU . 98.9 mt-10 -127.17 50.14 2.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.003 -1.06 . . . . 0.0 110.511 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.81 -39.93 86.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.159 -0.963 . . . . 0.0 110.082 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.53 163.87 26.43 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.003 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.259 0.552 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -120.13 140.0 51.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 110.122 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.88 91.1 7.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 110.086 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -149.94 98.62 2.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 110.139 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -137.57 122.81 19.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 110.338 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -152.18 -161.88 10.48 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.709 HG23 HD11 ' A' ' 34' ' ' LEU . 42.5 pt -136.07 157.92 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -1.204 . . . . 0.0 110.0 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 mm -101.5 113.4 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 110.026 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.714 HD11 ' HB ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -139.81 -173.8 3.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.337 -0.852 . . . . 0.0 109.885 -178.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 24.1 ptt-85 -115.77 139.81 49.81 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.943 -1.098 . . . . 0.0 110.619 -175.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.762 HG13 ' HA ' ' A' ' 81' ' ' ILE . 14.5 p -61.8 132.55 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.538 -0.726 . . . . 0.0 110.634 -176.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -108.78 145.33 35.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.63 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.957 ' HB3' HD11 ' A' ' 81' ' ' ILE . 84.8 tt0 -177.98 94.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.874 175.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.43 42.34 3.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.33 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -139.65 144.92 37.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.918 . . . . 0.0 110.181 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.0 t -60.08 -44.01 95.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.322 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -92.11 157.69 16.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 110.11 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.499 ' HB2' ' OD1' ' A' ' 70' ' ' ASP . 12.5 p-10 -135.04 71.3 69.2 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 110.272 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -67.33 112.47 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.963 1.507 . . . . 0.0 110.774 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.53 83.3 1.67 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.571 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 24.7 ptp -90.01 -9.87 47.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -1.167 . . . . 0.0 110.081 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 80.9 p -113.74 9.02 17.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 110.342 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.535 ' HD3' ' HB2' ' A' ' 53' ' ' ARG . 24.9 mmt85 -119.96 144.03 47.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.233 -0.917 . . . . 0.0 109.846 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.118 HG13 HG23 ' A' ' 67' ' ' VAL . 85.6 t -110.45 119.98 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 0.0 110.195 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.533 ' O ' HD12 ' A' ' 26' ' ' LEU . 5.1 ptt180 -90.25 116.66 28.4 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.753 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.922 HD13 HG12 ' A' ' 24' ' ' VAL . 1.1 mp -128.24 174.91 8.87 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 3.5 p-10 -91.67 177.54 6.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.84 -1.162 . . . . 0.0 110.404 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 87.0 mt-10 -60.04 -39.99 87.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.59 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 47.6 t -67.74 -58.33 4.82 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.107 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.583 ' C ' HD22 ' A' ' 33' ' ' LEU . 68.3 m -49.99 -30.04 9.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.684 -1.26 . . . . 0.0 109.629 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 51.6 ttp180 -81.73 -47.95 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 111.261 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -93.91 -16.86 23.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.767 -1.208 . . . . 0.0 111.199 -171.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.926 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.1 pt? -60.0 -28.77 67.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.131 . . . . 0.0 110.24 -176.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.926 ' H ' HD23 ' A' ' 33' ' ' LEU . 61.4 mt -101.91 -73.37 0.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 109.97 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 36' ' ' ALA . 12.6 t0 -170.02 -27.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -36.23 122.36 0.72 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.327 0.584 . . . . 0.0 110.933 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.716 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -115.65 179.32 4.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 38' ' ' ILE . 28.2 mm -54.64 128.27 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.985 -1.072 . . . . 0.0 109.897 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.62 18.36 75.75 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.575 172.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.441 ' OD1' ' OE2' ' A' ' 37' ' ' GLU . 79.5 m-20 -89.17 161.86 16.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.649 -1.501 . . . . 0.0 109.635 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.838 HG21 ' OG1' ' A' ' 92' ' ' THR . 94.0 t -99.62 135.92 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.058 -1.026 . . . . 0.0 110.499 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.736 HG22 ' C ' ' A' ' 52' ' ' GLY . 3.5 m -119.98 153.12 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.323 -0.861 . . . . 0.0 110.571 -177.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 86.5 tt0 -118.88 139.93 50.82 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.348 -0.845 . . . . 0.0 110.009 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.8 mp -119.98 145.11 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.022 -1.049 . . . . 0.0 110.754 -177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -150.49 95.28 2.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.353 -0.842 . . . . 0.0 111.023 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.999 ' HG3' HG12 ' A' ' 85' ' ' VAL . 9.7 tmtm? -97.85 -59.19 1.82 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.995 . . . . 0.0 109.852 173.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.58 HG23 ' C ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -113.21 -33.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.58 -0.7 . . . . 0.0 109.22 175.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 78.9 mtm-85 -136.56 178.42 7.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.566 -0.709 . . . . 0.0 109.603 174.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.607 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -89.1 132.26 34.88 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.163 -0.96 . . . . 0.0 110.386 -176.292 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.598 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 3.1 p -139.69 168.13 20.53 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.468 0.651 . . . . 0.0 109.695 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.755 HG13 ' HG ' ' A' ' 130' ' ' LEU . 2.8 m -115.24 175.16 2.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.55 -0.719 . . . . 0.0 110.66 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.736 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.78 179.75 48.2 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 174.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.535 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 51.1 mtp180 -125.82 176.13 7.16 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.274 -1.133 . . . . 0.0 110.027 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -99.15 127.07 52.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.351 -175.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -117.6 164.81 14.39 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 175.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -89.87 121.74 32.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.439 -0.788 . . . . 0.0 109.803 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.791 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -62.82 132.4 52.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.604 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.4 mtt-85 -57.11 -47.4 99.13 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 118.799 -1.16 . . . . 0.0 108.708 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 38.5 Cg_endo -92.76 97.17 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.96 1.505 . . . . 0.0 108.975 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -75.56 33.51 0.11 Allowed 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.429 -0.794 . . . . 0.0 110.977 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -145.73 -28.54 0.43 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.055 -1.028 . . . . 0.0 110.631 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -87.03 -25.76 24.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 109.129 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.791 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 18.3 m120 -81.1 42.33 0.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.639 -0.663 . . . . 0.0 110.269 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.528 ' CD ' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.73 9.52 43.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 0.0 109.788 176.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.89 27.62 0.05 OUTLIER Glycine 0 N--CA 1.48 1.577 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.465 HG22 ' CZ ' ' A' ' 10' ' ' ARG . 45.8 pt -140.78 141.71 31.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.272 -1.134 . . . . 0.0 109.653 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.118 HG23 HG13 ' A' ' 24' ' ' VAL . 2.4 p -117.01 128.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.979 . . . . 0.0 109.848 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.478 ' HD3' ' HD3' ' A' ' 25' ' ' ARG . 78.7 ttt180 -90.82 119.38 30.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.759 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.6 pp -133.31 165.03 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 110.473 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.571 ' OD2' ' N ' ' A' ' 21' ' ' MET . 89.2 m-20 -80.01 169.2 18.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 109.734 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.2 m -60.04 -39.95 87.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.413 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.1 -46.6 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.927 . . . . 0.0 110.161 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.756 ' CE ' HD13 ' A' ' 44' ' ' ILE . 16.8 tpt -60.06 -42.81 95.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.212 -0.93 . . . . 0.0 109.582 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.427 ' HD2' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -61.75 -39.97 93.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.691 173.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -69.98 -23.41 63.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 110.443 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 73' ' ' MET . 75.3 m-20 -60.1 -39.99 88.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.033 -1.042 . . . . 0.0 110.641 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.58 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.1 p -98.96 -37.09 9.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.901 -1.124 . . . . 0.0 110.577 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 114.92 33.18 1.72 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.776 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -109.99 162.79 14.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.14 -1.212 . . . . 0.0 110.401 -177.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.633 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -110.04 169.96 8.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.349 -0.844 . . . . 0.0 109.26 177.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.957 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -52.79 144.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.194 177.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.99 0.34 60.15 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.0 m-20 -58.89 -162.83 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.801 -1.411 . . . . 0.0 110.36 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 15.3 ptpt -135.13 113.64 11.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.477 -0.764 . . . . 0.0 109.77 176.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.999 HG12 ' HG3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -123.74 156.37 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.355 -0.841 . . . . 0.0 109.629 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -102.9 119.79 39.47 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.813 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.526 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 45.6 t -102.04 119.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.55 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' HG2' ' HA3' ' A' ' 6' ' ' GLY . 84.4 mtm-85 -116.76 140.48 49.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.998 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 24.0 tttm -72.34 145.33 47.85 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 110.879 -177.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.555 HG23 HG12 ' A' ' 41' ' ' VAL . 2.2 m -147.4 -167.95 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.651 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -134.06 168.61 18.5 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 109.653 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.838 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -112.21 159.26 18.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.077 -1.015 . . . . 0.0 111.149 -174.295 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.423 ' H ' ' HA ' ' A' ' 162' ' ' VAL . 7.4 pt-20 -150.08 170.54 18.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 mm -88.3 96.49 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.467 -1.396 . . . . 0.0 110.219 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.928 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.58 147.81 21.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.508 -0.745 . . . . 0.0 110.643 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 169' ' ' LYS . 9.7 ptmt -115.69 -24.9 8.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.805 . . . . 0.0 111.01 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.748 ' HB3' HD23 ' A' ' 156' ' ' LEU . 42.7 tttp -149.99 125.84 10.46 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.759 -1.213 . . . . 0.0 110.691 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.007 HG23 HG22 ' A' ' 155' ' ' THR . 7.3 p -139.46 146.96 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.176 -0.953 . . . . 0.0 110.293 176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.604 ' C ' HD23 ' A' ' 100' ' ' LEU . 95.4 m -119.56 138.37 53.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.069 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.829 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -140.01 174.17 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -143.95 102.38 4.88 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 110.752 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -56.15 128.88 32.0 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.0 110.048 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.094 HG23 ' HB2' ' A' ' 177' ' ' ALA . 74.8 mt -95.94 104.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 110.282 -177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.856 HD12 ' CG ' ' A' ' 108' ' ' GLN . 15.2 pt -140.83 -160.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.867 . . . . 0.0 109.933 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.539 ' CB ' ' OD1' ' A' ' 107' ' ' ASP . 41.5 mmt180 -110.3 155.54 21.93 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.421 178.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -58.45 -16.01 13.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.68 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.539 ' OD1' ' CB ' ' A' ' 105' ' ' ARG . 33.5 p-10 -104.09 34.06 3.21 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.79 -0.569 . . . . 0.0 109.596 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.856 ' CG ' HD12 ' A' ' 104' ' ' ILE . 1.6 pp0? -81.42 144.33 31.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.133 -0.98 . . . . 0.0 110.277 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.491 ' H ' HD11 ' A' ' 142' ' ' LEU . 33.6 ttm180 -96.04 -11.15 26.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.495 -0.753 . . . . 0.0 111.011 -175.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -98.03 53.58 1.09 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 110.017 -175.016 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.515 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 10.8 ptmt -100.59 140.37 34.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 109.809 176.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.06 -70.38 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.413 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 76.42 -170.95 54.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 113' ' ' GLY . 46.1 mt-10 42.37 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.212 -1.169 . . . . 0.0 110.278 177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.05 -10.13 69.69 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.545 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.7 tp -64.05 -40.06 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -1.173 . . . . 0.0 110.13 176.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 116' ' ' ILE . 41.3 tt0 -59.93 -42.75 94.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.857 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.67 -37.3 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.872 . . . . 0.0 109.817 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -59.99 -39.36 85.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.833 . . . . 0.0 109.684 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 170' ' ' ILE . 67.3 t -60.03 -47.25 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.58 ' HA ' ' CD2' ' A' ' 124' ' ' LEU . 2.5 mt-30 -60.04 -41.37 92.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 109.885 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -60.11 -41.53 92.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 110.293 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.71 -48.58 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 110.919 -176.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 120' ' ' VAL . 0.3 OUTLIER -96.28 3.69 52.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.005 -1.06 . . . . 0.0 110.905 -172.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.618 ' HA ' HG22 ' A' ' 164' ' ' ILE . 3.4 tt -41.58 165.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 110.492 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 164' ' ' ILE . 51.8 ptt85 33.95 47.43 0.18 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.365 -0.834 . . . . 0.0 111.319 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.7 OUTLIER -133.61 135.06 24.33 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.949 -1.094 . . . . 0.0 111.051 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.844 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 7.4 Cg_endo -54.33 119.76 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.815 1.429 . . . . 0.0 109.498 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.672 ' O ' HG22 ' A' ' 162' ' ' VAL . 93.5 mmm -133.26 141.94 48.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.586 -1.321 . . . . 0.0 110.738 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.773 ' H ' HD13 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -151.67 145.93 25.42 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.703 0.763 . . . . 0.0 110.752 175.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -53.47 158.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.594 -0.691 . . . . 0.0 111.085 -174.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 73.6 -6.17 1.84 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.83 -0.544 . . . . 0.0 110.798 177.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.735 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.3 p30 -70.22 169.15 14.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 173.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -136.01 138.95 42.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -140.35 169.97 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.986 -1.071 . . . . 0.0 110.338 -177.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.2 t -140.43 143.54 35.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.245 -0.909 . . . . 0.0 110.257 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.666 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 13.3 t -118.99 -69.4 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.368 -0.833 . . . . 0.0 110.776 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.666 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 43.2 Cg_endo -71.88 130.78 17.26 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.176 1.093 . . . . 0.0 110.277 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -97.0 47.25 1.65 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -128.5 159.08 36.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -1.111 . . . . 0.0 110.386 -178.263 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -132.91 -168.9 2.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.187 -0.946 . . . . 0.0 110.545 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.563 ' N ' ' OG1' ' A' ' 141' ' ' THR . 83.7 mt -143.94 -132.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.554 -0.716 . . . . 0.0 109.937 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -55.72 -151.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 110.428 176.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.29 60.06 3.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.64 161.02 13.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.447 -1.031 . . . . 0.0 110.243 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.9 t -139.95 156.62 46.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.322 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.595 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 101.74 -87.96 0.67 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 43.37 49.14 6.04 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.557 -0.966 . . . . 0.0 111.244 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.734 ' HG ' HD12 ' A' ' 103' ' ' ILE . 2.4 pp -140.24 169.56 17.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.854 -1.154 . . . . 0.0 109.836 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -92.35 129.19 38.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.036 -1.04 . . . . 0.0 110.094 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.743 ' HB2' HD11 ' A' ' 103' ' ' ILE . 57.8 tptt -108.6 108.39 19.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 110.157 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.735 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.2 t -79.72 136.22 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 110.036 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.89 -22.74 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 110.784 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -150.01 151.24 32.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.843 -1.161 . . . . 0.0 110.976 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.007 HG22 HG23 ' A' ' 98' ' ' VAL . 34.5 p -141.66 169.39 17.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.629 -0.669 . . . . 0.0 109.389 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.44 -40.27 0.46 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.698 -178.197 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.973 ' CB ' HG11 ' A' ' 162' ' ' VAL . 17.1 Cg_exo -58.99 -164.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.718 1.378 . . . . 0.0 110.425 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.518 ' HB3' HG22 ' A' ' 160' ' ' VAL . 23.6 t -89.98 -171.36 3.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.804 175.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -67.44 -6.09 17.78 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.165 -0.959 . . . . 0.0 110.498 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 158' ' ' SER . 23.8 m -87.59 148.3 43.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 O-C-N 121.398 -0.814 . . . . 0.0 110.405 -177.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.665 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.9 Cg_endo -46.23 143.34 7.86 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 124.267 1.667 . . . . 0.0 110.628 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.973 HG11 ' CB ' ' A' ' 157' ' ' PRO . 9.1 m -130.04 159.37 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 0.0 109.597 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -103.58 122.43 44.96 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.838 -1.163 . . . . 0.0 110.13 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.756 ' CD1' HG21 ' A' ' 168' ' ' THR . 8.0 mm -69.54 158.31 6.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.68 -0.638 . . . . 0.0 110.196 -176.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.64 167.08 26.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.53 -23.09 57.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -1.043 . . . . 0.0 110.248 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -89.99 -12.07 39.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.152 -0.967 . . . . 0.0 110.087 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 95' ' ' ALA . 5.6 m -57.75 179.38 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.129 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.567 ' H ' HG22 ' A' ' 168' ' ' THR . 50.0 mtpt -140.54 159.66 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.217 -0.927 . . . . 0.0 109.511 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.812 HG23 HD21 ' A' ' 100' ' ' LEU . 4.3 mt -140.02 168.0 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.196 -0.94 . . . . 0.0 110.834 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.529 ' N ' ' CG2' ' A' ' 170' ' ' ILE . 13.5 mt-10 -139.17 131.73 28.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.609 -0.682 . . . . 0.0 110.195 175.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.501 HD13 ' HG ' ' A' ' 100' ' ' LEU . 37.2 mm -119.97 119.94 61.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.41 -0.807 . . . . 0.0 109.87 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.475 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 6.1 ptp180 -89.12 163.15 15.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.23 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.507 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 96.5 mt-10 -100.03 12.88 35.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.339 -0.85 . . . . 0.0 110.575 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 3.8 tt0 -94.08 109.21 40.76 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.929 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.2 Cg_exo -72.22 -155.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.115 1.587 . . . . 0.0 110.322 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.094 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -85.57 44.98 1.15 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.495 0.664 . . . . 0.0 110.217 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 47.4 t -54.11 -59.27 4.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.526 -0.734 . . . . 0.0 110.643 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -84.73 3.99 34.81 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.998 -1.064 . . . . 0.0 110.136 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.414 ' C ' HD23 ' A' ' 181' ' ' LEU . 62.6 t -111.0 129.93 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 110.055 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.697 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -119.42 -44.89 2.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.479 -179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -152.52 160.7 43.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 110.404 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -59.9 -30.0 68.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 0.0 110.222 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.06 -166.83 52.06 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.427 179.617 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 57.1 ttm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.296 0.57 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 1' ' ' MET . 96.9 mt-10 54.49 40.04 31.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 110.088 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.3 t -60.11 -40.01 88.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.948 . . . . 0.0 110.187 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' OD1' ' HD3' ' A' ' 88' ' ' ARG . 18.3 t-20 -142.36 116.75 9.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.445 ' O ' HD13 ' A' ' 34' ' ' LEU . 32.2 m120 -139.39 152.99 47.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 110.086 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -152.01 -166.2 13.85 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.017 ' CG2' HD12 ' A' ' 33' ' ' LEU . 37.3 pt -135.75 159.98 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -1.179 . . . . 0.0 109.811 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.7 mt -101.26 118.64 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 110.409 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.838 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.7 pt? -139.2 -170.78 2.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.289 -0.882 . . . . 0.0 109.559 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.7 ptp180 -107.9 135.45 49.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.818 -1.176 . . . . 0.0 110.802 -173.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.02 ' CG2' HD11 ' A' ' 69' ' ' ILE . 14.3 p -62.97 131.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.578 -0.702 . . . . 0.0 110.774 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -113.91 152.97 30.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.928 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 -174.89 109.58 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 110.246 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.52 -65.09 1.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 110.412 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -115.11 128.22 56.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.228 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 t -140.22 101.17 4.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.215 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -93.22 -14.35 27.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.052 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 46.1 p-10 -139.05 70.02 41.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.174 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.468 ' HA ' ' CB ' ' A' ' 70' ' ' ASP . 27.7 Cg_exo -57.62 140.9 94.92 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.068 1.562 . . . . 0.0 110.557 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.42 30.95 10.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.541 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 27.7 ptt? -88.12 0.02 56.51 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.146 -1.208 . . . . 0.0 109.105 174.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.6 m 49.98 40.15 20.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.372 -0.83 . . . . 0.0 110.487 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 21' ' ' MET . 69.4 mtp180 -118.23 135.58 54.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.111 -0.993 . . . . 0.0 110.486 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.094 HG13 HG23 ' A' ' 67' ' ' VAL . 97.5 t -120.0 124.28 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.102 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.548 ' O ' HD12 ' A' ' 26' ' ' LEU . 7.2 ptt180 -92.27 120.05 32.45 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.786 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.767 HD13 HG12 ' A' ' 24' ' ' VAL . 1.0 OUTLIER -134.05 164.81 26.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.574 -0.704 . . . . 0.0 109.825 -176.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -93.54 -177.34 4.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.004 -1.06 . . . . 0.0 110.555 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.02 -47.33 86.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.672 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 58.1 m -66.32 -43.74 85.33 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.45 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.114 ' O ' HD22 ' A' ' 33' ' ' LEU . 55.8 p -60.81 -26.89 67.63 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 53.3 ttp180 -88.35 -45.93 9.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.584 -0.697 . . . . 0.0 110.89 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 33' ' ' LEU . 99.5 mtt180 -76.59 -10.04 59.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 0.0 109.896 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.114 HD22 ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -41.25 -30.03 0.15 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.607 0.718 . . . . 0.0 109.948 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.762 ' H ' HD23 ' A' ' 33' ' ' LEU . 73.8 mt -139.98 -61.18 0.53 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.574 -0.704 . . . . 0.0 110.63 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 36' ' ' ALA . 16.2 t0 -169.98 -28.73 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.241 -0.912 . . . . 0.0 110.551 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.619 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -23.71 118.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.558 0.694 . . . . 0.0 111.457 -175.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.659 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.4 pt-20 -104.63 177.59 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 38' ' ' ILE . 26.5 mm -58.1 122.59 8.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 120.963 -1.086 . . . . 0.0 109.933 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.562 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 74.51 30.14 60.67 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 33.8 m-20 -89.28 174.4 7.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.832 -1.393 . . . . 0.0 109.411 170.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.637 HG21 ' N ' ' A' ' 92' ' ' THR . 96.6 t -99.38 124.69 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.97 -1.081 . . . . 0.0 110.238 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.67 HG11 HG23 ' A' ' 54' ' ' VAL . 2.5 m -111.82 140.04 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.27 -0.893 . . . . 0.0 110.489 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' C ' HD12 ' A' ' 44' ' ' ILE . 41.7 tt0 -108.1 143.91 36.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.506 -0.746 . . . . 0.0 109.764 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.905 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.8 mp -119.8 144.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.068 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.1 tt0 -151.51 87.69 1.39 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.833 -1.167 . . . . 0.0 111.604 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.761 ' HB2' HG12 ' A' ' 85' ' ' VAL . 38.5 tttp -98.57 -75.95 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 110.287 171.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.51 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -91.78 -33.81 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.481 -0.762 . . . . 0.0 109.62 177.424 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.6 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 91.6 mtt180 -143.93 -172.31 3.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 110.126 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.686 ' C ' HD21 ' A' ' 130' ' ' LEU . 14.2 mptt -87.95 132.19 34.32 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 110.679 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.554 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -133.95 158.78 42.62 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.293 0.568 . . . . 0.0 110.226 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.12 161.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.861 . . . . 0.0 110.174 178.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.575 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -176.92 179.39 47.89 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 173.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.82 -178.78 3.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.248 -1.148 . . . . 0.0 109.981 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.67 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -110.47 135.3 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 110.373 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 m-85 -128.02 167.67 16.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.285 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 35.2 ptt180 -89.32 124.9 34.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.078 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.8 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -61.84 131.54 50.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.946 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.644 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 11.5 mtt180 -59.51 -42.09 90.22 Favored Pre-proline 0 N--CA 1.49 1.527 0 C-N-CA 119.101 -1.039 . . . . 0.0 109.367 175.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.644 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 29.3 Cg_endo -94.33 99.83 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.886 1.467 . . . . 0.0 108.998 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 12.0 pt-20 -72.77 32.61 0.07 Allowed 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.392 -0.817 . . . . 0.0 110.859 -175.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 73.6 m-20 -148.58 -26.66 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 0.0 110.701 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 66' ' ' ILE . 52.9 mt-10 -86.26 -28.48 23.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.134 -0.979 . . . . 0.0 109.109 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.8 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 43.5 m-80 -81.12 42.22 0.64 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.361 0.6 . . . . 0.0 110.375 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HD3' ' OD2' ' A' ' 27' ' ' ASP . 37.2 mmtt -96.76 6.32 48.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.287 177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.4 29.55 0.05 OUTLIER Glycine 0 N--CA 1.477 1.426 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 9' ' ' LEU . 45.7 pt -140.78 145.12 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.224 -1.162 . . . . 0.0 109.525 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.094 HG23 HG13 ' A' ' 24' ' ' VAL . 2.6 p -123.17 130.0 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.827 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.539 ' CD ' ' HD3' ' A' ' 25' ' ' ARG . 71.3 ttt180 -91.6 114.62 27.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 110.131 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.02 HD11 ' CG2' ' A' ' 11' ' ' VAL . 1.6 pt -130.16 159.98 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.679 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 95.8 m-20 -81.09 169.57 17.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.854 . . . . 0.0 110.227 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -57.86 -22.55 48.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.07 -48.84 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.905 ' HE1' HD13 ' A' ' 44' ' ' ILE . 97.0 mmm -60.03 -43.91 94.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.953 . . . . 0.0 109.6 176.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -59.98 -40.49 89.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.25 -0.906 . . . . 0.0 110.04 174.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -69.49 -35.87 75.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.148 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.532 ' HB3' HG22 ' A' ' 50' ' ' THR . 20.6 m120 -60.01 -39.96 87.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.269 -0.894 . . . . 0.0 110.372 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.6 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 28.7 p -98.36 -35.79 10.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 110.607 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.51 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 109.92 28.05 4.34 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.603 ' CB ' ' HD3' ' A' ' 46' ' ' LYS . . . -100.39 177.63 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.242 . . . . 0.0 111.016 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.903 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -122.81 172.24 8.6 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -0.853 . . . . 0.0 109.196 175.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.928 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -62.19 142.23 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.717 -1.239 . . . . 0.0 110.561 179.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.566 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 74.55 -0.61 55.15 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 173.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -59.65 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.097 -1.237 . . . . 0.0 110.33 175.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 19.1 pttp -133.2 116.33 16.09 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.575 -0.703 . . . . 0.0 109.904 177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 46' ' ' LYS . 2.3 m -122.12 160.12 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.226 -0.921 . . . . 0.0 110.023 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 40.1 tttt -107.4 120.66 42.77 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.523 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 72.3 t -103.96 122.86 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.959 . . . . 0.0 109.998 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.521 ' HD3' ' OD1' ' A' ' 4' ' ' ASN . 96.1 mtt180 -110.0 148.03 32.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.629 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.619 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 2.4 tmtt? -93.86 136.01 34.59 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.056 -1.027 . . . . 0.0 110.53 -177.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' VAL . 2.1 m -149.81 -170.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.927 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 52.7 mtt180 -132.85 164.41 26.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 110.41 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.637 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.45 159.39 17.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 111.224 -176.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.653 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.8 pt-20 -150.42 169.99 20.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 94' ' ' ILE . 48.5 mm -89.17 101.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.827 -1.17 . . . . 0.0 110.264 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.918 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.38 135.46 53.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.266 -0.896 . . . . 0.0 110.184 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.552 ' HG3' ' HG ' ' A' ' 156' ' ' LEU . 7.1 ptpp? -97.24 -29.75 13.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -0.973 . . . . 0.0 111.112 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.682 ' HB3' HD23 ' A' ' 156' ' ' LEU . 47.3 tttm -151.27 126.66 10.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 110.789 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.037 HG23 HG22 ' A' ' 155' ' ' THR . 9.2 p -136.53 145.98 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.904 -1.122 . . . . 0.0 110.881 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -119.74 139.45 52.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.051 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.746 HD21 HG23 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -134.55 166.09 23.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.505 -177.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -139.51 89.65 11.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.33 -0.857 . . . . 0.0 110.466 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.0 Cg_exo -59.65 128.74 28.09 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.997 1.525 . . . . 0.0 110.434 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.049 HG23 ' HB2' ' A' ' 177' ' ' ALA . 56.7 mt -89.9 93.69 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 178.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.626 HG13 HD23 ' A' ' 110' ' ' LEU . 11.8 pt -150.72 -166.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.629 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.491 ' HB2' ' HG3' ' A' ' 108' ' ' GLN . 20.8 mmm180 -93.71 153.09 18.53 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.669 173.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.667 ' HA ' HD21 ' A' ' 110' ' ' LEU . 48.2 mtmt -59.23 -18.62 38.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 110.192 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -103.95 9.97 36.44 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 111.155 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.491 ' HG3' ' HB2' ' A' ' 105' ' ' ARG . 40.0 mt-30 -92.26 -79.97 0.37 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.884 -1.135 . . . . 0.0 110.927 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.567 ' H ' HD12 ' A' ' 104' ' ' ILE . 34.0 ttm180 -118.76 -16.75 9.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.922 . . . . 0.0 110.97 -175.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.667 HD21 ' HA ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -98.32 46.56 1.0 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.054 -176.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -137.63 64.01 1.53 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.576 -0.703 . . . . 0.0 110.184 179.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -140.87 -60.16 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.091 -1.006 . . . . 0.0 110.508 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.52 -173.43 54.33 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 47.39 87.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.19 -1.182 . . . . 0.0 110.494 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.74 -2.73 87.29 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.557 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.2 tp -64.19 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -1.189 . . . . 0.0 110.257 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.557 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -67.31 -39.98 85.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.905 176.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.04 -31.46 69.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.743 176.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -60.05 -41.69 92.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 110.076 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.759 HG12 ' CD1' ' A' ' 170' ' ' ILE . 55.0 t -60.08 -45.92 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.57 ' O ' ' HB ' ' A' ' 125' ' ' ILE . 4.2 mt-30 -60.0 -42.74 94.93 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 110.273 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.13 -47.94 83.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.481 -0.762 . . . . 0.0 110.151 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.17 75.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.532 -0.73 . . . . 0.0 110.318 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.524 HD12 ' CG1' ' A' ' 120' ' ' VAL . 51.5 mt -93.76 -5.72 47.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 110.416 -176.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.846 HD11 ' HG2' ' A' ' 166' ' ' GLU . 2.5 tt -45.91 167.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.926 -1.109 . . . . 0.0 110.207 -172.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 164' ' ' ILE . 32.0 ptt180 33.82 48.24 0.21 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.672 -0.642 . . . . 0.0 111.768 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 9.3 mmt85 -136.57 148.98 65.93 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 120.533 -1.355 . . . . 0.0 111.83 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.838 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 14.6 Cg_exo -66.19 130.6 24.52 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 124.24 1.652 . . . . 0.0 109.653 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.522 ' SD ' HG13 ' A' ' 164' ' ' ILE . 39.9 mtp -130.58 150.06 51.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.44 -1.412 . . . . 0.0 111.207 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.686 HD21 ' C ' ' A' ' 49' ' ' LYS . 16.5 tp -144.44 107.93 4.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.663 -0.648 . . . . 0.0 109.637 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.2 pm0 -44.71 142.9 1.55 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.359 -175.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.571 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 80.39 -0.85 1.96 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.125 0.488 . . . . 0.0 110.259 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.603 ' OD2' HG21 ' A' ' 152' ' ' VAL . 4.2 p-10 -70.0 179.4 2.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 0.0 109.85 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.525 ' OD1' ' HD2' ' A' ' 151' ' ' LYS . 13.4 m-80 -150.17 136.1 18.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.632 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -139.99 162.35 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.008 -1.057 . . . . 0.0 110.303 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.3 t -141.03 144.04 34.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.459 -0.776 . . . . 0.0 110.282 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.7 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 34.8 t -127.45 -69.35 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 110.938 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.7 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 38.2 Cg_endo -70.42 124.08 10.48 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.073 1.038 . . . . 0.0 110.386 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -96.07 46.87 1.84 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pp -126.85 153.03 46.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.438 -1.037 . . . . 0.0 110.33 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -141.71 -167.67 2.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.209 -0.932 . . . . 0.0 110.506 -179.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.577 ' N ' ' OG1' ' A' ' 141' ' ' THR . 84.4 mt -136.23 -109.92 0.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.604 -0.685 . . . . 0.0 109.909 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.49 -159.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 110.38 177.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.66 56.25 4.74 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 145' ' ' GLN . 13.7 pt20 -101.26 159.05 15.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.393 -1.063 . . . . 0.0 110.375 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.3 t -139.99 155.69 46.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.034 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.775 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 119.95 -84.58 0.37 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.775 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.5 OUTLIER 43.17 49.6 5.63 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.426 -1.044 . . . . 0.0 110.995 177.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.502 ' HG ' HD12 ' A' ' 103' ' ' ILE . 1.6 pp -140.02 166.69 23.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.907 -1.121 . . . . 0.0 110.026 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 30.0 m-85 -92.52 129.6 38.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.525 ' HD2' ' OD1' ' A' ' 134' ' ' ASN . 19.3 tptp -112.31 103.63 11.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.873 . . . . 0.0 109.75 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.603 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.1 t -77.44 140.01 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 109.638 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.14 -25.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.99 -1.069 . . . . 0.0 111.372 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 45.0 tptt -140.24 129.93 24.38 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.587 -1.321 . . . . 0.0 110.885 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.037 HG22 HG23 ' A' ' 98' ' ' VAL . 59.7 p -129.99 166.31 20.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.389 -0.82 . . . . 0.0 109.164 174.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -89.05 -35.47 0.42 Allowed Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.084 -1.01 . . . . 0.0 110.98 -176.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 1.048 ' CG ' HG11 ' A' ' 162' ' ' VAL . 31.6 Cg_exo -53.1 -179.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.4 1.211 . . . . 0.0 110.417 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.709 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -84.83 49.76 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 0.0 110.516 -179.238 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 158' ' ' SER . 41.6 mmtm 59.99 20.03 9.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.502 -0.749 . . . . 0.0 110.012 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.731 ' O ' HG13 ' A' ' 162' ' ' VAL . 11.5 m -109.41 159.74 30.3 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.411 -0.806 . . . . 0.0 110.326 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.555 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.1 Cg_endo -53.87 123.29 13.09 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.198 1.631 . . . . 0.0 110.2 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 1.048 HG11 ' CG ' ' A' ' 157' ' ' PRO . 5.0 m -129.78 158.46 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.879 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.5 tt0 -103.2 128.1 50.29 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.009 177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.945 HD12 HG21 ' A' ' 168' ' ' THR . 10.7 mm -70.26 154.22 8.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.636 -0.665 . . . . 0.0 110.036 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.07 170.98 24.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.846 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -56.88 -21.27 28.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -1.088 . . . . 0.0 110.074 -177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -90.45 -21.42 21.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 109.791 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.945 HG21 HD12 ' A' ' 164' ' ' ILE . 69.3 m -54.85 138.83 41.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.012 -176.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' LYS . 99.1 mttt -93.08 149.52 21.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.133 -0.979 . . . . 0.0 109.59 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.759 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.1 mt -130.0 160.52 40.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 110.935 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.496 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 30.8 mt-10 -135.19 136.12 41.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.637 -0.665 . . . . 0.0 110.173 175.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.59 HD11 HG21 ' A' ' 120' ' ' VAL . 40.6 mm -119.98 122.27 68.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.429 -0.794 . . . . 0.0 109.67 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.613 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 6.4 ptp180 -88.43 149.98 23.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -0.991 . . . . 0.0 110.148 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.479 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 75.2 mm-40 -90.28 -0.56 57.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.945 . . . . 0.0 110.418 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 0.9 OUTLIER -98.44 108.7 49.2 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.981 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 13.3 Cg_exo -71.34 -154.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.241 1.653 . . . . 0.0 110.59 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.049 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -72.82 54.91 0.38 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.72 -0.612 . . . . 0.0 109.883 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 52.9 m -96.32 120.04 35.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 110.002 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 178' ' ' SER . 81.4 tt0 60.12 19.91 9.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.893 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.26 138.98 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.778 . . . . 0.0 110.239 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 181' ' ' LEU . 0.9 OUTLIER -118.18 70.52 0.81 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 110.465 -177.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 183' ' ' GLU . 45.7 mt-10 -59.99 -40.02 87.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.087 177.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 182' ' ' GLU . 96.9 mt-10 58.74 39.99 23.64 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.437 -0.79 . . . . 0.0 110.297 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.97 -39.94 98.68 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -178.943 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.348 0.594 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.03 -39.98 87.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 110.133 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.2 m -70.1 151.39 45.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 0.0 110.489 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -89.58 127.57 35.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.384 -0.823 . . . . 0.0 110.281 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -146.11 169.07 19.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.467 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -150.72 -155.24 6.81 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.965 ' CG2' HD12 ' A' ' 33' ' ' LEU . 12.2 pt -131.08 159.98 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -1.13 . . . . 0.0 109.193 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.614 ' C ' HD23 ' A' ' 9' ' ' LEU . 92.2 mt -100.64 122.5 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.011 -1.055 . . . . 0.0 110.676 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.857 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -139.62 -175.81 4.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.596 177.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 33.5 ptt180 -110.68 139.72 45.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.869 -1.145 . . . . 0.0 110.964 -175.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.972 HG23 HD11 ' A' ' 69' ' ' ILE . 14.6 p -61.82 130.05 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.661 -0.649 . . . . 0.0 110.755 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.648 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -107.84 151.62 25.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 110.423 177.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.569 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 -176.86 155.42 1.25 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -167.29 -72.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.923 . . . . 0.0 110.272 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -141.92 114.04 8.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.312 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.0 p -159.99 164.42 33.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.116 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.494 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 69.7 p -70.35 159.8 33.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.107 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.642 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -54.66 -40.2 81.58 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.786 -176.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 13.1 Cg_exo -67.16 171.36 11.54 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.57 1.3 . . . . 0.0 110.496 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.03 20.25 36.93 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.453 ' SD ' HG11 ' A' ' 72' ' ' VAL . 25.5 ptt? -86.81 3.17 46.33 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.368 -1.078 . . . . 0.0 109.267 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.5 m -117.86 12.84 13.94 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.459 -0.776 . . . . 0.0 110.385 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -124.1 140.04 53.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.291 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.074 HG13 HG23 ' A' ' 67' ' ' VAL . 78.7 t -119.46 118.46 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 3.2 ptt180 -88.6 117.36 27.5 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.944 -1.103 . . . . 0.0 109.431 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.2 pt? -136.63 169.09 18.28 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.672 -0.642 . . . . 0.0 109.353 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 7.6 p-10 -97.12 -171.96 2.33 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.806 -1.184 . . . . 0.0 111.17 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -59.8 -49.22 78.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.49 -0.757 . . . . 0.0 109.476 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 22.8 t -62.03 -47.39 84.97 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 120.059 -0.657 . . . . 0.0 110.409 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.115 ' O ' HD22 ' A' ' 33' ' ' LEU . 25.1 t -57.59 -29.64 64.64 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.173 -0.955 . . . . 0.0 109.545 178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 60.0 ttp85 -85.89 -45.47 11.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 111.081 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -80.09 -4.85 54.5 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.008 -1.058 . . . . 0.0 110.111 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.115 HD22 ' O ' ' A' ' 30' ' ' SER . 2.0 pt? -47.49 -27.92 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -0.788 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.766 ' H ' HD23 ' A' ' 33' ' ' LEU . 71.6 mt -139.9 -60.04 0.54 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.659 -0.65 . . . . 0.0 110.377 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' C ' ' A' ' 36' ' ' ALA . 44.1 t0 -170.75 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.905 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB2' ' HD3' ' A' ' 89' ' ' LYS . . . -19.94 124.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.563 0.697 . . . . 0.0 111.824 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.3 pt-20 -116.88 -179.76 3.78 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 29.7 mm -59.99 130.1 23.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.777 -1.202 . . . . 0.0 109.689 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.518 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 78.75 19.13 73.92 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.942 173.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.544 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 85.1 m-20 -90.24 171.9 9.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.595 -1.532 . . . . 0.0 109.779 172.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.696 HG21 ' N ' ' A' ' 92' ' ' THR . 61.1 t -98.91 138.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.942 -1.099 . . . . 0.0 110.522 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.618 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.9 m -126.46 139.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -107.41 145.3 33.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.595 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.805 HD13 ' HE1' ' A' ' 73' ' ' MET . 3.6 mp -120.02 148.29 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.982 -1.074 . . . . 0.0 110.446 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 40.9 tt0 -151.45 94.17 1.98 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.977 . . . . 0.0 110.779 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.992 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.8 tmtm? -98.84 -66.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.703 173.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.574 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -106.72 -32.78 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.477 -0.764 . . . . 0.0 109.481 175.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 74.6 mtt85 -136.87 -172.64 3.23 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.674 ' HB3' HD21 ' A' ' 130' ' ' LEU . 36.7 mttt -88.83 139.28 30.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.984 -1.073 . . . . 0.0 111.05 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.579 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -137.69 160.18 39.94 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.299 0.571 . . . . 0.0 110.221 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.676 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -123.13 161.22 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.269 -0.894 . . . . 0.0 109.977 178.018 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -177.62 -179.78 47.93 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 174.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' A' ' 54' ' ' VAL . 51.9 ttp180 -121.69 169.37 10.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.452 -1.028 . . . . 0.0 110.16 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -91.48 138.86 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.92 . . . . 0.0 111.014 -172.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -128.55 162.66 26.74 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.502 -0.749 . . . . 0.0 109.887 174.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -89.01 123.63 33.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.891 . . . . 0.0 110.128 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.809 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.19 139.13 58.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.027 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.603 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -59.99 -48.91 93.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.15 174.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 36.4 Cg_endo -91.67 99.1 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.866 1.456 . . . . 0.0 108.993 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -73.91 36.34 0.09 Allowed 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.585 -0.697 . . . . 0.0 111.126 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -145.39 -36.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.073 -1.017 . . . . 0.0 111.165 -178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.8 pt-20 -85.87 -24.43 26.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.905 -1.122 . . . . 0.0 110.172 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.809 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 31.6 m120 -82.3 37.82 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -0.893 . . . . 0.0 110.695 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 49.1 pttt -98.49 18.17 17.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 109.641 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.79 20.85 0.03 OUTLIER Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.522 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 46.0 pt -141.61 157.01 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -1.068 . . . . 0.0 109.191 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.074 HG23 HG13 ' A' ' 24' ' ' VAL . 4.6 p -135.57 131.11 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.863 -1.148 . . . . 0.0 109.86 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.648 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 34.6 ttm180 -96.99 118.16 32.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.974 -1.079 . . . . 0.0 110.24 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.972 HD11 HG23 ' A' ' 11' ' ' VAL . 3.7 pt -131.69 172.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.491 -0.756 . . . . 0.0 110.639 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' ' 17' ' ' THR . 7.6 t70 -78.61 170.08 17.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.371 -0.831 . . . . 0.0 109.978 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 53.2 p -65.34 -27.56 68.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 110.01 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.453 HG11 ' SD ' ' A' ' 21' ' ' MET . 54.4 t -68.44 -46.12 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.805 ' HE1' HD13 ' A' ' 44' ' ' ILE . 12.7 tpt -60.33 -44.69 95.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.457 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 79' ' ' ALA . 43.6 ttp180 -60.17 -40.03 88.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 0.0 109.721 174.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -71.48 -22.99 61.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.578 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 73' ' ' MET . 59.3 m-20 -60.01 -36.88 78.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 0.0 110.272 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.544 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.2 p -98.4 -38.82 9.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 0.0 110.319 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.574 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 117.21 36.36 1.03 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 177.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.82 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -110.45 167.93 9.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -1.204 . . . . 0.0 110.475 -176.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.663 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -113.72 169.77 8.74 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.241 -0.912 . . . . 0.0 109.226 176.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -54.58 139.44 13.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 120.924 -1.11 . . . . 0.0 110.767 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.55 2.2 79.45 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 172.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -58.8 -162.88 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.023 -1.281 . . . . 0.0 110.445 175.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 21.9 pttm -133.61 113.48 12.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.422 -0.799 . . . . 0.0 109.981 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.992 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -125.09 160.12 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.389 -0.82 . . . . 0.0 109.586 178.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.5 tttt -110.24 125.4 53.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 110.048 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.584 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 66.1 t -99.25 119.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.368 -0.832 . . . . 0.0 110.009 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.479 ' NH2' ' HD3' ' A' ' 86' ' ' LYS . 84.4 mtt85 -103.19 145.2 30.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.832 . . . . 0.0 109.234 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 36' ' ' ALA . 29.8 tptt -99.74 135.42 41.19 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.595 -1.242 . . . . 0.0 110.94 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.488 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 3.1 m -150.08 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.575 0.702 . . . . 0.0 110.132 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.457 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 33.1 mtp85 -127.87 172.41 10.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.582 -0.699 . . . . 0.0 110.598 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.696 ' N ' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.46 163.42 12.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 111.172 -176.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.61 ' HG2' HG12 ' A' ' 162' ' ' VAL . 14.9 pt-20 -150.22 169.94 20.14 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.3 mm -89.01 100.62 10.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.909 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -53.89 139.94 32.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.315 -0.866 . . . . 0.0 110.173 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 17.8 ptpt -95.56 -28.75 14.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.203 -0.936 . . . . 0.0 110.999 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 21.6 ttpt -150.6 120.0 6.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.707 -1.246 . . . . 0.0 110.616 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.927 HG23 HG22 ' A' ' 155' ' ' THR . 8.2 p -130.03 140.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.01 . . . . 0.0 111.022 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.742 HG23 ' HB3' ' A' ' 171' ' ' GLU . 38.2 m -116.68 148.75 40.74 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.489 -0.757 . . . . 0.0 110.07 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.886 ' N ' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -150.7 179.94 7.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.006 -1.059 . . . . 0.0 110.678 178.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB2' ' HD2' ' A' ' 173' ' ' ARG . . . -144.45 101.14 4.74 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 111.117 -174.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.483 ' HG3' ' CE2' ' A' ' 150' ' ' PHE . 13.0 Cg_exo -65.52 129.52 22.7 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.038 1.547 . . . . 0.0 110.035 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.991 HG23 ' HB2' ' A' ' 177' ' ' ALA . 69.0 mt -90.95 110.27 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.135 -0.978 . . . . 0.0 110.366 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.811 HD12 ' CG ' ' A' ' 108' ' ' GLN . 18.0 pt -147.58 -156.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 122.08 0.943 . . . . 0.0 110.462 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.51 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 67.0 mtp85 -130.07 162.41 28.84 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.419 0.628 . . . . 0.0 110.902 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -57.37 -17.08 10.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.4 -0.813 . . . . 0.0 110.087 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.51 ' OD1' ' HB2' ' A' ' 105' ' ' ARG . 34.4 p-10 -102.87 32.67 3.57 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.444 0.64 . . . . 0.0 109.444 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.811 ' CG ' HD12 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -81.04 147.02 30.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.805 . . . . 0.0 109.97 -176.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.881 ' HB3' HD22 ' A' ' 142' ' ' LEU . 5.3 ttt85 -89.3 -12.54 40.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.432 -0.793 . . . . 0.0 110.76 -174.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 110' ' ' LEU . 1.3 pp -98.52 51.56 1.0 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.026 -1.047 . . . . 0.0 110.206 -177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 16.5 ptmt -105.17 96.77 6.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.373 -0.829 . . . . 0.0 109.862 174.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -101.77 -61.99 1.31 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.933 -1.104 . . . . 0.0 110.386 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.734 ' H ' HD12 ' A' ' 116' ' ' ILE . . . 75.83 174.02 35.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.094 -1.603 . . . . 0.0 109.094 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 48.15 94.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.043 -1.269 . . . . 0.0 110.02 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.85 -6.62 80.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.734 HD12 ' H ' ' A' ' 113' ' ' GLY . 20.8 tt -60.13 -38.28 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.192 -1.181 . . . . 0.0 110.259 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.0 mt-10 -60.22 -41.9 94.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.117 -0.99 . . . . 0.0 109.763 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -68.91 -36.05 77.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.16 -41.15 92.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.401 -0.812 . . . . 0.0 109.714 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 170' ' ' ILE . 58.5 t -60.27 -45.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.275 174.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 168' ' ' THR . 3.1 mt-30 -59.85 -41.8 92.21 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.576 -0.703 . . . . 0.0 110.319 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -60.18 -49.83 76.08 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.342 -0.849 . . . . 0.0 109.835 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.29 -40.29 70.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -0.753 . . . . 0.0 110.722 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.489 ' N ' ' CD2' ' A' ' 124' ' ' LEU . 4.4 mm? -93.36 -0.87 56.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.191 -0.943 . . . . 0.0 110.956 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.2 tt -47.96 165.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.97 -1.081 . . . . 0.0 110.075 -177.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 164' ' ' ILE . 9.7 ptm180 32.23 46.28 0.06 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.537 -0.727 . . . . 0.0 111.37 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.483 ' HG3' ' HD2' ' A' ' 128' ' ' PRO . 0.0 OUTLIER -128.07 133.6 25.31 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.997 -1.064 . . . . 0.0 110.667 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 27.6 Cg_exo -58.49 139.35 90.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.995 1.524 . . . . 0.0 109.756 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.532 ' HG3' HG12 ' A' ' 164' ' ' ILE . 92.2 mmm -133.66 146.92 51.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.373 -1.455 . . . . 0.0 110.891 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 49' ' ' LYS . 14.5 tp -147.8 112.12 5.24 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.3 pm0 -46.69 139.51 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.625 -1.297 . . . . 0.0 110.108 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.575 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 79.71 -3.14 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.254 0.549 . . . . 0.0 110.468 -179.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 130' ' ' LEU . 1.3 p30 -68.47 -169.96 0.18 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 175.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.408 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 23.5 m-80 -147.01 155.52 42.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.879 . . . . 0.0 109.704 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.35 169.92 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.074 -1.016 . . . . 0.0 109.937 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.4 t -131.08 147.85 52.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.405 -0.809 . . . . 0.0 110.609 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.658 HG13 ' HD2' ' A' ' 138' ' ' PRO . 84.7 t -102.76 148.27 35.3 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.521 -0.737 . . . . 0.0 109.756 178.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.658 ' HD2' HG13 ' A' ' 137' ' ' VAL . 1.6 Cg_endo -44.73 166.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.971 1.511 . . . . 0.0 110.598 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.93 79.87 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.085 ' O ' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -132.51 155.36 48.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -1.115 . . . . 0.0 110.028 178.678 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.997 ' N ' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -179.85 -169.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.07 -1.019 . . . . 0.0 110.924 -177.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.881 HD22 ' HB3' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -145.41 -116.67 0.08 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.696 -0.628 . . . . 0.0 109.596 178.066 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -56.58 -157.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.084 -1.01 . . . . 0.0 110.03 175.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -83.04 81.17 1.76 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.528 ' NE2' HD21 ' A' ' 142' ' ' LEU . 1.9 pt20 -96.43 165.45 12.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.443 -1.033 . . . . 0.0 110.114 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -140.02 154.47 47.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.277 -0.889 . . . . 0.0 110.401 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.638 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 84.62 -88.63 1.57 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.4 OUTLIER 43.7 49.4 6.7 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.7 -0.882 . . . . 0.0 111.098 177.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.759 ' CG ' HD12 ' A' ' 103' ' ' ILE . 1.2 pp -134.8 160.97 36.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.031 -1.043 . . . . 0.0 109.522 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.483 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 37.4 m-85 -98.13 130.57 44.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.965 . . . . 0.0 110.372 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 133' ' ' ASP . 18.6 tptm -115.13 108.79 17.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.666 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 132' ' ' GLN . 10.6 t -75.23 131.82 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.104 -0.998 . . . . 0.0 110.091 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.2 t -113.0 -25.44 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.216 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -148.31 151.16 34.9 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.707 -1.246 . . . . 0.0 111.12 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.927 HG22 HG23 ' A' ' 98' ' ' VAL . 82.4 p -142.54 162.27 35.92 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.673 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -88.9 -34.19 0.41 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.283 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.969 ' CG ' HG11 ' A' ' 162' ' ' VAL . 35.4 Cg_exo -54.39 -171.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.285 1.15 . . . . 0.0 110.118 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.562 ' O ' HG13 ' A' ' 160' ' ' VAL . 15.7 t -88.19 43.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 0.0 110.35 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 158' ' ' SER . 33.1 mmtp 61.27 20.0 10.64 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.856 ' O ' HG13 ' A' ' 162' ' ' VAL . 18.2 m -105.58 154.75 38.95 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.676 ' HB3' HG12 ' A' ' 51' ' ' VAL . 1.3 Cg_endo -48.61 119.89 4.67 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.08 1.568 . . . . 0.0 110.131 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.969 HG11 ' CG ' ' A' ' 157' ' ' PRO . 6.3 m -129.54 159.97 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.138 175.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -110.01 136.72 48.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.104 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.78 ' CD1' HG21 ' A' ' 168' ' ' THR . 14.7 mm -71.11 154.63 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 121.692 -0.63 . . . . 0.0 110.225 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.63 170.02 24.37 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 175.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -58.05 -23.11 53.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -1.119 . . . . 0.0 110.264 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -94.04 -15.61 24.63 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.135 -0.978 . . . . 0.0 110.699 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.78 HG21 ' CD1' ' A' ' 164' ' ' ILE . 91.9 m -58.43 144.02 43.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.989 -1.069 . . . . 0.0 109.91 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 23.0 mttp -97.51 154.32 17.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.889 -1.132 . . . . 0.0 109.763 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.672 ' CD1' HG12 ' A' ' 120' ' ' VAL . 2.7 mt -130.09 164.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.088 -1.008 . . . . 0.0 111.04 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.742 ' HB3' HG23 ' A' ' 99' ' ' THR . 16.7 mt-10 -138.16 137.47 37.68 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.34 0.59 . . . . 0.0 110.147 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.641 HD13 HD21 ' A' ' 100' ' ' LEU . 31.8 mm -122.16 129.29 75.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.443 -0.785 . . . . 0.0 109.797 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.445 ' NE ' ' HB2' ' A' ' 175' ' ' GLU . 6.8 ptm180 -89.28 174.22 7.96 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.081 -1.012 . . . . 0.0 110.275 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.512 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 67.1 mm-40 -116.21 4.02 13.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.94 . . . . 0.0 111.293 -174.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.445 ' HB2' ' NE ' ' A' ' 173' ' ' ARG . 2.6 mt-10 -98.77 107.45 43.22 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.967 -1.083 . . . . 0.0 110.464 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.0 Cg_exo -72.52 -156.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.109 1.583 . . . . 0.0 110.772 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.991 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -85.02 56.43 3.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.8 -0.563 . . . . 0.0 110.07 178.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 39.5 m -66.65 124.33 22.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 110.022 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 178' ' ' SER . 79.8 tt0 60.07 14.91 4.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.362 -0.836 . . . . 0.0 110.869 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.0 t -98.25 113.83 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.992 -1.068 . . . . 0.0 109.992 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 181' ' ' LEU . 0.5 OUTLIER -175.19 84.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -0.879 . . . . 0.0 110.366 -179.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.16 -40.21 89.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 109.965 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -63.48 140.0 58.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.369 -0.832 . . . . 0.0 110.195 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 158.22 160.21 10.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.197 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 54.7 ttm . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.189 0.519 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 1' ' ' MET . 96.8 mt-10 55.82 39.96 30.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.229 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -84.23 139.73 32.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.354 -0.841 . . . . 0.0 110.169 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -108.25 129.57 55.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.942 . . . . 0.0 110.392 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -149.99 159.98 43.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.107 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -152.89 -168.22 16.57 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.838 ' CG2' HD12 ' A' ' 33' ' ' LEU . 26.6 pt -134.16 166.77 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.386 -1.067 . . . . 0.0 109.861 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.492 HD11 ' HD3' ' A' ' 86' ' ' LYS . 35.2 mm -103.22 115.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 110.341 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 9' ' ' LEU . 1.7 pt? -138.19 -172.75 3.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.088 -1.008 . . . . 0.0 109.7 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 35.6 ptt180 -112.19 138.0 49.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.838 -1.164 . . . . 0.0 110.765 -174.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.087 ' CG2' HD11 ' A' ' 69' ' ' ILE . 8.4 p -62.03 134.61 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.531 -0.73 . . . . 0.0 110.54 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -111.6 166.64 10.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.391 -0.818 . . . . 0.0 110.89 -177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.774 ' CB ' HD11 ' A' ' 81' ' ' ILE . 51.5 tp10 -172.43 110.06 0.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.339 -0.85 . . . . 0.0 110.122 174.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 15' ' ' ASN . . . -109.08 157.03 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 109.849 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 90.3 m-20 53.68 -167.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -0.984 . . . . 0.0 109.659 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.685 ' C ' HG23 ' A' ' 17' ' ' THR . 2.8 t -167.79 178.98 4.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.097 -1.002 . . . . 0.0 110.561 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.685 HG23 ' C ' ' A' ' 16' ' ' SER . 1.2 p 60.8 26.3 16.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.392 -0.817 . . . . 0.0 110.331 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.592 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 14.6 p-10 -149.92 58.31 3.15 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 110.809 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 11.8 Cg_exo -68.9 118.37 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.684 1.36 . . . . 0.0 109.893 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.17 -93.94 0.05 OUTLIER Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.575 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.0 ptp -157.69 -37.1 0.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.709 -0.877 . . . . 0.0 109.28 175.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.575 ' CB ' ' O ' ' A' ' 21' ' ' MET . 0.4 OUTLIER 161.6 60.02 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.252 0.549 . . . . 0.0 109.958 -177.304 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -120.06 141.11 50.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.142 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 53.0 t -110.13 119.89 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HD3' ' HD3' ' A' ' 68' ' ' ARG . 4.6 ptt180 -89.27 121.67 31.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.787 -1.196 . . . . 0.0 109.524 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.928 HD21 HG22 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -137.32 166.81 22.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.761 -174.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' N ' ' HB3' ' A' ' 63' ' ' ASN . 6.4 p-10 -101.49 -170.39 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.906 -1.121 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.1 -44.41 94.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.539 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 44.9 t -65.98 -49.9 66.2 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.346 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.068 ' O ' HD22 ' A' ' 33' ' ' LEU . 58.1 m -56.38 -27.33 55.87 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 49.2 ttp180 -85.58 -48.29 9.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.87 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -83.08 -6.06 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.038 . . . . 0.0 110.011 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.068 HD22 ' O ' ' A' ' 30' ' ' SER . 1.8 pt? -44.12 -28.16 0.47 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.621 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.837 ' H ' HD23 ' A' ' 33' ' ' LEU . 82.9 mt -143.8 -59.98 0.4 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.517 -0.74 . . . . 0.0 110.617 176.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 36' ' ' ALA . 14.3 t0 -170.88 -22.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.302 -0.873 . . . . 0.0 110.852 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -30.77 127.56 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 110.915 -175.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.66 ' O ' HG11 ' A' ' 54' ' ' VAL . 2.3 pt-20 -112.51 -178.08 3.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 38' ' ' ILE . 34.7 mm -59.98 120.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 120.945 -1.097 . . . . 0.0 109.976 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.597 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 72.8 33.55 60.13 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 174.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 2.2 m-20 -89.52 178.86 6.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.806 -1.408 . . . . 0.0 109.556 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 92' ' ' THR . 79.5 t -99.26 129.58 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.203 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 52' ' ' GLY . 7.5 m -123.57 147.2 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.433 -0.792 . . . . 0.0 110.625 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.519 ' OE2' ' NH2' ' A' ' 88' ' ' ARG . 86.0 tt0 -115.62 139.95 49.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.542 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.928 HD13 ' CE ' ' A' ' 73' ' ' MET . 3.1 mp -122.78 147.61 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 0.0 110.566 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.4 tt0 -150.08 97.61 2.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 110.633 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.024 ' CG ' HG12 ' A' ' 85' ' ' VAL . 14.3 tmtt? -98.62 -67.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.566 HG22 ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -102.32 -35.46 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.162 173.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 92.9 mtt-85 -127.63 -168.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.31 0.576 . . . . 0.0 109.736 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.975 ' HG2' HD21 ' A' ' 130' ' ' LEU . 1.3 ttpm? -103.73 137.2 42.1 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.36 -0.838 . . . . 0.0 110.212 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.763 ' HA ' HD23 ' A' ' 130' ' ' LEU . 8.7 p -142.8 170.53 15.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.603 -0.686 . . . . 0.0 110.254 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.2 OUTLIER -122.84 167.76 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.521 -0.737 . . . . 0.0 109.902 177.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.818 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -177.7 179.05 48.42 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -117.0 163.97 15.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.505 -0.997 . . . . 0.0 110.139 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.928 HG22 HD21 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -97.35 137.5 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.07 -1.018 . . . . 0.0 110.45 -172.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.3 m-85 -122.12 166.48 14.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 110.116 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -89.65 124.44 34.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 110.328 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.709 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.33 132.58 50.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.097 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -58.74 -46.04 99.59 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.984 -1.072 . . . . 0.0 109.296 173.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 58' ' ' ARG . 14.7 Cg_endo -89.89 99.18 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.022 1.538 . . . . 0.0 109.055 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -73.11 33.62 0.07 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.557 -0.715 . . . . 0.0 110.866 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 59' ' ' PRO . 52.8 t0 -148.78 -29.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 110.703 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.69 -29.22 22.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.438 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.709 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 4.7 m120 -80.94 39.35 0.49 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.699 . . . . 0.0 110.629 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 11.3 ptpt -98.54 10.71 40.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.606 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.62 26.74 0.05 OUTLIER Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.442 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.4 pt -141.05 142.67 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.304 -1.115 . . . . 0.0 109.436 174.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 1.8 p -119.47 125.89 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.117 -0.99 . . . . 0.0 109.995 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.509 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 70.4 ttt180 -90.05 113.04 24.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.087 HD11 ' CG2' ' A' ' 11' ' ' VAL . 3.0 pt -126.17 163.04 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.432 -0.793 . . . . 0.0 110.77 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 21' ' ' MET . 91.6 m-20 -69.92 158.67 35.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.81 . . . . 0.0 109.932 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.592 ' HA ' ' NE ' ' A' ' 74' ' ' ARG . 79.9 p -61.7 -24.64 66.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.59 -42.88 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 110.323 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.928 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -59.92 -49.98 75.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.089 -1.007 . . . . 0.0 109.929 178.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -63.87 -33.44 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.101 -0.999 . . . . 0.0 109.682 176.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.501 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 60.4 t-20 -68.08 -32.57 72.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.962 . . . . 0.0 109.933 175.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.439 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 98.5 m-20 -60.03 -40.01 87.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.877 . . . . 0.0 110.535 -178.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.458 ' HB2' ' H ' ' A' ' 48' ' ' ARG . 27.6 p -98.34 -38.52 9.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.602 -176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.564 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 120.16 40.63 0.58 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 175.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.765 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -116.03 158.44 23.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.944 -1.327 . . . . 0.0 110.726 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.613 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -112.44 166.84 10.94 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 175.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.774 HD11 ' CB ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -51.33 139.96 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.989 -1.069 . . . . 0.0 110.505 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.28 0.61 72.05 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 171.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -58.18 -160.12 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.876 -1.367 . . . . 0.0 110.225 174.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 40.1 pttt -132.62 113.32 12.89 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.549 -0.719 . . . . 0.0 109.813 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.024 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -124.35 159.67 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.201 -0.937 . . . . 0.0 109.898 -179.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.6 ttpt -105.21 127.96 53.18 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.218 -0.927 . . . . 0.0 109.868 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.502 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 63.3 t -109.84 121.29 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 109.714 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' NH2' ' OE2' ' A' ' 43' ' ' GLU . 84.4 mtm180 -110.23 140.03 44.78 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.456 -0.777 . . . . 0.0 109.552 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.59 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -91.22 136.69 32.92 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.069 -1.02 . . . . 0.0 110.001 -177.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.479 HG23 HG12 ' A' ' 41' ' ' VAL . 2.7 m -150.01 -171.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.539 -0.725 . . . . 0.0 110.212 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.515 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . 1.6 ptm85 -126.8 170.07 12.57 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.643 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.47 165.34 11.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.054 -1.029 . . . . 0.0 111.078 -175.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.566 ' CG ' HG12 ' A' ' 162' ' ' VAL . 14.4 pt-20 -149.96 167.72 25.86 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm -89.57 97.78 7.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.542 -1.349 . . . . 0.0 110.336 -177.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.88 161.8 1.47 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.361 -0.837 . . . . 0.0 110.663 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.907 ' HE3' HD22 ' A' ' 156' ' ' LEU . 25.0 pttt -125.44 -24.71 3.87 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 110.493 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.959 ' CB ' HD12 ' A' ' 156' ' ' LEU . 15.7 tttp -150.92 127.81 11.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.843 -1.16 . . . . 0.0 110.394 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.993 HG23 HG22 ' A' ' 155' ' ' THR . 7.4 p -139.94 144.65 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 110.351 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.458 ' OG1' ' CB ' ' A' ' 171' ' ' GLU . 94.2 m -118.52 132.27 56.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 110.253 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.763 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -128.09 160.02 33.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.375 -178.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HB2' ' HG2' ' A' ' 173' ' ' ARG . . . -138.83 93.69 10.55 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.607 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 34.7 Cg_exo -54.53 134.48 62.05 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.98 1.516 . . . . 0.0 110.264 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.009 HG23 ' CB ' ' A' ' 177' ' ' ALA . 75.3 mt -90.0 107.69 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.359 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.96 HD12 ' HG2' ' A' ' 108' ' ' GLN . 15.5 pt -146.55 -158.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.769 0.795 . . . . 0.0 109.731 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 108' ' ' GLN . 75.9 mtp180 -110.19 155.76 21.55 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.498 178.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -59.33 -14.93 13.37 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.929 0.871 . . . . 0.0 109.868 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.519 ' OD1' ' HB3' ' A' ' 105' ' ' ARG . 12.2 p-10 -112.19 40.48 2.19 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.736 -0.602 . . . . 0.0 109.581 176.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.96 ' HG2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -79.02 168.4 19.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.452 -173.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -109.09 -17.57 13.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.136 -0.977 . . . . 0.0 111.023 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.695 ' H ' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -99.17 53.22 0.96 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.875 -1.141 . . . . 0.0 111.229 -174.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.525 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 7.3 ptmt -97.83 119.97 37.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 0.0 110.12 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.831 ' HB2' HD13 ' A' ' 116' ' ' ILE . 17.2 m-85 -100.12 -78.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.335 -0.853 . . . . 0.0 110.463 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.09 -178.08 54.12 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 47.2 87.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.204 -1.174 . . . . 0.0 110.169 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.78 -2.65 88.0 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.831 HD13 ' HB2' ' A' ' 112' ' ' PHE . 9.5 tp -60.17 -37.62 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -1.221 . . . . 0.0 110.314 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.461 ' N ' HG23 ' A' ' 116' ' ' ILE . 96.7 mt-10 -59.92 -42.79 94.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.112 -0.992 . . . . 0.0 109.997 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.84 -37.49 76.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 175.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -59.96 -39.23 84.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.559 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.79 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.5 t -60.07 -47.8 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.674 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.74 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -61.39 -40.03 92.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 177.481 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.05 -46.43 89.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.27 -0.894 . . . . 0.0 109.968 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.61 -41.29 65.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.547 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.6 mm? -94.31 -4.3 48.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.168 -0.957 . . . . 0.0 111.227 -174.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.758 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.5 tt -44.49 167.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.774 -1.203 . . . . 0.0 110.267 -176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 164' ' ' ILE . 52.9 ptt85 33.3 51.21 0.3 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.666 -0.646 . . . . 0.0 111.788 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -137.79 150.22 67.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 120.833 -1.167 . . . . 0.0 111.074 175.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.841 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 18.2 Cg_endo -65.56 130.35 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.042 1.549 . . . . 0.0 110.026 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.577 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 88.1 mmm -125.0 139.17 54.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.515 -1.366 . . . . 0.0 111.052 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.975 HD21 ' HG2' ' A' ' 49' ' ' LYS . 11.6 tp -144.15 113.59 7.02 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.636 -0.665 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 7.3 pm0 -47.47 143.87 3.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.915 -1.116 . . . . 0.0 110.359 -177.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 88.4 mm-40 81.33 -6.09 1.57 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.111 0.482 . . . . 0.0 110.334 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.618 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.1 p30 -69.88 173.78 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.149 -0.969 . . . . 0.0 109.903 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.468 ' HB3' HD13 ' A' ' 149' ' ' LEU . 32.8 m-80 -137.72 146.9 44.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.802 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -140.47 170.04 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.085 -1.009 . . . . 0.0 110.144 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.24 135.82 34.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.346 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.694 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 37.4 t -128.95 -68.54 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 110.815 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.694 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 37.7 Cg_endo -70.49 126.37 12.76 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.112 1.059 . . . . 0.0 110.33 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -98.32 47.19 1.48 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.474 HD11 HD12 ' A' ' 110' ' ' LEU . 1.4 pp -126.3 156.81 39.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -1.084 . . . . 0.0 110.273 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -139.84 -169.43 2.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.14 -0.975 . . . . 0.0 110.596 -179.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.562 ' N ' ' OG1' ' A' ' 141' ' ' THR . 83.4 mt -141.97 -126.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.638 -0.664 . . . . 0.0 109.927 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -53.9 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.72 59.32 4.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.778 ' NE2' HD21 ' A' ' 148' ' ' LEU . 14.0 pt20 -97.61 164.07 12.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.415 -1.05 . . . . 0.0 110.162 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 t -139.48 159.81 41.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.226 -178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 101.99 -88.21 0.68 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.778 HD21 ' NE2' ' A' ' 145' ' ' GLN . 80.6 mt 49.48 45.49 23.95 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.187 -1.184 . . . . 0.0 111.002 176.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.893 ' HG ' HD12 ' A' ' 103' ' ' ILE . 1.9 pp -140.46 169.59 17.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.871 -1.143 . . . . 0.0 109.862 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 29.4 m-85 -92.09 120.31 32.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.079 -1.013 . . . . 0.0 110.236 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -104.87 110.63 23.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.072 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.618 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.5 t -76.37 138.86 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 t -117.38 -28.39 2.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.194 -0.941 . . . . 0.0 111.047 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -148.59 151.51 35.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.767 -1.208 . . . . 0.0 111.173 -177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.993 HG22 HG23 ' A' ' 98' ' ' VAL . 63.8 p -139.75 158.29 44.34 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.959 HD12 ' CB ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -89.1 -34.01 0.4 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.057 -1.027 . . . . 0.0 110.867 -176.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.988 ' CB ' HG11 ' A' ' 162' ' ' VAL . 16.5 Cg_exo -56.99 -161.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 O-C-N 123.269 1.141 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.432 ' HB3' HG22 ' A' ' 160' ' ' VAL . 13.3 t -90.13 179.09 6.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 109.869 176.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.418 ' HE2' ' NZ ' ' A' ' 49' ' ' LYS . 13.9 tttt -61.31 -10.12 6.47 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.863 . . . . 0.0 110.425 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 158' ' ' SER . 13.6 m -84.66 153.13 61.04 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.467 -0.77 . . . . 0.0 110.159 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.529 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -48.87 142.76 18.68 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.248 1.657 . . . . 0.0 110.613 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.988 HG11 ' CB ' ' A' ' 157' ' ' PRO . 13.7 m -130.02 160.0 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 86.1 tt0 -108.71 127.51 54.05 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.022 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.836 HD12 HG21 ' A' ' 168' ' ' THR . 12.9 mm -71.08 153.05 8.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-O 121.434 0.635 . . . . 0.0 110.334 -176.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.546 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.94 166.91 26.15 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.605 ' HB3' HD11 ' A' ' 125' ' ' ILE . 13.6 pt-20 -56.95 -19.81 20.12 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.369 -1.077 . . . . 0.0 110.197 -177.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.16 -14.03 39.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.304 -0.872 . . . . 0.0 110.326 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.836 HG21 HD12 ' A' ' 164' ' ' ILE . 21.0 m -62.04 147.8 46.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 109.856 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 96' ' ' LYS . 52.4 mttm -94.46 157.5 15.98 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.929 -1.107 . . . . 0.0 110.256 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.79 HD12 ' CG1' ' A' ' 120' ' ' VAL . 3.4 mm -118.93 129.91 74.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.363 -0.835 . . . . 0.0 110.691 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.58 ' O ' HD13 ' A' ' 172' ' ' ILE . 20.1 mt-10 -110.96 130.08 55.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -0.868 . . . . 0.0 110.225 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.58 HD13 ' O ' ' A' ' 171' ' ' GLU . 33.5 mm -125.8 125.74 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.884 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.581 ' NE ' ' O ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -89.29 167.26 13.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 0.0 110.713 -177.144 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 99.1 mt-10 -106.07 -9.56 16.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.928 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' A' ' 173' ' ' ARG . 2.5 tp10 -98.53 109.36 52.54 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.382 -0.824 . . . . 0.0 109.901 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.492 ' HB3' HG12 ' A' ' 104' ' ' ILE . 12.8 Cg_exo -71.37 -155.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.14 1.6 . . . . 0.0 110.504 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.009 ' CB ' HG23 ' A' ' 103' ' ' ILE . . . -79.79 53.12 1.57 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.45 0.643 . . . . 0.0 110.046 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 43.0 t -101.8 120.57 40.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 110.037 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 178' ' ' SER . 83.0 tt0 59.97 19.96 9.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.091 -1.005 . . . . 0.0 109.847 -177.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.469 HG13 ' HB2' ' A' ' 182' ' ' GLU . 10.4 p -73.75 155.85 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.533 -0.73 . . . . 0.0 110.29 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 pp -70.02 -5.9 29.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.83 . . . . 0.0 110.66 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.469 ' HB2' HG13 ' A' ' 180' ' ' VAL . 98.9 mt-10 -60.05 -42.83 95.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.09 -1.006 . . . . 0.0 110.397 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -64.02 140.02 58.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.277 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 114.88 -153.35 17.69 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.513 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 95.9 mtp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.07 0.462 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 4' ' ' ASN . 99.9 mt-10 56.31 169.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 110.086 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 3.8 m 57.75 -79.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.466 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 2' ' ' GLU . 39.0 t30 -97.01 120.88 38.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.225 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -135.51 -179.99 5.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.383 -179.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -148.33 -161.04 9.35 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.969 HG21 HD22 ' A' ' 33' ' ' LEU . 47.6 pt -131.01 160.01 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -1.189 . . . . 0.0 109.936 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.1 mt -99.55 114.46 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 110.239 -178.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.2 pt? -137.86 -172.39 3.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.313 -0.867 . . . . 0.0 109.96 178.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 10.8 ptp180 -115.55 139.05 50.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.785 -1.197 . . . . 0.0 110.714 -172.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.95 HG23 HD11 ' A' ' 69' ' ' ILE . 4.6 p -61.17 137.91 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.505 -0.747 . . . . 0.0 110.115 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -120.97 155.6 33.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 110.478 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.541 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -176.31 -91.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 175.032 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.714 ' H ' HD11 ' A' ' 81' ' ' ILE . . . 50.01 -140.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.015 -1.053 . . . . 0.0 109.835 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -79.94 113.97 18.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 110.02 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.1 p -144.04 151.14 39.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 110.166 179.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -108.81 14.36 24.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 109.946 178.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 18' ' ' ASP . 18.2 p30 -130.04 71.43 82.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.469 -0.77 . . . . 0.0 110.206 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -61.79 166.01 12.85 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.046 1.551 . . . . 0.0 110.17 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.54 93.6 0.1 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.0 ptp -86.66 -17.33 34.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -1.145 . . . . 0.0 109.487 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.3 m -102.41 0.02 33.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 109.958 174.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 95.6 mtt180 -122.45 138.55 54.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.456 -0.778 . . . . 0.0 109.945 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 67' ' ' VAL . 92.8 t -116.6 120.03 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 0.0 110.237 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.649 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.9 OUTLIER -92.41 119.97 32.46 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.757 -1.177 . . . . 0.0 109.945 177.814 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.927 HD23 HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -134.41 173.32 11.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.675 -177.06 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.482 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 17.5 p-10 -93.2 179.76 5.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.83 -1.169 . . . . 0.0 110.481 -178.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -59.97 -43.19 95.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.378 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.492 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 63.3 m -65.08 -44.56 88.52 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.545 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.711 ' CB ' HD12 ' A' ' 26' ' ' LEU . 59.4 m -60.0 -40.06 87.93 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.951 -1.093 . . . . 0.0 109.193 176.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 59.3 ttt180 -71.37 -44.4 65.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.876 -0.515 . . . . 0.0 111.734 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -93.34 -6.18 47.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.755 -1.216 . . . . 0.0 111.199 -169.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.032 HD12 ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -59.2 -31.37 68.96 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.584 -178.527 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.032 ' N ' HD12 ' A' ' 33' ' ' LEU . 31.6 mt -116.57 -66.4 1.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.111 -0.993 . . . . 0.0 110.674 175.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 36' ' ' ALA . 17.1 t0 -171.84 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.191 -0.943 . . . . 0.0 110.244 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.72 ' HB2' ' HG3' ' A' ' 89' ' ' LYS . . . -23.92 120.14 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.579 0.704 . . . . 0.0 111.408 -176.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.649 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -105.24 175.25 5.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.938 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.407 HG12 ' NH2' ' A' ' 31' ' ' ARG . 45.5 mm -56.69 127.15 15.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 120.966 -1.084 . . . . 0.0 109.663 178.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 76.06 24.49 68.9 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.39 174.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.81 174.0 8.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.724 -1.456 . . . . 0.0 109.247 171.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 91' ' ' ARG . 92.6 t -102.59 130.01 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.995 -1.066 . . . . 0.0 110.432 -174.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.593 HG11 HG23 ' A' ' 54' ' ' VAL . 2.2 m -115.02 137.31 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -0.864 . . . . 0.0 110.393 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -107.34 141.67 38.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.435 -0.79 . . . . 0.0 109.847 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.6 mp -120.99 148.2 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.024 -1.047 . . . . 0.0 110.182 -176.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 39.3 tt0 -152.37 92.32 1.68 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.97 -1.081 . . . . 0.0 111.288 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.726 ' HD2' HG12 ' A' ' 85' ' ' VAL . 59.6 tttp -97.83 -77.05 0.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.028 -1.045 . . . . 0.0 110.123 172.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.609 HG21 ' CA ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -96.0 -29.97 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.638 0.732 . . . . 0.0 109.688 176.76 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.447 ' H ' ' HB2' ' A' ' 77' ' ' CYS . 71.6 mtt85 -141.34 -172.7 3.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.608 -0.683 . . . . 0.0 109.463 176.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.712 ' C ' HD21 ' A' ' 130' ' ' LEU . 18.3 mttt -88.78 141.06 28.82 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.813 -177.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.568 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -140.37 156.47 46.4 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.388 0.614 . . . . 0.0 110.111 -179.103 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.596 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -126.07 160.15 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 110.142 -179.657 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.451 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -176.88 -177.45 45.84 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 174.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.413 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 96.0 mtt-85 -117.05 -179.01 3.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -1.071 . . . . 0.0 109.761 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.649 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -109.31 135.9 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.062 -1.023 . . . . 0.0 110.681 -175.003 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.543 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 1.3 m-85 -127.16 168.98 13.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.569 -0.707 . . . . 0.0 110.057 176.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -93.59 124.15 37.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 110.152 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.746 ' HB1' ' OD1' ' A' ' 63' ' ' ASN . . . -64.4 139.37 58.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.884 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.673 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 9.8 mtt-85 -57.31 -49.63 92.79 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.953 -1.092 . . . . 0.0 108.993 174.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.673 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 57.4 Cg_endo -93.08 98.51 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 109.034 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.54 37.07 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 O-C-N 121.593 -0.692 . . . . 0.0 110.482 -177.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 59' ' ' PRO . 68.3 m-20 -144.16 -33.67 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 110.461 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' O ' HG12 ' A' ' 66' ' ' ILE . 48.7 mt-10 -85.62 -28.92 24.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.304 178.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.746 ' OD1' ' HB1' ' A' ' 57' ' ' ALA . 14.7 m120 -81.31 38.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.649 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 31.9 pttt -98.9 12.64 35.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.059 -1.026 . . . . 0.0 109.759 176.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -179.76 24.88 0.04 OUTLIER Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.478 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 45.7 pt -141.07 142.87 29.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.336 -1.097 . . . . 0.0 109.28 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 24' ' ' VAL . 2.9 p -119.97 126.05 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.024 -1.048 . . . . 0.0 109.894 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.499 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 31.9 mmt180 -89.95 102.33 15.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.085 -1.009 . . . . 0.0 110.153 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.95 HD11 HG23 ' A' ' 11' ' ' VAL . 3.3 pt -125.26 169.93 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.408 -0.808 . . . . 0.0 110.68 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.09 161.68 26.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.41 -0.806 . . . . 0.0 109.992 177.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.629 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 43.8 m -63.16 -16.8 61.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -0.907 . . . . 0.0 110.324 -178.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 63.8 t -71.16 -49.16 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.036 . . . . 0.0 110.322 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.721 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -59.97 -49.5 77.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.907 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.629 ' HG2' ' HA ' ' A' ' 71' ' ' SER . 3.7 ppt_? -64.08 -28.73 69.98 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.085 -1.009 . . . . 0.0 109.653 175.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.472 ' N ' ' HG3' ' A' ' 74' ' ' ARG . 19.6 t-20 -73.08 -30.28 63.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.959 -1.088 . . . . 0.0 110.388 175.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 73' ' ' MET . 13.9 m120 -60.04 -40.02 87.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 110.87 -173.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.447 ' HB2' ' H ' ' A' ' 48' ' ' ARG . 25.9 p -99.3 -37.23 9.34 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.097 -1.002 . . . . 0.0 110.605 -177.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.609 ' CA ' HG21 ' A' ' 47' ' ' VAL . . . 126.87 33.53 0.64 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.705 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . . . -99.36 140.04 34.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -1.078 . . . . 0.0 110.179 -177.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.607 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -103.26 162.57 12.87 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.14 -0.975 . . . . 0.0 108.981 174.156 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.714 HD11 ' H ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -52.84 135.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.013 -1.054 . . . . 0.0 110.649 -177.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.93 -0.25 66.98 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 172.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 80' ' ' SER . 0.2 OUTLIER -57.79 -160.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.982 -1.305 . . . . 0.0 110.427 176.683 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -134.7 114.91 13.17 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.0 177.17 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.726 HG12 ' HD2' ' A' ' 46' ' ' LYS . 1.7 m -124.67 160.07 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.828 178.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 79.6 tttt -105.12 124.97 50.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.916 176.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.635 ' CG2' HD21 ' A' ' 9' ' ' LEU . 65.8 t -109.93 123.72 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.148 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.545 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 82.2 mtt85 -103.46 151.62 22.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.74 178.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.72 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 8.0 tmtt? -98.11 133.16 42.94 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 110.21 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.547 ' N ' ' HD3' ' A' ' 89' ' ' LYS . 2.3 m -150.3 -167.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.45 0.643 . . . . 0.0 109.975 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.552 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 27.5 mtp180 -129.29 178.11 6.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.408 -0.807 . . . . 0.0 110.27 176.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.534 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.24 161.15 14.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -0.914 . . . . 0.0 111.233 -175.888 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.546 ' CG ' HG12 ' A' ' 162' ' ' VAL . 18.2 pt-20 -148.22 164.78 32.94 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 94' ' ' ILE . 5.0 mp -88.86 97.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.47 -1.394 . . . . 0.0 110.22 -175.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.93 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.53 139.14 38.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 110.141 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' CD ' ' HG ' ' A' ' 156' ' ' LEU . 15.1 ptpt -100.09 -27.69 13.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.991 -179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.815 ' HB3' HD23 ' A' ' 156' ' ' LEU . 79.2 tttt -149.97 121.52 7.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.954 -1.091 . . . . 0.0 110.449 -176.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.097 HG23 HG22 ' A' ' 155' ' ' THR . 7.5 p -135.69 143.23 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 110.383 -179.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 90.4 m -117.81 133.54 55.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 110.066 -177.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -132.35 164.9 25.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 110.223 -178.061 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 173' ' ' ARG . . . -138.91 83.57 18.47 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.221 -0.924 . . . . 0.0 110.804 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 24.2 Cg_exo -58.74 125.5 18.48 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.94 1.495 . . . . 0.0 110.173 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.759 HG23 ' HB2' ' A' ' 177' ' ' ALA . 35.2 mm -90.28 108.17 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.227 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.628 ' CD1' HD23 ' A' ' 110' ' ' LEU . 1.1 pp -150.7 -171.73 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.159 -0.963 . . . . 0.0 110.798 179.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.732 ' HD3' HD13 ' A' ' 142' ' ' LEU . 83.8 mtp180 -91.19 166.23 13.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.466 -0.771 . . . . 0.0 110.04 176.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.671 ' HA ' HD21 ' A' ' 110' ' ' LEU . 8.5 ptpt -59.26 -15.42 15.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.052 -1.03 . . . . 0.0 110.891 -174.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 34.3 p-10 -122.76 25.81 8.51 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.561 -0.712 . . . . 0.0 110.659 -177.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.576 ' NE2' HD11 ' A' ' 142' ' ' LEU . 2.6 mm-40 -98.0 -81.27 0.44 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.027 -1.045 . . . . 0.0 111.198 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.513 ' HB3' HG12 ' A' ' 104' ' ' ILE . 37.1 ttm-85 -106.62 -14.56 15.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.126 -0.984 . . . . 0.0 111.47 -172.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.797 ' O ' HD12 ' A' ' 110' ' ' LEU . 1.2 pp -98.31 56.68 1.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.951 -1.093 . . . . 0.0 110.154 -176.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.52 ' HD3' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -140.95 68.22 1.35 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.784 . . . . 0.0 110.028 177.112 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.628 ' HB2' HD12 ' A' ' 116' ' ' ILE . 12.0 m-85 -138.18 -39.48 0.54 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 110.472 -177.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . 78.95 -159.83 46.01 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 113' ' ' GLY . 19.3 pt-20 -31.22 141.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.931 -0.747 . . . . 0.0 111.086 -177.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.14 -10.0 72.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 175.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.628 HD12 ' HB2' ' A' ' 112' ' ' PHE . 16.2 tt -69.06 -40.53 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -1.173 . . . . 0.0 110.387 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.6 mt-10 -69.95 -39.95 75.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.093 -1.004 . . . . 0.0 110.049 175.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.03 -30.69 69.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.506 176.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' ' HG3' ' A' ' 122' ' ' ARG . 64.8 t80 -59.86 -37.78 80.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.406 -0.809 . . . . 0.0 109.53 176.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.764 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.4 t -59.88 -49.98 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.027 -1.046 . . . . 0.0 109.878 176.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.649 ' HG3' HD11 ' A' ' 170' ' ' ILE . 4.9 mt-30 -59.96 -44.11 94.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 110.312 177.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.554 ' HG3' ' N ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -63.58 -34.33 77.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 110.024 -175.825 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 122' ' ' ARG . . . -84.22 -41.81 16.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.676 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 4.4 mm? -96.02 2.29 53.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 111.394 -174.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.628 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.4 tt -47.95 165.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.797 -1.189 . . . . 0.0 110.209 -175.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HG2' HG23 ' A' ' 125' ' ' ILE . 9.7 ptp85 34.97 49.57 0.41 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.499 -0.75 . . . . 0.0 111.464 -178.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -132.5 136.47 27.98 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.782 -1.199 . . . . 0.0 110.907 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.818 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -60.07 129.78 31.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 124.041 1.548 . . . . 0.0 109.892 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.678 ' SD ' HD11 ' A' ' 164' ' ' ILE . 16.4 mtt -125.22 146.2 49.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.428 -1.42 . . . . 0.0 110.875 -178.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.712 HD21 ' C ' ' A' ' 49' ' ' LYS . 14.4 tp -144.18 105.59 4.26 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.616 -0.677 . . . . 0.0 109.6 -176.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 3.7 pm0 -43.11 143.86 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.956 -1.09 . . . . 0.0 110.345 -175.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER 77.15 -0.72 2.88 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.163 0.506 . . . . 0.0 110.392 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.606 ' OD1' HG21 ' A' ' 152' ' ' VAL . 3.9 p-10 -69.93 -179.46 1.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 109.934 174.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 151' ' ' LYS . 18.4 m-80 -145.73 141.89 28.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.488 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.01 164.73 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.94 -1.1 . . . . 0.0 110.31 -179.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.2 t -140.72 149.96 42.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.475 -0.766 . . . . 0.0 110.359 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.691 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 40.1 t -130.19 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 111.154 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.691 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 41.3 Cg_endo -71.02 138.87 34.72 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.115 1.06 . . . . 0.0 110.672 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -111.67 52.23 0.65 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 141' ' ' THR . 0.7 OUTLIER -122.65 178.82 4.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.148 -1.207 . . . . 0.0 110.111 179.063 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.12 -174.24 3.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 111.089 -179.157 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.975 HD12 ' NE2' ' A' ' 145' ' ' GLN . 88.1 mt -144.9 -153.54 0.48 Allowed 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.263 0.554 . . . . 0.0 109.889 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.42 81.67 6.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.175 -0.953 . . . . 0.0 110.31 179.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 54.99 60.22 9.12 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.269 -176.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.975 ' NE2' HD12 ' A' ' 142' ' ' LEU . 6.5 pt20 -96.45 168.02 10.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.722 -1.457 . . . . 0.0 110.218 178.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.0 t -140.03 152.37 46.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.873 . . . . 0.0 110.322 177.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.24 -86.99 0.8 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 177.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.88 HD11 ' CD ' ' A' ' 145' ' ' GLN . 11.2 mt 49.5 30.64 3.54 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.23 -1.159 . . . . 0.0 111.782 176.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.612 HD12 ' C ' ' A' ' 150' ' ' PHE . 3.1 pp -141.51 169.92 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.601 -1.312 . . . . 0.0 110.107 177.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.612 ' C ' HD12 ' A' ' 149' ' ' LEU . 17.6 m-85 -89.53 137.8 32.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.244 -0.91 . . . . 0.0 109.94 176.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.422 ' HD2' ' OD1' ' A' ' 134' ' ' ASN . 33.4 tptt -121.12 102.22 8.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 109.874 178.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.606 HG21 ' OD1' ' A' ' 133' ' ' ASP . 2.2 t -77.06 140.73 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -0.88 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.6 t -131.23 -26.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.092 -1.005 . . . . 0.0 111.22 -176.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.54 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 6.4 tptm -140.04 134.54 31.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.843 -1.161 . . . . 0.0 110.591 -177.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.097 HG22 HG23 ' A' ' 98' ' ' VAL . 48.8 p -134.02 165.54 24.79 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.54 -0.725 . . . . 0.0 109.396 176.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.45 -39.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.646 -176.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.972 ' CB ' HG11 ' A' ' 162' ' ' VAL . 17.2 Cg_exo -59.43 -170.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.639 1.336 . . . . 0.0 109.984 179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.46 -158.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.27 -0.894 . . . . 0.0 109.998 177.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -70.19 -7.83 45.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.381 -0.825 . . . . 0.0 110.669 -177.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 160' ' ' VAL . 34.3 m -88.1 149.5 45.4 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 110.931 -175.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.596 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -50.02 140.75 31.39 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.367 1.719 . . . . 0.0 110.811 179.761 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.972 HG11 ' CB ' ' A' ' 157' ' ' PRO . 4.6 m -130.08 157.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.022 -1.049 . . . . 0.0 109.96 172.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -103.61 130.0 50.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.314 -0.866 . . . . 0.0 110.37 177.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.892 ' CD1' HG21 ' A' ' 168' ' ' THR . 19.1 mm -71.34 150.23 9.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 178.135 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -140.92 170.13 24.65 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 175.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -53.77 -24.76 16.15 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.354 -1.086 . . . . 0.0 110.169 -176.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.634 ' OE2' HG21 ' A' ' 94' ' ' ILE . 18.0 pt-20 -89.67 -18.4 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.899 . . . . 0.0 111.025 -175.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.892 HG21 ' CD1' ' A' ' 164' ' ' ILE . 95.7 m -56.94 147.23 24.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.178 -0.951 . . . . 0.0 110.078 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' LYS . 74.1 mmtt -95.77 161.24 14.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.839 -1.163 . . . . 0.0 110.36 -178.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.764 HD12 ' CG1' ' A' ' 120' ' ' VAL . 24.4 mm -119.97 130.63 74.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 110.696 -178.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.476 ' OE1' ' HE2' ' A' ' 97' ' ' LYS . 21.7 mt-10 -113.97 126.2 54.87 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.077 -1.014 . . . . 0.0 110.368 171.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 120' ' ' VAL . 32.1 mm -123.17 132.19 71.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.019 -177.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.542 ' HG2' ' CB ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -88.43 149.17 23.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.995 . . . . 0.0 110.387 -176.631 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 97.9 mt-10 -93.52 -1.04 56.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.269 -0.895 . . . . 0.0 110.785 -176.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.533 ' O ' ' CD ' ' A' ' 173' ' ' ARG . 85.9 tt0 -96.93 108.38 43.12 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 178.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 11.1 Cg_exo -73.14 -155.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.021 1.538 . . . . 0.0 110.79 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.759 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -82.7 56.27 3.31 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.72 -0.612 . . . . 0.0 109.93 176.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 48.0 t -100.11 122.97 43.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.351 -0.843 . . . . 0.0 109.93 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 178' ' ' SER . 95.0 mt-10 60.08 19.98 9.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.433 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 178' ' ' SER . 63.7 t -108.22 120.53 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 0.0 110.142 177.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.737 HD11 ' HA3' ' A' ' 185' ' ' GLY . 0.8 OUTLIER -126.14 19.92 7.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.493 -178.53 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 181' ' ' LEU . 47.1 tt0 39.99 -130.02 0.34 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.317 -0.864 . . . . 0.0 110.234 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.95 150.07 47.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.992 -1.068 . . . . 0.0 110.509 -178.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 110.65 -7.16 29.86 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.737 ' HA3' HD11 ' A' ' 181' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.314 0.578 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.428 ' O ' ' ND2' ' A' ' 5' ' ' ASN . 14.8 pt-20 -67.89 -19.47 65.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 110.301 -179.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -59.96 -40.01 87.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 110.331 -179.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.479 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 23.4 t-20 -95.37 100.67 12.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.146 -0.971 . . . . 0.0 110.367 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 4' ' ' ASN . 98.6 m-20 -141.52 165.07 28.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.966 177.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -146.33 -166.96 12.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.024 HG21 HD22 ' A' ' 33' ' ' LEU . 9.1 pt -136.28 159.96 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.439 -1.036 . . . . 0.0 109.418 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.61 ' C ' HD23 ' A' ' 9' ' ' LEU . 96.7 mt -101.47 121.06 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.003 -1.061 . . . . 0.0 110.216 -179.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.809 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -136.96 -171.25 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 110.557 178.576 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.487 ' HB3' HG22 ' A' ' 66' ' ' ILE . 53.0 ttp180 -107.51 132.85 52.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 111.099 -172.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.937 HG23 HD11 ' A' ' 69' ' ' ILE . 13.2 p -61.67 138.36 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.469 -0.77 . . . . 0.0 110.314 176.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -123.05 145.01 48.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -0.907 . . . . 0.0 110.597 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.961 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -178.56 96.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.989 174.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.61 77.31 1.33 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.334 -0.854 . . . . 0.0 110.364 -178.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.6 167.23 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.155 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.3 m -59.99 -40.09 88.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.905 178.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.1 p -131.24 138.73 49.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 110.017 175.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 1.3 p30 -131.63 73.19 79.57 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.423 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -65.15 168.33 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.968 1.51 . . . . 0.0 110.192 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.78 75.07 1.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.419 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . 20.7 ptt? -86.44 -9.91 55.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.177 -1.19 . . . . 0.0 109.895 177.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 75.4 m -134.35 13.04 3.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.83 176.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.47 ' HD3' ' CZ ' ' A' ' 55' ' ' TYR . 97.3 mtt180 -114.38 137.28 52.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.374 -0.829 . . . . 0.0 109.994 -177.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.083 HG13 HG23 ' A' ' 67' ' ' VAL . 87.9 t -119.44 120.66 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 -179.018 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 25' ' ' ARG . 4.9 ptt180 -92.36 119.54 32.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.7 176.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -134.73 -172.31 3.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 0.0 110.179 179.836 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.501 ' OD2' ' HB3' ' A' ' 64' ' ' LYS . 13.9 p-10 -106.9 -179.93 4.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.026 -1.046 . . . . 0.0 110.539 -178.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -60.01 -44.46 94.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.579 -177.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 t -59.9 -46.7 88.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.535 -0.728 . . . . 0.0 110.211 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.59 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 59.9 m -59.97 -36.5 77.26 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.062 -1.024 . . . . 0.0 109.213 175.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.675 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 35.0 ttp180 -70.06 -44.54 68.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 111.186 178.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -90.26 -10.36 44.52 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.838 -1.164 . . . . 0.0 111.687 -171.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.024 HD22 HG21 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -50.17 -27.06 5.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.711 -1.243 . . . . 0.0 109.135 -178.566 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.003 ' N ' HD12 ' A' ' 33' ' ' LEU . 59.0 mt -130.11 -69.24 0.67 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.511 -0.743 . . . . 0.0 110.583 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -172.63 11.19 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.948 -1.095 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . . . -52.02 133.6 32.78 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.921 -1.112 . . . . 0.0 110.199 -176.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.679 ' O ' HG11 ' A' ' 54' ' ' VAL . 1.1 pt-20 -118.32 174.32 6.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 38' ' ' ILE . 28.2 mm -58.95 119.65 3.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 120.814 -1.179 . . . . 0.0 109.722 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 73.4 35.54 56.12 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.629 174.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.572 ' HB3' ' CE ' ' A' ' 89' ' ' LYS . 33.6 m-20 -89.1 178.93 6.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.633 -1.51 . . . . 0.0 109.718 172.348 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.737 HG21 HG23 ' A' ' 92' ' ' THR . 76.7 t -99.39 123.54 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 110.585 -176.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' HD2' ' A' ' 89' ' ' LYS . 3.8 m -122.08 147.28 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.618 -0.676 . . . . 0.0 110.518 -177.029 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' OE2' ' HD2' ' A' ' 49' ' ' LYS . 85.3 tt0 -111.19 137.09 49.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.0 109.746 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.8 mp -117.63 140.87 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.0 -1.063 . . . . 0.0 110.55 -176.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 86.3 tt0 -151.59 96.67 2.29 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.611 -1.306 . . . . 0.0 112.106 -174.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.105 ' HE3' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -98.43 -80.24 0.46 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.52 -1.362 . . . . 0.0 110.443 168.014 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -83.63 -36.67 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.701 -0.624 . . . . 0.0 109.717 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.015 ' CZ ' HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -135.33 -155.5 0.65 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 109.388 172.067 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 48' ' ' ARG . 3.9 mtmm -114.85 133.81 55.65 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.072 0.939 . . . . 0.0 112.271 -177.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 1.015 HG23 ' CZ ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -119.5 179.88 4.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.311 177.5 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.576 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -136.09 160.42 38.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.871 170.646 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.66 -168.96 39.32 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 176.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.35 -168.25 1.54 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.419 -1.048 . . . . 0.0 109.752 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -115.72 130.0 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 -178.534 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.47 ' CZ ' ' HD3' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -116.95 164.92 13.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.542 -0.724 . . . . 0.0 110.427 178.592 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.64 119.74 30.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.437 -0.79 . . . . 0.0 110.132 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -64.37 140.08 58.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.838 179.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -56.13 -50.64 86.28 Favored Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 118.876 -1.129 . . . . 0.0 108.919 175.294 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 50.9 Cg_endo -93.45 97.43 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.753 1.396 . . . . 0.0 108.946 178.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.21 38.73 0.14 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 110.711 -174.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 62' ' ' GLU . 30.6 p-10 -142.32 -37.89 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.124 -0.985 . . . . 0.0 110.833 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.554 ' HG3' HD11 ' A' ' 66' ' ' ILE . 19.5 pt-20 -86.75 -18.9 30.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.003 -1.06 . . . . 0.0 109.676 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.503 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 9.8 m-80 -81.72 35.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.459 -0.775 . . . . 0.0 110.78 177.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.501 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 64.5 pttt -98.86 16.62 21.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.049 . . . . 0.0 109.614 176.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 178.21 23.26 0.03 OUTLIER Glycine 0 N--CA 1.48 1.599 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.554 HD11 ' HG3' ' A' ' 62' ' ' GLU . 45.7 pt -140.39 156.85 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.149 174.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.083 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -136.36 131.05 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 54.1 ttp85 -91.05 118.55 30.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.0 -1.063 . . . . 0.0 110.009 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.937 HD11 HG23 ' A' ' 11' ' ' VAL . 3.2 pt -130.17 167.71 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 110.717 178.075 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 34.9 p-10 -80.02 170.71 16.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 110.1 178.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.3 m -59.98 -31.88 70.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 110.417 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.5 HG12 HD21 ' A' ' 76' ' ' ASN . 54.5 t -68.05 -46.5 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.703 -175.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.601 ' CE ' HD13 ' A' ' 44' ' ' ILE . 4.7 ttt -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.513 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.754 ' NH1' HD13 ' A' ' 81' ' ' ILE . 58.0 ttt180 -60.06 -42.89 95.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 110.12 172.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -71.75 -25.09 61.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.137 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.5 HD21 HG12 ' A' ' 72' ' ' VAL . 94.3 m-20 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 110.569 -177.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.709 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 16.7 p -97.88 -37.93 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.791 -1.193 . . . . 0.0 110.92 -175.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' N ' ' SG ' ' A' ' 77' ' ' CYS . . . 112.58 31.48 2.55 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.706 ' CB ' ' HD2' ' A' ' 46' ' ' LYS . . . -115.07 178.11 4.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.289 . . . . 0.0 111.763 -170.197 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.587 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -126.79 170.02 12.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.071 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.961 HD11 ' HB3' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -59.47 150.67 5.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.77 -1.206 . . . . 0.0 110.198 178.789 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' A' ' 10' ' ' ARG . . . 75.56 -3.52 48.33 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 174.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.521 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 2.0 m-20 -58.58 -162.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.033 -1.275 . . . . 0.0 110.378 176.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 60.1 pttt -134.8 116.96 15.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.454 -0.779 . . . . 0.0 109.82 177.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.105 HG12 ' HE3' ' A' ' 46' ' ' LYS . 1.2 m -117.34 143.39 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 109.532 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 78.6 tttt -93.59 119.04 32.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.536 175.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.631 HG21 HD11 ' A' ' 9' ' ' LEU . 85.8 t -99.38 123.3 52.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.304 -0.873 . . . . 0.0 109.678 -178.144 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.583 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 99.6 mtt180 -110.0 146.16 35.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.659 179.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.673 ' HD3' ' HB2' ' A' ' 36' ' ' ALA . 27.1 tptt -96.65 134.8 39.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.056 -1.028 . . . . 0.0 110.152 -177.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.573 HG23 HG12 ' A' ' 41' ' ' VAL . 2.7 m -147.61 -170.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 110.125 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 14.2 ptm180 -127.24 171.21 11.66 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 177.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.737 HG23 HG21 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -97.86 162.92 13.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.966 -1.084 . . . . 0.0 111.019 -176.153 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.77 ' CG ' HG12 ' A' ' 162' ' ' VAL . 12.4 pt-20 -150.72 161.88 41.79 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 94' ' ' ILE . 4.3 mp -89.16 97.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.6 -1.312 . . . . 0.0 110.261 -176.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.742 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -54.92 165.0 0.7 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.372 178.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 169' ' ' LYS . 2.1 pttt -134.9 -19.25 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.364 -0.835 . . . . 0.0 110.632 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.832 ' HB3' HD23 ' A' ' 156' ' ' LEU . 77.4 tttt -150.74 119.99 6.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.895 -1.128 . . . . 0.0 110.558 176.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.103 HG23 HG22 ' A' ' 155' ' ' THR . 8.8 p -138.76 142.65 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.958 -1.089 . . . . 0.0 110.669 178.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.489 ' C ' HD23 ' A' ' 100' ' ' LEU . 96.3 m -117.17 142.65 46.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.351 -0.843 . . . . 0.0 110.116 -179.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.72 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -139.8 172.64 12.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.337 -0.852 . . . . 0.0 110.334 -178.54 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' HG2' ' A' ' 173' ' ' ARG . . . -143.99 94.04 5.95 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 0.0 111.021 -175.127 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 14.7 Cg_exo -64.31 126.84 17.79 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.001 1.527 . . . . 0.0 110.056 179.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.641 ' CG2' ' HB2' ' A' ' 177' ' ' ALA . 77.5 mt -93.11 119.93 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.17 -0.956 . . . . 0.0 110.52 -177.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.143 HD12 ' HG2' ' A' ' 108' ' ' GLN . 16.9 pt -149.31 -157.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.962 0.887 . . . . 0.0 110.629 178.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.55 ' O ' ' HG3' ' A' ' 108' ' ' GLN . 23.5 mmm180 -110.08 153.39 24.72 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.341 0.591 . . . . 0.0 110.399 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -59.8 -14.24 13.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.268 -0.895 . . . . 0.0 109.992 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 11.9 p-10 -122.62 42.3 3.21 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.827 -0.546 . . . . 0.0 109.808 179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 1.143 ' HG2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -81.22 176.61 9.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.126 -0.984 . . . . 0.0 110.481 -174.558 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.676 ' HB3' HD21 ' A' ' 142' ' ' LEU . 34.4 ttm180 -96.7 -16.45 20.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 111.096 -176.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 110' ' ' LEU . 1.1 pp -99.52 70.5 1.69 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.513 -176.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.524 ' HB3' ' NE2' ' A' ' 108' ' ' GLN . 1.7 ptmt -119.96 125.91 49.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 0.0 110.032 175.43 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -144.19 -62.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 110.519 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.49 -169.22 54.28 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -177.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 45.46 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.26 -1.141 . . . . 0.0 110.085 176.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.1 -13.05 60.52 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 175.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 117' ' ' GLU . 12.8 tt -59.99 -39.42 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.118 -1.225 . . . . 0.0 110.078 176.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.529 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.9 mt-10 -59.96 -41.31 91.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -0.968 . . . . 0.0 109.782 178.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.02 -33.33 71.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.741 175.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -60.0 -40.05 87.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.688 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.634 HG12 ' CD1' ' A' ' 170' ' ' ILE . 55.9 t -60.04 -45.65 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.963 175.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 168' ' ' THR . 2.7 mt-30 -60.03 -44.79 94.4 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.363 -0.836 . . . . 0.0 109.81 178.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -62.63 -42.48 99.62 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.492 -0.755 . . . . 0.0 110.144 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.412 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -73.28 -41.79 63.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 110.506 179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.556 ' N ' HD22 ' A' ' 124' ' ' LEU . 4.4 mm? -95.45 0.04 52.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.192 -0.943 . . . . 0.0 110.983 -176.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.9 tt -44.82 163.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.925 -1.109 . . . . 0.0 110.095 -177.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 32.6 ptt-85 33.78 48.33 0.21 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.54 -0.725 . . . . 0.0 111.281 -178.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.495 ' HG2' ' HD2' ' A' ' 128' ' ' PRO . 0.2 OUTLIER -134.04 137.76 29.05 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.854 -1.154 . . . . 0.0 111.195 179.296 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.852 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 32.5 Cg_exo -54.87 127.48 26.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.003 1.528 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.581 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 95.9 mmm -126.21 140.83 52.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.495 -1.378 . . . . 0.0 110.79 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 7.8 tp -139.69 112.02 7.67 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 -177.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 8.4 pt-20 -48.6 145.33 3.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.695 -1.253 . . . . 0.0 110.144 -177.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.574 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 74.58 -1.71 3.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.647 -0.658 . . . . 0.0 110.815 -178.744 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.612 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.9 p30 -68.81 -170.4 0.22 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.986 -1.071 . . . . 0.0 110.206 175.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -146.92 157.12 43.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.57 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.93 169.77 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.084 -1.01 . . . . 0.0 110.016 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 47.5 t -118.17 152.14 36.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.48 -0.763 . . . . 0.0 110.645 -176.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.674 HG13 ' HD2' ' A' ' 138' ' ' PRO . 23.9 t -99.88 148.26 34.56 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.424 -0.797 . . . . 0.0 109.894 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.674 ' HD2' HG13 ' A' ' 137' ' ' VAL . 3.3 Cg_endo -49.89 -175.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.009 1.531 . . . . 0.0 110.517 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -72.05 58.82 1.43 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -177.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 141' ' ' THR . 0.2 OUTLIER -122.32 139.76 53.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -1.185 . . . . 0.0 110.104 178.325 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.593 ' N ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -150.6 -168.89 3.23 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.286 -0.884 . . . . 0.0 110.629 -179.055 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.867 HD12 ' NE2' ' A' ' 145' ' ' GLN . 86.4 mt -140.69 -154.77 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.652 -0.655 . . . . 0.0 110.306 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.7 77.99 5.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 110.446 -177.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.89 62.05 6.75 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.17 -176.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.867 ' NE2' HD12 ' A' ' 142' ' ' LEU . 7.9 pt20 -94.81 -179.37 4.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.828 -1.395 . . . . 0.0 109.949 178.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -138.78 152.13 47.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.408 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.606 ' O ' HD23 ' A' ' 149' ' ' LEU . . . 93.61 -88.79 1.25 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.2 OUTLIER 41.57 41.89 1.8 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.524 -0.986 . . . . 0.0 111.265 177.23 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 103' ' ' ILE . 1.3 pp -140.75 164.82 29.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.877 -1.14 . . . . 0.0 109.946 176.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 14.1 m-85 -100.54 132.32 45.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.112 -0.993 . . . . 0.0 110.089 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.446 ' HD3' HG23 ' A' ' 153' ' ' VAL . 2.9 tmtm? -118.67 108.32 14.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 110.086 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.612 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.2 t -77.45 138.6 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.893 . . . . 0.0 109.868 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.446 HG23 ' HD3' ' A' ' 151' ' ' LYS . 32.9 t -117.18 -32.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 110.915 -177.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 131' ' ' GLU . 60.9 tttm -148.38 149.29 31.5 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.363 -178.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.103 HG22 HG23 ' A' ' 98' ' ' VAL . 82.2 p -133.2 170.46 15.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.832 HD23 ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -88.47 -37.64 0.45 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.031 . . . . 0.0 110.907 -177.746 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.916 ' CG ' HG11 ' A' ' 162' ' ' VAL . 23.8 Cg_exo -55.61 -171.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.415 1.218 . . . . 0.0 110.284 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 -158.35 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.395 -0.816 . . . . 0.0 110.077 176.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -85.4 42.58 0.96 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.221 -0.924 . . . . 0.0 110.269 -177.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 162' ' ' VAL . 33.3 m -140.03 158.73 66.6 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.17 -0.957 . . . . 0.0 110.562 -177.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.576 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.48 136.58 40.54 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.267 1.667 . . . . 0.0 110.957 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.916 HG11 ' CG ' ' A' ' 157' ' ' PRO . 9.2 m -132.07 159.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.167 -0.958 . . . . 0.0 109.835 173.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.4 tt0 -105.54 127.52 53.07 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.176 -0.953 . . . . 0.0 110.281 175.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.79 ' CD1' HG21 ' A' ' 168' ' ' THR . 9.0 mm -71.21 157.39 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.653 -0.655 . . . . 0.0 110.376 -177.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.34 167.03 25.36 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.545 ' HB3' HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.31 -22.29 61.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.41 -1.053 . . . . 0.0 110.48 -177.161 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -88.72 -14.18 37.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.273 -178.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.79 HG21 ' CD1' ' A' ' 164' ' ' ILE . 10.0 m -58.16 155.39 11.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.489 -0.757 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 96' ' ' LYS . 21.8 mttt -109.22 148.56 30.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 178.5 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.701 HG23 HD21 ' A' ' 100' ' ' LEU . 2.2 mt -130.23 160.0 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 111.254 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.45 ' HB3' HG23 ' A' ' 99' ' ' THR . 10.2 mt-10 -133.5 132.16 40.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.671 -0.643 . . . . 0.0 110.02 175.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.483 HD13 ' HG ' ' A' ' 100' ' ' LEU . 48.5 mm -120.01 122.97 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.389 -0.819 . . . . 0.0 109.956 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 101' ' ' ALA . 8.8 ptp180 -88.5 154.38 20.4 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.006 -1.059 . . . . 0.0 110.469 -179.084 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 174' ' ' GLU . 86.5 tt0 -99.78 9.94 42.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.291 -0.88 . . . . 0.0 110.332 -175.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 10.6 tt0 -91.27 109.96 39.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 109.816 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.7 Cg_exo -72.24 -156.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.146 1.603 . . . . 0.0 110.649 -179.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.641 ' HB2' ' CG2' ' A' ' 103' ' ' ILE . . . -77.23 53.27 0.99 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.675 -0.64 . . . . 0.0 110.054 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 18.7 m -107.19 120.04 41.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 109.962 177.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 81.9 tt0 59.91 19.95 8.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.465 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 182' ' ' GLU . 25.2 t -62.67 135.62 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.176 -0.953 . . . . 0.0 109.987 178.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 pp -69.94 -19.94 63.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 0.0 110.266 -177.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 180' ' ' VAL . 46.0 mt-10 -88.17 123.6 32.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.234 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -60.06 -39.92 87.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 110.287 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 152.54 -178.57 29.63 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 CA-C-O 118.013 -1.437 . . . . 0.0 109.529 179.749 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.128 0.489 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -40.17 88.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.299 -178.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m -61.55 141.43 57.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.385 -0.822 . . . . 0.0 110.381 179.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -89.87 116.79 28.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.218 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -152.85 168.16 26.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 110.005 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -149.1 -160.04 8.91 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.924 HD13 ' CD2' ' A' ' 33' ' ' LEU . 14.7 pt -136.91 168.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -1.137 . . . . 0.0 109.51 178.403 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.757 ' C ' HD23 ' A' ' 9' ' ' LEU . 93.2 mt -104.29 125.72 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.649 -177.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.844 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -147.44 178.61 8.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.645 -0.659 . . . . 0.0 109.694 178.279 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.795 ' HG2' HG22 ' A' ' 66' ' ' ILE . 11.7 ptp180 -104.22 137.83 41.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 110.768 -173.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.955 HG23 HD11 ' A' ' 69' ' ' ILE . 8.4 p -61.98 130.63 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 110.547 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -111.38 162.85 14.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.51 177.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.565 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 81.5 tt0 -178.93 -115.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.405 -0.809 . . . . 0.0 110.121 175.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 13' ' ' GLU . . . 59.97 46.26 11.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.885 -1.134 . . . . 0.0 110.202 -178.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -129.12 165.51 21.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.0 110.394 -179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 17' ' ' THR . 13.5 m -71.62 159.94 33.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 -178.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.463 ' C ' ' HD3' ' A' ' 19' ' ' PRO . 74.0 p 41.66 -153.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.898 . . . . 0.0 110.307 179.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.542 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 8.2 p-10 -135.46 61.94 46.82 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.15 -0.969 . . . . 0.0 110.759 -178.404 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 18' ' ' ASP . 12.0 Cg_exo -69.34 117.04 4.81 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.863 1.454 . . . . 0.0 110.411 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.9 63.69 0.88 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 176.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 27.6 ptm -89.92 -1.71 58.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.309 -1.112 . . . . 0.0 110.011 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.4 p -148.93 16.48 0.96 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.521 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.627 ' HD2' ' CZ ' ' A' ' 55' ' ' TYR . 45.5 mtm180 -128.29 147.22 50.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.978 HG13 HG23 ' A' ' 67' ' ' VAL . 85.2 t -117.95 122.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.942 -1.099 . . . . 0.0 110.494 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -98.01 120.46 38.45 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.037 177.598 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -139.95 172.82 12.22 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.233 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.576 ' N ' ' OG ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -89.94 178.91 6.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.611 -1.306 . . . . 0.0 110.883 -175.156 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 28' ' ' GLU . 86.9 mt-10 -59.91 -40.03 87.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.365 -0.834 . . . . 0.0 109.258 -178.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -50.07 55.76 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.311 -178.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.687 ' HA ' HD23 ' A' ' 33' ' ' LEU . 11.3 p -55.49 -34.63 64.75 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.145 -0.972 . . . . 0.0 109.566 177.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.54 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 40.0 ttm180 -81.18 -44.2 18.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.507 -0.746 . . . . 0.0 111.302 179.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -85.29 -10.02 56.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.915 -1.116 . . . . 0.0 110.81 -172.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.121 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.3 pp -57.01 -31.8 65.48 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.318 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.121 ' N ' HD12 ' A' ' 33' ' ' LEU . 15.4 mt -105.68 -79.83 0.56 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.145 -0.972 . . . . 0.0 109.782 172.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.41 16.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.559 -0.713 . . . . 0.0 110.31 178.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.54 ' HB3' ' HG3' ' A' ' 31' ' ' ARG . . . -66.61 141.5 57.79 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.982 -1.074 . . . . 0.0 111.072 -171.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.841 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.6 OUTLIER -133.63 -178.91 5.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.176 174.782 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 38' ' ' ILE . 38.0 mm -74.5 74.72 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.854 -1.154 . . . . 0.0 110.279 178.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.428 ' H ' HG11 ' A' ' 54' ' ' VAL . . . 172.23 -6.16 0.03 OUTLIER Glycine 0 N--CA 1.483 1.803 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.836 -169.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -107.96 159.95 16.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.292 -1.711 . . . . 0.0 110.773 -172.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.612 HG11 ' HB2' ' A' ' 161' ' ' PRO . 69.2 t -99.62 133.01 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.407 -0.808 . . . . 0.0 109.821 179.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 52' ' ' GLY . 5.1 m -109.72 143.56 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.424 -175.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' C ' HD12 ' A' ' 44' ' ' ILE . 87.9 tt0 -111.75 141.44 45.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.676 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.826 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.1 mp -119.97 147.12 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 110.442 -178.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' ARG . 82.2 tt0 -151.16 94.51 2.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.022 -1.049 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.012 ' CG ' HG12 ' A' ' 85' ' ' VAL . 8.7 tmtt? -98.88 -66.21 0.91 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 109.588 173.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.566 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -107.09 -33.99 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 175.928 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 51.5 mtt85 -133.21 -168.23 2.05 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.591 -0.693 . . . . 0.0 109.445 175.091 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.72 ' C ' HD21 ' A' ' 130' ' ' LEU . 5.9 mtmt -91.52 138.43 31.58 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.597 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.567 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -136.98 158.11 45.2 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.26 0.552 . . . . 0.0 109.963 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.543 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -122.66 160.99 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 110.004 178.475 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.653 ' O ' HG22 ' A' ' 42' ' ' VAL . . . -174.05 176.38 46.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 172.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 54' ' ' VAL . 34.6 ttm180 -111.78 171.32 7.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -1.047 . . . . 0.0 110.139 -178.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.841 HG11 ' O ' ' A' ' 37' ' ' GLU . 5.4 p -89.55 126.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.046 -1.034 . . . . 0.0 110.91 -172.051 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.627 ' CZ ' ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -123.32 167.22 14.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 175.523 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -99.25 126.38 45.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 110.088 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.568 ' HB1' ' ND2' ' A' ' 63' ' ' ASN . . . -64.16 137.45 57.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 178.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.674 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 6.2 mtt180 -59.05 -45.22 99.51 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 120.885 -1.135 . . . . 0.0 109.082 174.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.674 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 32.9 Cg_endo -92.97 98.39 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.794 1.418 . . . . 0.0 108.887 178.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 14.7 pt-20 -75.57 36.78 0.13 Allowed 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.485 -0.759 . . . . 0.0 110.855 -173.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 60' ' ' GLU . 74.1 m-20 -144.65 -38.84 0.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.855 -177.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 59' ' ' PRO . 12.2 pt-20 -84.21 -22.23 30.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.568 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 17.4 m-80 -81.65 39.44 0.54 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 110.542 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.549 ' HG2' ' OD2' ' A' ' 27' ' ' ASP . 61.2 mtpt -98.64 14.38 28.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.464 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . 177.49 24.69 0.03 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.795 HG22 ' HG2' ' A' ' 10' ' ' ARG . 46.9 pt -141.82 157.16 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -1.048 . . . . 0.0 109.246 175.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.978 HG23 HG13 ' A' ' 24' ' ' VAL . 2.8 p -131.55 129.98 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.037 -1.039 . . . . 0.0 109.935 178.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.529 ' HD2' ' HD2' ' A' ' 25' ' ' ARG . 81.6 mtt180 -96.78 120.11 36.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.054 -1.029 . . . . 0.0 110.681 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.955 HD11 HG23 ' A' ' 11' ' ' VAL . 3.0 pt -134.43 168.28 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.613 -0.68 . . . . 0.0 110.533 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 18' ' ' ASP . 26.2 p-10 -78.95 174.97 10.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.425 -0.797 . . . . 0.0 110.193 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.441 ' CA ' ' OE2' ' A' ' 13' ' ' GLU . 83.3 p -62.69 -38.52 90.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.714 -177.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.9 -43.38 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.134 -0.979 . . . . 0.0 110.359 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.533 ' CE ' HD13 ' A' ' 44' ' ' ILE . 7.6 tpt -59.99 -47.86 84.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.64 178.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.402 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 63.5 ttp85 -60.17 -40.11 88.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 109.964 174.143 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -71.35 -24.62 62.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.467 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 93.9 m-20 -60.13 -39.57 86.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 110.675 -177.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.505 ' C ' HG23 ' A' ' 47' ' ' VAL . 29.1 p -98.27 -37.85 9.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -176.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.566 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 118.07 36.56 0.94 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 176.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -112.5 161.26 16.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -1.205 . . . . 0.0 110.367 -176.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.608 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -109.65 166.01 11.24 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.263 -0.898 . . . . 0.0 109.296 176.622 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -51.09 138.16 8.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.04 -1.038 . . . . 0.0 110.553 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 83' ' ' ASP . . . 78.46 0.21 78.02 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 171.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 2.2 m-20 -56.05 -158.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.119 -1.224 . . . . 0.0 110.423 174.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 49.5 pttt -136.05 109.64 8.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.515 -0.741 . . . . 0.0 110.139 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.012 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -124.51 154.88 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.259 -0.9 . . . . 0.0 109.883 179.68 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 34.3 ttmt -100.65 125.51 47.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 177.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.601 HG21 HD11 ' A' ' 9' ' ' LEU . 74.1 t -99.51 120.79 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.991 179.372 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.48 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 99.4 mtt180 -109.67 157.48 19.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 110.007 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' O ' HG13 ' A' ' 90' ' ' VAL . 59.5 tttm -100.03 137.09 38.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 110.619 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.513 HG21 ' CG ' ' A' ' 161' ' ' PRO . 2.2 m -150.38 -169.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.636 -0.665 . . . . 0.0 110.369 177.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 34.7 mtp180 -133.75 179.98 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.378 -0.826 . . . . 0.0 110.426 177.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.61 HG23 HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -105.19 156.92 17.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.131 -177.259 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.618 ' CG ' HG12 ' A' ' 162' ' ' VAL . 13.5 pt-20 -150.26 169.94 20.17 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.18 98.63 8.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 110.398 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.99 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -56.02 135.41 52.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.367 -0.833 . . . . 0.0 110.262 178.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.533 ' CG ' ' HG ' ' A' ' 156' ' ' LEU . 1.0 OUTLIER -98.09 -27.79 14.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.016 . . . . 0.0 111.105 -178.809 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.527 ' HB3' HD23 ' A' ' 156' ' ' LEU . 14.4 ttpt -150.16 130.96 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.811 -1.181 . . . . 0.0 110.248 178.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.999 HG23 HG22 ' A' ' 155' ' ' THR . 9.4 p -138.31 140.06 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 110.95 -179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.516 ' OG1' ' OE1' ' A' ' 171' ' ' GLU . 90.3 m -106.1 133.94 50.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.53 -0.731 . . . . 0.0 110.02 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -128.34 160.0 33.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.495 -0.753 . . . . 0.0 110.502 -178.28 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.5 84.02 24.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 110.466 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 150' ' ' PHE . 29.2 Cg_exo -55.98 127.23 25.22 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.884 1.465 . . . . 0.0 110.356 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.749 HG23 ' HB2' ' A' ' 177' ' ' ALA . 72.7 mt -96.11 89.86 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.047 -1.033 . . . . 0.0 110.856 -177.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.509 HG23 ' C ' ' A' ' 103' ' ' ILE . 18.4 pt -152.59 -152.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.984 0.897 . . . . 0.0 110.424 172.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.533 ' HB2' ' CG ' ' A' ' 108' ' ' GLN . 54.7 mmm-85 -132.0 162.67 30.16 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.745 173.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -59.39 -22.57 61.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.1 -179.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 35.8 p-10 -118.91 28.68 8.14 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.677 -0.639 . . . . 0.0 110.473 -178.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.615 ' OE1' HD12 ' A' ' 142' ' ' LEU . 4.0 mm-40 -90.0 -80.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.032 -1.043 . . . . 0.0 110.294 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.852 ' HG2' HD11 ' A' ' 142' ' ' LEU . 31.2 mtm180 -107.9 -76.66 0.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 110.151 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.745 ' H ' HD23 ' A' ' 110' ' ' LEU . 2.1 pt? -130.34 160.04 35.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.954 . . . . 0.0 110.667 -176.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -92.12 171.65 8.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.691 179.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.701 ' CA ' HG13 ' A' ' 116' ' ' ILE . 13.3 m-30 -90.6 -62.74 1.39 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.134 -0.979 . . . . 0.0 109.824 -178.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 116' ' ' ILE . . . 90.16 165.0 40.29 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 173.061 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.05 139.94 54.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.511 -0.993 . . . . 0.0 109.576 179.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.35 5.62 77.82 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -175.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.701 HG13 ' CA ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -59.79 -32.45 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -1.181 . . . . 0.0 109.627 176.866 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 170' ' ' ILE . 98.8 mt-10 -60.02 -43.76 95.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.97 . . . . 0.0 109.968 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -66.28 -34.26 77.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 109.69 175.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -37.26 78.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.382 -0.823 . . . . 0.0 109.626 177.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.716 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.5 t -60.16 -47.83 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.177 -0.952 . . . . 0.0 109.888 174.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.762 ' HG2' HD11 ' A' ' 170' ' ' ILE . 0.0 OUTLIER -62.18 -40.05 94.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 0.0 109.849 177.631 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -59.93 -41.25 91.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.119 179.035 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.83 -40.09 23.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.672 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.639 ' N ' HD22 ' A' ' 124' ' ' LEU . 3.7 mm? -93.16 -0.88 56.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.109 -0.995 . . . . 0.0 111.091 -175.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.805 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.2 tt -47.92 168.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.861 -1.149 . . . . 0.0 110.242 -176.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' ILE . 31.7 ptt-85 32.96 48.29 0.13 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.703 -0.623 . . . . 0.0 112.119 178.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 124' ' ' LEU . 1.4 mmt180 -137.96 148.42 60.32 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.387 -1.446 . . . . 0.0 111.806 175.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.849 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 20.6 Cg_exo -62.9 132.69 38.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 124.321 1.695 . . . . 0.0 109.931 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.544 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 96.4 mmm -131.09 148.06 52.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 0.0 110.901 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.72 HD21 ' C ' ' A' ' 49' ' ' LYS . 15.0 tp -145.7 115.06 7.13 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.581 -0.699 . . . . 0.0 109.772 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 4.9 pt-20 -49.32 136.38 15.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.918 -1.114 . . . . 0.0 110.401 -176.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.615 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.14 -3.94 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.2 0.524 . . . . 0.0 110.273 179.749 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.555 ' OD2' HG21 ' A' ' 152' ' ' VAL . 1.4 p30 -68.04 -170.98 0.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.0 110.314 175.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.565 ' HB3' HD13 ' A' ' 149' ' ' LEU . 9.7 m-80 -150.94 134.46 16.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.476 -0.765 . . . . 0.0 109.445 178.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -140.28 165.7 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.908 -1.12 . . . . 0.0 110.713 -177.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.8 t -140.69 145.84 37.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.413 -0.804 . . . . 0.0 110.365 176.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.724 ' HB ' ' HD3' ' A' ' 138' ' ' PRO . 4.8 t -104.97 -48.39 0.13 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.339 -0.851 . . . . 0.0 111.065 179.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.724 ' HD3' ' HB ' ' A' ' 137' ' ' VAL . 73.8 Cg_endo -87.55 143.27 6.25 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.352 1.185 . . . . 0.0 110.222 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -101.1 46.52 1.29 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.91 156.47 48.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.306 -1.114 . . . . 0.0 110.371 -177.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 1.1 t -122.18 -162.19 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.126 -0.984 . . . . 0.0 110.594 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.852 HD11 ' HG2' ' A' ' 109' ' ' ARG . 89.3 mt -138.28 -154.67 0.54 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.788 -0.57 . . . . 0.0 110.097 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.92 64.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.49 -176.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 142' ' ' LEU . . . 57.75 66.19 3.01 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -176.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.416 ' NE2' ' CB ' ' A' ' 148' ' ' LEU . 5.0 pt20 -101.26 179.71 4.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.816 -1.402 . . . . 0.0 109.97 178.33 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -133.89 153.14 51.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -0.999 . . . . 0.0 110.639 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 82.6 -86.41 1.47 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.181 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.3 OUTLIER 40.19 36.29 0.31 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.477 -1.013 . . . . 0.0 111.078 176.916 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.565 HD13 ' HB3' ' A' ' 134' ' ' ASN . 3.3 pp -140.95 167.89 21.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.985 -1.072 . . . . 0.0 109.399 176.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 10.4 m-85 -89.69 118.62 29.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.927 -1.108 . . . . 0.0 109.721 177.404 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 109.95 22.02 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.555 HG21 ' OD2' ' A' ' 133' ' ' ASP . 3.4 t -75.96 135.64 26.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.705 179.026 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.531 HG21 ' NH2' ' A' ' 173' ' ' ARG . 43.2 t -114.8 -32.14 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.069 -1.02 . . . . 0.0 110.932 -176.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -148.35 139.22 23.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.967 -1.083 . . . . 0.0 110.673 -177.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.999 HG22 HG23 ' A' ' 98' ' ' VAL . 58.8 p -129.16 169.54 14.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.635 176.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.701 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 0.2 OUTLIER -89.16 -32.45 0.39 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 111.18 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.907 ' CG ' HG11 ' A' ' 162' ' ' VAL . 24.6 Cg_exo -56.29 -165.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.372 1.196 . . . . 0.0 110.237 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.723 ' O ' HG13 ' A' ' 160' ' ' VAL . 13.0 t -89.76 41.21 1.03 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.251 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 158' ' ' SER . 64.6 mttt 60.74 18.05 8.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.767 . . . . 0.0 109.657 -177.297 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.854 ' O ' HG13 ' A' ' 162' ' ' VAL . 14.9 m -108.18 160.0 28.58 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 110.089 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.612 ' HB2' HG11 ' A' ' 41' ' ' VAL . 1.1 Cg_endo -50.18 121.15 7.14 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 O-C-N 124.167 1.614 . . . . 0.0 110.266 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.99 HG21 ' HB2' ' A' ' 95' ' ' ALA . 6.2 m -129.73 159.45 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.619 176.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 43.7 tt0 -105.93 127.63 53.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.135 -0.978 . . . . 0.0 109.993 178.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.975 HD12 HG21 ' A' ' 168' ' ' THR . 11.2 mm -71.85 153.09 8.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.678 -0.639 . . . . 0.0 110.285 -176.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.527 ' O ' ' NE2' ' A' ' 121' ' ' GLN . . . -141.86 167.52 25.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.476 ' HB3' HD11 ' A' ' 125' ' ' ILE . 21.9 pt-20 -57.7 -19.62 28.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.42 -1.047 . . . . 0.0 110.322 -176.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -90.0 -9.99 46.63 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.228 -0.92 . . . . 0.0 110.023 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.975 HG21 HD12 ' A' ' 164' ' ' ILE . 46.8 m -63.76 151.65 41.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 176.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 96' ' ' LYS . 38.6 mmtm -96.64 163.05 13.18 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.085 -1.009 . . . . 0.0 109.767 178.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.762 HD11 ' HG2' ' A' ' 121' ' ' GLN . 18.4 mm -122.66 132.59 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.297 -0.877 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.516 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 58.4 mt-10 -124.17 133.27 53.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.577 172.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 120' ' ' VAL . 6.1 mt -137.46 139.37 43.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.517 -0.739 . . . . 0.0 110.306 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.531 ' NH2' HG21 ' A' ' 153' ' ' VAL . 10.1 ptp180 -88.86 159.46 17.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 110.304 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.486 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 99.1 mt-10 -98.16 7.25 46.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 110.365 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -96.76 109.03 46.6 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.861 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 12.4 Cg_exo -71.67 -155.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.171 1.616 . . . . 0.0 110.403 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -88.41 55.24 3.33 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.701 -0.624 . . . . 0.0 110.18 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 5.1 m -92.0 104.67 17.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 178' ' ' SER . 77.3 mm-40 57.43 19.89 5.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 109.934 177.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.99 -21.84 24.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.264 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 182' ' ' GLU . 2.7 pp -60.02 -44.04 94.86 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.407 -177.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.731 ' N ' HD12 ' A' ' 181' ' ' LEU . 88.6 tt0 -62.61 -51.03 68.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.0 110.318 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.06 -39.95 87.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.135 -0.978 . . . . 0.0 110.404 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.74 151.03 33.49 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -178.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 CA-C-O 118.004 -1.442 . . . . 0.0 109.507 -179.534 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 74.6 mtm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.237 0.542 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 1' ' ' MET . 97.7 mt-10 56.18 39.74 30.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.4 t -62.26 -40.07 94.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.238 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 89' ' ' LYS . 4.4 t-20 -112.3 121.06 43.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 110.259 179.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.689 ' HB3' HD22 ' A' ' 34' ' ' LEU . 96.0 m-20 -121.03 142.58 49.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.253 179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 87' ' ' VAL . . . -144.95 179.14 22.28 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 177.039 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.015 HG23 HD11 ' A' ' 34' ' ' LEU . 44.4 pt -135.34 159.04 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -1.177 . . . . 0.0 109.994 -179.402 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -101.17 120.01 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.354 -178.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.0 pt? -138.36 -171.8 3.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.351 -0.843 . . . . 0.0 110.255 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.522 ' HG3' ' HA2' ' A' ' 82' ' ' GLY . 32.6 ttp180 -101.65 133.39 46.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.232 -0.917 . . . . 0.0 110.915 -174.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.861 HG13 ' H ' ' A' ' 82' ' ' GLY . 11.1 p -62.82 129.83 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 110.257 176.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . . . -112.14 148.84 33.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.358 -0.839 . . . . 0.0 110.34 179.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.656 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.5 tt0 -179.21 140.02 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 176.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 15' ' ' ASN . . . -110.31 -0.53 17.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.403 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 87.0 m-20 56.48 38.97 30.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.315 -178.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.6 p -122.68 12.32 9.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.3 p -130.01 140.18 50.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 0.0 110.538 -178.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.725 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -91.05 -29.0 0.32 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.301 -0.874 . . . . 0.0 111.725 -178.47 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' A' ' 18' ' ' ASP . 34.3 Cg_exo -52.56 -168.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.132 1.069 . . . . 0.0 110.75 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.494 ' HA2' ' OD2' ' A' ' 70' ' ' ASP . . . 162.97 68.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.499 ' SD ' ' HD3' ' A' ' 23' ' ' ARG . 21.2 ptp -97.63 14.78 25.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -1.13 . . . . 0.0 110.273 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.04 40.01 19.15 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.273 -0.892 . . . . 0.0 110.212 -177.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HD3' ' SD ' ' A' ' 21' ' ' MET . 33.1 ptt180 -91.54 137.71 32.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.306 -0.871 . . . . 0.0 109.863 176.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.15 HG13 HG23 ' A' ' 67' ' ' VAL . 90.1 t -110.08 117.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.09 178.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.481 ' O ' ' OD1' ' A' ' 63' ' ' ASN . 1.3 ptm180 -96.81 120.56 37.37 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.981 -1.075 . . . . 0.0 109.909 178.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.671 ' H ' HD23 ' A' ' 26' ' ' LEU . 1.2 pt? -136.38 175.27 9.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.664 -0.648 . . . . 0.0 109.542 -175.39 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.558 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 23.4 p-10 -92.04 179.73 5.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.769 -1.207 . . . . 0.0 110.743 -175.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -60.08 -42.19 94.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.39 -0.819 . . . . 0.0 109.24 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 54.2 m -65.84 -55.89 14.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.074 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.603 ' C ' HD22 ' A' ' 33' ' ' LEU . 23.3 t -49.91 -30.21 9.73 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.739 -1.225 . . . . 0.0 109.564 177.235 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HA ' HD11 ' A' ' 26' ' ' LEU . 63.3 ttp85 -80.57 -48.86 12.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 111.327 179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -94.42 -14.66 25.02 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.712 -1.242 . . . . 0.0 111.611 -173.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.936 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.1 pt? -60.05 -28.71 68.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -178.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 7' ' ' ILE . 77.1 mt -103.36 -75.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.074 -1.016 . . . . 0.0 110.186 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 5.6 t70 -169.58 -25.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.605 0.717 . . . . 0.0 109.176 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' N ' ' HD2' ' A' ' 89' ' ' LYS . . . -35.52 119.38 0.52 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.4 0.619 . . . . 0.0 110.772 -179.094 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.473 ' O ' HG11 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -105.1 178.27 4.61 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.246 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 38' ' ' ILE . 19.0 mm -60.22 127.63 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 120.872 -1.143 . . . . 0.0 110.074 177.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.533 ' H ' HG12 ' A' ' 54' ' ' VAL . . . 77.55 23.36 67.78 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.717 172.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' OD1' ' OE2' ' A' ' 37' ' ' GLU . 81.8 m-20 -89.16 171.69 9.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.719 -1.459 . . . . 0.0 109.639 172.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.471 HG21 ' OG1' ' A' ' 92' ' ' THR . 76.4 t -98.92 129.3 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.09 -176.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.608 HG11 HG23 ' A' ' 54' ' ' VAL . 1.7 m -117.06 141.12 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 -175.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' C ' HD12 ' A' ' 44' ' ' ILE . 41.0 tt0 -109.78 141.74 42.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 177.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.873 HD13 ' HE1' ' A' ' 73' ' ' MET . 4.1 mp -120.46 151.29 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.816 -1.177 . . . . 0.0 110.559 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -150.71 93.11 1.91 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.311 -0.868 . . . . 0.0 110.353 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.022 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 9.1 ttpt -98.44 -65.13 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.703 174.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.017 ' CG2' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -111.82 -30.94 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.637 0.732 . . . . 0.0 109.264 176.112 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HB2' ' HA ' ' A' ' 77' ' ' CYS . 32.4 mtt85 -136.64 -171.52 2.93 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.714 -0.616 . . . . 0.0 109.372 174.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.736 ' HB3' HD21 ' A' ' 130' ' ' LEU . 7.0 mttm -88.31 136.94 32.74 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.986 -1.072 . . . . 0.0 110.459 -177.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.553 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -135.85 156.88 48.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.349 0.595 . . . . 0.0 110.296 -178.861 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 161' ' ' PRO . 0.1 OUTLIER -124.52 160.59 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.868 . . . . 0.0 109.793 176.999 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' O ' HG22 ' A' ' 42' ' ' VAL . . . 178.88 179.72 48.68 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.387 -1.387 . . . . 0.0 109.714 176.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -113.91 165.45 12.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -1.046 . . . . 0.0 109.985 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG23 HG11 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -89.33 139.99 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.016 . . . . 0.0 110.693 -173.576 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 26' ' ' LEU . 1.4 m-85 -125.29 161.38 27.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.504 -0.748 . . . . 0.0 110.443 175.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.43 ' CZ ' ' CB ' ' A' ' 56' ' ' ARG . 24.8 ttp-105 -93.62 127.02 39.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -0.835 . . . . 0.0 110.314 177.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 59' ' ' PRO . . . -65.9 140.0 58.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.578 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 4.4 mmm180 -56.78 -46.76 99.82 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.969 -1.082 . . . . 0.0 109.127 173.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 32.0 Cg_endo -91.57 98.33 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.997 1.525 . . . . 0.0 109.127 178.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.56 35.68 0.1 Allowed 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.641 -0.662 . . . . 0.0 110.765 -175.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -148.46 -34.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.515 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.37 -24.66 27.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.197 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.521 ' HB3' ' N ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -81.29 41.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.718 -0.614 . . . . 0.0 110.318 176.204 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 3.3 pttt -98.59 9.76 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 178.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -177.84 26.75 0.06 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 176.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 66' ' ' ILE . 46.0 pt -140.13 141.22 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.178 -1.189 . . . . 0.0 109.645 175.036 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.15 HG23 HG13 ' A' ' 24' ' ' VAL . 2.6 p -120.02 121.93 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.042 -1.036 . . . . 0.0 110.101 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 73.5 ttt180 -91.95 118.16 30.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 110.24 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.726 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.5 pp -130.01 160.04 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 110.41 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.494 ' OD2' ' HA2' ' A' ' 20' ' ' GLY . 96.1 m-20 -75.78 159.99 30.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.005 177.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.4 t -53.45 -29.95 38.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.913 -175.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.55 -48.53 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 0.0 110.121 -175.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.873 ' HE1' HD13 ' A' ' 44' ' ' ILE . 3.5 tpt -60.0 -45.14 93.72 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.707 177.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' O ' ' SG ' ' A' ' 77' ' ' CYS . 66.9 ttp85 -60.01 -40.09 88.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.778 174.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -69.93 -27.43 64.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.152 -0.968 . . . . 0.0 110.384 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -21.79 63.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 110.825 -175.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.493 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 18.6 p -101.78 -25.84 13.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.99 -1.069 . . . . 0.0 110.854 -178.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.547 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 98.0 23.47 13.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 176.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 1.022 ' HB1' ' HD2' ' A' ' 46' ' ' LYS . . . -109.02 -168.82 1.39 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.045 -1.268 . . . . 0.0 110.933 -172.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.575 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -127.61 170.17 12.95 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.656 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -61.49 144.59 13.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 0.0 110.324 177.164 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.861 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.74 -1.92 65.72 Favored Glycine 0 C--N 1.297 -1.638 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 172.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.512 ' N ' HG12 ' A' ' 11' ' ' VAL . 2.3 m-20 -56.62 -167.2 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.035 -1.274 . . . . 0.0 110.189 176.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 44.1 pttt -127.16 113.33 16.24 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.392 -0.817 . . . . 0.0 109.753 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.71 HG12 ' CG ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -121.15 158.13 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -177.122 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 85.2 tttt -110.03 125.54 53.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.729 175.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.527 ' O ' ' CA ' ' A' ' 6' ' ' GLY . 62.8 t -104.22 122.03 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.945 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 89.4 mtt180 -110.34 140.22 44.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 109.429 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 36' ' ' ALA . 11.0 tttt -84.77 138.95 32.3 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.077 -1.014 . . . . 0.0 110.237 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.423 HG13 ' ND2' ' A' ' 4' ' ' ASN . 2.0 m -150.05 -169.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 176.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 48.0 ptt85 -128.39 172.21 11.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.464 177.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.471 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -102.06 163.15 12.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.004 -1.06 . . . . 0.0 111.018 -175.773 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.554 ' CG ' HG12 ' A' ' 162' ' ' VAL . 19.1 pt-20 -150.04 169.57 20.92 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.028 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.81 99.13 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.723 -1.236 . . . . 0.0 110.373 -176.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.83 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.25 140.77 48.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -0.837 . . . . 0.0 110.564 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.71 ' CD ' HD23 ' A' ' 156' ' ' LEU . 29.3 pttt -105.36 -26.08 12.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 111.316 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.891 ' CB ' HD22 ' A' ' 156' ' ' LEU . 22.0 tttp -148.16 128.56 13.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.687 -1.258 . . . . 0.0 110.623 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.114 HG23 HG22 ' A' ' 155' ' ' THR . 7.5 p -140.86 148.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.371 -0.83 . . . . 0.0 110.558 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 154' ' ' LYS . 94.5 m -120.04 132.11 55.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.212 -0.93 . . . . 0.0 110.131 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.74 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -123.71 159.3 29.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.534 -178.53 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 173' ' ' ARG . . . -141.07 93.78 8.05 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.385 -0.822 . . . . 0.0 110.354 -178.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 23.7 Cg_exo -58.78 129.83 34.04 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.057 1.556 . . . . 0.0 110.32 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.09 HG23 ' HB2' ' A' ' 177' ' ' ALA . 88.4 mt -91.14 106.34 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.2 -0.938 . . . . 0.0 110.328 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.087 HG21 HD21 ' A' ' 110' ' ' LEU . 4.6 pt -142.87 -161.7 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 0.0 110.065 177.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.486 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 18.8 mmm180 -140.59 -161.62 1.23 Allowed 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.361 176.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -59.47 -12.31 6.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.817 176.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.561 ' O ' HD12 ' A' ' 142' ' ' LEU . 36.6 p-10 -99.61 28.43 4.67 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.846 -0.534 . . . . 0.0 109.956 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 1.081 ' CB ' HD12 ' A' ' 104' ' ' ILE . 15.5 pt20 -78.1 126.14 30.38 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.061 -1.024 . . . . 0.0 110.346 -175.091 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.72 ' HB2' HD11 ' A' ' 142' ' ' LEU . 12.2 tpt180 -95.16 -11.26 28.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.579 -0.701 . . . . 0.0 110.252 -179.035 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.087 HD21 HG21 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -97.97 67.5 1.94 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 109.914 -175.785 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 10.5 ptmt -129.64 127.03 39.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.53 -0.731 . . . . 0.0 109.508 176.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.622 ' HB2' HD13 ' A' ' 116' ' ' ILE . 28.7 m-85 -146.46 -55.92 0.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.131 -0.98 . . . . 0.0 110.657 -176.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 114' ' ' GLU . . . 75.72 -166.89 54.69 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -177.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 11.6 pt-20 34.64 97.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.649 -0.913 . . . . 0.0 110.624 178.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.85 -6.64 77.75 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 177.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.622 HD13 ' HB2' ' A' ' 112' ' ' PHE . 9.8 tp -59.99 -39.06 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -1.171 . . . . 0.0 110.11 177.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HA ' HD11 ' A' ' 172' ' ' ILE . 96.8 mt-10 -59.97 -41.74 92.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -35.21 74.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -0.853 . . . . 0.0 109.755 175.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.392 -0.818 . . . . 0.0 110.2 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.611 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -60.52 -45.17 97.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.346 -0.846 . . . . 0.0 109.821 175.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.624 ' HG3' ' CG1' ' A' ' 170' ' ' ILE . 5.9 mt-30 -60.01 -42.8 95.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 110.335 175.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -59.98 -46.56 89.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.405 -0.81 . . . . 0.0 109.953 -178.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.529 ' C ' HD22 ' A' ' 124' ' ' LEU . . . -70.17 -46.71 64.07 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.516 -0.74 . . . . 0.0 110.741 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 124' ' ' LEU . 4.6 mm? -100.76 8.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.075 -1.015 . . . . 0.0 111.827 -173.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.891 HD11 ' HG2' ' A' ' 166' ' ' GLU . 1.2 tt -49.12 165.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.56 -1.337 . . . . 0.0 109.852 -176.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.549 ' HA ' ' HG2' ' A' ' 163' ' ' GLU . 31.9 ptt180 33.31 45.98 0.09 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.428 -0.795 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 129' ' ' MET . 0.0 OUTLIER -128.46 134.24 26.06 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.044 -1.035 . . . . 0.0 110.589 179.046 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.829 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 6.6 Cg_endo -54.2 129.42 34.38 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.881 1.464 . . . . 0.0 109.942 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.56 ' HG3' ' CG1' ' A' ' 164' ' ' ILE . 97.8 mmm -126.53 143.13 51.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.568 -1.333 . . . . 0.0 110.929 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' A' ' 49' ' ' LYS . 13.6 tp -142.95 107.56 4.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 0.0 109.645 -177.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.606 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 2.2 pt-20 -46.24 140.34 4.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 0.0 110.822 -174.638 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.606 ' CB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER 83.2 -3.37 1.24 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.256 0.55 . . . . 0.0 110.343 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.529 ' OD2' HG21 ' A' ' 152' ' ' VAL . 2.1 p30 -69.86 -171.02 0.37 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.302 -0.874 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.49 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 15.6 m-80 -142.48 156.53 45.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.067 176.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -136.84 170.69 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.328 -177.612 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.8 t -102.91 164.24 11.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 110.308 -176.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.736 HG13 ' HD2' ' A' ' 138' ' ' PRO . 53.2 t -99.55 146.87 32.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.736 ' HD2' HG13 ' A' ' 137' ' ' VAL . 10.9 Cg_endo -59.6 66.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.256 1.661 . . . . 0.0 110.622 -179.689 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 137' ' ' VAL . . . 42.68 57.6 3.87 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 176.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.536 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -139.37 139.05 37.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.009 -1.289 . . . . 0.0 110.264 176.668 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.557 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -160.97 -169.04 2.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.847 . . . . 0.0 110.231 -179.51 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' A' ' 109' ' ' ARG . 82.6 mt -144.02 -135.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.473 -0.767 . . . . 0.0 110.004 -178.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 142' ' ' LEU . . . -54.63 -155.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 109.902 175.206 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.25 78.79 1.4 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 173.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -93.54 157.09 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -1.079 . . . . 0.0 109.919 178.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.9 t -119.53 146.19 45.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.945 . . . . 0.0 110.429 -178.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.748 ' C ' HD23 ' A' ' 148' ' ' LEU . . . 86.88 -88.69 1.59 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -178.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.748 HD23 ' C ' ' A' ' 147' ' ' GLY . 0.5 OUTLIER 42.15 48.01 4.09 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.48 -1.012 . . . . 0.0 110.942 176.864 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.614 ' CG ' HD12 ' A' ' 103' ' ' ILE . 1.2 pp -139.99 168.99 18.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.939 -1.101 . . . . 0.0 109.742 177.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.463 ' O ' HG13 ' A' ' 135' ' ' ILE . 10.9 m-85 -93.96 129.37 40.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.161 -0.962 . . . . 0.0 110.116 -178.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.49 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 24.4 tptm -114.72 107.81 15.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.944 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.529 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.9 t -76.15 135.93 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.943 . . . . 0.0 109.647 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.7 t -121.62 -27.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 110.934 -177.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 22.0 tttt -139.53 143.49 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.794 -1.191 . . . . 0.0 110.923 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.114 HG22 HG23 ' A' ' 98' ' ' VAL . 46.5 p -139.95 157.2 46.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.605 -0.685 . . . . 0.0 109.503 174.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.891 HD22 ' CB ' ' A' ' 97' ' ' LYS . 3.2 tp -88.97 -33.96 0.41 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 111.069 -177.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 1.048 ' CB ' HG11 ' A' ' 162' ' ' VAL . 15.3 Cg_exo -57.57 -165.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.38 1.2 . . . . 0.0 109.971 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.4 t -90.09 179.71 5.87 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.222 -0.924 . . . . 0.0 109.901 175.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -60.28 -7.68 2.11 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.257 -0.902 . . . . 0.0 110.903 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.39 152.78 58.37 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.498 -179.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.569 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 1.2 Cg_endo -50.24 141.77 30.52 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.402 1.738 . . . . 0.0 110.933 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 1.048 HG11 ' CB ' ' A' ' 157' ' ' PRO . 6.2 m -129.98 158.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 172.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 126' ' ' ARG . 86.9 tt0 -106.66 128.68 54.37 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.074 -1.016 . . . . 0.0 110.048 176.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.862 ' CD1' HG21 ' A' ' 168' ' ' THR . 13.3 mm -70.23 156.25 7.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.539 -0.726 . . . . 0.0 110.125 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.65 171.2 24.49 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.891 ' HG2' HD11 ' A' ' 125' ' ' ILE . 98.9 mt-10 -59.01 -25.7 63.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.264 -1.139 . . . . 0.0 110.118 -178.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.68 -11.2 40.47 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.151 -0.968 . . . . 0.0 110.494 -176.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.862 HG21 ' CD1' ' A' ' 164' ' ' ILE . 92.1 m -59.0 145.71 40.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.093 -1.004 . . . . 0.0 110.343 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 79.0 mttt -93.59 147.29 23.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.956 -1.09 . . . . 0.0 109.945 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.624 ' CG1' ' HG3' ' A' ' 121' ' ' GLN . 1.0 OUTLIER -121.61 141.35 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -178.184 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.411 ' OE1' ' OG1' ' A' ' 99' ' ' THR . 44.7 mt-10 -124.9 128.88 49.33 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 171.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 117' ' ' GLU . 2.7 mp -123.26 119.95 58.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.562 -0.711 . . . . 0.0 110.052 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.5 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 8.5 ptp180 -89.08 159.67 17.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.002 . . . . 0.0 110.443 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 174' ' ' GLU . 58.7 mp0 -99.98 10.0 42.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.993 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' A' ' 173' ' ' ARG . 11.1 tt0 -95.52 109.92 48.15 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.407 -0.808 . . . . 0.0 109.833 179.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 17.1 Cg_exo -68.51 -152.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.298 -2.09 0 O-C-N 124.202 1.632 . . . . 0.0 110.275 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.09 ' HB2' HG23 ' A' ' 103' ' ' ILE . . . -74.88 49.33 0.41 Allowed 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.551 -0.718 . . . . 0.0 110.435 -177.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 41.5 t -59.93 -65.59 0.65 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.307 -0.87 . . . . 0.0 110.75 -178.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -62.29 -11.65 16.27 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.031 -1.043 . . . . 0.0 110.499 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.572 ' HB ' ' HB1' ' A' ' 177' ' ' ALA . 39.1 t -90.16 110.06 21.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.513 -0.742 . . . . 0.0 110.106 -178.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 182' ' ' GLU . 0.7 OUTLIER -147.76 46.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -178.878 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 181' ' ' LEU . 69.9 mm-40 57.6 171.42 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.341 178.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -60.04 140.18 56.97 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.287 -0.883 . . . . 0.0 110.421 179.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -149.66 177.24 27.95 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 178.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.504 -179.961 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 75.3 mtm . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.234 0.54 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 1' ' ' MET . 99.3 mt-10 55.23 40.04 31.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.07 179.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.4 p -81.08 169.97 16.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.422 -0.799 . . . . 0.0 110.35 -179.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -89.47 109.98 20.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.273 -178.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.522 ' O ' HD13 ' A' ' 34' ' ' LEU . 98.6 m-20 -132.82 167.46 20.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 110.298 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 88' ' ' ARG . . . -145.78 -169.99 14.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 177.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.869 HD13 ' CD2' ' A' ' 33' ' ' LEU . 21.4 pt -132.54 154.38 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -1.133 . . . . 0.0 109.952 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 86.0 mt -94.91 119.17 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.95 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.814 HD11 ' HB ' ' A' ' 67' ' ' VAL . 1.4 pt? -136.03 -168.85 2.3 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.221 -0.924 . . . . 0.0 110.314 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' CG ' ' HA2' ' A' ' 82' ' ' GLY . 20.2 ttp180 -106.55 130.01 54.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.377 -0.827 . . . . 0.0 110.957 -175.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.973 HG23 HD11 ' A' ' 69' ' ' ILE . 11.5 p -62.53 137.71 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 110.461 175.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -120.91 156.58 31.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 0.0 110.245 177.418 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.53 ' O ' HD11 ' A' ' 81' ' ' ILE . 86.4 tt0 -177.44 136.88 0.2 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 110.368 177.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 13' ' ' GLU . . . 179.98 74.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 16' ' ' SER . 38.2 t-20 -161.57 164.96 29.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.445 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.467 ' C ' ' HG1' ' A' ' 17' ' ' THR . 60.3 p -70.8 166.4 21.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 178.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.467 ' HG1' ' C ' ' A' ' 16' ' ' SER . 74.6 p 44.65 -156.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.043 -177.244 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.4 p30 -132.77 65.85 75.19 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.118 -0.989 . . . . 0.0 110.768 -178.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 17' ' ' THR . 12.1 Cg_exo -68.42 128.48 17.36 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.916 1.482 . . . . 0.0 110.476 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.54 60.7 1.09 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.505 ' SD ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -90.6 -1.03 57.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.227 -1.16 . . . . 0.0 110.156 176.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.505 ' N ' ' SD ' ' A' ' 21' ' ' MET . 21.9 p -153.1 13.79 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.229 -0.919 . . . . 0.0 110.7 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.588 ' HD2' ' CE1' ' A' ' 55' ' ' TYR . 26.1 mmt180 -120.06 141.39 49.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -0.984 . . . . 0.0 110.476 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.873 HG13 HG23 ' A' ' 67' ' ' VAL . 95.8 t -114.52 119.99 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 177.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -97.41 119.92 36.84 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.959 -1.088 . . . . 0.0 110.035 177.403 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.027 HD22 ' CB ' ' A' ' 30' ' ' SER . 1.8 mt -140.78 177.75 7.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.551 -0.718 . . . . 0.0 110.154 -177.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' CB ' ' A' ' 30' ' ' SER . 28.1 p-10 -93.65 179.35 5.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.833 -177.281 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.99 -40.97 90.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.349 -177.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -68.83 -42.68 76.84 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.308 -177.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.027 ' CB ' HD22 ' A' ' 26' ' ' LEU . 57.7 m -59.95 -40.84 90.36 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.031 -1.043 . . . . 0.0 109.573 177.008 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.568 ' CG ' ' O ' ' A' ' 36' ' ' ALA . 52.3 ttp180 -74.19 -44.21 54.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.588 -0.695 . . . . 0.0 111.469 177.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -88.63 -11.61 44.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.88 -1.138 . . . . 0.0 111.07 -170.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.086 HD12 ' N ' ' A' ' 34' ' ' LEU . 1.1 pp -57.73 -32.59 67.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.775 -1.203 . . . . 0.0 109.559 -177.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.086 ' N ' HD12 ' A' ' 33' ' ' LEU . 17.1 mt -106.44 -72.65 0.71 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.122 -0.986 . . . . 0.0 110.475 175.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' C ' ' A' ' 36' ' ' ALA . 6.8 t0 -170.04 -27.68 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.503 -0.748 . . . . 0.0 109.717 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.789 ' HB1' ' NZ ' ' A' ' 89' ' ' LYS . . . -28.68 124.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.383 0.611 . . . . 0.0 111.455 -178.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.55 ' O ' HG11 ' A' ' 54' ' ' VAL . 2.6 pt-20 -113.48 -175.16 2.61 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 170.233 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 38' ' ' ILE . 19.3 mm -60.53 134.14 25.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.947 -1.096 . . . . 0.0 109.61 174.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.55 ' H ' ' CG1' ' A' ' 54' ' ' VAL . . . 79.77 14.62 80.74 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.237 172.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' ' CE ' ' A' ' 89' ' ' LYS . 87.0 m-20 -88.97 167.29 13.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.301 -1.705 . . . . 0.0 110.033 173.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.582 HG21 ' OG1' ' A' ' 92' ' ' THR . 50.1 t -99.71 129.08 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.046 -1.034 . . . . 0.0 110.454 -175.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.689 HG12 ' CD ' ' A' ' 89' ' ' LYS . 1.4 m -114.59 146.09 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.256 -0.903 . . . . 0.0 110.527 -178.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 49' ' ' LYS . 86.5 tt0 -112.22 144.27 41.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.41 -0.806 . . . . 0.0 109.35 177.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 44' ' ' ILE . 4.2 mp -117.18 148.03 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.948 -1.095 . . . . 0.0 110.586 -177.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -151.06 90.6 1.62 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.931 -1.106 . . . . 0.0 111.178 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.083 ' CG ' HG12 ' A' ' 85' ' ' VAL . 13.4 tmtt? -98.21 -59.64 1.71 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.031 . . . . 0.0 109.86 172.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.551 HG21 ' C ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -114.26 -35.52 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.744 0.783 . . . . 0.0 109.069 177.532 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 77' ' ' CYS . 83.9 mtm-85 -133.06 -175.99 3.97 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.657 ' C ' HD21 ' A' ' 130' ' ' LEU . 9.3 mttp -88.34 130.71 35.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.075 -1.016 . . . . 0.0 110.175 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.526 ' OG1' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -129.96 168.11 17.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.643 -0.66 . . . . 0.0 110.391 -178.703 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -125.81 162.55 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 179.392 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.561 ' C ' HG22 ' A' ' 42' ' ' VAL . . . -179.29 -176.97 47.41 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 176.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 54.9 mtp180 -123.38 -168.47 1.77 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.354 -1.086 . . . . 0.0 109.977 -178.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 37' ' ' GLU . 0.5 OUTLIER -111.09 131.61 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.06 -1.025 . . . . 0.0 111.202 -174.03 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.588 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -125.65 162.76 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 0.0 110.467 175.146 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -90.0 125.87 35.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.496 -0.753 . . . . 0.0 110.061 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB2' ' C ' ' A' ' 26' ' ' LEU . . . -64.62 139.75 58.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.075 -1.016 . . . . 0.0 110.035 178.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.662 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 1.2 mtp180 -58.51 -49.84 91.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 109.275 174.071 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' A' ' 58' ' ' ARG . 17.9 Cg_endo -91.53 99.46 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.812 1.427 . . . . 0.0 108.885 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.6 34.16 0.07 Allowed 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.527 -0.733 . . . . 0.0 110.857 -174.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 59' ' ' PRO . 12.4 p-10 -149.8 -30.77 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.099 -1.0 . . . . 0.0 110.674 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -84.47 -25.26 29.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.157 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.513 ' ND2' ' HB1' ' A' ' 57' ' ' ALA . 10.2 m-80 -81.25 40.07 0.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.774 -0.579 . . . . 0.0 110.554 179.082 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -97.81 11.71 36.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.035 -1.041 . . . . 0.0 109.553 177.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 9' ' ' LEU . . . -178.49 25.6 0.05 OUTLIER Glycine 0 N--CA 1.48 1.611 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 176.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.426 ' CG1' ' HA ' ' A' ' 63' ' ' ASN . 44.9 pt -140.11 141.21 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.131 -1.217 . . . . 0.0 109.508 174.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.873 HG23 HG13 ' A' ' 24' ' ' VAL . 7.6 p -120.38 129.04 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.107 -0.996 . . . . 0.0 110.16 -179.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 28.5 ttm180 -94.26 112.8 24.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.253 -177.043 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.973 HD11 HG23 ' A' ' 11' ' ' VAL . 2.4 pt -131.33 168.5 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.531 -0.731 . . . . 0.0 110.632 -179.191 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.506 ' OD1' ' HB2' ' A' ' 73' ' ' MET . 31.6 p-10 -81.8 176.15 9.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 177.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.2 p -70.01 -29.1 66.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.272 -0.893 . . . . 0.0 110.671 -177.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.7 -47.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.069 -1.02 . . . . 0.0 110.42 -176.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.709 ' CE ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.62 -43.45 97.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.953 . . . . 0.0 109.515 178.965 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' NH1' HG13 ' A' ' 81' ' ' ILE . 45.3 ttp180 -60.02 -41.08 91.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.935 173.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -69.95 -24.29 63.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 73' ' ' MET . 95.6 m-20 -60.0 -37.46 79.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.011 . . . . 0.0 110.633 -177.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.479 ' C ' HG23 ' A' ' 47' ' ' VAL . 30.0 p -98.26 -33.36 11.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.034 -1.041 . . . . 0.0 110.439 -177.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.551 ' C ' HG21 ' A' ' 47' ' ' VAL . . . 113.94 26.75 3.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 176.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.626 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . . . -103.58 168.54 9.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -1.14 . . . . 0.0 110.275 -176.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.917 ' O ' HG11 ' A' ' 11' ' ' VAL . 0.6 OUTLIER -115.72 177.97 4.48 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.569 179.273 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.53 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -64.32 140.27 19.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.028 -1.045 . . . . 0.0 110.532 178.414 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 11' ' ' VAL . . . 77.15 -3.35 58.3 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 173.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.548 ' N ' HG12 ' A' ' 11' ' ' VAL . 1.1 m-20 -58.08 -167.44 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.913 -1.345 . . . . 0.0 110.303 175.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 19.1 pttp -128.36 111.58 13.5 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.885 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 46' ' ' LYS . 1.2 m -118.37 155.42 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.377 -0.827 . . . . 0.0 110.251 179.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 37.7 ttmt -100.24 123.6 44.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -0.968 . . . . 0.0 109.837 176.055 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.795 HG23 HD21 ' A' ' 9' ' ' LEU . 80.3 t -102.28 123.65 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.933 178.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.524 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 91.4 mtt180 -111.97 148.2 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.581 178.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.789 ' NZ ' ' HB1' ' A' ' 36' ' ' ALA . 10.5 tptt -100.0 130.04 46.12 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.015 -1.053 . . . . 0.0 110.049 -179.086 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.06 -166.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.596 -0.69 . . . . 0.0 110.15 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -129.12 171.46 12.38 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.543 -0.723 . . . . 0.0 109.67 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.582 ' OG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -107.43 159.97 16.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.023 -1.048 . . . . 0.0 111.117 -174.618 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 157' ' ' PRO . 19.6 pt-20 -147.8 173.46 12.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.5 mm -89.2 105.73 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.821 -1.175 . . . . 0.0 110.267 -175.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 162' ' ' VAL . . . -57.2 139.24 53.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.974 ' CG ' HD23 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -101.34 -30.48 11.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.7 178.212 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.769 ' HB3' HD22 ' A' ' 156' ' ' LEU . 23.6 tttt -150.03 128.76 12.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.878 -1.139 . . . . 0.0 110.493 -179.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.043 HG23 HG22 ' A' ' 155' ' ' THR . 9.9 p -139.92 143.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -0.869 . . . . 0.0 110.384 -178.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.628 HG23 ' HB3' ' A' ' 171' ' ' GLU . 54.6 m -114.79 138.36 50.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.127 -178.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -133.42 165.43 24.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HB2' ' HG2' ' A' ' 173' ' ' ARG . . . -144.16 99.97 4.96 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 110.605 -177.112 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.478 ' HD2' ' NH1' ' A' ' 173' ' ' ARG . 28.3 Cg_exo -56.1 138.25 82.15 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.887 1.467 . . . . 0.0 110.239 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 38.5 mm -99.06 102.81 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.152 -0.967 . . . . 0.0 110.762 -177.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.848 HD12 ' CB ' ' A' ' 108' ' ' GLN . 4.1 pt -144.62 173.46 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.059 -1.026 . . . . 0.0 110.244 171.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.545 ' O ' ' HG2' ' A' ' 108' ' ' GLN . 95.2 mtt180 -129.41 -138.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.994 -178.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -58.62 -12.34 4.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.932 -1.105 . . . . 0.0 109.735 175.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -98.3 26.23 5.58 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.634 -0.666 . . . . 0.0 110.062 177.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.848 ' CB ' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -83.06 95.6 8.1 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.072 -1.018 . . . . 0.0 109.563 177.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 109' ' ' ARG . 14.0 ttp180 -107.06 -8.54 16.5 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.438 0.637 . . . . 0.0 109.974 -178.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.84 HD21 HG21 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -97.7 61.98 1.63 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.392 -0.817 . . . . 0.0 109.661 -176.13 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 10.9 ptmt -97.33 120.91 38.56 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.58 -0.7 . . . . 0.0 109.41 176.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.729 ' HB2' HD12 ' A' ' 116' ' ' ILE . 11.0 m-85 -95.93 -41.53 8.75 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.115 -0.991 . . . . 0.0 110.42 -174.062 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.448 ' O ' ' HB ' ' A' ' 116' ' ' ILE . . . 77.97 -157.8 45.6 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 113' ' ' GLY . 21.9 pt-20 -39.1 142.16 0.25 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.719 -0.871 . . . . 0.0 110.15 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.43 -16.03 42.19 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 178.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' A' ' 112' ' ' PHE . 20.9 tt -61.83 -39.45 83.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.107 -1.231 . . . . 0.0 110.096 174.276 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.657 ' HA ' HG21 ' A' ' 170' ' ' ILE . 95.6 mt-10 -60.01 -42.82 95.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -65.86 -40.02 91.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.843 . . . . 0.0 109.607 174.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -60.57 -39.97 89.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.471 -0.768 . . . . 0.0 109.916 178.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.686 ' CG1' HD12 ' A' ' 170' ' ' ILE . 54.6 t -60.09 -47.67 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.889 176.076 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.656 ' HG3' HD11 ' A' ' 170' ' ' ILE . 5.3 mt-30 -60.02 -43.78 95.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 176.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -59.99 -43.28 95.25 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.45 -0.781 . . . . 0.0 109.887 -176.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.59 60.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.56 -0.712 . . . . 0.0 110.597 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 47.9 mt -94.33 -4.7 48.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.067 -1.021 . . . . 0.0 110.928 -171.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.741 ' HA ' HG22 ' A' ' 164' ' ' ILE . 2.4 tt -45.51 166.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.883 -1.136 . . . . 0.0 109.962 -172.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 164' ' ' ILE . 35.6 ptt180 33.45 46.72 0.12 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.7 -0.625 . . . . 0.0 111.578 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.489 ' HB3' ' O ' ' A' ' 124' ' ' LEU . 9.0 tpp180 -134.13 135.3 24.02 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.73 -1.231 . . . . 0.0 111.547 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.841 ' HA ' ' O ' ' A' ' 162' ' ' VAL . 11.1 Cg_endo -59.51 124.19 14.96 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.989 1.521 . . . . 0.0 109.526 178.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.458 ' SD ' HG13 ' A' ' 164' ' ' ILE . 20.0 mtp -132.1 147.44 52.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.361 -1.462 . . . . 0.0 111.269 -177.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.657 HD21 ' C ' ' A' ' 49' ' ' LYS . 2.1 tp -148.36 115.95 6.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.649 -0.657 . . . . 0.0 109.23 -176.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.598 ' HB3' HG23 ' A' ' 155' ' ' THR . 0.7 OUTLIER -40.43 156.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.052 -1.03 . . . . 0.0 110.514 -174.412 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER 70.58 -3.49 1.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.812 -0.555 . . . . 0.0 111.202 179.483 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.656 ' OD2' HG21 ' A' ' 152' ' ' VAL . 3.9 p-10 -70.18 178.64 2.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.925 -1.109 . . . . 0.0 109.882 173.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.455 ' OD1' ' CD ' ' A' ' 151' ' ' LYS . 20.0 m-80 -145.26 140.96 28.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 109.807 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -139.97 161.76 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.022 -1.049 . . . . 0.0 110.432 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.0 t -140.62 146.57 38.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.583 -0.698 . . . . 0.0 110.227 178.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.648 ' HB ' ' CD ' ' A' ' 138' ' ' PRO . 18.2 t -119.34 -67.67 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 111.088 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.648 ' CD ' ' HB ' ' A' ' 137' ' ' VAL . 42.3 Cg_endo -71.83 147.12 49.45 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.192 1.101 . . . . 0.0 110.559 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -117.92 54.93 0.59 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.1 pp -129.97 156.18 44.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -1.224 . . . . 0.0 110.335 -178.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -146.11 -169.52 3.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.189 -0.945 . . . . 0.0 110.795 -179.44 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.762 HD21 ' NE2' ' A' ' 145' ' ' GLN . 0.3 OUTLIER -143.63 -111.15 0.11 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.805 -0.56 . . . . 0.0 110.144 179.122 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.5 52.37 0.96 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.0 110.548 -177.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.71 71.4 0.78 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -177.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.762 ' NE2' HD21 ' A' ' 142' ' ' LEU . 2.0 pt20 -94.85 169.96 9.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.857 -1.378 . . . . 0.0 110.238 178.026 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.9 t -138.48 151.03 47.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.322 -0.861 . . . . 0.0 110.476 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.576 ' O ' ' HG ' ' A' ' 148' ' ' LEU . . . 101.05 -95.8 1.44 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 147' ' ' GLY . 0.2 OUTLIER 39.76 40.2 0.64 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.556 -0.967 . . . . 0.0 110.913 175.727 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 149' ' ' LEU . 4.2 pp -140.52 169.73 17.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -0.95 . . . . 0.0 109.538 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -90.27 128.25 36.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.021 -1.049 . . . . 0.0 109.904 178.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.455 ' CD ' ' OD1' ' A' ' 134' ' ' ASN . 29.0 tptp -109.3 106.52 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 110.12 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.656 HG21 ' OD2' ' A' ' 133' ' ' ASP . 2.8 t -76.75 140.19 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 109.918 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.41 -23.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 111.242 -176.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 99' ' ' THR . 49.2 tptt -149.07 142.04 24.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.743 -1.223 . . . . 0.0 110.684 -176.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 1.043 HG22 HG23 ' A' ' 98' ' ' VAL . 72.5 p -140.02 160.01 40.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.497 -0.752 . . . . 0.0 109.372 176.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.974 HD23 ' CG ' ' A' ' 96' ' ' LYS . 10.8 tp -89.48 -29.17 0.35 Allowed Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.163 -0.96 . . . . 0.0 111.44 -175.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.944 ' CG ' HG11 ' A' ' 162' ' ' VAL . 35.5 Cg_exo -53.78 -170.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.086 1.045 . . . . 0.0 110.5 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.601 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -89.85 41.35 1.04 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 110.433 -178.254 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 158' ' ' SER . 37.1 mttt 62.31 19.95 11.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.452 -0.78 . . . . 0.0 109.851 -177.3 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.781 ' O ' HG13 ' A' ' 162' ' ' VAL . 20.0 m -110.37 160.04 29.89 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.495 -0.753 . . . . 0.0 110.057 178.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.541 ' HB3' HG12 ' A' ' 51' ' ' VAL . 5.3 Cg_endo -53.1 122.24 10.79 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.123 1.591 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.944 HG11 ' CG ' ' A' ' 157' ' ' PRO . 3.9 m -127.07 155.26 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 110.437 178.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -100.47 126.21 46.87 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.282 176.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.919 HD12 HG21 ' A' ' 168' ' ' THR . 12.8 mm -70.39 153.21 8.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.722 -0.611 . . . . 0.0 110.005 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.98 168.79 25.9 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 176.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -57.13 -21.77 34.94 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.231 -1.158 . . . . 0.0 110.229 -176.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -90.53 -10.74 42.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.715 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.919 HG21 HD12 ' A' ' 164' ' ' ILE . 93.5 m -59.81 143.45 51.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.057 -1.027 . . . . 0.0 110.241 -179.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 97' ' ' LYS . 86.4 mttt -90.02 149.22 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.032 -1.043 . . . . 0.0 109.892 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.686 HD12 ' CG1' ' A' ' 120' ' ' VAL . 4.5 mm -115.42 130.06 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.846 -177.271 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.628 ' HB3' HG23 ' A' ' 99' ' ' THR . 20.8 mt-10 -111.92 128.38 56.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.165 -0.96 . . . . 0.0 110.316 171.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.477 HD11 HG21 ' A' ' 120' ' ' VAL . 39.2 mm -123.37 127.86 74.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.194 -177.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.603 ' CD ' ' O ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -89.58 152.38 21.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.877 . . . . 0.0 110.468 -179.136 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 98.9 mt-10 -97.4 0.51 47.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.295 -0.878 . . . . 0.0 110.7 -178.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.603 ' O ' ' CD ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -97.88 107.8 42.42 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 0.0 109.938 179.137 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 174' ' ' GLU . 20.6 Cg_exo -66.84 -155.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.944 0 O-C-N 123.837 1.44 . . . . 0.0 110.821 -179.287 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.96 54.98 3.1 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.766 -0.584 . . . . 0.0 110.047 -178.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 179' ' ' GLU . 31.0 p -98.57 120.16 38.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.424 -0.797 . . . . 0.0 110.062 178.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 178' ' ' SER . 97.8 mt-10 59.97 20.0 9.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.445 -0.785 . . . . 0.0 110.111 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 178' ' ' SER . 94.4 t -99.84 -3.78 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.445 -0.784 . . . . 0.0 110.509 -179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.688 HD12 ' O ' ' A' ' 181' ' ' LEU . 1.1 pp -80.12 60.11 3.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 0.0 110.005 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -80.24 -11.06 59.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.335 -179.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -59.99 140.07 57.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 109.944 -177.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.82 -168.54 21.07 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.588 . . . . . . . . 0 0 . 1 stop_ save_